<SEC-DOCUMENT>0000927653-21-000039.txt : 20210512
<SEC-HEADER>0000927653-21-000039.hdr.sgml : 20210512
<ACCEPTANCE-DATETIME>20210512160957
ACCESSION NUMBER:		0000927653-21-000039
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		147
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210512
DATE AS OF CHANGE:		20210512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		21915160

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mck-20210331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:0a91717b-5b9a-4470-a716-9c00214a8bdd,g:f2a8631c-ae82-4a44-9090-35d7005e9a98,d:08f9baf810c0412e93ea6effc6d22995--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mck="http://mckesson123.com/20210331" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml8zLTItMS0xLTA_b7fe1024-d890-4154-ad12-8d509e2c1ec6">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml85LTItMS0xLTA_b47ac418-8bec-4ead-888a-e47f32a9e432">FY</ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml8xMC0yLTEtMS0w_a5fb761c-ad32-49ee-ae5a-874cb3b45b21">2021</ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml8xNi0yLTEtMS0w_79cc2838-9035-47be-b610-613ba364e09f">false</ix:nonNumeric><ix:nonNumeric contextRef="i53d8a73c06cb4aeab2d0b96b4bc01eaa_D20200401-20210331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ic14d146f7e5242688d6fe3f6efc8e39d_D20200401-20210331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NDY_e4780d27-ecc2-4ddb-b012-e0b781a25964">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="idae8b11cffbb4c71a6764d8f5f1dd25b_I20210331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ib2785c217ff445e9ac72874428f97a52_I20210331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i3dc566d0125146099a9b13ba87eab912_I20210331" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i8e804c1181df47ba96ad8f1464e4cb0b_D20200401-20210331" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYwNw_af6d397b-2d02-4293-8753-eb30ffd6bb25">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="idaa61cae38f84791aeb5726163d539c5_D20200401-20210331" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY2NQ_b7165f1b-8051-446f-8b5c-d34606827cfc">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A0.625notesDue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9650e19e52e846e28fe7e52623004983_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3.125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9e194b3a461f4ad28b6e6b95517ccd7d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5dbd0bda906d4b768524dcfc6aadc6cd_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d8ec19e753d451794e088409f68157c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ff0501dacd84f6d9a8a0874bbdc5b3c_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i694f7a1a7fe8492981ba38c56efece34_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa47717062f4d0faa776c2def60876c_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7f6d03c0214b888f11ce73ebb56fd5_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d5e858b51e4d099bb4436a00d94e8a_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae70566f5363452bbc98260415fc04bd_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i022a2642b16245d083cb80c539e560b3_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b7fb92a6f244829cf78e65a255ee88_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8246b55c8e504364a5c352ba370995ad_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a514ba214224efd98713a38fa41dbe7_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8bfcf07f30410981669a5bf1af7c02_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58e169e9c83f487291f51edc0b6c3ae1_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93dcfcc89c2542b0928b50c7d3e432c2_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36dce71a26114b94909aaa9ba795fdb2_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b14f9878614f92a269ff6fccb37f69_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib174f082f2e349489ff2dd2b20330381_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd683332b3f4798998789f66099e34e_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ccd14692cf3450cb539e1a2cf941e8d_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f6cfedc37948ddbaa4a17a60061842_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84e4eb45170844d593b83b2afa4fab92_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48ceaabbb16f4ec6b0bf0f94817e2803_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id46086fa9b504b8fa9969e5e6955dfca_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1dcb375e934b61af2234db5c9acb4f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51ee753b2d3f41df8075fc700e912fd6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40ae5de5a7ed451daaf6f336a3613e5b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3195958993f542039d26aa1dc1a5932a_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4544e477b1841a4bdb6022ce255ba46_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c41e20baa14761a136adaf102659bb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0a498773ac34aab9e6acb8ed6ca7397_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6cd908e9ae944c589f15bfc5295981c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127912e4703a4c4b93b3568d503e21a8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8b8e2f7e988499db2ca37a472ba95a1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5501cbeadb6d4216937dff20e26e9da7_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6fff2a93e148f184cb8d32b86c426e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7317175ef4774a10ab306d8ad80b27be_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa843649b4b43898ba141c6242d8f29_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ca8bc8a3df45a680bddb6d68e1a14c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16590f20bcb54d93a46c868388bd8b15_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i818384a7497d4ec3b819a10a8009bce7_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0854da8f001b4fb5b20e5b1a8e5cca76_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bd1bf93b1f14f26ac73ea236f36768e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f8f7c8825848e3b9c0073f40137455_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieace64892e6e4c64b170a9943f943cff_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06dd26a3871a4b7ebada11dbaa7622fe_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a5bbb75dc3b4b22a7678ca731073aea_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia36cd1fb5104458194118cf1f7a5b4e5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6c63db23ba743c9a62c831ddf5c11fe_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47ce9e7fee2540b681fbd42059c7386b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bbfa761b88c4adcbd3850e152c97132_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i405042e0c105499e829dac8d3ddb2458_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id919c60b59754f78a678ad703c842d1b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i209c6d9d06f94525a18e4a67e9b962a5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice9f595a7fdb4b7cbdd8bf02e8444022_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e42c0d706c481b84e088c5d5c7d229_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e9843c614c4c8790797c45327bd623_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460cb8fdc68d4e3ab755d83b3ce58795_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5bccaa8d2ae4c7dab8a934455b32ae4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23d25bd272041a8865720072fc8a546_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i164671a6fa094474b24478df67ffb27e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2be497f4e442e0a366c6eda71cc339_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aece504dbcf4457aacac81f8f54a390_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i703f281903e14c92bc829e04ebb959ad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6290fbbe29f84c1db97283a012272162_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0516ac692388404c8f088c9e1ab4cc78_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb86a9ba62104883927379cb8bd96649_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9384c8d2c240451493d40ead28d2d250_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13f69d981df240f483b999053f8a2547_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a6bb29286494ed2aec32dd02ab9445e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="iea92921488274912b519ed84b11ab23f_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>mck:customer</xbrli:measure></xbrli:unit><xbrli:context id="i3130d916740b4d2393240ae5139a6d53_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1a9fca715b904e98b76ea386572b0b03_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f771eff0414af9b947ca5a7031556b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1eb1f08e1664c6cb53a8da1be89cca7_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d8e2f4787a4d32a764107acdbc0c3f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f49f517b19c4c2794bc573c91dfd166_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddad10a5e1484e3ba28181133cb79477_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7262554200c4a4687b065b0139747a9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b15db7a10914e64aff0c0319c0b1858_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dfc9a103be247469a824e16d2593cc4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie77f379fcbbf4fabbb3643c1b75c74a4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d8a73c06cb4aeab2d0b96b4bc01eaa_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia82280b01acd4961b7aae7ec8926f663_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76008cf481ff411789c581d87a72f149_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bb50cd186cb4d44ac0d335a56971982_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b5a4c9debc4c86ab2c641342640b2b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bdf98ffd5304512a88b518b82d6beb4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife3b4b3b997b40d1a537f1ca3f6bb09e_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60451fdfabe047148d4b51b02b328315_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b559a4e264f45ee945d6b0221a18668_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i654d1dad39ce486b88ccef35f4514f39_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7818cbb3de24ccbb1dac5ff7b38d12d_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia627eaf413b944f6b1c661f64f89cf46_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i259565e15d4a4094b3aced351e91b60f_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac6925e5e124f20b294923d15d675f7_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361b795666d34b31b8211423ea941c60_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5bd022186748f590c69707cd4dd76e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedbe6776c92141caaf1984304c817a24_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd00748603f4a9080c3102d09966644_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb31c3511004f7bb84b6fba7982478b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e6a6da26e9b4155a7aabc172f840db7_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30576561fec8410d980f65c38dfcecbd_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd767dd763314f3aad75379a29aafa5f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9433d8dd83764dfea4d20d7175cc58c0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1030ca9e1fc410c8e4ba04e704c20ad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e9b372ac3ef458da34c6cb29ae83063_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d40932572f640b9bcc963fb3703530a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26588b430f834252bbb0d603ebc07230_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i042fc3b5ed1f4aa3a5c7fc3404044ced_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b846dbf18184734b8d20351ecc09b72_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i841091b6641c4e1fa2288424caf2b82f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c09144465e346119dd58fd135e50dc7_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e4b982be8b4c07a12efc2fd23a51a9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f50743c2174eb7a016ece0cb708476_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaaa8cff6eb04a468bc164e1f8da8570_D20191212-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-12</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea5796edba9442e6b00a331d1b1e9822_I20210512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icefee79d5ff5443ca7262dbcfe111692_I20210512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfff1c8522e849f6b8c9ddbfa45a1161_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46055f5e4516432ba38d8c9b9db6958f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i912d8febc0b34abfb3c6779710303600_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de6ea66ebe14d0aa48b24590c1d9d98_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7c3bcfde504c2e81c6aeef0f7c2335_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c5f4c8c13a414ca948dcf78225083b_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07b3c611cb044e9f8e830461fdf3567b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i321f8a74eae848a98872fbdb652c3f4d_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1bb20faa42444db36850f067394ea5_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0577d068867b4047b8f768bd9973668f_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80ffc4dde20a400090fcecd0cd478cc8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i873585d906e0415888503e1bd163b490_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf5263ca156f4aaf9c2116924eccdf08_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93911baafae14119b73921f40093ba4c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i092c23031111426996897acf81001bca_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1294e78624d84a32b4b75b80df724f52_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a7bd3f5bbee48eaa0f146d217a2f213_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80b896d088b49df9c9446e7f21d4353_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb32341a67694453bf4b80c090e9acd1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81dcf14d4c484311a890c1aa873abcc5_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b443c41cb334b4084c134a614b5a4aa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc2495d4fd44412ae23a2d9511fc6b0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d6c47ebd084b828cdbdba1b8f159f8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44f353b74f6e48ea8c63365f74249445_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36b955ce23d4198b6aa3769dcf60d35_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3156368b6aea45b4b87b5079622f2703_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie781b28ab2254939ac913ef650232aa3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d7e3dfff1504af6a6970090a4e7c85f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbfa7f443c9f4c30be51cebaefbd7dd1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07652793af6e402c8f56ae5bf525de5d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8770b26e8a104e24a96561be14d9b01f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47cb8d8061744a318fce0b3384617786_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33bc232cff8a4f12a4e890a4672e8218_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90e94470ed16447396b9f1012b944606_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f8ead53d3e4be5b9320bb684b9f13a_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fc5fdf86d854199b0de26fe3d7aef0b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f79d90a93144c60981f623c356fc6bf_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d5408029404b5aa8938a311b6434f3_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:IntangibleAssetandStoreAssetsImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a36ca67ff5f42bbbbcf4d6660b6af27_D20180601-20180601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:MedicalSpecialtiesDistributorsLLCMSDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-01</xbrli:startDate><xbrli:endDate>2018-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60d887dd975b47fcb23c06b79e73a02a_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:MedicalSpecialtiesDistributorsLLCMSDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca54959e5e04b8c9414f83bc32f7efe_D20180601-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:MedicalSpecialtiesDistributorsLLCMSDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1182c1c4af8746449b50307d67f448c1_D20170403-20170403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-04-03</xbrli:startDate><xbrli:endDate>2017-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3088cf57426d4c8e9292e7c571001c3b_I20170403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616817b40eb74cfb8ae329d9816e7420_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id07b7f77830b43c69cfefaf0b8e7b960_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia99cfa38235e449aa90c06cd0c7c8a59_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia84584b6586641aaa11065062b0d4dcf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68df8813101f4e9ca695e42eb2c1ba7b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e93491e63641d6a447af76bfba5be9_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74e9a04c993b47eea348dc69be94ad03_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33ea0a3bee2a42b3b14918ca313d0f3f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7752154a30be4b70b7c200da7c5e0314_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2875e0d883e04e789a166269b0168d5f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d6d0051e254f03868cd2b4c4a08616_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb3af9567d84570a2e07fa7cc1ca3e8_I20130731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ea335282264bd19c87da915b541a3d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic14d146f7e5242688d6fe3f6efc8e39d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bca6f61ec8d4af0a1acb791483f3894_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d84699d924747a3b932295e7377ba8c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dc1c1e592264d43b77791466a65bd52_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5481893297be481981506a5801e443ba_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PeRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9c17219d084d969cda29f0f32fcdaf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00b9e27715eb4321801361f74b4928b1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98600c393115470c98af4ebaf984768f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac7d90041b41485e9c066b6c9648022c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8db5d79f8f98449ba80a73798cc2250c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabba4ee1a62b45e6bbc176b0dc8941b3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i521d39c0b3084c2d99a90fc226922cdd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79ee321ad30d41dfad64c6a2f32533ec_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5415cd5dc724d9b839b382de490cae8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad526e199d5f45e8b0138cf1dc4218d3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbba704ea17245a79664996d4d4b9fb9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:SettlementofExecutiveRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2be0b266e4404fb2d3170fc25c0e2d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:PendingAndFutureOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8758a2f6ea4f4877a3355c52d963a658_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be1b4de02944aa881e317723693e477_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8132f157c2a4e22b4c467d61f9c078e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9c0a94c8b144ce82c5a2e1c8a76a41_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i864d4657d9144642ae333aa935acbc46_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061bc9a2eb8443769ce87eeb86b06600_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd3e34ab71b46dc924bf5b41dcdda09_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7aa6fa69f9c4cda930b030fe075c224_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5de4bf26a814949a75f192c559706a9_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f55ef7798384062876c3372deac9867_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i587fb85617b64a75ac242f855f331d8c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc43acfc0194bbeb7cffc75f3ccb983_D20180919-20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-19</xbrli:startDate><xbrli:endDate>2018-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78e6c9a100924eb4a8e0c5dfffff754e_I20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39fe8b1ce4de400880c9ed586d6d03db_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f5f4ec4cae4f6e9da1a608fe5d9874_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e4424a4e7440b9964b4ce2f73e59a5_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76995eaf2114e8d988d829663827be2_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeede0913be2432eaa8dd89edabc33b8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340398f3d8eb427ab2285890104702d2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b9841e941249b08fc5e771cceb886b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6f0649588c42f2bdddd0e48e3b2d52_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d9d3f777851405d93c2e2401895ce61_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892cb0c916c746b5913bcd1ffb140a80_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7244d83910406eaec9d88c79969937_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idae8b11cffbb4c71a6764d8f5f1dd25b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i655f79d1e2274f738d115518f92c4d45_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2785c217ff445e9ac72874428f97a52_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfec5575dbf43a9a693ee576ed1162d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if42165365f8c4ba0b45f5d4a12bda439_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:RealPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dc566d0125146099a9b13ba87eab912_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50261dbb728457db6b2202486d75ef0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i064068b262474876b81e803f24785e0b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ccd5ab037e84574a05e7c5dc7569e59_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ccd1d1dd0a411aa2bfd0ef422868fb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i364113e13bbf4a32a9613f4ab676e5a9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a47ac4fb69943f8aab869a358429d1f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c8074ac9194cc5b11720dc788c0285_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf0f12f556ae4391817c093cf4fca373_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab002e4a10964495a81aca3a26ea2afc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib938fa6a5d404ab8951cd038035b8ff7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a85046f59343e3874040608ed73655_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d099d3619b4467b8a30ab61cc9c0d8e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i797fe852990443559f1b76029e7fcf9c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id273e9fcef44447d91bf8cd1482cdbf9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccdd71b92ffa4cb2b159c9a557fb6ba8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:PharmaceuticalDistributionsReportingUnitJune2018OneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:PharmaceuticalDistributionsReportingUnitJune2018TwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:PharmaceuticalDistributionsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1bdeaded28d4c20b8bc6c14bf14a03b_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportingunit"><xbrli:measure>mck:reportingUnit</xbrli:measure></xbrli:unit><xbrli:context id="i51bc045598984a19b5941cc09fe4a679_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:EuropeanPharmaceuticalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525585ece4e54dc0a604cd4df25d2040_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if73673afe5e746dd9e39e057c20d1cf6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c7700e033044992bf7e96f6acc26b3f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i186279a7a33f4fcfa37e6fef3fe64356_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c8579ef483457a80d6870cfb506627_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c566e2cc944ab4adc2b416c6c7c147_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f4ff464ee184805b122b85d506ac0dd_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if42e75c31e164d77af6f02af0d548d0d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaea9dc7de4704cbcb84065259f650ed8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07691837bf0a422d9cfd06b65bbb66dc_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if54e2d3096fe4a5bb88683649ed1f110_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b90045a4160435fb93b6eb170a34cff_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idad5179cf12841eb8fdb5f299a912be3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463096ed8566457a89faf1810193937b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37afd48eccae41908ebb82b9e0f372ee_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i807ddd84576b420db9656e79fe28a804_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366c1509c4ae4991b52b1307f982e915_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0dc323a371466e8a0168d08ca2e5f0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51455de7ffa1400baa450520b0823664_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8cd624dd46b47528454592cac989b47_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i718d836dece1446592aaaa01bd324fa7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f0b9a87ad6e4141a43b6aebf1030aae_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie61256ac66bc4a89bf0d0e09ae475b1a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i587960ff5f064537a59834dc9b5fbc36_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c1ce0a35b1b4a30af455e59d15c6150_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ea3a78f9a71459f928d5d15a5f30881_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a0f7b532354353862735fa61a7edbe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba3a1f603304391b936ce6bcb7a6a27_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3407317f0374140aae578c6d0eb0b07_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6926f446a23d49a8b4e4110e67b160cb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133b5953d54f4f1bb1cc4a7cb16391a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc40734152a45aeabea7c982026d0fa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64567396009c44829d2a1fd050d1a1b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib84ee20fa4f8433396754e0437027fb6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifadf20024dc74f81b440ab0ab2eb2913_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SixPercentNotesDueMarchOneTwoThousandFortyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id423c4b7c4a945db8071e337c9c82ed1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SixPercentNotesDueMarchOneTwoThousandFortyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc1a0012fd84f509095b06c9f66d6bb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79cf5d2e990240698629bdc50a7c0b88_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad9c1207b15f466a861980e7222a1537_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee10f2cf891e40f2a38c0aced30d76ea_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i392b65805f5f4e48a0907f99ecf50ee2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5014024a7cf34617ac4cd1a096cecac1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee0c0121e554ad5b84e809395a86c66_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54751c16577f40f1adff8f7e2bff79f8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b5b1fc662a44e0791f2dba244a47860_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a099094e354b889a5a5c3a182329bc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2976b57beaaf4c6b8a89e64c910a5a7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d39d3584f824d5dbcfadf658383ee87_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba24a5eef2484a6dbc6addbb8b2b3743_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:LongtermDebtCurrentMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aa607516b08415b8dce58c739355d62_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:LongtermDebtCurrentMaturitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aada2c5a8f5413086253c28368973fe_I20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c1c7b3092c543bda3ed926c574d2405_D20201203-20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-03</xbrli:startDate><xbrli:endDate>2020-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61675c05b34a420fb0aef206c120e3cc_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i933936a7522f4f269eb80826407de7b6_I20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="ifb20c63e640a48478f01df43a5ecbce5_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901c6c235d094bfeab2e2891bf22868d_D20190315-20190315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-15</xbrli:startDate><xbrli:endDate>2019-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7191c4e470a4de89c4f6e0fc96b493c_I20190315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide437db67fec4724871353bf3fed014f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0059e39d8c4440982d888fd5a4c442_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2d3ff5a5a4b4484a95420609dd9e074_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16d322c911e24b2f90df8075e4ef4d6c_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie473d5c5a4eb40bbbc2a53be66040614_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fdddf6ceeed47308e55c0b30b5a067c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabf91ccb11c7473fb82ceedddfc105f2_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9864559fa95841a4af3fb0942788d567_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21fdbc4f6fd449c485c175357858b379_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d0a48f582bd40e3b1f786f6699f0b4a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia279c8899da54bf6ae860b25947dc8d0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ac5a2189034cdfb61933a472118b09_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieadecf82b6ad4545a68ef16b493ea917_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cd94c1fc48d45739e8b1372c7918e91_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="participant"><xbrli:measure>mck:participant</xbrli:measure></xbrli:unit><xbrli:context id="i4e9be4f901904d0db4fe7ad9ae72362b_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a2621176fea4a8888c6313b92cf10ad_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5ba1ae721343ac88b4d010889406e8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9627a61887468a9b6718ee20810f41_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eb73386cbae4db0b0d708fc5a5494fd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d45b209bd246fa9f5fb6ed35063c90_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3d13dff04ec4f91a0b1fe60fc9e3c43_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3877ec01b10348049e885c6fbd8c2093_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5561711868a406dba2571e3837b5f92_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i482d755915844552a319acd0ebad87c2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id79c7f3385b140858233d773cf42bb7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i752dc55059cc4447a0accfa4c957834d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad18cf43caca4fa9b52b9f44c52fa56a_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4352db6f20a74338aa9b3bada49da7c4_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65c96e5196c41e1bd6da83734b674a0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie471c931528e4e2f9855c322fe699fec_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd98e54551df4f7484c8d4d12a663576_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef839e73eff43848516318cebe57433_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if80d3a019b9947fca48a1095d9bfbf33_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a9ed363669a4fdfa3cc41d133ad481b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia504be01cf094a55828dfdd970c95bf7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf49a496e76a4343af193f0f4a7974df_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff7247931a914ff28d1893274243b53a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e7186c429a445e93197d83b847b0f1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd37c0efe2444846b8dbc5093721ff2d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia64a863540ee4b698d1bfb5e37c210e8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia086abbf885e4851977fa3b0dc5873b4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieddab407ff0b4324b0c636ff14ea949d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52ce91aa281c4dacbc249f21d1c8cb63_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebcc6ceb48874567b7361b7a9293eb5a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e199c99040b47adbfe27d08e7241826_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9de1d4c7fe7f434aa5351ea9e7492d11_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d6e4ce540141978ff1ca84f802062f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3fc200020647f1b1811620c34c8b73_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251a6c64448049b085a70bfdf3b66f0d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d8680e23f234d63971e7108407c5ba6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a00b451ff94034895b6946d7a38db1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ba0213d39194a988ddbaf8d509a9ff9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6660febcd05a4ddd91b2880f7aa36913_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63eb6a5f45a34ec1b15088e8d927fa66_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed65ff56e894a1286cad47c9f8a5d88_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02cdbba97e7740f58868b386a457b134_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6baf74c2370245c78b8481e1f70d7407_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9d21d88c6642b49925de8143031180_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7137372572264ce2af8c977e3e539757_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93548af7026745198b9efa38f1eec08d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b6e42fbe1ee49f4a2526d4ce9934227_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9c1363fee943e8884e04ee49ac6551_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52a3fc127ad472a8539e3ee6bb1d8ef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4165a5bc7db3475f9aba7f68b27c0c23_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic55b1ddc17a1405aa6e108d536b9ba0c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a05b66006e4eb1908e988b90b7c584_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0faaa4d4d048a391122a9b7f845605_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34cdfe04f367491a94ee3b1a4e525875_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i922690c523a74696a506676b6c3c8293_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3da32ab3fea74b268e5f8d39e57ab030_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib686c0f367e5401cb4d26df1ffa0ab31_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9cb2b02f0a347969390424b0f1f5db9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c6a46adee414a2ebe17ba74ea9a1405_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69f649e07f96460d9704c43f741f4af4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24c319a97c0492aadc927a233e73092_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc03f35a99e4203abcbc456a09c3804_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f5537dbd7704790be3e79071a25edb0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d4143c9b1147849d5c123548037925_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aaf48c142ae4eeb8c19be8ab65b1e29_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00b4fef7c31c4a70876df028d549534e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bfc6674c5834a339d83ac6ffe6cba98_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic63f6364c6b240679b6ac191aaf72880_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfb3425ba7cd445f84b23ec22c53919b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafacf2945ba549808ec2d53831cb3ac2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f0be6b3b254094b68a2267dc7b119b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30ec3913d2a24972a6ed10647552acc7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75aeb536cafe4a8ca7661d227b781a7d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae17de65aad448a1be8ef9cde1a3083b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8be00e7305947d29917c0a90318f87b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522f5c831bd24654aa4f2e255332199f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i752cfd53540f4acd8c7907a47b064fa7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06c71ba2610427fabe2fd8eba480224_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8bbd8b67344a6184b0aafa7b5e6d28_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a442011c4b4e62a01c94084b029d73_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667557a44ad64ee88484a6c4fb179948_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia182f02d29944e6e98fc4ad018ea349c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ee3888e9874369a385166f1dc2d756_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifccd58ee2c094daf8d0a763a2263760d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8cadf8c988e45fb883101ea1a6a10f3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:FirstPartOfPayContributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd62e97be4e40009772be77a6677117_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:SecondPartOfPayContributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c346010601f41a8883754f4737da9a4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie25f16fc97a74b6186d5dbaa0dabe3da_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd0ad5cd9f64967ab1d489f14880abc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c4bea63e16a4f178e9d9a0b8adb9aa6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8874cbe0e0bd4d968ce32dccacb9e82d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i1f7e095fc24d45e9a294900b86a6d643_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5180872f1daf4367ae60ec035bbdeeb2_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="i817dc0da95ba4e5d978cb261392a4458_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1e06122bde42dea54156fed96f14ab_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c95a543404e41e2af0a9d67836a7894_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4912f098ebbb49ec84aab8167ce6c62f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia231762ec9524000b72d1100dc01e0b9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i817e532872ff41b49bff73a8ac0e47c5_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53fd7c4598e7493daae729bcc3ff421e_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53702046a4124ad485291bebe82245b0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12d54840073946439b15c638a7e7457f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21004c9f5a8c4f50a7843faadd219c08_I20200427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82c3ffdbb3a41a5aec156304f17e31c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractsandCrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5299bd1dd919404fbdaf72f5fea0b8af_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractsandCrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c5c584197cb47379b1b7c14225ff68f_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractsandCrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia984cf8845c74e7289319379358fa6fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01610a464cf24d10b1649f93c6dd325f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65491e199804aaa88bd166f8ca3be43_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib007a62583634542927bd84b71663f81_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c9fbb71f394a7681cd8e128c4ca678_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa2fbd8be98466d8391902894ef72d2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0e75b865efa47ec9f317da6494e4d4d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd3f0773896b4e48973d8fa8546e4b4f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1388407356724e0ea750cc0fcc36009e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08745885db4845b2929c65f0e1a8560d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90cf6f7bcf9f490b8486918cc3e7f3a8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbf63d8d1d545b2bdcd18abc08e8ac8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7854a867193e4d57bbd9c6cd7fc41e84_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95fc81c6ff294b6fb53c554a85f12552_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied797e934f764283b9613debb2b85b60_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia427b71cb3fc4506aa62b238fa8e4181_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied59589914674a3e8f6c2970536feb07_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia49068b8e285481ea485b20083b13688_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d3478fa53f14391b83ba8ebc23863e8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a217938b29b4446aff7ba0b8ec251f4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cbe7452a1e9407e9cef048f9838a43c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e07f2f6223f4fadb6d3a4b0459ad972_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c2e845aabd4458a28f546f452aa7cb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia738d64059fd4e028976c6a7a8405915_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6e2683da2654d0d952236373c6802fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i281f035f8d7243408d9c4ff727319f57_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565d983f5a0443089f472cb1d490b842_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94edb97965974ee69d4b3074e0161dc4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94fb664a24dd4a318195465e100eff7d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e804c1181df47ba96ad8f1464e4cb0b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f06168993540edb69d2eaf0d4aad1a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa61cae38f84791aeb5726163d539c5_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie94373a23dc74d088079c736cb431ae4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8aaa878041344688e3f4286b29f0360_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide8bc86e5ceb4bf5b7a0cfc3b386f8f3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeef638bf5d34fbab16454219b83a7ce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="idcf9ef2946a445b3af2f2e36d9726303_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe8ab04e6f547139155bb2d610a399b_I20200113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489dd58bf6eb415bb081e0bb67be780c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="ia7becbc8d137484d97debb021a37e776_D20171205-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-05</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51f39bcd0abc4530b8f9a45566eff664_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="stateattorney"><xbrli:measure>mck:stateAttorney</xbrli:measure></xbrli:unit><xbrli:unit id="county"><xbrli:measure>mck:county</xbrli:measure></xbrli:unit><xbrli:unit id="company"><xbrli:measure>mck:company</xbrli:measure></xbrli:unit><xbrli:context id="i245fe60a1a194d789edf2b7c72c37e2d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i766ba6b8f9cf468f8ffca287b3b91d7a_D20191021-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-21</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d07872c38ef46b8904d51cac9def92e_D20191021-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-21</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c7bc7242d74503a6137340007d1f16_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47f6d83c6e74e48a98de97db2204260_D20190225-20190225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-25</xbrli:startDate><xbrli:endDate>2019-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>mck:complaint</xbrli:measure></xbrli:unit><xbrli:context id="if9fc6847924f490e8b2c037e203b3e48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="relator"><xbrli:measure>mck:relator</xbrli:measure></xbrli:unit><xbrli:context id="ia64a274f0b7d4166afaa7f5a3c655f98_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d60389839f46b4a37688dfbe3d091d_I20201023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb9993f891b42a9b62b094fea769814_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e7ce3047a83413690e5e7de38e566c3_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="fax_number"><xbrli:measure>mck:fax_number</xbrli:measure></xbrli:unit><xbrli:context id="i69de364d379c40dc8fe389a7c7c04ab8_I20190813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="fax"><xbrli:measure>mck:fax</xbrli:measure></xbrli:unit><xbrli:unit id="investmentfund"><xbrli:measure>mck:investmentFund</xbrli:measure></xbrli:unit><xbrli:context id="i4dbc322ec79448d1be4e868ba2ba06cd_D20171229-20171229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-29</xbrli:startDate><xbrli:endDate>2017-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325d4bdea1e649a3a53c4623ba9c8558_D20171230-20171230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-30</xbrli:startDate><xbrli:endDate>2017-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-04-16</xbrli:startDate><xbrli:endDate>2013-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="defendant"><xbrli:measure>mck:defendant</xbrli:measure></xbrli:unit><xbrli:context id="ibe2ccd127a8d4663b1bebbcc74fb5b01_D20180403-20180403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-03</xbrli:startDate><xbrli:endDate>2018-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="city"><xbrli:measure>mck:city</xbrli:measure></xbrli:unit><xbrli:context id="i2ed46708d24e42d5b26a1ec4e6a3ed61_I20180403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="officer"><xbrli:measure>mck:officer</xbrli:measure></xbrli:unit><xbrli:context id="ib77506c67e6348619cb8db92d4005f93_I20181212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85d1442fd2694c819407a70aafa1bffb_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i241bdb994a38412ea8d52d2de2c21019_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6bbf73876be402592d7ed83f5fa934f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ConsolidatedActionsvSureScriptsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaa7143e43f54500bac344b182f4e41a_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6cab553ef4649228197f51778134e0f_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="softwareproduct"><xbrli:measure>mck:softwareProduct</xbrli:measure></xbrli:unit><xbrli:context id="i56b06f9b88e745caa7ce9e463ac4f6b6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id02805e7f2944185bec84529e72a977d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>mck:site</xbrli:measure></xbrli:unit><xbrli:context id="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c1da308c4b4144b44b8bf3d8fb146b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia01db295201a4e96a3ef82db44b6fdc5_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043439014160460cb387b7eff982bfc3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fa25f7377e2432b8ee48290f92300f5_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c1aa1b3a0dc420f9bef7793ceda75bd_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id903d050fec841a29536a88e85b3a251_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f355bd7dad94edaa42f6261dbd8637e_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c441ae8aa364ac5981834da3de52970_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b13d6d7fdc4db998f4aad71d5d3642_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49da1197585148a08970cd158baac052_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c6dcc996c542ce806943993094a62d_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e04822e0566406b894ca9c180380691_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba0d73afdaf4b6d95e21bc354b2880d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03252b88bd734ce7a56608ddb4d375e6_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3c5d000b0d24643ae449965b3c153e6_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideef425eabb04ab1a5e71cbf9973e5f2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47ea8d9084a4afca5dba67392106eea_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb2e27caae16447596fd19fbd3c9a88d_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ce45207fbd4b11992c8b235c7acdc4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8458e101d22b48b086cd13c117b50596_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa299a34d5fc4bc9b76f73609f2764c6_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25daf5026b554fff9b18eed266aeb5b3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c768d5a4a684f049a881df6f6e2b57b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4560aec4e3b49c4bac2fdf164699f86_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2556775e1fe47e6992440fb0541be59_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c24314d9c3e4d9f94843d3a48b7eede_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaed4a2b4af4445f83330c94eec2f1a2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1234f72c09014e849c5e914cbc33f91a_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i739cbdd44da747b7add6dc8608dd1b5a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15be07b9acdf4513a30f3849808f530c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07af8a5be55944b695812fe13bfcd58b_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec9cc36803c34f05a0d2e66ae17760bd_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38c5b221e50b470489c015c3be354825_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc447cc3eef4e94805a56f586f3f29b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5380417ed05b451283f8c1532ae7d259_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9a8afb096ba4b8086b849fdbc536601_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3429f651eb54a16929355b743eaba52_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffce4b8d4569411a9a36db18bed95dc2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c1e0d879d74d0ba80ac1c15a6e17d3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i621e3a8fa6994bd5a5330f05ec7cdff3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie174ba8ffb9244afb1dd4b6122d4fbd3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba47de0abc2f48d494cd9612200292a8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17c5e4430f874e8f99d8a1bf5f30f24c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04923cda81624c0c88a55ac1efd640f3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:CaliforniaFoundationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88386d48d0584a11aad721e5144c887a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:McKessonFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7481f6650044b3dba08713c24b295ca_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie85e4307493243a5b472a5635d3adc29_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia887d330153d49cf8839b2dd8a1d6605_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b60cdb02b3c4589b40ac24c56bb249e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i944454336222406cbbe7e294bceecc04_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i175e65bdb63d42c090c72de7f9bdc403_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:unit id="numberofproducts"><xbrli:measure>mck:numberOfProducts</xbrli:measure></xbrli:unit><xbrli:context id="i14a2c0c157ca4b96abb1b4665b27847c_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i573770b6d3a94d0387b01cf824758b6e_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42e59ef5f2b45d2973487b75779a397_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e52c8b4b824321aa0ff56c256f2680_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4526ff802af4c7fa6b4487275290425_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RexallHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ThirdPartySellerofRexallHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c4775af5034c77bdf45a4edf0c4a19_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd9d23495db4b029833f9c192227a5c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida17c5841f1c46d28608950ca8175e62_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2310b3bfad364c4897f644c867bc31cb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a2364550eaa48c195ef408353004029_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if74e45a0662448e0b98940f6a00fba1a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bdb37666904471ea46cdc51ef04aaf9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab5c8e5207d049d0a2b702571549ad35_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3215d0d8384a40fba66e6eab5a09fb04_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfe85c1cae3f4955b9ab92d284409069_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17077ebbd39449f5af1aad884f3154eb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fd853d831a42d78a02ffd4cf5ac851_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if946cdebc5f04a91a11501d5fecd0111_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc939e12662e498ca3e1db10c83b89a6_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fcf90e365b49d3bc8fc8b908d184c5_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316723b66fa24fcd88e37d193316fd03_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4255c61bac0b4de1850d7e4a694151da_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1401c1c016fb4cc5a4325e0076ce4cfc_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i511a93c4c27f432094e7f2f67db30fc4_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i912ede9886ea43629d3666f2abe8894a_D20180401-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i08f9baf810c0412e93ea6effc6d22995_1"></div><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTky_a09cff56-76c5-406f-b125-7ce731606d2e">10-K</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NjMxMmFmMGJhZWI5NGZjMGJkNTAwZTg2NDVhYjIzZWEvdGFibGVyYW5nZTo2MzEyYWYwYmFlYjk0ZmMwYmQ1MDBlODY0NWFiMjNlYV8wLTAtMS0xLTA_c033c4c9-2953-4cd3-92be-e3cfa9e98003">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8xMTk_d42ff439-2096-4f54-b1e4-ec029a2f4b36"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8xMTk_5a767053-b358-4af4-991f-661d05c5dbc8">March&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric> </span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YjdiNmI4YzM4NDU4NGQ0YWJmNjllOTFmNjFkMjVkNjYvdGFibGVyYW5nZTpiN2I2YjhjMzg0NTg0ZDRhYmY2OWU5MWY2MWQyNWQ2Nl8wLTAtMS0xLTA_6ea5c060-8c53-47eb-8ff4-6855d3438e11">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg4_003f2ca5-33da-454b-a2c7-02be717dbe62">1-13252</ix:nonNumeric> </span></div><div style="text-align:center"><img src="mck-20210331_g1.jpg" alt="mck-20210331_g1.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTkz_510d0976-a521-4d3e-a68f-ab3c2de66160">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.898%"><tr><td style="width:1.0%"></td><td style="width:50.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6ODc0YzkxMTYzNjMwNDYyNTg4NGFjYWZlNDRhMjFmYTgvdGFibGVyYW5nZTo4NzRjOTExNjM2MzA0NjI1ODg0YWNhZmU0NGEyMWZhOF8wLTAtMS0xLTA_2bdb55bd-8910-408e-a2d1-ccae0f7911dd">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6ODc0YzkxMTYzNjMwNDYyNTg4NGFjYWZlNDRhMjFmYTgvdGFibGVyYW5nZTo4NzRjOTExNjM2MzA0NjI1ODg0YWNhZmU0NGEyMWZhOF8wLTItMS0xLTA_8b5b766b-d104-4180-8e4f-6d0e384f0f61">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTgy_b66a190f-5939-4894-b896-dd42e2883db7">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTk0_82e0e8bd-87e2-4fa4-ae9a-85c80f3e86ff">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTk1_2d24211e-f271-4e8b-a203-42ad73a5e953">TX</ix:nonNumeric> <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTgz_b6f4051d-383a-4749-8fac-7e061d32c4e3">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg1_8a438985-332b-480c-8271-1f9850f8f9b5">972</ix:nonNumeric>) <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg0_4b6fd049-b0aa-4de2-8ecb-0579dcdd6fd3">446-4800</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:208.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18xLTAtMS0xLTA_31f04eae-ff92-40a0-9e4c-94e5036273f6">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18xLTEtMS0xLTA_b1b47be1-f301-4a0f-a16f-13d0f072e96e">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18xLTItMS0xLTA_c8ca8cda-6a78-44bc-9246-7cc8d39df6e2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18yLTAtMS0xLTA_f4527eb8-eab5-4834-8f9a-ca769dfe7e84">0.625% Notes due 2021</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18yLTEtMS0xLTA_afdd9a74-a993-4225-8cdd-27705a267403">MCK21A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18yLTItMS0xLTA_b7f5c502-67a5-4737-8914-21af539191e8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18zLTAtMS0xLTA_67f41c13-650d-4b89-a788-201f0dc59d1d">1.500% Notes due 2025</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18zLTEtMS0xLTA_5538c3aa-8be6-4ad2-883e-7eb959b048ae">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18zLTItMS0xLTA_b0d99595-64a2-450c-9e3e-5cf1f4bd22da">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9650e19e52e846e28fe7e52623004983_D20200401-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN180LTAtMS0xLTA_5a4859c1-7a78-4e93-b4a0-3c01bb91c5bb">1.625% Notes due 2026</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9650e19e52e846e28fe7e52623004983_D20200401-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN180LTEtMS0xLTA_3beaf0e4-dac8-41b0-b9d1-58e2f0761688">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9650e19e52e846e28fe7e52623004983_D20200401-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN180LTItMS0xLTA_ab50a4dd-ae39-4e9e-8f77-bb5fe6f2f4a3">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN181LTAtMS0xLTA_e05d8fa4-9ece-41b3-909c-c552cd9266d4">3.125% Notes due 2029</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN181LTEtMS0xLTA_74512c78-2738-4599-b7fd-c54126dbdb97">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN181LTItMS0xLTA_c43844c3-cf60-4d91-9945-7f60017cfd0a">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities&#160;Act.&#160;&#160; <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg2_85cdae63-6aac-4241-a771-f7e7eb6e03f6">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the&#160;Act.&#160;&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTk2_3901bfb3-cc39-4657-a542-60d51ffb2a54">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160; &#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTkx_7cfee3d4-6c7b-4e7c-983f-30f11de1246f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160; <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg5_8e755897-d3b8-4f1d-aa0a-60845af0f054">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YzgyYmY4M2ExZmI2NDlkNjkxOGJhOGJhMjUwYTJjNjgvdGFibGVyYW5nZTpjODJiZjgzYTFmYjY0OWQ2OTE4YmE4YmEyNTBhMmM2OF8wLTAtMS0xLTA_3373d022-f4fb-41ee-aa28-d5643a534eb1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YzgyYmY4M2ExZmI2NDlkNjkxOGJhOGJhMjUwYTJjNjgvdGFibGVyYW5nZTpjODJiZjgzYTFmYjY0OWQ2OTE4YmE4YmEyNTBhMmM2OF8xLTYtMS0xLTA_45e20dcd-f8ef-4ce5-917a-b12891578847">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YzgyYmY4M2ExZmI2NDlkNjkxOGJhOGJhMjUwYTJjNjgvdGFibGVyYW5nZTpjODJiZjgzYTFmYjY0OWQ2OTE4YmE4YmEyNTBhMmM2OF8yLTYtMS0xLTA_7640df68-62c1-4d6f-a7e5-c470813279eb">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8xOTc5MTIwOTMwNDAyNg_18ad2b99-7217-4f46-908a-ca1af8337db6">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTkw_de95249e-be67-4790-831c-030bb3fa6aa1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the closing price as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter, September&#160;30, 2020, was approximately $<ix:nonFraction unitRef="usd" contextRef="i9e194b3a461f4ad28b6e6b95517ccd7d_I20200930" decimals="-8" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8yOTA5_01f2eda9-a862-4a5d-879b-2c9d3c0f3955">23.9</ix:nonFraction> billion.</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares of common stock outstanding on April 30, 2021: <ix:nonFraction unitRef="shares" contextRef="i5dbd0bda906d4b768524dcfc6aadc6cd_I20210430" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8yOTc1_6350458f-902c-4343-ba85-09603713d47f">158,186,277</ix:nonFraction></span></div><div style="margin-bottom:2pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg3_f329117f-8476-4d72-9911-8700778826f7" continuedAt="ib9fd9be01c9c46889fa48d7a6448a4e3" escape="true">DOCUMENTS INCORPORATED BY REFERENCE</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ib9fd9be01c9c46889fa48d7a6448a4e3">Portions of the registrant&#8217;s Proxy Statement for its 2021 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</ix:continuation></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_13">3</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_16">14</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_19">24</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_22">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_25">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_28">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_31">Executive Officers of the Registrant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_31">26</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_34">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_37">Market for the Registrant's Common Equity, Related Stockholder Matters and </a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_37">Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_37">27</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_2579">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_2579">29</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_43">29</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_73">61</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_76">63</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_241">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_241">139</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_244">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_244">139</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_247">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_247">139</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_250">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_253">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_253">139</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_256">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_256">139</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_259">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_259">140</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_262">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_262">141</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_265">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_265">141</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_268">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_271">Exhibits and Financial Statement Schedule</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_271">142</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_274">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_274">148</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_286">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_286">149</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_10"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_13"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Business.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (&#8220;McKesson,&#8221; the &#8220;Company,&#8221; or &#8220;we,&#8221; and other similar pronouns), originally founded in 1833, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this document to a particular year shall mean the Company&#8217;s fiscal year. The Company was incorporated on July 7, 1994 in the State of Delaware.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act,&#8221;) are available free of charge on the Company&#8217;s website (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.mckesson.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the &#8220;Investors &#8212; Financials &#8212; SEC Filings&#8221; caption) as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission (&#8220;SEC&#8221; or the &#8220;Commission&#8221;). The content on any website referred to in this Annual Report on Form 10-K is not incorporated by reference into this report, unless expressly noted otherwise. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers, including the Company, that file electronically with the SEC. The address of the website is </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company operates its business in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter (&#8220;OTC&#8221;) pharmaceutical drugs, and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada where we own, partner or franchise with retail pharmacies, and support better, safer patient care by delivering vital medicines, supplies, and information technology solutions.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. We offer more than 275,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our RxTS segment brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients. Together, we work across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions that help people get the medicine they need to live healthier lives.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Pharmaceutical Segment:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and OTC pharmaceutical drugs along with other healthcare-related products to customers. This business provides solutions and services to pharmacies, hospitals and other providers, pharmaceutical manufacturers, physicians, payers, and patients throughout the U.S. and Puerto Rico. We also source generic pharmaceutical drugs through our joint sourcing entity, ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;). </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment operates and serves customers through a network of 33 distribution centers, as well as a strategic redistribution center, a primary and a secondary redistribution center. We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability. For example, we offer McKesson Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality. We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maximize distribution efficiency and effectiveness, we follow the Six Sigma methodology, which is an analytical approach that emphasizes setting high-quality objectives, collecting data, and analyzing results to a fine degree in order to improve processes, reduce costs, and enhance service accuracy and safety. We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals. We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four primary customer pharmaceutical distribution channels: (i) retail national accounts which include national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers, (ii) independent, small, and medium chain retail pharmacies, (iii) institutional healthcare providers such as hospitals, health systems, integrated delivery networks, and long-term care providers, and (iv) provider solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail National Accounts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide business solutions that help retail national account customers increase revenues and profitability. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Central Fill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> - Prescription refill service that enables pharmacies to more quickly refill prescriptions remotely, more accurately, and at a lower cost, while reducing inventory levels and improving customer service.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Redistribution Centers - Three facilities totaling over 930,000 square feet that offer access to inventory for single source warehouse purchasing, including pharmaceuticals and biologics. These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">McKesson SynerGx&#174; - Generic pharmaceutical purchasing program and inventory management that helps pharmacies maximize their cost savings with a broad selection of generic drugs, competitive pricing, and one-stop shopping.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">Inventory Management - An integrated solution comprising forecasting software and automated replenishment technologies that reduce inventory-carrying costs.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">ExpressRx Track&#8482; - Pharmacy automation solution featuring state-of-the-art robotics, upgraded imaging, and expanded vial capabilities, and industry-leading speed and accuracy in a small footprint. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent, Small and Medium Chain Retail Pharmacies: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide managed care contracting, branding and advertising, merchandising, purchasing, operational efficiency, and automation that help independent pharmacists focus on patient care while improving profitability. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart&#174; - Health Mart&#174; is a national network of approximately 5,000 independently-owned pharmacies and is one of the industry&#8217;s most comprehensive pharmacy franchise programs. Health Mart&#174; provides franchisees support for managed care contracting, branding and local marketing solutions, the Health Mart private label line of products, merchandising solutions, and programs for enhanced patient support.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart Atlas&#174; - Comprehensive managed care and reconciliation assistance services that help independent pharmacies save time, access competitive reimbursement rates, and improve cash flow.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Reimbursement Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;MRA&#8221;) - MRA is one of the industry&#8217;s most comprehensive reimbursement optimization packages, comprising financial services (automated claim resubmission), analytic services, and customer care.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson OneStop Generics&#174; - Generic pharmaceutical purchasing program that helps pharmacies maximize their cost savings with a broad selection of generic drugs, competitive pricing, and one-stop shopping.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sunmark&#174; - Complete line of products that provide retail independent pharmacies with value-priced alternatives to national brands.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FrontEdge&#8482; - Strategic planning, merchandising, and price maintenance program that helps independent pharmacies maximize store profitability.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Sponsored Clinical Services (&#8220;SCS&#8221;) Network - Access to patient-support services that allow pharmacists to earn service fees and to develop stronger patient relationships.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson RxOwnership Program - Assist independent pharmacist owners with the opportunity to remain independent via succession planning and business operation loans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Institutional Healthcare Providers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide electronic ordering/purchasing and supply chain management systems that help customers improve financial performance, increase operational efficiencies, and deliver better patient care. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fulfill-Rx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Ordering and inventory management system that empowers hospitals to optimize the often complicated processes related to unit-based cabinet replenishment and inventory management.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Asset Management - Award-winning inventory optimization and purchasing management program that helps institutional providers lower costs while ensuring product availability.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SKY Packaging - Blister, Unit of Use, and Unit dose packaging containing the most widely prescribed dosages and strengths in generic oral-solid and liquid medications. SKY Packaging enables acute care, long-term care, and institutional pharmacies to provide cost-effective, uniform packaging.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Plasma and Biologics - A full portfolio of plasma-derivatives and biologic products.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson OneStop Generics&#174; - Described above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provider Solutions:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment provides a range of solutions to oncology and other specialty practices and offers community specialists (oncologists, rheumatologists, ophthalmologists, urologists, neurologists, and other specialists) an extensive set of customizable products and services designed to strengthen core practice operations, enhance value-based care delivery, and expand their service offering to patients. Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs. Services in provider solutions include specialty drug distribution, group purchasing organizations (&#8220;GPO&#8221;) like Onmark&#174;, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention&#8217;s (&#8220;CDC&#8221;) Vaccines for Children program. Additionally, to support the U.S. efforts to fight the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic, this segment is distributing the COVID-19 vaccines manufactured by ModernaTX, Inc. and Janssen Biotech Inc., a Janssen pharmaceutical company of Johnson &amp; Johnson, at the direction of the U.S. government. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This business provides a variety of solutions, including practice operations, healthcare information technology, revenue cycle management and managed care contracting solutions, evidence-based guidelines, and quality measurements to support U.S. Oncology Network (&#8220;USON&#8221;), one of the nation&#8217;s largest networks of physician-led, integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. We also support U.S. Oncology Research, one of the nation&#8217;s largest research networks, specializing in oncology clinical trials.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners. Ontada also partners with oncology providers and biopharma partners to perform real-world evidence studies, retrospective research, and to provide clinical data insights, advisory solutions and education opportunities.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment also offers solutions which enable its customers to drive greater efficiencies in their day to day operations, effectively managing their inventories and complying with complex government regulations. Solutions include McKesson Pharmacy Systems, MacroHelix and Supply Logix, all of which provide innovative software technology and services that support retail pharmacies and hospitals.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we discuss specialty products or services, we consider the following factors: diseases requiring complex treatment regimens such as cancer and rheumatoid arthritis; plasma and biologics products; ongoing clinical monitoring requirements, high-cost, special handling, storage, and delivery requirements and, in some cases, exclusive distribution arrangements. Our use of the term &#8220;specialty&#8221; may not be comparable to that used by other industry participants, including our competitors.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Segment:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries where we own, partner, or franchise with retail pharmacies and operate through two businesses: Pharmaceutical Distribution and Retail Pharmacy. Our operations in Canada, including Rexall retail pharmacies, support better, safer patient care by delivering vital medicines, supplies, and information technology solutions throughout Canada.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe. This business functions as a vital link, using technology-enabled management systems at our regional wholesale branches to connect manufacturers to retail pharmacies, supplying medicines and other products sold in pharmacies. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our European Retail Pharmacy business serves patients and consumers in European countries directly through approximately 2,100 of our own pharmacies and 5,500 participant pharmacies operating under brand partnership arrangements. In addition, this business includes outpatient dispensing, eCommerce and homecare arrangements mainly in the United Kingdom (&#8220;U.K.&#8221;), and provides traditional prescription pharmaceuticals, non-prescription products and medical services, and operates under the Lloyds pharmacy branding in Belgium, Ireland, Italy, Sweden, and the U.K. In addition, we partner with independent pharmacies under local banner programs. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada is one of the largest pharmaceutical wholesale and retail distributors in Canada. The wholesale business delivers products to retail pharmacies, hospitals, long-term care centers, clinics and institutions in Canada through a national network of distribution centers and provides logistics and distribution services for manufacturers. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond wholesale pharmaceutical logistics and distribution, McKesson Canada provides automation and technology solutions to its retail and hospital customers. Additionally, McKesson Canada provides comprehensive specialty health services to Canadians, including a national network of specialty pharmacies, personalized patient care and support programs, and INVIVA, Canada&#8217;s first and largest accredited network of private infusion clinics.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Canada retail business includes over 2,500 banner pharmacies under the IDA, Guardian, The Medicine Shoppe, Remedy&#8217;sRx, Proxim, and Uniprix banners, and more than 400 owned pharmacies under the Rexall brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels. McKesson Canada also owns and operates Well.ca, a leading Canadian online health and wellness retailer.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical-Surgical Solutions Segment:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment delivers medical-supply distribution, logistics, biomedical maintenance, and other services to healthcare providers across the alternate-site spectrum. Our more than 250,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and home health agencies. We distribute medical-surgical supplies (such as gloves, needles, syringes and wound care products), infusion pumps, laboratory equipment and pharmaceuticals. Through a network of distribution centers within the U.S., we offer more than 275,000 products from national brand manufacturers and McKesson&#8217;s own high-quality product line. Through the right mix of products and services, we help improve efficiencies, profitability and compliance. We also never lose focus on helping customers improve patient and business outcomes. We develop customized plans to address the product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff. We deliver for our customers, so they can deliver and care for their patients. Additionally, under a contract with the Department of Health and Human Services (&#8220;HHS&#8221;), McKesson&#8217;s Medical-Surgical business leverages its expertise to manage the assembly of supply kits needed to administer COVID-19 vaccines, as well as some of the sourcing of those supplies. The kits are being produced and distributed at the direction of HHS to support the administration of all vaccines approved in the U.S. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prescription Technology Solutions Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Prescription Technology Solutions segment works across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next generation patient access and adherence solutions and operates primarily through the following businesses:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">CoverMyMeds &#8211; Provides solutions to help patients get the medications they need to live healthy lives by seamlessly connecting the healthcare network to improve medication access; thereby increasing speed to therapy and reducing prescription abandonment. By facilitating appropriate access to medications, the company can help its customers avoid millions of dollars each year in administrative waste and avoidable medical spending caused by prescription abandonment. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">RelayHealth Pharmacy Solutions &#8211; Provides workflow solutions to connect key healthcare stakeholders with more than 50,000 U.S. retail pharmacies and processes more than 18 billion pharmacy transactions annually.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">RxCrossroads &#8211; Uses deep insights and innovative technology to help biopharma manufacturers thrive throughout the product lifecycle and create flexible, connected solutions that increase access, adherence, and safe use conditions for therapies and interventions. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Prescription Automation (&#8220;MPA&#8221;) &#8211; Provides customized pharmacy automation technology that allows our partners to control costs, work faster, offer higher-quality products, and better serve patients.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Multi-Client Central Fill as a Service &#8211; McKesson-owned pharmacy that utilizes MPA dispensing automation to enable low-cost fulfillment of up to 50,000 prescriptions daily for retail and independent pharmacy customers, new digital pharmacies, and manufacturers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change Healthcare: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity ownership interest in Change Healthcare JV, a joint venture, has been accounted for using the equity method of accounting. Change Healthcare JV provided software and analytics, network solutions, and technology-enabled services that deliver wide-ranging financial, operational, and clinical benefits to payers, providers and consumers. On March&#160;10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split-off transaction. This transaction reduced our investment in the Change Healthcare JV to zero. Refer to Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K for additional information related to this transaction.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring, Business Combinations, Investments, and Divestitures </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have undertaken additional strategic initiatives in recent years designed to further focus on our core healthcare businesses and enhance our competitive position. These initiatives are detailed in Financial Notes 2, 3, 4, and 5, &#8220;Investment in Change Healthcare Joint Venture,&#8221; &#8220;Held for Sale,&#8221; &#8220;Restructuring, Impairment, and Related Charges,&#8221; and &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face highly competitive global environments. Additionally, in recent years the healthcare industry has been subject to increasing consolidation. In the pharmaceutical distribution environment in which our U.S. Pharmaceutical and International segments operate, we face strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations. Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local global retailers, including chain and independent pharmacies. We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, home health care agencies, and alternative health sites with competition from a wide range of national and regional medical supply and equipment distributors throughout the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our RxTS business experiences substantial competition from many companies, including other software services firms, consulting firms, shared service vendors, and internet-based companies with technology applicable to the healthcare industry. Competition in this business varies in size from large to small companies, in geographical coverage, and in scope and breadth of products and services offered. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we compete with other service providers, pharmaceutical and other healthcare manufacturers, as well as other potential customers of our businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses. We believe that our scale and diversity of product and service offerings are our primary competitive advantages. In all areas, key competitive factors include price, quality of service, breadth of product lines, innovation and, in some cases, convenience to the customer. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents, Trademarks, Copyrights, and Licenses</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson and its subsidiaries hold patents, copyrights, trademarks, and trade secrets related to McKesson products and services. We pursue patent protection for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous. Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide. In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, in the aggregate, McKesson&#8217;s confidential information, patents, copyrights, trademarks, and intellectual property licenses are important to its operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same. We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers. We periodically receive notices alleging that our products or services infringe on third party patents and other intellectual property rights. These claims may result in McKesson entering settlement agreements, paying damages, discontinuing use or sale of accused products, or ceasing other activities. While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operation. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson&#8217;s products or services. While it may be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice, such licenses generally can be obtained on commercially reasonable terms. We believe our operations and products and services are not materially dependent on any single license or other agreement with any third party.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our vision for a healthier world begins with our employees, who strive to bring our mission to life every day. As a company, we deliver programs that focus on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential. At March 31, 2021, we had approximately 76,000 employees worldwide, including 17,000 part-time employees and 32,000 employees in the U.S.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity, and Inclusion (&#8220;DEI&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At McKesson, we are committed to making DEI integral to everything we do, because we believe building a healthier future is everyone&#8217;s business. We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion as an important element that drives long-term shareholder value. During 2021, we appointed the newly created role of chief impact officer, who will drive our strategy and execution related to DEI as well as sustainability, environmental, social, and governance (&#8220;ESG&#8221;), and philanthropy. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, women and people of color represented the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">McKesson<br/> Overall</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">McKesson </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leadership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Metric </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">People of Color </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) (5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The data for our metrics is derived from our voluntary, self-identification process as of March 31, 2021 and therefore represents our best estimate at this time. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents our leadership at the vice president level and above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents worldwide employees.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents U.S. employees only as the data for Canada and Europe is not available.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">People of Color includes the following races and ethnicities: Hispanic or Latino, Black or African American, Asian, Native Hawaiian or Other Pacific Islander, American Indian or Alaska Native, or Two or More Races.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Culture and Leadership:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> What sets McKesson apart as an exceptional place is our people. Our employees understand that together, unified by our global I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CARE and ILEAD principles, we fulfill our mission of improving care in every setting. Our I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company. ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition and shared commitment to leadership. By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health &#8211; for our company, our customers, and the patients they serve for years to come. We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments. These values and behaviors help make McKesson unique.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Employees: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support employee growth, we provide regular feedback and training, and work to create and maintain inclusive work settings where everyone can bring their authentic self to work and feel welcomed and appreciated, and where their perspectives are sought out, heard, and considered. Through training, we encourage leaders to embrace diverse perspectives and lead inclusively. Employee development programs include training, coaching, and 360-degree assessments, which can support the careers of future leaders and their teams. We offer financial assistance programs for higher education opportunities that support employees&#8217; career growth at the company. To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal fairness, market competitiveness, and pay for performance. We operate in several countries and our benefits offerings vary accordingly. We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other benefits offerings, when possible. In response to the COVID-19 pandemic, we offered extended medical benefits covering COVID-19 related visits, treatment and testing, expanded telehealth options, emergency paid time off (&#8220;PTO&#8221;), and a platform for employees to donate their regular PTO to co-workers who were more impacted by COVID-19. We also seek employee feedback through an annual employee opinion survey, which assesses our employees&#8217; levels of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Safety:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our security and safety departments employ systems designed to continually monitor our facilities and work environment to help identify and prevent or mitigate any potential risks. This includes having procedures in place and investing in equipment for both physical and electronic security. We routinely assess facilities to monitor closely adherence to established security and safety standards. If we identify a vulnerability, it is documented, and the facility prepares an action plan. Our employees receive specialized training related to their role, work setting, and equipment used in their work environment. As our processes evolve, we update relevant safety training modules, which may include new employee training programs. In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees. The various responses we put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging. For additional information on our response to COVID-19 in the workplace, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II included in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson, generally and in many of the highly regulated industries in which it operates, is subject to oversight by various federal, state, and local governmental entities. Failure to comply with laws, regulations, and guidance promulgated by those entities could have a material adverse impact to the Company&#8217;s business operations, reputation, results of operations, and financial position.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controlled Substances:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are subject to the operating and security standards of the Drug Enforcement Administration (&#8220;DEA&#8221;), the U.S. Food and Drug Administration (&#8220;FDA&#8221;), various state boards of pharmacy, state health departments, HHS, the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), and other comparable agencies. We have received monetary penalties and/or licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in an inability to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company is a defendant in approximately 3,200 cases alleging claims related to the distribution of controlled substances (opioids), as described in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this Annual Report on Form 10-K. The plaintiffs in those cases include governmental entities (such as states, provinces, counties and municipalities) as well as businesses, groups and individuals. As a result of ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1 billion for the year ended March 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in our Consolidated Statement of Operations in this Annual Report on Form 10-K. Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. The adverse outcome of legal proceedings might also involve significant expense, management time and distraction, and risk of loss that can be difficult to predict or quantify. In addition to this litigation, legislative or regulatory measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict. For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Contracts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with government entities are subject to unique compliance risks and typically are subject to procurement laws that include socio-economic, employment practices, environmental protection, recordkeeping and accounting, and other requirements. We are subject to government audits, investigations and oversight proceedings. Government agencies routinely review and audit government contractors to determine whether they are complying with contractual and legal requirements. If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work. These requirements complicate our business and increase our compliance burden and material non-compliance could harm our reputation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Local, state, and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste, and abuse affecting Medicare, Medicaid, other government healthcare programs, and government contracts. Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws, regulation, and government guidance on fraud and abuse. Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations. Failure to comply with applicable laws, regulations, and government guidance, including but not limited to those involving the regulation of controlled substances, the federal Anti-Kickback Statute, and others, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Patient Protection and Affordable Care Act (&#8220;ACA&#8221;) significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. There are also further efforts to broaden healthcare coverage. U.S. lawmakers also have explored proposals to reduce drug prices, including requiring price transparency and drug importation measures. Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs. For example, provincial governments have taken steps to reduce consumer prices for generic pharmaceuticals and, in some provinces, change professional allowances paid to pharmacists by generic manufacturers. Many European governments provide or subsidize healthcare to consumers and regulate pharmaceutical prices, patient eligibility and reimbursement levels in order to control government healthcare system costs. Some European governments have implemented or are considering austerity measures to reduce healthcare spending. These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices. There is substantial uncertainty about the likelihood, timing and results of these health reform efforts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, there have been increasing efforts by governments to regulate the pharmaceutical distribution system in order to prevent the introduction of counterfeit, adulterated and/or mislabeled drugs into the pharmaceutical distribution system, otherwise known as pedigree tracking. For example, the U.S. Drug Quality and Security Act of 2013 (&#8220;DQSA&#8221;) requires us to participate in a federal prescription drug track and trace system that preempts state drug pedigree requirements, and the U.S. Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs. We also have record-keeping and other obligations under the E.U. Falsified Medicines Directive. Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Security and Privacy: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction. For example, under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) we must maintain administrative, physical and technological safeguards to protect individually identifiable health information (&#8220;protected health information&#8221;) and ensure the confidentiality, integrity, and availability of electronic protected health information. We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (&#8220;GDPR&#8221;) in the European Union, the Personal Information Protection and Electronic Documents Act (&#8220;PIPEDA&#8221;) in Canada, and the California Consumer Protection Act (&#8220;CCPA&#8221;). Some privacy laws prohibit the transfer of personal information to certain other jurisdictions. We are subject to privacy and data protection compliance audits or investigations by various government agencies. Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs. We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws. Our efforts to comply with privacy laws complicate our operations and add to our compliance costs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our external service providers use technology and systems to perform our business operations, such as the secure electronic transmission, processing, storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce. Despite physical, technical, and administrative security measures that we implement in order to, among other things, address regulatory requirements, our technology systems and operations may continue to be subject to cybersecurity incidents. The risk of cybersecurity incidents may be increased due to a variety of factors, both internal and external. A cybersecurity incident might involve a material data breach or other material impact to the integrity and operations of the technology systems and operations, which might result in litigation or regulatory action.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to many environmental and hazardous materials regulations, including those relating to radiation-emitting equipment operated at U.S. Oncology Network practices. Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below. We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws. We are committed to maintaining compliance with all environmental laws applicable to our operations, products and services and to reducing our environmental impact across all aspects of our business. We meet this commitment through an environmental strategy and sustainability program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations. Agreements with the Environmental Protection Agency and certain states may require environmental assessments and cleanups at several closed sites. These matters are described further in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability for environmental remediation and other environmental costs is accrued when the Company considers it probable and can reasonably estimate the costs. Environmental costs and accruals, including that related to our legacy chemical distribution operations, presently are not material to our operations or financial position. Although there is no assurance that existing or future environmental laws applicable to our operations or products will not have a material adverse impact on our operations or financial condition, we do not currently anticipate material capital expenditures for environmental matters. Other than the expected expenditures that may be required in connection with our legacy chemical distribution operations, we do not anticipate making substantial capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future. The amount of our capital expenditures for environmental compliance was not material in 2021 and is not expected to be material in the next year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Climate Change Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governments in the U.S. and abroad are considering new or expanded laws to address climate change. Such laws may include limitations on greenhouse gas (&#8220;GHG&#8221;) emissions, mandates that companies implement processes to monitor and disclose climate-related matters, additional taxes or offset charges on specified energy sources, and other requirements. Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions. New or expanded climate-related laws could impose substantial costs on us. Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information about the Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During 2021, sales to our ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;) accounted for approximately 51% of our total consolidated revenues. Sales to our largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of our total consolidated revenues in 2021. In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023. Our ten largest customers comprised approximately 32%, and CVS was approximately 19%, of total trade accounts receivable at March&#160;31, 2021. We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. Substantially all of these revenues and accounts receivable are included in our U.S. Pharmaceutical segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Suppliers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than 7% of our purchases in 2021. The loss of a supplier could adversely affect our business if alternate sources of supply are unavailable. We believe that our relationships with our suppliers are generally sound. The ten largest suppliers in 2021 accounted for approximately 50% of our purchases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our distribution arrangements with the manufacturers provides us compensation based on a percentage of our purchases. In addition, we have certain distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices. For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development (&#8220;R&amp;D&#8221;) expenses were $74&#160;million, $96&#160;million, and $71&#160;million during 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Information About Foreign and Domestic Operations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain financial information relating to foreign and domestic operations is included in Financial Note 22, &#8220;Segments of Business,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K. See &#8220;Risk Factors&#8221; in Item 1A of Part I below for information regarding risks associated with our foreign operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II of this report and the &#8220;Risk Factors&#8221; in Item 1A of Part I of this report, contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 (&#8220;Securities Act&#8221;) and section 21E of the Securities Exchange Act of 1934, as amended. Some of these statements can be identified by use of forward-looking words such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; or &#8220;estimates,&#8221; or the negative of these words, or other comparable terminology. The discussion of financial trends, strategy, plans, or intentions may also include forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under &#8220;Risk Factors&#8221; and in our publicly available SEC filings and press releases. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_16"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below identifies certain representative risks that might cause our actual business results to materially differ from our estimates. It is not practical to identify or describe all risks and uncertainties that might materially impact our business operations, reputation, financial position or results of operations. Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial. This is not a complete statement of all potential risks and uncertainties.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation and Regulatory Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience costly and disruptive legal disputes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely named as a defendant in litigation or regulatory proceedings and other legal disputes, which may include asserted class action litigation, such as those described in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this report. Regulatory proceedings might involve allegations such as false claims, healthcare fraud and abuse, and antitrust violations. Civil litigation proceedings might involve commercial, employment, environmental, intellectual property, tort and other claims. Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations. The outcome of legal disputes is difficult to predict. Outcomes can occur that are not justified by the evidence or existing law. The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter is favorably resolved. Accordingly, any legal dispute might have a materially adverse impact on our reputation, our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience losses not covered by insurance.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to risks that are inherent in the distribution, manufacturing, dispensing and administration of pharmaceuticals and medical-surgical supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans. For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs and expiration of drugs. Although we seek to maintain adequate insurance coverage, such as property insurance for inventory and professional and general liability insurance, coverages on acceptable terms might be unavailable, or coverages might not cover our losses. We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability. Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience costly legal disputes, government actions and adverse publicity regarding our role in distributing controlled substances such as opioids.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in approximately 3,200 cases alleging claims related to the distribution of controlled substances (opioids), as described in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this report. We regularly are named as a defendant in similar, new cases. The plaintiffs in those cases include governmental entities (such as states, provinces, counties and municipalities) as well as businesses, groups and individuals. The cases allege violations of controlled substance laws and other laws, and they make common law claims such as negligence and public nuisance. Many of these cases raise novel theories of liability. Any proceedings can have unexpected outcomes that are not justified by evidence or existing law. All proceedings involve significant expense, management time and distraction, and risk of loss that can be difficult to predict or quantify. It is not uncommon for claims to be resolved over many years. Proceedings can result in monetary damages, penalties and fines, and injunctive or other relief. Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome. Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations. The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience increased costs to distribute controlled substances such as opioids.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict. For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation. Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive, complex and challenging healthcare and other laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our industry is highly regulated, and further regulation of our distribution businesses and technology products and services could impose increased costs, negatively impact our profit margins and the profit margins of our customers, delay the introduction or implementation of our new products, or otherwise negatively impact our business and expose the Company to litigation and regulatory investigations. For example, we are subject to many environmental and hazardous materials regulations, including those relating to radiation-emitting equipment operated at U.S. Oncology Network practices. Additionally, we are subject to various routine agency (e.g., Drug Enforcement Administration (&#8220;DEA&#8221;), the U.S. Food and Drug Administration (&#8220;FDA&#8221;)) inspections to determine compliance with various federal regulations. Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive and frequently changing local, state and federal laws and regulations relating to healthcare fraud, waste and abuse.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Local, state and federal governments continue to strengthen their position and scrutiny over practices involving or allegedly involving fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs. Our relationships with pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to laws and regulations on fraud and abuse, which among other things: (1) prohibit persons from soliciting, offering, receiving or paying any remuneration in order to induce the referral of a patient for treatment or to induce the ordering or purchasing of items or services that are in any way paid for by Medicare, Medicaid or other government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such as Medicare and Medicaid. Many of these laws, regulations, and government guidance, including those relating to marketing incentives, are vague or indefinite and have not been interpreted by the courts. The laws may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations. Failures to comply with applicable laws subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs. These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the operating and security standards of the DEA, the FDA, various state boards of pharmacy, state health departments, Department of Health and Human Services (&#8220;HHS&#8221;), the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) and other comparable agencies. Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, HHS, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale. For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances. Noncompliance with these requirements has resulted in monetary penalties and/or licensing sanctions. For example, under a January 2017 agreement with the DEA and Department of Justice we paid $150 million to settle potential administrative and civil claims about our practices for reporting suspicious orders of controlled substances and the DEA suspended, on a staggered basis for limited periods of time, our registrations to distribute certain controlled substances from four distribution centers. As of March&#160;31, 2021, suspensions at the four distribution centers had all expired by their own terms. If we are not able to obtain, maintain or renew permits, licenses or other regulatory approvals needed for the operation of our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pedigree tracking laws increase our compliance burden and our pharmaceutical distribution costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been increasing efforts by governments to regulate the pharmaceutical distribution system in order to prevent the introduction of counterfeit, adulterated and/or mislabeled drugs into the pharmaceutical distribution system, otherwise known as pedigree tracking. For example, the U.S. Drug Quality and Security Act of 2013 (&#8220;DQSA&#8221;) requires us to participate in a federal prescription drug track and trace system that preempts state drug pedigree requirements, and the U.S. Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs. We also have record-keeping and other obligations under the E.U. Falsified Medicines Directive. Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs, and they might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy and data protection laws increase our compliance burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction. For example, under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) we must maintain administrative, physical and technological safeguards to protect individually identifiable health information (&#8220;protected health information&#8221;) and ensure the confidentiality, integrity and availability of electronic protected health information. We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation in the European Union (&#8220;GDPR&#8221;), the Personal Information Protection and Electronic Documents Act (&#8220;PIPEDA&#8221;) in Canada, and the California Consumer Protection Act (&#8220;CCPA&#8221;). Some privacy laws prohibit the transfer of personal information to certain other jurisdictions. We are subject to privacy and data protection compliance audits or investigations by various government agencies. Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, and other costs. We also have contractual obligations to customers that might be breached if we fail to comply with privacy laws. Our efforts to comply with privacy laws complicates our operations and adds to our compliance costs. A significant privacy breach or failure to comply with privacy laws might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-bribery and anti-corruption laws increase our compliance burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws prohibiting improper payments and bribery, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar regulations in foreign jurisdictions. The U.K. Bribery Act, for example, prohibits both domestic and international bribery, as well as bribery across both private and public sectors. An organization that fails to prevent bribery committed by anyone associated with the organization can be charged under the U.K. Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery. Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company and Operational Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might record significant charges from impairment to goodwill, intangibles and other assets or investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required under U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) to test our goodwill for impairment annually or more frequently if indicators for potential impairment exist. Indicators that are considered include significant changes in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends or a significant decline in the Company&#8217;s stock price and/or market capitalization for a sustained period of time. In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable. Factors that may be considered a change in circumstances indicating that the carrying value of our intangible and other long-lived assets may not be recoverable include slower growth rates, the loss of a significant customer, burdensome new laws or divestiture of a business or asset for less than its carrying value. There are inherent uncertainties in management&#8217;s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible and other long-lived assets. Any material changes in key assumptions, including failure to meet business plans, negative changes in government reimbursement rates, a deterioration in the U.S. and global financial markets, an increase in interest rate or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may decrease the projected cash flows or increase the discount rates and could potentially result in an impairment charge. For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments. We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our external service providers use technology and systems to perform our business operations, such as the secure electronic transmission, processing, storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce. Despite physical, technical, and administrative security measures, our technology systems and operations have been, and likely will continue to be, subject to cyberattacks from sources beyond our control. Cybersecurity incidents include actual or attempted unauthorized access, tampering, malware insertion, ransomware attacks or other system integrity events. The risk of cyberattacks may be increased due to a variety of factors, both internal and external. A cybersecurity incident might involve a material data breach or other material impact to the integrity and operations of our technology systems, which might result in litigation or regulatory action, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business operations, reputation, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience significant problems with information systems or networks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on sophisticated information systems and networks to perform our business operations, such as to obtain, rapidly process, analyze and manage data that facilitate the purchase and distribution of thousands of inventory items from distribution centers. If those information systems suffer errors, interruptions, or become unavailable, there might be a materially adverse impact on our business operations, reputation, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products or services might not conform to specifications or perform as we intend.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market. Healthcare professionals delivering patient care tend to have heightened sensitivity to system and software errors. If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients. Errors or failures might damage our reputation and negatively affect future sales. A failure of a system or software to conform to specifications might constitute a breach of warranty that could result in repair costs, contract termination, refunds of amounts previously paid or claims for damages. Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be impeded in providing customers online services and data access.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide remote services that involve hosting customer data and operating software on our own or third party systems. Our customers rely on their ability to access the systems and their data as needed. The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cyberattacks. If the timely delivery of medical care or other customer business requirements are impaired by data access, network or systems problems, we could be exposed to significant claims and reputational harm. Any such problems might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might not realize expected benefits from business process initiatives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may implement restructuring, cost reduction or other business process initiatives that might result in extraordinary charges and expenses, failures to achieve our desired objectives, or unintended consequences such as distraction of our management and employees, business disruption, attrition beyond any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be unable to successfully complete or integrate acquisitions or other business combinations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business. To fund acquisitions, we may require financing that may not be available on acceptable terms. We may not receive regulatory approvals needed to complete proposed transactions, or such approvals may be subject to delays or conditions that reduce transaction benefits. Achieving the desired outcomes of business combinations involves significant risks including: diverting management&#8217;s attention from other business operations; challenges with assimilating the acquired businesses, such as integration of operations and systems; failure or delay in realizing operating synergies; difficulty retaining key acquired company personnel; unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business. Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive forum provisions in our Bylaws could limit our stockholders&#8217; ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Court of Chancery of the State of Delaware or the United States District Court for the District of Delaware if the Court of Chancery does not have or declines to accept jurisdiction (collectively, &#8220;Delaware Courts&#8221;). Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action. These provisions of the bylaws are not a waiver of, and do not relieve anyone of duties to comply with, federal securities laws including those specifying the exclusive jurisdiction of federal courts under the Exchange Act and concurrent jurisdiction of federal and state courts under the Securities Act. To the extent that these provisions of the bylaws limit a current or former stockholder&#8217;s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders. A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations and our financial position or results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by delays or other difficulties with divestitures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we decide to sell assets or a business, we may encounter difficulty in finding buyers or exit strategies on acceptable terms or in a timely manner, which could delay the achievement of our strategic objectives. After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected. We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture. We might have financial exposure in a divested business, such as through minority equity ownership, financial or performance guarantees, indemnities or other obligations, such that conditions outside of our control might negate the expected benefits of the disposition. Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might not realize the expected tax treatment from our split-off of Change Healthcare.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed a separation of its interest in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;). The divestiture was effected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (the &#8220;Exchange Offer&#8221;), followed by a merger of SpinCo with and into Change Healthcare Inc. (&#8220;Change&#8221;), with Change surviving the merger (the &#8220;Merger&#8221; and, together with the Exchange Offer, the &#8220;Transactions&#8221;). The Company received an opinion from outside legal counsel to the effect that the Transactions qualified as generally tax-free transactions to the Company and its shareholders for U.S. federal income tax purposes. An opinion of legal counsel is not binding on the Internal Revenue Service (the &#8220;IRS&#8221;) or the courts, and the IRS or the courts may not agree with the intended tax-free treatment of the Transactions. In addition, the opinion could not be relied upon if certain assumptions, representations and undertakings upon which the opinion was based are materially inaccurate or incomplete, or are violated in any material respect. If the intended tax-free treatment of the Transactions is not sustained, the Company and its stockholders who participated in the Transactions may be required to pay substantial U.S. federal income taxes. In connection with the Transactions, the Company, SpinCo, Change and the Change Healthcare JV entered into the Tax Matters Agreement, which governs their respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, tax contests and other tax sharing regarding U.S. federal, state and local, and non-U.S. taxes, other tax matters and related tax returns. Under the Tax Matters Agreement, Change is required to indemnify the Company if the Transactions become taxable as a result of certain actions by Change or SpinCo, or as a result of certain changes in ownership of the stock of Change after the Merger. If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by outsourcing or similar third-party relationships.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to perform certain business and administrative functions for us. We might not adequately develop, implement and monitor these outsourced service providers, and we might not realize expected cost savings or other benefits. Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services. For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in retail pharmacy operations or maintaining profitability.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy included expanding our retail pharmacy operations. Our retail pharmacy operations involve numerous risks, such as the following ones. We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market preferences. Competition from our retail pharmacy operations might strain relationships with our retail pharmacy customers. Consolidation of retail pharmacies with third party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability. Failure to maintain profitable retail pharmacy operations may result in significant costs, including those associated with site closures and reductions in workforce. If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our revenue from, and have a significant portion of our accounts receivable with, a small number of customers. At March&#160;31, 2021, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 19% of our trade receivables, and those of our ten largest customers combined accounted for approximately 51% of our consolidated revenues and approximately 32% of our trade receivables. A material default in payment, reduction in purchases, or the loss of business from a large customer might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our contracts with government entities involve future funding and compliance risks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with government entities are subject to risks such as lack of funding and compliance with unique requirements. For example, government contract purchase obligations are typically subject to the availability of funding, which may be eliminated or reduced. In addition, the future volume of products or services purchased by a government customer is uncertain. Our government contracts might not be renewed or might be terminated for convenience with little or no prior notice. Government contracts typically expose us to higher potential liability than do other types of contracts. In addition, government contracts typically are subject to procurement laws that include socio-economic, employment practices, environmental protection, recordkeeping and accounting and other requirements. For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations. We are subject to government audits, investigations and oversight proceedings. Government agencies routinely review and audit government contractors to determine whether they are complying with contractual and legal requirements. If we fail to comply with these requirements, or we fail an audit, we are subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work. These requirements complicate our business and increase our compliance burden. The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate as a distributor in government-sponsored vaccination programs, such as the U.S. government&#8217;s COVID-19 distribution program (&#8220;Federal COVID-19 Response&#8221;). We also provide supplies used for vaccine administration in the Federal COVID-19 Response. Our participation in such programs exposes us to various uncertainties. For example, the novel nature of the SARS-CoV&#8209;2 virus and the broad scope of the ongoing COVID-19 vaccine distribution program introduce uncertainty about what volumes of products may become available for distribution by us, the effectiveness of vaccines, and the cost of distribution. Because of such uncertainties, our operating results may be subject to variability. Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges. Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business. Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We might be harmed by changes in our relationships or contracts with suppliers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to structure our pharmaceutical distribution agreements with manufacturers to ensure that we are appropriately and predictably compensated for the services we provide. Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot control the frequency or magnitude of pharmaceutical price changes. We might be unable to renew pharmaceutical distribution agreements with manufacturers in a timely and favorable manner. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might infringe intellectual property rights or our intellectual property protections might be inadequate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our products and services do not infringe the proprietary rights of third parties, but third parties have asserted infringement claims against us and may do so in the future. If a court were to hold that we infringed other&#8217;s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions. We rely on trade secret, patent, copyright and trademark laws, nondisclosure obligations and other contractual provisions and technical measures to protect our proprietary rights in our products and solutions. We might initiate costly and time-consuming litigation to protect our trade secrets, to enforce our patent, copyright and trademark rights and to determine the scope and validity of the proprietary rights of others. Our intellectual property protection efforts might be inadequate to protect our rights. Our competitors might develop non-infringing products or services equivalent or superior to ours. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be unable to successfully recruit and retain qualified employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract, engage, develop and retain qualified and experienced employees, including key executives and other talent, is essential for us to meet our objectives. We compete with many other businesses to attract and retain employees. Competition among potential employers might result in increased salaries, benefits or other employee-related costs, or in our failure to recruit and retain employees. We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles. Employees might not successfully transition into new roles. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry and Economic Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems. The healthcare industry and related government programs are changing. Some of these changes increase our risks and create uncertainties for our business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, some changes in reimbursement methodologies (including government rates) for pharmaceuticals, medical treatments and related services reduce profit margins for us and our customers and impose new legal requirements on healthcare providers. Those changes have included cuts in Medicare and Medicaid reimbursement levels, changes in the basis for payments, shifting away from fee-for-service and towards value-based payments and risk-sharing models, and increases in the use of managed care.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Patient Protection and Affordable Care Act (&#8220;ACA&#8221;) significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. There are continued efforts to challenge the ACA. There are also efforts to broaden healthcare coverage. U.S. lawmakers also have explored proposals to reduce drug prices, including requiring price transparency and drug importation measures. These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, PBM, managed care organizations and other industry stakeholders look to implement new transactional flows and adapt their business models.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs. For example, provincial governments have taken steps to reduce consumer prices for generic pharmaceuticals and, in some provinces, change professional allowances paid to pharmacists by generic manufacturers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many European governments provide or subsidize healthcare to consumers and regulate pharmaceutical prices, patient eligibility and reimbursement levels in order to control government healthcare system costs. Some European governments have implemented or are considering austerity measures to reduce healthcare spending. These measures exert pressure on the pricing and reimbursement timelines for pharmaceuticals and may cause our customers to purchase fewer of our products and services or influence us to reduce prices.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there is substantial uncertainty about the likelihood, timing and results of these health reform efforts, their implementation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by competition and industry consolidation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses face a highly competitive global environment with strong competition from international, national, regional and local full-line, short-line and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies and large payer organizations. In addition, our businesses face competition from various other service providers and from pharmaceutical and other healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses. Due to consolidation, a few large suppliers control a significant share of the pharmaceuticals market. This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers. Many of our customers, including healthcare organizations, have consolidated and have greater power to negotiate favorable prices. Consolidation by our customers, suppliers and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin. Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants. These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by changes or disruptions in product supply.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our supply arrangements might be interrupted or adversely affected by a variety of causes over which we have no control, such as export controls or trade sanctions, labor disputes, unavailability of key manufacturing sites, inability to procure raw materials, quality control concerns, ethical sourcing issues, supplier&#8217;s financial distress, natural disasters, civil unrest or acts of war. Our inventory might be requisitioned, diverted or allocated by government order such as under emergency, disaster and civil defense declarations. For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships. Changes in the healthcare industry&#8217;s or our suppliers&#8217; pricing, selling, inventory, distribution or supply policies or practices could significantly reduce our revenues and net income. We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals. Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted as a result of our distribution of generic pharmaceuticals.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our generic pharmaceuticals distribution business is subject to pricing risks. We might be adversely impacted if our ClarusONE generic pharmaceutical sourcing joint venture with Walmart, Inc. is unsuccessful or experiences margins declines. Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents. The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims. These risks, as well as changes in the availability, pricing volatility, reimbursement rates for generic drugs, or significant changes in the nature, frequency or magnitude of generic pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by an economic slowdown or recession.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An economic slowdown or recession affecting our businesses in one or more regions could reduce the prices our customers are able or willing to pay for our products and services and the volume of their purchases. This risk is increased by the COVID-19 pandemic. Any economic slowdown or recession might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volatility and disruption in global capital and credit markets, including the bankruptcy or restructuring of certain financial institutions, reduced lending activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing. We generally sell our products and services under short-term unsecured credit arrangements. An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us. Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit. Suppliers might be unable to make payments due to us for fees, returned products or incentives. These risks are increased by the COVID-19 pandemic. Interest rate increases or changes in capital market conditions might impede our or our customers&#8217; or suppliers&#8217; ability or cost to obtain credit. Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulties in sourcing or selling products due to a variety of causes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We might experience difficulties and delays in sourcing and selling products due to a variety of causes, such as: difficulties in complying with the legal requirements for export or import of pharmaceuticals or components; suppliers&#8217; failure to satisfy production demand; manufacturing or supply problems such as inadequate resources; and real or perceived quality issues. Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions. The FDA banned certain manufacturers from selling raw materials and drug ingredients in the U.S. due to quality issues. The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by tax legislation or challenges to our tax positions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the tax laws in the U.S. at the federal, state and local government levels and to the tax laws of many other jurisdictions in which we operate or sell products or services. Tax laws might change in ways that adversely affect our tax positions, effective tax rate and cash flow. The tax laws are extremely complex and subject to varying interpretations. We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us. Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts. Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals. Any of these risks might have a materially adverse impact on our business operations, our cash flows and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by the Brexit withdrawal of the United Kingdom from the European Union.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operations in the U.K. and the European Union (&#8220;E.U.&#8221;) and face risks associated with the uncertainty and potential disruptions that might follow the U.K. withdrawing from the European Union (&#8220;Brexit&#8221;). Brexit could adversely affect political, regulatory, economic or market conditions and contribute to instability in global political institutions, regulatory agencies and financial markets. For example, we might experience volatility in exchange rates and interest rates and changes in laws regulating our U.K. operations. Customers might reduce purchases due to the uncertainty caused by Brexit. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by fluctuations in foreign currency exchange rates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business in various currencies, including the U.S. dollar, euro, British pound sterling and Canadian dollar. Changes in foreign currency exchange rates could reduce our revenues, increase our costs or otherwise adversely affect our financial results reported in U.S. dollars. For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar. We also have currency exchange risk due to intercompany loans denominated in various currencies. The COVID-19 pandemic has affected and might increase currency exchange rate volatility. We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge a portion of our foreign currency exchange rate risks. These hedging activities may not completely offset the adverse financial effects of unfavorable movements in foreign currency exchange rates during the time the hedges are in place. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events and other catastrophic events.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We might be adversely affected by events outside of our control, including: widespread public health issues, such as epidemic or pandemic infectious diseases; natural disasters such as earthquakes, floods or severe weather; political events such as terrorism, military conflicts and trade wars; and other catastrophic events. These events can disrupt operations for us, our suppliers, our vendors, and our customers. For example, in February 2021, a severe winter storm affecting the United States temporarily impacted our distribution business operations, primarily in Texas. They might affect consumer confidence levels and spending. In response to these events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate. In particular, the rapid and widespread transmission of the SARS-CoV-2 novel coronavirus beginning in late 2019 impacts us in significant ways. For example, to mitigate the spread of the COVID-19 disease caused by SARS-CoV-2, we implemented travel restrictions and remote working arrangements for most of our employees in order to minimize physical contact, and we implemented additional sanitation and personal protection measures in our warehouse, retail pharmacy and delivery operations. These measures might not fully mitigate COVID-19 risks to our workforce and we could experience unusual levels of absenteeism that might impair operations and delay delivery of products. The COVID-19 pandemic affects product manufacturing, supply and transport availability and cost. The pandemic reduces demand for some products due to delays or cancellations of elective medical procedures, consumer self-isolation and business closures, among other reasons. The COVID-19 pandemic influences shortages of some products, with product allocation resulting in delivery delays for customers. The ongoing impacts of the pandemic might cause a general economic slowdown or recession in one or more markets, disruptions and volatility in global capital markets and other broad and adverse effects on the economy, business conditions, commercial activity and the healthcare industry. The pandemic might impact our business operation, financial position and results of operation in unpredictable ways that depend on highly uncertain future developments, such as determining the effectiveness of current or future government actions to address the public health or economic impacts of the pandemic. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-term effects of climate change are difficult to predict and may be widespread. The impacts may include physical risks (such as rising sea levels or frequency and severity of extreme weather conditions), social and human effects (such as population dislocations or harm to health and well-being), compliance costs and transition risks (such as regulatory or technology changes) and other adverse effects. The effects could impair, for example, the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require. We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory, and business interruption due to weather events that may be attributable to climate change. These events and impacts could materially adversely affect our business operations, financial position or results of operation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by changes in accounting standards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are subject to the application of U.S. GAAP, which periodically is revised or reinterpreted. From time to time, we are required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the Financial Accounting Standards Board (&#8220;FASB&#8221;) and the SEC. It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems. Such changes might have a materially adverse impact on our financial position or results of operations.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_19"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_22"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the nature of our principal businesses, our plant, warehousing, retail pharmacies, office and other facilities are operated in widely dispersed locations, primarily throughout North America and Europe. Retail pharmacies and most warehouses are typically owned or leased on a long-term basis. We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels. Information as to material lease commitments is included in Financial Note 11, &#8220;Leases,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_25"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain legal proceedings in which we are involved are discussed in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements appearing in this Annual Report on Form&#160;10-K. Disclosure of an environmental proceeding where a governmental agency is a party generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_28"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_31"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding the executive officers of the Company, including their principal occupations during the past five years. The number of years of service with the Company includes service with predecessor companies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships between any of the executive officers or directors of the Company. The executive officers are elected on an annual basis generally and their term expires at the first meeting of the Board of Directors (&#8220;Board&#8221;) following the annual meeting of stockholders, or until their successors are elected and have qualified, or until death, resignation, or removal, whichever is sooner.</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Position with Registrant and Business Experience</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer since April 2019; President and Chief Operating Officer from August 2018 to March 2019; Chairman of the Management Board of McKesson Europe AG from 2017 to 2018; President and Chief Operating Officer, McKesson Europe from 2016 to 2017; President of North America Distribution and Services from 2015 to 2016; Executive Vice President, Corporate Strategy and Business Development from 2012 to 2015; and a director since April 2019.&#160;Service with the Company - 24 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Britt J. Vitalone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer since January 2018; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical from July 2014 to December 2017; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical and Specialty Health from October 2017 to December 2017; Senior Vice President of Corporate Finance and M&amp;A Finance from March 2012 to June 2014.&#160;Service with the Company - 15 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy Faber</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Human Resources Officer since October 2019. Previously, Senior Vice President of Human Resources. Service with the Company - 10 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nancy Flores</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Information Officer and Chief Technology Officer since January 2020; Chief Information Officer, Johnson Controls from 2018 to July 2019. Corporate Officer and Vice President of Business and Technology Services, Abbott Laboratories from 1996 to 2018. Service with the Company - 1 year.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tom Rodgers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Strategy Officer since June 2020. Previously Senior Vice President and Managing Director of McKesson Ventures from 2014-2020. Service with the Company - 7 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lori A. Schechter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer and General Counsel since June 2014; Associate General Counsel from January 2012 to June 2014; Litigation Partner, Morrison &amp; Foerster LLP from 1995 to December 2011. Service with the Company - 9&#160;years.</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_34"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_37"></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal market on which our common stock is traded is the New York Stock Exchange (&#8220;NYSE&#8221;) under the trading symbol of &#8220;MCK.&#8221;</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holders: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of record holders of our common stock at March&#160;31, 2021 was approximately 4,841.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In July 2020, our quarterly dividend was raised from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board.&#160;We declared regular cash dividends of $1.67 and $1.62 per share in the years ended March&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Information relating to this item is provided under Part III, Item 12, to this Annual Report on Form 10-K.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last three years, our share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in May 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to our Split-off of the Change Healthcare JV as described in Financial Note 20, &#8220;Stockholders' Equity&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">$8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on our Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we retired&#160;5.0 million&#160;or&#160;$542 million&#160;of our treasury shares previously repurchased. Under the applicable state law, these shares resume the status of authorized and unissued shares upon retirement. In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings. Accordingly, our retained earnings and additional paid-in capital were reduced by&#160;$472 million&#160;and $70 million, respectively, during 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our share repurchases during the fourth quarter of 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021 - January 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2021 - February 28, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2021 - March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Price Performance Graph*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The following graph compares the cumulative total stockholder return on our common stock for the periods indicated with the Standard &amp; Poor&#8217;s 500 Index and the S&amp;P 500 Health Care Index. The S&amp;P 500 Health Care Index was selected as a comparator because it is generally available to investors and broadly used by other companies in the same industry.</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><img src="mck-20210331_g2.jpg" alt="mck-20210331_g2.jpg" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* Assumes $100 invested in McKesson Common Stock and in each index on March 31, 2016 and that all dividends are reinvested.</span></div></td></tr></table></div><div id="i08f9baf810c0412e93ea6effc6d22995_2579"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Reserved.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_43"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See Item 1 - Business - Forward-Looking Statements in Part I of this Annual Report on Form 10-K for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a list of certain risk factors applicable to our business, financial condition, and results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. We partner with life sciences companies, manufacturers, providers, pharmacies, governments, and other healthcare organizations to help provide the right medicines</span><span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We implemented a new segment reporting structure commencing with the second quarter of 2021, which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). Other, for retrospective periods presented, consists of our equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect our new segment structure and current period presentation. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021. Refer to Financial Note 22, &#8220;Segments of Business,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for further information regarding our reportable segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, previously the U.S. Pharmaceutical and Specialty Solutions reportable segment, continues to distribute branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a new reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;) and was unaffected by the segment realignment.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">RxTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a new reportable segment that brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve our biopharma and life sciences partners and patients. RxCrossroads was previously included in our former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the year ended March 31, 2021. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coronavirus disease 2019 (&#8220;COVID-19&#8221;) impacted our results of operations for the year ended March 31, 2021. Following the declaration of COVID-19 as a global pandemic by the World Health Organization (&#8220;WHO&#8221;) on March 11, 2020, there was a temporary increase in demand for pharmaceuticals across our businesses. Subsequently, pharmaceutical distribution volumes decreased during the first quarter as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government shutdowns and shelter-in-place orders. The recovery from the COVID-19 pandemic continued to fluctuate throughout our fiscal year. We benefited from demand for COVID-19 tests, favorable contributions from our vaccine and related ancillary supply kit distribution programs as discussed further below, and savings from reduced travel and meetings throughout 2021;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expanded our existing contractual relationship with the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) through an amendment to our existing Vaccines for Children Program contract to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines. We have also partnered with the Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer to manage the assembly and distribution of the ancillary supplies needed to administer COVID-19 vaccines; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2020, we began distributing certain COVID-19 vaccines under the direction of the CDC. Through the end of the fiscal year, we had distributed approximately 100 million of COVID-19 vaccine doses. For a more in-depth discussion of how COVID-19 impacted our business, operations, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Revenues of $238.2 billion, reflects a 3% increase from the prior year primarily in our U.S. Pharmaceutical segment driven by market growth;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Gross profit increased 1% from the prior year primarily in our Medical-Surgical Solutions segment driven by sales of COVID-19 tests;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses in 2021 includes the following: </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a charge of $8.1 billion related to our estimated liability for opioid-related claims as further described in the Opioid-Related Litigation and Claims section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below; and</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">charges of $115&#160;million to impair certain long-lived assets within our International segment; partially offset by</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a net gain of $131&#160;million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Other income, net in 2021 includes net gains of $133&#160;million related to our equity investments;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Diluted loss per common share from continuing operations attributable to McKesson Corporation in 2021 of $28.26 reflects the aforementioned items, net of any respective tax impacts, and a lower share count compared to the prior year driven largely by the separation of our investment in Change Healthcare JV on March 10, 2020;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 1, 2020, we completed the contribution of our German pharmaceutical wholesale business to a newly formed joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;) in which we have a 30% ownership interest; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 3, 2020, we completed a public offering of 0.90% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $500&#160;million and repaid $1.0 billion of long-term debt in 2021. Refer to Financial Note 13, &#8220;Debt and Financing Activities,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for more information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We returned $1.0&#160;billion of cash to shareholders through $770&#160;million of common stock repurchases, including the value of equity awards surrendered for tax withholding, and $276&#160;million of dividend payments during 2021. On July 29, 2020, we raised our quarterly dividend from $0.41 to $0.42 per common share; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2021, our Board of Directors (the &#8220;Board&#8221;) approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#8217;s common stock. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, a novel strain of coronavirus, which causes the infectious disease known as COVID-19, was reported in Wuhan, China. The WHO declared COVID-19 a &#8220;Public Health Emergency of International Concern&#8221; on January 30, 2020 and a global pandemic on March 11, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate the nature and extent of the impacts COVID-19 has on our business and operations. The pandemic developed rapidly during our fourth quarter of 2020 and continued to evolve throughout 2021. Infection rates varied throughout our fiscal year, peaking in January 2021. A significant number of new COVID-19 cases continue to be reported, particularly in the U.S. These also include cases from new and emerging COVID-19 variants, which could have the potential to be more severe, spread more easily, require different treatments, or change the effectiveness of current vaccines. However, vaccines which have met the U.S. Food and Drug Administration&#8217;s (&#8220;FDA&#8217;s&#8221;) standards for safety, effectiveness, and manufacturing quality needed to support Emergency Use Authorization (&#8220;EUA&#8221;), are currently being administered across the country, as further discussed below. As of March 31, 2021, nearly 154 million doses of COVID-19 vaccines have been administered in the U.S. according to the CDC. The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, federal, state, and local government directives and policies have been put in place in the U.S. to enhance availability of medications and supplies to meet the increased demand, assist front-line healthcare providers, manage public health concerns by creating social distancing, and address the economic impacts, including sharply reduced business activity, increased unemployment, and overall uncertainty presented by this healthcare emergency. Similar governmental actions have occurred in Canada and Europe, the timing of which has varied across geographies. In December 2020, the FDA issued an EUA for the Pfizer-BioNTech COVID-19 vaccine manufactured by Pfizer, Inc. (&#8220;Pfizer Vaccine&#8221;) and the Moderna COVID-19 vaccine manufactured by ModernaTX, Inc. (&#8220;Moderna Vaccine&#8221;) to be distributed in the U.S. These authorizations were followed by an EUA for the Janssen COVID-19 vaccine manufactured by Janssen Biotech Inc., a Janssen pharmaceutical company of Johnson &amp; Johnson, (&#8220;Janssen Vaccine&#8221;) in February 2021. Government-coordinated administrative or allocation decisions at the federal, state, and local levels may cause variability in the timing and volume of COVID-19 vaccine distribution and administration activities. Our role in the distribution of COVID-19 vaccines in the U.S. as well as the assembly and distribution of related ancillary supply kits is discussed further below. Similar COVID-19 vaccine authorizations have occurred in Canada and Europe. McKesson Canada&#8217;s corporately owned retail pharmacy chain, Rexall, as well as independent pharmacy banners are supporting Canada&#8217;s vaccination efforts. McKesson Europe is also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines across several European countries, but administering them in pharmacies as well.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, we are well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (&#8220;PPE&#8221;), and medicine reach our customers and patients. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response to COVID-19 in the Workplace</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees. The various responses we put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19. We expanded employee medical benefits covering COVID-19 related visits, treatments, and testing as well as expanded telehealth options to protect employee safety. We provided further support including additional emergency leave and an internal paid time off donation platform for employees impacted by COVID-19. For employees whose roles require presence at our facilities, we enhanced safety by promoting the practice of social distancing, providing reminders to wash or disinfect hands and avoid unnecessary face touching, making face masks available, placing hand sanitizers within our operating environments, and periodically cleaning and disinfecting our facilities. For employees whose roles do not require presence at our facilities, we added technology resources to support their working remotely. These responses were initially put in place during our fourth quarter of 2020. During the second quarter of 2021, we also implemented on-site workplace temperature screening as we continue to adapt our health and safety practices in response to the COVID-19 pandemic. When working in frozen vaccine storage environments, employees are provided with protective gear, including special clothing, gloves, and facial gear. These steps to protect employee safety have resulted in limited disruption from COVID-19 to our normal business operations, productivity trends, and have not materially impacted our operating expenses or operating margins.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the impact of our telecommuting and work-from-home policies on our system of internal controls and we have concluded that these policies did not have a material effect on our internal control over financial reporting during the year ended March 31, 2021. We also took various actions to mitigate the impact of COVID-19 on our results from operations through cost-containment and payroll-related expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the onset of the COVID-19 pandemic late in our fourth quarter of 2020, we experienced higher pharmaceutical distribution volumes and increased retail pharmacy foot traffic as our customers increased supplies on hand in March, which drove unfavorability in our results of operations when comparing 2021 versus 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we experienced growth in pharmaceutical distribution and specialty drug volumes at a lower rate in the U.S., while pharmaceutical distribution volumes decreased in Europe and Canada due to the COVID-19 pandemic, as compared to the same prior year period. Specialty drug volumes increased, but were negatively impacted by lower demand for elective specialty drugs, as compared to the same prior year period. We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors&#8217; offices, which was partially offset by demand for PPE and COVID-19 tests. Additionally, the decreased traffic in doctors&#8217; offices and general shelter-in-place guidance by governmental authorities negatively impacted retail pharmacy foot traffic in both Europe and Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we experienced improvements in prescription volumes and primary care patient visits during our second quarter of 2021, the impact and recovery of COVID-19 for the second half of our fiscal year was non-linear and tracked with patient mobility. We also saw increased demand for COVID-19 tests and continued sales of PPE throughout the year in our Medical-Surgical Solutions segment partially offset by the impacts of social distancing measures which resulted in a less severe cough, cold, and flu season, savings for reduced travel and meetings across the enterprise, as well as improvements of retail pharmacy foot traffic in Europe and Canada. The vaccine and related ancillary kit distribution in the U.S. favorably impacted our results in the second half of fiscal 2021 as further discussed below. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, we expanded our contractual relationship with the CDC through an amendment to our existing Vaccines for Children Program contract for the distribution of certain COVID-19 vaccines. The COVID-19 vaccine distribution agreement with the CDC was finalized during the third quarter of 2021. We support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines. In the centralized model, the U.S. government directs us on the distribution of the vaccines and related supplies to point-of-care sites across the country. We make no decisions on where products are to be distributed nor how the products are allocated between the various provider sites and ultimately administered to the individuals receiving a vaccine. We utilize our expertise and capabilities to support the CDC&#8217;s efforts to vaccinate everyone in the U.S. who wants to receive a COVID-19 vaccine. The CDC and McKesson collaborated similarly in response to the 2009 H1N1 pandemic. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began distributing the Moderna Vaccine in the U.S. and in March 2021, we began distributing the Janssen Vaccine. We may distribute other future authorized COVID-19 vaccines that are refrigerated or frozen. Ancillary supply kits may be shipped either together with the Moderna Vaccine and Janssen Vaccine or in advance of the vaccines. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. The Pfizer Vaccine, which is ultra-frozen, is not being distributed by McKesson, although we are providing ancillary supplies needed for its administration. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 23, 2020, we announced our contract with the HHS under which our Medical-Surgical Solutions segment manages the assembly and distribution of ancillary supply kits needed to administer COVID-19 vaccines, including sourcing some of those supplies. We also have an agreement with Pfizer to assemble and distribute ancillary supply kits needed to administer that particular COVID-19 vaccine. Ancillary supply kits include alcohol prep pads, face shields, surgical masks, needles and syringes, and other vaccine administration items. For the Pfizer Vaccine, ancillary supply kits also include the diluent needed to administer the ultra-frozen vaccine. We began assembling the ancillary supply kits in September 2020 in preparation for vaccine authorization and subsequent distribution. Ancillary supply kits to administer the Pfizer Vaccine are shipped directly to point-of-care sites, and all other ancillary supply kits are shipped to our dedicated vaccine distribution centers. The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment. The future financial impact of the arrangements with the CDC and HHS depend on numerous uncertainties, which are described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To manage the COVID-19 vaccine and ancillary supply kit distribution, we have set up special, dedicated vaccine distribution centers that include large-scale, custom freezers and refrigerators to safely store and process millions of vaccine doses. These facilities can scale to meet the demand of increasing volumes of vaccines being manufactured. We have also set up distribution centers for kitting and inventory management as part of our contract with the HHS. We are working with delivery partners to manage the delivery of vaccines and ancillary supply kits from our centralized vaccine distribution centers to point-of-care destinations as directed by the CDC. The capital expenditures we made during 2021 to prepare for vaccine and ancillary supply kit distribution were not material to our financial condition or liquidity.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March 31, 2021, the demand for COVID-19 tests, the year over year impact from PPE and other related products, net of inventory charges, as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately 20% in segment revenues and segment operating profit. Additionally, the distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment contributed approximately 2% in segment operating profit for the year ended March 31, 2021. During our fourth quarter of 2020, we experienced a temporary increase in demand for pharmaceuticals. Subsequently, during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes for the year ended March 31, 2021. During the year ended March 31, 2021, selling, distribution, general, and administrative expenses decreased as a result of the pandemic, largely due to savings from restricted travel and decreased meetings. The favorable reduction in selling, distribution, general, and administrative expenses was partially offset by increased costs of transport, costs for enhanced procedures to sanitize operating facilities, and costs of providing PPE and other related products for employee use. Additionally, increased costs for certain PPE compressed our margins. Certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels. That inventory valuation, if not supported by market resale prices, may be written down to net realizable value. We may also write-off inventory due to decreased customer demand and excess inventory. During the year ended March 31, 2021, we recorded charges totaling $136&#160;million in cost of sales on certain PPE and other related products due to inventory impairments and excess inventory in our Medical-Surgical Solutions segment. Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods, we are taking measures to mitigate such risk. Overall, these COVID-19 related items had a net favorable impact on consolidated income (loss) from continuing operations before income taxes for the year ended March 31, 2021 compared to the prior year. Impacts to future periods due to COVID-19 may differ based on future developments, which is described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were able to maintain appropriate labor and overall vendor supply levels during the year ended March 31, 2021. Our inventory levels have fluctuated in response to supply availability and customer demand patterns for certain products, with varying inventory level impacts depending on the specific product within our portfolio. We collaborated closely with the federal government and other healthcare stakeholders to source more critical PPE to the U.S. This collaboration expedited the shipment of critical medical supplies to areas hit hardest by COVID-19, as identified by the Federal Emergency Management Agency. As our supply levels improve, and the federal government evolves guidance on the prioritization of providers or geographic markets, we will continue to adapt our distribution policies. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) to address the economic impact of the COVID-19 pandemic. Among other things, the CARES Act provides certain changes to tax laws and includes provisions to provide relief for citizens, companies, healthcare providers and patients, and others. We have deferred certain employer payroll taxes and continue to monitor the potential impact of other tax legislation changes as result of the CARES Act, including refundable payroll tax credits on certain qualified wages. We anticipate changes due to the CARES Act in the timing of certain cash flows, with no material impact to our financial results for the year ended March 31, 2021. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021 (the &#8220;CA Act&#8221;), which enhances and expands certain provisions of the CARES Act. The CA Act did not have a material impact on our financial condition, results of operations, or liquidity for the year ended March 31, 2021 nor do we currently expect a material impact on our future financial results. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated balance sheets and ability to maintain financial liquidity remains strong. We have experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses. We remain well-capitalized with access to liquidity from our revolving credit facility. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Supply Chain </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to monitor the COVID-19 pandemic impacts on our supply chain. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by the COVID-19 pandemic, we are proactively working with manufacturers, industry partners, and government agencies to meet the needs of our customers during the pandemic. We have assembled a Critical Care Drug Task Force, made up of our procurement specialists, clinical health systems pharmacists, and supply chain professionals, that is focused on securing additional product where available, sourcing back-up products, and protecting our operations across all locations and facilities. We are also working with manufacturers through several channels, including our ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;) and global sourcing teams in London, and our leaders are actively engaged in addressing potential shortages. We have engaged with industry partners and government agencies to gain visibility into supply and demand. Additionally, we have a robust Business Continuity and Disaster Recovery Program (&#8220;BCRP&#8221;) and we have proactively enhanced our BCRP in response to the COVID-19 pandemic to protect the supply chain to minimize disruption in healthcare, protect our customers, ensure the safety and security of our employees and workplaces, and ensure the continuity of critical business processes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The situation remains fluid and we are taking a proactive approach to protect inventory during this crisis and ensure our provider partners have needed supplies and medications to help prevent the spread of the disease and treat those that are ill. COVID-19 has put an unprecedented strain on the supply of high-demand PPE, including N95 masks, gloves, as well as disinfecting sprays and wipes. The supply chain has improved over the initial impact of pandemic-related demand, and we continue to closely monitor demand by customer type and certain PPE and infection prevention items are still in short supply. Our allocation approach has helped us avoid stock outs in many critical product categories, allowing us to provide PPE supplies to many more customers for a much longer time. We anticipate these market conditions will remain for the foreseeable future. Our efforts to help the supply chain have included sourcing products from new suppliers all over the world, working closely with the federal government to help with the nation&#8217;s response and collaborating with partners to source, develop, and deliver new products to market. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Forward-Looking Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity. The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new strains or variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the effectiveness of COVID-19 vaccines and governmental measures in controlling the spread of the virus; and the effectiveness of treatments of infected individuals. Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will return remains challenging. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts. Material changes to key assumptions and estimates can decrease the projected cash flows or increase the discount rates and have resulted in impairment charges of certain long-lived assets as disclosed in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K, and could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of this Annual Report on Form 10-K for a disclosure of risk factors related to COVID-19.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in approximately 3,200 legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. Those proceedings include approximately 2,900 federal cases and approximately 300 state court cases throughout the U.S., and cases in Puerto Rico and Canada. We continue to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions and other government entities (&#8220;governmental entities&#8221;). We are in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework under which, in order to resolve the claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by us, of which more than 90% is anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#8217; attorneys fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have concluded that discussions under that framework have reached a stage at which a broad settlement of opioid claims by governmental entities is probable, and the loss related thereto can be reasonably estimated as of March&#160;31, 2021. As a result of that conclusion, and our assessment of certain other opioid-related claims, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims. Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#8220;Long-term litigation liabilities&#8221; in our Consolidated Balance Sheet as of March&#160;31, 2021. Moreover, in light of this uncertainty, the amount of any ultimate loss may differ materially from the amount accrued. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continue to be involved in discussions regarding a potential broad settlement framework, we also continue to prepare for trial in these pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10&#8209;K for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Opioid Statutes </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect our business in ways that we may not be able to predict. In April 2018, the State of New York adopted the Opioid Stewardship Act (&#8220;OSA&#8221;) which required the imposition of an annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State of New York appealed to the U.S. Court of Appeals for the Second Circuit. The State of New York has subsequently adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018. The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the U.S. Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The due date for filing such a petition is May 17, 2021. Unless the appellate court&#8217;s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years. During the second quarter of 2021, we reflected an estimated liability of $50&#160;million for the OSA surcharge in our accompanying consolidated financial statements on the assumption that the appellate court&#8217;s decision will stand. Refer to Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10&#8209;K for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.987%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,754&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,340)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">- </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the years ended March&#160;31, 2021 and 2020 compared to the respective prior years primarily due to market growth, including expanded business with existing customers, within our U.S. Pharmaceutical segment. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the year ended March&#160;31, 2021 compared to the prior year primarily in our Medical-Surgical Solutions segment driven by the demand for COVID-19 tests and the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines, partially offset by the unfavorable impact from PPE and other related products largely due to inventory charges. Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S. Pharmaceutical segment. Gross profit was unfavorably impacted by the adverse impacts from COVID-19 largely during the first quarter of 2021, including disruptions of doctors&#8217; office operations, deferred or cancelled elective procedures, lower demand for pharmaceuticals, and overall reduction of foot traffic in pharmacies. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the year ended March 31, 2020 compared to the prior year primarily due to market growth in our Medical-Surgical Solutions segment, partially offset by unfavorable effects of foreign currency exchange fluctuations. Gross profit and gross profit margin for the year ended March 31, 2020 compared to the prior year were unfavorably impacted by lower gains from antitrust legal settlements, partially offset by higher last-in, first-out (&#8220;LIFO&#8221;) credits in 2020. The impact from COVID-19 increased gross profit by less than 1% and decreased gross profit margin by less than 10 basis points for the year ended March 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the years ended March&#160;31, 2021, 2020, and 2019 included LIFO inventory credits of $38&#160;million, $252&#160;million, and $210&#160;million, respectively. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. The higher LIFO credits in 2020 compared to 2019 is primarily driven by higher generic deflation. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Estimates&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section included in this Financial Review for further information. Gross profit for the years ended March&#160;31, 2021, 2020, and 2019 also included net cash proceeds received of $181&#160;million, $22&#160;million, and $202&#160;million, respectively, representing our share of antitrust legal settlements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary and description of the components of our total operating expenses for the years ended March&#160;31, 2021, 2020, and 2019 is as follows: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, and administrative expenses.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A. We have reclassified prior period amounts to conform to the current period presentation.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Goodwill impairments charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist. The resulting goodwill impairment charges are reflected within this line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">NM </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.07&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - computation not meaningful </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses and total operating expenses as a percentage of revenues increased for the year ended March&#160;31, 2021 compared to the prior year, and decreased for the year ended March&#160;31, 2020 compared to the prior year. Total operating expenses for the years ended March&#160;31, 2021, 2020, and 2019 were affected by the following significant items:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG&amp;A includes opioid-related costs of $153&#160;million, primarily related to litigation expenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects cost savings of $95&#160;million on travel and entertainment due to travel and meeting restrictions associated with COVID-19;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects charges of $58&#160;million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we have a 30% ownership interest within our International segment. Refer to Financial Note 3, &#8220;Held for Sale,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for more information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes a charge of $50&#160;million related to our estimated liability under the OSA as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A also includes lower operating expenses due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and a divestiture in our Medical-Surgical Solutions segment that closed in 2020; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Claims and litigation charges, net includes a charge of $8.1 billion related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Claims and litigation charges, net includes a net gain of $131&#160;million reflecting insurance proceeds received, net of attorneys' fees and expenses awarded to plaintiffs' counsel, in connection with the previously reported $175 million settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill impairment charges of $69&#160;million were recorded in connection with our segment realignment that commenced in the second quarter of 2021. Refer to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Goodwill Impairment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $115&#160;million primarily related to our retail pharmacy businesses in Canada and Europe within our International segment, and the remaining $219&#160;million primarily represents costs associated with our operating model and cost optimization efforts in our corporate headquarters and International segment; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes charges of $275 million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes opioid-related costs of $150 million, primarily related to litigation expenses;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net includes a settlement charge of $82 million recorded in connection with an agreement to settle all opioid-related claims filed by two Ohio counties;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $112 million, primarily for our United Kingdom (&#8220;U.K.&#8221;) business (mainly pharmacy licenses) and Rexall Health retail business (&#8220;Rexall Health&#8221;) (mainly customer relationships) within our International segment, and the remaining $156 million primarily represents employee severance and exit-related costs related to our 2019 restructuring initiatives, as further discussed below; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses includes higher SDG&amp;A due to our business acquisitions and to support business growth, as well as our technology initiatives, partially offset by favorable effects of foreign currency exchange fluctuations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes opioid-related costs of $114 million, primarily related to litigation expenses, and increased expenses due to our business acquisitions and to support growth, partially offset by a gain from an escrow settlement of $97 million representing certain indemnity and other claims related to our 2017 acquisition of Rexall Health and a credit of $90 million for the derecognition of a liability related to the tax receivable agreement (&#8220;TRA&#8221;) payable to the shareholders of Change Healthcare, Inc. (&#8220;Change&#8221;);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill impairment charges of $1.8 billion in our European Retail Pharmacy (&#8220;European RP&#8221;) and European Pharmaceutical Distribution (&#8220;European PD&#8221;) reporting units within the International segment. Of these impairment charges, $238 million was recognized upon the 2019 first quarter segment changes, which resulted in two new reporting units. The remaining charges primarily were due to declines in the reporting units&#8217; estimated future cash flows and the selection of higher discount rates. These impairment charges generally were not deductible for income tax purposes. The declines in estimated future cash flows primarily were attributed to additional government reimbursement reductions and competitive pressures within the U.K. The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate. At March&#160;31, 2019, both the European RP and European PD reporting units had no remaining goodwill balances; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restructuring, impairment, and related charges, net primarily includes employee severance and exit-related costs of $352 million for our 2019 restructuring initiatives, as further discussed below and long-lived asset impairment charges of $245 million primarily for our U.K. business (mainly pharmacy licenses) within our International segment driven by additional government reimbursement reductions and competitive pressures in the U.K.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Overview of Our Business&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, our operating structure was realigned commencing in the second quarter of 2021 into four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. The second quarter segment realignment resulted in changes in multiple reporting units across the Company. As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our European RP reporting unit of $69&#160;million during the second quarter of 2021. At March&#160;31, 2021, the balance of goodwill for our reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of our reporting units in Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed in 2021 did not indicate any impairment of goodwill. As of the testing date, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Estimates&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Financial Review for further information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2019, we voluntarily changed our annual goodwill impairment testing date from January 1 to October 1 to better align with the timing of our annual long-term planning process. This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. Refer to Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for further information.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily led us to rationalize our office space in North America. Where we determine to cease using office space, we plan to exit the portion of the facility no longer used. We also may retain and repurpose certain other office locations. We expect to incur total charges of approximately $180 million to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. This initiative is expected to be completed in 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we committed to an initiative within the U.K., which is included in our International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. We expect to incur total charges of approximately $85 million to $90 million, of which $57 million of charges were recorded to date. The initiative is expected to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, we committed to certain programs to continue our operating model and cost optimization efforts. We continue to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. Total charges of $297 million were recorded to date. This initiative was substantially complete in 2021 and remaining costs we expect to record under this initiative are not material. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also committed to certain actions in connection with the previously announced relocation of our corporate headquarters from San Francisco, California to Irving, Texas, which became effective April 1, 2019. Total charges of $105 million were recorded to date. The relocation was substantially complete in January 2021 and remaining costs we expect to record under this initiative, primarily relating to lease costs, are not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2018, we committed to a restructuring plan, which primarily consisted of the closures of underperforming retail pharmacy stores in the U.K., and a reduction in workforce. The plan was substantially complete in 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2018, we announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize our operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, we committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges for the years ended March&#160;31, 2021, 2020, and 2019 also includes long-lived asset impairment charges of $115&#160;million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe within our International segment. In addition, certain charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in our Consolidated Statements of Operations and were not material for the years ended March&#160;31, 2021, 2020, and 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the year ended March&#160;31, 2021 increased compared to the prior year primarily due to net gains recognized from our equity investments of $133&#160;million. This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 17, &#8220;Fair Value Measurements,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K. In future periods, fair value adjustments recognized in our operating results for these types of investments may be adversely impacted by market volatility. Other income, net also increased year over year due to pension settlement charges of $122 million recognized in 2020 related to our previously approved termination of the frozen U.S. defined benefit pension plan. In connection with the pension plan termination, we purchased annuity contracts from an insurer that will pay and administer the future pension benefits of the remaining participants.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net, for the year ended March&#160;31, 2020 decreased compared to the prior year primarily due to the 2020 pension settlement charges described above and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">higher gains recognized from the sale of investments in 2019, partially offset by higher net settlement gains in 2020 from our derivative contracts. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Earnings and Charges from Investment in Change Healthcare Joint Venture </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of our investment in Change Healthcare JV on March 10, 2020, we accounted for this investment using the equity method of accounting. Excluding the impairment and transaction-related items described below, our proportionate share of loss from our investment in Change Healthcare JV for the years ended March 31, 2020 and 2019 was $119 million and $194 million, respectively, which primarily includes transaction and integration expenses incurred by the joint venture and basis differences between the joint venture and McKesson including amortization of fair value adjustments. During the first quarter of 2020 and for the year ended March 31, 2019, we owned approximately 70% of this joint venture. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#8220;IPO&#8221;). On July 1, 2019, upon the completion of its IPO, Change contributed net cash proceeds it received from its offering of common stock to Change Healthcare JV in exchange for additional membership interests of Change Healthcare JV at the equivalent of its offering price of $13 per share. The proceeds from the concurrent offering of other securities were also used by Change to acquire certain securities of Change Healthcare JV. As a result, McKesson&#8217;s equity interest in Change Healthcare JV was reduced from 70% to approximately 58.5%, which was used to recognize our proportionate share in net loss from Change Healthcare JV, commencing in the second quarter of 2020. As a result of the ownership dilution to 58.5% from 70%, we recognized a dilution loss of approximately $246 million in the second quarter of 2020. Additionally, our proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO and further diluted our ownership.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, we recorded an other-than-temporary-impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to our investment in Change Healthcare JV, representing the difference between the carrying value of our investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included within &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in our Consolidated Statements of Operations for the year ended March 31, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, we completed the previously announced separation of our interest in Change Healthcare JV, which eliminated our investment in the joint venture. The separation was effected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly owned subsidiary of the Company that held all of our interest in Change Healthcare JV, to certain of our stockholders through an exchange offer (&#8220;Split-off&#8221;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#8220;Merger&#8221;). </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the exchange offer, on March 9, 2020, we distributed all 176.0 million outstanding shares of common stock of SpinCo to participating holders of the Company&#8217;s common stock in exchange for 15.4 million shares of McKesson common stock. Following consummation of the exchange offer, on March 10, 2020, the Merger was consummated, with each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and Merger are intended to be generally tax-free transactions to McKesson and its shareholders for U.S. federal income tax purposes. Following the Split-off, we do not beneficially own any of Change&#8217;s outstanding securities. In connection with this transaction, we recognized a net gain for financial reporting purposes of $414 million during the fourth quarter of 2020, which was largely driven by the reversal of a related deferred tax liability. Under the agreement with Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed. Any such change is not expected to be material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the separation, Change Healthcare&#160;JV is required under the TRA to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, resulting from depreciation or amortization allocated to Change by McKesson. The receipt of any payments under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings, which creates uncertainty over the amount, timing and probability of the gain recognized. As such, we accounted for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 nor 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased in 2021 compared to the prior year primarily due to the repayment of $1.0 billion of long-term debt in the third quarter of 2021 and a decrease in the issuance of commercial paper. Interest expense decreased in 2020 compared to the prior year primarily due to a decrease in the issuance of commercial paper, partially offset by a decrease in interest income from our derivative contracts. Interest expense fluctuates based on timing, amounts and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax (Benefit) Expense </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax (benefit) expense of ($695 million), $18 million, and $356 million for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Our reported income tax (benefit) expense rates were (13.8%), 1.6%, and 58.4% in 2021, 2020, and 2019, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported income tax rate for 2021 was impacted by the charge for opioid-related claims of $8.1 billion ($6.8 billion after-tax). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported income tax expense rate for 2020 was favorably impacted by a net gain on the Change Healthcare JV divestiture of $414 million (pre-tax and after-tax), which was intended to generally be a tax-free split-off for U.S. federal income tax purposes, and unfavorably impacted by charges of $275 million (pre-tax and after-tax) to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA. Refer to Financial Note 2,&#8220;Investment in Change Healthcare Joint Venture&#8221; and Note 3,&#8220;Held for Sale,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10&#8209;K for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported income tax expense rate for 2019 was unfavorably impacted by charges of $1.8 billion (pre-tax and after-tax) to impair the carrying value of goodwill of our European RP and European PD reporting units within the International segment, given that these charges are generally not deductible for tax purposes. Refer to Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10&#8209;K for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties. Although our major taxing jurisdictions include the U.S., Canada, and the U.K., we are subject to income taxes in numerous foreign jurisdictions. Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We believe that we have made adequate provision for all income tax uncertainties. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income (Loss) from Discontinued Operations, Net of Tax </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from discontinued operations, net of tax, was $(1) million, $(6) million, and $1 million for the years ended March&#160;31, 2021, 2020, and 2019, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests primarily represents ClarusONE, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe AG (&#8220;McKesson Europe&#8221;) share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;).&#160;Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Redeemable noncontrolling interests are presented outside of McKesson Corporation stockholders&#8217; equity (deficit) on our consolidated balance sheet. Refer to Financial Note 9, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for additional information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to McKesson Corporation </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to McKesson Corporation was $(4.5) billion, $900 million, and $34 million for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Diluted earnings (loss) per common share attributable to McKesson Corporation was $(28.26), $4.95, and $0.17 for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Net loss per diluted share for the year ended March 31, 2021 is calculated by excluding dilutive securities from the denominator due to their antidilutive effects. Additionally, our 2021, 2020, and 2019 diluted earnings (loss) per share reflect the cumulative effects of share repurchases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (loss) per common share was calculated based on a weighted-average number of shares outstanding of 160.6 million, 181.6 million, and 197.3 million for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases, including the impact of shares exchanged as part of the split-off from our investment in Change Healthcare JV, as discussed above.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_46"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results: </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,051&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the year ended March&#160;31, 2021 increased 4% compared to the prior year primarily due to market growth, including branded pharmaceutical price increases, growth in specialty pharmaceuticals, and higher volumes from retail national account customers, partially offset by branded to generic drug conversions. Revenues for this segment were unfavorably impacted by fluctuations in demand for pharmaceuticals in retail pharmacies and institutional healthcare providers due to COVID-19 largely during the onset of the pandemic in late March 2020 and during our first quarter of 2021 combined with the loss of certain customers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the year ended March&#160;31, 2020 increased 9% compared to the prior year primarily due to market growth, including branded pharmaceutical price increases, growth in specialty pharmaceuticals, higher volumes from retail national account customers, partially offset by branded to generic drug conversions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the year ended March&#160;31, 2021 decreased 6% compared to the prior year. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 9% primarily due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and to a lesser extent, the exit of unprofitable customers in our Canadian business. Revenues for this segment were also unfavorably impacted by lower volumes from the adverse impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the year ended March&#160;31, 2020 increased 1% compared to the prior year. Excluding the unfavorable effects of foreign currency exchange fluctuations, revenues for this segment increased 4% primarily due to market growth in our European pharmaceutical distribution and retail pharmacy businesses. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the year ended March&#160;31, 2021 increased 22% compared to the prior year largely due to sales of COVID-19 tests and PPE.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the year ended March&#160;31, 2020 increased 9% compared to the prior year primarily due to market growth in our primary care business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the year ended March&#160;31, 2021 increased 7% compared to the prior year driven by increased volume with new and existing customers primarily in our CoverMyMeds business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the year ended March&#160;31, 2020 increased 9% compared to the prior year primarily driven by increased volume with new and existing customers.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_49"></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">- </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.00)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.67&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.64&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.26&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for our reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from our equity method investment in Change Healthcare JV, which we split-off in the fourth quarter of 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes a charge of $50&#160;million for the year ended March 31, 2021 related to our estimated liability under the OSA.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment for the years ended March 31, 2021 and 2020 includes charges of $58 million and $275 million, respectively, to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA. This segment&#8217;s operating loss for the years ended March 31, 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion, respectively, as well as long-lived asset impairment charges for the years ended March 31, 2021, 2020, and 2019 of $115&#160;million, $112 million, and $245 million, respectively, primarily related to our retail pharmacy businesses in Canada and Europe.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2021 includes charges totaling $136&#160;million on certain PPE and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our RxTS segment for the year ended March 31, 2019 includes a gain of $56 million from the divestiture of an equity investment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020. Operating loss for the year ended March 31, 2019 includes a credit of $90 million for the derecognition of a liability related to the TRA payable to the shareholders of Change.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the year ended March 31, 2021 includes a charge of $8.1 billion related to our estimated liability for opioid-related claims, net gains of $133 million from our equity investments, and a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. Corporate expenses, net for the year ended March 31, 2020 includes pension settlement charges of $122 million and a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March&#160;31, 2021 compared to the prior year primarily due to an increase in net cash proceeds received of $159 million in 2021 compared to 2020 representing our share of antitrust legal settlements, growth in specialty pharmaceuticals, and the contribution from our vaccine distribution programs. This was partially offset by a decrease in LIFO credits of $214 million, a charge of $50&#160;million recorded in 2021 related to our estimated liability under the OSA, net impacts from COVID-19, including a less severe cough, cold, and flu season, as well as increased costs for strategic growth initiatives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March&#160;31, 2020 compared to the prior year primarily due to market growth in our specialty business. Operating profit and operating profit margin were favorably impacted by a charge of $61 million related to a customer bankruptcy in 2019 and an increase in LIFO credits of $42 million. Operating profit and operating profit margin were unfavorably impacted by customer mix and a decrease in net cash proceeds received of $180 million representing our share of antitrust legal settlements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss and operating loss margin improved for the year ended March&#160;31, 2021 compared to the prior year primarily due to a decrease in the charges recorded to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture with WBA, of which $58 million and $275 million was reflected for the years ended March 31, 2021 and 2020, respectively. This was partially offset by a goodwill impairment charge of $69 million recorded in the second quarter of 2021 related to our European retail pharmacy business. The impacts from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses within Europe also caused unfavorability in our segment results year over year.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss and operating loss margin improved for the year ended March&#160;31, 2020 compared to the prior year primarily due to goodwill impairment charges of $1.8 billion in 2019 and a decrease in long-lived asset impairment charges of $112 million in 2020 compared to $245 million in 2019. This was partially offset by the fair value remeasurement charges in 2020 described above and a gain from an escrow settlement of $97 million in 2019 related to our 2017 acquisition of Rexall Health.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin increased for the year ended March&#160;31, 2021 compared to prior year primarily due to COVID-19, including demand for COVID-19 tests and PPE, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines. This was partially offset by inventory charges on certain PPE and other related products, unfavorability in our primary care business due to customer closures largely during the first quarter of 2021, and a less severe cough, cold, and flu season. Additionally, operating profit was favorable year over year due to lower operating expenses, including a decrease in our provision for bad debts.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin increased for the year ended March&#160;31, 2020 compared to prior year primarily due to market growth in our primary care business and lower restructuring charges, partially offset by the remeasurement of assets and liabilities to fair value related to a divestiture that was completed in 2020 and higher operating expenses, including an increase in our provision for bad debts. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit remained relatively flat for the year ended March&#160;31, 2021 compared to prior year primarily due to higher operating expenses to support business growth, offset by increased volume with new and existing customers. Operating profit margin decreased for the year ended March&#160;31, 2021 compared to prior year primarily due to higher operating expenses. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit and operating profit margin increased for the year ended March&#160;31, 2020 compared to prior year primarily due to increased volumes with new and existing customers, integration costs incurred in 2019 for our acquisition of RxCrossroads that closed during the fourth quarter of 2018, partially offset by a gain of $56 million from the divestiture of an equity investment in 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss for Other for the year ended March 31, 2020 includes an OTTI charge of $1.2 billion and a dilution loss of $246 million related to our investment in Change Healthcare JV, partially offset by a net gain of $414 million related to the completed separation of our interest in Change Healthcare JV during the fourth quarter of 2020. Operating loss for Other for the year ended March 31, 2019 includes a credit of $90 million for the derecognition of a liability related to the TRA payable to the shareholders of Change. Operating loss for Other also includes our proportionate share of loss from Change Healthcare JV of $119 million and $194 million for the years ended March 31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net increased for the year ended March 31, 2021 compared to the prior year due to a charge of $8.1 billion related to our estimated liability for opioid-related claims. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net for 2021 also includes net gains recognized from our equity investments of $133 million and a net gain of $131 million recognized in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. Corporate expenses, net, for 2020 includes pension settlement charges of $122 million, an opioid claim settlement charge of $82 million, and net settlement gains of $26 million recognized from our derivative contracts. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 vs. 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net, increased for the year ended March 31, 2020 compared to the prior year primarily due to the pension settlement charges and opioid claim settlement charge mentioned above, as well as higher costs for technology initiatives, partially offset by net settlement gains recognized in 2020 from our derivative contracts. Corporate expenses, net, for 2020 also included charitable contribution expenses of approximately $20 million primarily for the McKesson Foundation. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_52"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Operations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign operations represented approximately 15%, 17%, and 18% of our consolidated revenues in 2021, 2020, and 2019, respectively. Foreign operations are subject to certain risks, including currency fluctuations. We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate. We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar. As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.&#160;In discussing our operating results, we may use the term &#8220;foreign currency exchange fluctuations,&#8221; which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar. We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.&#160;In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars. Additional information regarding our foreign operations is included in Financial Note 22, &#8220;Segments of Business,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K. </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_55"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 5, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K for additional information.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_58"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal 2022 Outlook</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company&#8217;s fiscal 2022 outlook is contained in our Form 8-K dated May&#160;6, 2021. That Form 8-K should be read in conjunction with the forward-looking statements in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review, as well as the cautionary statements in Item 1, "Business - Forward-Looking Statements," and Item 1A, "Risk Factors," in Part I of this Annual Report on Form 10-K.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_61"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider an accounting estimate to be critical if the estimate requires us to make assumptions about matters that were uncertain at the time the accounting estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations. Below are the estimates that we believe are critical to the understanding of our operating results and financial condition. Other accounting policies are described in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K. Because of the uncertainty inherent in such estimates, actual results may differ from these estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Doubtful Accounts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide short-term credit and other customer financing arrangements to customers who purchase our products and services. Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories. We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans. We estimate the receivables for which we do not expect full collection based on historical collection rates and specific knowledge regarding the current creditworthiness of our customers and record an allowance in our consolidated financial statements for these amounts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, and reasonable and supportable forecasts to develop its allowance for doubtful accounts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 51% of total consolidated revenues in 2021 and comprised approximately 32% of total trade accounts receivable at March&#160;31, 2021. Sales to our largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of our total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March&#160;31, 2021. As a result, our sales and credit concentration is significant. We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve methodologies are assessed annually based on historical losses and economic, business and market trends. In addition, reserves are reviewed quarterly and updated if unusual circumstances or trends are present. We believe the reserves maintained and expenses recorded in 2021 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, trade and notes receivables were $17.5 billion prior to allowances of $211 million. In 2021, 2020 and, 2019, our provision for bad debts was $4 million, $91 million, and $132 million, respectively. At March&#160;31, 2021 and 2020, the allowance as a percentage of trade and notes receivables was 1.2% and 1.4%, respectively. An increase or decrease of a hypothetical 0.1% in the 2021 allowance as a percentage of trade and notes receivables would result in an increase or decrease in the provision for bad debts of approximately $18 million. The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios. Additional information concerning our allowance for doubtful accounts may be found in Schedule II included in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inventories consist of merchandise held for resale. We report inventories at the lower of cost or net realizable value, except for inventories determined using the LIFO method which are valued at the lower of LIFO cost or market. LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts and other incentives received from vendors relating to the purchase or distribution of inventory are considered product discounts and are accounted for as a reduction in the cost of inventory and are recognized when the inventory is sold. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, total inventories, net were $19.2 billion and $16.7 billion, respectively, in our Consolidated Balance Sheets. The LIFO method was used to value approximately 58% and 60% of our inventories at March 31, 2021 and 2020, respectively. If we had used the moving average method of inventory valuation, inventories would have been approximately $406&#160;million and $444&#160;million higher than the amounts reported at March 31, 2021 and 2020, respectively. These amounts are equivalent to our LIFO reserves. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. We recognized LIFO credits of $38 million, $252 million, and $210 million, respectively, in 2021, 2020, and 2019 in our Consolidated Statements of Operations. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Excluding LIFO reserves, our inventory reserves as of March&#160;31, 2021 and 2020 were $263 million and $96 million, respectively. The increase was primarily due to 2021 charges totaling $136 million on certain PPE and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, our LIFO inventory is valued at the lower of LIFO or market.&#160;As of March&#160;31, 2021 and 2020, inventories at LIFO did not exceed market. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether an inventory valuation allowance is required, we consider various factors including estimated quantities of slow-moving inventory by reviewing on-hand quantities, outstanding purchase obligations and forecasted sales. Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories. We write down inventories which are considered excess and obsolete as a result of these reviews. These factors could make our estimates of inventory valuation differ from actual results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows and the assessment of the asset&#8217;s expected useful life. Refer to Financial Note 5, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report on Form 10-K for additional information regarding our acquisitions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Long-Lived Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of acquiring businesses, we have $9.5 billion and $9.4&#160;billion of goodwill at March&#160;31, 2021 and 2020, respectively, and $2.9&#160;billion and $3.2&#160;billion of intangible assets, net at March 31, 2021 and 2020, respectively. We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist. Indicators that are considered include significant declines in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends, or a significant decline in the Company&#8217;s stock price and/or market capitalization for a sustained period of time. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or a component, one level below our operating segments, for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach. Under the market approach, we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, we use a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. In addition, we compare the aggregate of the reporting units&#8217; fair values to our market capitalization as further corroboration of the fair values.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of fair value result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions at a point in time. Judgments made in determining an estimate of fair value may materially impact our results of operations.&#160;The valuations are based on information available as of the impairment testing date and are based on expectations and assumptions that have been deemed reasonable by management. Any material changes in key assumptions, including failure to meet business plans, negative changes in government reimbursement rates, deterioration in the U.S. and global financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may decrease the projected cash flows or increase the discount rates and could potentially result in an impairment charge. Under the market approach, significant estimates and assumptions also include the selection of appropriate guideline companies and the determination of appropriate valuation multiples to apply to the reporting unit. Under the income approach, significant estimates and assumptions also include the determination of discount rates.&#160;The discount rates represent the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing, which are weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital structure. Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units&#8217; future cash flow projections. An increase in the unsystematic risk premium increases the discount rate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the 2019 annual goodwill impairment tests, the estimated fair values of our reporting units, excluding the Europe Retail Pharmacy and Europe Pharmaceutical Distribution reporting units in our International segment, exceeded their carrying values. The impairment testing performed in 2020 did not indicate any material impairment of goodwill. The segment change in the second quarter of 2021 prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. At March&#160;31, 2021, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of our reporting units in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our McKesson Canada reporting unit in our International segment and our RxCrossroads reporting unit in our RxTS segment exceeded the carrying values of these reporting units by 11% and 14%, respectively, in 2021. The goodwill balance of these reporting units was $1.5&#160;billion for McKesson Canada and $312&#160;million for RxCrossroads at March&#160;31, 2021 or approximately 19% of the consolidated goodwill balance. Generally, a decline in estimated future cash flows in excess of 16% for McKesson Canada and 17% for RxCrossroads or an increase in the discount rate in excess of approximately 1.5% could result in an indication of goodwill impairment for these reporting units in future reporting periods. Other risks, expenses and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions that we were unable to anticipate as of the testing date may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods. Refer to Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, all of our intangible and other long-lived assets are amortized or depreciated based on the pattern of their economic consumption or on a straight-line&#160;basis over their estimated useful lives, ranging from one to 38 years.&#160;We review intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.&#160;Determination of recoverability of intangible assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition.&#160;Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.&#160;Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.&#160;They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing consideration of all the factors described previously could result in further impairment charges in the future, which could adversely affect our net income. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K for additional information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Equity Method Investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We evaluate our investments for other-than-temporary impairments when circumstances indicate those assets may be impaired. When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment. We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value. Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors. Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain restructuring reserves which require significant estimates related to the timing and amount of future employee severance and other exit-related costs to be incurred when the restructuring actions take place. We generally recognize employee severance costs when payments are probable and amounts are estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates. Other exit-related costs are recognized as incurred. In connection with these restructuring actions, we also assess the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax expense and deferred tax assets and liabilities reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax provision and in evaluating income tax uncertainties and include those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, which remains unfinalized, and which may differ from the actual amounts of tax benefit recognized. We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating our ability to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income. In estimating future taxable income, we develop assumptions including the amount of future federal, state and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Should tax laws change, our tax expense and cash flows could be materially impacted. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the calculation of our tax liabilities includes estimates for uncertainties in the application of complex new tax regulations across multiple global jurisdictions where we conduct our operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which, additional taxes and related interest will be due. If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result. If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, including claims with customers and vendors, pending and potential legal actions for damages, investigations relating to laws and regulations and other matters arising out of the normal conduct of our business. When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided. Legal fees are recognized as incurred when the legal services are provided.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the potential loss or range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties. In conjunction with the preparation of the accompanying financial statements, we considered matters related to ongoing controlled substances claims to which we are a party. As a result of ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework to resolve the claims of governmental entities, and our assessment of certain other opioid-related claims, we have reached a stage at which a broad settlement of opioid claims by governmental entities is probable and recorded a charge of $8.1&#160;billion for the year ended March 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in our Consolidated Statement of Operations in this report. Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, consolidated financial position, cash flows or liquidity. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report on Form 10-K for additional information. </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_64"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. As described within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, the COVID-19 pandemic continues to develop rapidly. We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us. We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility. Additionally, long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. We have seen continued improvement in conditions in the debt markets and commercial paper markets as the Federal Reserve has taken steps to stabilize the markets. At March 31, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided from operating activities was $4.5 billion, $4.4 billion, and $4.0 billion for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021. Operating activities for the year ended March 31, 2020 were affected by increases in drafts and accounts payable of $4.0 billion primarily associated with timing, replenishing inventory stocks, and effective working capital management, and an increase in receivables of $2.5 billion primarily due to revenue growth. Operating activities for the year ended March 31, 2019 were affected by increases in drafts and accounts payable of $2.0 billion primarily due to increased inventory purchases and timing of payments, and an increase in receivables of $1.0 billion due to the overall increase in sales volume and timing of receipts. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-cash items within operating activities for the year ended March 31, 2021 primarily includes stock-based compensation of $151 million and fair value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA. Other non-cash items for the year ended March 31, 2020 primarily includes fair value remeasurement charges of $275 million described above, pension settlement charges of $122 million, and stock-based compensation of $119 million. Additionally, we made a cash payment of $114 million from the executive benefit retirement plan in 2020. Other non-cash items for the year ended March 31, 2019 primarily includes stock-based compensation of $95 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $415 million, $579 million, and $1.4 billion for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Investing activities for the year ended March&#160;31, 2021 include $451 million and $190 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in capital expenditures for property, plant, and equipment and capitalized software, respectively. Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities for the year ended March&#160;31, 2020 include $362 million and $144 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in capital expenditures for property, plant, and equipment and capitalized software, respectively, and $133 million of net cash payments for acquisitions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities for the year ended March&#160;31, 2019 include $905 million of net cash payments for acquisitions, including $784 million for our acquisition of Medical Specialties Distributors LLC, $426 million and $131 million in capital expenditures for property, plant, and equipment and capitalized software, respectively, and $101 million of net cash proceeds from sales of businesses and investments. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $1.7 billion, $2.7 billion, and $2.2&#160;billion for the years ended March&#160;31, 2021, 2020, and 2019, respectively. Financing activities for the year ended March&#160;31, 2021 include cash receipts of $6.3 billion and payments of $6.3 billion from short-term borrowings, primarily commercial paper, along with the issuance of the 2025 Notes in a principal amount of $500&#160;million, the retirement of our $700&#160;million total principal amount of notes due on November 30, 2020 at a fixed interest rate of 3.65% upon maturity, and the redemption of our 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. The notes were redeemed using cash on hand and proceeds from the 2025 Notes. Financing activities for the year ended March&#160;31, 2021 also include $770 million of cash paid for stock repurchases and $276 million of dividends paid. Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases. Other financing activities for the year ended March 31, 2021 also include restricted cash net inflow related to funds temporarily held on behalf of unaffiliated medical practice groups and a payment of $49 million to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities for the year ended March&#160;31, 2020 include cash receipts of $21.4 billion and payments of $21.4 billion from short-term borrowings, primarily commercial paper.&#160;Financing activities for the year ended March&#160;31, 2020 also include $2.0 billion of cash paid for stock repurchases, repayments of long-term debt of $298 million, and $294 million of dividends paid.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities for the year ended March&#160;31, 2019 include cash receipts of $37.3 billion and payments of $37.3 billion from short-term borrowings, primarily commercial paper. We received cash from long-term debt issuances of $1.1 billion and made repayments on long-term debt of $1.1 billion in 2019. Financing activities for the year ended March&#160;31, 2019 also include $1.6 billion of cash paid for stock repurchases and $292 million of dividends paid.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the share repurchase activity over the last three years is as follows:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in May 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to the Split-off of the Change Healthcare JV as described below. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">$8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on our Consolidated Balance Sheet as of March&#160;31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last three years, our share repurchases were transacted through both open market transactions and ASR programs with third party financial institutions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we retired&#160;5.0 million&#160;or&#160;$542 million&#160;of the Company&#8217;s treasury shares previously repurchased. Under the applicable state law, these shares resume the status of authorized and unissued shares upon retirement. In accordance with our accounting policy, we allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings. Accordingly, our retained earnings and additional paid-in capital were reduced by&#160;$472 million and $70 million&#160;during 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2020, we completed the Split-off of our interest in the Change Healthcare JV. In connection with the Split-off, we distributed all 176.0 million outstanding shares of SpinCo common stock, which held all of the Company&#8217;s interests in the Change Healthcare JV, to participating holders of the Company&#8217;s common stock in exchange for 15.4 million shares of McKesson stock, which are now held as treasury stock on our consolidated balance sheet. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change and each share of SpinCo common stock was converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. See Note 2, &#8220;Investment in Change Healthcare Joint Venture&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10-K for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total authorization outstanding for repurchase of the Company&#8217;s common stock was $2.8 billion at March&#160;31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. As described within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, the COVID-19 pandemic continues to develop rapidly. We continue to monitor its impact on demand within parts of our business, as well as trends potentially impacting the timing or ability for some of our customers to pay amounts owed to us.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selected Measures of Liquidity and Capital Resources:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days sales outstanding for: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on McKesson stockholders&#8217; equity (deficit) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.5)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Based on year-end balances and sales or cost of sales for the last 90 days of the year.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of&#160;March&#160;31, 2021 and 2020&#160;included approximately $2.3 billion and&#160;$1.7 billion&#160;of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other current liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements. The COVID-19 pandemic has potential to increase the variations in our working capital, which we continue to monitor closely.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital improved at March&#160;31, 2021 compared to the prior year primarily due to an increase in cash and cash equivalents and inventory, partially offset by an increase in drafts and accounts payable and a decrease in receivables. Consolidated working capital decreased at March 31, 2020 compared to the prior year primarily due to an increase in drafts and accounts payable and the current portion of long-term debt for term notes due in 2021, partially offset by an increase in receivables and cash and cash equivalents. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the year ended March 31, 2021 primarily due to a decrease in stockholders&#8217; equity driven by net loss for the year and share repurchases. Our unfavorable return on McKesson&#8217;s stockholder&#8217;s equity (deficit) as of March 31, 2021 was also driven by net loss for the year. Net loss for the year ended March 31, 2021 includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Financial Review and Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying consolidated financial statements included in this Annual Report on Form 10&#8209;K. Our debt to capital ratio increased for 2020 primarily due to a decrease in stockholders&#8217; equity driven by the Split-off of our interest in Change Healthcare JV and share repurchases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, we raised our quarterly dividend from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. Dividends were $1.67 per share in 2021, $1.62 per share in 2020, and $1.51 per share in 2019. We anticipate that we will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors. In 2021, 2020, and 2019, we paid total cash dividends of $276&#160;million, $294&#160;million, and $292 million, respectively. Additionally, as required under the Domination Agreement, we are obligated to pay an annual recurring compensation amount of &#8364;0.83 per McKesson Europe share (effective January 1, 2015) to the noncontrolling shareholders of McKesson Europe.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations: </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table and information below presents our significant financial obligations and commitments at March&#160;31, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 1 to 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 3 to 5</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">On balance sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (3) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Off balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,346&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,940&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,024&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents maturities of the Company&#8217;s long-term obligations, including an immaterial amount of finance lease obligations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents undiscounted minimum operating lease obligations under non-cancelable operating leases having an initial remaining term over one year and is not adjusted for imputed interest. Refer to Financial Note 11, &#8220;Leases&#8221; to the consolidated financial statements appearing in this Annual Report on Form&#160;10-K for more information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents interest that will become due on our fixed rate long-term debt obligations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">A purchase obligation is defined as an arrangement to purchase goods or services that is enforceable and legally binding on the Company. These obligations primarily relate to inventory purchases and capital commitments. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes agreements under which we have guaranteed the repurchase of our customers&#8217; inventory and our customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual obligations table above excludes the following obligations:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, the liability recorded for uncertain tax positions, excluding associated interest and penalties, was approximately $738 million. Additionally, any future payments that may be made related to our estimated litigation liability of $8.1 billion for opioid-related claims, as described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section in this Financial Review and Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report on Form 10-K, are excluded. The ultimate amount and timing of any future cash settlements related to these items cannot be predicted with reasonable certainty.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our banks and insurance companies have issued $146 million of standby letters of credit and surety bonds at March&#160;31, 2021. These were issued on our behalf and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and our workers&#8217; compensation and automotive liability programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our redeemable noncontrolling interests primarily relate to our consolidated subsidiary, McKesson Europe. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During 2021, we paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. During 2020 and 2019, there were no material exercises of the Put Right. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance of redeemable noncontrolling interests is reported at the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The carrying value of redeemable noncontrolling interests is also adjusted each period for the portion of other comprehensive income attributable to the noncontrolling shareholders, which is primarily due to changes in foreign currency exchange rates. At March&#160;31, 2021 and 2020, the carrying value of redeemable noncontrolling interests related to McKesson Europe of $1.3 billion and $1.4 billion, respectively, exceeded the maximum redemption value of $1.2 billion. In future periods, unfavorable foreign currency exchange rate fluctuations between the Euro and the U.S. dollar could adversely impact the carrying value of our redeemable noncontrolling interests and require an adjustment to increase the balance of our redeemable noncontrolling interests to its maximum redemption value. Such adjustments would be recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in our consolidated statements of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six month&#8217;s advance notice. The Put Amount, Compensation Amount, and the guaranteed dividend were subject to ongoing appraisal proceedings. On April 12, 2021, we received the Stuttgart Court of Appeals&#8217; final ruling confirming the original put value of &#8364;22.99 per share and the annual recurring compensation of &#8364;0.83 per McKesson Europe share. The Put Right exercise window will expire on June 15, 2021. While the ultimate amount of any future cash payments related to exercises of the Put Right are uncertain, Put Right exercises could result in cash payments of up to approximately $1.3 billion prior to the expiration of the Put Right.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 9, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the consolidated financial statements included in this Annual Report on Form 10-K for additional information on redeemable noncontrolling interests.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Detailed information regarding our debt and financing activities is included in Financial Note 13, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report on Form 10-K.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_67"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELATED PARTY BALANCES AND TRANSACTIONS </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our related party balances and transactions is included in Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; and Financial Note 21, &#8220;Related Party Balances and Transactions,&#8221; to the consolidated financial statements included in this Annual Report on Form&#160;10-K.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_70"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted, as well as those that have been recently issued but not yet adopted by us, are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements appearing in this Annual Report on Form 10-K.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_73"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balances earn interest at variable rates. At March&#160;31, 2021 and 2020, we had $6.3 billion and $4.0 billion, respectively, in cash and cash equivalents. The effect of a hypothetical 50 bp increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and variable rate debt, would have resulted in a favorable impact to earnings in 2021 and 2020 of approximately $17 million and $6 million, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Concluded)</span></div><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign exchange risk: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollar. Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars. We are also exposed to foreign exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain foreign exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. The forward contracts and cross-currency swaps are intended to reduce the income statement effects from fluctuations in foreign exchange rates and have been designated as cash flow hedges. These programs reduce but do not entirely eliminate foreign exchange risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and 2020, the effect of a hypothetical adverse 10% change in the underlying foreign currency exchange rates would have impacted the fair value of our foreign exchange contracts by approximately $267 million and $435 million, respectively. However, our risk management programs are designed such that the potential loss in value of these risk management portfolios described above would be largely offset by changes in the value of the underlying exposure. Refer to Financial Note 16, &#8220;Hedging Activities,&#8221; for more information on our foreign currency forward contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selected hypothetical change in interest rates and foreign currency exchange rates does not reflect what could be considered the best or worst case scenarios.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_76"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Supplementary Data.</span></div><div style="margin-bottom:12pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_79">Management's Annual Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_79">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_82">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_82">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">Consolidated Statements of Operations for the years ended March 31, 2021, 2020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85"> and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">Consolidated Statements of Comprehensive Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88"> (Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88"> for the years ended March 31, 2021, 2020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91">Consolidated Balance Sheets as of March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_97">Consolidated Statements of Stockholders&#8217; Equity for the years ended March 31, 2021, 2020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_97">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_97"> and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_97">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_103">Consolidated Statements of Cash Flows for the years ended March 31, 2021, 2020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_103">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_103"> and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_103">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_106">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_106">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_109">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_109">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_115">Note 2 - Investment in Change Healthcare Joint Venture</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_115">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_121">Note 3 - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_121">85</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_127">Note 4 - Restructuring, Impairment, and Related Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_127">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_133">Note 5 - Business Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_133">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_136">Note 6 - Share-Based Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_136">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_142">Note 7 - Other Income, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_142">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_145">Note 8 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_145">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_151">Note 9 - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_151">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_157">Note 10 - Earnings per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_157">101</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_166">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_166">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_166"> - Leases</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_166">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_172">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_172">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_172"> - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_172">106</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_178">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_178">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_178"> - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_178">109</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_184">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_184">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_184"> - Variable Interest Entities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_184">111</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_190">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_190">5</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_190"> - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_190">111</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_196">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_196">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_196"> - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_196">117</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_202">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_202">7</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_202"> - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_202">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_208">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_208">18</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_208"> - Financial Guarantees and Warranties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_208">122</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_214">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_214">19</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_214"> - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_214">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_220">Note 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_220">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_220"> - Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_220">130</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_226">Note 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_226">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_226"> - Related Party Balances and Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_226">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_229">Note 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_229">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_229"> - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_229">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_235">Note 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_235">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_235"> - Quarterly Financial Information (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_235">138</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_79"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management of McKesson Corporation is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the framework and criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March&#160;31, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deloitte &amp; Touche LLP, an independent registered public accounting firm, audited the financial statements included in this Annual Report on Form 10-K and has also audited the effectiveness of the Company&#8217;s internal control over financial reporting as of March&#160;31, 2021. This audit report appears on the following page of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;12, 2021 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Brian S. Tyler</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_82"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of McKesson Corporation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of McKesson Corporation and subsidiaries (the &#8220;Company&#8221;) as of March&#160;31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity, and cash flows, for each of the three years in the period ended March&#160;31, 2021, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the &#8220;financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of March&#160;31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended March&#160;31, 2021, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March&#160;31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Accounting Principle</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 11 to the financial statements, effective April 1, 2019, the Company adopted the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) new standard related to leases using the modified retrospective basis.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our responsibility is to express an opinion on these financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Liabilities - Broad Settlement of Opioid Claims brought by Governmental Entities - Refer to Note 1 and Note 19 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances, including opioids. The Company is named as a defendant along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, tribal nations, health and welfare funds, third-party payors and individuals. The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives, who represent states, their political subdivisions and other government entities (&#8220;governmental entities&#8221;), regarding a framework under which the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by the Company to resolve the claims brought by governmental entities (&#8220;broad settlement of opioid claims&#8221;). When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its estimate for the ultimate loss. The Company reviews all loss contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. The Company also performs an assessment of loss contingencies where a loss is reasonably possible. If it is reasonably possible that a loss may have been incurred and the effect on the financial statements could be material, the Company discloses the nature of the loss contingency and an estimate of the possible loss or range of loss or a statement that such an estimate cannot be made within the notes to the financial statements. For the year ended March 31, 2021, management believes that a loss through broad settlement of opioid claims brought by governmental entities is both probable and reasonably estimable, and accordingly, recorded a charge in the amount of $8.0 billion, which represents management&#8217;s best estimate of future loss related to these specific matters.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the potential broad settlement of opioid claims as a critical audit matter because of the significant judgment and challenges auditing management&#8217;s determination of whether such loss is probable and reasonably estimable. Specifically, auditing management&#8217;s determination and disclosure of whether the contingent loss arising from the potential broad settlement of opioid claims is probable, and the related measurement of such loss, is subjective and requires significant judgment given that the potential loss is based upon settlement terms that have not yet been finalized.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the potential broad settlement of opioid claims included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to the potential broad settlement of opioid claims, and approval of the accounting treatment and related disclosures based on the most recent facts and circumstances. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We inquired of the Company&#8217;s internal and external legal counsel, as well as executives and other members of management, to understand the basis for the Company&#8217;s conclusion that a loss related to a potential broad settlement of opioid claims, is probable and reasonably estimable as of March 31, 2021. In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the status of discussions with plaintiffs&#8217; counsel and the Company&#8217;s intent regarding the framework for a potential broad settlement of opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s analysis of the potential broad settlement of opioid claims, including the methodology used by management to determine the probability of such loss. We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of a potential broad settlement of opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined Board of Directors meeting minutes, including relevant sub-committee meeting minutes, held inquiries with a director serving on the sub-committee, and compared to internal and external counsel&#8217;s written responses to our inquiry letters.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We performed public domain searches for evidence contrary to management&#8217;s analysis.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our specialists in accounting for loss contingencies, we evaluated the facts, evidence and the Company&#8217;s related accounting treatment for the potential broad settlement of opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the potential broad settlement of opioid claims.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We obtained written representations from executives and internal counsel of the Company.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined proposed terms related to the potential broad settlement framework.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the Company&#8217;s related disclosures for consistency with our testing.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain Tax Position - Broad Settlement of Opioid Claims brought by Governmental Entities - Refer to Note 1 and Note 8 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March 31, 2021, the Company recognized $1.3 billion of tax benefit related to a potential broad settlement of opioid claims and had an additional $0.5 billion of potential benefit relating to an uncertain tax position that had not been recognized. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized. The Company uses significant judgment in evaluating the technical tax merits of income tax benefits that qualify for recognition, including the determination of the amount that is more likely than not of being realized for U.S. federal and state income tax purposes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the Company&#8217;s uncertain tax position related to the charge for the potential broad settlement of opioid claims as a critical audit matter because of the challenges in auditing management&#8217;s estimate of the amount of income tax benefit that qualifies for recognition. Specifically, auditing management&#8217;s uncertain tax position in this area was challenging because the assumptions and estimates involved in management&#8217;s analysis required significant judgment as they are based upon the potential terms of a broad settlement, including provisions related to deductibility, that have not yet been finalized. There is also significant judgment associated with the assessment of the technical tax merits of such a settlement, including the related interpretation of applicable tax laws and regulations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Company's uncertain tax position associated with a potential broad settlement of opioid claims included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to the Company&#8217;s assessment of the technical merits of its tax position, including the Company&#8217;s assessment as to the amount of benefit that is more likely than not to be realized.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our tax specialists, we evaluated the facts, evidence and the Company&#8217;s related income tax analysis for the charge related to the potential broad settlement of opioid claims, including assumptions used by management to measure the related recognized and unrecognized tax benefits.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We inquired of the Company&#8217;s internal and external legal counsel to understand the basis for the Company&#8217;s conclusion that a portion of the potential broad settlement of opioid claims would be deductible based on the most recent discussions with plaintiffs&#8217; counsel.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We held inquiries with the Company&#8217;s external income tax advisors and we also read and evaluated management&#8217;s documentation of information received from these external advisors, which informed the basis of management&#8217;s position related to the uncertain tax position associated with the potential broad settlement of opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We compared management's income tax assessment of this matter to the treatment of other recorded opioid charges to evaluate the consistency of the Company&#8217;s judgments related to the uncertain tax position.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated any events subsequent to March 31, 2021 that might impact our evaluation of the Company&#8217;s uncertain tax position related to the charge for the potential broad settlement of opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We obtained written representations from executives and internal counsel of the Company.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined proposed terms related to the potential broad settlement framework.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the Company&#8217;s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the potential broad settlement of opioid claims.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill - Refer to Note 1 and Note 12 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s evaluation of goodwill for impairment involves comparing the carrying amount of each reporting unit to its fair value on the first day of the third fiscal quarter or whenever the Company believes a potential indicator of impairment requiring a more frequent assessment has occurred. The Company uses a combination of the income and market approaches to estimate reporting unit fair value. Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, the Company uses a discounted cash flow (&#8220;DCF&#8221;) model where cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. The rate used to discount to present value includes an unsystematic risk premium, which is intended to address uncertainty related to the reporting unit&#8217;s future cash flow projections. The goodwill balance was $9.5 billion as of March 31, 2021, of which $1.5 billion was allocated to the McKesson Canada reporting unit. The fair value of all reporting units exceeded their respective carrying amounts as of the measurement date and, therefore, no impairment was recognized.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium. In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by expected risk of changes in the Canadian business and regulatory environments. Auditing management&#8217;s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve more senior members of the team and our fair value specialists.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Company&#8217;s selection of a discount rate, including consideration of the unsystematic risk premium, for the McKesson Canada reporting unit included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to management&#8217;s goodwill impairment evaluation, including those related to the selection of a discount rate and consideration of an unsystematic risk premium.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s ability to accurately forecast operating results for the McKesson Canada reporting unit by comparing actual results to management&#8217;s historical forecasts, in order to consider the reasonableness and adequacy of management&#8217;s selected unsystematic risk premium.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actual results of historical strategic plans</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Internal communications to management and the Board of Directors</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation and comparing to the discount rate selected by management.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Deloitte &amp; Touche LLP</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas, Texas</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 12, 2021</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1968.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMi0xLTEtMS0w_89c73bb1-4748-4b55-8718-f717ce9042ae">238,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMi0zLTEtMS0w_787e3cf2-de8e-448d-8e2b-72e412614c7d">231,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMi01LTEtMS0w_6054df05-a4ed-4bbe-b274-a0e812df150a">214,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMy0xLTEtMS0w_0295aa97-4994-471b-9e80-8602f89b212f">226,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMy0zLTEtMS0w_5999bba8-9c7d-42f2-8c5e-db9176949083">219,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMy01LTEtMS0w_d88d0494-1a56-4b5e-8667-1f86036f60d7">202,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNC0xLTEtMS0w_70000d98-c29f-4a5c-ac10-7084a967e921">12,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNC0zLTEtMS0w_9cdce47e-d47f-4385-a902-09024df2cafe">12,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNC01LTEtMS0w_e684a174-88c5-4470-bfec-6cf43155ebfa">11,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNS0xLTEtMS0xMTMwNA_8b74743c-ec64-4ba2-bc96-d96ff7b0e881">8,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNS0zLTEtMS0xMTMwNw_f158dc8d-ee5f-4ca2-be39-8c95e9bcfb06">9,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNS01LTEtMS0xMTMwOQ_9fb4123c-377b-4c82-b7fb-3a696dc2c4d7">8,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0xLTEtMS0xMDQ3OQ_9ccf7c20-57c8-4499-9f98-f953c7ddb262">7,936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0zLTEtMS0xMDQ3Ng_c5ee8b9f-28ba-4f25-8ee7-ad0d5212f0c2">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC01LTEtMS0xMDQ4MQ_809883ea-b20b-48f5-bf9a-99fbb3381a31">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0xLTEtMS0w_3653e7ec-e705-4976-b9fb-446f2acde336">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0zLTEtMS0w_b6dcf296-7c5c-40d3-9dd1-f9cb6b2b1bda">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC01LTEtMS0w_a777aa3c-2aa5-4eb0-9636-03a0cc477aec">1,797</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOS0xLTEtMS0w_5556946e-0b4c-4dd0-9f5a-2d1206d09d18">334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOS0zLTEtMS0w_0463a2e3-ca14-4877-a8d9-502b9dcea256">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOS01LTEtMS0w_aced6904-ee6a-4779-aef4-859d03ef8442">597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTItMS0xLTEtMA_c5628b79-0e76-4a63-afcc-85254fcedcf6">17,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTItMy0xLTEtMA_e0a515eb-16f7-4a0f-8382-8c5559e1f475">9,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTItNS0xLTEtMA_52f6ea49-b3f7-4b86-8b62-dde9b9c6f9ae">10,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTMtMS0xLTEtMA_41f02c6d-51ad-48e5-8c5f-a65bbe9a9403">5,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTMtMy0xLTEtMA_b56b9f23-169d-498f-8861-d98df1a3ea59">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTMtNS0xLTEtMA_044da66e-b51e-4136-8329-4df2954308d9">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTQtMS0xLTEtMA_148b3015-f7dc-4507-b62c-2f855253e1c7">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTQtMy0xLTEtMA_daec7458-dea2-4ff7-80f9-a4b4174759f7">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTQtNS0xLTEtMA_ebb5ddcd-accf-4bc0-ab02-a392a09a7f30">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare <br/>Joint Venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTUtMS0xLTEtMA_ae5bf8be-e682-4ed1-b438-b8d2a368a60e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTUtMy0xLTEtMA_4dfc8095-a335-4156-92d7-d91538aa430f">1,108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTUtNS0xLTEtMA_97a83eb7-32fb-4e18-aea8-91e0c335d18d">194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTctMS0xLTEtMA_da338c38-ca16-42aa-ae9a-12e1282eda99">217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTctMy0xLTEtMA_37f213de-efb5-4851-97fa-f40bbb728b1b">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTctNS0xLTEtMA_9f48cc53-9d12-47d9-a004-aeaaafdbb35d">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTgtMS0xLTEtMA_65dc43d0-bf85-48e6-936e-f1a8394aaa6e">5,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTgtMy0xLTEtMA_c925a72b-6d50-4262-a691-9977f14eba5f">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTgtNS0xLTEtMA_1f5d9a78-85db-4104-bade-b1d518e9a165">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTktMS0xLTEtMA_a72a55d2-7f11-4a53-83a9-69f90ab2221a">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTktMy0xLTEtMA_7137fce1-6d6d-4633-b7ab-fc9018daaf7a">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTktNS0xLTEtMA_5f68af78-090a-41fe-b6bd-44a519a161e6">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjAtMS0xLTEtMA_6a998846-c236-4f52-ab10-f603da041159">4,339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjAtMy0xLTEtMA_f2d5d70b-ecae-4f10-a546-f78f7d98d1df">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjAtNS0xLTEtMA_eeac7a9a-437e-4100-9936-b35fa3652d9e">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjEtMS0xLTEtMA_44537d97-851d-48d1-91bd-de71345269df">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjEtMy0xLTEtMA_3621d9d2-3b6e-4693-aa33-9552d2a5aec8">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjEtNS0xLTEtMA_4245185f-0752-4017-afdb-58d96a84249e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjItMS0xLTEtMA_e53cf4a7-a85c-4612-8f01-776f0a9806b7">4,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjItMy0xLTEtMA_12c87381-ebe0-464b-a1a3-cfbba42c0c59">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjItNS0xLTEtMA_a154e2ac-b985-4493-a562-36b35d427864">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjMtMS0xLTEtMA_4eae314e-ef5f-4995-adcb-2d63aa0ee235">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjMtMy0xLTEtMA_ef033e90-9639-4f9d-8029-2d5ec2c135d7">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjMtNS0xLTEtMA_d02cfc9f-30ff-489a-a861-fa11ec9e1f2e">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjQtMS0xLTEtMA_1633d813-3ed2-406d-9272-f353c3db6b77">4,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjQtMy0xLTEtMA_53a89290-aa74-44af-9e8f-aaa9958fc6c2">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjQtNS0xLTEtMA_739f4d23-d5a9-47e8-914c-ee0a232f4630">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjgtMS0xLTEtMA_7317537c-c31c-44d4-988c-42d0e7848a4e">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjgtMy0xLTEtMA_c56d803f-0104-4611-8a47-00eb53eb7946">4.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjgtNS0xLTEtMA_4f6de90f-6223-478a-82da-48eef2e52fa8">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjktMS0xLTEtMA_ae33454f-035f-4d0d-bb53-0ff08f45f6b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjktMy0xLTEtMA_b9ca9448-f3e6-4018-9ecb-cc6c66309c22">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjktNS0xLTEtMA_c9f407c1-2daa-43ef-a34a-417002ee7775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzAtMS0xLTEtMA_340037f8-0547-4f21-b9b3-beb351278d93">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzAtMy0xLTEtMA_42e36a91-924e-4bb3-870b-cf89cc326a48">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzAtNS0xLTEtMA_e858756a-1af7-4173-8634-2949356aa043">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzItMS0xLTEtMA_b2ac2a1c-bd81-43d8-ac2b-9f04d12d62c4">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzItMy0xLTEtMA_b117fbb6-b9c3-4a7f-a4f7-e855e9224d3e">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzItNS0xLTEtMA_f594d6da-069d-417e-8079-59aeca7d9bae">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzMtMS0xLTEtMA_4ba52991-982b-4197-9b62-4ce8334eacdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzMtMy0xLTEtMA_20e4fc2c-ccab-441e-9633-645b5b82d231">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzMtNS0xLTEtMA_9dc5583c-9079-4bd0-8b2c-d20b0d5e9e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzQtMS0xLTEtMA_5ec89326-f0e1-415a-8e10-ec749e1e7ea8">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzQtMy0xLTEtMA_fbb12a63-8050-42bf-9a21-fbf357ed839f">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzQtNS0xLTEtMA_524a660c-49dc-4210-bd0f-e1b99b9e6485">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzctMS0xLTEtMA_10528f5c-760f-44d3-9370-f181aa97ae63">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzctMy0xLTEtMA_48d64069-c0f2-4843-a5ad-5e5446f444ce">181.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzctNS0xLTEtMA_901b36b7-da41-4d5a-8608-d807820629b4">197.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzgtMS0xLTEtMA_2b153867-5ac3-4bfa-9494-af9e3139675a">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzgtMy0xLTEtMA_3145c92d-4d9b-4d6c-bd75-a9c4f996590f">180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzgtNS0xLTEtMA_aaa90aca-072b-4efd-9881-c3821e7628b5">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">70</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:64.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMi0xLTEtMS0w_04caae0a-6596-4291-aa4c-1570663d2897">4,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMi0zLTEtMS0w_12c87381-ebe0-464b-a1a3-cfbba42c0c59">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMi01LTEtMS0w_a154e2ac-b985-4493-a562-36b35d427864">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNS0xLTEtMS0w_13531b69-6308-45cb-bee8-54f948495785">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNS0zLTEtMS0w_c472cb40-a1d8-43cf-aed3-87945b780ce7">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNS01LTEtMS0w_6df2653a-a38a-46ec-96b3-c8906fe7e0e1">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNi0xLTEtMS0w_4cc752a4-4bcc-4f84-a047-fcb451663992">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNi0zLTEtMS0w_026aab61-1ebf-4009-9cc7-93ef1a6d5706">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNi01LTEtMS0w_0a0065b3-984b-4c44-94c2-3ffba765e06a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNy0xLTEtMS0w_34997c00-d4dc-4acc-93ea-6a8493be7b52">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNy0zLTEtMS0w_d2913a18-eda2-4773-815c-470b6fffe923">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNy01LTEtMS0w_77e6b4d4-ffea-4a69-9586-be247d33f289">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfOC0xLTEtMS0w_24da0fb7-7852-4847-9f77-5e5f0707ece2">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfOC0zLTEtMS0w_97a589cd-0d6d-4efa-98fd-6e26750e858c">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfOC01LTEtMS0w_2f8f8702-e8fa-499c-8468-4ab2a73bf639">198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTAtMS0xLTEtMA_8976595b-4142-4880-907c-10aed5f72c9d">4,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTAtMy0xLTEtMA_aa6027fb-d12d-42dc-889a-09616ea7a2a0">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTAtNS0xLTEtMA_9d3163e1-63e3-46e4-9097-0b74fd166cb4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTEtMS0xLTEtMA_5523486d-e457-4e64-9b8c-ecb3c64fa0fe">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTEtMy0xLTEtMA_ba63e128-ea14-4d35-9421-3ca13a3dea3b">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTEtNS0xLTEtMA_0dad5f1d-9bb9-41b0-8327-591f47115513">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTItMS0xLTEtMA_9a71f6a8-0c4e-41b6-a25d-8373259faacd">4,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTItMy0xLTEtMA_b70c7f84-d627-44f0-add0-d29b81066079">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTItNS0xLTEtMA_38fa9e38-2ba6-4219-bbcf-51af6fa562c9">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">71</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNC0xLTEtMS0w_1efeb1db-dbea-48ef-82ca-7a28f49fa42b">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNC0zLTEtMS0w_17e49458-f1d5-4c30-960c-c9aff32e6238">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNS0xLTEtMS0w_fe222d1d-00f8-4b5b-ba32-46aabf932da6">19,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNS0zLTEtMS0w_d3383f8d-2839-49bd-8c98-3900104f0c90">19,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNi0xLTEtMS0w_46be8f38-9ae7-46a5-bc91-f7e8bcfdc4bd">19,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNi0zLTEtMS0w_e1ee35cd-9bb4-459a-9116-844d16dcad47">16,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNy0xLTEtMS0w_481e8583-17dc-432e-bca5-248e09259798">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNy0zLTEtMS0w_ccfc2aa1-7a15-4db3-841a-e882c7642257">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOC0xLTEtMS0w_c789808c-81af-4e2e-8be7-a29dd81f793d">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOC0zLTEtMS0w_b0bc0998-095d-4228-97ae-5dd0a874f50d">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOS0xLTEtMS0w_75218621-042f-43a7-8f6e-aa3fb2cc3b84">45,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOS0zLTEtMS0w_1e44e6d4-97e2-46ba-b8a9-62e9e73df382">42,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTAtMS0xLTEtMA_765bfff0-239f-4345-9d3d-b3758d1b6bba">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTAtMy0xLTEtMA_96d9f699-aaf2-4a60-9203-9a8fe0d6af6e">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTEtMS0xLTEtMA_62337c08-e880-47d0-8f20-55a5c1ba7ad6">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTEtMy0xLTEtMA_10c8b385-b4fb-4889-8187-e162dfa82318">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTItMS0xLTEtMA_ddb70966-32a0-4703-835f-b8ffb12e7ffd">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTItMy0xLTEtMA_ad61e4ff-3a08-402a-a82c-e430fce8dafc">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTMtMS0xLTEtMA_62d4f6c5-1a90-49bf-9bb3-6652717b38bf">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTMtMy0xLTEtMA_8a03bc6a-b622-4091-9dee-e4a3c24b62c2">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTUtMS0xLTEtMA_1b379a7a-85f3-4556-8549-cdb7123bfd0f">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTUtMy0xLTEtMA_1eff90aa-e3a3-4598-a185-f100028c20ed">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTYtMS0xLTEtMA_3afae63b-9861-4220-be5e-46969f5c049e">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTYtMy0xLTEtMA_ad87a2a0-178b-43b8-b9bd-f084b6101e9c">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTktMS0xLTEtMA_470f78e3-0d84-48b9-b649-2b655bb751a8">38,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTktMy0xLTEtMA_1170d723-9a8b-4240-a2b9-9023cc5c1e18">37,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjEtMS0xLTEtMA_6fae33d0-beda-4c74-b4d4-19dfee00cf12">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjEtMy0xLTEtMA_d98162f5-5c59-4131-8377-2d5f213a140e">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjItMS0xLTEtMA_c62977cb-5ceb-4397-a1dd-1c1004ffa69e">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjItMy0xLTEtMA_6cdb2905-3337-4c5a-a7af-c0b5de9ac98b">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjMtMS0xLTEtMA_61e51607-4e04-44ec-a37a-6b7378b3200e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjMtMy0xLTEtMA_f83bf7be-b4cb-4764-9e70-512da119f5b8">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjQtMS0xLTEtMA_169d1d8e-1e3b-48c7-9716-547abce660f0">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjQtMy0xLTEtMA_591959cf-2cf1-44cd-be4e-12f788394bf4">3,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjUtMS0xLTEtMA_0181db77-f106-45b2-9d2f-87a27a9c1627">44,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjUtMy0xLTEtMA_ee5a09b0-fa19-4c4a-ac41-99d0a09872e0">42,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjYtMS0xLTEtMA_7ee1fd30-23fa-4aa2-9c32-0f3251d012c0">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjYtMy0xLTEtMA_1fa450ee-d24f-4be5-a2b1-b9d90130c292">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjctMS0xLTEtMA_a0f0c832-57c3-4d39-b07a-847e9014a11a">1,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjctMy0xLTEtMA_ac597009-5f6a-4128-9dac-ae55b912432a">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMS0xLTEtMA_10825e8c-8f9b-45b9-8918-941265e88d6c">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMy0xLTEtMA_02cf211d-9cd3-4ede-b395-20104c125809">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMS0xLTEtNTQxMA_32d88f8c-da93-428b-86ab-719fe53c2538">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMy0xLTEtNTQxMw_502e39a1-1b00-492c-9a25-8b2f9c584189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjktMS0xLTEtMA_c26e026a-ca89-457b-9ffe-ffc52d8c2732">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjktMy0xLTEtMA_b839c289-91d3-4c6e-b852-68a622b0ae03">1,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingent liabilities (Note 19)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzAtMS0xLTEtMA_dff5600d-4dd1-4aed-9ecc-9c60eccc7ace"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzAtMy0xLTEtMA_240ec577-4dff-4474-8065-d6239ce5c7c5"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzEtMS0xLTEtMA_03ecb014-3e26-4c83-bb94-13122815b31f">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzEtMy0xLTEtMA_ecc91cb8-a3e3-442a-88cf-2f5eaffce79b">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; equity (deficit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTA_7dc4e592-6b6b-4531-8a97-86c614dce43f"><ix:nonFraction unitRef="usdPerShare" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTA_86563031-aff8-479c-8049-69646c7058c1">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTc_293c7ff8-9f64-4c08-8d38-4c9f8bcc88df"><ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTc_c7739521-cf06-4ddc-ae84-d1b2b8a54159">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_2c28dcc4-3ddf-4189-9a38-75ba3196ad89"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_8b4d68e3-0c64-42e9-9582-d916c458b72d"><ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_9df6d099-04e3-4481-a66a-3332ddc2cac3"><ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_a74f896b-a468-4749-83f0-b192d352495f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMS0xLTEtMA_1f6c2e54-942c-4c81-89c4-5ed42cc4064d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMy0xLTEtMA_e90c8da8-c92d-4d98-8a40-8081306966a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNDY_5f75559f-26b8-4bb0-bde9-9cda1898dc45"><ix:nonFraction unitRef="usdPerShare" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNDY_ef7cb01e-e802-4940-be79-0ec527bbd858">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNTQ_3a900187-618f-4471-b773-9187ce09ad71"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNTQ_cfa19af9-65f0-4f81-8222-0bc0bb5006a9">800</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNDA_e567143a-749e-4b87-bc7e-ee0b51a47d9e">273</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwMzU_13d1c22d-40e4-49c8-bdc4-aeee14a1963a">272</ix:nonFraction> shares issued at March 31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMS0xLTEtMA_8e547bd2-fd0b-4011-9467-8e5e512f13fd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMy0xLTEtMA_9f28eef6-d324-4ddf-98a4-710bfbca6195">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzUtMS0xLTEtMA_0cb1e6ef-789e-42d0-91cd-51cb936245fa">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzUtMy0xLTEtMA_a8f8ba2e-a2d3-4e83-874c-09802e5b1166">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzYtMS0xLTEtMA_c9209890-2a4e-4ab0-a1d9-270ae55bbc6b">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzYtMy0xLTEtMA_b9f0b2a7-e630-42d0-9dca-316a2e3e26e5">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzctMS0xLTEtMA_509e4b67-1029-496f-85b8-f7a9d1efe0a6">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzctMy0xLTEtMA_75cc43f8-0d48-4d82-b4b8-e33d5f0004d5">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjljMmFkODA5NjBhMTRmM2NhNzk0MWE2NDAyODYxMjA1XzU0OTc1NTgxMzg5NzM_d069a41e-4666-40fa-bed4-7de1152fb6cb">115</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjljMmFkODA5NjBhMTRmM2NhNzk0MWE2NDAyODYxMjA1XzU0OTc1NTgxMzg5Njg_0fe21e62-05ce-4945-a039-286c64b00713">110</ix:nonFraction> shares at March 31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMS0xLTEtMA_17bd7f0d-232c-4b87-b7b2-eb329e97f6c3">13,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMy0xLTEtMA_9d41a519-fdb9-45a1-b4d2-fe06abbdcf80">12,892</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDAtMS0xLTEtMA_88932165-7c60-4d85-a2fb-6d556311a01e">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDAtMy0xLTEtMA_508850bf-96e1-4c1e-80b7-020ccc32a787">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDEtMS0xLTEtMA_e05c3086-2305-448b-8110-45ebb7c63f58">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDEtMy0xLTEtMA_e069a09f-f647-4cf5-970f-fc46b0071d64">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDItMS0xLTEtMA_c01c7937-8994-4bc4-b13e-01811c0ca530">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDItMy0xLTEtMA_3eed4ad4-c541-4cef-a32b-908f26b6766c">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests, and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDMtMS0xLTEtMA_5f3318b3-179d-4946-8a88-f89c52c7b087">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDMtMy0xLTEtMA_4eb57728-505d-4a7c-b183-4d3a6d3a2c3d">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">72</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.435%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">McKesson Corporation Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common <br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xLTEtMS0w_d4f534a2-65aa-4bcc-a016-78047027fb50">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0zLTEtMS0w_c8a4e6b7-3f80-49e5-a5dc-0a12b5fb23ba">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff0501dacd84f6d9a8a0874bbdc5b3c_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy01LTEtMS0w_6379b0d7-dead-4011-b536-2024458ad3ef">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i694f7a1a7fe8492981ba38c56efece34_I20180331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy03LTEtMS0w_554f129f-1146-4919-aa12-ef2a984d1cc5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa47717062f4d0faa776c2def60876c_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy05LTEtMS0w_a8c89cc6-3db9-420f-86ee-56064a06df52">12,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe7f6d03c0214b888f11ce73ebb56fd5_I20180331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xMS0xLTEtMA_5f2869c8-855f-44e7-99a2-56d4277e95e7">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i33d5e858b51e4d099bb4436a00d94e8a_I20180331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xMy0xLTEtMA_de3ac2b9-dbbd-4dd2-98f0-c2e051451c16">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33d5e858b51e4d099bb4436a00d94e8a_I20180331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xNS0xLTEtMA_15b28c8a-e133-426a-bdbc-75b3b495bc52">7,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae70566f5363452bbc98260415fc04bd_I20180331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xNy0xLTEtMA_472d8767-d035-4bf5-87e6-a9153aee6fda">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022a2642b16245d083cb80c539e560b3_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xOS0xLTEtMA_7c75c600-587f-4ca3-9612-a90a8a08054c">10,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b7fb92a6f244829cf78e65a255ee88_I20180331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC05LTEtMS05NTM5_b2e7f663-4ecf-464c-8837-e994780d56c8">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8246b55c8e504364a5c352ba370995ad_I20180331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xOS0xLTEtOTUzOQ_77fdbc62-0ae4-4d00-b27c-913bcef2423e">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balances, April 1, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a514ba214224efd98713a38fa41dbe7_I20180331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xLTEtMS05NTYx_de924d6b-d7e6-46d0-a45c-3ff6329146fd">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a514ba214224efd98713a38fa41dbe7_I20180331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0zLTEtMS05NTYx_236fcbb1-88c4-49a2-8b41-18bb12651777">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8bfcf07f30410981669a5bf1af7c02_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS01LTEtMS05NTYx_0cb42b5f-48d0-4568-b626-106c78fe9392">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58e169e9c83f487291f51edc0b6c3ae1_I20180331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS03LTEtMS05NTYx_9e0b1bed-8d70-4d1b-ada9-42b0c99632b5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93dcfcc89c2542b0928b50c7d3e432c2_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS05LTEtMS05NTYx_71c9b2dd-37e6-41d5-b83d-97732318b678">13,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36dce71a26114b94909aaa9ba795fdb2_I20180331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xMS0xLTEtOTU2MQ_f4859f6f-091d-480d-b2b8-02add604f222">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i04b14f9878614f92a269ff6fccb37f69_I20180331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xMy0xLTEtOTU2MQ_c5beb63e-38ad-4e4b-aeff-167fc5887494">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04b14f9878614f92a269ff6fccb37f69_I20180331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xNS0xLTEtOTU2MQ_5c15cf4c-9fbc-4f55-acc5-c779fe86b4e3">7,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib174f082f2e349489ff2dd2b20330381_I20180331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xNy0xLTEtOTU2MQ_b465110e-50ad-4cfc-b209-c87421ffdec9">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd683332b3f4798998789f66099e34e_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xOS0xLTEtOTU2MQ_ad57618c-de36-4910-b6b7-614368171274">10,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ccd14692cf3450cb539e1a2cf941e8d_D20180401-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xLTEtMS0w_e0602c25-64bf-417c-ba40-5653951e64be">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC01LTEtMS0w_f60e3f64-d44c-4e3f-aa0d-74ee04351e9e">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xNS0xLTEtMA_12e5f745-ad40-4472-8e23-caf9810c94e7">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xOS0xLTEtMA_56f2cac8-b62e-4864-bf8e-10f56a969ee3">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS01LTEtMS0w_47ee9050-0ace-4bcf-8f24-c692e96b4cca">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xOS0xLTEtMA_391b11d1-1c54-4459-8cfe-65b9aae0db0a">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNi0xNy0xLTEtMA_91564922-e274-49cf-a450-9e0a92060ae7">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNi0xOS0xLTEtMA_329839d4-5ef3-4b45-a8f6-c77bf0d6b9a6">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1f6cfedc37948ddbaa4a17a60061842_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNy0xMS0xLTEtMA_829e1105-7228-438f-96d5-a7e354e167c5">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNy0xOS0xLTEtMA_4dab49ca-28c8-480d-8547-65ff12891f55">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOC05LTEtMS0w_356824f7-94dc-4b1a-816c-7188f80182c0">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOC0xNy0xLTEtMA_c4832a55-e718-40af-a468-16025ee2f832">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOC0xOS0xLTEtMA_6a882a10-01be-4563-9b9b-4b203ca4950b">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS01LTEtMS0w_ab4dfb65-3cee-40dd-b0f7-8d530383b41e">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS0xMy0xLTEtMA_f4da037b-efa1-4fdd-b632-dbc461d07b84">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS0xNS0xLTEtMA_d01d95c7-1861-4f00-857f-1f58b84aa3d7">1,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS0xOS0xLTEtMA_c7d2f90b-ea6c-4e4e-8227-489358a0d978">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5ccd14692cf3450cb539e1a2cf941e8d_D20180401-20190331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMS0xLTEtMA_a26832b9-1228-45b0-844e-a9670b2b5fc3">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtNS0xLTEtMA_cf03b2e0-fb46-4ee9-902a-2466d040950f">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtOS0xLTEtMA_f65800db-d42d-40a8-8124-802b6012d3a7">472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMTMtMS0xLTA_1b80791c-5671-4dbe-ac17-f68f198f0ced">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMTUtMS0xLTA_cc92407a-fbcb-4492-8ecf-9059c0fdddf1">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMTktMS0xLTA_458ca3e5-567b-4d3e-8c00-fc273aa01a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwMGE5YzI5ZTM0YzQ2YmNiMDc4NDk0NTkwNGZkNGRmXzU0OTc1NTgxMzg5MzY_54850eee-3b71-42a0-86cc-1191977aa72a">1.51</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTEtOS0xLTEtMA_4948b90c-d5db-4d82-8c27-bce9b5fd6b4b">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTEtMTktMS0xLTA_e2d19168-1e17-4a8d-b25e-a015cfd6d4aa">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84e4eb45170844d593b83b2afa4fab92_D20180401-20190331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItNy0xLTEtMA_979610bc-a32e-401c-b9d8-03a0d9c7a7a2">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItOS0xLTEtMA_ad2b8d6a-4b2d-453a-a718-90219e92997f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItMTctMS0xLTA_1f66785e-c2df-4b15-ade8-d4abd5d76bec">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItMTktMS0xLTA_a86543f3-4bd3-4d2a-a7d0-53e972c845c8">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48ceaabbb16f4ec6b0bf0f94817e2803_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMS0xLTEtMA_a75713e2-040c-4c85-81b9-74573c6d5bbd">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ceaabbb16f4ec6b0bf0f94817e2803_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMy0xLTEtMA_6bbcf297-6b1b-4844-aca9-8eabeaf8acbe">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id46086fa9b504b8fa9969e5e6955dfca_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtNS0xLTEtMA_3cec8320-1982-4349-97b3-2f4d8cf3d10f">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f1dcb375e934b61af2234db5c9acb4f_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtNy0xLTEtMA_fac542f4-5bdb-4619-96ad-660c31af65a4">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ee753b2d3f41df8075fc700e912fd6_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtOS0xLTEtMA_ede421ee-ccf0-4833-907f-327c0a10dc7d">12,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40ae5de5a7ed451daaf6f336a3613e5b_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTEtMS0xLTA_8e847032-728f-434b-b0c8-cb5b4407bbf2">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3195958993f542039d26aa1dc1a5932a_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTMtMS0xLTA_503b6923-7334-4615-80d2-d88af2f257e1">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3195958993f542039d26aa1dc1a5932a_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTUtMS0xLTA_44cb8f30-6433-4641-9e58-0e06dfc94261">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4544e477b1841a4bdb6022ce255ba46_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTctMS0xLTA_5ba481d2-130c-4aa2-88d1-dcb8e33a1465">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTktMS0xLTA_bb072d8a-6e5d-4e5f-802f-178855f485e2">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a498773ac34aab9e6acb8ed6ca7397_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTQtOS0xLTEtMA_f97edb46-42fd-4b83-ab78-57125acf967d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6cd908e9ae944c589f15bfc5295981c_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTQtMTktMS0xLTA_8a006749-e68a-44c9-9ecf-07bbfdf647ea">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balances, April 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i127912e4703a4c4b93b3568d503e21a8_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMS0xLTEtMA_953502fb-af4f-4029-b8f4-667a219330c3">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127912e4703a4c4b93b3568d503e21a8_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMy0xLTEtMA_f78ec847-5598-402f-89a9-158ed5f09cfa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b8e2f7e988499db2ca37a472ba95a1_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtNS0xLTEtMA_76af72aa-2a68-471d-a44f-e33b554b625b">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5501cbeadb6d4216937dff20e26e9da7_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtNy0xLTEtMA_2f7a8b05-04ca-427b-b224-b6613b66efa3">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd6fff2a93e148f184cb8d32b86c426e_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtOS0xLTEtMA_460e0600-aabb-4609-867f-c14e7a4ac0e9">12,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7317175ef4774a10ab306d8ad80b27be_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTEtMS0xLTA_f7999df0-33e1-4106-8118-68dcb7155534">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibfa843649b4b43898ba141c6242d8f29_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTMtMS0xLTA_278b5967-f394-4fb1-ad9d-74c8e65fd411">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfa843649b4b43898ba141c6242d8f29_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTUtMS0xLTA_bf2694ae-fbd3-439e-a862-2f15cdc9e7b2">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ca8bc8a3df45a680bddb6d68e1a14c_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTctMS0xLTA_d7588013-72ca-46c3-b8e1-97b3524b8f1e">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16590f20bcb54d93a46c868388bd8b15_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTktMS0xLTA_32becb0e-e499-4a3b-ba92-509850f17d32">8,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i818384a7497d4ec3b819a10a8009bce7_D20190401-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtMS0xLTEtMA_b091595e-8eb4-4915-995c-fc578d8f090a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0854da8f001b4fb5b20e5b1a8e5cca76_D20190401-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtNS0xLTEtMA_faf3066c-e15c-452a-b301-0c8473708e1e">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtMTUtMS0xLTA_453c9324-eec2-4fc6-a4d7-6c2981cbe4de">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtMTktMS0xLTA_e761c96b-3391-458f-bd0f-552f030d9d0f">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0854da8f001b4fb5b20e5b1a8e5cca76_D20190401-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTctNS0xLTEtMA_647044b0-515d-4381-96cc-83c7b603387b">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTctMTktMS0xLTA_45bfa3a8-2cc3-4f5d-81ce-d3469afe6652">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTgtMTctMS0xLTA_2558c37b-7c4f-40f2-aa58-40adb9e95f04">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTgtMTktMS0xLTA_fd3db5c7-d9f5-417b-86b9-7e6e580bc936">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd1bf93b1f14f26ac73ea236f36768e_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTktMTEtMS0xLTA_c0e433ac-06d9-49e8-b5b8-688a4edd0e60">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTktMTktMS0xLTA_f9faffa2-baac-4e64-986f-a88d6704eafe">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjAtOS0xLTEtMA_f85c8f5d-9f4f-48b4-af6e-3044e184c205">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjAtMTctMS0xLTA_8dc78541-929a-49d1-a57c-a1638f914dd6">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjAtMTktMS0xLTA_b6239d71-a62d-47ee-ba98-b573d247dd2a">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjEtMTMtMS0xLTA_5d0e8bd8-c5ec-46ce-bb6b-90b66e5fe7c4">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjEtMTUtMS0xLTA_ad3fcd6d-8fe8-4afc-8794-db54abf91d4a">1,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjEtMTktMS0xLTA_d0c25688-2632-461a-bf08-2b2ef3617b94">1,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Change Healthcare share exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331" decimals="-6" name="mck:StockExchangedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjItMTMtMS0xLTA_163ec818-3e78-4afa-af80-b471c598ad34">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:StockExchangedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjItMTUtMS0xLTA_7b29babc-9a3e-4028-9c25-8262b893cd47">2,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:StockExchangedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjItMTktMS0xLTA_4cc5682c-49c1-44b3-bb25-a7169df679a4">2,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZhYzU0OWQyZTMxMjRlMTI4MTVhYjhhOGU4NTY3NWY4XzU0OTc1NTgxMzg5MzY_8d94f901-7692-4f9b-a8ef-7d32260f0c32">1.62</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjMtOS0xLTEtMA_bdd47042-5b86-490c-8ce5-cf6d21d673e4">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjMtMTktMS0xLTA_ac956a6b-a8dc-499f-9192-c81a5d4ac63d">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i818384a7497d4ec3b819a10a8009bce7_D20190401-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtMy0xLTEtMA_f9615e4f-0f32-4bd5-9daa-ab6c806fcb62">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f8f7c8825848e3b9c0073f40137455_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtNy0xLTEtMA_732be685-fdeb-44c5-83ee-c3085b1847e6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtOS0xLTEtMA_bfba6560-5c70-4148-aad8-e51463968e42">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtMTktMS0xLTA_ce3d9111-0abc-4e8e-b5f4-21bc7a26eef5">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieace64892e6e4c64b170a9943f943cff_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMS0xLTEtMA_4e16190f-1576-4c8f-ad03-c709c17c510f">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieace64892e6e4c64b170a9943f943cff_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMy0xLTEtMA_4f44aa08-b8b3-48b6-b0a8-54fb48c09b20">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dd26a3871a4b7ebada11dbaa7622fe_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtNS0xLTEtMA_629b05c7-2d68-4b37-9068-fad5ad5ed07a">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5bbb75dc3b4b22a7678ca731073aea_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtNy0xLTEtMA_bfac7c77-ec74-46b6-8459-0411438e4107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia36cd1fb5104458194118cf1f7a5b4e5_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtOS0xLTEtMA_17ed5458-bfe9-4255-9ce3-cb4bce59a9a9">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6c63db23ba743c9a62c831ddf5c11fe_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTEtMS0xLTA_300ca59f-7b7a-4dce-93ee-c46faf81f4a1">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i47ce9e7fee2540b681fbd42059c7386b_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTMtMS0xLTA_b5f97076-a50d-4f4a-af3e-e0f17555db06">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47ce9e7fee2540b681fbd42059c7386b_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTUtMS0xLTA_2b6ecea5-f145-44a3-ba1f-04fafae228f0">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bbfa761b88c4adcbd3850e152c97132_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTctMS0xLTA_f83512bd-9144-4403-82f7-ae41d3f7c9dc">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTktMS0xLTA_a5448bcd-2059-4767-8939-b4e1fa12b81c">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i405042e0c105499e829dac8d3ddb2458_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjYtOS0xLTEtMA_6c973a4f-f4f1-4fc1-975e-08c4f0f18aea">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id919c60b59754f78a678ad703c842d1b_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjYtMTktMS0xLTA_f618dcca-3164-4ef0-9d96-43cbd0940334">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balances, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i209c6d9d06f94525a18e4a67e9b962a5_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMS0xLTEtMA_917a33ed-9f54-4ebf-9cb5-1653c7cd9198">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i209c6d9d06f94525a18e4a67e9b962a5_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMy0xLTEtMA_34d5cc5f-44d4-4be1-a805-3af1a8b15a2e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice9f595a7fdb4b7cbdd8bf02e8444022_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctNS0xLTEtMA_3cf35bd8-8374-4873-b79f-acf326220261">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7e42c0d706c481b84e088c5d5c7d229_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctNy0xLTEtMA_72fbbb97-9da2-4f2a-a263-f29a6ec5f851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e9843c614c4c8790797c45327bd623_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctOS0xLTEtMA_6f20609c-d9f0-4559-b4c5-5eb716d34d07">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i460cb8fdc68d4e3ab755d83b3ce58795_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTEtMS0xLTA_9d18a847-990b-4dcd-b848-7e3bf8355bcb">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id5bccaa8d2ae4c7dab8a934455b32ae4_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTMtMS0xLTA_808b06c8-fc99-41dd-bda8-ee3f7b60001e">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5bccaa8d2ae4c7dab8a934455b32ae4_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTUtMS0xLTA_4404ea6a-90cb-4af6-8b9e-a59a6fa9e84e">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23d25bd272041a8865720072fc8a546_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTctMS0xLTA_43329261-d5d7-4f86-b9d8-acc0838dcfba">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i164671a6fa094474b24478df67ffb27e_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTktMS0xLTA_80783f9e-cc79-4163-b198-767a9f61b66c">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c2be497f4e442e0a366c6eda71cc339_D20200401-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtMS0xLTEtMA_4cead7d0-c3cb-4740-bede-b4f91990d70b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtNS0xLTEtMA_65f6e5c5-c2a0-4a4d-bad1-911f36bcdf9b">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtMTUtMS0xLTA_13b6dc27-ea0d-43e4-848b-85beabd1eab7">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtMTktMS0xLTA_27236a71-ec52-4631-9208-819a34686d2b">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjktNS0xLTEtMA_b954dfae-1f1e-4ceb-abd4-a2d4cdfcc808">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjktMTktMS0xLTA_3d6b956d-384a-4740-aae5-7af522d42b6e">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzAtMTctMS0xLTA_81a8f552-1452-4d8a-bb8c-7621f9b1bb81">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzAtMTktMS0xLTA_0a0ede39-a1b5-4dde-9b2c-93221ebaab5a">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aece504dbcf4457aacac81f8f54a390_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzEtMTEtMS0xLTA_bac71ff4-0248-4453-b390-8be27391df87">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzEtMTktMS0xLTA_a279d21c-1591-4eb3-86d0-4f98df1de061">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzItOS0xLTEtMA_67101562-77a1-4102-a3f5-c44e627c33fd">4,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzItMTctMS0xLTA_048ec7d8-6801-4be6-a23f-57c888e57fc8">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzItMTktMS0xLTA_557b7d9d-8db4-4077-a8cc-366d6a07e5fe">4,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtNS0xLTEtMjAzMjc_a894ca24-dc8a-473f-b385-f27594716731">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtMTktMS0xLTIwMzI3_27414128-40f0-4e4a-899f-5bdce11b073d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzMtMTMtMS0xLTA_63764fad-3131-4ae2-bb60-394dae9e58ad">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzMtMTUtMS0xLTA_1fa4ce12-a506-42c4-ba44-fe8a3660f789">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzMtMTktMS0xLTA_8c01b253-6969-4c59-a7af-7c071f4b3ede">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjkxNTI2NTJhMzU3OTRmODVhZWZlMDVjMjE0ZDI4ZTk3XzU0OTc1NTgxMzg5MzM_93ac5576-aaae-4574-b3f3-e3a4f970aad6">1.67</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtOS0xLTEtMA_ce124a9f-bda1-44d0-b6f1-cae80594be91">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtMTktMS0xLTA_e185a11a-9eb2-47f0-8c25-1cd1de096d72">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzYtNS0xLTEtMA_90a8c39b-c251-4b11-8734-d6f528eba709">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzYtOS0xLTEtMA_8c7d1431-2851-432f-969d-695c2d0b6a1f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzYtMTktMS0xLTA_067a34e0-602e-448d-8325-d69f8ba46663">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i703f281903e14c92bc829e04ebb959ad_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMS0xLTEtMA_77c45515-df5d-493a-8acf-f8967b24624f">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i703f281903e14c92bc829e04ebb959ad_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMy0xLTEtMA_4b57db58-f00e-4044-9f7c-8626096ff86a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6290fbbe29f84c1db97283a012272162_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctNS0xLTEtMA_04dee46e-b1f2-4002-bb78-9e69964136b5">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0516ac692388404c8f088c9e1ab4cc78_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctNy0xLTEtMA_82102f30-f3d7-4cbf-84dc-ab4c740f4b38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb86a9ba62104883927379cb8bd96649_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctOS0xLTEtMA_ed53c048-be8b-4944-8e08-64f408714ebd">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9384c8d2c240451493d40ead28d2d250_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTEtMS0xLTA_f7435651-d4dc-41fb-b9e9-060883970338">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i13f69d981df240f483b999053f8a2547_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTMtMS0xLTA_1bd4743a-ad42-40e9-bbba-73aae8a855a9">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13f69d981df240f483b999053f8a2547_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTUtMS0xLTA_0d0174d3-9d16-498c-a1ce-6b25ff0d965b">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a6bb29286494ed2aec32dd02ab9445e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTctMS0xLTA_8c441cc5-a2f2-456d-ba45-20c5f175c72e">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTktMS0xLTA_e9fd314a-28b1-4541-b1f1-ca3ccb4198c4">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">73</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMtMS0xLTEtMA_652bbdee-f61e-4b35-9934-871ba8fd0cc5">4,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMtMy0xLTEtMA_6bdd1354-378c-4d66-885d-f5cefa08cd16">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMtNS0xLTEtMA_3282e107-52b7-4643-b092-dd8ce2382bc7">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUtMS0xLTEtMA_305c0994-9732-454d-98c0-d85d1616e7b3">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUtMy0xLTEtMA_994f946b-3df3-4c4e-9eec-672910e53e78">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUtNS0xLTEtMA_39d83d66-bdcc-4a23-8e3d-06f7b89d0b92">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzYtMS0xLTEtMA_3e6c2c5f-adcb-4f97-9185-562564c1a7b5">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzYtMy0xLTEtMA_9cbc9251-34c4-4570-bda5-263b4765b68c">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzYtNS0xLTEtMA_c7314be5-b933-4555-a22c-e2976ba7e6d3">632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzgtMS0xLTEtMA_b52eb355-1223-41e4-8c92-eba33e6d7a2d">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzgtMy0xLTEtMA_1c6f6019-1ab2-41bd-b7a8-b7c47de80b54">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzgtNS0xLTEtMA_a9abaa2e-8784-4e24-a6eb-846e6ba04ca9">2,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzktMS0xLTEtMA_2d194199-26f6-4222-b845-cbcea7d82f26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzktMy0xLTEtMA_2ec9ac40-08c1-42ba-8ccf-7019c8512aea">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzktNS0xLTEtMA_4239b019-f9c2-4741-887c-0efa263b1273">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEwLTEtMS0xLTA_34104b72-e3aa-4654-ba70-cd67511037e0">908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEwLTMtMS0xLTA_614cd74f-1e08-441e-8d80-67fcc3efdfef">342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEwLTUtMS0xLTA_4f4c6a22-1256-4e01-a849-99b2ac510154">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzExLTEtMS0xLTA_8fd59cc9-51be-4245-9cd5-464fc3ff1533">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzExLTMtMS0xLTA_83239b96-abc9-4e8f-b4f9-1402b127a0c8">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzExLTUtMS0xLTA_cbbb18c8-f17c-40c0-866b-3f58abdabc41">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEyLTEtMS0xLTA_a85d4bd2-44d0-4853-8d54-1add77936ebf">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEyLTMtMS0xLTA_c4128bad-d531-4eca-8952-9ffb7b6d606c">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss from sales of businesses and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEzLTEtMS0xLTA_05db85a4-3690-4b32-a772-ab54330626b7">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEzLTMtMS0xLTA_8420d046-eb2b-49bb-b3e5-def2768d14a6">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEzLTUtMS0xLTA_b0f877d7-1797-4ebe-89f2-e33955961db2">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE0LTEtMS0xLTA_24372ef7-a27a-4e07-9fae-ee1cf7536421">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE0LTMtMS0xLTA_c39cfdba-8e58-4dc3-aefe-f89ab6afba89">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE0LTUtMS0xLTA_092a7a8f-dd65-4d74-87de-52b8c9828d0c">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE2LTEtMS0xLTA_e147bb44-9a74-48de-986d-0b24dc083596">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE2LTMtMS0xLTA_3aebfc50-5f12-4b8f-ac65-fe7b57fab56b">2,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE2LTUtMS0xLTA_b09d42a5-659a-4c5f-a4fc-e8495447c315">967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE3LTEtMS0xLTA_84a944ec-4618-4cfc-bae2-c1760f88e9aa">2,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE3LTMtMS0xLTA_713f322d-0ba3-4479-bced-32fc2787ef25">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE3LTUtMS0xLTA_01ce3bb0-567b-4ba6-85ea-b05cf3784d6b">368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE4LTEtMS0xLTA_377536d2-da53-4370-94a1-686dbcfefc6b">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE4LTMtMS0xLTA_1672f9c4-72fa-4a7a-9dc0-e2ea9f2c3dfe">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE4LTUtMS0xLTA_e6e9ebbc-fd22-4a86-9008-1cc4337dd483">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="mck:IncreaseDecreaseinOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE5LTEtMS0xLTA_f9915779-ffa0-48a1-a461-761c0e868f2c">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="mck:IncreaseDecreaseinOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE5LTMtMS0xLTA_e6a2a654-117b-4dc7-861f-23bb2cbd579a">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTEtMS0xLTA_0e43d346-0903-4e14-ab17-aae243620405">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTMtMS0xLTA_9a232844-1c06-47f0-b9fe-c798686c0210">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTUtMS0xLTA_f584ec82-a4c1-4f79-9d49-2e71449471d9">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTEtMS0xLTU3OTY_830b88f6-b22b-42f4-8133-d159eb3b4663">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTMtMS0xLTU4MDE_f3fbaea0-cae4-486b-8642-9f383e2951d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTUtMS0xLTU4MDQ_8c03a39e-d18c-48e1-b767-ad7a76c7d6da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIxLTEtMS0xLTA_e0c1ebef-0ebb-4a1c-bbe8-e46ae3a90479">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIxLTMtMS0xLTA_6686ad21-e7e1-4fa4-86da-c9acb4eb4c9f">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIxLTUtMS0xLTA_570ff685-0a67-47b5-9ebb-b25547e4279a">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIzLTEtMS0xLTA_fb97462c-a1d6-4012-8e5e-82f591d7d240">4,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIzLTMtMS0xLTA_09edd739-e695-435c-a7d6-0e4fd82892f5">4,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIzLTUtMS0xLTA_09241b1b-c39f-4d57-a13f-f74556f99162">4,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI2LTEtMS0xLTA_92ff2644-9c4e-41f2-b3c3-0bb8d90a2b42">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI2LTMtMS0xLTA_6520c397-bf82-40ce-a660-2e10c0cbb438">362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI2LTUtMS0xLTA_1e6fac70-166c-47b6-af64-ef40b8ffaf7e">426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI3LTEtMS0xLTA_328ad4a5-e4c4-4987-9dad-89d4a0e794d0">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI3LTMtMS0xLTA_7cb2657f-6da3-44bb-adc4-d34b302a8924">144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI3LTUtMS0xLTA_7544c7d9-c5d3-4540-8bac-140c4ae1bc95">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI4LTEtMS0xLTA_b9089d6a-925f-4b4d-85d6-5db20e1a4aaa">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI4LTMtMS0xLTA_781accc4-3057-48f8-9873-57f7f326e1aa">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI4LTUtMS0xLTA_91022de7-e5de-46e4-9855-b9d7b5d67e41">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI5LTEtMS0xLTA_158eafdd-f760-4d9a-8828-9eb63901945c">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI5LTMtMS0xLTA_b630a2dd-6efe-4398-bf76-44e0dc6188ee">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI5LTUtMS0xLTA_32770f4d-d401-4e45-b9f9-b227e919a19d">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMxLTEtMS0xLTA_892a98fd-e03c-4f81-8420-20375d786a51">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMxLTMtMS0xLTA_286c3c99-4053-4e4f-a6f4-3bb51e712d61">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMxLTUtMS0xLTA_13b9cf18-9f11-47f6-8352-faa78ae4d19e">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMyLTEtMS0xLTA_ca0d6ddc-381a-47e3-bcc5-a62c48a88025">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMyLTMtMS0xLTA_0cd6e5aa-f81c-4656-8fc4-5f8eae3442d1">579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMyLTUtMS0xLTA_f7d3004e-6a7b-4593-ab81-7899cb769e91">1,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM1LTEtMS0xLTA_d79167c9-611d-4729-8f38-0c494d5084d7">6,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM1LTMtMS0xLTA_f44a8d03-99ed-4c83-b50f-81feaeefe420">21,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM1LTUtMS0xLTA_c90daa6d-52e0-4ec8-bfd4-3d11802cef60">37,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM2LTEtMS0xLTA_58cf1f12-660c-4ce5-80e6-2ca011a648c3">6,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM2LTMtMS0xLTA_3fc8b443-70ae-42e9-9491-ceec311e2db1">21,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM2LTUtMS0xLTA_bc8b49bc-00a1-4f70-a701-fcbb292b2319">37,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuances of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM3LTEtMS0xLTA_250b45b6-d7a6-4875-9301-0dd5a787c648">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM3LTMtMS0xLTA_4c9ddef1-55fe-4883-87e1-9f08fac4fd8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM3LTUtMS0xLTA_276c139e-47a4-49d1-8b57-53f388abeab5">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM4LTEtMS0xLTA_37e8f543-e4a4-46bb-b631-0a3c2d9f5a99">1,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM4LTMtMS0xLTA_686ccf5d-bd4b-4c31-b4eb-c33341686167">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM4LTUtMS0xLTA_f0de0f32-1174-4de9-9531-a367ec0ffaba">1,112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQxLTEtMS0xLTA_7eb49cd6-2667-429c-890f-2b04ab3dba50">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQxLTMtMS0xLTA_a1d97ba0-47ca-46f6-a8c2-62b73c43b834">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQxLTUtMS0xLTA_5679aaa9-a08a-40ca-ad1e-dc524e6af76d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases, including shares surrendered for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQyLTEtMS0xLTA_94553dec-a0ef-4eff-b99e-8d6cb2e5b862">770</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQyLTMtMS0xLTA_7f49ac92-ff74-49ad-b39d-bab520948f21">1,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQyLTUtMS0xLTA_ed56d9ef-ac20-4184-8359-2a3fc769b92b">1,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQzLTEtMS0xLTA_76f92538-0da8-4fdc-90bd-0b170ed6166d">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQzLTMtMS0xLTA_ce21a6c9-97a9-46ff-830c-c4837424bb35">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQzLTUtMS0xLTA_80850a6b-98fb-437c-a972-524bf67d91f2">292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ0LTEtMS0xLTA_165af378-0b06-41bb-980c-6267174f7335">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ0LTMtMS0xLTA_9faca0f3-84ca-482c-b880-edd76a79f678">301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ0LTUtMS0xLTA_ea2b346b-245e-4c9c-8b22-206f9578929a">355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ1LTEtMS0xLTA_8d66136d-c2a4-4e92-bab4-fb9c56857095">1,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ1LTMtMS0xLTA_37f164d5-897e-4dd6-8787-519118063e13">2,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ1LTUtMS0xLTA_e43c247b-39a1-421a-8fcf-6496f4266883">2,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ2LTEtMS0xLTA_3620160a-97de-4d6a-9ff2-faec39cb404b">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ2LTMtMS0xLTA_074075dc-c45d-4444-973d-aaeadc6f8f38">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ2LTUtMS0xLTA_f86f3001-0281-4c25-b510-f4aa2290a6da">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ3LTEtMS0xLTA_eb99d7e1-1ba5-4b40-8673-2c8313dee3c8">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ3LTMtMS0xLTA_c0bbf0a4-b802-4bf9-a410-a0b7fa24d051">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ3LTUtMS0xLTA_d569b870-f81a-47a1-8f13-71af3a3f58e1">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTEtMS0xLTA_c8eabf82-13ad-4f3f-bc6f-6503c02fa5ac">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTMtMS0xLTA_cb355167-74c5-44e5-b5d2-0189d888cbe4">2,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022a2642b16245d083cb80c539e560b3_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTUtMS0xLTA_afcc20c8-ad0c-4c93-bfbc-918b92817040">2,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ5LTEtMS0xLTA_28183324-7de4-4668-8ed6-8059c83c8d52">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ5LTMtMS0xLTA_12bc64a5-4b26-4939-89a0-f0dc73908f84">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ5LTUtMS0xLTA_0be5569b-064a-4afb-a58b-366d2bd46ddb">2,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Restricted cash at end of year included in Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTEtMS0xLTYyMzQ_21879f62-d578-4edd-aa63-0541ed2eb1d8">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTMtMS0xLTYyNDE_221fae26-8874-4b31-89e2-256f4e9f430a">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTUtMS0xLTYyNDU_c7c75951-1de1-445e-a5b8-6cd6f323ac84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUwLTEtMS0xLTYyMzE_2d949de6-50a5-4a75-bbf1-f5524e0a2285">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUwLTMtMS0xLTYyNDE_6790cba0-cb7e-49db-8dd1-ff0b8a902f6d">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUwLTUtMS0xLTYyNDU_18ade387-2806-444d-89a0-2ec975fc1955">2,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU0LTEtMS0xLTk3ODE_414718a8-e900-4816-970e-5c3fa425340f">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU0LTMtMS0xLTk3ODM_979d3d13-21d2-4ec6-8ed9-96c517488c70">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU0LTUtMS0xLTk3ODU_f7f2fcfc-fb28-4d6b-b9dd-a76df72be6eb">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU1LTEtMS0xLTk3ODE_5c8a2649-a8cb-4ae5-bf98-32ddcaa17607">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU1LTMtMS0xLTk3ODM_dc57527e-d0d4-4949-bcbc-949fd1119160">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU1LTUtMS0xLTk3ODU_db9505f0-cb35-41af-a442-d9a48dde77c9">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">74</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_106"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i08f9baf810c0412e93ea6effc6d22995_109"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDQ1_9be701ec-e0f2-423b-8b63-8d3ab2dffb44" continuedAt="ic5565bf701f24c0b9082a938acd9eda0" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="ic5565bf701f24c0b9082a938acd9eda0" continuedAt="ia8c75a63e162447599d1bc35f0471d97"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global provider of healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing with the second quarter of 2021, the Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="iea92921488274912b519ed84b11ab23f_D20200701-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzIxOTkwMjMzMDAxNTc_215e1f71-88e7-4593-bb39-85046fd60a3d">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. Refer to Financial Note 22, &#8220;Segments of Business,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzM1_8956dad5-b514-4aa0-80ed-fa1dfb45e51e" continuedAt="i936cbe605ad34313846bf817a86c7f15" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i936cbe605ad34313846bf817a86c7f15">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights (&#8220;variable interest entities&#8221; or &#8220;VIEs&#8221;) and determines which business entity is the primary beneficiary of the VIE. The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzY2_27bd3ec0-2649-4254-ac4d-537039b789a0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTA3_919d3aa1-495a-4b9b-b07a-c74feb37abb1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior year amounts have been reclassified to conform to the current year presentation.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzgy_51f2db4f-813d-4cab-82ef-e80a6c9adecc" continuedAt="i96aaabc7397b4a38b5116b9691f063e5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires that the Company make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The severity, magnitude and duration, as well as the economic consequences of the coronavirus diseases 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing, and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i96aaabc7397b4a38b5116b9691f063e5">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#8217;s consolidated financial results.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzM2_737a6b4e-35b0-4f35-807d-c0dae453ae49" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ia8c75a63e162447599d1bc35f0471d97" continuedAt="id7a489632c904de2b7627abe878f0110"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDc5_27cc79d2-30f1-412a-9621-32f20a08aa4a" continuedAt="i9a666adb3215404599d4f19318df4610" escape="true">Restricted Cash</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9a666adb3215404599d4f19318df4610">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets.</ix:continuation> As of March&#160;31, 2021, restricted cash primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Consolidated Balance Sheet as of March&#160;31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzA4_c11a339c-4908-4c5a-9c2a-e4991fcef8ea" continuedAt="i7518e3f8f8be477ba4daa2e6c4a88299" escape="true">Marketable Securities Available-for-Sale</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7518e3f8f8be477ba4daa2e6c4a88299">: The Company&#8217;s marketable securities, which are available-for-sale, are carried at fair value and are included in &#8220;Prepaid expenses and other&#8221; in the Consolidated Balance Sheets. The unrealized gains and losses, net of the related tax effect, computed in marking these securities to market have been reported in stockholders&#8217; equity. At March&#160;31,&#160;2021 and 2020, marketable securities were not material. In determining whether an other-than-temporary decline in market value has occurred, the Company considers the duration that, and extent to which, the fair value of the investment is below its cost, the financial condition and future prospects of the issuer or underlying collateral of a security, and its intent and ability to retain the security in order to allow for an anticipated recovery in fair value. Other-than-temporary declines in fair value from amortized cost for available-for-sale equity securities that the Company intends to sell or would more likely than not be required to sell before the expected recovery of the amortized cost basis are charged to other income (expense), net, in the period in which the loss occurs.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDY0_6fc9b656-3f7b-4d0c-b0aa-d36777c9d953" continuedAt="i47010b62748d4421816b33c0f2558c9a" escape="true">Equity Method Investments:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47010b62748d4421816b33c0f2558c9a"> Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5MzczOTM3_ab0aa067-b771-403b-aa2b-b70ba605fd7f" continuedAt="i0f03bce2c28749588ad314af75f31b5e" escape="true">Receivables, Net and Allowances for Doubtful Accounts: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i0f03bce2c28749588ad314af75f31b5e">The Company&#8217;s receivables are presented net of an allowance for doubtful accounts and primarily consist of trade accounts receivables from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:CreditLossFinancialInstrumentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4NjYw_f439cb63-06fc-488f-a19e-62e574fc3f95" escape="true">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.</ix:nonNumeric> Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzMyOTg1MzQ5NjczMjg_fce80aaa-8c25-4afc-ab96-805b7fd1a911">198</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTMwMDY_792ea3fc-cd72-4a9c-ae2c-0159ca85d020">224</ix:nonFraction> million were included in &#8220;Receivables, net&#8221; on the Consolidated Balance Sheet as of March&#160;31, 2021 and 2020, respectively. Changes in the allowance were not material for the year ended March&#160;31, 2021.</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5MzczOTM4_8805b2ee-9a44-49fa-9abc-1697ec473589" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:AccountsReceivableCustomerAccountsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzItMS0xLTEtMTUxNDE_cbc1ca6d-cebf-4350-8e62-a378b655a14e">17,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:AccountsReceivableCustomerAccountsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzItMy0xLTEtMTUxNDE_98b5b986-12b8-491d-ac91-f29f9ccc3b7e">17,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzMtMS0xLTEtMTUxNDE_f1d54b58-97e5-4722-a32f-530f92b187bf">2,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzMtMy0xLTEtMTUxNDE_bd7372a8-1b9e-4140-80a2-1709d21b50ad">3,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzQtMS0xLTEtMTUxNDE_c1620d1f-2415-407e-93f9-77db01e04fd2">19,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzQtMy0xLTEtMTUxNDE_5b5f9621-c7cb-4d64-9b9d-e21c10e209b7">20,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzUtMS0xLTEtMTUxNDE_bda03d5a-1878-4a17-b2a8-2ecc90ae446b">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzUtMy0xLTEtMTUxNDE_20dbc792-6bd7-4890-bf39-f896039a5895">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzYtMS0xLTEtMTUxNDE_6a19a8ef-cde6-4d3b-bcda-962cfcf46eaa">19,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzYtMy0xLTEtMTUxNDE_d9cb34d9-4024-4947-9d5d-60fa8c15fe33">19,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="id7a489632c904de2b7627abe878f0110" continuedAt="i67a67c04cc934677999b2edffa6ac057"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzk2_0c01905a-9877-46ba-91c4-a66f3dda5c35" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2021, sales to the Company&#8217;s <ix:nonFraction unitRef="customer" contextRef="i3130d916740b4d2393240ae5139a6d53_D20200401-20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberofLargestCustomers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzY4MjQ_e232fe06-ca6b-4eb5-aca1-052d1cab8b76">ten</ix:nonFraction> largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately <ix:nonFraction unitRef="number" contextRef="i3130d916740b4d2393240ae5139a6d53_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzY5MjU_ebf03638-b86b-4887-a498-c31618c09a15">51</ix:nonFraction>% of its total consolidated revenues and approximately <ix:nonFraction unitRef="number" contextRef="i1a9fca715b904e98b76ea386572b0b03_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzY5ODE_48f2645d-74cd-4025-b726-ff26a160fdb5">32</ix:nonFraction>% of total trade accounts receivable at March&#160;31, 2021. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately <ix:nonFraction unitRef="number" contextRef="i93f771eff0414af9b947ca5a7031556b_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzcxMjc_c3e2c051-fe35-45e1-9da4-169d90a0431e">21</ix:nonFraction>% of its total consolidated revenues in 2021 and comprised approximately <ix:nonFraction unitRef="number" contextRef="ie1eb1f08e1664c6cb53a8da1be89cca7_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzcxOTk_bad4bf49-3e83-43f4-8bc7-7cd729e2e937">19</ix:nonFraction>% of total trade accounts receivable at March&#160;31, 2021. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:FinanceLoansAndLeasesReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDUw_38ff9438-e44a-478a-80af-e197965d6206" continuedAt="i8a1c013b76114f82a061d3a95d0c89c0" escape="true">Financing Receivables: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8a1c013b76114f82a061d3a95d0c89c0">The Company assesses and monitors credit risk associated with financing receivables, primarily notes receivable, through regular review of its collections experience in determining its allowance for loan losses. On an ongoing basis, the Company also evaluates credit quality of its financing receivables utilizing historical collection rates and write-offs, as well as considering existing economic conditions, to determine if an allowance is required.</ix:continuation> As of March&#160;31, 2021 and 2020, financing receivables were not material to the Company&#8217;s consolidated financial statements. Financing receivables and the related allowances are included in &#8220;Receivables, net&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets.</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTE4_beab590b-8c48-410b-8dc0-beb5dffc434b" continuedAt="ic3c9202ba1264f61859795604c474c7e" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LIFO method was used to value approximately <ix:nonFraction unitRef="number" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwMzE2_1c70064c-1f7f-42bc-a573-727456a27169">58</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwMzIz_7bf9d436-6b98-4f3a-9225-ac889a691018">60</ix:nonFraction>% of the Company&#8217;s inventories at March&#160;31, 2021 and 2020, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNDg1_c512b0d3-4c38-4c55-a3ba-fc1d08ce7854">406</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNDky_b880bc80-7942-43e3-9187-3c2509f7baf3">444</ix:nonFraction>&#160;million higher than the amounts reported at March&#160;31, 2021 and 2020, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNzQw_d6b513cd-4d5d-4332-8837-e67dceaf98e9">38</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNzQ0_85c5ac70-52c4-4d16-91f4-232f05761fa6">252</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNzUx_fd398e51-2a95-4060-a835-dc1eae68a54f">210</ix:nonFraction> million in 2021, 2020, and 2019, respectively, in &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Excluding LIFO reserves, inventory reserves as of March&#160;31, 2021 and 2020 were $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTI2MDI_04459003-f615-4928-9778-0fa83a440618">263</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTI2MTI_1cf52139-c138-43e6-92de-5558fa0affa7">96</ix:nonFraction> million, respectively. The increase was primarily due to charges in 2021 totaling $<ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTI1OTM_a1bbb6c5-bfcb-4f15-a592-759f70616b63">136</ix:nonFraction> million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment. These charges are recorded in "Cost of sales" in the Consolidated Statements of Operations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3c9202ba1264f61859795604c474c7e">The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market.</ix:continuation> As of March&#160;31, 2021 and 2020, inventories at LIFO did not exceed market.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTQ2_170f16d1-e5ff-446d-af1c-cfa87b2b98b3" continuedAt="i74566ac1e2d34914a992ecb3e0840700" escape="true">Shipping and Handling Costs: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i74566ac1e2d34914a992ecb3e0840700">The Company includes costs to pack and deliver inventory to its customers in Selling, distribution, general, and administrative expenses.</ix:continuation> Shipping and handling costs of $<ix:nonFraction unitRef="usd" contextRef="i52d8e2f4787a4d32a764107acdbc0c3f_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzExNzU5_016080c6-dd1d-441e-896d-22ab5fa5b1bd">1.0</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i4f49f517b19c4c2794bc573c91dfd166_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzExNzYz_410ee52a-6424-4bfd-b82d-7d0a54763c97">1.0</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="iddad10a5e1484e3ba28181133cb79477_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzExNzcx_cbface8a-1611-4f1a-8f47-d37fdc33e009">951</ix:nonFraction> million were recognized in 2021, 2020, and 2019, respectively. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i67a67c04cc934677999b2edffa6ac057" continuedAt="i096d6c2d8d84448b9325fd356581267a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:HeldforSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDkw_6732798c-d19e-48e6-8938-9649a1adcf1c" continuedAt="ie9871b37661c4dcf82739923f21f7988" escape="true">Held for Sale: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie9871b37661c4dcf82739923f21f7988">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.</ix:continuation> Refer to Financial Note 3, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzg5_024d6494-c46b-43fe-b552-4fff066209a9" continuedAt="i6dfa6b1c8875416893897330e15b8a06" escape="true">Property, Plant, and Equipment, Net: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i6dfa6b1c8875416893897330e15b8a06">Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from <ix:nonNumeric contextRef="ic7262554200c4a4687b065b0139747a9_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4NjY0_047e0b32-918e-4dc6-8e8a-c1b3c876196b">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i5b15db7a10914e64aff0c0319c0b1858_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4Njgy_17e1e6a1-8185-4e7f-9729-026dc20791fb">30</ix:nonNumeric> years for building and improvements and <ix:nonNumeric contextRef="i4dfc9a103be247469a824e16d2593cc4_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4Njkx_93495acc-722b-48b0-8f5e-5bde03aa4fe0">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ie77f379fcbbf4fabbb3643c1b75c74a4_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4NzEy_ef3b4311-5932-4bfe-9167-503b93e86fce">15</ix:nonNumeric> years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.</ix:continuation> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5MzczOTM5_b4291bc5-b2f9-4489-947b-a868ee6c3b75" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March&#160;31, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzItMS0xLTEtMTQ1MzQ_48e8fb7a-b967-4b63-8745-9d0773e286f7">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzItMy0xLTEtMTQ1MzQ_252f42dd-6c28-41b6-b90d-207592d57b2f">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzMtMS0xLTEtMTQ1MzQ_a509e256-b9a2-4570-8847-214c1c5ab395">1,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzMtMy0xLTEtMTQ1MzQ_70e8b584-f8b1-4518-aa9a-e666e4107ff3">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzQtMS0xLTEtMTQ1MzQ_c892863f-e440-4c0c-98c1-821f04de22c4">2,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzQtMy0xLTEtMTQ1MzQ_4e5675f2-b87b-4a7b-8900-ec8e215fcd63">2,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzUtMS0xLTEtMTQ1MzQ_c6421372-c344-4837-b17a-d202eb9aff0b">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzUtMy0xLTEtMTQ1MzQ_f4c7b6bd-bf14-4a9d-904b-d9aefc30e6ba">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzYtMS0xLTEtMTQ1MzQ_8c99cd63-6466-4f0c-aa1f-e7a2379d903f">4,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzYtMy0xLTEtMTQ1MzQ_e0dc2c00-a695-448c-a3f8-38d0ed05f674">4,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzctMS0xLTEtMTQ1MzQ_9caf710e-ed70-4879-9900-7e3ac954611a">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzctMy0xLTEtMTQ1MzQ_83f3a009-ec57-45e8-9aef-aba390b56bd5">1,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzgtMS0xLTEtMTQ1MzQ_e0d201d6-acef-4f12-b981-b57da249a07d">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzgtMy0xLTEtMTQ1MzQ_82a62ec4-f5c2-4382-bfcc-e5c0db3f5f64">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense for property, plant, and equipment, net and amortization of finance leases was $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDIzOTUzODU_d865f8f6-ff45-4c9c-b220-688502b8d46f">344</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDIzOTU0MTc_cf64e439-3728-420a-b0d4-8cebd9a0653e">335</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDIzOTU0OTY_81770b95-2fdf-4e35-9994-43bf849e1ca8">317</ix:nonFraction>&#160;million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzIx_ee6ffdbe-8d9a-41d1-bad4-0f5e5187f370" continuedAt="i459b35d948084915a11efdc94ebb064e" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i096d6c2d8d84448b9325fd356581267a" continuedAt="i4b699d8ff22a4f9fa609722f2bc2c3fc"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i459b35d948084915a11efdc94ebb064e">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</ix:continuation></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTEw_04746cfd-ad9e-4536-961c-e1d42af934fa" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2">one</span> to <ix:nonNumeric contextRef="ia82280b01acd4961b7aae7ec8926f663_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzc4_2541aede-be09-4b79-b903-89fdf0423f21">38</ix:nonNumeric> years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTU2_eb3dcf66-d237-4f0a-974c-a05bbb6ddf88" continuedAt="i6c50b1ac66924452b3a557eac6af84e3" escape="true">Capitalized Software Held for Internal Use: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6c50b1ac66924452b3a557eac6af84e3">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed <ix:nonNumeric contextRef="ia82280b01acd4961b7aae7ec8926f663_D20200401-20210331" format="ixt-sec:duryear" name="mck:CapitalizedSoftwareHeldforInternalUseUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NTI4_488e328b-c678-4001-83fe-d65afb0a680f">10</ix:nonNumeric> years.</ix:continuation> As of March&#160;31, 2021 and 2020, capitalized software held for internal use was $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NTk2_8436d022-ab3a-4092-875c-b103be2ed364">513</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NjAz_21f55d84-67ba-439e-830d-4278efe4c526">400</ix:nonFraction> million, respectively, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NjQy_d453b0a1-1e20-4312-83ef-bffa8cfb5da2">1.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NjQ5_b0b1bc50-86b1-4c3d-b264-8a7ac23b9e4b">1.3</ix:nonFraction> billion, respectively, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MDAxMjQ_d37b8338-41d3-4240-9e3b-6ae1ba1fc98d">117</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MDAxMzI_9cda9a37-535c-45f6-9f4e-af672d8bc2f8">129</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MDAxNTY_344efe37-79ec-4310-a970-0eccdde132d5">137</ix:nonFraction>&#160;million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:InsuranceProgramsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDY2_93d53cdf-6661-4a0c-a265-c726b5b17bd2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;), from which it obtains coverage for catastrophic exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company, as discussed in more detail in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within Operating Expenses in the Consolidated Statements of Operations.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDk5_01263e40-252b-44c3-b09a-bbfcc714bd50" continuedAt="ie8ed088ca4644044b2fed7e2b033a00a" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately <ix:nonFraction unitRef="number" contextRef="i76008cf481ff411789c581d87a72f149_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODE4_42ba2d20-3421-4f77-a459-c394e3cbb272"><ix:nonFraction unitRef="number" contextRef="i8bb50cd186cb4d44ac0d335a56971982_D20190401-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODE4_4753e8cf-1e6e-4c30-a617-71695564880e">98</ix:nonFraction></ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i20b5a4c9debc4c86ab2c641342640b2b_D20190401-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODI1_0c7ee65c-b35a-4832-96f1-94b7ada89935"><ix:nonFraction unitRef="number" contextRef="i9bdf98ffd5304512a88b518b82d6beb4_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODI1_5266363f-2fe9-4301-99fa-8d1c17614412">2</ix:nonFraction></ix:nonFraction>% of total revenues for each of the years ended March&#160;31, 2021 and 2020, respectively. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i4b699d8ff22a4f9fa609722f2bc2c3fc" continuedAt="ice329701f67545b68b8610589730582a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie8ed088ca4644044b2fed7e2b033a00a" continuedAt="i4b743e8b3a4e4cadbfb8ca510e531340">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NDkz_2bf6e611-6641-4cd0-b4a3-49371b21e71e"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-8" format="ixt:numdotdecimal" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NDkz_db05d647-b755-4c3e-b3be-f58cc8f752e1">3.1</ix:nonFraction></ix:nonFraction> billion in each of 2021 and 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-8" format="ixt:numdotdecimal" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NTE2_a61b31d3-2a16-41aa-96e9-7aa5ea636678">2.9</ix:nonFraction> billion in 2019. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March&#160;31, 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </ix:continuation></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b743e8b3a4e4cadbfb8ca510e531340">The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March&#160;31, 2021 and 2020. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:SupplierIncentivesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDMx_26197c61-1f41-4759-b3c9-3777926d1750" continuedAt="ic97036f1ad324d0cba46023d2c840ac1" escape="true">Supplier Incentives:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic97036f1ad324d0cba46023d2c840ac1"> Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:SupplierReservesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTM3_4c9bed00-4829-48b9-8070-492206a815e6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzU2_48670e68-3b86-4846-8890-306c29e461aa" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:InterestExpensePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDEy_5bf429aa-2f19-42ac-990d-1c4cec1553f9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDcw_9fc8bbc5-9510-44b6-9396-8c5c9ff58f55" continuedAt="i7dc8be7125894938abd964cc4e39c065" escape="true">Foreign Currency Translation:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7dc8be7125894938abd964cc4e39c065"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; equity accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income (loss), net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material to the Company&#8217;s consolidated results of operations in 2021, 2020, or 2019. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</ix:continuation>&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ice329701f67545b68b8610589730582a" continuedAt="i67511c839da947ad8b056c57f5fcda2c"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzE2_cfe5c7b9-dfe6-4a7a-8637-733e0f8f17c0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income (loss), net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg5MTQ3_483b32f3-cd16-49af-80ac-3f38df42b7a2" continuedAt="i69e7e475eef64b88a82b85470567391d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income. Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity but are excluded from earnings. The Company&#8217;s other comprehensive income primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency including gains and losses on net investment hedges, unrealized gains and losses on cash flow hedges, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i69e7e475eef64b88a82b85470567391d">unrealized gains and losses on retirement-related benefit plans.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzk0_699d05d2-1dd2-442d-9a0d-5494d6c9537f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#8217;s consolidated entities including Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;) and ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 9, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for more information.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzg2_f072d6fe-6c75-4b23-ac9e-3fd5810fd27c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTAx_13b85a6c-43d5-44ac-9896-765fbb6432ae" continuedAt="ia5dbb2747d9e426c80c9bb569995e005" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i67511c839da947ad8b056c57f5fcda2c" continuedAt="if6d6e10b0a6b433587628c26b78ba0de"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia5dbb2747d9e426c80c9bb569995e005">The Company reviews all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to ongoing controlled substances claims to which the Company is a party.</ix:continuation></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDMy_abb1aacd-d062-4a63-bc5c-d1e093b50d90" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are recognized as incurred.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzQ0_a53ab597-4c5d-4a16-a4c9-eedf8b84ffb2" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDAw_b39870c3-f3d4-46e2-957a-fc1e600c1e6e" continuedAt="i11bd606e0c1b42b896b97cbbb096d824" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standard Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify, and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="if6d6e10b0a6b433587628c26b78ba0de"><ix:continuation id="i11bd606e0c1b42b896b97cbbb096d824"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="ife3b4b3b997b40d1a537f1ca3f6bb09e_I20200401" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzU0OTc1NTgxOTg1MTg_80acdeb8-45a6-42d5-94f6-3c7f5852ac49">13</ix:nonFraction> million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The adoption of this amended guidance is not expected to have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div></ix:continuation></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_115"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzEwNjg2_e614e211-ca06-423f-8ee8-dd5f16075add" continuedAt="i85b2817682ba4722b99b3aa34bacb83f" escape="true">Investment in Change Healthcare Joint Venture </ix:nonNumeric></span></div><ix:continuation id="i85b2817682ba4722b99b3aa34bacb83f" continuedAt="iff47375196dc42fdb44f843f7f49a1aa"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2017, the Company contributed the majority of its McKesson Technology Solutions businesses to form a joint venture, the Change Healthcare JV, under a contribution agreement between McKesson and Change Healthcare Inc. (&#8220;Change&#8221;) and others, including shareholders of Change. In exchange for the contribution, the Company initially owned approximately <ix:nonFraction unitRef="number" contextRef="i60451fdfabe047148d4b51b02b328315_I20170331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzQyNQ_d96da3b9-34fb-492e-85a6-d66c34373bc5">70</ix:nonFraction>% of the joint venture, with the remaining equity ownership of approximately <ix:nonFraction unitRef="number" contextRef="i8b559a4e264f45ee945d6b0221a18668_I20170331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzUwMw_fd4d3747-051e-4b9a-b13c-9335e1a3bfd2">30</ix:nonFraction>% held by Change. The Change Healthcare JV was jointly governed by McKesson and shareholders of Change. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i654d1dad39ce486b88ccef35f4514f39_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE0ODI_0da0778c-9e1a-49f1-8b9c-389221c171eb">888</ix:nonFraction> million. Change contributed the proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib7818cbb3de24ccbb1dac5ff7b38d12d_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE1NTU_9189ff7a-6b31-4102-8ada-15695dde9c97">609</ix:nonFraction> million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia627eaf413b944f6b1c661f64f89cf46_I20190701" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE3MTk_a31ac0ac-9c69-4c67-8967-900f5175cbd8">13</ix:nonFraction> per share. The proceeds of $<ix:nonFraction unitRef="usd" contextRef="i654d1dad39ce486b88ccef35f4514f39_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE3OTg_5710d57f-dce0-40a9-8055-c117b0a4b713">279</ix:nonFraction> million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately <ix:nonFraction unitRef="number" contextRef="i60451fdfabe047148d4b51b02b328315_I20170331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIyMDU_d96da3b9-34fb-492e-85a6-d66c34373bc5">70</ix:nonFraction>% to approximately <ix:nonFraction unitRef="number" contextRef="i259565e15d4a4094b3aced351e91b60f_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIyMjU_3e116396-43ae-433c-9af8-12da1377d971">58.5</ix:nonFraction>% while Change owned approximately <ix:nonFraction unitRef="number" contextRef="i3ac6925e5e124f20b294923d15d675f7_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIyNjE_826c91b3-acdd-4792-8317-07965b6cc062">41.5</ix:nonFraction>% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a dilution loss of $<ix:nonFraction unitRef="usd" contextRef="i361b795666d34b31b8211423ea941c60_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIzODg_963089ef-ca00-4933-92e5-3fb0709caec7">246</ix:nonFraction> million, primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. The Company&#8217;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. These amounts were included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations for the year ended March&#160;31, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded an other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $<ix:nonFraction unitRef="usd" contextRef="i4e5bd022186748f590c69707cd4dd76e_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQwMDY_34acfaab-0bd2-4e8e-8067-1c7de5493a47">1.2</ix:nonFraction> billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations for the year ended March&#160;31, 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iff47375196dc42fdb44f843f7f49a1aa" continuedAt="i4bbacd3ae2554e3aa96a93fe7e31f4d6"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation of the Change Healthcare JV</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV. The separation was affected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly-owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (&#8220;Split-off&#8221;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#8220;Merger&#8221;).</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Split-off, on March 9, 2020, the Company distributed all <ix:nonFraction unitRef="shares" contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:ExchangeOfferSharesDistributed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzU2MjA_eb47b93a-3c0c-4dc0-965e-15dbbf20fe6c">176.0</ix:nonFraction> million outstanding shares of common stock of SpinCo to participating holders of the Company&#8217;s common stock in exchange for <ix:nonFraction unitRef="shares" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentStockAccepted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzU3Mzk_4abf1ae2-c153-45a2-b2f0-c2a8e47f2b06"><ix:nonFraction unitRef="shares" contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:ExchangeOfferSharesExchanged" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzU3Mzk_c6a59160-2359-48b6-9896-a597e0ed2d18">15.4</ix:nonFraction></ix:nonFraction> million shares of McKesson common stock which now are held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 20, &#8220;Stockholders' Equity,&#8221; for more information. Following consummation of the exchange offer, on March 10, 2020, SpinCo was merged with and into Change Healthcare, and each share of SpinCo common stock converted into <ix:nonFraction unitRef="shares" contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310" decimals="INF" format="ixt-sec:numwordsen" name="mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzYwODU_bba22226-c700-48a6-adcf-ef483d4dc178">one</ix:nonFraction> share of Change common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzYxMjg_bd1ade41-2999-435f-a331-5fcfb7c62740">0.001</ix:nonFraction> per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and the Merger are intended to be generally tax-free transactions for U.S. federal income tax purposes. Following the Split-off, the Company does not beneficially own any of Change&#8217;s outstanding securities. In the fourth quarter of 2020, the Company recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzY1MTI_785def8a-4592-40bd-822e-89e7e2ac3fc5">414</ix:nonFraction> million related to the transaction which is included under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations for the year ended March&#160;31, 2020. <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzEwNjg1_6a42b6de-e633-4dc9-a77c-f05019739cbd" continuedAt="id8063808d26c48409fd74dfe6e0e461e" escape="true">The net gain was calculated as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><ix:continuation id="id8063808d26c48409fd74dfe6e0e461e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of McKesson common stock accepted (<ix:nonFraction unitRef="shares" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentStockAccepted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMC0xLTEtMC90ZXh0cmVnaW9uOjJjMTkyZTg0MDMzYzRhMTc4NGVhNWE0MjE4MDBiNDQyXzU0OTc1NTgxMzkwMDA_4abf1ae2-c153-45a2-b2f0-c2a8e47f2b06"><ix:nonFraction unitRef="shares" contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:ExchangeOfferSharesExchanged" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMC0xLTEtMC90ZXh0cmVnaW9uOjJjMTkyZTg0MDMzYzRhMTc4NGVhNWE0MjE4MDBiNDQyXzU0OTc1NTgxMzkwMDA_c6a59160-2359-48b6-9896-a597e0ed2d18">15.4</ix:nonFraction></ix:nonFraction> million shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="2" name="mck:EquityMethodInvestmentStockAcceptedAverageCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMC0xLTEtMC90ZXh0cmVnaW9uOjJjMTkyZTg0MDMzYzRhMTc4NGVhNWE0MjE4MDBiNDQyXzU0OTc1NTgxMzkwMTM_0265b775-3654-4832-9d95-a9103a9a9a43">131.97</ix:nonFraction> per share on March 9, 2020)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentFairValueofStockAccepted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMS0xLTEtMA_81d25000-37a9-4cf2-afe1-2d12c91fdef6">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the Change Healthcare JV at exchange date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzItMS0xLTEtMA_aee1de87-3f4d-40ac-9ce3-dfc29b76ff6c">2,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-6" name="mck:EquityMethodInvestmentsReversalofDeferredTaxLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzMtMS0xLTEtMA_fdd562e4-bd21-4c1c-b4d8-433a5e492ce3">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of accumulated other comprehensive attributable to the joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-6" sign="-" name="mck:EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzQtMS0xLTEtMA_bf79ef95-0f65-40d6-9bbf-bb79bb97f1f5">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-6" name="mck:EquityMethodInvestmentTransactionCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzUtMS0xLTEtMA_60d207ee-3280-4c51-8ab2-3b42a79bcb0b">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on split-off of the Change Healthcare JV</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzYtMS0xLTEtMA_36d2786e-ef13-49c2-93b5-ec039ed82df8">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investment in the Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment in the joint venture was accounted for using the equity method of accounting on a one-month reporting lag. The Company&#8217;s accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements. Effective April&#160;1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance and, in the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $<ix:nonFraction unitRef="usd" contextRef="iedbe6776c92141caaf1984304c817a24_I20190401" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzAwMzI_482289c6-6332-4807-b690-7349cf87b6d3">80</ix:nonFraction> million, net of tax, in the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its proportionate share of loss from its investment in the Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQzNjc_92add040-3112-4584-873f-fb84834696a4">119</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzAyMTA_6a3cc216-ea4b-469a-87c1-6903791f78f0">194</ix:nonFraction> million in 2020 and 2019, respectively. The Company&#8217;s proportionate share of income or loss from this investment includes transaction and integration expenses incurred by the Change Healthcare JV and basis differences between the joint venture and McKesson including amortization of fair value adjustments primarily representing incremental intangible amortization and removal of profit associated with the recognition of deferred revenue. These amounts were recorded under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of the Change Healthcare JV, McKesson, the Change Healthcare JV and certain shareholders of Change entered into various ancillary agreements, including transition services agreements (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;) and certain other agreements. Fees incurred or earned from the Advisory Agreement were not material for 2020 and 2019. Fees incurred or earned from the TSA were not material in 2021 and were $<ix:nonFraction unitRef="usd" contextRef="ibcb31c3511004f7bb84b6fba7982478b_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MjY_23ac5aba-7987-4d73-8d07-0f3ba79e448d">22</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i1e6a6da26e9b4155a7aabc172f840db7_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MDA_63aa0dc1-35b4-432a-8b8e-a49ad15bb09c">60</ix:nonFraction> million in 2019. The Advisory Agreement was terminated in 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i4bbacd3ae2554e3aa96a93fe7e31f4d6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company renegotiated the terms of the TRA which resulted in the extinguishment and derecognition of the $<ix:nonFraction unitRef="usd" contextRef="i30576561fec8410d980f65c38dfcecbd_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="mck:GainLossonDerecognitionofLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MTY_67159958-359b-4473-a701-8df09e6f27a9">90</ix:nonFraction> million non-current liability payable to the shareholders of Change.&#160;In exchange for the shareholders of Change agreeing to extinguish the liability, the Company agreed to an allocation of certain tax amortization that had the effect of reducing the amount of a distribution from the Change Healthcare JV that would otherwise have been required to be made to the shareholders of Change.&#160;As a result of the renegotiation, McKesson was relieved from any potential future obligations associated with the non-current liability and recognized a credit of $<ix:nonFraction unitRef="usd" contextRef="i30576561fec8410d980f65c38dfcecbd_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="mck:GainLossonDerecognitionofLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MTI_67159958-359b-4473-a701-8df09e6f27a9">90</ix:nonFraction> million in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statement of Operations in 2019.&#160;At March&#160;31, 2021 and 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="icd767dd763314f3aad75379a29aafa5f_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzgzNjc_86a6b136-49f4-459d-92af-057dcf83feba"><ix:nonFraction unitRef="usd" contextRef="i9433d8dd83764dfea4d20d7175cc58c0_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzgzNjc_8f3649ea-0adf-4cd0-a71f-45fd9ecc9f44">no</ix:nonFraction></ix:nonFraction>&#160;outstanding payable balance to the shareholders of Change under the TRA.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax years ended March 31, 2020 and 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare&#160;JV, the aforementioned TRA agreement requires the Change Healthcare&#160;JV to pay McKesson <ix:nonFraction unitRef="number" contextRef="id1030ca9e1fc410c8e4ba04e704c20ad_I20210331" decimals="INF" name="mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2Xzk1OTE_c1d484b5-7fbf-4500-b849-05829d0ec709">85</ix:nonFraction>% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare&#160;JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with <ix:nonFraction unitRef="usd" contextRef="i5e9b372ac3ef458da34c6cb29ae83063_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DueFromRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE5NzkxMjA5MzIwMjIz_d6165dbd-4885-4ee7-bea0-7547d6b2b821"><ix:nonFraction unitRef="usd" contextRef="id1030ca9e1fc410c8e4ba04e704c20ad_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DueFromRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE5NzkxMjA5MzIwMjIz_e4e12c34-0337-400a-87de-dfdf0c800cc9">no</ix:nonFraction></ix:nonFraction> receivable recognized as of March 31, 2021 or 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the separation transaction in the fourth quarter of 2020, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_121"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5Mzc_c4c704cd-a66a-4acd-abee-1039a8c9f82b" continuedAt="i8821366cc89942f69f44faded585a636" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></ix:nonNumeric></div><ix:continuation id="i8821366cc89942f69f44faded585a636" continuedAt="iac0ad23420b24f0fa4fb37790a2adc11"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities that have met the classification as held for sale were $<ix:nonFraction unitRef="usd" contextRef="i2d40932572f640b9bcc963fb3703530a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTI1OTE_40b33387-e12f-4a50-bbbf-d070e07bf7dc">12</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2d40932572f640b9bcc963fb3703530a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTI2MDg_a93f1d26-7d8f-4e67-8ffb-df068cf02b6c">9</ix:nonFraction>&#160;million, respectively, as of March&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i26588b430f834252bbb0d603ebc07230_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzkx_7853fc3a-8063-4ae8-8f00-8f8cb57ceb51">906</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i26588b430f834252bbb0d603ebc07230_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzk4_96a1a671-8796-43ac-9653-f4d164e16bcf">683</ix:nonFraction> million, respectively, as of March&#160;31, 2020. The amounts at March&#160;31, 2020 primarily consisted of the majority of the Company&#8217;s German pharmaceutical wholesale business as described below. This disposal group had been recorded as assets and liabilities held for sale since the third quarter of 2020 through its contribution to a joint venture in the third quarter of 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Wholesale Joint Venture</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed its previously announced transaction with Walgreens Boots Alliance (&#8220;WBA&#8221;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson has a <ix:nonFraction unitRef="number" contextRef="i042fc3b5ed1f4aa3a5c7fc3404044ced_I20201101" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NDc0MTY_6282e611-cb31-4447-939d-eeba2fdc2136">30</ix:nonFraction>% noncontrolling interest.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received included a receivable amount of $<ix:nonFraction unitRef="usd" contextRef="i8b846dbf18184734b8d20351ecc09b72_I20201101" decimals="-6" format="ixt:numdotdecimal" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4MTg_bb4e03de-5dbc-431a-8b28-eeba6f76ca21">41</ix:nonFraction>&#160;million, primarily related to working capital and net debt adjustments from WBA, and the <ix:nonFraction unitRef="number" contextRef="i042fc3b5ed1f4aa3a5c7fc3404044ced_I20201101" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4MjU_6282e611-cb31-4447-939d-eeba2fdc2136">30</ix:nonFraction>% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was <ix:nonFraction unitRef="usd" contextRef="i841091b6641c4e1fa2288424caf2b82f_I20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4MzM_69b7d7e0-5255-4efd-ac54-55f3cf2ed054">nil</ix:nonFraction> as of March&#160;31, 2021. The Company accounts for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i5c09144465e346119dd58fd135e50dc7_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4Mzk_21e54f64-ed89-4f81-b1dc-65f85e037dfd">291</ix:nonFraction>&#160;million as of the transaction date, which was paid to the Company in the third quarter of 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iac0ad23420b24f0fa4fb37790a2adc11"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the contribution, the Company recorded losses of $<ix:nonFraction unitRef="usd" contextRef="ia6e4b982be8b4c07a12efc2fd23a51a9_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GainLossOnSaleOfBusinessNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4NzM_1c985067-46f2-48ce-a05c-fdb404269cf8"><ix:nonFraction unitRef="usd" contextRef="ia6e4b982be8b4c07a12efc2fd23a51a9_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4NzM_d5daf1a3-3290-4519-8bb9-b4659e9983cb">58</ix:nonFraction></ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GainLossOnSaleOfBusinessNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTY4OTA_367e58cb-e303-436d-873a-adb11be5e1fb"><ix:nonFraction unitRef="usd" contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTY4OTA_f3b51c1d-527e-409e-8ea2-1015688fe0ea">275</ix:nonFraction></ix:nonFraction>&#160;million (pre-tax and after-tax), respectively, in the years ended March&#160;31, 2021 and 2020, which includes adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#8220;Operating expenses&#8221; in the Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods; however, these adjustments are not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on November 1, 2020, there were <ix:nonFraction unitRef="usd" contextRef="ic5f50743c2174eb7a016ece0cb708476_I20201101" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5NzkxMjA5MzE0OTg1_656ba047-7f38-4080-9786-a2682d1f84f4"><ix:nonFraction unitRef="usd" contextRef="ic5f50743c2174eb7a016ece0cb708476_I20201101" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5NzkxMjA5MzE0OTg1_71880b7d-b548-43e9-bb04-d12f247d5d67">no</ix:nonFraction></ix:nonFraction> assets or liabilities of the German pharmaceutical wholesale joint venture classified as held for sale on the Company&#8217;s Consolidated Balance Sheet. <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5Mzg_c0393e5b-72c0-42d3-9f68-65a4f2c7f1b6" continuedAt="iebd76197747a48ac87fd48fd2c56bcfe" escape="true">The total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#8217;s Consolidated Balance Sheet as of March&#160;31, 2020, were as follows:</ix:nonNumeric></span></div><ix:continuation id="iebd76197747a48ac87fd48fd2c56bcfe"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzMtMS0xLTEtMA_98b69a09-f144-4c8f-a2f8-b6b471f02ff5">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzQtMS0xLTEtMA_6d8e1b24-01cb-4f12-ad9d-828de8179bbc">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzYtMS0xLTEtMA_d9918a13-5ebd-48af-8c4a-8247542ee05a">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less cost to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzctMS0xLTEtMA_83a60cc5-704a-46c8-b2b9-db132425e95f">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzgtMS0xLTEtMA_2993d0e3-c56a-429c-9dda-3a519dd562f3">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzEyLTEtMS0xLTA_9ce3136b-d3ef-4352-9434-cd1c0f992984">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzEzLTEtMS0xLTA_d5637146-3e53-4a25-b949-f4884c53f10c">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzE0LTEtMS0xLTA_92c39d02-4cfc-4c79-ae94-e38f1338df60">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzE1LTEtMS0xLTA_e1687282-ca7e-49cb-8bd3-34e2e58fba75">656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the effect of approximately $<ix:nonFraction unitRef="usd" contextRef="iaaaa8cff6eb04a468bc164e1f8da8570_D20191212-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE4ODE_01d50483-24f2-4685-ad48-d351dce02cc9">3</ix:nonFraction> million of favorable cumulative foreign currency translation adjustment.</span></div></ix:continuation></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_127"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzg2NjA_d61b7583-acaf-4f8e-93d3-fc89419b38c7" continuedAt="i65ad62aec5504ef5bad54c17d5a7976a" escape="true">Restructuring, Impairment, and Related Charges </ix:nonNumeric></span></div><ix:continuation id="i65ad62aec5504ef5bad54c17d5a7976a" continuedAt="ie38b1f4d8d674b7cbc0a77876cb80363"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzkx_381ef7eb-a2d0-48ec-820a-b75d98834f40">334</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzk1_bef4bb8f-23e1-4b28-b11a-800644fe9104">268</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzEwMg_a8ffee19-6128-4f06-9940-aca0f65d6a77">597</ix:nonFraction> million in 2021, 2020, and 2019, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations and were not material for the years ended 2021, 2020, and 2019.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of its office space in North America. Where the Company determines to cease using office space, it plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="iea5796edba9442e6b00a331d1b1e9822_I20210512" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxOTA2OTQ_5e10e3c8-5fa9-4926-aa14-d53e0307c394">180</ix:nonFraction>&#160;million&#160;to $<ix:nonFraction unitRef="usd" contextRef="icefee79d5ff5443ca7262dbcfe111692_I20210512" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxOTA2NTE_455026b7-e152-44c2-b6a5-194fcb901db0">280</ix:nonFraction>&#160;million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. This initiative is expected to be completed in 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie38b1f4d8d674b7cbc0a77876cb80363" continuedAt="i0ff2a3c8d6fe4df9b3e2d7512251249c"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Under this initiative, the Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="icfff1c8522e849f6b8c9ddbfa45a1161_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjM2MjA_e618f974-e798-49ed-b222-339468ab67ab">85</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i46055f5e4516432ba38d8c9b9db6958f_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjM2Mjc_8491cf40-f72e-465f-bb38-019e1501573e">90</ix:nonFraction> million. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i912d8febc0b34abfb3c6779710303600_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjM2NjY_abfa0687-41f7-4d3e-a57a-86d5c295a387">57</ix:nonFraction> million in 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i0de6ea66ebe14d0aa48b24590c1d9d98_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjU4MjM_dba12f16-a476-4c21-b353-dc9d523931d0">62</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6b7c3bcfde504c2e81c6aeef0f7c2335_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjU4Mjk_ef4f81e9-aa10-42b8-9d0f-d9e606e51c78">72</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if2c5f4c8c13a414ca948dcf78225083b_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjU4Mzg_dd5d4e70-7848-48ec-85ae-b75c31f024f3">163</ix:nonFraction> million in 2021, 2020, and 2019, respectively, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i07b3c611cb044e9f8e830461fdf3567b_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjc2ODg_8ab68503-8265-4118-a755-159974459a77">28</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i321f8a74eae848a98872fbdb652c3f4d_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjc2OTQ_088a53e1-3b56-4b4a-ad7f-5e68009b9797">44</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i1c1bb20faa42444db36850f067394ea5_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjc3MDM_2c18f855-074c-4675-a18b-b104ef73e15c">33</ix:nonFraction> million in 2021, 2020, and 2019, respectively, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021 and remaining costs the Company expects to record under this initiative, primarily relating to lease costs, are not material.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2018, the Company committed to a restructuring plan, which primarily consisted of the closures of underperforming retail pharmacy stores in the U.K., included in its International segment, and a reduction in workforce. In 2019, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i0577d068867b4047b8f768bd9973668f_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjkyNzc_73c88be2-23db-4427-8678-6b6a876d3c88">18</ix:nonFraction> million, consisting primarily of employee severance and lease exit costs, with $<ix:nonFraction unitRef="usd" contextRef="i80ffc4dde20a400090fcecd0cd478cc8_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjkzNTI_76ba4939-0765-4adc-badf-eabdd7bde7a0">92</ix:nonFraction> million of total charges recorded through the end of 2019. The plan was substantially completed in 2020 and additional charges were not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2018, the Company announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize the Company&#8217;s operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, the Company committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i873585d906e0415888503e1bd163b490_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzEwMTI_7c5c5090-a24c-46dc-bdbc-d02727cf5fa6">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idf5263ca156f4aaf9c2116924eccdf08_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzEwMzQ_82dff0a5-67e7-4295-8325-3047c1f0d3a4">135</ix:nonFraction> million in 2020 and 2019, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0ff2a3c8d6fe4df9b3e2d7512251249c" continuedAt="i3eedfb68e57d4243a7c9f4e574ef24c1"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzg2NTc_a2223cab-9073-44bb-aae0-b0fcaceb08e5" continuedAt="i4285f51e001240828ffdfd2c653f1d35" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItMS0xLTEtMA_4aeecc3b-632f-465d-8fef-b37c2951ca4d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItMy0xLTEtMA_ac7eef72-3bc4-4624-b1a1-ad7dabfffb35">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItNS0xLTEtMA_791dc3bc-722d-4a77-a096-49dad7e81c4f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItNy0xLTEtMA_121f1939-8a21-43c3-9783-6b7008de8b4a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItOS0xLTEtMA_87e418ff-9038-42d3-a9b1-6986ec6bf0a7">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItMTEtMS0xLTA_1d5efa0e-3617-4f3f-a4d1-e85550a9602f">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtMS0xLTEtMA_fae90241-b740-4db4-b40a-e6cf5ccd19b7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtMy0xLTEtMA_54b5ff1d-cf61-4b30-9d96-c60e3840f629">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtNS0xLTEtMA_6592a222-6c65-45cd-b2d8-abca44228b70">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtNy0xLTEtMA_7d5d6366-c163-464b-8450-1e9746111f77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtOS0xLTEtMA_9be30a5d-50fa-4866-9451-faf0afd4cece">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtMTEtMS0xLTA_eddfb544-b531-4c39-8b8f-6a8519610433">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtMS0xLTEtMA_5fa89f8a-ef59-48f1-ab2e-f0ac25d52f7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtMy0xLTEtMA_de6f821a-e36e-48a0-9ece-f4686c930645">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtNS0xLTEtMA_8c9391a9-d41f-482f-8bc6-1b2544a989e2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtNy0xLTEtMA_c141800f-51ec-4ab2-b6e5-b429b5c7bb93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtOS0xLTEtMA_10f39c61-68a2-40c4-8421-799e79b7cb78">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtMTEtMS0xLTA_1a08f4e8-9828-454d-a46d-6c413d52e70c">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtMS0xLTEtMA_ecbf1eef-79ce-4008-a2d0-44bd6b4b3a34">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtMy0xLTEtMA_53fa0a77-b7ec-405a-9277-664b40991439">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtNS0xLTEtMA_8aa5f3a0-0a8f-46ca-ac48-68d2ded4ec0b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtNy0xLTEtMA_4a998a7c-76b7-454c-a4dd-65d84ce54547">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtOS0xLTEtMA_ffa15db7-c450-4b1d-9081-d58751fba84d">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtMTEtMS0xLTA_e1526492-8803-491c-9150-2f7e0b457629">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItMS0xLTEtMA_4c7d42c4-4ed2-45c7-8db4-ad04a778009c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItMy0xLTEtMA_a935fadc-2a53-412c-8ed4-4b7abc8da886">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItNS0xLTEtMA_5fdd96d9-5bfb-48a1-8ada-53a5db4e60e1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItNy0xLTEtMA_5d406628-4333-42a4-afe7-3c3d836a3c2f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItOS0xLTEtMA_c14ac28c-2038-4498-a0b4-95212890ee78">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItMTEtMS0xLTA_dbcb0f7b-46a0-4127-a2f5-72920459df59">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtMS0xLTEtMA_848d2ebf-43e7-424b-abf4-53d42493d265">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtMy0xLTEtMA_6d1d52af-bf42-4720-914c-5a25c8ba8922">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtNS0xLTEtMA_2b700343-c5e3-4059-aa1e-0fcb8a2e2009">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtNy0xLTEtMA_d132df7a-1143-4b2f-a226-954431466e4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtOS0xLTEtMA_3bf6d473-6a4b-4c0c-b796-3649baa32ad5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtMTEtMS0xLTA_8cacac2e-fec6-4ec3-892c-8a50b7230ca4">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtMS0xLTEtMA_399773ef-19c7-4ac4-9dd8-728fd360668a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtMy0xLTEtMA_48589b10-098b-4d0d-9010-b45b14a9cdf6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtNS0xLTEtMA_15c6e0dd-3258-4369-a8de-1b5745bfdd5a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtNy0xLTEtMA_7c28e2e7-dfa4-4e23-abfb-249d7881c0e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtOS0xLTEtMA_cc7bebe8-e367-4b7a-84cd-ee4055887b02">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtMTEtMS0xLTA_5cf36d54-383e-4ce7-8ba2-0eca3f0c7801">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtMS0xLTEtMA_5fcea241-c715-4146-84bd-f47681453931">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtMy0xLTEtMA_64ed932b-6486-4db7-a27c-3a9c8f096473">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtNS0xLTEtMA_859d3875-53af-4c49-a645-268d208c1b9c">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtNy0xLTEtMA_7c19ef6a-44ab-450b-aa25-7994bf802008">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtOS0xLTEtMA_0fcebac2-2abe-4e8c-a08e-77a9d4a331ae">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtMTEtMS0xLTA_dfc25899-76e8-42f4-9650-0a29ad8dc53a">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with dispositions and costs related to the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i3eedfb68e57d4243a7c9f4e574ef24c1" continuedAt="i0e09ab54c47e4c1b88b9e166bf83b5c4"><ix:continuation id="i4285f51e001240828ffdfd2c653f1d35" continuedAt="i2a06cd1a0a3d482bbcefa340ae53e805"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2019 consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItMS0xLTEtMTU5MDk_558f2f16-a97c-4b66-9e1f-b2b0c4e3ea23">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItMy0xLTEtMTU5MDk_ed1c2c91-3a6e-4ba1-97a5-76899bb67db2">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItNS0xLTEtMTU5MDk_f45bca0e-a6c5-48a4-89b4-bf86e60f39eb">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItNy0xLTEtMTU5MDk_c2c5fbb1-d2b6-40e9-a7c1-d449f707b7b4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItOS0xLTEtMTU5MDk_92960052-98d0-4a46-b2a2-e879479b4b5a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItMTEtMS0xLTE1OTA5_231a3122-01da-4fc6-8f7a-7c3554e85ce0">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtMS0xLTEtMTU5MDk_57c38250-c6ad-4ea2-a49e-0d9811c9c805">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtMy0xLTEtMTU5MDk_3b4df569-0dd8-41fc-813d-a79684b6fd5e">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtNS0xLTEtMTU5MDk_a9c74322-295c-4f08-8b76-50a93695ecf1">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtNy0xLTEtMTU5MDk_1f33c4a8-9ccb-4191-b49e-2a7b51095d52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtOS0xLTEtMTU5MDk_570878da-2fe4-487e-8fcc-d949756871b2">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtMTEtMS0xLTE1OTA5_12bbcadc-bc7d-4136-ab2c-3c26e7ae3c51">164</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtMS0xLTEtMTU5MDk_83962b2f-e9bf-4076-9bd3-aa4bf680d5a5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtMy0xLTEtMTU5MDk_96ac0b88-268b-41f5-8168-5af786c596d4">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtNS0xLTEtMTU5MDk_8348a35c-f785-4a1d-bd3a-44b00c9bae6a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtNy0xLTEtMTU5MDk_37cbb643-48a7-41d4-9521-21a457208a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtOS0xLTEtMTU5MDk_f7094d5b-deca-4842-89fb-ae1052643a9b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtMTEtMS0xLTE1OTA5_5f20f5fb-f84e-4d79-89b3-94d8aca9f7a5">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtMS0xLTEtMTU5MDk_17ce83d0-1878-4c37-80be-17c2892c8820">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtMy0xLTEtMTU5MDk_0b7494ef-5387-4739-9ae0-ef805ede4f80">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtNS0xLTEtMTU5MDk_d8e61688-c197-42b0-a50f-978064507258">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtNy0xLTEtMTU5MDk_20817f69-cd83-40c1-8bda-60d44fbaa6cb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtOS0xLTEtMTU5MDk_ca316e8d-573d-4b3d-bd3f-8b97c63d041d">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtMTEtMS0xLTE1OTA5_751c978e-279e-4a1e-bf9b-889746e85017">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model cost optimization efforts and U.K. restructuring initiative focusing on underperforming retail pharmacy stores described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include lease and other contract exit costs associated with closures of facilities and retail pharmacy stores as well as project consulting fees.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March&#160;31, 2021 and 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1294e78624d84a32b4b75b80df724f52_I20190331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMS0xLTEtODk5MA_cbc45eb8-dab2-4a0b-8e24-83899d713687">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a7bd3f5bbee48eaa0f146d217a2f213_I20190331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMy0xLTEtODk5Ng_fee02ac6-7742-4e93-8731-0621d1d2cfa1">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80b896d088b49df9c9446e7f21d4353_I20190331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNS0xLTEtODk5Ng_ec274078-6f57-440c-8cff-9840cf08e085">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb32341a67694453bf4b80c090e9acd1_I20190331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNy0xLTEtODk5Ng_60de7919-3fab-4857-bfc0-4f071ca66d9c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81dcf14d4c484311a890c1aa873abcc5_I20190331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtOS0xLTEtODk5Ng_ed4d7027-d860-4b1e-bb58-b0b1047ddb45">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMTEtMS0xLTkwMDQ_3d03024e-2a37-4a5f-b609-8e34ce240c4e">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMS0xLTEtODk5MA_383b0cce-7129-47fd-b1b7-410b93eebafd">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMy0xLTEtODk5Ng_f7c586b6-ca0a-4739-a116-dc6e52529ddb">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNS0xLTEtODk5Ng_c00b3680-c8d2-4727-997a-fc02602ffa32">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNy0xLTEtODk5Ng_99a3692a-f6d8-43c0-b897-782a32dd0860">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItOS0xLTEtODk5Ng_9e48448b-a6d7-4836-b43d-3048130869fb">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMTEtMS0xLTkwMDQ_d5e33d55-82a0-4549-b198-16ed69a2eb78">156</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMS0xLTEtODk5MA_9de5ac92-6c02-4642-84f1-071e22a44d0b">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMy0xLTEtODk5Ng_7bf31afe-9fd2-4f51-9c8c-47b79c292b1a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNS0xLTEtODk5Ng_9e4820d8-04fb-46b0-972b-b92e49e4d062">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNy0xLTEtODk5Ng_02f1ded0-6f4c-4418-86fe-95fb8da467f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtOS0xLTEtODk5Ng_9860c8db-f81a-461e-9a05-0ce88bc18a13">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMTEtMS0xLTkwMDQ_83912e8a-84fa-4704-b183-f1bfbfa86cb7">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMS0xLTEtODk5MA_0f67c666-87f7-419a-bf03-1852ae885a4f">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMy0xLTEtODk5Ng_8cb28405-8a45-49d0-9efa-8d109b4f6945">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNS0xLTEtODk5Ng_96d23924-640e-40de-9513-7ea22b095d74">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNy0xLTEtODk5Ng_13f162ea-6963-41b2-890a-5818353c48ba">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtOS0xLTEtODk5Ng_9882baeb-74fb-43a9-a411-a19936ca8712">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMTEtMS0xLTkwMDQ_86bca653-73de-4e64-b416-508e96d21493">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMS0xLTEtODk5MA_2e19ec8d-68c4-459d-a593-9c050354f3fb">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMy0xLTEtODk5Ng_604a4c2b-128f-40c2-b2a3-6e5eb8cff6ff">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNS0xLTEtODk5Ng_565eb7d1-2e9e-49fe-b10d-c7af3585beea">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNy0xLTEtODk5Ng_d43ced02-1b9f-4d7e-9d00-675dd3ade347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtOS0xLTEtODk5Ng_0f923628-2914-4ca5-b25b-1f20a4a1fbd1">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMTEtMS0xLTkwMDQ_d17937d1-0e4c-4cef-bc19-db53dcb6cde9">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b443c41cb334b4084c134a614b5a4aa_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMS0xLTEtMA_395e71c0-25b0-458f-8e56-5e28c253d44f">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc2495d4fd44412ae23a2d9511fc6b0_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMy0xLTEtMA_bff2bfee-79b7-43a1-8978-21941573eca0">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d6c47ebd084b828cdbdba1b8f159f8_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNS0xLTEtMA_bec30864-86d1-4439-9320-f1424ba7d4f3">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f353b74f6e48ea8c63365f74249445_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNy0xLTEtMA_fdc55140-0812-4dcc-8ac7-17edcf2ead7b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36b955ce23d4198b6aa3769dcf60d35_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtOS0xLTEtMA_bb6e53a3-34f1-44f5-bfcd-388df888e4a0">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMTEtMS0xLTA_6ab50347-e8d4-4ae1-803d-734e010412f4">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMS0xLTEtMA_6641619e-bd81-40fa-9e96-36082efff58c">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMy0xLTEtMA_a9ffc41a-c9a1-44cc-8c41-4c3ecae30ae5">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNS0xLTEtMA_36d0c025-3b09-4eee-88d0-a3fba3dd74b4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNy0xLTEtMA_c214561b-6bea-4c8e-b033-fa62d8b5e63e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItOS0xLTEtMA_27713cc6-1c3e-4c34-b8cd-a061d6bc575e">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMTEtMS0xLTA_4947fd0a-3d11-47ef-8410-b8a48e3c75ed">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMS0xLTEtMA_4232c852-9690-4daa-8775-27dc8f06a29b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMy0xLTEtMA_6b4b8458-e0e3-41e4-ab8a-e4db2a5785a5">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNS0xLTEtMA_e43053e1-7b16-4a3d-be8e-66d3e4356652">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNy0xLTEtMA_33284fd1-b2d3-41b3-a94a-cd4ab86b67ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtOS0xLTEtMA_0c74893d-7a5f-4cb7-afb7-b9726a9c1138">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMTEtMS0xLTA_4b344d33-3a7e-4f3d-a511-fee6e9b4a0cf">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMS0xLTEtMA_5827b9b3-d81b-4954-a9bb-6560a97762c7">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMy0xLTEtMA_d62d0ea9-7aa5-44f6-b835-982912b01759">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNS0xLTEtMA_31839492-5f38-4726-9d79-5f5c075f7776">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNy0xLTEtMA_f4dd6402-76df-4001-8e67-80cacee4c71b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtOS0xLTEtMA_cb429f39-2eea-4d2b-a022-1dd3278b96ec">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMTEtMS0xLTA_94903bb1-7dfe-4cf7-9118-e52768d0f9ee">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMS0xLTEtMA_f4425bd9-bd21-409e-bfe9-a41678f69df9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMy0xLTEtMA_b1607556-3a44-4be5-bd48-3e7c31e552e3">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNS0xLTEtMA_2b6b3f41-3c3a-436a-8993-13352151df61">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNy0xLTEtMA_3a7e7aea-8b91-470e-b496-c56ccddec36c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtOS0xLTEtMA_9a0aaccf-4b2f-4962-b1c4-8cbd622f03b8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMTEtMS0xLTA_3393e65b-5006-4831-bdf1-69b3c1fd69ee">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3156368b6aea45b4b87b5079622f2703_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtMS0xLTEtMA_32be0454-75fa-43a1-9f48-200eefcdbb89">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie781b28ab2254939ac913ef650232aa3_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtMy0xLTEtMA_ba04143d-cb2e-4cef-912b-76fbf313560c">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7e3dfff1504af6a6970090a4e7c85f_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtNS0xLTEtMA_6c55f9fb-bade-4ae8-af7d-30854a3117a4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbfa7f443c9f4c30be51cebaefbd7dd1_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtNy0xLTEtMA_c97c9007-f6f0-45c0-8bf6-ffe35c1b4d4c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07652793af6e402c8f56ae5bf525de5d_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtOS0xLTEtMA_5a9e6261-4f2c-4a90-acfb-a2383ebe3d0c">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtMTEtMS0xLTA_6563862d-a844-4e30-bfe0-02b3b21b7535">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;As of March&#160;31, 2020, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM1OTg_798f63e0-fcb3-434f-b7bc-da6961d2c440">157</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i8770b26e8a104e24a96561be14d9b01f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM2MTA_6e15e0f8-130f-451e-9b91-bfd51a2950db">118</ix:nonFraction> million was recorded in Other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="i47cb8d8061744a318fce0b3384617786_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM2NTk_4360c882-07cd-487c-b320-bb2bd03bab21">39</ix:nonFraction> million was recorded in Other non-current liabilities. </span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i2a06cd1a0a3d482bbcefa340ae53e805">(2)&#160;&#160;&#160;&#160;As of March&#160;31, 2021, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM3NTM_a30bb04c-20e4-4489-94eb-8944f626b181">151</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i33bc232cff8a4f12a4e890a4672e8218_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM3NjU_c16acb31-526a-41f0-b57b-7db5ad3e007a">99</ix:nonFraction> million was recorded in Other accrued liabilities and $<ix:nonFraction unitRef="usd" contextRef="i90e94470ed16447396b9f1012b944606_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM4MTQ_bbdd3cbe-96ad-4309-a81c-bdeb8187d81c">52</ix:nonFraction> million was recorded in Other non-current liabilities.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0e09ab54c47e4c1b88b9e166bf83b5c4"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzYwNDczMTM5NzQyNDg_d106ec8c-1b8b-404c-bfef-767ce2f953a1">115</ix:nonFraction> million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="if2f8ead53d3e4be5b9320bb684b9f13a_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzYwNDczMTM5NzQyNzY_7f531e65-f340-4892-9872-ffd9b15b3f03">82</ix:nonFraction> million to impair certain long-lived and intangible assets for its retail pharmacy business in Europe within the Company&#8217;s International segment. These charges related primarily to intangible assets associated with pharmacy licenses within the U.K retail business due to a decline in estimated future cash flows driven by additional U.K. government reimbursement reductions communicated in the third quarter of 2020. The Company used a combination of an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived and intangible assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company performed an interim impairment test of long-lived and intangible assets for its Rexall Health retail business, within the Company's International segment, due to the decline in the estimated future cash flows primarily driven by lower than expected growth in both prescription volume and sales of non-prescription goods. As a result, the Company recognized a charge of $<ix:nonFraction unitRef="usd" contextRef="i9fc5fdf86d854199b0de26fe3d7aef0b_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNTY3MDE_6b868798-f598-49be-9784-44ca69864660">30</ix:nonFraction> million to impair certain long-lived and intangible assets, primarily customer relationships. The Company utilized an income approach (a DCF method) for estimating the fair value of the long-lived and intangible assets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i1f79d90a93144c60981f623c356fc6bf_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzYwNDczMTM5NzQzMDQ_f6c31c24-e142-4552-8b2b-610e3436c485">210</ix:nonFraction>&#160;million to impair certain long-lived assets (primarily pharmacy licenses) for its U.K. retail business, within the Company&#8217;s International segment, primarily driven by government reimbursement reductions and competitive pressures in the U.K. The Company used an income approach (a DCF method) or a combination of an income approach and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i18d5408029404b5aa8938a311b6434f3_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzc3NDk_2ea4b361-2fbb-44ce-8b32-c90f14667206">35</ix:nonFraction> million to impair certain intangible assets (primarily customer relationships) for its Rexall Health retail business within the Company&#8217;s International segment. The impairments were primarily the result of the decline in estimated future cash flows for this business. The estimated cash flow projections were negatively affected by a lower projected overall growth rate from the ongoing impact of government regulations in 2019. The Company utilized an income approach (a DCF method) for estimating the fair value of long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the long-lived and intangible assets described above is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company-specific information. Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; for more information on nonrecurring fair value measurements.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_133"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzY2ODM_71c4fd48-8d55-43f8-949d-45c184158cc1" continuedAt="i02df8bd469bd4b9eb73fbf2cc9ee5b85" escape="true">Business Acquisitions and Divestitures</ix:nonNumeric></span></div><ix:continuation id="i02df8bd469bd4b9eb73fbf2cc9ee5b85" continuedAt="ibf08bd26fe934de5a5438ea24f81ce4f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, the Company did not complete any material acquisitions. During 2021, 2020, and 2019, the Company did not complete any material divestitures other than the contribution of the majority of its German wholesale business to a newly formed joint venture, as described in Financial Note 3, &#8220;Held for Sale,&#8221; in 2021 and the separation of the Change Healthcare JV, as described in Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; in 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes. However, if the assets of another company are acquired, the goodwill may be deductible for tax purposes. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ibf08bd26fe934de5a5438ea24f81ce4f" continuedAt="i5b9584abf6884c9ebdcaa2a90e477537"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Acquisition</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Specialties Distributors LLC (&#8220;MSD&#8221;)</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2018, the Company completed its acquisition of MSD for the net purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i1a36ca67ff5f42bbbbcf4d6660b6af27_D20180601-20180601" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzQzOQ_250836f9-d9d7-464e-8846-0950fccab8e2">784</ix:nonFraction> million, which was funded from cash on hand. MSD is a leading national distributor of infusion and medical-surgical supplies as well as a provider of biomedical services to alternate site and home health providers. The financial results of MSD have been included in the Company&#8217;s Consolidated Statements of Operations within its Medical-Surgical Solutions segment since the acquisition date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets acquired and liabilities assumed as of the acquisition date were finalized upon completion of the measurement period in the first quarter of 2020. The final purchase price allocation included acquired identifiable intangibles of $<ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzEwODA_c61cc7ba-2ccc-47f8-9f76-92c9257afb86">326</ix:nonFraction> million primarily representing customer relationships with a weighted-average life of <ix:nonNumeric contextRef="i4ca54959e5e04b8c9414f83bc32f7efe_D20180601-20190531" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzExNjE_f55873ca-964d-4d82-bfa9-25f51c949e7b">18</ix:nonNumeric> years. </span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzY2NzU_a8efab86-d1b7-40d4-829a-2d577154581f" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final recording of the fair value of the assets acquired and liabilities assumed for this acquisition as of the acquisition date, including immaterial adjustments made during the measurement period:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.437%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;as of the Acquisition Date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzEtNy0xLTEtMA_93ba2b25-325f-466c-8e6f-423d3dac6367">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets, net of cash and cash equivalents acquired</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzItNy0xLTEtMA_02af81f2-79d4-4a03-ab9d-5b663bbcb526">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzMtNy0xLTEtMA_9c1066ac-bbef-495e-a54a-0add92675dbf">388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzQtNy0xLTEtMA_427b9ab5-1ffb-4235-820c-0702e698108c">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzUtNy0xLTEtMA_aaea5bb7-6f0b-499c-bf35-434de8e8d9c7">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzYtNy0xLTEtMA_e60d8d04-c0ac-4b5b-bcfa-9684b387921d">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzctNy0xLTEtMA_123a2b22-dc32-49be-b283-22c284017c3b">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired, net of cash and cash equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531" decimals="-6" name="mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzgtNy0xLTEtMA_bc6ae8ef-9505-4ad9-a631-eb7d792cf6c8">784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Final amounts as of May 31, 2019.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CoverMyMeds LLC (&#8220;CMM&#8221;)</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2017, the Company completed its acquisition of CMM for the net purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i1182c1c4af8746449b50307d67f448c1_D20170403-20170403" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzI3MTU_feee1550-b9f4-4c11-bae0-15df6f1719cb">1.3</ix:nonFraction> billion, which was funded from cash on hand. Pursuant to the agreement, McKesson&#8217;s purchase consideration was subject to an additional $<ix:nonFraction unitRef="usd" contextRef="i3088cf57426d4c8e9292e7c571001c3b_I20170403" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzMxMzU_dbbe9058-6fb7-441f-8065-5f6a24b6deaa">160</ix:nonFraction> million of contingent consideration based on CMM&#8217;s financial performance for 2018 and 2019. Pursuant to the agreement, the Company paid additional contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i616817b40eb74cfb8ae329d9816e7420_D20190501-20190531" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzM5OTc_d5270b9b-7566-4f35-aba9-3fec7dac406c">69</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id07b7f77830b43c69cfefaf0b8e7b960_D20180501-20180531" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzU0OTc1NTgxNTE2ODg_9ffa70e7-6414-4bcc-b7df-b7ffc6b81e3b">68</ix:nonFraction> million in May 2019 and May 2018, respectively. As of March&#160;31, 2020, the related liability was <ix:nonFraction unitRef="usd" contextRef="ia99cfa38235e449aa90c06cd0c7c8a59_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzQwNzY_6ffd910c-3022-47ae-af0b-4fdf8a681df2">nil</ix:nonFraction>. </span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5b9584abf6884c9ebdcaa2a90e477537">During the three years presented, the Company also completed a number of other de minimis acquisitions within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.</ix:continuation> </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_136"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNTQ_68c53d3c-9744-4f02-a8c7-09e84b25daa7" continuedAt="i88530bc19da14748bb9545cce1e4442d" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i88530bc19da14748bb9545cce1e4442d" continuedAt="idc09c58b87b64ddea6aa5e8ef8fff0c4">The Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#8220;RSUs&#8221;), performance-based stock units (&#8220;PSUs&#8221;, formerly referred to as total shareholder return units or &#8220;TSRUs&#8221;), performance-based restricted stock units (&#8220;PeRSUs&#8221;), stock options, and an employee stock purchase plan (&#8220;ESPP&#8221;) (collectively, &#8220;share-based awards&#8221;). Most of the share-based awards are granted in the first quarter of each fiscal year.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="idc09c58b87b64ddea6aa5e8ef8fff0c4" continuedAt="i061e15d090ca48a4b9e8b4c6defe06e5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on Net Income</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNjA_f24dce38-86f1-414b-8d56-a936ed03f242" continuedAt="i12ed983afde24c959b56e7110806ecab" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.539%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84584b6586641aaa11065062b0d4dcf_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzItMS0xLTEtMA_97e6b90f-be3e-4f0c-8776-dd08e0e7ceb6">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68df8813101f4e9ca695e42eb2c1ba7b_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzItMy0xLTEtMA_34e425e5-2832-4cf9-8444-3854e822a115">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e93491e63641d6a447af76bfba5be9_D20180401-20190331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzItNS0xLTEtMA_3403e865-ba6f-417d-b38a-8860365c1797">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e9a04c993b47eea348dc69be94ad03_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzMtMS0xLTEtMA_134d4b63-922e-424e-adbb-44a461a49688">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ea0a3bee2a42b3b14918ca313d0f3f_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzMtMy0xLTEtMA_3f35abc3-f3d9-4831-8dc3-06f8b2a73eae">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7752154a30be4b70b7c200da7c5e0314_D20180401-20190331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzMtNS0xLTEtMA_4c7b7a40-d8c4-4483-a826-62600de82142">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzQtMS0xLTEtMA_500d5003-b309-49f3-9b73-daa388bb594e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2875e0d883e04e789a166269b0168d5f_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzQtMy0xLTEtMA_e38f860a-1dd5-4305-a31e-16aadf0ec67a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d6d0051e254f03868cd2b4c4a08616_D20180401-20190331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzQtNS0xLTEtMA_bf6bd636-fb29-4156-910b-e2af1293f78d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzUtMS0xLTEtMA_fa455723-dd23-494e-a80b-ca2fe5ef011e">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzUtMy0xLTEtMA_29cd65cf-f4c7-4e5f-ac15-5807fc0dda28">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzUtNS0xLTEtMA_547f186f-7868-487f-9c7c-4a75535329c4">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzYtMS0xLTEtMA_5ada2046-e890-4bdb-98a1-c9aa4f42d17e">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzYtMy0xLTEtMA_6bcbe2f6-b256-4835-ad23-4a6af638ad3f">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzYtNS0xLTEtMA_055b2f49-1742-431c-963c-1e8f0d2e224e">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzctMS0xLTEtMA_2b871116-c9bd-4749-a2ba-ba6a2ab8e62e">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzctMy0xLTEtMA_11cb0a44-0ec0-4a65-9768-76f87fba3003">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzctNS0xLTEtMA_27a21806-764f-4a21-b069-99751103e243">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs, PeRSUs, and PSUs.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i12ed983afde24c959b56e7110806ecab" continuedAt="ife69f88d641f46498f6cb787de6de404">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="ife69f88d641f46498f6cb787de6de404">Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2021, 2020, and 2019 included discrete income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE3NjA_2a58e96f-1416-4041-8924-83a2d50e3f8e">2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE3Njc_85f5c322-535c-4312-8b40-4246fbacbe00">2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzU0OTc1NTgxNDgzOTc_40dfcaeb-218f-4400-82d6-fd34396dcd19">4</ix:nonFraction>&#160;million, respectively.</ix:continuation> </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company&#8217;s stockholders approved the 2013 Stock Plan to replace the 2005 Stock Plan. Under these stock plans, the Company may issue restricted stock, RSUs, PSUs, PeRSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserves <ix:nonFraction unitRef="shares" contextRef="i1bb3af9567d84570a2e07fa7cc1ca3e8_I20130731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzIyMzk_3f9444b4-c59d-4802-9355-3ced3c79f69e">30</ix:nonFraction> million shares plus unused reserved shares under the 2005 Stock Plan. As of March&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="if9ea335282264bd19c87da915b541a3d_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzIzMTQ_1f2b88a1-64c3-41dc-b536-4d286572cb17">20</ix:nonFraction> million shares remain available for future grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs entitle the holder to receive a specified number of shares of the Company&#8217;s common stock which vest over a period of generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NDY_e4780d27-ecc2-4ddb-b012-e0b781a25964">three</span> to <ix:nonNumeric contextRef="i7bca6f61ec8d4af0a1acb791483f3894_D20200401-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NTI_d6fed5e3-0f2e-402d-beab-7f9c962cced0">four years</ix:nonNumeric> as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the market price of the Company&#8217;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March&#160;31, 2021, approximately <ix:nonFraction unitRef="shares" contextRef="i7d84699d924747a3b932295e7377ba8c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzMyMzY_94c1fcaf-7a60-41fb-8c5d-5c58d3a91a2c">82,000</ix:nonFraction> RSUs for the Company&#8217;s directors are vested.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a <ix:nonNumeric contextRef="i3dc1c1e592264d43b77791466a65bd52_D20200401-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzUx_a8520e9a-a25e-4458-aee2-132bc4baee61">three-year</ix:nonNumeric> performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally <ix:nonNumeric contextRef="i3dc1c1e592264d43b77791466a65bd52_D20200401-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzQwMTU_15d32d13-78a2-4afd-90c5-724a24b1cc9e">three years</ix:nonNumeric>. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date. For PSUs that are eligible for cash settlement and designated as liability awards, the Company re-measures the fair value at the end of each reporting period and adjusts a corresponding liability in its Consolidated Balance Sheets for changes in fair value.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i061e15d090ca48a4b9e8b4c6defe06e5" continuedAt="i2c79e77dfe2140ecabcefd0e2e6220ea"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PeRSUs are awards for which the number of RSUs awarded is conditional upon the attainment of one or more performance objectives over a specified period. All outstanding PeRSU awards have completed the performance period and are now classified and accounted for as RSUs. The Company did <ix:nonFraction unitRef="shares" contextRef="i5481893297be481981506a5801e443ba_D20200401-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzM3_6a487ac4-02ab-464f-a203-7fbe187f4b5a">no</ix:nonFraction>t grant any PeRSUs during the years ended March&#160;31, 2021 and 2020. </span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzODA_5bc80087-90c7-47c0-9ff5-4b20fc6d1379" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzItMS0xLTEtMA_28db7c88-b887-434c-a00d-8353725c4a96">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzItMy0xLTEtMA_a2d60701-6099-404a-ad9b-c1dfea055e6b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzItNS0xLTEtMA_8833491b-af01-456a-9348-7149e236911d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzMtMS0xLTEtMA_091fe519-20de-4a2f-a83d-36181c819a3a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzMtMy0xLTEtMA_951ccf8d-3d15-4b73-9d1d-5d99965f3eab">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzMtNS0xLTEtMA_c046989a-193d-4c35-9e82-be1c901b8260">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzQtMS0xLTEtMA_3cc15a00-e401-47c6-ad47-24f731e5dfbf">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzQtMy0xLTEtMA_8ec435f7-39c0-4bcf-be1d-7b17b4f2c803">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzQtNS0xLTEtMA_46aad932-027e-4b9c-a791-3d11efe752cf">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzUtMS0xLTEtMA_82c5d399-f6c8-40e3-96a8-447e5c92c603">3</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzUtMy0xLTEtMA_f839a1a8-2542-46f3-bd65-79a0bc8c846a">3</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzUtNS0xLTEtMA_50617682-eabf-43ec-9004-dd02c87b2225">3</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNjM_ef91bbb2-45f8-4496-90a7-0e11f8ac0cf8" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs, PSUs, and PeRSUs) during 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa9c17219d084d969cda29f0f32fcdaf_I20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzEtMS0xLTEtMA_9d9627d1-ed88-42e3-83f7-12132e1bc4db">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa9c17219d084d969cda29f0f32fcdaf_I20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzEtMy0xLTEtMA_334b25f4-24e1-4086-add5-894a61958f6e">135.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzItMS0xLTEtMA_3aaa40f2-3e40-43f4-9e3f-e1aef7caab79">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzItMy0xLTEtMA_8a27250f-57c2-4506-a71c-8cef04639d64">155.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzMtMS0xLTEtMA_35769440-a36d-43b0-b00a-6efeaefee305">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="2" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzMtMy0xLTEtMA_87efc27b-33f6-4df1-8c92-3497c24500ad">133.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzQtMS0xLTEtMA_79e03b33-42b4-4f1b-a857-ae70fb3e660e">1</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzQtMy0xLTEtMA_ecdbcf09-ea6e-45bd-84e8-4838b6bcd75c">147.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzUtMS0xLTEtMA_78bd9ecf-b572-41c7-9e76-83f6465d1895">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzUtMy0xLTEtMA_10475703-9701-4dc5-b23e-c61bffffbb63">142.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:DataRelatedtoRSUActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNDk_abaf2dc9-bb7a-4d07-a1bf-3cedf512edca" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzItMS0xLTEtMA_a99b7d77-2c96-43a3-84be-50a1f5df2271">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzItMy0xLTEtMA_576a6bf2-6129-411c-96da-4bf9b04535a8">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzItNS0xLTEtMA_95291ad6-eba5-4142-a725-98a84f40e26a">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzMtMS0xLTEtMA_cdc980c8-5efd-43c8-ba3d-3e44098339cc">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9c17219d084d969cda29f0f32fcdaf_I20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzMtMy0xLTEtMA_135c3c01-a895-4465-a199-04524e83a5ea">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b9e27715eb4321801361f74b4928b1_I20190331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzMtNS0xLTEtMA_c1905642-3bf6-4a74-81b6-9d6116381191">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzQtMS0xLTEtMA_b2c06b17-bd98-4a7b-91ab-e118915da768">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzQtMy0xLTEtMA_f36a96c2-dc47-4621-81c9-55051dd3325f">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzQtNS0xLTEtMA_1fb2b1ad-a6fb-45e9-b3d5-46ceaca6b638">2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of <ix:nonNumeric contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzYyMzA_d68270e5-1d2a-42e4-853d-dcda15fbb45d">seven years</ix:nonNumeric> and follow a <ix:nonNumeric contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzUw_4a77ac7c-f9e8-450f-878b-b88c17acd0a6">four-year</ix:nonNumeric> vesting schedule.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i2c79e77dfe2140ecabcefd0e2e6220ea" continuedAt="i08474a4d14e4437cbebd38e44f779750"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNDA_c2ea00c0-d10a-4475-bb44-fa7caea82d44" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the fair value of employee stock options were as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended <br/>March 31, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzItNC0xLTEtMA_18504909-ba9c-4333-b3ba-3c56110c8e13">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzMtNC0xLTEtMA_c86840af-20d1-44d5-83a7-f450819f41c0">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzQtNC0xLTEtMA_61638b72-e268-4e99-a15c-6ee453469847">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzUtNC0xLTEtMA_358d4121-5318-4f1b-accc-d1a6ffcf7092">4.6</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company did <ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzQ1_0c0a64df-0f65-4262-ae6b-7b4b8caea843"><ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzQ1_d1aae6b6-bbbd-43c3-a1c6-16d73f74c99a">no</ix:nonFraction></ix:nonFraction>t grant any stock options during the years ended March&#160;31, 2021 and 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The computation of expected volatility was based on a combination of the historical volatility of the Company&#8217;s common stock and implied market volatility. The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Expected dividend yield is based on historical experience and investors&#8217; current expectations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The risk-free interest rate for periods within the expected life of the option is based on the constant maturity U.S. Treasury rate in effect at the grant date.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The expected life of the options is based primarily on historical employee stock option exercises and other behavioral data and reflects the impact of changes in the contractual life of current option grants compared to the Company&#8217;s historical grants.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNDQ_773f4240-9271-4dd6-aa36-79d91bb9c761" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March&#160;31, 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98600c393115470c98af4ebaf984768f_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMC0xLTEtMA_f9deff7d-49f6-4d88-bde3-14359274c282">118.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i98600c393115470c98af4ebaf984768f_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMi0xLTEtMA_73c5d8c9-6537-4020-862c-8c596d50883a">183.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItNC0xLTEtMA_fbb8db71-db6f-43b0-b0cc-702353b73f89">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98600c393115470c98af4ebaf984768f_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItNi0xLTEtMA_259a52ad-a86a-4b90-93b2-150eef3fd302">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItOC0xLTEtMA_cc083c42-294e-4c14-ab05-5057b7bbca19">166.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMTAtMS0xLTA_e9fa420d-2a81-4085-92c1-13c2c21c3f2b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMTItMS0xLTA_c4275f75-709d-45e6-a7fb-c2bb822aad43">171.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMC0xLTEtMA_d2181112-f2a1-4262-9c6d-ebf0732d48c9">183.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMi0xLTEtMA_9385137f-0cd0-4bc4-bac5-3ed4d125a483">237.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtNC0xLTEtMA_f5f62aa1-784d-4245-87a4-98d2f07a21a4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtNi0xLTEtMA_1486ffc5-fb15-4aa6-9e99-11675388191f">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtOC0xLTEtMA_6fb16283-e23f-4740-aa51-bffc270e298e">216.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMTAtMS0xLTA_09dc27bd-88d1-43f8-b817-d6d0f14eccf2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMTItMS0xLTA_11023946-602e-49bc-9077-a28ae2ca4108">216.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzQtNC0xLTEtMA_c20ee8e2-528d-405a-a0db-f679070f3fe2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzQtMTAtMS0xLTA_e7772bcf-f085-4a36-ade0-ff9b55d3b7fb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNzA_5f7fe07c-5de0-472e-bc09-2832b584625e" continuedAt="i6256e0f6768649bea89a103beba2c384" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during 2021:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtMS0xLTEtMA_e3fa10fb-5eba-4162-976f-b502e556d627">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtMy0xLTEtMA_b39aaf10-2521-4279-ac8e-b3ea08776f1f">180.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtNS0xLTEtMA_2b8c7057-22fa-4242-8c36-ee280ef925d6">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtNy0xLTEtMA_759839e0-ce78-4e6f-bb07-e631348ab0ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzItMS0xLTEtMA_b6035590-feee-4b88-9808-e3c104acf0fb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzItMy0xLTEtMA_09b08a75-7203-48e1-adc4-d838f4ebd983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzMtMS0xLTEtMA_e722bc8c-c445-467d-8300-99b7741dc285">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzMtMy0xLTEtMA_7a26fee8-1f03-4e9b-9022-3c19753aa01b">187.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzQtMS0xLTEtMA_e2db3cb9-f08a-49a0-9b63-532abe738364">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzQtMy0xLTEtMA_0c8c52e1-a948-44bb-bd16-f7cfc620ca1a">153.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtMS0xLTEtMA_fcb7fdca-5810-48e4-ab99-de08a6a62bb5">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtMy0xLTEtMA_626469b8-1660-4455-98c4-7b09c14d0a12">183.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtNS0xLTEtMA_94c403cc-de57-4778-ad61-fd102ec73e99">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtNy0xLTEtMA_eb1895cf-4f51-4ee3-a5e5-ec9c12d4e471">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtMS0xLTEtMA_7269892f-1902-4e37-ac54-14442db9be55">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtMy0xLTEtMA_a6825872-5d91-41c5-bf7d-7f427020e83a">183.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtNS0xLTEtMA_04f4c3fb-8943-41d9-b1c2-e65946e05b93">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtNy0xLTEtMA_d4911faf-6d3c-4b17-8547-d827a5b72f1c">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctMS0xLTEtMA_9e2b6571-0932-4e90-b0a2-4c5eedea7671">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctMy0xLTEtMA_5277bb5e-b4c8-4b09-b7ee-e1fa03a83f23">189.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctNS0xLTEtMA_bc9751fd-8e0b-4c3c-9458-b7ddaff2ecb3">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctNy0xLTEtMA_6a0a224f-433c-469b-835d-f24af4f2b11c">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i6256e0f6768649bea89a103beba2c384" continuedAt="ifed33daa5e7744ce99261bdd71620494">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="ifed33daa5e7744ce99261bdd71620494">The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i08474a4d14e4437cbebd38e44f779750"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNTM_1adb9217-c700-473f-8a66-5b627c3d3456" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzItMS0xLTEtMA_80e41214-c2e6-4cd4-883c-2026c021ee24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzItMy0xLTEtMA_e414f509-c6e1-41f7-a054-195fdabcdc92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzItNS0xLTEtMA_ff1dc848-03aa-43f5-a1dc-f0345ac9e16a">34.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzMtMS0xLTEtMA_6798ed39-56ab-4e8b-9010-de5a0052b885">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzMtMy0xLTEtMA_b6f4e3f7-a2cd-4c1d-a5bc-17f33de51d43">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzMtNS0xLTEtMA_ce59574e-69a9-47a8-99bc-bf11e06b3683">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzQtMS0xLTEtMA_6f830bb9-e337-4d96-9a91-559a99423db2">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzQtMy0xLTEtMA_fcacc732-217e-42ad-9d3f-1b6926b01c65">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzQtNS0xLTEtMA_702c5a13-57cc-433d-a17b-d3873ebb3a26">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzUtMS0xLTEtMA_80c9e9d1-221b-4589-825f-40942f3b6fa3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzUtMy0xLTEtMA_59f9b57e-0d30-4c78-80af-009737d1b89a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzUtNS0xLTEtMA_0395c637-7b1b-4fd2-9df3-b177482e6998">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzYtMS0xLTEtMA_1a4e5ab6-cb05-47ef-8de8-e290c463f5d9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzYtMy0xLTEtMA_2ec0ac12-b7ef-40d7-91fb-3909f5e4c52f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzYtNS0xLTEtMA_ab72ef8b-2c3f-4543-afd7-a99cc4553cdf">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabba4ee1a62b45e6bbc176b0dc8941b3_I20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzctMS0xLTEtMA_853a08fd-9c27-490b-9eae-5171bac58137">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521d39c0b3084c2d99a90fc226922cdd_I20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzctMy0xLTEtMA_a8c8588a-66cf-4579-b4d9-ecfd3f547553">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ee321ad30d41dfad64c6a2f32533ec_I20190331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzctNS0xLTEtMA_07bb1cfb-9619-4c60-a53c-b16a5ee3692d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzgtMS0xLTEtMA_be01cf87-9f78-4f9b-9cf0-f82bdb353f4d">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzgtMy0xLTEtMA_4f8d601a-0267-4e6a-b565-37ad39dd9eef">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzgtNS0xLTEtMA_48ec3b66-b5f4-45b2-89dd-df2edc26c0ab">2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ESPP under which <ix:nonFraction unitRef="shares" contextRef="ia5415cd5dc724d9b839b382de490cae8_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzgzNDc_82761e62-15f1-4267-89f6-767fd152d637">21</ix:nonFraction> million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock through payroll deductions. The deductions occur over <ix:nonNumeric contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331" format="ixt-sec:durwordsen" name="mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzQ5_ebf73217-89ae-4ccc-8d3b-61f7c1aec3c0">three-month</ix:nonNumeric> purchase periods and the shares are then purchased at <ix:nonFraction unitRef="number" contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzg1OTM_fb4d683f-c781-40ff-a5c1-5f014b1b4c9e">85</ix:nonFraction>% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The <ix:nonFraction unitRef="number" contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzg3OTk_258920fe-91e3-4d9a-a93f-a30d0daf2a96">15</ix:nonFraction>% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in 2021, 2020, and 2019. At March&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="ia5415cd5dc724d9b839b382de490cae8_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkyODg_c0e095d5-d677-4fe9-b206-33393bcb48ce">2</ix:nonFraction> million shares remain available for issuance.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_142"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzUwNA_6a42e495-1280-4bb5-b08e-7c98e3898a45" continuedAt="i566b2af4bd734e7ba7ad3b4f4fad98e2" escape="true">Other Income, Net</ix:nonNumeric></span></div><ix:continuation id="i566b2af4bd734e7ba7ad3b4f4fad98e2"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzUxMQ_fa73cdfa-97bb-428e-9696-20f9249536f9" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzItMS0xLTEtMA_1a5a88d9-7266-48ba-87fe-8c9e148b944e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzItMy0xLTEtMA_080e4385-29b5-4e1f-8715-30e47a05babd">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzItNS0xLTEtMA_aa7042c8-f97e-4b48-a601-85ba9b3796b9">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzMtMS0xLTEtMA_c87d7174-66fb-468c-9a08-9beb9aa5daf9">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzMtMy0xLTEtMA_63b214ee-5624-4c48-a3e8-129f50a649c8">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzMtNS0xLTEtMA_92689a4a-2bd9-4eed-9c40-ea1de82926cd">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMS0xLTEtMjExOTA_9735c874-7c3a-448f-9e5f-8f50d3f42b40">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMy0xLTEtMjExOTA_31afbfc9-5ab4-4d73-bcd2-a49a9cc26e2a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtNS0xLTEtMjExOTA_26b00c9e-96c2-432e-a1ee-0dcbaafe2706">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses from pension plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzUtMS0xLTEtMjExOTQ_375747ec-4aa6-461d-b1b2-2f36afaf7fbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzUtMy0xLTEtMjExOTQ_04325300-8d6c-4795-a2bd-8fe0c23dd07f">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzUtNS0xLTEtMjExOTQ_aefc5400-e9f8-40e9-a48a-50a7b75d802a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of equity method investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMS0xLTEtMA_d6e03cfd-27bc-419b-b749-066f8f923906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMy0xLTEtMA_ac9dd7f2-5d03-4d36-9a7b-02c0440455f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtNS0xLTEtMA_2486eff4-e2c3-4e8e-9747-9fa70996315e">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzYtMS0xLTEtMA_b687d05c-6c47-4108-9ef7-4625e2a9f75a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzYtMy0xLTEtMA_fb4afb5b-8126-4e22-88e4-b559c073e77c">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzYtNS0xLTEtMA_b7708eab-533f-4fe0-b4b7-991f1ef8cc71">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzctMS0xLTEtMA_148b3015-f7dc-4507-b62c-2f855253e1c7">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzctMy0xLTEtMA_3ad81218-f437-4713-9f38-31fdd4460e5f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzctNS0xLTEtMA_fd052afe-e188-4c0c-90da-f2ebbcd6b5e6">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments and were included within Corporate expenses, net. Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; and to Financial Note 22, &#8220;Segments of Business.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes $<ix:nonFraction unitRef="usd" contextRef="iad526e199d5f45e8b0138cf1dc4218d3_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzMwMw_db60cb2f-d939-42d4-b49a-1a2c9a479748">116</ix:nonFraction> million from the termination of the U.S. defined benefit pension plan and $<ix:nonFraction unitRef="usd" contextRef="ifbba704ea17245a79664996d4d4b9fb9_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzM3Mg_d34f9e01-dcda-447e-b2ad-b436a202503e">11</ix:nonFraction> million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 15, &#8220;Pension Benefits.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents a gain from the sale of an equity investment to a third party included in RxTS during 2019.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_145"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMjA_186df066-456c-4f46-aed0-f277a2cd137e" continuedAt="i9e0d206260624db48d245b7b4b5ad805" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i9e0d206260624db48d245b7b4b5ad805" continuedAt="i0a508f67cd3e4bb583e1af910ec01148"><div style="margin-bottom:12pt;text-align:center"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMTA_859dca80-95fb-4509-8807-542dc017c9ed" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzMtMS0xLTEtMA_deedf645-61eb-4934-9741-021e17a2e22b">6,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzMtMy0xLTEtMA_01347301-ea8a-45cb-9c50-e923b91c1bb7">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzMtNS0xLTEtMA_46acfddf-093f-4f80-86d3-76d37c8668d1">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzQtMS0xLTEtMA_4041cd38-6c8c-41c2-9d4e-9d1142fed778">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzQtMy0xLTEtMA_456307c7-b9c9-4000-af0f-17c0b7b53c22">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzQtNS0xLTEtMA_2bc28acc-8246-4983-b531-bc5f43da727d">902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzUtMS0xLTEtMA_c4e5f568-c00d-48e7-aa86-5abba4528ce6">5,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzUtMy0xLTEtMA_ee95f747-cb8f-41ff-b2d6-5c66f057616d">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzUtNS0xLTEtMA_2ed8ddab-fa17-481d-a1b2-a5949f885e8a">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMTQ_0abbc75c-8066-4b3f-98f6-a91828a1a8cf" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzMtMS0xLTEtMA_a1222c21-9d14-42d9-928a-8128a25a6516">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzMtMy0xLTEtMA_62161e72-0110-4ded-bf42-a3aa03398401">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzMtNS0xLTEtMA_56ed6c40-8b5d-4b51-bc75-4759e44ffec8">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzQtMS0xLTEtMA_59f7fe13-e7f8-470b-8e52-ebc1f8a80ed9">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzQtMy0xLTEtMA_ad63617d-74ff-4243-b4c8-ffdaa643899c">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzQtNS0xLTEtMA_5681a358-8f33-468e-a696-151724c9f525">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzUtMS0xLTEtMA_d0ee0d3f-8e94-44b4-854b-054523b562fc">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzUtMy0xLTEtMA_7b11271a-bc84-4d6a-a286-946f836b0093">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzUtNS0xLTEtMA_a2193147-e624-4d3a-918f-4af4bb5f1cf5">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzYtMS0xLTEtMA_9edacc37-5f58-41ec-b220-61a4963e12d9">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzYtMy0xLTEtMA_cd2e26b9-095b-44dd-96cf-df275ba5c0d2">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzYtNS0xLTEtMA_2189367f-6bce-4290-8bd3-734919939a43">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzktMS0xLTEtMA_1e0ca83e-997f-4a3e-a98c-742b486d5daa">562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzktMy0xLTEtMA_fec508d1-ac4c-470e-98c3-b24089ec0b15">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzktNS0xLTEtMA_b04fa20f-48f3-4907-9673-471cb2ff4a48">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEwLTEtMS0xLTA_82eb94dd-3419-4321-a61f-14fb4f0d0e1f">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEwLTMtMS0xLTA_fc5b047e-9025-4dea-9887-92a58d5697a7">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEwLTUtMS0xLTA_fecaa9ab-7e84-437e-a09a-4dd659a976b0">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzExLTEtMS0xLTA_e68b70d7-ddc4-4904-b882-47e22705b413">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzExLTMtMS0xLTA_07afd045-f582-4ccc-a589-5d763ac2784d">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzExLTUtMS0xLTA_58a7d16e-dc85-46f7-88df-571e2593de0d">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEyLTEtMS0xLTA_a700691d-165b-41b7-9782-435524d0af1c">908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEyLTMtMS0xLTA_c5973476-7d10-4d55-bdb4-7a31af3bd790">342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEyLTUtMS0xLTA_00df101f-e11b-4f0e-9d05-0c2bc3f558d1">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEzLTEtMS0xLTA_925c7f37-e0ad-4a2f-9d5b-814a794a6fea">695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEzLTMtMS0xLTA_fc12f915-9f1b-437b-b528-5e4be6e24acd">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEzLTUtMS0xLTA_3f36521f-8e69-4a72-a2c3-9b4948baa193">356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported an income tax benefit rate of <ix:nonFraction unitRef="number" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzI5Ng_097378c2-01cb-4ad1-9da5-d09b73b4eed9">13.8</ix:nonFraction>% in 2021. Income tax expense rates were <ix:nonFraction unitRef="number" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzMwMw_1786673f-cb31-43d3-81e0-68ec5203171e">1.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzM1Mw_d71e3ae5-483c-410f-9ba5-a7d422e85ff7">58.4</ix:nonFraction>% in 2020 and 2019, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to the impact of opioid-related claims of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTAwMTc_b7b4d34b-50c3-42f7-a336-2a56782efaf3">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTAwMjM_12072986-4f44-41ec-876f-351d8cd88041">6.8</ix:nonFraction> billion after-tax) in 2021, the impact of the Change Healthcare joint venture divestiture in 2020, the impact of nondeductible impairment charges in 2019, and varying proportions of income attributable to foreign countries that have income tax rates different from the U.S. rate.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0a508f67cd3e4bb583e1af910ec01148" continuedAt="iae3672d3ab1a4846b7237ec803e12a16"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMjM_a3771465-85bf-400b-ab7b-c8c91c6342fb" continuedAt="i69a8e14a80f44fddb76065e98f8c7caa" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of <ix:nonFraction unitRef="number" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgzOA_9c4f6935-946e-4ba7-8e6d-87d76635669f"><ix:nonFraction unitRef="number" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgzOA_ebfb3bb2-2cc3-4184-a7c2-d60466030d87">21</ix:nonFraction></ix:nonFraction>% to income before income taxes is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzItMS0xLTEtMA_65a6154c-b219-4282-95f5-f365d1e4f33c">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzItMy0xLTEtMA_e6de8e90-bdbc-4253-aaa1-fab1b8c8e432">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzItNS0xLTEtMA_842bc664-4b82-413b-81b2-ba705cea39a9">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzMtMS0xLTEtMA_d886e335-434f-4e7a-88b4-84cfaca29aa5">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzMtMy0xLTEtMA_17f33f27-acf2-4f0b-a6a4-1539b93b8ca8">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzMtNS0xLTEtMA_fc99c821-e7ea-4bcd-a6b0-b90f184c3e33">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzQtMS0xLTEtMA_70c5e508-3ee0-41e0-a203-ebeebab177f0">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzQtMy0xLTEtMA_bda9f2e2-310a-47ba-b077-10d9cd0730f7">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzQtNS0xLTEtMA_08cf0a7c-2a69-48a5-ae69-e6bae3bbfab0">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzUtMS0xLTEtMA_b0367d97-dbf0-4c76-8a99-ebba4bb28e1c">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzUtMy0xLTEtMA_423551a2-bb12-471d-992a-e70e7a1c5029">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzUtNS0xLTEtMA_8a931409-cf34-4cac-8cc4-19f386b05b8c">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzYtMS0xLTEtMA_17007f41-a1be-4ead-a055-35ada56e3a78">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzYtMy0xLTEtMA_526ccf79-001d-4bc0-b643-2e0819fe0a8e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzYtNS0xLTEtMA_86d5c752-e21d-4788-bffe-fdb02d8ffd5a">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzctMS0xLTEtMA_158b6eda-10b1-4330-892c-ffff1dac8ff8">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzctMy0xLTEtMA_518e3fb2-c9e7-48e2-be86-9b755b9f2c65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzctNS0xLTEtMA_c8250e61-127d-4b57-a184-e9e878de8aac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzgtMS0xLTEtMA_3781ba2b-b167-4739-b8e0-0cb92e506e17">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzgtMy0xLTEtMA_e89bcfda-d887-43cb-9c1f-f53051c43dec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzgtNS0xLTEtMA_27a9114f-7dce-4b8e-8dc9-22f9a8fb27ed">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-free gain on investment exit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzktMS0xLTEtMA_7868eb81-d968-4a03-bef9-e9b17cf68d26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzktMy0xLTEtMA_c847d2d4-ed83-4f23-a826-3e33c7c2d556">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzktNS0xLTEtMA_09403742-12c6-4f79-be04-8ef389996075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of change in U.S. tax rate on temporary differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEwLTEtMS0xLTA_e5bd9adb-2c51-4a59-8519-cdda6f07951f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEwLTMtMS0xLTA_3bad0adc-41ac-49c7-bc0c-ae0010c1497c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEwLTUtMS0xLTA_50d497df-c8d8-4b7a-a82e-d4cf1c019d33">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEyLTEtMS0xLTA_d6937459-647b-4a27-b1f5-c14c342906c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEyLTMtMS0xLTA_5e63a302-3afa-472b-8a14-693090b22b85">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEyLTUtMS0xLTA_b966f74e-0dcb-4db7-81bb-1acdb006e301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEzLTEtMS0xLTA_8eebf86b-4e08-40d9-8dc0-48dbe219a61c">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEzLTMtMS0xLTA_09a9b6a3-4c6f-4071-932a-86a9a7f87999">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEzLTUtMS0xLTA_ed8d830c-5af8-4c04-a227-9ddf8d3a762b">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzE0LTEtMS0xLTA_158f694f-fb00-4011-b263-4ea95eec7535">695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzE0LTMtMS0xLTA_007cc7ac-bd69-48ce-88da-2227e0a48b19">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzE0LTUtMS0xLTA_a400462d-607e-41d4-9f8c-bb17a38061ba">356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for additional information regarding the separation of the Change Healthcare JV.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i69a8e14a80f44fddb76065e98f8c7caa" continuedAt="ie6c1fd248a6948f1a8a1e8fbc440d0f4">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="ie6c1fd248a6948f1a8a1e8fbc440d0f4">The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzExNzU_beea5f5c-ff14-4e65-982f-8bcc7bdd5327">5</ix:nonFraction> million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzExNzk_3733f2c5-4d42-42b4-8dcc-a47ec2bbd06b"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzExNzk_78798f70-45c8-4976-b8be-df627bb45ebc">7</ix:nonFraction></ix:nonFraction> million in each of 2020 and 2019.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rate for 2021 was impacted by the charge for pending and future opioid-related claims of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTExNjU_b7b4d34b-50c3-42f7-a336-2a56782efaf3">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTExODM_12072986-4f44-41ec-876f-351d8cd88041">6.8</ix:nonFraction> billion after-tax), as described further in Financial Note 19, &#8220;Commitments and Contingent Liabilities.&#8221; The Company recorded a deferred tax benefit of $<ix:nonFraction unitRef="usd" contextRef="iff2be0b266e4404fb2d3170fc25c0e2d_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzIxOTkwMjMyNzIxMjM_94b97687-00c6-4f4f-9a7e-80fdf98f4617">1.3</ix:nonFraction>&#160;billion, which is net of certain non-deductible expenses and an unrecognized tax benefit of $<ix:nonFraction unitRef="usd" contextRef="iff2be0b266e4404fb2d3170fc25c0e2d_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzIxOTkwMjMyNzIxMzc_10f727aa-7b24-41de-8a95-daf1ea0111be">455</ix:nonFraction> million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2019, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. In both instances, the transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTEyNTU_ef6f0609-1c29-4190-ad18-a25adb264fe0">105</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:IncomeTaxExpenseBenefitDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTEyNzI_4a5705aa-7806-4258-b12c-555e1a25ca4f">42</ix:nonFraction> million were recognized for 2021 and 2019, respectively, with a corresponding increase to a deferred tax assets for the temporary difference arising from the buyer&#8217;s excess tax basis.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV as described in Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture.&#8221; The Company&#8217;s reported income tax expense rate for 2020 was favorably impacted by this transaction given that it was intended to generally be a tax-free split-off for U.S. federal income tax purposes. In the fourth quarter of 2020, the Company recognized a net gain for financial reporting purposes of $<ix:nonFraction unitRef="usd" contextRef="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzE2NzQ_785def8a-4592-40bd-822e-89e7e2ac3fc5">414</ix:nonFraction> million related to the separation transaction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax expense rate for 2020 was unfavorably impacted by non-cash charges of $<ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzE4NTA_2d6969b8-196d-475a-8192-6c590a0f2a63">275</ix:nonFraction> million to remeasure the carrying value of assets and liabilities held for sale related to the formation of a new German wholesale joint venture within the Company&#8217;s International segment. Refer to Financial Note 3, &#8220;Held for Sale,&#8221; for more information on this transaction which closed in the third quarter of 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax expense rate for 2019 was unfavorably impacted by non-cash charges of $<ix:nonFraction unitRef="usd" contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzIyNDk_28bbb74f-4aef-411f-bb63-f93b3b445cac">1.8</ix:nonFraction> billion to impair the carrying value of goodwill for its International segment, given that these charges are generally not deductible for tax purposes. Refer to Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iae3672d3ab1a4846b7237ec803e12a16" continuedAt="i9fd94bef78b34b518101b656e226b763"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgwOTA_f5e9f853-ce72-41cd-a92c-e724ae9a2201" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzMtMS0xLTEtMA_0777c9b4-ba70-4c79-9fd6-c67207648f08">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzMtMy0xLTEtMA_da782445-d3f6-4ac0-a9b3-8edfd1887af7">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:DeferredTaxAssetLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMS0xLTEtMjM3MTk_0a34acb6-5054-4db1-a59f-2864481adf7d">724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:zerodash" name="mck:DeferredTaxAssetLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMy0xLTEtMjM3MTk_89110ebe-a2ac-4a67-8a3b-e442bc156291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMS0xLTEtMA_09a3138c-1d1e-42a7-856f-952e83be49b8">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMy0xLTEtMA_671519c0-925a-41d0-8402-cf980a53608e">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzUtMS0xLTEtMA_a9410222-f146-4603-9546-1a6020a9b50c">974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzUtMy0xLTEtMA_46a09c32-dc76-4081-b5d4-272a7e358f0a">828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:DeferredTaxAssetLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzYtMS0xLTEtMA_1e97614c-8ece-4dab-9159-03affdd8885b">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="mck:DeferredTaxAssetLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzYtMy0xLTEtMA_1f89905e-df44-4e73-8bec-28fa9e988ce5">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzctMS0xLTEtMA_589c7371-ec91-4a13-971b-e56d7581dad7">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzctMy0xLTEtMA_e80104e0-2abb-4a47-a5ea-115144eec842">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzgtMS0xLTEtMA_f57630e4-5664-48a5-ba7b-d41022d0b92b">2,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzgtMy0xLTEtMA_55578414-d151-4d5b-9b51-f2378a770663">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzktMS0xLTEtMA_c3da8ab1-615e-4042-8de1-23b33eae23c6">864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzktMy0xLTEtMA_89ff48ee-7f8e-46c4-b35b-159f9babe843">833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEwLTEtMS0xLTA_6533629f-a99d-4a9d-aaeb-327cf6383ed7">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEwLTMtMS0xLTA_f1ac9b98-7456-4315-9ed1-9e498a9e04f9">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEyLTEtMS0xLTA_bdd09df0-ab60-4e44-8d23-141848eb500d">1,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEyLTMtMS0xLTA_e97fa19a-c75b-4a99-8f08-23790c7bcb31">1,947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEzLTEtMS0xLTA_efcd29ff-e887-46db-aec8-45980f8d48f5">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEzLTMtMS0xLTA_2c8c59fa-8a21-45ce-9567-0cf677d5dc8e">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE0LTEtMS0xLTA_515cd1b8-7893-4d60-b049-15fc54b4759a">411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE0LTMtMS0xLTA_891b7deb-316f-4962-86ad-42b9833d2b54">531</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:DeferredTaxLiabilitiesLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE2LTEtMS0xLTA_eb080346-f1b2-419e-95d0-e7f4c74931fc">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="mck:DeferredTaxLiabilitiesLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE2LTMtMS0xLTA_630b7a30-50e9-4230-8c72-d3f7952d7d0d">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE3LTEtMS0xLTA_f83e7782-bccd-48d6-a318-e85a79fe449d">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE3LTMtMS0xLTA_c3f3c2be-0f86-4572-9c23-41233a6e59b6">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE4LTEtMS0xLTA_cf14fe6f-0623-45fd-9165-e59676acb851">3,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE4LTMtMS0xLTA_fbcb6359-b0f5-4a4f-a53e-cc5ea1b28e5b">3,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE5LTEtMS0xLTA_1d6d03fa-a061-4eae-8906-cbbf69159829">1,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE5LTMtMS0xLTA_aca0da32-7242-47cf-b797-3de8ace96151">2,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIxLTEtMS0xLTA_95c6df4d-085f-4783-be1c-70e6a164f15a">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIxLTMtMS0xLTA_124699fb-1423-4e10-bebe-0418fc3250ba">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIyLTEtMS0xLTA_e2f8c290-cdc8-40c0-84fa-1821f77d802d">1,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIyLTMtMS0xLTA_f2636c30-86d7-43c7-8cc6-88e0e495b1cb">2,255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIzLTEtMS0xLTA_7f4e6a90-4113-4aad-89e0-4ecf25af18a3">1,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIzLTMtMS0xLTA_47940bf5-7330-4ced-a344-b49a9e547e6d">2,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzQ3MzE_c3da8ab1-615e-4042-8de1-23b33eae23c6">864</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzQ3Mzg_89ff48ee-7f8e-46c4-b35b-159f9babe843">833</ix:nonFraction> million in 2021 and 2020, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The increase in the valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzQ5MzM_8930184a-f2c9-4763-91fb-51d142633bce">31</ix:nonFraction> million in the current year relates primarily to net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has federal, state, and foreign net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i8758a2f6ea4f4877a3355c52d963a658_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzUyMjI_49fc6aba-9069-4edd-a21f-c5f4263d89b3">2.4</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i9be1b4de02944aa881e317723693e477_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzUyMjY_dc7116fb-dc69-44cd-bb18-ffd8ccf90947">3.9</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="if8132f157c2a4e22b4c467d61f9c078e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzUyMzM_81a2d699-d245-48b9-ac24-eac1fd269015">2.2</ix:nonFraction> billion at March&#160;31, 2021. Federal and state net operating losses will expire at various dates from 2022 through 2041. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i2f9c0a94c8b144ce82c5a2e1c8a76a41_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0NzY_a043c6c7-635b-4a7f-8f91-099b330cddd7">783</ix:nonFraction> million with indefinite lives. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9fd94bef78b34b518101b656e226b763"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMTY_72744a42-bd4f-43f5-882a-129d5514f731" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.245%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzItMS0xLTEtMA_c682b0bb-c6e1-458a-85ee-2ade49b72fea">958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzItMy0xLTEtMA_d9f3856d-6ddf-4c9d-8f69-2c04b39a0f10">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022a2642b16245d083cb80c539e560b3_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzItNS0xLTEtMA_435763e1-72f3-430d-a93c-c3383322f881">1,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzMtMS0xLTEtMA_89c5b481-6d47-4ece-9bb7-ab05a88660a4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzMtMy0xLTEtMA_e78d1595-57b9-4667-af38-5a56ff7e80cc">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzMtNS0xLTEtMA_c05ac5d4-296e-4f2c-93cd-35dbf4da9828">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzQtMS0xLTEtMA_507c1701-b17d-4dcc-b3e6-041a58b59e80">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzQtMy0xLTEtMA_8557c22f-0c1a-4c69-946c-5658baeed9d6">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzQtNS0xLTEtMA_a2f4f422-c0db-4ab6-a074-5f9fb3c5b30d">234</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzUtMS0xLTEtMA_18f9c1b1-8b2f-444b-9e90-469ed0a32eff">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzUtMy0xLTEtMA_68481664-9ad7-4a27-bb31-520ab19d4fa9">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzUtNS0xLTEtMA_55a469b8-23ca-468c-aa3b-27ec9dd891de">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzYtMS0xLTEtMA_afb1e30f-6c1d-4bfe-8295-36c10bd8d50f">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzYtMy0xLTEtMA_31a45069-6f3e-4007-9324-2d27d2b564c0">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzYtNS0xLTEtMA_867fd56a-8578-486e-b49a-f985dc22b288">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzctMS0xLTEtMA_6d6a2f1e-49f7-4c26-b776-6dd00139d93c">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzctMy0xLTEtMA_e867226f-b8e8-409d-b459-60f35ddc2893">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzctNS0xLTEtMA_af3ebd6f-88bb-45ed-a6a1-20e7ffe8744a">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzgtMS0xLTEtMA_5bffaa07-332a-4649-9797-35f1041ff9fd">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzgtMy0xLTEtMA_b431c0b1-fd42-49c1-81c0-ce7c7b44eda6">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzgtNS0xLTEtMA_9258a651-afc6-4525-aefe-0fbc7fca39f2">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzktMS0xLTEtMA_84725607-75e7-4f7b-8082-0ec1adb9e134">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzktMy0xLTEtMA_6e08b0bd-5251-4ee0-8d64-44035e5c60f0">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzktNS0xLTEtMA_8116a30f-6408-4d70-b79c-9f5ba7ac2b50">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTQ5Mzg_debb080b-ccf2-4d46-98b7-f38517922548">1.8</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU3MDA_9e3faf22-d37b-4616-ace9-80259604a412">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate, if recognized. The increase in unrecognized tax benefits in 2021 compared to 2020 is primarily attributable to uncertainty in connection with the deductibility of Opioid-related litigation and claims. Because many uncertainties associated with any potential settlement arrangements or other resolutions of opioid claims including provisions related to deductibility have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; for more information. The decrease in unrecognized tax benefits in 2020 compared to 2019 is primarily attributable to the favorable resolution of an outstanding California tax refund claim which decreased unrecognized tax benefits by $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzYwODQ_c972d6ab-ad04-4d6a-a00d-b92f3e0e0b52">91</ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefit may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTQxNDE_44417499-fbab-4c0b-9945-43f24ac91256">93</ix:nonFraction> million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY1NDY_21ed7386-d218-4fc9-a540-d9e513f79c1e">9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY1NTM_604aab70-7154-43e5-b642-3e05e00fe898">23</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY1OTg_04fd6dde-89d3-4f43-aa75-71504f9decc1">33</ix:nonFraction> million in 2021, 2020, and 2019, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March&#160;31, 2021 and 2020, it accrued $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY3MjE_d6574d13-8b6c-47b8-bb16-1cb50dc2d1a3">101</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY3Mjg_31679ea0-e8fe-4474-b9d3-363eabb45c1c">91</ix:nonFraction>&#160;million cumulatively in interest and penalties on unrecognized tax benefits.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign operations of approximately $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4Xzc1NDk_de76aaec-5ffb-4cd4-831f-5c7b04ccab5c">6.0</ix:nonFraction> billion were considered indefinitely reinvested. Following enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_151"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzQ0MjY_162667b8-e1db-4654-b184-320357ca391a" continuedAt="i778d7485da904a149bca0e00e69c1ae8" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i778d7485da904a149bca0e00e69c1ae8" continuedAt="idabd7f359bad41358c07c61107ba4be9"> </ix:continuation></span></div><ix:continuation id="idabd7f359bad41358c07c61107ba4be9" continuedAt="ia806b6b63bcd47fa98cb37ccbd3f29d3"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i864d4657d9144642ae333aa935acbc46_I20210412" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4Nw_17c76198-0e64-4c48-9805-43f8caf7cb74"><ix:nonFraction unitRef="eurPerShare" contextRef="i061bc9a2eb8443769ce87eeb86b06600_I20210331" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4Nw_507640eb-ff32-44e8-810f-6e24e21d158b">0.83</ix:nonFraction></ix:nonFraction> per share. As a result, during 2021, 2020, and 2019, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzU0OA_cfad3ffe-b9e6-4054-a411-1a5eb4870e53">43</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3bd3e34ab71b46dc924bf5b41dcdda09_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzU1Mg_b225cc62-000d-42e2-839c-182871b1d442">42</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ie7aa6fa69f9c4cda930b030fe075c224_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzU1OQ_66326eca-efd7-423a-9af8-eab46cda1db3">45</ix:nonFraction> million, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ia806b6b63bcd47fa98cb37ccbd3f29d3" continuedAt="ieceb4b5379424305a27601db35be26aa"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ia5de4bf26a814949a75f192c559706a9_I20210412" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4Xzk3NQ_18539c34-9dc4-482a-8226-297de4906004"><ix:nonFraction unitRef="eurPerShare" contextRef="i3f55ef7798384062876c3372deac9867_I20210331" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4Xzk3NQ_4a54aa15-1f3d-438e-8fda-38ef8ee89389">22.99</ix:nonFraction></ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:PutRightValueInterestRateSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzEwMzg_467851bb-f8c5-48fd-8984-026de3110c8b">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTc3_9946e94f-7b66-485c-a827-1cf192869dda">49</ix:nonFraction> million to purchase <ix:nonFraction unitRef="shares" contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331" decimals="-5" format="ixt:numdotdecimal" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTg1_9daf401c-d45c-425d-ab46-7ed0eaaca1be">1.8</ix:nonFraction>&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTY5_9946e94f-7b66-485c-a827-1cf192869dda">49</ix:nonFraction> million, and the associated effect of the increase in the Company&#8217;s ownership interest on its equity of $<ix:nonFraction unitRef="usd" contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTkx_691d9bef-f60c-4a25-a773-9e8cb20e22f4">3</ix:nonFraction> million was recorded as a net increase to McKesson&#8217;s stockholders paid-in capital. During 2020 and 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At March&#160;31, 2021 and 2020, the carrying value of redeemable noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE5NzU_13dd03d3-9849-4329-b22c-b5f2a9cb7322">1.3</ix:nonFraction> billion and&#160;$<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE5ODI_10818df1-d412-4440-9e6c-e571e085b00e">1.4</ix:nonFraction> billion, respectively, exceeded the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="i3f55ef7798384062876c3372deac9867_I20210331" decimals="-7" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIwMjY_c3e1e427-5df2-4b9e-875b-149b74e75623">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i587fb85617b64a75ac242f855f331d8c_I20200331" decimals="-7" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIwMzM_e6604e59-67cd-4c43-94dd-12b8d07cb13e">1.2</ix:nonFraction> billion, respectively. At March&#160;31, 2021 and 2020, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i3f55ef7798384062876c3372deac9867_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIwODM_1f7e7811-62b3-4a28-b944-00d617b35a7f">78</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i587fb85617b64a75ac242f855f331d8c_I20200331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE5MjQxNDUzNDkyNjEw_ff88f493-bd74-4de6-91b4-c513e275bdee">77</ix:nonFraction>%, respectively, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Appraisal Proceedings</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court (the &#8220;Court&#8221;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="idbc43acfc0194bbeb7cffc75f3ccb983_D20180919-20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePriceIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzI5NDE_4c11a912-ad51-477f-8e62-82d88d7cd99b">0.51</ix:nonFraction> resulting in an adjusted Put Amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i78e6c9a100924eb4a8e0c5dfffff754e_I20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzI5ODM_4f0db03d-88d5-4875-b72e-e7c0d2542fd7">23.50</ix:nonFraction>. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ia5de4bf26a814949a75f192c559706a9_I20210412" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI1Mjg_18539c34-9dc4-482a-8226-297de4906004"><ix:nonFraction unitRef="eurPerShare" contextRef="i3f55ef7798384062876c3372deac9867_I20210331" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI1Mjg_4a54aa15-1f3d-438e-8fda-38ef8ee89389">22.99</ix:nonFraction></ix:nonFraction>, thereby rejecting the lower court&#8217;s increase, and the recurring compensation shall remain &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i864d4657d9144642ae333aa935acbc46_I20210412" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI2Mjc_17c76198-0e64-4c48-9805-43f8caf7cb74"><ix:nonFraction unitRef="eurPerShare" contextRef="i061bc9a2eb8443769ce87eeb86b06600_I20210331" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI2Mjc_507640eb-ff32-44e8-810f-6e24e21d158b">0.83</ix:nonFraction></ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE and Vantage, which were $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM2NzQ_e05c3086-2305-448b-8110-45ebb7c63f58">196</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM2ODE_e069a09f-f647-4cf5-970f-fc46b0071d64">217</ix:nonFraction> million at March&#160;31, 2021 and 2020, respectively, in the Company&#8217;s Consolidated Balance Sheets. During 2021, 2020, and 2019, respectively, the Company allocated a total of&#160;$<ix:nonFraction unitRef="usd" contextRef="i39fe8b1ce4de400880c9ed586d6d03db_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM3OTg_c1aa42e0-9252-4339-b467-58360a30d435">156</ix:nonFraction> million,&#160;$<ix:nonFraction unitRef="usd" contextRef="id1f5f4ec4cae4f6e9da1a608fe5d9874_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4MDI_19748d73-a365-4c40-a724-c82a383ae33a">178</ix:nonFraction> million, and&#160;$<ix:nonFraction unitRef="usd" contextRef="i97e4424a4e7440b9964b4ce2f73e59a5_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4MDk_8c65e335-3093-46d7-b2b4-224cba494801">176</ix:nonFraction> million of net income to noncontrolling interests. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ieceb4b5379424305a27601db35be26aa"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzQ0MzM_ce6d544b-ef21-4643-a128-89bcb8ba198d" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March&#160;31, 2021, 2020, and 2019 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/>Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae70566f5363452bbc98260415fc04bd_I20180331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtMi0xLTEtMjExMjM_13837b4a-544b-4754-99eb-b59a0e639b5e">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76995eaf2114e8d988d829663827be2_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtNC0xLTEtMjExMjc_874505a9-1445-4fa9-9866-bd0de6fba5c8">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItMi0xLTEtMjExMjM_2a0498c1-40bf-49cb-b6a0-87efce928610">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItNC0xLTEtMjExMjc_b799af88-e69f-43fc-980d-aa0c96d69bf1">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtMi0xLTEtMjExMjM_f9857684-57ee-4eac-8ca2-1f4a6f36fa2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtNC0xLTEtMjExMjc_3c3f96fd-3287-4149-9ad2-90bd3d960fa1">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzQtNC0xLTEtMjExMjc_6f00561a-0461-44cd-ad7f-ac77d51b2663">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtMi0xLTEtMjExMjM_b4a9ef6e-4c56-4342-b468-722c94f290e0">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtNC0xLTEtMjExMjc_558000e3-7f2a-46d9-8f73-178dc2eb142a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtMi0xLTEtMjExMjM_1f498caa-cf2c-4ac9-a427-052940fa22bc">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtNC0xLTEtMjExMjc_d7b8fcbb-44d4-492e-a748-0b7a7145fefb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4544e477b1841a4bdb6022ce255ba46_I20190331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtMi0xLTEtMA_bc1bda77-e48e-4278-9098-2ca540c0f93a">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeede0913be2432eaa8dd89edabc33b8_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtNC0xLTEtMA_56c1059b-fa8a-470c-a663-5af90badd62a">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItMi0xLTEtMA_f93ae848-8b94-4344-add5-a20fd476e35d">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItNC0xLTEtMA_6d55a8e5-0d44-4a99-a890-08a019215eb3">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtMi0xLTEtMA_bc4f281a-5ebe-4fe3-91a6-0719cb860f19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtNC0xLTEtMA_8871c238-7b9c-4f95-9d0d-dfc795b7b015">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzQtNC0xLTEtMA_2c7fb98e-c37d-4f38-84b2-955433ab79be">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtMi0xLTEtMA_bf0d9702-85aa-49f9-9270-6954fb973269">154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtNC0xLTEtMA_519e154a-8706-4aa0-9ede-5e5f367087f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtMi0xLTEtMA_5b73da6f-ce9d-406c-98f9-bd6074e3cf72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtNC0xLTEtMA_2ca6cc2c-5cf3-411e-af2a-07fda1e35271">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bbfa761b88c4adcbd3850e152c97132_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzctMi0xLTEtMA_b1491f2a-bca3-495b-9f0a-a9cf92fe6963">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b9841e941249b08fc5e771cceb886b_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzctNC0xLTEtMA_fbfe08b3-4b7c-493c-b86b-bdbe5e27c093">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzgtMi0xLTEtMA_267eacac-bec2-48ea-8b32-a8e749b19621">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzgtNC0xLTEtMA_4ebddac2-562b-4279-b7ec-9e112b498f11">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzktMi0xLTEtMA_320fafe4-af1c-492b-be30-a57e1fa8c807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzktNC0xLTEtMA_fbb20123-5831-43bb-8c5a-aee224b6635a">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEwLTQtMS0xLTA_b657be08-87d5-41c5-b28f-1dae33759d6e">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzExLTItMS0xLTA_5c59f65c-7399-4eee-83b5-b9e90b4fa595">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzExLTQtMS0xLTA_2b01be8f-33bf-45ca-b5c2-37e29e57b747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of put right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEyLTQtMS0xLTIwOTkw_63c8e942-37f5-4304-99e6-e184b8a0fdba">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEyLTItMS0xLTA_14f08272-b495-44ea-857d-109fea09ba4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEyLTQtMS0xLTA_9e981c8f-64d6-4aee-b3c0-798048c4b992">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a6bb29286494ed2aec32dd02ab9445e_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEzLTItMS0xLTA_0c869186-6f0b-4a3e-accd-3532d8d8541e">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6f0649588c42f2bdddd0e48e3b2d52_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEzLTQtMS0xLTA_a206ac2a-cf20-4950-92bf-f92463076909">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_157"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzkyMw_9cc67e4c-37fb-4568-9f14-e9836049a88a" continuedAt="ib4afd9d78096498d84771601f4d3d81b" escape="true">Earnings per Common Share</ix:nonNumeric></span></div><ix:continuation id="ib4afd9d78096498d84771601f4d3d81b" continuedAt="i59de9fe78b1045d3b10d6f213e93fd43"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted loss per common share for the year ended March&#160;31, 2021 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately <ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzEyMDk0NjI3OTA3NTcy_05dc61f7-00cc-468c-9ce9-8be4ba6cf64e">2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzEyMDk0NjI3OTA3NTgw_78b4b2a9-a572-4c89-b576-28f0de2f0d07">3</ix:nonFraction> million of potentially dilutive securities for 2020 and 2019, respectively, were excluded from the computations of diluted net earnings per common share, as they were anti-dilutive.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i59de9fe78b1045d3b10d6f213e93fd43" continuedAt="i575905763e354a0db4d7297e78b44157"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzkyMQ_76f9a234-e6cb-4afc-8f9a-5140c122eaf7" continuedAt="i698dd82a1922455795ed55294f016b57" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzItMS0xLTEtMA_7ad5e67a-3a29-42fe-9b8e-1ab7b8c9d6bf">4,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzItMy0xLTEtMA_b7ded87f-fcc4-40f9-a53c-07edbffe6216">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzItNS0xLTEtMA_97cd0087-52f4-496a-b6c2-68d5f43674d3">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzMtMS0xLTEtMA_b9d5e71e-c0f8-45d3-b864-89a4f3ef2ea1">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzMtMy0xLTEtMA_8effcdb1-8caf-4e05-9175-db9dd452dca8">220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzMtNS0xLTEtMA_0bd174b1-d000-45ad-a990-238dc000c1f1">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzQtMS0xLTEtMA_a1f3c650-aaca-42e3-b89a-9ca9d884f0d9">4,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzQtMy0xLTEtMA_ccf58a36-0100-42d0-9ba7-97674824da97">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzQtNS0xLTEtMA_60bce2a1-629f-42e1-a1c2-8301fb9d7698">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzUtMS0xLTEtMA_4d5bca78-253e-45b0-87a6-5d8a7d26aea5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzUtMy0xLTEtMA_5cf88de6-71a6-49cc-9659-70f9b6a42871">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzUtNS0xLTEtMA_2148fc4a-064c-400b-8fda-92182b8908f3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzYtMS0xLTEtMA_de7f3781-77f4-4dcc-9715-69a0d3b3e4ed">4,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzYtMy0xLTEtMA_5238b0bc-100c-4a8a-9c0b-709378bc8462">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzYtNS0xLTEtMA_484318c1-302b-4ce4-a759-408e2effd2dd">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzktMS0xLTEtMA_762524df-da76-40e4-952b-dd893ce34d0b">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzktMy0xLTEtMA_20a4344d-160a-48cf-bfea-4e63a82c8fb1">180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzktNS0xLTEtMA_47e0a1ec-d8f4-4200-a848-b96b4ecb4619">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEyLTEtMS0xLTA_3fc48b61-69f7-46e6-ada4-23c129b27ab7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEyLTMtMS0xLTA_decf342f-4a9f-427d-b039-02b797d05724">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEyLTUtMS0xLTA_cccc64df-92ad-4b7f-a102-b1c6e5b3a599">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEzLTEtMS0xLTA_32aa9abd-767e-4105-8aa6-0e46eb9a68d5">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEzLTMtMS0xLTA_f14d444d-bd0c-446c-af6d-0b0ac2f273ae">181.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEzLTUtMS0xLTA_6be3b78e-d3e2-4a1d-b90a-16c4fa8b7057">197.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE3LTEtMS0xLTA_5e75880e-770a-489e-9426-e1cee57417f7">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE3LTMtMS0xLTA_e3986145-40ef-4a72-9e6b-23f6deab1e0c">4.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE3LTUtMS0xLTA_99a43231-6877-4e6b-be25-8ecec867f54e">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE4LTEtMS0xLTA_fed113ec-2fb6-4e20-a201-13db5e515634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE4LTMtMS0xLTA_353636f4-a262-415f-bf69-005540b13bdb">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE4LTUtMS0xLTA_1063c8ef-dbf2-4fd8-b1db-ae79d693d186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE5LTEtMS0xLTA_7c30861e-d337-4857-9f60-9f7966db727b">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE5LTMtMS0xLTA_620d5ec6-e651-4582-ac4e-2cce35772b5f">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE5LTUtMS0xLTA_f3a3509f-17cc-4f36-8b1b-4eea1d002bfe">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIxLTEtMS0xLTA_da86927f-6030-4adc-bc8b-4e9dcd4b5e2c">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIxLTMtMS0xLTA_608ca8c4-64f0-4935-b635-46fc2e2070d6">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIxLTUtMS0xLTA_9e1b6cae-987a-410c-aee9-4f3028f49a01">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIyLTEtMS0xLTA_95d82939-b64b-48aa-909b-4b6ae3a2763e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIyLTMtMS0xLTA_a575818e-1fde-4887-80bb-31c08567cae7">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIyLTUtMS0xLTA_0fcfb3d8-64d7-413c-923b-ecd770774b5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIzLTEtMS0xLTA_d1e8f89f-eba5-46bc-a6bd-26927d028294">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIzLTMtMS0xLTA_c39c25cb-c061-49b6-9ecf-4becb2c9eb12">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIzLTUtMS0xLTA_ecd8f7d7-3dab-46af-8613-5826fe21a60b">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i575905763e354a0db4d7297e78b44157" continuedAt="i07ec3fefe44f47998ead46b524fadbfe"><ix:continuation id="i698dd82a1922455795ed55294f016b57" continuedAt="i9976fe2f4bf9487ebb9d3dbc943b9aa5">(1)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i07ec3fefe44f47998ead46b524fadbfe"><ix:continuation id="i9976fe2f4bf9487ebb9d3dbc943b9aa5">Certain computations may reflect rounding adjustments.</ix:continuation></ix:continuation> </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_166"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:LessorDirectFinancingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzQ_d191ecde-c480-4400-af4d-bb6e7865a328" continuedAt="icd430b55cbcb4e57a5ee69c7ad5493d7" escape="true"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzU_dbfbcb2a-d8bb-4e54-8a01-4bd0fb872590" continuedAt="iaa6d8989c358426bbd033d82569dda36" escape="true"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzY_23a342e2-6635-4e5c-b03e-a6d56fe8eb49" continuedAt="idf48d3aa07f4407cb627b26927ea54eb" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icd430b55cbcb4e57a5ee69c7ad5493d7" continuedAt="ic1efcd835daa40da8185e7b2123f4d14"><ix:continuation id="iaa6d8989c358426bbd033d82569dda36" continuedAt="i6d8b688695a2409f99653a59bf591385"><ix:continuation id="idf48d3aa07f4407cb627b26927ea54eb" continuedAt="i68950b46e3f44f83abb5dbe3e68598f4">In the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i0d9d3f777851405d93c2e2401895ce61_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjc5MTM_1e0dfbd6-88cb-498f-b671-848392341d8d">2.2</ix:nonFraction>&#160;billion of operating lease liabilities, $<ix:nonFraction unitRef="usd" contextRef="i0d9d3f777851405d93c2e2401895ce61_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjc5NDk_0928a2f0-de5a-4edb-83fe-0c46314098d8">2.1</ix:nonFraction>&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="i892cb0c916c746b5913bcd1ffb140a80_I20190401" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjgwMjI_8dd2ece1-5c7c-43f0-ad81-d0299785d2e7">69</ix:nonFraction>&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $<ix:nonFraction unitRef="usd" contextRef="ifc7244d83910406eaec9d88c79969937_D20190401-20190401" decimals="-6" format="ixt:numdotdecimal" name="mck:OperatingLeaseImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjk3Mzg_432591eb-0116-4514-9fe1-f715701258f9">89</ix:nonFraction>&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.</ix:continuation></ix:continuation></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic1efcd835daa40da8185e7b2123f4d14" continuedAt="i05e0e65cf19d42fa9da33a80bda5635c"><ix:continuation id="i6d8b688695a2409f99653a59bf591385" continuedAt="ib6577ec166a941338eafa938bd9ac8eb"><ix:continuation id="i68950b46e3f44f83abb5dbe3e68598f4" continuedAt="i72351481aad941fcbf006259d0467203"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768">one</span>&#160;to <ix:nonNumeric contextRef="i655f79d1e2274f738d115518f92c4d45_I20210331" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQzNQ_06240fa9-6904-4d3e-877d-870e927bf52f">15</ix:nonNumeric> years, while remaining terms for equipment leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3">one</span> to <ix:nonNumeric contextRef="i9cfec5575dbf43a9a693ee576ed1162d_I20210331" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzE5NzkxMjA5MzE0MjU5_2388a906-ac2f-47ca-9ab0-167c73c63115">five years</ix:nonNumeric>. Most real property leases contain renewal options (typically for&#160;<ix:nonNumeric contextRef="if42165365f8c4ba0b45f5d4a12bda439_I20210331" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzE5NzkxMjA5MzE0MjYw_44dd6c3d-dd63-4709-9abe-86f5058c6038">five-year</ix:nonNumeric> increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i05e0e65cf19d42fa9da33a80bda5635c" continuedAt="i0167275b58ed4740a074a42f85070b0b"><ix:continuation id="ib6577ec166a941338eafa938bd9ac8eb" continuedAt="i7cb318eb289248819478425541dc27cb"><ix:continuation id="i72351481aad941fcbf006259d0467203" continuedAt="ie0f798ad3f9d46f788152a088e09dfc3"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzk_67ed1b26-86de-43d0-aa9e-315a257dca38" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzMtMS0xLTEtMA_62337c08-e880-47d0-8f20-55a5c1ba7ad6">2,100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzMtMi0xLTEtNjkxMg_10c8b385-b4fb-4889-8187-e162dfa82318">1,886</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzUtMS0xLTEtMA_c62977cb-5ceb-4397-a1dd-1c1004ffa69e">390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzUtMi0xLTEtNjkxNQ_6cdb2905-3337-4c5a-a7af-c0b5de9ac98b">354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzYtMS0xLTEtMA_10825e8c-8f9b-45b9-8918-941265e88d6c">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzYtMi0xLTEtNjkyNw_02cf211d-9cd3-4ede-b395-20104c125809">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzctMS0xLTEtMA_d5ccf89a-5093-4af8-8e8b-48a7432312ff">2,257</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzctMi0xLTEtNjkxOQ_108c85a7-fdb5-47d2-bfab-b250f5cf8f06">2,014</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEwLTEtMS0xLTA_4405f8ec-3b00-4db7-805e-f13a9f857407">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEwLTItMS0xLTY5MDI_77cdcf45-8d72-4383-83e6-2c6743e78edb">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEyLTEtMS0xLTA_6b1543b1-df40-4ae6-827b-1fb2050923ff">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEyLTItMS0xLTY5MDI_988204b2-5195-404f-9d69-9cb742352337">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEzLTEtMS0xLTA_28d5b570-82bf-4215-beef-195d907275dc">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEzLTItMS0xLTY5MDI_5117484d-1d08-457f-9331-07365925eb9a">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE0LTEtMS0xLTA_68745a88-d10f-4b30-9063-0c3620921ba9">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE0LTItMS0xLTY5MDI_5e9ae0b3-6370-4aeb-97c3-6e6859b6b27e">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE3LTEtMS0xLTA_436140f7-bfe8-4c4c-9ea4-25a2ae006dc1">7.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE3LTItMS0xLTY5MDI_cdd2ed1b-2aa2-4f3d-8d05-82968cf6fd5b">7.7</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE4LTEtMS0xLTA_e83c5254-315b-40ff-a5c4-ce2e44528d04">10.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE4LTItMS0xLTY5MDI_5ec59b33-1578-4e20-971f-6d0f68d7c25c">12.1</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIxLTEtMS0xLTA_76920163-9c26-4bf5-afd8-335e5debb4b1">2.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIxLTItMS0xLTY5MDI_c2407319-870c-4c1f-a898-4c4f098fb5aa">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIyLTEtMS0xLTA_5d25ae92-ad3c-4a7d-a949-8d40dd044734">2.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIyLTItMS0xLTY5MDI_e2cfbbef-3e22-42cb-ad52-f76aa609e48e">2.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwODM_951390dc-f0ad-457e-bbfa-e4135ec24c29" continuedAt="ibed6e8c787ce4b37bec94cc2e92b9315" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEtMS0xLTEtNjgyOA_0c26bc55-8fe0-4fa5-9749-57f2c2fa7767">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEtMS0xLTEtMA_4740930b-3703-4236-9ac1-7de8f939598a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzItMS0xLTEtNjgyOA_61a4c9ae-e357-49b9-a35d-62b8a44a64e3">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzItMS0xLTEtMA_b35cf367-4f0d-4612-b228-e5051776c628">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzUtMS0xLTEtNjgzMg_fb86007b-ae08-4468-8b3e-efda4b0bef8b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzUtMS0xLTEtMA_056af442-3cac-4029-aca9-5d095d4056b7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzYtMS0xLTEtNjgzMg_2fe0ec8d-f994-4ccc-bd10-e5883d81e512">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzYtMS0xLTEtMA_3f3c6e47-0cf7-4b05-8d36-0d209a32194e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzctMS0xLTEtNjgzMg_a083e332-5397-4134-8048-3005da78b983">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzctMS0xLTEtMA_511b122a-7437-4d10-9657-3606ce0ac743">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzktMS0xLTEtNjg0MA_ce57d6f2-a660-448f-9049-85cdbd8f40b5">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzktMS0xLTEtMA_6986e584-6979-4d3e-b1d6-84951cfbb18b">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEwLTEtMS0xLTY4NDA_a3ae30db-5bee-4695-abad-0f02e0d89081">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEwLTEtMS0xLTA_a15f811c-9ce6-42af-9320-7e8968a92b80">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzExLTEtMS0xLTY4NDA_2d213685-9e66-4663-a7c7-ab0a44df001b">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzExLTEtMS0xLTA_665cbc4d-e6fa-47ab-86cd-1f80ad0c405c">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under operating leases was $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzI2MzA_f7c6e650-5ce1-485c-925d-7fe102f220f6">576</ix:nonFraction> million in 2019.</span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0167275b58ed4740a074a42f85070b0b"><ix:continuation id="i7cb318eb289248819478425541dc27cb"><ix:continuation id="ie0f798ad3f9d46f788152a088e09dfc3"><div style="text-indent:18pt"><ix:continuation id="ibed6e8c787ce4b37bec94cc2e92b9315" continuedAt="i598a4574697245628b044931799b9c8a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzItMS0xLTEtNzAwMg_d6442e30-c82e-4a65-b161-70ec12739a56">362</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzItMS0xLTEtMA_ec58cd6d-2331-49fa-9dc0-67ce260971be">377</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzMtMS0xLTEtNzAwMg_a42e2dd6-89d1-4b99-91e7-1be481879c49">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzMtMS0xLTEtMA_8fe38022-4631-4791-9150-bb7de87934b7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzQtMS0xLTEtNzAwMg_de5d2027-8a1d-44c1-8da8-ef859e53f3b8">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzQtMS0xLTEtMA_074b235c-a748-430e-8814-f027e7097989">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzYtMS0xLTEtNzAwNw_828e23ca-c284-4007-89f2-07ecc9ff8c34">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzYtMS0xLTEtMA_480fdc2f-4da2-4cba-ba0b-d6b5bd28fd41">2,378</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzctMS0xLTEtNzAwNw_6d5a950b-5f80-4c4b-9dd1-fc037d3b910e">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzctMS0xLTEtMA_e0582127-51e2-4f2d-bd36-e4b2caa27294">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"><ix:continuation id="i598a4574697245628b044931799b9c8a" continuedAt="ic7f1f911a7044e39ae8331d5088600cd"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $<ix:nonFraction unitRef="usd" contextRef="i0d9d3f777851405d93c2e2401895ce61_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzI3NDg3NzkwNzY4MTc_a0fbc20c-810c-4c01-8e86-5842909b47c9">2.1</ix:nonFraction>&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic7f1f911a7044e39ae8331d5088600cd">.</ix:continuation> </span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzI_8879452c-3a08-4e0f-b528-dff0ffea9932" escape="true"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwODU_4b35c5ca-b13f-465c-8bd6-7df5e67a59b2" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:52.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzItMS0xLTEtMA_942f0c7c-547e-41b5-b92e-3025162f2bed">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzItMy0xLTEtMA_6a57e3e8-8ae9-4c94-8b2c-dd21e669f8f1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzItNS0xLTEtMA_7558c6b1-b4d2-4e88-9c6e-c4ec137f38f6">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzMtMS0xLTEtMA_c33371a6-d480-483e-a8aa-f963cb4963c2">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzMtMy0xLTEtMA_c8fa8ccc-ef4f-4230-b3ae-5f3efdb22075">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzMtNS0xLTEtMA_8cc07259-8d5e-4e27-ba00-a01bf64f5fa4">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzQtMS0xLTEtMA_d7ca4e85-4762-44cb-a0be-4cfa2be05c82">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzQtMy0xLTEtMA_6c4fdd46-0353-4be1-8b9b-2e8a9d8c65f1">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzQtNS0xLTEtMA_aa475417-4961-4d9c-a007-245caeb50804">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzUtMS0xLTEtMA_24458042-d6f8-4820-b9f3-c0430aa51e7e">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzUtMy0xLTEtMA_9cf5f783-e29f-4e7f-b3a8-1462d66a0e61">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzUtNS0xLTEtMA_05e233ba-26cd-4c86-9b2c-5f37a1219c86">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzYtMS0xLTEtMA_c608db1e-b096-43bd-a280-0f2a3edfd4b2">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzYtMy0xLTEtMA_03944273-2c44-43cb-ac1f-cd59b9fda581">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzYtNS0xLTEtMA_0d8da7d4-581f-4cd5-8d39-b284fb0802bc">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzctMS0xLTEtMA_33cc667e-8513-419b-aafd-09a72d35d2f6">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzctMy0xLTEtMA_25af219f-db13-446e-9033-d77924604ee9">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzctNS0xLTEtMA_1c25af3c-66cd-4b1b-be3a-5994fc25225b">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzgtMS0xLTEtMA_f66a2904-46e0-4a55-822a-5a93a047d7ee">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzgtMy0xLTEtMA_26e81402-9d2e-428c-bd3c-fd2e4277349c">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:LeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzgtNS0xLTEtMA_c884af83-ea90-420a-9c42-6c86f695dba4">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzktMS0xLTEtMA_4afb7cb2-4f9d-450e-a8b6-440c39956935">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzktMy0xLTEtMA_31438157-ebcb-4b15-abee-146b93db95dc">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="mck:LeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzktNS0xLTEtMA_3a17d382-6dc7-4d63-ba8d-b6b3970e9bc7">282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzEwLTEtMS0xLTA_55e7f36b-f711-4dda-a6a5-4b16ec3ae65a">2,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzEwLTMtMS0xLTA_f3b30242-fe90-4c2f-8c37-b35c3b42750f">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzEwLTUtMS0xLTA_18a53e1b-255f-4be8-938d-85671930e2c3">2,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:LessorLeasePaymentstobeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzI5OTk_c114a6ff-2329-4807-baf1-e3dc0ab9e60a">202</ix:nonFraction> million which are due under future noncancellable subleases.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMxODA_6b264863-db61-4e14-b761-3299deb38750">217</ix:nonFraction> million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db">five</span> to <ix:nonNumeric contextRef="ib50261dbb728457db6b2202486d75ef0_I20210331" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMjU_bc2ee05e-b24e-47f5-baf9-98997c260afb">15</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjI2MTY_62eb89c7-686c-4f38-a84d-48aee2043467">298</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzM5MjY_1fb42691-61cb-483d-9253-2d186eca56f2">272</ix:nonFraction> million, respectively, with a weighted-average remaining lease term of approximately <ix:nonNumeric contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" format="ixt-sec:durwordsen" name="mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzM5OTE_51598778-4f0a-4894-b208-b3dd6348a561"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" format="ixt-sec:durwordsen" name="mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzM5OTE_79876216-8d50-4fc0-b9ed-a10d6b65b2d9">seven years</ix:nonNumeric></ix:nonNumeric>. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.</span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_172"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzgwODE_bfdca80b-b195-43fd-aebe-bc52cdeb049a" continuedAt="i6d5f9c5ed9f44a6da77abfec79a9f532" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><ix:continuation id="i6d5f9c5ed9f44a6da77abfec79a9f532" continuedAt="iafeba165284b4772ad89022a942db623"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzgwODI_7205a079-d904-4005-869a-e81aa06bd35d" continuedAt="icf151f0e395044878ae2f6ad4011e9fa" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064068b262474876b81e803f24785e0b_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtMS0xLTEtMA_7f224842-e670-4834-994f-b6342ab81e93">3,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ccd5ab037e84574a05e7c5dc7569e59_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtMy0xLTEtMA_d4ade6e8-0ede-4284-bd96-44b348932e15">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ccd1d1dd0a411aa2bfd0ef422868fb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtNS0xLTEtMA_98bd0c53-17d1-4df4-9b9d-907b4c014294">2,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364113e13bbf4a32a9613f4ab676e5a9_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtNy0xLTEtMA_509d5cad-b6a0-473e-90c0-1a0ffe2097fa">1,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtOS0xLTEtMA_474ac4fa-3645-4f1b-9bf6-112ffc0cefbe">9,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItMS0xLTEtMA_ce9f310a-2a19-49bc-a208-c880145fff7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItMy0xLTEtMA_25195a5b-794e-4b45-a53d-cec5e651c9ff">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItNS0xLTEtMA_4c954b47-f3cc-4aa0-8037-03ae5ca1609c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItNy0xLTEtMA_962cffff-a195-4782-b2b9-ed49d4233e56">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItOS0xLTEtMA_79fe1135-6dbe-45bf-bcf2-6385283d2eed">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtMS0xLTEtMA_7c9bac9c-e58d-4306-9da7-ba6f6e1d8674">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtMy0xLTEtMA_d52cbbd3-c013-4842-a04d-991e2e9c10b2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtNS0xLTEtMA_5499f1b3-d47e-4a1b-96ad-cb3bbffd7532">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtNy0xLTEtMA_e90c9bad-4c23-425c-9a70-247e6f6ac324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtOS0xLTEtMA_e133df61-eb26-4b60-b258-cbba10df6146">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtMS0xLTEtMA_ef713b0d-f0ea-401e-9c8a-f13063be7a60">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtMy0xLTEtMTYwMjc_333338b0-84da-4962-8d24-6cb669e3fcd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtNS0xLTEtMA_6c99e257-8aea-4e64-9140-4cf0163018de">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtNy0xLTEtMA_11aa5173-fe19-4b3c-93c4-06deb387f2d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtOS0xLTEtMA_c082686c-383a-42cb-b5a7-ed5529d28e43">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtMS0xLTEtMA_d804c622-1dbf-4623-90e2-b6fef17e1b96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtMy0xLTEtMA_dea0c8a7-3bdf-4e28-acde-fe4e529ebc34">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtNS0xLTEtMA_18a17a2c-2c6b-481c-b20c-66a1ba767bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtNy0xLTEtMA_d71d74ab-5298-4cec-8982-cd071f3688af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtOS0xLTEtMA_921cde17-52f1-410e-b1d8-957198e830a8">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtMS0xLTEtMA_d8fd66b3-0d5e-462b-b2a2-763e6fff73b2">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtMy0xLTEtMA_5ad0136c-db61-4292-b554-ad75fb13df20">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtNS0xLTEtMA_7c255a4d-c689-44af-88aa-5f5a00833996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtNy0xLTEtMA_52a2e67e-4bf0-466f-b4f5-c2ec0264ce9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtOS0xLTEtMA_cd95c18d-eb23-44aa-963c-19995d12c889">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a47ac4fb69943f8aab869a358429d1f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctMS0xLTEtMA_728140a2-3c03-45da-8309-8dd35b8224c9">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c8074ac9194cc5b11720dc788c0285_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctMy0xLTEtMA_bdf7793a-e8bf-4dcc-922e-b77aafff2407">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0f12f556ae4391817c093cf4fca373_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctNS0xLTEtMA_f607ec56-1f6d-4a19-a5e3-faebdfae8a53">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab002e4a10964495a81aca3a26ea2afc_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctNy0xLTEtMA_bc39b5ce-4725-43f2-9475-78372c829047">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctOS0xLTEtMA_046a5541-3ba4-4771-af5e-9a80f962b38b">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtMS0xLTEtMA_42315645-a4cf-40d5-8b16-6e9ae0fbe32d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtMy0xLTEtMA_393e3dcc-cba1-4192-91b2-f802a3209fef">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtNS0xLTEtMA_8bfc5ec8-1f5d-4acc-a821-b063664bb959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtNy0xLTEtMA_81ad3f75-91a8-4472-9400-1194570c4cfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtOS0xLTEtMA_6c80e9f8-b0be-4195-ac54-ba5b168e73a1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktMS0xLTEtMA_108eeabc-9595-4364-a17e-fbb31a963935">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktMy0xLTEtMA_05850d2b-6509-4986-b0e2-1435c9d5ecf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktNS0xLTEtMA_84503075-a7d0-47cd-85e8-e0c8e0af5776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktNy0xLTEtMA_ce64117d-7821-4905-a398-b84002c72d3a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktOS0xLTEtMA_332660c3-b262-452a-b684-5745a5cf6cbf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTEtMS0xLTA_2dfe9610-a450-4bfa-a557-5cf266b84c6a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTMtMS0xLTA_8cd8d61f-f51c-47a3-83e7-803af079058e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTUtMS0xLTA_e880e06a-f02f-4376-94b3-824db88bec09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTctMS0xLTA_4142d4ad-5b82-40fd-ab86-dc8b0d28c8ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTktMS0xLTA_eda46a5e-3424-4da2-a21a-67d027f11433">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTEtMS0xLTA_5b096890-92a4-4d67-a2b3-e1f5ffd1dffb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTMtMS0xLTA_a471679f-ea07-4d6b-ac02-2692a0033bf4">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTUtMS0xLTA_4ce7fefd-7c0a-4a07-86b3-179fa7f1d8d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTctMS0xLTA_dd4df386-8e2c-4d77-ab95-9b172fcc7809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTktMS0xLTA_87284ff0-95b9-4229-bd08-fe9a9e1f0fdb">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTEtMS0xLTA_e8d6020e-3174-4f4a-ab14-773117079242">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTMtMS0xLTA_04a963ca-6220-4364-9c3f-d4febfb723a3">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTUtMS0xLTA_734f048a-f64d-4770-b3ac-2af33fe67ecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTctMS0xLTA_ff9c345d-6916-44c5-84d3-5504dea67a55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTktMS0xLTA_09d0efec-cc0c-4c92-85f0-f33cc5b839cc">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib938fa6a5d404ab8951cd038035b8ff7_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTEtMS0xLTA_f4f55b27-361a-4d1f-9b9f-025c28ca98f4">3,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a85046f59343e3874040608ed73655_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTMtMS0xLTA_d0756f2b-3297-42dc-badd-498a1bbb89ec">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d099d3619b4467b8a30ab61cc9c0d8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTUtMS0xLTA_df821092-9adb-44b8-9d62-7075bbd6485d">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i797fe852990443559f1b76029e7fcf9c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTctMS0xLTA_cdebd48c-7930-408a-a5c7-488d69f69288">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTktMS0xLTA_e30b2132-7d5c-4a58-99cf-8a1a5cf4851f">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Impairment Charges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis each year and at an interim date, if indicators of potential impairment exist. On October 1, 2019, the Company voluntarily changed its annual goodwill impairment testing date from January&#160;1 to October 1 to better align with the timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from October 1, 2019 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units was determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#8217;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#8217;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iafeba165284b4772ad89022a942db623" continuedAt="id4c6255ba8c74d52864fb2e15f6a568d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill charges listed below were recorded in &#8220;Goodwill impairment charges&#8221; in the Consolidated Statements of Operations. Most of the goodwill impairment for these reporting units were generally not deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="segment" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzU0OTc1NTgxNTExNDE_9acdf32e-8fef-415c-a38a-9860d97cdfd5">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="id273e9fcef44447d91bf8cd1482cdbf9_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzU0OTc1NTgxNTExNDg_582931f1-d2b5-49af-9be5-7f5c76fd0587">69</ix:nonFraction> million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. At March&#160;31, 2021, the balance of goodwill for the reporting units in Europe was approximately <ix:nonFraction unitRef="usd" contextRef="iccdd71b92ffa4cb2b159c9a557fb6ba8_I20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:Goodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzE5NzkxMjA5MzE1MTgz_1903f39b-0ebd-4af8-a887-6da3f59d7b13">nil</ix:nonFraction> and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment testing performed in 2020 did not indicate any material impairment of goodwill.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><ix:continuation id="icf151f0e395044878ae2f6ad4011e9fa" continuedAt="i0ad04f3b722346eb91259119cba3edac"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment testing performed in 2019 resulted in the following impairment charges:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except rates)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarter Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reporting Unit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Terminal Growth Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill Impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630" decimals="3" name="mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzItNi0xLTEtMA_a1e9f54a-1fd1-4993-957e-5522a505f017">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630" decimals="4" name="mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzItOC0xLTEtMA_7441f84a-b104-418b-b5c5-34238235e206">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzItMTAtMS0xLTA_3b95ee24-5826-4150-80eb-9f5b319ffd32">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630" decimals="3" name="mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzMtNi0xLTEtMA_c328de35-c0aa-4577-90e6-77580c4a8fdd">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630" decimals="4" name="mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzMtOC0xLTEtMA_bb0f05fa-24e8-401b-bc79-2ade963aa761">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzMtMTAtMS0xLTA_be2c560f-ece1-4e0f-8e4c-3c8153f0634d">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630" decimals="3" name="mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzQtNi0xLTEtMA_c0a121d4-fe6a-4516-a6a5-7c6d002c303a">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630" decimals="4" name="mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzQtOC0xLTEtMA_ddaf2317-383b-4f2a-ad69-e18337211550">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzQtMTAtMS0xLTA_b20829ef-3f14-4817-821b-c62a16155d7c">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331" decimals="3" name="mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzUtNi0xLTEtMA_37312ddf-81cb-4f47-af0d-4d5388eb7814">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331" decimals="4" name="mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzUtOC0xLTEtMA_95a5ec4b-0aa4-4428-9049-909c169e3092">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzUtMTAtMS0xLTA_53d6a104-edcb-4923-b984-5ec2e2ecadee">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331" decimals="3" name="mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzYtNi0xLTEtMA_e1d3a01e-6921-4763-819b-1b22ca343d35">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331" decimals="4" name="mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzYtOC0xLTEtMA_a86c1422-19f9-4a6c-8976-f893908d7d1c">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzYtMTAtMS0xLTA_0c38d211-cdd8-498c-b2b3-cfa5df04f8e4">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzctMTAtMS0xLTA_63ab2625-2196-4d49-a0e5-c87385d2fd1b">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">As described above, the Company implemented its new segment reporting structure in the second quarter of 2021 and its European Pharmaceutical Solutions segment and its Rexall Health business in Canada became part of the International segment. Amounts included herein were previously included within the former European Pharmaceutical Solutions segment.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Represents pre-tax and after-tax amounts, except for an aggregate $<ix:nonFraction unitRef="usd" contextRef="i1f79d90a93144c60981f623c356fc6bf_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="mck:GoodwillImpairmentLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzMyMTI_d64be552-272c-438c-821d-69957516a758">20</ix:nonFraction> million of tax charges related to the March 2019 Retail Pharmacy impairment. Total goodwill impairment for 2019 also included $<ix:nonFraction unitRef="usd" contextRef="ia1bdeaded28d4c20b8bc6c14bf14a03b_D20181001-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzMzMzM_b83088f8-e20c-4ba2-8f52-f29a3111772c">21</ix:nonFraction> million related to the Company&#8217;s Rexall Health business, within the International segment, recorded in the third quarter of 2019.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Prior to implementing its new segment reporting structure in the first quarter of 2019, the Company&#8217;s European operations were considered a single reporting unit. Following the change in reportable segments, its European Pharmaceutical Solutions segment was divided into <ix:nonFraction unitRef="reportingunit" contextRef="i51bc045598984a19b5941cc09fe4a679_D20180401-20180630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzM3MDc_a2fb3b60-acfa-4041-aa72-fb5a5dea9d70">two</ix:nonFraction> distinct reporting units, Retail Pharmacy (&#8220;RP&#8221;), formerly Consumer Solutions, and Pharmaceutical Distribution (&#8220;PD&#8221;), formerly Pharmacy Solutions, for the purposes of goodwill impairment testing. This change required performance of a goodwill impairment test for these <ix:nonFraction unitRef="reportingunit" contextRef="i51bc045598984a19b5941cc09fe4a679_D20180401-20180630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzM5ODA_a2fb3b60-acfa-4041-aa72-fb5a5dea9d70">two</ix:nonFraction> new reporting units which resulted in a goodwill impairment charge as PD&#8217;s estimated fair value was lower than its reassigned carrying value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Both RP and PD projected a decline in the estimated future cash flows primarily triggered by U.K. government actions which were announced on June 29, 2018. An interim goodwill impairment test for these reporting units identified that their carrying values exceeded their estimated fair value and resulted in an impairment charge.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="id4c6255ba8c74d52864fb2e15f6a568d"><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><ix:continuation id="i0ad04f3b722346eb91259119cba3edac"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">As a result of the annual goodwill impairment test, the carrying values of the PD and RP reporting units exceeded their estimated fair value which required the Company to record impairment charges for the reporting units. These additional impairments were primarily due to declines in the reporting units&#8217; estimated future cash flows and the selection of higher discount rates. The declines in estimated future cash flows were primarily attributed to additional government reimbursement reductions and competitive pressures within the U.K. The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate. As of March&#160;31, 2019 the entire remaining goodwill balances of both reporting units were impaired.</span></ix:continuation></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; for more information on these nonrecurring fair value measurements. As of March&#160;31, 2021 and 2020, accumulated goodwill impairment losses in the Company&#8217;s International segment were $<ix:nonFraction unitRef="usd" contextRef="ie5a85046f59343e3874040608ed73655_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzczODQ_a6a51858-617b-4480-8fc7-308e6ab30675">3.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i30c8074ac9194cc5b11720dc788c0285_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc1MTc_a2027d90-c80b-46d5-be07-a1a0fcfb7aaf">3.5</ix:nonFraction> billion, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzgwODA_b98c2fed-9328-4471-810f-c5455e1ebd34" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:22.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i525585ece4e54dc0a604cd4df25d2040_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMS0xLTEtMA_5dd47be1-2f67-467c-a7b1-2319ab481f07">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73673afe5e746dd9e39e057c20d1cf6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMy0xLTEtMA_d401f790-b6dd-48d5-8f01-7d1682eeaed6">3,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if73673afe5e746dd9e39e057c20d1cf6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItNS0xLTEtMA_a4d00b7e-5198-4aa1-95a4-b5f828124967">2,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73673afe5e746dd9e39e057c20d1cf6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItNy0xLTEtMA_64edf77c-8c3f-497b-b944-bc19fd55fc42">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7700e033044992bf7e96f6acc26b3f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItOS0xLTEtMA_83e6deab-df0d-4725-a269-a43e87ef4fd8">3,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c7700e033044992bf7e96f6acc26b3f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMTEtMS0xLTA_2776f1be-3552-412a-8f59-0e19073101e5">1,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7700e033044992bf7e96f6acc26b3f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMTMtMS0xLTA_3c767803-9391-4361-acfb-d4ef37d558b0">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i186279a7a33f4fcfa37e6fef3fe64356_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMS0xLTEtMA_cabf6ccf-5747-4c36-8589-a6f9e3523541">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c8579ef483457a80d6870cfb506627_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMy0xLTEtMA_62b2e84a-3a18-4189-9bb9-f0f7439afbde">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35c8579ef483457a80d6870cfb506627_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtNS0xLTEtMA_825b8674-82d6-47c4-a0c5-bd819d753b9e">513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c8579ef483457a80d6870cfb506627_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtNy0xLTEtMA_79fa5b53-567d-4c05-ae95-8850bfd82292">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c566e2cc944ab4adc2b416c6c7c147_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtOS0xLTEtMA_30a8d376-87d6-40a2-b9b3-d66f942a26d7">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77c566e2cc944ab4adc2b416c6c7c147_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMTEtMS0xLTA_b347122c-6a0e-4d19-aff5-dbea87e0f68b">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c566e2cc944ab4adc2b416c6c7c147_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMTMtMS0xLTA_2d15524c-39c2-489f-9f7a-8a3ab09f2a92">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f4ff464ee184805b122b85d506ac0dd_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMS0xLTEtMA_8a798667-6d96-421b-8895-80d78f6dc965">23</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42e75c31e164d77af6f02af0d548d0d_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMy0xLTEtMA_b7eafc87-81dd-4e70-a8f1-e27622942abc">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if42e75c31e164d77af6f02af0d548d0d_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtNS0xLTEtMA_a65a0e2e-af11-4ea9-a472-cc4fbb619981">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42e75c31e164d77af6f02af0d548d0d_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtNy0xLTEtMA_496fa0de-cf99-4e0b-bd13-874697ba71ae">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea9dc7de4704cbcb84065259f650ed8_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtOS0xLTEtMA_b2473c4a-261f-4633-b351-fdc16f5e523b">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea9dc7de4704cbcb84065259f650ed8_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMTEtMS0xLTA_8506f242-4da1-47b7-b5fb-ba5875939555">232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea9dc7de4704cbcb84065259f650ed8_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMTMtMS0xLTA_28a0ba50-d502-493d-abb2-50bb0b5dfee6">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07691837bf0a422d9cfd06b65bbb66dc_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMS0xLTEtMA_cb46c624-c087-476f-aa96-434ae379e7c2">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMy0xLTEtMA_1175d30c-bb57-4e4b-8b65-ef6e716a41be">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtNS0xLTEtMA_0a02bff6-0b98-42c5-bb18-ea51cfbe8371">394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtNy0xLTEtMA_3ff7f140-55ae-41a9-a065-65efc9de87c2">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54e2d3096fe4a5bb88683649ed1f110_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtOS0xLTEtMA_77e5f920-0374-4ee0-9bb9-47da4367a668">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if54e2d3096fe4a5bb88683649ed1f110_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMTEtMS0xLTA_30cbf238-27b9-4da9-979b-7f37377637f2">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54e2d3096fe4a5bb88683649ed1f110_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMTMtMS0xLTA_6817a536-38bd-45e0-bbff-160aa54ef1b5">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b90045a4160435fb93b6eb170a34cff_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMS0xLTEtMA_ad65c191-223d-4fc8-a09e-b523a5fb8ca8">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad5179cf12841eb8fdb5f299a912be3_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMy0xLTEtMA_50a51cb0-febf-4838-86a2-84df08f3c369">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idad5179cf12841eb8fdb5f299a912be3_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtNS0xLTEtMA_3c8bd62a-2f12-4a5b-abd4-5e56242f17cd">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad5179cf12841eb8fdb5f299a912be3_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtNy0xLTEtMA_43dbc263-e3a3-41ae-b845-4aef07aa69da">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463096ed8566457a89faf1810193937b_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtOS0xLTEtMA_c7aae583-c3a8-4fa8-bed7-54c374cb7304">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i463096ed8566457a89faf1810193937b_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMTEtMS0xLTA_4df51409-df8f-4735-94ff-4641fd521f97">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463096ed8566457a89faf1810193937b_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMTMtMS0xLTA_4d992208-c507-487f-8965-3b4c4a262e7c">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i37afd48eccae41908ebb82b9e0f372ee_D20200401-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMS0xLTEtMA_8993fb8a-59df-4efb-b788-a108aaa630fb">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807ddd84576b420db9656e79fe28a804_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMy0xLTEtMA_0d973122-8b5c-47d7-b4c3-27da3ccdfd3a">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i807ddd84576b420db9656e79fe28a804_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctNS0xLTEtMA_c8d9641e-0b0b-4eda-ae79-ebc02ccbcad6">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807ddd84576b420db9656e79fe28a804_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctNy0xLTEtMA_86ca728a-35a7-400b-993b-42a649314969">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366c1509c4ae4991b52b1307f982e915_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctOS0xLTEtMA_cf28e589-7d57-47c1-96da-043190f1d6a2">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i366c1509c4ae4991b52b1307f982e915_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMTEtMS0xLTA_121adf68-ac72-414e-ba53-4eccd8501ce1">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366c1509c4ae4991b52b1307f982e915_I20200331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMTMtMS0xLTA_875f0fa8-e1c3-42fa-b383-7ae44870e9d7">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtMy0xLTEtMA_b9672d90-569f-4b33-b873-81b645d37528">6,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtNS0xLTEtMA_80921061-d5fb-4fcb-9f03-ba6e0cd3100b">3,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtNy0xLTEtMA_76dcdeaf-74a8-4fe0-909a-83dc6e28d060">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtOS0xLTEtMA_0edf0951-1985-4b60-83af-a50e0a2c5016">6,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtMTEtMS0xLTA_b09d1826-6ace-41c8-8b2d-36c4973fde15">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtMTMtMS0xLTA_ee272282-c7a7-4646-8b7f-9828ba01c96a">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc3MTk_55b48a43-bc26-47cc-9068-061143dc42e0">422</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc3MjM_1a7e4771-9aef-420e-b472-92a05a805b04">462</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc3MzA_8b33a8bc-cd54-4ef7-b1cc-4af2e586ada0">485</ix:nonFraction> million for 2021, 2020, and 2019, respectively. Estimated annual amortization expense of intangible assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4MjY_882afb3d-7c0d-4f65-a833-683893f344c7">370</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4MzA_b6d8166b-7ea9-4628-9dc3-734f7c57ffb0">270</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4MzQ_3de38f63-70d4-4c35-bfb5-f1db3001e811">259</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4Mzg_b665c79b-d667-4720-a980-1d844f0df4db">253</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4NDU_67db8aab-7ab9-477b-8fed-b50565720774">220</ix:nonFraction> million for 2022 through 2026, and $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4NzE_78e276d9-07a4-456a-81d0-db45cfb1eed0">1.5</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of March&#160;31,&#160;2021 and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; for more information on intangible asset impairment charges recorded in 2021, 2020, and 2019.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_178"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU4MjM_2b570f9e-8e3f-4318-9e70-fcc492caa323" continuedAt="iaab9bf6a4a1d4c6e9fef628c078b5b76" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="iaab9bf6a4a1d4c6e9fef628c078b5b76" continuedAt="i30176c7c01254a439d9edf397f907247"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU4Mjk_1bf7576d-d959-4430-bca9-1532e3f458d2" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a0dc323a371466e8a0168d08ca2e5f0_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjkxMjQyN2Q4ZTQyNzQyOTQ5ZjA1ZGEzZDhlMDRmYjEzXzE2NDkyNjc0NDE3MDY_48ea5f11-ecdb-405d-a61e-69860f7d9bcc">3.65</ix:nonFraction>% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0dc323a371466e8a0168d08ca2e5f0_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzMtMS0xLTEtMA_52cfe527-2f1e-48cb-a8fc-1c0da206266a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51455de7ffa1400baa450520b0823664_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzMtMy0xLTEtMA_e8e73d76-66de-4e20-962c-35bd1b371c64">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8cd624dd46b47528454592cac989b47_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmFiOGFjZTM0MjRlNDQ2Yjk5MmU4ZTk3M2Y3YmUxYjg0XzE2NDkyNjc0NDE3MDI_f1df80ee-0d1c-4105-8a0e-cae096e19bcf">4.75</ix:nonFraction>% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8cd624dd46b47528454592cac989b47_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzQtMS0xLTEtMA_85ee6805-9c75-472d-9f4e-c8f93e01a520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718d836dece1446592aaaa01bd324fa7_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzQtMy0xLTEtMA_f513c230-ef3d-4d5d-8344-b01219d2e94a">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRiZTMyYzRjMWEyYjQ2ZWFhMWU1NmM4MDBiZDkzZjMwXzE2NDkyNjc0NDE3MDY_21df8db8-daa0-4c48-8632-43c1d48ce90e">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzUtMS0xLTEtMA_9e48d14c-9114-4aae-9078-6c5ffc2304cd">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0b9a87ad6e4141a43b6aebf1030aae_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzUtMy0xLTEtMA_0f860c34-eafe-4557-ad45-dcd4766b7ed1">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie61256ac66bc4a89bf0d0e09ae475b1a_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzYtMC0xLTEtMC90ZXh0cmVnaW9uOjRkNjE3NTRkMjYwYjQwMTM4NjBkZjhjMDhiOWU2M2NmXzE2NDkyNjc0NDE3MDM_34da9302-6c0b-4bde-9db3-a74a95ee3a3d">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie61256ac66bc4a89bf0d0e09ae475b1a_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzYtMS0xLTEtMA_0491d79f-6a69-4bd4-803d-828585ecdbe7">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i587960ff5f064537a59834dc9b5fbc36_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzYtMy0xLTEtMA_a901a855-19a9-4773-97c3-2b19fdfbb0c4">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c1ce0a35b1b4a30af455e59d15c6150_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzctMC0xLTEtMC90ZXh0cmVnaW9uOjdlZTcwYjVjZjBhMTQ5ZmJhYzhkNmFkMDVmYWQ4NTZjXzE2NDkyNjc0NDE3MDM_cc2fc4d0-673f-4569-b724-8208e66ce075">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c1ce0a35b1b4a30af455e59d15c6150_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzctMS0xLTEtMA_b220bcbc-6f20-4658-9d15-fcea4d1431fa">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea3a78f9a71459f928d5d15a5f30881_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzctMy0xLTEtMA_6a0e95a8-abfa-4b98-b739-74fb6fb8bcd0">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9a0f7b532354353862735fa61a7edbe_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMC0xLTEtMTAyNDIvdGV4dHJlZ2lvbjpjYTgyMWZmM2RhYWU0NjYxOTJjMmMwYzNkODgwZGZmN18xNjQ5MjY3NDQxNjk0_e5e60ef0-649b-493e-9967-f18ad2badada">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9a0f7b532354353862735fa61a7edbe_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMS0xLTEtMTAyNzU_28910094-7d72-4bff-ab60-58bb8fe4e76a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ba3a1f603304391b936ce6bcb7a6a27_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMy0xLTEtMTAyNzU_1123be7b-4544-4ebd-add4-6b742d30534b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3407317f0374140aae578c6d0eb0b07_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmI4MDgwMDE4MWM3YTRmMzFhMjI5NjkxY2Y2MzllN2ZhXzE2NDkyNjc0NDE3MDc_c59d8d25-57c9-48f1-bbce-14fcc7291521">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3407317f0374140aae578c6d0eb0b07_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMS0xLTEtMA_b9804934-69ec-4034-860d-326acd4f314e">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6926f446a23d49a8b4e4110e67b160cb_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMy0xLTEtMA_c8bd518c-5540-44ff-baa3-b24a6bf9bf51">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i133b5953d54f4f1bb1cc4a7cb16391a1_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFkY2RlM2FjOTM3MDRmYTI4ZDg2Nzc1ZDM1ZGJiNGRkXzE2NDkyNjc0NDE3MDY_46a5667f-4f88-48e3-a74f-b175cee3038e">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133b5953d54f4f1bb1cc4a7cb16391a1_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzktMS0xLTEtMA_1ecfb657-79a8-43c9-9eaf-54e7ec88b3c1">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc40734152a45aeabea7c982026d0fa_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzktMy0xLTEtMA_e0c59a48-a852-49e1-8727-edb8657a055b">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64567396009c44829d2a1fd050d1a1b7_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo2NDJiZWJmMTFiMjM0YWI4OTFkYjhkNzlkNjZkMDNhNl8xNjQ5MjY3NDQxNzAx_259423cb-3cdc-4a74-9198-1099e53399ac">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64567396009c44829d2a1fd050d1a1b7_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEwLTEtMS0xLTA_c56af952-983d-480d-93e3-de376fe36eff">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84ee20fa4f8433396754e0437027fb6_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEwLTMtMS0xLTA_edbc0429-f0b9-4903-b655-3033d85d77e9">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifadf20024dc74f81b440ab0ab2eb2913_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo2YWRiZGRhNzZhNGU0MjhiYmU5ZjMyNzU4NTVjYzhlZF8xNjQ5MjY3NDQxNzAy_fc2e2175-37a4-4773-bcf2-b590a2fc7a05">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifadf20024dc74f81b440ab0ab2eb2913_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzExLTEtMS0xLTA_d5b2b843-fdd7-460f-bc5b-99af06c9acdd">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id423c4b7c4a945db8071e337c9c82ed1_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzExLTMtMS0xLTA_a184dde3-a914-491f-8efd-992499eb1262">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bc1a0012fd84f509095b06c9f66d6bb_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZDk2ZGRiNzViYzU0NDI1YTU1MGU4MjkzMTIyZDdmNl8xNjQ5MjY3NDQxNzAz_410d794c-3088-414c-8d52-6d2db328695b">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc1a0012fd84f509095b06c9f66d6bb_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEyLTEtMS0xLTA_4dd14967-9017-41c2-a61f-8365fa95068b">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79cf5d2e990240698629bdc50a7c0b88_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEyLTMtMS0xLTA_7d01890c-b545-43f4-bfd8-e5d5cd658a75">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad9c1207b15f466a861980e7222a1537_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjphOGU1MjgzZTkyNzc0OGQ2OGQzNmQyNWEzN2RiZDMzMl8xNjQ5MjY3NDQxNzA5_ab95225b-26ed-427a-b3ed-5616a21d4164">0.63</ix:nonFraction>% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad9c1207b15f466a861980e7222a1537_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE1LTEtMS0xLTA_d8b916cf-36eb-422c-a09b-99fb9d6491be">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee10f2cf891e40f2a38c0aced30d76ea_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE1LTMtMS0xLTA_e2989dac-a7f7-4d66-829e-504ee541e1e9">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i392b65805f5f4e48a0907f99ecf50ee2_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo4OWNmZjJjYzViNmY0ZDMwOThhMmEyMzlhMzZlNmFmY18xNjQ5MjY3NDQxNzEx_9599a7e9-05c7-42be-bd6b-75aefcde476d">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i392b65805f5f4e48a0907f99ecf50ee2_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE2LTEtMS0xLTA_b3a21c6f-05c8-4855-9619-978922e84c42">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5014024a7cf34617ac4cd1a096cecac1_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE2LTMtMS0xLTA_eacc809b-159e-4dec-a705-34889711f315">659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ee0c0121e554ad5b84e809395a86c66_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjplYmEwZDViYjdkZjM0ZmYyODE0ZjE0YzNhOTIyYTJjY18xNjQ5MjY3NDQxNzE0_ad0a588f-e4cd-4bb9-8879-384ff395b4c6">1.63</ix:nonFraction>% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee0c0121e554ad5b84e809395a86c66_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE3LTEtMS0xLTA_bc3d6361-a625-428c-b374-48e50d50f598">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54751c16577f40f1adff8f7e2bff79f8_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE3LTMtMS0xLTA_2f2db761-dc5e-4bce-ad5a-4fcf593d43aa">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b5b1fc662a44e0791f2dba244a47860_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo0YjAzNzFmN2QzYzg0MmM1YTJjZTNjYmVmNjZkOThkOF8xNjQ5MjY3NDQxNzE5_8bc2915d-a79f-4d34-8bf7-6516fffec577">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b5b1fc662a44e0791f2dba244a47860_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE4LTEtMS0xLTA_c8e6081d-51fc-46ab-9f97-35406f128e91">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a099094e354b889a5a5c3a182329bc_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE4LTMtMS0xLTA_cd3ba703-fbe3-4a0d-81f7-362e88026755">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2976b57beaaf4c6b8a89e64c910a5a7e_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIwLTEtMS0xLTA_d733b9fb-f29b-4dd4-8af3-90ade57f1087">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d39d3584f824d5dbcfadf658383ee87_I20200331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIwLTMtMS0xLTA_604ab7dc-cfbc-4d3c-b1bf-30767ba75e26">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIxLTEtMS0xLTA_aec9e056-0b8f-4c65-8a94-c87294e76c02">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIxLTMtMS0xLTA_c3fef0ba-6316-49ed-8382-acb30308ccb7">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIyLTEtMS0xLTA_c014d11b-e54b-4bde-be53-a7c61037ce1a">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIyLTMtMS0xLTA_5e60e191-295c-49db-b23b-db937c7ad27c">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIzLTEtMS0xLTA_6b765c04-7287-4888-a256-264405d89ce0">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIzLTMtMS0xLTA_8a7cd643-1150-4504-9a32-c37f2a8efb51">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March&#160;31, 2021 and 2020, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzQ2MA_132cf115-0f16-428c-95e8-774d1aadaebe">7.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzQ2Nw_79399694-b1f8-47e0-a262-608e086ac60b">7.4</ix:nonFraction> billion, respectively, of total debt was outstanding, of which $<ix:nonFraction unitRef="usd" contextRef="iba24a5eef2484a6dbc6addbb8b2b3743_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUxMA_74d5232c-75aa-4386-9bb0-ef650970fd58">742</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4aa607516b08415b8dce58c739355d62_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUxNw_ca232d73-123e-4b15-ab3c-9fb7476a41cf">1.1</ix:nonFraction> billion, respectively, was included in &#8220;Current portion of long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i2aada2c5a8f5413086253c28368973fe_I20201203" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDc5NTI_d8f72a7a-7da4-4859-a0fb-3921db13bd27">0.90</ix:nonFraction>% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i2aada2c5a8f5413086253c28368973fe_I20201203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDc5NTY_46760eb5-b0de-4c92-8f7e-908ae36a81c2">500</ix:nonFraction>&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="i1c1c7b3092c543bda3ed926c574d2405_D20201203-20201203" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDc5NjM_e9d2ccb3-c97b-42b9-807e-0281a1f58ae4">496</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2021, the Company retired its <ix:nonFraction unitRef="number" contextRef="i61675c05b34a420fb0aef206c120e3cc_I20201130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzIxOTkwMjMyNzQ2MzM_041d510c-ffb5-40ac-9db2-1334a3b75916">3.65</ix:nonFraction>% $<ix:nonFraction unitRef="usd" contextRef="i61675c05b34a420fb0aef206c120e3cc_I20201130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDk1NDQ_71fcc49d-4cfe-4b3f-a8eb-46c77e6753bd">700</ix:nonFraction>&#160;million total principal of notes due on November 30, 2020 upon maturity. On December 1, 2020, the Company redeemed its <ix:nonFraction unitRef="number" contextRef="i933936a7522f4f269eb80826407de7b6_I20201201" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDk1NTQ_bd656ce9-2d0f-44bd-9251-7a9af65b8935">4.75</ix:nonFraction>% $<ix:nonFraction unitRef="usd" contextRef="i933936a7522f4f269eb80826407de7b6_I20201201" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDk1NTk_2c3e2665-8e98-4c4b-9900-673d097d439d">323</ix:nonFraction>&#160;million total principal of notes due on March 1, 2021 prior to maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above. In 2020, the Company repaid at maturity its &#8364;<ix:nonFraction unitRef="eur" contextRef="ifb20c63e640a48478f01df43a5ecbce5_D20190401-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NjE_10625be4-33c3-4b86-8eca-32898857216b">250</ix:nonFraction> million Floating Rate Euro Notes due February 12, 2020. In 2019, the Company repaid at maturity its $<ix:nonFraction unitRef="usd" contextRef="i901c6c235d094bfeab2e2891bf22868d_D20190315-20190315" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE3NTY_e754beb6-5a18-425b-9fad-d7707f260f89">1.1</ix:nonFraction> billion <ix:nonFraction unitRef="number" contextRef="ia7191c4e470a4de89c4f6e0fc96b493c_I20190315" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE3NTk_8667c955-ab3a-4d7e-af5e-bcbe93ecf984">2.28</ix:nonFraction>% notes due March 15, 2019.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i30176c7c01254a439d9edf397f907247"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each note, which constitutes a &#8220;Series&#8221;, is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed&#160;by materially similar indentures and officers&#8217; certificates. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc. and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase that Series from the holders at a price equal to <ix:nonFraction unitRef="number" contextRef="ide437db67fec4724871353bf3fed014f_D20200401-20210331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzI3ODA_0086f906-f02a-4ce9-8aea-55fe72f332cb">101</ix:nonFraction>%&#160;of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments of long-term debt are $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0MTc_5766e210-f675-4c7d-9f49-d66f0f3b5df6">742</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0Mjc_16d35105-cbc0-4175-bf49-1a085204d64c">838</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0Mzc_68b44762-4094-4fcb-921f-041566703553">1.1</ix:nonFraction> billion in 2024, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0NDc_217c974d-1a0f-4dc6-a39e-94cac0a8d15f">34</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0NTc_2d838c09-9a1a-4af1-b14f-ce02b303d7a8">1.2</ix:nonFraction> billion in 2026, and $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0NzA_6cbda89f-70c9-4eda-9d95-5e1004542d07">3.2</ix:nonFraction> billion thereafter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company entered into a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="i3a0059e39d8c4440982d888fd5a4c442_I20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM1ODM_639e206e-0deb-42c8-a9af-e38e044f4d1e">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="if2d3ff5a5a4b4484a95420609dd9e074_D20190901-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE5NzkxMjA5MzEyNzkw_5fda9d41-5978-42bb-b48e-c98138e5781e">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i16d322c911e24b2f90df8075e4ef4d6c_I20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM2NzE_993865bc-4309-4ad5-9b09-ef625bd367fd">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="ie473d5c5a4eb40bbbc2a53be66040614_D20200401-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM4MjI_8197e1b7-7822-4f33-bcde-31b6468b8320">no</ix:nonFraction>&#160;borrowings during 2021 and 2020 and <ix:nonFraction unitRef="usd" contextRef="i3fdddf6ceeed47308e55c0b30b5a067c_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM4NTA_6aa05816-3673-4d70-aa48-d46178981f2c">no</ix:nonFraction> amounts outstanding as of March&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At March&#160;31, 2021, the Company was in compliance with all covenants. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the $<ix:nonFraction unitRef="usd" contextRef="iabf91ccb11c7473fb82ceedddfc105f2_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NTk1MDY_24b93f16-f24f-434d-8f59-6edf852a4d16">3.5</ix:nonFraction> billion <ix:nonNumeric contextRef="i9864559fa95841a4af3fb0942788d567_D20190901-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE5NzkxMjA5MzE5MDQw_63cef3a9-ec66-4cd0-919b-bdc763b61bb0">five-year</ix:nonNumeric> senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019 and had <ix:nonFraction unitRef="usd" contextRef="i21fdbc4f6fd449c485c175357858b379_D20190401-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NTk3NTY_c3b0feab-8b23-4d26-b7fa-a78b4d2f3891">no</ix:nonFraction> borrowings during the six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="i4d0a48f582bd40e3b1f786f6699f0b4a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUyNDY_969ed05a-8d59-4936-b888-c1d3a10b2580">8</ix:nonFraction> million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="i4d0a48f582bd40e3b1f786f6699f0b4a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUyNzg_bebff933-9106-4566-b12f-d1bc65c38fce">152</ix:nonFraction> million as of March&#160;31, 2021. Borrowings and repayments were not material in 2021 and 2020 and amounts outstanding under these credit lines were not material as of March&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="ia279c8899da54bf6ae860b25947dc8d0_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU2MzI_0b92062e-dc9b-46a7-8f29-593086d98232">4.0</ix:nonFraction> billion in outstanding commercial paper notes. During 2021 and 2020, it borrowed $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MDQ_6ff8ed31-4f78-4b13-830d-294767065aef">6.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MTE_633d74df-6622-4cb3-acb6-a12cb59b6ba1">21.4</ix:nonFraction> billion, respectively, and repaid $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MjU_88e8ef66-44b6-4087-a0e6-79aa686360c2">6.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MzI_e4d450df-a5e8-4e8a-aadc-9f654d9839da">21.4</ix:nonFraction> billion, respectively, under the program. At March&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="usd" contextRef="i39ac5a2189034cdfb61933a472118b09_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3Nzk_80f4d3c6-8d9e-4695-ad22-11cd86debdff"><ix:nonFraction unitRef="usd" contextRef="ia279c8899da54bf6ae860b25947dc8d0_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3Nzk_996d65fc-cb7f-4be6-875f-41bda6444243">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_184"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzI5Mzg_933fa1b6-b91d-4964-a63d-c5d70eb58725" continuedAt="if11c8f3d85354eab95c71fa820154fbf" escape="true">Variable Interest Entities </ix:nonNumeric></span></div><ix:continuation id="if11c8f3d85354eab95c71fa820154fbf"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs, if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#8217;s Consolidated Statements of Operations and Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $<ix:nonFraction unitRef="usd" contextRef="ieadecf82b6ad4545a68ef16b493ea917_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1MDI_9fb7c15f-dd30-4da8-9a05-10710c29e7ea">662</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieadecf82b6ad4545a68ef16b493ea917_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1MDk_9852b5d5-90a1-415a-a0c8-b259bd1531ea">74</ix:nonFraction> million, respectively, at March&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i4cd94c1fc48d45739e8b1372c7918e91_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1MjI_1101068f-96c1-4062-b3f5-4c368d3d3719">695</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4cd94c1fc48d45739e8b1372c7918e91_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1Mjk_8b76de4e-a49f-4a5b-9f59-197214660b59">82</ix:nonFraction> million, respectively, at March&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual or other relationships with the VIEs. The Company&#8217;s most significant relationships are with oncology and other specialty practices. Under these practice arrangements, it generally owns or leases all of the real estate and equipment used by the affiliated practices and manages the practices&#8217; administrative functions. It also has relationships with certain pharmacies in Europe with whom it may provide financing, have equity ownership, and/or a supply agreement whereby it supplies the vast majority of the pharmacies&#8217; purchases. The Company&#8217;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzI1NzI_37638abf-4724-437c-a009-a9e32d13c116">1.5</ix:nonFraction> billion at March&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzI1OTU_9e717784-1621-463c-aa55-6559565db19f">1.4</ix:nonFraction> billion at March&#160;31, 2020, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 18, &#8220;Financial Guarantees and Warranties.&#8221; The Company believes there is no material loss exposure on these assets or from these relationships.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_190"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDc2_100c58e7-cef1-4d0c-992e-df809b1a7004" continuedAt="i109b507af24e4f24910dcce5c2ccf1a5" escape="true">Pension Benefits </ix:nonNumeric></span></div><ix:continuation id="i109b507af24e4f24910dcce5c2ccf1a5" continuedAt="ieaa86ec453fe4828a1aa9e4b2c687fff"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Pension Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an unfunded nonqualified supplemental defined benefit plan for certain U.S. executives, as well as benefit pension plans for eligible employees outside the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately <ix:nonFraction unitRef="participant" contextRef="i4e9be4f901904d0db4fe7ad9ae72362b_D20190601-20190630" decimals="-2" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanSettlementPlanParticipants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzExOTc_c53b7d93-e68e-4941-9cd7-e76f135c30bd">1,300</ix:nonFraction> participants elected to receive the settlement, and lump sum payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i4e9be4f901904d0db4fe7ad9ae72362b_D20190601-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEyODc_fe3e4a69-ee99-47b6-8d77-62efbc851eb0">49</ix:nonFraction> million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i4a2621176fea4a8888c6313b92cf10ad_D20190401-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE0NjI_2fb1a781-c7b6-4b54-86a7-9e598c7e09cd">17</ix:nonFraction> million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $<ix:nonFraction unitRef="usd" contextRef="ief5ba1ae721343ac88b4d010889406e8_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTk_a848ce68-da9f-460f-858b-9a21a14174c0">280</ix:nonFraction> million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future pension benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $<ix:nonFraction unitRef="usd" contextRef="ief5ba1ae721343ac88b4d010889406e8_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxMTM_705a6402-b251-42c8-9adc-b993dbe2790c">105</ix:nonFraction> million was recorded during the second quarter of 2020. Settlement charges were included within &#8220;Other income, net,&#8221; in the Consolidated Statements of Operations for the year ended March 31, 2020. As of March 31, 2020, this defined benefit pension plan had an accumulated comprehensive loss of approximately <ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE5NzkxMjA5MzM2NjQy_9245818b-09fb-44bd-8a3f-d59732ecd200">nil</ix:nonFraction>.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ieaa86ec453fe4828a1aa9e4b2c687fff" continuedAt="i90f4bff044f4486b90be2a60d0888e88"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, a cash payment of $<ix:nonFraction unitRef="usd" contextRef="icb9627a61887468a9b6718ee20810f41_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI0NDc_4355ad03-70b2-481b-8b30-a068ca187515">114</ix:nonFraction> million was made to settle a participant&#8217;s liability from the executive benefit retirement plan. As a result, a majority of the remaining recorded unrecognized losses in accumulated other comprehensive loss for this Plan were recognized as expense and a settlement charge of approximately $<ix:nonFraction unitRef="usd" contextRef="icb9627a61887468a9b6718ee20810f41_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI3Mzk_937172d6-7ccf-4b3f-9a73-5261500da97c">11</ix:nonFraction> million was recorded in &#8220;Other income, net&#8221;, in the Consolidated Statements of Operations. As of March 31, 2020 and 2019, this plan had an accumulated comprehensive loss of approximately $<ix:nonFraction unitRef="usd" contextRef="i9eb73386cbae4db0b0d708fc5a5494fd_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI5NTA_b81fb677-48d5-496c-8df5-fd5bcd1076e5">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id7d45b209bd246fa9f5fb6ed35063c90_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI5NTc_0bd717a7-96b2-4191-85bb-c28ce31cf9cc">12</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway, the United Kingdom, Germany, and Canada. Benefits for these plans are based primarily on each employee&#8217;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#8220;SPK&#8221;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law. In the U.K., the Company has subsidiaries that participate in a joint pension plan. The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe&#8217;s Management Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="ic3d13dff04ec4f91a0b1fe60fc9e3c43_I20201231" decimals="-6" format="ixt:numdotdecimal" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyOTIyNjQ_2813d134-70b8-432c-b60e-91e1dfee408e">187</ix:nonFraction>&#160;million of pension liabilities included in liabilities held for sale and $<ix:nonFraction unitRef="usd" contextRef="i3877ec01b10348049e885c6fbd8c2093_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyNzY5MzI_533f9637-9c71-4e0f-aab5-e4a2e108e13c">33</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit plan assets and obligations are measured as of the Company&#8217;s fiscal year-end. <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTQw_94f9658c-fce2-4386-8a80-21782ea126a5" continuedAt="i9b5bb465159c41db96589ede00afe37f" escape="true">The net periodic expense for the Company&#8217;s pension plans is as follows:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i9b5bb465159c41db96589ede00afe37f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtMS0xLTEtMA_3ed14b37-027a-45f9-85ce-5db6d5a65254">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtMy0xLTEtMA_37dd5345-f4f2-4072-930d-3c48dbb3535e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtNS0xLTEtMA_a18c2f0b-2ba0-4300-a46c-9d710ae488d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtNy0xLTEtMA_5ad67877-94d9-4cd1-b372-a11592406d16">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtOS0xLTEtMA_9c006327-e9b4-443c-96a1-e0b7a0a61fdb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtMTEtMS0xLTA_e5a9308c-1dc0-47c3-80f2-1ff0650f2893">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtMS0xLTEtMA_ae599365-6162-44c7-bc55-04f778e7e641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtMy0xLTEtMA_635e2596-2e2d-4ec2-a460-2c22f165232b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtNS0xLTEtMA_d0050a72-9a23-405b-b73c-8715dae09114">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtNy0xLTEtMA_82bdbe91-89ce-427d-9768-44fbf6b532b2">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtOS0xLTEtMA_fe4c6d46-9484-416a-80c7-4a4a9a7475c7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtMTEtMS0xLTA_55d617fc-a1c0-4096-ba5c-983ef0958f27">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtMS0xLTEtMA_a45b2082-ccaf-4a99-83a9-6d34fda99260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtMy0xLTEtMA_1c8b1ef3-bf15-4ba2-98f1-a993773c9389">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtNS0xLTEtMA_b15682f0-61f4-495b-aeac-877de00967b4">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtNy0xLTEtMA_1f634ed6-b548-4db0-9e71-12fde1031f4d">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtOS0xLTEtMA_f131bd28-91fc-416a-94de-282882e959c7">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtMTEtMS0xLTA_0955eebc-1154-4735-b58d-379e65fe3958">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtMS0xLTEtMA_ba34f32f-5d72-4101-97eb-22d631938359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtMy0xLTEtMA_7f027b87-6ee3-480b-8c30-903952d3af97">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtNS0xLTEtMA_5f9f8e2c-b935-4db9-bbc5-88a8d24f6e33">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtNy0xLTEtMA_d616f6e0-6355-4865-a3b6-279281d3c847">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtOS0xLTEtMA_e56a7c8d-b091-4475-b6b8-6d6039145d46">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtMTEtMS0xLTA_9c69d005-83e8-4d1b-a005-db55fc2a3e04">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctMS0xLTEtMA_2434a1af-55d9-46a0-b07a-8fa7084ed21b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctMy0xLTEtMA_1b855ade-70d7-4a61-9a4e-bb45deb0bc7b">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctNS0xLTEtMA_baba3374-609f-4ad3-9a21-d970860b347c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctNy0xLTEtMA_f5d4b78a-d72b-4f6e-8ff5-ad17a813b4a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctOS0xLTEtMA_5e2bad70-ef90-4e32-a5f9-b614fa80adf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctMTEtMS0xLTA_9180468e-109b-4958-97f4-e4461f855cbb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtMS0xLTEtMA_040bc6e2-3028-40cd-8b05-47c4cedc2715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtMy0xLTEtMA_57feb9b9-159f-42fe-960c-33c0d5d98f60">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtNS0xLTEtMA_9adbd380-6c48-4448-87e7-232d5f5c4848">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtNy0xLTEtMA_495b6a1f-c1da-48ab-94c6-4af2bdcca93e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtOS0xLTEtMA_954ac25a-571e-446f-8130-b1acebefcb5e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtMTEtMS0xLTA_d014f428-de9a-44d2-9180-cea4fb7a973a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="INF" name="mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzQxODE_f88822b8-38fa-4f4b-87fb-244aa50e6557">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i90f4bff044f4486b90be2a60d0888e88" continuedAt="if602f3d8c5e340a68f6df75f29d5b33a"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTQx_0dbdd503-9352-45da-8289-c5ed991523be" continuedAt="i8b08a537993d494cabdc1286f4045e60" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans is as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtMS0xLTEtMA_ee1e2f1d-ce37-4d2e-9e61-604405f99a24">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad18cf43caca4fa9b52b9f44c52fa56a_I20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtMy0xLTEtMA_3cbe714f-7449-4717-ba38-5b4c562db200">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtNS0xLTEtMA_949dbcdd-175c-4a05-954a-eaf534cde0da">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352db6f20a74338aa9b3bada49da7c4_I20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtNy0xLTEtMA_616626ad-d42c-44f5-8b93-fd0eb0d5d34f">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtMS0xLTEtMA_77fdd58b-939b-485d-8d51-94c8f4f0c4dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtMy0xLTEtMA_f2d3f7ae-8d69-44b3-8ccb-e82d7586ab5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtNS0xLTEtMA_421761c2-b969-4de9-bc0f-de869648bed0">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtNy0xLTEtMA_290355f7-2707-4c96-8166-e06ab59b78e5">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtMS0xLTEtMA_ea648ff5-9461-41a2-9428-85c80b208119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtMy0xLTEtMA_7f002487-6b86-4719-8c0a-085b45a27c6f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtNS0xLTEtMA_dad6ee45-71da-46c7-a2cb-88cfe072d3b9">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtNy0xLTEtMA_ee54eba3-becd-4c6a-9e6b-1d0f389bd771">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctMS0xLTEtMA_d2ce6353-d39b-4b18-bc39-7323e0e1b3ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctMy0xLTEtMA_c4c84b6a-f26b-4a58-a7d4-7a09d54772ff">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctNS0xLTEtMA_26298699-7a40-429e-b064-8c3f5537e9f7">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctNy0xLTEtMA_c2acffbd-5ad6-4d5f-9fa3-f1c24b49d0e7">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtMS0xLTEtMA_0b28a194-6c81-4cbc-8a41-8ca7560e6514">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtMy0xLTEtMA_e099381e-acad-4744-a62f-0d4d0e3678e1">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtNS0xLTEtMA_100b5be1-abe1-44a1-9d6a-f6495e157ffb">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtNy0xLTEtMA_ecbbce55-45e9-4374-9fb3-720cf1dcb60f">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity Premium Transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktMS0xLTEtMA_1f856629-89d8-4700-892a-fab8c0561067">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktMy0xLTEtMA_d4a44f0f-52ec-41a1-83da-b706bf1cc90a">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktNS0xLTEtMA_c627d0ef-8797-445f-a396-1cf97b342581">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktNy0xLTEtMA_b9c92e36-5a0c-4e13-b6a3-db0e66194744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTEtMS0xLTA_8dede175-3992-49f4-b004-3e70426aed5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTMtMS0xLTA_3ee6625c-22a0-4fb0-bbe7-ef924bf04df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTUtMS0xLTA_8226ddd5-483d-439f-bbe7-ac4e8bdd6df1">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTctMS0xLTA_110f882d-8210-4f05-bec4-d75a947441c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTEtMS0xLTA_8d9fb4cc-c93e-4e41-8fce-8caf739bebca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTMtMS0xLTA_a4bd5c0d-c8ed-447c-afb8-6fd09f334e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTUtMS0xLTA_cc04dc7a-3349-413b-8f42-5867bff47887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTctMS0xLTA_7328d523-3a12-4080-b9c8-44d755e57119">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTEtMS0xLTA_a918e292-9cc3-4cba-b947-f7bd6722b8bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTMtMS0xLTA_730a37ed-295d-4b00-9f0c-c6d269c82cd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTUtMS0xLTA_2b5d2f13-edf7-4bc9-8d96-65773dab39a8">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTctMS0xLTA_cb67e9d6-177f-4b03-aa20-049c1397093c">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTEtMS0xLTA_c9393f0f-da38-4067-bef1-764d023e1e77">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTMtMS0xLTA_781cb22c-cef1-4198-b692-4fbf85caf562">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTUtMS0xLTA_d0274399-211d-4a78-b205-b4e32fc43c78">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTctMS0xLTA_bc9dcd09-1ae1-4952-9436-f99e3d88906a">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTEtMS0xLTA_6e93a16d-0524-4c46-94bb-ff5cf6e0967d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad18cf43caca4fa9b52b9f44c52fa56a_I20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTMtMS0xLTA_84ff4c69-c333-43b2-8baf-60b662d5f6ec">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTUtMS0xLTA_bb13f42e-5e17-4add-a9ec-e50fd4f366c1">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4352db6f20a74338aa9b3bada49da7c4_I20190331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTctMS0xLTA_ecd8bbcb-7f38-497b-b307-964574eba398">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTEtMS0xLTA_aa0f96f0-6762-4f71-9b53-0a567b3c8936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTMtMS0xLTA_82a62bfb-27c4-4d2c-9fd4-b994e0a12a95">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTUtMS0xLTA_9f70fbe4-9244-47f6-a045-96d47cf368e6">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTctMS0xLTA_22b632cf-9b01-44c5-9d10-b9116f14567b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTEtMS0xLTA_2c654b3c-c04d-4ace-b065-67eaf53feae7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTMtMS0xLTA_f2c6c6c6-e721-4187-ac94-9d99921de688">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTUtMS0xLTA_1874f5a0-bec2-418d-92d3-4e11a7652921">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTctMS0xLTA_09391f1f-72ea-47c6-82b3-a1f8d8dbe154">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTEtMS0xLTA_01b33c34-7d1c-455b-af11-ffa70cc68e5a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTMtMS0xLTA_5d6b804d-b957-4588-9870-7912678f7b1f">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTUtMS0xLTA_b18c7208-ce4c-4385-8d8a-3226122e2403">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTctMS0xLTA_1a99c1ae-5fb8-4d98-ab22-f4d679282cf7">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity Premium Transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTEtMS0xLTA_1a20fd14-f324-4094-8b2d-68eb86ff1174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTMtMS0xLTA_7bfefe53-4e75-43ef-bc5e-2aa96f959220">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTUtMS0xLTA_ff779524-f5a2-4594-a295-b014f84b67b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTctMS0xLTA_79b5d25d-364e-463a-bdd4-56df55fcffec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTEtMS0xLTA_9e22d3a0-aac3-49ad-8a13-390b981d52ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTMtMS0xLTA_09dafb0d-28ca-4e22-87ba-4185d058be53">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTUtMS0xLTA_1fe92d58-df3e-4bee-be98-e2ce9b75ac77">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTctMS0xLTA_95384820-371a-4089-a386-78fcf85b31d0">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTEtMS0xLTA_37bf5031-a443-481f-890f-ed3d4af68798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTMtMS0xLTA_b60e3b29-42c5-4248-9277-5bcfd8c5053c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTUtMS0xLTA_2df78aac-8b75-41f4-8152-c7e6fc0d4906">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTctMS0xLTA_b3d1467a-6a39-441f-9a56-dda17f9d75df">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTEtMS0xLTA_790f0b72-b10e-413b-874f-67756e0fdb1b">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTMtMS0xLTA_8ac96f82-f96a-476b-9ae9-8762abb464cd">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTUtMS0xLTA_044a9d75-536d-4078-92ee-ec411cad60b0">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTctMS0xLTA_f0c5b09a-adca-4cf4-a4c4-4d8aecd32a07">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTEtMS0xLTA_715578e3-e84a-4f59-85e0-ea570219d8a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTMtMS0xLTA_dcc9e9bc-0d5d-4267-83d3-53bf3f28a43a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTUtMS0xLTA_fc02d298-d76a-430f-a81e-302c7770fa13">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTctMS0xLTA_353d2f58-3d12-4489-b9d7-8333a13159c3">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTEtMS0xLTA_7416500b-cdee-42e4-b47a-8b185bc7eb81">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTMtMS0xLTA_ceb4c02d-e294-4f52-9dd6-1a11d6c90479">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTUtMS0xLTA_92233d2c-603c-4ee8-af16-df2add5fc65b">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTctMS0xLTA_d536adf0-a980-4a00-aeb2-db9e0c76d1bb">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTEtMS0xLTA_3fe6dabd-702a-4b9c-8a47-ce831434b56f">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTMtMS0xLTA_2d3c7a64-edb6-46c3-9fc3-c2f4d2e10587">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTUtMS0xLTA_ef4f268f-b9d3-4837-a19b-f97814bdce43">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTctMS0xLTA_090f1a43-57b2-4ca2-95b8-5377849520e6">189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTEtMS0xLTA_3bf9a2b0-61ac-481f-91bb-38f84f6d7fa1">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTMtMS0xLTA_e5ef1741-e038-460e-994f-a3ecb947b848">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTUtMS0xLTA_6c1f36f8-6ec8-45b5-9334-dba7c1a4aaf6">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTctMS0xLTA_e12bc774-2f28-4c53-aa5c-a0356c4ea22c">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i8b08a537993d494cabdc1286f4045e60" continuedAt="i912cfbd2a314421499313ec1e3dbb246">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i912cfbd2a314421499313ec1e3dbb246">The divestiture relates to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included within current liabilities and totaled $<ix:nonFraction unitRef="usd" contextRef="ie471c931528e4e2f9855c322fe699fec_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyOTIyMDE_6e40eee4-733d-4279-b919-6bf575139882">151</ix:nonFraction>&#160;million at March&#160;31, 2020.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial loss of $<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyNzkyOTI_26298699-7a40-429e-b064-8c3f5537e9f7">89</ix:nonFraction> million in 2021 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1MTI_1ec20be3-5f5d-408c-b631-80030e693bae">32</ix:nonFraction>&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased from <ix:nonFraction unitRef="number" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1Mzk_bdfe5976-2102-4a3c-9184-87fe99952245">2.03</ix:nonFraction>% as of March&#160;31, 2020 to <ix:nonFraction unitRef="number" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1NDY_deb2e032-1481-4d1d-ad39-d38cd4dc11de">1.89</ix:nonFraction>% as of March&#160;31, 2021. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1MjU_9786745b-f1eb-4784-a0c1-2fc649416a8e">57</ix:nonFraction>&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestiture in 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="if602f3d8c5e340a68f6df75f29d5b33a" continuedAt="i6ec6a3141006454e8359d43707c4aad4"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI0OTg_c2acffbd-5ad6-4d5f-9fa3-f1c24b49d0e7">36</ix:nonFraction> million in 2020 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODM0NDY_52399aaf-c17e-463a-8103-17fbc99e87ca">6</ix:nonFraction>&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased from <ix:nonFraction unitRef="number" contextRef="i4352db6f20a74338aa9b3bada49da7c4_I20190331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODM0Njc_384bac3c-f6f5-4dfb-bdbf-6ea5361b492d">2.13</ix:nonFraction>% as of March&#160;31, 2019 to <ix:nonFraction unitRef="number" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODM1MTk_cab86767-218a-4ff9-a992-44b4b5d081b9">2.03</ix:nonFraction>% as of March&#160;31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE5NzkxMjA5MzM2NjQ3_5d061866-ae22-4c82-93c4-3400e1ed7351">42</ix:nonFraction>&#160;million gain): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes mortality, and other changes. The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODMyNjA_dc3a83a9-dd56-49f5-92f0-0045a493c176">23</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTUz_08bf1c87-3c63-477b-901f-e1f98b274761" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtMS0xLTEtMA_86ab113d-c796-4645-9d1f-8053147b09fc">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtMy0xLTEtMA_1bd4643a-8147-4f34-aa4a-7ea1f8dd0117">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtNS0xLTEtMA_7c93d104-1839-4eb0-9727-9e1d380039dc">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtNy0xLTEtMA_f9811365-de1f-4590-be39-710521282073">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtMS0xLTEtMA_b0d429eb-c741-45cf-8ef1-27bf5cbed91f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtMy0xLTEtMA_8f1840b5-d004-4f2a-a816-7d8d7db6339d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtNS0xLTEtMA_fcb0056c-6b3f-4431-9c54-ed29609388c8">847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtNy0xLTEtMA_94b9e288-a600-4049-b884-09866906a987">856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtMS0xLTEtMA_12c9ad82-a336-4a87-8875-c60207180d77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtMy0xLTEtMA_ac28617f-75cd-4180-8244-19c38675cbd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtNS0xLTEtMA_e047b450-f6e7-4063-850e-cb0250da2034">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtNy0xLTEtMA_5999c620-e5de-413b-be80-efc1b5df4511">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDc3_b0cf572c-623d-45ee-9def-17b322b8a9eb" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive income consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtMS0xLTEtMA_c8221446-3839-4458-b8d9-789ac45a29bd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtMy0xLTEtMA_8d8d3f33-61ea-40b2-b254-a4c2b54e2502">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtNS0xLTEtMA_666d48b4-e32f-4e41-9123-c37c8e334fb8">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtNy0xLTEtMA_42e33570-04b9-4fe0-9afc-a9c17d8901a8">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtMS0xLTEtMA_2913fe81-2c96-43e5-b54b-7caae5069184">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtMy0xLTEtMA_c3500e6a-f730-4101-aba0-56960ae8d885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtNS0xLTEtMA_8b7d3f61-6115-40b5-b039-828d4b1074b7">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtNy0xLTEtMA_99d3e33b-fcad-40a8-84bb-5e24f5cc4a1f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtMS0xLTEtMA_03ffb3e9-cb9e-4112-b2eb-7382452d56ef">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtMy0xLTEtMA_f346aaaf-f7e1-49c8-8719-2e329b139dac">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtNS0xLTEtMA_1ad1569b-627f-4318-988d-e3428fe96e10">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtNy0xLTEtMA_1b63b988-ae45-4ba2-a072-061fbb83f9c1">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTAw_b04dfc11-1ae6-4d02-a138-1f921fb551f7" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive income were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:44.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.745%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtMS0xLTEtMA_3b128926-e899-42dd-8f1d-2eacb5b47c3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtMy0xLTEtMA_3d0b486b-0272-471f-a1a1-0908fe8f02af">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtNS0xLTEtMA_8492ff0f-4fde-462b-8431-7f9757c483c6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtNy0xLTEtMA_94cacf92-2cd8-4cfd-bf8b-48c47dbcb39e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtOS0xLTEtMA_f1d700ba-9d2b-4770-b4c7-02ba746610f8">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtMTEtMS0xLTA_cbe280c5-dd1c-42e3-af54-85422d93fc8e">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtMS0xLTEtMA_7e86b4b0-861a-4b63-94a9-2bd1604e1406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtMy0xLTEtMA_16e25987-b3d1-452d-9ea2-61ac037427bf">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtNS0xLTEtMA_f2bf8160-17aa-4106-9f25-073ed6a61e0c">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtNy0xLTEtMA_3316947a-de74-4380-856d-5c0df76a2373">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtOS0xLTEtMA_5db4d9a3-583c-47b1-80ec-25fded90b354">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtMTEtMS0xLTA_893967a3-6818-4d27-b15f-f031dd4bc98b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit (cost)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctMS0xLTEtMA_140aefb6-19c6-4e2b-bed7-31d183e36bed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctMy0xLTEtMA_c465fd71-8777-4da5-8c50-c45a10363fda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctNS0xLTEtMA_4743370a-c9fe-41c5-9f12-be112e55e380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctNy0xLTEtMA_249a6a05-5d54-443a-bcd1-3877b46108f4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctOS0xLTEtMA_ea73ace8-6470-4c9d-b123-7d219e7f3fb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctMTEtMS0xLTA_7ab9a3d8-cfa8-480f-bf6d-0f1f302c2e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtMS0xLTEtMA_7adc413a-5c65-4d3c-80f2-c1d2d3b0096d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtMy0xLTEtMA_e94a2284-3e59-4446-8be1-8bf2072da46a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtNS0xLTEtMA_8b23310d-9295-47c3-b33c-9722307eb161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtNy0xLTEtMA_fb38c1e5-bba5-40ad-903f-0f0c42767bd6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtOS0xLTEtMA_e56304f3-ba2d-447b-b05f-dd12e66e23a9">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtMTEtMS0xLTA_58a3c62f-7017-4e31-9d5e-c8de8c236460">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss (income) </span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktMS0xLTEtMA_c75e08bb-414a-4572-91ac-a40b39572722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktMy0xLTEtMA_6e32b79a-563b-4065-a9c8-ff1314d3e6f6">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktNS0xLTEtMA_6c31760a-1a8a-4b81-b026-0b67bf13e84f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktNy0xLTEtMA_a878f4ef-d797-4560-a92e-8f6cf6cc5461">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktOS0xLTEtMA_08445fa6-fec3-4b6b-ba9d-e3309e549281">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktMTEtMS0xLTA_f1d42e25-3547-424f-ad49-ff5cd048389d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="ifd98e54551df4f7484c8d4d12a663576_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODY0MjM_d43e0e6c-52ec-4204-8898-24cad597d61d">33</ix:nonFraction>&#160;million in actuarial losses for pension plans to stockholders&#8217; equity in 2021 as a result of the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; The Company recognized $<ix:nonFraction unitRef="usd" contextRef="ieef839e73eff43848516318cebe57433_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU0MDI_850ae69d-ea6e-4147-b4da-ddde5ba7e037">127</ix:nonFraction> million in actuarial losses for the pension plans to stockholders&#8217; equity in 2020 as a result of $<ix:nonFraction unitRef="usd" contextRef="iad526e199d5f45e8b0138cf1dc4218d3_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU0OTI_db60cb2f-d939-42d4-b49a-1a2c9a479748">116</ix:nonFraction> million from the termination of the U.S. defined benefit pension plan and $<ix:nonFraction unitRef="usd" contextRef="ifbba704ea17245a79664996d4d4b9fb9_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU1NjE_d34f9e01-dcda-447e-b2ad-b436a202503e">11</ix:nonFraction> million from the settlement from the executive benefit retirement plan for a retired executive. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected benefit obligations related to the Company&#8217;s unfunded U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="if80d3a019b9947fca48a1095d9bfbf33_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU3NDI_e9afe555-12fd-4e6a-a7cc-3c0ba8f67c4b">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9eb73386cbae4db0b0d708fc5a5494fd_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU3NDk_d0ad0d56-019f-4205-b025-4a34a7422d60">10</ix:nonFraction> million at March&#160;31,&#160;2021 and 2020, respectively. Pension obligations for its unfunded plans are based on the recommendations of independent actuaries. Projected benefit obligations relating to the Company&#8217;s unfunded non-U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="i8a9ed363669a4fdfa3cc41d133ad481b_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU5NjM_2b22eeb4-b039-4185-87cd-1ba21e989dd6">162</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia504be01cf094a55828dfdd970c95bf7_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU5NzA_cfa70245-a466-4ca8-b4b8-7eac2e1c7b23">298</ix:nonFraction> million at March&#160;31,&#160;2021 and 2020, respectively. Funding obligations for its non-U.S. plans vary based on the laws of each non-U.S. jurisdiction.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i6ec6a3141006454e8359d43707c4aad4" continuedAt="i19961a3ef33841d2ab7752682fcf9a39"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for the Company&#8217;s pension plans are as follows: $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxNjg_ae00863f-d196-44fa-ba1a-8311782803fd">43</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxNzI_9a677b1c-afdd-496d-9f61-44889f41b171">36</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxNzY_bb991266-18d7-4627-b110-353cf1233551">37</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxODA_aa99ae56-66d8-416f-9de5-c50cee831eb4">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxODc_ea8cbdfb-2f70-410a-9616-6b73cd801c3e">38</ix:nonFraction> million for 2022 to 2026 and $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYyMDc_2ccf0022-8f70-408a-b0a8-d53817c40fe9">202</ix:nonFraction> million for 2027 through 2031. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#8217;s pension plans are $<ix:nonFraction unitRef="usd" contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzY0NDY_df8dc69b-4557-4144-a849-056035c687b1">24</ix:nonFraction> million for 2022.</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDk4_5262fe80-4e4f-4108-bf45-80a0109ce002" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:40.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtMS0xLTEtMA_78fec52c-73fe-4ab9-baf0-b0a78f0f41e7">3.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtMy0xLTEtMA_9b93fd7e-17c9-4d9c-918b-4e757c1d3c1e">3.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtNS0xLTEtMA_1eb6c1f5-4f8c-4c79-907e-75af8215f486">3.83</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtNy0xLTEtMA_2d015a30-c5f3-4505-980e-6cc62fc01e0f">1.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtOS0xLTEtMA_71218dd8-101c-4412-b051-9eb05893b57d">2.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtMTEtMS0xLTA_cb9535ac-0281-4db4-8e6b-8cfcf3ba7174">2.35</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzUtNy0xLTEtMA_66a2fbc9-dd27-470c-b6eb-17574f2d6d1a">3.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzUtOS0xLTEtMA_c0112fd5-43cc-4b73-b1fa-dbbc75c5e522">2.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzUtMTEtMS0xLTA_a002e318-ed4c-4558-921b-fa3f36fb3f37">3.13</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtMy0xLTEtMA_49f3c969-e4ee-4c8d-93f1-a24037c44485">4.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtNS0xLTEtMA_947304bf-eb10-4a6c-acef-dcadaccbb297">5.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtNy0xLTEtMA_626efc90-94ba-41a1-96e4-4710f5f280a1">2.56</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtOS0xLTEtMA_4fed17db-3492-4117-919e-84d3dc26d36e">3.01</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtMTEtMS0xLTA_a1befc13-7e35-4dc9-9159-805d782c74d0">3.71</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtMS0xLTEtMA_5b1f830f-3423-4f9d-9503-4bd7f991231b">2.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtMy0xLTEtMA_a61254bc-bd58-4ff9-92b3-e8942f727614">3.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtNS0xLTEtMA_2edcdd25-b331-4faf-829e-bf4c39729b3c">3.65</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtNy0xLTEtMA_5d0ebe14-0cdd-4e58-acf4-7931635dac6e">1.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtOS0xLTEtMA_a496536d-eeb3-42a6-a7fb-3b8da2baade9">2.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtMTEtMS0xLTA_5a4fbd23-3c1a-4636-a5fb-0ba5640e5bf2">2.13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="4" name="mck:BenefitObligationsAssumptionsRateIncreaseinCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzktNy0xLTEtMA_f7c0df9e-56ee-4e41-b492-a705c7c0751f">3.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="4" name="mck:BenefitObligationsAssumptionsRateIncreaseinCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzktOS0xLTEtMA_8ff9768c-0a4c-44ba-bd59-851d58a66530">2.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="4" name="mck:BenefitObligationsAssumptionsRateIncreaseinCompensation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzktMTEtMS0xLTA_01344846-7242-4b41-b9c4-d589cc09c2fc">3.18</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. For March&#160;31, 2021, the Company&#8217;s U.S. defined benefit liabilities are valued using a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzcxNDY_bf445f0a-0a56-488a-9b43-723bf76e4dea">2.35</ix:nonFraction>%, which represents a decrease of <ix:nonFraction unitRef="number" contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzcxODE_2b787e3f-a6c9-4f6e-81d3-58fda6a285c1">73</ix:nonFraction> basis points from its 2020 weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzcyNDM_b0afd216-b483-438d-9c57-1dcb50872afb">3.08</ix:nonFraction>%. The Company&#8217;s non-U.S. defined benefit pension plan liabilities are valued using a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzczNjU_a767259c-96ad-469d-8dd9-182fafaf6548">1.89</ix:nonFraction>%, which represents a decrease of <ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzc0MDA_960646bc-78b9-4be1-86db-231fdd90e44a">14</ix:nonFraction> basis points from its 2020 weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzc0NjI_a4fa0c60-af99-4d15-95af-a54faafad41c">2.03</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For non-U.S. plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i19961a3ef33841d2ab7752682fcf9a39" continuedAt="iac93a8d175c94889acf24bb468f1c293"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. <ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDc5_995b888c-457a-4d8d-bec1-4c7cd8739e3c" continuedAt="ic6653f38b08a45f982040e1edaff9ac8" escape="true">The following tables represent the Company&#8217;s pension plan assets as of March&#160;31, 2021 and 2020, using the fair value hierarchy by asset class:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="ic6653f38b08a45f982040e1edaff9ac8" continuedAt="i147b267a8e4140c9982dfe2df5eadc58"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf49a496e76a4343af193f0f4a7974df_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMS0xLTEtMA_42e60c13-c899-43fb-911b-007570d6ec53">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff7247931a914ff28d1893274243b53a_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMy0xLTEtMA_45e8a913-1401-495a-a238-bae090e1a25b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e7186c429a445e93197d83b847b0f1_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtNS0xLTEtMA_f7cdfbaa-0746-4a6b-b590-257ffc57accb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd37c0efe2444846b8dbc5093721ff2d_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtNy0xLTEtMA_3a36d165-4e6b-4229-89ba-540f80d0d5b2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia64a863540ee4b698d1bfb5e37c210e8_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtOS0xLTEtMA_f2bcd68f-ff02-4c5b-8d7c-f382f0684e92">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia086abbf885e4851977fa3b0dc5873b4_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMTEtMS0xLTA_6b0936e0-2ec0-41ba-8bb9-9537169f991b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieddab407ff0b4324b0c636ff14ea949d_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMTMtMS0xLTA_f8676a0a-a66d-4713-9f56-7d577e8c4e4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ce91aa281c4dacbc249f21d1c8cb63_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMTUtMS0xLTA_62ce0ef6-4579-4bf5-a439-11655c390f38">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebcc6ceb48874567b7361b7a9293eb5a_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMS0xLTEtMA_f9a423d7-dbdd-4b88-af4d-83f1f23485de">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e199c99040b47adbfe27d08e7241826_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMy0xLTEtMA_668e6896-1da0-4da2-a960-789f402255b3">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de1d4c7fe7f434aa5351ea9e7492d11_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtNS0xLTEtMA_6c7f2038-fe9c-452a-84cc-69b778e0e82b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d6e4ce540141978ff1ca84f802062f_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtNy0xLTEtMA_966b7b07-cb0c-4f72-bd2f-6fd2d1319545">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3fc200020647f1b1811620c34c8b73_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtOS0xLTEtMA_96a88808-bd37-411c-ab49-538f798eba29">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251a6c64448049b085a70bfdf3b66f0d_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMTEtMS0xLTA_8b76a577-3c51-4d80-a70e-7ae9814d2b13">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d8680e23f234d63971e7108407c5ba6_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMTMtMS0xLTA_f9dcc866-9d3a-42f7-9d11-c01f5b967b0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a00b451ff94034895b6946d7a38db1_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMTUtMS0xLTA_9ca4edcb-9721-424f-b8f1-de72f6e450cd">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ba0213d39194a988ddbaf8d509a9ff9_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMS0xLTEtMA_0e652fbd-cd0b-4214-ac81-8318a831e700">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660febcd05a4ddd91b2880f7aa36913_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMy0xLTEtMA_4af3baab-1867-4858-9d30-55618e7e6cd2">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63eb6a5f45a34ec1b15088e8d927fa66_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtNS0xLTEtMA_2d74afee-507e-457a-85c1-a65e87de24bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed65ff56e894a1286cad47c9f8a5d88_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtNy0xLTEtMA_94802e26-54ba-4d9b-a404-3e78c7e62097">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02cdbba97e7740f58868b386a457b134_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtOS0xLTEtMA_fcf1ce63-eaa2-42be-a5d8-cfdb87f7204c">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6baf74c2370245c78b8481e1f70d7407_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMTEtMS0xLTA_4060edcf-f655-44ff-8c0b-67d34a259f09">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9d21d88c6642b49925de8143031180_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMTMtMS0xLTA_20c5ca40-1dd5-4e2e-83d7-727cc2a8a906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7137372572264ce2af8c977e3e539757_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMTUtMS0xLTA_b946c251-c5fe-407d-87ff-b5ec504d628a">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93548af7026745198b9efa38f1eec08d_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMS0xLTEtMA_1bc9de82-a5b9-4f5e-b971-cfad5b0fd331">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6e42fbe1ee49f4a2526d4ce9934227_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMy0xLTEtMA_36ca70f6-ccf8-4b44-af80-dd8fe7a550f0">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9c1363fee943e8884e04ee49ac6551_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktNS0xLTEtMA_8b07d0f8-7d81-489e-b4c8-deea93db688d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52a3fc127ad472a8539e3ee6bb1d8ef_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktNy0xLTEtMA_38d718a8-7aba-4b9f-8684-97117f0cda98">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4165a5bc7db3475f9aba7f68b27c0c23_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktOS0xLTEtMA_160bebb6-f278-48db-90d9-d84be069d4bb">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55b1ddc17a1405aa6e108d536b9ba0c_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMTEtMS0xLTA_92ba1410-283e-4e2e-ba14-03710f3d5107">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48a05b66006e4eb1908e988b90b7c584_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMTMtMS0xLTA_916d7a9b-1fac-4a1f-981c-88532cdec385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0faaa4d4d048a391122a9b7f845605_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMTUtMS0xLTA_5107cccb-07c8-4350-a3ca-65670ca693e5">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34cdfe04f367491a94ee3b1a4e525875_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTEtMS0xLTA_ca4e11b5-9424-423e-a271-aeaa8fb1addf">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922690c523a74696a506676b6c3c8293_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTMtMS0xLTA_8528fc57-4a9b-4bb0-87cd-4241aab2c619">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da32ab3fea74b268e5f8d39e57ab030_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTUtMS0xLTA_0e3cf339-64d2-410c-8fc7-843bcd3049f3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib686c0f367e5401cb4d26df1ffa0ab31_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTctMS0xLTA_e220fc2b-d09a-497c-9208-db2c7847b5c2">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cb2b02f0a347969390424b0f1f5db9_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTktMS0xLTA_d771761a-46d8-4863-aabb-7be5270b8ae3">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6a46adee414a2ebe17ba74ea9a1405_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTExLTEtMS0w_87541cba-4fda-4c04-877f-76d9194a2343">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f649e07f96460d9704c43f741f4af4_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTEzLTEtMS0w_bf150165-8136-4a8e-869c-85bf7d1a7b2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24c319a97c0492aadc927a233e73092_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTE1LTEtMS0w_7b7a755d-bd47-42b7-8605-2bbdd0130bc9">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc03f35a99e4203abcbc456a09c3804_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTEtMS0xLTA_d7b98c48-cbfd-431b-add5-b56eb4f04983">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5537dbd7704790be3e79071a25edb0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTMtMS0xLTA_4e4869cb-cc0b-44da-be02-04dbafb33150">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d4143c9b1147849d5c123548037925_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTUtMS0xLTA_bd2c12b5-347c-40fd-89d4-7a40b21a7f87">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aaf48c142ae4eeb8c19be8ab65b1e29_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTctMS0xLTA_262b1781-2a9e-4bb1-bc5b-584b86d2d2a7">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b4fef7c31c4a70876df028d549534e_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTktMS0xLTA_5e85e620-8783-4ec5-9ba8-6169bbb9ceda">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bfc6674c5834a339d83ac6ffe6cba98_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTExLTEtMS0w_d8812f11-baa1-4166-9a51-0ebfe030f5dd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic63f6364c6b240679b6ac191aaf72880_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTEzLTEtMS0w_e457dc3b-5f21-4c5f-a721-293c0381fe40">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb3425ba7cd445f84b23ec22c53919b_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTE1LTEtMS0w_659ad977-4180-4ce3-8a02-583bd429974f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafacf2945ba549808ec2d53831cb3ac2_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTEtMS0xLTA_91f49469-71d3-49db-a20a-2eec14a3dc42">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f0be6b3b254094b68a2267dc7b119b_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTMtMS0xLTA_85670248-765a-4e2f-a1f9-4e75c5562e7d">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ec3913d2a24972a6ed10647552acc7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTUtMS0xLTA_040328bc-b073-4415-af89-dfe7fab49a6c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75aeb536cafe4a8ca7661d227b781a7d_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTctMS0xLTA_c226a771-9174-40ed-8514-a9829637b8d4">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae17de65aad448a1be8ef9cde1a3083b_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTktMS0xLTA_60e7ab77-d8d4-4413-8ab3-2f9a530343cf">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8be00e7305947d29917c0a90318f87b_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTExLTEtMS0w_3bae4281-be5c-4125-af67-fad2c1a617a5">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i522f5c831bd24654aa4f2e255332199f_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTEzLTEtMS0w_f2a41dec-55f0-4aac-9c2b-b6b4a0797195">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752cfd53540f4acd8c7907a47b064fa7_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTE1LTEtMS0w_c395ac81-f6d8-4d15-bc97-41c5e4ceb2b8">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06c71ba2610427fabe2fd8eba480224_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE4LTctMS0xLTA_387ad720-e3e9-496e-9ab2-0a2b44ae2cda">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8bbd8b67344a6184b0aafa7b5e6d28_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE4LTE1LTEtMS0w_cdbd0744-1d61-457f-9120-1b5e2808ea0a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a442011c4b4e62a01c94084b029d73_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIxLTctMS0xLTA_b29eaa9a-caee-40f5-8ade-7cc4f70bb758">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667557a44ad64ee88484a6c4fb179948_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIxLTE1LTEtMS0w_f0c8ac66-662c-416d-98fb-e53a61df16e7">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIyLTctMS0xLTA_e4a37c61-39b9-47c9-8e52-84deedfc6004">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIyLTE1LTEtMS0w_d75d8d54-d34f-4c7d-b5e1-3c1ef40d9713">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i147b267a8e4140c9982dfe2df5eadc58">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia182f02d29944e6e98fc4ad018ea349c_D20200401-20210331" decimals="2" name="mck:UnitValueOfCashAndCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEwNTEy_830d6fd0-3155-459b-9688-65ca8ca3bb01">1.00</ix:nonFraction>. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iac93a8d175c94889acf24bb468f1c293" continuedAt="i5732159297b34dd289be35cee324f23e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other - At March&#160;31, 2021 and 2020, this includes $<ix:nonFraction unitRef="usd" contextRef="i86ee3888e9874369a385166f1dc2d756_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEzMDQx_d38152ae-3d58-4841-af9d-78cff4240ba8">36</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifccd58ee2c094daf8d0a763a2263760d_I20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEzMDQ4_1943b021-10b1-49c0-82d6-39674679f11e">29</ix:nonFraction> million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity attributable to Level 3 plan assets was not material for the years ended March&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#8220;POA&#8221;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#8217;s withdrawal liability and contributions may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributions and amounts accrued for U.S. Plans were not material for the years ended March&#160;31, 2021, 2020, and 2019. Contributions to the POA for non-U.S. Plans exceeding <ix:nonFraction unitRef="number" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="INF" name="mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjA2_e315c421-caf3-4de1-94c4-f8e4198fe732">5</ix:nonFraction>% of total plan contributions were&#160;$<ix:nonFraction unitRef="usd" contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjQy_7ea2f860-ef17-4866-9f26-3879458fb3a4">22</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjQ2_84d59901-5adc-415c-993e-fca8b6b6c84c">17</ix:nonFraction> million, and&#160;$<ix:nonFraction unitRef="usd" contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjUz_c8e0cb31-ae5c-47ab-87af-2ff2ff8e18ab">27</ix:nonFraction> million in 2021, 2020, and 2019, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately <ix:nonFraction unitRef="number" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="2" name="mck:MultiemployerPlanFundedStatusPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1Mzkw_cf820a0c-c2ce-49b6-b9e4-ac6f064e633b">78</ix:nonFraction>% as of March&#160;31, 2021. <ix:nonFraction unitRef="usd" contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:MultiemployerPlansWithdrawalObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1NDAz_1e5134c8-ec37-41f8-8ce2-c8f36001493d">No</ix:nonFraction> amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contributory retirement savings plan (&#8220;RSP&#8221;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to <ix:nonFraction unitRef="number" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1Njk1_62e9b277-537a-4424-924e-95b23c429aff">75</ix:nonFraction>% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to <ix:nonFraction unitRef="number" contextRef="id8cadf8c988e45fb883101ea1a6a10f3_D20200401-20210331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1ODQ5_f83433a9-f9d5-4c8d-bb7d-4391ba1dea0a">100</ix:nonFraction>% of the employee&#8217;s first <ix:nonFraction unitRef="number" contextRef="id8cadf8c988e45fb883101ea1a6a10f3_D20200401-20210331" decimals="INF" name="mck:EmployeeContributions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1ODc2_14b1aa4c-d7d8-4357-a7bc-a177903d3149">3</ix:nonFraction>% of pay contributed and <ix:nonFraction unitRef="number" contextRef="i6dd62e97be4e40009772be77a6677117_D20200401-20210331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1OTAy_68b662a2-6994-43c6-beb0-308f4674a5bc">50</ix:nonFraction>% for the next <ix:nonFraction unitRef="number" contextRef="i6dd62e97be4e40009772be77a6677117_D20200401-20210331" decimals="INF" name="mck:EmployeeContributions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1OTE4_cbd8e288-8c68-4952-bb83-20cc35f570f6">2</ix:nonFraction>% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE2MjU4_9392c548-9829-4dce-a0c0-ac3e1f62f886">102</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE2MjYy_2e3b3900-2f59-4195-8f32-3b511ae799bf">102</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE2MjY5_f66c9450-da81-4831-b6fd-d56d4d04e0bd">92</ix:nonFraction> million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postretirement Benefits</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5732159297b34dd289be35cee324f23e">The Company maintains a number of postretirement benefits, primarily consisting of healthcare and life insurance (&#8220;welfare&#8221;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic (credit) expense for the Company&#8217;s postretirement welfare benefits was not material for the years ended March 31, 2021, 2020, and 2019. The benefit obligation at March 31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i0c346010601f41a8883754f4737da9a4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDY1_ada76b66-d37f-403f-87df-465489d51b72">64</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie25f16fc97a74b6186d5dbaa0dabe3da_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDcy_cc6fe8f1-c48d-40ae-8d96-88962e02a799">65</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_196"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzEwNTEz_11a45ec6-068f-4188-9f74-e1420ee39cd9" continuedAt="icda646e12d9d41c59c2de000ecf32daa" escape="true">Hedging Activities</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icda646e12d9d41c59c2de000ecf32daa" continuedAt="i61ca5849ddc046f1921e167709ed86c1">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i61ca5849ddc046f1921e167709ed86c1" continuedAt="i886d16df18b344be8f08fe9a6443bd3f"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i9bd0ad5cd9f64967ab1d489f14880abc_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzE0OTk_0471c5ea-d5e0-4888-a4f4-2fd2a08cd286"><ix:nonFraction unitRef="eur" contextRef="i2c4bea63e16a4f178e9d9a0b8adb9aa6_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzE0OTk_dbd71a1c-b085-4291-b1fe-45623b263a7d">1.7</ix:nonFraction></ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. In December 2019, the Company prospectively de-designated from net investment hedges &#8364;<ix:nonFraction unitRef="eur" contextRef="i8874cbe0e0bd4d968ce32dccacb9e82d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzI1MjQ_732de181-4f33-4fd7-8bcd-9101063fcc4c">250</ix:nonFraction> million of its Euro-denominated notes which matured in February 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2019, the Company also had &#163;<ix:nonFraction unitRef="gbp" contextRef="i1f7e095fc24d45e9a294900b86a6d643_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzI2MTc_d873f7bd-5188-4885-a76c-da43d98905ce">450</ix:nonFraction> million British pound sterling-denominated notes designated as non-derivative net investment hedges. On September 30, 2019, the Company de-designated its &#163;<ix:nonFraction unitRef="gbp" contextRef="i5180872f1daf4367ae60ec035bbdeeb2_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzI3NjY_836ed81e-20bd-4112-8cc3-c4076da14876">450</ix:nonFraction> million British pound sterling-denominated notes prospectively from net investment hedges as the hedging relationship ceased to be effective. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMwMDM_f0bcb044-179b-4a1b-b49f-46938ad131f7">118</ix:nonFraction> million in 2021 and gains of $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMwMTA_5061b6c8-193b-49a8-a295-53acdd1bf587">39</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMwNDA_9c4d65ec-74b4-48d3-8d15-bf608477a21e">259</ix:nonFraction> million in 2020 and 2019, respectively. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during 2020 resulted in gains of $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMxNTM_d8666de6-4b14-434d-a9c2-6fe5990ead3d">34</ix:nonFraction> million which were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March&#160;31, 2021 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="i817dc0da95ba4e5d978cb261392a4458_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNDk3MjE_108fdc12-3be6-4fb1-afb8-fd4d27a394ff">500</ix:nonFraction> million and $<ix:nonFraction unitRef="cad" contextRef="ibe1e06122bde42dea54156fed96f14ab_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNDk3NDM_c5acfe8c-2bf1-405d-93b0-bf3bcaa360e3">1.5</ix:nonFraction> billion Canadian dollars, respectively. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March&#160;31, 2021, 2020, and 2019. In 2021, cross-currency swaps with an aggregate gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="i817dc0da95ba4e5d978cb261392a4458_I20210331" decimals="INF" format="ixt:numdotdecimal" name="mck:DerivativeNotionalAmountMatured" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNDk5OTc_149bbbd1-cdfa-4643-9af5-29d9dc86bb93">999</ix:nonFraction> million Canadian dollars matured and the remaining cross-currency swaps will mature in November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2019, the Company also had cross-currency swaps designated as net investment hedges with a total gross notional amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="i5c95a543404e41e2af0a9d67836a7894_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzQ5MjA_fcb85d10-e950-4fc8-9419-86e540de8a9b">932</ix:nonFraction> million British pound sterling. In 2020, the Company terminated these swaps due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $<ix:nonFraction unitRef="usd" contextRef="i4912f098ebbb49ec84aab8167ce6c62f_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzUyMTQ_2e51945c-99d3-4b1a-a6ad-4bd66f5663b4">84</ix:nonFraction> million and resulted in a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="i4912f098ebbb49ec84aab8167ce6c62f_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzUyNTQ_dad7615e-c11d-48a0-b736-f3a22f76180a">34</ix:nonFraction> million in 2020. This gain was recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i886d16df18b344be8f08fe9a6443bd3f" continuedAt="i1cf0c631f7dc42188b372c74f6bbf503"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="ia231762ec9524000b72d1100dc01e0b9_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0Nzk_94bc3b02-7ffb-4ff5-9ec4-8352ce08f2a7">119</ix:nonFraction> million in 2021 and gains of $<ix:nonFraction unitRef="usd" contextRef="i817e532872ff41b49bff73a8ac0e47c5_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0ODY_0cbac356-ebb6-46a6-9d7f-692032f06d41">76</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i53fd7c4598e7493daae729bcc3ff421e_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU1MTY_78f109e7-8842-4498-aa26-765491267f9a">53</ix:nonFraction> million in 2020 and 2019, respectively. There was no ineffectiveness in the Company&#8217;s hedges for the years ended March&#160;31, 2021 and 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;<ix:nonFraction unitRef="gbp" contextRef="i5180872f1daf4367ae60ec035bbdeeb2_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU4MzU_836ed81e-20bd-4112-8cc3-c4076da14876">450</ix:nonFraction> million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;<ix:nonFraction unitRef="gbp" contextRef="i5180872f1daf4367ae60ec035bbdeeb2_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzYxODc_836ed81e-20bd-4112-8cc3-c4076da14876">450</ix:nonFraction> million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At March&#160;31, 2021 and 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="i53702046a4124ad485291bebe82245b0_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzc2NTM_9e128c9a-6bd9-4089-b9aa-f9f46fa26e31">2.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i12d54840073946439b15c638a7e7457f_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTA1NzM_fdf9a92d-33c7-4e79-af39-05acc09b5de3">2.9</ix:nonFraction> billion, respectively, which are designated as cash flow hedges. These swaps will mature between May 2021 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE2NjE_f675e728-a4f8-4dff-8524-b5913443dda6">500</ix:nonFraction> million and &#8364;<ix:nonFraction unitRef="eur" contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE2Nzc_f5e0cdd9-683f-4d0a-bb7a-6ac8b6ce5722">600</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE2OTM_f675e728-a4f8-4dff-8524-b5913443dda6">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;<ix:nonFraction unitRef="eur" contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE3MDg_f5e0cdd9-683f-4d0a-bb7a-6ac8b6ce5722">600</ix:nonFraction> million swaps. The $<ix:nonFraction unitRef="usd" contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE3MjM_f675e728-a4f8-4dff-8524-b5913443dda6">500</ix:nonFraction> million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 13, &#8220;Debt and Financing Activities,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="ib82c3ffdbb3a41a5aec156304f17e31c_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzgyNTM_9cd4fc5a-0461-46f1-a415-ef6481319052">42</ix:nonFraction> million in 2021 and gains of $<ix:nonFraction unitRef="usd" contextRef="i5299bd1dd919404fbdaf72f5fea0b8af_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzgyNjA_42a9d23a-d571-4c36-a223-0cbcfbb3c28e">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5c5c584197cb47379b1b7c14225ff68f_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzgyOTA_f79f513f-0212-4115-8b41-6d448cf08e7e">28</ix:nonFraction> million in 2020 and 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations were not material in 2021, 2020, and 2019. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the years ended March&#160;31, 2021, 2020, and 2019. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in value included in earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At March&#160;31, 2021 and 2020, the total gross notional amounts of these contracts were $<ix:nonFraction unitRef="usd" contextRef="ia984cf8845c74e7289319379358fa6fb_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzkwMDI_dc111f1e-6457-4500-9619-9a30f4ceb227">39</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i01610a464cf24d10b1649f93c6dd325f_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzkwMDk_c365e99f-5055-4524-aa97-775f345d379c">29</ix:nonFraction> million, respectively. These contracts will predominately mature between April 2021 and December 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in the fair values were not material in 2021, 2020, and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i1cf0c631f7dc42188b372c74f6bbf503" continuedAt="i35d2683f013442408b89fb1b98ac8871"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the non-derivative net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="if65491e199804aaa88bd166f8ca3be43_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzk4MzQ_6b86f17a-e27d-413c-bf75-20a47d77d32d">250</ix:nonFraction> million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they are offsetting matured in February 2020 and were not designated for hedge accounting. Changes in the fair value for contracts not designated as hedges are recorded directly in earnings. In 2020, losses of $<ix:nonFraction unitRef="usd" contextRef="ib007a62583634542927bd84b71663f81_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzEwMTUy_6b43050c-f461-4c19-8fdb-c2b6c722d5be">44</ix:nonFraction> million were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations, which offset the ineffectiveness on the Company&#8217;s non-derivative net investment hedges noted above. </span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzEwNTAz_bd77b8ee-7cf8-465f-8b09-0c4cf80ec16a" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.286%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(current)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c9fbb71f394a7681cd8e128c4ca678_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtMi0xLTEtMA_707fa1e1-f585-484f-af02-d99aceec491e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfa2fbd8be98466d8391902894ef72d2_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtMy0xLTEtMA_816f3f88-6075-42eb-a675-37011b214e83">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0e75b865efa47ec9f317da6494e4d4d_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtNC0xLTEtMA_229b7a3a-aba6-42f3-a4fc-d4b6434df5ba">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd3f0773896b4e48973d8fa8546e4b4f_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtNi0xLTEtMA_abb1184b-f476-46a1-a58e-dcd120ff2e7b">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1388407356724e0ea750cc0fcc36009e_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtNy0xLTEtMA_3746b6e6-d1e0-46f6-8b78-928c4ef57d85">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08745885db4845b2929c65f0e1a8560d_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtOC0xLTEtMA_831e0526-f128-4144-b105-a8c64425c3a7">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90cf6f7bcf9f490b8486918cc3e7f3a8_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtMi0xLTEtMA_98fdb91c-9a0a-4011-8bf7-232f39c4e2b5">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fbf63d8d1d545b2bdcd18abc08e8ac8_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtMy0xLTEtMA_a6f49106-281b-4142-9f09-d0854de3397e">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7854a867193e4d57bbd9c6cd7fc41e84_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtNC0xLTEtMA_08e21029-1cb3-4a3d-9c31-f5c49e2b5590">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95fc81c6ff294b6fb53c554a85f12552_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtNi0xLTEtMA_2fc08d49-218d-4cd2-bcc7-0bebcd9e47bf">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied797e934f764283b9613debb2b85b60_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtNy0xLTEtMA_fed1983b-c96c-4ac4-946f-cf76486152cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427b71cb3fc4506aa62b238fa8e4181_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtOC0xLTEtMA_bdd709e9-0548-497b-9410-9763f878daef">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied59589914674a3e8f6c2970536feb07_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMi0xLTEtNDA4MQ_9ec65aee-5ea4-42fb-b645-cc34da52cbc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied59589914674a3e8f6c2970536feb07_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMy0xLTEtNDA4NQ_df86951e-db73-4f11-8cd9-5a2dd40e4f48">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied59589914674a3e8f6c2970536feb07_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNC0xLTEtNDA4NQ_49457b6e-17fc-417a-8471-4e8c9eb5d01b">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNi0xLTEtNDA5Mw_63d37162-071d-4d38-969f-10a77a382729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNy0xLTEtNDA5Mw_9f8d0e0d-2c7b-490e-aa27-cce9321d7dd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctOC0xLTEtNDA5Mw_9c5fde7f-738d-4d26-835d-7454d9f6e253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMi0xLTEtMA_bfde96a3-1121-4187-86c3-0ddc4a22cdca">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMy0xLTEtMA_7cec01cc-6ee3-4203-97ec-7675d4515960">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia49068b8e285481ea485b20083b13688_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNi0xLTEtMA_ca6b1ae1-1f91-481f-99ee-54e0dcd8b802">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia49068b8e285481ea485b20083b13688_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNy0xLTEtMA_773609ed-5de6-4282-b719-fbbe58befee1">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d3478fa53f14391b83ba8ebc23863e8_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktMi0xLTEtMA_be99d302-f48b-4cf0-9c58-aa986875e5c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d3478fa53f14391b83ba8ebc23863e8_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktMy0xLTEtMA_7403b78b-b3f0-4ca3-b7b7-a04fd617cfab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d3478fa53f14391b83ba8ebc23863e8_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktNC0xLTEtMA_a5d9f386-c535-4526-8985-c7e5e9f2674b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a217938b29b4446aff7ba0b8ec251f4_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktNi0xLTEtMA_f8540eff-989c-4175-ab6e-c38c30aea244">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a217938b29b4446aff7ba0b8ec251f4_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktNy0xLTEtMA_3c27e230-6b3f-44ab-b693-03f433b2e76b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a217938b29b4446aff7ba0b8ec251f4_I20200331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktOC0xLTEtMA_53b94d58-1788-4421-b85a-6fecadaa1ad2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTItMS0xLTA_301f462c-43ba-496f-b2ad-699778819f74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTMtMS0xLTA_2d1d2aa2-0195-4ec0-994e-c79e20faf0d8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTQtMS0xLTA_9acd6b80-b93c-4348-b25e-9a04d8ef0579">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cbe7452a1e9407e9cef048f9838a43c_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTYtMS0xLTA_7df64524-387a-4e17-8ba8-25fd4466d206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cbe7452a1e9407e9cef048f9838a43c_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTctMS0xLTA_13c68187-ccec-4c62-9ae2-111821a552bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cbe7452a1e9407e9cef048f9838a43c_I20200331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTgtMS0xLTA_427a36bc-0076-402b-810a-9c6755d1b542">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e07f2f6223f4fadb6d3a4b0459ad972_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTItMS0xLTA_04b29028-a5a0-4249-8125-d774cfa965cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e07f2f6223f4fadb6d3a4b0459ad972_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTMtMS0xLTA_b015e6dc-c757-4147-ab62-a0d7c764c79e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c2e845aabd4458a28f546f452aa7cb_I20200331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTYtMS0xLTA_836a929d-bb69-4ac1-8985-fa52f191ad7a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c2e845aabd4458a28f546f452aa7cb_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTctMS0xLTA_e5e7e59c-e87c-40ee-8295-96c6f51d982a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i35d2683f013442408b89fb1b98ac8871">Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; for more information on these recurring fair value measurements.</ix:continuation> </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_202"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzUyMTc_6c1736b2-ef59-488c-ae81-1122adefaeeb" continuedAt="ic4401cdb6cff4afcac607f52af70a736" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ic4401cdb6cff4afcac607f52af70a736" continuedAt="i0047e31ce9084751a9c8d0ad6d2d6bdb"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March 31, 2021 and 2020 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzE2NDkyNjc0OTEyMjE_9f8c215f-1344-4d2d-8c47-49cdae4f6299">1.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzE2NDkyNjc0OTEyMzY_d2f641eb-c10f-47f5-a9ba-6dcc0044c976">2.0</ix:nonFraction> billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at March 31, 2021 and 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0047e31ce9084751a9c8d0ad6d2d6bdb" continuedAt="i20d13f65a775472892133190a314d122"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 16, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQwNjg4_1c0a59cb-d909-4ead-adf4-52018b1ff2d8">269</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQwNzAz_ec6d879d-1fc6-4af9-bcc4-16ef992db5cc">170</ix:nonFraction>&#160;million at March&#160;31, 2021 and 2020, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. During 2021, several of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities, while others were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of 2021. Net gains related to the Company&#8217;s investments in these equity securities were approximately $<ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQwODI3_98fc916a-a53b-46b5-91fa-3726c76b20c2">133</ix:nonFraction> million for the year ended March&#160;31, 2021. These gains were recorded in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. There were no other material changes in the carrying value of these investments during the year ended March&#160;31, 2021. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges&#8221; and Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ia738d64059fd4e028976c6a7a8405915_I20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQyNDYz_31bf6b87-e407-40d2-be29-6a98188965d6"><ix:nonFraction unitRef="usd" contextRef="id6e2683da2654d0d952236373c6802fc_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQyNDYz_7add210c-ec9e-4183-a7c0-88e460ea303c">no</ix:nonFraction></ix:nonFraction> liabilities measured at fair value on a nonrecurring basis at March&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i20d13f65a775472892133190a314d122"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzE5NzkxMjA5MzQ4MTY5_25170707-6855-4db9-9478-faa0e0d021d1" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is also recorded at cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281f035f8d7243408d9c4ff727319f57_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItMS0xLTEtMTYxMzg_a4d444c8-def6-49f2-a3ab-1b5f9564c160">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565d983f5a0443089f472cb1d490b842_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItMi0xLTEtMTYxMzg_995c8bc6-d4e8-4180-8d28-33856f9200ab">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94edb97965974ee69d4b3074e0161dc4_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItNC0xLTEtMTU0NTU_48414662-9c4a-4633-96ce-020ba9e1419e">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fb664a24dd4a318195465e100eff7d_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItNS0xLTEtMTYxNDA_725a989d-8246-4bb8-8985-3efa66a8041f">7,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of the reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information regarding goodwill impairment charges recorded for certain reporting units during 2021 and 2019. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges&#8221; under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Assets Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_208"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="mck:FinancialGuaranteesAndWarrantiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzMzNzM_12023d41-c484-4a48-b47f-22d95e020bb6" continuedAt="i36367510b1bd4c6bb8be5b9748836cbd" escape="true">Financial Guarantees and Warranties</ix:nonNumeric></span></div><ix:continuation id="i36367510b1bd4c6bb8be5b9748836cbd" continuedAt="i331d23f42aa4483fb72ff9affe970b03"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Guarantees</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain of its customers&#8217; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#8217; inventory or its customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#8217;s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYwNw_af6d397b-2d02-4293-8753-eb30ffd6bb25">one</span> to <ix:nonNumeric contextRef="ia3f06168993540edb69d2eaf0d4aad1a_D20200401-20210331" format="ixt-sec:durwordsen" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYxMw_1513a701-8ef0-4297-a15a-1f5746d3e8af">two years</ix:nonNumeric>. Customers&#8217; debt guarantees generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY2NQ_b7165f1b-8051-446f-8b5c-d34606827cfc">one</span> to <ix:nonNumeric contextRef="ie94373a23dc74d088079c736cb431ae4_D20200401-20210331" format="ixt-sec:durwordsen" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY3MQ_aca599be-f572-4d09-a0c1-d3c86cdfb3c1">ten years</ix:nonNumeric> and are primarily provided to facilitate financing for certain customers. The majority of the Company&#8217;s customers&#8217; debt guarantees are secured by certain assets of the customer. At March&#160;31, 2021, the maximum amounts of inventory repurchase guarantees and customers&#8217; debt guarantees were $<ix:nonFraction unitRef="usd" contextRef="id8aaa878041344688e3f4286b29f0360_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzk2MA_13f590d3-642b-431b-b7ec-a63a5fe82648">329</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide8bc86e5ceb4bf5b7a0cfc3b386f8f3_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzk2Nw_3d472dae-5ed2-42cd-8ce7-f3202c736b2a">143</ix:nonFraction> million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees are as follows: $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GuaranteeObligationsExposureExpiringinYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzEwOTI_cf7b6a05-3d96-42c0-9fb7-bf9d568dea2a">268</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GuaranteeObligationsExposureExpiringinYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzEwOTY_6cd9f412-f4c5-48fa-8ee8-94dff571f486">26</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GuaranteeObligationsExposureExpiringinYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMDA_39a0bcb3-7da3-4ac8-85a1-1ef27034149b">33</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GuaranteeObligationsExposureExpiringinYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMDQ_281d026a-872e-49ea-9514-f14aa565675c">11</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GuaranteeObligationsExposureExpiringinYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMTE_0c5f4270-b278-49f4-84df-083085053c54">15</ix:nonFraction> million&#160;from 2022 through 2026 and $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMzc_1ea29151-1150-47c2-bb0a-6261161b37cb">119</ix:nonFraction> million thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, the Company&#8217;s banks and insurance companies have issued $<ix:nonFraction unitRef="usd" contextRef="ibeef638bf5d34fbab16454219b83a7ce_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzEyMTU_8e579538-016c-4c29-a502-be91019d7323">146</ix:nonFraction> million of standby letters of credit and surety bonds, which were issued on the Company&#8217;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and its workers&#8217; compensation and automotive liability programs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i331d23f42aa4483fb72ff9affe970b03"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#8217;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_214"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMzNzcx_9ae6edb5-eefd-4f2c-8167-810180bc4c74" continuedAt="if7c63a4af7dd46b8b139b1048152bf4c" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><ix:continuation id="if7c63a4af7dd46b8b139b1048152bf4c" continuedAt="i0368309bc5fe4ac6b7144eaf9029dbff"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Case No. 17-md-2804. At present, there are approximately <ix:nonFraction unitRef="case" contextRef="idcf9ef2946a445b3af2f2e36d9726303_I20210331" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzM0ODY_58a5b539-836f-43f3-ad1f-596bf36af4ce">2,900</ix:nonFraction> cases under the jurisdiction of the MDL court.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0368309bc5fe4ac6b7144eaf9029dbff" continuedAt="ib0b8a64c1ac64a7ab40eba51aca4cb80"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i5fe8ab04e6f547139155bb2d610a399b_I20200113" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzM5MTg_e08f88d7-4b6f-402f-ad63-54b3bbed0790">Three</ix:nonFraction> cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case began on May 3, 2021. These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for December 6, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma. The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately <ix:nonFraction unitRef="case" contextRef="i489dd58bf6eb415bb081e0bb67be780c_I20210331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzQ3NDM_22c5a3c2-7c6e-46f6-8081-b57b3a829e27">300</ix:nonFraction> similar state court cases pending in <ix:nonFraction unitRef="state" contextRef="ia7becbc8d137484d97debb021a37e776_D20171205-20210331" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzQ3ODM_25f274a4-8682-4fcd-89ea-cacfe721256e">38</ix:nonFraction> states plus Puerto Rico, along with <ix:nonFraction unitRef="case" contextRef="i51f39bcd0abc4530b8f9a45566eff664_I20210331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMyOTA4NjM_a7c864a4-1064-4244-a724-05e11cb95789">3</ix:nonFraction> cases in Canada. These include actions filed by <ix:nonFraction unitRef="stateattorney" contextRef="ia7becbc8d137484d97debb021a37e776_D20171205-20210331" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzQ4NDI_7407bd35-658b-4a2e-b30d-94234d5164cc">26</ix:nonFraction> state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and <ix:nonFraction unitRef="county" contextRef="i489dd58bf6eb415bb081e0bb67be780c_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCounties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzUzMDE_0aad32be-83e6-4216-80df-5c0fb7af6164">two</ix:nonFraction> New York county governments, is scheduled to begin in June 2021, the cases brought by the Ohio and Washington attorneys general are scheduled to go to trial in September 2021, and the case brought by the Alabama attorney general is scheduled to go to trial in November 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions and other government entities (&#8220;governmental entities&#8221;). The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework under which, in order to resolve claims of governmental entities, the <ix:nonFraction unitRef="company" contextRef="i245fe60a1a194d789edf2b7c72c37e2d_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU4MTk_cbd0f247-3be1-4db2-a0d9-eb663c1d28ed">three</ix:nonFraction> largest U.S. pharmaceutical distributors would pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="i766ba6b8f9cf468f8ffca287b3b91d7a_D20191021-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU4OTk_2c4aa8bf-7bcc-4c66-8213-4c7aff6d6237">21.0</ix:nonFraction> billion over a period of <ix:nonNumeric contextRef="i766ba6b8f9cf468f8ffca287b3b91d7a_D20191021-20210331" format="ixt-sec:duryear" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU5MDc_8086558b-150a-40be-bdb2-b58913252fc0">18</ix:nonNumeric> years, with up to approximately $<ix:nonFraction unitRef="usd" contextRef="i5d07872c38ef46b8904d51cac9def92e_D20191021-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU5MzY_e1868fa3-ae7e-451a-9655-eaa0827bd959">8.0</ix:nonFraction> billion to be paid by the Company, of which more than <ix:nonFraction unitRef="number" contextRef="i81c7bc7242d74503a6137340007d1f16_I20210331" decimals="2" name="mck:LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NzkxMjA5MzczOTkw_98eba4de-05cf-491a-b1f5-63b77b174d61">90</ix:nonFraction>% is anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the <ix:nonFraction unitRef="company" contextRef="i245fe60a1a194d789edf2b7c72c37e2d_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzYyMzM_cbd0f247-3be1-4db2-a0d9-eb663c1d28ed">three</ix:nonFraction> distributors, including the Company, to adopt changes to anti-diversion programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the governmental entities that would participate in any such settlement. The framework contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless concluded that there was sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disclosed in its financial statements for the quarter ended December 31, 2020 its determination that discussions under that framework reached a stage at which a broad settlement of opioid claims by governmental entities was probable, and for which the loss could be reasonably estimated. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of that conclusion, and its assessment of certain other opioid-related claims, the Company recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMyOTUwMTk_f3b1a175-9d1e-40d7-802f-e40cef3adab9">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionAfterTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMyOTUwMjg_65378c18-95ff-4503-bbc4-292aadaa9644">6.8</ix:nonFraction> billion after-tax) within &#8220;Claims and litigation charges, net&#8221; in the Consolidated Statements of Operations related to its share of the settlement framework described above, as well as those certain other opioid-related claims. There was no change to the estimated liability as of March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the uncertainties, as described below, of the timing of amounts that would be paid with respect to these charges, they were recorded in &#8220;Long-term litigation liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021. In addition, for the same reasons, the amount of loss that the Company ultimately might incur may differ materially from the amounts accrued.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ib0b8a64c1ac64a7ab40eba51aca4cb80" continuedAt="ic390a603339c4b77b91c6a8583f1756b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions with attorneys general and other parties continue. If the negotiating parties agree on terms under the framework for a broad resolution of claims of governmental entities, then those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. In some cases, discovery has been paused during the parties&#8217; discussions. While the Company continues to be involved in discussions regarding a potential broad settlement framework, the Company also continues to prepare for trial in these pending matters. The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as 3 cases brought by governmental entities in Canada. These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, including the uncertain scope of participation by governmental entities in any potential settlement under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2018, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Manchester v. Purdue Pharma, L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within&#160;<ix:nonNumeric contextRef="id47f6d83c6e74e48a98de97db2204260_D20190225-20190225" format="ixt-sec:durday" name="mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMDEwOTc_1ecf8af1-6e71-4ff1-a08a-98bab1aeae78">90</ix:nonNumeric> days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with <ix:nonFraction unitRef="complaint" contextRef="if9fc6847924f490e8b2c037e203b3e48_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NzkxMjA5Mzc2MTQ5_88921444-e070-4738-93f8-78eadc54b51e">two</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by the same <ix:nonFraction unitRef="relator" contextRef="ia64a274f0b7d4166afaa7f5a3c655f98_D20191201-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofRelators" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMDIwMTk_7a2eeb8f-7967-4f49-97f4-aa6b1409f7e3">two</ix:nonFraction> relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Coverage Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i66d60389839f46b4a37688dfbe3d091d_I20201023" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NzkxMjA5Mzc0MDAx_06a61e90-db1b-425e-8f61-85eef49676fa">Two</ix:nonFraction> cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AIU Insurance Company et al. v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ace Property and Casualty Insurance Company v. McKesson Corporation et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic390a603339c4b77b91c6a8583f1756b" continuedAt="i8898e70ff9904b3789e9dd4eb1bf5525"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$<ix:nonFraction unitRef="usd" contextRef="ideb9993f891b42a9b62b094fea769814_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEyNDM3_ef0598c0-34d9-4206-bc03-11c08f2c72eb">500</ix:nonFraction>&#160;to&#160;$<ix:nonFraction unitRef="usd" contextRef="i9e7ce3047a83413690e5e7de38e566c3_D20130517-20130517" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEyNDQz_9e1f660d-ff48-4e95-9245-620ae12d77ad">1,500</ix:nonFraction>&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#8217; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#8217;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, <ix:nonFraction unitRef="fax_number" contextRef="i69de364d379c40dc8fe389a7c7c04ab8_I20190813" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyClassActionNumberofFaxesRemainingintheClass" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEzMzEx_7d8dfc27-3a75-456a-9f37-2dea51ecb625">9,490</ix:nonFraction> fax numbers remain in the class, representing <ix:nonFraction unitRef="fax" contextRef="i69de364d379c40dc8fe389a7c7c04ab8_I20190813" decimals="INF" format="ixt:numdotdecimal" name="mck:LossContingencyClassActionNumberofFaxesReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEzMzYw_24339272-36a2-43b2-8195-16f50b8b83ab">48,769</ix:nonFraction> faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#8217; claim for treble damages. Plaintiffs&#8217; moved for summary judgment on the same day. On December 24, 2020, the court declined to decertify the class but modified the class definition to distinguish between physical faxes (kept in the class) versus online or e-fax recipients (removed from the class). On March 19, 2021, the court denied summary judgment for plaintiffs on the issue of liability but found that McKesson&#8217;s affirmative defense of prior consent fails as a matter of law and precluded McKesson from presenting individualized evidence of consent at trial. On McKesson&#8217;s motion for summary judgment, the court demurred and will let the issue of treble damages go to the jury. Trial has been scheduled for October 18, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2017, <ix:nonFraction unitRef="investmentfund" contextRef="i4dbc322ec79448d1be4e868ba2ba06cd_D20171229-20171229" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEzNjQ2_d45ded8c-27ac-4df3-a609-d5fa8a755726">two</ix:nonFraction> investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#8220;Dragonfly GmbH &amp; Co KGaA&#8221;), a subsidiary of the Company, in a German court in Stuttgart, Germany,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.&#160;18 O 455/17. On December 30, 2017,&#160;<ix:nonFraction unitRef="investmentfund" contextRef="i325d4bdea1e649a3a53c4623ba9c8558_D20171230-20171230" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE0MDAz_4fc31d87-c62d-4763-9376-4e1cfa088dd4">four</ix:nonFraction>&#160;investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#8217;s takeover offer in its acquisition of Celesio AG, filed a complaint,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#8217;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December&#160;19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof), which was rejected on November 17, 2020, making the dismissal final and binding. With no further right to appeal, Plaintiffs filed an objection against the decision of the Federal Court of Justice on November 27, 2020, claiming their right to be heard had been violated. On March 16, 2021, the Federal Court of Justice (Bundesgerichtshof) issued an order granting the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs leave to appeal. On March 15, 2019, the lower court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 13, 2019, plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof). On March 16, 2021, the Federal Court of Justice (Bundesgerichtshof) issued an order granting the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiffs leave to appeal.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i8898e70ff9904b3789e9dd4eb1bf5525" continuedAt="ieeacd9d95b9f4a7e8342af61703a51a3"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2018, the Company&#8217;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#8220;kickbacks&#8221; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#8217; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#8217;s decision on the United States&#8217; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#8217;s claims under the False Claims Act. The relator sought a re-hearing en banc at the Seventh Circuit, which was denied. The relator&#8217;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020. On February 10, 2021, the relator filed a Petition for Writ of Certiorari at the United States Supreme Court seeking review of the Seventh Circuit&#8217;s ruling.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by <ix:nonFraction unitRef="relator" contextRef="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofRelators" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE3MTkw_e8407ce0-46b1-43c6-94a8-404a849a782f">two</ix:nonFraction> relators, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE3MjQ3_387b332e-b8b4-4e69-a6d9-1695325d07d8">21</ix:nonFraction> states and the District of Columbia, against USON and <ix:nonFraction unitRef="defendant" contextRef="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofAdditionalDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE3MzA0_cf904c10-c385-47f4-b610-070b6dda47c2">five</ix:nonFraction> other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#8217; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#8217;s motion to dismiss the claims pled against it, with leave to amend. On November&#160;16, 2018, the relators filed a fourth amended complaint. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;) was served with a fifth amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hanks v. Amgen, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV-08-03096 (SJ). Previously, the U.S. declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#8217;s motion to dismiss. Following the relator&#8217;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#8217;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2018, a second amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint was filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="ibe2ccd127a8d4663b1bebbcc74fb5b01_D20180403-20180403" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5Mzk5_9145571c-7bb8-4fc3-97d1-06ff33a2e079">30</ix:nonFraction> states, the District of Columbia, and <ix:nonFraction unitRef="city" contextRef="i2ed46708d24e42d5b26a1ec4e6a3ed61_I20180403" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCitiesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NDQw_2c97b927-46bc-43fc-9ea5-be34459b1634">two</ix:nonFraction> cities against McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc. and US Oncology Specialty, L.P., alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG). The United States and the named states have declined to intervene in the case. On October 15, 2018, the Company filed a motion to dismiss the complaint as to all named defendants. On February&#160;4, 2019, the court granted the motion to dismiss in part and denied it in part, leaving the Company and Oncology Therapeutics Network Corporation as the only remaining defendants in the case. On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of another complaint filed by the same relator, alleging the same misconduct and seeking the same relief with respect to US Oncology, Inc., purportedly on behalf of the same government entities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ieeacd9d95b9f4a7e8342af61703a51a3" continuedAt="i77c39bfaa86a4055bdfb3701c73f16b1"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#8217;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic Center, LLC v. Becton, Dickinson, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#8217;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. Defendants filed a motion to dismiss the amended complaint, which the district court granted on March 15, 2021. Plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit on March 23, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and <ix:nonFraction unitRef="officer" contextRef="ib77506c67e6348619cb8db92d4005f93_I20181212" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofFormerOfficers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIzMzcz_d7e4c430-1f47-4ab8-a2b6-4599b0e55e3d">two</ix:nonFraction>&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#8217;s motion for class certification.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, The Great Atlantic &amp; Pacific Tea Company (&#8220;A&amp;P&#8221;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re The Great Atlantic &amp; Pacific Tea Company, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Adv. Proc. No. 17-08264.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company&#8217;s subsidiary NDCHealth Corporation dba RelayHealth (&#8220;RelayHealth&#8221;) was served with <ix:nonFraction unitRef="complaint" contextRef="i85d1442fd2694c819407a70aafa1bffb_I20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI1NzYw_7fbfbac0-eb6e-4591-ba0c-2d43428585da">three</ix:nonFraction> purported class action complaints filed in the United States District Court for the Northern District of Illinois. The complaints allege that RelayHealth violated the Sherman Act by entering into an agreement with co-defendant Surescripts, LLC not to compete in the electronic prescription routing market, and by conspiring with Surescripts, LLC to monopolize that market, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Powell Prescription Center, et al. v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-06627; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-06778; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Falconer Pharmacy, Inc. v. Surescripts LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-07035. In November 2019, <ix:nonFraction unitRef="complaint" contextRef="i241bdb994a38412ea8d52d2de2c21019_I20191130" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI2Mzkz_efb322af-f170-4a5e-855b-f622a3989fd7">three</ix:nonFraction> similar complaints were filed in the United States District Court for the Northern District of Illinois. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7445; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Whitman v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-7448; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BBK Global Corp. v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7640. In December 2019, the <ix:nonFraction unitRef="complaint" contextRef="if6bbf73876be402592d7ed83f5fa934f_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI2NzEy_4ed24d30-4f2a-439b-bf63-a59f10dc1d89">six</ix:nonFraction> actions were consolidated in the Northern District of Illinois. The complaints seek relief including treble damages, attorney fees, and costs. Subject to final court approval, plaintiffs and RelayHealth reached an agreement in June 2020 to resolve the class action lawsuits and RelayHealth paid into escrow an amount not material in the context of the Company&#8217;s overall financial results. The settlement does not include any admission of liability, and RelayHealth expressly denies wrongdoing.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., <ix:nonFraction unitRef="state" contextRef="icaa7143e43f54500bac344b182f4e41a_D20200701-20200731" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMTgxMjA_fa59dbb2-95aa-4be0-b70b-04cb3460daa5">27</ix:nonFraction> states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i77c39bfaa86a4055bdfb3701c73f16b1" continuedAt="icfc8a8a02c0a41e88886d7f918ffdb7e"><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017 and August 2018, respectively, the Company was served with&#160;<ix:nonFraction unitRef="case" contextRef="ib6cab553ef4649228197f51778134e0f_I20180831" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI3OTM5_d1154ca2-7661-46fe-a1e6-d21ef9de0ebb">two</ix:nonFraction>&#160;separate Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York relating to the certification the Company obtained for <ix:nonFraction unitRef="softwareproduct" contextRef="ib6cab553ef4649228197f51778134e0f_I20180831" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberofSoftwareProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI4MTAx_69257d15-9316-4f98-a15e-8715fa765868">two</ix:nonFraction> software products under the U.S. Department of Health and Human Services&#8217; Electronic Health Record Incentive Program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April and June 2019, the United States Attorney&#8217;s Office for the Eastern District of New York served grand jury subpoenas seeking documents related to the Company&#8217;s anti-diversion policies and procedures and its distribution of Schedule II controlled substances. The Company believes the subpoenas are part of a broader investigation by that office into pharmaceutical manufacturers&#8217; and distributors&#8217; compliance with the Controlled Substances Act and related statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 12, 2019, the New York Department of Financial Services sent a Notice of Intent to Commence Enforcement Action to McKesson Corporation and PSS World Medical, Inc. for alleged violations of the New York Insurance Law and/or New York Financial Services Law, and seeking civil monetary penalties, in connection with manufacturing and distributing opioids in New York. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the United States Attorney&#8217;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV is also part of the investigation. On April 23, 2021, McKesson received correspondence from the Belgian Competition Authority seeking civil penalties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" format="ixt:numdotdecimal" name="mck:OpioidStewardshipActNewYorkAnnualSurcharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU0OTc1NTgyMTM1ODg_267e79fe-540f-4680-be43-cf393755b3ca">100</ix:nonFraction>&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $<ix:nonFraction unitRef="usd" contextRef="i56b06f9b88e745caa7ce9e463ac4f6b6_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMjYzMTQ_f97e8556-2947-436e-8454-250e57b07f1e">50</ix:nonFraction> million pre-tax charge ($<ix:nonFraction unitRef="usd" contextRef="id02805e7f2944185bec84529e72a977d_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualProvisionAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMjYzMjE_154d9036-97b0-4cfe-9ab8-b1481f5b5dc6">37</ix:nonFraction> million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March&#160;31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March&#160;31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The due date for filing such a petition is May 17, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="icfc8a8a02c0a41e88886d7f918ffdb7e"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V.&#160;Environmental Matters</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily as a result of the operation of the Company&#8217;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at <ix:nonFraction unitRef="site" contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:SiteContingencyNumberofSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMwNjY2_adedcb55-191d-44c2-9307-7be8533aa65d">five</ix:nonFraction> sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a determination by the Company&#8217;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#8217;s probable loss associated with the remediation costs for these <ix:nonFraction unitRef="site" contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:SiteContingencyNumberofSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMTI1_adedcb55-191d-44c2-9307-7be8533aa65d">five</ix:nonFraction> sites is $<ix:nonFraction unitRef="usd" contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccrualForEnvironmentalLossContingenciesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMTM3_710f2f52-e3f1-4f27-870c-88e0c84e0c6b">10</ix:nonFraction> million, net of amounts anticipated from third parties. The $<ix:nonFraction unitRef="usd" contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccrualForEnvironmentalLossContingenciesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMTky_710f2f52-e3f1-4f27-870c-88e0c84e0c6b">10</ix:nonFraction> million is expected to be paid out between <ix:nonNumeric contextRef="i27c1da308c4b4144b44b8bf3d8fb146b_D20200401-20210331" name="us-gaap:SiteContingencyTimeFrameOfDisbursements" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMjMw_19390ff1-6c30-4c81-b2cd-f3f24b27889b">April 2021</ix:nonNumeric> and <ix:nonNumeric contextRef="ia01db295201a4e96a3ef82db44b6fdc5_D20200401-20210331" name="us-gaap:SiteContingencyTimeFrameOfDisbursements" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMjM3_edb7b3e0-00aa-4318-bac3-da97ae0e8ae3">March 2051</ix:nonNumeric>. The Company has accrued for the estimated probable loss for these environmental matters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been designated as a Potentially Responsible Party (&#8220;PRP&#8221;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at <ix:nonFraction unitRef="site" contextRef="i043439014160460cb387b7eff982bfc3_D20200401-20210331" decimals="INF" name="mck:HazardousSubstanceSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxNTQx_af569406-7258-4ced-90d6-fc34eb22b66d">14</ix:nonFraction> sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. At <ix:nonFraction unitRef="site" contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberofSitesSelectedforPreferredRemedy" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxODE2_26b506c8-f319-4a97-8d16-613ee499e650">one</ix:nonFraction> of these sites, the United States Environmental Protection Agency has selected a preferred remedy with an estimated cost of approximately $<ix:nonFraction unitRef="usd" contextRef="i043439014160460cb387b7eff982bfc3_D20200401-20210331" decimals="-7" format="ixt:numdotdecimal" name="mck:EstimatedEnvironmentalAssessmentAndCleanupCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxOTU3_562b69b1-e6ab-4202-bf10-669d9a736e1e">1.4</ix:nonFraction> billion. It is not certain at this point in time what proportion of this estimated liability will be borne by the Company. Accordingly, the Company&#8217;s estimated probable loss at those <ix:nonFraction unitRef="site" contextRef="i043439014160460cb387b7eff982bfc3_D20200401-20210331" decimals="INF" name="mck:HazardousSubstanceSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMyMTM1_af569406-7258-4ced-90d6-fc34eb22b66d">14</ix:nonFraction> sites is approximately $<ix:nonFraction unitRef="usd" contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccrualForEnvironmentalLossContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMyMTYx_07e95df6-f222-4575-b118-b9a825c364ed">28</ix:nonFraction> million, which has been accrued for in the Consolidated Balance Sheets. However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VI. Value Added Tax Assessments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various countries outside the U.S. which&#160;collect value added taxes (&#8220;VAT&#8221;).&#160;The determination of the manner in which a VAT applies to the Company&#8217;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received&#160;assessments for VAT&#160;which are in&#160;various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions.&#160;Certain&#160;VAT assessments relate to years covered by an indemnification agreement.&#160;Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.&#160;However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or&#160;results of operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VII. Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $<ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMzAyMjA_5881ebf1-2f24-4acf-95e2-d028bc1edced">181</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMzAyMzQ_67ebe760-3d07-4eb4-96ac-d6205320c579">22</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMzAyNDk_62a4c465-374e-45fc-b314-7571cdae99ce">202</ix:nonFraction> million in 2021, 2020, and 2019, respectively, which were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VIII. Other Matters </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings and claims will not have a material impact on the Company&#8217;s financial position or results of operations.</span></div></ix:continuation><div id="i08f9baf810c0412e93ea6effc6d22995_220"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4Mzg_42655130-55b8-413d-b2a2-1e614ca2b86a" continuedAt="i91ff7361e647496b95df425614074890" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i91ff7361e647496b95df425614074890" continuedAt="ida9efadd61104493854cd8aba3026288">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4_75d01ff9-39a1-40b7-8607-146b3544e925">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ida9efadd61104493854cd8aba3026288" continuedAt="i1df3b01fb41144029822fee547191a2c"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the quarterly dividend was raised from $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTg3MTAw_98b9dc5e-ed05-49e2-a2a4-ded17e39b5a7">0.41</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i2fa25f7377e2432b8ee48290f92300f5_D20200701-20200731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTg3MTA3_574dbd04-db2c-41e6-b7ad-ea29f849877f">0.42</ix:nonFraction> per common share for dividends declared on or after such date by the Board. Dividends were $<ix:nonFraction unitRef="usdPerShare" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzM5OQ_d571f2ec-53cc-4b4e-a53c-f74cf3d4544f">1.67</ix:nonFraction> per share in 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQxOQ_0f10697a-7834-442a-b44b-6adbb0cdd05b">1.62</ix:nonFraction> per share in 2020, and $<ix:nonFraction unitRef="usdPerShare" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ0Mg_86593dd4-a9ba-482b-b537-18be2b16347e">1.51</ix:nonFraction> per share in 2019. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#8217;s future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:AcceleratedShareRepurchasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4NDc_467c37a7-05e2-4e8c-a942-9569487dd5d1" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the share repurchase activity over the last three years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022a2642b16245d083cb80c539e560b3_I20180331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzItNi0xLTEtMA_e5bf677b-6c82-4b3d-b40c-a508ff3075ef">1,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in May 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1aa1b3a0dc420f9bef7793ceda75bd_I20180531" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtNi0xLTEtMTMyMDY_9da50cf5-18c8-4ac2-a1a5-8aeb86e4ee92">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtMi0xLTEtMA_b71721c1-5e3e-4d9e-948c-d905a0579ea4">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtNC0xLTEtMA_93396d32-44f5-46cb-89d9-08f2a78a94ca">132.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtNi0xLTEtMA_9245afe0-9656-4678-a4d5-151efb2fa5ec">1,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtMi0xLTEtOTYxMg_b22b4cd2-2030-450f-8444-0cc949cf03a3">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtNC0xLTEtOTYxOQ_b5000591-9140-4820-a839-50f86f23a15a">117.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtNi0xLTEtOTYyOQ_423b8cff-5abd-4df4-9b1a-2696df96deb2">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzQtNi0xLTEtMA_2a6039e9-80ce-4e60-8de5-358d8a8b7044">3,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id903d050fec841a29536a88e85b3a251_D20190401-20200331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzgtMi0xLTEtOTY5Ng_03acef57-11bb-4936-b835-266fffedfbc2">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id903d050fec841a29536a88e85b3a251_D20190401-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzgtNC0xLTEtOTcxNA_e6c20c52-9c20-4b03-9b8d-d48d77a16a7d">144.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id903d050fec841a29536a88e85b3a251_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtNi0xLTEtMA_7553776e-8428-4b88-8c37-5c9bf04213f3">1,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzctMi0xLTEtMA_8a25b554-d300-4792-b5c8-53fcd569f67a">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzctNC0xLTEtMA_4419574e-07c8-4fa8-84ca-422d71bf393b">127.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzctNi0xLTEtMA_c670c4d3-8cfc-4652-8e1a-3a2ef4be0bd9">600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzgtNi0xLTEtMA_fba23d6a-6d91-4de7-98eb-3554bf537453">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f355bd7dad94edaa42f6261dbd8637e_I20210131" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzExLTYtMS0xLTEzMjA2_a90f71eb-27e8-4c4b-b2a0-14ff383116b7">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEzLTItMS0xLTEzMjA2_32edac1d-0491-4e29-8b3f-712ef78b72a4">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEzLTQtMS0xLTEzMjA2_2032c0e8-e154-4918-b699-94867a716a53">160.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEzLTYtMS0xLTEzMjA2_372d7873-3991-48cb-8477-c103744e5127">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEwLTYtMS0xLTA_0cc76499-9762-4313-a9f5-aad46f15126a">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to the Company&#8217;s Split-off of the Change Healthcare JV as described below.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">$<ix:nonFraction unitRef="usd" contextRef="i9c441ae8aa364ac5981834da3de52970_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:AccruedShareRepurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTg4NDM3_6edeb597-3425-4ceb-a352-0bb8a35bf288">8</ix:nonFraction>&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last three years, the Company&#8217;s share repurchases were transacted through both open market transactions and ASR programs with third party financial institutions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company retired <ix:nonFraction unitRef="shares" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesRetired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzM2MTM_ab407e80-fcc8-4622-a22f-5f56b378b8b6">5.0</ix:nonFraction> million or $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredParValueMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzM2MTk_82db3502-abfe-4431-9420-1c8ebb54a458">542</ix:nonFraction> million&#160;of its treasury shares previously repurchased. Under the applicable state law, these shares resume the status of authorized and unissued shares upon retirement. In accordance with the Company&#8217;s accounting policy, any excess of share repurchase price over par value is allocated between additional paid-in capital and retained earnings. Accordingly, its retained earnings and additional paid-in capital were reduced by $<ix:nonFraction unitRef="usd" contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredParValueMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQwNDA_ccde832f-8306-417d-8503-d1bb445d52e5">472</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockRetiredParValueMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQwNDc_d6ed9e0f-2595-4573-9f28-c5d79edc68cb">70</ix:nonFraction> million, respectively, during 2019.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i1df3b01fb41144029822fee547191a2c" continuedAt="i09537dd8140a4f94870e889ce06c70aa"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2020, the Company completed the Split-off of its interest in the Change Healthcare JV. In connection with the Split-off, the Company distributed all <ix:nonFraction unitRef="shares" contextRef="i63b13d6d7fdc4db998f4aad71d5d3642_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:ExchangeOfferSharesDistributed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ3MTM_c18fcd73-fb6a-4bbe-9a9a-dcd355645751">176.0</ix:nonFraction> million outstanding shares of SpinCo common stock, which held all of the Company&#8217;s interests in the Change Healthcare JV, to participating holders of the Company&#8217;s common stock in exchange for <ix:nonFraction unitRef="shares" contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentStockAccepted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ5MDE_39f4a7d9-b5e1-426d-a14e-40064e026a98"><ix:nonFraction unitRef="shares" contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309" decimals="-5" format="ixt:numdotdecimal" name="mck:ExchangeOfferSharesExchanged" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ5MDE_7daf8abd-e5e3-41a4-9bf6-523565c16474">15.4</ix:nonFraction></ix:nonFraction> million shares of McKesson stock, which are now held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change with each share of SpinCo common stock converted into <ix:nonFraction unitRef="shares" contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310" decimals="INF" format="ixt-sec:numwordsen" name="mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzUxODM_bba22226-c700-48a6-adcf-ef483d4dc178">one</ix:nonFraction> share of Change common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzUyNDM_bd1ade41-2999-435f-a331-5fcfb7c62740">0.001</ix:nonFraction> per share, with cash being paid in lieu of fractional shares of Change common stock. See Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for more information. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4NDU_af5d55af-cad5-4100-b20c-d00455e51c45" continuedAt="ib4486d45eb5e4bf2a4dd6a7d419b1616" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWI2M2E5ZTQyMDRjMzhhMTgyOTBkMTI4NDJiNDU4XzU0OTc1NTgxMzkwMDg_be988693-67b4-4b6a-b4db-2d7ef099f252">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWI2M2E5ZTQyMDRjMzhhMTgyOTBkMTI4NDJiNDU4XzU0OTc1NTgxMzkwMTY_89cba88c-205e-4b20-9c10-4bdba9674cd1">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWI2M2E5ZTQyMDRjMzhhMTgyOTBkMTI4NDJiNDU4XzU0OTc1NTgxMzkwMjQ_79ee6432-452b-462c-a3e1-1b4fdbb9713e">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMS0xLTEtMA_1ab98349-92e9-4778-b635-5ea25c016c05">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMy0xLTEtMA_246add55-fcea-4ef3-9892-3986e07cb5cd">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtNS0xLTEtMA_f75fd46b-bc2c-44b4-a92a-6e16808e8a11">431</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIyMDAxNzFlYTJkYTQxOGM4NzkwMmViYTdjYWE3YmMwXzU0OTc1NTgxMzg5Njg_ae0a11ea-202e-43f2-bc00-6a47479becdb">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIyMDAxNzFlYTJkYTQxOGM4NzkwMmViYTdjYWE3YmMwXzU0OTc1NTgxMzg5NzU_7d8e1689-2cde-4e5c-b6d8-c0fccda783e1">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIyMDAxNzFlYTJkYTQxOGM4NzkwMmViYTdjYWE3YmMwXzU0OTc1NTgxMzg5ODQ_fb8316e6-ad8e-49d4-b144-2314c6b9a249">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMS0xLTEtMA_42a9f658-ee78-4009-b43a-7ee9c4c119c2">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMy0xLTEtMA_efa3456f-1c2e-47c5-8cc7-3a9591a897d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtNS0xLTEtMA_81c69c80-871e-486f-850b-a74300ffc318">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzUtMS0xLTEtMA_79e95c9f-9b15-4a79-8148-fcad870ae9a1">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzUtMy0xLTEtMA_d595913f-fc67-47a2-854f-9c3049cf8a56">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzUtNS0xLTEtMA_27deafc5-d8da-4656-b109-62b8b9ecb357">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMC0xLTEtMC90ZXh0cmVnaW9uOmM3NDIyMDY2YmI1MTRhOGU4NjQ5NDMwNDMxYjYyOGZkXzU0OTc1NTgxMzkwMjU_38d490b3-3773-4776-ac13-c3a2fdf0c073">62</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMC0xLTEtMC90ZXh0cmVnaW9uOmM3NDIyMDY2YmI1MTRhOGU4NjQ5NDMwNDMxYjYyOGZkXzU0OTc1NTgxMzkwMzY_bdd0f530-e0b1-488f-8e09-7bc7b76519c3">30</ix:nonFraction>), and $(<ix:nonFraction unitRef="usd" contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMC0xLTEtMC90ZXh0cmVnaW9uOmM3NDIyMDY2YmI1MTRhOGU4NjQ5NDMwNDMxYjYyOGZkXzU0OTc1NTgxMzkwNDU_c5ad975f-2156-4eea-aec3-9d39b9204518">71</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMS0xLTEtMA_4f4a7efd-afb5-4aff-8137-16d9750325df">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMy0xLTEtMA_4afe4493-abc4-4ff7-8a3a-c40fd7b594b0">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctNS0xLTEtMA_4a487b63-8be4-4b5a-b307-2389b7f442cf">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmRhNzI4MzQ4NjQ5ODQxZWY5MjBlN2U5OTk3OTc3M2NhXzU0OTc1NTgxMzg5Njc_fe5d114d-7e4f-4919-b9ca-ea6765f92c24">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmRhNzI4MzQ4NjQ5ODQxZWY5MjBlN2U5OTk3OTc3M2NhXzU0OTc1NTgxMzg5NzY_5e62752a-00cf-4a7e-b2e0-8a505658fb31">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmRhNzI4MzQ4NjQ5ODQxZWY5MjBlN2U5OTk3OTc3M2NhXzU0OTc1NTgxMzg5ODQ_b6246d13-5ce2-4446-94f1-aea9dde8ed84">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMS0xLTEtMA_4c672433-05f3-493d-a0e6-ee377b349164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMy0xLTEtMA_59019a1b-70bf-4a3f-a335-8a7cfcbe5a5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtNS0xLTEtMA_d3253dfe-ab22-4755-ac1c-ac741c0946ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzktMS0xLTEtMA_998813f7-0442-470e-9c25-0b378131ed31">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzktMy0xLTEtMA_32be45aa-5c41-4bd5-acaf-b167999803b4">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzktNS0xLTEtMA_fdeed4c2-cba2-4bf8-9bdf-43e2eee4609a">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjplYzNmZTc2YmJlZGE0ZWVkODFkNzZkOGJhNmQzYzI0OF81NDk3NTU4MTM5MDIw_b5e33a13-39cd-4a65-ac13-c9020416d643">6</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjplYzNmZTc2YmJlZGE0ZWVkODFkNzZkOGJhNmQzYzI0OF81NDk3NTU4MTM5MDMw_c59a6671-1aa2-410b-96bb-264bd7448646">12</ix:nonFraction>), and $(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjplYzNmZTc2YmJlZGE0ZWVkODFkNzZkOGJhNmQzYzI0OF81NDk3NTU4MTM5MDM4_ba1cf1eb-b9cd-4fd6-a02f-3f441bcbc5ee">4</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTEtMS0xLTA_5d87b989-6cfc-4cc1-a185-7952cf6ff9ce">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTMtMS0xLTA_02cc7973-bd9a-48e7-a5f1-fe2ae3e0c517">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e04822e0566406b894ca9c180380691_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTUtMS0xLTA_6361c371-4efb-4566-9460-f2cf3adb8e42">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="icba0d73afdaf4b6d95e21bc354b2880d_D20200401-20210331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo4NWEyZjZkYTc2NjE0N2U3YmJhM2Q5M2EwYTc4NjE2YV81NDk3NTU4MTM4OTY4_dac2c6fa-19d0-4741-bc10-25d0321502dc">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="i03252b88bd734ce7a56608ddb4d375e6_D20190401-20200331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo4NWEyZjZkYTc2NjE0N2U3YmJhM2Q5M2EwYTc4NjE2YV81NDk3NTU4MTM4OTc3_dd1631d8-569d-4946-9d40-6a1cf2bdcd59">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="id3c5d000b0d24643ae449965b3c153e6_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo4NWEyZjZkYTc2NjE0N2U3YmJhM2Q5M2EwYTc4NjE2YV81NDk3NTU4MTM4OTg2_dae9013c-d2d1-4cf4-8f5b-bf308f75e2b0">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTEtMS0xLTA_81c0c57a-db64-4ff8-8387-0e981b781bba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTMtMS0xLTA_86c7a596-fb62-4a46-bfe8-559631d94274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e04822e0566406b894ca9c180380691_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTUtMS0xLTA_a2143970-8e37-4a85-bcce-ba3267164704">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEzLTEtMS0xLTA_06d1f360-f942-4992-89a7-04d233b3b573">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEzLTMtMS0xLTA_fae8e3bc-a1b4-4edf-b6b8-78b583fddf7a">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e04822e0566406b894ca9c180380691_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEzLTUtMS0xLTA_adf6cb82-d82d-4a45-8b61-0b1798e2624f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YjBmZGIyNWU0MGQ0ZjA1YTkzMzJlNzc5MDU1NmFmMF81NDk3NTU4MTM5MTAy_307740a1-6f9f-4522-a90b-4ebcc72e05d4">2</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YjBmZGIyNWU0MGQ0ZjA1YTkzMzJlNzc5MDU1NmFmMF81NDk3NTU4MTM5MTEw_80fb6fdb-a741-4161-a35a-1d727ce49a2b">8</ix:nonFraction>), and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YjBmZGIyNWU0MGQ0ZjA1YTkzMzJlNzc5MDU1NmFmMF81NDk3NTU4MTM5MTE2_72501057-7c70-4d83-a63a-b758ce998454">5</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideef425eabb04ab1a5e71cbf9973e5f2_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTEtMS0xLTA_46723e4f-2f1d-4e93-813b-bb7aba27cbc5">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47ea8d9084a4afca5dba67392106eea_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTMtMS0xLTA_60abe25f-d907-4d72-99b8-b93c3b0caf71">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb2e27caae16447596fd19fbd3c9a88d_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTUtMS0xLTA_2578931e-00e9-4d47-82ea-41f9a566354d">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZWViMzI4ODllODA0YmYzYmI4NThjNWEzZGZjODRiOF81NDk3NTU4MTM5MDUw_b69401f2-2ab7-48e4-8096-e2a557297834">1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZWViMzI4ODllODA0YmYzYmI4NThjNWEzZGZjODRiOF81NDk3NTU4MTM5MDU4_a91731c9-8843-4853-bb7a-e825e6d39ee4">1</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZWViMzI4ODllODA0YmYzYmI4NThjNWEzZGZjODRiOF81NDk3NTU4MTM5MDY4_739965d0-3f5b-4c52-ac26-621f0ef09c82">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ce45207fbd4b11992c8b235c7acdc4_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTEtMS0xLTA_27f527e0-b169-42aa-acf7-b823f16b5651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8458e101d22b48b086cd13c117b50596_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTMtMS0xLTA_03ec55f9-0219-42d5-9392-fd670ca5af58">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa299a34d5fc4bc9b76f73609f2764c6_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTUtMS0xLTA_e6a43301-61c8-48b8-a774-8602e99bb397">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1NjdmZjU0ZmRjY2Q0ZWRmYWFlYTBkYjFhN2RlYTVlZl81NDk3NTU4MTM4OTg1_643fdc60-4722-4957-a254-a6b943b46ceb">nil</ix:nonFraction>, <ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1NjdmZjU0ZmRjY2Q0ZWRmYWFlYTBkYjFhN2RlYTVlZl81NDk3NTU4MTM4OTkz_ec4f2340-44a5-49aa-a75c-57c0218353cc">nil</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1NjdmZjU0ZmRjY2Q0ZWRmYWFlYTBkYjFhN2RlYTVlZl81NDk3NTU4MTM5MDAx_a1d6ea72-bb18-43a8-a6cb-a24229534a70">nil</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25daf5026b554fff9b18eed266aeb5b3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTEtMS0xLTA_56d0e3ad-4378-4cff-a0f2-4ff125e033eb">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c768d5a4a684f049a881df6f6e2b57b_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTMtMS0xLTA_e1f744b6-0c00-4ffd-b64f-f5c3d7f67c40">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4560aec4e3b49c4bac2fdf164699f86_D20180401-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTUtMS0xLTA_1b4d63d7-3e9e-4011-9dc0-0fcd8c631f86">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MTg1ZTIwMzlkYTg0NWZlYTg1YTM4NjY3MjBhY2VmMV81NDk3NTU4MTM4OTk2_fa4bca0e-4582-445a-95db-1ba8a09a6955">9</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MTg1ZTIwMzlkYTg0NWZlYTg1YTM4NjY3MjBhY2VmMV81NDk3NTU4MTM5MDA2_da76a5cc-fe84-4daa-ba3f-c6b4f88712f0">33</ix:nonFraction>, and <ix:nonFraction unitRef="usd" contextRef="id2556775e1fe47e6992440fb0541be59_D20180401-20190331" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MTg1ZTIwMzlkYTg0NWZlYTg1YTM4NjY3MjBhY2VmMV81NDk3NTU4MTM5MDEy_8702ee4b-4ccb-42fd-a492-75d04bae4e5f">nil</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTEtMS0xLTA_6bc9f60f-30e6-4dcc-bf82-24d3695d52f5">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTMtMS0xLTA_0090ce75-de70-4de4-936a-912b0542208c">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2556775e1fe47e6992440fb0541be59_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTUtMS0xLTA_06c954e1-f1d6-4f22-af3f-3e3ee5bd693c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE5LTEtMS0xLTA_b7e89a2c-7e91-4609-83d8-979257766305">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE5LTMtMS0xLTA_aa8274e0-a3a6-476d-a0fc-864f12123b3b">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2556775e1fe47e6992440fb0541be59_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE5LTUtMS0xLTA_3fbde136-519f-4317-8af1-8248eaa1dcec">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzIxLTEtMS0xLTA_c39a8cc4-ac14-4f3c-bef5-63bb32486747">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzIxLTMtMS0xLTA_c44c6c52-2c56-45ca-bd98-90e1168f7305">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzIxLTUtMS0xLTA_d745f4d5-778c-49fd-8a41-a3de70c1bff6">198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021, 2020, and 2019 include net foreign currency translation adjustments of $(<ix:nonFraction unitRef="usd" contextRef="i0c24314d9c3e4d9f94843d3a48b7eede_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY1NDI_c89e9a30-e115-4e84-9e0e-347857211a95">60</ix:nonFraction>) million, $<ix:nonFraction unitRef="usd" contextRef="ieaed4a2b4af4445f83330c94eec2f1a2_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTgzODU5_68751899-bd14-43f4-8274-6d13ced6d12f">1</ix:nonFraction> million, and $(<ix:nonFraction unitRef="usd" contextRef="i1234f72c09014e849c5e914cbc33f91a_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTgzODY4_e48ecfb7-46cb-4a4e-b7f5-264b7810a48c">61</ix:nonFraction>) million, respectively, attributable to noncontrolling and redeemable noncontrolling interests.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021 primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Consolidated Statements of Operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i09537dd8140a4f94870e889ce06c70aa" continuedAt="iee2e9d0a8b2b43e8b068d689237f0510"><ix:continuation id="ib4486d45eb5e4bf2a4dd6a7d419b1616"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021, 2020, and 2019 include foreign currency adjustments of $(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY3NDI_d3408258-068a-4276-91f9-e033fd299545">118</ix:nonFraction>) million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY3NDk_8b378c53-affa-422e-8a1a-45cb1912e17a">39</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY3NjY_c708125c-1728-4af2-ae0e-95ef111cccc9">259</ix:nonFraction> million, respectively, on the net investment hedges from the Euro and British pound sterling-denominated notes. 2021, 2020, and 2019 also include foreign currency adjustments of $(<ix:nonFraction unitRef="usd" contextRef="ia231762ec9524000b72d1100dc01e0b9_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY5MTc_5fbebb68-2e30-440f-afb2-9be5088da1b3">119</ix:nonFraction>) million, $<ix:nonFraction unitRef="usd" contextRef="i817e532872ff41b49bff73a8ac0e47c5_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY5MjQ_96f487a1-bec7-443f-a9d7-754cdf82bfa7">76</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i53fd7c4598e7493daae729bcc3ff421e_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY5NDE_9911ff1c-0176-421a-9b29-1ce89956ec4c">53</ix:nonFraction> million, respectively, on the net investment hedges from the cross-currency swaps. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 2021 and 2020 net actuarial gains of $<ix:nonFraction unitRef="usd" contextRef="i739cbdd44da747b7add6dc8608dd1b5a_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzcwMzY_16b2a392-e6c6-4948-8d1f-c57bcbf0f780">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i15be07b9acdf4513a30f3849808f530c_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTgzOTQz_812deb45-a7b5-434c-9883-657b3dbb02b7">2</ix:nonFraction> million, respectively, and 2019 net actuarial loss of $<ix:nonFraction unitRef="usd" contextRef="i07af8a5be55944b695812fe13bfcd58b_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzcwODg_e70db43c-d9bf-4b87-a420-03ca895f348c">5</ix:nonFraction> million were attributable to noncontrolling and redeemable noncontrolling interests. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into &#8220;Cost of sales&#8221; and &#8220;Operating expenses&#8221; in the Consolidated Statements of Operations. The related tax expense was reclassified into &#8220;Income tax benefit (expense)&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2020 primarily reflects a reclassification of losses in 2020 upon the termination of the Plan from &#8220;Accumulated other comprehensive loss&#8221; to &#8220;Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the Company&#8217;s Consolidated Statement of Operations.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE5NzkxMjA5MzE2OTQ3_ce9737aa-87f2-4810-bed9-f808ebc0b637" continuedAt="i6e86269ce8d542749c147724c30ad7e1" escape="true">Information regarding changes in the Company&#8217;s accumulated other comprehensive income (loss) by component are as follows:</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;text-align:center"><ix:continuation id="iee2e9d0a8b2b43e8b068d689237f0510"><ix:continuation id="i6e86269ce8d542749c147724c30ad7e1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec9cc36803c34f05a0d2e66ae17760bd_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItMS0xLTEtMjMzNTM_6de58c01-f6d8-44b6-bf56-f9da9ed8f190">1,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c5b221e50b470489c015c3be354825_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItMy0xLTEtMjMzNTM_d16474f9-e9c6-4f9a-a5fe-134e4c0e0041">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dc447cc3eef4e94805a56f586f3f29b_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItNS0xLTEtMjMzNTM_9d7b5e2d-25c5-49d2-bd91-ed08ae0af16e">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5380417ed05b451283f8c1532ae7d259_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItNy0xLTEtMjMzNTM_5b949908-d741-4fd5-a8d6-d31f5bef986a">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40ae5de5a7ed451daaf6f336a3613e5b_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItOS0xLTEtMjMzNTM_ac3a0fd8-56b1-4697-8a7c-578f6422592c">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtMS0xLTEtMjMzNTM_6ada95ae-c281-41a5-a476-dfec44a71cd2">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtMy0xLTEtMjMzNTM_444e9438-fed9-46c0-9726-979afb0002ed">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtNS0xLTEtMjMzNTM_2b62bebe-3ab0-4e81-ad3e-f16ab19f9fd6">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtNy0xLTEtMjMzNTM_8b775a51-85dd-435b-932c-ffcf309676d9">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtOS0xLTEtMjMzNTM_282d7fb1-5229-49cc-9c76-6af4b5aa9b24">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtMS0xLTEtMjMzNTM_4de92bc5-4ff7-4a62-a3d9-a27ff06df1e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtMy0xLTEtMjMzNTM_0e241807-6caf-4f08-ab89-e423656bd997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtNS0xLTEtMjMzNTM_18bc5662-4477-4723-9737-50ea3420cd9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtNy0xLTEtMjMzNTM_03672151-cdc2-472e-9609-c4c0ea8be832">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtOS0xLTEtMjMzNTM_4bf4e168-0498-49d1-9cb2-c5453776775d">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtMS0xLTEtMjMzNTM_c08df965-1679-49cd-be5a-d25d40f4421f">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtMy0xLTEtMjMzNTM_0473006c-3ed4-447f-bda6-b7d2261e8e8d">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtNS0xLTEtMjMzNTM_9e710c5c-1d80-41b8-b9d0-eb9a6cc396e1">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtNy0xLTEtMjMzNTM_484da5c8-1e0d-4e8f-b3ff-222880fb865b">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtOS0xLTEtMjMzNTM_81a2ac96-6bf0-4f7b-a55d-ae22f33e4190">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtMS0xLTEtMjMzNTM_8ff06ada-2a2c-47b1-832d-83215f66892a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtMy0xLTEtMjMzNTM_1f0fa80a-864f-4ce7-b5c3-4b964bb9718e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtNS0xLTEtMjMzNTM_f23556c3-e408-4322-b95c-94d15dcbcbff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtNy0xLTEtMjMzNTM_f2f3dbaa-ae84-4c7c-a00a-bd014c51e6a4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtOS0xLTEtMjMzNTM_1c174b50-2c95-4367-9dcd-f6b31d0d68f6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctMS0xLTEtMjMzNTM_bfb96a4b-6f83-4258-a4d7-046ed86f6076">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctMy0xLTEtMjMzNTM_532d45de-cc1f-4266-a75f-5f7a6e20f587">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctNS0xLTEtMjMzNTM_b84656f1-f068-4fba-acba-8d846eb62a68">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctNy0xLTEtMjMzNTM_9216a48e-2cd7-498a-9405-7e0d0b82d2f7">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctOS0xLTEtMjMzNTM_5eac08b2-645b-4757-a0d9-c4149e96cfba">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9a8afb096ba4b8086b849fdbc536601_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtMS0xLTEtMjMzNTM_b67a3c69-768d-464c-a9fd-1074e92452ca">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3429f651eb54a16929355b743eaba52_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtMy0xLTEtMjMzNTM_d41dd1f1-cf6d-4ec2-a940-a0c4a69ce1ad">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffce4b8d4569411a9a36db18bed95dc2_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtNS0xLTEtMjMzNTM_d0f473a8-f4c0-471a-b830-7dbabf47b8bc">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c1e0d879d74d0ba80ac1c15a6e17d3_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtNy0xLTEtMjMzNTM_b61c9c29-65c7-41fc-89dc-e6e18e968ada">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6c63db23ba743c9a62c831ddf5c11fe_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtOS0xLTEtMjMzNTM_41ad64ed-c8ab-4477-b8c9-bc06e060c9ce">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktMS0xLTEtMjMzNTM_c64cba9e-7934-471b-8b86-e6f3e2a2a481">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktMy0xLTEtMjMzNTM_3bf9c532-c76b-4699-b93a-2fb83434b0ff">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktNS0xLTEtMjMzNTM_5d900dca-2119-426f-be31-e8cd6a1c3e62">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktNy0xLTEtMjMzNTM_333341ba-4c12-4ec9-aeb5-a12f4a3a1597">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktOS0xLTEtMjMzNTM_3d766a52-0ae6-43b1-b8ea-5e6d6d6fbe67">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTEtMS0xLTIzMzUz_bea31833-9238-4e65-ad82-842d249bdd53">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTMtMS0xLTIzMzUz_3c3fbf84-e818-45eb-9093-c645f0c8c3c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTUtMS0xLTIzMzUz_bc1c6a17-d1e9-4c79-aad0-2ffe8e548277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTctMS0xLTIzMzUz_9f53b0a7-4ccb-4d63-9334-317c04db524c">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTktMS0xLTIzMzUz_956f1a84-fa89-4845-8112-0428cb81fa20">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTEtMS0xLTIzMzUz_19337cb2-880b-4a73-b562-4da8a2de45a5">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTMtMS0xLTIzMzUz_e13a1828-0b88-4b35-be81-a57c21c74d48">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTUtMS0xLTIzMzUz_6b9a3af7-4fd8-445b-9ceb-06c9d2c8c049">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTctMS0xLTIzMzUz_6c9d9fd8-5d47-444d-9332-85c8b6aaff58">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTktMS0xLTIzMzUz_632747d2-7d99-4eae-8ffc-1d2053764182">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTEtMS0xLTIzMzUz_551e5615-cb70-4515-8661-a9fb0398f7f3">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTMtMS0xLTIzMzUz_bae3fd75-0a6b-4b7e-9aa0-91b49757c8e4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTUtMS0xLTIzMzUz_f123968b-11d3-4963-9421-9df9796edb4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTctMS0xLTIzMzUz_d6eb4cb3-2a32-45cf-9763-f9aaed98471d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTktMS0xLTIzMzUz_9e892289-d0f0-46f8-8535-c47db1b1a2f4">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTEtMS0xLTIzMzUz_00b470ef-5912-40ca-bca0-7bafe277f556">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTMtMS0xLTIzMzUz_d012ca36-4e10-4f68-8620-659441a464f4">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTUtMS0xLTIzMzUz_62f34fc1-e5d3-4e1d-8211-376f1e985f1c">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTctMS0xLTIzMzUz_0494ba4f-1f9e-466d-9065-b31912e28849">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTktMS0xLTIzMzUz_0f771789-905c-4af4-9131-c2a8c83a8853">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i621e3a8fa6994bd5a5330f05ec7cdff3_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTEtMS0xLTIzMzUz_f51a1848-fcd4-49d3-989f-6de860ddc8ae">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie174ba8ffb9244afb1dd4b6122d4fbd3_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTMtMS0xLTIzMzUz_b061b93b-b2ea-463d-ab62-754056634fca">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba47de0abc2f48d494cd9612200292a8_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTUtMS0xLTIzMzUz_04f9578c-61db-498d-bdcc-09a466606da2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17c5e4430f874e8f99d8a1bf5f30f24c_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTctMS0xLTIzMzUz_ab114808-110d-4097-800a-ff42e88ac2d8">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9384c8d2c240451493d40ead28d2d250_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTktMS0xLTIzMzUz_ef2da6c8-b381-441b-964c-5d640687bd5a">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_226"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzIxNjE_294e5ed1-44e9-43bf-91ae-f1dae9ee9571" continuedAt="i0ebae0f8db9847c19a7fdda839ad0507" escape="true">Related Party Balances and Transactions</ix:nonNumeric></span></div><ix:continuation id="i0ebae0f8db9847c19a7fdda839ad0507" continuedAt="ief424a47fcf64ff7ad047e9971511b29"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, a public benefit California foundation (&#8220;Foundation&#8221;) was established to provide opioid education to patients, caregivers, and providers, address policy issues, and increase patient access to life-saving treatments.&#160;Certain officers of the Company also serve as directors and officers of the Foundation. During 2019, the Company paid cash of $<ix:nonFraction unitRef="usd" contextRef="i04923cda81624c0c88a55ac1efd640f3_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzU0OTc1NTgxNDI3MDE_3ad7e536-5dc5-491c-a861-d7ab59c95bb3">100</ix:nonFraction> million to the Foundation to settle an outstanding pledge it made in 2018. During the fourth quarter of 2020, the Company also contributed $<ix:nonFraction unitRef="usd" contextRef="i88386d48d0584a11aad721e5144c887a_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2Xzg1Nw_b88c66bc-090e-49eb-904e-43f7ceb889a5">20</ix:nonFraction> million to the McKesson Foundation, which supports the Company&#8217;s employees and their community involvement efforts, with a special focus on cancer. A portion of this contribution was directed to an emergency employee assistance fund administered by the Emergency Assistance Foundation, an independent nonprofit organization, to provide support for employees impacted by the COVID-19 pandemic.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $<ix:nonFraction unitRef="usd" contextRef="ia7481f6650044b3dba08713c24b295ca_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzEzMTk0MTM5NTM1NDk5_a31400ec-2c0e-405a-9e9d-e4b31377d296">178</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ie85e4307493243a5b472a5635d3adc29_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE1MDI_957f1413-821a-4bbb-8adf-0ffae119ff28">141</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ia887d330153d49cf8839b2dd8a1d6605_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE1MDY_3fa07a77-f674-44e9-8a08-8e1cb07b5496">137</ix:nonFraction> million, are included in the Consolidated Statements of Operations for the years ended March&#160;31, 2021, 2020, and 2019, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 2020, and 2019, the Company&#8217;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $<ix:nonFraction unitRef="usd" contextRef="i4b60cdb02b3c4589b40ac24c56bb249e_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzEzMTk0MTM5NTM1NTM2_686c8142-a3e0-4ee5-8edd-91444f063279">111</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i944454336222406cbbe7e294bceecc04_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE4OTI_4cc7fea9-00a7-4f04-ab4d-ab3b3daf0962">60</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i175e65bdb63d42c090c72de7f9bdc403_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE4OTk_39642216-d9f9-4a6e-b2a7-9c9981f5a123">34</ix:nonFraction> million, respectively. Trade receivables related to these transactions from this investee were not material as of March&#160;31, 2021 and 2020.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ief424a47fcf64ff7ad047e9971511b29">Refer to Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for information regarding related party balances and transactions with Change and the Change Healthcare JV.</ix:continuation> </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_229"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzIwMzQwOTY1MTU3MDU4_d0afd8bb-dcea-48e0-b8b7-30a9fde2c88e" continuedAt="i7cd0870357bd4bff916fe639f9e4d204" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="i7cd0870357bd4bff916fe639f9e4d204" continuedAt="i9c89158988004b6da3526f04e4d4664e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="segment" contextRef="iea92921488274912b519ed84b11ab23f_D20200701-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzMzk2NjY_215e1f71-88e7-4593-bb39-85046fd60a3d">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="iccdd71b92ffa4cb2b159c9a557fb6ba8_I20210331" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzMzk5Mzk_367c21f9-2120-423f-b3a7-3cb347072f29">13</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="numberofproducts" contextRef="i9d099d3619b4467b8a30ab61cc9c0d8e_I20210331" decimals="-1" format="ixt:numdotdecimal" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzU0OTc1NTgxNzM3NDQ_eeeaae28-f5bd-4813-8eea-e8bf91951c30">275,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the United States.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9c89158988004b6da3526f04e4d4664e" continuedAt="idac60072d8d1447d92e76e00fa00e757"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve the Company&#8217;s biopharma and life sciences partners and patients. RxTS works across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="idac60072d8d1447d92e76e00fa00e757" continuedAt="iee19d42be2d14ec3bfe6e212b305a4b9"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzYyNjQ_48c22930-6508-4a91-9ebf-91fee91db8ee" continuedAt="i867138e18e5a4401839ebdd718f3b2dd" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMtMS0xLTEtMA_c6034d96-93fd-48d2-abbe-5d9305e8d276">189,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMtMy0xLTEtMA_d9a14ce2-e032-4fde-a866-53404bc86eae">181,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a2c0c157ca4b96abb1b4665b27847c_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMtNS0xLTEtMA_7f04aa11-7a3c-421d-b42f-3e0964ffe029">166,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzQtMS0xLTEtMA_d71d35af-0c46-4747-abe1-20f51195da1a">35,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzQtMy0xLTEtMA_77047f70-37cc-438d-8d12-23dc9bdcc8c3">38,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzQtNS0xLTEtMA_974dbfda-5cfb-4161-984e-83341a83e3fa">38,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzUtMS0xLTEtMA_0532ed76-d238-4244-a825-3a3fdabaf608">10,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzUtMy0xLTEtMA_7503abdd-f9f9-4ec8-9498-368ec6d7b386">8,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573770b6d3a94d0387b01cf824758b6e_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzUtNS0xLTEtMA_2350bc39-f5d3-4322-b0bb-c7bfb10d1234">7,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzYtMS0xLTEtMA_23c770b9-85e1-4540-ae78-cf4f211859be">2,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzYtMy0xLTEtMA_c12d54f9-8780-43ff-b79f-b2e7f78284e4">2,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42e59ef5f2b45d2973487b75779a397_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzYtNS0xLTEtMA_b9caa84b-ab85-4025-bfac-bb22bf66536f">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzctMS0xLTEtMA_8f6fbb93-90da-4ff9-9724-6275c66e9041">238,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzctMy0xLTEtMA_af0075cb-989f-47d6-9868-8b728cdc1184">231,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzctNS0xLTEtMA_c1778371-dff4-4694-b8ee-e9ba05fd867f">214,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEwLTEtMS0xLTA_b5072033-13ff-4994-a6e6-dbc6f3354590">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEwLTMtMS0xLTA_90d97206-a225-4c4a-a5d6-c2c88ad98f78">2,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEwLTUtMS0xLTA_9879b884-eb84-4dbf-8906-817a1b67a6ef">2,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzExLTEtMS0xLTA_96a3a37c-edea-405b-923d-cb642917384d">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzExLTMtMS0xLTA_786a44c5-5ba2-4cf2-863b-4c71ca17e667">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzExLTUtMS0xLTA_dbb1101f-a865-48db-ab5f-2d48486a3cf7">1,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEyLTEtMS0xLTA_9ce663e4-d1d8-4637-a390-754c5d417fc7">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEyLTMtMS0xLTA_5328846f-e247-4f44-9362-d0c77a1e9883">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEyLTUtMS0xLTA_7c8c65f6-7cab-40c6-8806-7df17b608dba">455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTEtMS0xLTcyMjE_d4218f13-5933-4bf5-b857-f4c9d52255a7">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTMtMS0xLTcyMjE_fee54346-6631-458f-a568-ff09612e221a">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTUtMS0xLTcyMjE_5b57a908-d835-4209-b1db-77852a3bda1b">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTEtMS0xLTA_5c5d5e1d-d082-4d6b-ae5a-982b3655e43c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTMtMS0xLTA_78da07fd-2bb5-47a0-b4f3-6099757b4eab">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTUtMS0xLTA_fa4eac45-84a9-434d-9ad7-f7de699d15c6">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE0LTEtMS0xLTA_1c6265bf-6900-40bc-b211-26ca35524b60">3,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE0LTMtMS0xLTA_ea085212-d984-44a4-ba51-27587215a366">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE0LTUtMS0xLTA_af38d434-46e4-4110-a3da-a3515705281c">1,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE1LTEtMS0xLTA_8a740d2a-21ee-48df-ba3a-5652d15ac1d7">8,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE1LTMtMS0xLTA_42986523-221f-4fb8-8de6-da1cdb773e9c">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE1LTUtMS0xLTA_2af9973f-394a-4358-a509-640fbae2f3ec">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE3LTEtMS0xLTA_ea394c92-edb2-4ad7-b1f0-bfe036ab3bbd">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE3LTMtMS0xLTA_14e37bdc-76aa-4526-940e-48a80680d61a">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE3LTUtMS0xLTA_25f611d1-9074-4181-9fc1-7cefbdf5dde3">264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE4LTEtMS0xLTA_81ebf2cc-5660-4f21-96b7-e16a3d9164bf">5,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE4LTMtMS0xLTA_305503c8-c734-4631-8e23-15a49593c923">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE4LTUtMS0xLTA_df8a017f-3161-41c9-b93c-8fd49930ba75">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIxLTEtMS0xLTA_efd6e821-8f32-4828-bf59-e4f27c10850d">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIxLTMtMS0xLTA_35a19c5c-9b44-4ffc-ae07-936d6e373d15">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIxLTUtMS0xLTA_7c718ae4-1ebd-4993-b358-70832855a6f8">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIyLTEtMS0xLTA_c7c9ec80-8329-4412-a2d0-3b79d2086813">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIyLTMtMS0xLTA_68d1cc52-c25a-48ea-93ad-eb06e6c6e757">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIyLTUtMS0xLTA_ff687e03-f7c3-4703-abbb-7259dbe95c9a">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIzLTEtMS0xLTA_dcf7d514-af9e-421a-b038-322bef8bbe3a">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIzLTMtMS0xLTA_69185f43-c124-45fb-bd1b-d01834dbaa0a">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIzLTUtMS0xLTA_52c5114d-4adb-48c9-94c1-b22adb1baf8a">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTEtMS0xLTcyNTA_57b3e4a7-fa89-45d9-ab93-7ae9bef19968">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTMtMS0xLTcyNTA_8c0c36eb-0c07-40d2-9905-c8dc3c9c99d7">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTUtMS0xLTcyNTA_8255b02c-b375-4cd5-8bf6-c16ef4f5dbb9">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTEtMS0xLTA_8c2eb633-8361-4d7f-b6c1-bd5ccc85c7a2">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTMtMS0xLTA_438ae199-4ff5-4a88-9d2f-a0a9c8fe61e8">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTUtMS0xLTA_debf0bdf-3930-483a-bb8c-5ee534f4df92">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI2LTEtMS0xLTA_c0cd1012-02b3-463e-9dca-3ecf0d7fae2d">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI2LTMtMS0xLTA_acc254a6-21ea-472a-a33f-79f5aae481c2">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI2LTUtMS0xLTA_fbcfcc81-ef79-48f2-bfac-67541b3f031b">949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI5LTEtMS0xLTA_f3316f93-8a95-4c4b-a973-2b67f0ea1a17">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI5LTMtMS0xLTA_a61e2d6d-1b50-4701-96c5-3be8ea34d149">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI5LTUtMS0xLTA_2e6816b9-49d3-4553-9c10-bbb393e9d21d">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMwLTEtMS0xLTA_efaf497b-5e05-4fe4-9610-725b82b5db17">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMwLTMtMS0xLTA_72ef5110-4223-4d3b-a38c-608ecab58787">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMwLTUtMS0xLTA_408b06b1-49fb-4b23-978e-b61fc9ffe204">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMxLTEtMS0xLTA_6d10709c-37b6-4423-a5c2-86cffc240c5e">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMxLTMtMS0xLTA_e593bee5-8b1c-4c54-af1d-731199aa5e46">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMxLTUtMS0xLTA_c8bc427a-9cd6-440b-b800-7d3e22fbc5b9">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTEtMS0xLTcyOTE_f56a4d15-87bf-4916-a99d-716b4410d677">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTMtMS0xLTcyOTE_acf19b1b-bc70-436f-b0d4-ab39f86af908">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTUtMS0xLTcyOTE_8e773b13-ecce-4431-9326-71715cbe2d6d">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMzLTEtMS0xLTA_ddc47e28-1473-4b8c-87ed-cf4d7888ae11">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMzLTMtMS0xLTA_dcb070c7-10c0-49c0-817e-54dafa2ad2f9">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092c23031111426996897acf81001bca_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMzLTUtMS0xLTA_edbcfc98-66a9-49db-94c6-a3d03a0b1e57">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTEtMS0xLTA_f931e9eb-3445-4004-9053-ee316f92c48b">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTMtMS0xLTA_c6873a6b-11aa-4747-a954-eed1516179dc">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTUtMS0xLTA_fa5e335b-adce-4552-b102-3038c482c420">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDE_4c6732c1-0ab8-4219-a547-ee47e8533fed"><ix:nonFraction unitRef="number" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDE_c1cff88f-2d4c-4b6a-8b86-09896fa5ee32"><ix:nonFraction unitRef="number" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDE_dfa43487-0c41-47df-8652-dc3323863e39">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTM_7536067e-9f35-400d-85b5-4a1d01bd2cb6"><ix:nonFraction unitRef="number" contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTM_c56c6060-d752-424a-833c-9cde8ddd4456"><ix:nonFraction unitRef="number" contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTM_ec4186ab-a9ed-43bc-bb81-b5fdac48cc54">7</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the International segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTc_3b80081b-4603-45b7-a097-543f059e690b"><ix:nonFraction unitRef="number" contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTc_4ec15a31-903c-4e3a-802d-0d21b9dee768"><ix:nonFraction unitRef="number" contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTc_832abce6-37a1-4add-b86b-4d08eb675ff5">2</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately <ix:nonFraction unitRef="number" contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDU_75ef80fa-be68-44af-acb8-edd4e1e95cc4"><ix:nonFraction unitRef="number" contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDU_d2657b73-302c-42a6-8ad6-d8071b0341d0"><ix:nonFraction unitRef="number" contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDU_dde7983f-a4a3-440b-b379-47c2c1e014f4">39</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iee19d42be2d14ec3bfe6e212b305a4b9"><ix:continuation id="i867138e18e5a4401839ebdd718f3b2dd"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for 2021, 2020, and 2019 includes credits of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzI5NjI_6e36f6ea-5276-41e1-bcce-3e6d7d180dc3">38</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzI5NjY_aa1345b0-6a9a-4bc1-9591-a4ac64076ec4">252</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzI5NzM_8fb81f3c-2f41-45ae-80b1-1ea1f7145aee">210</ix:nonFraction> million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2021, 2020, and 2019 also includes $<ix:nonFraction unitRef="usd" contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjU5ODQ_5881ebf1-2f24-4acf-95e2-d028bc1edced">181</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTk4NzM_67ebe760-3d07-4eb4-96ac-d6205320c579">22</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTk4Nzc_62a4c465-374e-45fc-b314-7571cdae99ce">202</ix:nonFraction> million, respectively, of cash receipts for the Company&#8217;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="i56b06f9b88e745caa7ce9e463ac4f6b6_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDE2NzQ_f97e8556-2947-436e-8454-250e57b07f1e">50</ix:nonFraction> million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; and operating profit for 2019 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="i14a2c0c157ca4b96abb1b4665b27847c_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzMyNzA_ed3ae486-12cc-410e-a547-b1da6980a917">61</ix:nonFraction> million related to a customer bankruptcy.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for 2021 and 2020 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i37e52c8b4b824321aa0ff56c256f2680_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTg5MDE_1af1af30-1d4d-4c19-9d77-91bb5dcd276e"><ix:nonFraction unitRef="usd" contextRef="i37e52c8b4b824321aa0ff56c256f2680_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTg5MDE_af76dd76-3a3f-4137-8f26-110017af2515">58</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GainLossOnSaleOfBusinessNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjI0MDY_367e58cb-e303-436d-873a-adb11be5e1fb"><ix:nonFraction unitRef="usd" contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjI0MDY_f3b51c1d-527e-409e-8ea2-1015688fe0ea">275</ix:nonFraction></ix:nonFraction> million (both pre-tax and after-tax), respectively, to remeasure to fair value the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture, as further discussed in Financial Note 3, &#8220;Held for Sale.&#8221; Operating loss for 2021, 2020, and 2019 includes long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjMwODg_f0642153-666b-403e-8b81-332fb586ce68">115</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTY5ODc_cd9f2420-7107-47ec-9a06-5ff76c0428a8">112</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjMwNzg_06dff2e7-92a9-434f-bb12-7a19b84c6330">245</ix:nonFraction> million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges.&#8221; Operating loss for 2021 and 2019 includes goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDc_a6efd2c7-98a6-48c3-bd67-449114874d25"><ix:nonFraction unitRef="usd" contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDc_ea546acb-4ff9-4810-afec-17c4f35e31ec">69</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDQ_74ba2270-0e3b-4b0a-b107-5c33bcec7c6c"><ix:nonFraction unitRef="usd" contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLossNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDQ_cbc3ec39-1caf-4e5b-a680-f53bc1d1ecee">1.8</ix:nonFraction></ix:nonFraction> billion (both pre-tax and after-tax), respectively, as discussed in more detail in Financial Note 12, &#8220;Goodwill and Intangible Assets, Net.&#8221; In addition, operating loss for 2019 includes a gain from an escrow settlement of $<ix:nonFraction unitRef="usd" contextRef="ib4526ff802af4c7fa6b4487275290425_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPreviousAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjQ1OTE_381a49b3-a2ad-4e0b-8726-b10f8185b27d">97</ix:nonFraction> million (pre-tax and after-tax) representing certain indemnity and other claims related to the Company&#8217;s 2017 acquisition of Rexall Health.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for 2021 includes charges totaling $<ix:nonFraction unitRef="usd" contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDM0MjE_a1bbb6c5-bfcb-4f15-a592-759f70616b63">136</ix:nonFraction> million on certain personal protective equipment and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s RxTS segment&#8217;s operating profit for 2019 includes a gain of $<ix:nonFraction unitRef="usd" contextRef="ia42e59ef5f2b45d2973487b75779a397_D20180401-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjAxNTE_ba6609e3-8d41-4b29-ac78-1c1792d19868">56</ix:nonFraction> million recognized from the sale of an equity investment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for 2020 includes an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzM5ODY_212283e9-a3ff-45e1-a73e-3d66735cf989">1.2</ix:nonFraction> billion and a dilution loss of $<ix:nonFraction unitRef="usd" contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQwMzU_98e75c31-a83c-4936-b036-80d9f623eefa">246</ix:nonFraction> million associated with the Company&#8217;s investment in the Change Healthcare JV, partially offset by a net gain of $<ix:nonFraction unitRef="usd" contextRef="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzMyOTg1MzQ5MjQxNDY_785def8a-4592-40bd-822e-89e7e2ac3fc5">414</ix:nonFraction> million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2019 includes a credit of $<ix:nonFraction unitRef="usd" contextRef="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:GainLossonDerecognitionofLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDYzMjE_c3143cb0-ebe9-4737-a52e-8980bce19369">90</ix:nonFraction> million for the derecognition of the TRA liability payable to the shareholders of Change. Operating loss for 2020 and 2019 also includes the Company&#8217;s proportionate share of loss from the Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDY1NTE_123b7160-614d-43f1-80f6-ecdf23f1f279">119</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDY1NTk_50d6a00a-7f42-40dc-96ab-ed2afafd39cc">194</ix:nonFraction> million, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, for 2021 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDQwNzU_f3b1a175-9d1e-40d7-802f-e40cef3adab9">8.1</ix:nonFraction> billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 19, &#8220;Commitments and Contingent Liabilities." Corporate expenses, net, for 2021 also includes net gains of $<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzMyOTg1MzQ5MjYxMjE_445e6cb6-69a9-459f-bd01-71870ac4d918">133</ix:nonFraction> million associated with certain of the Company&#8217;s equity investments and a net gain of $<ix:nonFraction unitRef="usd" contextRef="i60c4775af5034c77bdf45a4edf0c4a19_D20200401-20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDQ2NzU_a48a92b9-bc20-4f74-84f1-5eb2562831d4">131</ix:nonFraction> million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for 2020 includes settlement charges of $<ix:nonFraction unitRef="usd" contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzU1NzY_62e7c8dc-85f9-450a-ae74-f4c941ae8e4a">122</ix:nonFraction> million for the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $<ix:nonFraction unitRef="usd" contextRef="icbd9d23495db4b029833f9c192227a5c_D20190401-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzU2ODc_832b9b0c-a179-42b4-bdd6-664ba1cceecb">82</ix:nonFraction> million related to opioid claims.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div></ix:continuation><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzYyNDY_7b9f5f24-d4a6-4f88-b693-f36ae42fbc11" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3156368b6aea45b4b87b5079622f2703_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzMtMS0xLTEtMA_10a6745b-bcfc-4c3c-9734-13ffd63409a8">35,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b443c41cb334b4084c134a614b5a4aa_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzMtMy0xLTEtMA_ac148bfa-1258-4422-89e0-1d1877771afe">33,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie781b28ab2254939ac913ef650232aa3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzQtMS0xLTEtMA_4265102a-22d3-4a77-ab99-f31d240fb339">14,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc2495d4fd44412ae23a2d9511fc6b0_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzQtMy0xLTEtMA_63272eb9-1506-418d-9d3d-fedf31a2dcb0">14,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7e3dfff1504af6a6970090a4e7c85f_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzUtMS0xLTEtMA_49e8870c-5bd4-4d3f-aa61-09af340c6306">5,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d6c47ebd084b828cdbdba1b8f159f8_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzUtMy0xLTEtMA_76b95fd2-7259-4f8c-93bf-bab446c00d3f">5,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbfa7f443c9f4c30be51cebaefbd7dd1_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzYtMS0xLTEtNzM2Ng_fd9abb1b-8557-4ea4-ac21-f7a5d4d1db4f">3,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f353b74f6e48ea8c63365f74249445_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzYtMy0xLTEtNzM2Ng_6b7b5260-9c93-4155-8f82-e96ac0cf7065">3,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07652793af6e402c8f56ae5bf525de5d_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzctMS0xLTEtMA_4f078613-7ad1-4393-adb9-b6c077124555">5,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36b955ce23d4198b6aa3769dcf60d35_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzctMy0xLTEtMA_a483374f-547c-4098-b827-daa1f48578d7">3,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzgtMS0xLTEtMA_2ecae84a-81b2-43d8-bc84-79d6fb7d7c3d">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzgtMy0xLTEtMA_71b021dc-3989-415d-8b04-f4f456254faf">61,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida17c5841f1c46d28608950ca8175e62_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzExLTEtMS0xLTA_63b96ef7-6b4b-44a6-9ba7-d15b66b8bc12">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2310b3bfad364c4897f644c867bc31cb_I20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzExLTMtMS0xLTA_2353196f-a7c5-4660-a6c6-198c9d2e2662">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2364550eaa48c195ef408353004029_I20210331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEyLTEtMS0xLTA_55bde92f-ec15-4b0e-bf2d-09ba3ec0385a">984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74e45a0662448e0b98940f6a00fba1a_I20200331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEyLTMtMS0xLTA_c2fe50c7-5ded-456e-8e47-744ed676ac96">892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEzLTEtMS0xLTA_9f0acb52-299e-42ea-bd1e-05bc54fcedb5">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEzLTMtMS0xLTA_10a955d4-450d-4ef5-b9b4-beafa7b18a7e">2,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_235"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Concluded)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90ZXh0cmVnaW9uOmY1ZGU2NTQyYmQ0NjQ2ZGViODk5OGRmODM5MDkyZTdlXzM5MjU_0bcccb16-2c9e-4e34-964c-443b4111deeb" continuedAt="i93c1af8d208f4d748277f2ac73dbaff1" escape="true">Quarterly Financial Information (Unaudited)</ix:nonNumeric></span></div><ix:continuation id="i93c1af8d208f4d748277f2ac73dbaff1" continuedAt="i9bd77b24ca8e48609ef435977900b9fe"><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90ZXh0cmVnaW9uOmY1ZGU2NTQyYmQ0NjQ2ZGViODk5OGRmODM5MDkyZTdlXzM5MDk_465adb90-b356-4978-a129-3d4b6321ffb5" continuedAt="i152cd69d19ac4119bd18f502db8f9549" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year. Selected quarterly financial information for the last two years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth <br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItMS0xLTEtMA_2ce346d2-d035-4f4f-b7b0-fa84f5093d0f">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItMy0xLTEtMA_ac467e22-c6fd-4611-b91c-e116cb27c2b5">60,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItNS0xLTEtMA_b27832a2-b62c-4723-8772-d7878ad65abe">62,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItNy0xLTEtMA_2e540b71-75d0-4c99-89fc-e9448b86a50d">59,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtMS0xLTEtMA_a62a609f-01d9-48c7-aea4-ec8c13fb61b6">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtMy0xLTEtMA_0ad52893-bd2c-4dd7-8bfc-47de67adf4ef">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtNS0xLTEtMA_f4004040-f062-4720-bce5-12dac395a2e2">3,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtNy0xLTEtMA_c8e36f37-17fe-455c-85f2-153e3534066e">3,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) after income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtMS0xLTEtMA_957c85d7-5e9e-4d2d-b80c-f1a4d0a133db">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtMy0xLTEtMA_62416dbe-813f-463c-a4af-f0e97f917621">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtNS0xLTEtMA_18cca83d-0705-4717-a61d-e47779f96464">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtNy0xLTEtMA_99bbbee0-c786-485c-8b05-376fb633bbe6">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtMS0xLTEtMA_33f3a755-aa3b-4296-ab0b-66a9907ae375">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtMy0xLTEtMA_949cde40-a9da-40f3-9a65-ce16dbcf7507">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtNS0xLTEtMA_f4353fbe-cd2b-4e01-a5a4-466d800f4a57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtNy0xLTEtMA_7ae6dfdd-a9d2-418f-b0e8-d5571adeb2ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctMS0xLTEtMA_e72a84d0-78ce-4603-bf14-7aec215c27fb">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctMy0xLTEtMA_8b7f7552-ba34-45d5-bf4a-5baa0159a6ed">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctNS0xLTEtMA_312cef3b-feb7-465b-9d83-07f340a24da4">6,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctNy0xLTEtMA_4a74e272-0a4b-45b8-bb40-20ea3f0bdc63">713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtMS0xLTEtMA_855e5043-55e2-42c7-84a0-61a7c8d610a1">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtMy0xLTEtMA_53bdee3a-a827-4bca-8c00-0016e9a0a2a2">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtNS0xLTEtMA_335b6e47-e681-49ed-a2af-20bc1dad42d3">6,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtNy0xLTEtMA_e62c6030-9750-44c7-b026-abc2a0297119">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to McKesson Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTEtMS0xLTA_2e48e87f-944b-41c3-abb2-917de193c437">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTMtMS0xLTA_d0d973e5-299b-4542-ad9d-0c60c388df2d">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTUtMS0xLTA_845e118e-90ab-401c-810f-608f82130260">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTctMS0xLTA_fb9f2c0c-b17c-482c-b6cc-834e9737c97d">4.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTEtMS0xLTA_456fcb01-f616-4261-8658-46c41efa84d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTMtMS0xLTA_7df720f2-5e72-4eb7-8a2c-953f84c782d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTUtMS0xLTA_0f2ecfd6-87bb-4185-9467-868b4bb6900d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTctMS0xLTA_82e4d5f6-0c5e-4a10-a841-78e07752fbff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTEtMS0xLTA_e84bc68d-085c-481e-b229-676b60f89509">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTMtMS0xLTA_a7a7a805-bb40-40bc-9c15-91f8ae56fcc2">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTUtMS0xLTA_9fb56a4d-e16a-4902-802c-a3653699f222">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTctMS0xLTA_f9fd3790-b97e-4250-989a-c5fee6dca67a">4.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTEtMS0xLTA_f0dcb6ae-dc0a-4841-bac0-9f5813500dcd">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTMtMS0xLTA_46fbf528-37f7-4d36-b46d-b519df75348b">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTUtMS0xLTA_d071be04-bbab-485b-9f44-7644d7e6bfd9">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTctMS0xLTA_0756697d-a8f9-4911-bb6b-875a9a5ce6a3">4.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTEtMS0xLTA_67ede1b1-b00e-483c-ad4a-8e2358fe36e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTMtMS0xLTA_821fd331-b397-4b8a-b085-5a450bd3105f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTUtMS0xLTA_c4af8437-2400-467a-8ab4-0107125bbe95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTctMS0xLTA_baf15262-df59-4dfb-b5f6-3e39e97b3b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTEtMS0xLTA_ad57a512-ffb2-4fe4-90a7-f2813d1a4544">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTMtMS0xLTA_260f75c2-7f3f-400e-a6bf-cee3c9bb6449">3.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTUtMS0xLTA_a7c9cf04-29e6-43db-85b7-48773d28407b">39.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTctMS0xLTA_b7b096c5-765c-432f-a9c4-9ffdc914c1f7">4.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth <br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTEtMS0xLTE2NzA1_03ac4787-c201-4db6-8a3c-0190853f7045">55,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTMtMS0xLTE2NzA1_d626ba45-ea50-4d21-82ae-0a1d7afa94f8">57,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTUtMS0xLTE2NzA1_92bb01fa-7dc7-457f-8e6b-056323ec1add">59,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTctMS0xLTE2NzA1_95f619d9-4c63-4c31-8a1a-c9b53b5c6e21">58,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTEtMS0xLTE2NzM4_2ab955c5-65dd-4dc7-846e-551dc4a286c3">2,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTMtMS0xLTE2NzM4_2e02032c-3c88-413d-ae8d-3987f6544a0d">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTUtMS0xLTE2NzM4_09853840-7f95-44a1-9ea1-f3994c9189bf">3,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTctMS0xLTE2NzM4_e3e90ee8-2677-4f1d-b0db-763283ca519e">3,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) after income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTEtMS0xLTE2NzA1_edf59faf-5ebc-4345-bc80-7073126b428d">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTMtMS0xLTE2NzA1_ad957127-fe02-4f39-a7f4-9fd0815185dd">676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTUtMS0xLTE2NzA1_88d997bf-4bfb-44de-9a17-1382857df16b">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTctMS0xLTE2NzA1_d390672d-e6b1-4681-8365-3220e5da2fe7">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTEtMS0xLTE2NzA1_7af85847-0bda-4339-9529-0d5d9c714618">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTMtMS0xLTE2NzA1_9a3803fc-4bd3-4bc4-90f4-0fcc83b2ffae">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTUtMS0xLTE2NzA1_9f4acff8-7775-4a14-b1f9-c7552792b071">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTctMS0xLTE2NzA1_03564a0c-8ce4-4b5e-b930-c7fc69d497e5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTEtMS0xLTE2NzA1_e913c3fc-02bd-42b1-973f-276bf8e4099b">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTMtMS0xLTE2NzA1_2780338d-0928-439d-85bf-704f1f185c12">677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTUtMS0xLTE2NzA1_9a4e8c75-2b16-4f2c-94d2-7e84523acdd0">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTctMS0xLTE2NzA1_b7dcf06c-f524-46a6-8de3-c43192b73642">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTEtMS0xLTE2NzM4_29c33fe6-8fbd-47c5-b28a-5a4cdb382c05">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTMtMS0xLTE2NzM4_4aaf1b52-8fbb-4d8e-a36e-69e02f244cf2">730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTUtMS0xLTE2NzM4_1866a4fb-7c5d-47e4-9bf2-a946aac7ea0a">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTctMS0xLTE2NzM4_9f3947a7-0a9a-4a44-a300-11492e84a0a4">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to McKesson Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTEtMS0xLTE2NzA1_ca4e4ea0-043d-42cf-91dd-9cb515dc798f">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTMtMS0xLTE2NzA1_279dd6eb-1ec2-4797-88e2-ef817881aaaa">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTUtMS0xLTE2NzA1_0e2a6651-ae2a-479a-95b4-53a5e94ba8bf">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTctMS0xLTE2NzA1_2835ec56-3997-4b60-8e2d-cd988319dbb8">5.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTEtMS0xLTE2NzM4_1b808a84-fb84-4299-8b22-aa85df398c6a">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTMtMS0xLTE2NzM4_c91f8b10-7176-4eeb-82c0-5d3945968ba9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTUtMS0xLTE2NzM4_864b3359-5281-48d2-8638-99b8e6c58564">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTctMS0xLTE2NzM4_ada3d498-5cae-46b2-a1de-2afb2fc07df6">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTEtMS0xLTI2NzM0_5b834e6b-7e4b-432d-b863-4ab0cc2cd042">2.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTMtMS0xLTI2NzM0_e9c0aa63-a8fc-4dfe-bdc6-f59a39f91235">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTUtMS0xLTI2NzM0_5c8fd699-7ca8-43c9-8293-f134f37b87e2">1.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTctMS0xLTI2NzM0_5ceab9ff-b8a7-453a-812a-7aada7174157">5.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTEtMS0xLTE2NzM4_21c67a66-1760-4785-8b70-458e87c3519d">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTMtMS0xLTE2NzM4_45a381e7-bc5c-4812-9dbe-07b27994bb97">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTUtMS0xLTE2NzM4_e76dea2a-86ed-4162-90b8-d13699162221">1.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTctMS0xLTE2NzM4_783624d1-7393-4128-bb00-f13e07f19ad2">5.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTEtMS0xLTE2NzM4_9b1acd21-80fe-4d49-9a19-023b333bdec4">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTMtMS0xLTE2NzM4_6115ec9b-86cc-4c28-864d-900f601ade2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTUtMS0xLTE2NzM4_ac5e0fdc-a590-49d2-b561-f03f26fe7cbf">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTctMS0xLTE2NzM4_3eb0c24c-2b9f-4cb1-aa99-f3b3e94f8bbe">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTEtMS0xLTI2NzM2_57819691-888e-4e7c-88b0-1c4ea1f22428">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTMtMS0xLTI2NzM2_dc7aa938-0bfa-4d6e-8214-5a3a7dc6dff5">3.99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTUtMS0xLTI2NzM2_369c4bdf-87cb-4029-a87f-5733c87c15b9">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTctMS0xLTI2NzM2_0fc674c6-2716-4d1f-bae7-2eb33107be0f">5.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i9bd77b24ca8e48609ef435977900b9fe" continuedAt="i3db6cdaa7a6f4a0e9e8d3296d6ae76c4"><ix:continuation id="i152cd69d19ac4119bd18f502db8f9549" continuedAt="ia1dfec1b28c54acba6de89458222b615">(2)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i3db6cdaa7a6f4a0e9e8d3296d6ae76c4"><ix:continuation id="ia1dfec1b28c54acba6de89458222b615">As a result of the Company&#8217;s reported net loss for the third quarter of 2021 and the second quarter of 2020, potentially dilutive securities were excluded from the per share computations for those quarters due to their antidilutive effect.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_241"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_244"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this report and have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Control over Financial Reporting</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s report on the Company&#8217;s internal control over financial reporting (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and the related report of our independent registered public accounting firm are included in this Annual Report on Form 10-K, under the headings, &#8220;Management&#8217;s Annual Report on Internal Control Over Financial Reporting&#8221; and &#8220;Report of Independent Registered Public Accounting Firm&#8221; and are incorporated herein by reference.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_247"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_250"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_253"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our Directors is incorporated by reference from the discussion under Item 1 of our Proxy Statement for the 2021 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) under the heading &#8220;Election of Directors.&#8221; Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading &#8220;Information about our Executive Officers.&#8221; Information about our Audit Committee, including the members of the committee and our Audit Committee Financial Expert, is incorporated by reference from the discussion under Item 1 of our Proxy Statement under the headings &#8220;The Board, Committees and Meetings,&#8221; and &#8220;Audit Committee Report.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the Code of Conduct applicable to all employees, officers and directors can be found on our website, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.mckesson.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under the caption &#8220;Investors - Corporate Governance.&#8221; The Company&#8217;s Corporate Governance Guidelines and Charters for the Audit, Compensation and Governance Committees can also be found on our website under the same caption.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to post on its website required information regarding any amendment to, or waiver from, the Code of Conduct that applies to our Chief Executive Officer, Chief Financial Officer, Controller and persons performing similar functions within four business days after any such amendment or waiver. </span></div><div id="i08f9baf810c0412e93ea6effc6d22995_256"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this item is incorporated by reference from the discussion under the heading &#8220;Executive Compensation&#8221; in our Proxy Statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_259"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about security ownership of certain beneficial owners and management is incorporated by reference from the discussion under the heading &#8220;Principal Shareholders&#8221; in our Proxy Statement.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information as of March&#160;31, 2021 with respect to the plans under which the Company&#8217;s common stock is authorized for issuance:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plan Category<br/>(In millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities<br/>to be issued upon<br/>exercise of<br/>outstanding options,<br/>warrants and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">exercise price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">outstanding options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">warrants and rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">security holders</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">security holders</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   The weighted-average exercise price set forth in this column is calculated excluding outstanding restricted stock unit (&#8220;RSU&#8221;) awards, since recipients are not required to pay an exercise price to receive the shares subject to these awards.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)   Represents option and RSU awards outstanding under the following plans: (i) 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan; (ii) the 2005 Stock Plan; and (iii) the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)   Represents 2.23 million shares available for purchase under the 2000 Employee Stock Purchase Plan and 19.67 million shares available for grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of equity plans that have been approved by the Company&#8217;s stockholders. The plans are administered by the Compensation Committee of the Board of Directors, except for the portion of the 2013 Stock Plan and 2005 Stock Plan related to non-employee directors, which is administered by the Board of Directors or its Governance Committee.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Stock Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2013 Stock Plan was adopted by the Board of Directors on May 22, 2013 and approved by the Company&#8217;s stockholders on July 31, 2013. The 2013 Stock Plan permits the grant of awards in the form of stock options, stock appreciation rights, restricted stock (&#8220;RS&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance-based restricted stock units (&#8220;PeRSUs&#8221;), performance shares, and other share-based awards. The number of shares reserved for issuance under the 2013 Stock Plan equals the sum of (i) 30.0 million shares, (ii) the number of shares reserved but unissued under the 2005 Stock Plan as of the effective date of the 2013 Stock Plan, and (iii) the number of shares that become available for reuse under the 2005 Stock Plan following the effective date of the 2013 Stock Plan. For any one share of common stock issued in connection with an RS, RSU, performance share or other full share award, three and one-half shares shall be deducted from the shares available for future grants. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, including in respect of the payment of applicable taxes, or shares repurchased on the open market with proceeds from the exercise of options shall not be returned to the reserve of shares available for issuance under the 2013 Stock Plan. Shares withheld to satisfy tax obligations relating to the vesting of a full-share award shall be returned to the reserve of shares available for issuance under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted at no less than fair market value and those options granted under the 2013 Stock Plan generally have a contractual term of seven years. Options generally become exercisable in four equal annual installments beginning one year after the grant date. The vesting of RS or RSUs is determined by the Compensation Committee at the time of grant. Beginning with awards granted in fiscal year 2021, RS and RSUs generally vest over three years. RSUs granted under the PeRSU program vest three years following the end of the performance period. The Company&#8217;s executive officers and other members of senior management are annually granted performance awards called performance stock units (&#8220;PSUs&#8221;), which have a three-year performance period and are payable in shares without an additional vesting period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors may be granted an award on the date of each annual meeting of the stockholders for up to 5,000 RSUs, as determined by the Board. Such non-employee director award is fully vested on the date of the grant.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2005 Stock Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2005 Stock Plan was adopted by the Board of Directors on May 25, 2005 and approved by the Company&#8217;s stockholders on July 27, 2005. The 2005 Stock Plan permits the granting of up to 42.5 million shares in the form of stock options, RS, RSUs, PeRSUs, performance shares and other share-based awards. For any one share of common stock issued in connection with an RS, RSU, performance share or other full-share award, two shares shall be deducted from the shares available for future grants. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, shares withheld to satisfy tax obligations relating to the vesting of a full-share award or shares repurchased on the open market with proceeds from the exercise of options shall not be returned to the reserve of shares available for issuance under the 2005 Stock Plan. Stock options were granted at no less than fair market value and options granted under the 2005 Stock Plan generally have a contractual term of seven years.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the effectiveness of the 2013 Stock Plan, no further shares were made subject to award under the 2005 Stock Plan. Shares reserved but unissued under the 2005 Stock Plan as of the effective date of the 2013 Stock Plan, and shares that become available for reuse under the 2005 Stock Plan following the effectiveness of the 2013 Stock Plan, will be available for awards under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan was approved by the Company&#8217;s stockholders on July 30, 1997; however, stockholder approval of the 2005 Stock Plan on July 27, 2005 had the effect of terminating the 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan such that no new awards would be granted under the 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2000 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 of the Internal Revenue Code. In March 2002, the Board amended the ESPP to allow for participation in the plan by employees of certain of the Company&#8217;s international and other subsidiaries. Currently, 21.1&#160;million shares have been approved by stockholders for issuance under the ESPP.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is implemented through a continuous series of three-month purchase periods (&#8220;Purchase Periods&#8221;) during which contributions can be made toward the purchase of common stock under the plan. Each eligible employee may elect to authorize regular payroll deductions during the next succeeding Purchase Period, the amount of which may not exceed 15% of a participant&#8217;s compensation. At the end of each Purchase Period, the funds withheld by each participant will be used to purchase shares of the Company&#8217;s common stock. The purchase price of each share of the Company&#8217;s common stock is 85% of the fair market value of each share on the last day of the applicable Purchase Period. In general, the maximum number of shares of common stock that may be purchased by a participant for each calendar year is determined by dividing $25,000 by the fair market value of one share of common stock on the offering date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There currently are no equity awards outstanding that were granted under equity plans that were not submitted for approval by the Company&#8217;s stockholders.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_262"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to certain transactions with directors and management is incorporated by reference from the Proxy Statement under the heading &#8220;Related Party Transactions Policy and Transactions with Related Persons.&#8221; Information regarding Director independence is incorporated by reference from the Proxy Statement under the heading &#8220;Director Independence.&#8221; Additional information regarding certain related party balances and transactions is included in the Financial Review section of this report and Financial Note 21, &#8220;Related Party Balances and Transactions&#8221; to the consolidated financial statements appearing in this report.</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_265"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Accounting Fees and Services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding principal accountant fees and services is set forth under the heading &#8220;Ratification of Appointment of Deloitte &amp; Touche LLP as the Company&#8217;s Independent Registered Public Accounting Firm for Fiscal 2022&#8221; in our Proxy Statement and all such information is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_268"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i08f9baf810c0412e93ea6effc6d22995_271"></div><div style="-sec-extract:summary;margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits and Financial Statement Schedule.</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:88.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1)   Consolidated Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_82">Report of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_82">65</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">Consolidated Statements of Operations for the years ended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">March 31, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85"> and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_85">70</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">Consolidated Statements of Comprehensive Income</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88"> (L</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">oss)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88"> for the years ended March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88"> and 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_88">71</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91">Consolidated Balance Sheets as of March&#160;31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91"> and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_91">72</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_97">Consolidated Statements of Stockholders&#8217; Equity for the years ended March&#160;31, 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_97">73</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_103">Consolidated Statements of Cash Flows for the years ended March&#160;31, 2021, 2020, and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_103">74</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_106">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_106">75</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(2)   Financial Statement Schedule</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_277">Schedule II-Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_277">143</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other schedules not included have been omitted because of the absence of conditions under which they are required or because the required information, where material, is shown in the financial statements, financial notes or supplementary financial information.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_283">(a)(3)   Exhibits submitted with this Annual Report on Form 10-K as filed with the SEC and those incorporated by reference to other filings are listed on the Exhibit Index</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_283">144</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_277"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><ix:nonNumeric contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90ZXh0cmVnaW9uOmQ5NjA4MTVmNzI4ODQ1Y2E5ODg4OGMyYzRkMjY3NWI0XzE2NQ_0dc64606-bf26-42c2-81de-2e9c2666f27c" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions From Allowance Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at End of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bdb37666904471ea46cdc51ef04aaf9_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtMS0xLTEtMA_8352a29f-a8d4-4d47-bcc1-8839c752298f">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtMy0xLTEtMA_bc3f9cfc-a9f6-4c62-8bb3-151b317c1aa6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtNS0xLTEtMA_fe6ca49b-4689-432a-bab8-7a1a509bd9ec">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtNy0xLTEtMA_aa7c74e8-b03e-4ac0-b681-602570dfe7d3">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab5c8e5207d049d0a2b702571549ad35_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtOS0xLTEtMA_23c87789-33d3-47d7-add4-af451d5432a4">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3215d0d8384a40fba66e6eab5a09fb04_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtMS0xLTEtMA_fbb690f8-1b29-4c67-8490-b26614aefd97">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtMy0xLTEtMA_4e15450b-6fc7-472c-a327-5e76c6389344">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtNS0xLTEtMA_0270666d-5169-41d4-bd70-d5050151aba0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtNy0xLTEtMA_13364216-f34f-447d-9260-415c6cddbc55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe85c1cae3f4955b9ab92d284409069_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtOS0xLTEtMA_9bb8da36-7a48-45c1-900c-c7a6fb22cacf">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtMS0xLTEtMA_e9f0c55c-0b68-431d-ac13-266d004a9e25">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtMy0xLTEtMA_3d6aed1e-fed5-42a6-a786-811c6d538c0c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtNS0xLTEtMA_586c6499-3e84-49b2-9644-1e9f6815a863">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtNy0xLTEtMA_d5de94d3-dc35-41f9-bbd9-78be60e03040">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtOS0xLTEtMA_313d5b75-2cc6-40c5-8c5d-c1ae35935cc9">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17077ebbd39449f5af1aad884f3154eb_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtMS0xLTEtMA_3edc0877-c3df-40f6-a6ea-5c22562e94ca">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtMy0xLTEtMA_37828c6f-c353-419b-a483-cd42dda0fe08">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtNS0xLTEtMA_3dd6ad6c-1e9c-4f9b-ab65-caffc781a0e3">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtNy0xLTEtMA_0e2ccaee-6198-4d52-84fc-fd9e58657c96">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bdb37666904471ea46cdc51ef04aaf9_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtOS0xLTEtMA_03b52895-0bbc-42d5-a157-0e6f193d35af">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fd853d831a42d78a02ffd4cf5ac851_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktMS0xLTEtMA_dac53c99-cda8-448d-99ba-c7acf9569913">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktMy0xLTEtMA_d0f62749-e739-46d4-88b2-5eeb5615e08a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktNS0xLTEtMA_c8e1fc8a-c34f-49e1-8228-cba7aa6f9182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktNy0xLTEtMA_69b189d8-3df7-45b0-872f-c2c01243c474">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3215d0d8384a40fba66e6eab5a09fb04_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktOS0xLTEtMA_15f4f10e-c700-47f3-b7f0-1f90ab02dc13">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTEtMS0xLTA_e51835cb-be81-450b-8ef5-dc8027a682d2">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTMtMS0xLTA_b1e2d13d-faee-44de-8149-3bab8363136d">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTUtMS0xLTA_0adcf47c-992b-40b8-99ca-fffaaa0bb190">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTctMS0xLTA_90de3794-208b-4b35-a951-52e256b711f6">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTktMS0xLTA_92eaef36-cf37-4eb9-974b-8440ceaabf90">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if946cdebc5f04a91a11501d5fecd0111_I20180331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTEtMS0xLTA_b86f9809-765c-47bc-805b-fb091a8c8fbc">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTMtMS0xLTA_5e077293-3e80-4a9e-93c8-ada44177915b">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTUtMS0xLTA_2401aad4-59b6-4ed2-acdd-01b627292032">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTctMS0xLTA_85217ba2-86e5-44ab-bc03-30e32c3de618">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17077ebbd39449f5af1aad884f3154eb_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTktMS0xLTA_6099d89b-13ca-44a0-97e4-7b3bd713f5f8">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc939e12662e498ca3e1db10c83b89a6_I20180331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTEtMS0xLTA_ae9c14f7-be91-48d7-a1cd-1029b24cf0aa">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTMtMS0xLTA_49ccf1e3-02c4-49e1-a3b7-4d45ffb649ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTUtMS0xLTA_117c8f53-8b7f-4e34-8e6b-5921ba19259b">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTctMS0xLTA_352caea5-b170-4671-a663-405a86adde3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23fd853d831a42d78a02ffd4cf5ac851_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTktMS0xLTA_4c66affa-1fe7-4df3-8755-d24f896aae69">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022a2642b16245d083cb80c539e560b3_I20180331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTEtMS0xLTA_4b115291-7739-42de-962a-180975411db0">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTMtMS0xLTA_d0f1d1bd-94ad-42bf-81e8-581e2ce1c375">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTUtMS0xLTA_1c3596d0-630e-4f6f-b1a4-899c0deb9d6e">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTctMS0xLTA_421677d9-bc23-42d0-8c30-b47df31f97c2">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTktMS0xLTA_e31134cd-bd50-4417-a7c4-55559a609e4c">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6fcf90e365b49d3bc8fc8b908d184c5_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzItMy0xLTEtMA_a0d358a2-759b-4a43-beb6-ed149f503ee8">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i316723b66fa24fcd88e37d193316fd03_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzItNS0xLTEtMA_7766acfb-d6d9-4f90-99fa-d9c7f6917870">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4255c61bac0b4de1850d7e4a694151da_D20180401-20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzItNy0xLTEtMA_dbe14361-e5dd-481e-a5d5-8e6d842ddfbe">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credited to other accounts and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1401c1c016fb4cc5a4325e0076ce4cfc_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzMtMy0xLTEtMA_27f412b2-517d-42fa-afba-10a4a5de2819">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511a93c4c27f432094e7f2f67db30fc4_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzMtNS0xLTEtMA_89f24363-8e92-4454-b7dc-6ea28d654db4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912ede9886ea43629d3666f2abe8894a_D20180401-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzMtNy0xLTEtMA_68a48e22-447c-496a-aa2d-c7ee05555300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzQtMy0xLTEtMA_828f8a4b-cbd1-4933-9d1a-5b2ed6c10392">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzQtNS0xLTEtMA_69023297-9519-4b9e-9d2b-2d0f6d4a458f">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzQtNy0xLTEtMA_3b9b6763-9984-424c-a9fa-0fe58fb0161b">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown as deductions from current and non-current receivables (current allowances were $<ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMS0xLTEtMC90ZXh0cmVnaW9uOjdiYjAyMTFlMzdhOTRmZTVhNTdhMzRhOTliNGM2MDEwXzU0OTc1NTgxMzkwODI_4c703ac9-97ad-49a0-bbef-e12d04e20394">250</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMS0xLTEtMC90ZXh0cmVnaW9uOjdiYjAyMTFlMzdhOTRmZTVhNTdhMzRhOTliNGM2MDEwXzU0OTc1NTgxMzkwOTk_73541841-5d84-4a21-b591-a18dd62f136f">265</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMS0xLTEtMC90ZXh0cmVnaW9uOjdiYjAyMTFlMzdhOTRmZTVhNTdhMzRhOTliNGM2MDEwXzU0OTc1NTgxMzkxMTU_99e00b3a-9096-4223-ac6d-f2f520ef4cd1">279</ix:nonFraction> million at March 31, 2021, 2020, and 2019, respectively)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMy0xLTEtMA_edc87e76-0fed-4ce7-8f18-4cc43461cc5f">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8ec19e753d451794e088409f68157c_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtNS0xLTEtMA_40793e0b-73a5-4982-9314-e4d13652de2f">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c41e20baa14761a136adaf102659bb_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtNy0xLTEtMA_90cff12e-bd1b-4eab-a160-98fc560180d7">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primarily represents reclassifications to other balance sheet accounts.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_283"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements included as exhibits to this report are included to provide information regarding their terms and not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements may contain representations and warranties by each of the parties to the applicable agreement that were made solely for the benefit of the other parties to the applicable agreement, and;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified under &#8220;Incorporated by Reference&#8221; in the table below are on file with the Commission and are incorporated by reference as exhibits hereto.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312516641582/d221363dex21.htm">Agreement of Contribution and Sale, dated as of June 28, 2016, by and among McKesson Corporation, PF2 NewCo LLC, PF2 NewCo Intermediate Holdings, LLC, PF2 NewCo Holdings, LLC, HCIT Holdings, Inc., Change Healthcare, Inc., Change Aggregator L.P. and H&amp;F Echo Holdings, L.P.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 5, 2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517073411/d354020dex21.htm">Amendment No.&#160;1 to Agreement Contribution and Sale, dated as of March&#160;1, 2017, by and among by and among Change Healthcare LLC, Change Healthcare Intermediate Holdings, LLC, Change Healthcare Holdings, LLC, HCIT Holdings, Inc., Change Healthcare, Inc., a Delaware corporation, for itself and in its capacity as Echo Representative, certain affiliates of The Blackstone Group, L.P., certain affiliates of Hellman&#160;&amp; Friedman LLC, and McKesson Corporation, a Delaware corporation.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520029095/d881002dex21.htm">Separation and Distribution Agreement by and between McKesson Corporation, PF2 SpinCo, Inc., Change Healthcare Inc., Change Healthcare LLC, Change</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520029095/d881002dex21.htm"> Healthcare</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520029095/d881002dex21.htm"> Intermediate Holdings, LLC and Change Healthcare Holdings, LLC (including form of Tax Matters Agreement)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 10, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012311071695/f59658exv3w1.htm">Amended and Restated Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on July 27, 2011.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765320000021/amendedandrestatedby-l.htm">Amended and Restated By-Laws of the Company, as amended March 11, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/0000929624-97-000781.txt">Indenture, dated as of March 11, 1997, by and between the Company, as issuer, and The First National Bank of Chicago, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 19, 1997</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/0000929624-97-000853.txt">Officers&#8217; Certificate, dated as of March 11, 1997, and related Form of 2027 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-30899</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 8, 1997</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095013407004753/f27940exv4w1.htm">Indenture, dated as of March 5, 2007, by and between the Company, as issuer, and The Bank of New York Trust Company, N.A., as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 5, 2007</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012311019414/f58489exv4w2.htm">First Supplemental Indenture, dated as of February&#160;28, 2011, to the Indenture, dated as of March 5, 2007, among the Company, as issuer, the Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), and Wells Fargo Bank, National Association, as trustee, and related Form of 2021 Note and Form of 2041 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512490067/d447856dex41.htm">Indenture, dated as of December 4, 2012, by and between the Company, as issuer, and Wells Fargo Bank, National Association, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 4, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512490067/d447856dex42.htm">Officers&#8217; Certificate, dated as of December 4, 2012, and related Form of 2022 Note.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 4, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312513097422/d498651dex42.htm">Officers&#8217; Certificate, dated as of March 8, 2013, and related Form of 2023 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 8, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312514090428/d690531dex42.htm">Officers&#8217; Certificate, dated as of March 10, 2014, and related Form of 2024 Note, and Form of 2044 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2014</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517047290/d347385dex41.htm">Officer&#8217;s Certificate, dated as of February 17, 2017, and related Form of 2021 Euro Note, Form of 2025 Euro Note, and Form of 2029 Sterling Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 17, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518040775/d730912dex41.htm">Officer&#8217;s Certificate, dated as of February 12, 2018, and related Form of 2026 Euro Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518051049/d507348dex41.htm">Officer&#8217;s Certificate, dated as of February 16, 2018, and related Form of 2028 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518339803/d634589dex41.htm">Officer&#8217;s Certificate, dated as of November&#160;30, 2018, and</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518339803/d634589dex41.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518339803/d634589dex41.htm">Form of 2029 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312520309508/d17547dex41.htm">Officer&#8217;s Certificate, dated as of December&#160;3, 2020, and related Form of 2025 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit414x3312021.htm">Description of the Company&#8217;s Securities.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014904001115/f99032exv10w4.htm">McKesson Corporation 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan, as amended through January 29, 2003.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 10, 2004</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014903001297/f90251exv10w6.txt">McKesson Corporation Supplemental Profit Sharing Investment Plan, as amended and restated on January 29, 2003.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 6, 2003</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765319000021/mckexhibit10209302019.htm">McKesson Corporation Supplemental Retirement Savings Plan, as amended and restated effective July 30, 2019.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014908000067/f39986exv10w7.htm">McKesson Corporation Deferred Compensation Administration Plan II, as amended and restated as of October 28, 2004, and Amendment No. 1 thereto effective July 25, 2007.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 7, 2008</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765319000021/mckexhibit10109302019.htm">McKesson Corporation Deferred Compensation Administration Plan III, as amended and restated effective July 30, 2019.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310004952/f54717exv10w1.htm">McKesson Corporation Executive Survivor Benefits Plan, as amended and restated as of January 20, 2010. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000010/mck_exhibit1011x3312013.htm">McKesson Corporation Severance Policy for Executive Employees, as amended and restated April 23, 2013.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 7, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mckexhibit1083312020.htm">McKesson Corporation Change in Control Policy for Selected Executive Employees, as amended and restated effective January 28, 2020.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312515271990/d35635dex101.htm">McKesson Corporation Management Incentive Plan, effective July 29, 2015.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765315000006/mck_exhibit101x06302015.htm">Form of Statement of Terms and Conditions Applicable to Awards Pursuant to the McKesson Corporation Management Incentive Plan, effective May 26, 2015.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 29, 2015</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765318000020/mck_exhibit101x09302018.htm">McKesson Corporation Long-Term Incentive Plan, as amended and restated effective May 26, 2015, as amended effective October 23, 2018.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 25, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765316000020/mck_exhibit1014x3312016.htm">Forms of Statement of Terms and Conditions Applicable to Awards Pursuant to the McKesson Corporation Long-Term Incentive Plan, effective May 24, 2016.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310070537/f56102exv10w4.htm">McKesson Corporation 2005 Stock Plan, as amended and restated on July 28, 2010.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 30, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512316890/d371102dex102.htm">Forms of (i) Statement of Terms and Conditions, (ii) Stock Option Grant Notice and (iii), Restricted Stock Unit Agreement, each as applicable to Awards under the McKesson Corporation 2005 Stock Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000015/mck_8kxannualxmeetingxex10-1.htm">McKesson Corporation 2013 Stock Plan, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000015/mck_8kxannualxmeetingxex10-1.htm">effect</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000015/mck_8kxannualxmeetingxex10-1.htm">ive July 31, 2013</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000015/mck_8kxannualxmeetingxex10-1.htm">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit1016x3312021.htm">Forms of Statement of Terms and Conditions and Grant Notices Applicable to Awards Pursuant to the McKesson Corporation 2013 Stock Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517073411/d354020dex101.htm">Third Amended and Restated Limited Liability Company Agreement of Change Healthcare LLC, dated as of March&#160;1, 2017.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765316000020/mck_exhibit1019x3312016.htm">Form of Commercial Paper Dealer Agreement between McKesson Corporation, as Issuer, and the Dealer.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312515351348/d68211dex101.htm">Credit Agreement, dated as of October 22, 2015, among the Company and Certain Subsidiaries, as Borrowers, Bank of America, N.A. as Administrative Agent, Bank of America, N.A. (acting through its Canada Branch), Citibank, N.A. and Barclays Bank PLC, as Swing Line Lenders, Wells Fargo Bank, National Association as L/C Issuer, Barclays Bank PLC, Citibank N.A., Wells Fargo Bank, National Association as Co-Syndication Agents, Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., The Bank of Tokyo-Mitsubishi UFJ, Ltd. as Co-Documentation Agents, and The Other Lenders Party Thereto, and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Barclays Bank PLC, Citigroup Global Markets Inc., Goldman Sachs Bank USA, J.P. Morgan Securities, LLC, The Bank of Tokyo-Mitsubishi UFJ, Ltd. and Wells Fargo Securities, LLC as Joint Lead Arrangers and Joint Book Runners.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 23, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312514035645/d668841dex101.htm">Amendment No. 2, dated January 30, 2014, and Amendment No. 1, dated November 15, 2013, to the Credit Agreement and the Credit Agreement  dated as of September 23, 2011, among the Company and McKesson Canada Corporation, collectively, the Borrowers, Bank of America, N.A. as Administrative Agent, Bank of America, N.A. (acting through its Canada branch), as Canadian Administrative Agent, JPMorgan Chase Bank, N.A. and Wells Fargo Bank, National Association, as Co-Syndication Agents, Wells Fargo Bank, National Association as L/C Issuer, The Bank of Tokyo-Mitsubishi UFJ, LTD., The Bank of Nova Scotia and U.S. Bank National Association as Co-Documentation Agents, and The Other Lenders Party Thereto, and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Sole Lead Arranger and Sole Book Manager.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-3252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2014</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">Credit Agreement dated as of September 25, 2019, among the Company and certain subsidiaries, as borrowers, Bank of America, N.A., as administrative agent, Barclays Bank PLC, Citibank, N.A., Wells Fargo Bank, National Association, Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., and HSBC Securities (USA) Inc., as co-syndication agents, the lenders party thereto, the letter of credit issuers party thereto ("20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm"> Credit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">Facility</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">").</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 27, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex101-creditagreementamend.htm">Amendment No. 1, dated February 1, 2021, to the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">2020 Credit Facility</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex101-creditagreementamend.htm">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex102-creditagreementamend.htm">Amendment No. 2, dated March 31, 2021, to the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">2020 Credit Facility</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex102-creditagreementamend.htm">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310043581/f54765exv10w27.htm">Form of Director and Officer Indemnification Agreement.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520082540/d863918d8k.htm">Description of Separation Letter between the Company and Bansi Nagji, Executive Vice President and Chief Strategy and Business Development Officer, dated March 17, 2020.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 23, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">Tax Matters Agreement, by and between McKesson Corporation, PF2 SpinCo, Inc., Change Healthcare Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">Change Healthcare LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">and Change Healthcare Holdings, LLC </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">dated as of March 9, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit21x3312021.htm">List of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit21x3312021.htm">Significant </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit21x3312021.htm">Subsidiaries of the Registrant.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhbit23x3312021.htm">Consent of Independent Registered Public Accounting Firm, Deloitte &amp; Touche LLP.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x3312021.htm">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x3312021.htm">Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934 as amended, and adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x3312021.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Annual Report on Form 10-K for the fiscal year ended March&#160;31, 2021, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Stockholders' Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant agrees to furnish to the Commission upon request a copy of each instrument defining the rights of security holders with respect to issues of long-term debt of the registrant, the authorized principal amount of which does not exceed 10% of the total assets of the registrant.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_274"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;Form 10-K Summary</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="i08f9baf810c0412e93ea6effc6d22995_286"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i08f9baf810c0412e93ea6effc6d22995_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCKESSON CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:  May 12, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian S. Tyler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Marie L. Knowles</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marie L. Knowles, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Britt J. Vitalone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bradley E. Lerman</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bradley E. Lerman, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sundeep G. Reddy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Linda Mantia</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sundeep G. Reddy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Linda Mantia, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dominic J. Caruso</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Maria Martinez</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dominic J. Caruso, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maria Martinez, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ N. Anthony Coles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Edward A. Mueller</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N. Anthony Coles, M.D., Director<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Edward A. Mueller, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ M. Christine Jacobs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Susan R. Salka</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M. Christine Jacobs, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Susan R. Salka, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald R. Knauss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kenneth E. Washington</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Donald R. Knauss, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kenneth E. Washington, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:  May 12, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>2
<FILENAME>mck_exhibit414x3312021.htm
<DESCRIPTION>EX-4.14
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8f9839814f58462e84e0914b5ac5ffe0_1"></div><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">DESCRIPTION OF THE COMPANY&#8217;S SECURITIES REGISTERED    <br>PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following are brief descriptions of (a) the common stock, $0.01 par value per share (the &#8220;Common Stock&#8221;), (b) the 0.625% Notes due 2021 (the &#8220;2021 Notes&#8221;), (c) the 1.500% Notes due 2025 (the &#8220;2025 Notes&#8221;), (d) the 1.625% Notes due 2026 (the &#8220;2026 Notes&#8221;) and (e) the 3.125% Notes due 2029 (the &#8220;2029 Notes and, collectively with the 2021 Notes, the 2025 Notes and the 2026 Notes, the &#8220;Notes&#8221;), of McKesson Corporation (the &#8220;Company&#8221; or &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;), which are the only securities of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;).   </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Common Stock</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following descriptions of the Common Stock and of certain provisions of Delaware law do not purport to be complete and are subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated&#160;by-laws&#160;and the Delaware General Corporation Law (&#8220;DGCL&#8221;). Copies of our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;have been filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and are incorporated by reference herein. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the date hereof, our authorized capital stock consists of 900,000,000 shares, of which 800,000,000 shares are Common Stock and 100,000,000 shares are preferred stock, par value $0.01 per share. We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and&#47;or preferred stock. Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.  All of our outstanding shares of Common Stock are fully paid and&#160;non-assessable. </font></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dividend Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Subject to the dividend rights of the holders of any outstanding preferred stock, the holders of shares of Common Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Rights Upon Liquidation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities and any liquidation preferences of outstanding preferred stock.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Conversion, Redemption and Preemptive Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Holders of our Common Stock have no conversion, redemption, preemptive or similar rights.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders. Our amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.</font></div><div style="margin-top:18pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated&#160;By-Laws</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;contain certain provisions that may be deemed to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation also provides that any action required or permitted to be taken by the holders of Common Stock may be effected only at an annual or special meeting of such holders, and that stockholders may act in lieu of such meetings only by unanimous written consent. Our amended and restated&#160;by-laws&#160;provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer or a majority of our board of directors for any purpose at any time. Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated&#160;by-laws.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated&#160;by-laws&#160;establish an advance notice procedure for the nomination, other than by or at the direction of our board of directors, of candidates for election as directors as well as for other stockholder proposals to be considered at annual meetings of stockholders. In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the annual meeting and must contain certain specified information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to our amended and restated certificate of incorporation and the DGLC, our amended and restated certificate of incorporation may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon. Our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;provide that our amended and restated&#160;by-laws&#160;may be amended by a vote of a majority of our board of directors. In addition, our amended and restated&#160;by-laws&#160;provide that our amended and restated&#160;by-laws&#160;may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exclusive Forum Provision of our Amended and Restated By-Laws</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Court of Chancery of the State of Delaware or the United States District Court for the District of Delaware if the Court of Chancery does not have or declines to accept jurisdiction (collectively, &#8220;Delaware Courts&#8221;). Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;203 of Delaware General Corporation Law</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are subject to the &#8220;business combination&#8221; statute of the DGCL. In general, such statute prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an &#8220;interested stockholder,&#8221; unless&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such transaction is approved by our board of directors prior to the date the interested stockholder obtains such status,</font></td></tr></table></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">upon consummation of such transaction, the &#8220;interested stockholder&#8221; beneficially owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by (a)&#160;persons who are directors and also officers and (b)&#160;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer, or<br></font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the &#8220;business combination&#8221; is approved by our board of directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least&#160;66-2&#47;3%&#160;of the outstanding voting stock which is not owned by the &#8220;interested stockholder.&#8221;</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A &#8220;business combination&#8221; includes mergers, asset sales and other transactions resulting in financial benefit to the &#8220;interested stockholder.&#8221; An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns (or within three years, did own) beneficially 15% or more of a corporation&#8217;s voting stock. The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.</font></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Effects of Authorized But Unissued Stock</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our authorized but unissued shares of Common Stock and preferred stock may be issued without additional stockholder approval and may be utilized for a variety of corporate purposes, including future offerings to raise additional capital or to facilitate corporate acquisitions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The issuance of preferred stock could have the effect of delaying or preventing a change in control of us. The issuance of preferred stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders. In certain circumstances, such issuance could have the effect of decreasing the market price of our Common Stock.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One of the effects of the existence of unissued and unreserved Common Stock or preferred stock may be to enable our board of directors to issue shares to persons friendly to current management, which could render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of management. Such additional shares also could be used to dilute the stock ownership of persons seeking to obtain control of us.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Limitation of Liability of Directors</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation contains a provision that limits the liability of our directors for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by the Delaware General Corporation Law. Such limitation does not, however, affect the liability of a director (1)&#160;for any breach of the director&#8217;s duty of loyalty to us or our stockholders, (2)&#160;for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3)&#160;in respect of certain unlawful dividend payments or stock redemptions or purchases and (4)&#160;for any transaction from which the director derives an improper personal benefit. The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders&#8217; derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1)&#160;through (4) above. This provision does not limit or eliminate our rights or the rights of our stockholders to seek&#160;non-monetary&#160;relief such as an injunction or rescission in the event of a breach of a director&#8217;s duty of care. In addition, our directors and officers have indemnification protection.</font></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.</font></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our Common Stock is listed on the New York Stock Exchange under the symbol &#8220;MCK&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">Description of Notes</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">General</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 17, 2017, we issued &#163;450,000,000 aggregate principal amount of 3.125% Notes due 2029, &#8364;600,000,000 aggregate principal amount of 0.625% Notes due 2021 and &#8364;600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued &#8364;500,000,000 aggregate principal amount of 1.625% Notes due 2026.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">   </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each series of the Notes was issued pursuant to the Indenture, dated as of December&#160;4, 2012 (the &#8220;Indenture&#8221;) between the Company and Wells Fargo Bank, National Association, as trustee (the &#8220;Trustee&#8221;), in each case, as supplemented by an Officer&#8217;s Certificate setting forth certain terms of the applicable series of the Notes (the &#8220;Officer&#8217;s Certificates&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each series of the Notes is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and future unsecured and unsubordinated indebtedness from time to time outstanding. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following descriptions of the Indenture, the Officer&#8217;s Certificates and the Notes do not purport to be complete and are subject to and qualified in their entirety by reference to the Indenture, the Officer&#8217;s Certificates and the Notes, which have been filed with the SEC and are incorporated by reference herein. Unless otherwise specified, all capitalized and undefined terms in this &#8220;Description of Notes&#8221; have the meanings specified in the Indenture. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:18pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General Terms of the Indenture</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may issue, from time to time, debt securities, in one or more series, that will consist of either our senior debt (&#8220;Senior Debt Securities&#8221;), our senior subordinated debt (&#8220;Senior Subordinated Debt Securities&#8221;), our subordinated debt (&#8220;Subordinated Debt Securities&#8221;) or our junior subordinated debt (&#8220;Junior Subordinated Debt Securities&#8221; and, together with the Senior Subordinated Debt Securities and the Subordinated Debt Securities, the &#8220;Subordinated Securities&#8221;).&#160; The Indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated by us. Except for the limitations on consolidation, merger and sale of all or substantially all of our assets contained in the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Consolidation, Merger or Sale. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to, any person unless (a)&#160;we will be the continuing corporation or (b)&#160;the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a&#160;co-obligor&#160;of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such&#160;co-obligor,&#160;if any, expressly assumes our obligations on the debt securities and under the Indenture. In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing. Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This covenant would not apply to any recapitalization transaction, a change of control of the Company or a highly leveraged transaction, unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Events of Default. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise indicated, the term &#8220;Event of Default,&#8221; when used in the Indenture with respect to the debt securities of any series, means any of the following&#58;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to pay interest for 30 days after the date payment on any debt security of such series is due and payable&#59; provided that an extension of an interest payment period by the Company in accordance with the terms of the debt securities shall not constitute a failure to pay interest&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to pay principal or premium, if any, on any debt security of such series when due, either at maturity, upon any redemption, by declaration or otherwise&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to perform any other covenant in the Indenture or the debt securities of such series (&#8220;other covenants&#8221;) for 90 days after notice that performance was required&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">events in bankruptcy, insolvency or reorganization of the Company&#59; or</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any other Event of Default provided in the applicable resolution of our board of directors or the officers&#8217; certificate or supplemental Indenture under which we issue such series of debt securities.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">An Event of Default for a particular series of debt securities does not necessarily constitute an Event of Default for any other series of debt securities issued under the Indenture. If an Event of Default relating to the payment of interest, principal or any sinking fund installment involving any series of debt securities has occurred and is continuing, the Trustee or the holders of not less than 25% in aggregate principal amount of the debt securities of each affected series may declare the entire principal of all the debt securities of that series to be due and payable immediately.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Event of Default relating to the performance of other covenants occurs and is continuing for a period of 90 days after notice of such, or if any other Event of Default occurs and is continuing involving all of the series of Senior Debt Securities, then the Trustee or the holders of not less than 25% in aggregate principal amount of all of the series of Senior Debt Securities may declare the entire principal amount of all of the series of Senior Debt Securities due and payable immediately.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Similarly, if an Event of Default relating to the performance of other covenants occurs and is continuing for a period of 90 days after notice of such, or if any other Event of Default occurs and is continuing involving all of the series of Subordinated Securities, then the Trustee or the holders of not less than 25% in aggregate principal amount of all of the series of Subordinated Securities may declare the entire principal amount of all of the series of Subordinated Securities due and payable immediately.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, however, the Event of Default relating to the performance of other covenants or any other Event of Default that has occurred and is continuing is for less than all of the series of Senior Debt Securities or Subordinated Securities, as the case may be, then the Trustee or the holders of not less than 25% in aggregate principal amount of each affected series of the Senior Debt Securities or the Subordinated Securities, as the case may be, may declare the entire principal amount of all debt securities of such affected series due and payable immediately. The holders of not less than a majority in aggregate principal amount of the debt securities of a series may, after satisfying conditions, rescind and annul any of the above-described declarations and consequences involving the series.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Event of Default relating to events in bankruptcy, insolvency or reorganization of the Company occurs and is continuing, then the principal amount of all of the debt securities outstanding, and any accrued interest, will automatically become due and payable immediately, without any declaration or other act by the Trustee or any holder.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture imposes limitations on suits brought by holders of debt securities against us. Except as provided below, no holder of debt securities of any series may institute any action against us under the Indenture unless&#58;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the holder has previously given to the Trustee written notice of default and continuance of that default&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the holders of at least 25% in principal amount of the outstanding debt securities of the affected series have requested that the Trustee institute the action&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the requesting holders have offered the Trustee security or indemnity reasonably satisfactory to it for expenses and liabilities that may be incurred by bringing the action&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Trustee has not instituted the action within 60 days of the request&#59; and</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Trustee has not received inconsistent direction by the holders of a majority in principal amount of the outstanding debt securities of the affected series.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, each holder of debt securities of any series has the right, which is absolute and unconditional, to receive payment of the principal of, and premium and interest, if any, on, such debt securities when due and to institute suit for the enforcement of any such payment, and such rights may not be impaired without the consent of that holder of debt securities.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We will be required to file annually with the Trustee a certificate, signed by an officer of the Company, stating whether or not the officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Modification of the Indenture.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture provides that we and the Trustee may enter into supplemental indentures without the consent of the holders of debt securities to&#58;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">secure any debt securities&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence the assumption by a successor corporation of our obligations&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">add covenants for the protection of the holders of debt securities&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cure any ambiguity or correct any inconsistency in the Indenture&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">establish the forms or terms of debt securities of any series&#59; and</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence and provide for the acceptance of appointment by a successor Trustee.</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture also provides that we and the Trustee may, with the consent of the holders of not less than a majority in aggregate principal amount of debt securities of all series of Senior Debt Securities or Subordinated Securities, as the case may be, then outstanding and affected thereby (voting as one class), add any provisions to, or change in any manner, eliminate or modify in any way the provisions of, the Indenture or modify in any manner the rights of the holders of the debt securities. We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby&#58;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">extend the final maturity of any debt security&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the principal amount or premium, if any&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the rate or extend the time of payment of interest&#59;</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce any amount payable on redemption&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">change the currency in which the principal (other than as may be provided otherwise with respect to a series), premium, if any, or interest is payable&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the amount of the principal of any debt security issued with an original issue discount that is payable upon acceleration or provable in bankruptcy&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">modify any of the subordination provisions or the definition of senior indebtedness applicable to any Subordinated Securities in a manner adverse to the holders of those securities&#59;</font></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">alter provisions of the Indenture relating to the debt securities not denominated in U.S. dollars&#59;</font></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">impair the right to institute suit for the enforcement of any payment on any debt security when due&#59; or</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the percentage of holders of debt securities of any series whose consent is required for any modification of the Indenture.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Officer&#8217;s Certificate contains the following covenants.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Definitions. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Attributable Debt&#8221; shall mean in connection with a sale and lease-back transaction the lesser of (a)&#160;the fair value of the assets subject to such transaction, as determined by our Board of Directors, or (b)&#160;the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Consolidated Subsidiary&#8221; shall mean any Subsidiary (as defined in the Indenture), substantially all the property of which is located, and substantially all the operations of which are conducted, in the United States of America whose financial statements are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Exempted Debt&#8221; shall mean the sum of the following as of the date of determination&#58; (1)&#160;Indebtedness of ours and our Consolidated Subsidiaries incurred after the date of issuance of the notes and secured by liens not permitted by the limitation on liens provisions, and (2)&#160;Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Indebtedness&#8221; shall mean all items classified as indebtedness on our most recently available consolidated balance sheet, in accordance with accounting principles generally accepted in the United States of America.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Qualified Receivables Transaction&#8221; shall mean any transaction or series of transactions entered into by us or any of our Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1)&#160;a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2)&#160;any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other obligations in respect of such accounts receivable or inventory, proceeds of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Receivables Subsidiary&#8221; shall mean a Subsidiary of ours which engages in no activities other than in connection with the financing of accounts receivable or inventory (a)&#160;no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)&#160;is guaranteed by us or any Subsidiary of ours (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction), (2) is recourse or obligates us or any Subsidiary of ours in any way other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction or (3)&#160;subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of &#8220;Qualified Receivables Transaction&#8221;), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b)&#160;with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c)&#160;with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary&#8217;s financial condition or cause such Subsidiary to achieve certain levels of operating results.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Liens</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. We covenant that, so long as any of the Notes remain outstanding, we will not, and will not permit any Consolidated Subsidiary, to create or assume any Indebtedness for money borrowed which is secured by a mortgage, pledge, security interest or lien (&#8220;liens&#8221;) of or upon any assets, whether now owned or hereafter acquired, of ours or any such Consolidated Subsidiary without equally and ratably securing the notes by a lien ranking equally to and ratably with (or, at our option, senior to) such secured Indebtedness, except that the foregoing restriction shall not apply to&#58;</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on assets of any corporation existing at the time such corporation becomes a Consolidated Subsidiary&#59;</font></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on assets existing at the time of acquisition thereof, or to secure the payment of the purchase price of such assets, or to secure indebtedness incurred or guaranteed by us or a Consolidated Subsidiary for the purpose of financing the purchase price of such assets or improvements or construction thereon, which indebtedness is incurred or guaranteed prior to, at the time of or within 360 days after such acquisition, or in the case of real property, completion of such improvement or construction or commencement of full operation of such property, whichever is later&#59;</font></div></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens securing indebtedness owed by any Consolidated Subsidiary to us or another wholly owned Subsidiary&#59;</font></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of a corporation existing at the time such corporation is merged into or consolidated with us or a Subsidiary or at the time of a purchase, lease or other acquisition of the assets of the corporation or firm as an entirety or substantially as an entirety by us or a Subsidiary&#59;</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of ours or a Consolidated Subsidiary in favor of the United States of America or any state thereof, or in favor of any other country, or political subdivision thereof, to secure certain payments pursuant to any contract or statute or to secure any indebtedness incurred or guaranteed for the purpose of financing all or any part of the purchase price, or, in the case of real property, the cost of construction, of the assets subject to such liens, including, but not limited to, liens incurred in connection with pollution control, industrial revenue or similar financing&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any extension, renewal or replacement, or successive extensions, renewals or replacements, in whole or in part, of any lien referred to in the foregoing&#59;</font></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain statutory liens or other similar liens arising in the ordinary course of our or a Consolidated Subsidiary&#8217;s business, or certain liens arising out of government contracts&#59;</font></div></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain pledges, deposits or liens made or arising under the worker&#8217;s compensation or similar legislation or in certain other circumstances&#59;</font></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain liens in connection with legal proceedings, including certain liens arising out of judgments or awards&#59;</font></div></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens for certain taxes or assessments, landlord&#8217;s liens and liens and charges incidental to the conduct of the business or the ownership of our assets or those of a Consolidated Subsidiary, which were not incurred in connection with the borrowing of money and which do not, in our opinion, materially impair the use of such assets in the operation of our business or that of such Consolidated Subsidiary or the value of such assets for the purposes thereof&#59;</font></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens relating to accounts receivable of ours or any of our Subsidiaries which have been sold, assigned or otherwise transferred to another Person in a transaction classified as a sale of accounts receivable in accordance with accounting principles generally accepted in the United States of America, to the extent the sale by us or the applicable Subsidiary is deemed to give rise to a lien in favor of the purchaser thereof in such accounts receivable or the proceeds thereof&#59; or</font></div></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of ours or any of our Subsidiaries (including Receivables Subsidiaries) incurred in connection with a Qualified Receivables Transaction.</font></div></td></tr></table></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the above, we or any of our Consolidated Subsidiaries may, without securing the notes, create or assume any Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions&#59; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.</font></div><div style="text-align:justify;text-indent:24.75pt"><font><br></font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Sale and Lease-Back Transactions.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sale and lease-back transactions, except such transactions involving leases for less than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a)&#160;we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b)&#160;the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness. The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2021 Notes</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2021 Notes bear interest at the rate of 0.625%&#160;per year.  Interest on the 2021 Notes is payable on August&#160;17 of each year.  The 2021 Notes will mature on August&#160;17, 2021.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2021 Notes prior to&#160;July&#160;17, 2021, the date that is one month before their maturity date, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;July 17, 2021, we may redeem the 2021 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2021 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2021 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2021 Notes in whole, the Company will be required to offer to repurchase the 2021 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2021 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2025 Notes</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2025 Notes bear interest at the rate of 1.500%&#160;per year.  Interest on the 2025 Notes is payable on November&#160;17 of each year.   The 2025 Notes will mature on November&#160;17, 2025.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2025 Notes prior to&#160;August&#160;17, 2025, the date that is three months before their maturity date, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;August&#160;17, 2025, we may redeem the 2025 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2025 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2025 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2025 Notes in whole, the Company will be required to offer to repurchase the 2025 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2025 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2026 Notes</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2026 Notes bear interest at the rate of 1.625%&#160;per year. Interest on the 2026 Notes is payable on October&#160;30 of each year.  The 2025 Notes will mature on October 30, 2026.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2026 Notes for cash in whole, at any time, or in part, from time to time, prior to maturity, at a redemption price that includes accrued and unpaid interest and a make-whole premium.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2026 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of the 2026 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2026 Notes in whole, the Company will be required to offer to repurchase the 2026 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2026 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2029 Notes</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2029 Notes bear interest at the rate of 3.125%&#160;per year.  Interest on the 2029 Notes is payable on February&#160;17 of each year.  The 2029 Notes will mature on February&#160;17, 2029.</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2029 Notes prior to&#160;November&#160;17, 2028, the date that is three months before their maturity date in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;November&#160;17, 2028, we may redeem the 2029 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2029 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2029 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2029 Notes in whole, the Company will be required to offer to repurchase the 2029 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2029 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concerning the Trustee</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Wells Fargo Bank, National Association is the Trustee under the Indenture with respect to the Notes. We may maintain deposit accounts or conduct other banking transactions with the Trustee in the ordinary course of business.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.14</font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Governing Law</font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture and Notes are governed by, and construed in accordance with, the laws of the State of New York, including, without limitation, Sections&#160;5-1401&#160;and&#160;5-1402&#160;of the New York General Obligations Law and New York Civil Practice Law and Rules 327(b).</font></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our 2021 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK21A.&#8221; Our 2025 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK25.&#8221;  Our 2026 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK26.&#8221;  Our 2029 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK29.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">13</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>3
<FILENAME>mck_exhibit1016x3312021.htm
<DESCRIPTION>EX-10.16
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i65a864439b37454185d98623168064f8_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTOR</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Div Equiv Units</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNITS GRANTED TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For Grants Beginning July 22, 2021</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Outside Director's country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards.  With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders.  An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Number of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Restricted Stock Units (&#34;Units&#34;) granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $180,000 (with any fractional Unit rounded up to the nearest whole Unit).  In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $120,000 (with any fractional Unit rounded up to the nearest whole Unit).  Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000.  A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award. The number of such additional Restricted Stock Units shall be calculated by dividing (a) the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by (b) the Fair Market Value per Share on the payment date for such dividend. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Automatic Deferral Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). &#8220;Separation of service&#8221; shall have the meaning provided under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP&#160;III&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award. Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If an Outside Director is not a United States citizen or resident, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein.  Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt">Data Privacy Information and Consent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis.  If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction.  Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i65a864439b37454185d98623168064f8_1649267441836"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTOR</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Div Equiv Cash</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNITS GRANTED TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For Grants Beginning July 22, 2021</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Outside Director's country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards.  With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders.  An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Number of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Restricted Stock Units (&#34;Units&#34;) granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $180,000 (with any fractional Unit rounded up to the nearest whole Unit).  In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $120,000 (with any fractional Unit rounded up to the nearest whole Unit).  Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000.  A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be credited on behalf of an Outside Director to a deferred cash account until such time as the underlying Shares are issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Automatic Deferral Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). &#8220;Separation of service&#8221; shall have the meaning provided under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP&#160;III&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If an Outside Director is not a United States citizen or resident, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered, or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein.  Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state, or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt">Data Privacy Information and Consent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration, and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis.  If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction.  Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i65a864439b37454185d98623168064f8_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EXECUTIVE OFFICERS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective for Grants Beginning May 25, 2021</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Non-Statutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Non Statutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Non Statutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Non Statutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Non Statutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Non Statutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Non Statutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short&#8209;Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section&#160;V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice, or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.61pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered, or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;mckesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant&#8217;s jurisdictions(s).  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended, or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan, in accordance with the terms and conditions of such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet.  A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="i65a864439b37454185d98623168064f8_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective for Grants Beginning May 25, 2021</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short&#8209;Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">PERFORMANCE STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.&#160;14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.61pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;mckesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant's jurisdiction. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan, in accordance with the terms and conditions of such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet.  A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="i65a864439b37454185d98623168064f8_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective for Grants Beginning May 25, 2021</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Non-Statutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Non Statutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Non Statutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Non Statutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Non Statutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Non Statutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Non Statutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Non Statutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short&#8209;Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Participant validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.61pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered, or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;mckesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended, or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan, in accordance with the terms and conditions of such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="i65a864439b37454185d98623168064f8_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM OF AWARD AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SPECIAL INCENTIVE AWARD</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNITS AND RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GRANTED PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">GRANT OF AWARD</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Participant is hereby granted an Award of Performance Stock Units (&#8220;PSUs&#8221;) and Restricted Stock Units (&#8220;RSUs&#8221;), the terms and conditions of which are set forth herein.  The Grant Date is &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;,&#160;2018.  This Award Agreement is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">PERFORMANCE STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Participant is hereby granted a target Award of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Performance Stock Units (the &#8220;PSU Award&#8221;), subject to the terms and conditions set forth herein.  The PSU Award is an &#8220;Other Share-Based Award&#8221; as provided under Section 11 of the Plan.  The PSU Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Lapse of Performance Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance goals applicable to the PSU Award are attached as Exhibit A to this Award Agreement.  The vesting and payment of the PSU Award is also subject to Section II.3, Section II.4 and Section&#160;IV.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Payment of Earned PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As soon as practicable following the end of the performance period, Compensation Committee shall determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fifty percent (50%) of the Shares underlying earned PSUs shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  The remaining fifty percent (50%) of such earned PSUs shall be subject to one additional year of vesting service and shall be evidenced by the issuance of a One-Year RSU Award on the terms and conditions set forth in Section II.4.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Termination of Service Prior to Determination of Performance Against Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section II.3(B) or Section II.3(C)) prior to the lapse of the performance restrictions imposed on the PSU Award, this PSU Award shall be canceled, and all the rights of the Participant to the PSU Award shall immediately terminate.  If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the PSU Award ceases to be a bona fide employee of the Corporation or an Affiliate prior to completion of the performance period as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the performance period, an amount in cash equal to the value of a prorated portion of the PSU Award, equal to (1)&#160;the target number of PSUs subject to the PSU Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance results determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on April 1, 2018&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in Exhibit A&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to receive, following completion of the performance period, an amount in cash equal to the value of the earned PSUs, paid in installments at the same times as actively employed holders of PSU Awards and calculated as though the Participant had continued to be employed by the Corporation or one of its Affiliates during the entire performance period and additional one-year vesting period applicable to the One-Year RSU Award as set forth in Section&#160;II.4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then the Participant shall be eligible to receive an amount in cash equal to one-half (1&#47;2) of the value of the earned PSUs, paid at the same time as actively employed holders of PSU Awards are paid the first installment of Shares, and calculated as though the Participant had continued to be employed by the Corporation or one of its Affiliates during the entire performance period&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, such Participant shall be eligible for the Normal Retirement benefit set forth in Section&#160;II.3(B)(ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grant of One-Year RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the PSU Award, if any, an award of Restricted Stock Units with respect to one-half (50%) of such earned PSUs (the &#8220;One-Year RSU Award&#8221;) will be granted to the Participant on the terms and conditions set forth below and subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">The restrictions applicable to the One-Year RSU Award shall lapse with respect to 100% of the underlying Shares on the first anniversary of the Grant Date with respect to such One-Year RSU Award, subject to Section II.4(C) and Section IV.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents shall be credited in respect of the One-Year RSU Award.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the One-Year RSU Award, and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the One-Year RSU Award are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the One-Year RSU Award.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section II.4(C)(ii) or Section II.4(C)(iii)) prior to the lapse of the restrictions imposed on the One-Year RSU Award, any unvested Restricted Stock Units subject to the One-Year RSU Award shall be canceled, and all the rights of the Participant to the One-Year RSU Award shall immediately terminate.  If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary herein, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the One-Year RSU Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Death or Long-Term Disability, then the restrictions imposed on the One-Year RSU Award shall lapse on the date of such termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Normal Retirement, the One-Year RSU Award shall not be cancelled and will vest and be paid on the first anniversary of such Grant Date, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the applicable Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which such RSU Award is scheduled to vest and be paid, the restrictions applicable to such RSU Award shall lapse upon the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:33pt;text-decoration:underline">Payment of Performance Stock Units and Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided with respect to the payment of earned PSUs in cash following certain terminations of employment under Section&#160;II.3, payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Performance Stock Units or Restricted Stock Units, as applicable.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">THREE-YEAR RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant is hereby granted an Award of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Restricted Stock Units (the &#8220;RSU Award&#8221;), subject to the terms and conditions set forth herein.  The RSU Award also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third anniversary of the Grant Date, subject to Sections III.4 and IV.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on such RSU Award, and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying such RSU Award are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the applicable RSU Award, including the same vesting restrictions as the RSU Award.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section III.4(B) or Section III.4(C)) prior to the lapse of the restrictions imposed on the Award, any unvested Restricted Stock Units subject to the RSU Award shall be canceled, and all the rights of the Participant to such portion of the RSU Award shall immediately terminate.  If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary herein, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the RSU Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of the RSU Award, such award shall not be cancelled and will vest and be paid on the third anniversary of such Grant Date, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the applicable Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which such RSU Award is scheduled to vest and be paid, the restrictions applicable to such RSU Award shall lapse upon the termination date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on the Restricted Stock Units, such units that were not otherwise forfeited pursuant to the terms of the Plan and this Award Agreement shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Award Agreement to the contrary notwithstanding, if the Administrator determines that the Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Performance Stock Units and Restricted Stock Units, to the extent the restrictions have not lapsed, shall immediately and automatically be forfeited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the restrictions imposed on an RSU Award (including any unpaid Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to the PSU Award and any RSU Award, measured at the date on which Shares (or cash, if applicable) was paid in respect of the PSU Award or on which such RSU Award vested. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;IV which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;IV.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any portion of the PSU Award or an RSU Award granted hereby (for purposes of this Section V, &#8220;RSU Award&#8221; shall include time-vesting RSU awards granted under Section III or Section IV) that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;), which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i)&#160;in the case of the PSU Award, shall consist of restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the PSU Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock units lapsing at the end of the PSU Award&#8217;s performance period, with continued vesting after the Change in Control based only on continued service to the Corporation or an Affiliate, as though a time-based vesting award&#59; and (ii) in the case of an RSU Award, shall consist of restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the RSU Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VI.17), based on the fair market value of the underlying shares on the vesting date. If any portion of the PSU Award or an RSU Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of the PSU Award, such Award shall vest based upon deemed attainment of target performance or actual performance achieved, if greater, if such Change in Control occurs during the performance period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, (i)&#160;any unvested portion of the PSU Award shall continue to vest with respect to that number of Shares that reflects the deemed attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control, such vesting occurring at such time or times as (x)&#160;performance would have been measured and (y)&#160;the related RSU Award would have vested absent such Change in Control, and (ii)&#160;any unvested portion of an RSU Award shall continue to vest according to the terms and conditions of such Award and&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of this PSU Award or an RSU Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VI.17), based on the fair market value of the underlying Shares on the vesting date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">PARTICIPANT RIGHTS&#59; MISCELLANEOUS  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant is covered by the Stock Ownership Policy at the time of settlement of an Award granted hereunder, the Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant shall not be permitted to sell, transfer, pledge, assign or encumber the Performance Stock Units or Restricted Stock Units granted hereby, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Participant nor any person entitled to exercise the Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Performance Stock Units or Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of the Participant at any time.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards granted hereby to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Awards granted hereby and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of the Awards granted hereby shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to the Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under this Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect the Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant or vesting of the Award, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (ii) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (i) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (ii)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (iii) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Awards is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Awards will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Awards will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">in consideration of the grant of the Awards, no claim or entitlement to compensation or damages shall arise from forfeiture of the Awards which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Awards, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">for purposes of the Awards, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Merrill Lynch and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) request access or copies of Data the Corporation processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finally, the Participant understands that the Corporation may rely on a different legal basis for the processing or transfer of Data in the future and&#47;or request that the Participant provide another data privacy consent form.  If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgement or data privacy consent form to the Employer or the Corporation (or any other acknowledgements, agreements or consents that may be required by the Employer or the Corporation) that the Corporation and&#47;or the Employer may deem necessary to obtain under the data privacy laws in the Participant&#8217;s country, either now or in the future.  The Participant understands that the Participant will not be able to participate in the Plan if the Participant fails to execute any such acknowledgement, agreement or consent requested by the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant has received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (i) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Award Agreement, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this agreement between the Participant and the Corporation evidencing the grant of the PSU Award and the RSU Award, the terms of which are set forth herein and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an Affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an Affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an Affiliate (or, if providing service to the Corporation or an Affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet.  A Participant or the Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, CA 94104.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Participant has executed this Award Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;NAME OF EXECUTIVE&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;TITLE&#93;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><div id="i65a864439b37454185d98623168064f8_16"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUTSIDE DIRECTOR</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MCKESSON CORPORATION 2013 STOCK PLAN </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.374%"><tr><td style="width:1.0%"></td><td style="width:54.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100% vested on grant date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2013 Stock Plan, as may be amended from time to time (the &#8220;Plan&#8221;) to receive shares of common stock of the Company (&#8220;Shares&#8221;).  This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement, which along with the Plan set forth the terms of your grant.   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at www.mckesson.com&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and </font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;I have access to the Company&#8217;s web site&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The Plan and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;I accept ALL the terms and conditions as set forth in the Plan and the ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:256.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* 2013 Stock Plan Prospectus for Non-Employee Directors</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* ST&#38;Cs </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country specific) </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.356%"><tr><td style="width:1.0%"></td><td style="width:44.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Please see Appendix</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2013 Stock Plan (the &#8220;Plan&#8221;) which represent the contingent right to receive shares of common stock of the Company (&#8220;Shares&#8221;).  This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement. Your Restricted Stock Unit Agreement and your RSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;) and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time).</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:256.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2013 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* ST&#38;Cs Applicable to ___________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country-specific)</font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May 2019</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Exhibit 10.16</font></div><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNIT GRANT NOTICE</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"></td><td style="width:44.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target PSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Period&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY&#160;20__ - FY&#160;20__</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you target performance stock units (&#8220;PSUs&#8221;) under the Company&#8217;s 2013 Stock Plan (the &#8220;Plan&#8221;).  This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided with this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Performance Stock Unit Agreement.  Your Performance Stock Unit Agreement and your PSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;), and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your PSUs will be earned subject to the Company&#8217;s attainment of performance goals that have been pre-established by the Compensation Committee (the &#8220;Committee&#8221;) of the Company&#8217;s Board of Directors.  You may receive 0% - 200% of the target number of PSUs set forth above.  PSUs, if earned, will be paid in the form of shares of the Company&#8217;s Common Stock (&#8220;Shares&#8221;) that are not subject to any further vesting restrictions.  The Committee has the sole discretion to determine the Company&#8217;s performance against the pre-established goals after completion of the performance period, and to authorize the grant of Shares.  </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of PSUs.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:256.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan Documents and Related Policies</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* 2013 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* ST&#38;Cs Applicable to __________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country specific)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May 2019</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>mck_exhibit21x3312021.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib4892d16663040d4b8d667d5a0455570_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 21</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">SUBSIDIARIES OF THE REGISTRANT</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:19pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">There is no parent of the Company. The following is a listing of the significant subsidiaries of the Company.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JURISDICTION</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OF</font></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORGANIZATION</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Europe AG</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Europe Holdings GmbH &#38; Co. KGaA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Global Procurement &#38; Sourcing Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Bermuda IP2A Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Bermuda IP3A Limited</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Holdings, Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Top Holdings, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Specialty Care Distribution LLC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson UK Finance I Limited</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson US Finance Corporation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monarch Insurance Company LLC</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Oncology Holdings, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Oncology, Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>mck_exhbit23x3312021.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6d7db294b2d8401c9514c1b4b98c1f50_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 23</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333-213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May&#160;12, 2021, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation&#8217;s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March&#160;31, 2021.</font></div><div style="margin-bottom:19pt;text-align:justify"><font><br></font></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.233%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Deloitte &#38; Touche LLP</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas, Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 12, 2021</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>mck_exhibit311x3312021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4c65bb9b39454f3a84804545f68ee121_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May 12, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>mck_exhibit312x3312021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4758ecb0cec14a788de2c606a8b588ad_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May 12, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>mck_exhibit32x3312021.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8fefb8366bec4d0384ffc767aa9810fa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-K for the year ended March&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><font><br></font></div><div style="margin-top:29pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 12, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 12, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>mck-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0a91717b-5b9a-4470-a716-9c00214a8bdd,g:f2a8631c-ae82-4a44-9090-35d7005e9a98-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://mckesson123.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>100010002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100030004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100040005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>100050006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals">
        <link:definition>100060007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100070008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>240044001 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesNetDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails">
        <link:definition>240054002 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails">
        <link:definition>240064003 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVenture" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture">
        <link:definition>210071002 - Disclosure - Investment in Change Healthcare Joint Venture</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVentureTables" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables">
        <link:definition>230083002 - Disclosure - Investment in Change Healthcare Joint Venture (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVentureDetails" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails">
        <link:definition>240094004 - Disclosure - Investment in Change Healthcare Joint Venture (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails">
        <link:definition>240104005 - Disclosure - Investment in Change Healthcare Joint Venture - Net Gain on Split-off of Change Healthcare JV (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>210111003 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleTables" roleURI="http://mckesson123.com/role/HeldforSaleTables">
        <link:definition>230123003 - Disclosure - Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>240134006 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>240144007 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>210151004 - Disclosure - Restructuring, Impairment, and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>230163004 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>240174008 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails">
        <link:definition>240184009 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails">
        <link:definition>240194010 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestitures" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures">
        <link:definition>210201005 - Disclosure - Business Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresTables" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables">
        <link:definition>230213005 - Disclosure - Business Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails">
        <link:definition>240224011 - Disclosure - Business Acquisitions and Divestitures - Acquisition of Medical Specialties Distributors (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>240234012 - Disclosure - Business Acquisitions and Divestitures - Fair Values Recognized of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails">
        <link:definition>240244013 - Disclosure - Business Acquisitions and Divestitures - Acquisition of CoverMyMeds (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://mckesson123.com/role/ShareBasedCompensation">
        <link:definition>210251006 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://mckesson123.com/role/ShareBasedCompensationTables">
        <link:definition>230263006 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240274014 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails">
        <link:definition>240284015 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails">
        <link:definition>240294016 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails">
        <link:definition>240304017 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails">
        <link:definition>240314018 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails">
        <link:definition>240324019 - Disclosure - Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofOptionsOutstandingDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails">
        <link:definition>240334020 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofStockOptionActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails">
        <link:definition>240344021 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails">
        <link:definition>240354022 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNet" roleURI="http://mckesson123.com/role/OtherIncomeNet">
        <link:definition>210361007 - Disclosure - Other Income, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetTables" roleURI="http://mckesson123.com/role/OtherIncomeNetTables">
        <link:definition>230373007 - Disclosure - Other Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetDetails" roleURI="http://mckesson123.com/role/OtherIncomeNetDetails">
        <link:definition>240384023 - Disclosure - Other Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>210391008 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://mckesson123.com/role/IncomeTaxesTables">
        <link:definition>230403008 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
        <link:definition>240414024 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails">
        <link:definition>240424025 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240434026 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails">
        <link:definition>240444027 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfDeferredTaxBalancesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails">
        <link:definition>240454028 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails">
        <link:definition>240464029 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>210471009 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>230483009 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>240494030 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails">
        <link:definition>240504031 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShare" roleURI="http://mckesson123.com/role/EarningsperCommonShare">
        <link:definition>210511010 - Disclosure - Earnings per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShareTables" roleURI="http://mckesson123.com/role/EarningsperCommonShareTables">
        <link:definition>230523010 - Disclosure - Earnings per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails">
        <link:definition>240534032 - Disclosure - Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShareNarrativeDetails" roleURI="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails">
        <link:definition>240544033 - Disclosure - Earnings per Common Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://mckesson123.com/role/Leases">
        <link:definition>210551011 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://mckesson123.com/role/LeasesTables">
        <link:definition>230563011 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://mckesson123.com/role/LeasesNarrativeDetails">
        <link:definition>240574034 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalbalancesheetinformationDetails" roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails">
        <link:definition>240584035 - Disclosure - Leases - Supplemental balance sheet information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofleasecostsDetails" roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails">
        <link:definition>240594036 - Disclosure - Leases - Components of lease costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalcashflowinformationDetails" roleURI="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails">
        <link:definition>240604037 - Disclosure - Leases - Supplemental cash flow information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofleaseliabilitiesDetails" roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails">
        <link:definition>240614038 - Disclosure - Leases - Maturities of lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofleaseliabilitiesDetails_1" roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1">
        <link:definition>240614038 - Disclosure - Leases - Maturities of lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofleaseliabilitiesDetails_2" roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2">
        <link:definition>240614038 - Disclosure - Leases - Maturities of lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>210621012 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>230633012 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>240644039 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails">
        <link:definition>240654040 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Impairment Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails">
        <link:definition>240664041 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>240674042 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails">
        <link:definition>240684043 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>210691013 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>230703013 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>240714044 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails">
        <link:definition>240724045 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>240734046 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails">
        <link:definition>240744047 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://mckesson123.com/role/VariableInterestEntities">
        <link:definition>210751014 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesDetails" roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails">
        <link:definition>240764048 - Disclosure - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>210771015 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsTables" roleURI="http://mckesson123.com/role/PensionBenefitsTables">
        <link:definition>230783014 - Disclosure - Pension Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>240794049 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails">
        <link:definition>240804050 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails">
        <link:definition>240814051 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails">
        <link:definition>240824052 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>240834053 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>240844054 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails">
        <link:definition>240854055 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails">
        <link:definition>240864056 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsOtherPostretirementBenefitsPlanDetails" roleURI="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails">
        <link:definition>240874057 - Disclosure - Pension Benefits - Other Postretirement Benefits Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>210881016 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>230893015 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>240904058 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails">
        <link:definition>240914059 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>210921017 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>230933016 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>240944060 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
        <link:definition>240954061 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialGuaranteesandWarranties" roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties">
        <link:definition>210961018 - Disclosure - Financial Guarantees and Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialGuaranteesandWarrantiesDetails" roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails">
        <link:definition>240974062 - Disclosure - Financial Guarantees and Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>210981019 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails">
        <link:definition>240994063 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://mckesson123.com/role/StockholdersEquity">
        <link:definition>211001020 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://mckesson123.com/role/StockholdersEquityTables">
        <link:definition>231013017 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>241024064 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofShareRepurchasesDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails">
        <link:definition>241034065 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
        <link:definition>241044066 - Disclosure - Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
        <link:definition>241054067 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyBalancesandTransactions" roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions">
        <link:definition>211061021 - Disclosure - Related Party Balances and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyBalancesandTransactionsDetails" roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails">
        <link:definition>241074068 - Disclosure - Related Party Balances and Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>211081022 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>231093018 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessNarrativeDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails">
        <link:definition>241104069 - Disclosure - Segments of Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessScheduleofSegmentInformationDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails">
        <link:definition>241114070 - Disclosure - Segments of Business - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails">
        <link:definition>241124071 - Disclosure - Segments of Business - Segment Assets and Property, Plant and Equipment, Net by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnaudited" roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited">
        <link:definition>211131023 - Disclosure - Quarterly Financial Information (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedTables" roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables">
        <link:definition>231143019 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails">
        <link:definition>241154072 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule of Quarterly Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>211161024 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>241174073 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" abstract="true" name="RestrictedStockUnitsandPerformancebasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" abstract="true" name="InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OperatingLeaseImpairmentLossNetOfTax" abstract="false" name="OperatingLeaseImpairmentLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PerformancebasedStockUnitsMember" abstract="true" name="PerformancebasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePriceIncrease" abstract="false" name="NoncontrollingInterestsPutRightExercisePriceIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_HazardousSubstanceSites" abstract="false" name="HazardousSubstanceSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:positiveIntegerItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" abstract="false" name="ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" abstract="false" name="NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GermanWholesaleBusinessMember" abstract="true" name="GermanWholesaleBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PeRSUsMember" abstract="true" name="PeRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_HeldforSalePolicyTextBlock" abstract="false" name="HeldforSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearFour" abstract="false" name="LeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ShareholderDerivativeActionMember" abstract="true" name="ShareholderDerivativeActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" abstract="false" name="LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_GuarantorObligationsPeriod" abstract="false" name="GuarantorObligationsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" abstract="true" name="PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EnvironmentalLitigationMember" abstract="true" name="EnvironmentalLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NewYorkOpioidTaxSurchargeMember" abstract="true" name="NewYorkOpioidTaxSurchargeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GainLossOnSaleOfBusinessNetOfTax" abstract="false" name="GainLossOnSaleOfBusinessNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" abstract="false" name="GoodwillImpairedMethodforFairValueDeterminationDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StockExchangedDuringPeriodValue" abstract="false" name="StockExchangedDuringPeriodValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_SupplierIncentivesPolicyPolicyTextBlock" abstract="false" name="SupplierIncentivesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" abstract="true" name="GuaranteeObligationsInventoryRepurchaseGuaranteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ExchangeOfferSharesExchanged" abstract="false" name="ExchangeOfferSharesExchanged" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" abstract="true" name="TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NumberofSoftwareProducts" abstract="false" name="NumberofSoftwareProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" abstract="true" name="OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ThirdPartySellerofRexallHealthMember" abstract="true" name="ThirdPartySellerofRexallHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" abstract="false" name="EquityMethodInvestmentsReversalofDeferredTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ChangeHealthcareLLCChangeHealthcareMember" abstract="true" name="ChangeHealthcareLLCChangeHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_GoodwillImpairmentLossTax" abstract="false" name="GoodwillImpairmentLossTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedContributionPlanMatchingAxis" abstract="true" name="DefinedContributionPlanMatchingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" abstract="false" name="DeferredTaxLiabilitiesLeaseRightofuseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OpenMarketTransactionsMember" abstract="true" name="OpenMarketTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" abstract="true" name="StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A1.625NotesDue2026Member" abstract="true" name="A1.625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_A3.125NotesDue2029Member" abstract="true" name="A3.125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" abstract="true" name="UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" abstract="false" name="DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" abstract="true" name="DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" abstract="true" name="FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentCarryingAmount" abstract="false" name="EquityMethodInvestmentCarryingAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" abstract="false" name="EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearThree" abstract="false" name="LeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherAllowancesMember" abstract="false" name="OtherAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActNewYorkAnnualSurcharge" abstract="false" name="OpioidStewardshipActNewYorkAnnualSurcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofAdditionalDefendants" abstract="false" name="LossContingencyNumberofAdditionalDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_OtherNoncurrentAssetsLiabilitiesMember" abstract="true" name="OtherNoncurrentAssetsLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesReceived" abstract="false" name="LossContingencyClassActionNumberofFaxesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" abstract="true" name="EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RexallHealthMember" abstract="true" name="RexallHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" abstract="false" name="DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RangeOneMember" abstract="false" name="RangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RangeTwoMember" abstract="false" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentTransactionCostsIncurred" abstract="false" name="EquityMethodInvestmentTransactionCostsIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" abstract="false" name="SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GainLossonDerecognitionofLiability" abstract="false" name="GainLossonDerecognitionofLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_GrossProfitNetofExpensesIncludingOtherIncome" abstract="false" name="GrossProfitNetofExpensesIncludingOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedContributionPlanMatchingDomain" abstract="true" name="DefinedContributionPlanMatchingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" abstract="true" name="PharmaceuticalDistributionsReportingUnitJune2018OneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseinOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseinOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A2013StockPlanMember" abstract="true" name="A2013StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleJointVentureMember" abstract="true" name="GermanPharmaceuticalWholesaleJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RealPropertyMember" abstract="true" name="RealPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_LessorLeasePaymentstobeReceived" abstract="false" name="LessorLeasePaymentstobeReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" abstract="false" name="DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" abstract="false" name="LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_SeparationofChangeHealthcareJVMember" abstract="true" name="SeparationofChangeHealthcareJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" abstract="false" name="LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="LeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_DeferredTaxAssetLitigationAndClaims" abstract="false" name="DeferredTaxAssetLitigationAndClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ServicesBusinessMember" abstract="true" name="ServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" abstract="true" name="TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_FinancialGuaranteesAndWarrantiesAbstract" abstract="true" name="FinancialGuaranteesAndWarrantiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" abstract="true" name="PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofCounties" abstract="false" name="LossContingencyNumberofCounties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EquityMethodInvestmentStockAcceptedAverageCost" abstract="false" name="EquityMethodInvestmentStockAcceptedAverageCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" abstract="false" name="EffectiveIncomeTaxRateReconciliationLitigationAndClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" abstract="true" name="UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" abstract="false" name="TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" abstract="true" name="ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" abstract="false" name="EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_DefinedBenefitPlanOtherFundsMember" abstract="true" name="DefinedBenefitPlanOtherFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFiveThereafter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" abstract="true" name="UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="LeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" abstract="false" name="CapitalizedSoftwareHeldforInternalUseUsefulLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_AccruedShareRepurchases" abstract="false" name="AccruedShareRepurchases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CaliforniaFoundationMember" abstract="true" name="CaliforniaFoundationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" abstract="false" name="CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFive" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" abstract="false" name="EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearTwo" abstract="false" name="GuaranteeObligationsExposureExpiringinYearTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" abstract="true" name="ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" abstract="false" name="OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofRelators" abstract="false" name="LossContingencyNumberofRelators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_GlobalFacilityMember" abstract="true" name="GlobalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" abstract="true" name="UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" abstract="true" name="OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" abstract="true" name="UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ConsolidatedActionsvSureScriptsLLCMember" abstract="true" name="ConsolidatedActionsvSureScriptsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NotesDueMay302029Member" abstract="true" name="NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" abstract="false" name="IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearFive" abstract="false" name="LeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" abstract="false" name="DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" abstract="false" name="OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" abstract="true" name="StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_UnitValueOfCashAndCashEquivalents" abstract="false" name="UnitValueOfCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" abstract="false" name="LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EvanstonPolicePensionFundv.McKessonCorporationMember" abstract="true" name="EvanstonPolicePensionFundv.McKessonCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" abstract="true" name="CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentStockAccepted" abstract="false" name="EquityMethodInvestmentStockAccepted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDue" abstract="false" name="LeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearOne" abstract="false" name="GuaranteeObligationsExposureExpiringinYearOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" abstract="false" name="ValuationAllowancesAndReservesDeductionsWrittenOffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualProvisionAfterTax" abstract="false" name="LossContingencyAccrualProvisionAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" abstract="true" name="FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_GuaranteeObligationsCustomersDebtMember" abstract="true" name="GuaranteeObligationsCustomersDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" abstract="false" name="LossContingencyClassActionNumberofFaxesRemainingintheClass" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsSegmentMember" abstract="true" name="PrescriptionTechnologySolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EuropeanPharmaceuticalSolutionsMember" abstract="true" name="EuropeanPharmaceuticalSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="LeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PharmaceuticalDistributionsReportingUnitMember" abstract="true" name="PharmaceuticalDistributionsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_OperatingModelAndCostOptimizationProgramsMember" abstract="true" name="OperatingModelAndCostOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ExchangeOfferSharesDistributed" abstract="false" name="ExchangeOfferSharesDistributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_SiteContingencyNumberofSites" abstract="false" name="SiteContingencyNumberofSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NorwegianPublicServicePensionFundSPKMember" abstract="true" name="NorwegianPublicServicePensionFundSPKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofFormerOfficers" abstract="false" name="LossContingencyNumberofFormerOfficers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A475NotesDueMarch12021Member" abstract="true" name="A475NotesDueMarch12021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_FinancialGuaranteesAndWarrantiesTextBlock" abstract="false" name="FinancialGuaranteesAndWarrantiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_ForwardContractsandCrossCurrencySwapsMember" abstract="true" name="ForwardContractsandCrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccountsReceivableCustomerAccountsGross" abstract="false" name="AccountsReceivableCustomerAccountsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" abstract="true" name="ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" abstract="false" name="RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" abstract="true" name="ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" abstract="true" name="PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyDamagesSoughtPerViolationValue" abstract="false" name="LossContingencyDamagesSoughtPerViolationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SecondPartOfPayContributionMember" abstract="false" name="SecondPartOfPayContributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_FirstPartOfPayContributionMember" abstract="false" name="FirstPartOfPayContributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_InsuranceCoverageLitigationMember" abstract="true" name="InsuranceCoverageLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_InsuranceProgramsPolicyTextBlock" abstract="false" name="InsuranceProgramsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_TerminationofU.SDefinedBenefitPensionPlanMember" abstract="true" name="TerminationofU.SDefinedBenefitPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofCitiesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberofCitiesFiledOnBehalfOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NotesDueNovember302020Member" abstract="true" name="NotesDueNovember302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IntangibleAssetandStoreAssetsImpairmentMember" abstract="true" name="IntangibleAssetandStoreAssetsImpairmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_SupplierReservesPolicyTextBlock" abstract="false" name="SupplierReservesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_PendingAndFutureOpioidRelatedClaimsMember" abstract="true" name="PendingAndFutureOpioidRelatedClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NumberofSitesSelectedforPreferredRemedy" abstract="false" name="NumberofSitesSelectedforPreferredRemedy" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_TaxReceivableAgreementTRAMember" abstract="true" name="TaxReceivableAgreementTRAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DerivativeNotionalAmountMatured" abstract="false" name="DerivativeNotionalAmountMatured" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EquityMethodInvestmentFairValueofStockAccepted" abstract="false" name="EquityMethodInvestmentFairValueofStockAccepted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberofLargestCustomers" abstract="false" name="NumberofLargestCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" abstract="false" name="EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" abstract="false" name="FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_November2018CrossCurrencySwapsMember" abstract="true" name="November2018CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestsMaximumRedemptionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitDiscreteItems" abstract="false" name="IncomeTaxExpenseBenefitDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" abstract="false" name="SixPercentNotesDueMarchOneTwoThousandFortyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" abstract="true" name="ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" abstract="false" name="IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" abstract="false" name="GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" abstract="false" name="DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseandOtherObligationsMember" abstract="true" name="LeaseandOtherObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" abstract="false" name="BenefitObligationsAssumptionsRateIncreaseinCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_A1.500NotesDue2025Member" abstract="true" name="A1.500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFour" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFour" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" abstract="true" name="EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" abstract="false" name="DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StockExchangedDuringPeriodShares" abstract="false" name="StockExchangedDuringPeriodShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearThree" abstract="false" name="GuaranteeObligationsExposureExpiringinYearThree" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" abstract="true" name="PharmaceuticalDistributionsReportingUnitJune2018TwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" abstract="false" name="PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" abstract="false" name="EstimatedEnvironmentalAssessmentAndCleanupCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CoverMyMedsLLCMember" abstract="true" name="CoverMyMedsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" abstract="true" name="ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" abstract="false" name="DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InreNationalPrescriptionOpiateLitigationMember" abstract="true" name="InreNationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_MedicalSpecialtiesDistributorsLLCMSDMember" abstract="true" name="MedicalSpecialtiesDistributorsLLCMSDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanSettlementPlanParticipants" abstract="false" name="DefinedBenefitPlanSettlementPlanParticipants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" abstract="false" name="SECSchedule1209ValuationAllowancesandReservesCurrentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_McKessonFoundationMember" abstract="true" name="McKessonFoundationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ChangeHealthcareInc.Member" abstract="true" name="ChangeHealthcareInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" abstract="false" name="LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LongtermDebtCurrentMaturitiesMember" abstract="true" name="LongtermDebtCurrentMaturitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mck_A0.625notesDue2021Member" abstract="true" name="A0.625notesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" abstract="true" name="TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" abstract="true" name="TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" abstract="true" name="KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_MultiemployerPlanFundedStatusPercentage" abstract="false" name="MultiemployerPlanFundedStatusPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_DataRelatedtoRSUActivityTableTextBlock" abstract="false" name="DataRelatedtoRSUActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" abstract="false" name="EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" abstract="true" name="EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_MachineryEquipmentAndOtherMember" abstract="true" name="MachineryEquipmentAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" abstract="true" name="TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_WalgreensBootsAllianceJointVentureMember" abstract="true" name="WalgreensBootsAllianceJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_EmployeeContributions" abstract="false" name="EmployeeContributions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_RetailPharmacyReportingUnitMember" abstract="true" name="RetailPharmacyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DistributionandRetailBusinessMember" abstract="true" name="DistributionandRetailBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" abstract="true" name="ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_DeferredTaxAssetLeaseObligations" abstract="false" name="DeferredTaxAssetLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TransitionServicesAgreementsTSAMember" abstract="true" name="TransitionServicesAgreementsTSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_LargestCustomerMember" abstract="true" name="LargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStatesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberofStatesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_SettlementofExecutiveRetirementBenefitsMember" abstract="true" name="SettlementofExecutiveRetirementBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_U.S.PharmaceuticalandSpecialtySolutionsMember" abstract="true" name="U.S.PharmaceuticalandSpecialtySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" abstract="false" name="PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>mck-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0a91717b-5b9a-4470-a716-9c00214a8bdd,g:f2a8631c-ae82-4a44-9090-35d7005e9a98-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20210331.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_400a0b30-ec91-493a-b4f3-48e81c610426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_61d00fb5-347d-4dd0-8c88-d33ce6f489af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_400a0b30-ec91-493a-b4f3-48e81c610426" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_61d00fb5-347d-4dd0-8c88-d33ce6f489af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6dfb119e-731a-496c-8989-5bb4273fd8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_400a0b30-ec91-493a-b4f3-48e81c610426" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6dfb119e-731a-496c-8989-5bb4273fd8ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_afec0515-4d32-44b2-91ee-0fce800c3699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_7e2c028f-782d-4976-a76e-909bb998578e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_afec0515-4d32-44b2-91ee-0fce800c3699" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_7e2c028f-782d-4976-a76e-909bb998578e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_fdb265e3-28ec-4f3a-8ff6-cbb271ef5572" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_afec0515-4d32-44b2-91ee-0fce800c3699" xlink:to="loc_us-gaap_LegalFees_fdb265e3-28ec-4f3a-8ff6-cbb271ef5572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9605ae52-572e-4c27-bd2d-bb961f3e38bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_afec0515-4d32-44b2-91ee-0fce800c3699" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9605ae52-572e-4c27-bd2d-bb961f3e38bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7eaf9e86-351d-4f72-bc43-dc7cb2794983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_afec0515-4d32-44b2-91ee-0fce800c3699" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7eaf9e86-351d-4f72-bc43-dc7cb2794983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_25ea3883-8d26-40bf-b374-6cf0e095a16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_e2cf6313-ba40-4820-b9a0-8d18755076d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_25ea3883-8d26-40bf-b374-6cf0e095a16e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_e2cf6313-ba40-4820-b9a0-8d18755076d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a39af1a1-6bee-48a4-8b38-187517fc3a8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_25ea3883-8d26-40bf-b374-6cf0e095a16e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_a39af1a1-6bee-48a4-8b38-187517fc3a8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_30d97216-afee-4845-ab1a-41bf3c3cd681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0552a9ad-b054-4533-b553-29316b571c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_30d97216-afee-4845-ab1a-41bf3c3cd681" xlink:to="loc_us-gaap_GrossProfit_0552a9ad-b054-4533-b553-29316b571c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_429375d5-3ebd-4d2d-a2f1-28cbc74dd032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_30d97216-afee-4845-ab1a-41bf3c3cd681" xlink:to="loc_us-gaap_OperatingExpenses_429375d5-3ebd-4d2d-a2f1-28cbc74dd032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4b5c05dd-5364-435d-b908-4b17ccc5f0dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_89554825-1a8a-413b-8dc2-fdd81d591de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4b5c05dd-5364-435d-b908-4b17ccc5f0dd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_89554825-1a8a-413b-8dc2-fdd81d591de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3944c541-3b52-4931-8284-9e1430fba6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4b5c05dd-5364-435d-b908-4b17ccc5f0dd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3944c541-3b52-4931-8284-9e1430fba6b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c91319b-104b-4943-852b-480f68265ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25d5bff6-5b7d-45f5-a434-94ffbc3a59a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c91319b-104b-4943-852b-480f68265ddb" xlink:to="loc_us-gaap_ProfitLoss_25d5bff6-5b7d-45f5-a434-94ffbc3a59a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57966660-b639-41f6-942f-43bb034eff7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c91319b-104b-4943-852b-480f68265ddb" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57966660-b639-41f6-942f-43bb034eff7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_78c53536-f575-4258-9410-ffeff7e2e1b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_19028e9b-44d7-4558-bda5-d3c0cd9ddfcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_78c53536-f575-4258-9410-ffeff7e2e1b8" xlink:to="loc_us-gaap_OperatingIncomeLoss_19028e9b-44d7-4558-bda5-d3c0cd9ddfcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_053d2ef3-6b92-446c-9e19-4bd69f2d4ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_78c53536-f575-4258-9410-ffeff7e2e1b8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_053d2ef3-6b92-446c-9e19-4bd69f2d4ae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d181c10b-545d-40e2-874b-e0d57e9b7972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_78c53536-f575-4258-9410-ffeff7e2e1b8" xlink:to="loc_us-gaap_InterestExpense_d181c10b-545d-40e2-874b-e0d57e9b7972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_7ff8ef25-d698-454c-ac7e-849859fd4254" xlink:href="mck-20210331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_78c53536-f575-4258-9410-ffeff7e2e1b8" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_7ff8ef25-d698-454c-ac7e-849859fd4254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_dd16c86c-62a4-4911-a2f0-9054a8094a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_52fa6006-40a4-4ac0-8431-707cbfa26127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_dd16c86c-62a4-4911-a2f0-9054a8094a55" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_52fa6006-40a4-4ac0-8431-707cbfa26127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a438ca49-2ebe-4722-aca5-2a8b762512f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_dd16c86c-62a4-4911-a2f0-9054a8094a55" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a438ca49-2ebe-4722-aca5-2a8b762512f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a3ad23ae-9da2-44db-bb5a-12d470b1231c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b6d1a44a-ede8-4443-91e6-f6c2bc5cf8c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a3ad23ae-9da2-44db-bb5a-12d470b1231c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b6d1a44a-ede8-4443-91e6-f6c2bc5cf8c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_193ef560-e690-4d61-853c-42eb3835360a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a3ad23ae-9da2-44db-bb5a-12d470b1231c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_193ef560-e690-4d61-853c-42eb3835360a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_713ddad9-2e23-462c-8f98-3d5ec55d08ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0acfda6d-b08c-43b3-91a4-7136a979d9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_713ddad9-2e23-462c-8f98-3d5ec55d08ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0acfda6d-b08c-43b3-91a4-7136a979d9e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d405f272-cdf6-4478-b080-f05c85615e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_713ddad9-2e23-462c-8f98-3d5ec55d08ef" xlink:to="loc_us-gaap_ProfitLoss_d405f272-cdf6-4478-b080-f05c85615e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_11ee9bfc-631d-4702-ad01-448c1302d6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4fbdead4-3374-45f0-8d31-973c2e269bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_11ee9bfc-631d-4702-ad01-448c1302d6b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4fbdead4-3374-45f0-8d31-973c2e269bff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_de707637-d53b-4b73-83ae-64e1524b55e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_11ee9bfc-631d-4702-ad01-448c1302d6b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_de707637-d53b-4b73-83ae-64e1524b55e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b1065790-5248-4bb7-826f-08fe32381c88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_11ee9bfc-631d-4702-ad01-448c1302d6b0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b1065790-5248-4bb7-826f-08fe32381c88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fc43a6d3-6846-4562-be3d-89ccaab78f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a4994835-fd34-47f6-9c06-58f6313e1a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fc43a6d3-6846-4562-be3d-89ccaab78f1e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a4994835-fd34-47f6-9c06-58f6313e1a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8529e992-163e-4e75-9fe7-7355106279d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fc43a6d3-6846-4562-be3d-89ccaab78f1e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8529e992-163e-4e75-9fe7-7355106279d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd58abe8-33d8-4d76-a914-b95001a5f090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd58abe8-33d8-4d76-a914-b95001a5f090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a071c402-5622-47ef-b567-6fb60539d4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_LiabilitiesCurrent_a071c402-5622-47ef-b567-6fb60539d4e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_dab5fbec-c3c0-41f7-b03a-27cd5a08748a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_dab5fbec-c3c0-41f7-b03a-27cd5a08748a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_deb83c22-813c-46d6-a1c8-7170fabd9220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_deb83c22-813c-46d6-a1c8-7170fabd9220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_80e7e0c0-29b9-41bf-82da-fe6b24c5bbff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_80e7e0c0-29b9-41bf-82da-fe6b24c5bbff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9c8998d2-b943-44db-be7f-4804a56f8d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9c8998d2-b943-44db-be7f-4804a56f8d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b306d90a-9306-497c-ac08-9386768e1db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b306d90a-9306-497c-ac08-9386768e1db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_594add95-058c-44a5-9943-4d6875c22e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_594add95-058c-44a5-9943-4d6875c22e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_78fe4188-8837-4126-a023-a26fbe8325b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_07afc445-c460-42ee-9832-9cec6b939399" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_78fe4188-8837-4126-a023-a26fbe8325b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b67ed2ab-1692-431f-827a-2b420814a23d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c305f7d-8e43-4c1d-850e-cf788ee6014c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b67ed2ab-1692-431f-827a-2b420814a23d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c305f7d-8e43-4c1d-850e-cf788ee6014c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_a21f474a-dc3b-4a43-9c6c-ada66c9e491d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b67ed2ab-1692-431f-827a-2b420814a23d" xlink:to="loc_us-gaap_ReceivablesNetCurrent_a21f474a-dc3b-4a43-9c6c-ada66c9e491d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7eaf3696-6ce9-486b-800b-86f4db9811d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b67ed2ab-1692-431f-827a-2b420814a23d" xlink:to="loc_us-gaap_InventoryNet_7eaf3696-6ce9-486b-800b-86f4db9811d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d8e775fb-4fbd-4854-8d9a-a0ad4ddd6b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b67ed2ab-1692-431f-827a-2b420814a23d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d8e775fb-4fbd-4854-8d9a-a0ad4ddd6b51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_be8dc754-810e-40cc-af9a-0f5c8e5506f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b67ed2ab-1692-431f-827a-2b420814a23d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_be8dc754-810e-40cc-af9a-0f5c8e5506f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e4876faa-7e60-47e3-9004-82579dbbc421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:to="loc_us-gaap_PreferredStockValue_e4876faa-7e60-47e3-9004-82579dbbc421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c6d8cb90-4940-4981-9d8c-4ea307e36c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:to="loc_us-gaap_CommonStockValue_c6d8cb90-4940-4981-9d8c-4ea307e36c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5b091c13-450d-4a04-9e30-ad8c8c8e79fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5b091c13-450d-4a04-9e30-ad8c8c8e79fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_db6f8ce3-9fb7-4147-9f91-177071d4f1f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_db6f8ce3-9fb7-4147-9f91-177071d4f1f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8005aea8-d7c1-479f-b752-03f021905b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8005aea8-d7c1-479f-b752-03f021905b6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_04605c38-1290-4647-b9a7-995d7737b4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1f119fc8-b332-4df9-ae07-3660fdc91716" xlink:to="loc_us-gaap_TreasuryStockValue_04605c38-1290-4647-b9a7-995d7737b4a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1395dc9f-0f1a-4029-9fb8-3c77470f32ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:to="loc_us-gaap_AssetsCurrent_1395dc9f-0f1a-4029-9fb8-3c77470f32ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_084f4a8a-9341-49d8-9480-7c56d5caa706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_084f4a8a-9341-49d8-9480-7c56d5caa706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3e3399fe-93d0-492f-a214-190cfc75cca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:to="loc_us-gaap_Goodwill_3e3399fe-93d0-492f-a214-190cfc75cca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2145ac99-5559-4dc3-aba0-b5b1ddbe6f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2145ac99-5559-4dc3-aba0-b5b1ddbe6f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fb2b5fab-dedd-496f-94d1-44d4e597b668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fb2b5fab-dedd-496f-94d1-44d4e597b668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f06d8a09-ef53-4453-8212-ed933e5e903f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_be9af410-2d1e-466e-b7d1-b0437b6e4d0a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f06d8a09-ef53-4453-8212-ed933e5e903f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db45c2f7-78f9-43c6-a551-e59cf39f3093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e44a2b6e-fc90-46b1-96a4-0d7dfcefee18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db45c2f7-78f9-43c6-a551-e59cf39f3093" xlink:to="loc_us-gaap_StockholdersEquity_e44a2b6e-fc90-46b1-96a4-0d7dfcefee18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5eb9de32-ad6a-44b0-9149-f995450f2abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db45c2f7-78f9-43c6-a551-e59cf39f3093" xlink:to="loc_us-gaap_MinorityInterest_5eb9de32-ad6a-44b0-9149-f995450f2abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d6f20b31-0405-4e64-9db7-783eedc78fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e5612088-f2d4-4f2c-a94e-8be0ff9a40c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6f20b31-0405-4e64-9db7-783eedc78fb6" xlink:to="loc_us-gaap_AccountsPayableCurrent_e5612088-f2d4-4f2c-a94e-8be0ff9a40c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5499c0a1-8aa9-494f-bc2a-611cfa7c3c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6f20b31-0405-4e64-9db7-783eedc78fb6" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5499c0a1-8aa9-494f-bc2a-611cfa7c3c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_73d26a14-8eb9-4545-aebd-ae84ac08d9a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6f20b31-0405-4e64-9db7-783eedc78fb6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_73d26a14-8eb9-4545-aebd-ae84ac08d9a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_81c14756-e624-463c-8083-9f1404ca26d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6f20b31-0405-4e64-9db7-783eedc78fb6" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_81c14756-e624-463c-8083-9f1404ca26d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_69cac837-b45f-4383-a99f-7dc923ced40b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6f20b31-0405-4e64-9db7-783eedc78fb6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_69cac837-b45f-4383-a99f-7dc923ced40b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8b649835-cd4c-432c-b7e5-385ea9c12325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_ProfitLoss_8b649835-cd4c-432c-b7e5-385ea9c12325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_23aac070-9cda-48f6-ba6f-c2ef7111ccfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_23aac070-9cda-48f6-ba6f-c2ef7111ccfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_184841c3-0579-41ad-927f-0146ee096fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_184841c3-0579-41ad-927f-0146ee096fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5c4724eb-fef1-4e4b-aca7-df22147aabf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5c4724eb-fef1-4e4b-aca7-df22147aabf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_98745992-f076-4fa4-8e3f-72373a5a108e" xlink:href="mck-20210331.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_98745992-f076-4fa4-8e3f-72373a5a108e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_b6dffc0a-374e-4ba8-a45b-61f0c7c06562" xlink:href="mck-20210331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_b6dffc0a-374e-4ba8-a45b-61f0c7c06562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_715b8dbb-60f3-4db4-a6e7-a0de4802f85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_715b8dbb-60f3-4db4-a6e7-a0de4802f85a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3e2b6ee3-0175-442c-8e5b-2a30496a194a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3e2b6ee3-0175-442c-8e5b-2a30496a194a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_09aa057a-1ccf-47eb-93a8-9544d6b1a288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_09aa057a-1ccf-47eb-93a8-9544d6b1a288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b8f9cd5a-9528-4464-b4ff-bc53a7c741bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_OperatingLeaseExpense_b8f9cd5a-9528-4464-b4ff-bc53a7c741bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_0463a6a3-0462-48ee-8f75-ab9979391101" xlink:href="mck-20210331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_0463a6a3-0462-48ee-8f75-ab9979391101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4ab23b52-8413-4343-afc4-3eb104031a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_Depreciation_4ab23b52-8413-4343-afc4-3eb104031a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_539fc16c-d247-4680-9eae-66dd2c036996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_539fc16c-d247-4680-9eae-66dd2c036996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_a4e13d67-5f30-4f98-b293-ae1392c9ab1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_AdjustmentForAmortization_a4e13d67-5f30-4f98-b293-ae1392c9ab1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_cc6525b5-b813-4997-9664-f870eaaaf8e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_cc6525b5-b813-4997-9664-f870eaaaf8e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f652dd6a-70c6-47bd-910a-290a001b9aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f652dd6a-70c6-47bd-910a-290a001b9aa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_fe57e248-7146-4b04-a2e2-19c75fd35d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38742d0-1622-479b-85dc-ff37285f0733" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_fe57e248-7146-4b04-a2e2-19c75fd35d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26e64c79-7412-40ca-90d7-9bc38627091d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e9d3f2e-0f7b-4d3a-baeb-19a060c15ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26e64c79-7412-40ca-90d7-9bc38627091d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e9d3f2e-0f7b-4d3a-baeb-19a060c15ae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_c7813f0b-c000-4971-970a-124b34e163fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26e64c79-7412-40ca-90d7-9bc38627091d" xlink:to="loc_us-gaap_RestrictedCashCurrent_c7813f0b-c000-4971-970a-124b34e163fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55d8d4c1-22ef-4db0-80bc-b8e469f22fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_334abb3e-0802-44fe-86c1-6ba6ede3727a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55d8d4c1-22ef-4db0-80bc-b8e469f22fd0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_334abb3e-0802-44fe-86c1-6ba6ede3727a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6dddc99-e4a4-4420-aafe-5f235d6e41c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55d8d4c1-22ef-4db0-80bc-b8e469f22fd0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6dddc99-e4a4-4420-aafe-5f235d6e41c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55db159c-3fa8-4e22-a4bf-49129b9aa4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55d8d4c1-22ef-4db0-80bc-b8e469f22fd0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_55db159c-3fa8-4e22-a4bf-49129b9aa4b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_67de064d-3271-43a9-a327-a9955f676256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55d8d4c1-22ef-4db0-80bc-b8e469f22fd0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_67de064d-3271-43a9-a327-a9955f676256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d308f1a2-3587-442c-ba3a-6bcd611f0e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52a5d6a2-54bf-480d-ad6c-cd9cedd3ed45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d308f1a2-3587-442c-ba3a-6bcd611f0e63" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52a5d6a2-54bf-480d-ad6c-cd9cedd3ed45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_41f3e2c4-7371-4f9a-b858-f02bdc3c9d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d308f1a2-3587-442c-ba3a-6bcd611f0e63" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_41f3e2c4-7371-4f9a-b858-f02bdc3c9d1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f6755424-2c84-4ace-b9f9-e1a626d55360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d308f1a2-3587-442c-ba3a-6bcd611f0e63" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f6755424-2c84-4ace-b9f9-e1a626d55360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_85d92d54-68b8-4468-9cfd-343d09904876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d308f1a2-3587-442c-ba3a-6bcd611f0e63" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_85d92d54-68b8-4468-9cfd-343d09904876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_35551d71-7d10-43e4-b7b0-5fdf74d06aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d308f1a2-3587-442c-ba3a-6bcd611f0e63" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_35551d71-7d10-43e4-b7b0-5fdf74d06aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_df93f2d3-02f0-4280-b782-f8c2ba17df2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_df93f2d3-02f0-4280-b782-f8c2ba17df2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_47be3a0c-61c1-4d8a-93c9-0220a8dbfaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_47be3a0c-61c1-4d8a-93c9-0220a8dbfaea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e2d4519e-8eb7-4cf4-90a7-ad7098e29327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e2d4519e-8eb7-4cf4-90a7-ad7098e29327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_5729a6b4-7a0c-4a59-a262-179054807654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_5729a6b4-7a0c-4a59-a262-179054807654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_39ff3b31-2218-47ff-ae4c-a6dc0461f6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_39ff3b31-2218-47ff-ae4c-a6dc0461f6d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e03f4a63-c04b-4027-b29b-5362893d3002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e03f4a63-c04b-4027-b29b-5362893d3002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_a2d97b06-7eaa-4bc9-b137-dd5b88e496cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_a2d97b06-7eaa-4bc9-b137-dd5b88e496cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fd14d985-a858-47c9-9ee5-a08199219100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6db46990-dfcb-4b67-89fc-e73b5cda771d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fd14d985-a858-47c9-9ee5-a08199219100" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_1ddc27af-127b-40be-92cd-837bb0d98d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_2a7c58c6-6944-431c-be61-12137c66e9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_1ddc27af-127b-40be-92cd-837bb0d98d4b" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_2a7c58c6-6944-431c-be61-12137c66e9c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e37b1184-7b53-4460-83c3-8c3819932a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_1ddc27af-127b-40be-92cd-837bb0d98d4b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e37b1184-7b53-4460-83c3-8c3819932a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_85ac4bb7-ba18-4a00-ba7a-e8e288d2753b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross_9969a213-b2d2-407b-958a-e79e8cd357f9" xlink:href="mck-20210331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_85ac4bb7-ba18-4a00-ba7a-e8e288d2753b" xlink:to="loc_mck_AccountsReceivableCustomerAccountsGross_9969a213-b2d2-407b-958a-e79e8cd357f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_8f492fbc-4abc-489f-82f1-b19b78ec032a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_85ac4bb7-ba18-4a00-ba7a-e8e288d2753b" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_8f492fbc-4abc-489f-82f1-b19b78ec032a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f092961b-ab37-41d7-8361-f68825442c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_124b9a93-8d1e-4819-b85f-dddbcd9b28cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f092961b-ab37-41d7-8361-f68825442c2a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_124b9a93-8d1e-4819-b85f-dddbcd9b28cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_508b766e-f032-4145-bd30-a695b2bccc12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f092961b-ab37-41d7-8361-f68825442c2a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_508b766e-f032-4145-bd30-a695b2bccc12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5cdfb678-710c-40e7-9262-baccae98638f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_b3f0511e-a5a2-4e2f-8f25-6dc1ed4e2e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_5cdfb678-710c-40e7-9262-baccae98638f" xlink:to="loc_us-gaap_ConstructionInProgressGross_b3f0511e-a5a2-4e2f-8f25-6dc1ed4e2e3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_594d3f7d-630c-4c6b-8f48-94c85ac6e130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_5cdfb678-710c-40e7-9262-baccae98638f" xlink:to="loc_us-gaap_Land_594d3f7d-630c-4c6b-8f48-94c85ac6e130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther_d12c43d1-03cd-47c2-aa59-5ffd2621895e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_5cdfb678-710c-40e7-9262-baccae98638f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOther_d12c43d1-03cd-47c2-aa59-5ffd2621895e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_a92f2fb7-df0b-49ea-9d9a-cc921ee57ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_5cdfb678-710c-40e7-9262-baccae98638f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_a92f2fb7-df0b-49ea-9d9a-cc921ee57ff0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b4b4e97-0a8f-4154-9783-fab49be3a26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_b19b8ff0-1a5f-40bf-bf87-d94e0ba65bed" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b4b4e97-0a8f-4154-9783-fab49be3a26e" xlink:to="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_b19b8ff0-1a5f-40bf-bf87-d94e0ba65bed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount_6b7239ed-e0fd-49b3-8ad2-ac63d5bc2ccf" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b4b4e97-0a8f-4154-9783-fab49be3a26e" xlink:to="loc_mck_EquityMethodInvestmentCarryingAmount_6b7239ed-e0fd-49b3-8ad2-ac63d5bc2ccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_a903a236-a604-451a-9d40-a5d59c760370" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentsReversalofDeferredTaxLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b4b4e97-0a8f-4154-9783-fab49be3a26e" xlink:to="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_a903a236-a604-451a-9d40-a5d59c760370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_801c17ee-982b-4423-b7d1-78d5e1788320" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b4b4e97-0a8f-4154-9783-fab49be3a26e" xlink:to="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_801c17ee-982b-4423-b7d1-78d5e1788320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_2f7f5a0c-dbe9-4757-bf14-487906dbd0db" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b4b4e97-0a8f-4154-9783-fab49be3a26e" xlink:to="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_2f7f5a0c-dbe9-4757-bf14-487906dbd0db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSale"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c5f9ff7e-47bb-48fa-9b88-d8df9bf2249d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_36e3f79b-bad8-469e-97e5-2eaa93606744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c5f9ff7e-47bb-48fa-9b88-d8df9bf2249d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_36e3f79b-bad8-469e-97e5-2eaa93606744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0cd8eeec-ab02-4b5c-b3c1-d3fb6df70f56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c5f9ff7e-47bb-48fa-9b88-d8df9bf2249d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_0cd8eeec-ab02-4b5c-b3c1-d3fb6df70f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_3d3c7d1f-9cb7-449c-b3ad-3c0f84d66ec6" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c5f9ff7e-47bb-48fa-9b88-d8df9bf2249d" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_3d3c7d1f-9cb7-449c-b3ad-3c0f84d66ec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_79786ce1-fc92-4cb3-87eb-4994cb19e3aa" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c5f9ff7e-47bb-48fa-9b88-d8df9bf2249d" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_79786ce1-fc92-4cb3-87eb-4994cb19e3aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_19985003-2cba-4544-be51-9340a69fc77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_f0de7acb-a31a-42f3-9731-282c03784dcf" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_19985003-2cba-4544-be51-9340a69fc77e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_f0de7acb-a31a-42f3-9731-282c03784dcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_88b160ca-c304-4d5f-81d0-4e8f990ef4ba" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_19985003-2cba-4544-be51-9340a69fc77e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_88b160ca-c304-4d5f-81d0-4e8f990ef4ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_dc322a59-cabd-4cea-957b-16824a6ee9d1" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_19985003-2cba-4544-be51-9340a69fc77e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_dc322a59-cabd-4cea-957b-16824a6ee9d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_794da361-5c13-41a8-ada1-0c77671bf9d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_ca70b435-fd07-48b8-ae07-c2300f106564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_794da361-5c13-41a8-ada1-0c77671bf9d6" xlink:to="loc_us-gaap_SeveranceCosts1_ca70b435-fd07-48b8-ae07-c2300f106564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_5accca6c-4797-4236-ab26-06d1e849130c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_794da361-5c13-41a8-ada1-0c77671bf9d6" xlink:to="loc_us-gaap_BusinessExitCosts1_5accca6c-4797-4236-ab26-06d1e849130c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_89a26e2c-a3b9-464c-8e7c-8c01ea38272e" xlink:href="mck-20210331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_794da361-5c13-41a8-ada1-0c77671bf9d6" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_89a26e2c-a3b9-464c-8e7c-8c01ea38272e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestitures"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2c0aab96-1eab-4ee2-aff7-546366fdaeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2c0aab96-1eab-4ee2-aff7-546366fdaeb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_715ac5da-ff83-469e-b920-2b9bfbfae216" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_715ac5da-ff83-469e-b920-2b9bfbfae216" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b7cee5f5-1073-475b-ab5f-09fa69f85fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_us-gaap_Goodwill_b7cee5f5-1073-475b-ab5f-09fa69f85fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_aa7ba2c0-eb8e-4073-888a-6a7c0c733610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_aa7ba2c0-eb8e-4073-888a-6a7c0c733610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7d44a072-bdd8-4866-94db-ccd79f206a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_7d44a072-bdd8-4866-94db-ccd79f206a87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9aa48d23-261b-42c0-9767-b791a53675db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9aa48d23-261b-42c0-9767-b791a53675db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1ef3ad97-1cef-46f0-b58a-c909662d67ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_be09056a-0ffc-422b-a409-84152772c83d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1ef3ad97-1cef-46f0-b58a-c909662d67ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_f5015bcd-4ba8-4c2d-b75e-5d1b6c22f3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5d575de2-c4d8-43c2-951a-f04b025055e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_f5015bcd-4ba8-4c2d-b75e-5d1b6c22f3e5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5d575de2-c4d8-43c2-951a-f04b025055e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b99fea47-a007-44dd-84c9-88097a80738f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_f5015bcd-4ba8-4c2d-b75e-5d1b6c22f3e5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b99fea47-a007-44dd-84c9-88097a80738f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationSummaryofOptionsOutstandingDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNet" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNet"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/OtherIncomeNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNetTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_31d32208-7882-4962-9f47-30aca65a6492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_31d32208-7882-4962-9f47-30aca65a6492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_e85372dd-c94e-40e1-8eee-e083d358ee3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_e85372dd-c94e-40e1-8eee-e083d358ee3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6b9fdd2d-28bd-4a33-8185-e090442e8d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6b9fdd2d-28bd-4a33-8185-e090442e8d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1decd3f4-bbe0-4931-bf2f-c16687c079ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1decd3f4-bbe0-4931-bf2f-c16687c079ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e20a17d7-c63a-439a-a8e5-a37ffee14451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e20a17d7-c63a-439a-a8e5-a37ffee14451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a4c5ef92-b1f2-4f7c-bb0f-c7cf7d98687b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_db844806-8a6b-4eac-9b43-040896e7fc39" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a4c5ef92-b1f2-4f7c-bb0f-c7cf7d98687b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_29a3090b-0023-41a4-9f26-7276e9b7653f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_95a19092-125d-45d7-9753-75ec1bace841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_29a3090b-0023-41a4-9f26-7276e9b7653f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_95a19092-125d-45d7-9753-75ec1bace841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_953b97c7-bf35-410d-b2c5-9c49b8e8cb88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_29a3090b-0023-41a4-9f26-7276e9b7653f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_953b97c7-bf35-410d-b2c5-9c49b8e8cb88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5de71b00-3edd-42cd-b6af-d783c8099e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_52105267-50d4-4d6f-9ee5-349a2cb13aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5de71b00-3edd-42cd-b6af-d783c8099e70" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_52105267-50d4-4d6f-9ee5-349a2cb13aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5a0e6605-fb09-4cf9-b7c7-3d6edb1c9fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5de71b00-3edd-42cd-b6af-d783c8099e70" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5a0e6605-fb09-4cf9-b7c7-3d6edb1c9fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d2e657e2-55f5-4220-9628-eac7ddb24e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fe4ed446-d50c-4dc0-8b01-718dc8f981bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d2e657e2-55f5-4220-9628-eac7ddb24e11" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fe4ed446-d50c-4dc0-8b01-718dc8f981bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e80dbc3a-b6ba-42d6-9239-32a2ca157460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d2e657e2-55f5-4220-9628-eac7ddb24e11" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e80dbc3a-b6ba-42d6-9239-32a2ca157460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f9734af0-2316-44c1-894e-8ff28d53b4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d2e657e2-55f5-4220-9628-eac7ddb24e11" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f9734af0-2316-44c1-894e-8ff28d53b4d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89df3b4f-6a65-4a14-b3cd-35b93369d01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1057a735-a867-4ebb-bd93-29962315a80f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89df3b4f-6a65-4a14-b3cd-35b93369d01b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1057a735-a867-4ebb-bd93-29962315a80f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_64089f54-9329-4248-8455-130f8daebe40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89df3b4f-6a65-4a14-b3cd-35b93369d01b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_64089f54-9329-4248-8455-130f8daebe40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_26d44b5b-6ee6-4996-90a5-b7ee7bf2a4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_89df3b4f-6a65-4a14-b3cd-35b93369d01b" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_26d44b5b-6ee6-4996-90a5-b7ee7bf2a4c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ff766867-a2b7-4827-ba68-ef8e0af51e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ff766867-a2b7-4827-ba68-ef8e0af51e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b5a0e8a3-1ffe-4abc-ad01-33d6e6d84b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b5a0e8a3-1ffe-4abc-ad01-33d6e6d84b96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_ef6bda7c-2d80-4022-b77b-382478ba5cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_ef6bda7c-2d80-4022-b77b-382478ba5cf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_6fa1e5c3-e934-44d3-9999-27b46a5a05b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_6fa1e5c3-e934-44d3-9999-27b46a5a05b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_89cf6629-06c6-44bf-9c67-e7138fabc6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_89cf6629-06c6-44bf-9c67-e7138fabc6dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_7b0a7fd0-f18a-48d3-857a-711279eb323b" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_7b0a7fd0-f18a-48d3-857a-711279eb323b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_48a3d570-6ec3-42f2-9689-6165f17eb160" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_48a3d570-6ec3-42f2-9689-6165f17eb160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_675a5cc8-27ce-40d0-9a6a-a7ad2d783a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_675a5cc8-27ce-40d0-9a6a-a7ad2d783a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_e912797c-9fbd-4a44-9e97-be0ed0137729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_e912797c-9fbd-4a44-9e97-be0ed0137729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_7d2845e8-4ce2-42aa-ab12-0a8ce8568b9a" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_7d2845e8-4ce2-42aa-ab12-0a8ce8568b9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_843644da-2f26-424a-8af4-3484559d3c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_11de7c6e-c76a-4b5c-8a6f-964ddd920480" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_843644da-2f26-424a-8af4-3484559d3c0a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f413be3c-c384-4417-8500-78f9b58a6811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f413be3c-c384-4417-8500-78f9b58a6811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_3fbd3c50-8823-4f87-8769-4ff54373a2f6" xlink:href="mck-20210331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_3fbd3c50-8823-4f87-8769-4ff54373a2f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b8da9d20-b860-49d3-b137-a7aa10505435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b8da9d20-b860-49d3-b137-a7aa10505435" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f9625318-c47a-4c97-bf1c-5e39973e74ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f9625318-c47a-4c97-bf1c-5e39973e74ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_d4d02136-09e0-4589-a1ef-01360929153a" xlink:href="mck-20210331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_d4d02136-09e0-4589-a1ef-01360929153a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_bc55ec1d-f427-43dd-bff4-6a701d0d9109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eeb36e36-2587-4e39-b0e6-c14149561ec7" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_bc55ec1d-f427-43dd-bff4-6a701d0d9109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d42ce643-11a7-4867-abe5-b11760eac6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_d90a4a42-1000-4f9b-93fb-56bf0acbcd09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d42ce643-11a7-4867-abe5-b11760eac6ca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_d90a4a42-1000-4f9b-93fb-56bf0acbcd09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7600c531-f143-472f-a9ce-8e93742b0377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d42ce643-11a7-4867-abe5-b11760eac6ca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7600c531-f143-472f-a9ce-8e93742b0377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_80bac8da-db18-43f9-ae98-5dd1bb3db97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d42ce643-11a7-4867-abe5-b11760eac6ca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_80bac8da-db18-43f9-ae98-5dd1bb3db97b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_e1eaafca-01f0-416b-8098-685c830724ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d42ce643-11a7-4867-abe5-b11760eac6ca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_e1eaafca-01f0-416b-8098-685c830724ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_9ad337ea-1853-42f9-895e-8870a760bd68" xlink:href="mck-20210331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_d42ce643-11a7-4867-abe5-b11760eac6ca" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_9ad337ea-1853-42f9-895e-8870a760bd68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d0efb074-fd24-4fbb-a8a8-9fa58560a144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b11fecfb-97f3-4f98-a22f-76d4a82a93d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_d0efb074-fd24-4fbb-a8a8-9fa58560a144" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b11fecfb-97f3-4f98-a22f-76d4a82a93d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d12c350d-e758-429d-b514-9fb9f1d94c32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_d0efb074-fd24-4fbb-a8a8-9fa58560a144" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d12c350d-e758-429d-b514-9fb9f1d94c32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3fcfdf34-0dbf-426e-9907-cfdb1d2fbca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2e45dd6c-a59d-43af-8266-edec0094ee5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3fcfdf34-0dbf-426e-9907-cfdb1d2fbca7" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2e45dd6c-a59d-43af-8266-edec0094ee5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b43c94b3-c4a5-4748-9ea7-a4b6338a4375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3fcfdf34-0dbf-426e-9907-cfdb1d2fbca7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b43c94b3-c4a5-4748-9ea7-a4b6338a4375" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShare"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_04f8a3a3-fe16-47c8-82ae-4c9c3ca4b1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1a336de8-4878-4220-acc4-775c32b5f353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_04f8a3a3-fe16-47c8-82ae-4c9c3ca4b1fc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1a336de8-4878-4220-acc4-775c32b5f353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1dfc9370-a05c-4b79-8c0b-a0aa2ea54b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_04f8a3a3-fe16-47c8-82ae-4c9c3ca4b1fc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1dfc9370-a05c-4b79-8c0b-a0aa2ea54b4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_127a75a9-b780-4762-9951-c8046addd3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c84f231a-8029-47c1-a93a-a87657a8cccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_127a75a9-b780-4762-9951-c8046addd3ad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c84f231a-8029-47c1-a93a-a87657a8cccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_294312c3-caae-4ec0-b033-1fa3b69ce4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_127a75a9-b780-4762-9951-c8046addd3ad" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_294312c3-caae-4ec0-b033-1fa3b69ce4d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54cbe998-3770-481d-bff0-2a05bca53108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_0992be6f-3d6a-44c3-9ecf-1b3d530e1727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_54cbe998-3770-481d-bff0-2a05bca53108" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_0992be6f-3d6a-44c3-9ecf-1b3d530e1727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ab5d17e6-7b91-45e1-aeae-791c83eef66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_54cbe998-3770-481d-bff0-2a05bca53108" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ab5d17e6-7b91-45e1-aeae-791c83eef66f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/Leases" xlink:type="simple" xlink:href="mck-20210331.xsd#Leases"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesSupplementalbalancesheetinformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f6c42c9a-c6ce-48e2-be09-b28baae778bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_7ff5d8f3-5955-433d-8c83-518169ed53f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_f6c42c9a-c6ce-48e2-be09-b28baae778bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_7ff5d8f3-5955-433d-8c83-518169ed53f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_49ad73f9-6fb7-44f9-b48f-220866a6004d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_f6c42c9a-c6ce-48e2-be09-b28baae778bb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_49ad73f9-6fb7-44f9-b48f-220866a6004d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_64fd6c22-5ebe-4ffa-92ea-eaae36b5cca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7046046c-d8c1-4723-a25f-f8d5a004f3e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_64fd6c22-5ebe-4ffa-92ea-eaae36b5cca7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7046046c-d8c1-4723-a25f-f8d5a004f3e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6f4cf533-5cd8-42ac-98c7-dc76391a9707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_64fd6c22-5ebe-4ffa-92ea-eaae36b5cca7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6f4cf533-5cd8-42ac-98c7-dc76391a9707" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_fa631f7c-7e56-496b-9ef7-7faf40bbd98f" xlink:href="mck-20210331.xsd#mck_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f75206ec-9e5a-4255-ad8f-b5eeed629eec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_FinanceLeaseCost_fa631f7c-7e56-496b-9ef7-7faf40bbd98f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f75206ec-9e5a-4255-ad8f-b5eeed629eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ab5499f3-9eaa-4be1-9afa-7ad31d0188bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_FinanceLeaseCost_fa631f7c-7e56-496b-9ef7-7faf40bbd98f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ab5499f3-9eaa-4be1-9afa-7ad31d0188bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_83356863-034d-4f24-8796-c9f30597655f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_e26cc96b-5fdc-4529-9696-360a5d09c86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_83356863-034d-4f24-8796-c9f30597655f" xlink:to="loc_us-gaap_ShortTermLeaseCost_e26cc96b-5fdc-4529-9696-360a5d09c86c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_bd350af6-48e9-4de6-bcdc-84a8e0ac8d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_83356863-034d-4f24-8796-c9f30597655f" xlink:to="loc_us-gaap_OperatingLeaseCost_bd350af6-48e9-4de6-bcdc-84a8e0ac8d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_27ceae4f-2b4f-4b80-9a3a-e71c7ed46ba3" xlink:href="mck-20210331.xsd#mck_FinanceLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_83356863-034d-4f24-8796-c9f30597655f" xlink:to="loc_mck_FinanceLeaseCost_27ceae4f-2b4f-4b80-9a3a-e71c7ed46ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_2c49747a-0a10-4a6c-a56f-6c9d23bdbe6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_83356863-034d-4f24-8796-c9f30597655f" xlink:to="loc_us-gaap_VariableLeaseCost_2c49747a-0a10-4a6c-a56f-6c9d23bdbe6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_ff0abd64-e1f3-4b77-b82b-eceb6f9094eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_83356863-034d-4f24-8796-c9f30597655f" xlink:to="loc_us-gaap_SubleaseIncome_ff0abd64-e1f3-4b77-b82b-eceb6f9094eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesSupplementalcashflowinformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_8fbbacb7-bdce-42ba-be08-c20c909690ca" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b80b7b24-7739-471d-ad54-edc20409b706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour_8fbbacb7-bdce-42ba-be08-c20c909690ca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b80b7b24-7739-471d-ad54-edc20409b706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa123246-1006-42b5-8389-362675b98fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour_8fbbacb7-bdce-42ba-be08-c20c909690ca" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fa123246-1006-42b5-8389-362675b98fc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_2ff8849b-a507-4dc5-b64d-53f99b2cb52a" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:to="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_2ff8849b-a507-4dc5-b64d-53f99b2cb52a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_7b21d598-b598-4feb-8c06-2656765fbb45" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearTwo_7b21d598-b598-4feb-8c06-2656765fbb45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_93c2c969-f54e-4234-a95e-d75b46feb29a" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearThree_93c2c969-f54e-4234-a95e-d75b46feb29a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_860957be-c291-4d7c-8d9d-2ec4482bb502" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFour_860957be-c291-4d7c-8d9d-2ec4482bb502" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_f496eecc-5104-4562-a36f-cf9231851540" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFive_f496eecc-5104-4562-a36f-cf9231851540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_868f1a00-381e-42fa-8cc2-cc1880d90ef0" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_ef462f56-9473-42cf-90bd-af26bedbdfd4" xlink:to="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_868f1a00-381e-42fa-8cc2-cc1880d90ef0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_4c6fa0de-ed3c-49f0-9695-4a0b981f73e4" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_220644e6-32d6-4d53-9824-cd47fe8e0d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive_4c6fa0de-ed3c-49f0-9695-4a0b981f73e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_220644e6-32d6-4d53-9824-cd47fe8e0d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f4f9ed00-a29f-43a6-bb80-969224cb741e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive_4c6fa0de-ed3c-49f0-9695-4a0b981f73e4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f4f9ed00-a29f-43a6-bb80-969224cb741e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_96a47460-8b4b-483d-9e78-12dac469352b" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f424978c-a0d7-41fb-8b86-9bf4d2e17242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_96a47460-8b4b-483d-9e78-12dac469352b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f424978c-a0d7-41fb-8b86-9bf4d2e17242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_95b0d9d0-dedd-4251-94ca-371c6e382fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_96a47460-8b4b-483d-9e78-12dac469352b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_95b0d9d0-dedd-4251-94ca-371c6e382fc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3c525fb0-889e-4928-8db0-c02dadea7b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c0df8f74-b975-4d70-afd5-b6f04f09c6de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3c525fb0-889e-4928-8db0-c02dadea7b0c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c0df8f74-b975-4d70-afd5-b6f04f09c6de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5d2ef71a-f504-4567-9cae-ec1314c9157d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3c525fb0-889e-4928-8db0-c02dadea7b0c" xlink:to="loc_us-gaap_OperatingLeaseLiability_5d2ef71a-f504-4567-9cae-ec1314c9157d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_92e34f51-799a-4d7a-ad8e-33a05b95a7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_76a440b3-a18f-4def-b854-76d6113c5505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_92e34f51-799a-4d7a-ad8e-33a05b95a7a6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_76a440b3-a18f-4def-b854-76d6113c5505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_57a21f40-887f-4638-b784-18c2597b7610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_92e34f51-799a-4d7a-ad8e-33a05b95a7a6" xlink:to="loc_us-gaap_FinanceLeaseLiability_57a21f40-887f-4638-b784-18c2597b7610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_4511bd91-c384-46e5-a4db-d2b9f34fdccc" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5d93cd7c-4f71-486e-8536-fc6db693af36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo_4511bd91-c384-46e5-a4db-d2b9f34fdccc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5d93cd7c-4f71-486e-8536-fc6db693af36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d73b340e-e880-4975-97d1-13ecf1bf9fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo_4511bd91-c384-46e5-a4db-d2b9f34fdccc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d73b340e-e880-4975-97d1-13ecf1bf9fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_2e2ca624-ccf7-4b69-90b5-6f734b54c4e3" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_27716a22-3ce4-4f4b-b6df-80ed8be11f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_2e2ca624-ccf7-4b69-90b5-6f734b54c4e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_27716a22-3ce4-4f4b-b6df-80ed8be11f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_58c5fa97-3715-4458-a283-fa9287efba4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_2e2ca624-ccf7-4b69-90b5-6f734b54c4e3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_58c5fa97-3715-4458-a283-fa9287efba4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_e1b0aaa4-3eaf-4e0a-96da-0706ea1d419c" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8484bc24-65e9-4cfb-9112-3c1cd88d6b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree_e1b0aaa4-3eaf-4e0a-96da-0706ea1d419c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8484bc24-65e9-4cfb-9112-3c1cd88d6b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7b7393db-f5cb-4a3b-969a-2efaf1e830cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree_e1b0aaa4-3eaf-4e0a-96da-0706ea1d419c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7b7393db-f5cb-4a3b-969a-2efaf1e830cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_886b9ac6-695a-4d61-ae76-44ce491590ad" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7a953497-bb8a-48ac-b98a-fb3abc84c025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount_886b9ac6-695a-4d61-ae76-44ce491590ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7a953497-bb8a-48ac-b98a-fb3abc84c025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_fb2873ca-1d48-41bc-a595-ecd733d37a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount_886b9ac6-695a-4d61-ae76-44ce491590ad" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_fb2873ca-1d48-41bc-a595-ecd733d37a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_94d9c3ba-aa0d-412d-96f5-0166d656b8ec" xlink:href="mck-20210331.xsd#mck_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bf656195-de72-437c-84ca-23cf016a1bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiability_94d9c3ba-aa0d-412d-96f5-0166d656b8ec" xlink:to="loc_us-gaap_OperatingLeaseLiability_bf656195-de72-437c-84ca-23cf016a1bfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a26d91a7-a2da-4c27-aab4-cc31fd12f709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiability_94d9c3ba-aa0d-412d-96f5-0166d656b8ec" xlink:to="loc_us-gaap_FinanceLeaseLiability_a26d91a7-a2da-4c27-aab4-cc31fd12f709" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_75ae9232-0335-44c5-bcb3-67b8abf0e95f" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5144cb13-64d8-4bf6-81fd-f0676d51ea3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_75ae9232-0335-44c5-bcb3-67b8abf0e95f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5144cb13-64d8-4bf6-81fd-f0676d51ea3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b6178694-6154-41eb-8383-deb6aeaa223c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_75ae9232-0335-44c5-bcb3-67b8abf0e95f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b6178694-6154-41eb-8383-deb6aeaa223c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_556f6c1c-a4ee-4ad0-9643-3c0973b87e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_556f6c1c-a4ee-4ad0-9643-3c0973b87e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1c1e9ba9-8b07-4dc3-bcd3-60bf9ebebbf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1c1e9ba9-8b07-4dc3-bcd3-60bf9ebebbf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_eb6eedb8-fe85-48a9-87e6-450c6c4d96c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_eb6eedb8-fe85-48a9-87e6-450c6c4d96c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_68dd9987-5cd6-4522-ad8f-985a99418a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_68dd9987-5cd6-4522-ad8f-985a99418a8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cb8fe759-ee15-4b86-ba20-a7e47890da5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cb8fe759-ee15-4b86-ba20-a7e47890da5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_639e20e1-3a06-47b3-ac4d-347dff61b325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a28743f1-0269-4abb-be0e-1bb00103f4a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_639e20e1-3a06-47b3-ac4d-347dff61b325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e4f5941a-35ca-45ed-ab40-a12b1348ef3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e4f5941a-35ca-45ed-ab40-a12b1348ef3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fffc5feb-b4ed-4067-9e1b-f788800fcfb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fffc5feb-b4ed-4067-9e1b-f788800fcfb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6a1ad835-6050-4c63-92b3-894d6bb68d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6a1ad835-6050-4c63-92b3-894d6bb68d81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ab5e0abd-4695-4e2c-b431-24bd7876b9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ab5e0abd-4695-4e2c-b431-24bd7876b9d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4a2df376-ef35-48cb-b867-24b7d640fbde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4a2df376-ef35-48cb-b867-24b7d640fbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8460f9dc-8275-4dc5-9d25-fc6e0c53fceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_363e6bde-5ba6-4a70-909d-b94d1dd3a7f1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8460f9dc-8275-4dc5-9d25-fc6e0c53fceb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_2"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_e7004e5a-40b2-4e24-8adb-f00e10f07532" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_8690f1b1-8e83-4c31-9f10-f9635d37d195" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_e7004e5a-40b2-4e24-8adb-f00e10f07532" xlink:to="loc_mck_LeaseLiabilityUndiscountedExcessAmount_8690f1b1-8e83-4c31-9f10-f9635d37d195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_3e5dc51f-da6a-4877-aeb1-d56e304dcdd6" xlink:href="mck-20210331.xsd#mck_LeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_e7004e5a-40b2-4e24-8adb-f00e10f07532" xlink:to="loc_mck_LeaseLiability_3e5dc51f-da6a-4877-aeb1-d56e304dcdd6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e80dac3a-78ff-4052-8a96-79d1aed53383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c73a0cec-65a4-41cb-b062-cc6fb2fc6b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e80dac3a-78ff-4052-8a96-79d1aed53383" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c73a0cec-65a4-41cb-b062-cc6fb2fc6b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5dd82f34-8e0c-404d-ae3a-8e946e0bbc4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e80dac3a-78ff-4052-8a96-79d1aed53383" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5dd82f34-8e0c-404d-ae3a-8e946e0bbc4b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a2ed481c-700a-4015-8a6b-6e59257ac52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_083cb8b7-a3e7-4a54-87ad-e76ba0c261bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a2ed481c-700a-4015-8a6b-6e59257ac52a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_083cb8b7-a3e7-4a54-87ad-e76ba0c261bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d8723df5-e40a-4e1f-844d-b5669f1583d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a2ed481c-700a-4015-8a6b-6e59257ac52a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d8723df5-e40a-4e1f-844d-b5669f1583d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="mck-20210331.xsd#VariableInterestEntities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/VariableInterestEntities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#VariableInterestEntitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefits"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_097fc77d-a4ab-461c-8efd-e9648e5197b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_3d6679aa-b29b-49d3-86f3-72957c887e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_097fc77d-a4ab-461c-8efd-e9648e5197b9" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_3d6679aa-b29b-49d3-86f3-72957c887e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_e7e5580f-e4f8-4beb-a9d2-dd83b43674bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_097fc77d-a4ab-461c-8efd-e9648e5197b9" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_e7e5580f-e4f8-4beb-a9d2-dd83b43674bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_262f4730-4349-4a63-856e-16772d4d3f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_097fc77d-a4ab-461c-8efd-e9648e5197b9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_262f4730-4349-4a63-856e-16772d4d3f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_ad8927b3-e943-42f5-9893-70b6d8d475ee" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_097fc77d-a4ab-461c-8efd-e9648e5197b9" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_ad8927b3-e943-42f5-9893-70b6d8d475ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_6e467c8f-2c1b-46a1-8f5d-586c6d8ca809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_097fc77d-a4ab-461c-8efd-e9648e5197b9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_6e467c8f-2c1b-46a1-8f5d-586c6d8ca809" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_50352d35-cfe6-4c95-8f9e-8b7a21c86b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4dcf62bb-02b7-4264-8230-2b83a24f58b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_50352d35-cfe6-4c95-8f9e-8b7a21c86b56" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4dcf62bb-02b7-4264-8230-2b83a24f58b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8b9168d5-746c-4194-9d39-55bdc2babf61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_50352d35-cfe6-4c95-8f9e-8b7a21c86b56" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8b9168d5-746c-4194-9d39-55bdc2babf61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_681dba6a-10e3-49ac-be6d-c95d243361e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_872959dc-5212-4ee7-b407-cf57e81d1a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_681dba6a-10e3-49ac-be6d-c95d243361e0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_872959dc-5212-4ee7-b407-cf57e81d1a84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ccdadbf1-9a6a-4f15-899a-def83eec5bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_681dba6a-10e3-49ac-be6d-c95d243361e0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ccdadbf1-9a6a-4f15-899a-def83eec5bc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b87ab60a-4b13-4aa4-8835-d36cb8a00107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_681dba6a-10e3-49ac-be6d-c95d243361e0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b87ab60a-4b13-4aa4-8835-d36cb8a00107" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_bedf43f5-5c7a-4422-890d-a29505379cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_7bd9b3be-0929-46dd-ba7e-6be8bb327306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_bedf43f5-5c7a-4422-890d-a29505379cd5" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_7bd9b3be-0929-46dd-ba7e-6be8bb327306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_e092e69b-658d-4cbf-89fe-ad43cc09ed44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_bedf43f5-5c7a-4422-890d-a29505379cd5" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_e092e69b-658d-4cbf-89fe-ad43cc09ed44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f18c2b3d-9892-4efe-836a-984ff44ada31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a4046b1e-9ef0-4a6c-b4ad-fde4b278e25e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f18c2b3d-9892-4efe-836a-984ff44ada31" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a4046b1e-9ef0-4a6c-b4ad-fde4b278e25e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9f27daea-b533-455c-a061-d39d6599de5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f18c2b3d-9892-4efe-836a-984ff44ada31" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9f27daea-b533-455c-a061-d39d6599de5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_99ee99c4-7a73-4c14-8f38-3d33ee08f588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f18c2b3d-9892-4efe-836a-984ff44ada31" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_99ee99c4-7a73-4c14-8f38-3d33ee08f588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_b8d41390-f0a5-46e4-910a-81d48bad3809" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_f18c2b3d-9892-4efe-836a-984ff44ada31" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_b8d41390-f0a5-46e4-910a-81d48bad3809" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsOtherPostretirementBenefitsPlanDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="simple" xlink:href="mck-20210331.xsd#FinancialGuaranteesandWarranties"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20210331.xsd#CommitmentsandContingentLiabilities"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofShareRepurchasesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8285ca9-e8e9-4b38-a65f-161efe19fef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dcef9fac-0a80-4579-9bb3-189fcd6179dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8285ca9-e8e9-4b38-a65f-161efe19fef1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dcef9fac-0a80-4579-9bb3-189fcd6179dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6d1b9bae-45d5-48da-8039-ba50cbdac07d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e8285ca9-e8e9-4b38-a65f-161efe19fef1" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6d1b9bae-45d5-48da-8039-ba50cbdac07d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7549ccc4-89ad-4903-bfeb-a6a8d96eabca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_816caaa0-9e3c-4bfd-8c8a-9adaadb8b9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7549ccc4-89ad-4903-bfeb-a6a8d96eabca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_816caaa0-9e3c-4bfd-8c8a-9adaadb8b9ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_0dad0a45-38e2-4757-8658-8aa7f63ca2eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7549ccc4-89ad-4903-bfeb-a6a8d96eabca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_0dad0a45-38e2-4757-8658-8aa7f63ca2eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="simple" xlink:href="mck-20210331.xsd#RelatedPartyBalancesandTransactions"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusiness"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_35469dba-f9ea-4fa4-a61a-90773f34c94c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_72d80d77-554f-4364-8d0a-a499f61953c0" xlink:href="mck-20210331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_35469dba-f9ea-4fa4-a61a-90773f34c94c" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_72d80d77-554f-4364-8d0a-a499f61953c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_9b1a03d4-f523-42f7-910f-2c8a146e3cff" xlink:href="mck-20210331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_35469dba-f9ea-4fa4-a61a-90773f34c94c" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_9b1a03d4-f523-42f7-910f-2c8a146e3cff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_10ba20ad-913b-44d3-b283-e3099740288f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_35469dba-f9ea-4fa4-a61a-90773f34c94c" xlink:to="loc_us-gaap_InterestExpense_10ba20ad-913b-44d3-b283-e3099740288f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnaudited"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnauditedTables"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="mck-20210331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>mck-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0a91717b-5b9a-4470-a716-9c00214a8bdd,g:f2a8631c-ae82-4a44-9090-35d7005e9a98-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20210331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended" id="if3e54179d20c4883aef5caf46a3d0e66_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fb90457a-f195-466b-a9b4-9f10d9d26375" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentType_fb90457a-f195-466b-a9b4-9f10d9d26375" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_8481ca6b-5244-4ddf-8dd3-e4b0a225a112" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentAnnualReport_8481ca6b-5244-4ddf-8dd3-e4b0a225a112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d40a1b0c-4f2f-4889-8876-954fee619501" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentPeriodEndDate_d40a1b0c-4f2f-4889-8876-954fee619501" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3306a17b-e512-449b-8a9b-12a56bda8fa2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_CurrentFiscalYearEndDate_3306a17b-e512-449b-8a9b-12a56bda8fa2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_36333b52-8f75-49c6-ba3c-5b82cb258c49" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentTransitionReport_36333b52-8f75-49c6-ba3c-5b82cb258c49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_34d27a49-ec1a-41f3-9a3c-a39f6abb83f5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityFileNumber_34d27a49-ec1a-41f3-9a3c-a39f6abb83f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7b261753-bcab-4783-8aef-84a31c6d67f2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityRegistrantName_7b261753-bcab-4783-8aef-84a31c6d67f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ed0a2bd2-928b-476a-938d-254f5e97dfcd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ed0a2bd2-928b-476a-938d-254f5e97dfcd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0409cda3-0f4f-4a3b-b4fa-8938acc22730" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityTaxIdentificationNumber_0409cda3-0f4f-4a3b-b4fa-8938acc22730" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4a63f801-7d8d-4f56-88db-801bccd44f29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressAddressLine1_4a63f801-7d8d-4f56-88db-801bccd44f29" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f3d715b6-619e-4992-bd39-edcb53b0c594" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressCityOrTown_f3d715b6-619e-4992-bd39-edcb53b0c594" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_738dc6b4-fb62-4c08-b63d-635d7ba1ae32" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressStateOrProvince_738dc6b4-fb62-4c08-b63d-635d7ba1ae32" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7f0250a1-d1a7-4417-9ade-1ce5e9b97cc3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressPostalZipCode_7f0250a1-d1a7-4417-9ade-1ce5e9b97cc3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_770d6151-ff83-4fe5-8aa3-5d8ae7e2601c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_CityAreaCode_770d6151-ff83-4fe5-8aa3-5d8ae7e2601c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3aa83d5c-3a81-40ec-810f-a1abf0022093" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_LocalPhoneNumber_3aa83d5c-3a81-40ec-810f-a1abf0022093" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1601d375-28af-4542-8e0a-9f93b2ed7364" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_Security12bTitle_1601d375-28af-4542-8e0a-9f93b2ed7364" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4731126b-d6f3-4aa8-a89f-5ee924c3a62d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_TradingSymbol_4731126b-d6f3-4aa8-a89f-5ee924c3a62d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d4ff00b4-c013-4511-afa5-0b1e802a5e62" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_SecurityExchangeName_d4ff00b4-c013-4511-afa5-0b1e802a5e62" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_47ddf474-283d-402b-a5f5-4695bfdc91df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_47ddf474-283d-402b-a5f5-4695bfdc91df" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_366925a1-8112-413d-bc99-e2fe0d041f5b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityVoluntaryFilers_366925a1-8112-413d-bc99-e2fe0d041f5b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ea85da6f-ac7f-4fd3-b007-9997c117dbb2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityCurrentReportingStatus_ea85da6f-ac7f-4fd3-b007-9997c117dbb2" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_881ad90d-17c4-4a4c-a2e1-a80f871492a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityInteractiveDataCurrent_881ad90d-17c4-4a4c-a2e1-a80f871492a0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_554b9afe-d805-4539-8915-24c6878e37f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityFilerCategory_554b9afe-d805-4539-8915-24c6878e37f9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0c78edd8-243e-4786-97b5-02a1250a5082" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntitySmallBusiness_0c78edd8-243e-4786-97b5-02a1250a5082" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b7e68194-444c-44df-be4c-1adba798c4fe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityEmergingGrowthCompany_b7e68194-444c-44df-be4c-1adba798c4fe" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_85326b7d-705b-40dc-8de9-a8df8a2e9ab2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_85326b7d-705b-40dc-8de9-a8df8a2e9ab2" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e3b70366-938b-43e4-9c78-8711ee9b5da7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityShellCompany_e3b70366-938b-43e4-9c78-8711ee9b5da7" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_d0f803f1-18c0-4b4a-bded-ba6171a00cbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityPublicFloat_d0f803f1-18c0-4b4a-bded-ba6171a00cbc" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_96ba0e4d-f4b0-4478-b1b8-ee103e318a4d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_96ba0e4d-f4b0-4478-b1b8-ee103e318a4d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4ec3e86b-24c3-4fc7-be1a-7391b79c369d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4ec3e86b-24c3-4fc7-be1a-7391b79c369d" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_950966f0-7c3a-4be5-acc0-3f8403f500ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityCentralIndexKey_950966f0-7c3a-4be5-acc0-3f8403f500ee" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4fdf6bc7-84a3-49c8-b969-8ad5e48c1647" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4fdf6bc7-84a3-49c8-b969-8ad5e48c1647" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ae5ece3e-d989-4200-b1e8-20ef13d89c9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentFiscalYearFocus_ae5ece3e-d989-4200-b1e8-20ef13d89c9a" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4f12abf4-39de-4601-8f1b-f2ab12e4f30e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_AmendmentFlag_4f12abf4-39de-4601-8f1b-f2ab12e4f30e" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c88333fc-8231-4d56-a484-ec8b1ecb9cfe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:to="loc_us-gaap_ClassOfStockDomain_c88333fc-8231-4d56-a484-ec8b1ecb9cfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:to="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9c130a5e-6f45-4266-8b3d-ed008da88bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_us-gaap_CommonStockMember_9c130a5e-6f45-4266-8b3d-ed008da88bf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0.625notesDue2021Member_57abcfe5-a400-48ea-ac5c-347a27beb84d" xlink:href="mck-20210331.xsd#mck_A0.625notesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A0.625notesDue2021Member_57abcfe5-a400-48ea-ac5c-347a27beb84d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member_40bf2edc-cae1-49b5-9c63-90e89a0b104c" xlink:href="mck-20210331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A1.500NotesDue2025Member_40bf2edc-cae1-49b5-9c63-90e89a0b104c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member_53f2979d-b954-42a8-8516-1635354046fc" xlink:href="mck-20210331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A1.625NotesDue2026Member_53f2979d-b954-42a8-8516-1635354046fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member_6ab34cf8-1ac5-4396-8b3d-ded2f2d145e1" xlink:href="mck-20210331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A3.125NotesDue2029Member_6ab34cf8-1ac5-4396-8b3d-ded2f2d145e1" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i797b03864252461c9192598c071cc291_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended" id="i6e97e33fcd464633ad1b35f5720d202c_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i63608d1c3a09422cbde67028cacd96ad_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i903ddba413724ea9b3b1508050a4102d_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="iff748d9ed4584b9592757c99d7458f29_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_426949f9-4af9-440b-9f59-d22dfd413919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_426949f9-4af9-440b-9f59-d22dfd413919" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4bf99b6b-65f6-4a3f-b3e3-d030604c675e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_SharesOutstanding_4bf99b6b-65f6-4a3f-b3e3-d030604c675e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d6254719-2672-425c-bf0a-542d28bffec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d6254719-2672-425c-bf0a-542d28bffec0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_478395aa-fd59-4f2a-9645-24969010ec6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_TreasuryStockShares_478395aa-fd59-4f2a-9645-24969010ec6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_21696121-4c8e-4385-98fe-c6d611214b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_21696121-4c8e-4385-98fe-c6d611214b61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0f295a27-aa8a-4c34-8c2e-cf565746f939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0f295a27-aa8a-4c34-8c2e-cf565746f939" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3299ebbc-7ec7-4f84-ad69-0abfb2ca21d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3299ebbc-7ec7-4f84-ad69-0abfb2ca21d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_23026f52-6945-4ccb-a3c3-4fd05e9c5f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_23026f52-6945-4ccb-a3c3-4fd05e9c5f00" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_635b55fb-d72a-4b7a-be11-4d1b890fc333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_635b55fb-d72a-4b7a-be11-4d1b890fc333" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_6458ac3c-17c7-4a07-9c0a-db0e11e5fa6d" xlink:href="mck-20210331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_6458ac3c-17c7-4a07-9c0a-db0e11e5fa6d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_5cdd85fa-24f2-4917-8f0e-bf6c90047221" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_5cdd85fa-24f2-4917-8f0e-bf6c90047221" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_261c9da3-dfd1-48c2-8848-f8c48292fbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_261c9da3-dfd1-48c2-8848-f8c48292fbce" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_08612f83-8bab-4a33-80cd-f55c18e0755d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_08612f83-8bab-4a33-80cd-f55c18e0755d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodShares_2a322752-f474-4a9c-a427-7ea595b5f6cd" xlink:href="mck-20210331.xsd#mck_StockExchangedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_StockExchangedDuringPeriodShares_2a322752-f474-4a9c-a427-7ea595b5f6cd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodValue_ecc4b52d-3aa1-4227-be7c-a285828c5237" xlink:href="mck-20210331.xsd#mck_StockExchangedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_StockExchangedDuringPeriodValue_ecc4b52d-3aa1-4227-be7c-a285828c5237" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_53f35ef8-b8e8-400c-9240-529a3aa8fac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_53f35ef8-b8e8-400c-9240-529a3aa8fac8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8ce6176b-2245-4975-8093-3f9b1e2d5ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8ce6176b-2245-4975-8093-3f9b1e2d5ff5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_a7f874d9-f5af-49b9-a70d-a7af995adbda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_DividendsCommonStockCash_a7f874d9-f5af-49b9-a70d-a7af995adbda" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_08c9a358-ca0d-4606-8184-ab4e7547b9e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockholdersEquityOther_08c9a358-ca0d-4606-8184-ab4e7547b9e6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c33a5dab-d0e5-4747-a7d7-6886620aff28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_72297da7-7415-440f-a75b-7dd63d7d3810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_70641791-ae4d-4813-9c23-2d4459dd8e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_426949f9-4af9-440b-9f59-d22dfd413919" xlink:to="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7c2348ac-609b-44b2-951a-1a6bd9b56d7c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7c2348ac-609b-44b2-951a-1a6bd9b56d7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b2574beb-9558-4afd-bc5e-9cc5a33c59aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b2574beb-9558-4afd-bc5e-9cc5a33c59aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_3daf4e02-6d5e-49d2-9261-c4ac04fdfb2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_3daf4e02-6d5e-49d2-9261-c4ac04fdfb2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d73f6793-8ac4-49f3-a6c4-739b798c8993_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:to="loc_us-gaap_EquityComponentDomain_d73f6793-8ac4-49f3-a6c4-739b798c8993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:to="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_71f6f09b-997c-4cef-9c7d-1e6903f7c521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_CommonStockMember_71f6f09b-997c-4cef-9c7d-1e6903f7c521" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_03311f08-e350-4e4a-91ed-301f11731e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_03311f08-e350-4e4a-91ed-301f11731e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_834a01bf-3358-4ac8-8965-4358d7b3802f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_834a01bf-3358-4ac8-8965-4358d7b3802f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_662035d0-bff3-4163-a080-d278e682225f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_RetainedEarningsMember_662035d0-bff3-4163-a080-d278e682225f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61576180-812d-4133-963c-b2272fd7828b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61576180-812d-4133-963c-b2272fd7828b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_866c889b-e189-4a1c-9428-7cbac2ce6b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_TreasuryStockMember_866c889b-e189-4a1c-9428-7cbac2ce6b12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f226cf4c-ae87-420b-b8e6-1d5eaa1811f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f226cf4c-ae87-420b-b8e6-1d5eaa1811f3" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="extended" id="i35fba16cac1f407494caf48832969b75_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i07d10640567f498d9d017bcfda9de7ff_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended" id="ic3ad4ed82a324ffe8420758eafd63c9b_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" id="i1c648a15c55c4f6ca5d0994ed4c7fe7e_SignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="extended" id="ic69d2115968e4a07b49acecfab566305_SignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended" id="i6b5d71c5fd524062b7289965b9d159c9_SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_7669cd4a-529f-478f-9cd5-fe44ead0094d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_NumberOfReportableSegments_7669cd4a-529f-478f-9cd5-fe44ead0094d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e0788bdd-3077-4bb0-9cba-cba5d85639ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e0788bdd-3077-4bb0-9cba-cba5d85639ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofLargestCustomers_b7764b1d-0577-40e5-999f-4eadf34ecfc2" xlink:href="mck-20210331.xsd#mck_NumberofLargestCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_mck_NumberofLargestCustomers_b7764b1d-0577-40e5-999f-4eadf34ecfc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_464f01c2-d093-4b37-b9a5-be5d4d19e2da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_464f01c2-d093-4b37-b9a5-be5d4d19e2da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_60e153b4-fa0d-4c20-9d99-8c28e78eed78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_60e153b4-fa0d-4c20-9d99-8c28e78eed78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_2ecbcb1c-861f-49b9-9756-8461caff20b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryLIFOReserve_2ecbcb1c-861f-49b9-9756-8461caff20b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_45be1bb5-b2de-4f1c-acf4-9bc6de243309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_45be1bb5-b2de-4f1c-acf4-9bc6de243309" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_84d36af6-0d2a-40e7-884b-41f3a1d65885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryValuationReserves_84d36af6-0d2a-40e7-884b-41f3a1d65885" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_7b3c4fff-5cf1-4048-aa22-478724e8e3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryWriteDown_7b3c4fff-5cf1-4048-aa22-478724e8e3ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e599515b-82f1-4bb2-8cb0-18ab1913dbb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e599515b-82f1-4bb2-8cb0-18ab1913dbb6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a2c93554-fdbb-4b2d-9da5-894ef64d9a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a2c93554-fdbb-4b2d-9da5-894ef64d9a67" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b8b41995-dc39-4ebc-b641-7053bfbe76f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b8b41995-dc39-4ebc-b641-7053bfbe76f7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1d19f3c8-de35-43cc-97d4-4e13d230964d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1d19f3c8-de35-43cc-97d4-4e13d230964d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_9d91ced7-449c-482e-9d0d-007814cc8354" xlink:href="mck-20210331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_9d91ced7-449c-482e-9d0d-007814cc8354" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_82cf97d8-8ba6-4a77-8856-f41aea087c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_82cf97d8-8ba6-4a77-8856-f41aea087c56" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_01613090-969a-4007-acec-a090d60627c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_01613090-969a-4007-acec-a090d60627c2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a8a69082-45ac-4b3a-b4f1-1271d1555afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a8a69082-45ac-4b3a-b4f1-1271d1555afb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_0db78e73-cd72-4a09-86a4-cb67d982614c" xlink:href="mck-20210331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_0db78e73-cd72-4a09-86a4-cb67d982614c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1226c6c8-0381-4747-b339-ed34a3b011be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1226c6c8-0381-4747-b339-ed34a3b011be" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_443ce70f-83dc-4b26-bba1-a6a0083bbfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_443ce70f-83dc-4b26-bba1-a6a0083bbfd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_da2979b6-70a8-44b1-bace-07cde12253ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_da2979b6-70a8-44b1-bace-07cde12253ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_300505a5-6b21-415c-8119-f84fbed4ea3b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_300505a5-6b21-415c-8119-f84fbed4ea3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_43e74fad-9465-49a1-afe4-e0fcc88654d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:to="loc_us-gaap_SalesRevenueNetMember_43e74fad-9465-49a1-afe4-e0fcc88654d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_57f00813-017c-4be8-8823-0297dc835298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:to="loc_us-gaap_AccountsReceivableMember_57f00813-017c-4be8-8823-0297dc835298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:to="loc_srt_NameOfMajorCustomerDomain_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_68b28136-d185-4583-834c-ae3d2517e031" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:to="loc_srt_NameOfMajorCustomerDomain_68b28136-d185-4583-834c-ae3d2517e031" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember_b469793e-1af0-43ce-9b04-6edb23fa51bc" xlink:href="mck-20210331.xsd#mck_LargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_68b28136-d185-4583-834c-ae3d2517e031" xlink:to="loc_mck_LargestCustomerMember_b469793e-1af0-43ce-9b04-6edb23fa51bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7bec67cd-c1a2-4746-acfb-225fc0dc6cac_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:to="loc_srt_ProductsAndServicesDomain_7bec67cd-c1a2-4746-acfb-225fc0dc6cac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:to="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_30f51050-c3d3-4f2b-b4d4-e81d506fc4c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:to="loc_us-gaap_ShippingAndHandlingMember_30f51050-c3d3-4f2b-b4d4-e81d506fc4c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember_a05d69df-6449-4eab-a7d5-52fa8cb2cfe5" xlink:href="mck-20210331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:to="loc_mck_DistributionandRetailBusinessMember_a05d69df-6449-4eab-a7d5-52fa8cb2cfe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember_017c8a83-a081-486c-b634-e54e6756d834" xlink:href="mck-20210331.xsd#mck_ServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:to="loc_mck_ServicesBusinessMember_017c8a83-a081-486c-b634-e54e6756d834" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7e1ed1de-6107-46dc-8eb4-b1258e0ad134_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7e1ed1de-6107-46dc-8eb4-b1258e0ad134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_28ffa5f8-92c3-4cad-b9e9-a0373cb8ed54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:to="loc_us-gaap_TypeOfAdoptionMember_28ffa5f8-92c3-4cad-b9e9-a0373cb8ed54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_94b84ae4-3d11-4363-986a-cc60c04c49fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_28ffa5f8-92c3-4cad-b9e9-a0373cb8ed54" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_94b84ae4-3d11-4363-986a-cc60c04c49fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:to="loc_us-gaap_EquityComponentDomain_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_af0a9d99-29df-44c0-aa8e-1f44b402e75a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:to="loc_us-gaap_EquityComponentDomain_af0a9d99-29df-44c0-aa8e-1f44b402e75a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_02a6f053-a25b-4633-b95e-1d59c7e167cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_af0a9d99-29df-44c0-aa8e-1f44b402e75a" xlink:to="loc_us-gaap_RetainedEarningsMember_02a6f053-a25b-4633-b95e-1d59c7e167cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_efa132ee-cd53-4d40-adf4-74932a167989_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:to="loc_srt_RangeMember_efa132ee-cd53-4d40-adf4-74932a167989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:to="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32a91980-c4fa-4dd4-b113-34251a6943ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:to="loc_srt_MinimumMember_32a91980-c4fa-4dd4-b113-34251a6943ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_75fd625a-17d7-4f97-8cd8-d763d8709486" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:to="loc_srt_MaximumMember_75fd625a-17d7-4f97-8cd8-d763d8709486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_877b69e0-4c13-4254-8337-c8ea0a0aeb2a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_877b69e0-4c13-4254-8337-c8ea0a0aeb2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e9df44af-6840-4e37-9bde-27a51e2e3c5f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e9df44af-6840-4e37-9bde-27a51e2e3c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b4729ecd-fcdf-4a24-b2ed-74ad4670ff8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e9df44af-6840-4e37-9bde-27a51e2e3c5f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b4729ecd-fcdf-4a24-b2ed-74ad4670ff8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3761bce8-1500-46f0-9e66-a8f235092b73_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:to="loc_us-gaap_SegmentDomain_3761bce8-1500-46f0-9e66-a8f235092b73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4867bbb5-48da-4f66-a70f-642ebc5bc3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:to="loc_us-gaap_SegmentDomain_4867bbb5-48da-4f66-a70f-642ebc5bc3fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a793a8f0-f595-4fa0-aa91-9e5f23023b9e" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4867bbb5-48da-4f66-a70f-642ebc5bc3fe" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a793a8f0-f595-4fa0-aa91-9e5f23023b9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eecb10c4-a4f0-4164-b17f-168d14c2716d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eecb10c4-a4f0-4164-b17f-168d14c2716d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1097a4b1-2536-4523-8e43-dd498ade0f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1097a4b1-2536-4523-8e43-dd498ade0f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember_5fec839b-dc98-4331-962d-92998eaecc00" xlink:href="mck-20210331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:to="loc_mck_MachineryEquipmentAndOtherMember_5fec839b-dc98-4331-962d-92998eaecc00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended" id="i24bf1539ed2e4891984086305c713d39_SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended" id="i3b473a5a45274d8e8017dd3ce3828995_SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended" id="id513a5c386b74328b26a6dcbef44190e_InvestmentinChangeHealthcareJointVenture"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables" xlink:type="extended" id="i7c0635723340463c83978181d553eacb_InvestmentinChangeHealthcareJointVentureTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended" id="idd919dc2848e4c4ab2d0e8ef9fafec27_InvestmentinChangeHealthcareJointVentureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bd408e4e-620f-47dd-93bc-876965b9d741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bd408e4e-620f-47dd-93bc-876965b9d741" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_d2fa4165-50ce-437b-b1ea-4fb1960297f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_d2fa4165-50ce-437b-b1ea-4fb1960297f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_77e0356a-f994-4172-a2ba-03c83600dac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_77e0356a-f994-4172-a2ba-03c83600dac3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_91fe39d0-2323-4b63-9d89-980024599956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_91fe39d0-2323-4b63-9d89-980024599956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_788e1ed5-4642-477b-8f27-cb5314817e90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_788e1ed5-4642-477b-8f27-cb5314817e90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2cb6d11e-e111-4f46-b12d-9301e237591b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2cb6d11e-e111-4f46-b12d-9301e237591b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_db9077bc-9326-476e-8455-3a64bc91e424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_db9077bc-9326-476e-8455-3a64bc91e424" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_a836ef0d-8907-4e69-9720-8e5390364c7e" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_ExchangeOfferSharesDistributed_a836ef0d-8907-4e69-9720-8e5390364c7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_7fcd4156-6c73-499b-9878-3cd7a7ef6ba8" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_ExchangeOfferSharesExchanged_7fcd4156-6c73-499b-9878-3cd7a7ef6ba8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e491a17e-4017-49f4-b87b-9d70aeb55bb1" xlink:href="mck-20210331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e491a17e-4017-49f4-b87b-9d70aeb55bb1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fa6ad178-fc04-40f2-aaaa-0ad1076d2d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fa6ad178-fc04-40f2-aaaa-0ad1076d2d0f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ac66980d-5665-4d7e-84aa-0ee76be826e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ac66980d-5665-4d7e-84aa-0ee76be826e1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e57e923-a639-4b5d-bc3e-8fc7037ef95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e57e923-a639-4b5d-bc3e-8fc7037ef95d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_77de1a3c-89a9-49c7-a83f-ff3db88e05d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_77de1a3c-89a9-49c7-a83f-ff3db88e05d5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_c10b8131-1b4e-4079-89d2-d0371e715144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_c10b8131-1b4e-4079-89d2-d0371e715144" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossonDerecognitionofLiability_5d62dcb8-8208-4b1b-9d1b-df74f82f7a46" xlink:href="mck-20210331.xsd#mck_GainLossonDerecognitionofLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_GainLossonDerecognitionofLiability_5d62dcb8-8208-4b1b-9d1b-df74f82f7a46" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_6664b0d9-e150-4210-97ec-69cfa12791a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_6664b0d9-e150-4210-97ec-69cfa12791a5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_2a47294c-efb6-4268-9427-cfd7716c0322" xlink:href="mck-20210331.xsd#mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_2a47294c-efb6-4268-9427-cfd7716c0322" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_95721de2-6631-4a46-818c-68a5c4589f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_DueFromRelatedParties_95721de2-6631-4a46-818c-68a5c4589f34" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_11ae8387-2d68-479f-a797-39ead2aa8502_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:to="loc_us-gaap_RelatedPartyDomain_11ae8387-2d68-479f-a797-39ead2aa8502_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_28f88504-97b9-4d6c-8e37-ffa357991152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:to="loc_us-gaap_RelatedPartyDomain_28f88504-97b9-4d6c-8e37-ffa357991152" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_0e8d0c01-34a3-4b70-8c17-04c3dff50153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_28f88504-97b9-4d6c-8e37-ffa357991152" xlink:to="loc_us-gaap_CorporateJointVentureMember_0e8d0c01-34a3-4b70-8c17-04c3dff50153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e41859aa-20a2-4066-8b9e-6ec1cf68ee26_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:to="loc_dei_EntityDomain_e41859aa-20a2-4066-8b9e-6ec1cf68ee26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_07d1a3ae-50b1-458e-9007-103caa636942" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:to="loc_dei_EntityDomain_07d1a3ae-50b1-458e-9007-103caa636942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_c4c8a2a2-7c1f-4377-b3b6-86e708443680" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_07d1a3ae-50b1-458e-9007-103caa636942" xlink:to="loc_mck_ChangeHealthcareInc.Member_c4c8a2a2-7c1f-4377-b3b6-86e708443680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1cfade66-2906-4c37-a6bd-4162f2f8eb8f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1cfade66-2906-4c37-a6bd-4162f2f8eb8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_44089280-8295-4062-b6df-fbac0cb4c2aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_44089280-8295-4062-b6df-fbac0cb4c2aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1708fcb-8e42-47cf-aaff-aef277456670" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_44089280-8295-4062-b6df-fbac0cb4c2aa" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1708fcb-8e42-47cf-aaff-aef277456670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d8f334d1-2779-40a1-a5ab-5abcb5eee616_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:to="loc_us-gaap_SegmentDomain_d8f334d1-2779-40a1-a5ab-5abcb5eee616_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7093717b-4ca4-4a42-bef3-06862db045f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:to="loc_us-gaap_SegmentDomain_7093717b-4ca4-4a42-bef3-06862db045f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_ccd5d9da-e583-4772-afd8-34785a528564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7093717b-4ca4-4a42-bef3-06862db045f6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_ccd5d9da-e583-4772-afd8-34785a528564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7c578fe1-439c-4826-a7ac-59879a12f4ea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:to="loc_srt_ConsolidationItemsDomain_7c578fe1-439c-4826-a7ac-59879a12f4ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_38e56d2a-1b6b-4827-ae73-4887eebb98ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:to="loc_srt_ConsolidationItemsDomain_38e56d2a-1b6b-4827-ae73-4887eebb98ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_83bcbd95-7440-496a-a39b-7d508570719b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_38e56d2a-1b6b-4827-ae73-4887eebb98ba" xlink:to="loc_us-gaap_OperatingSegmentsMember_83bcbd95-7440-496a-a39b-7d508570719b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b90db608-aefa-43a4-9584-144713bd3f15_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b90db608-aefa-43a4-9584-144713bd3f15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b74b998-8828-4fa0-a901-506fa4b6aca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b74b998-8828-4fa0-a901-506fa4b6aca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_826f812c-2d4f-401a-8422-2bbed1d87d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b74b998-8828-4fa0-a901-506fa4b6aca2" xlink:to="loc_us-gaap_IPOMember_826f812c-2d4f-401a-8422-2bbed1d87d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_89650336-7711-44a7-8aaa-3b113c0fa76b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_89650336-7711-44a7-8aaa-3b113c0fa76b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ed7da9ab-9de7-4447-a399-b6cfa9d1c690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ed7da9ab-9de7-4447-a399-b6cfa9d1c690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_f503fbe6-fb53-49c6-b81a-3b9aae348489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_ed7da9ab-9de7-4447-a399-b6cfa9d1c690" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_f503fbe6-fb53-49c6-b81a-3b9aae348489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0604238-8e09-4ab7-ba5c-c06e26f281f7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:to="loc_us-gaap_EquityComponentDomain_c0604238-8e09-4ab7-ba5c-c06e26f281f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_71ffde1a-b6a1-438f-8bf2-22cdb971575b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:to="loc_us-gaap_EquityComponentDomain_71ffde1a-b6a1-438f-8bf2-22cdb971575b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b2ba8dcf-6225-45e8-bcfc-1e28552f00c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_71ffde1a-b6a1-438f-8bf2-22cdb971575b" xlink:to="loc_us-gaap_RetainedEarningsMember_b2ba8dcf-6225-45e8-bcfc-1e28552f00c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_198897c7-6c19-463e-a09c-e38bcb337aa1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_198897c7-6c19-463e-a09c-e38bcb337aa1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_258f45ce-171b-40e5-a906-e11b4be070bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_258f45ce-171b-40e5-a906-e11b4be070bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_f6bc1a77-567b-45b3-a4f3-b424eb4cc600" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_258f45ce-171b-40e5-a906-e11b4be070bc" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_f6bc1a77-567b-45b3-a4f3-b424eb4cc600" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4a1c5081-db68-4a7b-8b89-56d3ffae2826_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4a1c5081-db68-4a7b-8b89-56d3ffae2826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember_3521c924-867c-49a5-9429-d6d93fa9f707" xlink:href="mck-20210331.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:to="loc_mck_TransitionServicesAgreementsTSAMember_3521c924-867c-49a5-9429-d6d93fa9f707" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_07b90ea3-a1f5-41dc-af9a-88cd769e07f0" xlink:href="mck-20210331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_07b90ea3-a1f5-41dc-af9a-88cd769e07f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05eb2ab4-a809-4a24-8f56-0737257828ca_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_05eb2ab4-a809-4a24-8f56-0737257828ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22de49f3-fc35-4ac0-8768-2f0ecaced960" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22de49f3-fc35-4ac0-8768-2f0ecaced960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_18267729-773c-4006-a419-ce2efba03bae" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22de49f3-fc35-4ac0-8768-2f0ecaced960" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_18267729-773c-4006-a419-ce2efba03bae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ebc98129-8f4e-4413-a247-f9a008fececf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ebc98129-8f4e-4413-a247-f9a008fececf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_55e25850-72e8-4f8b-acf2-5d181d7809d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_55e25850-72e8-4f8b-acf2-5d181d7809d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_032a1d0c-95f2-4fbf-842a-f5511ccef064" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_55e25850-72e8-4f8b-acf2-5d181d7809d2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_032a1d0c-95f2-4fbf-842a-f5511ccef064" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="extended" id="ibdf0dd9bdb864adc9040cfcec966d684_InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_09705a46-09b3-41f4-9caf-18dae60ba7b0" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_09705a46-09b3-41f4-9caf-18dae60ba7b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount_1477751a-49d1-4295-8973-d14392bee5cb" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentCarryingAmount_1477751a-49d1-4295-8973-d14392bee5cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_038edf3b-d90b-4c51-b537-dab329431a54" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentsReversalofDeferredTaxLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_038edf3b-d90b-4c51-b537-dab329431a54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_efa24b56-88e4-4247-b4ee-6e943ed0b757" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_efa24b56-88e4-4247-b4ee-6e943ed0b757" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_5987055d-ad3d-47ae-bc79-f8ba78dc2e9e" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_5987055d-ad3d-47ae-bc79-f8ba78dc2e9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9f2fecb8-dd06-46b3-8792-67725308a7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9f2fecb8-dd06-46b3-8792-67725308a7f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_eca63e3d-f7ec-4175-9d6f-66e0aa24f19e" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_ExchangeOfferSharesExchanged_eca63e3d-f7ec-4175-9d6f-66e0aa24f19e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_713f47d9-5f5a-49c4-8546-187d5b291af7" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_713f47d9-5f5a-49c4-8546-187d5b291af7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_43160ee0-8d2b-4076-ae0c-d725949b06a9" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAcceptedAverageCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_43160ee0-8d2b-4076-ae0c-d725949b06a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_28ec485a-3bb0-4ff8-9a21-19400e5fed63_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_28ec485a-3bb0-4ff8-9a21-19400e5fed63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_358f6ee1-1f18-45ec-a258-a9a65d05b1a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_358f6ee1-1f18-45ec-a258-a9a65d05b1a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_904cd8cd-85f0-4ad4-98bc-d3df1e31deaf" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_358f6ee1-1f18-45ec-a258-a9a65d05b1a6" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_904cd8cd-85f0-4ad4-98bc-d3df1e31deaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_36612986-a138-411d-abc8-b23e479c9f3b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_36612986-a138-411d-abc8-b23e479c9f3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_c9064a2a-a9e9-4f91-afa2-f723caf9c66d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_c9064a2a-a9e9-4f91-afa2-f723caf9c66d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_71089b56-0d3b-4a23-9672-180d8e2e26d1" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_c9064a2a-a9e9-4f91-afa2-f723caf9c66d" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_71089b56-0d3b-4a23-9672-180d8e2e26d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSale"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended" id="i1c117a1b3c774c559a91ee1f92d0c5a2_HeldforSale"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended" id="i6594ba403aa04a95b81dd05aa103da8a_HeldforSaleTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="ife2f3c8e7a334caf8519003c634e422d_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ae3c461b-e939-43e2-8807-af02d3449f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ae3c461b-e939-43e2-8807-af02d3449f40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a2e37d7-0d1b-4f5f-96f9-fb6bafa227ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a2e37d7-0d1b-4f5f-96f9-fb6bafa227ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8fe81557-c633-4c5e-8699-f365c2c6ad22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8fe81557-c633-4c5e-8699-f365c2c6ad22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_f3e279f4-13b2-4902-b78c-7b3dbf3d6262" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_f3e279f4-13b2-4902-b78c-7b3dbf3d6262" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f16589f0-448f-4751-8f95-ea1fc18c6140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_EquityMethodInvestments_f16589f0-448f-4751-8f95-ea1fc18c6140" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_42d9e967-391d-455c-abdc-cca75460e9ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_42d9e967-391d-455c-abdc-cca75460e9ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_3a44333e-dbff-493d-a3b7-ed60051ab5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_3a44333e-dbff-493d-a3b7-ed60051ab5f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8b06a6e0-853c-456b-ac8b-f94a73cddc4c" xlink:href="mck-20210331.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8b06a6e0-853c-456b-ac8b-f94a73cddc4c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be719043-cc98-4fd9-8f30-97e42e421523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be719043-cc98-4fd9-8f30-97e42e421523" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f163c93e-a868-4ec1-bf8f-89129db2dbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f163c93e-a868-4ec1-bf8f-89129db2dbf6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_2f9a5fc0-82a6-492c-a1be-bc17c23ecedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_2f9a5fc0-82a6-492c-a1be-bc17c23ecedf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_76fa8850-b4bb-45d6-8b72-69cdedba3f15_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_76fa8850-b4bb-45d6-8b72-69cdedba3f15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5fbb41d-257b-4a7a-9be7-472f2af3d8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5fbb41d-257b-4a7a-9be7-472f2af3d8e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_23e3522d-54cd-4363-9584-a138cc20ea4c" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5fbb41d-257b-4a7a-9be7-472f2af3d8e4" xlink:to="loc_mck_GermanWholesaleBusinessMember_23e3522d-54cd-4363-9584-a138cc20ea4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_216b4ecf-3177-4dd5-87ef-effdf4e5b131_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:to="loc_us-gaap_SegmentDomain_216b4ecf-3177-4dd5-87ef-effdf4e5b131_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_559ea474-84d3-43a6-95b1-232b63e9df54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:to="loc_us-gaap_SegmentDomain_559ea474-84d3-43a6-95b1-232b63e9df54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_3f10a3fc-3365-47a1-b44c-8389cab917c1" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_559ea474-84d3-43a6-95b1-232b63e9df54" xlink:to="loc_mck_InternationalSegmentMember_3f10a3fc-3365-47a1-b44c-8389cab917c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_363ef75e-c99f-4a27-911c-56492cc402ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_363ef75e-c99f-4a27-911c-56492cc402ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8ff7ab27-cd2e-465c-835c-ceb84527e258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8ff7ab27-cd2e-465c-835c-ceb84527e258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a55aa091-8ded-432a-b2ef-ba9aef5aecb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_8ff7ab27-cd2e-465c-835c-ceb84527e258" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a55aa091-8ded-432a-b2ef-ba9aef5aecb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5b5eddf7-0f79-4a62-89a9-0279a5772ab2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:to="loc_srt_OwnershipDomain_5b5eddf7-0f79-4a62-89a9-0279a5772ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_72aa420f-7a48-42e6-9adf-97f99cbf5908" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:to="loc_srt_OwnershipDomain_72aa420f-7a48-42e6-9adf-97f99cbf5908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_548c0259-9302-4232-8981-9d9a507b2dfd" xlink:href="mck-20210331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_72aa420f-7a48-42e6-9adf-97f99cbf5908" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_548c0259-9302-4232-8981-9d9a507b2dfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_964613d9-1f22-4895-9c02-633c876459c5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_964613d9-1f22-4895-9c02-633c876459c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_56e9a111-e7a1-40e7-aa80-8acdd7a82a7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_56e9a111-e7a1-40e7-aa80-8acdd7a82a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_fd92f461-7293-448e-8336-5eb264b55f42" xlink:href="mck-20210331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_56e9a111-e7a1-40e7-aa80-8acdd7a82a7c" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_fd92f461-7293-448e-8336-5eb264b55f42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_59f139a3-2917-4c81-a2dd-bb72726bbdb4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:to="loc_us-gaap_RelatedPartyDomain_59f139a3-2917-4c81-a2dd-bb72726bbdb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_91e3f50a-b6d3-4919-b99c-0055283b621a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:to="loc_us-gaap_RelatedPartyDomain_91e3f50a-b6d3-4919-b99c-0055283b621a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_03f00825-b735-459f-8ec1-dc49f7313c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_91e3f50a-b6d3-4919-b99c-0055283b621a" xlink:to="loc_us-gaap_CorporateJointVentureMember_03f00825-b735-459f-8ec1-dc49f7313c3d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="if3d2732d36cb4da0ac7998a3322d29fb_HeldforSaleAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d4e6b023-6ebd-4a3a-8789-4d89958d3cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d4e6b023-6ebd-4a3a-8789-4d89958d3cfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_18d51051-e1ee-475b-96db-ce9076a12080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_18d51051-e1ee-475b-96db-ce9076a12080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_bd39acc3-2af6-4a35-9c66-ab82dada058a" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_bd39acc3-2af6-4a35-9c66-ab82dada058a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_6805e349-266d-49c5-a8e7-d2cc92e37d80" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_6805e349-266d-49c5-a8e7-d2cc92e37d80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_40d7b052-427f-4ed5-8003-475fbed59a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_40d7b052-427f-4ed5-8003-475fbed59a35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_ae9cf3db-bba5-45c3-b6f9-d8efa765f502" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_ae9cf3db-bba5-45c3-b6f9-d8efa765f502" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_993b1a45-a17a-4d1b-94f5-00c0baa20c5b" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_993b1a45-a17a-4d1b-94f5-00c0baa20c5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_0f8ae477-e1df-498c-bb3d-3bd68d86eb4e" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_0f8ae477-e1df-498c-bb3d-3bd68d86eb4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3b52d32c-7bd1-4221-834a-09d16db9c147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3b52d32c-7bd1-4221-834a-09d16db9c147" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f7ee6db-8ca8-4e1b-8a49-3187c989325f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f7ee6db-8ca8-4e1b-8a49-3187c989325f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fa3191c-a4d2-4787-b215-8d248b75d786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fa3191c-a4d2-4787-b215-8d248b75d786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_2474daad-46a8-4759-927a-c8337bd82acd" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fa3191c-a4d2-4787-b215-8d248b75d786" xlink:to="loc_mck_GermanWholesaleBusinessMember_2474daad-46a8-4759-927a-c8337bd82acd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_10251949-4ada-4d57-a87b-ea66c57a6302_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_10251949-4ada-4d57-a87b-ea66c57a6302_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_88692d90-8571-458b-81f2-da8100c2142e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_88692d90-8571-458b-81f2-da8100c2142e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8395cda7-5dcc-4c17-a77b-1ae356fadbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_88692d90-8571-458b-81f2-da8100c2142e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8395cda7-5dcc-4c17-a77b-1ae356fadbec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended" id="ibbb9cd3991ab43829646d94b6e8d5f03_RestructuringImpairmentandRelatedCharges"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended" id="i378aa196c6ce46299956c5f31f4410fa_RestructuringImpairmentandRelatedChargesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="i444c2be8feaa427c984e27e3bc8de5c6_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5b131a5f-8de9-4e12-b44e-a8d398f38ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5b131a5f-8de9-4e12-b44e-a8d398f38ccd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b7af372a-f768-4662-a983-8690f9391a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b7af372a-f768-4662-a983-8690f9391a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_278fdc11-9eab-4f40-be28-4655d4dc7ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringCharges_278fdc11-9eab-4f40-be28-4655d4dc7ff5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_06add3d4-5229-45a3-b37b-661092e3d8db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_06add3d4-5229-45a3-b37b-661092e3d8db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_48762b5e-1099-4849-a27a-fae10d2a6670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringReserve_48762b5e-1099-4849-a27a-fae10d2a6670" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ff5cb6f0-b3de-49e4-90cc-3b2c1eb8549d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_AssetImpairmentCharges_ff5cb6f0-b3de-49e4-90cc-3b2c1eb8549d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25582994-68d1-46ca-b68e-cbb7aefd4915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25582994-68d1-46ca-b68e-cbb7aefd4915" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e88dd374-0c6c-4a6c-a3bc-1605ecbc6d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e88dd374-0c6c-4a6c-a3bc-1605ecbc6d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_140d76fb-8145-475c-8b1c-81acdc907e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e88dd374-0c6c-4a6c-a3bc-1605ecbc6d00" xlink:to="loc_us-gaap_SubsequentEventMember_140d76fb-8145-475c-8b1c-81acdc907e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e0902b29-b312-4d8a-b86c-2c3637e89e93_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:to="loc_us-gaap_RestructuringPlanDomain_e0902b29-b312-4d8a-b86c-2c3637e89e93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:to="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_204c7963-b4bb-4f05-b26b-fa7ca3a8e8de" xlink:href="mck-20210331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:to="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_204c7963-b4bb-4f05-b26b-fa7ca3a8e8de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_3707d1ad-3d92-41b9-9256-9744a4d67832" xlink:href="mck-20210331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_3707d1ad-3d92-41b9-9256-9744a4d67832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_2fc77a73-a7bf-467c-a3a6-2759ab2591ba" xlink:href="mck-20210331.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_2fc77a73-a7bf-467c-a3a6-2759ab2591ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_aa1dd633-8195-4eb8-9801-e3624068d356_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_aa1dd633-8195-4eb8-9801-e3624068d356_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_338b140a-3769-46bf-87d7-a1092982b1cc" xlink:href="mck-20210331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_338b140a-3769-46bf-87d7-a1092982b1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_fd5e3135-34d6-40bb-91a8-bb1fabfaeb56" xlink:href="mck-20210331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_fd5e3135-34d6-40bb-91a8-bb1fabfaeb56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_8335b833-4dc9-4eb2-a88c-fdef31f8857c" xlink:href="mck-20210331.xsd#mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_8335b833-4dc9-4eb2-a88c-fdef31f8857c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IntangibleAssetandStoreAssetsImpairmentMember_d24d8c6e-fa87-4dd5-a094-93c0c78aefd9" xlink:href="mck-20210331.xsd#mck_IntangibleAssetandStoreAssetsImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_IntangibleAssetandStoreAssetsImpairmentMember_d24d8c6e-fa87-4dd5-a094-93c0c78aefd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6d7bbf89-dadc-4308-8c0a-585d9702748c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:to="loc_srt_RangeMember_6d7bbf89-dadc-4308-8c0a-585d9702748c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:to="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_79e8051e-17ef-44e3-92ba-d5f2c61aff7a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:to="loc_srt_MinimumMember_79e8051e-17ef-44e3-92ba-d5f2c61aff7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e6d355c0-e25b-4b6a-a19f-ffc3782b3844" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:to="loc_srt_MaximumMember_e6d355c0-e25b-4b6a-a19f-ffc3782b3844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d553fd37-cc5a-49d5-bd4f-b91964488fe6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:to="loc_us-gaap_SegmentDomain_d553fd37-cc5a-49d5-bd4f-b91964488fe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_633e4611-41a2-4091-8a04-ee30041908f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:to="loc_us-gaap_SegmentDomain_633e4611-41a2-4091-8a04-ee30041908f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_d38aea54-4e50-4a9a-ad9b-34e3d295d5ab" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_633e4611-41a2-4091-8a04-ee30041908f6" xlink:to="loc_mck_InternationalSegmentMember_d38aea54-4e50-4a9a-ad9b-34e3d295d5ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_52ce48a1-d573-4d59-80db-90dc551d3acb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:to="loc_srt_SegmentGeographicalDomain_52ce48a1-d573-4d59-80db-90dc551d3acb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0525e1af-16a1-4326-b9eb-d751b7695496" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:to="loc_srt_SegmentGeographicalDomain_0525e1af-16a1-4326-b9eb-d751b7695496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_b22308c4-9dcf-46dc-80d6-43bfe62991fb" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0525e1af-16a1-4326-b9eb-d751b7695496" xlink:to="loc_country_GB_b22308c4-9dcf-46dc-80d6-43bfe62991fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_0773e851-1730-44a5-8c93-a14b5921078a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:to="loc_us-gaap_ReportingUnitDomain_0773e851-1730-44a5-8c93-a14b5921078a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:to="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_37ff4666-db06-4902-93b7-f5f50102f19a" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_37ff4666-db06-4902-93b7-f5f50102f19a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_9a80fc6a-ac88-4111-a693-e3c050709bf2" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:to="loc_mck_RexallHealthMember_9a80fc6a-ac88-4111-a693-e3c050709bf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_894c3aa0-2bac-4e80-bafb-f4933d03f6d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_894c3aa0-2bac-4e80-bafb-f4933d03f6d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a7cafb1-9fcf-4755-b83e-b54bfce18124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a7cafb1-9fcf-4755-b83e-b54bfce18124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5549fb98-0c46-4d17-ad2c-ead5ea972f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a7cafb1-9fcf-4755-b83e-b54bfce18124" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5549fb98-0c46-4d17-ad2c-ead5ea972f3a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="extended" id="i4bb93191465647d1ab52336d6e95adb1_RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_9554fc65-1663-42fb-b95c-4b3e25eb0545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_SeveranceCosts1_9554fc65-1663-42fb-b95c-4b3e25eb0545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_ebe2337e-4830-40d0-8eb7-886a668d7e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_BusinessExitCosts1_ebe2337e-4830-40d0-8eb7-886a668d7e00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_3165700c-6d2b-4c0c-ae02-c50873e10e45" xlink:href="mck-20210331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_3165700c-6d2b-4c0c-ae02-c50873e10e45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_56bfefbe-8012-4d24-bdcf-e717faddaa7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_RestructuringCharges_56bfefbe-8012-4d24-bdcf-e717faddaa7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:to="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_63047ca9-9a92-4803-bb59-9a12d74ef921_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:to="loc_srt_ConsolidationItemsDomain_63047ca9-9a92-4803-bb59-9a12d74ef921_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:to="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fa7e6f2b-3219-4f21-9244-66b95109a8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:to="loc_us-gaap_OperatingSegmentsMember_fa7e6f2b-3219-4f21-9244-66b95109a8bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8cc20d49-fa4f-465d-a7fc-4ecb0b563051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8cc20d49-fa4f-465d-a7fc-4ecb0b563051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_970e34dd-ec58-4979-80ab-613405339372_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:to="loc_us-gaap_SegmentDomain_970e34dd-ec58-4979-80ab-613405339372_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:to="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_d7e5a58e-b7be-462e-8968-7842d7f2abe3" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_USPharmaceuticalSegmentMember_d7e5a58e-b7be-462e-8968-7842d7f2abe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_5d203c93-a288-48e5-8220-b952269a9d8b" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_InternationalSegmentMember_5d203c93-a288-48e5-8220-b952269a9d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_8ce1291f-d35d-44be-aeaf-517328b608f2" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_8ce1291f-d35d-44be-aeaf-517328b608f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e946807b-78d3-4ce4-a843-bf83c4a41605" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e946807b-78d3-4ce4-a843-bf83c4a41605" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended" id="i6eab3839f7c0437d99d146abf5afb8ca_RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_b4353ddb-94d5-4672-acd5-9c785e01d31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_b4353ddb-94d5-4672-acd5-9c785e01d31a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_726f2ee5-2328-4352-ae35-0c2d81b226ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserve_726f2ee5-2328-4352-ae35-0c2d81b226ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ee482faf-8a1f-4941-adaf-7f1ca2a6ff48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringCharges_ee482faf-8a1f-4941-adaf-7f1ca2a6ff48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_91706a48-f863-4ce2-ae18-9914cb7850e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_91706a48-f863-4ce2-ae18-9914cb7850e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d709540b-a31b-4192-a966-ff75ad712544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_PaymentsForRestructuring_d709540b-a31b-4192-a966-ff75ad712544" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_d7e356dd-c6ac-465e-a053-5c45330b4bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_d7e356dd-c6ac-465e-a053-5c45330b4bd7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_89b09294-08f7-41aa-ade9-1b339de46197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_b4353ddb-94d5-4672-acd5-9c785e01d31a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e9a8e2ad-1d15-4567-abbb-37ebafd7d017_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e9a8e2ad-1d15-4567-abbb-37ebafd7d017_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_1595483f-7404-4e28-8158-8b5eb29b366a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_1595483f-7404-4e28-8158-8b5eb29b366a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7ff2c235-8be7-4d46-a1c8-c1bb276dd1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7ff2c235-8be7-4d46-a1c8-c1bb276dd1d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a94b4bbf-b611-49e8-81ff-6a7d46c203c0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:to="loc_srt_ConsolidationItemsDomain_a94b4bbf-b611-49e8-81ff-6a7d46c203c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:to="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d089f336-81d6-479a-9de5-103dbae3ebd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:to="loc_us-gaap_OperatingSegmentsMember_d089f336-81d6-479a-9de5-103dbae3ebd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9b5366c9-0b57-4c33-96e3-99500fbbfa27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9b5366c9-0b57-4c33-96e3-99500fbbfa27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0c884684-e0b3-48b3-8cb1-c55b2f844a90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:to="loc_us-gaap_SegmentDomain_0c884684-e0b3-48b3-8cb1-c55b2f844a90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:to="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_483ba177-e7c3-4053-a219-7f1d651df584" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_USPharmaceuticalSegmentMember_483ba177-e7c3-4053-a219-7f1d651df584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_b4f30dcf-d3f8-4eb7-b383-c3cbcea3caf7" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_InternationalSegmentMember_b4f30dcf-d3f8-4eb7-b383-c3cbcea3caf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a2799015-b23a-41b8-a687-1fd66a0c72dc" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a2799015-b23a-41b8-a687-1fd66a0c72dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_72b62e85-6c21-4aeb-8395-6c9b7b236f60" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_72b62e85-6c21-4aeb-8395-6c9b7b236f60" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestitures"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="extended" id="i6cf9b7aec616442892099469d7ef0f09_BusinessAcquisitionsandDivestitures"/>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="extended" id="i78bedf785de54ed884be49348e56b95c_BusinessAcquisitionsandDivestituresTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" xlink:type="extended" id="i4d9dbf637b16425b88d1d8b7b2e80873_BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_985c255f-4dfe-4744-98e9-9c3830ea9307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_985c255f-4dfe-4744-98e9-9c3830ea9307" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ac5a80a7-efc6-457f-9af9-e61d00ae5d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ac5a80a7-efc6-457f-9af9-e61d00ae5d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_15420cf5-a3bb-496a-a814-6d29f0353665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_15420cf5-a3bb-496a-a814-6d29f0353665" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24b42e87-69b7-45a2-9c7a-2f84440eedc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24b42e87-69b7-45a2-9c7a-2f84440eedc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_83df6c42-d4d8-4b44-ac9f-d454c73340f8" xlink:href="mck-20210331.xsd#mck_MedicalSpecialtiesDistributorsLLCMSDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24b42e87-69b7-45a2-9c7a-2f84440eedc2" xlink:to="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_83df6c42-d4d8-4b44-ac9f-d454c73340f8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i0d911b7a024343f7a2d82271c4305ab9_BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ccf95afd-ec3e-45ce-97a1-a598da3ed716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf95afd-ec3e-45ce-97a1-a598da3ed716" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e2848cc-d313-4c5e-9285-acc29b2d7e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e2848cc-d313-4c5e-9285-acc29b2d7e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_8f0fe1d5-13d2-48b4-b8ed-1c91af246087" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_8f0fe1d5-13d2-48b4-b8ed-1c91af246087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4aea0750-e38b-4523-98cb-0b3c69d00d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_Goodwill_4aea0750-e38b-4523-98cb-0b3c69d00d27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a3c4f642-f5be-44bf-a741-306221761062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a3c4f642-f5be-44bf-a741-306221761062" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a5774480-a17e-45ea-9860-f0f5ac0c1186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a5774480-a17e-45ea-9860-f0f5ac0c1186" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_79e67560-42ab-4052-a936-169e69aabd75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_79e67560-42ab-4052-a936-169e69aabd75" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_38ccb3e1-7238-403f-86a4-90c90ef0b6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_38ccb3e1-7238-403f-86a4-90c90ef0b6dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_002270ac-41c7-491e-8c4d-872e95a0dbe1" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_002270ac-41c7-491e-8c4d-872e95a0dbe1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf95afd-ec3e-45ce-97a1-a598da3ed716" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec331a98-1afc-4ef8-8b42-ed60e207cc47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec331a98-1afc-4ef8-8b42-ed60e207cc47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_0e259d97-13c3-469d-821e-8fc11de59ea4" xlink:href="mck-20210331.xsd#mck_MedicalSpecialtiesDistributorsLLCMSDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec331a98-1afc-4ef8-8b42-ed60e207cc47" xlink:to="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_0e259d97-13c3-469d-821e-8fc11de59ea4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" xlink:type="extended" id="ie0523759034a46a8a82e68614958f92b_BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_69008fef-291f-43de-9276-1eb0a7f05b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_69008fef-291f-43de-9276-1eb0a7f05b66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ccc8d1b3-bd48-4e33-b80f-f9d29764c46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ccc8d1b3-bd48-4e33-b80f-f9d29764c46d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_08854910-12a8-4649-b2e1-6fcd63fdedd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_08854910-12a8-4649-b2e1-6fcd63fdedd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_923edeef-9fda-4e88-b9bb-b4c0cd5cab4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_923edeef-9fda-4e88-b9bb-b4c0cd5cab4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1499ce16-2379-40b9-8768-286bc5e3c24f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1499ce16-2379-40b9-8768-286bc5e3c24f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0316556c-7cc9-4614-9dde-9ced0481a6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0316556c-7cc9-4614-9dde-9ced0481a6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CoverMyMedsLLCMember_5b902eda-471a-4a15-9d60-4d48753fe85f" xlink:href="mck-20210331.xsd#mck_CoverMyMedsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0316556c-7cc9-4614-9dde-9ced0481a6ba" xlink:to="loc_mck_CoverMyMedsLLCMember_5b902eda-471a-4a15-9d60-4d48753fe85f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensation"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="extended" id="i0f5978a1da6643c0bc57f6292480baa7_ShareBasedCompensation"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="extended" id="i852aa8aeab4146f3911ee110689aed24_ShareBasedCompensationTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i04bd5fd97c4c499091ff8b0f8bb3dff2_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_823344c7-845a-41fc-9055-150fa235ae57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_823344c7-845a-41fc-9055-150fa235ae57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a255041d-4534-40a1-a4d9-56ff6cda495a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a255041d-4534-40a1-a4d9-56ff6cda495a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_54fe7c82-077c-4937-8aad-d662bf6d4001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_54fe7c82-077c-4937-8aad-d662bf6d4001" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f0fb6a9-85f6-463c-95cb-3b6113769c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f0fb6a9-85f6-463c-95cb-3b6113769c77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_8ffa6286-3c5c-4474-845a-7504495a1281" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_8ffa6286-3c5c-4474-845a-7504495a1281" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4ba50119-c267-4757-8e32-434e0812e8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4ba50119-c267-4757-8e32-434e0812e8f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e8bfc023-fed6-49d2-8591-c8d6ef5eeae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e8bfc023-fed6-49d2-8591-c8d6ef5eeae9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_624643f6-3195-4be2-91f4-78aa082e3c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_624643f6-3195-4be2-91f4-78aa082e3c7b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2a8da3d5-aadb-4a30-ab4a-0c88eeeebd52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2a8da3d5-aadb-4a30-ab4a-0c88eeeebd52" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_7f183ac1-fdf4-4b87-9718-6f5cc5b7ac9f" xlink:href="mck-20210331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_7f183ac1-fdf4-4b87-9718-6f5cc5b7ac9f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b408bca1-ffda-4789-bb67-777cd4096b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b408bca1-ffda-4789-bb67-777cd4096b75" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_6ac8db58-2714-4d21-a66f-65dcf34d5eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_6ac8db58-2714-4d21-a66f-65dcf34d5eb2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0a85873e-d381-48ce-8fdf-647c3e373126_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:to="loc_us-gaap_PlanNameDomain_0a85873e-d381-48ce-8fdf-647c3e373126_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3ed8192c-9ade-4b63-a399-fc3386d2373f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:to="loc_us-gaap_PlanNameDomain_3ed8192c-9ade-4b63-a399-fc3386d2373f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember_23a79aae-786c-4e21-a112-6216bd4cf7f3" xlink:href="mck-20210331.xsd#mck_A2013StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3ed8192c-9ade-4b63-a399-fc3386d2373f" xlink:to="loc_mck_A2013StockPlanMember_23a79aae-786c-4e21-a112-6216bd4cf7f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_39520f30-7eca-4fb7-ad63-e9c1cc703c8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_39520f30-7eca-4fb7-ad63-e9c1cc703c8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fa699529-81ff-42e9-9d3d-928c2034eda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fa699529-81ff-42e9-9d3d-928c2034eda9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember_2690b90c-f4cf-42d4-903a-18ead74124c3" xlink:href="mck-20210331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_mck_PerformancebasedStockUnitsMember_2690b90c-f4cf-42d4-903a-18ead74124c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PeRSUsMember_140dc8e9-d2ec-4587-99f4-eac3fa4cceea" xlink:href="mck-20210331.xsd#mck_PeRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_mck_PeRSUsMember_140dc8e9-d2ec-4587-99f4-eac3fa4cceea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a54c9fa9-c6ab-4fef-9140-9a0862c0c939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a54c9fa9-c6ab-4fef-9140-9a0862c0c939" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_76b10648-979f-4f0b-846c-f0024c272083" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_us-gaap_EmployeeStockMember_76b10648-979f-4f0b-846c-f0024c272083" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5882e17f-20a3-4e37-9bc4-890a84bf0fc5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:to="loc_srt_RangeMember_5882e17f-20a3-4e37-9bc4-890a84bf0fc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:to="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7d8d9b4-84cb-4abc-bcb3-0cc5916da117" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:to="loc_srt_MinimumMember_e7d8d9b4-84cb-4abc-bcb3-0cc5916da117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bae8b9a1-3ed2-4f15-b50f-6175a02e5cdc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:to="loc_srt_MaximumMember_bae8b9a1-3ed2-4f15-b50f-6175a02e5cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3206840-b631-4c03-936b-e341acb9acc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3206840-b631-4c03-936b-e341acb9acc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_59a0a867-5469-4589-9f99-0479614f2b5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3206840-b631-4c03-936b-e341acb9acc5" xlink:to="loc_srt_DirectorMember_59a0a867-5469-4589-9f99-0479614f2b5c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended" id="i83933c0701ec4b4b9367c449276aae6c_ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1715cce0-8303-452d-b031-7d5ab5297e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1715cce0-8303-452d-b031-7d5ab5297e17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07406ebd-9d91-4c08-8c95-609fd4cde5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07406ebd-9d91-4c08-8c95-609fd4cde5d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2c4cce8d-5d47-47c4-ac10-66a568b747f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2c4cce8d-5d47-47c4-ac10-66a568b747f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:to="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_db88aa20-f607-47cb-be40-795f0a92ad0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_db88aa20-f607-47cb-be40-795f0a92ad0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_161dabc1-c71d-44e4-a807-89ec18c34607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_161dabc1-c71d-44e4-a807-89ec18c34607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_0982a313-fcbc-4a45-abb5-9ba4e655eb86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:to="loc_us-gaap_StockOptionMember_0982a313-fcbc-4a45-abb5-9ba4e655eb86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_6aebe705-d2f5-4c1f-b949-8cbafec93873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:to="loc_us-gaap_EmployeeStockMember_6aebe705-d2f5-4c1f-b949-8cbafec93873" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended" id="i7c398e0222254dd59fc871bb6e071d13_ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_23fb4de8-93c1-49b9-adbf-45746dc08763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_23fb4de8-93c1-49b9-adbf-45746dc08763" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_15f90904-4ad4-4e18-8e04-0f1279899e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_15f90904-4ad4-4e18-8e04-0f1279899e79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc504a1-c349-4302-94f3-60753e038556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc504a1-c349-4302-94f3-60753e038556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9285dfbe-eaaa-4ced-a799-5b1e43e43985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9285dfbe-eaaa-4ced-a799-5b1e43e43985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:to="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abb0a6c9-e254-426f-ab4d-f87a705ac24a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_abb0a6c9-e254-426f-ab4d-f87a705ac24a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b95e9934-3b18-4919-87da-48f0e903aa4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b95e9934-3b18-4919-87da-48f0e903aa4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9e4eba6d-c4b3-4602-9098-5178f2004888" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b95e9934-3b18-4919-87da-48f0e903aa4c" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9e4eba6d-c4b3-4602-9098-5178f2004888" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended" id="i0ab43a2ec6de418eb3ce4083eb1d0e2a_ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d879e08e-c9b5-4931-9e5a-3c72ade66412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d879e08e-c9b5-4931-9e5a-3c72ade66412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a8b21eaa-38ea-4c61-8cdb-dc6ab0cfcedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a8b21eaa-38ea-4c61-8cdb-dc6ab0cfcedf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_42ea3046-e53b-42f8-9bba-5dbab422ffd0" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_42ea3046-e53b-42f8-9bba-5dbab422ffd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c996553-11d4-4939-aa87-b42f7c1dcdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c996553-11d4-4939-aa87-b42f7c1dcdd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_65589252-3753-43b2-9c6d-000519d9cd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fda692b-13d5-440d-9893-aaa407aace71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fda692b-13d5-440d-9893-aaa407aace71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d673af9-49cc-4f8c-b6f7-0e0a2b814edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d673af9-49cc-4f8c-b6f7-0e0a2b814edd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_5a45f128-6f96-4fc7-8f02-750bccc75b52" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_5a45f128-6f96-4fc7-8f02-750bccc75b52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_251437a5-bce7-4639-a4c5-d249dd9147b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_251437a5-bce7-4639-a4c5-d249dd9147b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b7cddb6-b6ab-4a6e-8f76-c62efdc87fd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:to="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_665d8334-420f-4921-8e51-b6aa37723c28_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_665d8334-420f-4921-8e51-b6aa37723c28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_132bacf2-87ba-4445-9452-75809c30c89c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_132bacf2-87ba-4445-9452-75809c30c89c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_f58c70f2-5aba-43a3-8a36-fc0480b756c4" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_132bacf2-87ba-4445-9452-75809c30c89c" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_f58c70f2-5aba-43a3-8a36-fc0480b756c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended" id="i377aa99298e1443db3a904f54ad49b5c_ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5f7f3ea3-8b95-4f12-ab7e-6795712650c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5f7f3ea3-8b95-4f12-ab7e-6795712650c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74958b00-d321-4683-b2fb-da986eb4f38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74958b00-d321-4683-b2fb-da986eb4f38c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e3a17c71-ac52-4679-8457-fd5dd0a5926a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e3a17c71-ac52-4679-8457-fd5dd0a5926a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:to="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc75ae9c-1c90-448f-80b3-0bdcfe931a28_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc75ae9c-1c90-448f-80b3-0bdcfe931a28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2905fbf3-8529-4007-a2ff-b38c6f614701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2905fbf3-8529-4007-a2ff-b38c6f614701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_fb7d295a-243a-4f4f-b9b1-3794bcae3627" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2905fbf3-8529-4007-a2ff-b38c6f614701" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_fb7d295a-243a-4f4f-b9b1-3794bcae3627" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="extended" id="i6d1059ab9267436c8af4d90da7d740ed_ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6fc3f073-2ea5-41af-8acc-d2d6615613ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6fc3f073-2ea5-41af-8acc-d2d6615613ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_59d58ae3-bc0e-40e3-a365-0dfe7e00d2c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_59d58ae3-bc0e-40e3-a365-0dfe7e00d2c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_24192de7-8aff-4802-9d45-be570843ef40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_24192de7-8aff-4802-9d45-be570843ef40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b7d8e50a-2633-4919-a272-d3680c223f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b7d8e50a-2633-4919-a272-d3680c223f2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:to="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6188ef7a-d451-4ee9-8f58-771ad5ba0745_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6188ef7a-d451-4ee9-8f58-771ad5ba0745_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e8063c8-02ff-4b63-a4fc-946d5a945c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e8063c8-02ff-4b63-a4fc-946d5a945c5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e8bb053f-d911-49e8-9f50-7d26747e211e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e8063c8-02ff-4b63-a4fc-946d5a945c5c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e8bb053f-d911-49e8-9f50-7d26747e211e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationSummaryofOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="extended" id="i3742b8063e684591b7a2743be726f59d_ShareBasedCompensationSummaryofOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f3d28d5a-d5ec-4507-a7a3-3ed250159994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f3d28d5a-d5ec-4507-a7a3-3ed250159994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_916d26c4-b94a-444a-a3b9-6241cfb48e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_916d26c4-b94a-444a-a3b9-6241cfb48e13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_aae8fe3c-e0ac-4e88-b1e6-00efdb123034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_aae8fe3c-e0ac-4e88-b1e6-00efdb123034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d577696c-f58f-4997-bb9f-97fc1232ffa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d577696c-f58f-4997-bb9f-97fc1232ffa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_27071b51-7290-4bd3-a2b9-54e83b27dad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_27071b51-7290-4bd3-a2b9-54e83b27dad3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1e374e4-cbf6-4192-a75b-299dc6c3498d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1e374e4-cbf6-4192-a75b-299dc6c3498d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70fdfa5e-3a02-4421-92f6-0eb5c57011d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70fdfa5e-3a02-4421-92f6-0eb5c57011d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_36099811-fedc-4596-a26a-113907f1d11c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_36099811-fedc-4596-a26a-113907f1d11c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeOneMember_95e89a37-7c5e-4520-ab9a-ca8216289956" xlink:href="mck-20210331.xsd#mck_RangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:to="loc_mck_RangeOneMember_95e89a37-7c5e-4520-ab9a-ca8216289956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeTwoMember_f6c667c3-2b83-4797-9c80-b5d1f6e4f767" xlink:href="mck-20210331.xsd#mck_RangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:to="loc_mck_RangeTwoMember_f6c667c3-2b83-4797-9c80-b5d1f6e4f767" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended" id="i18997046658e459ea35dc410490d1b3e_ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended" id="i78bc536631744abd84d7a9d9103081a3_ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_acdbabd7-5a38-49f8-b70a-402cedfff79b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_acdbabd7-5a38-49f8-b70a-402cedfff79b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_df9d5400-d0f5-49df-a27f-c1cb929566a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_df9d5400-d0f5-49df-a27f-c1cb929566a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_acb1fdf9-4508-4922-bb16-06c838dcb8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_acb1fdf9-4508-4922-bb16-06c838dcb8cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_dae6812b-a712-446e-9cd4-53656f495590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_dae6812b-a712-446e-9cd4-53656f495590" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3d4bbfeb-c1bc-4ac3-b816-78292e0fcfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3d4bbfeb-c1bc-4ac3-b816-78292e0fcfbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8cc56ab-119c-4ed9-9285-4867de6850e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8cc56ab-119c-4ed9-9285-4867de6850e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7a417fa2-b104-4a37-b86a-cf86d354b099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7a417fa2-b104-4a37-b86a-cf86d354b099" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:to="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3200a69f-d760-4e90-bfed-6f13d32cd41b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3200a69f-d760-4e90-bfed-6f13d32cd41b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d429c623-ffdf-42c4-a00c-d451d5f294e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d429c623-ffdf-42c4-a00c-d451d5f294e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f2fe69b4-ac6e-45e8-b6ea-d3ea5a2c86fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d429c623-ffdf-42c4-a00c-d451d5f294e6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f2fe69b4-ac6e-45e8-b6ea-d3ea5a2c86fb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNet" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNet"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/OtherIncomeNet" xlink:type="extended" id="i6c5f88c86f854f8db5312607c814dc62_OtherIncomeNet"/>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNetTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="extended" id="i75099a0b4cb343d0b2e6361de3a0b411_OtherIncomeNetTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNetDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/OtherIncomeNetDetails" xlink:type="extended" id="ia1002a99b90a4245843f36b54efb9f86_OtherIncomeNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0bd799fe-4be3-4d58-b705-ea0ac548f83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0bd799fe-4be3-4d58-b705-ea0ac548f83b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_271fe007-b793-4053-908b-16ef6818cc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_271fe007-b793-4053-908b-16ef6818cc53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dda21faf-9a4c-4e08-850d-5551b3301f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dda21faf-9a4c-4e08-850d-5551b3301f42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_35277303-c1ab-4a0b-89b4-8a80e8e21a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_35277303-c1ab-4a0b-89b4-8a80e8e21a7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9b4a3aa6-0bed-4f0b-99fc-643fd31ff028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9b4a3aa6-0bed-4f0b-99fc-643fd31ff028" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_49ef3a2f-2930-400f-a663-3a57a85cc6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_49ef3a2f-2930-400f-a663-3a57a85cc6f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2377e21c-d60c-44e8-8a4c-f904cdf7ef18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2377e21c-d60c-44e8-8a4c-f904cdf7ef18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_40f1d103-70da-4d65-8544-2fb42aa76ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b3b09ec8-dd90-4917-8acf-4952eb5aca7c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:to="loc_us-gaap_RelatedPartyDomain_b3b09ec8-dd90-4917-8acf-4952eb5aca7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8963f848-fd90-4a3e-bfcf-f460b10b79e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:to="loc_us-gaap_RelatedPartyDomain_8963f848-fd90-4a3e-bfcf-f460b10b79e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_58573a31-c1d1-4cb8-b8a2-8b2dd04929c6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_8963f848-fd90-4a3e-bfcf-f460b10b79e3" xlink:to="loc_srt_ExecutiveOfficerMember_58573a31-c1d1-4cb8-b8a2-8b2dd04929c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_5078ba61-d299-41ca-bb17-f8f072a9846e" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_5078ba61-d299-41ca-bb17-f8f072a9846e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_89aa84e1-602f-47d2-8047-1b6ce66f588e" xlink:href="mck-20210331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_89aa84e1-602f-47d2-8047-1b6ce66f588e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a6ad9717-8eef-4135-9ec7-fb310f862f91_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a6ad9717-8eef-4135-9ec7-fb310f862f91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b0dfcf7b-d047-4c02-a0e1-a780f153b29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b0dfcf7b-d047-4c02-a0e1-a780f153b29d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_badaf18f-b1c9-47e0-a841-66e638888ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b0dfcf7b-d047-4c02-a0e1-a780f153b29d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_badaf18f-b1c9-47e0-a841-66e638888ffb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_eb3acec5-77e3-4c3b-84d5-3b3765b546ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_eb3acec5-77e3-4c3b-84d5-3b3765b546ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4b3767c3-84c3-4ec7-9e33-03425b72945c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4b3767c3-84c3-4ec7-9e33-03425b72945c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_723e2ed5-55f1-4662-a742-76ea930a3fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4b3767c3-84c3-4ec7-9e33-03425b72945c" xlink:to="loc_us-gaap_DomesticPlanMember_723e2ed5-55f1-4662-a742-76ea930a3fc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_87f3dd1f-babd-4fb0-8618-c72df75bb236" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_723e2ed5-55f1-4662-a742-76ea930a3fc6" xlink:to="loc_country_US_87f3dd1f-babd-4fb0-8618-c72df75bb236" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended" id="i77e33aba686947e89832ee3cfe14ebfe_IncomeTaxes"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="extended" id="i0e7a07aa4fd64bcd84da0bc5ce9cabde_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended" id="i8efd4243885c4fd5b654012f4aec1d79_IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended" id="if57b7d9af602498d9092189fcfa646d9_IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i56eb10156220457d82a32c979e07378f_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c1d7550-ec86-40ea-8861-55c409e1193e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c1d7550-ec86-40ea-8861-55c409e1193e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_45768bf7-b43a-413c-a12c-1fd74f1af5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_45768bf7-b43a-413c-a12c-1fd74f1af5a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_afdbdb02-b669-432e-a5b7-e33ed221e023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_afdbdb02-b669-432e-a5b7-e33ed221e023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_dcb2d92b-4e34-4dfe-bdd4-563bedea971c" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_dcb2d92b-4e34-4dfe-bdd4-563bedea971c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_b3a1451d-b1c0-466c-8909-d17e9276eeb8" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_b3a1451d-b1c0-466c-8909-d17e9276eeb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_771a7f54-7793-4667-a983-ba30022d4c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_771a7f54-7793-4667-a983-ba30022d4c53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_f6102f75-87e4-4423-8fb8-bb53ae42ec27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_f6102f75-87e4-4423-8fb8-bb53ae42ec27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_d8a1ba38-99ae-4d7a-84b0-a8990a4c1a11" xlink:href="mck-20210331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_d8a1ba38-99ae-4d7a-84b0-a8990a4c1a11" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_31320d00-e4a0-4d86-adf7-2c1322dc6888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_31320d00-e4a0-4d86-adf7-2c1322dc6888" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_f08212f9-5950-4ccf-a182-34d22456e675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_f08212f9-5950-4ccf-a182-34d22456e675" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_deb87d99-bb72-4759-bc34-b2e8c227eaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_deb87d99-bb72-4759-bc34-b2e8c227eaea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f52f2930-d6c8-46b8-8516-3daca65f7e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f52f2930-d6c8-46b8-8516-3daca65f7e05" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e9e0ce0f-b5b6-4e96-85f8-7794e276b268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e9e0ce0f-b5b6-4e96-85f8-7794e276b268" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_45a4ce73-6781-49be-8969-ceaf22b27c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_OperatingLossCarryforwards_45a4ce73-6781-49be-8969-ceaf22b27c59" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e2430f5f-0b1e-4995-b4d5-d7e1b70587c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e2430f5f-0b1e-4995-b4d5-d7e1b70587c1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fd20c3a8-3705-4017-a561-5b52ce6a2c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fd20c3a8-3705-4017-a561-5b52ce6a2c93" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_afaffffb-8d70-4960-8ad0-ba078652c5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d24b8879-8250-4824-91e9-dff08632a441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d24b8879-8250-4824-91e9-dff08632a441" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_e4c42dfc-410f-4729-a7e4-0c9128e1114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_e4c42dfc-410f-4729-a7e4-0c9128e1114d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_56d7f6db-78cf-4abc-ad76-17fdb34566b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_56d7f6db-78cf-4abc-ad76-17fdb34566b8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_e12f38de-5d5f-4f7b-96e9-137787c49fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_e12f38de-5d5f-4f7b-96e9-137787c49fd7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_6a4faf4b-fb3b-4aff-9536-190515c3b825_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_6a4faf4b-fb3b-4aff-9536-190515c3b825_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_835bed7d-b13d-461d-b4dd-5b6be1f45d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_835bed7d-b13d-461d-b4dd-5b6be1f45d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_5ab7acb5-4896-4257-9519-f84accfde2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_835bed7d-b13d-461d-b4dd-5b6be1f45d57" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_5ab7acb5-4896-4257-9519-f84accfde2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_dc5c233a-ea71-4cb5-adca-9dc762184ccc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:to="loc_us-gaap_LossContingencyNatureDomain_dc5c233a-ea71-4cb5-adca-9dc762184ccc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_4e8ac695-421d-4817-8a54-19a7fee760be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:to="loc_us-gaap_LossContingencyNatureDomain_4e8ac695-421d-4817-8a54-19a7fee760be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PendingAndFutureOpioidRelatedClaimsMember_c0912409-eab1-4435-8106-2841a0b02aa2" xlink:href="mck-20210331.xsd#mck_PendingAndFutureOpioidRelatedClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_4e8ac695-421d-4817-8a54-19a7fee760be" xlink:to="loc_mck_PendingAndFutureOpioidRelatedClaimsMember_c0912409-eab1-4435-8106-2841a0b02aa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc48c6db-da0f-4331-9ae2-97b4dc8158db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:to="loc_us-gaap_SegmentDomain_fc48c6db-da0f-4331-9ae2-97b4dc8158db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c39f0048-c517-42c3-8229-3a40d6d6c585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:to="loc_us-gaap_SegmentDomain_c39f0048-c517-42c3-8229-3a40d6d6c585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_cf1659b3-bf96-4ce5-a37d-e20b40d127e1" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c39f0048-c517-42c3-8229-3a40d6d6c585" xlink:to="loc_mck_InternationalSegmentMember_cf1659b3-bf96-4ce5-a37d-e20b40d127e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_d39a8272-35e6-4a89-9803-750f0b022059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:to="loc_us-gaap_DomesticCountryMember_d39a8272-35e6-4a89-9803-750f0b022059" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5c234f6a-0c74-4eaa-8b90-6202d62f74ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5c234f6a-0c74-4eaa-8b90-6202d62f74ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_afdceadb-85ee-41c5-ab03-3145187f8e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:to="loc_us-gaap_ForeignCountryMember_afdceadb-85ee-41c5-ab03-3145187f8e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_34722239-5ea6-46db-8e82-cb965c8d8c7e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_34722239-5ea6-46db-8e82-cb965c8d8c7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cc9b4d5b-e839-4393-a06c-e76d783e74e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cc9b4d5b-e839-4393-a06c-e76d783e74e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_ecd1a83f-f66b-4ab0-ae15-36d035de382d" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_cc9b4d5b-e839-4393-a06c-e76d783e74e9" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_ecd1a83f-f66b-4ab0-ae15-36d035de382d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6115cc81-5934-461b-aa22-b63b9af939c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:to="loc_us-gaap_RelatedPartyDomain_6115cc81-5934-461b-aa22-b63b9af939c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_abd82ddc-f77e-44b8-83d5-127f21069a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:to="loc_us-gaap_RelatedPartyDomain_abd82ddc-f77e-44b8-83d5-127f21069a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_7b78523a-3bf2-424d-80c8-745beaf50294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_abd82ddc-f77e-44b8-83d5-127f21069a3e" xlink:to="loc_us-gaap_CorporateJointVentureMember_7b78523a-3bf2-424d-80c8-745beaf50294" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended" id="i784f622d5d1d4599b86aa87c992edd70_IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended" id="i1b8dd2bfddf241c6b523b39bf0b75073_IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i323156b05ac34a8d9fcb5cd6e320f2f4_IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended" id="ieb30d7f2c0fd4c0dad45f2d63de4774c_RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended" id="i4bc4bd44715445f8ad3321b304420b75_RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="i11f511fddcd24c448a87a9425f21d1c4_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_ff3d32dd-7403-48b8-a963-60dbf8b57f65" xlink:href="mck-20210331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_ff3d32dd-7403-48b8-a963-60dbf8b57f65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_a9b5fc8a-a92a-4b18-a373-5aa1ef359922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_a9b5fc8a-a92a-4b18-a373-5aa1ef359922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_bb35065a-3089-4880-9635-8a677227d642" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_bb35065a-3089-4880-9635-8a677227d642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_b4f3845a-50bd-4470-a76b-9b5386920adf" xlink:href="mck-20210331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_PutRightValueInterestRateSpread_b4f3845a-50bd-4470-a76b-9b5386920adf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_1ae1609d-1abf-4571-b89c-9f3c79b1bf3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_1ae1609d-1abf-4571-b89c-9f3c79b1bf3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bcf0f385-665c-43f1-b72d-51ed54c399d3" xlink:href="mck-20210331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bcf0f385-665c-43f1-b72d-51ed54c399d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c22b2eb0-729f-4c03-b75e-de8964c90cbe" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c22b2eb0-729f-4c03-b75e-de8964c90cbe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f32ca133-c73e-4742-bd59-8c77a812b960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f32ca133-c73e-4742-bd59-8c77a812b960" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_9d65c833-2d68-49ec-8f8e-c281710b1fac" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_9d65c833-2d68-49ec-8f8e-c281710b1fac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_16f0e98c-6cfb-4af1-86c0-2dbbd76b8a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_16f0e98c-6cfb-4af1-86c0-2dbbd76b8a96" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_8cc58142-bc98-47f2-b1ed-8111b42cba43" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_8cc58142-bc98-47f2-b1ed-8111b42cba43" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_26876cba-f47a-4a58-8686-f65e70efa499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_MinorityInterest_26876cba-f47a-4a58-8686-f65e70efa499" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4531cd64-fb96-4b65-b927-cf20b0602e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4531cd64-fb96-4b65-b927-cf20b0602e01" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ccab207a-c571-49cd-a1bd-39d6ee494595_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ccab207a-c571-49cd-a1bd-39d6ee494595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_36828319-7e0a-4746-8d39-3a380260aba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_36828319-7e0a-4746-8d39-3a380260aba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_827ba79f-3eb5-41d4-b3bd-dc3a670065fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_36828319-7e0a-4746-8d39-3a380260aba7" xlink:to="loc_us-gaap_SubsequentEventMember_827ba79f-3eb5-41d4-b3bd-dc3a670065fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2616afb1-08df-45f2-868d-6f64b3d84c5a_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:to="loc_dei_EntityDomain_2616afb1-08df-45f2-868d-6f64b3d84c5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_35e68d03-1a54-46be-b04c-2a5266633257" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:to="loc_dei_EntityDomain_35e68d03-1a54-46be-b04c-2a5266633257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_b86ef966-07c4-4775-ae73-d439f493a328" xlink:href="mck-20210331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_35e68d03-1a54-46be-b04c-2a5266633257" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_b86ef966-07c4-4775-ae73-d439f493a328" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9a10394-8756-4220-98ad-d353b9bf699b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:to="loc_srt_OwnershipDomain_a9a10394-8756-4220-98ad-d353b9bf699b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:to="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_5e2fca2a-4b83-4e69-81f4-58fe03164f4c" xlink:href="mck-20210331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_5e2fca2a-4b83-4e69-81f4-58fe03164f4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_706e00dd-3ebc-4218-8423-e4cbe13eecb2" xlink:href="mck-20210331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_706e00dd-3ebc-4218-8423-e4cbe13eecb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:to="loc_us-gaap_EquityComponentDomain_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:to="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_f6c2c453-d59b-4ca4-86a1-661df935ace7" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_f6c2c453-d59b-4ca4-86a1-661df935ace7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9c66f8aa-dd0f-4bef-8743-68be650600b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9c66f8aa-dd0f-4bef-8743-68be650600b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended" id="ib9a06aca1572449091c68c8e67e058d1_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_27e9f9ab-45a6-4bc3-852e-fdab069cbd77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_27e9f9ab-45a6-4bc3-852e-fdab069cbd77" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d4b492fd-b503-49e2-9317-e14c1d5563d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_MinorityInterest_d4b492fd-b503-49e2-9317-e14c1d5563d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_abf6cf9a-19eb-4ae5-8e13-216b6cd78634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_abf6cf9a-19eb-4ae5-8e13-216b6cd78634" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b74dd588-9ce2-4486-bd1a-52b7999f24d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b74dd588-9ce2-4486-bd1a-52b7999f24d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9bb1b6e9-fe68-4ae8-81c2-3107c620449b" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9bb1b6e9-fe68-4ae8-81c2-3107c620449b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f8c47fc8-fca9-4a54-9465-065be5cc7ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_112391b3-14ef-4bdf-92a7-33b2bbfe9fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_112391b3-14ef-4bdf-92a7-33b2bbfe9fae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_97495d5d-65a7-498e-95bb-011947157290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_97495d5d-65a7-498e-95bb-011947157290" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_03dc9eb7-b98a-4ec8-96eb-ea4dd6f59f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_98d8504b-21cd-4b59-a835-de282cb77709" xlink:href="mck-20210331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_98d8504b-21cd-4b59-a835-de282cb77709" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4523cda7-8688-48e4-9a69-0ad0783a7e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4523cda7-8688-48e4-9a69-0ad0783a7e03" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ea5af0ac-4581-49d8-9e8f-014c44f525f6" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ea5af0ac-4581-49d8-9e8f-014c44f525f6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e570b4bc-86e6-413a-af26-89bdaec0ce76" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_9b9a70d0-cd80-4fe2-984b-bd74da7c26b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_27e9f9ab-45a6-4bc3-852e-fdab069cbd77" xlink:to="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_79915d23-b42e-443f-a746-bdfbe7192df7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:to="loc_us-gaap_EquityComponentDomain_79915d23-b42e-443f-a746-bdfbe7192df7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:to="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c0627543-7385-4835-8d28-3ea3718c10fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c0627543-7385-4835-8d28-3ea3718c10fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_33cd8ba3-cd30-49bb-ac5a-b19c00aa460c" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_33cd8ba3-cd30-49bb-ac5a-b19c00aa460c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShare"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="extended" id="ic531e68656fc4a72859c48b897d57884_EarningsperCommonShare"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="extended" id="iecb04ede1d144a9cb207ac093b349c2d_EarningsperCommonShareTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended" id="if5bfaa61c91c451a9e07d2c85ed49fed_EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="extended" id="i835aafa6510641f79c1f274bbdc6d9a0_EarningsperCommonShareNarrativeDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/Leases" xlink:type="simple" xlink:href="mck-20210331.xsd#Leases"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/Leases" xlink:type="extended" id="iba08f44585844ca190aaba6ead53b90c_Leases"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesTables" xlink:type="extended" id="iae2353d0c103445eabdb97e75bd6ada1_LeasesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended" id="if6d5f4d2e68d483cbe053ec624c249ed_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4b95ccb3-1bc8-45bf-aa1b-f63d0efad667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_OperatingLeaseLiability_4b95ccb3-1bc8-45bf-aa1b-f63d0efad667" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_15e48107-7546-48af-9f4e-68bfc79afd64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_15e48107-7546-48af-9f4e-68bfc79afd64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a608ac59-9753-4379-afd7-af36f5081ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a608ac59-9753-4379-afd7-af36f5081ca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseImpairmentLossNetOfTax_87953e59-0e89-46dc-8ba6-74f23dcb83ab" xlink:href="mck-20210331.xsd#mck_OperatingLeaseImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_OperatingLeaseImpairmentLossNetOfTax_87953e59-0e89-46dc-8ba6-74f23dcb83ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d1928642-71af-4990-822e-94c9cb9a0e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d1928642-71af-4990-822e-94c9cb9a0e68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_802dbd70-5780-4309-9cfa-5073512d169a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_802dbd70-5780-4309-9cfa-5073512d169a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_f96265fa-5016-4fff-94b3-6ee2f1b2ada6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_f96265fa-5016-4fff-94b3-6ee2f1b2ada6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived_d5134380-0671-4c11-8ef9-8398828f74eb" xlink:href="mck-20210331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_LessorLeasePaymentstobeReceived_d5134380-0671-4c11-8ef9-8398828f74eb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6170ab98-335e-4468-bcb3-cd0345a32832" xlink:href="mck-20210331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6170ab98-335e-4468-bcb3-cd0345a32832" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_d8e2f33f-775d-4063-a090-731a09292444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_d8e2f33f-775d-4063-a090-731a09292444" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_4a35c00d-b296-4bbb-b5cb-40ea45019e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_4a35c00d-b296-4bbb-b5cb-40ea45019e6f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_fedd4097-b1a1-4532-af6b-ae268211c902" xlink:href="mck-20210331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_fedd4097-b1a1-4532-af6b-ae268211c902" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d4e7179b-9291-40bb-91b5-9d9c3effbf8c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:to="loc_us-gaap_EquityComponentDomain_d4e7179b-9291-40bb-91b5-9d9c3effbf8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7107c0d8-5d3b-43f5-8cb7-cb946f069120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:to="loc_us-gaap_EquityComponentDomain_7107c0d8-5d3b-43f5-8cb7-cb946f069120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_05793058-e623-497d-a562-e3c98dc497f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7107c0d8-5d3b-43f5-8cb7-cb946f069120" xlink:to="loc_us-gaap_RetainedEarningsMember_05793058-e623-497d-a562-e3c98dc497f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f35c1bbd-15c7-4b85-b78f-ce3eb91bb407" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f35c1bbd-15c7-4b85-b78f-ce3eb91bb407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34f43865-2c83-4cbe-a7ec-645789bdc8d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f35c1bbd-15c7-4b85-b78f-ce3eb91bb407" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34f43865-2c83-4cbe-a7ec-645789bdc8d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44efb7f9-0212-4117-bf3a-40b983c21371_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:to="loc_srt_RangeMember_44efb7f9-0212-4117-bf3a-40b983c21371_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:to="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cdda109e-0d80-4378-8ddf-74a17863093b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:to="loc_srt_MinimumMember_cdda109e-0d80-4378-8ddf-74a17863093b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6e713579-d4a5-4470-84bf-2b2ef0a4b5ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:to="loc_srt_MaximumMember_6e713579-d4a5-4470-84bf-2b2ef0a4b5ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8e7334dd-a462-419f-84da-008827966c0f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8e7334dd-a462-419f-84da-008827966c0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_19d363b3-87ea-429e-848b-a1150fb9d6de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:to="loc_us-gaap_BuildingMember_19d363b3-87ea-429e-848b-a1150fb9d6de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_87d25e74-11e4-4847-acaf-15ca0a1feb97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:to="loc_us-gaap_EquipmentMember_87d25e74-11e4-4847-acaf-15ca0a1feb97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember_68d74acb-67cf-42c9-9436-b81fcb1da54e" xlink:href="mck-20210331.xsd#mck_RealPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:to="loc_mck_RealPropertyMember_68d74acb-67cf-42c9-9436-b81fcb1da54e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesSupplementalbalancesheetinformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="extended" id="i13dbbd5c7bb544a891ca08f395c13e5b_LeasesSupplementalbalancesheetinformationDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended" id="i6b7fb5b68e4f42c4aa7988ee411cba46_LeasesComponentsofleasecostsDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesSupplementalcashflowinformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="extended" id="ia3e83b21ef474d75b6ff470524007825_LeasesSupplementalcashflowinformationDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="extended" id="i5b599567f30341939e76e44959e8dacd_LeasesMaturitiesofleaseliabilitiesDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended" id="i6c5537fa4633482da88c2ab39ebad689_GoodwillandIntangibleAssetsNet"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended" id="ibb9ccc66a87c4661b662e423ad4047af_GoodwillandIntangibleAssetsNetTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="i5e41d0dc73ab4945bebd6b469ec48c20_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_94dddefc-d63c-4d19-a21a-d94830dc3756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_94dddefc-d63c-4d19-a21a-d94830dc3756" xlink:to="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6e41f5ee-c229-456b-a5e0-c1128fea9ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_Goodwill_6e41f5ee-c229-456b-a5e0-c1128fea9ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6b177134-b9bc-4746-87e0-d20037655062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6b177134-b9bc-4746-87e0-d20037655062" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5f71721c-8abe-4375-b2e0-c2bf2047d5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5f71721c-8abe-4375-b2e0-c2bf2047d5be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_11879876-80a4-4c97-8aa9-2c23e11a3539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_11879876-80a4-4c97-8aa9-2c23e11a3539" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d210d981-db85-4a0f-a35e-05d910333683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d210d981-db85-4a0f-a35e-05d910333683" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b6a4be83-75db-4085-b16e-10684abfad85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b6a4be83-75db-4085-b16e-10684abfad85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa145ca7-d886-4c59-a19a-2f4215d0b1ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_94dddefc-d63c-4d19-a21a-d94830dc3756" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4a2c355-d753-43f9-b770-3ede08321f02_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:to="loc_us-gaap_SegmentDomain_e4a2c355-d753-43f9-b770-3ede08321f02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:to="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_bfc48387-434d-4fc2-857f-f1ef780a1b31" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_USPharmaceuticalSegmentMember_bfc48387-434d-4fc2-857f-f1ef780a1b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_3ca46f73-0d4b-4cae-8fa2-19e6b1958bfe" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_InternationalSegmentMember_3ca46f73-0d4b-4cae-8fa2-19e6b1958bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_87812f87-0f0a-486c-8f6e-30cf2afd297b" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_87812f87-0f0a-486c-8f6e-30cf2afd297b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e16702e6-4c08-439c-aec0-cb5ac95e9091" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e16702e6-4c08-439c-aec0-cb5ac95e9091" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" xlink:type="extended" id="i9ee6cc92b6e6436288fb34a502c30fe1_GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_56ba21fd-4197-472f-a67f-e3fba6689b03" xlink:href="mck-20210331.xsd#mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_56ba21fd-4197-472f-a67f-e3fba6689b03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_2d966ea1-f2f9-4653-8f56-89d8c47b1c93" xlink:href="mck-20210331.xsd#mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_2d966ea1-f2f9-4653-8f56-89d8c47b1c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_bb0fcf54-b320-4df3-a3e9-6ab0f221b640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_bb0fcf54-b320-4df3-a3e9-6ab0f221b640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9684779c-d694-43ba-a1e4-7c6de31a1437_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:to="loc_us-gaap_SegmentDomain_9684779c-d694-43ba-a1e4-7c6de31a1437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5202f990-e0f7-4c56-b96f-bf8694d73e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:to="loc_us-gaap_SegmentDomain_5202f990-e0f7-4c56-b96f-bf8694d73e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_149d2719-0375-4554-8265-b702618a2521" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5202f990-e0f7-4c56-b96f-bf8694d73e1e" xlink:to="loc_mck_InternationalSegmentMember_149d2719-0375-4554-8265-b702618a2521" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:to="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_c982e4f2-c706-4172-9c2f-7b44b1aaa293_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:to="loc_us-gaap_ReportingUnitDomain_c982e4f2-c706-4172-9c2f-7b44b1aaa293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:to="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_709e2861-14f9-4f7c-bea3-87585088c14d" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_709e2861-14f9-4f7c-bea3-87585088c14d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_7cdd8b75-37a7-4fe7-84ec-c5ade3d1e366" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_7cdd8b75-37a7-4fe7-84ec-c5ade3d1e366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_35f85515-e641-467d-b77e-e79b2b427344" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_35f85515-e641-467d-b77e-e79b2b427344" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitMember_6bba534f-9ab4-4e7c-9c4a-75751e0f1af6" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_PharmaceuticalDistributionsReportingUnitMember_6bba534f-9ab4-4e7c-9c4a-75751e0f1af6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_11d84474-ca04-440a-b555-cac923849f0b" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_RexallHealthMember_11d84474-ca04-440a-b555-cac923849f0b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended" id="i632a093a7e214062adbd6e7f45320d0d_GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_36d00e4a-a023-40e4-ba1c-5c982056b74d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_NumberOfReportableSegments_36d00e4a-a023-40e4-ba1c-5c982056b74d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_52c1aa12-3cfc-4b5b-84e1-0ec4484ef10b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_52c1aa12-3cfc-4b5b-84e1-0ec4484ef10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_243196a0-d93f-41cf-acdd-e463de99d777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_Goodwill_243196a0-d93f-41cf-acdd-e463de99d777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairmentLossTax_46382db7-b192-4cf7-b5b6-d6e0e1dca7b1" xlink:href="mck-20210331.xsd#mck_GoodwillImpairmentLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_mck_GoodwillImpairmentLossTax_46382db7-b192-4cf7-b5b6-d6e0e1dca7b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_535349e1-e4df-421a-8c46-feb1d8aac8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_NumberOfReportingUnits_535349e1-e4df-421a-8c46-feb1d8aac8f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d4d7bbe1-8752-4bdd-b7a2-6140fdae33fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d4d7bbe1-8752-4bdd-b7a2-6140fdae33fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_098cc8e8-de20-4a6f-bd1c-2e83051c0d70_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:to="loc_us-gaap_ReportingUnitDomain_098cc8e8-de20-4a6f-bd1c-2e83051c0d70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:to="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_530af15c-b7c7-4a5c-9178-c0a3f51bddee" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_530af15c-b7c7-4a5c-9178-c0a3f51bddee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_563c2f7b-1b7e-4a8b-8ce9-f16215d070db" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:to="loc_mck_RexallHealthMember_563c2f7b-1b7e-4a8b-8ce9-f16215d070db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4ebda52a-a6fe-4082-9894-b833ad32f114_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:to="loc_us-gaap_SegmentDomain_4ebda52a-a6fe-4082-9894-b833ad32f114_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:to="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_d7e91cc6-b450-4d28-a08d-2bdf8e117e4c" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:to="loc_mck_InternationalSegmentMember_d7e91cc6-b450-4d28-a08d-2bdf8e117e4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanPharmaceuticalSolutionsMember_c354b169-b1f9-4b32-a258-2f5bcb3870ab" xlink:href="mck-20210331.xsd#mck_EuropeanPharmaceuticalSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:to="loc_mck_EuropeanPharmaceuticalSolutionsMember_c354b169-b1f9-4b32-a258-2f5bcb3870ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d9a520e3-89bd-49c3-8677-8a4272c896fb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:to="loc_srt_SegmentGeographicalDomain_d9a520e3-89bd-49c3-8677-8a4272c896fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4a633b6a-42db-4f2f-ae34-62f160eaf167" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:to="loc_srt_SegmentGeographicalDomain_4a633b6a-42db-4f2f-ae34-62f160eaf167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_39ff0984-0fbc-42a5-8a8f-28bdd4859425" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4a633b6a-42db-4f2f-ae34-62f160eaf167" xlink:to="loc_srt_EuropeMember_39ff0984-0fbc-42a5-8a8f-28bdd4859425" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="i23cb8200a97b4d89b7afb55e36144e37_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_94d3f7a0-8005-41f9-bf71-20a02847e6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_94d3f7a0-8005-41f9-bf71-20a02847e6e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc550c82-6abc-4cce-8bd9-38b2edc8038e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc550c82-6abc-4cce-8bd9-38b2edc8038e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e2426684-40f8-469b-95d9-f8885c3aa2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e2426684-40f8-469b-95d9-f8885c3aa2f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b7e6ef99-8f31-4dff-a896-ca64d4b35f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b7e6ef99-8f31-4dff-a896-ca64d4b35f39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_05944082-4b80-419a-b776-53b29fcefb95_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_05944082-4b80-419a-b776-53b29fcefb95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a60de79a-2970-467d-a98d-24c9ae680bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a60de79a-2970-467d-a98d-24c9ae680bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_11a45994-92c2-438a-abb4-962b5d6d6a98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_ServiceAgreementsMember_11a45994-92c2-438a-abb4-962b5d6d6a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_85a7edd7-03bd-454f-88a2-0b13178dd732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_LicensingAgreementsMember_85a7edd7-03bd-454f-88a2-0b13178dd732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_ac141d09-4576-4a10-a64d-6ce45bc14a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_ac141d09-4576-4a10-a64d-6ce45bc14a8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55373ac6-b2f8-4064-8c17-f17cb80f9ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55373ac6-b2f8-4064-8c17-f17cb80f9ecf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_942c62a1-d935-4bd1-bfe1-7f1eee899e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_942c62a1-d935-4bd1-bfe1-7f1eee899e47" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="extended" id="iba7feee7cc304c60be37cee2c6513d1b_GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended" id="i6f797692c6244fa2a8f35867efb0e4e4_DebtandFinancingActivities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended" id="i973f4330de3c462cadd8c3bb66a30c80_DebtandFinancingActivitiesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i924615489cf94f208d14ad556654f8cc_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5277bc69-ab44-4dba-84a6-383e64861f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5277bc69-ab44-4dba-84a6-383e64861f1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f3ecb3d3-a9a5-442b-acd4-3c97e647595a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_LongTermDebt_f3ecb3d3-a9a5-442b-acd4-3c97e647595a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c0fd7160-d202-47f1-860e-f809361abfc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c0fd7160-d202-47f1-860e-f809361abfc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_38b2efd6-1fcc-44a7-a3bc-097c17600a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_38b2efd6-1fcc-44a7-a3bc-097c17600a30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_39dd8579-d6ca-4a12-8bd9-5299c2534a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_38086372-f1a5-4547-bc95-160188a5adad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_38086372-f1a5-4547-bc95-160188a5adad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_3aba9256-7cdf-450c-8cf2-2dabd7eb236c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:to="loc_us-gaap_LoansPayableMember_3aba9256-7cdf-450c-8cf2-2dabd7eb236c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember_14711825-d9cf-4e6e-94b4-7f3e5abd238b" xlink:href="mck-20210331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:to="loc_mck_LeaseandOtherObligationsMember_14711825-d9cf-4e6e-94b4-7f3e5abd238b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:to="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da87de8d-ba5c-4832-8098-a5107ecf3990_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da87de8d-ba5c-4832-8098-a5107ecf3990_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_5c82f2f7-27c2-4a5f-80fe-f3e1a5b0b6ef" xlink:href="mck-20210331.xsd#mck_NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_NotesDueNovember302020Member_5c82f2f7-27c2-4a5f-80fe-f3e1a5b0b6ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_0bbc1dbc-6c6a-4920-a64e-a87cd926f410" xlink:href="mck-20210331.xsd#mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_0bbc1dbc-6c6a-4920-a64e-a87cd926f410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_6def93b3-16eb-4392-98c9-a3f7994a5244" xlink:href="mck-20210331.xsd#mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_6def93b3-16eb-4392-98c9-a3f7994a5244" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_7b4c4700-4110-4a45-bea2-b8341d329854" xlink:href="mck-20210331.xsd#mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_7b4c4700-4110-4a45-bea2-b8341d329854" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_410cb05e-61cb-4a5e-aa80-8138bb083a0c" xlink:href="mck-20210331.xsd#mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_410cb05e-61cb-4a5e-aa80-8138bb083a0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_722cf562-e1bd-4f60-aca1-47788ef7f00a" xlink:href="mck-20210331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_A090NotesDueDecember32025Member_722cf562-e1bd-4f60-aca1-47788ef7f00a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_8b4d279a-deff-47b2-9c01-fdd1a652d9b8" xlink:href="mck-20210331.xsd#mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_8b4d279a-deff-47b2-9c01-fdd1a652d9b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_4efac4e9-318f-4419-b3ba-22aea715590d" xlink:href="mck-20210331.xsd#mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_4efac4e9-318f-4419-b3ba-22aea715590d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueMay302029Member_d23fd81f-d7dd-4349-97a6-beba119849fe" xlink:href="mck-20210331.xsd#mck_NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_NotesDueMay302029Member_d23fd81f-d7dd-4349-97a6-beba119849fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_fcfbbf09-a072-4bce-b0e8-3a27d0a6628c" xlink:href="mck-20210331.xsd#mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_fcfbbf09-a072-4bce-b0e8-3a27d0a6628c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_eb767dab-c554-4db5-83ab-6cac0e27cb95" xlink:href="mck-20210331.xsd#mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_eb767dab-c554-4db5-83ab-6cac0e27cb95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_747ecf96-fa94-4dcb-857d-923880ac3b5e" xlink:href="mck-20210331.xsd#mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_747ecf96-fa94-4dcb-857d-923880ac3b5e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_bda4d51a-499f-4521-9b1c-2981f68076f4" xlink:href="mck-20210331.xsd#mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_bda4d51a-499f-4521-9b1c-2981f68076f4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_b707f999-abde-43d9-8474-059e2ffd5361" xlink:href="mck-20210331.xsd#mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_b707f999-abde-43d9-8474-059e2ffd5361" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_1341bc02-8e92-4870-853c-7f3fc22adc55" xlink:href="mck-20210331.xsd#mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_1341bc02-8e92-4870-853c-7f3fc22adc55" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended" id="i09e01ef52c2d487abed42441269da1ec_DebtandFinancingActivitiesLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_44c8c9cb-cef4-4b24-ab15-674ce3abcf2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebt_44c8c9cb-cef4-4b24-ab15-674ce3abcf2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12192206-5502-4556-a85b-dfd108202153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12192206-5502-4556-a85b-dfd108202153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cb29d13a-9036-462d-be12-28e7cc24154d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cb29d13a-9036-462d-be12-28e7cc24154d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f23f3871-d0da-4ed7-b344-cb455d7760d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f23f3871-d0da-4ed7-b344-cb455d7760d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f43f54a0-919e-4265-86b5-5f612f1ef0e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f43f54a0-919e-4265-86b5-5f612f1ef0e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc9f66c8-f5f3-4777-a218-8c08df36ce1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc9f66c8-f5f3-4777-a218-8c08df36ce1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_dc1a250a-b40c-45c7-ab3d-81e6615cccb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_dc1a250a-b40c-45c7-ab3d-81e6615cccb7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d5c985ab-d2d0-4a17-b92a-f0b0449a8532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d5c985ab-d2d0-4a17-b92a-f0b0449a8532" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019a2bf2-350f-4bd8-b9f2-2feec0a517e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019a2bf2-350f-4bd8-b9f2-2feec0a517e2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_67bd53fe-9690-42ac-886f-b510182408d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_67bd53fe-9690-42ac-886f-b510182408d4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c5cabdd5-9082-4df3-a26d-f2278c10ed06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c5cabdd5-9082-4df3-a26d-f2278c10ed06" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_70f2a28d-e9dc-41af-ba77-64336fbe0f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_70f2a28d-e9dc-41af-ba77-64336fbe0f3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b879a831-4dbf-484f-a876-04042bc8fab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b879a831-4dbf-484f-a876-04042bc8fab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LongtermDebtCurrentMaturitiesMember_f7064ef8-6071-42e6-948f-3c8b40b0c6e8" xlink:href="mck-20210331.xsd#mck_LongtermDebtCurrentMaturitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b879a831-4dbf-484f-a876-04042bc8fab4" xlink:to="loc_mck_LongtermDebtCurrentMaturitiesMember_f7064ef8-6071-42e6-948f-3c8b40b0c6e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e521623e-af07-4cf3-b611-e3076e35bd64_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e521623e-af07-4cf3-b611-e3076e35bd64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_643a00ce-e2ad-42cf-ae31-8ad40ce5425f" xlink:href="mck-20210331.xsd#mck_NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_NotesDueNovember302020Member_643a00ce-e2ad-42cf-ae31-8ad40ce5425f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueMay302029Member_062e045a-e0cc-4472-b978-d1fa365996de" xlink:href="mck-20210331.xsd#mck_NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_NotesDueMay302029Member_062e045a-e0cc-4472-b978-d1fa365996de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_f85706d1-c5bd-422f-a64d-6b72ff7fc56d" xlink:href="mck-20210331.xsd#mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_f85706d1-c5bd-422f-a64d-6b72ff7fc56d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_e6ac99ab-b6b5-445a-bbf5-83a7122b0a05" xlink:href="mck-20210331.xsd#mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_e6ac99ab-b6b5-445a-bbf5-83a7122b0a05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_10a1f1b7-a133-4d28-8a2d-da2a61ecb26e" xlink:href="mck-20210331.xsd#mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_10a1f1b7-a133-4d28-8a2d-da2a61ecb26e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_c59ff969-0732-48a3-b9a3-389c3b3d7686" xlink:href="mck-20210331.xsd#mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_c59ff969-0732-48a3-b9a3-389c3b3d7686" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_3f666abf-29fc-4d80-b4eb-616851007970" xlink:href="mck-20210331.xsd#mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_3f666abf-29fc-4d80-b4eb-616851007970" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_f4a1749a-97d6-4aa3-ac8f-3bff0ea6878d" xlink:href="mck-20210331.xsd#mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_f4a1749a-97d6-4aa3-ac8f-3bff0ea6878d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_eceb11a3-6728-400c-a0be-1ffe0e683425" xlink:href="mck-20210331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_A090NotesDueDecember32025Member_eceb11a3-6728-400c-a0be-1ffe0e683425" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_ad758842-9724-473e-9a76-ad5f332eea72" xlink:href="mck-20210331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_A475NotesDueMarch12021Member_ad758842-9724-473e-9a76-ad5f332eea72" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2cc7c026-1279-4697-82e8-9ad13b679969_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2cc7c026-1279-4697-82e8-9ad13b679969_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_6c28b995-5fee-4b16-9606-2b2830cf1808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_6c28b995-5fee-4b16-9606-2b2830cf1808" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_0783f306-377d-4447-a815-0ab66f4a437f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:to="loc_us-gaap_LoansPayableMember_0783f306-377d-4447-a815-0ab66f4a437f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="i0e84cc385c1e470f8d169ae0a251e347_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5f6b3e-a38b-453b-8e56-76af5decab21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5f6b3e-a38b-453b-8e56-76af5decab21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_f4666285-b7c0-4172-a89e-0d186e9d7fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_DebtInstrumentTerm_f4666285-b7c0-4172-a89e-0d186e9d7fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_a1f2ea7b-7c47-4104-907a-f683ee9f3b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_a1f2ea7b-7c47-4104-907a-f683ee9f3b85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9c482c9b-88f1-44c6-b62f-1c2a6658452c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCredit_9c482c9b-88f1-44c6-b62f-1c2a6658452c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_1a224265-0312-43c9-a0b6-e7d6a743cbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_1a224265-0312-43c9-a0b6-e7d6a743cbc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1333c951-3dde-4193-a595-83d3e3294ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1333c951-3dde-4193-a595-83d3e3294ed6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3a820d81-d8da-43ce-ad69-3c2204cadecd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3a820d81-d8da-43ce-ad69-3c2204cadecd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_61c9641c-bef2-48a8-91fb-752747b1382d" xlink:href="mck-20210331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_61c9641c-bef2-48a8-91fb-752747b1382d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_91149741-c6ef-486c-b1ca-9b438dfa82e2" xlink:href="mck-20210331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_91149741-c6ef-486c-b1ca-9b438dfa82e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_50a49137-bb4e-4d33-8303-d671a7eeadaf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_50a49137-bb4e-4d33-8303-d671a7eeadaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c3259c3-53f2-49d5-b844-c535f094b218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c3259c3-53f2-49d5-b844-c535f094b218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_4feac82e-64f3-4378-a37d-32e517bea207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c3259c3-53f2-49d5-b844-c535f094b218" xlink:to="loc_us-gaap_UnsecuredDebtMember_4feac82e-64f3-4378-a37d-32e517bea207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c5e3e46b-ee2e-465a-8393-e0314dc7857e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:to="loc_us-gaap_CreditFacilityDomain_c5e3e46b-ee2e-465a-8393-e0314dc7857e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:to="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ecc7f1fc-95c4-429d-95bb-859508f062ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ecc7f1fc-95c4-429d-95bb-859508f062ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GlobalFacilityMember_02124203-cf9a-4959-b38a-adb1b62dad59" xlink:href="mck-20210331.xsd#mck_GlobalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:to="loc_mck_GlobalFacilityMember_02124203-cf9a-4959-b38a-adb1b62dad59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_fa71f65b-3cbe-42a0-8106-714023286762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:to="loc_us-gaap_LineOfCreditMember_fa71f65b-3cbe-42a0-8106-714023286762" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended" id="ie8701f93021f48ce946e9c14fae9bc6c_DebtandFinancingActivitiesCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03a1334b-8e53-4624-895e-b3c24bf6bbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03a1334b-8e53-4624-895e-b3c24bf6bbc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c732b7a2-1dc8-41d9-8e10-e78916cee849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c732b7a2-1dc8-41d9-8e10-e78916cee849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_4d444394-1523-48da-bd3b-61150e65e6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_4d444394-1523-48da-bd3b-61150e65e6a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a42491d9-38c4-40b1-913f-2eb628931350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_LongTermDebt_a42491d9-38c4-40b1-913f-2eb628931350" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:to="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3815e8cc-8b61-42bd-80da-c708c7f563ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:to="loc_us-gaap_CreditFacilityDomain_3815e8cc-8b61-42bd-80da-c708c7f563ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9ee8c1ad-6597-4fd3-93c8-5784f74f3ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:to="loc_us-gaap_CreditFacilityDomain_9ee8c1ad-6597-4fd3-93c8-5784f74f3ea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e7614123-79a4-435f-86ff-cf4e9cbfda05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9ee8c1ad-6597-4fd3-93c8-5784f74f3ea4" xlink:to="loc_us-gaap_CommercialPaperMember_e7614123-79a4-435f-86ff-cf4e9cbfda05" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="mck-20210331.xsd#VariableInterestEntities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/VariableInterestEntities" xlink:type="extended" id="i5df55f008ca54497a67e8a46d50f16e1_VariableInterestEntities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#VariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended" id="ifaa2dbac8be04027b6d7c6214544a8d9_VariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_959c4bd2-6aa9-4d1c-8fee-9f16b9e629a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_Assets_959c4bd2-6aa9-4d1c-8fee-9f16b9e629a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_017f29a7-2ff3-4ae9-ba54-acf7121539cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_Liabilities_017f29a7-2ff3-4ae9-ba54-acf7121539cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ef641fa2-a7b8-4036-ab96-ba98b21aace2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ef641fa2-a7b8-4036-ab96-ba98b21aace2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_31d6977f-6780-46ea-b833-e79952a8c0ce_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_31d6977f-6780-46ea-b833-e79952a8c0ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5c7f8372-4fd2-4988-bac3-4e1dfbfae777" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5c7f8372-4fd2-4988-bac3-4e1dfbfae777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_dfe87046-f644-4fb7-95d3-6b5e30182c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5c7f8372-4fd2-4988-bac3-4e1dfbfae777" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_dfe87046-f644-4fb7-95d3-6b5e30182c40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefits"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended" id="ic9624947bbf44da48a976b03c121c68b_PensionBenefits"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="extended" id="i1f2c937063794564846dfdee68cee752_PensionBenefitsTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="i6b390eb6996d4600a20da0b873443e35_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_230edef6-991a-43e8-beaf-bb29f3aeb39f" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_230edef6-991a-43e8-beaf-bb29f3aeb39f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_72bcd8c5-a6a1-4b26-905d-b10785c70794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_72bcd8c5-a6a1-4b26-905d-b10785c70794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_511fb23b-8104-44bc-b0b6-5f2315c1c031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_511fb23b-8104-44bc-b0b6-5f2315c1c031" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_f4e9406d-ec90-4a8d-887a-69910ef22e2c" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_f4e9406d-ec90-4a8d-887a-69910ef22e2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_00f1fc1c-f1ce-43c2-aab8-bcad639611db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_00f1fc1c-f1ce-43c2-aab8-bcad639611db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_33d9f615-c825-443f-8837-5a4e98e0eb5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_33d9f615-c825-443f-8837-5a4e98e0eb5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_26cd9aed-b47f-4d88-b9af-f00cc81c0828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_26cd9aed-b47f-4d88-b9af-f00cc81c0828" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_4473030c-3889-49da-9a92-0cdf0ceda8f3" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_4473030c-3889-49da-9a92-0cdf0ceda8f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b22b2df4-67d4-4f43-b018-f5ffb5fb979b" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b22b2df4-67d4-4f43-b018-f5ffb5fb979b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_6e758f3a-0472-43db-907a-c7eb5bbe27e0" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_6e758f3a-0472-43db-907a-c7eb5bbe27e0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_a4738c81-4977-4228-8bea-61c313f6e87b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_a4738c81-4977-4228-8bea-61c313f6e87b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_53d12a13-3ea2-442d-84cc-c8bfe3d52bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_53d12a13-3ea2-442d-84cc-c8bfe3d52bfe" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_f5f8eb82-1b84-4673-8fbf-7d6c91fb30f2" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_f5f8eb82-1b84-4673-8fbf-7d6c91fb30f2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8c24f78a-a984-476f-8281-62887411fdd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8c24f78a-a984-476f-8281-62887411fdd0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_2382280e-fa4c-4b3d-a7c4-a0460d5b7f99" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_2382280e-fa4c-4b3d-a7c4-a0460d5b7f99" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_095201d9-797f-43f3-baaf-aa2a8091cedf" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_095201d9-797f-43f3-baaf-aa2a8091cedf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f7877b75-1f81-474d-9711-1b8c082d37d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f7877b75-1f81-474d-9711-1b8c082d37d7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_b4c320d7-c882-485f-ad78-7aab2f50299a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_b4c320d7-c882-485f-ad78-7aab2f50299a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_519cb9d5-f5c3-4a27-89c4-e9cda29c0903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_519cb9d5-f5c3-4a27-89c4-e9cda29c0903" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_824e1c78-7b2d-48d1-a42a-bead5ee50a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_824e1c78-7b2d-48d1-a42a-bead5ee50a7a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_68e412bc-9784-428a-9581-976bcf79b926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_68e412bc-9784-428a-9581-976bcf79b926" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e3527a1d-be30-4456-adf3-f2942d2b4ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e3527a1d-be30-4456-adf3-f2942d2b4ca8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e145cdc-6b55-45a3-976e-53d85b76d950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e145cdc-6b55-45a3-976e-53d85b76d950" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bb31cc39-6c5b-403f-b77d-722894dd2e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bb31cc39-6c5b-403f-b77d-722894dd2e6e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7fe9e19c-532d-47b3-ada7-66682f5a974c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7fe9e19c-532d-47b3-ada7-66682f5a974c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_ccb88662-50c6-4389-a040-fa685719f540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_ccb88662-50c6-4389-a040-fa685719f540" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_5068216a-574b-41da-aaa9-2344c25dcbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_175ea172-68ef-421c-8393-91a4170854a6" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_175ea172-68ef-421c-8393-91a4170854a6" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents_3c4690ff-ead2-4648-b9ad-f533fefd02ef" xlink:href="mck-20210331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_UnitValueOfCashAndCashEquivalents_3c4690ff-ead2-4648-b9ad-f533fefd02ef" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_d7c82d17-9a07-4cac-b9d5-9e5e2e056594" xlink:href="mck-20210331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_d7c82d17-9a07-4cac-b9d5-9e5e2e056594" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_fa29d77d-ab31-4f83-acc3-755f052fac3d" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_fa29d77d-ab31-4f83-acc3-755f052fac3d" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage_2ce087c9-d8ef-40a1-abbc-d58f0dfea91c" xlink:href="mck-20210331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_MultiemployerPlanFundedStatusPercentage_2ce087c9-d8ef-40a1-abbc-d58f0dfea91c" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_af5826db-56a6-45fc-bcdc-4e66117eb8a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_af5826db-56a6-45fc-bcdc-4e66117eb8a6" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9f49adc5-f082-4a97-814d-a959a0bcf222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9f49adc5-f082-4a97-814d-a959a0bcf222" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_bf3fd086-c40a-4d2c-bfc8-991cd8452a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_bf3fd086-c40a-4d2c-bfc8-991cd8452a27" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions_f062f2bc-8e83-4313-a900-40a47d057b09" xlink:href="mck-20210331.xsd#mck_EmployeeContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_EmployeeContributions_f062f2bc-8e83-4313-a900-40a47d057b09" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_7b63122d-0e99-4fa4-bd59-c5f23a1953bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_7b63122d-0e99-4fa4-bd59-c5f23a1953bd" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4338dbac-1c6a-430b-b706-b4b4cb5a73de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_4338dbac-1c6a-430b-b706-b4b4cb5a73de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_72c8d7c8-04c1-4d15-8b51-03c6c933d512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_72c8d7c8-04c1-4d15-8b51-03c6c933d512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_72c8d7c8-04c1-4d15-8b51-03c6c933d512" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_4f0d81de-6ed2-4c6e-a37f-c6b621d42928" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_4f0d81de-6ed2-4c6e-a37f-c6b621d42928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_671d1f76-e791-4de4-b1c4-ba252c819f04" xlink:href="mck-20210331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_671d1f76-e791-4de4-b1c4-ba252c819f04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_817d963b-b202-474f-a372-03558aae7862_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:to="loc_us-gaap_RelatedPartyDomain_817d963b-b202-474f-a372-03558aae7862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_801d9f43-223a-465c-93fb-036ee7452236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:to="loc_us-gaap_RelatedPartyDomain_801d9f43-223a-465c-93fb-036ee7452236" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_560955d5-f026-45c9-9ce9-881744e28d62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_801d9f43-223a-465c-93fb-036ee7452236" xlink:to="loc_srt_ExecutiveOfficerMember_560955d5-f026-45c9-9ce9-881744e28d62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ebd5b49a-7733-4594-9be8-457ecd3f2339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:to="loc_us-gaap_DomesticPlanMember_ebd5b49a-7733-4594-9be8-457ecd3f2339" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1e4db7be-6fcc-4dea-b3db-8b38029ce64e" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_ebd5b49a-7733-4594-9be8-457ecd3f2339" xlink:to="loc_country_US_1e4db7be-6fcc-4dea-b3db-8b38029ce64e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4364af51-a854-482f-b924-a7afc79f25dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:to="loc_us-gaap_ForeignPlanMember_4364af51-a854-482f-b924-a7afc79f25dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_732c0cfc-8dc5-4f0c-9656-682d0912014b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_732c0cfc-8dc5-4f0c-9656-682d0912014b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fcc18d9d-c49a-4dc3-8ed8-11dc76c00d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fcc18d9d-c49a-4dc3-8ed8-11dc76c00d14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b1f6d127-b7fa-49ac-8cab-a8f1c65b66a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fcc18d9d-c49a-4dc3-8ed8-11dc76c00d14" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b1f6d127-b7fa-49ac-8cab-a8f1c65b66a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_8bc85901-c99b-42a1-b46a-d194c10f5542_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_8bc85901-c99b-42a1-b46a-d194c10f5542_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_b128696d-0251-418c-bbe4-6e77bd97a583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_b128696d-0251-418c-bbe4-6e77bd97a583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_43f23b40-9ead-4ff1-b0f4-3a5a89f5d7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_b128696d-0251-418c-bbe4-6e77bd97a583" xlink:to="loc_us-gaap_UnfundedPlanMember_43f23b40-9ead-4ff1-b0f4-3a5a89f5d7fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a0f30606-dd92-4eda-86e5-0d43ae53d6fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a0f30606-dd92-4eda-86e5-0d43ae53d6fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d2be7524-fbb1-4ea9-8e55-119d36cb8e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d2be7524-fbb1-4ea9-8e55-119d36cb8e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2be0fb91-e556-4143-94c1-d2c0179b7675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d2be7524-fbb1-4ea9-8e55-119d36cb8e3b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2be0fb91-e556-4143-94c1-d2c0179b7675" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_b591c238-b645-4ad6-8cc8-31df55cc6db1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:to="loc_us-gaap_RetirementPlanNameDomain_b591c238-b645-4ad6-8cc8-31df55cc6db1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_aee89eaf-8d4b-4157-b49b-48702e30bd3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:to="loc_us-gaap_RetirementPlanNameDomain_aee89eaf-8d4b-4157-b49b-48702e30bd3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember_c32f0562-abdb-4205-a73d-9e9ab3576b10" xlink:href="mck-20210331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_aee89eaf-8d4b-4157-b49b-48702e30bd3e" xlink:to="loc_mck_NorwegianPublicServicePensionFundSPKMember_c32f0562-abdb-4205-a73d-9e9ab3576b10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_f575ad5c-21f5-4f1c-9b57-00db88b02a35_default" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_f575ad5c-21f5-4f1c-9b57-00db88b02a35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember_d5f84925-326f-4c23-a5d9-81ae41f887f1" xlink:href="mck-20210331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:to="loc_mck_FirstPartOfPayContributionMember_d5f84925-326f-4c23-a5d9-81ae41f887f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember_0e55b5d6-eaff-4cb3-856e-1a47f414816e" xlink:href="mck-20210331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:to="loc_mck_SecondPartOfPayContributionMember_0e55b5d6-eaff-4cb3-856e-1a47f414816e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75e98985-fada-4d03-9e5b-703089254d43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75e98985-fada-4d03-9e5b-703089254d43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f4a4752-9afc-438d-93a2-046e43d31b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f4a4752-9afc-438d-93a2-046e43d31b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_8662d01b-65e3-492c-8e40-07f0c51b1159" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f4a4752-9afc-438d-93a2-046e43d31b89" xlink:to="loc_mck_GermanWholesaleBusinessMember_8662d01b-65e3-492c-8e40-07f0c51b1159" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended" id="i48fcd7a05abc4f609519373c96da9b54_PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_cf786c92-e290-4b47-8d16-eec6d8bbfab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_cf786c92-e290-4b47-8d16-eec6d8bbfab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b712cef1-12c0-402b-8458-8296a9399f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b712cef1-12c0-402b-8458-8296a9399f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f75221e7-fabe-4923-8691-b006c01e5d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f75221e7-fabe-4923-8691-b006c01e5d3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_f0158c2f-7fbb-49dd-99aa-3cda5b05b1b1" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_f0158c2f-7fbb-49dd-99aa-3cda5b05b1b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4d06b31e-3350-4eab-b5e0-fda7c9c9b5bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4d06b31e-3350-4eab-b5e0-fda7c9c9b5bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48537e01-57f9-4024-9c45-04dedeeca770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48537e01-57f9-4024-9c45-04dedeeca770" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a0f7f302-d46b-41f2-be8a-da1ee01aaf98_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a0f7f302-d46b-41f2-be8a-da1ee01aaf98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_b0f34b1b-c930-40cc-8b84-39e630715622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:to="loc_us-gaap_DomesticPlanMember_b0f34b1b-c930-40cc-8b84-39e630715622" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1f8c9213-525a-4dff-bd84-d2987765b2b3" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_b0f34b1b-c930-40cc-8b84-39e630715622" xlink:to="loc_country_US_1f8c9213-525a-4dff-bd84-d2987765b2b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5279e5ef-4d89-428c-ac44-3af78b3f76c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:to="loc_us-gaap_ForeignPlanMember_5279e5ef-4d89-428c-ac44-3af78b3f76c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c2f30e7f-9164-4a66-94f5-9e69e89caab3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c2f30e7f-9164-4a66-94f5-9e69e89caab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ff936390-6476-4b0e-83a9-1b51333d86f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ff936390-6476-4b0e-83a9-1b51333d86f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d0e96435-e9ab-4305-beac-04ab0c1344c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ff936390-6476-4b0e-83a9-1b51333d86f5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d0e96435-e9ab-4305-beac-04ab0c1344c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="i35e2ce88a50f4c51a98a85c4746aa03d_PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_209771bf-de51-4dfb-96ed-f30866a67ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_209771bf-de51-4dfb-96ed-f30866a67ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_fc9d43a6-2cef-48c5-a2f6-c94e66328f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_fc9d43a6-2cef-48c5-a2f6-c94e66328f63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_66813a72-4246-49bb-b04f-3cd11db3e71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_66813a72-4246-49bb-b04f-3cd11db3e71d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5051a760-7095-4785-bce4-31a6a6b0db8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5051a760-7095-4785-bce4-31a6a6b0db8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c487a14f-521d-445a-abcb-76a6d1c26b92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c487a14f-521d-445a-abcb-76a6d1c26b92" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_a32b0704-c950-4933-9223-8e965805e76e" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_a32b0704-c950-4933-9223-8e965805e76e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_c92fb81e-4290-4c61-978a-5b406575f7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_c92fb81e-4290-4c61-978a-5b406575f7fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_c0dd647e-b14d-4ac3-8244-0d7b2b8233ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_c0dd647e-b14d-4ac3-8244-0d7b2b8233ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_32213d3d-cc4c-4928-95a4-7ad584e85ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_32213d3d-cc4c-4928-95a4-7ad584e85ac4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_81e7990d-d3ca-433a-9d2a-981c65e55936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b870ea2c-fa0e-438c-bf0f-1501fedd7a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b870ea2c-fa0e-438c-bf0f-1501fedd7a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_8383d852-ca0f-4bd4-ab4a-a4840d8af484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_8383d852-ca0f-4bd4-ab4a-a4840d8af484" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_69371b1d-e5b7-44dd-8a8b-880326d49933" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_69371b1d-e5b7-44dd-8a8b-880326d49933" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0a463231-6610-4f03-8017-549a2cb69723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0a463231-6610-4f03-8017-549a2cb69723" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_566107e4-a901-46f1-8e5a-26bdda68084b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_566107e4-a901-46f1-8e5a-26bdda68084b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_8ce68069-e725-45e2-8208-fb350f597add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_8ce68069-e725-45e2-8208-fb350f597add" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5455f8bd-458d-4c42-ae2c-8726f104b93e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b7afc9af-cb99-4e76-a963-550d917b9bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b7afc9af-cb99-4e76-a963-550d917b9bfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_54604a5f-b402-428f-bd51-9a27266ca73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_54604a5f-b402-428f-bd51-9a27266ca73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ac477d6a-d8db-4633-a928-763d3cdf7b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ac477d6a-d8db-4633-a928-763d3cdf7b50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_812c7490-b50f-45ad-84a8-9bcd2bf05201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_812c7490-b50f-45ad-84a8-9bcd2bf05201" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_804b2014-6ce1-45f7-98a1-72598c79344f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_804b2014-6ce1-45f7-98a1-72598c79344f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c70c3137-3fb0-4239-bd86-e60affeb10c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c70c3137-3fb0-4239-bd86-e60affeb10c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ebc7cce5-fd58-4ac8-b71c-5aaf364d3edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:to="loc_us-gaap_DomesticPlanMember_ebc7cce5-fd58-4ac8-b71c-5aaf364d3edc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e4c46f57-b72f-4079-8a26-31c441edd100" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_ebc7cce5-fd58-4ac8-b71c-5aaf364d3edc" xlink:to="loc_country_US_e4c46f57-b72f-4079-8a26-31c441edd100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_14a21d68-b43d-4c7f-a5d2-f99ca828d282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:to="loc_us-gaap_ForeignPlanMember_14a21d68-b43d-4c7f-a5d2-f99ca828d282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_edc8cefb-b3e1-4823-9ea5-458bae6771cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_edc8cefb-b3e1-4823-9ea5-458bae6771cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_567718f8-d216-49b9-9fe1-936ec8202ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_edc8cefb-b3e1-4823-9ea5-458bae6771cb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_567718f8-d216-49b9-9fe1-936ec8202ae2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended" id="i10baa18199c6459e9b8941281e19c0ef_PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f90bae91-9d5a-439b-b1e3-54b8e5a2b42b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f90bae91-9d5a-439b-b1e3-54b8e5a2b42b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6e4c01c-0e53-4963-aed9-d35c6b01045d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6e4c01c-0e53-4963-aed9-d35c6b01045d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7f836650-695f-42cb-babc-5c7aaea79759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7f836650-695f-42cb-babc-5c7aaea79759" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_6d421cc3-f3e3-472f-b0e3-2ba8d7f1ca8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:to="loc_us-gaap_DomesticPlanMember_6d421cc3-f3e3-472f-b0e3-2ba8d7f1ca8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_470fe3fd-d030-4de2-bbf2-1038a2a06c76" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_6d421cc3-f3e3-472f-b0e3-2ba8d7f1ca8a" xlink:to="loc_country_US_470fe3fd-d030-4de2-bbf2-1038a2a06c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0d37081e-2d37-4140-8dd0-50ed403b3134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:to="loc_us-gaap_ForeignPlanMember_0d37081e-2d37-4140-8dd0-50ed403b3134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c178d3d6-99ee-4da7-9a95-88589c5a6504_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c178d3d6-99ee-4da7-9a95-88589c5a6504_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_55a414eb-dbcf-4d98-b88f-5184763852b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_55a414eb-dbcf-4d98-b88f-5184763852b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_77a75716-6aa4-4a94-abda-7a1ddbba3d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_55a414eb-dbcf-4d98-b88f-5184763852b4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_77a75716-6aa4-4a94-abda-7a1ddbba3d96" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="if66d4fe7f2694fe4afb335cfe0143e27_PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6a435b86-4e35-4e1b-a07c-f1f4a6a8578f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6a435b86-4e35-4e1b-a07c-f1f4a6a8578f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_249b7030-3421-4cee-a5ea-fc7d5a7938f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_249b7030-3421-4cee-a5ea-fc7d5a7938f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_49e21bc2-b36f-465f-9261-1ecb8db8d2db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_49e21bc2-b36f-465f-9261-1ecb8db8d2db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_02ea23c2-a67c-4837-a6b6-c9a293cf0307_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_02ea23c2-a67c-4837-a6b6-c9a293cf0307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_10abca43-2714-4094-a152-c097cae143b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:to="loc_us-gaap_DomesticPlanMember_10abca43-2714-4094-a152-c097cae143b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b4cf900-8e4b-44bd-8cc4-ca8cebcf448f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_10abca43-2714-4094-a152-c097cae143b0" xlink:to="loc_country_US_8b4cf900-8e4b-44bd-8cc4-ca8cebcf448f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_74c69316-98c6-4bd8-a229-65afe64d7ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:to="loc_us-gaap_ForeignPlanMember_74c69316-98c6-4bd8-a229-65afe64d7ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_658bd375-14dd-4c45-96eb-ef5ec7bb7c42_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_658bd375-14dd-4c45-96eb-ef5ec7bb7c42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c1137520-e102-43ec-9c06-bee754c45fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c1137520-e102-43ec-9c06-bee754c45fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a6acc9be-3642-4ce5-9872-3b49836bd945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_c1137520-e102-43ec-9c06-bee754c45fae" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a6acc9be-3642-4ce5-9872-3b49836bd945" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i781c0e1986654481956a6c05666e2a85_PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_956e56d3-be0d-4bfe-85a1-ae2a75771fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_956e56d3-be0d-4bfe-85a1-ae2a75771fab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d4ec0252-d2aa-4043-bdd3-7c0f5447e0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d4ec0252-d2aa-4043-bdd3-7c0f5447e0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_96cd6553-8d8d-4914-86e9-d691f558f2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_96cd6553-8d8d-4914-86e9-d691f558f2c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_4a632207-451a-4c61-bdc6-2ad3fc63a6d2" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_4a632207-451a-4c61-bdc6-2ad3fc63a6d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c4137a63-beb4-4f23-900d-a2b4cca6b5b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c4137a63-beb4-4f23-900d-a2b4cca6b5b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3b7a693a-d5c4-45b9-8528-439e4af53bf8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3b7a693a-d5c4-45b9-8528-439e4af53bf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_9c70f546-acac-4a79-a3f8-8332bea31de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:to="loc_us-gaap_DomesticPlanMember_9c70f546-acac-4a79-a3f8-8332bea31de7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_110ab4fb-f112-4ca6-813c-93a365bfbbef" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_9c70f546-acac-4a79-a3f8-8332bea31de7" xlink:to="loc_country_US_110ab4fb-f112-4ca6-813c-93a365bfbbef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2801973d-737f-4633-a6b6-b903bd7a50aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:to="loc_us-gaap_ForeignPlanMember_2801973d-737f-4633-a6b6-b903bd7a50aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4b655309-4929-4c77-b1e1-c6a44e9f002d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4b655309-4929-4c77-b1e1-c6a44e9f002d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e310c7fb-1068-4d49-a956-c5534043c534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4b655309-4929-4c77-b1e1-c6a44e9f002d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e310c7fb-1068-4d49-a956-c5534043c534" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended" id="i092af25222ad4ad3a2769b48c8dc4b3d_PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b33bb4ac-632c-47c3-9f2c-12c1d7daa3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b33bb4ac-632c-47c3-9f2c-12c1d7daa3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_627bc1eb-93bf-406e-99f6-21b2497d2e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_627bc1eb-93bf-406e-99f6-21b2497d2e12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_20f5f044-6e66-490b-a581-a805671458a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_20f5f044-6e66-490b-a581-a805671458a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_4feaf79d-8ee3-4b77-b524-32f0cebd8de7" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_4feaf79d-8ee3-4b77-b524-32f0cebd8de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_1d4e56b0-b9cb-4b55-afbc-b052030c228b" xlink:href="mck-20210331.xsd#mck_BenefitObligationsAssumptionsRateIncreaseinCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:to="loc_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_1d4e56b0-b9cb-4b55-afbc-b052030c228b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9eee880-d0b0-4eba-9036-bdc25b5e81f9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f9eee880-d0b0-4eba-9036-bdc25b5e81f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_703d297a-4e6a-4c08-9310-5818a1ce6d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:to="loc_us-gaap_DomesticPlanMember_703d297a-4e6a-4c08-9310-5818a1ce6d34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8fc9c4ba-26a0-404f-9046-606e47c2c32b" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_703d297a-4e6a-4c08-9310-5818a1ce6d34" xlink:to="loc_country_US_8fc9c4ba-26a0-404f-9046-606e47c2c32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4adf2018-d1ce-4742-90e9-60701aba24ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:to="loc_us-gaap_ForeignPlanMember_4adf2018-d1ce-4742-90e9-60701aba24ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4de348e7-7abc-4b02-a113-3838522c6caa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4de348e7-7abc-4b02-a113-3838522c6caa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_50147aa2-cff1-40b6-8263-87471aa05244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_50147aa2-cff1-40b6-8263-87471aa05244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_16f5cf41-5d2f-467d-bc48-e2e75bed41c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_50147aa2-cff1-40b6-8263-87471aa05244" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_16f5cf41-5d2f-467d-bc48-e2e75bed41c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended" id="ie8f73436c42e4dd0998b90e5745e9f8f_PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_84d93abd-5980-4e22-9486-fe64ab65b9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_15fcbce8-d73b-47a0-95e8-04f72e85621d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_84d93abd-5980-4e22-9486-fe64ab65b9e8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_15fcbce8-d73b-47a0-95e8-04f72e85621d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_84d93abd-5980-4e22-9486-fe64ab65b9e8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f6bef6d4-8857-4899-8088-d347f9e261f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f6bef6d4-8857-4899-8088-d347f9e261f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_fc2b40be-56d3-4fe2-a852-edbd2cb7ed02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f6bef6d4-8857-4899-8088-d347f9e261f1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_fc2b40be-56d3-4fe2-a852-edbd2cb7ed02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_01d6e471-f53b-46f5-bb1a-a01112974d60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_01d6e471-f53b-46f5-bb1a-a01112974d60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_7af2b31e-ef8d-4133-9574-30afa36b24d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:to="loc_us-gaap_DomesticPlanMember_7af2b31e-ef8d-4133-9574-30afa36b24d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_908901b0-a5a9-4035-b453-bd2f77cf2b7c" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_7af2b31e-ef8d-4133-9574-30afa36b24d5" xlink:to="loc_country_US_908901b0-a5a9-4035-b453-bd2f77cf2b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_f5fb6b7d-b972-4619-bd29-bc4c2f3931e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:to="loc_us-gaap_ForeignPlanMember_f5fb6b7d-b972-4619-bd29-bc4c2f3931e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d267ea4b-9d28-4d63-a303-541d862b1f0e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d267ea4b-9d28-4d63-a303-541d862b1f0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_338e8d6f-3384-478d-9dc3-7dc84a62a28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_338e8d6f-3384-478d-9dc3-7dc84a62a28e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_b3d0ff88-3a03-4f95-ae49-2836bcd89101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_MutualFundMember_b3d0ff88-3a03-4f95-ae49-2836bcd89101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_aa5172bd-56c2-40dc-8a06-a368be4b05bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_aa5172bd-56c2-40dc-8a06-a368be4b05bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_46e26c78-97db-4637-8c88-bbf90000c47c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_46e26c78-97db-4637-8c88-bbf90000c47c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_e8c1e7e0-f178-4a50-949a-9bad8cc07fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_FixedIncomeFundsMember_e8c1e7e0-f178-4a50-949a-9bad8cc07fe8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember_2da0a1a8-edcb-4295-a327-431c3da89211" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_mck_DefinedBenefitPlanOtherFundsMember_2da0a1a8-edcb-4295-a327-431c3da89211" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94e4ad65-6403-4fc3-a092-6b28e563aeb7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94e4ad65-6403-4fc3-a092-6b28e563aeb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3f72d2fa-646c-4942-866b-4d774fff0c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3f72d2fa-646c-4942-866b-4d774fff0c57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3f72d2fa-646c-4942-866b-4d774fff0c57" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6023c159-80a6-4da0-866a-f61faae06e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6023c159-80a6-4da0-866a-f61faae06e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67368135-effc-4856-879a-a88467b01bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67368135-effc-4856-879a-a88467b01bd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_92a39321-616a-4263-9755-e02d08db6c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_92a39321-616a-4263-9755-e02d08db6c98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_95f29f76-cf8a-4592-ac54-a886d6b78668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_95f29f76-cf8a-4592-ac54-a886d6b78668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f2dbd46d-1b4f-4ae3-96da-8008d015aefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f2dbd46d-1b4f-4ae3-96da-8008d015aefd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsOtherPostretirementBenefitsPlanDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails" xlink:type="extended" id="icd2b9e8f849f471c8f95e1cfcab333c5_PensionBenefitsOtherPostretirementBenefitsPlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_b4713553-0efd-46fe-bef0-d8ea2c1a169c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8a84f7cf-27ab-47dc-b650-c6078825a7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_b4713553-0efd-46fe-bef0-d8ea2c1a169c" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8a84f7cf-27ab-47dc-b650-c6078825a7ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_b4713553-0efd-46fe-bef0-d8ea2c1a169c" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_48fcb22e-a6b1-4301-a0fb-55b0ab777fed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_48fcb22e-a6b1-4301-a0fb-55b0ab777fed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f1ffea07-7f6d-4280-8c5c-13c410b81956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f1ffea07-7f6d-4280-8c5c-13c410b81956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9460704a-fc25-4a54-8863-5c5a749746c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f1ffea07-7f6d-4280-8c5c-13c410b81956" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9460704a-fc25-4a54-8863-5c5a749746c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended" id="i9e965c8ba0a94811b7478d0667c9428e_HedgingActivities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended" id="if6ba75d240db4dfab9d625c928fc56f3_HedgingActivitiesTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i739cf6beb1f44c61bf1dff7d4490affe_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1945ccd3-2134-4539-9155-365f6b7b879b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_LongTermDebt_1945ccd3-2134-4539-9155-365f6b7b879b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_fafcbb00-6b75-4606-a396-b5c72646cfb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_fafcbb00-6b75-4606-a396-b5c72646cfb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_d386c2d8-b9d2-4fc7-98fb-baa51ec439ee" xlink:href="mck-20210331.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_d386c2d8-b9d2-4fc7-98fb-baa51ec439ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_79bc75d2-57af-4e6a-91e1-0ebc43ed10f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_DerivativeNotionalAmount_79bc75d2-57af-4e6a-91e1-0ebc43ed10f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerivativeNotionalAmountMatured_e93f2767-b3b7-4ad7-b92c-837f7d587625" xlink:href="mck-20210331.xsd#mck_DerivativeNotionalAmountMatured"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_mck_DerivativeNotionalAmountMatured_e93f2767-b3b7-4ad7-b92c-837f7d587625" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_1b776496-4b02-454d-8f1d-176c67d1971c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_1b776496-4b02-454d-8f1d-176c67d1971c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_7f35b663-5add-40b7-a0c0-770cc9dea3b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_7f35b663-5add-40b7-a0c0-770cc9dea3b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_90802cb5-c72b-4f72-bda9-5d9cd87552e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_90802cb5-c72b-4f72-bda9-5d9cd87552e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7771dc2a-4369-424c-8830-4b46efb26f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7771dc2a-4369-424c-8830-4b46efb26f54" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_5d827045-0662-4ea0-a260-b5e79e4b8756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_5d827045-0662-4ea0-a260-b5e79e4b8756" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35e64f2a-2bc4-40a6-a636-ab9aee29093b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35e64f2a-2bc4-40a6-a636-ab9aee29093b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_e313fb02-c741-4980-a97b-169d4b58cb51" xlink:href="mck-20210331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:to="loc_mck_EuroDenominatedNotesMember_e313fb02-c741-4980-a97b-169d4b58cb51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_496d0834-a7a4-4260-a4d2-27c57a99419d" xlink:href="mck-20210331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_496d0834-a7a4-4260-a4d2-27c57a99419d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f8280172-c014-4d6d-bfeb-fbb07329f984_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f8280172-c014-4d6d-bfeb-fbb07329f984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ee42d16-4ec5-41e4-a46b-c2b70c5c8ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ee42d16-4ec5-41e4-a46b-c2b70c5c8ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_be149ca0-ffcf-4d05-9ffd-7b615085ae7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ee42d16-4ec5-41e4-a46b-c2b70c5c8ba0" xlink:to="loc_us-gaap_LoansPayableMember_be149ca0-ffcf-4d05-9ffd-7b615085ae7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2aef5e25-de80-42af-95d3-9b39633b769c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2aef5e25-de80-42af-95d3-9b39633b769c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7a13deec-e223-4ac0-bab5-123e7b71829f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7a13deec-e223-4ac0-bab5-123e7b71829f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_83adf0d0-486b-42f9-86b8-f2c141921341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:to="loc_us-gaap_CashFlowHedgingMember_83adf0d0-486b-42f9-86b8-f2c141921341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_580b27a0-d865-48bd-816d-7ea23e0db3de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_580b27a0-d865-48bd-816d-7ea23e0db3de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_be284283-df1c-4a75-b6f6-0c4ad5857deb" xlink:href="mck-20210331.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_be284283-df1c-4a75-b6f6-0c4ad5857deb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_3aacbf0f-c0c8-4b8b-96ca-f7c5b6f1aa92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_us-gaap_CurrencySwapMember_3aacbf0f-c0c8-4b8b-96ca-f7c5b6f1aa92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractsandCrossCurrencySwapsMember_26d87589-cc84-4e3b-9a21-0bfadde7cb0c" xlink:href="mck-20210331.xsd#mck_ForwardContractsandCrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_mck_ForwardContractsandCrossCurrencySwapsMember_26d87589-cc84-4e3b-9a21-0bfadde7cb0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6d078902-2b8f-4b49-823a-942724d2e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6d078902-2b8f-4b49-823a-942724d2e36b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_289d2cb0-e18d-40b4-bafb-528d866f2726" xlink:href="mck-20210331.xsd#mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_289d2cb0-e18d-40b4-bafb-528d866f2726" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3fa8d28e-3c32-46ab-986b-0382ca02e9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_us-gaap_InterestRateSwapMember_3fa8d28e-3c32-46ab-986b-0382ca02e9a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_70980040-c4c2-41ae-bb0e-e872dc235eee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:to="loc_us-gaap_HedgingDesignationDomain_70980040-c4c2-41ae-bb0e-e872dc235eee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:to="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8de98357-1a1a-46ad-9bcf-97b39b62a489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8de98357-1a1a-46ad-9bcf-97b39b62a489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3fd68a1c-b5f2-49eb-ac3f-cdbfcb27735a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:to="loc_us-gaap_NondesignatedMember_3fd68a1c-b5f2-49eb-ac3f-cdbfcb27735a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_c9a10bea-aa28-44f0-b0b4-007bbe94c214_default" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:to="loc_currency_AllCurrenciesDomain_c9a10bea-aa28-44f0-b0b4-007bbe94c214_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_993a00bf-3def-401c-9b92-6e3423175d13" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:to="loc_currency_AllCurrenciesDomain_993a00bf-3def-401c-9b92-6e3423175d13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_61645b44-ee70-4a1c-8e71-486665b1282b" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_993a00bf-3def-401c-9b92-6e3423175d13" xlink:to="loc_currency_GBP_61645b44-ee70-4a1c-8e71-486665b1282b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended" id="i5c47f83b175d4709bda4a0f5d3836679_HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c6081155-057a-425e-bcde-db7e30f1742d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c6081155-057a-425e-bcde-db7e30f1742d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1c0c079f-c59b-47ff-84ca-515f50f7900f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1c0c079f-c59b-47ff-84ca-515f50f7900f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0d1a9ccf-37d9-4952-a35d-a4237de901a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0d1a9ccf-37d9-4952-a35d-a4237de901a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_05217163-dbc5-4d60-abe9-d07eea7d4cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_05217163-dbc5-4d60-abe9-d07eea7d4cc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d8d40c6e-e64e-4c89-a478-772cdb137699_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d8d40c6e-e64e-4c89-a478-772cdb137699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9abc8066-5af2-46c9-b553-0720c0c2456b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9abc8066-5af2-46c9-b553-0720c0c2456b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_c42244cb-c255-432d-8440-32d782ad651b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:to="loc_us-gaap_CurrencySwapMember_c42244cb-c255-432d-8440-32d782ad651b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8bc6e119-b6c5-477f-8aa8-b452130b2c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:to="loc_us-gaap_InterestRateSwapMember_8bc6e119-b6c5-477f-8aa8-b452130b2c23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_67e24649-9658-430f-8208-1086bba31485_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:to="loc_us-gaap_HedgingDesignationDomain_67e24649-9658-430f-8208-1086bba31485_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:to="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_482e7fe4-7e1a-4f8b-a61e-93e80c48c275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_482e7fe4-7e1a-4f8b-a61e-93e80c48c275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e7f168cc-dad3-446f-819a-640e96b492f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:to="loc_us-gaap_NondesignatedMember_e7f168cc-dad3-446f-819a-640e96b492f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_639df897-917a-4113-80b5-5f117d9f5a38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_639df897-917a-4113-80b5-5f117d9f5a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_325a300c-4b9b-4349-956f-1340d0337616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_325a300c-4b9b-4349-956f-1340d0337616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8e01b7c0-70f8-4d8f-8fb4-3e37067033be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8e01b7c0-70f8-4d8f-8fb4-3e37067033be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_8076533d-4e89-4b55-a0b6-c53a62b44712" xlink:href="mck-20210331.xsd#mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_8076533d-4e89-4b55-a0b6-c53a62b44712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_b6f623d1-b035-4bef-9148-02182d2015f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_b6f623d1-b035-4bef-9148-02182d2015f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2d4b54b9-1854-40c1-8341-79a067c0ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2d4b54b9-1854-40c1-8341-79a067c0ff09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d2e2ec58-b050-4750-9041-538de011b295" xlink:href="mck-20210331.xsd#mck_OtherNoncurrentAssetsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d2e2ec58-b050-4750-9041-538de011b295" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended" id="i3c844ccd1b764800886b3c62fce0be5d_FairValueMeasurements"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i6509b27b8cfa402ebe3d2e5aa6c0cd61_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i944b2c68a0a74117b439b2c8472bd5c2_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e5e91181-90a4-4416-b4ca-1c3c3d33d644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e5e91181-90a4-4416-b4ca-1c3c3d33d644" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a8425058-c1c9-4f4b-b376-6068d91e8607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a8425058-c1c9-4f4b-b376-6068d91e8607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d6a774b5-c2d5-4dee-b9a9-b70d3c4e1a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d6a774b5-c2d5-4dee-b9a9-b70d3c4e1a6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2cb6614d-136b-4ea4-9d0a-efb56c2a8e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_2cb6614d-136b-4ea4-9d0a-efb56c2a8e6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9dfedbb6-2153-42ff-a990-933e4b78c135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9dfedbb6-2153-42ff-a990-933e4b78c135" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e6a22b3d-665b-4d29-917d-6ec2416da323_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e6a22b3d-665b-4d29-917d-6ec2416da323_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_29b3c583-5511-468b-87bf-0b42d83b0530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_29b3c583-5511-468b-87bf-0b42d83b0530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_114ececf-d4e7-4996-ba54-aafdcf875144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_29b3c583-5511-468b-87bf-0b42d83b0530" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_114ececf-d4e7-4996-ba54-aafdcf875144" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended" id="ia505bebab7824fa38c5d107a942b636b_FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_049cb9c5-0cf4-4901-bd4f-6d3f56ae0dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1063b780-3e07-408c-b117-5ac6411373c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_049cb9c5-0cf4-4901-bd4f-6d3f56ae0dce" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1063b780-3e07-408c-b117-5ac6411373c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_049cb9c5-0cf4-4901-bd4f-6d3f56ae0dce" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d2411946-8916-4555-9f3f-12ea1758d452_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d2411946-8916-4555-9f3f-12ea1758d452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7b491895-34cf-4704-891c-be3e3cf7138e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7b491895-34cf-4704-891c-be3e3cf7138e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9e2a855b-5eff-493c-b149-96d4dacdac1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9e2a855b-5eff-493c-b149-96d4dacdac1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_685e1e64-9da7-4ff5-b138-2af69b530997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_685e1e64-9da7-4ff5-b138-2af69b530997" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="simple" xlink:href="mck-20210331.xsd#FinancialGuaranteesandWarranties"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="extended" id="i28bd14e559014dc2ba4505661aac354a_FinancialGuaranteesandWarranties"/>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended" id="ia81bc6fde0844594a317dfaa7f53d792_FinancialGuaranteesandWarrantiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod_ead11098-047d-4a1b-8cde-369a8b289ca8" xlink:href="mck-20210331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuarantorObligationsPeriod_ead11098-047d-4a1b-8cde-369a8b289ca8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_a277ca83-a2d3-4011-b36a-192dea07109d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_a277ca83-a2d3-4011-b36a-192dea07109d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_cedd072a-8965-482a-a5a6-169ceb710eab" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_cedd072a-8965-482a-a5a6-169ceb710eab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_2bda36c4-e572-406a-a121-17e4855e0d68" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_2bda36c4-e572-406a-a121-17e4855e0d68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_ad003901-1eb8-4929-b577-3e62eb754b51" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_ad003901-1eb8-4929-b577-3e62eb754b51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8fa53027-3c69-49ab-90bb-2028bca5d253" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8fa53027-3c69-49ab-90bb-2028bca5d253" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_6aa0aa87-dade-4d37-a975-db7094c063e1" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_6aa0aa87-dade-4d37-a975-db7094c063e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_7d1367e1-ae08-470f-abd6-892b83a33526" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_7d1367e1-ae08-470f-abd6-892b83a33526" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_9ab60e5b-068c-497c-83d2-b4b2147d2343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_9ab60e5b-068c-497c-83d2-b4b2147d2343" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:to="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f3ab0124-558f-4bc8-a148-c32dae7beda4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:to="loc_srt_RangeMember_f3ab0124-558f-4bc8-a148-c32dae7beda4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:to="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_abf1cea6-c06a-46bc-8586-fac7b66eb412" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:to="loc_srt_MinimumMember_abf1cea6-c06a-46bc-8586-fac7b66eb412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5a84c3c6-aff3-46c2-8919-11536b0660ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:to="loc_srt_MaximumMember_5a84c3c6-aff3-46c2-8919-11536b0660ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_f0b9be75-fd01-427e-9763-621a99784ef7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_f0b9be75-fd01-427e-9763-621a99784ef7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_a75f0201-1e3d-453f-9522-abdf90e000ff" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:to="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_a75f0201-1e3d-453f-9522-abdf90e000ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember_09e99562-6bc1-4fdf-a57f-2d6697387cb5" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:to="loc_mck_GuaranteeObligationsCustomersDebtMember_09e99562-6bc1-4fdf-a57f-2d6697387cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_327b1153-a919-4ca1-a6fe-13c17e1dae7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_327b1153-a919-4ca1-a6fe-13c17e1dae7e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20210331.xsd#CommitmentsandContingentLiabilities"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended" id="i753fe76503864145b2a13e6b22be527e_CommitmentsandContingentLiabilities"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended" id="ib0b246d042934a598ddc140078f0c791_CommitmentsandContingentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_3deee4e2-cbef-4be4-858f-ce2f7005953c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_3deee4e2-cbef-4be4-858f-ce2f7005953c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_94e77d08-e303-46c3-ab4d-4934fdd1925a" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_94e77d08-e303-46c3-ab4d-4934fdd1925a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_43c68f03-7c76-4a7d-a965-08a42dd79bf8" xlink:href="mck-20210331.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_43c68f03-7c76-4a7d-a965-08a42dd79bf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_37be33cc-afcf-4489-8aa1-1102438c80b3" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_37be33cc-afcf-4489-8aa1-1102438c80b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_8261a5dc-eaab-41dc-8215-1007313481a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_8261a5dc-eaab-41dc-8215-1007313481a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_fad8599c-60d1-4ee9-8cdc-3f1666d6d025" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCounties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofCounties_fad8599c-60d1-4ee9-8cdc-3f1666d6d025" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0eaff357-0d6a-434f-b16c-c789019b855c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0eaff357-0d6a-434f-b16c-c789019b855c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_60f0c25f-4d13-4cc9-8201-37894bd1f9b0" xlink:href="mck-20210331.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_60f0c25f-4d13-4cc9-8201-37894bd1f9b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_8250e8ca-2f01-496c-8f23-7898ff89df50" xlink:href="mck-20210331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_8250e8ca-2f01-496c-8f23-7898ff89df50" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_88518d96-cb85-4d80-91af-1923b2cbdc28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_88518d96-cb85-4d80-91af-1923b2cbdc28" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax_007f3f4c-8bc8-40d1-91d2-e4aa1fc7fd42" xlink:href="mck-20210331.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyAccrualProvisionAfterTax_007f3f4c-8bc8-40d1-91d2-e4aa1fc7fd42" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_e9693190-850a-4a37-83ef-ac04b43a39d8" xlink:href="mck-20210331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_e9693190-850a-4a37-83ef-ac04b43a39d8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators_01ab76f8-96a3-40d3-928f-286a5ab5512e" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofRelators_01ab76f8-96a3-40d3-928f-286a5ab5512e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_3baebbd5-a32c-4edd-b12e-6e60378a36d2" xlink:href="mck-20210331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_3baebbd5-a32c-4edd-b12e-6e60378a36d2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_a6d11cad-c6ea-4827-8cdb-3e827270788d" xlink:href="mck-20210331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_a6d11cad-c6ea-4827-8cdb-3e827270788d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_a91cb243-3105-46e5-a405-c82f9fccbcde" xlink:href="mck-20210331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_a91cb243-3105-46e5-a405-c82f9fccbcde" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofAdditionalDefendants_a1a16b89-a26b-48d9-b146-0560b3b8da4b" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofAdditionalDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofAdditionalDefendants_a1a16b89-a26b-48d9-b146-0560b3b8da4b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_19398f52-6a51-42f4-bfcd-91925eb8d81d" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCitiesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_19398f52-6a51-42f4-bfcd-91925eb8d81d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers_41880ebd-b48c-4ed7-9e5e-d4ad3e46664a" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofFormerOfficers_41880ebd-b48c-4ed7-9e5e-d4ad3e46664a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts_c8890e8e-e774-48e9-92e0-831d536af5ad" xlink:href="mck-20210331.xsd#mck_NumberofSoftwareProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_NumberofSoftwareProducts_c8890e8e-e774-48e9-92e0-831d536af5ad" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_d5abb537-bd0b-4835-b03a-0381da4c5b63" xlink:href="mck-20210331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_d5abb537-bd0b-4835-b03a-0381da4c5b63" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SiteContingencyNumberofSites_06457688-80a2-46db-8f68-b6a97dc483ae" xlink:href="mck-20210331.xsd#mck_SiteContingencyNumberofSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_SiteContingencyNumberofSites_06457688-80a2-46db-8f68-b6a97dc483ae" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_0d6084cd-8796-435e-8cce-bc1d1adb54f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_0d6084cd-8796-435e-8cce-bc1d1adb54f0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SiteContingencyTimeFrameOfDisbursements_132e43a6-932f-4df1-9077-f441498d3364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SiteContingencyTimeFrameOfDisbursements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_SiteContingencyTimeFrameOfDisbursements_132e43a6-932f-4df1-9077-f441498d3364" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites_029be12d-f3f6-4d1e-8d81-58877d4b93cb" xlink:href="mck-20210331.xsd#mck_HazardousSubstanceSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_HazardousSubstanceSites_029be12d-f3f6-4d1e-8d81-58877d4b93cb" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSitesSelectedforPreferredRemedy_1d3f4e38-7957-4a16-b53f-8a4b02c35857" xlink:href="mck-20210331.xsd#mck_NumberofSitesSelectedforPreferredRemedy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_NumberofSitesSelectedforPreferredRemedy_1d3f4e38-7957-4a16-b53f-8a4b02c35857" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_84c97341-487c-44f0-8afa-69d2c27eefe2" xlink:href="mck-20210331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_84c97341-487c-44f0-8afa-69d2c27eefe2" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_2952658c-36bb-46fd-88b9-a642befa1e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_2952658c-36bb-46fd-88b9-a642befa1e73" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:to="loc_srt_LitigationCaseTypeDomain_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:to="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember_45d81829-f841-4c52-890e-955dbe1f3edb" xlink:href="mck-20210331.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_InreNationalPrescriptionOpiateLitigationMember_45d81829-f841-4c52-890e-955dbe1f3edb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_eabe78cf-fe73-4ec4-816d-618091b296f6" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_eabe78cf-fe73-4ec4-816d-618091b296f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_f1d3ca80-135c-4fe3-bf99-c5a85da5b7f9" xlink:href="mck-20210331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_f1d3ca80-135c-4fe3-bf99-c5a85da5b7f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember_9b4be514-2122-480d-94db-383d9e3b7c0f" xlink:href="mck-20210331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_InsuranceCoverageLitigationMember_9b4be514-2122-480d-94db-383d9e3b7c0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_fc17a3f3-0019-4857-895a-efb23b6ac5aa" xlink:href="mck-20210331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_fc17a3f3-0019-4857-895a-efb23b6ac5aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_be3ba2bc-553a-476c-91ce-56fc3d5379b9" xlink:href="mck-20210331.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_be3ba2bc-553a-476c-91ce-56fc3d5379b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_c55b7e93-e8da-44aa-91be-73b0de48a514" xlink:href="mck-20210331.xsd#mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_c55b7e93-e8da-44aa-91be-73b0de48a514" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_a6613fcc-c56b-4bd4-a209-298e4eaa9d28" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_a6613fcc-c56b-4bd4-a209-298e4eaa9d28" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_2bbc97d0-8dbe-498b-ad53-9ab99bb3596e" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_2bbc97d0-8dbe-498b-ad53-9ab99bb3596e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_93e0f080-b9e0-460c-aa6c-d027ce9b6ae6" xlink:href="mck-20210331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_93e0f080-b9e0-460c-aa6c-d027ce9b6ae6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_c178809c-1c41-4c7c-af1c-74d3ad72a3f9" xlink:href="mck-20210331.xsd#mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_c178809c-1c41-4c7c-af1c-74d3ad72a3f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_6695c753-e012-4838-a02b-858b6327fcc6" xlink:href="mck-20210331.xsd#mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_6695c753-e012-4838-a02b-858b6327fcc6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_b2e04d33-e0eb-4a28-b851-476678e65503" xlink:href="mck-20210331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_b2e04d33-e0eb-4a28-b851-476678e65503" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_c41267a8-8639-40a5-b91c-6873bbf301e5" xlink:href="mck-20210331.xsd#mck_ConsolidatedActionsvSureScriptsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_c41267a8-8639-40a5-b91c-6873bbf301e5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_bba79b3d-1466-46d5-9ab0-a552275e6417" xlink:href="mck-20210331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_bba79b3d-1466-46d5-9ab0-a552275e6417" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_7954e878-a083-48d3-b1cf-8ba71edc2004" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_7954e878-a083-48d3-b1cf-8ba71edc2004" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:to="loc_us-gaap_LitigationStatusDomain_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5b05614d-31bd-42fd-8b57-c8f143c0dbff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:to="loc_us-gaap_LitigationStatusDomain_5b05614d-31bd-42fd-8b57-c8f143c0dbff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_b415cb42-8df7-421f-a06a-1494cc76db2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5b05614d-31bd-42fd-8b57-c8f143c0dbff" xlink:to="loc_us-gaap_PendingLitigationMember_b415cb42-8df7-421f-a06a-1494cc76db2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:to="loc_srt_SegmentGeographicalDomain_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e6d353b5-3da5-40e2-956f-060b7d817c30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:to="loc_srt_SegmentGeographicalDomain_e6d353b5-3da5-40e2-956f-060b7d817c30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_9d380178-adfb-4047-b24e-33f81e727b63" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e6d353b5-3da5-40e2-956f-060b7d817c30" xlink:to="loc_country_CA_9d380178-adfb-4047-b24e-33f81e727b63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_204d7cf9-8da3-4dcc-be2f-158ce782ea8d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_204d7cf9-8da3-4dcc-be2f-158ce782ea8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_7b01ddeb-7068-4931-bdcf-6c7d335c1168" xlink:href="mck-20210331.xsd#mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_7b01ddeb-7068-4931-bdcf-6c7d335c1168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_9f36c296-7b9a-4a9d-96f9-7a927dc16b69" xlink:href="mck-20210331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_9f36c296-7b9a-4a9d-96f9-7a927dc16b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember_c20f4105-3b72-4b00-936d-63f3b4a2b55f" xlink:href="mck-20210331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_EnvironmentalLitigationMember_c20f4105-3b72-4b00-936d-63f3b4a2b55f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_1e108364-b138-402a-9627-482eb77d4101" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_1e108364-b138-402a-9627-482eb77d4101" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c8673f54-6eff-409a-bd7b-0238b821d084_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:to="loc_dei_EntityDomain_c8673f54-6eff-409a-bd7b-0238b821d084_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6f82b31e-1b05-4467-a0bb-04f1d2bef12c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:to="loc_dei_EntityDomain_6f82b31e-1b05-4467-a0bb-04f1d2bef12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_23aeff90-4a23-4eb6-a54b-53fbedd2ddbc" xlink:href="mck-20210331.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6f82b31e-1b05-4467-a0bb-04f1d2bef12c" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_23aeff90-4a23-4eb6-a54b-53fbedd2ddbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_be02efb5-bd20-43b9-bf98-27827b32c44c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:to="loc_srt_RangeMember_be02efb5-bd20-43b9-bf98-27827b32c44c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:to="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aa4a0b63-bd5a-47fd-befc-72d9b5194b20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:to="loc_srt_MinimumMember_aa4a0b63-bd5a-47fd-befc-72d9b5194b20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_533a6b03-fe87-4475-a9de-dbf4c676aeb6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:to="loc_srt_MaximumMember_533a6b03-fe87-4475-a9de-dbf4c676aeb6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended" id="ie79516584c5b4d3c9f23527a7e84fb5b_StockholdersEquity"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended" id="i67034399990e4765a5f98000b433c311_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i3f6480c2ac294691a28c93e19beb49c2_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_1ce7122c-e567-4c5a-bfaa-dc6091fc2e49" xlink:href="mck-20210331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_1ce7122c-e567-4c5a-bfaa-dc6091fc2e49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_94ce2feb-9d01-46d6-9253-203897649b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_94ce2feb-9d01-46d6-9253-203897649b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e141e1fa-0254-4068-9ef0-29058a6991ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e141e1fa-0254-4068-9ef0-29058a6991ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3b15466a-be36-409d-9d88-44bb9da43f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3b15466a-be36-409d-9d88-44bb9da43f7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_7dbd4d0d-13cc-4062-a093-49bfdb3c2cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_7dbd4d0d-13cc-4062-a093-49bfdb3c2cdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5354e61f-b6c6-4570-bed5-cd5c6eaaa144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5354e61f-b6c6-4570-bed5-cd5c6eaaa144" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bae3703e-7d33-4166-8db7-8759a1870529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bae3703e-7d33-4166-8db7-8759a1870529" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases_0b0b764b-c2fd-4021-8104-23217a50ec5f" xlink:href="mck-20210331.xsd#mck_AccruedShareRepurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_AccruedShareRepurchases_0b0b764b-c2fd-4021-8104-23217a50ec5f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_8fb108f2-84b9-4a61-86a8-cfd2a51ff0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_8fb108f2-84b9-4a61-86a8-cfd2a51ff0ee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_d45f4dd0-0375-464f-b14e-7688cd2ff1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_d45f4dd0-0375-464f-b14e-7688cd2ff1e1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_d03de176-9d48-4e70-8634-e331f1dbd059" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_ExchangeOfferSharesDistributed_d03de176-9d48-4e70-8634-e331f1dbd059" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_d1e1f696-eeee-47c3-beba-f06660c306e6" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_ExchangeOfferSharesExchanged_d1e1f696-eeee-47c3-beba-f06660c306e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_a0550f4e-43e4-4ea3-95ec-e78c6a8e9955" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_a0550f4e-43e4-4ea3-95ec-e78c6a8e9955" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e499672e-9dc0-4be3-8a54-248dcd8fc397" xlink:href="mck-20210331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e499672e-9dc0-4be3-8a54-248dcd8fc397" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_903fe608-d046-401f-9f1a-7df42f755fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_903fe608-d046-401f-9f1a-7df42f755fd8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_30a1db30-6f8b-4915-96c7-4396ef6ad03c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_30a1db30-6f8b-4915-96c7-4396ef6ad03c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e40243a-b9e9-46cb-86b9-27b8131dd1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e40243a-b9e9-46cb-86b9-27b8131dd1f1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_8f89d65a-5f01-490a-af26-905d4de1e053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_8f89d65a-5f01-490a-af26-905d4de1e053" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_8cf416f1-d5c0-4882-80c4-960d12c1e820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_8cf416f1-d5c0-4882-80c4-960d12c1e820" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_48a69eae-6954-4b3b-b7b1-035a8e5b77cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_48a69eae-6954-4b3b-b7b1-035a8e5b77cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_21e3ecc7-3064-4b9b-8cab-928a265f3961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_21e3ecc7-3064-4b9b-8cab-928a265f3961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_31449e12-4ca5-496d-9dc8-78513d28335c" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_21e3ecc7-3064-4b9b-8cab-928a265f3961" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_31449e12-4ca5-496d-9dc8-78513d28335c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_655d82d8-c59c-4a6f-9050-5b8efdf1fe96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_655d82d8-c59c-4a6f-9050-5b8efdf1fe96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_903c6f18-f844-4a72-80b9-df392626dcb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_655d82d8-c59c-4a6f-9050-5b8efdf1fe96" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_903c6f18-f844-4a72-80b9-df392626dcb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f843dcca-b3de-48fb-b9b7-9ec2d01eb065_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:to="loc_us-gaap_EquityComponentDomain_f843dcca-b3de-48fb-b9b7-9ec2d01eb065_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:to="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9fdf8da3-6314-43f6-98b2-0136f6f9d6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_RetainedEarningsMember_9fdf8da3-6314-43f6-98b2-0136f6f9d6b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_25c2d338-4a03-463f-9730-4d8e80a9a0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_25c2d338-4a03-463f-9730-4d8e80a9a0fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67547744-0909-478a-8e81-a8db25b887de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67547744-0909-478a-8e81-a8db25b887de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_71578327-2b2b-4381-b04a-ad1dbbfea019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_71578327-2b2b-4381-b04a-ad1dbbfea019" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember_1f7435c6-cead-4c4f-aad0-988f7dbbb8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember_1f7435c6-cead-4c4f-aad0-988f7dbbb8ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_335af7fc-9914-43f1-826c-eb25bdc097de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_335af7fc-9914-43f1-826c-eb25bdc097de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_98189a37-fd39-4a07-a9be-4c97cf3bceda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_98189a37-fd39-4a07-a9be-4c97cf3bceda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_424bba1b-ca72-4db0-b5b4-609d00a406a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_98189a37-fd39-4a07-a9be-4c97cf3bceda" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_424bba1b-ca72-4db0-b5b4-609d00a406a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ccfdc653-ddc3-43f9-8676-23cf96c5ba02_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ccfdc653-ddc3-43f9-8676-23cf96c5ba02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0da01029-ee5e-4262-825d-2d1846da92a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0da01029-ee5e-4262-825d-2d1846da92a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_c257ecea-44fd-473d-b742-1fb417a88319" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_0da01029-ee5e-4262-825d-2d1846da92a3" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_c257ecea-44fd-473d-b742-1fb417a88319" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="extended" id="i5651c00a9464447bb7cda5ce7292e9be_StockholdersEquityScheduleofShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3d910ce0-2adc-490e-9d9a-62bdc0c0f20c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3d910ce0-2adc-490e-9d9a-62bdc0c0f20c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_895dd4c4-b140-45b4-b6e7-2898327c5f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_895dd4c4-b140-45b4-b6e7-2898327c5f18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_82d38298-0489-4e89-ab6d-0e70ea19553e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_82d38298-0489-4e89-ab6d-0e70ea19553e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:href="mck-20210331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_106d0923-7859-4ce1-bfb0-7b0215c8a239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_106d0923-7859-4ce1-bfb0-7b0215c8a239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c5339c9e-791b-4218-8fae-d622369bb963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c5339c9e-791b-4218-8fae-d622369bb963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0d78f476-75f8-439a-8fcc-5dfd739f31b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_80141d98-efe0-407c-b5fc-ac7ff3fb17f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_80141d98-efe0-407c-b5fc-ac7ff3fb17f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember_c312762f-6757-4fe5-925d-1c7c29f5ddc5" xlink:href="mck-20210331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:to="loc_mck_OpenMarketTransactionsMember_c312762f-6757-4fe5-925d-1c7c29f5ddc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_46cd5be8-e534-4440-8d1a-8c4a12f98dd7" xlink:href="mck-20210331.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_46cd5be8-e534-4440-8d1a-8c4a12f98dd7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended" id="i3c414edf4069443386cdada15bfbd3cc_StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_676aa4fb-716e-4dc0-9bfd-ee273f5524d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_676aa4fb-716e-4dc0-9bfd-ee273f5524d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_57cac973-c197-441d-bbc3-1b111009977c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_57cac973-c197-441d-bbc3-1b111009977c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c549b17-7fe7-495e-a4ae-c439bbb5a640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c549b17-7fe7-495e-a4ae-c439bbb5a640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_619c7ac0-2fab-43e5-b7d9-318a2e8e8355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_619c7ac0-2fab-43e5-b7d9-318a2e8e8355" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_da0e2dcf-0add-4df5-a6f7-6a350ef8bc79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_da0e2dcf-0add-4df5-a6f7-6a350ef8bc79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bd1db3b6-935c-4e9a-8044-8e9758748051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bd1db3b6-935c-4e9a-8044-8e9758748051" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3cdbfa39-42e2-4f57-bc6e-7a2b97b88d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3cdbfa39-42e2-4f57-bc6e-7a2b97b88d54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ae5679ca-c8b9-474a-8c5c-9d0d56097798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ae5679ca-c8b9-474a-8c5c-9d0d56097798" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_26ecad21-71de-4f54-916c-a0bf34181824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_26ecad21-71de-4f54-916c-a0bf34181824" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_333721bb-56ee-4417-bdc6-08a8331f9bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_333721bb-56ee-4417-bdc6-08a8331f9bc3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_6b210a71-6024-4667-b3bc-c374fde311c4" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_6b210a71-6024-4667-b3bc-c374fde311c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:to="loc_us-gaap_EquityComponentDomain_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:to="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_407c0029-deb4-45c1-b4e6-4c93b6ab101e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_407c0029-deb4-45c1-b4e6-4c93b6ab101e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_22dadda3-a173-4f02-88d2-72cbcfb0791c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_22dadda3-a173-4f02-88d2-72cbcfb0791c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_a3378239-297b-4705-b1a3-7b36c3e5493e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_a3378239-297b-4705-b1a3-7b36c3e5493e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_4cf9fa0b-e32e-4215-bae4-e26a6fdc78f6" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_4cf9fa0b-e32e-4215-bae4-e26a6fdc78f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_7c25f015-3535-482c-a3a8-878edd47d7a0" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_7c25f015-3535-482c-a3a8-878edd47d7a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_b3ffc148-44db-4b3e-9f07-cbf850255f18" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_b3ffc148-44db-4b3e-9f07-cbf850255f18" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0cd77e34-2da3-4531-beac-e351fe2f5bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0cd77e34-2da3-4531-beac-e351fe2f5bc6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_e92e4341-c7be-4b7d-8640-9dd4d78a420a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_e92e4341-c7be-4b7d-8640-9dd4d78a420a" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended" id="i1f1634013a8041e98297e2c44beb1b02_StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4186f06-4bb4-4c29-9fe0-7457f2d3958a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4186f06-4bb4-4c29-9fe0-7457f2d3958a" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4570ae84-87ab-40c4-902a-81d1d547640e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4570ae84-87ab-40c4-902a-81d1d547640e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_06e96480-2f38-49ec-ab46-c693bd268d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_06e96480-2f38-49ec-ab46-c693bd268d0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5228b0fe-2713-454b-9e5f-e77a05ef81f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5228b0fe-2713-454b-9e5f-e77a05ef81f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7129939f-0221-4581-9a83-6ec62229267e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7129939f-0221-4581-9a83-6ec62229267e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6123af8a-5a30-42f3-bc22-2dc01809c3a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6123af8a-5a30-42f3-bc22-2dc01809c3a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_050b6bc9-63ed-4af8-bf74-8b65c79601dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_050b6bc9-63ed-4af8-bf74-8b65c79601dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0159603-f69a-4435-91e9-32f58aaa894d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4186f06-4bb4-4c29-9fe0-7457f2d3958a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_32e68c31-3f21-46fb-818c-932440b5882e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:to="loc_us-gaap_EquityComponentDomain_32e68c31-3f21-46fb-818c-932440b5882e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:to="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f2f5c60e-270d-4371-a34f-78a1e8f5e68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f2f5c60e-270d-4371-a34f-78a1e8f5e68a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_f89499e2-acf9-4a46-9686-15a031a2ead3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_f89499e2-acf9-4a46-9686-15a031a2ead3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_aef16adf-b757-4f66-a06e-dd31a5b989bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_aef16adf-b757-4f66-a06e-dd31a5b989bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_7ac66c84-d297-469c-af05-bbe5f8856cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_7ac66c84-d297-469c-af05-bbe5f8856cf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a46e98d8-ed23-427d-b623-279d03adf295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a46e98d8-ed23-427d-b623-279d03adf295" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="simple" xlink:href="mck-20210331.xsd#RelatedPartyBalancesandTransactions"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="extended" id="i1427c07ffdcf44039076d2ea49aa65f5_RelatedPartyBalancesandTransactions"/>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended" id="i015eec45786b4712b68859cee68348e3_RelatedPartyBalancesandTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2aa686c5-ca8f-4167-b23a-821e2349dea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2aa686c5-ca8f-4167-b23a-821e2349dea1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_47a24934-eb5d-47a5-a388-9e62b8100594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_47a24934-eb5d-47a5-a388-9e62b8100594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_63d787ca-0017-4af6-86eb-79cb8c594a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_RevenueFromRelatedParties_63d787ca-0017-4af6-86eb-79cb8c594a99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ef30f082-0560-475c-a45f-066ea1da4788_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ef30f082-0560-475c-a45f-066ea1da4788_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_22291985-0d8e-436b-a545-8ea3d7a1cdf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_22291985-0d8e-436b-a545-8ea3d7a1cdf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_56b9a288-c726-4536-a98b-e900f5cda510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_22291985-0d8e-436b-a545-8ea3d7a1cdf8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_56b9a288-c726-4536-a98b-e900f5cda510" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:to="loc_us-gaap_RelatedPartyDomain_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:to="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CaliforniaFoundationMember_2209b35c-0520-445c-b136-eedcdaf3c564" xlink:href="mck-20210331.xsd#mck_CaliforniaFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:to="loc_mck_CaliforniaFoundationMember_2209b35c-0520-445c-b136-eedcdaf3c564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonFoundationMember_74e670a0-9b95-488c-9473-40af6609e2f2" xlink:href="mck-20210331.xsd#mck_McKessonFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:to="loc_mck_McKessonFoundationMember_74e670a0-9b95-488c-9473-40af6609e2f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_1db85ddf-fdb7-4937-9b25-e937776a5678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:to="loc_us-gaap_InvesteeMember_1db85ddf-fdb7-4937-9b25-e937776a5678" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fba9e272-26e2-4546-99d3-eb0002236f46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:to="loc_us-gaap_SegmentDomain_fba9e272-26e2-4546-99d3-eb0002236f46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ae52f720-7405-4cde-ae60-65a1f3acecaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:to="loc_us-gaap_SegmentDomain_ae52f720-7405-4cde-ae60-65a1f3acecaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_91eaf0e6-aebe-4c2a-bd3e-144bae490a5b" xlink:href="mck-20210331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ae52f720-7405-4cde-ae60-65a1f3acecaf" xlink:to="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_91eaf0e6-aebe-4c2a-bd3e-144bae490a5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusiness"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended" id="i777fd778539d48b38ae9d514f30481f0_SegmentsofBusiness"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended" id="i1562beadeb1e4b569a5d9e74ad2660d4_SegmentsofBusinessTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended" id="ia3fb2373f700445cbc5575d66a598636_SegmentsofBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f7f351a1-d5ab-435a-9ced-8ca5299e6437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_NumberOfReportableSegments_f7f351a1-d5ab-435a-9ced-8ca5299e6437" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_dd80f43c-625d-4221-857b-0d26fdf73b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_dd80f43c-625d-4221-857b-0d26fdf73b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_79d9c692-2dac-4365-835b-8717de88a271" xlink:href="mck-20210331.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_79d9c692-2dac-4365-835b-8717de88a271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_4c9fdf1f-ad7c-4ac9-9ad9-4c0ace5ed2b9" xlink:href="mck-20210331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_4c9fdf1f-ad7c-4ac9-9ad9-4c0ace5ed2b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_59627509-855c-4e20-802e-009c2239b7c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_59627509-855c-4e20-802e-009c2239b7c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_af8e8dc2-faff-40f1-92ee-7e4717e16c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_af8e8dc2-faff-40f1-92ee-7e4717e16c9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_387c0a02-374b-4f46-98c8-688066091400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_387c0a02-374b-4f46-98c8-688066091400" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_94747631-deec-45f3-aa4e-080fa03b4bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_94747631-deec-45f3-aa4e-080fa03b4bf7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_154bfbca-fc5f-41a3-aeb0-a46f8f3bae48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_154bfbca-fc5f-41a3-aeb0-a46f8f3bae48" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_22899a98-b396-48e9-8f8d-affe40b0936b" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_22899a98-b396-48e9-8f8d-affe40b0936b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_b1efadbc-d9d2-49e1-a384-c24c4787e024" xlink:href="mck-20210331.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_b1efadbc-d9d2-49e1-a384-c24c4787e024" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_23430288-cd5b-48a0-a091-355be0a56266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_23430288-cd5b-48a0-a091-355be0a56266" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_683c41e2-07b4-4626-8f43-15fe0aa4983e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_AssetImpairmentCharges_683c41e2-07b4-4626-8f43-15fe0aa4983e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_3f44acf7-055a-40bb-8635-37c16f403742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_3f44acf7-055a-40bb-8635-37c16f403742" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_00b2e1b2-74d5-4060-8a17-19ed445ec1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_00b2e1b2-74d5-4060-8a17-19ed445ec1f2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPreviousAcquisition_fdafd723-5831-4ffd-b046-34af2dee7749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPreviousAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_ProceedsFromPreviousAcquisition_fdafd723-5831-4ffd-b046-34af2dee7749" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0953347e-24bb-405d-9a15-3009b49a90fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_InventoryWriteDown_0953347e-24bb-405d-9a15-3009b49a90fe" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_535e3c5a-9f3a-4868-9598-64c7f7c9dc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_535e3c5a-9f3a-4868-9598-64c7f7c9dc48" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_e95999ef-b85a-49df-8b3b-d57e05737059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_e95999ef-b85a-49df-8b3b-d57e05737059" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossonDerecognitionofLiability_2e0dc96d-bff0-470a-adb6-22f52ded88bd" xlink:href="mck-20210331.xsd#mck_GainLossonDerecognitionofLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_GainLossonDerecognitionofLiability_2e0dc96d-bff0-470a-adb6-22f52ded88bd" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f8f4408-f2ee-481f-b00a-df1db138b262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f8f4408-f2ee-481f-b00a-df1db138b262" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_8455a47f-2a4d-46ab-b93b-2645d886c3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_8455a47f-2a4d-46ab-b93b-2645d886c3b6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef8a6792-98e7-4e1b-8314-878c6f4ef653" xlink:href="mck-20210331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef8a6792-98e7-4e1b-8314-878c6f4ef653" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4bfd4517-f0e9-4e64-abfd-00f5d578e4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4bfd4517-f0e9-4e64-abfd-00f5d578e4eb" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6e2e7209-3fa6-40c5-95be-04883ac335df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6e2e7209-3fa6-40c5-95be-04883ac335df" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_338f3064-c39e-49ab-93f3-0c273a632908_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:to="loc_us-gaap_SegmentDomain_338f3064-c39e-49ab-93f3-0c273a632908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:to="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_efd882b9-9bc2-47aa-9437-0669ec7933fb" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_InternationalSegmentMember_efd882b9-9bc2-47aa-9437-0669ec7933fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_25b283a5-8eab-4b09-a6f0-0173c3f886fe" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_USPharmaceuticalSegmentMember_25b283a5-8eab-4b09-a6f0-0173c3f886fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e8b969b9-0d8c-45d1-bf90-9e3d1654c3cc" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e8b969b9-0d8c-45d1-bf90-9e3d1654c3cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_681bf5ee-5ef4-4f16-bb48-458175dc6363" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_681bf5ee-5ef4-4f16-bb48-458175dc6363" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c55ba953-1053-470b-a200-8fdb9118e3ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:to="loc_us-gaap_RelatedPartyDomain_c55ba953-1053-470b-a200-8fdb9118e3ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6df6e274-e92b-46b5-bc3d-1e9dc1b1bef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:to="loc_us-gaap_RelatedPartyDomain_6df6e274-e92b-46b5-bc3d-1e9dc1b1bef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_64399451-922b-4fe0-b9af-de1fbea07e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6df6e274-e92b-46b5-bc3d-1e9dc1b1bef3" xlink:to="loc_us-gaap_CorporateJointVentureMember_64399451-922b-4fe0-b9af-de1fbea07e35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d84ffc3b-8624-44a5-a10e-8af5f6a3d429_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d84ffc3b-8624-44a5-a10e-8af5f6a3d429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b61560d0-9fd8-4200-a40f-b25906c474b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b61560d0-9fd8-4200-a40f-b25906c474b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_32879aff-7fa1-467c-9663-999e73a3ed9d" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b61560d0-9fd8-4200-a40f-b25906c474b8" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_32879aff-7fa1-467c-9663-999e73a3ed9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e8d81a51-ba7c-466a-9c09-308dcbe91ab7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:to="loc_us-gaap_ReportingUnitDomain_e8d81a51-ba7c-466a-9c09-308dcbe91ab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_14335b03-d5ca-46e1-9f0d-c05979d23fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:to="loc_us-gaap_ReportingUnitDomain_14335b03-d5ca-46e1-9f0d-c05979d23fd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_ed80774b-54e9-447f-8d6a-2a47c9aa0aff" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_14335b03-d5ca-46e1-9f0d-c05979d23fd7" xlink:to="loc_mck_RexallHealthMember_ed80774b-54e9-447f-8d6a-2a47c9aa0aff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87f1b40f-aa27-4681-b36b-f18e1d4cb22a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87f1b40f-aa27-4681-b36b-f18e1d4cb22a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_59bc6eb0-aa7f-41d4-84d5-6c21f72e0828" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87f1b40f-aa27-4681-b36b-f18e1d4cb22a" xlink:to="loc_mck_RexallHealthMember_59bc6eb0-aa7f-41d4-84d5-6c21f72e0828" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c3773583-add6-4bec-ae37-d380916650e0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c3773583-add6-4bec-ae37-d380916650e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_61b8471f-362b-42ed-b6ec-8efa9fdde239" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_61b8471f-362b-42ed-b6ec-8efa9fdde239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThirdPartySellerofRexallHealthMember_2e0fba8d-e623-4107-9098-3775e1c08eaf" xlink:href="mck-20210331.xsd#mck_ThirdPartySellerofRexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_61b8471f-362b-42ed-b6ec-8efa9fdde239" xlink:to="loc_mck_ThirdPartySellerofRexallHealthMember_2e0fba8d-e623-4107-9098-3775e1c08eaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5144a2eb-2cc9-4d36-94c7-ab48e30b460b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:to="loc_srt_SegmentGeographicalDomain_5144a2eb-2cc9-4d36-94c7-ab48e30b460b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:to="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_1cd8f592-0cb4-4452-8306-484abc83e56e" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:to="loc_country_CA_1cd8f592-0cb4-4452-8306-484abc83e56e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_d3a38f7f-2211-44e1-8c41-1875586790a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:to="loc_srt_EuropeMember_d3a38f7f-2211-44e1-8c41-1875586790a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7d747d64-6f0f-46e4-851e-474bfb97b510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7d747d64-6f0f-46e4-851e-474bfb97b510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_11ef5c11-dfd5-4a3d-862f-c0c51e90f1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7d747d64-6f0f-46e4-851e-474bfb97b510" xlink:to="loc_us-gaap_DomesticPlanMember_11ef5c11-dfd5-4a3d-862f-c0c51e90f1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_161a66e1-bd20-4bdd-bf5e-d89b61cf88cf" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_11ef5c11-dfd5-4a3d-862f-c0c51e90f1e1" xlink:to="loc_country_US_161a66e1-bd20-4bdd-bf5e-d89b61cf88cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_dadac1d7-6924-47cb-8a44-e1ea07349825_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_dadac1d7-6924-47cb-8a44-e1ea07349825_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0c29e8ea-3812-4dea-aa22-38bddcd4d1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0c29e8ea-3812-4dea-aa22-38bddcd4d1bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_87c8c4a7-7b48-4489-ba6d-832f20cc0b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0c29e8ea-3812-4dea-aa22-38bddcd4d1bb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_87c8c4a7-7b48-4489-ba6d-832f20cc0b2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cd774821-0694-4090-a149-333dfc0716cd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:to="loc_srt_LitigationCaseTypeDomain_cd774821-0694-4090-a149-333dfc0716cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:to="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_b7bb2e1e-01d9-4e08-a1ea-45c2f3fdaa6c" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_b7bb2e1e-01d9-4e08-a1ea-45c2f3fdaa6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_10ac7d5a-5ace-458f-b411-4acf9edbe383" xlink:href="mck-20210331.xsd#mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:to="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_10ac7d5a-5ace-458f-b411-4acf9edbe383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_54956706-c129-4f08-b162-c52de49970a8" xlink:href="mck-20210331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:to="loc_mck_ShareholderDerivativeActionMember_54956706-c129-4f08-b162-c52de49970a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5842f4e0-97f6-4fdb-9d0a-dfb43726805c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:to="loc_srt_ConsolidationItemsDomain_5842f4e0-97f6-4fdb-9d0a-dfb43726805c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:to="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9a655555-b62b-48b6-87fc-c1e3be15c305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:to="loc_us-gaap_OperatingSegmentsMember_9a655555-b62b-48b6-87fc-c1e3be15c305" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fd677eae-fb2d-42f9-baa5-32bdf833c32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fd677eae-fb2d-42f9-baa5-32bdf833c32d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9efc7fde-04d1-4852-a69d-c95da2ee8f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9efc7fde-04d1-4852-a69d-c95da2ee8f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0617732f-c9a8-42bf-9ffe-45c1308aaf96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9efc7fde-04d1-4852-a69d-c95da2ee8f4e" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0617732f-c9a8-42bf-9ffe-45c1308aaf96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a46f38f3-6753-42d0-979d-804556ad26ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a46f38f3-6753-42d0-979d-804556ad26ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41d9e2f7-d510-4e62-ac09-188865277462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41d9e2f7-d510-4e62-ac09-188865277462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_321a266b-e76a-4ab9-bda6-ff43dff251d8" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41d9e2f7-d510-4e62-ac09-188865277462" xlink:to="loc_mck_GermanWholesaleBusinessMember_321a266b-e76a-4ab9-bda6-ff43dff251d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_3ca40269-6dfe-4527-8eba-660d0a7bb1a7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_3ca40269-6dfe-4527-8eba-660d0a7bb1a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_7fae05b8-96d7-4994-aa32-ba23a42f8cb5" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_7fae05b8-96d7-4994-aa32-ba23a42f8cb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_7e43ae1d-c712-4727-b2eb-0408f8a9455d" xlink:href="mck-20210331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_7e43ae1d-c712-4727-b2eb-0408f8a9455d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended" id="ife09192d4c2447ea8c1a08f946714ea7_SegmentsofBusinessScheduleofSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_1e84a96e-0ccf-4e8a-8225-f4b05e5a2814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_RevenuesAbstract_1e84a96e-0ccf-4e8a-8225-f4b05e5a2814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_543739f7-c26b-4404-b15b-03a3dcd91593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_1e84a96e-0ccf-4e8a-8225-f4b05e5a2814" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_543739f7-c26b-4404-b15b-03a3dcd91593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_1f57be6a-d77f-4ed3-b34a-4dba4fadf808" xlink:href="mck-20210331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_1f57be6a-d77f-4ed3-b34a-4dba4fadf808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_217fe228-bc17-4784-b575-ac9c57449231" xlink:href="mck-20210331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_217fe228-bc17-4784-b575-ac9c57449231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_511413e0-6d14-4d4c-9408-6cb285665c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_us-gaap_InterestExpense_511413e0-6d14-4d4c-9408-6cb285665c0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_343935ce-bffe-45c5-b745-a72419049a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_343935ce-bffe-45c5-b745-a72419049a8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_d217edf2-c86d-4083-a8ad-512a41685dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_d217edf2-c86d-4083-a8ad-512a41685dc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2fd84572-76ea-4bfc-93de-e746ca831dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_d217edf2-c86d-4083-a8ad-512a41685dc2" xlink:to="loc_us-gaap_DepreciationAndAmortization_2fd84572-76ea-4bfc-93de-e746ca831dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a05ac065-904a-4ec0-afd3-921250f920b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a05ac065-904a-4ec0-afd3-921250f920b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_6dde069e-5f9c-4d9b-baa8-a030d0279b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a05ac065-904a-4ec0-afd3-921250f920b5" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_6dde069e-5f9c-4d9b-baa8-a030d0279b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_59f4bb73-fa12-4403-b63e-fe677775d196_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:to="loc_us-gaap_SegmentDomain_59f4bb73-fa12-4403-b63e-fe677775d196_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:to="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_e20a27de-30b4-4df7-a196-51585f29afaa" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_USPharmaceuticalSegmentMember_e20a27de-30b4-4df7-a196-51585f29afaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4dbdde9e-2fdd-4ae2-af47-d8f548c6e134" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_InternationalSegmentMember_4dbdde9e-2fdd-4ae2-af47-d8f548c6e134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_547740a9-2d88-4bbf-93c4-cb025cb26e1f" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_547740a9-2d88-4bbf-93c4-cb025cb26e1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_eabce4c5-d409-4df9-aad4-acde26f8cece" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_eabce4c5-d409-4df9-aad4-acde26f8cece" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:to="loc_srt_ConsolidationItemsDomain_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:to="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d5a5c10d-489d-4d76-b501-c6e3363bc53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:to="loc_us-gaap_OperatingSegmentsMember_d5a5c10d-489d-4d76-b501-c6e3363bc53c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_32583e45-5d19-44d8-8fa1-f32bc8ce400f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:to="loc_us-gaap_CorporateNonSegmentMember_32583e45-5d19-44d8-8fa1-f32bc8ce400f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_47c214b3-361f-4357-a57a-bd21580fc9d2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:to="loc_srt_SegmentGeographicalDomain_47c214b3-361f-4357-a57a-bd21580fc9d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:to="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fa70ccda-0830-4c0a-b8c6-4ced3563ce9d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:to="loc_country_US_fa70ccda-0830-4c0a-b8c6-4ced3563ce9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_9c93bb41-48e5-419e-9cb7-a0e64c666098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:to="loc_us-gaap_NonUsMember_9c93bb41-48e5-419e-9cb7-a0e64c666098" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" xlink:type="extended" id="ic1e9a3365d544aeab0d6bc35914ddb02_SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_da4cb0e3-0485-4b27-9eca-97990d4d507c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:to="loc_us-gaap_AssetsAbstract_da4cb0e3-0485-4b27-9eca-97990d4d507c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_15315091-f6f2-41ae-9e27-16c44559c356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_da4cb0e3-0485-4b27-9eca-97990d4d507c" xlink:to="loc_us-gaap_Assets_15315091-f6f2-41ae-9e27-16c44559c356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3d482be4-7e6e-4419-b475-eca65a601ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3d482be4-7e6e-4419-b475-eca65a601ffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_8baa423c-a02d-4577-926a-b328054b77f8" xlink:href="mck-20210331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3d482be4-7e6e-4419-b475-eca65a601ffd" xlink:to="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_8baa423c-a02d-4577-926a-b328054b77f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e8e29794-75ce-4c0c-b475-00ae4720c2cd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:to="loc_srt_ConsolidationItemsDomain_e8e29794-75ce-4c0c-b475-00ae4720c2cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:to="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_305e661a-250a-4cac-af9f-746b756e9a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:to="loc_us-gaap_OperatingSegmentsMember_305e661a-250a-4cac-af9f-746b756e9a21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5144a624-d76d-4a1c-9ec8-b57e481e55d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5144a624-d76d-4a1c-9ec8-b57e481e55d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:to="loc_us-gaap_SegmentDomain_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:to="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_97bff15b-a2e5-42e4-a0d4-05d91a4c7910" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_USPharmaceuticalSegmentMember_97bff15b-a2e5-42e4-a0d4-05d91a4c7910" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_57a9073e-9f10-4b97-96a5-312e4c349472" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_InternationalSegmentMember_57a9073e-9f10-4b97-96a5-312e4c349472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_2d76daf4-d187-43c1-b899-ad45c09b0ae0" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_2d76daf4-d187-43c1-b899-ad45c09b0ae0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_0761ea9b-24d8-4428-891c-8d8114c41c8c" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_0761ea9b-24d8-4428-891c-8d8114c41c8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4ce5088c-e712-4410-a822-6d5f908ea2a2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:to="loc_srt_SegmentGeographicalDomain_4ce5088c-e712-4410-a822-6d5f908ea2a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:to="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e9ca5fbb-7898-4e59-8070-32cba84caa36" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:to="loc_country_US_e9ca5fbb-7898-4e59-8070-32cba84caa36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_21e4b687-f1d9-44f8-b1d6-3af6e4153c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:to="loc_us-gaap_NonUsMember_21e4b687-f1d9-44f8-b1d6-3af6e4153c77" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnaudited"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="extended" id="i6c95018613a3446d818bf82fe40e0c33_QuarterlyFinancialInformationUnaudited"/>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnauditedTables"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended" id="i49400edf7bd345fd921759a63ebc652f_QuarterlyFinancialInformationUnauditedTables"/>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" xlink:type="extended" id="i637e67adbccc408ab40f8a20157e0471_QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="mck-20210331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended" id="i3be0698a204a4d57805a5db99ab54188_SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="ibf5f168466a74c26879d4dba9607d382_SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0505ac31-29cc-4344-8ee2-620e15fa07cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_0505ac31-29cc-4344-8ee2-620e15fa07cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_20b05c8c-342e-4512-889c-fc626e49bcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_20b05c8c-342e-4512-889c-fc626e49bcf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_0c702f97-f8aa-4660-a951-8ebfbca3f9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_0c702f97-f8aa-4660-a951-8ebfbca3f9f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d57981da-a04a-4f22-a9a8-4df392360fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d57981da-a04a-4f22-a9a8-4df392360fb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_e6029409-84e8-46b1-a1e2-634ae8daa14d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_7d8d4223-61fe-4ae2-9532-4020a09e24e5" xlink:href="mck-20210331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:to="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_7d8d4223-61fe-4ae2-9532-4020a09e24e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_cf793303-9ccb-4cbb-86e2-948f92733651_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_cf793303-9ccb-4cbb-86e2-948f92733651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_f6db1052-56a4-429a-84f9-4ed63318b829" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_f6db1052-56a4-429a-84f9-4ed63318b829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember_f0cdc0ec-baa8-498c-8e8e-74849cd9597c" xlink:href="mck-20210331.xsd#mck_OtherAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_mck_OtherAllowancesMember_f0cdc0ec-baa8-498c-8e8e-74849cd9597c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_e7c33bd5-594a-4928-9795-09c3b5041ead" xlink:href="mck-20210331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_e7c33bd5-594a-4928-9795-09c3b5041ead" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_3fd5d8c1-74c9-4329-aee1-45fa8f58bb79" xlink:href="mck-20210331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_3fd5d8c1-74c9-4329-aee1-45fa8f58bb79" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>mck-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0a91717b-5b9a-4470-a716-9c00214a8bdd,g:f2a8631c-ae82-4a44-9090-35d7005e9a98-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_262a853b-bd02-457a-a459-de4aee4fe036_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_63475630-bd8c-4c00-85d1-6c78c183f7e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_9d0a9ca0-2d9a-4703-90ae-e9477bddb93c_terseLabel_en-US" xlink:label="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.28% Notes due March 15, 2019</link:label>
    <link:label id="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_label_en-US" xlink:label="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Two Eight Notes Due March Fifteenth Two Thousand Nineteen [Member]</link:label>
    <link:label id="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_documentation_en-US" xlink:label="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Two Eight Notes Due March Fifteenth Two Thousand Nineteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" xlink:href="mck-20210331.xsd#mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" xlink:to="lab_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a79d7ddb-7570-4771-af6b-c99dc100c953_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_24517be3-f805-4486-b83f-b6a9b1b60cb9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0222d94c-d865-4ed6-890d-e6f3b640b32d_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_9e9e67cc-bb73-4d88-9ba6-d1a3727176ee_terseLabel_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK)</link:label>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_label_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK) [Member]</link:label>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_documentation_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember" xlink:href="mck-20210331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NorwegianPublicServicePensionFundSPKMember" xlink:to="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_636f20c5-1c5d-4f31-ae80-fb6dcd44f0b0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0f3f97b1-eb79-405a-a5d2-ac134a69a849_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_40b6ca11-c103-4894-a2f2-9ecd1b3a449b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_be1991d8-9c33-4793-adad-19d742992365_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_8ff9be03-497a-4eda-996a-bb314f8fb6e7_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition accounting, transfers and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember_c5f89762-8d5d-4cf6-b30e-e52dac46dcd1_terseLabel_en-US" xlink:label="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset and Store Assets Impairment</link:label>
    <link:label id="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember_label_en-US" xlink:label="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset and Store Assets Impairment [Member]</link:label>
    <link:label id="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember_documentation_en-US" xlink:label="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset and Store Assets Impairment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IntangibleAssetandStoreAssetsImpairmentMember" xlink:href="mck-20210331.xsd#mck_IntangibleAssetandStoreAssetsImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IntangibleAssetandStoreAssetsImpairmentMember" xlink:to="lab_mck_IntangibleAssetandStoreAssetsImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_35f3cb7c-f7c2-447b-a8d5-40cd2e49bd4d_terseLabel_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_label_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_documentation_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:href="mck-20210331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:to="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_43279cd0-5c94-4383-89d7-dd462b3e04f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of change in U.S. tax rate on temporary differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_0f7640d2-ef3e-4f57-a3a5-6a451995ec37_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_7c412898-c152-407c-809a-32664150fd62_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3917292c-a7e6-42f3-8dac-8533b899af67_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_834e8e79-eeff-40e5-9ea7-9ef971c3cea5_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_42d9a3a5-4bad-4230-80d5-bd25f3c7b089_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3ee174b6-58ed-4562-81d6-69a7f4f20256_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_87448b0a-dbc6-4a3f-915b-658522315b11_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ae1a3dc1-b2d1-410d-9a67-2d1c74e903a1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_03b7a0da-137c-4de7-bb3e-b6ae743640e6_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_79fbe4da-7f75-405b-af16-a66940cbf2ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6689cea0-6ec5-401c-b24e-e8b226c79d10_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_5f5c5245-0a24-46e5-9d59-427cbdba6644_terseLabel_en-US" xlink:label="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_label_en-US" xlink:label="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Percent Notes Due March One Two Thousand Forty One [Member]</link:label>
    <link:label id="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_documentation_en-US" xlink:label="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Percent Notes Due March One Two Thousand Forty One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" xlink:href="mck-20210331.xsd#mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" xlink:to="lab_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7f6a3aa3-673a-4c4f-ba5a-3425e51b0f6e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7167d98c-62f6-43a4-9eb0-0cc5d1f1916e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_fb8b98d1-ceb4-48ef-8278-727b12be2f5c_terseLabel_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status (as a percent)</link:label>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_label_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Funded Status, Percentage</link:label>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_documentation_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Funded Status, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage" xlink:href="mck-20210331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MultiemployerPlanFundedStatusPercentage" xlink:to="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_9e7f8d25-c659-4882-9486-343b2a1b21f2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement payments made</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f345c3c6-d8e1-42b4-8f2b-a4d97477b1ad_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bb85aae6-77e6-40bb-a64a-4660488b4466_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c30fbe90-b92e-4e43-8d3c-96aa645a0a93_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_9ae2cbd7-ddbd-4c78-b521-c3c4f74016e1_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_1da55243-622e-4888-a6ee-9ca1c6fc5a7b_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc.</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_label_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareInc.Member" xlink:to="lab_mck_ChangeHealthcareInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7dada6e-1a61-4bc8-8685-b570f4ebbf27_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_1ce4d3fe-9fb5-4a48-8bc3-730e47e286cb_terseLabel_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</link:label>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_label_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</link:label>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_documentation_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:href="mck-20210331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:to="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_7838840b-bde5-4e15-92f5-20245cdf3ca7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_9430a7d2-e7ef-44a8-a8bd-db5daa716787_netLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_f7804180-5aba-4f6d-8ad4-3eb932a5290b_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fa4dcdec-6af5-4ddf-8215-70b531530ed0_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2b2674cd-2b71-47dc-907a-6537446176bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5323e20a-daa7-4580-be20-e3edbab890b3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_50a02130-b312-49d1-84f8-dffb55afc195_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c31c0fb4-b882-4c60-88c7-591ac2f1326c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_19b3aea3-24b5-4f8e-aa1d-93b8ec5889ea_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_caa55c04-7541-4058-894a-0f1757689e7d_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life (years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_ea1aa875-36e3-410e-9e04-5bfd07306b0f_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related litigation and claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_63a63e29-d7cc-47a0-bc81-4ea0a993467b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_efcf3241-2e82-4941-a4e8-dab813c61d54_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Shares Purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9a0ecbad-572b-4873-8302-08facd935f2f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_bfc86e11-061d-420b-b386-6c160ee2ad4c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made in exchange for additional membership interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1855261c-d7da-44e6-a5eb-a52e4f9c223c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72d36ea5-5b24-4c2e-aa27-b4df79eb9dca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3e87c4bb-434e-4999-9baf-fc1e5563557a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_824052cc-dd79-4644-b379-a7b8fd78cc8e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5d3c368a-0fa6-4e02-9c3b-6cd5c7ede52d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_05b444ee-191c-4edc-9b23-ace4c43f23b5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_5ee8b452-9d2f-450d-a056-0a6eb98f58ab_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_8ec6337b-3f71-48b4-bb0a-28f48e04694c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains associated with equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d1ca6a0f-18db-4f5b-a798-ecbbd4312532_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_89bd7933-1bf5-43b1-9de9-49b2e3794c24_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_85ca491e-db43-428a-b389-b45ab04ffb89_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_a0505946-c192-49c0-b183-908623a4f7e0_terseLabel_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit value of cash and cash equivalents (in dollars per share)</link:label>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_label_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit Value Of Cash And Cash Equivalents</link:label>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_documentation_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit value of cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents" xlink:href="mck-20210331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitValueOfCashAndCashEquivalents" xlink:to="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_acb46d26-bb92-46f1-8939-c4930387c056_terseLabel_en-US" xlink:label="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_label_en-US" xlink:label="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Seven Zero Percent Notes Due December Fifteen Two Thousand Twenty Two [Member]</link:label>
    <link:label id="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_documentation_en-US" xlink:label="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Seven Zero Percent Notes Due December Fifteen Two Thousand Twenty Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" xlink:href="mck-20210331.xsd#mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" xlink:to="lab_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2d21fb05-d469-4aeb-9bb7-f285edabdd30_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_2f63a0a5-b3c2-456f-9203-a92d96872b2b_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_51d0586c-d768-42f1-bdee-b4c4c4a0fbc5_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_ac0f70d2-70ad-44cb-8646-cbe742bef78c_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_5a5a5221-0a43-4f67-adb1-7bf6fd830f8e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_648eef5a-eb5d-4b58-ac34-adf5c326e823_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices lower limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_9794c6e1-4044-4df8-9e9b-9d2f51ec8676_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ExchangeOfferSharesExchanged_728fb68d-3835-4955-9d6b-227b1a3ed21c_terseLabel_en-US" xlink:label="lab_mck_ExchangeOfferSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock exchanged (shares)</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesExchanged_label_en-US" xlink:label="lab_mck_ExchangeOfferSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Exchanged</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesExchanged_documentation_en-US" xlink:label="lab_mck_ExchangeOfferSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Exchanged</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ExchangeOfferSharesExchanged" xlink:to="lab_mck_ExchangeOfferSharesExchanged" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_d9d320cf-5c8e-4bd4-b1b7-d1a1f430af0c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_be6ff8dd-fa5e-4304-93df-1068af547f06_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_48c5bd94-ce6d-4e20-ad4d-5884c65ff729_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_072fcb77-663b-474b-965c-0d21b3d8a08b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7b6c66ab-c3c5-486a-b60c-2f4adfa65f18_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_a6401f1a-9284-462c-81a3-02a655dba1b4_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2024</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Three</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_cb0f1f91-05d8-4753-af7e-1dce456df694_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_d45d092c-67b2-4dec-b0dc-82cc0ca046fc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ef2de578-2f01-4fbb-afa2-9a69a6e9fcfb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_aa715a15-1158-43bc-9403-885438254de3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_5f0e1449-708a-4fd7-9aaf-070c30b09584_terseLabel_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which payroll is deducted to purchase shares</link:label>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_label_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Period To Purchase Shares Through Payroll Deductions</link:label>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_documentation_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share based compensation period to purchase shares through payroll deductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:href="mck-20210331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:to="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_9ccb8782-5fd5-4821-97b5-b496ad9c9a0e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of stock options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_05b2b0d3-72c6-431e-8398-d5db4e55fe46_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e095e6bb-2850-4f96-b915-ed8fefacca68_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fees charged under the TSA</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_b3d18bfc-503d-4d52-b34c-cd6cd7178644_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThirdPartySellerofRexallHealthMember_bffb30a3-a0bb-49aa-b823-33767743b4f7_terseLabel_en-US" xlink:label="lab_mck_ThirdPartySellerofRexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party Seller of Rexall Health</link:label>
    <link:label id="lab_mck_ThirdPartySellerofRexallHealthMember_label_en-US" xlink:label="lab_mck_ThirdPartySellerofRexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party Seller of Rexall Health [Member]</link:label>
    <link:label id="lab_mck_ThirdPartySellerofRexallHealthMember_documentation_en-US" xlink:label="lab_mck_ThirdPartySellerofRexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party Seller of Rexall Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThirdPartySellerofRexallHealthMember" xlink:href="mck-20210331.xsd#mck_ThirdPartySellerofRexallHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThirdPartySellerofRexallHealthMember" xlink:to="lab_mck_ThirdPartySellerofRexallHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_f2eb3a12-ba3e-4174-8b2e-60d169c10843_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_73407527-5ccd-4c8a-9fa4-dc52055754c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_47feea1f-5784-4239-9ba8-0133a8ee42de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_76cf65af-ef46-49fa-a3ec-aceba9cfeeca_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6806a474-ddfb-4c1f-850a-b212eeca601e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_dae24054-925a-4bce-8310-5ff194aab172_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_0f82377d-18fe-4037-a690-1f2952245237_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b8923c58-71a9-4d03-acf1-386ffea87f64_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total consolidated revenues (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_a9d131e0-d62d-4a8b-aea3-d07a536113e6_totalLabel_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired, net of cash and cash equivalents</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_label_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of Cash and Cash Equivalents</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_documentation_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" xlink:to="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_00f24ce5-2d43-4355-a913-4ae89242a13b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_27866880-6375-4b6e-8a60-6f355b1ed7e9_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCounties_03612b19-30aa-4715-b343-746755d85fe2_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of county governments that brought case</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCounties_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Counties</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCounties_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCounties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Counties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCounties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCounties" xlink:to="lab_mck_LossContingencyNumberofCounties" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_4ccf2692-0dc8-4414-a06b-400f43d81f6f_terseLabel_en-US" xlink:label="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment, discount rate (percent)</link:label>
    <link:label id="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_label_en-US" xlink:label="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Method for Fair Value Determination, Discount Rate</link:label>
    <link:label id="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_documentation_en-US" xlink:label="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Method for Fair Value Determination, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" xlink:href="mck-20210331.xsd#mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" xlink:to="lab_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7157235a-c337-47df-8be6-f00f83b3027c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_54110832-bcad-4e98-af7e-acbd15bc6980_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of deferred tax liability</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reversal of Deferred Tax Liability</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reversal of Deferred Tax Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentsReversalofDeferredTaxLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" xlink:to="lab_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_c5509ca8-7c52-4ec5-be41-8a77df1ae2d8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_4572d3d3-6dde-478d-8a23-e7be37ab54c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingLeaseImpairmentLossNetOfTax_78b384d2-7e35-4619-b56d-cc4b3e17eb4b_terseLabel_en-US" xlink:label="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_mck_OperatingLeaseImpairmentLossNetOfTax_label_en-US" xlink:label="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss, Net of Tax</link:label>
    <link:label id="lab_mck_OperatingLeaseImpairmentLossNetOfTax_documentation_en-US" xlink:label="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:href="mck-20210331.xsd#mck_OperatingLeaseImpairmentLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:to="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1c5fae77-594c-49f3-89ac-7ee3e415c77e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_08ef9728-e254-447a-94c7-17f100c7133b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges related to customer bankruptcy</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_d9ddb01f-bf0a-43ea-bd8e-53efdc7d1fbb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_52c3bf73-a84b-4825-ab18-5287b55f5d0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and benefit related accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_201dae94-46d7-4802-94a1-8d5c635d756a_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate funds and Other</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Funds [Member]</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanOtherFundsMember" xlink:to="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_2359e152-f9d1-4364-a611-b7aa3e7a0b35_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_65f8c771-a1eb-4aef-b89f-63ba5a190819_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_4d515798-30d0-463c-84ce-8ccc16474871_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_e5eb4f3f-cfb1-4379-8e3b-21cada6100e0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_70ddafbb-91b9-41fa-a1a6-3299a8ba3ef5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_00d52e64-afed-4f45-8bf8-0bb43efcad7b_terseLabel_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution</link:label>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_label_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distributions Reporting Unit - June 2018 Two [Member]</link:label>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_documentation_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distributions Reporting Unit - June 2018 Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" xlink:to="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_89a662cb-0382-40ab-a805-8d1652e60371_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), before any tax effect, related to accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_b0c06c9b-839e-46c6-97e9-97b3fa2c5bd6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_3bc02e9d-7f68-4cc9-892a-7cfa34dbdc56_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities Available-for-Sale</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_2d1d5b85-6e28-40fd-8856-89a478ec8102_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:to="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7509e522-f554-4155-9720-d16255b9d10e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_61b47661-32de-458f-a3c1-6c8e7594c548_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fe0dbff-9f09-4df5-a957-afcd18f51223_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_26fa4d1c-3051-4b21-af3b-f20607c153d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_218db300-650a-4293-8bd1-0b764739288e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_4f495398-cfc7-4ecc-8fe4-75a633bde6b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:to="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_91ca7b51-6efe-4f84-9a75-0df88213c770_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_0bdb2de9-8610-42a1-8662-0cccda64d931_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_3e96e283-fe02-47b4-80df-66c4b79c1dc0_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss) resulting from demographic and assumption changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_89c32942-4de7-4f74-8252-1a23fae3776d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e0aaf89c-5f87-48a9-9886-8f5dd0fd175f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b6fe93d2-69c3-4b3e-ab81-e059fc0df7c4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9de25454-21c0-44a4-ba73-37e8a2da2f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_a7ba7403-bb5b-46e6-b0d2-96bba2bc24e1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34b64310-7b2a-46e2-8045-d8606b5c819d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_17de9796-868e-40d5-97b4-24a6740d3487_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_label_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:to="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HazardousSubstanceSites_8dcdff92-6511-4fff-bc77-4a1381e8443d_terseLabel_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites, number</link:label>
    <link:label id="lab_mck_HazardousSubstanceSites_label_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites</link:label>
    <link:label id="lab_mck_HazardousSubstanceSites_documentation_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites that hazardous substances were allegedly disposed at.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites" xlink:href="mck-20210331.xsd#mck_HazardousSubstanceSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HazardousSubstanceSites" xlink:to="lab_mck_HazardousSubstanceSites" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_104cf728-304b-47e2-b3f2-ba21418666c3_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity Premium Transfer</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Annuity Premium Transfer</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Annuity Premium Transfer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_4440bcbf-af6f-44dd-82fb-c63d9c878b71_terseLabel_en-US" xlink:label="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</link:label>
    <link:label id="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_label_en-US" xlink:label="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized</link:label>
    <link:label id="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_documentation_en-US" xlink:label="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:href="mck-20210331.xsd#mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:to="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8a95814c-4394-43ad-b9f1-6fd317d409e7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_99e8100b-b38f-46af-bc39-24aa97da548f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_d7b94141-b5c7-43e7-bb26-ac1af67a0469_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility)</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20210331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_51a2318a-e668-4b35-9bf5-90f708dc6f83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_8ca4ed18-e17e-490e-9f69-bbde9b7ccd6f_negatedLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net discrete tax benefit</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:href="mck-20210331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:to="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CoverMyMedsLLCMember_76f04edd-97a8-4159-af9d-d66f6937bf6c_terseLabel_en-US" xlink:label="lab_mck_CoverMyMedsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMM</link:label>
    <link:label id="lab_mck_CoverMyMedsLLCMember_label_en-US" xlink:label="lab_mck_CoverMyMedsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CoverMyMeds, LLC [Member]</link:label>
    <link:label id="lab_mck_CoverMyMedsLLCMember_documentation_en-US" xlink:label="lab_mck_CoverMyMedsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CoverMyMeds, LL ("CMM") [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CoverMyMedsLLCMember" xlink:href="mck-20210331.xsd#mck_CoverMyMedsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CoverMyMedsLLCMember" xlink:to="lab_mck_CoverMyMedsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_bdde192f-e407-4c14-8c4c-4c9198649efd_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K.</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_8549eb98-d096-47be-9bbc-90748ca74365_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_c515a5bc-5faf-4cd2-b72b-89f375e5e545_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss, Financial Instrument [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="lab_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SiteContingencyTimeFrameOfDisbursements_c15e9e8e-972e-4ab1-b7c1-15da5dd843c1_terseLabel_en-US" xlink:label="lab_us-gaap_SiteContingencyTimeFrameOfDisbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time frame of disbursements</link:label>
    <link:label id="lab_us-gaap_SiteContingencyTimeFrameOfDisbursements_label_en-US" xlink:label="lab_us-gaap_SiteContingencyTimeFrameOfDisbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Time Frame of Disbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SiteContingencyTimeFrameOfDisbursements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SiteContingencyTimeFrameOfDisbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SiteContingencyTimeFrameOfDisbursements" xlink:to="lab_us-gaap_SiteContingencyTimeFrameOfDisbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EnvironmentalLitigationMember_1117df71-4308-4823-bcf6-2041230d6cff_terseLabel_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation</link:label>
    <link:label id="lab_mck_EnvironmentalLitigationMember_label_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation [Member]</link:label>
    <link:label id="lab_mck_EnvironmentalLitigationMember_documentation_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember" xlink:href="mck-20210331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EnvironmentalLitigationMember" xlink:to="lab_mck_EnvironmentalLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_e4fa82b4-8b5b-49af-abcc-44839266acfd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding fair value of derivatives on a gross basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ffb10ac5-3e82-405f-bf28-e8757575c405_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_e464cc73-62c5-49ce-bc85-0a2c3d4a39b0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconsolidated VIE maximum exposure to loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_0916cc61-723d-4620-92fa-bb80b249c884_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_6dac3663-bdc8-4f14-932e-9c3b24f072cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_cac15f77-9612-4390-b7ed-a86debc1214d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedParties_3f7434ee-c7dd-4b25-8cae-e89939da876e_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedParties" xlink:to="lab_us-gaap_DueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_e0e7fc70-b5a6-4a63-a44e-309261df750e_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_56af0e1f-42df-4024-b4b5-5c6e145817c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_1bae6477-2189-4263-a7c8-eebd56500ea2_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges</link:label>
    <link:label id="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_label_en-US" xlink:label="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:href="mck-20210331.xsd#mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:to="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_0336c71d-4e1e-40a3-8e75-d50b11bf57f7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal option increments for leases (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_e5c5f7b3-0d66-43f5-8478-0b54d0fb7534_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_a3a4fef9-2f15-4bfd-99b9-2037b85c5e7e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d4bf9569-50ea-49c2-ac50-8b3a9f460667_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_9db494ba-05f4-4c4d-866a-526fe44e492e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_89b04b2f-22af-4393-ba1e-69c3da210f5c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_8f5e9c73-2124-4a35-9055-b469dddaae9d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_70ee4ead-e249-486f-8fdc-c70cab598c35_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_03a34c0c-1647-4408-978e-d16ca4e15da5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_70212a57-7389-440f-ae19-a20b359dea53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_74df9e68-901e-43a4-86b8-2c2034627ac1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3078e0de-4f66-44f3-a773-dd3915b05247_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_5443c4fb-7d9b-4465-8deb-30990bf2a44b_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fa96a40f-45b3-44ec-8c16-2e535be9ffdb_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_6fe254c4-a7f0-473a-8043-4cc4ac046b64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_af0dbb68-b424-46e1-be9a-034a4f0bbb5b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and handling costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_f3177741-ca81-4b42-8ae5-c2df2c7b661b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_e64e9164-28ea-4f39-9e51-4a8683dc057f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of lease costs and supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_085d30ba-442e-441f-9340-ba542cc69c64_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_6c1e0e74-d58d-49f4-b3f5-2e0271a0b34d_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Retirement-Related Benefit Plans, Foreign Currency Translation Adjustments and Other</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7e12f1cb-ad65-424e-8d8f-c258a791a1ce_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_38480e5b-4af9-467a-bd09-7cec6815800c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_d4d4f65d-9413-4e9d-b527-33cb061b283c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitMember_95cebf53-1473-47e7-8f2a-625734cf96b3_terseLabel_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution</link:label>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitMember_label_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distributions Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitMember_documentation_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distributions Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitMember" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmaceuticalDistributionsReportingUnitMember" xlink:to="lab_mck_PharmaceuticalDistributionsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_933f3c54-00ef-4bca-ae52-02027d18e1bc_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_44e91577-3994-4e0d-84da-e6c596182719_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_690d70b6-8228-45f6-ac97-6b54fa9b6317_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE consolidated assets</link:label>
    <link:label id="lab_us-gaap_Assets_54e59d5a-0a73-4a06-b83a-f9eeea9989fa_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_bf5a39de-f8d3-4c4e-a0a0-aad639afbbe0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Balances and Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cf1faf5b-a298-45f4-8280-a89ea3c8b358_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_0ebecca4-91d7-4227-a695-81d3e486e45f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3a58ea0e-4a17-44ca-bd17-761a0ebc601d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f70f7cd3-5e25-46eb-aa27-cb9ef4f94894_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_25a7225e-d7a2-4979-a07d-46d1075019a5_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_436e7c27-6357-4fc1-bfff-10a0beae19a2_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_ff9ed236-ed88-438f-9555-6e6f50ccae76_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_79f8fee6-d38b-41a9-bf12-bc73f8da3271_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20210331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_45a98cd5-83a2-43a1-878b-a51802350195_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_bb3eb656-f020-4060-b44b-668caa28cda6_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_75fd0459-4c57-4d2e-acdc-267adde3cbde_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Receivables</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0e917ab8-2eb5-4726-841c-c538645c9dcf_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_7981ab85-1457-4389-b4d0-78ce31ad3d72_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_182afaf5-cd3c-4282-a0c8-ac39288fdf7b_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_0f726bab-04ea-44d3-9467-d05374564d9d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_129956c0-c5a7-4894-9020-a706565e8e8a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_8d2a8d00-d4cb-43bc-95a3-437a719d224a_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt</link:label>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_label_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt [Member]</link:label>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsCustomersDebtMember" xlink:to="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b9260638-a757-45d1-8280-381cc99cb2d4_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE consolidated liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_967e6ad8-ba2a-42f6-a0d3-303f18c49afb_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum redemption value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:to="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_0bfea991-dec9-48c9-a6ec-20804179fc71_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_a618708c-81ee-420c-96ee-362cda8cf172_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_eb74e9ba-4621-44a0-be63-a4096070d000_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a63bb775-a5ba-49d0-9621-36d334ae612b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_24f8bfeb-ee65-4d15-8b5e-cdaaf9cd2c34_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_83e80601-7386-40d4-941f-a56128de501b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_6964802c-95c6-4929-b493-41188e416cbb_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_543b39c7-8d69-496b-8048-9836d4f788a9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest, weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentStockAccepted_0e4b3b94-fa6b-4815-93d5-b246526d11f3_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAccepted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAccepted_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAccepted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAccepted_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAccepted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentStockAccepted" xlink:to="lab_mck_EquityMethodInvestmentStockAccepted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_4a3ab633-afb6-4eb9-8bd6-313782523754_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_114190c5-a479-4835-8928-82270c59df04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_3b5a3b32-f7a8-4b72-8f27-0bc5254c58c4_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_428826bb-0096-43b0-a91b-d9e4f3a2ce75_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_79cad7e7-b8ec-49a9-8235-f1c07a21997e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_e942febd-c6ba-45e4-a144-b1d79547d3d9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable, weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_a7ec465e-0125-47b6-b9e7-da27d7a177c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fd8b366e-a63e-41d6-96c9-0ff1aec65a8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a6b37dc2-7429-45d4-9b56-3156e6dc1ab2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_f70fbedd-4f4f-4dc9-9146-bd118b468295_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20210331.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5be79eda-1003-40d4-a06f-bcd9fba8cb20_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_28bf5f57-75f7-4bf4-b8ee-746821e8f01d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3b031a86-585b-45d4-9419-70f6707b5b53_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_55630515-2b22-4ab6-8445-66d8b1d94a74_terseLabel_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange rate fluctuations</link:label>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_label_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</link:label>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:href="mck-20210331.xsd#mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:to="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_986cbb37-82a5-4067-a653-6eb01a65434a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_28d843d5-3c52-4c67-ab29-c6337584e710_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e3204330-f14d-4b14-a1ce-11be7647a2fd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of investment in joint venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_d82ccd9a-e4a9-46ab-bdff-cbf125f969d0_terseLabel_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Reserves</link:label>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_label_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Reserves [Policy Text Block]</link:label>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierReservesPolicyTextBlock" xlink:href="mck-20210331.xsd#mck_SupplierReservesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SupplierReservesPolicyTextBlock" xlink:to="lab_mck_SupplierReservesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_de5c1c96-0eb3-48b6-ae40-638e9c5613a5_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20210331.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_c064424d-ff48-409b-8b10-439890a74fda_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_ad410f77-fad0-4758-a6b1-c715ad2f86f6_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_2f365387-e7eb-4e4d-b906-1af719d13106_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_cf4e0253-8877-4cf5-9e0b-bd5a9a6874ad_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f3eb5f2-5376-4127-99a3-66ff5d30085a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_de6f38c7-41a9-43ff-b7d5-b094de055eff_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_2b43906f-5f12-4e20-b396-1358533d20c8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_073cfd76-2c26-400a-8ab1-88aae15dc9f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_afc0c3b1-1c58-4679-bc30-126eaf23b3d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_c269ec55-84c2-4c71-8521-c58a05e48860_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_23382c7e-a186-4643-8f20-3930a925259c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4a2d62d0-140b-4db7-9bf3-da1735c3d916_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase consideration paid in cash, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6e190649-902d-4b98-8b47-a43471b3710e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f645a706-d3df-4e91-bffe-e0608d19af03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of restricted stock unit award activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a648cf99-3020-45bc-8243-87ca4fce9868_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_195b2c50-fb4c-4b68-972f-f68df4837494_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received upon exercise</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ea0a7c7a-10f1-40da-9f36-36b84d94fa40_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4c2ee173-3875-4d21-b7ff-8f8e1962ddbc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_8d8bcbed-ed72-48ad-bb33-2efc2fe5a94c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ef95f096-2c2b-45e0-a8db-c5971fa7eb74_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_faf7c242-336b-4be3-8132-7e7b84487b62_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_68c81464-d016-4a7f-8175-7e8aaf9213e7_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_2c50f34d-87ce-4296-8dec-1a92860a6112_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_a35adb02-3fba-4238-9fcb-eb74dc4f5d1d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_6b675029-79a1-4e0d-a96a-a71796b23005_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_22af0823-5dc5-450c-8f23-bb398af88561_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f5c579d5-2874-4c63-b743-fda012b4e30c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3b432f2f-f26a-4f88-83dc-0b41b5025c63_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_84a8057a-8c19-488d-968e-9712cb271623_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_8211e5cb-d59b-4a30-a352-60bc8b299edd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss, prior service and transition obligation, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_f71a0e75-203f-47fe-9ce4-0002e34a1fa0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_273f4d1b-c76d-48fc-90fb-bb3bc7752558_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_57f3b435-40c4-4a3a-bf18-46a5e6cd224c_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_57b15271-909b-4a71-84f2-c7b9dd83a7db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2d8d6ce1-8e10-4ce5-a9bb-c829a0382706_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RexallHealthMember_1d463eca-69de-4d5e-ae02-a271ee2dddb9_terseLabel_en-US" xlink:label="lab_mck_RexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rexall Health</link:label>
    <link:label id="lab_mck_RexallHealthMember_label_en-US" xlink:label="lab_mck_RexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rexall Health [Member]</link:label>
    <link:label id="lab_mck_RexallHealthMember_documentation_en-US" xlink:label="lab_mck_RexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rexall Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RexallHealthMember" xlink:to="lab_mck_RexallHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_771daed3-b28d-477a-8d2c-b55ba91a5608_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax-free gain on investment exit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_8ae0ba94-8e8e-402d-b963-cce91cf7626e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a8d6ac90-d7af-497a-beaf-4ecd78bdce39_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_30c1db95-336a-4fb0-9859-a77228259b24_terseLabel_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_label_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Stock Units [Member]</link:label>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_documentation_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember" xlink:href="mck-20210331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PerformancebasedStockUnitsMember" xlink:to="lab_mck_PerformancebasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b1972e51-53e4-40b5-80f9-4c6e866be098_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_e3b84025-6c33-454c-853f-e9df0088791d_terseLabel_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution</link:label>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_label_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution [Member]</link:label>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_documentation_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember" xlink:href="mck-20210331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SecondPartOfPayContributionMember" xlink:to="lab_mck_SecondPartOfPayContributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_3f5afc0c-034b-47d7-990c-d75a2e025797_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_70426c96-379e-445f-b917-89a7cae304ab_terseLabel_en-US" xlink:label="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due March 1, 2021</link:label>
    <link:label id="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_label_en-US" xlink:label="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Notes Dues March One Two Thousand Twenty One [Member]</link:label>
    <link:label id="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_documentation_en-US" xlink:label="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Notes Dues March One Two Thousand Twenty One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" xlink:href="mck-20210331.xsd#mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" xlink:to="lab_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_3239b69c-03b9-4c69-8b54-bc0b1f94c103_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Alignment Plan</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_b0e0edba-44e6-44ca-937e-36a9468815f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockExchangedDuringPeriodShares_43f1673f-2887-4383-a16d-dec9da384177_negatedLabel_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare share exchange (in shares)</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodShares_label_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Shares</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodShares_documentation_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodShares" xlink:href="mck-20210331.xsd#mck_StockExchangedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockExchangedDuringPeriodShares" xlink:to="lab_mck_StockExchangedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_866641b7-c604-4f65-a713-9688f1e12104_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_96e464cd-0a16-422a-a28d-c5b959dbbc29_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3d6eba78-b7a3-46ef-8df6-322dc9ac41d7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8f010c00-c4a2-4c75-9c17-fb64ab9a3d96_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f99ecbc3-fa8a-4301-901b-9d2bed89dfbc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f5fc553a-0c0d-4bc6-be78-804f811f06d8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_5a2e8643-8780-4003-9205-273b60e1e7ad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e2bb764d-7c34-4cae-82a1-ef2797a1b6c3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_c65de4e8-c4fc-45ad-a3a8-d6534536942a_terseLabel_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_label_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action [Member]</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_documentation_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember" xlink:href="mck-20210331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareholderDerivativeActionMember" xlink:to="lab_mck_ShareholderDerivativeActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_d09144f9-90aa-4879-b6e1-3c6d4a61bfb5_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_bbc758bd-4e61-42d4-adb1-9be6cf733e1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_5acc2345-f7a4-4a8f-baa2-5ac081d1d98a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RangeTwoMember_46e99263-ecb5-43de-938d-3c607803bc1b_terseLabel_en-US" xlink:label="lab_mck_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two</link:label>
    <link:label id="lab_mck_RangeTwoMember_label_en-US" xlink:label="lab_mck_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:label id="lab_mck_RangeTwoMember_documentation_en-US" xlink:label="lab_mck_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeTwoMember" xlink:href="mck-20210331.xsd#mck_RangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RangeTwoMember" xlink:to="lab_mck_RangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_f457094a-a061-42d1-9bbd-f84666b4c686_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total plan contribution - exceeding (percent)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:to="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_97e41690-3698-4f1a-9594-82eb5e97f706_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:to="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_37a8d71b-05ac-4c9c-8178-b7fcaf101d21_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_a857aeff-12e8-4e02-82f9-f4e93ee6acad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1.625NotesDue2026Member_18d36921-4636-463b-bc3b-5144a853d75f_terseLabel_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes due 2026</link:label>
    <link:label id="lab_mck_A1.625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1.625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member" xlink:href="mck-20210331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1.625NotesDue2026Member" xlink:to="lab_mck_A1.625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_a4b1e3cf-efc9-4c76-b2f5-4920c1384566_terseLabel_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</link:label>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_label_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]</link:label>
    <link:label id="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_documentation_en-US" xlink:label="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:href="mck-20210331.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:to="lab_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_59732e95-725a-4ba4-bbcf-f89c790e4900_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_255fec8c-f6d1-4564-985a-4abff900c89a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_a2e545a5-caf7-4627-a004-c2c165067f28_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_69d0e425-56f8-47a5-ab29-2c48d2617d3f_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_cb38a073-3702-4c3b-8813-66b6ce4129b6_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2027 through 2031</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a51fb6a5-dd5a-487e-bf77-9f6593c1ae0d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_673117fb-c596-4de5-b91c-ba4021edec23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on net investment hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_5c424b95-4ec4-4b29-9725-b9fe744d7c16_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity Premium Transfer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_fd7b14e2-ded1-46a6-ac3d-90750b2c9f56_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of former officers</link:label>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_label_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Officers</link:label>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofFormerOfficers" xlink:to="lab_mck_LossContingencyNumberofFormerOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_3868a975-10d4-4b6d-8753-0daf4ac397f1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities of growth stage companies</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_8d156c08-f332-408a-8848-378e6bbbeef0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_1793a8b7-bd76-45dd-8540-ffc4cc6876e0_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c07528d7-e5ef-466c-ab1b-ecff059dc91f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfundedPlanMember_db8d1431-ca1b-42ba-bb33-2959109abe7a_terseLabel_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded plan</link:label>
    <link:label id="lab_us-gaap_UnfundedPlanMember_label_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Unfunded Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfundedPlanMember" xlink:to="lab_us-gaap_UnfundedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_945cbabf-dfad-46e3-b076-ee08a8028fdd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_c528a6df-6295-47ab-afc8-ab266e3f2054_terseLabel_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information</link:label>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="mck-20210331.xsd#mck_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e123eb3a-93dd-45ca-a407-31922481b9df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of details for charges recorded</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_48645e72-643e-4a4d-ba23-8943fb0ec246_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2022</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year One</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_57c4d19b-c235-4335-ac28-be85043c67b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_8838c6e6-7aa7-4924-a6a9-c6288a4f5d10_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_a7b3b835-4490-4ce2-b1e0-ccf148e58465_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_8cb6399e-7fbe-40d4-9c80-75411116c518_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:to="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_47162998-9216-4864-86af-76b45831564e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_50a39422-5399-488f-9f62-929eb79c2d48_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_563460a5-747a-4e31-aae9-740927e086b3_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_5e8e0431-f04e-492d-92f0-f05b231c681d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_dec0fa45-1a4b-4054-aeac-d313fc568210_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A0.625notesDue2021Member_45cebb30-f908-4ef4-ac21-165ad8105d75_terseLabel_en-US" xlink:label="lab_mck_A0.625notesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% Notes due 2021</link:label>
    <link:label id="lab_mck_A0.625notesDue2021Member_label_en-US" xlink:label="lab_mck_A0.625notesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021 [Member]</link:label>
    <link:label id="lab_mck_A0.625notesDue2021Member_documentation_en-US" xlink:label="lab_mck_A0.625notesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.625% notes Due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0.625notesDue2021Member" xlink:href="mck-20210331.xsd#mck_A0.625notesDue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A0.625notesDue2021Member" xlink:to="lab_mck_A0.625notesDue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_dd2ba7d5-b1b0-4386-ba3d-3836faface08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_d58b75e5-b546-4098-92a1-9d2a9000ba99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Data by Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_5bb6d837-e38e-444e-a513-5766a645266d_terseLabel_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assumptions used to estimate fair value of PSUs</link:label>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:href="mck-20210331.xsd#mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_992d7204-dde9-4664-bc40-0ba7912915bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_3cfee52a-47b3-441e-8850-c2bec5dedb53_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases selected for remand to other federal courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:to="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1057faed-6eb0-4ba6-92c6-0edcdc47fc9d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1f6ee51-a331-4c52-931f-3855bd47eea1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_7e2f029d-12a0-40bc-8d02-b61cab291a71_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right (in euro per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_1964ac10-84a9-49d6-99c4-7bb38a059327_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f79fd3c6-e215-4924-ba90-77f3e3a8c4b6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_f2075b9d-5ed5-4c72-8b40-a9e57bfdd571_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_69293924-b5ec-4b5b-b625-e428db6f7bfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of weighted-average assumptions used to estimate the fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d7fe4828-4207-4c23-8464-c66e465aff2a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_5e399c14-f466-455d-9f4e-73c27d943a69_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:href="mck-20210331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_1d9ca56b-45a4-495d-a5e4-bcc5c7451883_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_392a68d5-2d08-4895-b3cf-143654d44e50_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_a75226bb-505e-4271-8ee8-f30264e2df04_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_eaf8540c-b56f-4b59-99d2-944df503a36a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_60fab406-0968-40d2-a412-bce5755a29f0_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_d8effff0-7454-4b79-a00a-ecc17fa924f6_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_01dfc15f-7c6a-4a68-a40c-e7425ad8f662_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b6451f17-651f-4d84-9b7e-efaf10908603_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_28fbe272-f635-4ec4-8ca1-cbfd382f1778_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_50e58bbb-e822-45e6-ad2d-905fdbfe2e45_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_623f2370-b69a-40ce-a693-c631f7234821_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustments: adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_2e2cce0e-920d-4979-b1cf-6c6d7dfa5ac9_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ff2d6c3b-fed6-4159-9b97-78f30e369bb8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_9f4041e2-2c6e-47ec-b64d-da545aec1b66_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931</link:label>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_label_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:href="mck-20210331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:to="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_56b0d7cc-c26e-454c-a2b2-84c645ffbcbd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1fc1cd17-4f36-432e-b768-aa5a24bb52e3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_e75a2acf-6a78-4a5f-8f6a-4abe200703a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2ea30514-ee9b-4069-8a93-0926fb7f25d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate - Operating leases (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_dea37abb-5a90-4f40-999b-487adab18e66_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment charges, before tax</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_e565042f-95b6-44b5-9df7-a6741f654981_terseLabel_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_label_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture [Member]</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_documentation_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:href="mck-20210331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:to="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_fe4ed043-cd25-402a-afcc-1e87b79f97b4_terseLabel_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_label_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_documentation_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:href="mck-20210331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:to="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_a3150365-ec52-459a-a446-4ee7ca92b120_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3a133fc6-52c6-475c-80af-945a22386a27_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_e8af2875-c685-44e0-9c14-c4830b45df38_terseLabel_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives</link:label>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:href="mck-20210331.xsd#mck_SupplierIncentivesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:to="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3326052b-cc75-48a1-aa6d-5c372f4776bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_0f02fb51-ecfe-47d0-9e4a-ca89444b4725_terseLabel_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related litigation and claims</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_label_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Litigation and Claims</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_documentation_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Litigation and Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims" xlink:href="mck-20210331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxAssetLitigationAndClaims" xlink:to="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_99d2785e-fbbc-4fa0-86f4-b030970392ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bcfd4ea5-bc6d-4150-844f-3ce6cbe8b9ca_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_1076f53d-5780-401e-be30-eed3f1bdf77f_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:to="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_66aaad53-6672-4bde-8900-b4799a4932bd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_359a90f1-6d7b-4f30-bb67-28a0ee43568c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_a53802d8-10c0-4774-af19-e2d7c20a0b02_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Capital</link:label>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_label_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Additional Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAdditionalCapitalMember" xlink:to="lab_us-gaap_OtherAdditionalCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_6d0df264-82a6-4859-a663-a6a16ddab9d3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_3b3f3a0f-db81-4b3e-8909-f0f9c12dd535_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_74831757-94be-46ab-b1c7-aac2b2019ccb_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_979fcc45-abcd-4eeb-8be7-20c6eb6a8cf5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_95ce01b1-bfca-4466-bc09-8d44d4618eed_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:href="mck-20210331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_2563a927-406d-47b0-b090-2800de4d1486_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_2c84f20f-3483-4069-9223-37e1353044f8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d5d79e5d-d9f9-476f-b39d-fa71444b3630_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_593cc742-581f-47f3-b646-88a589906ea6_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_1e412421-689e-4039-b8c9-037669b7266f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges:</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_d2b24c7a-46fa-45fb-ade0-81da7aa25562_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_e8a8fc76-f3d5-4ad1-84a0-fb93e96f4cd3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_bb059bf3-b051-4dfa-9be7-b3cb1bdb616d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of market price for share purchase</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_21cd74dc-b1dc-4b01-88f7-0bf026e3be77_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_bbff0fbe-3aeb-431c-a8b7-a9a677238c80_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_f6370e84-8920-4f7c-9d40-0fa992d35758_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_5b08746c-6e09-4fc4-bcf2-75c3810a9b5c_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_345b84e0-a269-4699-b9ab-93e924396765_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2af94834-c75e-40ed-82f0-40d03233df5f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_7f474c26-c080-4499-b141-8d4e2c246a5f_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of shares repurchased over last three years</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_20da491a-1d0e-4c72-aa15-20ff2a0cc64f_terseLabel_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum sublease income</link:label>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_label_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Payments to be Received</link:label>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_documentation_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived" xlink:href="mck-20210331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LessorLeasePaymentstobeReceived" xlink:to="lab_mck_LessorLeasePaymentstobeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_abdf1d30-0d9f-4410-ac77-8887f159a55b_terseLabel_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_label_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_documentation_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:href="mck-20210331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:to="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_76a2c092-64fa-44a3-93b8-f12b1b0f45a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_2588fc57-5559-454a-a34b-c14bbf292c6a_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts accrued for liability</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Withdrawal Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:to="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_b9d1db55-7ff7-41db-9122-293be64dec33_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1732d931-7019-4f13-9694-f721a92bf1e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_f3fb6c1a-aecf-44ac-9d19-fc99a22608c4_terseLabel_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_label_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations [Member]</link:label>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_documentation_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember" xlink:href="mck-20210331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseandOtherObligationsMember" xlink:to="lab_mck_LeaseandOtherObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_09a2649e-d3c3-4d6c-820e-8ec16005e986_terseLabel_en-US" xlink:label="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment, terminal growth rate (percent)</link:label>
    <link:label id="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_label_en-US" xlink:label="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Method for Fair Value Determination, Terminal Growth Rate</link:label>
    <link:label id="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_documentation_en-US" xlink:label="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Method for Fair Value Determination, Terminal Growth Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" xlink:href="mck-20210331.xsd#mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" xlink:to="lab_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_8f70e233-4d49-436a-999f-bb3c443ea295_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_328473b3-1bb6-49de-83d0-a77c25136dc0_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of business held for sale to fair value less cost to sell (1)</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_96deaf8d-4988-4136-82af-5f72c1a1953c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_ffb3cca9-1077-45ef-baf9-9ef2fa5533e3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO reserve</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InreNationalPrescriptionOpiateLitigationMember_98f8af32-f768-4e54-84ac-346c11ea1cc9_terseLabel_en-US" xlink:label="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation</link:label>
    <link:label id="lab_mck_InreNationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_InreNationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:href="mck-20210331.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_InreNationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_2b2c6c69-4393-4c3d-8190-4698ab947eb5_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rates</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" xlink:to="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_56bd2dca-b105-454e-86ed-04b2597461d8_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_0764e400-bf72-4216-88f7-a35a12c9f38d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d4b86e7e-e833-4d21-aab4-958c14ece864_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_722e2e8a-7b0e-48e9-ae84-63a99f46fcb3_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_7d606780-61e8-4c83-9b03-fab0d036a079_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_29f04589-6eac-48c6-81bc-48c3fe50d558_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_de6ecdfd-5504-40f9-a047-2f90b43ad9de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_b4ae625d-289b-4b18-8f6d-27532582d4bb_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_0461ab65-ad27-4d31-af31-bea830623f5b_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20210331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfdc822f-1465-4938-96f0-bf1f725ea449_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_67884cc1-8e2a-44c3-b8e4-2da81357888e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_d7d1d499-8f64-4d13-8e70-6a42e44d29ba_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f5a2f099-ab87-436e-8f5d-779c421ec85b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_8857d953-195e-4c3a-9205-293e2631bec4_terseLabel_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_label_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance-based Stock Units [Member]</link:label>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_documentation_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance-based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:to="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fe214f8a-e152-4805-a248-ad8f568edd4d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_47c70ccb-8a9f-4753-b86a-6f4916dd8bac_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_cc1a67d6-f0ca-40f0-8084-210b0264119a_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held at NAV practical expedient</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_24aa964a-b04b-4b6f-a522-8c97fec09604_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f179ea6a-eba1-4612-84d9-d07f866bcf16_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_5825bdbc-26de-44fa-a737-e134a454fc1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_efb37aa5-30bf-4e3b-afc9-342d2fb20d25_verboseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_44d55ecd-4298-4a6e-bfb9-c7b084b4b5aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of options outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_721ce042-56ca-4ce1-8713-f68c7b4ec19f_verboseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested RSUs (in shares)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_b88df064-6c18-45e9-9480-b2c1d418d7a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_34e487a1-644c-4f6f-9f68-1a488404c5ea_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7157b526-485b-4869-948e-5948a10ab2a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9e3cd28f-af29-42a6-9764-939570773eef_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_2abb3d77-5c06-4eed-a150-8c39d686eb62_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_bbf5dba7-ada9-42b3-8452-3a7d12d14556_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_63c88e43-bde1-48c9-bb5c-de4e25a7f7cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized, 273 and 272 shares issued at March 31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_552f98d7-c6a8-42fc-ad8c-7ddbc73111a4_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_f5b0d0ee-35d9-48ed-997e-37b1f5de1b97_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e7468002-04a9-438b-be8f-959636aebc94_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_41cf8f58-a7a9-4d20-b537-d1afd90119ff_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_f43ed7b4-9aa2-4ea7-aa98-905f7c010ee6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of year included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_f4840d77-7dc8-4f67-9b37-0a42276773b7_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_d421e2e5-d5a0-485d-9e31-fdbd8e6b4c64_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_946f1e33-9f87-4f40-a70b-f5c5408484cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_7c821ef1-9cc2-458e-92d8-5bd35dc1c705_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4c2648f2-c155-408c-9c7c-93e9e50b7920_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_20d9d451-c6bb-4453-9dd7-f474d5913128_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_53fca60c-ac58-407d-922d-40a25f704308_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_744f2a5f-f51f-45f3-81dc-b0734e727258_terseLabel_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought per violation</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_label_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_documentation_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:href="mck-20210331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:to="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_179f68ae-142c-4ad9-b587-5610be647767_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_5b066723-3882-4ab2-ae20-e1c0c80ea588_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of put right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_9f10f31e-d64e-455e-9ca2-71ce48ac5826_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected total pre-tax charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_57069e74-d913-48bf-9ed3-78cdb87a5fc5_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_8b3afb94-fa3c-4dec-9cc7-ea02d7599951_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_ccee1f8a-df3a-4469-b547-e49dc17fb56b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6551cfec-c29f-4ec4-ac90-5071d899acfe_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_75d17a3e-0cef-4731-b01f-373df8913f7b_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:to="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NotesDueMay302029Member_1de0c265-1b62-4e9a-83f2-596939fdba5b_terseLabel_en-US" xlink:label="lab_mck_NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due May 30, 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueMay302029Member" xlink:href="mck-20210331.xsd#mck_NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NotesDueMay302029Member" xlink:to="lab_mck_NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ddc49f92-e5ed-4c36-8943-1a353011c49f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_758d96a8-e887-4903-898b-f733a7bd7f7b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe0452eb-a68f-4d1d-8726-4123d43dbce7_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember_a587a892-14ec-4948-8c52-944d67835a64_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_5b9a1215-1de1-4920-8814-9034a4238e21_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion expected to be applied towards the opioid crisis remediation (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Portion To Be Used For Remediation</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Portion To Be Used For Remediation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" xlink:href="mck-20210331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_84642314-6691-4ae6-9999-44056f6a6713_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Outstanding at Year End (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_cb1418e4-6719-48ca-a7e1-fd8cc17081f4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7d74e27f-b65d-4087-b2b6-351e2658ae1d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2b36b78f-2db2-4c99-8ccd-3ded9ae67371_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_27522096-3af1-4b72-9c73-2aa8992557cf_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_32f17e5b-f5de-4116-a96b-85b830f76d55_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_1b0fe595-80cb-4670-8a52-617ea609fdbc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_e727a36a-994a-480a-8746-17517bf2b760_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses from pension plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_dfb0fbc0-4ba5-4fa1-98cf-81a5e6a57b7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses from pension plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_3e2e0623-d474-4a7b-a9fc-51f652caf7d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5a8ddbb1-6dfe-40f3-bc4a-d550f8d5ae01_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b3157b4b-7912-42ec-8b7e-08adf9950672_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ed12bed1-eeee-4313-ab09-d2d4ea12e0c6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketTransactionsMember_4c824767-befc-4d3f-a0c9-1c4c3ea0de1b_terseLabel_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions</link:label>
    <link:label id="lab_mck_OpenMarketTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember" xlink:href="mck-20210331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketTransactionsMember" xlink:to="lab_mck_OpenMarketTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fb353471-ef5b-4ce6-ba83-53cf30a33a67_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a58e87c6-73c2-41d5-af82-52b6c50d1ace_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_cc40a763-0f48-40c6-996a-294683eec26c_terseLabel_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation</link:label>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_label_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation [Member]</link:label>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_documentation_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember" xlink:href="mck-20210331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InsuranceCoverageLitigationMember" xlink:to="lab_mck_InsuranceCoverageLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_d9792b43-7169-4e6d-a674-22f45c292e5a_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss resulting from discount rate changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss, Discount Rate</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1a92d360-f7ff-459d-88ec-2f53b4aaeb37_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a655ec8-84da-400c-a063-aabe52e3a121_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_0483e55a-65d3-4440-8f92-623dde227119_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plan participants elected to receive settlement payments</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0eb1c8cd-5a99-45ce-a92e-f8fb064cf714_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_c5b30550-6e3e-48b8-933b-3c098bda00e9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_e1eb96dd-08e1-4a07-b037-67f19e1e86e0_terseLabel_en-US" xlink:label="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:href="mck-20210331.xsd#mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:to="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_38de0a67-a72d-46b4-8b54-9eebc35416a6_terseLabel_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_label_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_documentation_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanWholesaleBusinessMember" xlink:to="lab_mck_GermanWholesaleBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4d473830-b01d-47af-b260-9ed674f478da_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_7f29e544-41fc-4b63-8552-b10f2f873f2f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_4b9a36ec-255a-4158-9339-9860c7569094_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20210331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_5fe8217a-b33e-489b-b11e-6d02355dc5ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss) and prior service credit (costs), tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_f0e69dc4-869b-4606-b029-a8166e24fa4c_terseLabel_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares distributed in split-off (shares)</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_8e1fd11d-8c17-4c04-8716-18ed7f6097e1_verboseLabel_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares distributed to stockholders (shares)</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_label_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Distributed</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_documentation_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ExchangeOfferSharesDistributed" xlink:to="lab_mck_ExchangeOfferSharesDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_331f0a7f-ce99-4157-9f18-a9fa94cd4af5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c6be90cc-4603-458f-a187-daedb29557b8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_ffaa36d8-cc27-4cfd-b8ce-4ca77dcfb85b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of market price deduction for share purchases</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_b5eb5d01-11b7-4b7a-891f-efb863887356_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_1ff57cb7-b8b3-4001-9a92-f41b7f5b8528_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_e9ca975a-7e72-4763-9adf-0cd49c05b2a9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_f99e010a-f250-4ba8-b497-96ec8191ecf8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_a1b3c794-dc30-41ac-b5e8-14afb3a3f6bd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_58e28678-5ab7-47db-85aa-88f216c6c3d2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_2392883c-bb15-4573-b5b0-24632c6c65d7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_93a6c52c-2efe-4b2f-9228-643d3e9c3984_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_ba7788a2-e18d-4402-aa20-d5be5e8a830a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_21ecc6c6-2794-480f-8317-19cd31281b6e_terseLabel_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business</link:label>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_label_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business [Member]</link:label>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_documentation_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember" xlink:href="mck-20210331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DistributionandRetailBusinessMember" xlink:to="lab_mck_DistributionandRetailBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_127d9c68-6b09-4be4-a630-0b80c9a758ba_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial gain, prior service cost and transition obligation, net of income tax (expense)</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_95733085-fd34-4cc3-9163-b98ba9e9499e_terseLabel_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment, and other</link:label>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_label_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, Equipment, and Other [Member]</link:label>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_documentation_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, Equipment, and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember" xlink:href="mck-20210331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MachineryEquipmentAndOtherMember" xlink:to="lab_mck_MachineryEquipmentAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_eaf5ee26-4dfe-47c7-9b7f-e6fb176feaab_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8524032d-2f55-4357-810d-e94f47eea330_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d512d179-28ff-4cf9-b04b-31d48eaa9c3a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign currency translation gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_bcf071ba-8352-4a84-8760-27e19cc03862_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4d0e5481-16bf-4023-a299-e154479c615e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c41ef11d-c830-4796-bdd0-dfc776d65551_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b36e4037-1fe5-48fd-b9d8-bd13fe379bf7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_c3ac3a2d-b0ac-49f9-8e99-772fd05ab9b6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, state and foreign net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_75450b6d-0728-4ea5-a4b4-5ddd71c56885_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c599c3e2-425c-4620-800e-704a8c70f942_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share Attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_282b7406-63da-44e7-a0b3-f846ca4a783d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charge</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_46c270b6-dfce-41e4-a17d-56966362dd7f_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_789cb43a-2eda-4e9a-8392-2ab503ed18e7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_10812ab4-f957-4889-8edf-cae14afe0d63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_a355b284-7919-4634-a7e1-5424d59cf987_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit (cost)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_a1e42e2f-4ca6-44f3-bfd6-e72f6e72ba9b_terseLabel_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_label_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_documentation_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:href="mck-20210331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:to="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofAdditionalDefendants_8d84d730-e5c6-4b58-906c-204cf49730f0_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other defendants in case</link:label>
    <link:label id="lab_mck_LossContingencyNumberofAdditionalDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberofAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberofAdditionalDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofAdditionalDefendants" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofAdditionalDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofAdditionalDefendants" xlink:to="lab_mck_LossContingencyNumberofAdditionalDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_cd4eb850-a78a-4308-878b-a068ffc09cdc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax loss on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bbf101fc-8a19-4b0a-b37d-3375619d0f3c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_60f540d1-ce13-470a-8d95-a79fab5c0d96_negatedTerseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f122ef87-c43f-49c6-8766-d00bb5177da5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofRelators_6be22909-1dbe-4c1f-a08a-a10371f82653_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of relators alleging violations</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelators_label_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelators_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofRelators" xlink:to="lab_mck_LossContingencyNumberofRelators" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_9b467aff-da96-4103-b253-93690d3acf87_terseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d8aef00-9cf8-4c16-8bd7-dcd0c4c25754_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e1d203bf-d463-4b4a-ad1a-dbf4754e1860_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_1f5df8e4-46f5-4fe3-9b00-3e2e8684b84f_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2025</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Four</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross_826e1c72-f38a-4d87-8ec8-b105a559e3d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation costs</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_3c2af784-527e-4085-b9a9-a01bd5a5ab6b_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_fcef51c9-3eaf-4fe6-a20b-4958cf89dbdf_terseLabel_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember" xlink:href="mck-20210331.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_November2018CrossCurrencySwapsMember" xlink:to="lab_mck_November2018CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_a2ad2ac1-0ee5-4d92-90bf-dac548a7177e_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement charges</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLoansAndLeasesReceivablePolicy_9a6e7cf2-ab71-4cde-b8b9-a7f8806a09bb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLoansAndLeasesReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivables</link:label>
    <link:label id="lab_us-gaap_FinanceLoansAndLeasesReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_FinanceLoansAndLeasesReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLoansAndLeasesReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLoansAndLeasesReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLoansAndLeasesReceivablePolicy" xlink:to="lab_us-gaap_FinanceLoansAndLeasesReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_c6f765ca-c5e0-492f-a8a8-bf30c71990d4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of plan exceeding total plan contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_9a3bcfa0-4ee4-413a-b307-556cb544f97b_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_3043fd4e-e2f3-4611-b0e6-4ed15ff453e4_negatedTerseLabel_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_documentation_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:href="mck-20210331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:to="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_63e9abb1-9a38-4451-94e2-b1944cf32b6d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_3707c58f-ed4c-461b-8ce0-f8cc99a2ce32_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4d5c7034-5a45-47be-9b26-6fde474a0978_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_fbf14ac3-60ec-4866-858f-d58ae54eb971_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_1ea3a3b2-5c66-4256-87be-a61800a52593_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8d5385e7-6698-4a91-a536-4d6ef1583209_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_df3558ff-6ac0-4f15-aad2-4d075dc97c4c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_9490807d-8b95-4563-82f3-136d850dda8a_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes remaining in class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:href="mck-20210331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f3e6fc94-1b3c-445f-b483-f564f7e79ef9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_318f4df7-8328-413d-a060-4df76202b11b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution expenses</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_84f2ce61-1a58-41d3-8f46-f829c133e7da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation and other assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_a4753e1c-f44f-4d99-bbf6-2cbe20c0191b_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_372d718e-a167-4dfa-aa09-36f117805b33_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate - Finance leases (percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_ee057666-fcb4-4fa3-b2e3-8ce8e7db71a7_terseLabel_en-US" xlink:label="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640</link:label>
    <link:label id="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_label_en-US" xlink:label="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]</link:label>
    <link:label id="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_documentation_en-US" xlink:label="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:href="mck-20210331.xsd#mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:to="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost_77e79ffe-5900-42c7-b38b-23efb2c190dc_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted, Average Cost</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted, Average Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAcceptedAverageCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:to="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_446969cf-fa0c-457e-aeaf-7b978d5917b9_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from net investment hedges</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_f49144ab-6fcc-4fc5-874b-f412348fa08e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_2528284a-0082-4390-9c99-943acda457e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_7e8c45ae-394b-4518-a9fb-f715356a12b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_eb9646d5-3a3d-4743-9a7f-826603f5a371_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_01e90504-479e-4fa5-8999-b874b5262a45_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_92845c8b-0671-4ee1-8312-619f003b2d55_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_a523ad43-4726-4aec-9634-040cba2581d3_terseLabel_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales returns from customers</link:label>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_label_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</link:label>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_documentation_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:href="mck-20210331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:to="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_bad721ba-09e7-494d-80a8-de9cc092ff80_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c9098e67-200d-4776-8e3c-1706714f07f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_065e9b3a-a72d-48e3-a801-8a379b217e91_terseLabel_en-US" xlink:label="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_label_en-US" xlink:label="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Six Three Percent Euro Notes Due October Two Thousand Twenty Six [Member]</link:label>
    <link:label id="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_documentation_en-US" xlink:label="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Six Three Percent Euro Notes Due October Two Thousand Twenty Six [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" xlink:href="mck-20210331.xsd#mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" xlink:to="lab_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a6d484ae-ea9e-4d65-8863-64c9ea2c9b5d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_89e0f26f-fd52-4456-8b24-4e3548ea749d_terseLabel_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer accounts</link:label>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_label_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Customer Accounts, Gross</link:label>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_documentation_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Customer Accounts, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross" xlink:href="mck-20210331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccountsReceivableCustomerAccountsGross" xlink:to="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ccf837ca-7e3f-4faf-9bd2-dcd1a7ce34c7_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9884350b-40c1-4a66-92ca-1c50af735b65_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_2a9bb4bd-5e38-48c4-a5e3-26f53a3eab15_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_23058fef-2334-4ac2-b6d0-a78ad757d372_terseLabel_en-US" xlink:label="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_label_en-US" xlink:label="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Eight Five Percent Notes Due March Fifteen Two Thousand Twenty Three [Member]</link:label>
    <link:label id="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_documentation_en-US" xlink:label="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Eight Five Percent Notes Due March Fifteen Two Thousand Twenty Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" xlink:href="mck-20210331.xsd#mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" xlink:to="lab_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d28e5359-d774-488a-a5da-4f4f102e316e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_6bbb600b-2f1d-464e-b917-60a0cbce8343_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from termination of swaps</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67bed0e7-c6dd-4a8f-a9eb-f8083e7ab2c7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_85fb1192-b4d1-4402-84cc-7e9aa5a83392_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_ad86c706-7629-442f-92db-1c88bca3eccf_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_01591605-d0f7-4dd3-8540-5cc86bd7d24d_verboseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeparationofChangeHealthcareJVMember_68b51d4f-f331-4490-bf04-48cbaf8994b8_terseLabel_en-US" xlink:label="lab_mck_SeparationofChangeHealthcareJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation of Change Healthcare JV</link:label>
    <link:label id="lab_mck_SeparationofChangeHealthcareJVMember_label_en-US" xlink:label="lab_mck_SeparationofChangeHealthcareJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation of Change Healthcare JV [Member]</link:label>
    <link:label id="lab_mck_SeparationofChangeHealthcareJVMember_documentation_en-US" xlink:label="lab_mck_SeparationofChangeHealthcareJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation of Change Healthcare JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeparationofChangeHealthcareJVMember" xlink:to="lab_mck_SeparationofChangeHealthcareJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_7fa96451-3571-41d9-9e9d-92ebec5ed046_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_a67c1efc-81ae-44ac-a503-e48dcda9ddf2_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_9b69bdf5-974d-4060-a112-685bf3e06588_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_29d73ae1-cd37-4ad1-9577-f8d223efc25c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_b00b4fe0-e4d7-43d9-b996-5b5a98f533b0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_76a11885-1d0a-4e3e-9d6c-c8e2e2900dbf_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_67f4321a-0e0c-43b2-bac1-2888d46dde29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_e2a405fd-d4b1-4454-9c02-10cc2288fd2f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_d2884353-ab73-4993-b877-1e233ced65e4_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_5d97fd63-0b23-48e9-8b35-a066a6ef335d_terseLabel_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_label_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge [Member]</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_documentation_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:href="mck-20210331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:to="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1e5ae44e-66b4-419d-923d-b36e5e0b3410_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7d450a80-494b-4505-bcf3-4aac1f120407_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentFairValueofStockAccepted_8e14d0fc-4eca-44ac-a3f8-1fbd12c5aa5d_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentFairValueofStockAccepted_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Fair Value of Stock Accepted</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentFairValueofStockAccepted_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Fair Value of Stock Accepted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:to="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_d2b255fa-eb2d-4bdf-b51f-e4d15f5781be_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest, net</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_55efe29a-33aa-4db8-bba1-5c16ff0b6cff_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_28c207eb-b6eb-450e-85cd-31c9569495be_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_6e1a98b3-f831-4a72-81fe-e3596bfe28b4_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax dilution loss</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b5aef57b-3e92-453f-b17e-e86e1ea1aa9c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_74f9540c-ea68-44e6-8702-92b9b33247f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5609e1ea-4cda-466b-876f-fcc44a21f232_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2c6de82f-a5a2-4e52-91bb-d5592321864e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f19e06b3-86b7-46fc-8dbf-b9fae1adf778_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_8d5157e5-7b9d-4649-bbc4-6433b52182a8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Par Value Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5a29b6f9-0367-4bd4-a896-c40bbd34a66c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash proceeds from IPO</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b0d6cb56-2fcf-4e32-966e-5f9841a22fd1_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4fd30bc2-49ba-4773-90c4-5b8fb612e088_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_4e006859-38cc-4cf6-8c7c-5f45a88a745d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_c56c7c7a-b4a1-426c-a20a-41eee4a98daf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable assumed</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_6b31b2cb-7ade-4dfe-9f3d-e4ee65fb383c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1f1baa3e-6037-4bf1-b711-d0934b727099_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, before tax</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_988c3b72-fea2-4d30-bc4f-0ee7a524ecb0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_c0c0935e-8f99-4e32-85c9-e672f76ad92e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value on a nonrecurring basis</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_271510e2-03b6-49b6-bd08-22ea0703a9e4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5ca02c64-60c0-4e02-a420-cc9f510cfd02_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_f33b419a-5849-4343-92da-aa7945e87e25_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberofSitesSelectedforPreferredRemedy_b60042bd-55d0-4545-a7f8-c68fe884117a_terseLabel_en-US" xlink:label="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites selected for preferred remediation</link:label>
    <link:label id="lab_mck_NumberofSitesSelectedforPreferredRemedy_label_en-US" xlink:label="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Sites Selected for Preferred Remedy</link:label>
    <link:label id="lab_mck_NumberofSitesSelectedforPreferredRemedy_documentation_en-US" xlink:label="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Sites Selected for Preferred Remedy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSitesSelectedforPreferredRemedy" xlink:href="mck-20210331.xsd#mck_NumberofSitesSelectedforPreferredRemedy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberofSitesSelectedforPreferredRemedy" xlink:to="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_6c9170ba-3f90-47b5-a904-a36e2fc557b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_7b103399-86e9-435a-97e6-038a9aca580a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_18c28731-6bbc-4482-9008-7768b7e3a9cb_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cities filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cities Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cities Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCitiesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_c4d273b5-d5d0-427a-a0de-2e5b82072786_terseLabel_en-US" xlink:label="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_label_en-US" xlink:label="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Nine Five Percent Notes Due February Sixteenth Two Thousand Twenty Eight [Member]</link:label>
    <link:label id="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_documentation_en-US" xlink:label="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Nine Five Percent Notes Due February Sixteenth Two Thousand Twenty Eight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" xlink:href="mck-20210331.xsd#mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" xlink:to="lab_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_26c8c72f-0b48-4367-b8d1-d9ff46a69c7a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e986e850-1504-4847-806a-f2e5ccd33e0a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_838287f4-d5a1-4e2c-afe3-b70c1d967d11_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_0a993145-adff-4aa2-acdf-7ec6bc4a6370_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement gain recorded in earnings</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:to="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4278a581-8e4b-4de0-a8ba-04f0d828f471_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b762357c-e0ec-4004-bc44-3d7da4ea834f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_8d1b025a-c220-43f5-9740-32bda8845842_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative liability, gross fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1638a0c-51e5-44a5-b1c2-cdb66434fb5a_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1baf8002-d80b-4cc8-9872-57d42f6446ee_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_bd5a4221-db4d-4c9c-9919-5017b84e900b_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7e484145-465c-4c18-8e0d-83e8981e33e5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_cd954e3d-d369-41c6-b75b-eb2e090a71e6_netLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_bb124b4e-f575-4c27-9a60-dcfda2d324a5_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_000ea4c9-19a6-4721-856b-9a7154da6979_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due After Year Five</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvesteeMember_14da1697-4b7e-4ef6-b5d5-3deeaaaefac6_terseLabel_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee</link:label>
    <link:label id="lab_us-gaap_InvesteeMember_label_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvesteeMember" xlink:to="lab_us-gaap_InvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_108d1098-75d2-4266-959d-ef6609cd785a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ae9edb0a-24a3-4e7a-b2f7-59311d0c2225_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_85def211-7e4d-46cf-8e69-289fb2093d6b_terseLabel_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of data related to restricted stock unit award activity</link:label>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_label_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Related to RSU Activity [Table Text Block]</link:label>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_documentation_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Related to RSU Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:href="mck-20210331.xsd#mck_DataRelatedtoRSUActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:to="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf8adcc6-b707-489b-ba06-289c11d08f54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_d1b526dc-2ff8-41b0-83a6-18d250e63875_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_f650a932-c5b6-45fc-8121-ad03043dc488_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_c033abbe-77de-4acc-924d-5b734ce1602f_terseLabel_en-US" xlink:label="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Euro Notes due February 12, 2020</link:label>
    <link:label id="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_label_en-US" xlink:label="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]</link:label>
    <link:label id="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_documentation_en-US" xlink:label="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:href="mck-20210331.xsd#mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:to="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_73c9b07e-3f91-4c3c-9cc6-772d001accd6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f6b1f891-2571-441c-b800-10cf5af45dac_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_9335b8bb-0451-4b67-aed9-d9afb7effb32_negatedTerseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_c80f6602-44e9-4e04-a94c-86a524e07fd0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes/disposals</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_bca7792b-e94a-4408-a699-a9e4fbcd0398_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_80448b83-59e0-4f1c-9381-4ca405a79d3c_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20210331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_386adc94-6e27-415b-9f2f-872ef29027f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_9e9b64de-469e-4129-9802-b52df28e605a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_07775bd3-c94d-4ec1-8099-35b4b8573725_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss) resulting from the difference between actual inflation and assumed inflation</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Inflation</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Inflation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cdd3cabd-1b0d-4a25-be94-f50ed0c017c5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_79705926-f02d-4a37-9d21-8ed5f135beac_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and asset impairment charges</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_6f2e92c7-5187-48dc-96fc-a0dfcd1a76e3_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase in interest (percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20210331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_65d329bb-9caf-4f73-91da-5705be4f6ca8_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6d4ec6f4-744b-402f-ba99-a48b684b8606_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0a160cd5-cd07-4a1c-bb6c-eb5d82f0f854_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_5947b47c-9a09-4c19-bc16-16cfd8a6d9b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_59583aca-2e13-4701-8c1a-8f0738654bcc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_9dc12d95-02ed-4fd7-a7b1-5cc19d5f9a64_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20210331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_a8d9c555-dbf6-4ff0-b3dc-35fdd2d8121c_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right increase (euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price, Increase</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_244a1e3b-888d-4480-a154-d6869d82a9ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_48707ee5-8cc1-4de5-8bad-6f2ee2fdb498_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_ac0845dc-8556-45a4-aa0c-a31a28694b32_terseLabel_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Programs</link:label>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_label_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Programs [Policy Text Block]</link:label>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceProgramsPolicyTextBlock" xlink:href="mck-20210331.xsd#mck_InsuranceProgramsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InsuranceProgramsPolicyTextBlock" xlink:to="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_a50dd166-bbca-4865-811b-6072c95bea79_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2c6d93c9-7e4e-4780-aa51-c53a60f0ab09_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_2da22752-cf9a-441c-8b43-158fa1e5b482_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_7f30eaba-c07a-49aa-ba94-ae6d8a0a61d1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2cab28eb-ed3d-46ba-9a2b-a966189b61f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_6f867ff4-fb88-4c47-938d-103309975426_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_ac361860-76fd-4b05-bf1a-f9d9bb9f9d70_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_754f16ab-9974-4ba0-9ee6-9b477831bd8b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_66cd216c-10cf-4fc4-bb8d-af9da24fb9b2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash proceeds from settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_1d4d7259-0c35-40fb-91db-f7fd2f783759_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:href="mck-20210331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:to="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_cbb43a4f-f85c-4bfd-8ab2-55bdddd17449_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_4721ba28-fe73-4da8-840c-8b6cb1fca5d6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_8c638bb7-064a-44fb-abd8-bcf175e0fbaf_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_715b312f-0a6b-4e8c-b3d8-d385ab435cb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_afd68175-bb49-47b6-866d-56cbaec5f6f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_20d73935-9c44-4bcc-b967-d51400ea8158_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_99acbc00-1e6b-4886-84ae-4f3fa0b58e41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_5c6393b9-b071-45cc-9815-324cd6b38e89_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_b510b8cf-6a8e-4d25-8284-8d77af8ab581_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GainLossonDerecognitionofLiability_35669de7-5800-4017-bf55-66c38ee31ff2_terseLabel_en-US" xlink:label="lab_mck_GainLossonDerecognitionofLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credit representing reduction in TRA liability</link:label>
    <link:label id="lab_mck_GainLossonDerecognitionofLiability_bec37811-e0e6-410a-b672-40860b8cbd3a_negatedTerseLabel_en-US" xlink:label="lab_mck_GainLossonDerecognitionofLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credit representing reduction in TRA liability</link:label>
    <link:label id="lab_mck_GainLossonDerecognitionofLiability_label_en-US" xlink:label="lab_mck_GainLossonDerecognitionofLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derecognition of Liability</link:label>
    <link:label id="lab_mck_GainLossonDerecognitionofLiability_documentation_en-US" xlink:label="lab_mck_GainLossonDerecognitionofLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derecognition of Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossonDerecognitionofLiability" xlink:href="mck-20210331.xsd#mck_GainLossonDerecognitionofLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GainLossonDerecognitionofLiability" xlink:to="lab_mck_GainLossonDerecognitionofLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6973c7bf-70b7-4238-9874-85dc8b78922f_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_8b8acc03-07ab-409e-b565-c380160f6ec7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2b8a6c3e-e019-475c-85f2-bedfe13f5e0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PeRSUsMember_cbedf05d-4877-4e63-9955-8c17fe467880_terseLabel_en-US" xlink:label="lab_mck_PeRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PeRSUs</link:label>
    <link:label id="lab_mck_PeRSUsMember_label_en-US" xlink:label="lab_mck_PeRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PeRSUs [Member]</link:label>
    <link:label id="lab_mck_PeRSUsMember_documentation_en-US" xlink:label="lab_mck_PeRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PeRSUs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PeRSUsMember" xlink:href="mck-20210331.xsd#mck_PeRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PeRSUsMember" xlink:to="lab_mck_PeRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_6d4e4da1-4ba2-4664-b6da-14dfa008dbdf_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember" xlink:href="mck-20210331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementTRAMember" xlink:to="lab_mck_TaxReceivableAgreementTRAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_14f80d2f-a09c-4c67-bf7a-d49b6bcadcdd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_f6895277-26d8-4d3d-bd18-888e35b5e73e_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_3c329f42-29c1-493a-a442-8733a5f3b54d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits and settlements</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_cd5bac90-3996-46c4-9b9c-1497b7dac57a_terseLabel_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Direct Financing Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:to="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_d48a5cef-0d0f-4d6e-a97b-63a395a8ecbc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_f47584fa-a131-48f5-8581-c3531acd4402_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_e14530c1-806b-4aed-8cb1-be10e7d12677_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e84cffad-70d6-4e71-9cbf-242369d2ad4d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_0000da2e-9cd0-43c6-9e68-f0fb5a7fe214_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Inventory Repurchase Guarantees</link:label>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_label_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Inventory Repurchase Guarantees [Member]</link:label>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GuaranteeObligationsInventoryRepurchaseGuaranteesMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:to="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_8377bcbc-4081-4e19-af71-b22a629a0259_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:to="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_9ebf1ac0-f7d7-4c36-b11e-fc12b3aa2e8b_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in basis points</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:to="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_c131daa7-0a21-446c-9e79-88ad01513af2_terseLabel_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period within which party can be substituted</link:label>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_label_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Party Substitution Period to Prevent Case Dismissal</link:label>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_documentation_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Party Substitution Period to Prevent Case Dismissal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:href="mck-20210331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:to="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_25974d2a-c38c-4f82-9308-88cd7f1f800a_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_e6f39067-e3a1-4d23-814d-751304776a39_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:to="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e8a2f25c-6701-48af-9b32-a6dd07d7086d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_2fc99a84-e8ab-42aa-8d42-b8d476b2f9b1_terseLabel_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_label_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_documentation_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis" xlink:to="lab_mck_DefinedContributionPlanMatchingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_60ac29a1-9e5b-4407-b39d-aff9a866c8cd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_8fd91d84-7032-4606-b3fa-a89541e2d40a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_525b93bd-deda-4979-8448-6026168f09df_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4ed3fb6-e0ef-4a0c-a6c9-13ff5f5f63c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_540d8d14-d102-4693-ba65-2ee6f800c441_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingent liabilities (Note 19)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1ba14631-2a6c-4f6d-863d-1bdd19889458_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible compensation (up to percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_eb8e1076-3544-460d-a84e-d32960e52327_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases, including shares surrendered for tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_e428579a-6cab-410f-94f9-878d71fc2310_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other income, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_eb4405bb-cc3d-4c54-8ab5-787b45605d55_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20210331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4018a8d9-12b7-478e-9a8c-f737ee4f0449_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a6d3d5cd-654b-4982-a0d5-eff998d533b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3a044835-9479-4536-b670-b5c0f5421f6d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_4c7405fc-49f1-4c71-8107-c084f522642b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in benefit obligations and plan assets for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e86f8c37-6b8d-48b7-8426-a27c4774d3ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_93364782-2be8-437f-b089-677b3ea0188b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_71488f51-b63f-4062-a734-7bb0dab26987_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c9ed0f40-b420-4d5e-b92f-ea25075ddb51_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_603c4fe9-797b-4695-ad5c-b5336715042b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_85e4e7c0-7a4f-48d3-bb34-15ae32c1c57a_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_500ed5af-6a74-4416-9ffe-2f924195a522_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_483d1eec-7785-4542-a179-590f4cd51691_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5af4492f-d3f2-46be-ac3c-b3b8aa3786c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_8b47a799-a2fa-4996-bc03-b7799777b13a_terseLabel_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York</link:label>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_label_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York [Member]</link:label>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_documentation_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:href="mck-20210331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:to="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_ba54c19e-c6b9-438f-a172-3fb4ac765a21_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d4806d70-2cf9-4ba1-9415-4eecff21868e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets and systems development costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_efc94cc1-cc9b-4879-99aa-87260c61f87a_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_09e4c913-4695-4119-ba1f-74efa8d5d312_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2369e906-e85b-4c78-bdea-aff836aa2afd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_302b24ac-8e94-42ba-a842-1ecb6ee48dd8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_54f36fdf-980b-43d3-8129-9819bff8c63d_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_9a934710-d147-47fe-9a44-d1940b587b57_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from contracts not designated as hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_37449ca7-1751-4ebc-869e-ebec74561a73_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_51da4ff8-a085-4833-887d-ceee70c38010_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20210331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_40add40c-a08b-4937-b8e7-c835865b8341_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RangeOneMember_5c4241a2-9c57-4a79-a192-224dfdcf5d2c_terseLabel_en-US" xlink:label="lab_mck_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One</link:label>
    <link:label id="lab_mck_RangeOneMember_label_en-US" xlink:label="lab_mck_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:label id="lab_mck_RangeOneMember_documentation_en-US" xlink:label="lab_mck_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeOneMember" xlink:href="mck-20210331.xsd#mck_RangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RangeOneMember" xlink:to="lab_mck_RangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_183b52e5-1522-435e-bee3-24231c3a4b3d_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_197cca07-257f-44e4-bc56-317f23a51f16_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_1731d4b5-8e4e-4524-953c-f434fbaa45a5_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital loss carryback</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Loss Carryback</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Loss Carryback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6f9c8514-71e8-4b83-a640-e2f18bd88f4c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_0bfa8237-f671-41f0-aa1d-3e96f744088d_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bbc4cf36-ff04-48ed-a70b-4432e37f465f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f33d882a-685a-4b2d-9182-b6ee4de89487_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_29b0af1b-d92a-4385-97de-c70cd25019f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_c0670e14-d8f7-4888-a512-2ec5b33598fa_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9f0ba6ac-1f17-4c2f-b80b-6f20412d413f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_2a52beb4-95c7-43dd-9062-50e17ec0f8f2_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_822d38b2-acdc-469c-8919-8387bce51414_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_263513d0-5822-4022-885a-0308bb66028b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt, thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c589e36-51dc-45ea-9569-fe9daf1c6fdc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1765ea28-511f-4f59-9e84-28ac5f0cb299_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuarantorObligationsPeriod_8029f5bf-70b4-44cb-a339-f1b318a59ae9_terseLabel_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt guarantee period</link:label>
    <link:label id="lab_mck_GuarantorObligationsPeriod_label_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Period</link:label>
    <link:label id="lab_mck_GuarantorObligationsPeriod_documentation_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod" xlink:href="mck-20210331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuarantorObligationsPeriod" xlink:to="lab_mck_GuarantorObligationsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_51061d76-0c5a-48c1-9870-b2b4cf02eba4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_9931502c-5771-4595-830d-fdb0655ede7e_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring compensation (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20210331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5a9d6c0b-6b3f-4146-9e33-ed0b398c935d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_6e0e79f8-4efb-4b8c-ad09-aa3e758fa964_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax pension settlement charges</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_78597097-9784-4cd6-b154-ab15c820b597_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax pension settlement charges</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_65640c01-c58d-407d-a339-2dffcdf2cc85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_d764aad4-5cbc-41c0-94ed-387b7ae2d8c6_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income commingled funds</link:label>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeFundsMember" xlink:to="lab_us-gaap_FixedIncomeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_3818d0a4-4f04-49bd-bacc-c6f01c3495d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_071606f3-88f2-46fc-8b23-e6690ca1cfb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_918706fc-c9c4-4363-9d67-b64739cb4dbc_terseLabel_en-US" xlink:label="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</link:label>
    <link:label id="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_label_en-US" xlink:label="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]</link:label>
    <link:label id="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_documentation_en-US" xlink:label="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:href="mck-20210331.xsd#mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:to="lab_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b4eead19-a79e-44b6-acd6-dc8199271a2b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_0939e3ac-c75e-469f-872a-0dfc3b97da29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_17cfb5b9-a9ea-47f8-8843-6114191c86a7_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_dd583e2a-cb1c-43d4-ab77-0c048e60abcf_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e24b114e-a845-42fb-b47c-15601a617751_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, after 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_fa36fa6d-d610-4996-8245-5e568c876127_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_55275d6b-938e-427f-ad51-69bc726d2ff5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2cd4fd36-bf69-44f1-b55f-198a32ff0e84_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, including current maturities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_da099991-fbf1-4267-a6fa-198df1c5113b_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_3d71131d-e5c7-42bc-9de5-4a3af636490c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_eacb55f3-c70c-488d-a9ee-a50ef0416786_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LongtermDebtCurrentMaturitiesMember_436f1370-e621-4b8a-9418-39b957420baf_terseLabel_en-US" xlink:label="lab_mck_LongtermDebtCurrentMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_mck_LongtermDebtCurrentMaturitiesMember_label_en-US" xlink:label="lab_mck_LongtermDebtCurrentMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities [Member]</link:label>
    <link:label id="lab_mck_LongtermDebtCurrentMaturitiesMember_documentation_en-US" xlink:label="lab_mck_LongtermDebtCurrentMaturitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LongtermDebtCurrentMaturitiesMember" xlink:href="mck-20210331.xsd#mck_LongtermDebtCurrentMaturitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LongtermDebtCurrentMaturitiesMember" xlink:to="lab_mck_LongtermDebtCurrentMaturitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_6b8b6ad6-0b9e-4fe8-8b7b-13677dfed08c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_a3a9570b-a1e3-4218-9ad5-2b49802313b6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_f8a33e41-8b0e-4d9e-9a85-abbe730a602c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_85894909-f8da-478c-87c4-8ca502afa362_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpensePolicyTextBlock_8c58c841-99bd-4bc5-85ff-e81a873387a6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpensePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpensePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpensePolicyTextBlock" xlink:to="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_df26c85e-4a6e-4839-8a48-8994f750f09d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bb19c1c8-2571-4fec-b40c-ef68c002979d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_b90d3695-82a3-40e8-8648-7300a9a0809f_terseLabel_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current allowances</link:label>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_label_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</link:label>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_documentation_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:href="mck-20210331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:to="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f49a1311-1305-4699-8456-53f6381e70c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_af3c6946-a507-4275-b3b7-b18392968fc9_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_e31925b8-d887-4147-accd-79b563c1977f_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDue" xlink:to="lab_mck_LeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_2456398f-ff03-4105-923d-5afafb189a5b_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_29a57683-4835-4270-be79-aa53058b3017_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bcfe6ad8-9651-4651-8223-efbd218878ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_9656bcb8-f084-4845-bfc4-61bae4222e30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to net income, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_ac503dd0-f584-4ed4-922e-0ab735b76809_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLossNetOfTax_fb8ac9d9-e8e7-4b7d-b5ef-7e909411f96a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment, after tax</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:to="lab_us-gaap_GoodwillImpairmentLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_b5848bf8-5297-40da-b189-52ecc017c237_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_af115836-ec21-4720-af9f-1e81a91c957c_terseLabel_en-US" xlink:label="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increase in compensation</link:label>
    <link:label id="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_label_en-US" xlink:label="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Obligations Assumptions Rate Increase in Compensation</link:label>
    <link:label id="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_documentation_en-US" xlink:label="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Obligations Assumptions Rate Increase in Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" xlink:href="mck-20210331.xsd#mck_BenefitObligationsAssumptionsRateIncreaseinCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" xlink:to="lab_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_ad9bc67e-2085-4f71-84f2-c9624a464a43_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Gain on Split-off of Change Healthcare JV</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d19799d1-b24e-4c70-ab1b-33189319f52d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4af36c61-f0fa-4818-b74a-0ae0625e3289_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_b6a5d17f-4a50-4f77-bb6a-f51c36d1a64b_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO inventory (percentage)</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory" xlink:to="lab_us-gaap_PercentageOfLIFOInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_fd43bbde-007a-4d72-93d5-26ca4b86b578_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4255a454-2082-490c-93f8-ff78d5ff280b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_01c0d189-ee79-48d3-a9b3-5c2cb89bed2a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_a763aecd-e589-419b-b01b-4c179b01c2c1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_66c329b8-5f41-41de-882a-b3ad57dd3430_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_9fe5ad78-dfd0-4b0a-a7f6-08adc0810c36_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4022f02e-7af9-499d-bcdc-a411a96c219e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3.125NotesDue2029Member_cd365be6-8fe9-42e2-93cb-86946f08839b_terseLabel_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2029</link:label>
    <link:label id="lab_mck_A3.125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3.125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member" xlink:href="mck-20210331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3.125NotesDue2029Member" xlink:to="lab_mck_A3.125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_ada7465f-2b38-471e-9908-9e0a764f0499_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b27f69c9-9e3f-4df9-90d6-e1f80256eeaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_b29fd3e5-6b38-4381-949e-f75f93816b50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa6f8072-8c67-4a28-bf67-6b7bf71b5c78_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember_6a9cca44-f46a-4afc-8f95-fd536412edbe_terseLabel_en-US" xlink:label="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Specialties Distributors LLC (&#8220;MSD&#8221;)</link:label>
    <link:label id="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember_label_en-US" xlink:label="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Specialties Distributors LLC (&#8220;MSD&#8221;) [Member]</link:label>
    <link:label id="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember_documentation_en-US" xlink:label="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Specialties Distributors LLC (&#8220;MSD&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember" xlink:href="mck-20210331.xsd#mck_MedicalSpecialtiesDistributorsLLCMSDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember" xlink:to="lab_mck_MedicalSpecialtiesDistributorsLLCMSDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_dd8568ff-7070-41fa-8ee2-35e79fcc5d2d_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_c034980a-8064-423e-b4a1-f4a60ff2cd03_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification to income statement, tax expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_2cf5072b-8d2c-486a-89e8-00ebe0ea0e60_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Other Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentCarryingAmount_25ba5bc1-939d-42a5-9b3d-c26dea4a5397_negatedLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in the Change Healthcare JV at exchange date</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentCarryingAmount_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Carrying Amount</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentCarryingAmount_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentCarryingAmount" xlink:to="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_61347b94-7ffa-4faf-a86a-e44108dddb35_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_091bddff-4804-47e5-824b-bb9fbff6a3bb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7cee4c7c-e91c-49cb-8b4e-09d082873f37_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_3643ea77-1230-4be5-8dc4-69b08771b805_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_8e65e7bc-1722-45f9-ad03-7ab1ec0fe3fe_terseLabel_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_label_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_documentation_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:to="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_3faf2f88-94a9-4f37-b467-705568f1dd2b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2c37cae4-88dc-4694-8f47-12d46ffa6a2f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_143266f6-f180-40a8-aa59-cd63a8c7a730_terseLabel_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets, net of cash and cash equivalents acquired</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_label_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Assets Net of Cash and Cash Equivalents</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_documentation_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Assets Net of Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" xlink:to="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_d02a3584-d01b-47aa-965a-603b19e00d7f_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of opioid-related claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_c0ace994-6b5d-41ab-83a8-d1c4f2c0cbce_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price paid per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_ab87c2ec-de30-4056-ad6d-5ceebc9869c1_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_8b719334-3b91-4345-98fa-465e669dd67b_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_af80ae88-6e2a-4cb0-8f69-e89e9358cde2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and other comprehensive loss (income)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_2c683460-d0b7-4437-b1a0-04e1d9cf5148_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible goodwill</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_e89d6a2e-3f0a-4ad3-a544-31b8ca9d556f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_ef070770-c48b-42f5-b8a5-1b599bfcad63_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_10e81389-e4fd-46e6-b56d-936793ad71fb_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_44abd9ec-0303-4b6e-99a6-0469b4966c36_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_21b8720a-42e1-4225-adfc-197ad181b3f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f1b5e6f0-e916-4681-a78c-4b28739c615c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_f7407379-5b7c-4e32-8f1d-956bed2a58a7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_307b0a7d-cb3d-42b2-8a47-570ae7510b09_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20210331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_73337fa8-2edd-4f3c-b00b-10cc0ee55a68_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5b8dd3c9-b085-43ea-9b1d-cec87fcb0bf6_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_3bc9b675-76b7-47ed-8c78-0b69a715c559_terseLabel_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;)</link:label>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_label_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_documentation_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember" xlink:href="mck-20210331.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TransitionServicesAgreementsTSAMember" xlink:to="lab_mck_TransitionServicesAgreementsTSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_827e0824-2c7b-4d3a-bd32-14b48d4457e2_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20210331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_2fcd5ff9-5ea1-41fa-ac31-4b0b1d0db8b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_7c94030f-78b3-428b-9ef3-f4bcae59546d_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_2b0cea2a-eed9-41bd-af1b-64f4912b2132_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_580a4d15-a55a-4b5c-b2e1-b0a4740f77fb_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized on the balance sheet</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPreviousAcquisition_54a421d2-9830-4ee8-862c-98e8956b1916_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPreviousAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from escrow settlement related to previous Acquisition</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPreviousAcquisition_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPreviousAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Previous Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPreviousAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPreviousAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPreviousAcquisition" xlink:to="lab_us-gaap_ProceedsFromPreviousAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_571949b5-48aa-4703-b0a7-3510457a3f4c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_18e6c87b-6686-4a30-9655-a3c931fcddbc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_5076c29a-2e51-4dfe-8579-b95361574ecc_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains on investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_286e401a-ece2-4a1f-84b7-1e4cb60af2f0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_591c008a-b6d8-4c78-a87c-dc4e68101cef_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b056d811-ec63-4d43-9261-782970205b62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per stock option (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_bd3029ef-2316-400b-847f-3cfe74cdc3c0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_3ad35660-2114-40cd-8121-cf33886879ad_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_fb2ff5a4-6001-4e37-a89a-5abeb3432c45_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge payable balance</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_006e5a10-de7d-4c7c-aaa5-81cf43566591_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_6c58b33b-2ba4-48b2-8c67-d2f6e8ca2a08_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment for contingent consideration earned</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_092bf4a7-8e89-469f-a69a-df4a5c2686e5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c7d287d8-7d1e-4aac-8a55-bd4aaa438ef1_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_61dc069b-47f9-42c8-85f0-d74d71edbf2c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_d334c537-d3a8-4148-bd40-c6947cdeebe7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GlobalFacilityMember_f3b881a9-07bc-4a83-9982-2f958fe0f857_terseLabel_en-US" xlink:label="lab_mck_GlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility</link:label>
    <link:label id="lab_mck_GlobalFacilityMember_label_en-US" xlink:label="lab_mck_GlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility [Member]</link:label>
    <link:label id="lab_mck_GlobalFacilityMember_documentation_en-US" xlink:label="lab_mck_GlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GlobalFacilityMember" xlink:href="mck-20210331.xsd#mck_GlobalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GlobalFacilityMember" xlink:to="lab_mck_GlobalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_399bc8eb-3d50-43c1-bc9c-db144729f22f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_aef1fd84-c700-4b23-b9a2-81ad0106fa9c_terseLabel_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_label_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_documentation_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:href="mck-20210331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:to="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_718a2eea-f53d-47c3-a528-692cae9f2209_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_6aa69791-50bb-43a8-9887-0a7cbbfe8004_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest (percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_0d17022f-d8fa-4643-902f-5e3bd7856114_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7ec109ea-00f4-4962-99bd-f8824cd51fdd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_03a4712b-351b-44ac-941f-fd21099dee8d_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_59149467-576b-4d38-a9e6-a9eefb1264b3_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_dcbd1134-fd26-4c2a-849e-33da2ce2d3e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract_db0412f2-6699-40b1-ac9e-5d402e335807_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) after income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_00b4aadb-df6b-477b-aa93-687cf6ca70b6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2df71929-f71c-46ed-b865-83be9a3d3ef8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ec21b7fa-2b2b-4678-b186-7d5e067ebc0f_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which stock option compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_6bf5a6dd-1a33-4204-b961-783f63a756a4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_705c4c5d-90af-4603-a2f3-92afa7f12bec_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_df9f7447-05e2-4a2f-8cad-19e14252ce8f_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_48bd258d-b8e7-4884-b56a-46df180089c6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_943ac337-be6b-49c5-aad5-8b69eaea800a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_415ead6c-00c8-4420-b84d-a2b25dddf8b2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_8aa36ef6-d882-4ad5-99c1-7828f82f4953_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unexpected actuarial losses (as a percent) (exceeding)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:to="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_fd40a5e3-edc2-4d9f-9ab9-6052fd979b37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_6790e01d-2cae-476d-b815-d1dc449567a3_terseLabel_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_label_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs [Member]</link:label>
    <link:label id="lab_mck_OperatingModelAndCostOptimizationProgramsMember_documentation_en-US" xlink:label="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model and Cost Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:href="mck-20210331.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:to="lab_mck_OperatingModelAndCostOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_41ce0958-c755-4a1c-a389-5694d897c18b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_057a627d-e9b3-41cb-b327-ea8ef416f6ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bf9f22a9-a6eb-43bc-9434-899da3300709_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values Recognized of Assets and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_fa21e05c-6e06-4bde-a084-315e088a6fd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of quarterly financial information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_468a31a9-4c2c-466b-be42-d776c54cd385_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_efd603f9-fc12-412a-9bdb-0b62126c2b75_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring after 2026</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five Thereafter</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_c5fb0da4-fd86-4bc9-8dbc-dde74697ee20_terseLabel_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains recorded in earnings for ineffectiveness of Company's non-derivative hedges</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_label_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_documentation_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:href="mck-20210331.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:to="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_187c86c5-f6b2-4221-8526-148b908643c5_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_1e4d4409-0195-421e-bad0-eaa5b69099dd_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4d0fa340-b972-4b70-b7b8-88705a23f8a4_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_c65138c1-9b36-4454-b216-6b9f21c43844_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_d65ac1b1-339d-42e6-93f7-df64f4a6a20b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_446ab3b6-fe79-4b68-be26-65c4ff513106_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_b6cbb3e6-a07e-4317-bb11-38bd3382ff3b_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_label_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:href="mck-20210331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:to="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_05d53ac5-0745-4a0d-ae9d-498bb6ff6da8_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_5fba29cc-bed7-4022-b154-8fbb634595c4_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax impact of opioid-related claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount, Net of Tax</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_c158fc1a-c02c-4aa8-ad86-3d9dd267db7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_3c01f3c0-566c-4a29-b042-b978c756c3f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Exercisable at Year End (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_d05f7ce3-6805-406e-ae56-174dc71f8bee_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LargestCustomerMember_0d199ce3-d377-48d0-b61e-6e79d4d94384_terseLabel_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS</link:label>
    <link:label id="lab_mck_LargestCustomerMember_label_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:label id="lab_mck_LargestCustomerMember_documentation_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember" xlink:href="mck-20210331.xsd#mck_LargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LargestCustomerMember" xlink:to="lab_mck_LargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_e5e34a23-08de-4238-a92c-52a8c017c8cc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2c85cdd2-e555-49df-9442-9c7218b5bec2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_193b1863-42ed-4390-9cb6-26624909cc55_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2026</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_ec867a60-9db4-4cfc-9c27-c48de3459c4e_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7080b2f5-5f9a-4bce-b4d4-f302287dc3b4_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_5465ee6e-18ae-409d-86ea-c678c6fb42a0_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_818b3c64-28b5-46f6-8b9f-1bbb16a1d85f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_05fbf9df-0c63-4de6-a269-0b1d56218ee8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_088cc283-2012-4751-bb5f-736c90fe7671_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0330aaa5-1aba-4326-aa28-47a74e262456_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_0e068219-aba5-47d8-986d-c3778972d96e_terseLabel_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities Payments Due [Abstract]</link:label>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities Payments Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:href="mck-20210331.xsd#mck_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_1e7b4386-6ce3-4e53-9066-11d71cc93496_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity contracts purchased</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:to="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_96e0afd0-2a83-4855-b0f2-2967a3d7c98d_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_11a8cf8e-ab58-4931-94a8-e870cfa789dc_verboseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_d5e8c275-a80b-4c08-adf0-acb2fa636cee_verboseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_aae33dee-45b4-4b16-b966-49e48b71f6f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_16994064-5e43-40cd-b23c-1349c5a7da1c_terseLabel_en-US" xlink:label="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Exit-related Costs and Asset Impairment Charges</link:label>
    <link:label id="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_label_en-US" xlink:label="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]</link:label>
    <link:label id="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_documentation_en-US" xlink:label="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:href="mck-20210331.xsd#mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:to="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d7d46488-b96a-4299-8ce3-4820a4b1452a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_517e30ad-8cdf-4e00-b9c2-f1f725997cec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e9a6c17c-fd93-49a7-835f-0784cc15d893_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_df38562e-177c-4a48-964a-3c301eade17f_terseLabel_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future lease payments</link:label>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_label_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</link:label>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_documentation_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:href="mck-20210331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:to="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_0e1405ad-33b5-4474-94bb-b41bd6177abc_terseLabel_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written-off</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_label_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances And Reserves Deductions Written Off [Member]</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_documentation_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, deductions written off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:href="mck-20210331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:to="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_3516eb54-657e-4c2c-8ee8-9247d4f2ec63_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2c9864ff-07cf-428c-9d8d-6a9e16bede2d_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_8cad7573-8c00-444e-808b-a42dad96c96e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_48c30af1-1dc6-479f-ba45-5799c230a65d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_a49a2616-dcb7-454c-b54b-3abaa4f50bd2_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit) related to adoption of amended accounting guidance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4aca34ed-2ff6-48a1-8ab7-e61753c1d1aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total authorization outstanding for repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0ca473cb-6238-40fc-8867-3452f0c2ee06_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8a62c465-cab5-449f-9ba5-c19beb79e449_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_5d38461a-33e4-4c72-a2fc-7dec9b7276eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RealPropertyMember_f0eb0a2f-9b2c-4ee4-a796-14e0a64b489c_terseLabel_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property</link:label>
    <link:label id="lab_mck_RealPropertyMember_label_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property [Member]</link:label>
    <link:label id="lab_mck_RealPropertyMember_documentation_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember" xlink:href="mck-20210331.xsd#mck_RealPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RealPropertyMember" xlink:to="lab_mck_RealPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_78340b0a-9bfa-42ed-ae1e-c64df2630af3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c81a9742-41e0-4654-8e27-5fee90cdc34b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_3770b974-a249-4e2a-a82a-3439d415de3c_terseLabel_en-US" xlink:label="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC</link:label>
    <link:label id="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_label_en-US" xlink:label="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]</link:label>
    <link:label id="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_documentation_en-US" xlink:label="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:href="mck-20210331.xsd#mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:to="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1c1bff87-cd37-47ef-89e8-cd3cd26a7efe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_016227ed-b7e7-4ad1-b407-c8b4147e7600_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_2b130730-bffd-44bc-9afe-535bf6a891dc_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b7fe911d-75f2-481c-bfb7-1b589faad4c3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b9a6dda6-22b9-4cd9-983a-1121f710fd1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_ba09cd4c-7ac9-450c-9e68-3b9b9f0b7488_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions From Allowance Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_5fd51ddc-7cc8-49e0-82ec-8e4f51848e7c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_98473f28-e30d-436d-9069-fbb592a43c24_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_61da88e0-4655-49f0-9dfd-0f88de43f7a3_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_36d8b7f3-c625-4791-83c3-d98076a171cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c60a7888-b854-40f4-8e85-9b7949194adc_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_1cd090c6-939a-4c1f-bc0f-a6b44bd57422_terseLabel_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_label_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_documentation_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:href="mck-20210331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:to="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_5d26c485-e208-4b47-bdfe-0aead6b11221_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_bbd1b211-7e98-4924-a2b0-7d015b6fa6f0_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20210331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_57a9f468-ea9f-4c5f-a34f-911a0f818d92_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_b08cf8aa-906e-44f9-abe6-263c71744875_terseLabel_en-US" xlink:label="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Eight Zero Percent Notes Due March Fifteenth Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Eight Zero Percent Notes Due March Fifteenth Two Thousand Twenty Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" xlink:href="mck-20210331.xsd#mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" xlink:to="lab_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_33fd965d-76f2-497c-ae4f-3b0f98d187d4_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d97e1d68-1245-424c-b95d-a065fcfdf7c9_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1615ee28-6bd5-410f-915a-d0642aebcb1e_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccruedShareRepurchases_5e9a951d-db21-4e11-a694-a6bfea487202_terseLabel_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued shares repurchased</link:label>
    <link:label id="lab_mck_AccruedShareRepurchases_label_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Share Repurchases</link:label>
    <link:label id="lab_mck_AccruedShareRepurchases_documentation_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Share Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases" xlink:href="mck-20210331.xsd#mck_AccruedShareRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccruedShareRepurchases" xlink:to="lab_mck_AccruedShareRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_aecef766-e8d1-451e-860d-ab2cd47b86e1_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2023</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Two</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c5128240-bd83-4e8e-951d-27d8bfcc50e4_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, net of income tax expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f8d71c8e-5474-4a29-b913-f5557d5d5d75_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_385c33ec-2bc6-4cdc-ba96-7643a27796a9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_08b8ac60-4b8b-422e-804d-45f7dc2f4a4c_terseLabel_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, useful life</link:label>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_label_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use, Useful Life</link:label>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_documentation_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:href="mck-20210331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:to="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_c6135e5d-5b00-4449-9da7-a451c528c8a1_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_fe857d15-23f4-4cd5-a8a8-a3d9f73bd66d_terseLabel_en-US" xlink:label="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_label_en-US" xlink:label="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point One Three Percent Sterling Notes Due February Two Thousand Twenty Nine [Member]</link:label>
    <link:label id="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_documentation_en-US" xlink:label="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point One Three Percent Sterling Notes Due February Two Thousand Twenty Nine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" xlink:href="mck-20210331.xsd#mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" xlink:to="lab_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_eb8c57b2-019c-418b-8409-4a647fd83e5d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_9dc6fb52-ca1b-47d5-b324-87bd83716797_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of share-based compensation expense and related tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_060b2913-e906-4fee-b77b-797333125a11_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_317ceaba-0c8d-4275-b6fe-e68609e3d439_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_7ff5056e-8875-474e-93aa-66f15f2c47e9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_5a5177c0-fac2-4983-b0e1-e0dc69a15ada_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_80a16168-f32e-4cdc-9a58-af202c6976c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a5f0f799-a4e8-457c-b813-8b5ad860bb63_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ConsolidatedActionsvSureScriptsLLCMember_39927986-bdc6-4f18-9719-b53d50ade44a_terseLabel_en-US" xlink:label="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Actions v SureScripts, LLC</link:label>
    <link:label id="lab_mck_ConsolidatedActionsvSureScriptsLLCMember_label_en-US" xlink:label="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Actions v SureScripts, LLC [Member]</link:label>
    <link:label id="lab_mck_ConsolidatedActionsvSureScriptsLLCMember_documentation_en-US" xlink:label="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Actions v SureScripts, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:href="mck-20210331.xsd#mck_ConsolidatedActionsvSureScriptsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:to="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_82bec746-de23-47b5-8c6f-67a25ae15edc_terseLabel_en-US" xlink:label="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Five Zero Percent Euro Notes Due November Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Five Zero Percent Euro Notes Due November Two Thousand Twenty Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" xlink:href="mck-20210331.xsd#mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" xlink:to="lab_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_86ab955b-8b5f-47f3-9fc2-851d56682f25_terseLabel_en-US" xlink:label="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes due August 17, 2021</link:label>
    <link:label id="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_label_en-US" xlink:label="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Point Six Three Percent Euro Notes Due August Two Thousand Twenty One [Member]</link:label>
    <link:label id="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_documentation_en-US" xlink:label="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Point Six Three Percent Euro Notes Due August Two Thousand Twenty One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" xlink:href="mck-20210331.xsd#mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" xlink:to="lab_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5702518a-6e74-466b-bd5d-c34bb2c1332b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company match employee contributions (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_9bbd546c-ee30-462f-b8d8-b0db670a3adc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_da045483-f17c-4ab4-9e66-8be358ccc1ce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_7f1a4123-996b-4fd2-b1e4-19547da25de9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_5f3b4a1e-8493-4785-a48b-90e99fd9acff_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release of accumulated other comprehensive attributable to the joint venture</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:to="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_cac0d7cb-59ef-44fd-a9f3-8b5c21364e07_terseLabel_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_label_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_documentation_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:href="mck-20210331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:to="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3a736302-dd6d-4c21-9eab-7599a237e8d3_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_7aa5e881-5bd6-4adf-983e-c6017d2bdc13_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_a89383f0-37df-4136-abe4-a9784942978a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_8471bab5-c52b-4cc4-a8a7-ff95e7846c5d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_5c03509a-9ba2-46da-b7c8-e1b02f3a718e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_80c4520a-2677-4104-99c4-09d4764a99b0_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost - benefits earned during the year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_336ba5e4-ac45-4670-89b3-040eb38fd678_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherAllowancesMember_21b033fc-6036-4f28-8055-dd5e46920d28_terseLabel_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other allowances</link:label>
    <link:label id="lab_mck_OtherAllowancesMember_label_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Allowances [Member]</link:label>
    <link:label id="lab_mck_OtherAllowancesMember_documentation_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember" xlink:href="mck-20210331.xsd#mck_OtherAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherAllowancesMember" xlink:to="lab_mck_OtherAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_519ed1bc-fb68-48bd-867c-f46432d905be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_86a2c16f-826e-4b62-bf30-37a08d1dea9d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1dc6c947-bf5e-4edc-b31f-8b45ea1425e8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_92151da6-a4fa-4142-b4f0-6b41f1dbb300_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_07bb397a-e1d9-4b4b-b0d9-8f1e75783a10_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_c560d3c4-13b8-4e65-abaa-23d3bc578cbe_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_label_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:href="mck-20210331.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:to="lab_mck_IncreaseDecreaseinOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cc4279e3-5d7a-4d3e-81bc-d2891ae73183_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d2cf88ec-c445-40d0-954d-8f41e18da852_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d126cac5-30a1-4d87-8c35-a7e98ef1d7ed_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recorded in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_d6d5f3e3-f9e6-4676-81b2-f164d6c8f53b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of complaints served</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_266bfb67-3b25-4c0c-9c19-5a9e111cd6dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_c6ce251d-1f04-4af4-b854-3a21879df84e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_03761460-467a-4fba-92b2-e403aba58558_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NotesDueNovember302020Member_c2d26220-6dbb-4dd6-908a-ec810f10252f_terseLabel_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.65% Notes due November 30, 2020</link:label>
    <link:label id="lab_mck_NotesDueNovember302020Member_label_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020 [Member]</link:label>
    <link:label id="lab_mck_NotesDueNovember302020Member_documentation_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member" xlink:href="mck-20210331.xsd#mck_NotesDueNovember302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NotesDueNovember302020Member" xlink:to="lab_mck_NotesDueNovember302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_2c52898b-437c-455c-9f54-0c794e73d835_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanPharmaceuticalSolutionsMember_aec84e48-37e1-410d-aad7-912ff72fcb36_terseLabel_en-US" xlink:label="lab_mck_EuropeanPharmaceuticalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Pharmaceutical Solutions</link:label>
    <link:label id="lab_mck_EuropeanPharmaceuticalSolutionsMember_label_en-US" xlink:label="lab_mck_EuropeanPharmaceuticalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Pharmaceutical Solutions [Member]</link:label>
    <link:label id="lab_mck_EuropeanPharmaceuticalSolutionsMember_documentation_en-US" xlink:label="lab_mck_EuropeanPharmaceuticalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Pharmaceutical Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanPharmaceuticalSolutionsMember" xlink:href="mck-20210331.xsd#mck_EuropeanPharmaceuticalSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanPharmaceuticalSolutionsMember" xlink:to="lab_mck_EuropeanPharmaceuticalSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlementofExecutiveRetirementBenefitsMember_2c57b5dc-ecc1-431e-bd99-74a14ed7a615_terseLabel_en-US" xlink:label="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Executive Retirement Benefits</link:label>
    <link:label id="lab_mck_SettlementofExecutiveRetirementBenefitsMember_label_en-US" xlink:label="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Executive Retirement Benefits [Member]</link:label>
    <link:label id="lab_mck_SettlementofExecutiveRetirementBenefitsMember_documentation_en-US" xlink:label="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Executive Retirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:href="mck-20210331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:to="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_5a9af534-503c-453e-8a58-08a064813353_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax other-than-temporary impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember_d9f41aed-271f-4de6-94d2-5a19deb2f908_terseLabel_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember_label_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan [Member]</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember_documentation_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:to="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_6706e50e-2d11-40d0-b085-9f9a67596b6f_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_McKessonFoundationMember_2c20b9e3-031e-4904-9481-c5c3ef4cb11d_terseLabel_en-US" xlink:label="lab_mck_McKessonFoundationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Foundation</link:label>
    <link:label id="lab_mck_McKessonFoundationMember_label_en-US" xlink:label="lab_mck_McKessonFoundationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Foundation [Member]</link:label>
    <link:label id="lab_mck_McKessonFoundationMember_documentation_en-US" xlink:label="lab_mck_McKessonFoundationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Foundation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonFoundationMember" xlink:href="mck-20210331.xsd#mck_McKessonFoundationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_McKessonFoundationMember" xlink:to="lab_mck_McKessonFoundationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_5c959028-ac78-4074-879f-d1ebe022ea2a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b0d7a70-3847-42ec-bacf-675cea1a8143_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_88977451-0ecf-4c4b-ba21-e8cac5c6d7aa_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_213213f0-9174-43bb-ab36-cbc2b7b00630_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_fba79fa9-0dc4-4e57-b661-ee186ea7bed3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_9d685d0f-4efc-4c33-8cac-750b8cb42a00_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a086b082-6e75-43af-b867-1e13e54f8b65_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c176aeda-b00f-4ce1-b39a-a12e666a6ec0_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ae4ad0c3-b273-4085-acc7-3f346879ebf2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_771eaf34-7311-4e71-9b79-61ca2b79a19d_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_0d3e4f94-ed02-4d39-b0b9-096ba714529e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues (1)</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_cf812dba-7297-4775-be81-3d298f3b6c5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of pension plan assets using fair value hierarchy by asset class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7d75eadf-1d38-4080-bf42-608490e724fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_cab177aa-e6fd-4f87-b78b-4b6a0136e97b_terseLabel_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldforSalePolicyTextBlock" xlink:href="mck-20210331.xsd#mck_HeldforSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldforSalePolicyTextBlock" xlink:to="lab_mck_HeldforSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_2c7e5643-9e12-4865-b015-9375dd031568_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20210331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4877c1ea-7a5b-49bc-815f-5ef9c9066fed_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a8d9bc30-ed6c-46e6-8c0d-3d032c3ff3b1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_442ded70-d13b-4c1e-8543-71fc1b691307_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cbcef38b-6a11-467c-97e9-a46da444d656_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_dd863f2f-f00a-4baa-9882-6e0e13a2e1ed_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SiteContingencyNumberofSites_c51b552e-cafc-47d3-bbb8-d8d0bfccce4a_terseLabel_en-US" xlink:label="lab_mck_SiteContingencyNumberofSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_mck_SiteContingencyNumberofSites_label_en-US" xlink:label="lab_mck_SiteContingencyNumberofSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency Number of Sites</link:label>
    <link:label id="lab_mck_SiteContingencyNumberofSites_documentation_en-US" xlink:label="lab_mck_SiteContingencyNumberofSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of sites requiring environmental conditions to be addressed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SiteContingencyNumberofSites" xlink:href="mck-20210331.xsd#mck_SiteContingencyNumberofSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SiteContingencyNumberofSites" xlink:to="lab_mck_SiteContingencyNumberofSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_51a5d31c-92f0-4868-bda4-6cd3d3e37f9d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_e976b7bf-9b87-413e-9790-4d37d571c88b_terseLabel_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated environmental assessment and cleanup costs</link:label>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_label_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Environmental Assessment And Cleanup Costs</link:label>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_documentation_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Environmental Assessment And Cleanup Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:href="mck-20210331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:to="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c0b339de-03be-4209-95b7-47615799dd91_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount expected to be paid</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_6a4be5cc-6e4e-4255-a0ad-352933434934_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_8bb35c8e-3c62-4e0a-85e8-0ebeee5cb0ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1.500NotesDue2025Member_d962f435-c1b6-4508-a9a1-5090478b6bc2_terseLabel_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes due 2025</link:label>
    <link:label id="lab_mck_A1.500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1.500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member" xlink:href="mck-20210331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1.500NotesDue2025Member" xlink:to="lab_mck_A1.500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6331203b-a548-4d00-b7d8-cfdb809a801a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_4c603352-aab4-411c-8328-21e5853dd9e3_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_eaf2ab84-097c-440a-a5a0-eb2441222b03_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_6d25805f-5a4f-467e-9a29-afed6ccff1bd_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_50223536-3f74-4072-be0d-aae92e5d8422_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_fb50f4a6-f38f-494d-a30e-9f3a7a8a85ae_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of decrease in unrecognized tax benefits that is reasonably possible in the next twelve months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_69bdb4bb-6ece-47e9-ba5b-4497ded59e35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_7fd80bb7-04ae-4555-8678-c22f66957e9d_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_0b5ac2d6-fc98-4608-80b7-5dc5789b3abb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expense</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b6315758-4f64-44df-ae90-69b616ac00c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_a14d35f8-2ca3-4a02-9d52-b5b8679b3c38_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_e3b9022f-562d-49b8-866c-a61319e86cb5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_8440fa1d-8be8-485a-8c70-f9355e21308e_verboseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_1126c059-6999-4b79-8a43-1b9fdf752512_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_ee257ae5-455d-453d-b27b-69ca7b515afa_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_e5dabd0c-ccbd-49e0-a5ad-78bc135cb607_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_72db9b01-e3e5-470e-b245-ad35cc925825_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash pre-tax charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_472f92a6-6771-4fba-9f5f-d9266aca924a_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ecaa8737-7548-4694-85a6-0cca9fcddf8a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_06a1092d-1203-483b-b902-f595d6252b8d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated pension obligation</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_48f76ed4-fc34-4119-803f-51036a956f67_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_b88e580d-36de-488c-8d45-ec39624fba3c_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding common shares</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_02d5c573-c8b4-4a5b-895c-1aba36153bf4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_77a0da23-9ab7-40bd-b61a-a482b22810fd_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_ca1a00a8-8dd8-4313-bd4c-3854d4020cae_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_70178356-a5bb-4d29-84f8-bbdcda74dd9a_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties on unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_6e2ba58f-8723-4ea3-a914-a52083b53191_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0c3b7065-ee8c-4907-b4b2-479f2cd4668b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_c82cd14b-8aa4-453d-9caf-2b48e9875e98_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:to="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_5055845b-f139-444e-a11d-f19006b98e64_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20210331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_99a01ba9-316d-4828-9651-adba254dab66_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical surgical products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20210331.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractsandCrossCurrencySwapsMember_b436cab3-0b85-42af-aec9-5cd81000af7a_terseLabel_en-US" xlink:label="lab_mck_ForwardContractsandCrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts and Cross Currency Swaps</link:label>
    <link:label id="lab_mck_ForwardContractsandCrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_ForwardContractsandCrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts and Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_ForwardContractsandCrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_ForwardContractsandCrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts and Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractsandCrossCurrencySwapsMember" xlink:href="mck-20210331.xsd#mck_ForwardContractsandCrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractsandCrossCurrencySwapsMember" xlink:to="lab_mck_ForwardContractsandCrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_55d551ad-61c2-4ebd-b044-8c5643a726d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_37715b44-8609-407a-ae67-de9da7337caa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_14037bd4-5a0c-4eee-9588-93f25c193b7d_terseLabel_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of data related to stock option activity</link:label>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_label_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award Data Related To Stock Option Activity [Table Text Block]</link:label>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_documentation_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:href="mck-20210331.xsd#mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:to="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9a1a14a0-9a64-4166-bcc5-b5701fcbd068_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_43bd562c-b331-4f48-883f-0722e904b1d1_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_417ea0c9-c7b4-4825-ab81-285de315212c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7e0eb15e-2cfd-4f75-b805-936e39432f46_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits realized related to exercise</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_f97ba42e-be60-4739-acde-1d1b0b5f5c42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_b69e09e8-96be-4cd2-873e-ba8ba4664adf_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recorded in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_12f17893-14ea-44c2-8a5e-995c91ddbedc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative asset, gross fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_ab57663f-c1a1-4bdf-8bfb-43d3f0013f8e_terseLabel_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_label_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Obligations</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_documentation_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations" xlink:href="mck-20210331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxAssetLeaseObligations" xlink:to="lab_mck_DeferredTaxAssetLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_28e1249b-dbce-4b63-9306-12e50e5f1ec4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5411341a-4c88-471b-b27f-39e706f46e58_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_e694f3c4-eccf-4a9c-b2c5-20ac5250efe8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_92f7a0a1-ba14-4494-845b-34faa55100e8_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest distributors</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:href="mck-20210331.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:to="lab_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_4b40c5f1-d7ab-4017-87b3-66dbfd34b425_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_4c2e05ec-1a61-41ea-a087-6d9dc1122e7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_6cae6462-a22f-4437-bc30-3091a709ea85_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_2a6bdec6-0023-4f90-b108-ef5ca5983859_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_cb423ce9-a8c8-4a51-aba5-fd41eafeaab0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_76c4da49-1c8d-4f0a-bf9a-150b48eab022_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_31269d33-d6c2-4da8-8645-84d9e06b147d_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity commingled funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_e5b60ef1-26c6-433b-8ba1-00bdee29878d_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_69982c14-ffce-4960-b8d2-b788b6154b37_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_37d7f39d-a9d7-4c88-83db-6f097a6f6deb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a173902a-7301-43b5-9964-532a5c5b3ca4_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would Impact income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GainLossOnSaleOfBusinessNetOfTax_d8c5f15c-f5b1-4663-a7b7-012be5153e0a_negatedTerseLabel_en-US" xlink:label="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax loss on sale of business</link:label>
    <link:label id="lab_mck_GainLossOnSaleOfBusinessNetOfTax_label_en-US" xlink:label="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Business, Net of Tax</link:label>
    <link:label id="lab_mck_GainLossOnSaleOfBusinessNetOfTax_documentation_en-US" xlink:label="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Business, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:href="mck-20210331.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:to="lab_mck_GainLossOnSaleOfBusinessNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f7fbaf85-e51b-41bf-86b0-9670bf653703_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_665f11c6-0ae6-44dc-b874-3fa678d8fc65_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_eea63a6a-1a54-41bd-950c-b8afd4484a66_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_9473990c-0454-4525-a53e-cd4559d89ac7_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, After Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax" xlink:href="mck-20210331.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualProvisionAfterTax" xlink:to="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_1f2dfe3b-980f-4bc1-a8d7-9d3d22f23a28_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_42ccd1ca-311a-49a6-9b0a-96aed1fb4afa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_e5e813f2-5349-4463-9830-4efe799a4c4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment/settlement loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_b28c4034-2948-46a4-8c6c-f2400a70deac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increase in compensation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ac1f3584-5a15-44ad-8ce7-e33f347211c6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (Years) - Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7657cc50-2bfc-4b2f-b518-bc1e700380cf_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_cfd80573-59a7-4de1-a11f-7bc84f359bfc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_83517364-84df-4cc9-8c58-b4c975d99ba7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ace70ec3-812f-4650-88bf-1b7c32a71b0e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_65854a58-3ed2-466d-a958-8798d4849c26_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_19df5ca8-bf27-4bf7-925f-e52619336129_terseLabel_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_label_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_documentation_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RetailPharmacyReportingUnitMember" xlink:to="lab_mck_RetailPharmacyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_41ee4e4f-eb74-47d7-91e8-4c8b5f5c3732_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and liabilities of German wholesale joint venture classified as held for sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_bae32cd4-7adc-45d3-82b4-d56b69331d46_terseLabel_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credited to other accounts and other</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_label_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances And Reserves Deductions Credited To Other Accounts [Member]</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_documentation_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, deductions credited to other accounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:href="mck-20210331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:to="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_7fa1eea8-028e-4c86-baa8-aa426f2a020c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_a9a78488-d325-4039-b555-14be55874a6c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves (excluding LIFO reserves)</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3d3bacb4-a3de-48db-983a-f1516fd05265_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_573a2dcc-7e45-4394-a495-31ab1e8da20f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_a433b039-ec51-490b-a2ce-333391b41bc2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_29791465-f8ce-42a9-9937-3aa741c23a62_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a5866824-f0f4-4714-b7cb-07cd50de78f8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_04925ed3-80df-4f77-9a2f-c9ebe6c052ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da386adc-50f3-4cca-8478-d90ea41d74bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_bb85fc5d-7b75-42cf-bf78-096cb71e218f_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_c9bd82c4-c54b-4fbe-9cde-3f5a276b7522_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GoodwillImpairmentLossTax_e82732bb-5770-4b6a-bd37-2db7a70b58f7_terseLabel_en-US" xlink:label="lab_mck_GoodwillImpairmentLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax charged related to impairment</link:label>
    <link:label id="lab_mck_GoodwillImpairmentLossTax_label_en-US" xlink:label="lab_mck_GoodwillImpairmentLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss, Tax</link:label>
    <link:label id="lab_mck_GoodwillImpairmentLossTax_documentation_en-US" xlink:label="lab_mck_GoodwillImpairmentLossTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairmentLossTax" xlink:href="mck-20210331.xsd#mck_GoodwillImpairmentLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GoodwillImpairmentLossTax" xlink:to="lab_mck_GoodwillImpairmentLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_b9d70399-0f56-460f-afb2-919160c24fb9_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_6d0bf7e0-2da4-48f6-af7f-e7fb9cb58106_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit for share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7f94a190-9266-4e05-bd5d-dad246c32f99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d03784fc-4e37-409f-ae51-3e96de622a5d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_9dd180e8-f0b7-4620-adb6-a94eb251784d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_1c40e8d2-4dea-4571-9522-09e02c40a785_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_fec73818-7192-4cdb-a99a-040a5c77895a_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_3fc6a8ba-cae9-437c-af5a-a1acfddf3fd9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_d4b7d30a-cdc3-4789-8888-509c4ada16fd_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_d92ee6ab-6956-4ea6-b79f-097cae6ad679_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_46751bb7-50bf-49c8-a0e1-2243468971c8_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_80c831c3-ece7-427c-a16c-9ea22845b0dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_87401731-2d82-432b-b833-7533e5e1f8fd_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiability_8ae68100-f534-4626-a159-464bbf5db7b7_totalLabel_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_mck_LeaseLiability_label_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_mck_LeaseLiability_documentation_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability" xlink:href="mck-20210331.xsd#mck_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiability" xlink:to="lab_mck_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fc58250e-f092-406e-a5a9-c4c165dd2c42_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fcfb8c0e-8409-4bb9-8152-b77e5c0fe256_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_7a9fff86-610a-42bb-890d-22f85d936b11_terseLabel_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_label_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Net of Expenses, Including Other Income</link:label>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_documentation_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Net of Expenses, Including Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:href="mck-20210331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:to="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNoncurrentAssetsLiabilitiesMember_e5edc9b4-4c8d-4a09-b694-469534ca24ac_terseLabel_en-US" xlink:label="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets/liabilities</link:label>
    <link:label id="lab_mck_OtherNoncurrentAssetsLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets / Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherNoncurrentAssetsLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets / Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:href="mck-20210331.xsd#mck_OtherNoncurrentAssetsLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:to="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_b97c4397-8320-4285-87d1-c9dbece815ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0f0d4b1e-3b7b-4739-8770-34bf656f00d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bccaa5ed-b290-49b2-b1a7-a16ab1a64c50_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations Disclosures</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_74ac4420-41e3-4db7-bd98-8adc70fb9ac5_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_4d6ba897-c623-4767-90ce-0197dbfb0440_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ServicesBusinessMember_f400098c-012a-49c3-b825-6701912c14a5_terseLabel_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business</link:label>
    <link:label id="lab_mck_ServicesBusinessMember_label_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business [Member]</link:label>
    <link:label id="lab_mck_ServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember" xlink:href="mck-20210331.xsd#mck_ServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ServicesBusinessMember" xlink:to="lab_mck_ServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_16e1605b-d4dd-46f9-b3d6-f43e697c3626_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected payment period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20210331.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8b71a8ad-195a-4d8d-8e2d-b34d22fe0aea_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_64f8cdbc-34d1-490b-b43d-8d8432dd3b86_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_c2fc85db-6a85-4ab2-b012-a6607581eddd_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_2ea439ab-b402-4dd8-bdf1-e8aedac81c93_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_5495b455-721a-49be-a3fc-2a282e73813c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_e63b1f29-358d-4f03-8631-68efed653f3b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4b32950d-c255-4082-9fc6-60b419f541d6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_8ea4db52-5655-4c9a-9d9a-8f9affb72f25_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOther_9c96a7f3-cdc9-416e-885e-e12d2a759d7a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment, and other</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOther_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOther" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_576d8757-c72e-4b7a-8f98-ea98a36a5758_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_25d55f33-9e92-4c20-b0fd-fe23a78bea38_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_c8308ad0-1d35-4d09-a2b2-5451d4614414_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8715772a-4cd1-4f5e-b544-35bd2fb44415_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1f801242-9ff9-4b4e-81f7-e503b76f8c2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c9ab0401-ee75-43ad-bb5a-2651770fc74f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_76ffd844-db0b-4a17-a5eb-0a20675e65c1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_db2bb691-b211-40cb-b7ed-aaf84a0bd3ee_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_3704748c-ffad-4a37-9779-5a95fa25d47a_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized actuarial loss and prior service costs</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:to="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_89a5242e-aa34-4b0c-8838-2aee7b42b905_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_label_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member" xlink:href="mck-20210331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMarch12021Member" xlink:to="lab_mck_A475NotesDueMarch12021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_393e4b34-8175-4510-9240-e36f4b961df6_terseLabel_en-US" xlink:label="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_label_en-US" xlink:label="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Eight Eight Percent Notes Due March Fifteenth Two Thousand Forty Four [Member]</link:label>
    <link:label id="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_documentation_en-US" xlink:label="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Eight Eight Percent Notes Due March Fifteenth Two Thousand Forty Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" xlink:href="mck-20210331.xsd#mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" xlink:to="lab_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_bf492b3a-68ba-4f57-85bf-1d0ad019fa23_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_712b1893-4c3e-4da3-abe3-736a36721625_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on the lapse of the applicable statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_15e7b94e-57d6-4587-bbb4-f12a3713c700_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_391903f6-38d6-4b50-b190-f8f8e595fd29_negatedTerseLabel_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right-of-use assets</link:label>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_label_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease Right-of-use Assets</link:label>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_documentation_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:href="mck-20210331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:to="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_9e6ca505-bb6c-4e19-a8ed-121d896f888e_terseLabel_en-US" xlink:label="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Two Counties In re: National Prescription Opiate Litigation</link:label>
    <link:label id="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Two Counties In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Two Counties In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:href="mck-20210331.xsd#mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c20a0286-ae16-46d8-aaa5-cdd01a3b4826_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign operations</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_6c18eb08-0d14-4ae5-90c1-9e4b1b53dce7_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c5363071-1360-41bb-81ed-948178611cb2_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_dbea94da-a854-4d08-8755-2e78f6cded3f_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f72da7fd-a215-48ad-89ab-c83e435604d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_8414f9fc-98ef-4e1c-94eb-66b40d5c5120_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer and participant contributions</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Contributions by Employer and Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Contributions by Employer and Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3febc15a-6ae9-41df-8b71-ddf95c2abfd1_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities excluded from diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_d88ee023-f48e-4f01-a70a-cb5d53c5d787_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_b5649e51-a975-4adc-9624-606aee767980_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e225ce1a-4613-4aba-8df4-61ff62c1624f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (Years) - Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_ea6e319b-0bd6-455c-9557-0103cfc2722d_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockExchangedDuringPeriodValue_6393046d-0bb6-405d-84a0-805f1bf11bbb_negatedLabel_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare share exchange</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodValue_label_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Value</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodValue_documentation_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodValue" xlink:href="mck-20210331.xsd#mck_StockExchangedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockExchangedDuringPeriodValue" xlink:to="lab_mck_StockExchangedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_22604ec2-e546-438b-bb98-902183c701ba_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" xlink:to="lab_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_26691796-c174-43a5-a1ae-2b68b2ce8c30_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e250df96-b9fd-4e19-a050-86cf478674ff_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a5e5bbed-3013-4d10-ba9e-abd59d0438c8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ee78b9f1-42b7-4f9c-8836-484c0c055824_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_39feda25-080d-457b-adaa-dc7474891c84_terseLabel_en-US" xlink:label="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares converted into per share converted (shares)</link:label>
    <link:label id="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_label_en-US" xlink:label="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</link:label>
    <link:label id="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_documentation_en-US" xlink:label="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:href="mck-20210331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:to="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExecutiveOfficerMember_33f12d80-9274-4fd4-b3a5-97db50713572_terseLabel_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retired executive</link:label>
    <link:label id="lab_srt_ExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember" xlink:to="lab_srt_ExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_36d47b3c-035f-44d7-a414-86622fd9d1bb_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_ccc1a450-684b-422a-9471-67a9071f947b_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_3a61814a-a051-4bd3-b691-0a09cab040c9_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d5d5cce3-491b-46aa-890f-e847dc93f903_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a0e41e1e-e7d9-442b-85c1-8dfee3019104_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8120bbf2-efa6-474b-b230-dfcc0af77df9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_0b9c8b9c-ad7a-47c2-8215-4bfd0bbd278d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_60ae0639-99d3-480f-a579-1b84e6134c6c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_446af44c-a22f-4b08-8832-824ad331fd64_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20210331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_edb2542f-d95b-4bdc-a4a7-fae328461321_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_cf4f6e31-cda7-4583-8f7e-18b3094d55ea_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_942f95ec-e9c5-4216-8211-401a36c31847_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2cf97935-dfdb-4c47-92c6-135bdb596e60_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_c486c641-e5e8-4024-b133-e85ccf23347a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_67a2e644-a1d8-4577-8343-ea798840c990_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derived revenues (percent)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20210331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentTransactionCostsIncurred_af44eef0-4501-4c2a-ba7a-3c337c7c0088_negatedTerseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Transaction costs incurred</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentTransactionCostsIncurred_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Transaction Costs Incurred</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentTransactionCostsIncurred_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Transaction Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:to="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_72915598-d804-4c74-b002-50966baf48df_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ddc10053-ce3c-43ce-9c8c-bc2998fffa3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_15887ad0-c244-4b42-b4d0-edbae029ff40_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3ccb3689-a773-4201-853f-93457456093e_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_c90aaf63-6f41-4ac2-a672-20d43072e1c5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c83d6f13-13fa-48b9-be34-ce39fe930e2e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_af5eb1b7-9d8e-48bf-a212-07ad43247a3b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_1f5d969c-492d-472a-8d46-c6bbaeede47d_terseLabel_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Domain]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_label_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Domain]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_documentation_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Defined Contribution Plan Matching [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain" xlink:to="lab_mck_DefinedContributionPlanMatchingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_b12d7808-ba9c-4247-94c1-85ea9c7955d3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4fa8d0cc-f339-4281-bafb-5ea35286bc3b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_6c6b95cc-89e4-4d7b-a356-e9086b8bfdb5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other asset impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_441c5800-2fa3-4357-976c-a0a1b1a1847f_terseLabel_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of plan asset value</link:label>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_label_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</link:label>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_documentation_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:href="mck-20210331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:to="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_2fa27338-a59e-4909-90c6-348de8a9db9c_negatedTerseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tax benefit on intellectual property transfer</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_8772b30c-4b12-40e0-8144-6fed91cec591_terseLabel_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distribution</link:label>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_label_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distributions Reporting Unit - June 2018 One [Member]</link:label>
    <link:label id="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_documentation_en-US" xlink:label="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Distributions Reporting Unit - June 2018 One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" xlink:to="lab_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_11bdb69b-d775-40c2-83e7-e9d788548411_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncancelable lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_7443965d-4d93-4d82-95e5-6b0a506dc3da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a3863719-5eed-4e2f-b8f3-dd84a76ea4f4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_e1f64f5a-b1ff-4918-8c55-21c13b4ff98c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring incurred to-date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fffc25bd-e7fd-4f65-9159-9c79d6363d59_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_8f5c9ace-8a9b-4eb2-ac09-1df3ce8dcf81_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5a811097-4577-4eef-96fe-ca61dbbed9cc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_80d4ce7e-0d73-427a-8f5c-3ac9e730009b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_46f6ab1d-5164-4b27-9204-e51cd4087c50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_69b14b3b-f77d-4565-ad91-e45e37b6b32f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of defined benefit plan amounts recognized in other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ce1589f5-30d3-4c1d-81ac-3d709dd11000_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_2317ae1a-0053-4efb-8a5c-a381f7e2e7f9_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinanceLeaseCost_a9e184f0-5206-457e-9e64-2d6298678515_totalLabel_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_mck_FinanceLeaseCost_label_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_mck_FinanceLeaseCost_documentation_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost" xlink:href="mck-20210331.xsd#mck_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinanceLeaseCost" xlink:to="lab_mck_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_33d649df-afe2-4072-88bd-26d9348afd5f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_7c1b3a92-90af-4588-b1dc-05afc9e15b33_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_ba3de024-b0b8-4062-a2f3-bd4edf44402a_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_e5e30f97-a35d-4bb5-8dcc-1e5aad4bb366_terseLabel_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution</link:label>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_label_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution [Member]</link:label>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_documentation_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember" xlink:href="mck-20210331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FirstPartOfPayContributionMember" xlink:to="lab_mck_FirstPartOfPayContributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_59fa9dc7-ec1d-4f65-8be2-824469f49d18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeContributions_3162352b-46db-4d74-9c25-8a8a3424f87e_terseLabel_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions (as a percent)</link:label>
    <link:label id="lab_mck_EmployeeContributions_label_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Contributions</link:label>
    <link:label id="lab_mck_EmployeeContributions_documentation_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions" xlink:href="mck-20210331.xsd#mck_EmployeeContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeContributions" xlink:to="lab_mck_EmployeeContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2013StockPlanMember_04749e6c-ef33-466c-ae22-4e70911b5c2b_terseLabel_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan</link:label>
    <link:label id="lab_mck_A2013StockPlanMember_label_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan [Member]</link:label>
    <link:label id="lab_mck_A2013StockPlanMember_documentation_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember" xlink:href="mck-20210331.xsd#mck_A2013StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2013StockPlanMember" xlink:to="lab_mck_A2013StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_24da8e5f-da77-4d85-9853-ac8973cca443_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_fc3da5ec-f5fe-4443-bf22-62442e0950de_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0f212d85-4942-4aa9-b668-c3a75c39c2cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_05f5282b-b993-479d-ac16-65ff0936fe73_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0d7554cd-4c1c-4dfb-acd3-5b93750b9191_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_2cac5592-459c-4c25-bc42-dd2cfb798aa3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_f655c938-7ce5-4cc9-9a11-18a0de7d2e51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_15c0b6dd-cfc6-42ff-b241-71e0049dc044_terseLabel_en-US" xlink:label="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths</link:label>
    <link:label id="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_label_en-US" xlink:label="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths [Member]</link:label>
    <link:label id="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_documentation_en-US" xlink:label="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" xlink:href="mck-20210331.xsd#mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" xlink:to="lab_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6d25df8b-c7a3-4468-9caf-4cddcd302163_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_686094a5-e2a4-4369-8349-9f1fa1010ec8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for remeasurement to fair value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DerivativeNotionalAmountMatured_83e433a3-ec84-4bcf-b870-6706198ed647_terseLabel_en-US" xlink:label="lab_mck_DerivativeNotionalAmountMatured" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of derivatives that matured</link:label>
    <link:label id="lab_mck_DerivativeNotionalAmountMatured_label_en-US" xlink:label="lab_mck_DerivativeNotionalAmountMatured" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Matured</link:label>
    <link:label id="lab_mck_DerivativeNotionalAmountMatured_documentation_en-US" xlink:label="lab_mck_DerivativeNotionalAmountMatured" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Matured</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerivativeNotionalAmountMatured" xlink:href="mck-20210331.xsd#mck_DerivativeNotionalAmountMatured"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DerivativeNotionalAmountMatured" xlink:to="lab_mck_DerivativeNotionalAmountMatured" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_a33cc72d-6052-4e38-bbfc-0bb1d2d5ad91_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:href="mck-20210331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_21f1a762-bc2e-4d86-8778-ec4c36c581f9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a5ba9f55-ce83-486b-8aed-1a524e2e2099_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3b505404-5533-4a22-b66e-1c6b7d6284c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_2a811cbb-f29e-4db4-884a-c79037fffe27_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CaliforniaFoundationMember_895e8228-82cd-4103-8ce4-306130428e48_terseLabel_en-US" xlink:label="lab_mck_CaliforniaFoundationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Foundation</link:label>
    <link:label id="lab_mck_CaliforniaFoundationMember_label_en-US" xlink:label="lab_mck_CaliforniaFoundationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Foundation [Member]</link:label>
    <link:label id="lab_mck_CaliforniaFoundationMember_documentation_en-US" xlink:label="lab_mck_CaliforniaFoundationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Foundation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CaliforniaFoundationMember" xlink:href="mck-20210331.xsd#mck_CaliforniaFoundationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CaliforniaFoundationMember" xlink:to="lab_mck_CaliforniaFoundationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_d65e85ca-ea66-4e96-a3e9-dc8457d3cbcd_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_48017987-0401-48a9-90cc-b52ebd9c542c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_eaaea119-ea83-49d9-8ace-b132cf1f3e23_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_78c56dba-6f32-4ca5-b102-c9e395f07a8c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberofLargestCustomers_41925f97-086c-4a41-8df0-5a1670f3654a_terseLabel_en-US" xlink:label="lab_mck_NumberofLargestCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of largest customers</link:label>
    <link:label id="lab_mck_NumberofLargestCustomers_label_en-US" xlink:label="lab_mck_NumberofLargestCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Largest Customers</link:label>
    <link:label id="lab_mck_NumberofLargestCustomers_documentation_en-US" xlink:label="lab_mck_NumberofLargestCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofLargestCustomers" xlink:href="mck-20210331.xsd#mck_NumberofLargestCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberofLargestCustomers" xlink:to="lab_mck_NumberofLargestCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_ee47a353-c4d8-424c-bbc9-300927ab3c15_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_e644907b-5045-44bf-8545-fec1c459f2a3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest in Joint Venture (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c3203100-0867-4570-a8c6-9e65ad3bb812_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e9d618c8-387d-4915-bc6b-a01a4d86f13c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0ea299c6-7a80-4b0c-82bc-0e44e3627dda_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_674c6476-dfee-4061-8403-ce579c0d4d3f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_d785c065-f9de-43dd-b112-486c79d14bef_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_07ea5ea1-5e78-46ca-8da5-5a17d46bc54b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_1e3ec856-fb5e-4673-a37f-69caf0a8108c_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:href="mck-20210331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_7261c266-f80b-4444-86fd-b5f80b996497_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_51f1daaf-d893-4ec2-859a-1e48cc7cf2f3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4500abaf-7e2e-4400-894e-628643f85894_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7ff84f25-006c-4e10-8f0a-c21f2cfbf9dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_794e448d-3104-425e-8c69-fe45ac17f4dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2c2f38e0-2387-4bbe-b360-2a6d81a304f6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ac499772-f7f7-49b4-9282-cb9c8dbed8b0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain from sale of equity method investment, pre-tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_4707aaf1-0755-4579-a2db-ebdf3c80fefc_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on split-off of the Change Healthcare JV</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_af45bfe4-cf1d-4355-9ce8-c9bbb44253b1_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_a27bfb60-e031-49d2-a636-a38268e2daee_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24672fc8-677e-4bc0-b9b4-68a7748d7426_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_09c19ddc-1783-4ec8-8947-e16a6093587a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bf0c7e60-6126-4e40-9724-79583c74a843_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_40d05386-37a9-4b0b-a6bb-16c2cf7f8dba_terseLabel_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_label_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Text Block]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_documentation_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial guarantees And warranties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:href="mck-20210331.xsd#mck_FinancialGuaranteesAndWarrantiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:to="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7ef84031-7f1d-44cf-9a54-92f54823ab43_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_0fa8daab-3177-49f4-9760-6ae5d6926899_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_2ad937d1-26e0-43d9-9119-10d4d259ef2b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment assets and property, plant and equipment, net by geographic areas</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_f2ef4ced-2c04-4b70-a88b-0529c7189ba3_negatedTotalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_29cd0ecc-afc7-4141-9c4f-7a7aabbb7788_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value on exercise</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_52053589-27a0-4be7-a70e-c286ec396740_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e75c2aa9-c0e4-4959-b6fa-d4a8bff8ac3f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_b63884be-0fef-4dab-a89f-876c06811a64_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated loss</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_da4248e1-abdf-41dd-a3c0-5f72be10763e_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cd9b7fff-7fe1-4d70-b1ee-0b13bb52294c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices upper limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_377d83ad-07e5-4c1f-afaa-cfb1e2207bf6_verboseLabel_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_label_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Including Net Capitalized Software</link:label>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_documentation_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Including Net Capitalized Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:href="mck-20210331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:to="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_cc44a52c-25e3-49a3-b46b-c179c514b1d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_389e2fdf-e8ab-425f-bb1c-a0e6632bf5de_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_8f25a5f6-1c58-4b54-801f-c4e5783711e0_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_afe2df31-3c7a-4803-a9ac-60a8d2e61d62_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_9fdbfbfc-b7f9-423e-8d38-0fa50bffa13d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contingent consideration that may be paid</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_a82b8dc4-6d42-4119-afb4-0d95f8bb063f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8269e447-4812-4516-b5e5-58a3503d6337_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cec958ed-7b38-478a-b8cc-5c6b3061d054_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility borrowing capacity (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_9f468b96-c0b1-4417-8771-3fa2d434e797_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2c76cc29-9356-46bb-8706-e33c5e1ff628_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8605949a-6271-4227-a654-543b48682201_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_cce9ebef-ee0e-4c27-9a02-4a8c5e70793e_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_676902dd-ceda-42a1-8b17-1378455ba5ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_dbcb5575-f228-478e-8e9a-e01807aa59a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from other security offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity" xlink:to="lab_us-gaap_ProceedsFromOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6b51f005-b5f1-4263-bb69-acfc524644ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3456947f-b4b3-453b-a589-d20761273146_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_478e3b5b-f93b-4550-8017-af89b719a0ae_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_5645658d-f1c6-4c35-9b39-a23a9273153b_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_cc67edbb-97c3-433d-80e0-bc5276ad7eca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_de6fdb45-fc94-464f-8956-fda7b4dac89d_negatedLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_8792f3d1-714c-468d-bbb6-3dc152169cfd_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_376b2c81-268a-4a22-b81e-bf87ba493ff6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net periodic expense for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_120ea329-b6a6-4cac-ba5f-683c3246c166_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c63d3a4d-91dc-4ba1-9b22-3e90acc4e6b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_7c5ac0b2-ccc3-4074-adfd-b7716c485268_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6550f6b3-f3fc-4909-a999-918dc76e924f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_8c2b8e57-37c8-4ae3-b70f-27b55a749e48_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease receivable</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b3da0748-9f2d-480e-8948-130e5f494019_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberofSoftwareProducts_1b12379f-300f-4ca1-bd30-ea2ae2b0e0b1_terseLabel_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of software products</link:label>
    <link:label id="lab_mck_NumberofSoftwareProducts_label_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Software Products</link:label>
    <link:label id="lab_mck_NumberofSoftwareProducts_documentation_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Software Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts" xlink:href="mck-20210331.xsd#mck_NumberofSoftwareProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberofSoftwareProducts" xlink:to="lab_mck_NumberofSoftwareProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_77155199-064c-4b52-9073-5ebcafd97862_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_d2c85808-4c8c-40a1-86f1-c73a444d820c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_cd005ab7-daf3-483a-ae2a-a92a3e55cf8f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1aced7a1-5525-4ac0-94bb-104bd15f54fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d1cb38ff-656b-4560-9f9b-485c1093012d_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_5d3a8de7-499e-447d-8c60-1f1850a3f9f8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_3a251268-3213-45ac-a090-9e322d9f3cb2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 115 and 110 shares at March 31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0421817b-2af5-48d3-9a29-af127598f8cd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_d666a1b4-9d68-4e9e-a9c0-84dcbedcbc47_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans, Defined Benefit</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_16c7ec0e-6642-40e0-8a9f-2a41269a20df_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rates for actuarial present value of benefit obligations (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_fc9a382a-62b5-4268-8045-6d30cee15a85_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PendingAndFutureOpioidRelatedClaimsMember_bf5002d2-0aed-42e3-b572-282690b9a24c_terseLabel_en-US" xlink:label="lab_mck_PendingAndFutureOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending and Future Opioid-Related Claims</link:label>
    <link:label id="lab_mck_PendingAndFutureOpioidRelatedClaimsMember_label_en-US" xlink:label="lab_mck_PendingAndFutureOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending and Future Opioid-Related Claims [Member]</link:label>
    <link:label id="lab_mck_PendingAndFutureOpioidRelatedClaimsMember_documentation_en-US" xlink:label="lab_mck_PendingAndFutureOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending and Future Opioid-Related Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PendingAndFutureOpioidRelatedClaimsMember" xlink:href="mck-20210331.xsd#mck_PendingAndFutureOpioidRelatedClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PendingAndFutureOpioidRelatedClaimsMember" xlink:to="lab_mck_PendingAndFutureOpioidRelatedClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_0d7b18f2-074a-4e49-9d4c-2a4c00c18142_terseLabel_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation</link:label>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_label_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation [Member]</link:label>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_documentation_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:href="mck-20210331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:to="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1a700a25-051a-4f9d-bcbf-941e96ee0899_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_16b1bb86-c261-4c5b-ab10-cd31f649fb63_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory federal income tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_776edda1-59a7-48bb-a206-5e057d42d152_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems" xlink:to="lab_us-gaap_GuaranteeObligationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_d437c21d-149c-4c4c-9d61-c20b7a8c67e1_terseLabel_en-US" xlink:label="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_label_en-US" xlink:label="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seven Point Six Five Percent Debentures Due March One Two Thousand Twenty Seven [Member]</link:label>
    <link:label id="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_documentation_en-US" xlink:label="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seven Point Six Five Percent Debentures Due March One Two Thousand Twenty Seven [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" xlink:href="mck-20210331.xsd#mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" xlink:to="lab_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_5a808ce6-ecb8-46f0-bbd8-cfc0ed35c149_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_511b7e60-8c71-42b4-ac9e-802dc348b8f2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_fe2d552d-5dff-4bb3-a921-166d4a80b7fd_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_1747e9a7-16ee-4bd3-8d65-d3de10b4dbdd_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax other-than-temporary impairment</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Other Than Temporary Impairment After Tax</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Other Than Temporary Impairment After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:to="lab_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_65a6a820-a967-47c5-838b-e87ae91b44d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount borrowed under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_81fa0e86-4687-4d6a-b5b0-f22164a9d633_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2a547a76-6458-47c0-ac41-b9460d8a45bc_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_14c67a39-e6ed-4ccf-8a2f-e909c8d048ff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_112b0c6a-981c-4212-9a2d-a3cec46a94b8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>mck-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:0a91717b-5b9a-4470-a716-9c00214a8bdd,g:f2a8631c-ae82-4a44-9090-35d7005e9a98-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20210331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_963bd0f7-8f0f-4eb2-9132-f8ec524d2c71" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_963bd0f7-8f0f-4eb2-9132-f8ec524d2c71" xlink:to="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c88333fc-8231-4d56-a484-ec8b1ecb9cfe" xlink:to="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9c130a5e-6f45-4266-8b3d-ed008da88bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_us-gaap_CommonStockMember_9c130a5e-6f45-4266-8b3d-ed008da88bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A0.625notesDue2021Member_57abcfe5-a400-48ea-ac5c-347a27beb84d" xlink:href="mck-20210331.xsd#mck_A0.625notesDue2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A0.625notesDue2021Member_57abcfe5-a400-48ea-ac5c-347a27beb84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member_40bf2edc-cae1-49b5-9c63-90e89a0b104c" xlink:href="mck-20210331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A1.500NotesDue2025Member_40bf2edc-cae1-49b5-9c63-90e89a0b104c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member_53f2979d-b954-42a8-8516-1635354046fc" xlink:href="mck-20210331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A1.625NotesDue2026Member_53f2979d-b954-42a8-8516-1635354046fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member_6ab34cf8-1ac5-4396-8b3d-ded2f2d145e1" xlink:href="mck-20210331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7753fc1f-e8b4-4154-bcc1-3718c8645209" xlink:to="loc_mck_A3.125NotesDue2029Member_6ab34cf8-1ac5-4396-8b3d-ded2f2d145e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_54f56d7d-c783-43b1-b6b6-e9403eb3e214" xlink:to="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fb90457a-f195-466b-a9b4-9f10d9d26375" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentType_fb90457a-f195-466b-a9b4-9f10d9d26375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_8481ca6b-5244-4ddf-8dd3-e4b0a225a112" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentAnnualReport_8481ca6b-5244-4ddf-8dd3-e4b0a225a112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d40a1b0c-4f2f-4889-8876-954fee619501" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentPeriodEndDate_d40a1b0c-4f2f-4889-8876-954fee619501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3306a17b-e512-449b-8a9b-12a56bda8fa2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_CurrentFiscalYearEndDate_3306a17b-e512-449b-8a9b-12a56bda8fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_36333b52-8f75-49c6-ba3c-5b82cb258c49" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentTransitionReport_36333b52-8f75-49c6-ba3c-5b82cb258c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_34d27a49-ec1a-41f3-9a3c-a39f6abb83f5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityFileNumber_34d27a49-ec1a-41f3-9a3c-a39f6abb83f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7b261753-bcab-4783-8aef-84a31c6d67f2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityRegistrantName_7b261753-bcab-4783-8aef-84a31c6d67f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ed0a2bd2-928b-476a-938d-254f5e97dfcd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ed0a2bd2-928b-476a-938d-254f5e97dfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0409cda3-0f4f-4a3b-b4fa-8938acc22730" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityTaxIdentificationNumber_0409cda3-0f4f-4a3b-b4fa-8938acc22730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4a63f801-7d8d-4f56-88db-801bccd44f29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressAddressLine1_4a63f801-7d8d-4f56-88db-801bccd44f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f3d715b6-619e-4992-bd39-edcb53b0c594" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressCityOrTown_f3d715b6-619e-4992-bd39-edcb53b0c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_738dc6b4-fb62-4c08-b63d-635d7ba1ae32" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressStateOrProvince_738dc6b4-fb62-4c08-b63d-635d7ba1ae32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7f0250a1-d1a7-4417-9ade-1ce5e9b97cc3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityAddressPostalZipCode_7f0250a1-d1a7-4417-9ade-1ce5e9b97cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_770d6151-ff83-4fe5-8aa3-5d8ae7e2601c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_CityAreaCode_770d6151-ff83-4fe5-8aa3-5d8ae7e2601c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3aa83d5c-3a81-40ec-810f-a1abf0022093" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_LocalPhoneNumber_3aa83d5c-3a81-40ec-810f-a1abf0022093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1601d375-28af-4542-8e0a-9f93b2ed7364" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_Security12bTitle_1601d375-28af-4542-8e0a-9f93b2ed7364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4731126b-d6f3-4aa8-a89f-5ee924c3a62d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_TradingSymbol_4731126b-d6f3-4aa8-a89f-5ee924c3a62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d4ff00b4-c013-4511-afa5-0b1e802a5e62" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_SecurityExchangeName_d4ff00b4-c013-4511-afa5-0b1e802a5e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_47ddf474-283d-402b-a5f5-4695bfdc91df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_47ddf474-283d-402b-a5f5-4695bfdc91df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_366925a1-8112-413d-bc99-e2fe0d041f5b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityVoluntaryFilers_366925a1-8112-413d-bc99-e2fe0d041f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ea85da6f-ac7f-4fd3-b007-9997c117dbb2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityCurrentReportingStatus_ea85da6f-ac7f-4fd3-b007-9997c117dbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_881ad90d-17c4-4a4c-a2e1-a80f871492a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityInteractiveDataCurrent_881ad90d-17c4-4a4c-a2e1-a80f871492a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_554b9afe-d805-4539-8915-24c6878e37f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityFilerCategory_554b9afe-d805-4539-8915-24c6878e37f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0c78edd8-243e-4786-97b5-02a1250a5082" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntitySmallBusiness_0c78edd8-243e-4786-97b5-02a1250a5082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b7e68194-444c-44df-be4c-1adba798c4fe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityEmergingGrowthCompany_b7e68194-444c-44df-be4c-1adba798c4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_85326b7d-705b-40dc-8de9-a8df8a2e9ab2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_85326b7d-705b-40dc-8de9-a8df8a2e9ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e3b70366-938b-43e4-9c78-8711ee9b5da7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityShellCompany_e3b70366-938b-43e4-9c78-8711ee9b5da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_d0f803f1-18c0-4b4a-bded-ba6171a00cbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityPublicFloat_d0f803f1-18c0-4b4a-bded-ba6171a00cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_96ba0e4d-f4b0-4478-b1b8-ee103e318a4d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_96ba0e4d-f4b0-4478-b1b8-ee103e318a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4ec3e86b-24c3-4fc7-be1a-7391b79c369d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4ec3e86b-24c3-4fc7-be1a-7391b79c369d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_950966f0-7c3a-4be5-acc0-3f8403f500ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_EntityCentralIndexKey_950966f0-7c3a-4be5-acc0-3f8403f500ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4fdf6bc7-84a3-49c8-b969-8ad5e48c1647" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4fdf6bc7-84a3-49c8-b969-8ad5e48c1647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ae5ece3e-d989-4200-b1e8-20ef13d89c9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_DocumentFiscalYearFocus_ae5ece3e-d989-4200-b1e8-20ef13d89c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4f12abf4-39de-4601-8f1b-f2ab12e4f30e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_d7c676bb-e273-47aa-bf53-903dcdd25a4e" xlink:to="loc_dei_AmendmentFlag_4f12abf4-39de-4601-8f1b-f2ab12e4f30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28af7112-d6cc-4dae-a71f-8548e4096a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28af7112-d6cc-4dae-a71f-8548e4096a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cff9922b-8966-4bab-92f6-4c1db5a65027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cff9922b-8966-4bab-92f6-4c1db5a65027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f0e95f95-2ef6-4c0d-8da1-7065b967f266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_GrossProfit_f0e95f95-2ef6-4c0d-8da1-7065b967f266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cf275fe4-7873-4597-8f1f-bc219dc8d4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cf275fe4-7873-4597-8f1f-bc219dc8d4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_90689942-c053-459b-9b31-857816245edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:to="loc_us-gaap_LegalFees_90689942-c053-459b-9b31-857816245edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c47a3f37-6f56-4b5a-888d-0b6824f5c2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c47a3f37-6f56-4b5a-888d-0b6824f5c2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a2eba4ab-395e-40d4-8f67-cc25354ffaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_a2eba4ab-395e-40d4-8f67-cc25354ffaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3fef2d54-80f2-48c7-8a0a-ae4afae9faf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4ac49c86-ef21-40f0-86ec-963c53a907df" xlink:to="loc_us-gaap_OperatingExpenses_3fef2d54-80f2-48c7-8a0a-ae4afae9faf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_44742ef3-2e83-4f18-8036-b457b81161c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_OperatingIncomeLoss_44742ef3-2e83-4f18-8036-b457b81161c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d3d878ae-cb44-442e-80c6-4ec681fc6057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d3d878ae-cb44-442e-80c6-4ec681fc6057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_d58b2610-e027-4e14-87b2-0c2a07c85baa" xlink:href="mck-20210331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_d58b2610-e027-4e14-87b2-0c2a07c85baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8b8d1fe2-5370-4735-994c-c3fd2660b45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_InterestExpense_8b8d1fe2-5370-4735-994c-c3fd2660b45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3328d8e-a079-4207-989d-c27da42a164b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3328d8e-a079-4207-989d-c27da42a164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_111ff9a4-f1a1-4164-a02f-4b7827044757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_111ff9a4-f1a1-4164-a02f-4b7827044757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_811cda68-c2c5-4299-ab9f-22752e30b8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_811cda68-c2c5-4299-ab9f-22752e30b8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c09b9ebb-e0d5-4673-b361-97ddfc11c8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c09b9ebb-e0d5-4673-b361-97ddfc11c8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_80906f7b-5807-4cfe-94b1-ab2caf243037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_ProfitLoss_80906f7b-5807-4cfe-94b1-ab2caf243037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b7aeb20-2475-4a57-b16f-98bb839b1acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b7aeb20-2475-4a57-b16f-98bb839b1acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ac97d8cd-096f-4d73-8637-6b6ba71830c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_NetIncomeLoss_ac97d8cd-096f-4d73-8637-6b6ba71830c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1e3ed945-2e5d-4834-9cc9-2e57c179eb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1e3ed945-2e5d-4834-9cc9-2e57c179eb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_e9c7cbd8-d6e7-4ca2-9228-d2cf9d936ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e3ed945-2e5d-4834-9cc9-2e57c179eb4d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_e9c7cbd8-d6e7-4ca2-9228-d2cf9d936ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_08b36bb5-c248-43d7-91e7-f1dd3370bb03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e9c7cbd8-d6e7-4ca2-9228-d2cf9d936ce4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_08b36bb5-c248-43d7-91e7-f1dd3370bb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8c39066e-7b8d-4818-8457-e1786e592a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e9c7cbd8-d6e7-4ca2-9228-d2cf9d936ce4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8c39066e-7b8d-4818-8457-e1786e592a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bffa69e0-f192-41e9-974a-28b9ebb81f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e9c7cbd8-d6e7-4ca2-9228-d2cf9d936ce4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bffa69e0-f192-41e9-974a-28b9ebb81f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_f8d0232c-9937-4652-beb0-80baaa607a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e3ed945-2e5d-4834-9cc9-2e57c179eb4d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_f8d0232c-9937-4652-beb0-80baaa607a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_44c421cf-371c-4bcf-acee-bc8d52596080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_f8d0232c-9937-4652-beb0-80baaa607a58" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_44c421cf-371c-4bcf-acee-bc8d52596080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_23ce6891-6d65-4058-930a-3376989d6b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_f8d0232c-9937-4652-beb0-80baaa607a58" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_23ce6891-6d65-4058-930a-3376989d6b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dbb72ece-c7f2-4c4d-869d-da4af87287cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_f8d0232c-9937-4652-beb0-80baaa607a58" xlink:to="loc_us-gaap_EarningsPerShareBasic_dbb72ece-c7f2-4c4d-869d-da4af87287cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c0ce2984-3a28-4f96-95fd-0300ba5a6a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2dcf012e-6f72-4884-a6be-f145c5b2fae3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c0ce2984-3a28-4f96-95fd-0300ba5a6a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39f7c5be-2c1e-4869-b55b-ad1bad719578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c0ce2984-3a28-4f96-95fd-0300ba5a6a2f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39f7c5be-2c1e-4869-b55b-ad1bad719578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dd366ee6-5255-449b-9e43-852561bf114f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c0ce2984-3a28-4f96-95fd-0300ba5a6a2f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dd366ee6-5255-449b-9e43-852561bf114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c461c31-3846-4cef-b2de-506d9355daeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d1427b33-8f6d-4c66-99e2-ca6308397031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c461c31-3846-4cef-b2de-506d9355daeb" xlink:to="loc_us-gaap_ProfitLoss_d1427b33-8f6d-4c66-99e2-ca6308397031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a415331e-ded1-4533-af21-5ad0b196c49b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c461c31-3846-4cef-b2de-506d9355daeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a415331e-ded1-4533-af21-5ad0b196c49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6e81f23f-b11f-4f51-8caf-2ce4f0d5b200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a415331e-ded1-4533-af21-5ad0b196c49b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6e81f23f-b11f-4f51-8caf-2ce4f0d5b200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f9b43e73-a4a5-4a39-9ffa-d89b613f2451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a415331e-ded1-4533-af21-5ad0b196c49b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f9b43e73-a4a5-4a39-9ffa-d89b613f2451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_79d23006-e8bf-4422-baaf-2045dc3d7e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a415331e-ded1-4533-af21-5ad0b196c49b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_79d23006-e8bf-4422-baaf-2045dc3d7e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ff75a330-caf2-41b0-b5ec-93c0cf3d7be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a415331e-ded1-4533-af21-5ad0b196c49b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ff75a330-caf2-41b0-b5ec-93c0cf3d7be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5b500b79-cdf7-4fed-a991-0931123f4daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c461c31-3846-4cef-b2de-506d9355daeb" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5b500b79-cdf7-4fed-a991-0931123f4daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cc7771cb-fe9e-4454-8175-2ca7ff85fb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c461c31-3846-4cef-b2de-506d9355daeb" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cc7771cb-fe9e-4454-8175-2ca7ff85fb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3025461e-5020-48cd-997b-e784de16b1ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c461c31-3846-4cef-b2de-506d9355daeb" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3025461e-5020-48cd-997b-e784de16b1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4cda28af-3691-439c-af4e-fece524e0b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4cda28af-3691-439c-af4e-fece524e0b3d" xlink:to="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6ca121d-6119-4b2a-8efc-8614bcc9df08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a6ca121d-6119-4b2a-8efc-8614bcc9df08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_30b66197-dedb-4e07-9b03-6c23274c3f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:to="loc_us-gaap_ReceivablesNetCurrent_30b66197-dedb-4e07-9b03-6c23274c3f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d6fb7506-3572-45ae-bf61-be3c06bfcf0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:to="loc_us-gaap_InventoryNet_d6fb7506-3572-45ae-bf61-be3c06bfcf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2f275d53-626c-4375-bb1d-19edb0b4a7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_2f275d53-626c-4375-bb1d-19edb0b4a7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_81f59d32-4806-4d82-b62f-4273deb92211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_81f59d32-4806-4d82-b62f-4273deb92211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_40ceef50-fd95-45f8-a9e4-1040f58b13e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e2d62017-3860-4a89-8dde-4f79f01199d8" xlink:to="loc_us-gaap_AssetsCurrent_40ceef50-fd95-45f8-a9e4-1040f58b13e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f985a350-9422-4e92-9c5a-ff9633837238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f985a350-9422-4e92-9c5a-ff9633837238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_38afa629-d2b9-4928-8254-207143f0a1cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_38afa629-d2b9-4928-8254-207143f0a1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fab006cd-1b72-4fcd-a282-eb426ece7851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_Goodwill_fab006cd-1b72-4fcd-a282-eb426ece7851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fec22c41-3d24-496e-97ef-fa9fc87228f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fec22c41-3d24-496e-97ef-fa9fc87228f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9fc0f80f-d2e4-46e3-923c-29f4b04d7039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9fc0f80f-d2e4-46e3-923c-29f4b04d7039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2c24d7c9-08e5-4a59-a89c-c6f68eca39cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6f82b120-70b6-4939-b3b6-dfbfe2b55d4f" xlink:to="loc_us-gaap_Assets_2c24d7c9-08e5-4a59-a89c-c6f68eca39cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4cda28af-3691-439c-af4e-fece524e0b3d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e72d7b25-bf8d-45c4-a816-ac3604555a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:to="loc_us-gaap_AccountsPayableCurrent_e72d7b25-bf8d-45c4-a816-ac3604555a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e364292e-31c7-4921-a121-6019fd586cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e364292e-31c7-4921-a121-6019fd586cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_634e8b05-6a70-47c3-88f7-a2264a046d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_634e8b05-6a70-47c3-88f7-a2264a046d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7a488cac-21d7-4847-92c1-69e7abee73d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7a488cac-21d7-4847-92c1-69e7abee73d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_99ab5f0d-af2f-4f3a-b49c-f03907b2b8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_99ab5f0d-af2f-4f3a-b49c-f03907b2b8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7e86dc88-4974-4043-89cf-ada21be5750b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a225589-0d5b-41ba-a809-647ca0e4d6ca" xlink:to="loc_us-gaap_LiabilitiesCurrent_7e86dc88-4974-4043-89cf-ada21be5750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_82f94eaa-74ce-4080-9afa-c2616563fb8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_82f94eaa-74ce-4080-9afa-c2616563fb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1dda18da-61e1-489f-bf11-29d281d0bf40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1dda18da-61e1-489f-bf11-29d281d0bf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bec88905-11e6-4a3c-a155-783f2a3ab507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bec88905-11e6-4a3c-a155-783f2a3ab507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_2d087601-8801-4da5-9074-23b46d86aa39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_2d087601-8801-4da5-9074-23b46d86aa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_18cdede6-f3e7-4974-854f-b9be56b431a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_18cdede6-f3e7-4974-854f-b9be56b431a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f9b43af0-3609-4705-9588-d6fe93cb9976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f9b43af0-3609-4705-9588-d6fe93cb9976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ac8500bd-a1ae-43df-a01a-9cfc08e019c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_ac8500bd-a1ae-43df-a01a-9cfc08e019c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2f387997-3ea4-430b-8aaa-c7cf58f21128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_PreferredStockValue_2f387997-3ea4-430b-8aaa-c7cf58f21128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_cefc461e-60bd-466b-9a9d-8f8e6f819394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_CommonStockValue_cefc461e-60bd-466b-9a9d-8f8e6f819394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9b0b6419-f711-4309-9398-f28082ec3701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9b0b6419-f711-4309-9398-f28082ec3701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cb7381cc-d402-4c2a-8cab-30baf4d776e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cb7381cc-d402-4c2a-8cab-30baf4d776e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_47a00b0b-4cca-4e1d-abfc-08d924a0b252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_47a00b0b-4cca-4e1d-abfc-08d924a0b252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_76cd4549-5388-42d8-8904-bd3d2d666de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_TreasuryStockValue_76cd4549-5388-42d8-8904-bd3d2d666de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f2285efe-6bfc-4a20-929f-c2ea361050c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_StockholdersEquity_f2285efe-6bfc-4a20-929f-c2ea361050c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_6ff3f9bf-d53f-4392-956b-9cfa2a22613f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_MinorityInterest_6ff3f9bf-d53f-4392-956b-9cfa2a22613f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_37062a7a-8764-4a26-8031-cf8aa3fc0c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0b5269d2-c8eb-4cd9-9b39-50fa33916585" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_37062a7a-8764-4a26-8031-cf8aa3fc0c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7065f91-ec28-444d-b229-36329f03176c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b249c4de-187e-40b5-9926-fedb2a531cec" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7065f91-ec28-444d-b229-36329f03176c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0df6e169-058e-4454-a8a8-5de32559e3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0df6e169-058e-4454-a8a8-5de32559e3d1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_70eac66c-be20-4e82-92fd-e77ceb717fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_70eac66c-be20-4e82-92fd-e77ceb717fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_50c524bb-f130-43cb-bf35-e4be3767de9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_50c524bb-f130-43cb-bf35-e4be3767de9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_078db5d4-1162-4a9d-ba59-bba0778099b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_PreferredStockSharesIssued_078db5d4-1162-4a9d-ba59-bba0778099b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7cb6dcf9-a80d-4889-825e-53dab7c566a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7cb6dcf9-a80d-4889-825e-53dab7c566a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9e03f514-2b93-45b3-bd58-c656fa11996d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9e03f514-2b93-45b3-bd58-c656fa11996d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7fdd0110-df3c-49a2-a765-7b374daf71eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7fdd0110-df3c-49a2-a765-7b374daf71eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d6418d43-0618-4b9b-87e6-2a85f28048c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_CommonStockSharesIssued_d6418d43-0618-4b9b-87e6-2a85f28048c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_e823da7a-b1e7-4d9e-94e5-4e6c0dcd6f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b32e6e2e-6b8a-4353-a60e-d721f6296c52" xlink:to="loc_us-gaap_TreasuryStockShares_e823da7a-b1e7-4d9e-94e5-4e6c0dcd6f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e7abe915-87ef-424c-944e-2af2a3dd4211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e7abe915-87ef-424c-944e-2af2a3dd4211" xlink:to="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7c2348ac-609b-44b2-951a-1a6bd9b56d7c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b2574beb-9558-4afd-bc5e-9cc5a33c59aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b2574beb-9558-4afd-bc5e-9cc5a33c59aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_3daf4e02-6d5e-49d2-9261-c4ac04fdfb2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_291d8d51-a022-4ea0-b22a-e53824a6e16e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_3daf4e02-6d5e-49d2-9261-c4ac04fdfb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d73f6793-8ac4-49f3-a6c4-739b798c8993" xlink:to="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_71f6f09b-997c-4cef-9c7d-1e6903f7c521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_CommonStockMember_71f6f09b-997c-4cef-9c7d-1e6903f7c521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_03311f08-e350-4e4a-91ed-301f11731e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_03311f08-e350-4e4a-91ed-301f11731e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_834a01bf-3358-4ac8-8965-4358d7b3802f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_834a01bf-3358-4ac8-8965-4358d7b3802f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_662035d0-bff3-4163-a080-d278e682225f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_RetainedEarningsMember_662035d0-bff3-4163-a080-d278e682225f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61576180-812d-4133-963c-b2272fd7828b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_61576180-812d-4133-963c-b2272fd7828b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_866c889b-e189-4a1c-9428-7cbac2ce6b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_TreasuryStockMember_866c889b-e189-4a1c-9428-7cbac2ce6b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f226cf4c-ae87-420b-b8e6-1d5eaa1811f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b4a69f9e-c8f6-4460-a5cc-d4a369ab5088" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f226cf4c-ae87-420b-b8e6-1d5eaa1811f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_426949f9-4af9-440b-9f59-d22dfd413919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_158085ab-b816-4991-83cc-1f1d8b2ffa34" xlink:to="loc_us-gaap_StatementLineItems_426949f9-4af9-440b-9f59-d22dfd413919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_426949f9-4af9-440b-9f59-d22dfd413919" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4bf99b6b-65f6-4a3f-b3e3-d030604c675e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_SharesOutstanding_4bf99b6b-65f6-4a3f-b3e3-d030604c675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d6254719-2672-425c-bf0a-542d28bffec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d6254719-2672-425c-bf0a-542d28bffec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_478395aa-fd59-4f2a-9645-24969010ec6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_TreasuryStockShares_478395aa-fd59-4f2a-9645-24969010ec6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_21696121-4c8e-4385-98fe-c6d611214b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_21696121-4c8e-4385-98fe-c6d611214b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0f295a27-aa8a-4c34-8c2e-cf565746f939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0f295a27-aa8a-4c34-8c2e-cf565746f939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3299ebbc-7ec7-4f84-ad69-0abfb2ca21d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3299ebbc-7ec7-4f84-ad69-0abfb2ca21d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_23026f52-6945-4ccb-a3c3-4fd05e9c5f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_23026f52-6945-4ccb-a3c3-4fd05e9c5f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_635b55fb-d72a-4b7a-be11-4d1b890fc333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_635b55fb-d72a-4b7a-be11-4d1b890fc333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_6458ac3c-17c7-4a07-9c0a-db0e11e5fa6d" xlink:href="mck-20210331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_6458ac3c-17c7-4a07-9c0a-db0e11e5fa6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_5cdd85fa-24f2-4917-8f0e-bf6c90047221" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_5cdd85fa-24f2-4917-8f0e-bf6c90047221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_261c9da3-dfd1-48c2-8848-f8c48292fbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_261c9da3-dfd1-48c2-8848-f8c48292fbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_08612f83-8bab-4a33-80cd-f55c18e0755d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_08612f83-8bab-4a33-80cd-f55c18e0755d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodShares_2a322752-f474-4a9c-a427-7ea595b5f6cd" xlink:href="mck-20210331.xsd#mck_StockExchangedDuringPeriodShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_StockExchangedDuringPeriodShares_2a322752-f474-4a9c-a427-7ea595b5f6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodValue_ecc4b52d-3aa1-4227-be7c-a285828c5237" xlink:href="mck-20210331.xsd#mck_StockExchangedDuringPeriodValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_mck_StockExchangedDuringPeriodValue_ecc4b52d-3aa1-4227-be7c-a285828c5237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_53f35ef8-b8e8-400c-9240-529a3aa8fac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_53f35ef8-b8e8-400c-9240-529a3aa8fac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8ce6176b-2245-4975-8093-3f9b1e2d5ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8ce6176b-2245-4975-8093-3f9b1e2d5ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_a7f874d9-f5af-49b9-a70d-a7af995adbda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_DividendsCommonStockCash_a7f874d9-f5af-49b9-a70d-a7af995adbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_08c9a358-ca0d-4606-8184-ab4e7547b9e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockholdersEquityOther_08c9a358-ca0d-4606-8184-ab4e7547b9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c33a5dab-d0e5-4747-a7d7-6886620aff28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_SharesOutstanding_c33a5dab-d0e5-4747-a7d7-6886620aff28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_72297da7-7415-440f-a75b-7dd63d7d3810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_72297da7-7415-440f-a75b-7dd63d7d3810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_70641791-ae4d-4813-9c23-2d4459dd8e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f303009e-5d90-44f7-815c-3d567fce9d4b" xlink:to="loc_us-gaap_TreasuryStockShares_70641791-ae4d-4813-9c23-2d4459dd8e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_455e2e1e-2d60-477c-9e58-13851383e51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_4d8ea80e-3717-4ce9-bb77-288ee6613bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_455e2e1e-2d60-477c-9e58-13851383e51b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_4d8ea80e-3717-4ce9-bb77-288ee6613bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_75f10ab2-9648-4ebc-81e2-6355ccc1117d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_455e2e1e-2d60-477c-9e58-13851383e51b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_75f10ab2-9648-4ebc-81e2-6355ccc1117d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db34db8c-8b6c-4e73-b5eb-79b141aee568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db34db8c-8b6c-4e73-b5eb-79b141aee568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4f6f727f-5a30-46be-84e4-2956f9d1f3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db34db8c-8b6c-4e73-b5eb-79b141aee568" xlink:to="loc_us-gaap_ProfitLoss_4f6f727f-5a30-46be-84e4-2956f9d1f3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db34db8c-8b6c-4e73-b5eb-79b141aee568" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_76308afe-0354-421c-93ff-97c1157c12fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_Depreciation_76308afe-0354-421c-93ff-97c1157c12fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_b3e4d7fc-7b88-453a-bf56-29f72124c530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_AdjustmentForAmortization_b3e4d7fc-7b88-453a-bf56-29f72124c530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_29e8a707-79da-4dce-80a7-0be5846272e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_29e8a707-79da-4dce-80a7-0be5846272e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_13b43669-5b33-40e6-9a2d-8761e013b5ee" xlink:href="mck-20210331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_13b43669-5b33-40e6-9a2d-8761e013b5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d6876e33-41e9-4ced-9d32-e3fba0526099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d6876e33-41e9-4ced-9d32-e3fba0526099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_ec12764d-d29d-4438-a079-885cc3a4d989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_ec12764d-d29d-4438-a079-885cc3a4d989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_4f5111be-1730-4c37-ad6b-d782848514e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_OperatingLeaseExpense_4f5111be-1730-4c37-ad6b-d782848514e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_324652d0-b4bc-49c1-94d4-4fe5987cfece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_324652d0-b4bc-49c1-94d4-4fe5987cfece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e426896f-9d72-40ea-ada3-184b61db2c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e426896f-9d72-40ea-ada3-184b61db2c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a53c7ddf-53b8-4ca6-8a97-d49eadc0c87e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_af59c157-41b1-46f4-ae03-c2d52468b4ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_af59c157-41b1-46f4-ae03-c2d52468b4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_484a2cf4-ff06-4dd8-9332-c6da7ef7c338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_484a2cf4-ff06-4dd8-9332-c6da7ef7c338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7e6bc19a-2bd1-4350-939d-e7353df5a721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7e6bc19a-2bd1-4350-939d-e7353df5a721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_63b044d3-20f1-46f6-bbca-99bcbce1f941" xlink:href="mck-20210331.xsd#mck_IncreaseDecreaseinOperatingLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_mck_IncreaseDecreaseinOperatingLeaseLiabilities_63b044d3-20f1-46f6-bbca-99bcbce1f941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_d5d69d02-fb2f-4310-84d8-67bd006b3848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_d5d69d02-fb2f-4310-84d8-67bd006b3848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_0d8e82df-546e-44db-aded-0b0a4172e93f" xlink:href="mck-20210331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_0d8e82df-546e-44db-aded-0b0a4172e93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a8977238-9ad9-47c9-9494-ba8e46740a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef5bbf6-4e4c-4bb5-9f85-ba1aa65e352d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_a8977238-9ad9-47c9-9494-ba8e46740a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_40bcb525-78be-4310-95a7-805fab70957f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db34db8c-8b6c-4e73-b5eb-79b141aee568" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_40bcb525-78be-4310-95a7-805fab70957f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e337e1f1-6f9b-4c8d-a971-8d23ce7b96af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e337e1f1-6f9b-4c8d-a971-8d23ce7b96af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_aadfe6a8-49f1-434b-bdb8-7581a5d03d04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_aadfe6a8-49f1-434b-bdb8-7581a5d03d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7b437a12-85cd-4c81-88db-30b43d7d1f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7b437a12-85cd-4c81-88db-30b43d7d1f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_c1a75d57-5c09-4851-84c8-87f46d452917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_c1a75d57-5c09-4851-84c8-87f46d452917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4595a47e-1800-4ac7-afee-7a7d23acc123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4595a47e-1800-4ac7-afee-7a7d23acc123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8065f198-b8a1-4d58-bcca-e7af1bf50cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d08b0e0-0723-4d2f-ba97-3bedc916da15" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8065f198-b8a1-4d58-bcca-e7af1bf50cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_604e380e-0384-426f-9d79-7aadc5e4b60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_604e380e-0384-426f-9d79-7aadc5e4b60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_653c8c63-de54-4d3e-aa60-ff1c67c70c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_653c8c63-de54-4d3e-aa60-ff1c67c70c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1073cf96-13d5-40a4-8f33-8fac161067b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1073cf96-13d5-40a4-8f33-8fac161067b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_805d98da-8433-4dbd-a39e-4edb8b4cf58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_805d98da-8433-4dbd-a39e-4edb8b4cf58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_edd32d5b-1573-44ea-9542-45a12aa4afe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_edd32d5b-1573-44ea-9542-45a12aa4afe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6f1327bf-f8b5-44b7-8c90-8a0cdd3ac8fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_edd32d5b-1573-44ea-9542-45a12aa4afe4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6f1327bf-f8b5-44b7-8c90-8a0cdd3ac8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_624e7536-03c2-4bea-b7b1-0928c49b318c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_edd32d5b-1573-44ea-9542-45a12aa4afe4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_624e7536-03c2-4bea-b7b1-0928c49b318c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_985a0084-2651-48d1-b3c5-4e007b7ef5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_985a0084-2651-48d1-b3c5-4e007b7ef5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9444f812-5a71-4b49-a282-28581039e13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9444f812-5a71-4b49-a282-28581039e13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f39e0f-d558-40c0-9c99-5f098b42da47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_317a429b-5506-4868-91e8-c0651e3820ac" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_79f39e0f-d558-40c0-9c99-5f098b42da47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe148796-5f19-4466-8062-ee88b65f1089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe148796-5f19-4466-8062-ee88b65f1089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_83fc91f2-f0a7-4f02-b751-8665577bd2eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_83fc91f2-f0a7-4f02-b751-8665577bd2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_200c6c63-6df0-43f7-bf8e-800308dc2f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_200c6c63-6df0-43f7-bf8e-800308dc2f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5cff9b95-4151-4dff-9c85-8f86d9ffc4a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5cff9b95-4151-4dff-9c85-8f86d9ffc4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8a23d487-ea2d-45cf-86ba-51a7f742288d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f2c2e9c1-7699-4e85-bb96-dea3dd1fd8e6" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8a23d487-ea2d-45cf-86ba-51a7f742288d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_4886330e-4b74-4559-a470-477d55283044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8a23d487-ea2d-45cf-86ba-51a7f742288d" xlink:to="loc_us-gaap_RestrictedCashCurrent_4886330e-4b74-4559-a470-477d55283044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_66cb99aa-b0c4-4285-bb9e-986d15748439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8a23d487-ea2d-45cf-86ba-51a7f742288d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_66cb99aa-b0c4-4285-bb9e-986d15748439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_b490b3f1-75bd-4293-8fa5-754baa84c8de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8a23d487-ea2d-45cf-86ba-51a7f742288d" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_b490b3f1-75bd-4293-8fa5-754baa84c8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_23ef5c9d-1903-47b9-a04d-3a84500a074a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b490b3f1-75bd-4293-8fa5-754baa84c8de" xlink:to="loc_us-gaap_InterestPaidNet_23ef5c9d-1903-47b9-a04d-3a84500a074a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ad9396ab-4219-4d3e-b143-80b5c275f027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b490b3f1-75bd-4293-8fa5-754baa84c8de" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ad9396ab-4219-4d3e-b143-80b5c275f027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_54c1d578-20f1-41f0-8436-0b81f7820dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2ff29747-b665-42d5-a515-c0ab5fa6b5c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_54c1d578-20f1-41f0-8436-0b81f7820dbf" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2ff29747-b665-42d5-a515-c0ab5fa6b5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_eaef602f-309f-486c-80cc-5749ac1558bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_eaef602f-309f-486c-80cc-5749ac1558bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_8890a929-98f3-4f79-9fea-6a99840ada1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_FiscalPeriod_8890a929-98f3-4f79-9fea-6a99840ada1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7e5c26c4-f186-4817-b96e-f3a2264658d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7e5c26c4-f186-4817-b96e-f3a2264658d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_55c106eb-6407-4357-8899-632770fcf5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_UseOfEstimates_55c106eb-6407-4357-8899-632770fcf5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1ea91e56-51f0-462f-b07e-c1b88d300a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1ea91e56-51f0-462f-b07e-c1b88d300a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f75c5661-e3c9-47d5-91db-090a8f3b997f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f75c5661-e3c9-47d5-91db-090a8f3b997f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_5f7defc7-5958-497f-8380-19989939ef69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_5f7defc7-5958-497f-8380-19989939ef69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_440c2493-baf3-4879-9dd2-3108b9c2cea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_440c2493-baf3-4879-9dd2-3108b9c2cea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_d2b0dc07-4503-452f-9e44-75088b4d612a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_d2b0dc07-4503-452f-9e44-75088b4d612a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_a3c24ab9-81e2-4e0a-b5fb-1d9141179e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_a3c24ab9-81e2-4e0a-b5fb-1d9141179e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_d58b5181-b524-4a11-83c9-8334494812cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_d58b5181-b524-4a11-83c9-8334494812cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLoansAndLeasesReceivablePolicy_590b061a-fca6-45cf-a02d-9044348b246f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLoansAndLeasesReceivablePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_FinanceLoansAndLeasesReceivablePolicy_590b061a-fca6-45cf-a02d-9044348b246f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_64b2a591-65c7-4f90-b5fa-32fcb8ed3557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_64b2a591-65c7-4f90-b5fa-32fcb8ed3557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_d0e63b4c-216a-4145-88a3-b634c37908ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_d0e63b4c-216a-4145-88a3-b634c37908ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldforSalePolicyTextBlock_841d8b9e-a3e6-496c-89ed-f80431096b73" xlink:href="mck-20210331.xsd#mck_HeldforSalePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_mck_HeldforSalePolicyTextBlock_841d8b9e-a3e6-496c-89ed-f80431096b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_afdd636f-417b-4560-9b74-6792fe2cf535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_afdd636f-417b-4560-9b74-6792fe2cf535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_f612ab9d-4dbd-4fba-9eff-642f83be54e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_f612ab9d-4dbd-4fba-9eff-642f83be54e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_1bca0590-b3bf-4ea2-b0f0-06ffd585e3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_1bca0590-b3bf-4ea2-b0f0-06ffd585e3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_24487fcc-9f6b-456f-8f62-dfeb51ddf471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_24487fcc-9f6b-456f-8f62-dfeb51ddf471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceProgramsPolicyTextBlock_a9589c5b-76c7-4342-91cf-26360521a018" xlink:href="mck-20210331.xsd#mck_InsuranceProgramsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_mck_InsuranceProgramsPolicyTextBlock_a9589c5b-76c7-4342-91cf-26360521a018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6e8fe632-7697-4be6-960f-aad30e815733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6e8fe632-7697-4be6-960f-aad30e815733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierIncentivesPolicyPolicyTextBlock_d9a63190-5def-42f7-8d69-2c315f262c01" xlink:href="mck-20210331.xsd#mck_SupplierIncentivesPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_mck_SupplierIncentivesPolicyPolicyTextBlock_d9a63190-5def-42f7-8d69-2c315f262c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierReservesPolicyTextBlock_1bcdd97b-7e50-4a2e-8624-eb2400a5fab6" xlink:href="mck-20210331.xsd#mck_SupplierReservesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_mck_SupplierReservesPolicyTextBlock_1bcdd97b-7e50-4a2e-8624-eb2400a5fab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_4affd931-a450-4296-8f72-7080c54a6651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_4affd931-a450-4296-8f72-7080c54a6651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpensePolicyTextBlock_552ee8d5-cddd-4405-9075-b5bdc53ee2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_InterestExpensePolicyTextBlock_552ee8d5-cddd-4405-9075-b5bdc53ee2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3fe4dd7e-3501-4c4d-b546-ad807ab8a0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3fe4dd7e-3501-4c4d-b546-ad807ab8a0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_e0c0ea23-eb94-4768-ad80-62c0cc19f4b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_e0c0ea23-eb94-4768-ad80-62c0cc19f4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d5972e4b-d5f1-42a3-80c3-75c2f4074b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d5972e4b-d5f1-42a3-80c3-75c2f4074b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_7aa3f3ab-f98e-4414-88ec-da4046413a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_7aa3f3ab-f98e-4414-88ec-da4046413a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c16b9fa8-8e0f-402f-945f-4e9a4f77b160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c16b9fa8-8e0f-402f-945f-4e9a4f77b160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_c467a217-3118-4422-9725-ce06549bb8d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_c467a217-3118-4422-9725-ce06549bb8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_9b452110-8738-40a7-90c0-84b37443b9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_9b452110-8738-40a7-90c0-84b37443b9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_cd55993f-2737-4b7b-adc0-272e8d21c9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_cd55993f-2737-4b7b-adc0-272e8d21c9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_46f3264c-f27f-41d6-b397-baa29ec389d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dab8cfe5-962a-4394-831a-5d29c4be699b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_46f3264c-f27f-41d6-b397-baa29ec389d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a7edc819-ec24-4b6f-9a9f-9e663e94381d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e8d4b0bc-c94d-4346-8c4a-c83cf19b19e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7edc819-ec24-4b6f-9a9f-9e663e94381d" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e8d4b0bc-c94d-4346-8c4a-c83cf19b19e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b1878e72-eff2-44e8-9fe1-7393b99b3002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7edc819-ec24-4b6f-9a9f-9e663e94381d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b1878e72-eff2-44e8-9fe1-7393b99b3002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c571b4bb-d5a6-477e-92bd-5e4f898cf041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c571b4bb-d5a6-477e-92bd-5e4f898cf041" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ab0d5f9e-fce0-4b89-a5db-fee0cffc8070" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_443ce70f-83dc-4b26-bba1-a6a0083bbfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_443ce70f-83dc-4b26-bba1-a6a0083bbfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_da2979b6-70a8-44b1-bace-07cde12253ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2f7ddc9f-f3ee-4871-af0a-57c725b157c2" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_da2979b6-70a8-44b1-bace-07cde12253ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_300505a5-6b21-415c-8119-f84fbed4ea3b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_43e74fad-9465-49a1-afe4-e0fcc88654d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:to="loc_us-gaap_SalesRevenueNetMember_43e74fad-9465-49a1-afe4-e0fcc88654d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_57f00813-017c-4be8-8823-0297dc835298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_48272361-df81-4fbf-bc85-d31412ef9049" xlink:to="loc_us-gaap_AccountsReceivableMember_57f00813-017c-4be8-8823-0297dc835298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_68b28136-d185-4583-834c-ae3d2517e031" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_9f87d6e0-0326-4e4c-af0f-5204ef9c9d2e" xlink:to="loc_srt_NameOfMajorCustomerDomain_68b28136-d185-4583-834c-ae3d2517e031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember_b469793e-1af0-43ce-9b04-6edb23fa51bc" xlink:href="mck-20210331.xsd#mck_LargestCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_68b28136-d185-4583-834c-ae3d2517e031" xlink:to="loc_mck_LargestCustomerMember_b469793e-1af0-43ce-9b04-6edb23fa51bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7bec67cd-c1a2-4746-acfb-225fc0dc6cac" xlink:to="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_30f51050-c3d3-4f2b-b4d4-e81d506fc4c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:to="loc_us-gaap_ShippingAndHandlingMember_30f51050-c3d3-4f2b-b4d4-e81d506fc4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember_a05d69df-6449-4eab-a7d5-52fa8cb2cfe5" xlink:href="mck-20210331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:to="loc_mck_DistributionandRetailBusinessMember_a05d69df-6449-4eab-a7d5-52fa8cb2cfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember_017c8a83-a081-486c-b634-e54e6756d834" xlink:href="mck-20210331.xsd#mck_ServicesBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c3acda41-e9e2-4403-b83c-9d53cfe42fdb" xlink:to="loc_mck_ServicesBusinessMember_017c8a83-a081-486c-b634-e54e6756d834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_28ffa5f8-92c3-4cad-b9e9-a0373cb8ed54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7e1ed1de-6107-46dc-8eb4-b1258e0ad134" xlink:to="loc_us-gaap_TypeOfAdoptionMember_28ffa5f8-92c3-4cad-b9e9-a0373cb8ed54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_94b84ae4-3d11-4363-986a-cc60c04c49fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_28ffa5f8-92c3-4cad-b9e9-a0373cb8ed54" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_94b84ae4-3d11-4363-986a-cc60c04c49fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_af0a9d99-29df-44c0-aa8e-1f44b402e75a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a5f6e3e-cf5a-4e88-9d41-ab1b5b9044f9" xlink:to="loc_us-gaap_EquityComponentDomain_af0a9d99-29df-44c0-aa8e-1f44b402e75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_02a6f053-a25b-4633-b95e-1d59c7e167cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_af0a9d99-29df-44c0-aa8e-1f44b402e75a" xlink:to="loc_us-gaap_RetainedEarningsMember_02a6f053-a25b-4633-b95e-1d59c7e167cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_efa132ee-cd53-4d40-adf4-74932a167989" xlink:to="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32a91980-c4fa-4dd4-b113-34251a6943ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:to="loc_srt_MinimumMember_32a91980-c4fa-4dd4-b113-34251a6943ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_75fd625a-17d7-4f97-8cd8-d763d8709486" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c79f7a69-24f4-4ffc-bc95-821fdb62a140" xlink:to="loc_srt_MaximumMember_75fd625a-17d7-4f97-8cd8-d763d8709486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e9df44af-6840-4e37-9bde-27a51e2e3c5f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_877b69e0-4c13-4254-8337-c8ea0a0aeb2a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e9df44af-6840-4e37-9bde-27a51e2e3c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b4729ecd-fcdf-4a24-b2ed-74ad4670ff8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e9df44af-6840-4e37-9bde-27a51e2e3c5f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b4729ecd-fcdf-4a24-b2ed-74ad4670ff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4867bbb5-48da-4f66-a70f-642ebc5bc3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3761bce8-1500-46f0-9e66-a8f235092b73" xlink:to="loc_us-gaap_SegmentDomain_4867bbb5-48da-4f66-a70f-642ebc5bc3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a793a8f0-f595-4fa0-aa91-9e5f23023b9e" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4867bbb5-48da-4f66-a70f-642ebc5bc3fe" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a793a8f0-f595-4fa0-aa91-9e5f23023b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eecb10c4-a4f0-4164-b17f-168d14c2716d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1097a4b1-2536-4523-8e43-dd498ade0f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1097a4b1-2536-4523-8e43-dd498ade0f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember_5fec839b-dc98-4331-962d-92998eaecc00" xlink:href="mck-20210331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f80febd-a773-40bd-99d7-ea6f597b1b22" xlink:to="loc_mck_MachineryEquipmentAndOtherMember_5fec839b-dc98-4331-962d-92998eaecc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3df40ef2-fdf3-44a8-bcb8-9622aaecc3e7" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_7669cd4a-529f-478f-9cd5-fe44ead0094d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_NumberOfReportableSegments_7669cd4a-529f-478f-9cd5-fe44ead0094d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e0788bdd-3077-4bb0-9cba-cba5d85639ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e0788bdd-3077-4bb0-9cba-cba5d85639ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofLargestCustomers_b7764b1d-0577-40e5-999f-4eadf34ecfc2" xlink:href="mck-20210331.xsd#mck_NumberofLargestCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_mck_NumberofLargestCustomers_b7764b1d-0577-40e5-999f-4eadf34ecfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_464f01c2-d093-4b37-b9a5-be5d4d19e2da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_464f01c2-d093-4b37-b9a5-be5d4d19e2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_60e153b4-fa0d-4c20-9d99-8c28e78eed78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_60e153b4-fa0d-4c20-9d99-8c28e78eed78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_2ecbcb1c-861f-49b9-9756-8461caff20b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryLIFOReserve_2ecbcb1c-861f-49b9-9756-8461caff20b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_45be1bb5-b2de-4f1c-acf4-9bc6de243309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_45be1bb5-b2de-4f1c-acf4-9bc6de243309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_84d36af6-0d2a-40e7-884b-41f3a1d65885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryValuationReserves_84d36af6-0d2a-40e7-884b-41f3a1d65885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_7b3c4fff-5cf1-4048-aa22-478724e8e3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_InventoryWriteDown_7b3c4fff-5cf1-4048-aa22-478724e8e3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e599515b-82f1-4bb2-8cb0-18ab1913dbb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e599515b-82f1-4bb2-8cb0-18ab1913dbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a2c93554-fdbb-4b2d-9da5-894ef64d9a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a2c93554-fdbb-4b2d-9da5-894ef64d9a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b8b41995-dc39-4ebc-b641-7053bfbe76f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b8b41995-dc39-4ebc-b641-7053bfbe76f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1d19f3c8-de35-43cc-97d4-4e13d230964d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1d19f3c8-de35-43cc-97d4-4e13d230964d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_9d91ced7-449c-482e-9d0d-007814cc8354" xlink:href="mck-20210331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_9d91ced7-449c-482e-9d0d-007814cc8354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_82cf97d8-8ba6-4a77-8856-f41aea087c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_82cf97d8-8ba6-4a77-8856-f41aea087c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_01613090-969a-4007-acec-a090d60627c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_01613090-969a-4007-acec-a090d60627c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a8a69082-45ac-4b3a-b4f1-1271d1555afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_a8a69082-45ac-4b3a-b4f1-1271d1555afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_0db78e73-cd72-4a09-86a4-cb67d982614c" xlink:href="mck-20210331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_0db78e73-cd72-4a09-86a4-cb67d982614c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1226c6c8-0381-4747-b339-ed34a3b011be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_98a9271a-73da-44c9-943d-87019d2800cf" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1226c6c8-0381-4747-b339-ed34a3b011be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract_d5e23eab-2a32-4bfd-ac1c-041367d1e948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross_faaaa1e4-0a37-4d05-9f54-402ab6656aec" xlink:href="mck-20210331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_d5e23eab-2a32-4bfd-ac1c-041367d1e948" xlink:to="loc_mck_AccountsReceivableCustomerAccountsGross_faaaa1e4-0a37-4d05-9f54-402ab6656aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_d888186a-331c-44b3-9097-5b9d842caa40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_d5e23eab-2a32-4bfd-ac1c-041367d1e948" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_d888186a-331c-44b3-9097-5b9d842caa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_09a59c17-210d-479a-a421-e3794afd25fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_d5e23eab-2a32-4bfd-ac1c-041367d1e948" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_09a59c17-210d-479a-a421-e3794afd25fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_91d50db5-07ba-4c68-bf74-1ff982202dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_d5e23eab-2a32-4bfd-ac1c-041367d1e948" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_91d50db5-07ba-4c68-bf74-1ff982202dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_aad640da-57f8-4033-8f00-a2089a1366b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_d5e23eab-2a32-4bfd-ac1c-041367d1e948" xlink:to="loc_us-gaap_ReceivablesNetCurrent_aad640da-57f8-4033-8f00-a2089a1366b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_325cc237-f89c-4425-87dc-8c48caf20283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_Land_325cc237-f89c-4425-87dc-8c48caf20283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_9e919761-d8cc-43fa-8ab6-9e2a6b7c888b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_9e919761-d8cc-43fa-8ab6-9e2a6b7c888b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther_b6cd043d-8b16-414a-a0fa-1a67796228a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOther_b6cd043d-8b16-414a-a0fa-1a67796228a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_06292c65-737d-414c-9eff-698cb69f59e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_ConstructionInProgressGross_06292c65-737d-414c-9eff-698cb69f59e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8c78bfca-179c-4a22-ae1a-716102a096ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8c78bfca-179c-4a22-ae1a-716102a096ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0fd5eb1f-e5c6-498b-a5a9-082617bc08bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0fd5eb1f-e5c6-498b-a5a9-082617bc08bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_429aa5bb-f3c3-4ca7-b771-5e13400227a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_d729610a-c4b2-45bd-899b-24ca7a71af47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_429aa5bb-f3c3-4ca7-b771-5e13400227a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVenture"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a9235db4-a2f9-4f22-ab5d-648d27813fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_a4dc4856-24b5-45ba-b4d8-42dc7b871b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a9235db4-a2f9-4f22-ab5d-648d27813fc1" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_a4dc4856-24b5-45ba-b4d8-42dc7b871b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_3aa8c296-2c42-4524-8b74-c6dbf1c3e56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_19f6693b-152d-4999-92f8-abe3eaa147ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_3aa8c296-2c42-4524-8b74-c6dbf1c3e56f" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_19f6693b-152d-4999-92f8-abe3eaa147ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ea7fdc2b-651f-41ed-a998-69e156eda885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ea7fdc2b-651f-41ed-a998-69e156eda885" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_28f88504-97b9-4d6c-8e37-ffa357991152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_11ae8387-2d68-479f-a797-39ead2aa8502" xlink:to="loc_us-gaap_RelatedPartyDomain_28f88504-97b9-4d6c-8e37-ffa357991152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_0e8d0c01-34a3-4b70-8c17-04c3dff50153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_28f88504-97b9-4d6c-8e37-ffa357991152" xlink:to="loc_us-gaap_CorporateJointVentureMember_0e8d0c01-34a3-4b70-8c17-04c3dff50153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_07d1a3ae-50b1-458e-9007-103caa636942" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e41859aa-20a2-4066-8b9e-6ec1cf68ee26" xlink:to="loc_dei_EntityDomain_07d1a3ae-50b1-458e-9007-103caa636942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_c4c8a2a2-7c1f-4377-b3b6-86e708443680" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_07d1a3ae-50b1-458e-9007-103caa636942" xlink:to="loc_mck_ChangeHealthcareInc.Member_c4c8a2a2-7c1f-4377-b3b6-86e708443680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_44089280-8295-4062-b6df-fbac0cb4c2aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1cfade66-2906-4c37-a6bd-4162f2f8eb8f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_44089280-8295-4062-b6df-fbac0cb4c2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1708fcb-8e42-47cf-aaff-aef277456670" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_44089280-8295-4062-b6df-fbac0cb4c2aa" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_b1708fcb-8e42-47cf-aaff-aef277456670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7093717b-4ca4-4a42-bef3-06862db045f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d8f334d1-2779-40a1-a5ab-5abcb5eee616" xlink:to="loc_us-gaap_SegmentDomain_7093717b-4ca4-4a42-bef3-06862db045f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_ccd5d9da-e583-4772-afd8-34785a528564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7093717b-4ca4-4a42-bef3-06862db045f6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_ccd5d9da-e583-4772-afd8-34785a528564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_38e56d2a-1b6b-4827-ae73-4887eebb98ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7c578fe1-439c-4826-a7ac-59879a12f4ea" xlink:to="loc_srt_ConsolidationItemsDomain_38e56d2a-1b6b-4827-ae73-4887eebb98ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_83bcbd95-7440-496a-a39b-7d508570719b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_38e56d2a-1b6b-4827-ae73-4887eebb98ba" xlink:to="loc_us-gaap_OperatingSegmentsMember_83bcbd95-7440-496a-a39b-7d508570719b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b74b998-8828-4fa0-a901-506fa4b6aca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b90db608-aefa-43a4-9584-144713bd3f15" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b74b998-8828-4fa0-a901-506fa4b6aca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_826f812c-2d4f-401a-8422-2bbed1d87d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b74b998-8828-4fa0-a901-506fa4b6aca2" xlink:to="loc_us-gaap_IPOMember_826f812c-2d4f-401a-8422-2bbed1d87d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ed7da9ab-9de7-4447-a399-b6cfa9d1c690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_89650336-7711-44a7-8aaa-3b113c0fa76b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ed7da9ab-9de7-4447-a399-b6cfa9d1c690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_f503fbe6-fb53-49c6-b81a-3b9aae348489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_ed7da9ab-9de7-4447-a399-b6cfa9d1c690" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_f503fbe6-fb53-49c6-b81a-3b9aae348489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_71ffde1a-b6a1-438f-8bf2-22cdb971575b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0604238-8e09-4ab7-ba5c-c06e26f281f7" xlink:to="loc_us-gaap_EquityComponentDomain_71ffde1a-b6a1-438f-8bf2-22cdb971575b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b2ba8dcf-6225-45e8-bcfc-1e28552f00c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_71ffde1a-b6a1-438f-8bf2-22cdb971575b" xlink:to="loc_us-gaap_RetainedEarningsMember_b2ba8dcf-6225-45e8-bcfc-1e28552f00c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_258f45ce-171b-40e5-a906-e11b4be070bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_198897c7-6c19-463e-a09c-e38bcb337aa1" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_258f45ce-171b-40e5-a906-e11b4be070bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_f6bc1a77-567b-45b3-a4f3-b424eb4cc600" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_258f45ce-171b-40e5-a906-e11b4be070bc" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_f6bc1a77-567b-45b3-a4f3-b424eb4cc600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4a1c5081-db68-4a7b-8b89-56d3ffae2826" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember_3521c924-867c-49a5-9429-d6d93fa9f707" xlink:href="mck-20210331.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:to="loc_mck_TransitionServicesAgreementsTSAMember_3521c924-867c-49a5-9429-d6d93fa9f707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_07b90ea3-a1f5-41dc-af9a-88cd769e07f0" xlink:href="mck-20210331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ae8e7e0a-c411-41f4-8c41-9867f4dd7298" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_07b90ea3-a1f5-41dc-af9a-88cd769e07f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22de49f3-fc35-4ac0-8768-2f0ecaced960" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_05eb2ab4-a809-4a24-8f56-0737257828ca" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22de49f3-fc35-4ac0-8768-2f0ecaced960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_18267729-773c-4006-a419-ce2efba03bae" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_22de49f3-fc35-4ac0-8768-2f0ecaced960" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_18267729-773c-4006-a419-ce2efba03bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_55e25850-72e8-4f8b-acf2-5d181d7809d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebc98129-8f4e-4413-a247-f9a008fececf" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_55e25850-72e8-4f8b-acf2-5d181d7809d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_032a1d0c-95f2-4fbf-842a-f5511ccef064" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_55e25850-72e8-4f8b-acf2-5d181d7809d2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_032a1d0c-95f2-4fbf-842a-f5511ccef064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e078a766-d606-4e1d-a4a0-3fa967ce556b" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bd408e4e-620f-47dd-93bc-876965b9d741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bd408e4e-620f-47dd-93bc-876965b9d741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_d2fa4165-50ce-437b-b1ea-4fb1960297f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_d2fa4165-50ce-437b-b1ea-4fb1960297f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_77e0356a-f994-4172-a2ba-03c83600dac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_77e0356a-f994-4172-a2ba-03c83600dac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_91fe39d0-2323-4b63-9d89-980024599956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_91fe39d0-2323-4b63-9d89-980024599956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_788e1ed5-4642-477b-8f27-cb5314817e90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_788e1ed5-4642-477b-8f27-cb5314817e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2cb6d11e-e111-4f46-b12d-9301e237591b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_2cb6d11e-e111-4f46-b12d-9301e237591b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_db9077bc-9326-476e-8455-3a64bc91e424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_db9077bc-9326-476e-8455-3a64bc91e424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_a836ef0d-8907-4e69-9720-8e5390364c7e" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_ExchangeOfferSharesDistributed_a836ef0d-8907-4e69-9720-8e5390364c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_7fcd4156-6c73-499b-9878-3cd7a7ef6ba8" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_ExchangeOfferSharesExchanged_7fcd4156-6c73-499b-9878-3cd7a7ef6ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e491a17e-4017-49f4-b87b-9d70aeb55bb1" xlink:href="mck-20210331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e491a17e-4017-49f4-b87b-9d70aeb55bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fa6ad178-fc04-40f2-aaaa-0ad1076d2d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fa6ad178-fc04-40f2-aaaa-0ad1076d2d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ac66980d-5665-4d7e-84aa-0ee76be826e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ac66980d-5665-4d7e-84aa-0ee76be826e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e57e923-a639-4b5d-bc3e-8fc7037ef95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e57e923-a639-4b5d-bc3e-8fc7037ef95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_77de1a3c-89a9-49c7-a83f-ff3db88e05d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_77de1a3c-89a9-49c7-a83f-ff3db88e05d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_c10b8131-1b4e-4079-89d2-d0371e715144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_c10b8131-1b4e-4079-89d2-d0371e715144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossonDerecognitionofLiability_5d62dcb8-8208-4b1b-9d1b-df74f82f7a46" xlink:href="mck-20210331.xsd#mck_GainLossonDerecognitionofLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_GainLossonDerecognitionofLiability_5d62dcb8-8208-4b1b-9d1b-df74f82f7a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_6664b0d9-e150-4210-97ec-69cfa12791a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_6664b0d9-e150-4210-97ec-69cfa12791a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_2a47294c-efb6-4268-9427-cfd7716c0322" xlink:href="mck-20210331.xsd#mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_2a47294c-efb6-4268-9427-cfd7716c0322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_95721de2-6631-4a46-818c-68a5c4589f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d5026351-1c60-4a2c-8921-e47a60874017" xlink:to="loc_us-gaap_DueFromRelatedParties_95721de2-6631-4a46-818c-68a5c4589f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_031fc558-d043-4f4a-b6d2-30099e89f2c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_031fc558-d043-4f4a-b6d2-30099e89f2c7" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_358f6ee1-1f18-45ec-a258-a9a65d05b1a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_28ec485a-3bb0-4ff8-9a21-19400e5fed63" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_358f6ee1-1f18-45ec-a258-a9a65d05b1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_904cd8cd-85f0-4ad4-98bc-d3df1e31deaf" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_358f6ee1-1f18-45ec-a258-a9a65d05b1a6" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_904cd8cd-85f0-4ad4-98bc-d3df1e31deaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_c9064a2a-a9e9-4f91-afa2-f723caf9c66d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_36612986-a138-411d-abc8-b23e479c9f3b" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_c9064a2a-a9e9-4f91-afa2-f723caf9c66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_71089b56-0d3b-4a23-9672-180d8e2e26d1" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_c9064a2a-a9e9-4f91-afa2-f723caf9c66d" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_71089b56-0d3b-4a23-9672-180d8e2e26d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b65c6085-ab9d-4abb-bcc3-c78cea7353f9" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_09705a46-09b3-41f4-9caf-18dae60ba7b0" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_09705a46-09b3-41f4-9caf-18dae60ba7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount_1477751a-49d1-4295-8973-d14392bee5cb" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentCarryingAmount_1477751a-49d1-4295-8973-d14392bee5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_038edf3b-d90b-4c51-b537-dab329431a54" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentsReversalofDeferredTaxLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability_038edf3b-d90b-4c51-b537-dab329431a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_efa24b56-88e4-4247-b4ee-6e943ed0b757" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_efa24b56-88e4-4247-b4ee-6e943ed0b757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_5987055d-ad3d-47ae-bc79-f8ba78dc2e9e" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_5987055d-ad3d-47ae-bc79-f8ba78dc2e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9f2fecb8-dd06-46b3-8792-67725308a7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9f2fecb8-dd06-46b3-8792-67725308a7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_eca63e3d-f7ec-4175-9d6f-66e0aa24f19e" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_ExchangeOfferSharesExchanged_eca63e3d-f7ec-4175-9d6f-66e0aa24f19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_713f47d9-5f5a-49c4-8546-187d5b291af7" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_713f47d9-5f5a-49c4-8546-187d5b291af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_43160ee0-8d2b-4076-ae0c-d725949b06a9" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAcceptedAverageCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_d7ba6df9-e8fa-4fab-8ea2-e8738c208476" xlink:to="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_43160ee0-8d2b-4076-ae0c-d725949b06a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_533673d7-7dcc-4b95-952e-20479fd6cf0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_dbdb1191-5e31-4704-aa8b-dd882a4f9b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_533673d7-7dcc-4b95-952e-20479fd6cf0f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_dbdb1191-5e31-4704-aa8b-dd882a4f9b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_02730183-b1b2-4066-944c-3b2f96cdf283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_c417bc13-b831-4a45-a1c3-9042c844c68d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_02730183-b1b2-4066-944c-3b2f96cdf283" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_c417bc13-b831-4a45-a1c3-9042c844c68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_31020c41-917a-4a3b-8c77-9c5994a6ea72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_31020c41-917a-4a3b-8c77-9c5994a6ea72" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5fbb41d-257b-4a7a-9be7-472f2af3d8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76fa8850-b4bb-45d6-8b72-69cdedba3f15" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5fbb41d-257b-4a7a-9be7-472f2af3d8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_23e3522d-54cd-4363-9584-a138cc20ea4c" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e5fbb41d-257b-4a7a-9be7-472f2af3d8e4" xlink:to="loc_mck_GermanWholesaleBusinessMember_23e3522d-54cd-4363-9584-a138cc20ea4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_559ea474-84d3-43a6-95b1-232b63e9df54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_216b4ecf-3177-4dd5-87ef-effdf4e5b131" xlink:to="loc_us-gaap_SegmentDomain_559ea474-84d3-43a6-95b1-232b63e9df54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_3f10a3fc-3365-47a1-b44c-8389cab917c1" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_559ea474-84d3-43a6-95b1-232b63e9df54" xlink:to="loc_mck_InternationalSegmentMember_3f10a3fc-3365-47a1-b44c-8389cab917c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8ff7ab27-cd2e-465c-835c-ceb84527e258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_363ef75e-c99f-4a27-911c-56492cc402ac" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8ff7ab27-cd2e-465c-835c-ceb84527e258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a55aa091-8ded-432a-b2ef-ba9aef5aecb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_8ff7ab27-cd2e-465c-835c-ceb84527e258" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a55aa091-8ded-432a-b2ef-ba9aef5aecb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_72aa420f-7a48-42e6-9adf-97f99cbf5908" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_5b5eddf7-0f79-4a62-89a9-0279a5772ab2" xlink:to="loc_srt_OwnershipDomain_72aa420f-7a48-42e6-9adf-97f99cbf5908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_548c0259-9302-4232-8981-9d9a507b2dfd" xlink:href="mck-20210331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_72aa420f-7a48-42e6-9adf-97f99cbf5908" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_548c0259-9302-4232-8981-9d9a507b2dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_56e9a111-e7a1-40e7-aa80-8acdd7a82a7c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_964613d9-1f22-4895-9c02-633c876459c5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_56e9a111-e7a1-40e7-aa80-8acdd7a82a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_fd92f461-7293-448e-8336-5eb264b55f42" xlink:href="mck-20210331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_56e9a111-e7a1-40e7-aa80-8acdd7a82a7c" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_fd92f461-7293-448e-8336-5eb264b55f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_91e3f50a-b6d3-4919-b99c-0055283b621a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_59f139a3-2917-4c81-a2dd-bb72726bbdb4" xlink:to="loc_us-gaap_RelatedPartyDomain_91e3f50a-b6d3-4919-b99c-0055283b621a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_03f00825-b735-459f-8ec1-dc49f7313c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_91e3f50a-b6d3-4919-b99c-0055283b621a" xlink:to="loc_us-gaap_CorporateJointVentureMember_03f00825-b735-459f-8ec1-dc49f7313c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f91173bf-3407-4b15-857e-6bf5734706db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ae3c461b-e939-43e2-8807-af02d3449f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ae3c461b-e939-43e2-8807-af02d3449f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a2e37d7-0d1b-4f5f-96f9-fb6bafa227ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a2e37d7-0d1b-4f5f-96f9-fb6bafa227ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8fe81557-c633-4c5e-8699-f365c2c6ad22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8fe81557-c633-4c5e-8699-f365c2c6ad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_f3e279f4-13b2-4902-b78c-7b3dbf3d6262" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_f3e279f4-13b2-4902-b78c-7b3dbf3d6262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f16589f0-448f-4751-8f95-ea1fc18c6140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_EquityMethodInvestments_f16589f0-448f-4751-8f95-ea1fc18c6140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_42d9e967-391d-455c-abdc-cca75460e9ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_42d9e967-391d-455c-abdc-cca75460e9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_3a44333e-dbff-493d-a3b7-ed60051ab5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_3a44333e-dbff-493d-a3b7-ed60051ab5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8b06a6e0-853c-456b-ac8b-f94a73cddc4c" xlink:href="mck-20210331.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_8b06a6e0-853c-456b-ac8b-f94a73cddc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be719043-cc98-4fd9-8f30-97e42e421523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be719043-cc98-4fd9-8f30-97e42e421523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f163c93e-a868-4ec1-bf8f-89129db2dbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f163c93e-a868-4ec1-bf8f-89129db2dbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_2f9a5fc0-82a6-492c-a1be-bc17c23ecedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_daa8a57c-947b-4378-9d34-843056593fec" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_2f9a5fc0-82a6-492c-a1be-bc17c23ecedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4d17d091-5489-4715-aa9b-09dd1a24455c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4d17d091-5489-4715-aa9b-09dd1a24455c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fa3191c-a4d2-4787-b215-8d248b75d786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8f7ee6db-8ca8-4e1b-8a49-3187c989325f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fa3191c-a4d2-4787-b215-8d248b75d786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_2474daad-46a8-4759-927a-c8337bd82acd" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2fa3191c-a4d2-4787-b215-8d248b75d786" xlink:to="loc_mck_GermanWholesaleBusinessMember_2474daad-46a8-4759-927a-c8337bd82acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_88692d90-8571-458b-81f2-da8100c2142e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_10251949-4ada-4d57-a87b-ea66c57a6302" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_88692d90-8571-458b-81f2-da8100c2142e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8395cda7-5dcc-4c17-a77b-1ae356fadbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_88692d90-8571-458b-81f2-da8100c2142e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8395cda7-5dcc-4c17-a77b-1ae356fadbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_01e9ddc1-b03f-484f-8257-788c0194654f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d4e6b023-6ebd-4a3a-8789-4d89958d3cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d4e6b023-6ebd-4a3a-8789-4d89958d3cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_18d51051-e1ee-475b-96db-ce9076a12080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_18d51051-e1ee-475b-96db-ce9076a12080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_bd39acc3-2af6-4a35-9c66-ab82dada058a" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent_bd39acc3-2af6-4a35-9c66-ab82dada058a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_6805e349-266d-49c5-a8e7-d2cc92e37d80" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_6805e349-266d-49c5-a8e7-d2cc92e37d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_40d7b052-427f-4ed5-8003-475fbed59a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_40d7b052-427f-4ed5-8003-475fbed59a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_ae9cf3db-bba5-45c3-b6f9-d8efa765f502" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_ae9cf3db-bba5-45c3-b6f9-d8efa765f502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_993b1a45-a17a-4d1b-94f5-00c0baa20c5b" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_993b1a45-a17a-4d1b-94f5-00c0baa20c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_0f8ae477-e1df-498c-bb3d-3bd68d86eb4e" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent_0f8ae477-e1df-498c-bb3d-3bd68d86eb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3b52d32c-7bd1-4221-834a-09d16db9c147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_82aadba2-c372-41c7-b94c-f9fceb62789b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3b52d32c-7bd1-4221-834a-09d16db9c147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a3363ff6-8f83-485b-a157-6d9dbbaa3ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_df51a3fd-5b21-4668-a614-f160409c7576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a3363ff6-8f83-485b-a157-6d9dbbaa3ee9" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_df51a3fd-5b21-4668-a614-f160409c7576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_27948762-761f-4780-a6c7-1d27621fc552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5ed8f5a2-0d38-4b1e-90a8-916cfa3c812d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_27948762-761f-4780-a6c7-1d27621fc552" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5ed8f5a2-0d38-4b1e-90a8-916cfa3c812d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_60e708b4-f00d-4f4b-a7f2-83321ea82391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_60e708b4-f00d-4f4b-a7f2-83321ea82391" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e88dd374-0c6c-4a6c-a3bc-1605ecbc6d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d2ecf9d3-1c20-4e3f-94ae-3021e5b8afd1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e88dd374-0c6c-4a6c-a3bc-1605ecbc6d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_140d76fb-8145-475c-8b1c-81acdc907e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e88dd374-0c6c-4a6c-a3bc-1605ecbc6d00" xlink:to="loc_us-gaap_SubsequentEventMember_140d76fb-8145-475c-8b1c-81acdc907e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_e0902b29-b312-4d8a-b86c-2c3637e89e93" xlink:to="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_204c7963-b4bb-4f05-b26b-fa7ca3a8e8de" xlink:href="mck-20210331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:to="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_204c7963-b4bb-4f05-b26b-fa7ca3a8e8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_3707d1ad-3d92-41b9-9256-9744a4d67832" xlink:href="mck-20210331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_3707d1ad-3d92-41b9-9256-9744a4d67832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingModelAndCostOptimizationProgramsMember_2fc77a73-a7bf-467c-a3a6-2759ab2591ba" xlink:href="mck-20210331.xsd#mck_OperatingModelAndCostOptimizationProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_02ac4454-8002-486c-a2e9-a877a3d33dfa" xlink:to="loc_mck_OperatingModelAndCostOptimizationProgramsMember_2fc77a73-a7bf-467c-a3a6-2759ab2591ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_aa1dd633-8195-4eb8-9801-e3624068d356" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_338b140a-3769-46bf-87d7-a1092982b1cc" xlink:href="mck-20210331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_338b140a-3769-46bf-87d7-a1092982b1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_fd5e3135-34d6-40bb-91a8-bb1fabfaeb56" xlink:href="mck-20210331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_fd5e3135-34d6-40bb-91a8-bb1fabfaeb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_8335b833-4dc9-4eb2-a88c-fdef31f8857c" xlink:href="mck-20210331.xsd#mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_8335b833-4dc9-4eb2-a88c-fdef31f8857c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IntangibleAssetandStoreAssetsImpairmentMember_d24d8c6e-fa87-4dd5-a094-93c0c78aefd9" xlink:href="mck-20210331.xsd#mck_IntangibleAssetandStoreAssetsImpairmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_f43e5427-572b-4997-ace3-4e5c9d86dd52" xlink:to="loc_mck_IntangibleAssetandStoreAssetsImpairmentMember_d24d8c6e-fa87-4dd5-a094-93c0c78aefd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6d7bbf89-dadc-4308-8c0a-585d9702748c" xlink:to="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_79e8051e-17ef-44e3-92ba-d5f2c61aff7a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:to="loc_srt_MinimumMember_79e8051e-17ef-44e3-92ba-d5f2c61aff7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e6d355c0-e25b-4b6a-a19f-ffc3782b3844" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdaf933a-3f3d-466b-9ee1-2d54a414beb7" xlink:to="loc_srt_MaximumMember_e6d355c0-e25b-4b6a-a19f-ffc3782b3844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_633e4611-41a2-4091-8a04-ee30041908f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d553fd37-cc5a-49d5-bd4f-b91964488fe6" xlink:to="loc_us-gaap_SegmentDomain_633e4611-41a2-4091-8a04-ee30041908f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_d38aea54-4e50-4a9a-ad9b-34e3d295d5ab" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_633e4611-41a2-4091-8a04-ee30041908f6" xlink:to="loc_mck_InternationalSegmentMember_d38aea54-4e50-4a9a-ad9b-34e3d295d5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0525e1af-16a1-4326-b9eb-d751b7695496" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_52ce48a1-d573-4d59-80db-90dc551d3acb" xlink:to="loc_srt_SegmentGeographicalDomain_0525e1af-16a1-4326-b9eb-d751b7695496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_b22308c4-9dcf-46dc-80d6-43bfe62991fb" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0525e1af-16a1-4326-b9eb-d751b7695496" xlink:to="loc_country_GB_b22308c4-9dcf-46dc-80d6-43bfe62991fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_0773e851-1730-44a5-8c93-a14b5921078a" xlink:to="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_37ff4666-db06-4902-93b7-f5f50102f19a" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_37ff4666-db06-4902-93b7-f5f50102f19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_9a80fc6a-ac88-4111-a693-e3c050709bf2" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_655e42f8-12b1-4d17-8a5f-fb9c064cb565" xlink:to="loc_mck_RexallHealthMember_9a80fc6a-ac88-4111-a693-e3c050709bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a7cafb1-9fcf-4755-b83e-b54bfce18124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_894c3aa0-2bac-4e80-bafb-f4933d03f6d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a7cafb1-9fcf-4755-b83e-b54bfce18124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5549fb98-0c46-4d17-ad2c-ead5ea972f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a7cafb1-9fcf-4755-b83e-b54bfce18124" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5549fb98-0c46-4d17-ad2c-ead5ea972f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0a97a3d-2407-431c-bda6-b2a293a0321e" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5b131a5f-8de9-4e12-b44e-a8d398f38ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5b131a5f-8de9-4e12-b44e-a8d398f38ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b7af372a-f768-4662-a983-8690f9391a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b7af372a-f768-4662-a983-8690f9391a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_278fdc11-9eab-4f40-be28-4655d4dc7ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringCharges_278fdc11-9eab-4f40-be28-4655d4dc7ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_06add3d4-5229-45a3-b37b-661092e3d8db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_06add3d4-5229-45a3-b37b-661092e3d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_48762b5e-1099-4849-a27a-fae10d2a6670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_RestructuringReserve_48762b5e-1099-4849-a27a-fae10d2a6670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ff5cb6f0-b3de-49e4-90cc-3b2c1eb8549d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_AssetImpairmentCharges_ff5cb6f0-b3de-49e4-90cc-3b2c1eb8549d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25582994-68d1-46ca-b68e-cbb7aefd4915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_32478789-e449-4124-b828-6cd47ca3fbab" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_25582994-68d1-46ca-b68e-cbb7aefd4915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bab3b786-64bd-48ca-ad9a-547506c1ce8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bab3b786-64bd-48ca-ad9a-547506c1ce8b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:to="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_63047ca9-9a92-4803-bb59-9a12d74ef921" xlink:to="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fa7e6f2b-3219-4f21-9244-66b95109a8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:to="loc_us-gaap_OperatingSegmentsMember_fa7e6f2b-3219-4f21-9244-66b95109a8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8cc20d49-fa4f-465d-a7fc-4ecb0b563051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6a1bd664-915a-4dbb-8b54-127b0469825a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8cc20d49-fa4f-465d-a7fc-4ecb0b563051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_970e34dd-ec58-4979-80ab-613405339372" xlink:to="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_d7e5a58e-b7be-462e-8968-7842d7f2abe3" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_USPharmaceuticalSegmentMember_d7e5a58e-b7be-462e-8968-7842d7f2abe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_5d203c93-a288-48e5-8220-b952269a9d8b" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_InternationalSegmentMember_5d203c93-a288-48e5-8220-b952269a9d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_8ce1291f-d35d-44be-aeaf-517328b608f2" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_8ce1291f-d35d-44be-aeaf-517328b608f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e946807b-78d3-4ce4-a843-bf83c4a41605" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_565d3bd8-821a-4c3e-9abb-b88eb6f1b508" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e946807b-78d3-4ce4-a843-bf83c4a41605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_014df643-5f66-4dc2-acc7-23d56e276341" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_9554fc65-1663-42fb-b95c-4b3e25eb0545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_SeveranceCosts1_9554fc65-1663-42fb-b95c-4b3e25eb0545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_ebe2337e-4830-40d0-8eb7-886a668d7e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_BusinessExitCosts1_ebe2337e-4830-40d0-8eb7-886a668d7e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_3165700c-6d2b-4c0c-ae02-c50873e10e45" xlink:href="mck-20210331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_3165700c-6d2b-4c0c-ae02-c50873e10e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_56bfefbe-8012-4d24-bdcf-e717faddaa7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f7928c64-741f-4a09-b5dc-e88d54ae54b7" xlink:to="loc_us-gaap_RestructuringCharges_56bfefbe-8012-4d24-bdcf-e717faddaa7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_654d8583-7d10-42b0-b33f-93caf3f6d93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_654d8583-7d10-42b0-b33f-93caf3f6d93f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e9a8e2ad-1d15-4567-abbb-37ebafd7d017" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_1595483f-7404-4e28-8158-8b5eb29b366a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_1595483f-7404-4e28-8158-8b5eb29b366a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7ff2c235-8be7-4d46-a1c8-c1bb276dd1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f8b6ba06-be50-4277-ab53-31027f4a5050" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7ff2c235-8be7-4d46-a1c8-c1bb276dd1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a94b4bbf-b611-49e8-81ff-6a7d46c203c0" xlink:to="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d089f336-81d6-479a-9de5-103dbae3ebd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:to="loc_us-gaap_OperatingSegmentsMember_d089f336-81d6-479a-9de5-103dbae3ebd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9b5366c9-0b57-4c33-96e3-99500fbbfa27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_55e165af-0a20-474c-aa92-23c7952cd944" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9b5366c9-0b57-4c33-96e3-99500fbbfa27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0c884684-e0b3-48b3-8cb1-c55b2f844a90" xlink:to="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_483ba177-e7c3-4053-a219-7f1d651df584" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_USPharmaceuticalSegmentMember_483ba177-e7c3-4053-a219-7f1d651df584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_b4f30dcf-d3f8-4eb7-b383-c3cbcea3caf7" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_InternationalSegmentMember_b4f30dcf-d3f8-4eb7-b383-c3cbcea3caf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_a2799015-b23a-41b8-a687-1fd66a0c72dc" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_a2799015-b23a-41b8-a687-1fd66a0c72dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_72b62e85-6c21-4aeb-8395-6c9b7b236f60" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_55b9c6c5-8513-4bd6-bc67-d7de5f8ff9e4" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_72b62e85-6c21-4aeb-8395-6c9b7b236f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_b4353ddb-94d5-4672-acd5-9c785e01d31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b85a4887-5b6c-457b-a5a2-bbe6a4f24571" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_b4353ddb-94d5-4672-acd5-9c785e01d31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_b4353ddb-94d5-4672-acd5-9c785e01d31a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_726f2ee5-2328-4352-ae35-0c2d81b226ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserve_726f2ee5-2328-4352-ae35-0c2d81b226ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ee482faf-8a1f-4941-adaf-7f1ca2a6ff48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringCharges_ee482faf-8a1f-4941-adaf-7f1ca2a6ff48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_91706a48-f863-4ce2-ae18-9914cb7850e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_91706a48-f863-4ce2-ae18-9914cb7850e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_d709540b-a31b-4192-a966-ff75ad712544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_PaymentsForRestructuring_d709540b-a31b-4192-a966-ff75ad712544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_d7e356dd-c6ac-465e-a053-5c45330b4bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_d7e356dd-c6ac-465e-a053-5c45330b4bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_89b09294-08f7-41aa-ade9-1b339de46197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_3951a538-d1c7-4b79-8fd8-1934391be206" xlink:to="loc_us-gaap_RestructuringReserve_89b09294-08f7-41aa-ade9-1b339de46197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7a068a2e-6f87-45f5-a8ef-986f1a229582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_a5f5ab5d-1917-4e0b-a356-e723dc02aca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7a068a2e-6f87-45f5-a8ef-986f1a229582" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_a5f5ab5d-1917-4e0b-a356-e723dc02aca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_08183c29-9aeb-42ae-bcde-eff0665dfeb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_644db88f-3b15-4522-aaf4-8996478788fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_08183c29-9aeb-42ae-bcde-eff0665dfeb0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_644db88f-3b15-4522-aaf4-8996478788fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b05c68ae-1257-4eef-aa49-fceadd0d207b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b05c68ae-1257-4eef-aa49-fceadd0d207b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24b42e87-69b7-45a2-9c7a-2f84440eedc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ed3aa769-b0a6-44ee-bfbb-a7b07c01056f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24b42e87-69b7-45a2-9c7a-2f84440eedc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_83df6c42-d4d8-4b44-ac9f-d454c73340f8" xlink:href="mck-20210331.xsd#mck_MedicalSpecialtiesDistributorsLLCMSDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_24b42e87-69b7-45a2-9c7a-2f84440eedc2" xlink:to="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_83df6c42-d4d8-4b44-ac9f-d454c73340f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ec312ec-a173-486f-82db-daa8261b9b14" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_985c255f-4dfe-4744-98e9-9c3830ea9307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_985c255f-4dfe-4744-98e9-9c3830ea9307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ac5a80a7-efc6-457f-9af9-e61d00ae5d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ac5a80a7-efc6-457f-9af9-e61d00ae5d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_15420cf5-a3bb-496a-a814-6d29f0353665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_03ca991c-5dbc-4cff-879f-d3aae1bce9e7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_15420cf5-a3bb-496a-a814-6d29f0353665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1de1cd91-12eb-464e-a49c-f4dcfc80578d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1de1cd91-12eb-464e-a49c-f4dcfc80578d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec331a98-1afc-4ef8-8b42-ed60e207cc47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc2a1053-9200-4c55-b6a0-7cc8cf72f53a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec331a98-1afc-4ef8-8b42-ed60e207cc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_0e259d97-13c3-469d-821e-8fc11de59ea4" xlink:href="mck-20210331.xsd#mck_MedicalSpecialtiesDistributorsLLCMSDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec331a98-1afc-4ef8-8b42-ed60e207cc47" xlink:to="loc_mck_MedicalSpecialtiesDistributorsLLCMSDMember_0e259d97-13c3-469d-821e-8fc11de59ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ccf95afd-ec3e-45ce-97a1-a598da3ed716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8363ea37-4c43-46e1-bb43-ba44b31abba6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ccf95afd-ec3e-45ce-97a1-a598da3ed716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccf95afd-ec3e-45ce-97a1-a598da3ed716" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e2848cc-d313-4c5e-9285-acc29b2d7e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e2848cc-d313-4c5e-9285-acc29b2d7e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_8f0fe1d5-13d2-48b4-b8ed-1c91af246087" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents_8f0fe1d5-13d2-48b4-b8ed-1c91af246087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4aea0750-e38b-4523-98cb-0b3c69d00d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_Goodwill_4aea0750-e38b-4523-98cb-0b3c69d00d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a3c4f642-f5be-44bf-a741-306221761062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a3c4f642-f5be-44bf-a741-306221761062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a5774480-a17e-45ea-9860-f0f5ac0c1186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a5774480-a17e-45ea-9860-f0f5ac0c1186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_79e67560-42ab-4052-a936-169e69aabd75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_79e67560-42ab-4052-a936-169e69aabd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_38ccb3e1-7238-403f-86a4-90c90ef0b6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_38ccb3e1-7238-403f-86a4-90c90ef0b6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_002270ac-41c7-491e-8c4d-872e95a0dbe1" xlink:href="mck-20210331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_e0a88308-2f0b-46ba-960d-6c399323da0a" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents_002270ac-41c7-491e-8c4d-872e95a0dbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6144e113-d4cd-43cf-812f-39d857c2694a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6144e113-d4cd-43cf-812f-39d857c2694a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0316556c-7cc9-4614-9dde-9ced0481a6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1499ce16-2379-40b9-8768-286bc5e3c24f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0316556c-7cc9-4614-9dde-9ced0481a6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CoverMyMedsLLCMember_5b902eda-471a-4a15-9d60-4d48753fe85f" xlink:href="mck-20210331.xsd#mck_CoverMyMedsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0316556c-7cc9-4614-9dde-9ced0481a6ba" xlink:to="loc_mck_CoverMyMedsLLCMember_5b902eda-471a-4a15-9d60-4d48753fe85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_250bef9c-df23-46f1-9609-ea99ce95a3b2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_69008fef-291f-43de-9276-1eb0a7f05b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_69008fef-291f-43de-9276-1eb0a7f05b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ccc8d1b3-bd48-4e33-b80f-f9d29764c46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_ccc8d1b3-bd48-4e33-b80f-f9d29764c46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_08854910-12a8-4649-b2e1-6fcd63fdedd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_08854910-12a8-4649-b2e1-6fcd63fdedd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_923edeef-9fda-4e88-b9bb-b4c0cd5cab4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa1a92fb-639b-47e6-9538-ec081f7c3788" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_923edeef-9fda-4e88-b9bb-b4c0cd5cab4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_945bbf0f-62f7-4f20-b7dc-23195aa064a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_286e2272-11ce-4ce2-8f27-097008cbcd96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_945bbf0f-62f7-4f20-b7dc-23195aa064a8" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_286e2272-11ce-4ce2-8f27-097008cbcd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_512d3d7e-9525-41e1-8a01-1519861e74ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_512d3d7e-9525-41e1-8a01-1519861e74ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_60558b13-4183-45d6-a5a0-fdf8ac018632" xlink:href="mck-20210331.xsd#mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_60558b13-4183-45d6-a5a0-fdf8ac018632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4df99d65-6f22-49c6-a8c5-02e19b23321e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4df99d65-6f22-49c6-a8c5-02e19b23321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DataRelatedtoRSUActivityTableTextBlock_53525307-c81e-4f3e-b660-a374513ea83e" xlink:href="mck-20210331.xsd#mck_DataRelatedtoRSUActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_mck_DataRelatedtoRSUActivityTableTextBlock_53525307-c81e-4f3e-b660-a374513ea83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4166c76c-de98-46bb-939b-55d5e6cb9447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4166c76c-de98-46bb-939b-55d5e6cb9447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_938913ed-c681-45be-94b8-2e437f93458b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_938913ed-c681-45be-94b8-2e437f93458b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ad6d8014-ce7b-48b8-8f0a-5219caca0aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ad6d8014-ce7b-48b8-8f0a-5219caca0aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_e0f75f43-ed57-4544-8061-de43d5027738" xlink:href="mck-20210331.xsd#mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04941392-8e92-498a-9ba1-ca7803bc15d8" xlink:to="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_e0f75f43-ed57-4544-8061-de43d5027738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32e7a4be-2e98-477f-bdf5-8d27eb2bfee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32e7a4be-2e98-477f-bdf5-8d27eb2bfee9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3ed8192c-9ade-4b63-a399-fc3386d2373f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0a85873e-d381-48ce-8fdf-647c3e373126" xlink:to="loc_us-gaap_PlanNameDomain_3ed8192c-9ade-4b63-a399-fc3386d2373f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember_23a79aae-786c-4e21-a112-6216bd4cf7f3" xlink:href="mck-20210331.xsd#mck_A2013StockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3ed8192c-9ade-4b63-a399-fc3386d2373f" xlink:to="loc_mck_A2013StockPlanMember_23a79aae-786c-4e21-a112-6216bd4cf7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_39520f30-7eca-4fb7-ad63-e9c1cc703c8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fa699529-81ff-42e9-9d3d-928c2034eda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fa699529-81ff-42e9-9d3d-928c2034eda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember_2690b90c-f4cf-42d4-903a-18ead74124c3" xlink:href="mck-20210331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_mck_PerformancebasedStockUnitsMember_2690b90c-f4cf-42d4-903a-18ead74124c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PeRSUsMember_140dc8e9-d2ec-4587-99f4-eac3fa4cceea" xlink:href="mck-20210331.xsd#mck_PeRSUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_mck_PeRSUsMember_140dc8e9-d2ec-4587-99f4-eac3fa4cceea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a54c9fa9-c6ab-4fef-9140-9a0862c0c939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a54c9fa9-c6ab-4fef-9140-9a0862c0c939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_76b10648-979f-4f0b-846c-f0024c272083" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84259105-0a65-4b1e-862e-5c6da7ca0e61" xlink:to="loc_us-gaap_EmployeeStockMember_76b10648-979f-4f0b-846c-f0024c272083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5882e17f-20a3-4e37-9bc4-890a84bf0fc5" xlink:to="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7d8d9b4-84cb-4abc-bcb3-0cc5916da117" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:to="loc_srt_MinimumMember_e7d8d9b4-84cb-4abc-bcb3-0cc5916da117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bae8b9a1-3ed2-4f15-b50f-6175a02e5cdc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e43b039d-6016-474d-b336-fb27f518f449" xlink:to="loc_srt_MaximumMember_bae8b9a1-3ed2-4f15-b50f-6175a02e5cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3206840-b631-4c03-936b-e341acb9acc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_c58ed9ee-0a8b-4fa4-9b86-41297a8119b0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3206840-b631-4c03-936b-e341acb9acc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_59a0a867-5469-4589-9f99-0479614f2b5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3206840-b631-4c03-936b-e341acb9acc5" xlink:to="loc_srt_DirectorMember_59a0a867-5469-4589-9f99-0479614f2b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2637c684-325e-42cf-b531-84bacb1ccdfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_823344c7-845a-41fc-9055-150fa235ae57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_823344c7-845a-41fc-9055-150fa235ae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a255041d-4534-40a1-a4d9-56ff6cda495a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a255041d-4534-40a1-a4d9-56ff6cda495a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_54fe7c82-077c-4937-8aad-d662bf6d4001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_54fe7c82-077c-4937-8aad-d662bf6d4001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f0fb6a9-85f6-463c-95cb-3b6113769c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f0fb6a9-85f6-463c-95cb-3b6113769c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_8ffa6286-3c5c-4474-845a-7504495a1281" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_8ffa6286-3c5c-4474-845a-7504495a1281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4ba50119-c267-4757-8e32-434e0812e8f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_4ba50119-c267-4757-8e32-434e0812e8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e8bfc023-fed6-49d2-8591-c8d6ef5eeae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e8bfc023-fed6-49d2-8591-c8d6ef5eeae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_624643f6-3195-4be2-91f4-78aa082e3c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_624643f6-3195-4be2-91f4-78aa082e3c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2a8da3d5-aadb-4a30-ab4a-0c88eeeebd52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2a8da3d5-aadb-4a30-ab4a-0c88eeeebd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_7f183ac1-fdf4-4b87-9718-6f5cc5b7ac9f" xlink:href="mck-20210331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_7f183ac1-fdf4-4b87-9718-6f5cc5b7ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b408bca1-ffda-4789-bb67-777cd4096b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b408bca1-ffda-4789-bb67-777cd4096b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_6ac8db58-2714-4d21-a66f-65dcf34d5eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bdd5418-7275-4033-b1b3-67d4558099ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_6ac8db58-2714-4d21-a66f-65dcf34d5eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9feee2d-a580-438a-accb-2dc5d0936419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e9feee2d-a580-438a-accb-2dc5d0936419" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:to="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_db88aa20-f607-47cb-be40-795f0a92ad0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_161dabc1-c71d-44e4-a807-89ec18c34607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_161dabc1-c71d-44e4-a807-89ec18c34607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_0982a313-fcbc-4a45-abb5-9ba4e655eb86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:to="loc_us-gaap_StockOptionMember_0982a313-fcbc-4a45-abb5-9ba4e655eb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_6aebe705-d2f5-4c1f-b949-8cbafec93873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71a256c7-3c8f-4b1d-a3d7-f1b503a97686" xlink:to="loc_us-gaap_EmployeeStockMember_6aebe705-d2f5-4c1f-b949-8cbafec93873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bfb4d297-9ebe-4b55-b1d8-a36ba4bbf6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1715cce0-8303-452d-b031-7d5ab5297e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1715cce0-8303-452d-b031-7d5ab5297e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07406ebd-9d91-4c08-8c95-609fd4cde5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07406ebd-9d91-4c08-8c95-609fd4cde5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2c4cce8d-5d47-47c4-ac10-66a568b747f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbc05fb0-df53-4dfa-90d1-260e106945ca" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2c4cce8d-5d47-47c4-ac10-66a568b747f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_92c73319-4182-401f-92c1-fb6ba789f663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_92c73319-4182-401f-92c1-fb6ba789f663" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:to="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b95e9934-3b18-4919-87da-48f0e903aa4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_abb0a6c9-e254-426f-ab4d-f87a705ac24a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b95e9934-3b18-4919-87da-48f0e903aa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9e4eba6d-c4b3-4602-9098-5178f2004888" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b95e9934-3b18-4919-87da-48f0e903aa4c" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9e4eba6d-c4b3-4602-9098-5178f2004888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_988cb369-2b10-4258-a394-8c9d7c065661" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_23fb4de8-93c1-49b9-adbf-45746dc08763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_23fb4de8-93c1-49b9-adbf-45746dc08763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_15f90904-4ad4-4e18-8e04-0f1279899e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_15f90904-4ad4-4e18-8e04-0f1279899e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc504a1-c349-4302-94f3-60753e038556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fc504a1-c349-4302-94f3-60753e038556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9285dfbe-eaaa-4ced-a799-5b1e43e43985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3555ccc4-2ada-4075-8e2b-f8802b742e0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9285dfbe-eaaa-4ced-a799-5b1e43e43985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_06bbec79-84f4-4a73-a60a-9047da78e3e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_06bbec79-84f4-4a73-a60a-9047da78e3e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:to="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_132bacf2-87ba-4445-9452-75809c30c89c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_665d8334-420f-4921-8e51-b6aa37723c28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_132bacf2-87ba-4445-9452-75809c30c89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_f58c70f2-5aba-43a3-8a36-fc0480b756c4" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_132bacf2-87ba-4445-9452-75809c30c89c" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_f58c70f2-5aba-43a3-8a36-fc0480b756c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ec5c485-75fd-45c2-bca0-f90429c76988" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d879e08e-c9b5-4931-9e5a-3c72ade66412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d879e08e-c9b5-4931-9e5a-3c72ade66412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a8b21eaa-38ea-4c61-8cdb-dc6ab0cfcedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a8b21eaa-38ea-4c61-8cdb-dc6ab0cfcedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_42ea3046-e53b-42f8-9bba-5dbab422ffd0" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_42ea3046-e53b-42f8-9bba-5dbab422ffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c996553-11d4-4939-aa87-b42f7c1dcdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c996553-11d4-4939-aa87-b42f7c1dcdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_65589252-3753-43b2-9c6d-000519d9cd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8b71fac4-3703-4752-93a3-6b7370d7bb86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_65589252-3753-43b2-9c6d-000519d9cd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5b87950-df53-469d-b336-d3dd8a8dcf34" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fda692b-13d5-440d-9893-aaa407aace71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8fda692b-13d5-440d-9893-aaa407aace71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d673af9-49cc-4f8c-b6f7-0e0a2b814edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d673af9-49cc-4f8c-b6f7-0e0a2b814edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_5a45f128-6f96-4fc7-8f02-750bccc75b52" xlink:href="mck-20210331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_5a45f128-6f96-4fc7-8f02-750bccc75b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_251437a5-bce7-4639-a4c5-d249dd9147b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_251437a5-bce7-4639-a4c5-d249dd9147b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b7cddb6-b6ab-4a6e-8f76-c62efdc87fd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_13a1fbbb-e631-4ba1-a085-3350d57a49f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b7cddb6-b6ab-4a6e-8f76-c62efdc87fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8be5d1b-4c0d-45e7-8781-355b79ec485b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a8be5d1b-4c0d-45e7-8781-355b79ec485b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:to="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2905fbf3-8529-4007-a2ff-b38c6f614701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cc75ae9c-1c90-448f-80b3-0bdcfe931a28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2905fbf3-8529-4007-a2ff-b38c6f614701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_fb7d295a-243a-4f4f-b9b1-3794bcae3627" xlink:href="mck-20210331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2905fbf3-8529-4007-a2ff-b38c6f614701" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_fb7d295a-243a-4f4f-b9b1-3794bcae3627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6299af10-f5ad-4f9a-a3de-e1ee360184f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5f7f3ea3-8b95-4f12-ab7e-6795712650c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5f7f3ea3-8b95-4f12-ab7e-6795712650c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74958b00-d321-4683-b2fb-da986eb4f38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_74958b00-d321-4683-b2fb-da986eb4f38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e3a17c71-ac52-4679-8457-fd5dd0a5926a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e7f48c3-5293-4b16-b810-b2d7883564cb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e3a17c71-ac52-4679-8457-fd5dd0a5926a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e3cf2ba-5122-4d77-b8bb-cbd0b1738c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e3cf2ba-5122-4d77-b8bb-cbd0b1738c3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:to="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e8063c8-02ff-4b63-a4fc-946d5a945c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6188ef7a-d451-4ee9-8f58-771ad5ba0745" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e8063c8-02ff-4b63-a4fc-946d5a945c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e8bb053f-d911-49e8-9f50-7d26747e211e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e8063c8-02ff-4b63-a4fc-946d5a945c5c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e8bb053f-d911-49e8-9f50-7d26747e211e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b69b3d6-5ed1-4bee-8b20-7e2213b9387d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6fc3f073-2ea5-41af-8acc-d2d6615613ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6fc3f073-2ea5-41af-8acc-d2d6615613ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_59d58ae3-bc0e-40e3-a365-0dfe7e00d2c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_59d58ae3-bc0e-40e3-a365-0dfe7e00d2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_24192de7-8aff-4802-9d45-be570843ef40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_24192de7-8aff-4802-9d45-be570843ef40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b7d8e50a-2633-4919-a272-d3680c223f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_95309c17-6856-49bf-8f13-2186cd533c4f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b7d8e50a-2633-4919-a272-d3680c223f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationSummaryofOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c85ae001-5103-4411-9009-fa17a8efc827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c85ae001-5103-4411-9009-fa17a8efc827" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_36099811-fedc-4596-a26a-113907f1d11c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeOneMember_95e89a37-7c5e-4520-ab9a-ca8216289956" xlink:href="mck-20210331.xsd#mck_RangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:to="loc_mck_RangeOneMember_95e89a37-7c5e-4520-ab9a-ca8216289956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeTwoMember_f6c667c3-2b83-4797-9c80-b5d1f6e4f767" xlink:href="mck-20210331.xsd#mck_RangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_98ae2e06-22cc-4125-b23e-49a8d6bce425" xlink:to="loc_mck_RangeTwoMember_f6c667c3-2b83-4797-9c80-b5d1f6e4f767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_286e8488-d4e4-43d9-a25a-d4e3a1b581d6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f3d28d5a-d5ec-4507-a7a3-3ed250159994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f3d28d5a-d5ec-4507-a7a3-3ed250159994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_916d26c4-b94a-444a-a3b9-6241cfb48e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_916d26c4-b94a-444a-a3b9-6241cfb48e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_aae8fe3c-e0ac-4e88-b1e6-00efdb123034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_aae8fe3c-e0ac-4e88-b1e6-00efdb123034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d577696c-f58f-4997-bb9f-97fc1232ffa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d577696c-f58f-4997-bb9f-97fc1232ffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_27071b51-7290-4bd3-a2b9-54e83b27dad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_27071b51-7290-4bd3-a2b9-54e83b27dad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1e374e4-cbf6-4192-a75b-299dc6c3498d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1e374e4-cbf6-4192-a75b-299dc6c3498d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70fdfa5e-3a02-4421-92f6-0eb5c57011d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_c81a4f39-6de1-4a45-98ae-8fa3eb60a754" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70fdfa5e-3a02-4421-92f6-0eb5c57011d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4be06391-e30f-4f0b-8292-10863e26fe58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4be06391-e30f-4f0b-8292-10863e26fe58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d438f681-0e87-4017-8e10-cbf1a9db22d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d438f681-0e87-4017-8e10-cbf1a9db22d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8df916a6-bcce-4294-91bb-4752e2998a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8df916a6-bcce-4294-91bb-4752e2998a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0acbd2f7-8335-41e3-b0e0-dbdf0ec65595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0acbd2f7-8335-41e3-b0e0-dbdf0ec65595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_632dba0e-c87f-40a4-8161-be8f2161182f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_632dba0e-c87f-40a4-8161-be8f2161182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a67a61a-1bc4-4ee2-b5bf-4ff2ca54c3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b260cb45-18a4-49a6-98ed-621db1707c15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a67a61a-1bc4-4ee2-b5bf-4ff2ca54c3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4be06391-e30f-4f0b-8292-10863e26fe58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_81da68d3-3bcc-4f6e-afbb-36e9fab54a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_81da68d3-3bcc-4f6e-afbb-36e9fab54a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5be28381-151d-4586-9de9-5022b93c444f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5be28381-151d-4586-9de9-5022b93c444f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d503cbca-fd9f-46ac-be0b-0310256e00f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d503cbca-fd9f-46ac-be0b-0310256e00f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_73723c8f-794f-4905-8b1d-09306516fe2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_73723c8f-794f-4905-8b1d-09306516fe2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a8bd60b0-22f8-4687-9a5c-6d94df0b04e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8ee9e317-4bea-463f-bb7e-0ef162e87970" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a8bd60b0-22f8-4687-9a5c-6d94df0b04e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75b55b06-8e11-4fc5-8c78-630163b9befc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4be06391-e30f-4f0b-8292-10863e26fe58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75b55b06-8e11-4fc5-8c78-630163b9befc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_aebabdae-467f-4c9a-80af-a5a417b110ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75b55b06-8e11-4fc5-8c78-630163b9befc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_aebabdae-467f-4c9a-80af-a5a417b110ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a0767243-56bf-4127-a64f-20e2e0223181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75b55b06-8e11-4fc5-8c78-630163b9befc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a0767243-56bf-4127-a64f-20e2e0223181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4be06391-e30f-4f0b-8292-10863e26fe58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a6990930-9263-4791-841b-54477c09e701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a6990930-9263-4791-841b-54477c09e701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_44de2517-2acf-49bd-ba5d-5156efd1308a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_44de2517-2acf-49bd-ba5d-5156efd1308a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9b107dd6-12f9-45c5-82cc-d4f9837546cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9b107dd6-12f9-45c5-82cc-d4f9837546cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_076e1844-9ea7-40c2-814b-3eaeb5dc85de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_076e1844-9ea7-40c2-814b-3eaeb5dc85de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_8a718b70-3eab-444b-8e60-a1055c02c223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_8a718b70-3eab-444b-8e60-a1055c02c223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_da242fc8-dcdb-4aec-9b19-038d56b96173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_da242fc8-dcdb-4aec-9b19-038d56b96173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_639d3b45-9544-4112-a14e-578faee5919b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_639d3b45-9544-4112-a14e-578faee5919b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_4f74d24a-300d-4d63-8335-b5769ddbbc29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b285bb4-0f89-4878-a856-438a94b8f8bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_4f74d24a-300d-4d63-8335-b5769ddbbc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39fac84f-8bcb-48d1-a4fe-e4a1e33e71e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39fac84f-8bcb-48d1-a4fe-e4a1e33e71e4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:to="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d429c623-ffdf-42c4-a00c-d451d5f294e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3200a69f-d760-4e90-bfed-6f13d32cd41b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d429c623-ffdf-42c4-a00c-d451d5f294e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f2fe69b4-ac6e-45e8-b6ea-d3ea5a2c86fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d429c623-ffdf-42c4-a00c-d451d5f294e6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f2fe69b4-ac6e-45e8-b6ea-d3ea5a2c86fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_261423f8-184b-44d9-813f-734056da1831" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_acdbabd7-5a38-49f8-b70a-402cedfff79b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_acdbabd7-5a38-49f8-b70a-402cedfff79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_df9d5400-d0f5-49df-a27f-c1cb929566a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_df9d5400-d0f5-49df-a27f-c1cb929566a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_acb1fdf9-4508-4922-bb16-06c838dcb8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_acb1fdf9-4508-4922-bb16-06c838dcb8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_dae6812b-a712-446e-9cd4-53656f495590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_dae6812b-a712-446e-9cd4-53656f495590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3d4bbfeb-c1bc-4ac3-b816-78292e0fcfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3d4bbfeb-c1bc-4ac3-b816-78292e0fcfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8cc56ab-119c-4ed9-9285-4867de6850e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c8cc56ab-119c-4ed9-9285-4867de6850e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7a417fa2-b104-4a37-b86a-cf86d354b099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e27ae8a-86f5-488d-94b4-469972f50e2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7a417fa2-b104-4a37-b86a-cf86d354b099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNet" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_314f1973-366d-4ef7-8ac9-64a774058586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_bd9599ee-6f58-47c1-93a6-ec6e79a064eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_314f1973-366d-4ef7-8ac9-64a774058586" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_bd9599ee-6f58-47c1-93a6-ec6e79a064eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2519a15f-a51c-4cba-b9a4-6e19c2c391b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_2825f6be-54f4-4691-bbf0-59db41a97301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_2519a15f-a51c-4cba-b9a4-6e19c2c391b8" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_2825f6be-54f4-4691-bbf0-59db41a97301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#OtherIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_8f52bcd7-133d-4027-839e-7ed84ccbc240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_8f52bcd7-133d-4027-839e-7ed84ccbc240" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8963f848-fd90-4a3e-bfcf-f460b10b79e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b3b09ec8-dd90-4917-8acf-4952eb5aca7c" xlink:to="loc_us-gaap_RelatedPartyDomain_8963f848-fd90-4a3e-bfcf-f460b10b79e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_58573a31-c1d1-4cb8-b8a2-8b2dd04929c6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_8963f848-fd90-4a3e-bfcf-f460b10b79e3" xlink:to="loc_srt_ExecutiveOfficerMember_58573a31-c1d1-4cb8-b8a2-8b2dd04929c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_bdcc0c6e-ed3e-4629-b6bb-2158e69eafc1" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_5078ba61-d299-41ca-bb17-f8f072a9846e" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_5078ba61-d299-41ca-bb17-f8f072a9846e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_89aa84e1-602f-47d2-8047-1b6ce66f588e" xlink:href="mck-20210331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f176de80-b62d-440e-959f-c12c60003dde" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_89aa84e1-602f-47d2-8047-1b6ce66f588e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b0dfcf7b-d047-4c02-a0e1-a780f153b29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a6ad9717-8eef-4135-9ec7-fb310f862f91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b0dfcf7b-d047-4c02-a0e1-a780f153b29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_badaf18f-b1c9-47e0-a841-66e638888ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b0dfcf7b-d047-4c02-a0e1-a780f153b29d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_badaf18f-b1c9-47e0-a841-66e638888ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4b3767c3-84c3-4ec7-9e33-03425b72945c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_eb3acec5-77e3-4c3b-84d5-3b3765b546ac" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4b3767c3-84c3-4ec7-9e33-03425b72945c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_723e2ed5-55f1-4662-a742-76ea930a3fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4b3767c3-84c3-4ec7-9e33-03425b72945c" xlink:to="loc_us-gaap_DomesticPlanMember_723e2ed5-55f1-4662-a742-76ea930a3fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_87f3dd1f-babd-4fb0-8618-c72df75bb236" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_723e2ed5-55f1-4662-a742-76ea930a3fc6" xlink:to="loc_country_US_87f3dd1f-babd-4fb0-8618-c72df75bb236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1736d749-3f1b-4183-b567-ca66abe6b1f4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0bd799fe-4be3-4d58-b705-ea0ac548f83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0bd799fe-4be3-4d58-b705-ea0ac548f83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_271fe007-b793-4053-908b-16ef6818cc53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_271fe007-b793-4053-908b-16ef6818cc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dda21faf-9a4c-4e08-850d-5551b3301f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dda21faf-9a4c-4e08-850d-5551b3301f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_35277303-c1ab-4a0b-89b4-8a80e8e21a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_35277303-c1ab-4a0b-89b4-8a80e8e21a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9b4a3aa6-0bed-4f0b-99fc-643fd31ff028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9b4a3aa6-0bed-4f0b-99fc-643fd31ff028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_49ef3a2f-2930-400f-a663-3a57a85cc6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_49ef3a2f-2930-400f-a663-3a57a85cc6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2377e21c-d60c-44e8-8a4c-f904cdf7ef18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2377e21c-d60c-44e8-8a4c-f904cdf7ef18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_40f1d103-70da-4d65-8544-2fb42aa76ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8352d84c-4155-49a9-95e3-3d345bbb950f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_40f1d103-70da-4d65-8544-2fb42aa76ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5c146b44-549a-40cb-b63b-dd9077ed6e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_4d8aa300-a802-4b1f-a090-c88399e9063f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c146b44-549a-40cb-b63b-dd9077ed6e15" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_4d8aa300-a802-4b1f-a090-c88399e9063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_63f7e24b-7da2-4a0b-b6b8-8029c0528a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_5c06c835-eeee-494f-8f49-23d8e7f6a46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63f7e24b-7da2-4a0b-b6b8-8029c0528a1c" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_5c06c835-eeee-494f-8f49-23d8e7f6a46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_27b75d7a-2070-40a0-aef1-330061d666ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63f7e24b-7da2-4a0b-b6b8-8029c0528a1c" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_27b75d7a-2070-40a0-aef1-330061d666ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8143934c-cc92-442e-986a-dbcf84813636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63f7e24b-7da2-4a0b-b6b8-8029c0528a1c" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8143934c-cc92-442e-986a-dbcf84813636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e691af9c-79cd-434e-89b5-cccf84bc7938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63f7e24b-7da2-4a0b-b6b8-8029c0528a1c" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e691af9c-79cd-434e-89b5-cccf84bc7938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_e284ed9c-29cd-4746-9162-c9101c58e927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63f7e24b-7da2-4a0b-b6b8-8029c0528a1c" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_e284ed9c-29cd-4746-9162-c9101c58e927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b9297567-a4ca-4835-b155-8d0bdc631dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_faa57aa0-a6e1-4a5a-948c-7b5b1a2df2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b9297567-a4ca-4835-b155-8d0bdc631dfe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_faa57aa0-a6e1-4a5a-948c-7b5b1a2df2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dc0056e6-af4c-4d13-ab30-1d3667901371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_faa57aa0-a6e1-4a5a-948c-7b5b1a2df2bc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_dc0056e6-af4c-4d13-ab30-1d3667901371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0dbf0c4b-4865-4965-8c6a-aa475574b67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_faa57aa0-a6e1-4a5a-948c-7b5b1a2df2bc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0dbf0c4b-4865-4965-8c6a-aa475574b67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3443e068-666d-41b3-90c5-20796fd1c28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_faa57aa0-a6e1-4a5a-948c-7b5b1a2df2bc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3443e068-666d-41b3-90c5-20796fd1c28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_30118704-393c-4d3a-acc3-2f504f2df62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0fde413b-6d1a-480b-998b-022076c53a57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30118704-393c-4d3a-acc3-2f504f2df62f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0fde413b-6d1a-480b-998b-022076c53a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_81c5378d-1873-4cde-8d23-48970a7b8e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0fde413b-6d1a-480b-998b-022076c53a57" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_81c5378d-1873-4cde-8d23-48970a7b8e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_60c9b719-2373-4d01-8616-d93a36401af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0fde413b-6d1a-480b-998b-022076c53a57" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_60c9b719-2373-4d01-8616-d93a36401af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_17a5cbd7-101b-478f-85db-435f915c98b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0fde413b-6d1a-480b-998b-022076c53a57" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_17a5cbd7-101b-478f-85db-435f915c98b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3c31c529-1ef5-4b28-a35e-682e4a9beb17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0fde413b-6d1a-480b-998b-022076c53a57" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3c31c529-1ef5-4b28-a35e-682e4a9beb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe2a371c-29dd-44df-b253-5c3dc82e16aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30118704-393c-4d3a-acc3-2f504f2df62f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe2a371c-29dd-44df-b253-5c3dc82e16aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3be2c410-c981-402a-a3c9-07584b76cfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe2a371c-29dd-44df-b253-5c3dc82e16aa" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3be2c410-c981-402a-a3c9-07584b76cfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_eee221d9-3554-42cf-ac91-5f8ec187a46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe2a371c-29dd-44df-b253-5c3dc82e16aa" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_eee221d9-3554-42cf-ac91-5f8ec187a46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_581b4b3a-acf5-4668-b2b8-cb222bb8f7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe2a371c-29dd-44df-b253-5c3dc82e16aa" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_581b4b3a-acf5-4668-b2b8-cb222bb8f7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1fdc485b-24cd-43e7-a817-cbb53c8a683a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_fe2a371c-29dd-44df-b253-5c3dc82e16aa" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1fdc485b-24cd-43e7-a817-cbb53c8a683a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5a90096f-5db1-4ff9-ad46-8f48427217f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30118704-393c-4d3a-acc3-2f504f2df62f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5a90096f-5db1-4ff9-ad46-8f48427217f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bfa9845e-3715-429a-a0bb-08bf483fe012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bfa9845e-3715-429a-a0bb-08bf483fe012" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_835bed7d-b13d-461d-b4dd-5b6be1f45d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6a4faf4b-fb3b-4aff-9536-190515c3b825" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_835bed7d-b13d-461d-b4dd-5b6be1f45d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_5ab7acb5-4896-4257-9519-f84accfde2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_835bed7d-b13d-461d-b4dd-5b6be1f45d57" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_5ab7acb5-4896-4257-9519-f84accfde2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_4e8ac695-421d-4817-8a54-19a7fee760be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_dc5c233a-ea71-4cb5-adca-9dc762184ccc" xlink:to="loc_us-gaap_LossContingencyNatureDomain_4e8ac695-421d-4817-8a54-19a7fee760be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PendingAndFutureOpioidRelatedClaimsMember_c0912409-eab1-4435-8106-2841a0b02aa2" xlink:href="mck-20210331.xsd#mck_PendingAndFutureOpioidRelatedClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_4e8ac695-421d-4817-8a54-19a7fee760be" xlink:to="loc_mck_PendingAndFutureOpioidRelatedClaimsMember_c0912409-eab1-4435-8106-2841a0b02aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c39f0048-c517-42c3-8229-3a40d6d6c585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc48c6db-da0f-4331-9ae2-97b4dc8158db" xlink:to="loc_us-gaap_SegmentDomain_c39f0048-c517-42c3-8229-3a40d6d6c585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_cf1659b3-bf96-4ce5-a37d-e20b40d127e1" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c39f0048-c517-42c3-8229-3a40d6d6c585" xlink:to="loc_mck_InternationalSegmentMember_cf1659b3-bf96-4ce5-a37d-e20b40d127e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_9afe49af-8cf6-4d4c-b988-b4da7ff8d2ee" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_d39a8272-35e6-4a89-9803-750f0b022059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:to="loc_us-gaap_DomesticCountryMember_d39a8272-35e6-4a89-9803-750f0b022059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5c234f6a-0c74-4eaa-8b90-6202d62f74ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5c234f6a-0c74-4eaa-8b90-6202d62f74ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_afdceadb-85ee-41c5-ab03-3145187f8e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b37ebf4c-660b-4daf-9cdb-68194a6e312e" xlink:to="loc_us-gaap_ForeignCountryMember_afdceadb-85ee-41c5-ab03-3145187f8e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cc9b4d5b-e839-4393-a06c-e76d783e74e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_34722239-5ea6-46db-8e82-cb965c8d8c7e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cc9b4d5b-e839-4393-a06c-e76d783e74e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_ecd1a83f-f66b-4ab0-ae15-36d035de382d" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_cc9b4d5b-e839-4393-a06c-e76d783e74e9" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_ecd1a83f-f66b-4ab0-ae15-36d035de382d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_abd82ddc-f77e-44b8-83d5-127f21069a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6115cc81-5934-461b-aa22-b63b9af939c0" xlink:to="loc_us-gaap_RelatedPartyDomain_abd82ddc-f77e-44b8-83d5-127f21069a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_7b78523a-3bf2-424d-80c8-745beaf50294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_abd82ddc-f77e-44b8-83d5-127f21069a3e" xlink:to="loc_us-gaap_CorporateJointVentureMember_7b78523a-3bf2-424d-80c8-745beaf50294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_33a59069-0a6b-4e2c-a510-30ab41b145f8" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c1d7550-ec86-40ea-8861-55c409e1193e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c1d7550-ec86-40ea-8861-55c409e1193e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_45768bf7-b43a-413c-a12c-1fd74f1af5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_45768bf7-b43a-413c-a12c-1fd74f1af5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_afdbdb02-b669-432e-a5b7-e33ed221e023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_afdbdb02-b669-432e-a5b7-e33ed221e023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_dcb2d92b-4e34-4dfe-bdd4-563bedea971c" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount_dcb2d92b-4e34-4dfe-bdd4-563bedea971c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_b3a1451d-b1c0-466c-8909-d17e9276eeb8" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax_b3a1451d-b1c0-466c-8909-d17e9276eeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_771a7f54-7793-4667-a983-ba30022d4c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_771a7f54-7793-4667-a983-ba30022d4c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_f6102f75-87e4-4423-8fb8-bb53ae42ec27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_f6102f75-87e4-4423-8fb8-bb53ae42ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_d8a1ba38-99ae-4d7a-84b0-a8990a4c1a11" xlink:href="mck-20210331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_d8a1ba38-99ae-4d7a-84b0-a8990a4c1a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_31320d00-e4a0-4d86-adf7-2c1322dc6888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_31320d00-e4a0-4d86-adf7-2c1322dc6888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_f08212f9-5950-4ccf-a182-34d22456e675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_f08212f9-5950-4ccf-a182-34d22456e675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_deb87d99-bb72-4759-bc34-b2e8c227eaea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_deb87d99-bb72-4759-bc34-b2e8c227eaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f52f2930-d6c8-46b8-8516-3daca65f7e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f52f2930-d6c8-46b8-8516-3daca65f7e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e9e0ce0f-b5b6-4e96-85f8-7794e276b268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e9e0ce0f-b5b6-4e96-85f8-7794e276b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_45a4ce73-6781-49be-8969-ceaf22b27c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_OperatingLossCarryforwards_45a4ce73-6781-49be-8969-ceaf22b27c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e2430f5f-0b1e-4995-b4d5-d7e1b70587c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e2430f5f-0b1e-4995-b4d5-d7e1b70587c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fd20c3a8-3705-4017-a561-5b52ce6a2c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_fd20c3a8-3705-4017-a561-5b52ce6a2c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_afaffffb-8d70-4960-8ad0-ba078652c5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_afaffffb-8d70-4960-8ad0-ba078652c5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d24b8879-8250-4824-91e9-dff08632a441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_d24b8879-8250-4824-91e9-dff08632a441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_e4c42dfc-410f-4729-a7e4-0c9128e1114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_e4c42dfc-410f-4729-a7e4-0c9128e1114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_56d7f6db-78cf-4abc-ad76-17fdb34566b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_56d7f6db-78cf-4abc-ad76-17fdb34566b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_e12f38de-5d5f-4f7b-96e9-137787c49fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_efd242a8-446c-4fe7-b3ca-f39fe57ec8dc" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_e12f38de-5d5f-4f7b-96e9-137787c49fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_47ad5156-a135-4b78-b775-6b4fa1d31c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_47ad5156-a135-4b78-b775-6b4fa1d31c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_558316e1-c3fd-4c6f-afdf-c7a0071dfb14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_558316e1-c3fd-4c6f-afdf-c7a0071dfb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fcb5f10b-13d2-42a5-9710-53340c9ef14d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fcb5f10b-13d2-42a5-9710-53340c9ef14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_f96c5052-c3d3-4a89-aaec-b3d44b8076ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_f96c5052-c3d3-4a89-aaec-b3d44b8076ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_0dc5d8a8-6db1-44c0-afe7-57afbaa6e3c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_0dc5d8a8-6db1-44c0-afe7-57afbaa6e3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_f6688b31-4759-4c55-af0c-95088e360313" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_f6688b31-4759-4c55-af0c-95088e360313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_8046155e-3d6c-423e-b373-2309a140ccf2" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_8046155e-3d6c-423e-b373-2309a140ccf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b3021bd8-32b0-44dc-9acd-1f1dc6a60806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_b3021bd8-32b0-44dc-9acd-1f1dc6a60806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7c03d8f7-cac0-41b4-8b46-f2ad703e83e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7c03d8f7-cac0-41b4-8b46-f2ad703e83e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_af9a0c5c-c1c1-4ef8-b029-9ebc7bc5d569" xlink:href="mck-20210331.xsd#mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_af9a0c5c-c1c1-4ef8-b029-9ebc7bc5d569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_b6b212ef-b43a-472b-b155-2cea85d8942c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_b6b212ef-b43a-472b-b155-2cea85d8942c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ce1d5ffd-2c92-47c0-8187-7feb01607c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10513c2c-c30c-4ed5-b695-2b15472b2a80" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ce1d5ffd-2c92-47c0-8187-7feb01607c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d4cbb61e-01d4-49d5-80f8-1f0389246f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d4cbb61e-01d4-49d5-80f8-1f0389246f06" xlink:to="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_4e036a50-c7c6-49a8-b51f-c9fc687a4480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_4e036a50-c7c6-49a8-b51f-c9fc687a4480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_d2cc29ed-77e0-4da1-a0d2-9b347142c3d7" xlink:href="mck-20210331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_d2cc29ed-77e0-4da1-a0d2-9b347142c3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_94a35fa6-75a1-4332-949d-6481cbf52d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_94a35fa6-75a1-4332-949d-6481cbf52d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ff876b47-ab9e-4ffb-8f6a-8703880e9bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ff876b47-ab9e-4ffb-8f6a-8703880e9bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_7d25b5d1-1787-4203-9fa0-fb0875db67f9" xlink:href="mck-20210331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_7d25b5d1-1787-4203-9fa0-fb0875db67f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b90b1aae-efe8-4a33-8195-b18dd732971b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b90b1aae-efe8-4a33-8195-b18dd732971b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2c4802f8-7a01-423c-a3dd-dfe4af9b9b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2c4802f8-7a01-423c-a3dd-dfe4af9b9b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5fd28de2-60d4-4973-83d9-fa1416c6db5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5fd28de2-60d4-4973-83d9-fa1416c6db5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0f0dbdf2-705c-45f3-ad7b-017ebb562a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_56c629ee-d956-482d-91e8-b961b0fbd124" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_0f0dbdf2-705c-45f3-ad7b-017ebb562a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d4cbb61e-01d4-49d5-80f8-1f0389246f06" xlink:to="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_f4f736a0-feb3-40e6-89a1-859b67b61715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_f4f736a0-feb3-40e6-89a1-859b67b61715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e52ab365-6448-4d07-8bbf-78e176698387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e52ab365-6448-4d07-8bbf-78e176698387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d939b583-5700-4927-ae04-b2c80a71b7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d939b583-5700-4927-ae04-b2c80a71b7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_da70c87b-5218-4823-a885-5228df62abdc" xlink:href="mck-20210331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_da70c87b-5218-4823-a885-5228df62abdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_0df18312-f9d3-441d-9157-1132e208c911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_0df18312-f9d3-441d-9157-1132e208c911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6ddbd7f7-3d63-4e4d-8c80-19d5d1533fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0941e1c0-11e2-4de2-90e4-38a02fec2dbc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6ddbd7f7-3d63-4e4d-8c80-19d5d1533fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4e36717b-4e9a-47eb-8bf7-7b506c91562f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d4cbb61e-01d4-49d5-80f8-1f0389246f06" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4e36717b-4e9a-47eb-8bf7-7b506c91562f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_0687f8c4-0a50-4379-9864-a7c0fc7a869b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d4cbb61e-01d4-49d5-80f8-1f0389246f06" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_0687f8c4-0a50-4379-9864-a7c0fc7a869b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ec838ade-a70d-4145-978b-a4a80caece13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d4cbb61e-01d4-49d5-80f8-1f0389246f06" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ec838ade-a70d-4145-978b-a4a80caece13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_56c75cb8-b903-432f-9183-b4d6868ec564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_56c75cb8-b903-432f-9183-b4d6868ec564" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4d0c9199-c800-4fae-b0fd-e9a1331d0cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4d0c9199-c800-4fae-b0fd-e9a1331d0cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_08e6b22f-b660-4713-a3d7-6b796249416e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_08e6b22f-b660-4713-a3d7-6b796249416e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_3fa1d187-8693-4981-ad2c-deffe0004362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_3fa1d187-8693-4981-ad2c-deffe0004362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_504e20b3-89ec-47b1-bd05-92ce31664861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_504e20b3-89ec-47b1-bd05-92ce31664861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_5f2f0ae0-8110-4524-9a59-02e48ad72489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_5f2f0ae0-8110-4524-9a59-02e48ad72489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fd56a2c5-1436-4bb0-a662-89f6adf9b0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fd56a2c5-1436-4bb0-a662-89f6adf9b0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_2e9006a9-69a4-422c-ada1-9deadf46e364" xlink:href="mck-20210331.xsd#mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_2e9006a9-69a4-422c-ada1-9deadf46e364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_20381da3-5874-4677-a0aa-9cae44892b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_992d7241-4a40-41c1-b15a-6057c03c4b67" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_20381da3-5874-4677-a0aa-9cae44892b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_1c367354-3826-48c0-ae04-c61eab71bcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_5fefe180-d60d-46c0-aec1-035bc8301f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_1c367354-3826-48c0-ae04-c61eab71bcc4" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_5fefe180-d60d-46c0-aec1-035bc8301f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_fa220139-8cfd-4c43-be37-595d41449ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_cb83bfbf-4803-4614-9c80-2f43d32785a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_fa220139-8cfd-4c43-be37-595d41449ec1" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_cb83bfbf-4803-4614-9c80-2f43d32785a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_5209d2e3-de32-44fe-8bd5-39e746142723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_5209d2e3-de32-44fe-8bd5-39e746142723" xlink:to="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_36828319-7e0a-4746-8d39-3a380260aba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccab207a-c571-49cd-a1bd-39d6ee494595" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_36828319-7e0a-4746-8d39-3a380260aba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_827ba79f-3eb5-41d4-b3bd-dc3a670065fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_36828319-7e0a-4746-8d39-3a380260aba7" xlink:to="loc_us-gaap_SubsequentEventMember_827ba79f-3eb5-41d4-b3bd-dc3a670065fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_35e68d03-1a54-46be-b04c-2a5266633257" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2616afb1-08df-45f2-868d-6f64b3d84c5a" xlink:to="loc_dei_EntityDomain_35e68d03-1a54-46be-b04c-2a5266633257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_b86ef966-07c4-4775-ae73-d439f493a328" xlink:href="mck-20210331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_35e68d03-1a54-46be-b04c-2a5266633257" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_b86ef966-07c4-4775-ae73-d439f493a328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_a9a10394-8756-4220-98ad-d353b9bf699b" xlink:to="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_5e2fca2a-4b83-4e69-81f4-58fe03164f4c" xlink:href="mck-20210331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_5e2fca2a-4b83-4e69-81f4-58fe03164f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_706e00dd-3ebc-4218-8423-e4cbe13eecb2" xlink:href="mck-20210331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_f6c66155-16ba-48aa-8f74-3af902638eac" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_706e00dd-3ebc-4218-8423-e4cbe13eecb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_47a9586c-c6ca-4285-bb9c-c0fe5b4c2288" xlink:to="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_f6c2c453-d59b-4ca4-86a1-661df935ace7" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_f6c2c453-d59b-4ca4-86a1-661df935ace7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9c66f8aa-dd0f-4bef-8743-68be650600b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c066b3d-dabf-4513-b10c-bef934011d2c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9c66f8aa-dd0f-4bef-8743-68be650600b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_75b9ce85-125d-45f6-9517-db6d1f1e9d4f" xlink:to="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_ff3d32dd-7403-48b8-a963-60dbf8b57f65" xlink:href="mck-20210331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_ff3d32dd-7403-48b8-a963-60dbf8b57f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_a9b5fc8a-a92a-4b18-a373-5aa1ef359922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_a9b5fc8a-a92a-4b18-a373-5aa1ef359922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_bb35065a-3089-4880-9635-8a677227d642" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_bb35065a-3089-4880-9635-8a677227d642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_b4f3845a-50bd-4470-a76b-9b5386920adf" xlink:href="mck-20210331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_PutRightValueInterestRateSpread_b4f3845a-50bd-4470-a76b-9b5386920adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_1ae1609d-1abf-4571-b89c-9f3c79b1bf3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_1ae1609d-1abf-4571-b89c-9f3c79b1bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bcf0f385-665c-43f1-b72d-51ed54c399d3" xlink:href="mck-20210331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bcf0f385-665c-43f1-b72d-51ed54c399d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c22b2eb0-729f-4c03-b75e-de8964c90cbe" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c22b2eb0-729f-4c03-b75e-de8964c90cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f32ca133-c73e-4742-bd59-8c77a812b960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f32ca133-c73e-4742-bd59-8c77a812b960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_9d65c833-2d68-49ec-8f8e-c281710b1fac" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_9d65c833-2d68-49ec-8f8e-c281710b1fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_16f0e98c-6cfb-4af1-86c0-2dbbd76b8a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_16f0e98c-6cfb-4af1-86c0-2dbbd76b8a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_8cc58142-bc98-47f2-b1ed-8111b42cba43" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_8cc58142-bc98-47f2-b1ed-8111b42cba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_26876cba-f47a-4a58-8686-f65e70efa499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_MinorityInterest_26876cba-f47a-4a58-8686-f65e70efa499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4531cd64-fb96-4b65-b927-cf20b0602e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3eb23dd0-e1a8-4b06-9e99-29cbaacd33bd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4531cd64-fb96-4b65-b927-cf20b0602e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_47aeb074-78a5-40f7-8d4a-9e985521302b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_47aeb074-78a5-40f7-8d4a-9e985521302b" xlink:to="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_79915d23-b42e-443f-a746-bdfbe7192df7" xlink:to="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c0627543-7385-4835-8d28-3ea3718c10fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c0627543-7385-4835-8d28-3ea3718c10fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_33cd8ba3-cd30-49bb-ac5a-b19c00aa460c" xlink:href="mck-20210331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_584c0f9a-7c0e-497a-9aa9-f7637942b61e" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_33cd8ba3-cd30-49bb-ac5a-b19c00aa460c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_27e9f9ab-45a6-4bc3-852e-fdab069cbd77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_f6cdf3da-8004-41f1-a42c-5f97163e090b" xlink:to="loc_us-gaap_MinorityInterestLineItems_27e9f9ab-45a6-4bc3-852e-fdab069cbd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_27e9f9ab-45a6-4bc3-852e-fdab069cbd77" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d4b492fd-b503-49e2-9317-e14c1d5563d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_MinorityInterest_d4b492fd-b503-49e2-9317-e14c1d5563d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_abf6cf9a-19eb-4ae5-8e13-216b6cd78634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_abf6cf9a-19eb-4ae5-8e13-216b6cd78634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b74dd588-9ce2-4486-bd1a-52b7999f24d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b74dd588-9ce2-4486-bd1a-52b7999f24d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9bb1b6e9-fe68-4ae8-81c2-3107c620449b" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_9bb1b6e9-fe68-4ae8-81c2-3107c620449b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f8c47fc8-fca9-4a54-9465-065be5cc7ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_MinorityInterest_f8c47fc8-fca9-4a54-9465-065be5cc7ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_112391b3-14ef-4bdf-92a7-33b2bbfe9fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_112391b3-14ef-4bdf-92a7-33b2bbfe9fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_97495d5d-65a7-498e-95bb-011947157290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_97495d5d-65a7-498e-95bb-011947157290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_03dc9eb7-b98a-4ec8-96eb-ea4dd6f59f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_98d8504b-21cd-4b59-a835-de282cb77709" xlink:href="mck-20210331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_98d8504b-21cd-4b59-a835-de282cb77709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4523cda7-8688-48e4-9a69-0ad0783a7e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4523cda7-8688-48e4-9a69-0ad0783a7e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ea5af0ac-4581-49d8-9e8f-014c44f525f6" xlink:href="mck-20210331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_ea5af0ac-4581-49d8-9e8f-014c44f525f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e570b4bc-86e6-413a-af26-89bdaec0ce76" xlink:href="mck-20210331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e570b4bc-86e6-413a-af26-89bdaec0ce76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_9b9a70d0-cd80-4fe2-984b-bd74da7c26b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_82070e27-5e9e-4aee-9740-0c0f498459be" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_9b9a70d0-cd80-4fe2-984b-bd74da7c26b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_caf9fbe0-32e3-4131-b442-c9e52d60acae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a0437558-4f19-4f5e-ad21-2b090298e53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_caf9fbe0-32e3-4131-b442-c9e52d60acae" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a0437558-4f19-4f5e-ad21-2b090298e53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8730672a-96f3-49c3-862f-99f677548b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e1f7955b-a11b-49b6-8118-2e16138b48a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8730672a-96f3-49c3-862f-99f677548b59" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e1f7955b-a11b-49b6-8118-2e16138b48a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4264216e-1898-41a7-8123-9228525340cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4264216e-1898-41a7-8123-9228525340cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e65b9d5b-fb2c-47c5-ac8f-e0df92f3c0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e65b9d5b-fb2c-47c5-ac8f-e0df92f3c0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_2e8666d1-cd2a-4ed2-a9bf-61a03e9f2b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_2e8666d1-cd2a-4ed2-a9bf-61a03e9f2b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0e6f7706-8e31-435b-963c-5b1b5f717cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0e6f7706-8e31-435b-963c-5b1b5f717cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_264ad80f-8567-4a9a-96ce-cb2fa1b9a7a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_NetIncomeLoss_264ad80f-8567-4a9a-96ce-cb2fa1b9a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fd92ed3a-63c7-4dd3-bbac-003129cde202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fd92ed3a-63c7-4dd3-bbac-003129cde202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e7d21f6-ea2d-4cc7-94df-12c9adbb0f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fd92ed3a-63c7-4dd3-bbac-003129cde202" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e7d21f6-ea2d-4cc7-94df-12c9adbb0f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c492a134-f0a6-48a3-b846-af6b230bf9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c492a134-f0a6-48a3-b846-af6b230bf9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6d44fe4-4be1-4199-8c6a-db91dafcc6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6d44fe4-4be1-4199-8c6a-db91dafcc6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2acb0153-56b1-4ba8-a1b4-23abd229c934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0b55e578-2b5f-44e0-8731-e09b48f4be70" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2acb0153-56b1-4ba8-a1b4-23abd229c934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_fe3fdd9b-027a-4aa7-bb86-4cb8dc5d7bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2acb0153-56b1-4ba8-a1b4-23abd229c934" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_fe3fdd9b-027a-4aa7-bb86-4cb8dc5d7bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_fedbff87-35de-4ef6-8824-b1ec9a50c4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_fe3fdd9b-027a-4aa7-bb86-4cb8dc5d7bc1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_fedbff87-35de-4ef6-8824-b1ec9a50c4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_35859c77-6cfb-41a2-a17e-3a771736d723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_fe3fdd9b-027a-4aa7-bb86-4cb8dc5d7bc1" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_35859c77-6cfb-41a2-a17e-3a771736d723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d67bdb11-0533-4cfc-b0e0-3a99d834edc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_fe3fdd9b-027a-4aa7-bb86-4cb8dc5d7bc1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d67bdb11-0533-4cfc-b0e0-3a99d834edc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_e592b32e-6a32-4d99-9160-3ae721075389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2acb0153-56b1-4ba8-a1b4-23abd229c934" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_e592b32e-6a32-4d99-9160-3ae721075389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_26e51fcb-5874-44e8-ad42-34493193e4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e592b32e-6a32-4d99-9160-3ae721075389" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_26e51fcb-5874-44e8-ad42-34493193e4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f03c0cf4-adeb-4bab-bf92-3e9e429383c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e592b32e-6a32-4d99-9160-3ae721075389" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f03c0cf4-adeb-4bab-bf92-3e9e429383c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_91ca17db-2a4d-4c8f-9c99-24187c262449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e592b32e-6a32-4d99-9160-3ae721075389" xlink:to="loc_us-gaap_EarningsPerShareBasic_91ca17db-2a4d-4c8f-9c99-24187c262449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#EarningsperCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e07ae9cb-9d2d-4b8e-bcde-807ea7762bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bbf2d85a-57fc-4b40-b277-64bc91e9abb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e07ae9cb-9d2d-4b8e-bcde-807ea7762bb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bbf2d85a-57fc-4b40-b277-64bc91e9abb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/Leases" xlink:type="simple" xlink:href="mck-20210331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_0de1b4b7-cf5d-4fd0-9511-cfad2c79570f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_f9ad7b8c-dc29-42e5-910c-e36e52ceacdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_0de1b4b7-cf5d-4fd0-9511-cfad2c79570f" xlink:to="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_f9ad7b8c-dc29-42e5-910c-e36e52ceacdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_7dd56c83-8b80-4533-aef0-fd9595c7808c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_0de1b4b7-cf5d-4fd0-9511-cfad2c79570f" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_7dd56c83-8b80-4533-aef0-fd9595c7808c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3efeb44a-c7cf-4238-83fd-a65b82127448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_0de1b4b7-cf5d-4fd0-9511-cfad2c79570f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3efeb44a-c7cf-4238-83fd-a65b82127448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_6f36333e-bc90-4ecd-8a19-6e77f9f537b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock_f96d9bd5-a2de-496c-bc3f-5f5a637876aa" xlink:href="mck-20210331.xsd#mck_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_6f36333e-bc90-4ecd-8a19-6e77f9f537b1" xlink:to="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock_f96d9bd5-a2de-496c-bc3f-5f5a637876aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_8d2367e0-750f-4d0c-aaf8-3201ba9a22fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_6f36333e-bc90-4ecd-8a19-6e77f9f537b1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_8d2367e0-750f-4d0c-aaf8-3201ba9a22fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6f4d6127-2408-4af6-84e1-36ee373b5ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_6f36333e-bc90-4ecd-8a19-6e77f9f537b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6f4d6127-2408-4af6-84e1-36ee373b5ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9da83a87-d33f-44f8-85df-177fc2c14675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_6f36333e-bc90-4ecd-8a19-6e77f9f537b1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9da83a87-d33f-44f8-85df-177fc2c14675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_0e846c8c-105b-4a50-90f7-985075de38a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_0e846c8c-105b-4a50-90f7-985075de38a1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7107c0d8-5d3b-43f5-8cb7-cb946f069120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d4e7179b-9291-40bb-91b5-9d9c3effbf8c" xlink:to="loc_us-gaap_EquityComponentDomain_7107c0d8-5d3b-43f5-8cb7-cb946f069120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_05793058-e623-497d-a562-e3c98dc497f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7107c0d8-5d3b-43f5-8cb7-cb946f069120" xlink:to="loc_us-gaap_RetainedEarningsMember_05793058-e623-497d-a562-e3c98dc497f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f35c1bbd-15c7-4b85-b78f-ce3eb91bb407" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_15c9d0f6-db90-4da7-86a8-b6a0075c0cb1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f35c1bbd-15c7-4b85-b78f-ce3eb91bb407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34f43865-2c83-4cbe-a7ec-645789bdc8d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f35c1bbd-15c7-4b85-b78f-ce3eb91bb407" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_34f43865-2c83-4cbe-a7ec-645789bdc8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_44efb7f9-0212-4117-bf3a-40b983c21371" xlink:to="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cdda109e-0d80-4378-8ddf-74a17863093b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:to="loc_srt_MinimumMember_cdda109e-0d80-4378-8ddf-74a17863093b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6e713579-d4a5-4470-84bf-2b2ef0a4b5ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6631ede8-d802-4558-9ea4-6c06617ab311" xlink:to="loc_srt_MaximumMember_6e713579-d4a5-4470-84bf-2b2ef0a4b5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8e7334dd-a462-419f-84da-008827966c0f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_19d363b3-87ea-429e-848b-a1150fb9d6de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:to="loc_us-gaap_BuildingMember_19d363b3-87ea-429e-848b-a1150fb9d6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_87d25e74-11e4-4847-acaf-15ca0a1feb97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:to="loc_us-gaap_EquipmentMember_87d25e74-11e4-4847-acaf-15ca0a1feb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember_68d74acb-67cf-42c9-9436-b81fcb1da54e" xlink:href="mck-20210331.xsd#mck_RealPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1096bd1e-ff68-446f-ac15-61a529f4df5f" xlink:to="loc_mck_RealPropertyMember_68d74acb-67cf-42c9-9436-b81fcb1da54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b35995bc-d45b-4521-9731-c387b643e7e7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4b95ccb3-1bc8-45bf-aa1b-f63d0efad667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_OperatingLeaseLiability_4b95ccb3-1bc8-45bf-aa1b-f63d0efad667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_15e48107-7546-48af-9f4e-68bfc79afd64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_15e48107-7546-48af-9f4e-68bfc79afd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a608ac59-9753-4379-afd7-af36f5081ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a608ac59-9753-4379-afd7-af36f5081ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseImpairmentLossNetOfTax_87953e59-0e89-46dc-8ba6-74f23dcb83ab" xlink:href="mck-20210331.xsd#mck_OperatingLeaseImpairmentLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_OperatingLeaseImpairmentLossNetOfTax_87953e59-0e89-46dc-8ba6-74f23dcb83ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d1928642-71af-4990-822e-94c9cb9a0e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d1928642-71af-4990-822e-94c9cb9a0e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_802dbd70-5780-4309-9cfa-5073512d169a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_802dbd70-5780-4309-9cfa-5073512d169a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_f96265fa-5016-4fff-94b3-6ee2f1b2ada6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_f96265fa-5016-4fff-94b3-6ee2f1b2ada6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived_d5134380-0671-4c11-8ef9-8398828f74eb" xlink:href="mck-20210331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_LessorLeasePaymentstobeReceived_d5134380-0671-4c11-8ef9-8398828f74eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6170ab98-335e-4468-bcb3-cd0345a32832" xlink:href="mck-20210331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6170ab98-335e-4468-bcb3-cd0345a32832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_d8e2f33f-775d-4063-a090-731a09292444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_d8e2f33f-775d-4063-a090-731a09292444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_4a35c00d-b296-4bbb-b5cb-40ea45019e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_4a35c00d-b296-4bbb-b5cb-40ea45019e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_fedd4097-b1a1-4532-af6b-ae268211c902" xlink:href="mck-20210331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fba3ba08-0317-459b-a356-c55680efbe82" xlink:to="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_fedd4097-b1a1-4532-af6b-ae268211c902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesSupplementalbalancesheetinformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_43af9e53-ff8c-4c20-808a-51e8f6beb491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_43af9e53-ff8c-4c20-808a-51e8f6beb491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_30b1bbb4-0731-4d04-b4bd-f7f4b87d0142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_30b1bbb4-0731-4d04-b4bd-f7f4b87d0142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ad6ba11b-4362-40c0-844e-b94b579b1391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ad6ba11b-4362-40c0-844e-b94b579b1391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a160090c-1b62-4402-9d0b-00b80426dabc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_OperatingLeaseLiability_a160090c-1b62-4402-9d0b-00b80426dabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_05597a3f-52f3-4bbd-b483-d95bf587a65f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_05597a3f-52f3-4bbd-b483-d95bf587a65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f6d65372-1633-4b8a-81a8-f19e27c1af61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f6d65372-1633-4b8a-81a8-f19e27c1af61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_e232ed46-91c1-466e-8483-2e8f1cf1a77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_e232ed46-91c1-466e-8483-2e8f1cf1a77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e9da6803-754b-40bf-b74e-ccc813b5dc42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_FinanceLeaseLiability_e9da6803-754b-40bf-b74e-ccc813b5dc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a0bf1c4e-a00d-4dad-9e17-657b749ff334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a0bf1c4e-a00d-4dad-9e17-657b749ff334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b46cbbe0-c329-4758-b50c-6ae1ce325f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b46cbbe0-c329-4758-b50c-6ae1ce325f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39762fe0-830a-405c-8e7f-5d7c27b292ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39762fe0-830a-405c-8e7f-5d7c27b292ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7e270add-9a2f-4294-91dd-a8b528171e92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_091fbbd2-6d8a-4fa9-8079-ef3e742af7b0" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_7e270add-9a2f-4294-91dd-a8b528171e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4c3bd55f-1d1f-40cd-8ee9-56a17d42fc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_ShortTermLeaseCost_4c3bd55f-1d1f-40cd-8ee9-56a17d42fc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_21038cee-652f-401e-bc3b-fdb4b34e83b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_OperatingLeaseCost_21038cee-652f-401e-bc3b-fdb4b34e83b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2fedd342-7887-4fcb-88a8-26837527e126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2fedd342-7887-4fcb-88a8-26837527e126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_83285b77-8cd8-4c58-ac32-133487a3e8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_83285b77-8cd8-4c58-ac32-133487a3e8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_0d6da1cf-199d-4e43-b757-f67d461a04ef" xlink:href="mck-20210331.xsd#mck_FinanceLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_mck_FinanceLeaseCost_0d6da1cf-199d-4e43-b757-f67d461a04ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_c1687407-763f-4395-9df8-7c3b98104c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_VariableLeaseCost_c1687407-763f-4395-9df8-7c3b98104c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_1ce7f7f9-64d5-4c2d-ac2c-fec9a0ecbd56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_SubleaseIncome_1ce7f7f9-64d5-4c2d-ac2c-fec9a0ecbd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a84a2214-5468-4caf-9463-fcd94ba47af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ef2a803-f866-446b-a264-9cab724a1ff6" xlink:to="loc_us-gaap_LeaseCost_a84a2214-5468-4caf-9463-fcd94ba47af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesSupplementalcashflowinformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_258f7057-f310-49c8-a8b6-b292fae96d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_23b8e64b-2a4d-40e9-9f8e-d0e7e2fdebc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_258f7057-f310-49c8-a8b6-b292fae96d8c" xlink:to="loc_us-gaap_OperatingLeasePayments_23b8e64b-2a4d-40e9-9f8e-d0e7e2fdebc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_079c2b3c-b767-467c-ba27-d63766b7e6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_258f7057-f310-49c8-a8b6-b292fae96d8c" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_079c2b3c-b767-467c-ba27-d63766b7e6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_14c27768-e363-421a-865f-076af0884203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_258f7057-f310-49c8-a8b6-b292fae96d8c" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_14c27768-e363-421a-865f-076af0884203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c52c89b9-4b2f-4deb-9cfa-22222b15fc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_258f7057-f310-49c8-a8b6-b292fae96d8c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c52c89b9-4b2f-4deb-9cfa-22222b15fc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_04866708-9244-487a-88ec-9034af8a47ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_258f7057-f310-49c8-a8b6-b292fae96d8c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_04866708-9244-487a-88ec-9034af8a47ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fcdc22a5-9947-4b6c-a6df-89c5e3327008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fcdc22a5-9947-4b6c-a6df-89c5e3327008" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c464d434-2030-4095-bf3b-f7a563742f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c464d434-2030-4095-bf3b-f7a563742f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_60854c20-6ba4-433b-8fa1-a0de5f5477b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_60854c20-6ba4-433b-8fa1-a0de5f5477b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_576726fd-6fd1-4628-9a90-1e01b47438a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_576726fd-6fd1-4628-9a90-1e01b47438a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ec9a092f-b90b-4647-84af-e4284167c041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ec9a092f-b90b-4647-84af-e4284167c041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_700da91e-a88f-4bd1-812e-b39913546d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_700da91e-a88f-4bd1-812e-b39913546d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_593a5420-caa2-4162-81e6-2bd5f047de32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_593a5420-caa2-4162-81e6-2bd5f047de32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53ee5aa2-0d3f-417b-994f-62e2a2c55f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53ee5aa2-0d3f-417b-994f-62e2a2c55f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_67cc4515-b1e6-49d7-bd39-4311bb10a29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_67cc4515-b1e6-49d7-bd39-4311bb10a29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ee4964cf-0edb-403b-bfcb-43befcc1731c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_90ab9cb9-a420-4c75-a9ac-45e0dd824729" xlink:to="loc_us-gaap_OperatingLeaseLiability_ee4964cf-0edb-403b-bfcb-43befcc1731c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fcdc22a5-9947-4b6c-a6df-89c5e3327008" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a7f5b89b-794f-495b-ba98-58cc59e483d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a7f5b89b-794f-495b-ba98-58cc59e483d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5aacabde-96ce-457f-ab38-3eba707100b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5aacabde-96ce-457f-ab38-3eba707100b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_cd0eddab-20cc-4744-b8ec-f85b82f0c289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_cd0eddab-20cc-4744-b8ec-f85b82f0c289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_383677d6-04b9-40f5-873a-04a2696bf147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_383677d6-04b9-40f5-873a-04a2696bf147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_85988115-50af-4be9-bb0c-482df5636dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_85988115-50af-4be9-bb0c-482df5636dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_fe75c0b1-79a6-414e-a9a9-8d3e4183de1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_fe75c0b1-79a6-414e-a9a9-8d3e4183de1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e53a8ca-ffe0-483a-9263-61cbc214acc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e53a8ca-ffe0-483a-9263-61cbc214acc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_18a3545f-5079-4cda-9b18-a5228f37001f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_18a3545f-5079-4cda-9b18-a5228f37001f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2e2b4db9-35f5-455d-835c-62da6da1d679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_872946f6-3e21-4c8b-923b-70ea5ade3154" xlink:to="loc_us-gaap_FinanceLeaseLiability_2e2b4db9-35f5-455d-835c-62da6da1d679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:href="mck-20210331.xsd#mck_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fcdc22a5-9947-4b6c-a6df-89c5e3327008" xlink:to="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_8a7fc04a-9e46-4858-9ebe-a4158957bb0a" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_8a7fc04a-9e46-4858-9ebe-a4158957bb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_1267ea08-043a-40d1-a836-2106410c9b86" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearTwo_1267ea08-043a-40d1-a836-2106410c9b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_a3d8a199-fed4-4d3b-8bb7-68fd1fce9d7e" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearThree_a3d8a199-fed4-4d3b-8bb7-68fd1fce9d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_11e29379-c06b-48ec-80c0-e45bfa4d3757" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFour_11e29379-c06b-48ec-80c0-e45bfa4d3757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_c23bbebc-cc6b-4bd3-91ba-89fe3df0e5ea" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFive_c23bbebc-cc6b-4bd3-91ba-89fe3df0e5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_ebeeee5f-9642-4554-ac30-f204ac36c661" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_ebeeee5f-9642-4554-ac30-f204ac36c661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_e4651ab3-fe6b-42cb-877b-57c17e5449aa" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityPaymentsDue_e4651ab3-fe6b-42cb-877b-57c17e5449aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_2215ee8d-282d-4d2c-8766-231a06f4e170" xlink:href="mck-20210331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiabilityUndiscountedExcessAmount_2215ee8d-282d-4d2c-8766-231a06f4e170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_3ff7beb0-738e-48d7-968d-049fea1f0f7d" xlink:href="mck-20210331.xsd#mck_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_930f7d00-e4ae-4afb-bf88-64f7bcaa7ad5" xlink:to="loc_mck_LeaseLiability_3ff7beb0-738e-48d7-968d-049fea1f0f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="simple" xlink:href="mck-20210331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_2"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da799115-1e3c-44d0-ac90-2ee5d28b328e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e305ce1c-af20-4de1-873f-dec7d5befc77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da799115-1e3c-44d0-ac90-2ee5d28b328e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e305ce1c-af20-4de1-873f-dec7d5befc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7586b889-91af-40db-99df-ce76d12197a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_e0b5e75f-683c-4ac3-ba21-d1c52c097ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7586b889-91af-40db-99df-ce76d12197a3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_e0b5e75f-683c-4ac3-ba21-d1c52c097ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5409bd03-8365-4a63-9eef-b79f0423c525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7586b889-91af-40db-99df-ce76d12197a3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5409bd03-8365-4a63-9eef-b79f0423c525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bcc23996-6a85-439f-b642-4ef3cfa2b7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bcc23996-6a85-439f-b642-4ef3cfa2b7b5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4a2c355-d753-43f9-b770-3ede08321f02" xlink:to="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_bfc48387-434d-4fc2-857f-f1ef780a1b31" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_USPharmaceuticalSegmentMember_bfc48387-434d-4fc2-857f-f1ef780a1b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_3ca46f73-0d4b-4cae-8fa2-19e6b1958bfe" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_InternationalSegmentMember_3ca46f73-0d4b-4cae-8fa2-19e6b1958bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_87812f87-0f0a-486c-8f6e-30cf2afd297b" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_87812f87-0f0a-486c-8f6e-30cf2afd297b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e16702e6-4c08-439c-aec0-cb5ac95e9091" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf80cb67-26cb-417b-a9ee-55a7c4ac3ad4" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e16702e6-4c08-439c-aec0-cb5ac95e9091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_94dddefc-d63c-4d19-a21a-d94830dc3756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bdd1001a-02a3-44ce-9f6a-552937a0e9f4" xlink:to="loc_us-gaap_GoodwillLineItems_94dddefc-d63c-4d19-a21a-d94830dc3756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_94dddefc-d63c-4d19-a21a-d94830dc3756" xlink:to="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6e41f5ee-c229-456b-a5e0-c1128fea9ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_Goodwill_6e41f5ee-c229-456b-a5e0-c1128fea9ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6b177134-b9bc-4746-87e0-d20037655062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6b177134-b9bc-4746-87e0-d20037655062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5f71721c-8abe-4375-b2e0-c2bf2047d5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5f71721c-8abe-4375-b2e0-c2bf2047d5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_11879876-80a4-4c97-8aa9-2c23e11a3539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_11879876-80a4-4c97-8aa9-2c23e11a3539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d210d981-db85-4a0f-a35e-05d910333683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d210d981-db85-4a0f-a35e-05d910333683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b6a4be83-75db-4085-b16e-10684abfad85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_b6a4be83-75db-4085-b16e-10684abfad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa145ca7-d886-4c59-a19a-2f4215d0b1ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a727cde-a5be-4ebf-bca2-b1cc501f8de0" xlink:to="loc_us-gaap_Goodwill_aa145ca7-d886-4c59-a19a-2f4215d0b1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f506b655-be2d-412d-ab27-81f03ed76a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f506b655-be2d-412d-ab27-81f03ed76a7e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5202f990-e0f7-4c56-b96f-bf8694d73e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9684779c-d694-43ba-a1e4-7c6de31a1437" xlink:to="loc_us-gaap_SegmentDomain_5202f990-e0f7-4c56-b96f-bf8694d73e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_149d2719-0375-4554-8265-b702618a2521" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5202f990-e0f7-4c56-b96f-bf8694d73e1e" xlink:to="loc_mck_InternationalSegmentMember_149d2719-0375-4554-8265-b702618a2521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:to="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_c982e4f2-c706-4172-9c2f-7b44b1aaa293" xlink:to="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_709e2861-14f9-4f7c-bea3-87585088c14d" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember_709e2861-14f9-4f7c-bea3-87585088c14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_7cdd8b75-37a7-4fe7-84ec-c5ade3d1e366" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_7cdd8b75-37a7-4fe7-84ec-c5ade3d1e366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_35f85515-e641-467d-b77e-e79b2b427344" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember_35f85515-e641-467d-b77e-e79b2b427344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmaceuticalDistributionsReportingUnitMember_6bba534f-9ab4-4e7c-9c4a-75751e0f1af6" xlink:href="mck-20210331.xsd#mck_PharmaceuticalDistributionsReportingUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_PharmaceuticalDistributionsReportingUnitMember_6bba534f-9ab4-4e7c-9c4a-75751e0f1af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_11d84474-ca04-440a-b555-cac923849f0b" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1ccccd92-3144-4c31-aa23-bb4fa5a3a6e4" xlink:to="loc_mck_RexallHealthMember_11d84474-ca04-440a-b555-cac923849f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_0632f8e1-a4ff-403a-9d31-6604badabcd8" xlink:to="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_56ba21fd-4197-472f-a67f-e3fba6689b03" xlink:href="mck-20210331.xsd#mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate_56ba21fd-4197-472f-a67f-e3fba6689b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_2d966ea1-f2f9-4653-8f56-89d8c47b1c93" xlink:href="mck-20210331.xsd#mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate_2d966ea1-f2f9-4653-8f56-89d8c47b1c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_bb0fcf54-b320-4df3-a3e9-6ab0f221b640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_567f5158-f732-4c32-8bc6-a064a374939d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_bb0fcf54-b320-4df3-a3e9-6ab0f221b640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_76364b7b-0f9b-41c9-8d17-c95fcb8d6d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_76364b7b-0f9b-41c9-8d17-c95fcb8d6d46" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_098cc8e8-de20-4a6f-bd1c-2e83051c0d70" xlink:to="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_530af15c-b7c7-4a5c-9178-c0a3f51bddee" xlink:href="mck-20210331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_530af15c-b7c7-4a5c-9178-c0a3f51bddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_563c2f7b-1b7e-4a8b-8ce9-f16215d070db" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6f97f53c-eddb-4c69-a54a-033de875aaa5" xlink:to="loc_mck_RexallHealthMember_563c2f7b-1b7e-4a8b-8ce9-f16215d070db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4ebda52a-a6fe-4082-9894-b833ad32f114" xlink:to="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_d7e91cc6-b450-4d28-a08d-2bdf8e117e4c" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:to="loc_mck_InternationalSegmentMember_d7e91cc6-b450-4d28-a08d-2bdf8e117e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanPharmaceuticalSolutionsMember_c354b169-b1f9-4b32-a258-2f5bcb3870ab" xlink:href="mck-20210331.xsd#mck_EuropeanPharmaceuticalSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ba2bf5b9-821b-40a7-a1b5-6db7d37b5ab1" xlink:to="loc_mck_EuropeanPharmaceuticalSolutionsMember_c354b169-b1f9-4b32-a258-2f5bcb3870ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4a633b6a-42db-4f2f-ae34-62f160eaf167" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d9a520e3-89bd-49c3-8677-8a4272c896fb" xlink:to="loc_srt_SegmentGeographicalDomain_4a633b6a-42db-4f2f-ae34-62f160eaf167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_39ff0984-0fbc-42a5-8a8f-28bdd4859425" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4a633b6a-42db-4f2f-ae34-62f160eaf167" xlink:to="loc_srt_EuropeMember_39ff0984-0fbc-42a5-8a8f-28bdd4859425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e083fa9b-d133-40f6-939d-0eea354cd17d" xlink:to="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_36d00e4a-a023-40e4-ba1c-5c982056b74d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_NumberOfReportableSegments_36d00e4a-a023-40e4-ba1c-5c982056b74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_52c1aa12-3cfc-4b5b-84e1-0ec4484ef10b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_52c1aa12-3cfc-4b5b-84e1-0ec4484ef10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_243196a0-d93f-41cf-acdd-e463de99d777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_Goodwill_243196a0-d93f-41cf-acdd-e463de99d777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GoodwillImpairmentLossTax_46382db7-b192-4cf7-b5b6-d6e0e1dca7b1" xlink:href="mck-20210331.xsd#mck_GoodwillImpairmentLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_mck_GoodwillImpairmentLossTax_46382db7-b192-4cf7-b5b6-d6e0e1dca7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_535349e1-e4df-421a-8c46-feb1d8aac8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_NumberOfReportingUnits_535349e1-e4df-421a-8c46-feb1d8aac8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d4d7bbe1-8752-4bdd-b7a2-6140fdae33fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5ec916f6-8412-4c50-bb14-fba904d65975" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d4d7bbe1-8752-4bdd-b7a2-6140fdae33fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2704561d-fc6e-48f4-b195-f96c8fc7bbfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2704561d-fc6e-48f4-b195-f96c8fc7bbfc" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_05944082-4b80-419a-b776-53b29fcefb95" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a60de79a-2970-467d-a98d-24c9ae680bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a60de79a-2970-467d-a98d-24c9ae680bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_11a45994-92c2-438a-abb4-962b5d6d6a98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_ServiceAgreementsMember_11a45994-92c2-438a-abb4-962b5d6d6a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_85a7edd7-03bd-454f-88a2-0b13178dd732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_LicensingAgreementsMember_85a7edd7-03bd-454f-88a2-0b13178dd732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_ac141d09-4576-4a10-a64d-6ce45bc14a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_ac141d09-4576-4a10-a64d-6ce45bc14a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55373ac6-b2f8-4064-8c17-f17cb80f9ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_55373ac6-b2f8-4064-8c17-f17cb80f9ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_942c62a1-d935-4bd1-bfe1-7f1eee899e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_79d7b1c9-01bd-4c06-a2f6-0512ef9f1184" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_942c62a1-d935-4bd1-bfe1-7f1eee899e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1c5f3d86-af89-4352-b5a6-7592e423c4f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_94d3f7a0-8005-41f9-bf71-20a02847e6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_94d3f7a0-8005-41f9-bf71-20a02847e6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc550c82-6abc-4cce-8bd9-38b2edc8038e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dc550c82-6abc-4cce-8bd9-38b2edc8038e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e2426684-40f8-469b-95d9-f8885c3aa2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e2426684-40f8-469b-95d9-f8885c3aa2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b7e6ef99-8f31-4dff-a896-ca64d4b35f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_af86c17b-476c-4c0e-8166-b824da86ded9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b7e6ef99-8f31-4dff-a896-ca64d4b35f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_82dad59a-865b-4afa-a544-42a90c64d5c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_82dad59a-865b-4afa-a544-42a90c64d5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f466da31-a9b2-45a6-972b-266658b14363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f466da31-a9b2-45a6-972b-266658b14363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1dc47dea-63a2-4755-8e52-3506298fa770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1dc47dea-63a2-4755-8e52-3506298fa770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dd7746ae-c648-4efc-a5ee-88c62b8b575c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dd7746ae-c648-4efc-a5ee-88c62b8b575c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5fe6b98a-99a2-47b2-82fc-5661b51402da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5fe6b98a-99a2-47b2-82fc-5661b51402da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bf3ae45b-1d4b-4205-b41b-dafd30ef2f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bf3ae45b-1d4b-4205-b41b-dafd30ef2f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_261ee628-6fd6-494f-87f5-2b11eaa1dddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25765353-1a9e-45c0-b443-0bd910756b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_261ee628-6fd6-494f-87f5-2b11eaa1dddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_52f8c427-4f50-4dcd-bdb8-4777b72a028e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_67e03912-3236-4c62-ade5-c81e8f45326e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_52f8c427-4f50-4dcd-bdb8-4777b72a028e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_67e03912-3236-4c62-ade5-c81e8f45326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2b6dd822-f3b8-475b-9101-d857b67b6456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_7f4b8970-2711-446d-ad55-88dfe317356b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2b6dd822-f3b8-475b-9101-d857b67b6456" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_7f4b8970-2711-446d-ad55-88dfe317356b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2df18fc7-3d79-4244-830e-89be85bc862f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2df18fc7-3d79-4244-830e-89be85bc862f" xlink:to="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_38086372-f1a5-4547-bc95-160188a5adad" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_3aba9256-7cdf-450c-8cf2-2dabd7eb236c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:to="loc_us-gaap_LoansPayableMember_3aba9256-7cdf-450c-8cf2-2dabd7eb236c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember_14711825-d9cf-4e6e-94b4-7f3e5abd238b" xlink:href="mck-20210331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673aab1a-95a6-4d5b-9286-41c8a73fafdb" xlink:to="loc_mck_LeaseandOtherObligationsMember_14711825-d9cf-4e6e-94b4-7f3e5abd238b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:to="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_da87de8d-ba5c-4832-8098-a5107ecf3990" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_5c82f2f7-27c2-4a5f-80fe-f3e1a5b0b6ef" xlink:href="mck-20210331.xsd#mck_NotesDueNovember302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_NotesDueNovember302020Member_5c82f2f7-27c2-4a5f-80fe-f3e1a5b0b6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_0bbc1dbc-6c6a-4920-a64e-a87cd926f410" xlink:href="mck-20210331.xsd#mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_0bbc1dbc-6c6a-4920-a64e-a87cd926f410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_6def93b3-16eb-4392-98c9-a3f7994a5244" xlink:href="mck-20210331.xsd#mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember_6def93b3-16eb-4392-98c9-a3f7994a5244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_7b4c4700-4110-4a45-bea2-b8341d329854" xlink:href="mck-20210331.xsd#mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember_7b4c4700-4110-4a45-bea2-b8341d329854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_410cb05e-61cb-4a5e-aa80-8138bb083a0c" xlink:href="mck-20210331.xsd#mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember_410cb05e-61cb-4a5e-aa80-8138bb083a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_722cf562-e1bd-4f60-aca1-47788ef7f00a" xlink:href="mck-20210331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_A090NotesDueDecember32025Member_722cf562-e1bd-4f60-aca1-47788ef7f00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_8b4d279a-deff-47b2-9c01-fdd1a652d9b8" xlink:href="mck-20210331.xsd#mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_8b4d279a-deff-47b2-9c01-fdd1a652d9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_4efac4e9-318f-4419-b3ba-22aea715590d" xlink:href="mck-20210331.xsd#mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember_4efac4e9-318f-4419-b3ba-22aea715590d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueMay302029Member_d23fd81f-d7dd-4349-97a6-beba119849fe" xlink:href="mck-20210331.xsd#mck_NotesDueMay302029Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_NotesDueMay302029Member_d23fd81f-d7dd-4349-97a6-beba119849fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_fcfbbf09-a072-4bce-b0e8-3a27d0a6628c" xlink:href="mck-20210331.xsd#mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_fcfbbf09-a072-4bce-b0e8-3a27d0a6628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_eb767dab-c554-4db5-83ab-6cac0e27cb95" xlink:href="mck-20210331.xsd#mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_eb767dab-c554-4db5-83ab-6cac0e27cb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_747ecf96-fa94-4dcb-857d-923880ac3b5e" xlink:href="mck-20210331.xsd#mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember_747ecf96-fa94-4dcb-857d-923880ac3b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_bda4d51a-499f-4521-9b1c-2981f68076f4" xlink:href="mck-20210331.xsd#mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember_bda4d51a-499f-4521-9b1c-2981f68076f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_b707f999-abde-43d9-8474-059e2ffd5361" xlink:href="mck-20210331.xsd#mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember_b707f999-abde-43d9-8474-059e2ffd5361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_1341bc02-8e92-4870-853c-7f3fc22adc55" xlink:href="mck-20210331.xsd#mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b9f57358-7f94-47e2-b55b-d9679927a87c" xlink:to="loc_mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember_1341bc02-8e92-4870-853c-7f3fc22adc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14326de1-7397-4119-b62b-8057bac8e86f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5277bc69-ab44-4dba-84a6-383e64861f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5277bc69-ab44-4dba-84a6-383e64861f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f3ecb3d3-a9a5-442b-acd4-3c97e647595a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_LongTermDebt_f3ecb3d3-a9a5-442b-acd4-3c97e647595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c0fd7160-d202-47f1-860e-f809361abfc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c0fd7160-d202-47f1-860e-f809361abfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_38b2efd6-1fcc-44a7-a3bc-097c17600a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2df5306d-0e4c-4469-b52f-b6829ce07761" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_38b2efd6-1fcc-44a7-a3bc-097c17600a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_39dd8579-d6ca-4a12-8bd9-5299c2534a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_69e21134-2c60-412c-8835-4e27621ee168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_69e21134-2c60-412c-8835-4e27621ee168" xlink:to="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b879a831-4dbf-484f-a876-04042bc8fab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bbe6cbb9-2fe6-4f1a-bdfe-4721e6170606" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b879a831-4dbf-484f-a876-04042bc8fab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LongtermDebtCurrentMaturitiesMember_f7064ef8-6071-42e6-948f-3c8b40b0c6e8" xlink:href="mck-20210331.xsd#mck_LongtermDebtCurrentMaturitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b879a831-4dbf-484f-a876-04042bc8fab4" xlink:to="loc_mck_LongtermDebtCurrentMaturitiesMember_f7064ef8-6071-42e6-948f-3c8b40b0c6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e521623e-af07-4cf3-b611-e3076e35bd64" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_643a00ce-e2ad-42cf-ae31-8ad40ce5425f" xlink:href="mck-20210331.xsd#mck_NotesDueNovember302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_NotesDueNovember302020Member_643a00ce-e2ad-42cf-ae31-8ad40ce5425f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueMay302029Member_062e045a-e0cc-4472-b978-d1fa365996de" xlink:href="mck-20210331.xsd#mck_NotesDueMay302029Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_NotesDueMay302029Member_062e045a-e0cc-4472-b978-d1fa365996de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_f85706d1-c5bd-422f-a64d-6b72ff7fc56d" xlink:href="mck-20210331.xsd#mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember_f85706d1-c5bd-422f-a64d-6b72ff7fc56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_e6ac99ab-b6b5-445a-bbf5-83a7122b0a05" xlink:href="mck-20210331.xsd#mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember_e6ac99ab-b6b5-445a-bbf5-83a7122b0a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_10a1f1b7-a133-4d28-8a2d-da2a61ecb26e" xlink:href="mck-20210331.xsd#mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember_10a1f1b7-a133-4d28-8a2d-da2a61ecb26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_c59ff969-0732-48a3-b9a3-389c3b3d7686" xlink:href="mck-20210331.xsd#mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember_c59ff969-0732-48a3-b9a3-389c3b3d7686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_3f666abf-29fc-4d80-b4eb-616851007970" xlink:href="mck-20210331.xsd#mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_3f666abf-29fc-4d80-b4eb-616851007970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_f4a1749a-97d6-4aa3-ac8f-3bff0ea6878d" xlink:href="mck-20210331.xsd#mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember_f4a1749a-97d6-4aa3-ac8f-3bff0ea6878d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_eceb11a3-6728-400c-a0be-1ffe0e683425" xlink:href="mck-20210331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_A090NotesDueDecember32025Member_eceb11a3-6728-400c-a0be-1ffe0e683425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_ad758842-9724-473e-9a76-ad5f332eea72" xlink:href="mck-20210331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1e6233f9-5aa3-4d2d-8c0c-e36a70d34d77" xlink:to="loc_mck_A475NotesDueMarch12021Member_ad758842-9724-473e-9a76-ad5f332eea72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2cc7c026-1279-4697-82e8-9ad13b679969" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_6c28b995-5fee-4b16-9606-2b2830cf1808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_6c28b995-5fee-4b16-9606-2b2830cf1808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_0783f306-377d-4447-a815-0ab66f4a437f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16b1f42f-3709-4d62-9870-e5f34b9bb97b" xlink:to="loc_us-gaap_LoansPayableMember_0783f306-377d-4447-a815-0ab66f4a437f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3e8872b3-1210-40e7-8c42-d631fea13be5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_44c8c9cb-cef4-4b24-ab15-674ce3abcf2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebt_44c8c9cb-cef4-4b24-ab15-674ce3abcf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12192206-5502-4556-a85b-dfd108202153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12192206-5502-4556-a85b-dfd108202153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cb29d13a-9036-462d-be12-28e7cc24154d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cb29d13a-9036-462d-be12-28e7cc24154d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f23f3871-d0da-4ed7-b344-cb455d7760d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_f23f3871-d0da-4ed7-b344-cb455d7760d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f43f54a0-919e-4265-86b5-5f612f1ef0e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f43f54a0-919e-4265-86b5-5f612f1ef0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc9f66c8-f5f3-4777-a218-8c08df36ce1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cc9f66c8-f5f3-4777-a218-8c08df36ce1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_dc1a250a-b40c-45c7-ab3d-81e6615cccb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_dc1a250a-b40c-45c7-ab3d-81e6615cccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d5c985ab-d2d0-4a17-b92a-f0b0449a8532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d5c985ab-d2d0-4a17-b92a-f0b0449a8532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019a2bf2-350f-4bd8-b9f2-2feec0a517e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_019a2bf2-350f-4bd8-b9f2-2feec0a517e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_67bd53fe-9690-42ac-886f-b510182408d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_67bd53fe-9690-42ac-886f-b510182408d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c5cabdd5-9082-4df3-a26d-f2278c10ed06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c5cabdd5-9082-4df3-a26d-f2278c10ed06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_70f2a28d-e9dc-41af-ba77-64336fbe0f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b811d6b-805c-4a18-aa63-a8cc7cd320fd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_70f2a28d-e9dc-41af-ba77-64336fbe0f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_62a1e334-d4f0-46c7-9e7d-8b800bfcb4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_62a1e334-d4f0-46c7-9e7d-8b800bfcb4c4" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a820d81-d8da-43ce-ad69-3c2204cadecd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_61c9641c-bef2-48a8-91fb-752747b1382d" xlink:href="mck-20210331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_61c9641c-bef2-48a8-91fb-752747b1382d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_91149741-c6ef-486c-b1ca-9b438dfa82e2" xlink:href="mck-20210331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6693ea5-4c5d-4b52-94fd-320a2f06bcdd" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_91149741-c6ef-486c-b1ca-9b438dfa82e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c3259c3-53f2-49d5-b844-c535f094b218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_50a49137-bb4e-4d33-8303-d671a7eeadaf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c3259c3-53f2-49d5-b844-c535f094b218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_4feac82e-64f3-4378-a37d-32e517bea207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c3259c3-53f2-49d5-b844-c535f094b218" xlink:to="loc_us-gaap_UnsecuredDebtMember_4feac82e-64f3-4378-a37d-32e517bea207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c5e3e46b-ee2e-465a-8393-e0314dc7857e" xlink:to="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ecc7f1fc-95c4-429d-95bb-859508f062ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ecc7f1fc-95c4-429d-95bb-859508f062ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GlobalFacilityMember_02124203-cf9a-4959-b38a-adb1b62dad59" xlink:href="mck-20210331.xsd#mck_GlobalFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:to="loc_mck_GlobalFacilityMember_02124203-cf9a-4959-b38a-adb1b62dad59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_fa71f65b-3cbe-42a0-8106-714023286762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cba0af0a-cfee-4d67-a267-ea4d7bc5651c" xlink:to="loc_us-gaap_LineOfCreditMember_fa71f65b-3cbe-42a0-8106-714023286762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_0a8ced72-494f-4150-8799-c55f06a5f078" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5f6b3e-a38b-453b-8e56-76af5decab21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5f6b3e-a38b-453b-8e56-76af5decab21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_f4666285-b7c0-4172-a89e-0d186e9d7fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_DebtInstrumentTerm_f4666285-b7c0-4172-a89e-0d186e9d7fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_a1f2ea7b-7c47-4104-907a-f683ee9f3b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_a1f2ea7b-7c47-4104-907a-f683ee9f3b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9c482c9b-88f1-44c6-b62f-1c2a6658452c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCredit_9c482c9b-88f1-44c6-b62f-1c2a6658452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_1a224265-0312-43c9-a0b6-e7d6a743cbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_1a224265-0312-43c9-a0b6-e7d6a743cbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1333c951-3dde-4193-a595-83d3e3294ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_947acabb-1b44-458a-946f-4630e4e71b73" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1333c951-3dde-4193-a595-83d3e3294ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_877317c0-5aba-457d-b30e-e2be29bd25c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_877317c0-5aba-457d-b30e-e2be29bd25c3" xlink:to="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:to="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9ee8c1ad-6597-4fd3-93c8-5784f74f3ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3815e8cc-8b61-42bd-80da-c708c7f563ba" xlink:to="loc_us-gaap_CreditFacilityDomain_9ee8c1ad-6597-4fd3-93c8-5784f74f3ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e7614123-79a4-435f-86ff-cf4e9cbfda05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9ee8c1ad-6597-4fd3-93c8-5784f74f3ea4" xlink:to="loc_us-gaap_CommercialPaperMember_e7614123-79a4-435f-86ff-cf4e9cbfda05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7ad3ec3-8259-418e-bc1f-13cf979c8636" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03a1334b-8e53-4624-895e-b3c24bf6bbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_03a1334b-8e53-4624-895e-b3c24bf6bbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c732b7a2-1dc8-41d9-8e10-e78916cee849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_c732b7a2-1dc8-41d9-8e10-e78916cee849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_4d444394-1523-48da-bd3b-61150e65e6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_4d444394-1523-48da-bd3b-61150e65e6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a42491d9-38c4-40b1-913f-2eb628931350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8b78b34-a3f7-4eaa-8cb0-d3156a941e40" xlink:to="loc_us-gaap_LongTermDebt_a42491d9-38c4-40b1-913f-2eb628931350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="mck-20210331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_527a9da4-12ca-4b17-842e-39c3116e6c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_2988d5f6-8933-4ebc-8355-d94bb605c72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_527a9da4-12ca-4b17-842e-39c3116e6c3d" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_2988d5f6-8933-4ebc-8355-d94bb605c72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#VariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_78c2e8a5-4adf-4fde-8e03-8e1cb3e612e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_78c2e8a5-4adf-4fde-8e03-8e1cb3e612e2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5c7f8372-4fd2-4988-bac3-4e1dfbfae777" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_31d6977f-6780-46ea-b833-e79952a8c0ce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5c7f8372-4fd2-4988-bac3-4e1dfbfae777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_dfe87046-f644-4fb7-95d3-6b5e30182c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5c7f8372-4fd2-4988-bac3-4e1dfbfae777" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_dfe87046-f644-4fb7-95d3-6b5e30182c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_c82fc015-a068-42e3-bdb7-aa00a886b30f" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_959c4bd2-6aa9-4d1c-8fee-9f16b9e629a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_Assets_959c4bd2-6aa9-4d1c-8fee-9f16b9e629a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_017f29a7-2ff3-4ae9-ba54-acf7121539cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_Liabilities_017f29a7-2ff3-4ae9-ba54-acf7121539cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ef641fa2-a7b8-4036-ab96-ba98b21aace2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_fa177c62-8cae-4eec-b1e9-084990566295" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ef641fa2-a7b8-4036-ab96-ba98b21aace2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_24664b57-b801-4f45-9679-178e112ed6cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_49c58f3f-6a85-431c-b7dd-44acecf92961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_24664b57-b801-4f45-9679-178e112ed6cb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_49c58f3f-6a85-431c-b7dd-44acecf92961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_189d6108-5d0f-4f57-bd2d-b9243315d3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_189d6108-5d0f-4f57-bd2d-b9243315d3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_9d6c28e6-b741-4ba7-9b54-5900a0c36d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_9d6c28e6-b741-4ba7-9b54-5900a0c36d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_a207dd4a-0f72-43e9-ba92-c7c063f406e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_a207dd4a-0f72-43e9-ba92-c7c063f406e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_599336b3-4538-4e8b-b241-6e1b60721111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_599336b3-4538-4e8b-b241-6e1b60721111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_bddaee66-56f2-42c3-97ca-a4bff0f05658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_bddaee66-56f2-42c3-97ca-a4bff0f05658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_dedb1f04-df17-4d97-899c-d8ddc750e8ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_dedb1f04-df17-4d97-899c-d8ddc750e8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_8dfe5484-7047-469a-8e66-e39fe715594e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6ef32777-98f8-4358-acf7-7072e7f85166" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_8dfe5484-7047-469a-8e66-e39fe715594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_84d98569-b030-4e65-b599-f5246909aecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_84d98569-b030-4e65-b599-f5246909aecf" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_72c8d7c8-04c1-4d15-8b51-03c6c933d512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_4338dbac-1c6a-430b-b706-b4b4cb5a73de" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_72c8d7c8-04c1-4d15-8b51-03c6c933d512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_72c8d7c8-04c1-4d15-8b51-03c6c933d512" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_4f0d81de-6ed2-4c6e-a37f-c6b621d42928" xlink:href="mck-20210331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_4f0d81de-6ed2-4c6e-a37f-c6b621d42928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_671d1f76-e791-4de4-b1c4-ba252c819f04" xlink:href="mck-20210331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_84907e8c-a2e9-40b4-bb78-8870244d569f" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_671d1f76-e791-4de4-b1c4-ba252c819f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_801d9f43-223a-465c-93fb-036ee7452236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_817d963b-b202-474f-a372-03558aae7862" xlink:to="loc_us-gaap_RelatedPartyDomain_801d9f43-223a-465c-93fb-036ee7452236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_560955d5-f026-45c9-9ce9-881744e28d62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_801d9f43-223a-465c-93fb-036ee7452236" xlink:to="loc_srt_ExecutiveOfficerMember_560955d5-f026-45c9-9ce9-881744e28d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9b04a39e-4d4d-45eb-b7fe-3147ab6921a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ebd5b49a-7733-4594-9be8-457ecd3f2339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:to="loc_us-gaap_DomesticPlanMember_ebd5b49a-7733-4594-9be8-457ecd3f2339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1e4db7be-6fcc-4dea-b3db-8b38029ce64e" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_ebd5b49a-7733-4594-9be8-457ecd3f2339" xlink:to="loc_country_US_1e4db7be-6fcc-4dea-b3db-8b38029ce64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4364af51-a854-482f-b924-a7afc79f25dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_dcf61611-ba81-485e-800b-b2c15ec7bd20" xlink:to="loc_us-gaap_ForeignPlanMember_4364af51-a854-482f-b924-a7afc79f25dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fcc18d9d-c49a-4dc3-8ed8-11dc76c00d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_732c0cfc-8dc5-4f0c-9656-682d0912014b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fcc18d9d-c49a-4dc3-8ed8-11dc76c00d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b1f6d127-b7fa-49ac-8cab-a8f1c65b66a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fcc18d9d-c49a-4dc3-8ed8-11dc76c00d14" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b1f6d127-b7fa-49ac-8cab-a8f1c65b66a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_b128696d-0251-418c-bbe4-6e77bd97a583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_8bc85901-c99b-42a1-b46a-d194c10f5542" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_b128696d-0251-418c-bbe4-6e77bd97a583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_43f23b40-9ead-4ff1-b0f4-3a5a89f5d7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_b128696d-0251-418c-bbe4-6e77bd97a583" xlink:to="loc_us-gaap_UnfundedPlanMember_43f23b40-9ead-4ff1-b0f4-3a5a89f5d7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d2be7524-fbb1-4ea9-8e55-119d36cb8e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a0f30606-dd92-4eda-86e5-0d43ae53d6fe" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d2be7524-fbb1-4ea9-8e55-119d36cb8e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2be0fb91-e556-4143-94c1-d2c0179b7675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d2be7524-fbb1-4ea9-8e55-119d36cb8e3b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2be0fb91-e556-4143-94c1-d2c0179b7675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_aee89eaf-8d4b-4157-b49b-48702e30bd3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b591c238-b645-4ad6-8cc8-31df55cc6db1" xlink:to="loc_us-gaap_RetirementPlanNameDomain_aee89eaf-8d4b-4157-b49b-48702e30bd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember_c32f0562-abdb-4205-a73d-9e9ab3576b10" xlink:href="mck-20210331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_aee89eaf-8d4b-4157-b49b-48702e30bd3e" xlink:to="loc_mck_NorwegianPublicServicePensionFundSPKMember_c32f0562-abdb-4205-a73d-9e9ab3576b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:href="mck-20210331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_f575ad5c-21f5-4f1c-9b57-00db88b02a35" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember_d5f84925-326f-4c23-a5d9-81ae41f887f1" xlink:href="mck-20210331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:to="loc_mck_FirstPartOfPayContributionMember_d5f84925-326f-4c23-a5d9-81ae41f887f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember_0e55b5d6-eaff-4cb3-856e-1a47f414816e" xlink:href="mck-20210331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_d76e533f-fb87-4a6a-b839-623ae4fb01e3" xlink:to="loc_mck_SecondPartOfPayContributionMember_0e55b5d6-eaff-4cb3-856e-1a47f414816e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f4a4752-9afc-438d-93a2-046e43d31b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_75e98985-fada-4d03-9e5b-703089254d43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f4a4752-9afc-438d-93a2-046e43d31b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_8662d01b-65e3-492c-8e40-07f0c51b1159" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7f4a4752-9afc-438d-93a2-046e43d31b89" xlink:to="loc_mck_GermanWholesaleBusinessMember_8662d01b-65e3-492c-8e40-07f0c51b1159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2f928b58-e926-4aae-9077-84df56b62649" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_230edef6-991a-43e8-beaf-bb29f3aeb39f" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_230edef6-991a-43e8-beaf-bb29f3aeb39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_72bcd8c5-a6a1-4b26-905d-b10785c70794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_72bcd8c5-a6a1-4b26-905d-b10785c70794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_511fb23b-8104-44bc-b0b6-5f2315c1c031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_511fb23b-8104-44bc-b0b6-5f2315c1c031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_f4e9406d-ec90-4a8d-887a-69910ef22e2c" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_f4e9406d-ec90-4a8d-887a-69910ef22e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_00f1fc1c-f1ce-43c2-aab8-bcad639611db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_00f1fc1c-f1ce-43c2-aab8-bcad639611db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_33d9f615-c825-443f-8837-5a4e98e0eb5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_33d9f615-c825-443f-8837-5a4e98e0eb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_26cd9aed-b47f-4d88-b9af-f00cc81c0828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_26cd9aed-b47f-4d88-b9af-f00cc81c0828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_4473030c-3889-49da-9a92-0cdf0ceda8f3" xlink:href="mck-20210331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_4473030c-3889-49da-9a92-0cdf0ceda8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b22b2df4-67d4-4f43-b018-f5ffb5fb979b" xlink:href="mck-20210331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b22b2df4-67d4-4f43-b018-f5ffb5fb979b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_6e758f3a-0472-43db-907a-c7eb5bbe27e0" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_6e758f3a-0472-43db-907a-c7eb5bbe27e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_a4738c81-4977-4228-8bea-61c313f6e87b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_a4738c81-4977-4228-8bea-61c313f6e87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_53d12a13-3ea2-442d-84cc-c8bfe3d52bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_53d12a13-3ea2-442d-84cc-c8bfe3d52bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_f5f8eb82-1b84-4673-8fbf-7d6c91fb30f2" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_f5f8eb82-1b84-4673-8fbf-7d6c91fb30f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8c24f78a-a984-476f-8281-62887411fdd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8c24f78a-a984-476f-8281-62887411fdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_2382280e-fa4c-4b3d-a7c4-a0460d5b7f99" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_2382280e-fa4c-4b3d-a7c4-a0460d5b7f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_095201d9-797f-43f3-baaf-aa2a8091cedf" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation_095201d9-797f-43f3-baaf-aa2a8091cedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f7877b75-1f81-474d-9711-1b8c082d37d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f7877b75-1f81-474d-9711-1b8c082d37d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_b4c320d7-c882-485f-ad78-7aab2f50299a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_b4c320d7-c882-485f-ad78-7aab2f50299a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_519cb9d5-f5c3-4a27-89c4-e9cda29c0903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_519cb9d5-f5c3-4a27-89c4-e9cda29c0903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_824e1c78-7b2d-48d1-a42a-bead5ee50a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_824e1c78-7b2d-48d1-a42a-bead5ee50a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_68e412bc-9784-428a-9581-976bcf79b926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_68e412bc-9784-428a-9581-976bcf79b926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e3527a1d-be30-4456-adf3-f2942d2b4ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e3527a1d-be30-4456-adf3-f2942d2b4ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e145cdc-6b55-45a3-976e-53d85b76d950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e145cdc-6b55-45a3-976e-53d85b76d950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bb31cc39-6c5b-403f-b77d-722894dd2e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_bb31cc39-6c5b-403f-b77d-722894dd2e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7fe9e19c-532d-47b3-ada7-66682f5a974c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7fe9e19c-532d-47b3-ada7-66682f5a974c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_ccb88662-50c6-4389-a040-fa685719f540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_ccb88662-50c6-4389-a040-fa685719f540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_5068216a-574b-41da-aaa9-2344c25dcbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_5068216a-574b-41da-aaa9-2344c25dcbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_175ea172-68ef-421c-8393-91a4170854a6" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_175ea172-68ef-421c-8393-91a4170854a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents_3c4690ff-ead2-4648-b9ad-f533fefd02ef" xlink:href="mck-20210331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_UnitValueOfCashAndCashEquivalents_3c4690ff-ead2-4648-b9ad-f533fefd02ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_d7c82d17-9a07-4cac-b9d5-9e5e2e056594" xlink:href="mck-20210331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_d7c82d17-9a07-4cac-b9d5-9e5e2e056594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_fa29d77d-ab31-4f83-acc3-755f052fac3d" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_fa29d77d-ab31-4f83-acc3-755f052fac3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage_2ce087c9-d8ef-40a1-abbc-d58f0dfea91c" xlink:href="mck-20210331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_MultiemployerPlanFundedStatusPercentage_2ce087c9-d8ef-40a1-abbc-d58f0dfea91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_af5826db-56a6-45fc-bcdc-4e66117eb8a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_af5826db-56a6-45fc-bcdc-4e66117eb8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9f49adc5-f082-4a97-814d-a959a0bcf222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9f49adc5-f082-4a97-814d-a959a0bcf222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_bf3fd086-c40a-4d2c-bfc8-991cd8452a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_bf3fd086-c40a-4d2c-bfc8-991cd8452a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions_f062f2bc-8e83-4313-a900-40a47d057b09" xlink:href="mck-20210331.xsd#mck_EmployeeContributions"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_mck_EmployeeContributions_f062f2bc-8e83-4313-a900-40a47d057b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_7b63122d-0e99-4fa4-bd59-c5f23a1953bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c81e0c64-4da6-47bb-9a57-5a0249aecfb2" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_7b63122d-0e99-4fa4-bd59-c5f23a1953bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5041c391-f278-4e8d-a4bb-32a5aa1eb53d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5041c391-f278-4e8d-a4bb-32a5aa1eb53d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a0f7f302-d46b-41f2-be8a-da1ee01aaf98" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_b0f34b1b-c930-40cc-8b84-39e630715622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:to="loc_us-gaap_DomesticPlanMember_b0f34b1b-c930-40cc-8b84-39e630715622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1f8c9213-525a-4dff-bd84-d2987765b2b3" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_b0f34b1b-c930-40cc-8b84-39e630715622" xlink:to="loc_country_US_1f8c9213-525a-4dff-bd84-d2987765b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5279e5ef-4d89-428c-ac44-3af78b3f76c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce41988f-5c1f-4a70-9f78-bfce328ba3b1" xlink:to="loc_us-gaap_ForeignPlanMember_5279e5ef-4d89-428c-ac44-3af78b3f76c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ff936390-6476-4b0e-83a9-1b51333d86f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c2f30e7f-9164-4a66-94f5-9e69e89caab3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ff936390-6476-4b0e-83a9-1b51333d86f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d0e96435-e9ab-4305-beac-04ab0c1344c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ff936390-6476-4b0e-83a9-1b51333d86f5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d0e96435-e9ab-4305-beac-04ab0c1344c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_333540f7-42c3-4040-89d7-920cff00ecb2" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_cf786c92-e290-4b47-8d16-eec6d8bbfab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_cf786c92-e290-4b47-8d16-eec6d8bbfab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b712cef1-12c0-402b-8458-8296a9399f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b712cef1-12c0-402b-8458-8296a9399f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f75221e7-fabe-4923-8691-b006c01e5d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f75221e7-fabe-4923-8691-b006c01e5d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_f0158c2f-7fbb-49dd-99aa-3cda5b05b1b1" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_f0158c2f-7fbb-49dd-99aa-3cda5b05b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4d06b31e-3350-4eab-b5e0-fda7c9c9b5bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_4d06b31e-3350-4eab-b5e0-fda7c9c9b5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48537e01-57f9-4024-9c45-04dedeeca770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e42e6540-c011-4a2e-b6b7-52536628267e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48537e01-57f9-4024-9c45-04dedeeca770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6fbd3e63-d549-4761-b822-4affaded466d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6fbd3e63-d549-4761-b822-4affaded466d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c70c3137-3fb0-4239-bd86-e60affeb10c2" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ebc7cce5-fd58-4ac8-b71c-5aaf364d3edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:to="loc_us-gaap_DomesticPlanMember_ebc7cce5-fd58-4ac8-b71c-5aaf364d3edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e4c46f57-b72f-4079-8a26-31c441edd100" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_ebc7cce5-fd58-4ac8-b71c-5aaf364d3edc" xlink:to="loc_country_US_e4c46f57-b72f-4079-8a26-31c441edd100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_14a21d68-b43d-4c7f-a5d2-f99ca828d282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9eb19db3-9d82-4e10-a43a-23f60b6da4ad" xlink:to="loc_us-gaap_ForeignPlanMember_14a21d68-b43d-4c7f-a5d2-f99ca828d282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_edc8cefb-b3e1-4823-9ea5-458bae6771cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9038f5ee-9043-49f0-a8bf-ba7ecbd90fee" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_edc8cefb-b3e1-4823-9ea5-458bae6771cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_567718f8-d216-49b9-9fe1-936ec8202ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_edc8cefb-b3e1-4823-9ea5-458bae6771cb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_567718f8-d216-49b9-9fe1-936ec8202ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_889edae7-311e-40da-850f-e6d72c69784e" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_209771bf-de51-4dfb-96ed-f30866a67ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_209771bf-de51-4dfb-96ed-f30866a67ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_fc9d43a6-2cef-48c5-a2f6-c94e66328f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_fc9d43a6-2cef-48c5-a2f6-c94e66328f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_66813a72-4246-49bb-b04f-3cd11db3e71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_66813a72-4246-49bb-b04f-3cd11db3e71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5051a760-7095-4785-bce4-31a6a6b0db8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5051a760-7095-4785-bce4-31a6a6b0db8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c487a14f-521d-445a-abcb-76a6d1c26b92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c487a14f-521d-445a-abcb-76a6d1c26b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_a32b0704-c950-4933-9223-8e965805e76e" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer_a32b0704-c950-4933-9223-8e965805e76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_c92fb81e-4290-4c61-978a-5b406575f7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_c92fb81e-4290-4c61-978a-5b406575f7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_c0dd647e-b14d-4ac3-8244-0d7b2b8233ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_c0dd647e-b14d-4ac3-8244-0d7b2b8233ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_32213d3d-cc4c-4928-95a4-7ad584e85ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_32213d3d-cc4c-4928-95a4-7ad584e85ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_81e7990d-d3ca-433a-9d2a-981c65e55936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ca0e1d10-8ae4-4e27-9db5-32ad16c24f23" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_81e7990d-d3ca-433a-9d2a-981c65e55936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b870ea2c-fa0e-438c-bf0f-1501fedd7a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b870ea2c-fa0e-438c-bf0f-1501fedd7a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_8383d852-ca0f-4bd4-ab4a-a4840d8af484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_8383d852-ca0f-4bd4-ab4a-a4840d8af484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_69371b1d-e5b7-44dd-8a8b-880326d49933" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_69371b1d-e5b7-44dd-8a8b-880326d49933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0a463231-6610-4f03-8017-549a2cb69723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0a463231-6610-4f03-8017-549a2cb69723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_566107e4-a901-46f1-8e5a-26bdda68084b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_566107e4-a901-46f1-8e5a-26bdda68084b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_8ce68069-e725-45e2-8208-fb350f597add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_8ce68069-e725-45e2-8208-fb350f597add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5455f8bd-458d-4c42-ae2c-8726f104b93e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_163aa20a-81b4-4b27-b604-a97c14ee8119" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5455f8bd-458d-4c42-ae2c-8726f104b93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b7afc9af-cb99-4e76-a963-550d917b9bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b7afc9af-cb99-4e76-a963-550d917b9bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ac55faf-e014-44b3-bdc2-568576cacc17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_54604a5f-b402-428f-bd51-9a27266ca73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_54604a5f-b402-428f-bd51-9a27266ca73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ac477d6a-d8db-4633-a928-763d3cdf7b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ac477d6a-d8db-4633-a928-763d3cdf7b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_812c7490-b50f-45ad-84a8-9bcd2bf05201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_812c7490-b50f-45ad-84a8-9bcd2bf05201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_804b2014-6ce1-45f7-98a1-72598c79344f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_701286fd-9133-4e85-9cb9-741335a1eadb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_804b2014-6ce1-45f7-98a1-72598c79344f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cc8641d0-0d28-4f43-bfc3-c098a15df087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cc8641d0-0d28-4f43-bfc3-c098a15df087" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_201e0a0c-c1ec-404b-83fa-9b0a6d33c0d0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_6d421cc3-f3e3-472f-b0e3-2ba8d7f1ca8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:to="loc_us-gaap_DomesticPlanMember_6d421cc3-f3e3-472f-b0e3-2ba8d7f1ca8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_470fe3fd-d030-4de2-bbf2-1038a2a06c76" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_6d421cc3-f3e3-472f-b0e3-2ba8d7f1ca8a" xlink:to="loc_country_US_470fe3fd-d030-4de2-bbf2-1038a2a06c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_0d37081e-2d37-4140-8dd0-50ed403b3134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_156b6234-3d8e-49d3-a088-182b663fa86a" xlink:to="loc_us-gaap_ForeignPlanMember_0d37081e-2d37-4140-8dd0-50ed403b3134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_55a414eb-dbcf-4d98-b88f-5184763852b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c178d3d6-99ee-4da7-9a95-88589c5a6504" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_55a414eb-dbcf-4d98-b88f-5184763852b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_77a75716-6aa4-4a94-abda-7a1ddbba3d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_55a414eb-dbcf-4d98-b88f-5184763852b4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_77a75716-6aa4-4a94-abda-7a1ddbba3d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10a2a8ae-46f7-4784-a0e7-e9282c4bb494" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f90bae91-9d5a-439b-b1e3-54b8e5a2b42b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f90bae91-9d5a-439b-b1e3-54b8e5a2b42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6e4c01c-0e53-4963-aed9-d35c6b01045d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6e4c01c-0e53-4963-aed9-d35c6b01045d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7f836650-695f-42cb-babc-5c7aaea79759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fc712853-6c68-4839-9574-dea119befac1" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7f836650-695f-42cb-babc-5c7aaea79759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_058a9bda-b755-4f21-b2e2-4aaf18cdf4c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_058a9bda-b755-4f21-b2e2-4aaf18cdf4c7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_02ea23c2-a67c-4837-a6b6-c9a293cf0307" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_10abca43-2714-4094-a152-c097cae143b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:to="loc_us-gaap_DomesticPlanMember_10abca43-2714-4094-a152-c097cae143b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b4cf900-8e4b-44bd-8cc4-ca8cebcf448f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_10abca43-2714-4094-a152-c097cae143b0" xlink:to="loc_country_US_8b4cf900-8e4b-44bd-8cc4-ca8cebcf448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_74c69316-98c6-4bd8-a229-65afe64d7ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_784e80d6-1a19-4d0a-a52b-92f077e7a876" xlink:to="loc_us-gaap_ForeignPlanMember_74c69316-98c6-4bd8-a229-65afe64d7ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c1137520-e102-43ec-9c06-bee754c45fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_658bd375-14dd-4c45-96eb-ef5ec7bb7c42" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c1137520-e102-43ec-9c06-bee754c45fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a6acc9be-3642-4ce5-9872-3b49836bd945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_c1137520-e102-43ec-9c06-bee754c45fae" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a6acc9be-3642-4ce5-9872-3b49836bd945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_34ceea4b-a789-4e15-b80e-ea8794e24fec" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6a435b86-4e35-4e1b-a07c-f1f4a6a8578f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6a435b86-4e35-4e1b-a07c-f1f4a6a8578f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_249b7030-3421-4cee-a5ea-fc7d5a7938f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_249b7030-3421-4cee-a5ea-fc7d5a7938f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_49e21bc2-b36f-465f-9261-1ecb8db8d2db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_92361800-451c-48b3-bcd3-b7a200d61e61" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_49e21bc2-b36f-465f-9261-1ecb8db8d2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea83b2e9-88b2-40b0-892e-f1d42334e854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea83b2e9-88b2-40b0-892e-f1d42334e854" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_3b7a693a-d5c4-45b9-8528-439e4af53bf8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_9c70f546-acac-4a79-a3f8-8332bea31de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:to="loc_us-gaap_DomesticPlanMember_9c70f546-acac-4a79-a3f8-8332bea31de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_110ab4fb-f112-4ca6-813c-93a365bfbbef" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_9c70f546-acac-4a79-a3f8-8332bea31de7" xlink:to="loc_country_US_110ab4fb-f112-4ca6-813c-93a365bfbbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2801973d-737f-4633-a6b6-b903bd7a50aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a7a62000-1c22-444f-87a0-c5884d33802e" xlink:to="loc_us-gaap_ForeignPlanMember_2801973d-737f-4633-a6b6-b903bd7a50aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4b655309-4929-4c77-b1e1-c6a44e9f002d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b7bdcfb1-e918-4dc0-b15f-fd8ddeb6771c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4b655309-4929-4c77-b1e1-c6a44e9f002d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e310c7fb-1068-4d49-a956-c5534043c534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_4b655309-4929-4c77-b1e1-c6a44e9f002d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e310c7fb-1068-4d49-a956-c5534043c534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c0abdf4c-629f-4a64-976f-a87344203f71" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_956e56d3-be0d-4bfe-85a1-ae2a75771fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_956e56d3-be0d-4bfe-85a1-ae2a75771fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d4ec0252-d2aa-4043-bdd3-7c0f5447e0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d4ec0252-d2aa-4043-bdd3-7c0f5447e0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_96cd6553-8d8d-4914-86e9-d691f558f2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_7696b599-42ca-4111-af58-98c147f18613" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_96cd6553-8d8d-4914-86e9-d691f558f2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_4a632207-451a-4c61-bdc6-2ad3fc63a6d2" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_4a632207-451a-4c61-bdc6-2ad3fc63a6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c4137a63-beb4-4f23-900d-a2b4cca6b5b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e1dbc791-012a-44b6-abf1-8ae17e2efaa4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c4137a63-beb4-4f23-900d-a2b4cca6b5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d886d61-7688-4f41-aacf-8b822b236357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d886d61-7688-4f41-aacf-8b822b236357" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f9eee880-d0b0-4eba-9036-bdc25b5e81f9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_703d297a-4e6a-4c08-9310-5818a1ce6d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:to="loc_us-gaap_DomesticPlanMember_703d297a-4e6a-4c08-9310-5818a1ce6d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8fc9c4ba-26a0-404f-9046-606e47c2c32b" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_703d297a-4e6a-4c08-9310-5818a1ce6d34" xlink:to="loc_country_US_8fc9c4ba-26a0-404f-9046-606e47c2c32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4adf2018-d1ce-4742-90e9-60701aba24ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_84ec1e1d-7856-43ae-ad30-24ebf390f6ca" xlink:to="loc_us-gaap_ForeignPlanMember_4adf2018-d1ce-4742-90e9-60701aba24ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_50147aa2-cff1-40b6-8263-87471aa05244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4de348e7-7abc-4b02-a113-3838522c6caa" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_50147aa2-cff1-40b6-8263-87471aa05244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_16f5cf41-5d2f-467d-bc48-e2e75bed41c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_50147aa2-cff1-40b6-8263-87471aa05244" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_16f5cf41-5d2f-467d-bc48-e2e75bed41c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f72625a0-139d-45ca-b3a2-09e9f08f21fb" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b33bb4ac-632c-47c3-9f2c-12c1d7daa3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b33bb4ac-632c-47c3-9f2c-12c1d7daa3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_627bc1eb-93bf-406e-99f6-21b2497d2e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_627bc1eb-93bf-406e-99f6-21b2497d2e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_20f5f044-6e66-490b-a581-a805671458a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7d3c6c34-7fcb-42f4-b1a4-a92b253d4507" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_20f5f044-6e66-490b-a581-a805671458a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5834efad-a561-4a51-9182-898a0481f367" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_4feaf79d-8ee3-4b77-b524-32f0cebd8de7" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates_4feaf79d-8ee3-4b77-b524-32f0cebd8de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_1d4e56b0-b9cb-4b55-afbc-b052030c228b" xlink:href="mck-20210331.xsd#mck_BenefitObligationsAssumptionsRateIncreaseinCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0d7eefb1-edaa-4d1f-9ec2-dab39a83f08c" xlink:to="loc_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation_1d4e56b0-b9cb-4b55-afbc-b052030c228b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_85eb160d-8980-4f12-9481-ceca6955d53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_85eb160d-8980-4f12-9481-ceca6955d53b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f6bef6d4-8857-4899-8088-d347f9e261f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2c2c4baa-ea2b-4b7a-ac8d-31a337bf1723" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f6bef6d4-8857-4899-8088-d347f9e261f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_fc2b40be-56d3-4fe2-a852-edbd2cb7ed02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f6bef6d4-8857-4899-8088-d347f9e261f1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_fc2b40be-56d3-4fe2-a852-edbd2cb7ed02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_01d6e471-f53b-46f5-bb1a-a01112974d60" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_7af2b31e-ef8d-4133-9574-30afa36b24d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:to="loc_us-gaap_DomesticPlanMember_7af2b31e-ef8d-4133-9574-30afa36b24d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_908901b0-a5a9-4035-b453-bd2f77cf2b7c" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_7af2b31e-ef8d-4133-9574-30afa36b24d5" xlink:to="loc_country_US_908901b0-a5a9-4035-b453-bd2f77cf2b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_f5fb6b7d-b972-4619-bd29-bc4c2f3931e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5d7d2beb-ba42-4523-9946-733ba3cb9418" xlink:to="loc_us-gaap_ForeignPlanMember_f5fb6b7d-b972-4619-bd29-bc4c2f3931e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d267ea4b-9d28-4d63-a303-541d862b1f0e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_338e8d6f-3384-478d-9dc3-7dc84a62a28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_338e8d6f-3384-478d-9dc3-7dc84a62a28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_b3d0ff88-3a03-4f95-ae49-2836bcd89101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_MutualFundMember_b3d0ff88-3a03-4f95-ae49-2836bcd89101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_aa5172bd-56c2-40dc-8a06-a368be4b05bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_aa5172bd-56c2-40dc-8a06-a368be4b05bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_46e26c78-97db-4637-8c88-bbf90000c47c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_46e26c78-97db-4637-8c88-bbf90000c47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_e8c1e7e0-f178-4a50-949a-9bad8cc07fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_us-gaap_FixedIncomeFundsMember_e8c1e7e0-f178-4a50-949a-9bad8cc07fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember_2da0a1a8-edcb-4295-a327-431c3da89211" xlink:href="mck-20210331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_186218d1-ae5b-4b04-8fb2-f7679a2f222d" xlink:to="loc_mck_DefinedBenefitPlanOtherFundsMember_2da0a1a8-edcb-4295-a327-431c3da89211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3f72d2fa-646c-4942-866b-4d774fff0c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_94e4ad65-6403-4fc3-a092-6b28e563aeb7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3f72d2fa-646c-4942-866b-4d774fff0c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3f72d2fa-646c-4942-866b-4d774fff0c57" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6023c159-80a6-4da0-866a-f61faae06e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6023c159-80a6-4da0-866a-f61faae06e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67368135-effc-4856-879a-a88467b01bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_00976de2-08a4-4636-9282-847c0d8bed96" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67368135-effc-4856-879a-a88467b01bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3e0bf3bf-6ec2-4ff4-afaf-8c85e97e093c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_92a39321-616a-4263-9755-e02d08db6c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_92a39321-616a-4263-9755-e02d08db6c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_95f29f76-cf8a-4592-ac54-a886d6b78668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_95f29f76-cf8a-4592-ac54-a886d6b78668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f2dbd46d-1b4f-4ae3-96da-8008d015aefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d7968f6b-23da-4eb6-990e-e008ca12cd83" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f2dbd46d-1b4f-4ae3-96da-8008d015aefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_84d93abd-5980-4e22-9486-fe64ab65b9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d80e7d29-0052-45bd-838a-669a5da4cf9a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_84d93abd-5980-4e22-9486-fe64ab65b9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_15fcbce8-d73b-47a0-95e8-04f72e85621d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_84d93abd-5980-4e22-9486-fe64ab65b9e8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_15fcbce8-d73b-47a0-95e8-04f72e85621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#PensionBenefitsOtherPostretirementBenefitsPlanDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5d33627-d6b9-4a6e-b825-b45705947dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5d33627-d6b9-4a6e-b825-b45705947dac" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f1ffea07-7f6d-4280-8c5c-13c410b81956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_48fcb22e-a6b1-4301-a0fb-55b0ab777fed" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f1ffea07-7f6d-4280-8c5c-13c410b81956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9460704a-fc25-4a54-8863-5c5a749746c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f1ffea07-7f6d-4280-8c5c-13c410b81956" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9460704a-fc25-4a54-8863-5c5a749746c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_b4713553-0efd-46fe-bef0-d8ea2c1a169c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_74981789-09e6-4044-9435-203960043bf0" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_b4713553-0efd-46fe-bef0-d8ea2c1a169c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8a84f7cf-27ab-47dc-b650-c6078825a7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_b4713553-0efd-46fe-bef0-d8ea2c1a169c" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8a84f7cf-27ab-47dc-b650-c6078825a7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15de9be3-8b83-4137-96ae-ef20e3abc2cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ca5991d8-ae66-475c-bb00-d0b1a61dbf07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15de9be3-8b83-4137-96ae-ef20e3abc2cb" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ca5991d8-ae66-475c-bb00-d0b1a61dbf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2ab797f1-c286-4ef5-a2eb-06a62ea87088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_17c3ceea-c5f4-4e42-9fd8-285bfee28714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2ab797f1-c286-4ef5-a2eb-06a62ea87088" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_17c3ceea-c5f4-4e42-9fd8-285bfee28714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8e8093ef-aa78-464f-9ca8-f3fc27f66eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8e8093ef-aa78-464f-9ca8-f3fc27f66eb8" xlink:to="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_35e64f2a-2bc4-40a6-a636-ab9aee29093b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_e313fb02-c741-4980-a97b-169d4b58cb51" xlink:href="mck-20210331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:to="loc_mck_EuroDenominatedNotesMember_e313fb02-c741-4980-a97b-169d4b58cb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_496d0834-a7a4-4260-a4d2-27c57a99419d" xlink:href="mck-20210331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7160ebbf-535e-4460-a6fb-a228814e710a" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_496d0834-a7a4-4260-a4d2-27c57a99419d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ee42d16-4ec5-41e4-a46b-c2b70c5c8ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f8280172-c014-4d6d-bfeb-fbb07329f984" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ee42d16-4ec5-41e4-a46b-c2b70c5c8ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_be149ca0-ffcf-4d05-9ffd-7b615085ae7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ee42d16-4ec5-41e4-a46b-c2b70c5c8ba0" xlink:to="loc_us-gaap_LoansPayableMember_be149ca0-ffcf-4d05-9ffd-7b615085ae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2aef5e25-de80-42af-95d3-9b39633b769c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7a13deec-e223-4ac0-bab5-123e7b71829f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7a13deec-e223-4ac0-bab5-123e7b71829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_83adf0d0-486b-42f9-86b8-f2c141921341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6856fcef-6540-4ebe-88c2-0c3be3c5e452" xlink:to="loc_us-gaap_CashFlowHedgingMember_83adf0d0-486b-42f9-86b8-f2c141921341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_580b27a0-d865-48bd-816d-7ea23e0db3de" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_be284283-df1c-4a75-b6f6-0c4ad5857deb" xlink:href="mck-20210331.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_be284283-df1c-4a75-b6f6-0c4ad5857deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_3aacbf0f-c0c8-4b8b-96ca-f7c5b6f1aa92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_us-gaap_CurrencySwapMember_3aacbf0f-c0c8-4b8b-96ca-f7c5b6f1aa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractsandCrossCurrencySwapsMember_26d87589-cc84-4e3b-9a21-0bfadde7cb0c" xlink:href="mck-20210331.xsd#mck_ForwardContractsandCrossCurrencySwapsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_mck_ForwardContractsandCrossCurrencySwapsMember_26d87589-cc84-4e3b-9a21-0bfadde7cb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6d078902-2b8f-4b49-823a-942724d2e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6d078902-2b8f-4b49-823a-942724d2e36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_289d2cb0-e18d-40b4-bafb-528d866f2726" xlink:href="mck-20210331.xsd#mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_289d2cb0-e18d-40b4-bafb-528d866f2726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3fa8d28e-3c32-46ab-986b-0382ca02e9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5db7dea7-8f4b-4b52-8b4c-4fd03fc11632" xlink:to="loc_us-gaap_InterestRateSwapMember_3fa8d28e-3c32-46ab-986b-0382ca02e9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_70980040-c4c2-41ae-bb0e-e872dc235eee" xlink:to="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8de98357-1a1a-46ad-9bcf-97b39b62a489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8de98357-1a1a-46ad-9bcf-97b39b62a489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3fd68a1c-b5f2-49eb-ac3f-cdbfcb27735a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0e2ee74-0c5a-48aa-897e-bb620887b4cb" xlink:to="loc_us-gaap_NondesignatedMember_3fd68a1c-b5f2-49eb-ac3f-cdbfcb27735a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_993a00bf-3def-401c-9b92-6e3423175d13" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_c9a10bea-aa28-44f0-b0b4-007bbe94c214" xlink:to="loc_currency_AllCurrenciesDomain_993a00bf-3def-401c-9b92-6e3423175d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_61645b44-ee70-4a1c-8e71-486665b1282b" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_993a00bf-3def-401c-9b92-6e3423175d13" xlink:to="loc_currency_GBP_61645b44-ee70-4a1c-8e71-486665b1282b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b509fcb-3d58-4a78-aa3d-c9e5d1251d64" xlink:to="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1945ccd3-2134-4539-9155-365f6b7b879b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_LongTermDebt_1945ccd3-2134-4539-9155-365f6b7b879b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_fafcbb00-6b75-4606-a396-b5c72646cfb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_fafcbb00-6b75-4606-a396-b5c72646cfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_d386c2d8-b9d2-4fc7-98fb-baa51ec439ee" xlink:href="mck-20210331.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_d386c2d8-b9d2-4fc7-98fb-baa51ec439ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_79bc75d2-57af-4e6a-91e1-0ebc43ed10f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_DerivativeNotionalAmount_79bc75d2-57af-4e6a-91e1-0ebc43ed10f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerivativeNotionalAmountMatured_e93f2767-b3b7-4ad7-b92c-837f7d587625" xlink:href="mck-20210331.xsd#mck_DerivativeNotionalAmountMatured"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_mck_DerivativeNotionalAmountMatured_e93f2767-b3b7-4ad7-b92c-837f7d587625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_1b776496-4b02-454d-8f1d-176c67d1971c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_1b776496-4b02-454d-8f1d-176c67d1971c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_7f35b663-5add-40b7-a0c0-770cc9dea3b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_7f35b663-5add-40b7-a0c0-770cc9dea3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_90802cb5-c72b-4f72-bda9-5d9cd87552e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_90802cb5-c72b-4f72-bda9-5d9cd87552e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7771dc2a-4369-424c-8830-4b46efb26f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7771dc2a-4369-424c-8830-4b46efb26f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_5d827045-0662-4ea0-a260-b5e79e4b8756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_29c00395-bdbf-4a14-a411-202d52a41578" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_5d827045-0662-4ea0-a260-b5e79e4b8756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_95289ce0-ccb7-42a0-8dd2-191520463e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_95289ce0-ccb7-42a0-8dd2-191520463e0b" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d8d40c6e-e64e-4c89-a478-772cdb137699" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9abc8066-5af2-46c9-b553-0720c0c2456b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9abc8066-5af2-46c9-b553-0720c0c2456b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_c42244cb-c255-432d-8440-32d782ad651b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:to="loc_us-gaap_CurrencySwapMember_c42244cb-c255-432d-8440-32d782ad651b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8bc6e119-b6c5-477f-8aa8-b452130b2c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b22b2d56-bdf0-4cbb-b127-b989eb6eb33a" xlink:to="loc_us-gaap_InterestRateSwapMember_8bc6e119-b6c5-477f-8aa8-b452130b2c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_67e24649-9658-430f-8208-1086bba31485" xlink:to="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_482e7fe4-7e1a-4f8b-a61e-93e80c48c275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_482e7fe4-7e1a-4f8b-a61e-93e80c48c275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e7f168cc-dad3-446f-819a-640e96b492f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9d1fbe8f-7e4a-4318-970a-fe3dc6e72c2a" xlink:to="loc_us-gaap_NondesignatedMember_e7f168cc-dad3-446f-819a-640e96b492f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_639df897-917a-4113-80b5-5f117d9f5a38" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_325a300c-4b9b-4349-956f-1340d0337616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_325a300c-4b9b-4349-956f-1340d0337616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8e01b7c0-70f8-4d8f-8fb4-3e37067033be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8e01b7c0-70f8-4d8f-8fb4-3e37067033be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_8076533d-4e89-4b55-a0b6-c53a62b44712" xlink:href="mck-20210331.xsd#mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_8076533d-4e89-4b55-a0b6-c53a62b44712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_b6f623d1-b035-4bef-9148-02182d2015f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_b6f623d1-b035-4bef-9148-02182d2015f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2d4b54b9-1854-40c1-8341-79a067c0ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2d4b54b9-1854-40c1-8341-79a067c0ff09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d2e2ec58-b050-4750-9041-538de011b295" xlink:href="mck-20210331.xsd#mck_OtherNoncurrentAssetsLiabilitiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3ed75a22-21e4-4102-af7d-c04c93652137" xlink:to="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d2e2ec58-b050-4750-9041-538de011b295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e05de3ea-32cc-4c3b-94c5-74019eb3b4bd" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c6081155-057a-425e-bcde-db7e30f1742d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c6081155-057a-425e-bcde-db7e30f1742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1c0c079f-c59b-47ff-84ca-515f50f7900f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_1c0c079f-c59b-47ff-84ca-515f50f7900f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0d1a9ccf-37d9-4952-a35d-a4237de901a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0d1a9ccf-37d9-4952-a35d-a4237de901a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_05217163-dbc5-4d60-abe9-d07eea7d4cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_25a7fd14-38f3-447e-ab63-119566ea961d" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_05217163-dbc5-4d60-abe9-d07eea7d4cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3edffb24-538c-4833-a41e-0594eb2aebf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_3a226dec-8995-4e90-8a55-d463913d5a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3edffb24-538c-4833-a41e-0594eb2aebf7" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_3a226dec-8995-4e90-8a55-d463913d5a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_afc1a0d2-3069-4ded-b0b4-393f2962ae07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6895fd3e-667c-409d-b460-1d35699c0dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_afc1a0d2-3069-4ded-b0b4-393f2962ae07" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_6895fd3e-667c-409d-b460-1d35699c0dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bff086f8-be24-4e19-b2e4-8b6fcd985f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bff086f8-be24-4e19-b2e4-8b6fcd985f73" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_29b3c583-5511-468b-87bf-0b42d83b0530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6a22b3d-665b-4d29-917d-6ec2416da323" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_29b3c583-5511-468b-87bf-0b42d83b0530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_114ececf-d4e7-4996-ba54-aafdcf875144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_29b3c583-5511-468b-87bf-0b42d83b0530" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_114ececf-d4e7-4996-ba54-aafdcf875144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1b1b2ae8-a5e8-4c30-ab22-35fd5b217d69" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e5e91181-90a4-4416-b4ca-1c3c3d33d644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_e5e91181-90a4-4416-b4ca-1c3c3d33d644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a8425058-c1c9-4f4b-b376-6068d91e8607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a8425058-c1c9-4f4b-b376-6068d91e8607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d6a774b5-c2d5-4dee-b9a9-b70d3c4e1a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d6a774b5-c2d5-4dee-b9a9-b70d3c4e1a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2cb6614d-136b-4ea4-9d0a-efb56c2a8e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_2cb6614d-136b-4ea4-9d0a-efb56c2a8e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9dfedbb6-2153-42ff-a990-933e4b78c135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07f92101-c81c-4c32-ade9-daecf37b31c6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9dfedbb6-2153-42ff-a990-933e4b78c135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_777d90d7-ce3d-4135-85a8-15a2e75c1108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_777d90d7-ce3d-4135-85a8-15a2e75c1108" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d2411946-8916-4555-9f3f-12ea1758d452" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7b491895-34cf-4704-891c-be3e3cf7138e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7b491895-34cf-4704-891c-be3e3cf7138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9e2a855b-5eff-493c-b149-96d4dacdac1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_9e2a855b-5eff-493c-b149-96d4dacdac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_685e1e64-9da7-4ff5-b138-2af69b530997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_9bfa2aa0-781b-424c-b956-fc65357f2846" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_685e1e64-9da7-4ff5-b138-2af69b530997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_049cb9c5-0cf4-4901-bd4f-6d3f56ae0dce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81d2d969-4cbb-4382-a007-ae4de6f1d5fd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_049cb9c5-0cf4-4901-bd4f-6d3f56ae0dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1063b780-3e07-408c-b117-5ac6411373c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_049cb9c5-0cf4-4901-bd4f-6d3f56ae0dce" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1063b780-3e07-408c-b117-5ac6411373c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="simple" xlink:href="mck-20210331.xsd#FinancialGuaranteesandWarranties"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_7d16773a-2629-4c6d-a76d-525383c87104" xlink:href="mck-20210331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock_a9c30ff1-c3f4-4fde-b7bc-3eaa08a57b51" xlink:href="mck-20210331.xsd#mck_FinancialGuaranteesAndWarrantiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_7d16773a-2629-4c6d-a76d-525383c87104" xlink:to="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock_a9c30ff1-c3f4-4fde-b7bc-3eaa08a57b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_6e0af435-1a84-48a1-9a13-844e8fa9da6a" xlink:href="mck-20210331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_6e0af435-1a84-48a1-9a13-844e8fa9da6a" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:to="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f3ab0124-558f-4bc8-a148-c32dae7beda4" xlink:to="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_abf1cea6-c06a-46bc-8586-fac7b66eb412" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:to="loc_srt_MinimumMember_abf1cea6-c06a-46bc-8586-fac7b66eb412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5a84c3c6-aff3-46c2-8919-11536b0660ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0ccaf8dc-a49c-46ad-b454-f7da216c2693" xlink:to="loc_srt_MaximumMember_5a84c3c6-aff3-46c2-8919-11536b0660ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_f0b9be75-fd01-427e-9763-621a99784ef7" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_a75f0201-1e3d-453f-9522-abdf90e000ff" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:to="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_a75f0201-1e3d-453f-9522-abdf90e000ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember_09e99562-6bc1-4fdf-a57f-2d6697387cb5" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:to="loc_mck_GuaranteeObligationsCustomersDebtMember_09e99562-6bc1-4fdf-a57f-2d6697387cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_327b1153-a919-4ca1-a6fe-13c17e1dae7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_54ae282c-7374-4c0d-9329-22ad8f88ea7d" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_327b1153-a919-4ca1-a6fe-13c17e1dae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_d76ddfb9-adbe-4c7a-90f7-93eb93d22c45" xlink:to="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod_ead11098-047d-4a1b-8cde-369a8b289ca8" xlink:href="mck-20210331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuarantorObligationsPeriod_ead11098-047d-4a1b-8cde-369a8b289ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_a277ca83-a2d3-4011-b36a-192dea07109d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_a277ca83-a2d3-4011-b36a-192dea07109d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_cedd072a-8965-482a-a5a6-169ceb710eab" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_cedd072a-8965-482a-a5a6-169ceb710eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_2bda36c4-e572-406a-a121-17e4855e0d68" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_2bda36c4-e572-406a-a121-17e4855e0d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_ad003901-1eb8-4929-b577-3e62eb754b51" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_ad003901-1eb8-4929-b577-3e62eb754b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8fa53027-3c69-49ab-90bb-2028bca5d253" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8fa53027-3c69-49ab-90bb-2028bca5d253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_6aa0aa87-dade-4d37-a975-db7094c063e1" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_6aa0aa87-dade-4d37-a975-db7094c063e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_7d1367e1-ae08-470f-abd6-892b83a33526" xlink:href="mck-20210331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_7d1367e1-ae08-470f-abd6-892b83a33526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_9ab60e5b-068c-497c-83d2-b4b2147d2343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_1aed2474-6f5b-4ce2-9766-09b9bf7310a6" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_9ab60e5b-068c-497c-83d2-b4b2147d2343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20210331.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75646964-a97c-49c1-be9b-31fcde480a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2bbf3922-9c2a-443a-9f28-93591848d2d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75646964-a97c-49c1-be9b-31fcde480a21" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2bbf3922-9c2a-443a-9f28-93591848d2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_84153023-5b36-496e-baf8-c0dd5f70b3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_84153023-5b36-496e-baf8-c0dd5f70b3a6" xlink:to="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4a1c3bfb-d910-49f5-ac90-a0ea94c561e9" xlink:to="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InreNationalPrescriptionOpiateLitigationMember_45d81829-f841-4c52-890e-955dbe1f3edb" xlink:href="mck-20210331.xsd#mck_InreNationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_InreNationalPrescriptionOpiateLitigationMember_45d81829-f841-4c52-890e-955dbe1f3edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_eabe78cf-fe73-4ec4-816d-618091b296f6" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_eabe78cf-fe73-4ec4-816d-618091b296f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_f1d3ca80-135c-4fe3-bf99-c5a85da5b7f9" xlink:href="mck-20210331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_f1d3ca80-135c-4fe3-bf99-c5a85da5b7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember_9b4be514-2122-480d-94db-383d9e3b7c0f" xlink:href="mck-20210331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_InsuranceCoverageLitigationMember_9b4be514-2122-480d-94db-383d9e3b7c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_fc17a3f3-0019-4857-895a-efb23b6ac5aa" xlink:href="mck-20210331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_fc17a3f3-0019-4857-895a-efb23b6ac5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_be3ba2bc-553a-476c-91ce-56fc3d5379b9" xlink:href="mck-20210331.xsd#mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_be3ba2bc-553a-476c-91ce-56fc3d5379b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_c55b7e93-e8da-44aa-91be-73b0de48a514" xlink:href="mck-20210331.xsd#mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember_c55b7e93-e8da-44aa-91be-73b0de48a514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_a6613fcc-c56b-4bd4-a209-298e4eaa9d28" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member_a6613fcc-c56b-4bd4-a209-298e4eaa9d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_2bbc97d0-8dbe-498b-ad53-9ab99bb3596e" xlink:href="mck-20210331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_2bbc97d0-8dbe-498b-ad53-9ab99bb3596e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_93e0f080-b9e0-460c-aa6c-d027ce9b6ae6" xlink:href="mck-20210331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_93e0f080-b9e0-460c-aa6c-d027ce9b6ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_c178809c-1c41-4c7c-af1c-74d3ad72a3f9" xlink:href="mck-20210331.xsd#mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_c178809c-1c41-4c7c-af1c-74d3ad72a3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_6695c753-e012-4838-a02b-858b6327fcc6" xlink:href="mck-20210331.xsd#mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_6695c753-e012-4838-a02b-858b6327fcc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_b2e04d33-e0eb-4a28-b851-476678e65503" xlink:href="mck-20210331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_b2e04d33-e0eb-4a28-b851-476678e65503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_c41267a8-8639-40a5-b91c-6873bbf301e5" xlink:href="mck-20210331.xsd#mck_ConsolidatedActionsvSureScriptsLLCMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_c41267a8-8639-40a5-b91c-6873bbf301e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_bba79b3d-1466-46d5-9ab0-a552275e6417" xlink:href="mck-20210331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_bba79b3d-1466-46d5-9ab0-a552275e6417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_7954e878-a083-48d3-b1cf-8ba71edc2004" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f8c12eca-f7b8-4dbb-84b0-24ac97b98cbc" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_7954e878-a083-48d3-b1cf-8ba71edc2004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5b05614d-31bd-42fd-8b57-c8f143c0dbff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_aff773d3-0e90-4a51-a24c-4a5e41f7cc8f" xlink:to="loc_us-gaap_LitigationStatusDomain_5b05614d-31bd-42fd-8b57-c8f143c0dbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_b415cb42-8df7-421f-a06a-1494cc76db2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5b05614d-31bd-42fd-8b57-c8f143c0dbff" xlink:to="loc_us-gaap_PendingLitigationMember_b415cb42-8df7-421f-a06a-1494cc76db2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e6d353b5-3da5-40e2-956f-060b7d817c30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6a9f8bb3-56d4-414b-9a57-11dfb5bd80fd" xlink:to="loc_srt_SegmentGeographicalDomain_e6d353b5-3da5-40e2-956f-060b7d817c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_9d380178-adfb-4047-b24e-33f81e727b63" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e6d353b5-3da5-40e2-956f-060b7d817c30" xlink:to="loc_country_CA_9d380178-adfb-4047-b24e-33f81e727b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_204d7cf9-8da3-4dcc-be2f-158ce782ea8d" xlink:to="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_7b01ddeb-7068-4931-bdcf-6c7d335c1168" xlink:href="mck-20210331.xsd#mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember_7b01ddeb-7068-4931-bdcf-6c7d335c1168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_9f36c296-7b9a-4a9d-96f9-7a927dc16b69" xlink:href="mck-20210331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_9f36c296-7b9a-4a9d-96f9-7a927dc16b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember_c20f4105-3b72-4b00-936d-63f3b4a2b55f" xlink:href="mck-20210331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_EnvironmentalLitigationMember_c20f4105-3b72-4b00-936d-63f3b4a2b55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_1e108364-b138-402a-9627-482eb77d4101" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_021308d0-3adf-4cce-8d7e-004e04e2e427" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_1e108364-b138-402a-9627-482eb77d4101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6f82b31e-1b05-4467-a0bb-04f1d2bef12c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c8673f54-6eff-409a-bd7b-0238b821d084" xlink:to="loc_dei_EntityDomain_6f82b31e-1b05-4467-a0bb-04f1d2bef12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_23aeff90-4a23-4eb6-a54b-53fbedd2ddbc" xlink:href="mck-20210331.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6f82b31e-1b05-4467-a0bb-04f1d2bef12c" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_23aeff90-4a23-4eb6-a54b-53fbedd2ddbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_be02efb5-bd20-43b9-bf98-27827b32c44c" xlink:to="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aa4a0b63-bd5a-47fd-befc-72d9b5194b20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:to="loc_srt_MinimumMember_aa4a0b63-bd5a-47fd-befc-72d9b5194b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_533a6b03-fe87-4475-a9de-dbf4c676aeb6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61ba72d4-fc51-4b52-b01f-ecbbcb0c7e41" xlink:to="loc_srt_MaximumMember_533a6b03-fe87-4475-a9de-dbf4c676aeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_68df67c9-a031-4edb-912a-6de4567ff05a" xlink:to="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_3deee4e2-cbef-4be4-858f-ce2f7005953c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_3deee4e2-cbef-4be4-858f-ce2f7005953c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_94e77d08-e303-46c3-ab4d-4934fdd1925a" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_94e77d08-e303-46c3-ab4d-4934fdd1925a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_43c68f03-7c76-4a7d-a965-08a42dd79bf8" xlink:href="mck-20210331.xsd#mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges_43c68f03-7c76-4a7d-a965-08a42dd79bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_37be33cc-afcf-4489-8aa1-1102438c80b3" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_37be33cc-afcf-4489-8aa1-1102438c80b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_8261a5dc-eaab-41dc-8215-1007313481a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_8261a5dc-eaab-41dc-8215-1007313481a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCounties_fad8599c-60d1-4ee9-8cdc-3f1666d6d025" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCounties"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofCounties_fad8599c-60d1-4ee9-8cdc-3f1666d6d025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0eaff357-0d6a-434f-b16c-c789019b855c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0eaff357-0d6a-434f-b16c-c789019b855c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_60f0c25f-4d13-4cc9-8201-37894bd1f9b0" xlink:href="mck-20210331.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_60f0c25f-4d13-4cc9-8201-37894bd1f9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_8250e8ca-2f01-496c-8f23-7898ff89df50" xlink:href="mck-20210331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation_8250e8ca-2f01-496c-8f23-7898ff89df50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_88518d96-cb85-4d80-91af-1923b2cbdc28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_88518d96-cb85-4d80-91af-1923b2cbdc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax_007f3f4c-8bc8-40d1-91d2-e4aa1fc7fd42" xlink:href="mck-20210331.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyAccrualProvisionAfterTax_007f3f4c-8bc8-40d1-91d2-e4aa1fc7fd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_e9693190-850a-4a37-83ef-ac04b43a39d8" xlink:href="mck-20210331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_e9693190-850a-4a37-83ef-ac04b43a39d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators_01ab76f8-96a3-40d3-928f-286a5ab5512e" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofRelators_01ab76f8-96a3-40d3-928f-286a5ab5512e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_3baebbd5-a32c-4edd-b12e-6e60378a36d2" xlink:href="mck-20210331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_3baebbd5-a32c-4edd-b12e-6e60378a36d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_a6d11cad-c6ea-4827-8cdb-3e827270788d" xlink:href="mck-20210331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_a6d11cad-c6ea-4827-8cdb-3e827270788d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_a91cb243-3105-46e5-a405-c82f9fccbcde" xlink:href="mck-20210331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_a91cb243-3105-46e5-a405-c82f9fccbcde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofAdditionalDefendants_a1a16b89-a26b-48d9-b146-0560b3b8da4b" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofAdditionalDefendants"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofAdditionalDefendants_a1a16b89-a26b-48d9-b146-0560b3b8da4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_19398f52-6a51-42f4-bfcd-91925eb8d81d" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofCitiesFiledOnBehalfOf"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_19398f52-6a51-42f4-bfcd-91925eb8d81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers_41880ebd-b48c-4ed7-9e5e-d4ad3e46664a" xlink:href="mck-20210331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_LossContingencyNumberofFormerOfficers_41880ebd-b48c-4ed7-9e5e-d4ad3e46664a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts_c8890e8e-e774-48e9-92e0-831d536af5ad" xlink:href="mck-20210331.xsd#mck_NumberofSoftwareProducts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_NumberofSoftwareProducts_c8890e8e-e774-48e9-92e0-831d536af5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_d5abb537-bd0b-4835-b03a-0381da4c5b63" xlink:href="mck-20210331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_d5abb537-bd0b-4835-b03a-0381da4c5b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SiteContingencyNumberofSites_06457688-80a2-46db-8f68-b6a97dc483ae" xlink:href="mck-20210331.xsd#mck_SiteContingencyNumberofSites"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_SiteContingencyNumberofSites_06457688-80a2-46db-8f68-b6a97dc483ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_0d6084cd-8796-435e-8cce-bc1d1adb54f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesGross"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_0d6084cd-8796-435e-8cce-bc1d1adb54f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SiteContingencyTimeFrameOfDisbursements_132e43a6-932f-4df1-9077-f441498d3364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SiteContingencyTimeFrameOfDisbursements"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_SiteContingencyTimeFrameOfDisbursements_132e43a6-932f-4df1-9077-f441498d3364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites_029be12d-f3f6-4d1e-8d81-58877d4b93cb" xlink:href="mck-20210331.xsd#mck_HazardousSubstanceSites"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_HazardousSubstanceSites_029be12d-f3f6-4d1e-8d81-58877d4b93cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSitesSelectedforPreferredRemedy_1d3f4e38-7957-4a16-b53f-8a4b02c35857" xlink:href="mck-20210331.xsd#mck_NumberofSitesSelectedforPreferredRemedy"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_NumberofSitesSelectedforPreferredRemedy_1d3f4e38-7957-4a16-b53f-8a4b02c35857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_84c97341-487c-44f0-8afa-69d2c27eefe2" xlink:href="mck-20210331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_84c97341-487c-44f0-8afa-69d2c27eefe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_2952658c-36bb-46fd-88b9-a642befa1e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ba8f3192-4efb-4997-bbe8-c13f3a9e30ce" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_2952658c-36bb-46fd-88b9-a642befa1e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_8aad6911-1e8e-445e-820d-ebaeaf788df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_facc3eae-1793-4ea4-975f-7cb018838b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8aad6911-1e8e-445e-820d-ebaeaf788df3" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_facc3eae-1793-4ea4-975f-7cb018838b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e9954374-71cd-4454-b017-f06098a44226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_a710d9ac-9175-4546-90fb-17f4fa127ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e9954374-71cd-4454-b017-f06098a44226" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_a710d9ac-9175-4546-90fb-17f4fa127ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_3423929b-e4f7-414c-bbf5-ae4d60209304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e9954374-71cd-4454-b017-f06098a44226" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_3423929b-e4f7-414c-bbf5-ae4d60209304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_24651f03-cac5-44ed-8752-437dda0b51a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e9954374-71cd-4454-b017-f06098a44226" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_24651f03-cac5-44ed-8752-437dda0b51a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_66110c83-f13b-4ae9-a3fc-c54c85db5b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_66110c83-f13b-4ae9-a3fc-c54c85db5b47" xlink:to="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_21e3ecc7-3064-4b9b-8cab-928a265f3961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_48a69eae-6954-4b3b-b7b1-035a8e5b77cf" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_21e3ecc7-3064-4b9b-8cab-928a265f3961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_31449e12-4ca5-496d-9dc8-78513d28335c" xlink:href="mck-20210331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_21e3ecc7-3064-4b9b-8cab-928a265f3961" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_31449e12-4ca5-496d-9dc8-78513d28335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_655d82d8-c59c-4a6f-9050-5b8efdf1fe96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fe5b6932-751b-4bf6-a8e1-0d1c77cc20e1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_655d82d8-c59c-4a6f-9050-5b8efdf1fe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_903c6f18-f844-4a72-80b9-df392626dcb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_655d82d8-c59c-4a6f-9050-5b8efdf1fe96" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_903c6f18-f844-4a72-80b9-df392626dcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f843dcca-b3de-48fb-b9b7-9ec2d01eb065" xlink:to="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9fdf8da3-6314-43f6-98b2-0136f6f9d6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_RetainedEarningsMember_9fdf8da3-6314-43f6-98b2-0136f6f9d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_25c2d338-4a03-463f-9730-4d8e80a9a0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_25c2d338-4a03-463f-9730-4d8e80a9a0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67547744-0909-478a-8e81-a8db25b887de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_67547744-0909-478a-8e81-a8db25b887de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_71578327-2b2b-4381-b04a-ad1dbbfea019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember_71578327-2b2b-4381-b04a-ad1dbbfea019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember_1f7435c6-cead-4c4f-aad0-988f7dbbb8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dfbc7989-6961-43e6-88dd-cca71875b779" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember_1f7435c6-cead-4c4f-aad0-988f7dbbb8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_98189a37-fd39-4a07-a9be-4c97cf3bceda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_335af7fc-9914-43f1-826c-eb25bdc097de" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_98189a37-fd39-4a07-a9be-4c97cf3bceda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_424bba1b-ca72-4db0-b5b4-609d00a406a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_98189a37-fd39-4a07-a9be-4c97cf3bceda" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_424bba1b-ca72-4db0-b5b4-609d00a406a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0da01029-ee5e-4262-825d-2d1846da92a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ccfdc653-ddc3-43f9-8676-23cf96c5ba02" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0da01029-ee5e-4262-825d-2d1846da92a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_c257ecea-44fd-473d-b742-1fb417a88319" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_0da01029-ee5e-4262-825d-2d1846da92a3" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_c257ecea-44fd-473d-b742-1fb417a88319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_392a9c1f-4701-4393-ac87-8e3fb8be3f41" xlink:to="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_1ce7122c-e567-4c5a-bfaa-dc6091fc2e49" xlink:href="mck-20210331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_1ce7122c-e567-4c5a-bfaa-dc6091fc2e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_94ce2feb-9d01-46d6-9253-203897649b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_94ce2feb-9d01-46d6-9253-203897649b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e141e1fa-0254-4068-9ef0-29058a6991ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e141e1fa-0254-4068-9ef0-29058a6991ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3b15466a-be36-409d-9d88-44bb9da43f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3b15466a-be36-409d-9d88-44bb9da43f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_7dbd4d0d-13cc-4062-a093-49bfdb3c2cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_7dbd4d0d-13cc-4062-a093-49bfdb3c2cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5354e61f-b6c6-4570-bed5-cd5c6eaaa144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_5354e61f-b6c6-4570-bed5-cd5c6eaaa144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bae3703e-7d33-4166-8db7-8759a1870529" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bae3703e-7d33-4166-8db7-8759a1870529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases_0b0b764b-c2fd-4021-8104-23217a50ec5f" xlink:href="mck-20210331.xsd#mck_AccruedShareRepurchases"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_AccruedShareRepurchases_0b0b764b-c2fd-4021-8104-23217a50ec5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_8fb108f2-84b9-4a61-86a8-cfd2a51ff0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_8fb108f2-84b9-4a61-86a8-cfd2a51ff0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_d45f4dd0-0375-464f-b14e-7688cd2ff1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_d45f4dd0-0375-464f-b14e-7688cd2ff1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_d03de176-9d48-4e70-8634-e331f1dbd059" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_ExchangeOfferSharesDistributed_d03de176-9d48-4e70-8634-e331f1dbd059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_d1e1f696-eeee-47c3-beba-f06660c306e6" xlink:href="mck-20210331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_ExchangeOfferSharesExchanged_d1e1f696-eeee-47c3-beba-f06660c306e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_a0550f4e-43e4-4ea3-95ec-e78c6a8e9955" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_a0550f4e-43e4-4ea3-95ec-e78c6a8e9955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e499672e-9dc0-4be3-8a54-248dcd8fc397" xlink:href="mck-20210331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_e499672e-9dc0-4be3-8a54-248dcd8fc397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_903fe608-d046-401f-9f1a-7df42f755fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_903fe608-d046-401f-9f1a-7df42f755fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_30a1db30-6f8b-4915-96c7-4396ef6ad03c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_30a1db30-6f8b-4915-96c7-4396ef6ad03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e40243a-b9e9-46cb-86b9-27b8131dd1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8e40243a-b9e9-46cb-86b9-27b8131dd1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_8f89d65a-5f01-490a-af26-905d4de1e053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_8f89d65a-5f01-490a-af26-905d4de1e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_8cf416f1-d5c0-4882-80c4-960d12c1e820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_d268e38b-d820-4d9d-affc-4be1422fd4f8" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_8cf416f1-d5c0-4882-80c4-960d12c1e820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d2810ab5-4116-40fe-9fc3-33b3acd28004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d2810ab5-4116-40fe-9fc3-33b3acd28004" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_80141d98-efe0-407c-b5fc-ac7ff3fb17f5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember_c312762f-6757-4fe5-925d-1c7c29f5ddc5" xlink:href="mck-20210331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:to="loc_mck_OpenMarketTransactionsMember_c312762f-6757-4fe5-925d-1c7c29f5ddc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_46cd5be8-e534-4440-8d1a-8c4a12f98dd7" xlink:href="mck-20210331.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_839c43dd-6091-4022-9c46-28d133f12bf1" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_46cd5be8-e534-4440-8d1a-8c4a12f98dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_51321761-c4d2-40bb-ac6e-eda58236a54e" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3d910ce0-2adc-490e-9d9a-62bdc0c0f20c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3d910ce0-2adc-490e-9d9a-62bdc0c0f20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_895dd4c4-b140-45b4-b6e7-2898327c5f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_895dd4c4-b140-45b4-b6e7-2898327c5f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_82d38298-0489-4e89-ab6d-0e70ea19553e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_82d38298-0489-4e89-ab6d-0e70ea19553e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:href="mck-20210331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_2a2b08d7-9de4-4336-b1c2-3972e8c42607" xlink:to="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_106d0923-7859-4ce1-bfb0-7b0215c8a239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_106d0923-7859-4ce1-bfb0-7b0215c8a239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c5339c9e-791b-4218-8fae-d622369bb963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_c5339c9e-791b-4218-8fae-d622369bb963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0d78f476-75f8-439a-8fcc-5dfd739f31b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_4d7a8d85-ef9a-4c30-959d-58281985146a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0d78f476-75f8-439a-8fcc-5dfd739f31b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_eaff3c62-3575-4aa8-a88f-3b78853c1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_eaff3c62-3575-4aa8-a88f-3b78853c1121" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6695cf7c-c01f-41cb-bd5a-d448bdc7dcd4" xlink:to="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_407c0029-deb4-45c1-b4e6-4c93b6ab101e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_407c0029-deb4-45c1-b4e6-4c93b6ab101e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_22dadda3-a173-4f02-88d2-72cbcfb0791c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_22dadda3-a173-4f02-88d2-72cbcfb0791c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_a3378239-297b-4705-b1a3-7b36c3e5493e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_a3378239-297b-4705-b1a3-7b36c3e5493e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_4cf9fa0b-e32e-4215-bae4-e26a6fdc78f6" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_4cf9fa0b-e32e-4215-bae4-e26a6fdc78f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_7c25f015-3535-482c-a3a8-878edd47d7a0" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_7c25f015-3535-482c-a3a8-878edd47d7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_b3ffc148-44db-4b3e-9f07-cbf850255f18" xlink:href="mck-20210331.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_b3ffc148-44db-4b3e-9f07-cbf850255f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0cd77e34-2da3-4531-beac-e351fe2f5bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0cd77e34-2da3-4531-beac-e351fe2f5bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_e92e4341-c7be-4b7d-8640-9dd4d78a420a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_df210af5-7536-47b1-b95b-547aebf507b9" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_e92e4341-c7be-4b7d-8640-9dd4d78a420a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_5cf1ff3e-d01f-463b-86d2-44f3a28230fa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_676aa4fb-716e-4dc0-9bfd-ee273f5524d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_676aa4fb-716e-4dc0-9bfd-ee273f5524d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_57cac973-c197-441d-bbc3-1b111009977c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_57cac973-c197-441d-bbc3-1b111009977c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c549b17-7fe7-495e-a4ae-c439bbb5a640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c549b17-7fe7-495e-a4ae-c439bbb5a640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_619c7ac0-2fab-43e5-b7d9-318a2e8e8355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_619c7ac0-2fab-43e5-b7d9-318a2e8e8355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_da0e2dcf-0add-4df5-a6f7-6a350ef8bc79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_da0e2dcf-0add-4df5-a6f7-6a350ef8bc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bd1db3b6-935c-4e9a-8044-8e9758748051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_bd1db3b6-935c-4e9a-8044-8e9758748051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3cdbfa39-42e2-4f57-bc6e-7a2b97b88d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3cdbfa39-42e2-4f57-bc6e-7a2b97b88d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ae5679ca-c8b9-474a-8c5c-9d0d56097798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ae5679ca-c8b9-474a-8c5c-9d0d56097798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_26ecad21-71de-4f54-916c-a0bf34181824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_26ecad21-71de-4f54-916c-a0bf34181824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_333721bb-56ee-4417-bdc6-08a8331f9bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_333721bb-56ee-4417-bdc6-08a8331f9bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_6b210a71-6024-4667-b3bc-c374fde311c4" xlink:href="mck-20210331.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97e92eeb-82ea-44d4-846a-8d8da19e3894" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_6b210a71-6024-4667-b3bc-c374fde311c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_68d116fb-a873-411f-8add-0ed5f0215cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_68d116fb-a873-411f-8add-0ed5f0215cfa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_32e68c31-3f21-46fb-818c-932440b5882e" xlink:to="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f2f5c60e-270d-4371-a34f-78a1e8f5e68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_f2f5c60e-270d-4371-a34f-78a1e8f5e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_f89499e2-acf9-4a46-9686-15a031a2ead3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_f89499e2-acf9-4a46-9686-15a031a2ead3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_aef16adf-b757-4f66-a06e-dd31a5b989bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_aef16adf-b757-4f66-a06e-dd31a5b989bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_7ac66c84-d297-469c-af05-bbe5f8856cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_7ac66c84-d297-469c-af05-bbe5f8856cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a46e98d8-ed23-427d-b623-279d03adf295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e101cf0-a418-43a3-9b89-0d74d1961621" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a46e98d8-ed23-427d-b623-279d03adf295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4186f06-4bb4-4c29-9fe0-7457f2d3958a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f36aad8a-bf9d-4ad7-9c69-415efd9f3b72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4186f06-4bb4-4c29-9fe0-7457f2d3958a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e4186f06-4bb4-4c29-9fe0-7457f2d3958a" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4570ae84-87ab-40c4-902a-81d1d547640e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4570ae84-87ab-40c4-902a-81d1d547640e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_06e96480-2f38-49ec-ab46-c693bd268d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_06e96480-2f38-49ec-ab46-c693bd268d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5228b0fe-2713-454b-9e5f-e77a05ef81f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5228b0fe-2713-454b-9e5f-e77a05ef81f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7129939f-0221-4581-9a83-6ec62229267e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7129939f-0221-4581-9a83-6ec62229267e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6123af8a-5a30-42f3-bc22-2dc01809c3a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6123af8a-5a30-42f3-bc22-2dc01809c3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_050b6bc9-63ed-4af8-bf74-8b65c79601dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_050b6bc9-63ed-4af8-bf74-8b65c79601dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0159603-f69a-4435-91e9-32f58aaa894d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3c58ce23-44f0-4ec8-a08b-d361fdd3b41b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0159603-f69a-4435-91e9-32f58aaa894d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="simple" xlink:href="mck-20210331.xsd#RelatedPartyBalancesandTransactions"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d1034b2e-66a3-4424-983f-8d8568153e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b128c024-58dc-42c6-bfee-07323579c913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d1034b2e-66a3-4424-983f-8d8568153e77" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b128c024-58dc-42c6-bfee-07323579c913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1ebf9ad6-6e71-40c6-a10b-cda99afe1db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1ebf9ad6-6e71-40c6-a10b-cda99afe1db4" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_22291985-0d8e-436b-a545-8ea3d7a1cdf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ef30f082-0560-475c-a45f-066ea1da4788" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_22291985-0d8e-436b-a545-8ea3d7a1cdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_56b9a288-c726-4536-a98b-e900f5cda510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_22291985-0d8e-436b-a545-8ea3d7a1cdf8" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_56b9a288-c726-4536-a98b-e900f5cda510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7b0cd7c5-aa0a-4fbe-bcf5-f5a035779a2a" xlink:to="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CaliforniaFoundationMember_2209b35c-0520-445c-b136-eedcdaf3c564" xlink:href="mck-20210331.xsd#mck_CaliforniaFoundationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:to="loc_mck_CaliforniaFoundationMember_2209b35c-0520-445c-b136-eedcdaf3c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonFoundationMember_74e670a0-9b95-488c-9473-40af6609e2f2" xlink:href="mck-20210331.xsd#mck_McKessonFoundationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:to="loc_mck_McKessonFoundationMember_74e670a0-9b95-488c-9473-40af6609e2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_1db85ddf-fdb7-4937-9b25-e937776a5678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvesteeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_71fa4bf3-88d3-4c33-a100-7eb19ff248e1" xlink:to="loc_us-gaap_InvesteeMember_1db85ddf-fdb7-4937-9b25-e937776a5678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ae52f720-7405-4cde-ae60-65a1f3acecaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fba9e272-26e2-4546-99d3-eb0002236f46" xlink:to="loc_us-gaap_SegmentDomain_ae52f720-7405-4cde-ae60-65a1f3acecaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_91eaf0e6-aebe-4c2a-bd3e-144bae490a5b" xlink:href="mck-20210331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ae52f720-7405-4cde-ae60-65a1f3acecaf" xlink:to="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_91eaf0e6-aebe-4c2a-bd3e-144bae490a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_90afa903-c3cc-4417-af17-7d3172bc1b56" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2aa686c5-ca8f-4167-b23a-821e2349dea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_2aa686c5-ca8f-4167-b23a-821e2349dea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_47a24934-eb5d-47a5-a388-9e62b8100594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_47a24934-eb5d-47a5-a388-9e62b8100594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_63d787ca-0017-4af6-86eb-79cb8c594a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d12a590a-aeb6-4318-817c-fdf3b6edf08e" xlink:to="loc_us-gaap_RevenueFromRelatedParties_63d787ca-0017-4af6-86eb-79cb8c594a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fa0f6cab-c4b8-4db5-9515-de45163bbf08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_18bd203e-47da-44bc-81d1-7bf3448a3621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fa0f6cab-c4b8-4db5-9515-de45163bbf08" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_18bd203e-47da-44bc-81d1-7bf3448a3621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_232a6177-b0d9-4500-b003-aa2d74e08e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5de7d05a-163a-4619-8c38-8e071f06fe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_232a6177-b0d9-4500-b003-aa2d74e08e0e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5de7d05a-163a-4619-8c38-8e071f06fe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_b81ca12d-5661-4959-a056-c2252872a4a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_232a6177-b0d9-4500-b003-aa2d74e08e0e" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_b81ca12d-5661-4959-a056-c2252872a4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bb11598c-f8ad-4be8-ae8d-b56dec6eec95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bb11598c-f8ad-4be8-ae8d-b56dec6eec95" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_338f3064-c39e-49ab-93f3-0c273a632908" xlink:to="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_efd882b9-9bc2-47aa-9437-0669ec7933fb" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_InternationalSegmentMember_efd882b9-9bc2-47aa-9437-0669ec7933fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_25b283a5-8eab-4b09-a6f0-0173c3f886fe" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_USPharmaceuticalSegmentMember_25b283a5-8eab-4b09-a6f0-0173c3f886fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e8b969b9-0d8c-45d1-bf90-9e3d1654c3cc" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e8b969b9-0d8c-45d1-bf90-9e3d1654c3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_681bf5ee-5ef4-4f16-bb48-458175dc6363" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d8a83a46-fad8-48a1-87c6-25f1034e5f05" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_681bf5ee-5ef4-4f16-bb48-458175dc6363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6df6e274-e92b-46b5-bc3d-1e9dc1b1bef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c55ba953-1053-470b-a200-8fdb9118e3ea" xlink:to="loc_us-gaap_RelatedPartyDomain_6df6e274-e92b-46b5-bc3d-1e9dc1b1bef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_64399451-922b-4fe0-b9af-de1fbea07e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6df6e274-e92b-46b5-bc3d-1e9dc1b1bef3" xlink:to="loc_us-gaap_CorporateJointVentureMember_64399451-922b-4fe0-b9af-de1fbea07e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b61560d0-9fd8-4200-a40f-b25906c474b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d84ffc3b-8624-44a5-a10e-8af5f6a3d429" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b61560d0-9fd8-4200-a40f-b25906c474b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_32879aff-7fa1-467c-9663-999e73a3ed9d" xlink:href="mck-20210331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b61560d0-9fd8-4200-a40f-b25906c474b8" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_32879aff-7fa1-467c-9663-999e73a3ed9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_14335b03-d5ca-46e1-9f0d-c05979d23fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_e8d81a51-ba7c-466a-9c09-308dcbe91ab7" xlink:to="loc_us-gaap_ReportingUnitDomain_14335b03-d5ca-46e1-9f0d-c05979d23fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_ed80774b-54e9-447f-8d6a-2a47c9aa0aff" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_14335b03-d5ca-46e1-9f0d-c05979d23fd7" xlink:to="loc_mck_RexallHealthMember_ed80774b-54e9-447f-8d6a-2a47c9aa0aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87f1b40f-aa27-4681-b36b-f18e1d4cb22a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5670e3fa-ffdf-439b-9bb8-0ebca1e5cf0c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87f1b40f-aa27-4681-b36b-f18e1d4cb22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_59bc6eb0-aa7f-41d4-84d5-6c21f72e0828" xlink:href="mck-20210331.xsd#mck_RexallHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87f1b40f-aa27-4681-b36b-f18e1d4cb22a" xlink:to="loc_mck_RexallHealthMember_59bc6eb0-aa7f-41d4-84d5-6c21f72e0828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_61b8471f-362b-42ed-b6ec-8efa9fdde239" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c3773583-add6-4bec-ae37-d380916650e0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_61b8471f-362b-42ed-b6ec-8efa9fdde239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThirdPartySellerofRexallHealthMember_2e0fba8d-e623-4107-9098-3775e1c08eaf" xlink:href="mck-20210331.xsd#mck_ThirdPartySellerofRexallHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_61b8471f-362b-42ed-b6ec-8efa9fdde239" xlink:to="loc_mck_ThirdPartySellerofRexallHealthMember_2e0fba8d-e623-4107-9098-3775e1c08eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5144a2eb-2cc9-4d36-94c7-ab48e30b460b" xlink:to="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_1cd8f592-0cb4-4452-8306-484abc83e56e" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:to="loc_country_CA_1cd8f592-0cb4-4452-8306-484abc83e56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_d3a38f7f-2211-44e1-8c41-1875586790a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e6e80711-ee1a-46e5-9a4b-982f100b6a25" xlink:to="loc_srt_EuropeMember_d3a38f7f-2211-44e1-8c41-1875586790a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7d747d64-6f0f-46e4-851e-474bfb97b510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bcf04e3d-a15f-4d65-8ed0-f4a78f03792c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7d747d64-6f0f-46e4-851e-474bfb97b510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_11ef5c11-dfd5-4a3d-862f-c0c51e90f1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7d747d64-6f0f-46e4-851e-474bfb97b510" xlink:to="loc_us-gaap_DomesticPlanMember_11ef5c11-dfd5-4a3d-862f-c0c51e90f1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_161a66e1-bd20-4bdd-bf5e-d89b61cf88cf" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_11ef5c11-dfd5-4a3d-862f-c0c51e90f1e1" xlink:to="loc_country_US_161a66e1-bd20-4bdd-bf5e-d89b61cf88cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0c29e8ea-3812-4dea-aa22-38bddcd4d1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dadac1d7-6924-47cb-8a44-e1ea07349825" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0c29e8ea-3812-4dea-aa22-38bddcd4d1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_87c8c4a7-7b48-4489-ba6d-832f20cc0b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0c29e8ea-3812-4dea-aa22-38bddcd4d1bb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_87c8c4a7-7b48-4489-ba6d-832f20cc0b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cd774821-0694-4090-a149-333dfc0716cd" xlink:to="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_b7bb2e1e-01d9-4e08-a1ea-45c2f3fdaa6c" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_b7bb2e1e-01d9-4e08-a1ea-45c2f3fdaa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_10ac7d5a-5ace-458f-b411-4acf9edbe383" xlink:href="mck-20210331.xsd#mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:to="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_10ac7d5a-5ace-458f-b411-4acf9edbe383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_54956706-c129-4f08-b162-c52de49970a8" xlink:href="mck-20210331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b5034969-ff24-458f-b16c-b8cb79e8be70" xlink:to="loc_mck_ShareholderDerivativeActionMember_54956706-c129-4f08-b162-c52de49970a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5842f4e0-97f6-4fdb-9d0a-dfb43726805c" xlink:to="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9a655555-b62b-48b6-87fc-c1e3be15c305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:to="loc_us-gaap_OperatingSegmentsMember_9a655555-b62b-48b6-87fc-c1e3be15c305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fd677eae-fb2d-42f9-baa5-32bdf833c32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e34c3046-92c5-4864-a041-453fb07a66aa" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fd677eae-fb2d-42f9-baa5-32bdf833c32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9efc7fde-04d1-4852-a69d-c95da2ee8f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c696a018-1589-44bf-9d2e-bbdcd0f7fa4f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9efc7fde-04d1-4852-a69d-c95da2ee8f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0617732f-c9a8-42bf-9ffe-45c1308aaf96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9efc7fde-04d1-4852-a69d-c95da2ee8f4e" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0617732f-c9a8-42bf-9ffe-45c1308aaf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41d9e2f7-d510-4e62-ac09-188865277462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a46f38f3-6753-42d0-979d-804556ad26ba" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41d9e2f7-d510-4e62-ac09-188865277462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_321a266b-e76a-4ab9-bda6-ff43dff251d8" xlink:href="mck-20210331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41d9e2f7-d510-4e62-ac09-188865277462" xlink:to="loc_mck_GermanWholesaleBusinessMember_321a266b-e76a-4ab9-bda6-ff43dff251d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_3ca40269-6dfe-4527-8eba-660d0a7bb1a7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_7fae05b8-96d7-4994-aa32-ba23a42f8cb5" xlink:href="mck-20210331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_7fae05b8-96d7-4994-aa32-ba23a42f8cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_7e43ae1d-c712-4727-b2eb-0408f8a9455d" xlink:href="mck-20210331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ba729378-e567-46ee-b668-4248567deed2" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_7e43ae1d-c712-4727-b2eb-0408f8a9455d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d4f74da-70b7-4acf-b367-cba3502daa9a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f7f351a1-d5ab-435a-9ced-8ca5299e6437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_NumberOfReportableSegments_f7f351a1-d5ab-435a-9ced-8ca5299e6437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_dd80f43c-625d-4221-857b-0d26fdf73b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_dd80f43c-625d-4221-857b-0d26fdf73b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_79d9c692-2dac-4365-835b-8717de88a271" xlink:href="mck-20210331.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_79d9c692-2dac-4365-835b-8717de88a271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_4c9fdf1f-ad7c-4ac9-9ad9-4c0ace5ed2b9" xlink:href="mck-20210331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_4c9fdf1f-ad7c-4ac9-9ad9-4c0ace5ed2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_59627509-855c-4e20-802e-009c2239b7c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_59627509-855c-4e20-802e-009c2239b7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_af8e8dc2-faff-40f1-92ee-7e4717e16c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_af8e8dc2-faff-40f1-92ee-7e4717e16c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_387c0a02-374b-4f46-98c8-688066091400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_387c0a02-374b-4f46-98c8-688066091400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_94747631-deec-45f3-aa4e-080fa03b4bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_94747631-deec-45f3-aa4e-080fa03b4bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_154bfbca-fc5f-41a3-aeb0-a46f8f3bae48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_154bfbca-fc5f-41a3-aeb0-a46f8f3bae48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_22899a98-b396-48e9-8f8d-affe40b0936b" xlink:href="mck-20210331.xsd#mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax_22899a98-b396-48e9-8f8d-affe40b0936b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnSaleOfBusinessNetOfTax_b1efadbc-d9d2-49e1-a384-c24c4787e024" xlink:href="mck-20210331.xsd#mck_GainLossOnSaleOfBusinessNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_GainLossOnSaleOfBusinessNetOfTax_b1efadbc-d9d2-49e1-a384-c24c4787e024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_23430288-cd5b-48a0-a091-355be0a56266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_23430288-cd5b-48a0-a091-355be0a56266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_683c41e2-07b4-4626-8f43-15fe0aa4983e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_AssetImpairmentCharges_683c41e2-07b4-4626-8f43-15fe0aa4983e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLossNetOfTax_3f44acf7-055a-40bb-8635-37c16f403742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLossNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GoodwillImpairmentLossNetOfTax_3f44acf7-055a-40bb-8635-37c16f403742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_00b2e1b2-74d5-4060-8a17-19ed445ec1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_00b2e1b2-74d5-4060-8a17-19ed445ec1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPreviousAcquisition_fdafd723-5831-4ffd-b046-34af2dee7749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPreviousAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_ProceedsFromPreviousAcquisition_fdafd723-5831-4ffd-b046-34af2dee7749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0953347e-24bb-405d-9a15-3009b49a90fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_InventoryWriteDown_0953347e-24bb-405d-9a15-3009b49a90fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_535e3c5a-9f3a-4868-9598-64c7f7c9dc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_535e3c5a-9f3a-4868-9598-64c7f7c9dc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_e95999ef-b85a-49df-8b3b-d57e05737059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_e95999ef-b85a-49df-8b3b-d57e05737059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossonDerecognitionofLiability_2e0dc96d-bff0-470a-adb6-22f52ded88bd" xlink:href="mck-20210331.xsd#mck_GainLossonDerecognitionofLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_GainLossonDerecognitionofLiability_2e0dc96d-bff0-470a-adb6-22f52ded88bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f8f4408-f2ee-481f-b00a-df1db138b262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f8f4408-f2ee-481f-b00a-df1db138b262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_8455a47f-2a4d-46ab-b93b-2645d886c3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_8455a47f-2a4d-46ab-b93b-2645d886c3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef8a6792-98e7-4e1b-8314-878c6f4ef653" xlink:href="mck-20210331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ef8a6792-98e7-4e1b-8314-878c6f4ef653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4bfd4517-f0e9-4e64-abfd-00f5d578e4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4bfd4517-f0e9-4e64-abfd-00f5d578e4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6e2e7209-3fa6-40c5-95be-04883ac335df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_98dd29ab-d517-44ec-900a-ada404202f36" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6e2e7209-3fa6-40c5-95be-04883ac335df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f4c8464f-dbd2-4d1a-9072-050729d46857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f4c8464f-dbd2-4d1a-9072-050729d46857" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_59f4bb73-fa12-4403-b63e-fe677775d196" xlink:to="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_e20a27de-30b4-4df7-a196-51585f29afaa" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_USPharmaceuticalSegmentMember_e20a27de-30b4-4df7-a196-51585f29afaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4dbdde9e-2fdd-4ae2-af47-d8f548c6e134" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_InternationalSegmentMember_4dbdde9e-2fdd-4ae2-af47-d8f548c6e134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_547740a9-2d88-4bbf-93c4-cb025cb26e1f" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_547740a9-2d88-4bbf-93c4-cb025cb26e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_eabce4c5-d409-4df9-aad4-acde26f8cece" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df531e37-7309-4ccf-918f-e1aa1018fa85" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_eabce4c5-d409-4df9-aad4-acde26f8cece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7be9cc95-6e32-4f0b-8c02-84f5c7aafa51" xlink:to="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d5a5c10d-489d-4d76-b501-c6e3363bc53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:to="loc_us-gaap_OperatingSegmentsMember_d5a5c10d-489d-4d76-b501-c6e3363bc53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_32583e45-5d19-44d8-8fa1-f32bc8ce400f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ab6a122f-f7f9-48e3-ab3a-46816aaed284" xlink:to="loc_us-gaap_CorporateNonSegmentMember_32583e45-5d19-44d8-8fa1-f32bc8ce400f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_47c214b3-361f-4357-a57a-bd21580fc9d2" xlink:to="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fa70ccda-0830-4c0a-b8c6-4ced3563ce9d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:to="loc_country_US_fa70ccda-0830-4c0a-b8c6-4ced3563ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_9c93bb41-48e5-419e-9cb7-a0e64c666098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ab91d1ba-c554-4a34-982a-5f4ba0b90d4f" xlink:to="loc_us-gaap_NonUsMember_9c93bb41-48e5-419e-9cb7-a0e64c666098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9f881128-2523-4171-9e28-c11896466635" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_1e84a96e-0ccf-4e8a-8225-f4b05e5a2814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_RevenuesAbstract_1e84a96e-0ccf-4e8a-8225-f4b05e5a2814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_543739f7-c26b-4404-b15b-03a3dcd91593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_1e84a96e-0ccf-4e8a-8225-f4b05e5a2814" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_543739f7-c26b-4404-b15b-03a3dcd91593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_1f57be6a-d77f-4ed3-b34a-4dba4fadf808" xlink:href="mck-20210331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_1f57be6a-d77f-4ed3-b34a-4dba4fadf808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_217fe228-bc17-4784-b575-ac9c57449231" xlink:href="mck-20210331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_217fe228-bc17-4784-b575-ac9c57449231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_511413e0-6d14-4d4c-9408-6cb285665c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_us-gaap_InterestExpense_511413e0-6d14-4d4c-9408-6cb285665c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_343935ce-bffe-45c5-b745-a72419049a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_a3bef120-3fe3-4f34-90ae-6895b6532f71" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_343935ce-bffe-45c5-b745-a72419049a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_d217edf2-c86d-4083-a8ad-512a41685dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_d217edf2-c86d-4083-a8ad-512a41685dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2fd84572-76ea-4bfc-93de-e746ca831dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_d217edf2-c86d-4083-a8ad-512a41685dc2" xlink:to="loc_us-gaap_DepreciationAndAmortization_2fd84572-76ea-4bfc-93de-e746ca831dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a05ac065-904a-4ec0-afd3-921250f920b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_439a5858-20f4-48f5-b6a1-1a94f8ca9b8e" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a05ac065-904a-4ec0-afd3-921250f920b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_6dde069e-5f9c-4d9b-baa8-a030d0279b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a05ac065-904a-4ec0-afd3-921250f920b5" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_6dde069e-5f9c-4d9b-baa8-a030d0279b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a93b4ca7-d1cc-48a7-99ff-3fcbef62f880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a93b4ca7-d1cc-48a7-99ff-3fcbef62f880" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e8e29794-75ce-4c0c-b475-00ae4720c2cd" xlink:to="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_305e661a-250a-4cac-af9f-746b756e9a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:to="loc_us-gaap_OperatingSegmentsMember_305e661a-250a-4cac-af9f-746b756e9a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5144a624-d76d-4a1c-9ec8-b57e481e55d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4cfab0d2-ae98-4248-b5e7-44e472eb1ddb" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5144a624-d76d-4a1c-9ec8-b57e481e55d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0837df7-a1c7-4761-bf73-aec0e5a9d7e8" xlink:to="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_97bff15b-a2e5-42e4-a0d4-05d91a4c7910" xlink:href="mck-20210331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_USPharmaceuticalSegmentMember_97bff15b-a2e5-42e4-a0d4-05d91a4c7910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_57a9073e-9f10-4b97-96a5-312e4c349472" xlink:href="mck-20210331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_InternationalSegmentMember_57a9073e-9f10-4b97-96a5-312e4c349472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_2d76daf4-d187-43c1-b899-ad45c09b0ae0" xlink:href="mck-20210331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_2d76daf4-d187-43c1-b899-ad45c09b0ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_0761ea9b-24d8-4428-891c-8d8114c41c8c" xlink:href="mck-20210331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5df19ab2-c052-4887-b057-f229aa57dfb1" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_0761ea9b-24d8-4428-891c-8d8114c41c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4ce5088c-e712-4410-a822-6d5f908ea2a2" xlink:to="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e9ca5fbb-7898-4e59-8070-32cba84caa36" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:to="loc_country_US_e9ca5fbb-7898-4e59-8070-32cba84caa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_21e4b687-f1d9-44f8-b1d6-3af6e4153c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b226dee1-9780-405b-a77a-5c714a270918" xlink:to="loc_us-gaap_NonUsMember_21e4b687-f1d9-44f8-b1d6-3af6e4153c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de11d5d2-9317-4f68-9aab-cbc81c9f81a6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_da4cb0e3-0485-4b27-9eca-97990d4d507c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:to="loc_us-gaap_AssetsAbstract_da4cb0e3-0485-4b27-9eca-97990d4d507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_15315091-f6f2-41ae-9e27-16c44559c356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_da4cb0e3-0485-4b27-9eca-97990d4d507c" xlink:to="loc_us-gaap_Assets_15315091-f6f2-41ae-9e27-16c44559c356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3d482be4-7e6e-4419-b475-eca65a601ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ce725af9-0e56-4fb8-980c-05fe7901f3ed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3d482be4-7e6e-4419-b475-eca65a601ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_8baa423c-a02d-4577-926a-b328054b77f8" xlink:href="mck-20210331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3d482be4-7e6e-4419-b475-eca65a601ffd" xlink:to="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_8baa423c-a02d-4577-926a-b328054b77f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnaudited"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_5475db72-8d56-4926-87f7-0739dc4fc77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_d4b82be1-16ba-4b08-95b3-83d846557aee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_5475db72-8d56-4926-87f7-0739dc4fc77b" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_d4b82be1-16ba-4b08-95b3-83d846557aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnauditedTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_13a63d4c-4d9a-4c4a-8a4d-9096c079d3d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_f500273d-3042-49c1-b47d-7319d6cdee3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_13a63d4c-4d9a-4c4a-8a4d-9096c079d3d7" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_f500273d-3042-49c1-b47d-7319d6cdee3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_394dcf10-2065-4084-ac41-a97654f47711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_394dcf10-2065-4084-ac41-a97654f47711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_88ec135a-5447-4f53-95e5-546e18ebe8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:to="loc_us-gaap_GrossProfit_88ec135a-5447-4f53-95e5-546e18ebe8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract_c230a9f3-88d3-4339-acf3-d9e95593e076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract_c230a9f3-88d3-4339-acf3-d9e95593e076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b3f952e8-06f4-4a04-8a20-0900ad97a9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract_c230a9f3-88d3-4339-acf3-d9e95593e076" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b3f952e8-06f4-4a04-8a20-0900ad97a9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ff022df8-63b3-45c9-a898-85ca8e84af44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract_c230a9f3-88d3-4339-acf3-d9e95593e076" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ff022df8-63b3-45c9-a898-85ca8e84af44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_55e335e1-3aef-4370-9720-36ac6b55c9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:to="loc_us-gaap_ProfitLoss_55e335e1-3aef-4370-9720-36ac6b55c9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a9f5a187-1ec9-4a0c-900d-6fb2269c419b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:to="loc_us-gaap_NetIncomeLoss_a9f5a187-1ec9-4a0c-900d-6fb2269c419b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fdffc0cc-941c-4e51-8563-0e0b81e7db41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_3a08b408-f7be-4e55-a648-1a4e5403b924" xlink:to="loc_us-gaap_EarningsPerShareAbstract_fdffc0cc-941c-4e51-8563-0e0b81e7db41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_7b310e7f-694f-43a5-b793-18329d1bfd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fdffc0cc-941c-4e51-8563-0e0b81e7db41" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_7b310e7f-694f-43a5-b793-18329d1bfd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e685c7e5-e7bf-4769-a6c2-2b0e5b372891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_7b310e7f-694f-43a5-b793-18329d1bfd45" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e685c7e5-e7bf-4769-a6c2-2b0e5b372891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_ed04e72e-a295-464a-bc9f-42c61b75500c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_7b310e7f-694f-43a5-b793-18329d1bfd45" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_ed04e72e-a295-464a-bc9f-42c61b75500c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_94180fa0-0662-486a-9c83-0ff3a3d9de7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_7b310e7f-694f-43a5-b793-18329d1bfd45" xlink:to="loc_us-gaap_EarningsPerShareDiluted_94180fa0-0662-486a-9c83-0ff3a3d9de7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_d53b6b22-2045-4f15-bfa1-1fe9def29ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fdffc0cc-941c-4e51-8563-0e0b81e7db41" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_d53b6b22-2045-4f15-bfa1-1fe9def29ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_6a1febca-eb2b-4654-8546-28df0ebd7a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d53b6b22-2045-4f15-bfa1-1fe9def29ca7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_6a1febca-eb2b-4654-8546-28df0ebd7a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_8bfcc850-dfc1-4c55-a7ee-737ad4f5a890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d53b6b22-2045-4f15-bfa1-1fe9def29ca7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_8bfcc850-dfc1-4c55-a7ee-737ad4f5a890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f1440dd3-216b-4ee3-896c-ff196cf8d649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d53b6b22-2045-4f15-bfa1-1fe9def29ca7" xlink:to="loc_us-gaap_EarningsPerShareBasic_f1440dd3-216b-4ee3-896c-ff196cf8d649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="mck-20210331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_20f20b0f-7c9b-4e13-ae12-969b3ff34743" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1d4ad7f5-d2ee-423b-b9e5-95ac28528ddb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_20f20b0f-7c9b-4e13-ae12-969b3ff34743" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1d4ad7f5-d2ee-423b-b9e5-95ac28528ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20210331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_22aee825-82ca-4cfc-8760-a0e1a5afe6bf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_22aee825-82ca-4cfc-8760-a0e1a5afe6bf" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_cf793303-9ccb-4cbb-86e2-948f92733651" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_f6db1052-56a4-429a-84f9-4ed63318b829" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_f6db1052-56a4-429a-84f9-4ed63318b829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember_f0cdc0ec-baa8-498c-8e8e-74849cd9597c" xlink:href="mck-20210331.xsd#mck_OtherAllowancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_mck_OtherAllowancesMember_f0cdc0ec-baa8-498c-8e8e-74849cd9597c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_e7c33bd5-594a-4928-9795-09c3b5041ead" xlink:href="mck-20210331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_e7c33bd5-594a-4928-9795-09c3b5041ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_3fd5d8c1-74c9-4329-aee1-45fa8f58bb79" xlink:href="mck-20210331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_bb935329-3730-4576-b084-9705fff20d3b" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_3fd5d8c1-74c9-4329-aee1-45fa8f58bb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_5d8a4d18-e5b4-4c9d-b5f8-e3b054e669e8" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0505ac31-29cc-4344-8ee2-620e15fa07cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_0505ac31-29cc-4344-8ee2-620e15fa07cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_20b05c8c-342e-4512-889c-fc626e49bcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_20b05c8c-342e-4512-889c-fc626e49bcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_0c702f97-f8aa-4660-a951-8ebfbca3f9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_0c702f97-f8aa-4660-a951-8ebfbca3f9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d57981da-a04a-4f22-a9a8-4df392360fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d57981da-a04a-4f22-a9a8-4df392360fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_e6029409-84e8-46b1-a1e2-634ae8daa14d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_04695325-f71f-47cc-98e9-c404fe5a3650" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_e6029409-84e8-46b1-a1e2-634ae8daa14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_7d8d4223-61fe-4ae2-9532-4020a09e24e5" xlink:href="mck-20210331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_888b89ec-3a95-4cd9-9e83-2646e977c2fe" xlink:to="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_7d8d4223-61fe-4ae2-9532-4020a09e24e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>mck-20210331_g1.jpg
<TEXT>
begin 644 mck-20210331_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]&_C!\5]*
M^"_@FY\3ZS#<SV,$B1LEJH9\L<#@D=_>OGS_ (>7?#;_ *!&O?\ ?B/_ .+K
MJO\ @H#_ ,FVZQ_U]6W_ *,%?E!Z5];E.64,91<ZN]SX?.LWQ.!Q"ITK6L?J
M?X+_ ."@GP[\;>+-(T"WL=7M+C4KE+6*:ZA18U9SA2Q#\#) Z5]/CGGM7X,6
M-]+IM];W<#%)X)%E1@<$,IR"#]17[:?!SQU%\2OAGX<\1PN'-]9QR2>TF,./
M^^@:YLWRV&"Y94MF=>1YK4Q_-"M\2.SXKYX^+G[;G@7X.^.+KPOJEKJ=[J%J
MB-*]E$C1J64,%R6'."/SKWO6-4@T32KS4+EO+MK6%II&/95!)_05^(GQ.\93
M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
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M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>mck-20210331_g2.jpg
<TEXT>
begin 644 mck-20210331_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%'
M]G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]
M^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4
M?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G
M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%'
M]G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]
M^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4
M?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G
M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%'
M]G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]
M^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4
M?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G
M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%'
M]G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]
M^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4
M?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G
M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%'
M]G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]
M^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4
M?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G
M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%'
M]G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?
M_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]
M^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\ \^,/_?H4
M?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G
M:?\ \^,/_?H4?V=I_P#SXP_]^A4U%    , 8 Z 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_\$]_^2)ZM
M_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*37NE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQGUOQW^SIKWPJUV\DN/^$+UI!ISR-DQV=TK.L7KA98YR/9P!P*^X* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH \+_ .">_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y
M(GJW_8]ZS_Z4FO=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_GP_:6^#>M_L_?'CQ3\(->M'BDT
M76)HK9G7'G6Q.Z"4>SQ,CCV:OW_\5^*O#?@;PU?>,?&&M6^G:7IEJ]S?WUW(
M$C@B099F)[ 5\%_$3]DWQ/\ \%;M>U/]HRZF7P%X8M--_L[X9SW&D![S6XUE
M+&]NP2K"!OF6- <@-N' /F@'Y=T5]5>+_P#@C)^WEX;UE]-T3X>Z3X@MU?"Z
MCI7B2UCB8>N+IXI!_P!\U[!^RS_P0P\=ZAX@M?$_[5WB2RT[28'623PSHEV9
MKJ[QSY<LZX2%3W,9=B,@%#AJ /7/^"%'P:UOP/\ L[^(/BMKEH\ \9ZTG]FJ
MZX,MI:JZ+*/8RR3J/]S/>ON*JF@:!HGA70[/PSX:TJ"QT_3[9+>QLK6,)'!$
MBA515'     ]JMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%?G3\4OV]/VD/VG_P!H/XB?"/\ 9N^+FB_#G0_@
M[\>O"/@342VAMJ&L:U=WMS#]HN9@UQ''!8 L\*0A&>X\J4F6,?)7T;X,^.?[
M8G@GX"?$>[^,WPLT'Q;\1?!GC'_A'_"5OX,M[C3M/\6"YBL&TZZ9;B2=K%&>
M_1+EM\JP>1.P+JG(!]$T5^7/[3'[;7_!:'_@ESXI\$_M%?MOW7P7^)'P7\4^
M,;'0/&^F_#70[^QO_"#W;[(I[:2Y<M=1*<C,@)=@$Q'O#CZD_;=_;:\;_#7]
MI/X/?L#?LY_V2/B?\9;R_N3K.N6;W5GX6T"P@:>\U*2!)(S/,P7R;>(NJ-*2
M7.V,HX!]145\I_!']L;XE> ?^"@>K?\ !-#]J'7M.UO7K[P#%XW^&/CG3]*%
MA_;NF"=[:[LKJW#M&E[;S(7#1$)+ X;RXRAW\?\ !/\ :]_:S_X*):G\8OB/
M^Q9X^\(^%/!'PP\9WW@_P(?$'AE]2/CC6;&)'N[BZD%Q']FTYI9$@B\C]Z0)
M)6?I$ #[<HKPW_@G%^W'X,_X*)_LA>%OVI/".@3:)-JR3VGB'PW=3"2;1=5M
MI6@N[-VP-VR5"58A2\;(VU=V![E0 4444 >%_P#!/?\ Y(GJW_8]ZS_Z4FO=
M*\+_ .">_P#R1/5O^Q[UG_TI->Z4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M\(/I'_/S>_\ @6U;%% "1H(HUC4G"J ,GFEHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_X)[_\ )$]6_P"Q
M[UG_ -*37NE>%_\ !/?_ )(GJW_8]ZS_ .E)KW2@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO&/VN?VIKGX(66F?#7
MX6Z"/$GQ.\8.UMX.\,Q'.#SNO+C!_=V\>"Q8D;MI&0 [( >JZC=67B"WU3PM
MHWBI;748[7RYI;&6)[C3VE0^7+L8,%;^)=ZD';T(S7%_LR?LS^"/V8/ +^$O
M#-U<ZGJ>HW37WB7Q+J1W7FLWKDEYYF))ZD[5R0H]269LG]DG]EV']GCPWJ.N
M^+O$<GB/Q]XLN%OO''BNYY>^N<'$4>0-D$>2J)@#&3@9VCUR@ HHHH *XOX[
M_'?P'^SWX#G\<^.;["C*6%A$P\Z]FQD1Q@_J>BCDUVE?E]^WI-\=Y/CO>I\<
M%V[=W_"/I:EOL8L]WRF#/7MO)^;=G/85^<>)W&F*X)X=>*PM%SJ3?+&5KP@V
MOBG_ .VK[3T/M^ N%L/Q5G7U>O54817,U?WI+M']7T1Q?Q]^/OCS]HGQY-XW
M\;WF%&4T[3HF/DV,.<B- ?S+=6/)[ ?47[!?[>GG_8O@?\<-:^?Y8/#_ (@N
MI/O=EMYV/?H$<]>%/."?B:BOXVX>X]XBX>XBEG%.JYU)N]12=U43W4O_ &UK
MX>FFA_3N=<(9)G62++)TU"$%[CBM8/HU^J^UUUU/VLHKQ3]@N;X[S_ BR?XX
M+_=_X1][HM]L:SV_*9\_AL)^8KC/8GVNO[\R3,UG644,<J<J?M(J7+-6DK]&
MOR[JS/X[S7 /*\RJX1SC/DDUS1=T[=OZT>@4445ZAYX4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 >%_\$]_^2)ZM_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*3
M7NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG8D<I"IR((^P5>V 20 !Z77S]3(L9Q/!O/5RT'MAXO3R=::MSR6ZA%JG%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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MS,<  =230!D?\(/I'_/S>_\ @6U>0_';]C)_VA/BAX<?Q[X\FE^'&B1&[O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY?:E+2RQV<NK0>$PD/94/Y4[RDULZDM'-]E91C]F*"BBBOHSQ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_X)[_\ )$]6
M_P"Q[UG_ -*37NE>%_\ !/?_ )(GJW_8]ZS_ .E)KW2@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *XC]HC2OC?KOPFU/0?V>-:TG3/%%]Y=O::KK!?
MR[&)W"RSJ%5MTB(69 1C<!G/0\1^UU^U'K?PIDTSX*? _1(_$/Q5\8 Q>&=$
MZQV4?(?4+H_P01X8\_>*D= Q%OPSXBT;]C#X!Z5I/Q\^-&I>*=;S(\]_?2&>
M]U6]E<R/%;1?>*!WVHO1%V@D"N;%XS"X##2Q&)FH0BKN4G9)>;9OAL-B,97C
M1H0<IRT22NW\C?\ V</V=OAY^RM\+D\#^%)7E<N]YX@U_4'S<ZI>,,RW4[D\
MDG/4X50!VS7'^)/VC/'?QHURY^''[(FG07@@D,6L?$#4(R=,TX]Q!D?Z3*.H
MQE>A^922*D'PW^,_[64Z:Q\=5NO!_@4L'M/ EE<%+S4DZJU]*N"BGKY2X/KM
M(#'W'PWX9\/>#M#MO#/A31;;3M/LXQ';6=G"(XXU] !^?N>:^6]MG'$VE#FP
MV%?VFN6M47]Q/6E!_P TE[1_9C#23^@]GEF0ZU>6OB/Y=Z4'_>:TJ27\J?(N
MKGK$XGX*?LV>"O@Y-<>)9;NYU_Q5J(SJ_BS66\R[N6/55)SY4?HB]@ 2V :]
M$HHKZ7+\NP.5858?"4U""Z+N]VWNVWJVVVWJVV>%C,;B\PQ#KXB;E)]7VZ)=
M$ELDK)+1(****[3E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BOSI^*7
M[>G[2'[3_P"T'\1/A'^S=\7-%^'.A_!WX]>$? FHEM#;4-8UJ[O;F'[1<S!K
MB.."P!9X4A",]QY4I,L8^2OK_P#9+\7?M*Z_H7B[PK^U3I_AH^(_"7C2;2+/
M6_"6GW%I8Z[I_P!CM+JWODM[B:9X'9;HQR1^;(JR0N%9@ : /5Z*^+OV;?VX
M_P!K'XA_\%?OBQ^PK\:_"?@G2/"O@CX7:;XC\/IX7N+F[N+B2[GB7?<7,Z1;
MBH+J$2% ,9);((];_P""@W[4?B;]F7X+65O\)]2\(Q_$KQYK]OX8^&4'CK46
MM=).JSJ\AN+QT.\6UO;Q3W,@3YW$/EIEY$! /=J*^7OV%M-_X+(P^/=6O/\
M@I#XJ_9SN/"W]C@:!:_!>TULWKWQE0[YY-1VHL*QAQM169F<'*A<-PGP3_:]
M_:S_ ."B6I_&+XC_ +%GC[PCX4\$?##QG?>#_ A\0>&7U(^.-9L8D>[N+J07
M$?V;3FED2"+R/WI DE9^D0 /MRBO#?\ @G%^W'X,_P""B?[(7A;]J3PCH$VB
M3:LD]IXA\-W4PDFT75;:5H+NS=L#=LE0E6(4O&R-M7=@>Y4 %%%% 'A?_!/?
M_DB>K?\ 8]ZS_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2DU[I0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%?*W[47_!7;]F+]G#Q!<^!=*-]XS\06;M'>6>@L@MK60'!CEN'.
MT,.01&)"I!#;3Q0!]4T5^?G@W_@O[\*]1UE+7QY^SYKNE6+/AKO3-9AO70=B
M8W2'\<,3Z9K[5^"GQV^%'[1/@:#XB_![QE:ZSI<S;&D@RLD$@ )BEC8!HG&1
M\K '!!&002 ==1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\
M_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_
M (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-
M[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6
MU;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;
M4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10
M!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P
M@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_
M ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1
M_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'
M_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[
M_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/
MS>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X
M%M6Q02 ,DX ZF@#'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VKFO'O[4_P"S
M7\+MZ?$'X\>$M*ECSNM;K7H!/QUQ$&+G\!6SXP^)VD^%_A=<_%C2="U;Q)8Q
M::E]:V/AFR^U7=_$X4KY$1*^8Q# @9&10!\P_P#!7+XZW?[-'[.$6D^ M9O;
M7Q#XROFTZSNEO6#VMJJ;KB5/]K!2,'J/.W @J*_'GKUK[K_X+ ?%'XL?'SPE
MX(\>Z[^S%XQ\"^'="U"]M(;_ ,5B**2[GNTA=4,"DM&0MJYR20<D?7YA^$WP
MFW^5XI\4VW'#6=G(.OH[C^0_$U\OQ=Q=E'!F42QV.EY1BOBG+I&*_-[):L]_
MASAS,N)\RCA,)'SE)[17=_HMV]$>=ZCH^JZ1Y7]IV$L'GQ"2'S4QO4]Q7MW_
M  3L_:0U;]G?]I70I)]5GC\.>(M0@TSQ-:K.41H9'V+.<?Q1,^\'K@.O1C6C
MXN\(Z3XRTEM+U2/GK#,H^:)O4?U'>O)-!^%/CRZ^+&B_#?0=,-SJ^JZO;VNC
MJC;5N)9)56,AOX1N(R3]WG/2ODO#CQ1R_CJE*A5BJ6*C=N%[J4?YH-[V^TMU
MOLSZ/C?@#&\)5%6IMU,/*R4[:I]I);7Z/9[;G] ?_"#Z1_S\WO\ X%M1_P (
M/I'_ #\WO_@6U<;^SU\0?VD?&PU:T_:'_9]LO!$MAY']FW>G^*X=2BU3?YGF
M%5C4-#LVI]\DMYG'W37,_%O]OKX1_ WXAZCX!^)G@3Q_I\.G&/\ XJ-/!MQ-
MIER'B23=#-%N+A=^QCM&&1ASC)_53\]/6/\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJ\G\'_ /!2?]A?QN572/VD_#UN6.-NLO+IV#[_ &I(\5[%X;\3^&_&
M6AV_B;PAXAL=5TV[4M:ZAIMVD\$R@D$I(A*L,@C@]0: *O\ P@^D?\_-[_X%
MM1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%%
M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M\'^)?$6I6=SJ+7:-XDUJ2^DM]T:)Y4;ORL0V9"\_,S'/-']D<1K;,G\Z5/\
M1(/[2R1[X%?*I/\ 5LXW_AMG2$XNOV;/B_ 1]]9O [ I]<2&C_AN7P&G-W\(
M/B7 O9IO!DH!/IPQK)\9_!?_ (* 6/C#5/$GPN_;*T&XTR\U&>XT_P ->)O
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M0_X7)^UU\0_D^&'[-EKX<MG_ -7JOC_5O+/XVL'[U2/J:/\ AG3]H3X@#?\
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MCA*4:<%TC%17W))'C8G%XO&U?:8BI*<N\FV_O=V%%%%=9SA1110!A^"OAGX
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M?YOD?U;ZC4Y.?GOI%WMR6^)/N]C]=/\ B*B_ZL2_\R?_ />RC_B*B_ZL2_\
M,G__ 'LK\BZ*^\_U,X:_Y\?^33_^2/S;_7_BW_H)_P#)*?\ \@?T7?\ !*[_
M (*H_P##S+_A._\ BQ/_  A/_"$_V7_S-']I?;?MGVO_ *=8/+V?9?\ :W>9
MVV\_75?D7_P:N_\ -=O^Y7_]RU?KI7Y+Q-@L-E^>5</AX\L(\ME=O>,6]6V]
MV?MW"&88O-.':&*Q4N:<N:[LE>TY):));)= HHHKP3Z4**** "BBB@ HHHH
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M= _M"X"D)Y1MXV(CR/WFX/URN,8.?2** /FG_AW1=>/3YW[2G[6_Q-\=[_\
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M=/\ @U=_YKM_W*__ +EJ_72OR+_X-7?^:[?]RO\ ^Y:OUTK\'XS_ .2EK_\
M;O\ Z1$_I/@#_DDL-_V__P"G)A1117RY]B%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!^6O_!9?_@E?KUO\9O#_ /P4K_X)
MY?$=O GQUOO'OAS3=2TJYEW>'O&-U]O@BM&U&'!"R1R)$3)M93Y0RH?]ZOU#
M_P $HO\ @HOXB_;]^%7BG2_C+\')_AW\7/A9XH?PO\5O!4DOF0V6I1KN$]M)
MD[[>4;BF22"K -(H65^*^,/[%G[?7@ZZO-'^ OQL\'>+_"6K?'NR\=Z7X?\
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M?M"?'>P2#QEK&BW%KXE9(5C%S>65[<6,ESM7Y5\XVWG87"CS?E &!7TG7/\
MPI^%O@#X'_#/0?@]\*_#4&C^&_#&DP:;HFEVQ8I;6T*!(TRQ+,< 99B68Y))
M))KH* ,GQU9^,;_PC?V?P_UBTT_6I("-.O;ZW,L,,F1AG0?>&,\5Y#_P@/\
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MUSOQ._:<_9W^#(D7XI?&KPUHDT8RUG>ZO$+@_2$$R-^"FD^ G[2?P?\ VFM
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MC>OTS7B_ZY9#4_W:4Z__ %ZIU*B_\"A%P7JY)'J_ZL9O#^/&-+_KY.$'_P"
MRDI?))L]4^Q>-_\ H-V7_@,?\:/L7C?_ *#=E_X#'_&O*A\-_P!N+Q<,^*/V
MA_#'A=&_UD'A3PQ]JX] ]T0P^O6E_P"&*[+Q!\_Q2_: ^(GB7=_K+2?Q";:T
M;Z11*,?]]4?VYG6(_P!URVIZU9TZ:^Y2J37S@@_LG*J/^\8Z'I3C.;_&,(_=
M([?Q5\0M-\#*S>-/BWX8TG:,D:E=Q0'\G<&O.]9_;C^#.FW9TS2?BQ!KE[_!
M9Z!H-S=N_P!&1-A_[ZKJ?"O[%O[+?@]A)I?P6T>=P<^9JL;7K$^O^D,_->B:
M-X?T'PY:"P\/:)9V$ Z0V5LD2?DH HY.-<3O+#T%Y*I6?WMT%\^5^@<W"U#:
M-:KZN%)?<E5?XKU/RM_:L\>?&WXC_$8^*?C)H^K:>LZ/_8-GJ.F2VD:6@8@&
M*.0#@X!9N23U/2O,:_77X^_ +P'^T3X#F\$>-[/##+Z=J,2CSK&;&!(A/Y%>
MC#@]B/R^^._P(\>?L]^/)_ WCFQPPR]A?Q*?)O8<X$D9/ZCJIX-?R)XJ^'F>
M\,9C+,JU66(HUG=U6M5-[J>]O[KV:TW5C^DO#WC3*<^P2P-*FJ-6FK*FMG%=
M8[7_ +W6^O4XNOO[]@/]G'Q!HWPMA\8>/_AGX:M+^ZG\_1[W4=(674#;MR&D
M+@^7D_=Q@E>HZ9Y3]@O]@OS_ +%\</CAHOR?+/X?\/W4?WNZW$ZGMT*(>O#'
MC /VS7Z9X+^&.*P,XY_FL>5RC^[IM*]G]N2:T_NI6?5]CX3Q1X]P^+B\GR]W
ML_?FF]U]F-GK_>>JZ+N8PL?&P&!K5D .@^RG_&E^Q>-_^@W9?^ Q_P :V**_
MI@_"#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/
ML7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q
M>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V
M7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?
M^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:V
M** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_QH^Q
M>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:V** ,?[%X
MW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?
M^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X
M#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8H
MH Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%X
MW_Z#=E_X#'_&MBB@#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?
M_H-V7_@,?\:/L7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X
M#'_&MBB@#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,
M?\:/L7C?_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@
M#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:/L7C?
M_H-V7_@,?\:V** ,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@#'^Q>-_^
M@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Q_L7C?_H-V7_@,?\:9/#XQMH7N;GQ#
M81QQJ6DD>#"JH&222>!7E'[6/_!0;X _LE7-KX-\0WM_XF\=ZL OA[X<>$+4
MWVLZC(P^0"!/]4A_OR;00&V[B,5XW;_LI_MD_P#!0>5/$7[??BV7X=?#>9Q)
M:? SP/JI$]]%G*KK&H)AI,\9ABPO0_NG!KTJ&72E25;$2]G3>S>\O\,=Y>ND
M5U:/)Q&:PC6>'PT?:U5NEHH_XY;1]-9/I%EKXD_\%(_B#\2/'EY\ O\ @G5X
M-M/BYXOM7\K5_$\49B\+^'F/&^YOLA9V'410D[@"%8LI6KOPF_X)A:WK7Q"M
M?VB/VYOBO#\8/B';_/I\>KV9_L'0"2#Y=A8<1C! _>.N25#[5;)KZ>^%WPG^
M&GP2\$V?PX^$?@;3/#NA:>FVTTO2;188D]6(4?,QZECEF/))/-=#5SS&-"#I
MX*/(GHY;SEZOHG_+&WFY&=/*IXB:JYA+VDEJHK2G'TC]IK^:5WU2CL8PL?&P
M&!K5D .@%J?\:7[%XW_Z#=E_X#'_ !K8HKRCVC'^Q>-_^@W9?^ Q_P :/L7C
M?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^
MQ>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C
M?_H-V7_@,?\ &MBB@#'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@#'^
MQ>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &MBB@!(PXC42L"VT;B!P32T44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 >%_P#!/?\ Y(GJW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[UG_TI->Z4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%([I&ADD<*JC+,QP /6@!:*\F^*7[=7[(?P:,D/C[]H#P[#<Q<26%A>?;
M;E3Z&&V$D@/U45O_  !_:"\'_M'^$[KQKX&T'Q!9:?;Z@UK#+X@T62R-V B/
MYT*R<O$=^T-P<JPP,#(!W5>#?\%._&.L>!?V#OB/KNA2NEQ+I$-B63J(KJZA
MM9?_ "',_-4_&/AC_@I3\1?%NJ:;X?\ B=\.OAUX9CU&:/2=2T_1YM6U6:V#
MD1RR1SD0*S)M;:.021VKE?B%_P $OYOBWX%UC3?C+^U=\1?&6MWFFS)IQU35
MQ;Z5:W90^5,+&%=N%DVL5W$$#% 'XS59_L?5?[*_MO[!+]D\WR_M&SY=WIFN
MZM/V=O'6@_$'4_!'Q*T*YTB?0KYK;5+>=<.95/W$/0@C!#C(*D$$Y%>G_P!A
MZ1_9']@_V?%]C\KR_L^WY=OI_P#7_&OQCC[QCRO@_,Z> P\/;U$U[5)V4(]5
M?_GX]TMEUW/U#@_PRS#B; 3QE:?LH-/V=U\4N]OY//=]-CYMK]A_V7O@%HW[
M:/[%/PC\1_%CXC>-[2VTOPY+I\^BZ#XDDLK34D@G:WC:Y1!ND8) ,,&!PQSG
M-?E\_P"S?X]\3_$?2_ 7PRT.?5I]>OEMM+@B&661N=KGHJJ 6+G@*I)Q@U^X
MOP5\!>#_ -F'X#>%_A7>^([*VM/#NBPVDM_=SK"D\JJ#++\Y &^0L^.VZOT[
M)L_RG/\ *H9E@JJE2DKWVMW4NS6S3V/@LSR?,<GS&6!Q5-QJ1>V]^S7=/HT8
M'PR_8-_8\^$)CF\$?L]^&TN(L&.]U&S^W7"GU$MR9'!^A%>M0PQ6\2P01*B(
MH5$1<!0.@ '05YCXJ_;1_9;\',T>J?&G1YW!QY>E.UZQ/I_HZOS6'_PVI8^(
M/D^%O[/_ ,1/$N[_ %=W!X>-M:-]996&/^^:Y*W&'#%"HZ?UN$IK[,'SR_\
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M\2?'>U^'7AOPHD<OG>&M >YN]1=BA$>^X?\ =#:^TG9P0",5M?M _L>_!O\
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M&*Z))+[D?D=6M6KSYZDG)]V[O\0HHHK4S"BBB@ HHHH **** "BBB@ HHHH
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MS?FVWYG9@\LP^#FZFLJCWG+63\K[)?W8I178****XCT0HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !%\7MIBV4=]>NBQ106UL'D^S6D$2+'%$TDK ;BTCLQ- 'S'\ ?^5F+X_?\
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MQO\ PC?V?P_UBTT_6I("-.O;ZW,L,,F1AG0?>&,\5Y#_ ,(#_P %!/\ HO\
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M'W\R!=W;_)H^JY9+X<3;U@U^3D'UW-X_%A+_ .&I%_FHGU%]B\;_ /0;LO\
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M  2S^%SZ;JEM'"?[;V)) 6(_XGE_GGZYK^>.OVB_X),_\%-O@?\ LZ?\$_?
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M /ECZ'_\@T?\/W?^"K'_ $=/_P"6/H?_ ,@U]Y_Q#S.O^?E/[Y?_ "!^:_\
M$4N'_P#GU5_\!A_\F?T+?8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-?ST
M_P##]W_@JQ_T=/\ ^6/H?_R#7Z+_ /! 7]N[]JS]MC_A;/\ PTY\5/\ A)O^
M$9_L'^Q/^)'8V7V;[1_:/G?\>D$6_=Y$7W]V-G&,G/!F?!N:95@9XJM.#C&U
M[.5]6EUBEN^YZ>3\?9/G68PP5"G44IWLY**6B<M;2;V78^__ +%XW_Z#=E_X
M#'_&C[%XW_Z#=E_X#'_&MBBODC[<Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V**
M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
MZ#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'
M^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:R?CO\=_A3^S-\*=5^-WQN\5
M?V)X7T3R/[3U/[#/<^3YT\=O'^[MT>1LRRQK\JG&[)P 2/G/_A^[_P $I_\
MHZ?_ ,L?7/\ Y!KMP^79AC(.="C.:O:\8MJ_:Z6YP8K-<KP-14\37A"35[2E
M&+MWLVM-&?47V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XU\N_P##]W_@E/\
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M&HE8%MHW$#@FEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M _W'MSG X'/:OKNBJ_MK-'O5;];/\TR?]7\F7PT4O2Z_)H^1?^';/[2>D_\
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MI_ADF_\ P%VE_P"2G] ?V[@Z?^\1G2_QPDE_X$DX?^3'U_17A'PC_P""GG[
M'QP:.#X??M7>$&N9>(K'6-0_LRY<_P!U8;P1.Q]@IKW.TO+34+6.^L+J.>&5
M \4T+AE=3T((X(]ZX:^&Q.&ERUH.+\TU^9Z.'Q>$QD.>A4C-=XM-?@24445@
M= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOD$_$O\ X+3?%H >#_V:?@_\)[:4_,_CGQA<:Y=Q+ZJ-/41E\=FX]:#^PO\
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M=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%>1_MZ?M7Z/^PS^QS\1/VMM;\+S:W#X%\-S:C'H\$WEM>S@A(82^#Y:M*Z!
MGPVU26PV,$ ]<HK\[O!WQS_X*>WG_"?_ !Z\#_'3X=>.)M&^&7A+Q@?AY#X-
MNDT>_M+V"_N9[;3+E+YIHIO)B_=W$@E6=U3=%&&&SW3]N?Q5_P %4=0^(GAS
MX:_\$U?"7PIM(8=*FU'QOXP^-$6HG3EWR>7:65DM@?,EN/W=Q)+D;8T\G)!E
M7(!].T5\!_LC?M#_ /!8B/\ X*2VO['7[;&N?L\ZIH-K\+KCQEXAN?A/HNLK
M<6<;W?V*PA>6^F"QO-,MPX'EOF.TEY4D&N@_:G_:;_X*2?&']IW7OV=?^"4?
MB3]G:-_AK9VT7Q)N/C1J&IO/+J=W&MQ';6<&FAG"P6S0/+)( I:]C13NCD
M/MRBN%_9HM/VDK+X&^'[?]K[6/!M]\1_LSMXIN/A]:W4.C><97*I:K=,9BBQ
MF-2SX+,K-M4$*.ZH **** /"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)Z
MM_V/>L_^E)KW2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8>&Y?'WA[6[P2>(O!.G7DU\ML]C(<">WMY//RORJ?/ 98SNN1^V'@[Q;X?\
M'WA'2O'?A+45O-*UK38+_3+M 0)[>:-9(W /."K \^M?"_Q%_P"">7[<O[67
MBWXG_"3]J/XS^"])^'GQ"\/>&-,\9Z_X"\+S6]]XGL[*2]>XLK1+B_F_LKS/
M-1999%N,I*5BP<NGV#\5/AGXGN?V;_$'P;_9\URR\(ZM)X,N=%\&ZF]NSP:)
M,;5H+6;RU(9EA.Q@H()V 9'6@#Y^_P""7%LWQG\9?'3_ (*"7[B9/BY\3)]*
M\&7 ^Z?"OAXR:38,F>0LUQ'J-V/47@..<UYM^W=_P;S?LA_M'ZQK_P"TE^S7
M)KGP@_:#FU"YUW0OBIX5\3WT<KZPY:0/=1M*R&-Y#AC$$D ;Y6P-I^S/V:?@
M5X2_9@_9Y\$?LY^!$ TCP/X5L-$L'V!3*EM D7FL/[[E2['J68DDDU\^_#3]
ME;_@JMILWB+X;?&#_@I7X;U_P3JVIW4ECXAT_P"$J67C"SL9G8BT@O(KL6,#
M(AVK<-9SN.H"G;M .F_X)!?M-_%G]L/_ ()N_"K]H3X[V"0>,M8T6XM?$K)"
ML8N;RRO;BQDN=J_*OG&V\["X4>;\H P*^DZY_P"%/PM\ ? _X9Z#\'OA7X:@
MT?PWX8TF#3=$TNV+%+:VA0)&F6)9C@#+,2S'))))-=!0!D^.K/QC?^$;^S^'
M^L6FGZU) 1IU[?6YEAADR,,Z#[PQGBO(?^$!_P""@G_1?_ G_A*2?_%5[I10
M!\X?\$\;'QXOP-U)9]=L6D'C351*PM3AI!-AR.> 6W$#L"*]W^Q>-_\ H-V7
M_@,?\:\C_P"">_\ R1/5O^Q[UG_TI->Z4 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
M0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO
M_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL44 8_V+QO_P!!NR_\!C_C1]B\;_\
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M6Q17\YG]6&/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XUL44 8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MPO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/?_DB>K?]CWK/_I2:]TH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO]/AMK+^T44OHNI&ZN86LTMKB/<+@+(LD,N5S*ODD XS_@UEU[4[G]ASXJ^
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MX5]_P4/_ .C@O G_ (2[T?\ "OO^"A__ $<%X$_\)=Z]ZHH \%_X5]_P4/\
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MA_\ T<%X$_\ "7>O>J* /!?^%??\%#_^C@O G_A+O1_PK[_@H?\ ]'!>!/\
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M\)=Z]ZHH \%_X5]_P4/_ .C@O G_ (2[T?\ "OO^"A__ $<%X$_\)=Z]ZHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME_L9_LD_$3]JG6/#%QK4'@+PG>:Q_9%J^Q[UX8R4AWX/EJS[0SX.Q26P<8H
M]0HKX,^-'[9G[6G[+O["?A'_ (*3>*/C+X/^(6CZF_AF]\3> ?#_ (4^SVEU
M8:S=VEL(M%NEG><W$1O$=&G,RSK$XV1%P4^\Z "BBB@ HHHH **** "BBB@
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M+:YC8$Q$+-$P<1Q;&!\*_:C^.?\ P7V\/_"'7OV\/@;H/P8TKP3H&FS:_8?
M[Q'HM_/X@O-!A0S%KR[#HL>H- IE-K%M6,GRM\CK\X!^D-%>/_L9?M86O[;7
M[%?@?]KGX:^$DLY/''A*/5+/0=5OVC2WNRI5[62=(G(19T=/-$;$J-X0YVUY
M!_P2S_;5_:6_:T^)/[1W@;]I7P_X4TN\^$?QBF\(Z/:>$(YS;FUAMT?S6EG.
M^9W+;MQ5!@@!!B@#Z_HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA7=865<D ^RZ*BOIY[:RFN;6S>YECB9H[='56E8#(4%B "3QDD#GFOC'PO\
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M[V6V#NZQH S^5N* $*6V[FQN(!]!T444 %%%% !1110 4444 %%%% !1110
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MEQ#:R3ND998(BH:0@9"C<0N3T&2!ZD5\W_L#_P#!1!OVX_B1\;?AS<? /5_
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M17XN5_1=_P $(O\ E%/\*_\ N.?^GW4*^+X[GAX91!UH.2]HM$^77EEULS]
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M(O\ :?\ A/??#3QM)9ZD;'4M2UO3+^PEO/[<;6+!Q)IUW<,(O-$"R;E5@ ^
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MXF?%WX#>./"]S+=^/_&_P<E\.WO@?68(YI%AFGCTZP@N;6<1JBY@WJ\R#?\
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M.'Q+^%^G74GAGQ;\1/%5M::WKZRH5;1DBTF><V]LV^5A<W$J,C,R+#LGED0
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MR=K_ (TTCX/?'O1_'?B_5;3Q-H5BC65G/!(T%NE]J$,DDS+Y@ **N4^]@@T
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M9>,/V0HIO$T$9^22:#6)!#,X'\:K%&@)Y"R$=&Q7Z'_%G_DE?B;_ +%^]_\
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M7(UN]UJEU)I=TDD=Q=1RJD-K+;-##L+NSL0FWX)_:I_X*I?'K]BOX&>,[_\
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MA5^PC\1_!FN72>7)K/Q<ATRRTK16/!EE6TU":XO2O)6*W0K*0%:: -YJ_/\
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M_'/ASX/ZOX)\+_$+0O%>DGPUKFF)8RVUG*CO<BZ%P83%$D MVWNJF5K8,YB
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M8W$\<D!?=L+,LFT#<BF@#T&BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC%O1-[_\#M=VM=W****]4\\**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>mck-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20210331"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mck-20210331.xsd" xlink:type="simple"/>
    <context id="ic5118698b0524b279b93760d74efaa12_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A0.625notesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9650e19e52e846e28fe7e52623004983_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3.125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9e194b3a461f4ad28b6e6b95517ccd7d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5dbd0bda906d4b768524dcfc6aadc6cd_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6d8ec19e753d451794e088409f68157c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i9ff0501dacd84f6d9a8a0874bbdc5b3c_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i694f7a1a7fe8492981ba38c56efece34_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i7fa47717062f4d0faa776c2def60876c_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ibe7f6d03c0214b888f11ce73ebb56fd5_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i33d5e858b51e4d099bb4436a00d94e8a_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="iae70566f5363452bbc98260415fc04bd_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i022a2642b16245d083cb80c539e560b3_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i61b7fb92a6f244829cf78e65a255ee88_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i8246b55c8e504364a5c352ba370995ad_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i4a514ba214224efd98713a38fa41dbe7_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ibe8bfcf07f30410981669a5bf1af7c02_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i58e169e9c83f487291f51edc0b6c3ae1_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i93dcfcc89c2542b0928b50c7d3e432c2_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i36dce71a26114b94909aaa9ba795fdb2_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i04b14f9878614f92a269ff6fccb37f69_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ib174f082f2e349489ff2dd2b20330381_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i1dd683332b3f4798998789f66099e34e_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i5ccd14692cf3450cb539e1a2cf941e8d_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="if1f6cfedc37948ddbaa4a17a60061842_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i84e4eb45170844d593b83b2afa4fab92_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i48ceaabbb16f4ec6b0bf0f94817e2803_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id46086fa9b504b8fa9969e5e6955dfca_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9f1dcb375e934b61af2234db5c9acb4f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i51ee753b2d3f41df8075fc700e912fd6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i40ae5de5a7ed451daaf6f336a3613e5b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3195958993f542039d26aa1dc1a5932a_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia4544e477b1841a4bdb6022ce255ba46_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i56c41e20baa14761a136adaf102659bb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic0a498773ac34aab9e6acb8ed6ca7397_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ie6cd908e9ae944c589f15bfc5295981c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i127912e4703a4c4b93b3568d503e21a8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia8b8e2f7e988499db2ca37a472ba95a1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5501cbeadb6d4216937dff20e26e9da7_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="icd6fff2a93e148f184cb8d32b86c426e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7317175ef4774a10ab306d8ad80b27be_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ibfa843649b4b43898ba141c6242d8f29_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i28ca8bc8a3df45a680bddb6d68e1a14c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i16590f20bcb54d93a46c868388bd8b15_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i818384a7497d4ec3b819a10a8009bce7_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0854da8f001b4fb5b20e5b1a8e5cca76_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6bd1bf93b1f14f26ac73ea236f36768e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie3f8f7c8825848e3b9c0073f40137455_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieace64892e6e4c64b170a9943f943cff_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i06dd26a3871a4b7ebada11dbaa7622fe_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7a5bbb75dc3b4b22a7678ca731073aea_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia36cd1fb5104458194118cf1f7a5b4e5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic6c63db23ba743c9a62c831ddf5c11fe_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i47ce9e7fee2540b681fbd42059c7386b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8bbfa761b88c4adcbd3850e152c97132_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i405042e0c105499e829dac8d3ddb2458_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id919c60b59754f78a678ad703c842d1b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i209c6d9d06f94525a18e4a67e9b962a5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ice9f595a7fdb4b7cbdd8bf02e8444022_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if7e42c0d706c481b84e088c5d5c7d229_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i93e9843c614c4c8790797c45327bd623_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i460cb8fdc68d4e3ab755d83b3ce58795_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id5bccaa8d2ae4c7dab8a934455b32ae4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic23d25bd272041a8865720072fc8a546_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i164671a6fa094474b24478df67ffb27e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8c2be497f4e442e0a366c6eda71cc339_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0aece504dbcf4457aacac81f8f54a390_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i703f281903e14c92bc829e04ebb959ad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6290fbbe29f84c1db97283a012272162_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0516ac692388404c8f088c9e1ab4cc78_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb86a9ba62104883927379cb8bd96649_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9384c8d2c240451493d40ead28d2d250_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13f69d981df240f483b999053f8a2547_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a6bb29286494ed2aec32dd02ab9445e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iea92921488274912b519ed84b11ab23f_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3130d916740b4d2393240ae5139a6d53_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1a9fca715b904e98b76ea386572b0b03_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i93f771eff0414af9b947ca5a7031556b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie1eb1f08e1664c6cb53a8da1be89cca7_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i52d8e2f4787a4d32a764107acdbc0c3f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f49f517b19c4c2794bc573c91dfd166_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iddad10a5e1484e3ba28181133cb79477_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic7262554200c4a4687b065b0139747a9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5b15db7a10914e64aff0c0319c0b1858_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4dfc9a103be247469a824e16d2593cc4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie77f379fcbbf4fabbb3643c1b75c74a4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i53d8a73c06cb4aeab2d0b96b4bc01eaa_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia82280b01acd4961b7aae7ec8926f663_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i76008cf481ff411789c581d87a72f149_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8bb50cd186cb4d44ac0d335a56971982_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i20b5a4c9debc4c86ab2c641342640b2b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9bdf98ffd5304512a88b518b82d6beb4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife3b4b3b997b40d1a537f1ca3f6bb09e_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i60451fdfabe047148d4b51b02b328315_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i8b559a4e264f45ee945d6b0221a18668_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i654d1dad39ce486b88ccef35f4514f39_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="ib7818cbb3de24ccbb1dac5ff7b38d12d_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="ia627eaf413b944f6b1c661f64f89cf46_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i259565e15d4a4094b3aced351e91b60f_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i3ac6925e5e124f20b294923d15d675f7_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i361b795666d34b31b8211423ea941c60_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e5bd022186748f590c69707cd4dd76e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-10</instant>
        </period>
    </context>
    <context id="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iedbe6776c92141caaf1984304c817a24_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="iffd00748603f4a9080c3102d09966644_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ibcb31c3511004f7bb84b6fba7982478b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1e6a6da26e9b4155a7aabc172f840db7_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i30576561fec8410d980f65c38dfcecbd_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="icd767dd763314f3aad75379a29aafa5f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9433d8dd83764dfea4d20d7175cc58c0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id1030ca9e1fc410c8e4ba04e704c20ad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5e9b372ac3ef458da34c6cb29ae83063_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2d40932572f640b9bcc963fb3703530a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i26588b430f834252bbb0d603ebc07230_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i042fc3b5ed1f4aa3a5c7fc3404044ced_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i8b846dbf18184734b8d20351ecc09b72_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i841091b6641c4e1fa2288424caf2b82f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5c09144465e346119dd58fd135e50dc7_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6e4b982be8b4c07a12efc2fd23a51a9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic5f50743c2174eb7a016ece0cb708476_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i4c88f05a91c64ccd9403c9344a22b92b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaaaa8cff6eb04a468bc164e1f8da8570_D20191212-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-12</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iea5796edba9442e6b00a331d1b1e9822_I20210512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-12</instant>
        </period>
    </context>
    <context id="icefee79d5ff5443ca7262dbcfe111692_I20210512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-12</instant>
        </period>
    </context>
    <context id="icfff1c8522e849f6b8c9ddbfa45a1161_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i46055f5e4516432ba38d8c9b9db6958f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i912d8febc0b34abfb3c6779710303600_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0de6ea66ebe14d0aa48b24590c1d9d98_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6b7c3bcfde504c2e81c6aeef0f7c2335_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if2c5f4c8c13a414ca948dcf78225083b_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i07b3c611cb044e9f8e830461fdf3567b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i321f8a74eae848a98872fbdb652c3f4d_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1c1bb20faa42444db36850f067394ea5_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i0577d068867b4047b8f768bd9973668f_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i80ffc4dde20a400090fcecd0cd478cc8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:OperatingModelAndCostOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i873585d906e0415888503e1bd163b490_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idf5263ca156f4aaf9c2116924eccdf08_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i93911baafae14119b73921f40093ba4c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i092c23031111426996897acf81001bca_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1294e78624d84a32b4b75b80df724f52_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9a7bd3f5bbee48eaa0f146d217a2f213_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id80b896d088b49df9c9446e7f21d4353_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="icb32341a67694453bf4b80c090e9acd1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i81dcf14d4c484311a890c1aa873abcc5_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7b443c41cb334b4084c134a614b5a4aa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1cc2495d4fd44412ae23a2d9511fc6b0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i59d6c47ebd084b828cdbdba1b8f159f8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i44f353b74f6e48ea8c63365f74249445_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib36b955ce23d4198b6aa3769dcf60d35_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3156368b6aea45b4b87b5079622f2703_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie781b28ab2254939ac913ef650232aa3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7d7e3dfff1504af6a6970090a4e7c85f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibbfa7f443c9f4c30be51cebaefbd7dd1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i07652793af6e402c8f56ae5bf525de5d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8770b26e8a104e24a96561be14d9b01f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i47cb8d8061744a318fce0b3384617786_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i33bc232cff8a4f12a4e890a4672e8218_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i90e94470ed16447396b9f1012b944606_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if2f8ead53d3e4be5b9320bb684b9f13a_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9fc5fdf86d854199b0de26fe3d7aef0b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1f79d90a93144c60981f623c356fc6bf_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i18d5408029404b5aa8938a311b6434f3_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:IntangibleAssetandStoreAssetsImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1a36ca67ff5f42bbbbcf4d6660b6af27_D20180601-20180601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:MedicalSpecialtiesDistributorsLLCMSDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-01</endDate>
        </period>
    </context>
    <context id="i60d887dd975b47fcb23c06b79e73a02a_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:MedicalSpecialtiesDistributorsLLCMSDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i4ca54959e5e04b8c9414f83bc32f7efe_D20180601-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:MedicalSpecialtiesDistributorsLLCMSDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i1182c1c4af8746449b50307d67f448c1_D20170403-20170403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-03</startDate>
            <endDate>2017-04-03</endDate>
        </period>
    </context>
    <context id="i3088cf57426d4c8e9292e7c571001c3b_I20170403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-03</instant>
        </period>
    </context>
    <context id="i616817b40eb74cfb8ae329d9816e7420_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="id07b7f77830b43c69cfefaf0b8e7b960_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ia99cfa38235e449aa90c06cd0c7c8a59_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:CoverMyMedsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia84584b6586641aaa11065062b0d4dcf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i68df8813101f4e9ca695e42eb2c1ba7b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i28e93491e63641d6a447af76bfba5be9_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i74e9a04c993b47eea348dc69be94ad03_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i33ea0a3bee2a42b3b14918ca313d0f3f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7752154a30be4b70b7c200da7c5e0314_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2875e0d883e04e789a166269b0168d5f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i52d6d0051e254f03868cd2b4c4a08616_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1bb3af9567d84570a2e07fa7cc1ca3e8_I20130731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-07-31</instant>
        </period>
    </context>
    <context id="if9ea335282264bd19c87da915b541a3d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic14d146f7e5242688d6fe3f6efc8e39d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7bca6f61ec8d4af0a1acb791483f3894_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7d84699d924747a3b932295e7377ba8c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3dc1c1e592264d43b77791466a65bd52_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5481893297be481981506a5801e443ba_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PeRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iaa9c17219d084d969cda29f0f32fcdaf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i00b9e27715eb4321801361f74b4928b1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="idba7d670fc874663a124e1d3598d51de_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3383581875ce407cb2084a70eeee7980_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i98600c393115470c98af4ebaf984768f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac7d90041b41485e9c066b6c9648022c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8db5d79f8f98449ba80a73798cc2250c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iabba4ee1a62b45e6bbc176b0dc8941b3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i521d39c0b3084c2d99a90fc226922cdd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i79ee321ad30d41dfad64c6a2f32533ec_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia5415cd5dc724d9b839b382de490cae8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iad526e199d5f45e8b0138cf1dc4218d3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifbba704ea17245a79664996d4d4b9fb9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:SettlementofExecutiveRetirementBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iff2be0b266e4404fb2d3170fc25c0e2d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:PendingAndFutureOpioidRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i8758a2f6ea4f4877a3355c52d963a658_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9be1b4de02944aa881e317723693e477_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8132f157c2a4e22b4c467d61f9c078e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f9c0a94c8b144ce82c5a2e1c8a76a41_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i864d4657d9144642ae333aa935acbc46_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="i061bc9a2eb8443769ce87eeb86b06600_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3bd3e34ab71b46dc924bf5b41dcdda09_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie7aa6fa69f9c4cda930b030fe075c224_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia5de4bf26a814949a75f192c559706a9_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="i3f55ef7798384062876c3372deac9867_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i587fb85617b64a75ac242f855f331d8c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idbc43acfc0194bbeb7cffc75f3ccb983_D20180919-20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-19</startDate>
            <endDate>2018-09-19</endDate>
        </period>
    </context>
    <context id="i78e6c9a100924eb4a8e0c5dfffff754e_I20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-19</instant>
        </period>
    </context>
    <context id="i39fe8b1ce4de400880c9ed586d6d03db_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id1f5f4ec4cae4f6e9da1a608fe5d9874_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i97e4424a4e7440b9964b4ce2f73e59a5_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="id76995eaf2114e8d988d829663827be2_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ibeede0913be2432eaa8dd89edabc33b8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i340398f3d8eb427ab2285890104702d2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i44b9841e941249b08fc5e771cceb886b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f6f0649588c42f2bdddd0e48e3b2d52_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0d9d3f777851405d93c2e2401895ce61_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i892cb0c916c746b5913bcd1ffb140a80_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="ifc7244d83910406eaec9d88c79969937_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="idae8b11cffbb4c71a6764d8f5f1dd25b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i655f79d1e2274f738d115518f92c4d45_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib2785c217ff445e9ac72874428f97a52_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9cfec5575dbf43a9a693ee576ed1162d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if42165365f8c4ba0b45f5d4a12bda439_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:RealPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3dc566d0125146099a9b13ba87eab912_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib50261dbb728457db6b2202486d75ef0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i064068b262474876b81e803f24785e0b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5ccd5ab037e84574a05e7c5dc7569e59_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i13ccd1d1dd0a411aa2bfd0ef422868fb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i364113e13bbf4a32a9613f4ab676e5a9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ice65da80b2be4a598701b12640e24cff_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8a47ac4fb69943f8aab869a358429d1f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i30c8074ac9194cc5b11720dc788c0285_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idf0f12f556ae4391817c093cf4fca373_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iab002e4a10964495a81aca3a26ea2afc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib938fa6a5d404ab8951cd038035b8ff7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie5a85046f59343e3874040608ed73655_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9d099d3619b4467b8a30ab61cc9c0d8e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i797fe852990443559f1b76029e7fcf9c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id273e9fcef44447d91bf8cd1482cdbf9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iccdd71b92ffa4cb2b159c9a557fb6ba8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:PharmaceuticalDistributionsReportingUnitJune2018OneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:PharmaceuticalDistributionsReportingUnitJune2018TwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:PharmaceuticalDistributionsReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia1bdeaded28d4c20b8bc6c14bf14a03b_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i51bc045598984a19b5941cc09fe4a679_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:EuropeanPharmaceuticalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i525585ece4e54dc0a604cd4df25d2040_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if73673afe5e746dd9e39e057c20d1cf6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7c7700e033044992bf7e96f6acc26b3f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i186279a7a33f4fcfa37e6fef3fe64356_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i35c8579ef483457a80d6870cfb506627_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i77c566e2cc944ab4adc2b416c6c7c147_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1f4ff464ee184805b122b85d506ac0dd_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if42e75c31e164d77af6f02af0d548d0d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaea9dc7de4704cbcb84065259f650ed8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i07691837bf0a422d9cfd06b65bbb66dc_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if54e2d3096fe4a5bb88683649ed1f110_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8b90045a4160435fb93b6eb170a34cff_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idad5179cf12841eb8fdb5f299a912be3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i463096ed8566457a89faf1810193937b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i37afd48eccae41908ebb82b9e0f372ee_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i807ddd84576b420db9656e79fe28a804_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i366c1509c4ae4991b52b1307f982e915_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5a0dc323a371466e8a0168d08ca2e5f0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i51455de7ffa1400baa450520b0823664_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic8cd624dd46b47528454592cac989b47_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i718d836dece1446592aaaa01bd324fa7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1f0b9a87ad6e4141a43b6aebf1030aae_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie61256ac66bc4a89bf0d0e09ae475b1a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i587960ff5f064537a59834dc9b5fbc36_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4c1ce0a35b1b4a30af455e59d15c6150_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9ea3a78f9a71459f928d5d15a5f30881_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib9a0f7b532354353862735fa61a7edbe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3ba3a1f603304391b936ce6bcb7a6a27_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic3407317f0374140aae578c6d0eb0b07_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6926f446a23d49a8b4e4110e67b160cb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i133b5953d54f4f1bb1cc4a7cb16391a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibbc40734152a45aeabea7c982026d0fa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i64567396009c44829d2a1fd050d1a1b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib84ee20fa4f8433396754e0437027fb6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifadf20024dc74f81b440ab0ab2eb2913_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SixPercentNotesDueMarchOneTwoThousandFortyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id423c4b7c4a945db8071e337c9c82ed1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SixPercentNotesDueMarchOneTwoThousandFortyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0bc1a0012fd84f509095b06c9f66d6bb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i79cf5d2e990240698629bdc50a7c0b88_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iad9c1207b15f466a861980e7222a1537_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iee10f2cf891e40f2a38c0aced30d76ea_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i392b65805f5f4e48a0907f99ecf50ee2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5014024a7cf34617ac4cd1a096cecac1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3ee0c0121e554ad5b84e809395a86c66_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i54751c16577f40f1adff8f7e2bff79f8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4b5b1fc662a44e0791f2dba244a47860_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie1a099094e354b889a5a5c3a182329bc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2976b57beaaf4c6b8a89e64c910a5a7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6d39d3584f824d5dbcfadf658383ee87_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iba24a5eef2484a6dbc6addbb8b2b3743_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:LongtermDebtCurrentMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4aa607516b08415b8dce58c739355d62_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:LongtermDebtCurrentMaturitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2aada2c5a8f5413086253c28368973fe_I20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-03</instant>
        </period>
    </context>
    <context id="i1c1c7b3092c543bda3ed926c574d2405_D20201203-20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-03</startDate>
            <endDate>2020-12-03</endDate>
        </period>
    </context>
    <context id="i61675c05b34a420fb0aef206c120e3cc_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i933936a7522f4f269eb80826407de7b6_I20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="ifb20c63e640a48478f01df43a5ecbce5_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i901c6c235d094bfeab2e2891bf22868d_D20190315-20190315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-15</startDate>
            <endDate>2019-03-15</endDate>
        </period>
    </context>
    <context id="ia7191c4e470a4de89c4f6e0fc96b493c_I20190315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-15</instant>
        </period>
    </context>
    <context id="ide437db67fec4724871353bf3fed014f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a0059e39d8c4440982d888fd5a4c442_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="if2d3ff5a5a4b4484a95420609dd9e074_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i16d322c911e24b2f90df8075e4ef4d6c_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie473d5c5a4eb40bbbc2a53be66040614_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3fdddf6ceeed47308e55c0b30b5a067c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iabf91ccb11c7473fb82ceedddfc105f2_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9864559fa95841a4af3fb0942788d567_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i21fdbc4f6fd449c485c175357858b379_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4d0a48f582bd40e3b1f786f6699f0b4a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia279c8899da54bf6ae860b25947dc8d0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i39ac5a2189034cdfb61933a472118b09_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ieadecf82b6ad4545a68ef16b493ea917_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4cd94c1fc48d45739e8b1372c7918e91_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4e9be4f901904d0db4fe7ad9ae72362b_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4a2621176fea4a8888c6313b92cf10ad_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ief5ba1ae721343ac88b4d010889406e8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icb9627a61887468a9b6718ee20810f41_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9eb73386cbae4db0b0d708fc5a5494fd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id7d45b209bd246fa9f5fb6ed35063c90_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic3d13dff04ec4f91a0b1fe60fc9e3c43_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3877ec01b10348049e885c6fbd8c2093_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id5561711868a406dba2571e3837b5f92_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i482d755915844552a319acd0ebad87c2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="id79c7f3385b140858233d773cf42bb7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i752dc55059cc4447a0accfa4c957834d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iad18cf43caca4fa9b52b9f44c52fa56a_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4352db6f20a74338aa9b3bada49da7c4_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if65c96e5196c41e1bd6da83734b674a0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie471c931528e4e2f9855c322fe699fec_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifd98e54551df4f7484c8d4d12a663576_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieef839e73eff43848516318cebe57433_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if80d3a019b9947fca48a1095d9bfbf33_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8a9ed363669a4fdfa3cc41d133ad481b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia504be01cf094a55828dfdd970c95bf7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaf49a496e76a4343af193f0f4a7974df_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iff7247931a914ff28d1893274243b53a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63e7186c429a445e93197d83b847b0f1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icd37c0efe2444846b8dbc5093721ff2d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia64a863540ee4b698d1bfb5e37c210e8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia086abbf885e4851977fa3b0dc5873b4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ieddab407ff0b4324b0c636ff14ea949d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i52ce91aa281c4dacbc249f21d1c8cb63_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iebcc6ceb48874567b7361b7a9293eb5a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0e199c99040b47adbfe27d08e7241826_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9de1d4c7fe7f434aa5351ea9e7492d11_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i76d6e4ce540141978ff1ca84f802062f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8e3fc200020647f1b1811620c34c8b73_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i251a6c64448049b085a70bfdf3b66f0d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4d8680e23f234d63971e7108407c5ba6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id1a00b451ff94034895b6946d7a38db1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0ba0213d39194a988ddbaf8d509a9ff9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6660febcd05a4ddd91b2880f7aa36913_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63eb6a5f45a34ec1b15088e8d927fa66_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6ed65ff56e894a1286cad47c9f8a5d88_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02cdbba97e7740f58868b386a457b134_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6baf74c2370245c78b8481e1f70d7407_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8c9d21d88c6642b49925de8143031180_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7137372572264ce2af8c977e3e539757_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i93548af7026745198b9efa38f1eec08d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3b6e42fbe1ee49f4a2526d4ce9934227_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2d9c1363fee943e8884e04ee49ac6551_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id52a3fc127ad472a8539e3ee6bb1d8ef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4165a5bc7db3475f9aba7f68b27c0c23_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic55b1ddc17a1405aa6e108d536b9ba0c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i48a05b66006e4eb1908e988b90b7c584_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3e0faaa4d4d048a391122a9b7f845605_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i34cdfe04f367491a94ee3b1a4e525875_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i922690c523a74696a506676b6c3c8293_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3da32ab3fea74b268e5f8d39e57ab030_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib686c0f367e5401cb4d26df1ffa0ab31_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie9cb2b02f0a347969390424b0f1f5db9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5c6a46adee414a2ebe17ba74ea9a1405_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i69f649e07f96460d9704c43f741f4af4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic24c319a97c0492aadc927a233e73092_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iadc03f35a99e4203abcbc456a09c3804_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7f5537dbd7704790be3e79071a25edb0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i86d4143c9b1147849d5c123548037925_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6aaf48c142ae4eeb8c19be8ab65b1e29_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i00b4fef7c31c4a70876df028d549534e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4bfc6674c5834a339d83ac6ffe6cba98_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic63f6364c6b240679b6ac191aaf72880_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idfb3425ba7cd445f84b23ec22c53919b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iafacf2945ba549808ec2d53831cb3ac2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i84f0be6b3b254094b68a2267dc7b119b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i30ec3913d2a24972a6ed10647552acc7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75aeb536cafe4a8ca7661d227b781a7d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iae17de65aad448a1be8ef9cde1a3083b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if8be00e7305947d29917c0a90318f87b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i522f5c831bd24654aa4f2e255332199f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i752cfd53540f4acd8c7907a47b064fa7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if06c71ba2610427fabe2fd8eba480224_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibe8bbd8b67344a6184b0aafa7b5e6d28_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i03a442011c4b4e62a01c94084b029d73_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i667557a44ad64ee88484a6c4fb179948_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia182f02d29944e6e98fc4ad018ea349c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i86ee3888e9874369a385166f1dc2d756_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifccd58ee2c094daf8d0a763a2263760d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id8cadf8c988e45fb883101ea1a6a10f3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:FirstPartOfPayContributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6dd62e97be4e40009772be77a6677117_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:SecondPartOfPayContributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c346010601f41a8883754f4737da9a4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie25f16fc97a74b6186d5dbaa0dabe3da_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9bd0ad5cd9f64967ab1d489f14880abc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2c4bea63e16a4f178e9d9a0b8adb9aa6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8874cbe0e0bd4d968ce32dccacb9e82d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f7e095fc24d45e9a294900b86a6d643_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5180872f1daf4367ae60ec035bbdeeb2_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i817dc0da95ba4e5d978cb261392a4458_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibe1e06122bde42dea54156fed96f14ab_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5c95a543404e41e2af0a9d67836a7894_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i4912f098ebbb49ec84aab8167ce6c62f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia231762ec9524000b72d1100dc01e0b9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i817e532872ff41b49bff73a8ac0e47c5_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i53fd7c4598e7493daae729bcc3ff421e_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i53702046a4124ad485291bebe82245b0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i12d54840073946439b15c638a7e7457f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i21004c9f5a8c4f50a7843faadd219c08_I20200427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-27</instant>
        </period>
    </context>
    <context id="ib82c3ffdbb3a41a5aec156304f17e31c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractsandCrossCurrencySwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5299bd1dd919404fbdaf72f5fea0b8af_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractsandCrossCurrencySwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5c5c584197cb47379b1b7c14225ff68f_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractsandCrossCurrencySwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia984cf8845c74e7289319379358fa6fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i01610a464cf24d10b1649f93c6dd325f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if65491e199804aaa88bd166f8ca3be43_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib007a62583634542927bd84b71663f81_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic0c9fbb71f394a7681cd8e128c4ca678_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icfa2fbd8be98466d8391902894ef72d2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia0e75b865efa47ec9f317da6494e4d4d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifd3f0773896b4e48973d8fa8546e4b4f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1388407356724e0ea750cc0fcc36009e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i08745885db4845b2929c65f0e1a8560d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i90cf6f7bcf9f490b8486918cc3e7f3a8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5fbf63d8d1d545b2bdcd18abc08e8ac8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7854a867193e4d57bbd9c6cd7fc41e84_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i95fc81c6ff294b6fb53c554a85f12552_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ied797e934f764283b9613debb2b85b60_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia427b71cb3fc4506aa62b238fa8e4181_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ied59589914674a3e8f6c2970536feb07_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia49068b8e285481ea485b20083b13688_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2d3478fa53f14391b83ba8ebc23863e8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4a217938b29b4446aff7ba0b8ec251f4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1cbe7452a1e9407e9cef048f9838a43c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6e07f2f6223f4fadb6d3a4b0459ad972_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id9c2e845aabd4458a28f546f452aa7cb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia738d64059fd4e028976c6a7a8405915_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id6e2683da2654d0d952236373c6802fc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i281f035f8d7243408d9c4ff727319f57_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i565d983f5a0443089f472cb1d490b842_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94edb97965974ee69d4b3074e0161dc4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i94fb664a24dd4a318195465e100eff7d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8e804c1181df47ba96ad8f1464e4cb0b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia3f06168993540edb69d2eaf0d4aad1a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idaa61cae38f84791aeb5726163d539c5_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie94373a23dc74d088079c736cb431ae4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id8aaa878041344688e3f4286b29f0360_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ide8bc86e5ceb4bf5b7a0cfc3b386f8f3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibeef638bf5d34fbab16454219b83a7ce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idcf9ef2946a445b3af2f2e36d9726303_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5fe8ab04e6f547139155bb2d610a399b_I20200113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-13</instant>
        </period>
    </context>
    <context id="i489dd58bf6eb415bb081e0bb67be780c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia7becbc8d137484d97debb021a37e776_D20171205-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-05</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i51f39bcd0abc4530b8f9a45566eff664_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i245fe60a1a194d789edf2b7c72c37e2d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i766ba6b8f9cf468f8ffca287b3b91d7a_D20191021-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-21</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5d07872c38ef46b8904d51cac9def92e_D20191021-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-21</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i81c7bc7242d74503a6137340007d1f16_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id47f6d83c6e74e48a98de97db2204260_D20190225-20190225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-25</startDate>
            <endDate>2019-02-25</endDate>
        </period>
    </context>
    <context id="if9fc6847924f490e8b2c037e203b3e48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia64a274f0b7d4166afaa7f5a3c655f98_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i66d60389839f46b4a37688dfbe3d091d_I20201023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="ideb9993f891b42a9b62b094fea769814_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i9e7ce3047a83413690e5e7de38e566c3_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i69de364d379c40dc8fe389a7c7c04ab8_I20190813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="i4dbc322ec79448d1be4e868ba2ba06cd_D20171229-20171229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-29</startDate>
            <endDate>2017-12-29</endDate>
        </period>
    </context>
    <context id="i325d4bdea1e649a3a53c4623ba9c8558_D20171230-20171230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-30</startDate>
            <endDate>2017-12-30</endDate>
        </period>
    </context>
    <context id="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-16</startDate>
            <endDate>2013-04-16</endDate>
        </period>
    </context>
    <context id="ibe2ccd127a8d4663b1bebbcc74fb5b01_D20180403-20180403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-03</startDate>
            <endDate>2018-04-03</endDate>
        </period>
    </context>
    <context id="i2ed46708d24e42d5b26a1ec4e6a3ed61_I20180403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-03</instant>
        </period>
    </context>
    <context id="ib77506c67e6348619cb8db92d4005f93_I20181212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-12</instant>
        </period>
    </context>
    <context id="i85d1442fd2694c819407a70aafa1bffb_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i241bdb994a38412ea8d52d2de2c21019_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="if6bbf73876be402592d7ed83f5fa934f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ConsolidatedActionsvSureScriptsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icaa7143e43f54500bac344b182f4e41a_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ib6cab553ef4649228197f51778134e0f_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i56b06f9b88e745caa7ce9e463ac4f6b6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id02805e7f2944185bec84529e72a977d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0f68a24f235c40b5829d9d37c436e1ab_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i27c1da308c4b4144b44b8bf3d8fb146b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia01db295201a4e96a3ef82db44b6fdc5_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i043439014160460cb387b7eff982bfc3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2fa25f7377e2432b8ee48290f92300f5_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i2c1aa1b3a0dc420f9bef7793ceda75bd_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="id903d050fec841a29536a88e85b3a251_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4f355bd7dad94edaa42f6261dbd8637e_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c441ae8aa364ac5981834da3de52970_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63b13d6d7fdc4db998f4aad71d5d3642_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i49da1197585148a08970cd158baac052_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i00c6dcc996c542ce806943993094a62d_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2e04822e0566406b894ca9c180380691_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="icba0d73afdaf4b6d95e21bc354b2880d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i03252b88bd734ce7a56608ddb4d375e6_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id3c5d000b0d24643ae449965b3c153e6_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ideef425eabb04ab1a5e71cbf9973e5f2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib47ea8d9084a4afca5dba67392106eea_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibb2e27caae16447596fd19fbd3c9a88d_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i63ce45207fbd4b11992c8b235c7acdc4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8458e101d22b48b086cd13c117b50596_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifa299a34d5fc4bc9b76f73609f2764c6_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i25daf5026b554fff9b18eed266aeb5b3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c768d5a4a684f049a881df6f6e2b57b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id4560aec4e3b49c4bac2fdf164699f86_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id2556775e1fe47e6992440fb0541be59_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i0c24314d9c3e4d9f94843d3a48b7eede_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieaed4a2b4af4445f83330c94eec2f1a2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1234f72c09014e849c5e914cbc33f91a_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i739cbdd44da747b7add6dc8608dd1b5a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i15be07b9acdf4513a30f3849808f530c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i07af8a5be55944b695812fe13bfcd58b_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iec9cc36803c34f05a0d2e66ae17760bd_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i38c5b221e50b470489c015c3be354825_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0dc447cc3eef4e94805a56f586f3f29b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5380417ed05b451283f8c1532ae7d259_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib9a8afb096ba4b8086b849fdbc536601_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id3429f651eb54a16929355b743eaba52_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iffce4b8d4569411a9a36db18bed95dc2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i26c1e0d879d74d0ba80ac1c15a6e17d3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i621e3a8fa6994bd5a5330f05ec7cdff3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie174ba8ffb9244afb1dd4b6122d4fbd3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iba47de0abc2f48d494cd9612200292a8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i17c5e4430f874e8f99d8a1bf5f30f24c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i04923cda81624c0c88a55ac1efd640f3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:CaliforniaFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i88386d48d0584a11aad721e5144c887a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:McKessonFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia7481f6650044b3dba08713c24b295ca_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie85e4307493243a5b472a5635d3adc29_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia887d330153d49cf8839b2dd8a1d6605_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i4b60cdb02b3c4589b40ac24c56bb249e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i944454336222406cbbe7e294bceecc04_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i175e65bdb63d42c090c72de7f9bdc403_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i14a2c0c157ca4b96abb1b4665b27847c_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i573770b6d3a94d0387b01cf824758b6e_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia42e59ef5f2b45d2973487b75779a397_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i37e52c8b4b824321aa0ff56c256f2680_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib4526ff802af4c7fa6b4487275290425_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ThirdPartySellerofRexallHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RexallHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i60c4775af5034c77bdf45a4edf0c4a19_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icbd9d23495db4b029833f9c192227a5c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ida17c5841f1c46d28608950ca8175e62_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2310b3bfad364c4897f644c867bc31cb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3a2364550eaa48c195ef408353004029_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if74e45a0662448e0b98940f6a00fba1a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2bdb37666904471ea46cdc51ef04aaf9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iab5c8e5207d049d0a2b702571549ad35_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3215d0d8384a40fba66e6eab5a09fb04_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idfe85c1cae3f4955b9ab92d284409069_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i17077ebbd39449f5af1aad884f3154eb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i23fd853d831a42d78a02ffd4cf5ac851_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if946cdebc5f04a91a11501d5fecd0111_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ifc939e12662e498ca3e1db10c83b89a6_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib6fcf90e365b49d3bc8fc8b908d184c5_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i316723b66fa24fcd88e37d193316fd03_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4255c61bac0b4de1850d7e4a694151da_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1401c1c016fb4cc5a4325e0076ce4cfc_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i511a93c4c27f432094e7f2f67db30fc4_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i912ede9886ea43629d3666f2abe8894a_D20180401-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="customer">
        <measure>mck:customer</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="reportingunit">
        <measure>mck:reportingUnit</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="participant">
        <measure>mck:participant</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="stateattorney">
        <measure>mck:stateAttorney</measure>
    </unit>
    <unit id="county">
        <measure>mck:county</measure>
    </unit>
    <unit id="company">
        <measure>mck:company</measure>
    </unit>
    <unit id="complaint">
        <measure>mck:complaint</measure>
    </unit>
    <unit id="relator">
        <measure>mck:relator</measure>
    </unit>
    <unit id="fax_number">
        <measure>mck:fax_number</measure>
    </unit>
    <unit id="fax">
        <measure>mck:fax</measure>
    </unit>
    <unit id="investmentfund">
        <measure>mck:investmentFund</measure>
    </unit>
    <unit id="defendant">
        <measure>mck:defendant</measure>
    </unit>
    <unit id="city">
        <measure>mck:city</measure>
    </unit>
    <unit id="officer">
        <measure>mck:officer</measure>
    </unit>
    <unit id="softwareproduct">
        <measure>mck:softwareProduct</measure>
    </unit>
    <unit id="site">
        <measure>mck:site</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="numberofproducts">
        <measure>mck:numberOfProducts</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml8zLTItMS0xLTA_b7fe1024-d890-4154-ad12-8d509e2c1ec6">0000927653</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml85LTItMS0xLTA_b47ac418-8bec-4ead-888a-e47f32a9e432">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml8xMC0yLTEtMS0w_a5fb761c-ad32-49ee-ae5a-874cb3b45b21">2021</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV80L2ZyYWc6N2EyMTE4NmJiYTdkNDRmMmFhMTVjMjlmOWY4ZmY5MjAvdGFibGU6ODdlMzRiMjhlNThlNGFhZmFjOGMwOTViZmQxYjFlOTIvdGFibGVyYW5nZTo4N2UzNGIyOGU1OGU0YWFmYWM4YzA5NWJmZDFiMWU5Ml8xNi0yLTEtMS0w_79cc2838-9035-47be-b610-613ba364e09f">false</dei:AmendmentFlag>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i53d8a73c06cb4aeab2d0b96b4bc01eaa_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic14d146f7e5242688d6fe3f6efc8e39d_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NDY_e4780d27-ecc2-4ddb-b012-e0b781a25964">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="idae8b11cffbb4c71a6764d8f5f1dd25b_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ib2785c217ff445e9ac72874428f97a52_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i3dc566d0125146099a9b13ba87eab912_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db">P5Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <mck:GuarantorObligationsPeriod
      contextRef="i8e804c1181df47ba96ad8f1464e4cb0b_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYwNw_af6d397b-2d02-4293-8753-eb30ffd6bb25">P1Y</mck:GuarantorObligationsPeriod>
    <mck:GuarantorObligationsPeriod
      contextRef="idaa61cae38f84791aeb5726163d539c5_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY2NQ_b7165f1b-8051-446f-8b5c-d34606827cfc">P1Y</mck:GuarantorObligationsPeriod>
    <dei:DocumentType
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTky_a09cff56-76c5-406f-b125-7ce731606d2e">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NjMxMmFmMGJhZWI5NGZjMGJkNTAwZTg2NDVhYjIzZWEvdGFibGVyYW5nZTo2MzEyYWYwYmFlYjk0ZmMwYmQ1MDBlODY0NWFiMjNlYV8wLTAtMS0xLTA_c033c4c9-2953-4cd3-92be-e3cfa9e98003">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8xMTk_d42ff439-2096-4f54-b1e4-ec029a2f4b36">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8xMTk_5a767053-b358-4af4-991f-661d05c5dbc8">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YjdiNmI4YzM4NDU4NGQ0YWJmNjllOTFmNjFkMjVkNjYvdGFibGVyYW5nZTpiN2I2YjhjMzg0NTg0ZDRhYmY2OWU5MWY2MWQyNWQ2Nl8wLTAtMS0xLTA_6ea5c060-8c53-47eb-8ff4-6855d3438e11">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg4_003f2ca5-33da-454b-a2c7-02be717dbe62">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTkz_510d0976-a521-4d3e-a68f-ab3c2de66160">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6ODc0YzkxMTYzNjMwNDYyNTg4NGFjYWZlNDRhMjFmYTgvdGFibGVyYW5nZTo4NzRjOTExNjM2MzA0NjI1ODg0YWNhZmU0NGEyMWZhOF8wLTAtMS0xLTA_2bdb55bd-8910-408e-a2d1-ccae0f7911dd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6ODc0YzkxMTYzNjMwNDYyNTg4NGFjYWZlNDRhMjFmYTgvdGFibGVyYW5nZTo4NzRjOTExNjM2MzA0NjI1ODg0YWNhZmU0NGEyMWZhOF8wLTItMS0xLTA_8b5b766b-d104-4180-8e4f-6d0e384f0f61">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTgy_b66a190f-5939-4894-b896-dd42e2883db7">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTk0_82e0e8bd-87e2-4fa4-ae9a-85c80f3e86ff">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTk1_2d24211e-f271-4e8b-a203-42ad73a5e953">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTgz_b6f4051d-383a-4749-8fac-7e061d32c4e3">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg1_8a438985-332b-480c-8271-1f9850f8f9b5">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg0_4b6fd049-b0aa-4de2-8ecb-0579dcdd6fd3">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18xLTAtMS0xLTA_31f04eae-ff92-40a0-9e4c-94e5036273f6">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18xLTEtMS0xLTA_b1b47be1-f301-4a0f-a16f-13d0f072e96e">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8b2dc79c3a4b4b32a0f1c3ad2c45097b_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18xLTItMS0xLTA_c8ca8cda-6a78-44bc-9246-7cc8d39df6e2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18yLTAtMS0xLTA_f4527eb8-eab5-4834-8f9a-ca769dfe7e84">0.625% Notes due 2021</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18yLTEtMS0xLTA_afdd9a74-a993-4225-8cdd-27705a267403">MCK21A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic983d99e6c07404884221400c87a0a8e_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18yLTItMS0xLTA_b7f5c502-67a5-4737-8914-21af539191e8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18zLTAtMS0xLTA_67f41c13-650d-4b89-a788-201f0dc59d1d">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18zLTEtMS0xLTA_5538c3aa-8be6-4ad2-883e-7eb959b048ae">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icbefcc6287a6436eae57ad3467d4eb84_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN18zLTItMS0xLTA_b0d99595-64a2-450c-9e3e-5cf1f4bd22da">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i9650e19e52e846e28fe7e52623004983_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN180LTAtMS0xLTA_5a4859c1-7a78-4e93-b4a0-3c01bb91c5bb">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9650e19e52e846e28fe7e52623004983_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN180LTEtMS0xLTA_3beaf0e4-dac8-41b0-b9d1-58e2f0761688">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9650e19e52e846e28fe7e52623004983_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN180LTItMS0xLTA_ab50a4dd-ae39-4e9e-8f77-bb5fe6f2f4a3">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN181LTAtMS0xLTA_e05d8fa4-9ece-41b3-909c-c552cd9266d4">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN181LTEtMS0xLTA_74512c78-2738-4599-b7fd-c54126dbdb97">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5876eeed3149424ebb57b89ba1d25185_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6NGQ2NmRiYjFiYmY4NDRiZWIzODVmZjk1ZWFhYmQxYTcvdGFibGVyYW5nZTo0ZDY2ZGJiMWJiZjg0NGJlYjM4NWZmOTVlYWFiZDFhN181LTItMS0xLTA_c43844c3-cf60-4d91-9945-7f60017cfd0a">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg2_85cdae63-6aac-4241-a771-f7e7eb6e03f6">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTk2_3901bfb3-cc39-4657-a542-60d51ffb2a54">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTkx_7cfee3d4-6c7b-4e7c-983f-30f11de1246f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg5_8e755897-d3b8-4f1d-aa0a-60845af0f054">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YzgyYmY4M2ExZmI2NDlkNjkxOGJhOGJhMjUwYTJjNjgvdGFibGVyYW5nZTpjODJiZjgzYTFmYjY0OWQ2OTE4YmE4YmEyNTBhMmM2OF8wLTAtMS0xLTA_3373d022-f4fb-41ee-aa28-d5643a534eb1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YzgyYmY4M2ExZmI2NDlkNjkxOGJhOGJhMjUwYTJjNjgvdGFibGVyYW5nZTpjODJiZjgzYTFmYjY0OWQ2OTE4YmE4YmEyNTBhMmM2OF8xLTYtMS0xLTA_45e20dcd-f8ef-4ce5-917a-b12891578847">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGFibGU6YzgyYmY4M2ExZmI2NDlkNjkxOGJhOGJhMjUwYTJjNjgvdGFibGVyYW5nZTpjODJiZjgzYTFmYjY0OWQ2OTE4YmE4YmEyNTBhMmM2OF8yLTYtMS0xLTA_7640df68-62c1-4d6f-a7e5-c470813279eb">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8xOTc5MTIwOTMwNDAyNg_18ad2b99-7217-4f46-908a-ca1af8337db6">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTkw_de95249e-be67-4790-831c-030bb3fa6aa1">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i9e194b3a461f4ad28b6e6b95517ccd7d_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8yOTA5_01f2eda9-a862-4a5d-879b-2c9d3c0f3955"
      unitRef="usd">23900000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5dbd0bda906d4b768524dcfc6aadc6cd_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8yOTc1_6350458f-902c-4343-ba85-09603713d47f"
      unitRef="shares">158186277</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xL2ZyYWc6ODgyNDkxMzJmMWI0NGYwMmEzYjM0NTlkY2ZhMThjOTYvdGV4dHJlZ2lvbjo4ODI0OTEzMmYxYjQ0ZjAyYTNiMzQ1OWRjZmExOGM5Nl8zMTg3_f329117f-8476-4d72-9911-8700778826f7">DOCUMENTS INCORPORATED BY REFERENCEPortions of the registrant&#x2019;s Proxy Statement for its 2021 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMi0xLTEtMS0w_89c73bb1-4748-4b55-8718-f717ce9042ae"
      unitRef="usd">238228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMi0zLTEtMS0w_787e3cf2-de8e-448d-8e2b-72e412614c7d"
      unitRef="usd">231051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMi01LTEtMS0w_6054df05-a4ed-4bbe-b274-a0e812df150a"
      unitRef="usd">214319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMy0xLTEtMS0w_0295aa97-4994-471b-9e80-8602f89b212f"
      unitRef="usd">226080000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMy0zLTEtMS0w_5999bba8-9c7d-42f2-8c5e-db9176949083"
      unitRef="usd">219028000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMy01LTEtMS0w_d88d0494-1a56-4b5e-8667-1f86036f60d7"
      unitRef="usd">202565000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNC0xLTEtMS0w_70000d98-c29f-4a5c-ac10-7084a967e921"
      unitRef="usd">12148000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNC0zLTEtMS0w_9cdce47e-d47f-4385-a902-09024df2cafe"
      unitRef="usd">12023000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNC01LTEtMS0w_e684a174-88c5-4470-bfec-6cf43155ebfa"
      unitRef="usd">11754000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNS0xLTEtMS0xMTMwNA_8b74743c-ec64-4ba2-bc96-d96ff7b0e881"
      unitRef="usd">8849000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNS0zLTEtMS0xMTMwNw_f158dc8d-ee5f-4ca2-be39-8c95e9bcfb06"
      unitRef="usd">9182000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfNS01LTEtMS0xMTMwOQ_9fb4123c-377b-4c82-b7fb-3a696dc2c4d7"
      unitRef="usd">8437000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:LegalFees
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0xLTEtMS0xMDQ3OQ_9ccf7c20-57c8-4499-9f98-f953c7ddb262"
      unitRef="usd">7936000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0zLTEtMS0xMDQ3Ng_c5ee8b9f-28ba-4f25-8ee7-ad0d5212f0c2"
      unitRef="usd">82000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC01LTEtMS0xMDQ4MQ_809883ea-b20b-48f5-bf9a-99fbb3381a31"
      unitRef="usd">37000000</us-gaap:LegalFees>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0xLTEtMS0w_3653e7ec-e705-4976-b9fb-446f2acde336"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC0zLTEtMS0w_b6dcf296-7c5c-40d3-9dd1-f9cb6b2b1bda"
      unitRef="usd">2000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOC01LTEtMS0w_a777aa3c-2aa5-4eb0-9636-03a0cc477aec"
      unitRef="usd">1797000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOS0xLTEtMS0w_5556946e-0b4c-4dd0-9f5a-2d1206d09d18"
      unitRef="usd">334000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOS0zLTEtMS0w_0463a2e3-ca14-4877-a8d9-502b9dcea256"
      unitRef="usd">268000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfOS01LTEtMS0w_aced6904-ee6a-4779-aef4-859d03ef8442"
      unitRef="usd">597000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:OperatingExpenses
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTItMS0xLTEtMA_c5628b79-0e76-4a63-afcc-85254fcedcf6"
      unitRef="usd">17188000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTItMy0xLTEtMA_e0a515eb-16f7-4a0f-8382-8c5559e1f475"
      unitRef="usd">9534000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTItNS0xLTEtMA_52f6ea49-b3f7-4b86-8b62-dde9b9c6f9ae"
      unitRef="usd">10868000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTMtMS0xLTEtMA_41f02c6d-51ad-48e5-8c5f-a65bbe9a9403"
      unitRef="usd">-5040000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTMtMy0xLTEtMA_b56b9f23-169d-498f-8861-d98df1a3ea59"
      unitRef="usd">2489000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTMtNS0xLTEtMA_044da66e-b51e-4136-8329-4df2954308d9"
      unitRef="usd">886000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTQtMS0xLTEtMA_148b3015-f7dc-4507-b62c-2f855253e1c7"
      unitRef="usd">223000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTQtMy0xLTEtMA_daec7458-dea2-4ff7-80f9-a4b4174759f7"
      unitRef="usd">12000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTQtNS0xLTEtMA_ebb5ddcd-accf-4bc0-ab02-a392a09a7f30"
      unitRef="usd">182000000</us-gaap:NonoperatingIncomeExpense>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTUtMS0xLTEtMA_ae5bf8be-e682-4ed1-b438-b8d2a368a60e"
      unitRef="usd">0</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTUtMy0xLTEtMA_4dfc8095-a335-4156-92d7-d91538aa430f"
      unitRef="usd">-1108000000</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTUtNS0xLTEtMA_97a83eb7-32fb-4e18-aea8-91e0c335d18d"
      unitRef="usd">-194000000</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts>
    <us-gaap:InterestExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTctMS0xLTEtMA_da338c38-ca16-42aa-ae9a-12e1282eda99"
      unitRef="usd">217000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTctMy0xLTEtMA_37f213de-efb5-4851-97fa-f40bbb728b1b"
      unitRef="usd">249000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTctNS0xLTEtMA_9f48cc53-9d12-47d9-a004-aeaaafdbb35d"
      unitRef="usd">264000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTgtMS0xLTEtMA_65dc43d0-bf85-48e6-936e-f1a8394aaa6e"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTgtMy0xLTEtMA_c925a72b-6d50-4262-a691-9977f14eba5f"
      unitRef="usd">1144000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTgtNS0xLTEtMA_1f5d9a78-85db-4104-bade-b1d518e9a165"
      unitRef="usd">610000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTktMS0xLTEtMA_a72a55d2-7f11-4a53-83a9-69f90ab2221a"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTktMy0xLTEtMA_7137fce1-6d6d-4633-b7ab-fc9018daaf7a"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMTktNS0xLTEtMA_5f68af78-090a-41fe-b6bd-44a519a161e6"
      unitRef="usd">356000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjAtMS0xLTEtMA_6a998846-c236-4f52-ab10-f603da041159"
      unitRef="usd">-4339000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjAtMy0xLTEtMA_f2d5d70b-ecae-4f10-a546-f78f7d98d1df"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjAtNS0xLTEtMA_eeac7a9a-437e-4100-9936-b35fa3652d9e"
      unitRef="usd">254000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjEtMS0xLTEtMA_44537d97-851d-48d1-91bd-de71345269df"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjEtMy0xLTEtMA_3621d9d2-3b6e-4693-aa33-9552d2a5aec8"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjEtNS0xLTEtMA_4245185f-0752-4017-afdb-58d96a84249e"
      unitRef="usd">1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjItMS0xLTEtMA_e53cf4a7-a85c-4612-8f01-776f0a9806b7"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjItMy0xLTEtMA_12c87381-ebe0-464b-a1a3-cfbba42c0c59"
      unitRef="usd">1120000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjItNS0xLTEtMA_a154e2ac-b985-4493-a562-36b35d427864"
      unitRef="usd">255000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjMtMS0xLTEtMA_4eae314e-ef5f-4995-adcb-2d63aa0ee235"
      unitRef="usd">199000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjMtMy0xLTEtMA_ef033e90-9639-4f9d-8029-2d5ec2c135d7"
      unitRef="usd">220000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjMtNS0xLTEtMA_d02cfc9f-30ff-489a-a861-fa11ec9e1f2e"
      unitRef="usd">221000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjQtMS0xLTEtMA_1633d813-3ed2-406d-9272-f353c3db6b77"
      unitRef="usd">-4539000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjQtMy0xLTEtMA_53a89290-aa74-44af-9e8f-aaa9958fc6c2"
      unitRef="usd">900000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjQtNS0xLTEtMA_739f4d23-d5a9-47e8-914c-ee0a232f4630"
      unitRef="usd">34000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjgtMS0xLTEtMA_7317537c-c31c-44d4-988c-42d0e7848a4e"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjgtMy0xLTEtMA_c56d803f-0104-4611-8a47-00eb53eb7946"
      unitRef="usdPerShare">4.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjgtNS0xLTEtMA_4f6de90f-6223-478a-82da-48eef2e52fa8"
      unitRef="usdPerShare">0.17</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjktMS0xLTEtMA_ae33454f-035f-4d0d-bb53-0ff08f45f6b6"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjktMy0xLTEtMA_b9ca9448-f3e6-4018-9ecb-cc6c66309c22"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMjktNS0xLTEtMA_c9f407c1-2daa-43ef-a34a-417002ee7775"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzAtMS0xLTEtMA_340037f8-0547-4f21-b9b3-beb351278d93"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzAtMy0xLTEtMA_42e36a91-924e-4bb3-870b-cf89cc326a48"
      unitRef="usdPerShare">4.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzAtNS0xLTEtMA_e858756a-1af7-4173-8634-2949356aa043"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzItMS0xLTEtMA_b2ac2a1c-bd81-43d8-ac2b-9f04d12d62c4"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzItMy0xLTEtMA_b117fbb6-b9c3-4a7f-a4f7-e855e9224d3e"
      unitRef="usdPerShare">5.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzItNS0xLTEtMA_f594d6da-069d-417e-8079-59aeca7d9bae"
      unitRef="usdPerShare">0.17</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzMtMS0xLTEtMA_4ba52991-982b-4197-9b62-4ce8334eacdb"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzMtMy0xLTEtMA_20e4fc2c-ccab-441e-9633-645b5b82d231"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzMtNS0xLTEtMA_9dc5583c-9079-4bd0-8b2c-d20b0d5e9e3c"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzQtMS0xLTEtMA_5ec89326-f0e1-415a-8e10-ec749e1e7ea8"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzQtMy0xLTEtMA_fbb12a63-8050-42bf-9a21-fbf357ed839f"
      unitRef="usdPerShare">4.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzQtNS0xLTEtMA_524a660c-49dc-4210-bd0f-e1b99b9e6485"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzctMS0xLTEtMA_10528f5c-760f-44d3-9370-f181aa97ae63"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzctMy0xLTEtMA_48d64069-c0f2-4843-a5ad-5e5446f444ce"
      unitRef="shares">181600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzctNS0xLTEtMA_901b36b7-da41-4d5a-8608-d807820629b4"
      unitRef="shares">197300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzgtMS0xLTEtMA_2b153867-5ac3-4bfa-9494-af9e3139675a"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzgtMy0xLTEtMA_3145c92d-4d9b-4d6c-bd75-a9c4f996590f"
      unitRef="shares">180600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84NS9mcmFnOmM2YjkxODE5NDZkMjQxNGVhZTU4ODVjNGRhM2FkNTA5L3RhYmxlOjk4Y2U5NjZiMmRjZDQ0YzY5MDA1YzgzN2E2ZmFhZGUzL3RhYmxlcmFuZ2U6OThjZTk2NmIyZGNkNDRjNjkwMDVjODM3YTZmYWFkZTNfMzgtNS0xLTEtMA_aaa90aca-072b-4efd-9881-c3821e7628b5"
      unitRef="shares">196300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMi0xLTEtMS0w_04caae0a-6596-4291-aa4c-1570663d2897"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMi0zLTEtMS0w_12c87381-ebe0-464b-a1a3-cfbba42c0c59"
      unitRef="usd">1120000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMi01LTEtMS0w_a154e2ac-b985-4493-a562-36b35d427864"
      unitRef="usd">255000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNS0xLTEtMS0w_13531b69-6308-45cb-bee8-54f948495785"
      unitRef="usd">184000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNS0zLTEtMS0w_c472cb40-a1d8-43cf-aed3-87945b780ce7"
      unitRef="usd">-66000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNS01LTEtMS0w_6df2653a-a38a-46ec-96b3-c8906fe7e0e1"
      unitRef="usd">-190000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNi0xLTEtMS0w_4cc752a4-4bcc-4f84-a047-fcb451663992"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNi0zLTEtMS0w_026aab61-1ebf-4009-9cc7-93ef1a6d5706"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNi01LTEtMS0w_0a0065b3-984b-4c44-94c2-3ffba765e06a"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNy0xLTEtMS0w_34997c00-d4dc-4acc-93ea-6a8493be7b52"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNy0zLTEtMS0w_d2913a18-eda2-4773-815c-470b6fffe923"
      unitRef="usd">-129000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfNy01LTEtMS0w_77e6b4d4-ffea-4a69-9586-be247d33f289"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfOC0xLTEtMS0w_24da0fb7-7852-4847-9f77-5e5f0707ece2"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfOC0zLTEtMS0w_97a589cd-0d6d-4efa-98fd-6e26750e858c"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfOC01LTEtMS0w_2f8f8702-e8fa-499c-8468-4ab2a73bf639"
      unitRef="usd">-198000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTAtMS0xLTEtMA_8976595b-4142-4880-907c-10aed5f72c9d"
      unitRef="usd">-4170000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTAtMy0xLTEtMA_aa6027fb-d12d-42dc-889a-09616ea7a2a0"
      unitRef="usd">1269000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTAtNS0xLTEtMA_9d3163e1-63e3-46e4-9097-0b74fd166cb4"
      unitRef="usd">57000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTEtMS0xLTEtMA_5523486d-e457-4e64-9b8c-ecb3c64fa0fe"
      unitRef="usd">146000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTEtMy0xLTEtMA_ba63e128-ea14-4d35-9421-3ca13a3dea3b"
      unitRef="usd">223000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTEtNS0xLTEtMA_0dad5f1d-9bb9-41b0-8327-591f47115513"
      unitRef="usd">155000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTItMS0xLTEtMA_9a71f6a8-0c4e-41b6-a25d-8373259faacd"
      unitRef="usd">-4316000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTItMy0xLTEtMA_b70c7f84-d627-44f0-add0-d29b81066079"
      unitRef="usd">1046000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV84OC9mcmFnOmRlMWZlYTJiYTQyNzRiMjViMDNhODU4M2E5MTJjNWZlL3RhYmxlOjk5NmFhOGQyNjdlYjQ1ZDNhY2UzZGRkZTRkYjhhOTg2L3RhYmxlcmFuZ2U6OTk2YWE4ZDI2N2ViNDVkM2FjZTNkZGRlNGRiOGE5ODZfMTItNS0xLTEtMA_38fa9e38-2ba6-4219-bbcf-51af6fa562c9"
      unitRef="usd">-98000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNC0xLTEtMS0w_1efeb1db-dbea-48ef-82ca-7a28f49fa42b"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNC0zLTEtMS0w_17e49458-f1d5-4c30-960c-c9aff32e6238"
      unitRef="usd">4015000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNS0xLTEtMS0w_fe222d1d-00f8-4b5b-ba32-46aabf932da6"
      unitRef="usd">19181000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNS0zLTEtMS0w_d3383f8d-2839-49bd-8c98-3900104f0c90"
      unitRef="usd">19950000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNi0xLTEtMS0w_46be8f38-9ae7-46a5-bc91-f7e8bcfdc4bd"
      unitRef="usd">19246000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNi0zLTEtMS0w_e1ee35cd-9bb4-459a-9116-844d16dcad47"
      unitRef="usd">16734000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNy0xLTEtMS0w_481e8583-17dc-432e-bca5-248e09259798"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNy0zLTEtMS0w_ccfc2aa1-7a15-4db3-841a-e882c7642257"
      unitRef="usd">906000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOC0xLTEtMS0w_c789808c-81af-4e2e-8be7-a29dd81f793d"
      unitRef="usd">665000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOC0zLTEtMS0w_b0bc0998-095d-4228-97ae-5dd0a874f50d"
      unitRef="usd">617000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOS0xLTEtMS0w_75218621-042f-43a7-8f6e-aa3fb2cc3b84"
      unitRef="usd">45382000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfOS0zLTEtMS0w_1e44e6d4-97e2-46ba-b8a9-62e9e73df382"
      unitRef="usd">42222000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTAtMS0xLTEtMA_765bfff0-239f-4345-9d3d-b3758d1b6bba"
      unitRef="usd">2581000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTAtMy0xLTEtMA_96d9f699-aaf2-4a60-9203-9a8fe0d6af6e"
      unitRef="usd">2365000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTEtMS0xLTEtMA_62337c08-e880-47d0-8f20-55a5c1ba7ad6"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTEtMy0xLTEtMA_10c8b385-b4fb-4889-8187-e162dfa82318"
      unitRef="usd">1886000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTItMS0xLTEtMA_ddb70966-32a0-4703-835f-b8ffb12e7ffd"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTItMy0xLTEtMA_ad61e4ff-3a08-402a-a82c-e430fce8dafc"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTMtMS0xLTEtMA_62d4f6c5-1a90-49bf-9bb3-6652717b38bf"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTMtMy0xLTEtMA_8a03bc6a-b622-4091-9dee-e4a3c24b62c2"
      unitRef="usd">3156000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTUtMS0xLTEtMA_1b379a7a-85f3-4556-8549-cdb7123bfd0f"
      unitRef="usd">2581000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTUtMy0xLTEtMA_1eff90aa-e3a3-4598-a185-f100028c20ed"
      unitRef="usd">2258000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTYtMS0xLTEtMA_3afae63b-9861-4220-be5e-46969f5c049e"
      unitRef="usd">65015000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTYtMy0xLTEtMA_ad87a2a0-178b-43b8-b9bd-f084b6101e9c"
      unitRef="usd">61247000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTktMS0xLTEtMA_470f78e3-0d84-48b9-b649-2b655bb751a8"
      unitRef="usd">38975000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMTktMy0xLTEtMA_1170d723-9a8b-4240-a2b9-9023cc5c1e18"
      unitRef="usd">37195000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjEtMS0xLTEtMA_6fae33d0-beda-4c74-b4d4-19dfee00cf12"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjEtMy0xLTEtMA_d98162f5-5c59-4131-8377-2d5f213a140e"
      unitRef="usd">1052000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjItMS0xLTEtMA_c62977cb-5ceb-4397-a1dd-1c1004ffa69e"
      unitRef="usd">390000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjItMy0xLTEtMA_6cdb2905-3337-4c5a-a7af-c0b5de9ac98b"
      unitRef="usd">354000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjMtMS0xLTEtMA_61e51607-4e04-44ec-a37a-6b7378b3200e"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjMtMy0xLTEtMA_f83bf7be-b4cb-4764-9e70-512da119f5b8"
      unitRef="usd">683000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjQtMS0xLTEtMA_169d1d8e-1e3b-48c7-9716-547abce660f0"
      unitRef="usd">3987000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjQtMy0xLTEtMA_591959cf-2cf1-44cd-be4e-12f788394bf4"
      unitRef="usd">3340000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjUtMS0xLTEtMA_0181db77-f106-45b2-9d2f-87a27a9c1627"
      unitRef="usd">44103000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjUtMy0xLTEtMA_ee5a09b0-fa19-4c4a-ac41-99d0a09872e0"
      unitRef="usd">42624000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjYtMS0xLTEtMA_7ee1fd30-23fa-4aa2-9c32-0f3251d012c0"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjYtMy0xLTEtMA_1fa450ee-d24f-4be5-a2b1-b9d90130c292"
      unitRef="usd">6335000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjctMS0xLTEtMA_a0f0c832-57c3-4d39-b07a-847e9014a11a"
      unitRef="usd">1411000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjctMy0xLTEtMA_ac597009-5f6a-4128-9dac-ae55b912432a"
      unitRef="usd">2255000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMS0xLTEtMA_10825e8c-8f9b-45b9-8918-941265e88d6c"
      unitRef="usd">1867000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMy0xLTEtMA_02cf211d-9cd3-4ede-b395-20104c125809"
      unitRef="usd">1660000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMS0xLTEtNTQxMA_32d88f8c-da93-428b-86ab-719fe53c2538"
      unitRef="usd">8067000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjgtMy0xLTEtNTQxMw_502e39a1-1b00-492c-9a25-8b2f9c584189"
      unitRef="usd">0</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjktMS0xLTEtMA_c26e026a-ca89-457b-9ffe-ffc52d8c2732"
      unitRef="usd">1715000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMjktMy0xLTEtMA_b839c289-91d3-4c6e-b852-68a622b0ae03"
      unitRef="usd">1662000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzAtMS0xLTEtMA_dff5600d-4dd1-4aed-9ecc-9c60eccc7ace"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzAtMy0xLTEtMA_240ec577-4dff-4474-8065-d6239ce5c7c5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzEtMS0xLTEtMA_03ecb014-3e26-4c83-bb94-13122815b31f"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzEtMy0xLTEtMA_ecc91cb8-a3e3-442a-88cf-2f5eaffce79b"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTA_7dc4e592-6b6b-4531-8a97-86c614dce43f"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTA_86563031-aff8-479c-8049-69646c7058c1"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTc_293c7ff8-9f64-4c08-8d38-4c9f8bcc88df"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUwOTc_c7739521-cf06-4ddc-ae84-d1b2b8a54159"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_2c28dcc4-3ddf-4189-9a38-75ba3196ad89"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_8b4d68e3-0c64-42e9-9582-d916c458b72d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_9df6d099-04e3-4481-a66a-3332ddc2cac3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmIwMTJiM2ZjOTRlODQ4YTI4MWZlMzlkMGExOTg1MTdiXzQ5NDc4MDIzMjUxMDI_a74f896b-a468-4749-83f0-b192d352495f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMS0xLTEtMA_1f6c2e54-942c-4c81-89c4-5ed42cc4064d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzMtMy0xLTEtMA_e90c8da8-c92d-4d98-8a40-8081306966a6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNDY_5f75559f-26b8-4bb0-bde9-9cda1898dc45"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNDY_ef7cb01e-e802-4940-be79-0ec527bbd858"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNTQ_3a900187-618f-4471-b773-9187ce09ad71"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNTQ_cfa19af9-65f0-4f81-8222-0bc0bb5006a9"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwNDA_e567143a-749e-4b87-bc7e-ee0b51a47d9e"
      unitRef="shares">273000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjFkMzM4MDVlYTRlOTQyOGU4NWRkYThlZTdmNzc5ZjMwXzU0OTc1NTgxMzkwMzU_13d1c22d-40e4-49c8-bdc4-aeee14a1963a"
      unitRef="shares">272000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMS0xLTEtMA_8e547bd2-fd0b-4011-9467-8e5e512f13fd"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzQtMy0xLTEtMA_9f28eef6-d324-4ddf-98a4-710bfbca6195"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzUtMS0xLTEtMA_0cb1e6ef-789e-42d0-91cd-51cb936245fa"
      unitRef="usd">6925000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzUtMy0xLTEtMA_a8f8ba2e-a2d3-4e83-874c-09802e5b1166"
      unitRef="usd">6663000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzYtMS0xLTEtMA_c9209890-2a4e-4ab0-a1d9-270ae55bbc6b"
      unitRef="usd">8202000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzYtMy0xLTEtMA_b9f0b2a7-e630-42d0-9dca-316a2e3e26e5"
      unitRef="usd">13022000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzctMS0xLTEtMA_509e4b67-1029-496f-85b8-f7a9d1efe0a6"
      unitRef="usd">-1480000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzctMy0xLTEtMA_75cc43f8-0d48-4d82-b4b8-e33d5f0004d5"
      unitRef="usd">-1703000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjljMmFkODA5NjBhMTRmM2NhNzk0MWE2NDAyODYxMjA1XzU0OTc1NTgxMzg5NzM_d069a41e-4666-40fa-bed4-7de1152fb6cb"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjljMmFkODA5NjBhMTRmM2NhNzk0MWE2NDAyODYxMjA1XzU0OTc1NTgxMzg5Njg_0fe21e62-05ce-4945-a039-286c64b00713"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMS0xLTEtMA_17bd7f0d-232c-4b87-b7b2-eb329e97f6c3"
      unitRef="usd">13670000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfMzktMy0xLTEtMA_9d41a519-fdb9-45a1-b4d2-fe06abbdcf80"
      unitRef="usd">12892000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDAtMS0xLTEtMA_88932165-7c60-4d85-a2fb-6d556311a01e"
      unitRef="usd">-21000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDAtMy0xLTEtMA_508850bf-96e1-4c1e-80b7-020ccc32a787"
      unitRef="usd">5092000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDEtMS0xLTEtMA_e05c3086-2305-448b-8110-45ebb7c63f58"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDEtMy0xLTEtMA_e069a09f-f647-4cf5-970f-fc46b0071d64"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDItMS0xLTEtMA_c01c7937-8994-4bc4-b13e-01811c0ca530"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDItMy0xLTEtMA_3eed4ad4-c541-4cef-a32b-908f26b6766c"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDMtMS0xLTEtMA_5f3318b3-179d-4946-8a88-f89c52c7b087"
      unitRef="usd">65015000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85MS9mcmFnOmRhMTlhNGJhYWFjZDQ4MzNhMDM0NzNiNzEyMzg3YjA4L3RhYmxlOjIxM2FiMmYyNWQwMzQxNzZiMWVmMGQ5Y2MzYjFlOWZkL3RhYmxlcmFuZ2U6MjEzYWIyZjI1ZDAzNDE3NmIxZWYwZDljYzNiMWU5ZmRfNDMtMy0xLTEtMA_4eb57728-505d-4a7c-b183-4d3a6d3a2c3d"
      unitRef="usd">61247000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xLTEtMS0w_d4f534a2-65aa-4bcc-a016-78047027fb50"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0zLTEtMS0w_c8a4e6b7-3f80-49e5-a5dc-0a12b5fb23ba"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ff0501dacd84f6d9a8a0874bbdc5b3c_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy01LTEtMS0w_6379b0d7-dead-4011-b536-2024458ad3ef"
      unitRef="usd">6188000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i694f7a1a7fe8492981ba38c56efece34_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy03LTEtMS0w_554f129f-1146-4919-aa12-ef2a984d1cc5"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7fa47717062f4d0faa776c2def60876c_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy05LTEtMS0w_a8c89cc6-3db9-420f-86ee-56064a06df52"
      unitRef="usd">12986000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe7f6d03c0214b888f11ce73ebb56fd5_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xMS0xLTEtMA_5f2869c8-855f-44e7-99a2-56d4277e95e7"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i33d5e858b51e4d099bb4436a00d94e8a_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xMy0xLTEtMA_de3ac2b9-dbbd-4dd2-98f0-c2e051451c16"
      unitRef="shares">73000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33d5e858b51e4d099bb4436a00d94e8a_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xNS0xLTEtMA_15b28c8a-e133-426a-bdbc-75b3b495bc52"
      unitRef="usd">-7655000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae70566f5363452bbc98260415fc04bd_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xNy0xLTEtMA_472d8767-d035-4bf5-87e6-a9153aee6fda"
      unitRef="usd">253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i022a2642b16245d083cb80c539e560b3_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMy0xOS0xLTEtMA_7c75c600-587f-4ca3-9612-a90a8a08054c"
      unitRef="usd">10057000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61b7fb92a6f244829cf78e65a255ee88_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC05LTEtMS05NTM5_b2e7f663-4ecf-464c-8837-e994780d56c8"
      unitRef="usd">154000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8246b55c8e504364a5c352ba370995ad_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xOS0xLTEtOTUzOQ_77fdbc62-0ae4-4d00-b27c-913bcef2423e"
      unitRef="usd">154000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i4a514ba214224efd98713a38fa41dbe7_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xLTEtMS05NTYx_de924d6b-d7e6-46d0-a45c-3ff6329146fd"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a514ba214224efd98713a38fa41dbe7_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0zLTEtMS05NTYx_236fcbb1-88c4-49a2-8b41-18bb12651777"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe8bfcf07f30410981669a5bf1af7c02_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS01LTEtMS05NTYx_0cb42b5f-48d0-4568-b626-106c78fe9392"
      unitRef="usd">6188000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58e169e9c83f487291f51edc0b6c3ae1_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS03LTEtMS05NTYx_9e0b1bed-8d70-4d1b-ada9-42b0c99632b5"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93dcfcc89c2542b0928b50c7d3e432c2_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS05LTEtMS05NTYx_71c9b2dd-37e6-41d5-b83d-97732318b678"
      unitRef="usd">13140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36dce71a26114b94909aaa9ba795fdb2_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xMS0xLTEtOTU2MQ_f4859f6f-091d-480d-b2b8-02add604f222"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i04b14f9878614f92a269ff6fccb37f69_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xMy0xLTEtOTU2MQ_c5beb63e-38ad-4e4b-aeff-167fc5887494"
      unitRef="shares">73000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04b14f9878614f92a269ff6fccb37f69_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xNS0xLTEtOTU2MQ_5c15cf4c-9fbc-4f55-acc5-c779fe86b4e3"
      unitRef="usd">-7655000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib174f082f2e349489ff2dd2b20330381_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xNy0xLTEtOTU2MQ_b465110e-50ad-4cfc-b209-c87421ffdec9"
      unitRef="usd">253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1dd683332b3f4798998789f66099e34e_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xOS0xLTEtOTU2MQ_ad57618c-de36-4910-b6b7-614368171274"
      unitRef="usd">10211000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5ccd14692cf3450cb539e1a2cf941e8d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xLTEtMS0w_e0602c25-64bf-417c-ba40-5653951e64be"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC01LTEtMS0w_f60e3f64-d44c-4e3f-aa0d-74ee04351e9e"
      unitRef="usd">75000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xNS0xLTEtMA_12e5f745-ad40-4472-8e23-caf9810c94e7"
      unitRef="usd">-12000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNC0xOS0xLTEtMA_56f2cac8-b62e-4864-bf8e-10f56a969ee3"
      unitRef="usd">63000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS01LTEtMS0w_47ee9050-0ace-4bcf-8f24-c692e96b4cca"
      unitRef="usd">92000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNS0xOS0xLTEtMA_391b11d1-1c54-4459-8cfe-65b9aae0db0a"
      unitRef="usd">92000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNi0xNy0xLTEtMA_91564922-e274-49cf-a450-9e0a92060ae7"
      unitRef="usd">184000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNi0xOS0xLTEtMA_329839d4-5ef3-4b45-a8f6-c77bf0d6b9a6"
      unitRef="usd">184000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if1f6cfedc37948ddbaa4a17a60061842_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNy0xMS0xLTEtMA_829e1105-7228-438f-96d5-a7e354e167c5"
      unitRef="usd">-132000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfNy0xOS0xLTEtMA_4dab49ca-28c8-480d-8547-65ff12891f55"
      unitRef="usd">-132000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOC05LTEtMS0w_356824f7-94dc-4b1a-816c-7188f80182c0"
      unitRef="usd">34000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOC0xNy0xLTEtMA_c4832a55-e718-40af-a468-16025ee2f832"
      unitRef="usd">176000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOC0xOS0xLTEtMA_6a882a10-01be-4563-9b9b-4b203ca4950b"
      unitRef="usd">210000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS01LTEtMS0w_ab4dfb65-3cee-40dd-b0f7-8d530383b41e"
      unitRef="usd">-150000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS0xMy0xLTEtMA_f4da037b-efa1-4fdd-b632-dbc461d07b84"
      unitRef="shares">13000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS0xNS0xLTEtMA_d01d95c7-1861-4f00-857f-1f58b84aa3d7"
      unitRef="usd">1777000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfOS0xOS0xLTEtMA_c7d2f90b-ea6c-4e4e-8227-489358a0d978"
      unitRef="usd">1627000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5ccd14692cf3450cb539e1a2cf941e8d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMS0xLTEtMA_a26832b9-1228-45b0-844e-a9670b2b5fc3"
      unitRef="shares">5000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtNS0xLTEtMA_cf03b2e0-fb46-4ee9-902a-2466d040950f"
      unitRef="usd">70000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtOS0xLTEtMA_f65800db-d42d-40a8-8124-802b6012d3a7"
      unitRef="usd">472000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMTMtMS0xLTA_1b80791c-5671-4dbe-ac17-f68f198f0ced"
      unitRef="shares">-5000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4a10fdbb9c174ba9a9cc3377ebbd3a76_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMTUtMS0xLTA_cc92407a-fbcb-4492-8ecf-9059c0fdddf1"
      unitRef="usd">-542000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTAtMTktMS0xLTA_458ca3e5-567b-4d3e-8c00-fc273aa01a9b"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjMwMGE5YzI5ZTM0YzQ2YmNiMDc4NDk0NTkwNGZkNGRmXzU0OTc1NTgxMzg5MzY_54850eee-3b71-42a0-86cc-1191977aa72a"
      unitRef="usdPerShare">1.51</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTEtOS0xLTEtMA_4948b90c-d5db-4d82-8c27-bce9b5fd6b4b"
      unitRef="usd">298000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTEtMTktMS0xLTA_e2d19168-1e17-4a8d-b25e-a015cfd6d4aa"
      unitRef="usd">298000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i84e4eb45170844d593b83b2afa4fab92_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItNy0xLTEtMA_979610bc-a32e-401c-b9d8-03a0d9c7a7a2"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItOS0xLTEtMA_ad2b8d6a-4b2d-453a-a718-90219e92997f"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItMTctMS0xLTA_1f66785e-c2df-4b15-ade8-d4abd5d76bec"
      unitRef="usd">52000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTItMTktMS0xLTA_a86543f3-4bd3-4d2a-a7d0-53e972c845c8"
      unitRef="usd">48000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i48ceaabbb16f4ec6b0bf0f94817e2803_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMS0xLTEtMA_a75713e2-040c-4c85-81b9-74573c6d5bbd"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48ceaabbb16f4ec6b0bf0f94817e2803_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMy0xLTEtMA_6bbcf297-6b1b-4844-aca9-8eabeaf8acbe"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id46086fa9b504b8fa9969e5e6955dfca_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtNS0xLTEtMA_3cec8320-1982-4349-97b3-2f4d8cf3d10f"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f1dcb375e934b61af2234db5c9acb4f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtNy0xLTEtMA_fac542f4-5bdb-4619-96ad-660c31af65a4"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51ee753b2d3f41df8075fc700e912fd6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtOS0xLTEtMA_ede421ee-ccf0-4833-907f-327c0a10dc7d"
      unitRef="usd">12409000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40ae5de5a7ed451daaf6f336a3613e5b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTEtMS0xLTA_8e847032-728f-434b-b0c8-cb5b4407bbf2"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3195958993f542039d26aa1dc1a5932a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTMtMS0xLTA_503b6923-7334-4615-80d2-d88af2f257e1"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3195958993f542039d26aa1dc1a5932a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTUtMS0xLTA_44cb8f30-6433-4641-9e58-0e06dfc94261"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4544e477b1841a4bdb6022ce255ba46_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTctMS0xLTA_5ba481d2-130c-4aa2-88d1-dcb8e33a1465"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTMtMTktMS0xLTA_bb072d8a-6e5d-4e5f-802f-178855f485e2"
      unitRef="usd">8287000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0a498773ac34aab9e6acb8ed6ca7397_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTQtOS0xLTEtMA_f97edb46-42fd-4b83-ab78-57125acf967d"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6cd908e9ae944c589f15bfc5295981c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTQtMTktMS0xLTA_8a006749-e68a-44c9-9ecf-07bbfdf647ea"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i127912e4703a4c4b93b3568d503e21a8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMS0xLTEtMA_953502fb-af4f-4029-b8f4-667a219330c3"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i127912e4703a4c4b93b3568d503e21a8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMy0xLTEtMA_f78ec847-5598-402f-89a9-158ed5f09cfa"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8b8e2f7e988499db2ca37a472ba95a1_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtNS0xLTEtMA_76af72aa-2a68-471d-a44f-e33b554b625b"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5501cbeadb6d4216937dff20e26e9da7_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtNy0xLTEtMA_2f7a8b05-04ca-427b-b224-b6613b66efa3"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd6fff2a93e148f184cb8d32b86c426e_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtOS0xLTEtMA_460e0600-aabb-4609-867f-c14e7a4ac0e9"
      unitRef="usd">12420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7317175ef4774a10ab306d8ad80b27be_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTEtMS0xLTA_f7999df0-33e1-4106-8118-68dcb7155534"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ibfa843649b4b43898ba141c6242d8f29_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTMtMS0xLTA_278b5967-f394-4fb1-ad9d-74c8e65fd411"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibfa843649b4b43898ba141c6242d8f29_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTUtMS0xLTA_bf2694ae-fbd3-439e-a862-2f15cdc9e7b2"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28ca8bc8a3df45a680bddb6d68e1a14c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTctMS0xLTA_d7588013-72ca-46c3-b8e1-97b3524b8f1e"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16590f20bcb54d93a46c868388bd8b15_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTUtMTktMS0xLTA_32becb0e-e499-4a3b-ba92-509850f17d32"
      unitRef="usd">8298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i818384a7497d4ec3b819a10a8009bce7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtMS0xLTEtMA_b091595e-8eb4-4915-995c-fc578d8f090a"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0854da8f001b4fb5b20e5b1a8e5cca76_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtNS0xLTEtMA_faf3066c-e15c-452a-b301-0c8473708e1e"
      unitRef="usd">113000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtMTUtMS0xLTA_453c9324-eec2-4fc6-a4d7-6c2981cbe4de"
      unitRef="usd">-20000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTYtMTktMS0xLTA_e761c96b-3391-458f-bd0f-552f030d9d0f"
      unitRef="usd">93000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0854da8f001b4fb5b20e5b1a8e5cca76_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTctNS0xLTEtMA_647044b0-515d-4381-96cc-83c7b603387b"
      unitRef="usd">115000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTctMTktMS0xLTA_45bfa3a8-2cc3-4f5d-81ce-d3469afe6652"
      unitRef="usd">115000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTgtMTctMS0xLTA_2558c37b-7c4f-40f2-aa58-40adb9e95f04"
      unitRef="usd">154000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTgtMTktMS0xLTA_fd3db5c7-d9f5-417b-86b9-7e6e580bc936"
      unitRef="usd">154000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6bd1bf93b1f14f26ac73ea236f36768e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTktMTEtMS0xLTA_c0e433ac-06d9-49e8-b5b8-688a4edd0e60"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMTktMTktMS0xLTA_f9faffa2-baac-4e64-986f-a88d6704eafe"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjAtOS0xLTEtMA_f85c8f5d-9f4f-48b4-af6e-3044e184c205"
      unitRef="usd">900000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjAtMTctMS0xLTA_8dc78541-929a-49d1-a57c-a1638f914dd6"
      unitRef="usd">178000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjAtMTktMS0xLTA_b6239d71-a62d-47ee-ba98-b573d247dd2a"
      unitRef="usd">1078000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjEtMTMtMS0xLTA_5d0e8bd8-c5ec-46ce-bb6b-90b66e5fe7c4"
      unitRef="shares">14000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjEtMTUtMS0xLTA_ad3fcd6d-8fe8-4afc-8794-db54abf91d4a"
      unitRef="usd">1934000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjEtMTktMS0xLTA_d0c25688-2632-461a-bf08-2b2ef3617b94"
      unitRef="usd">1934000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:StockExchangedDuringPeriodShares
      contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjItMTMtMS0xLTA_163ec818-3e78-4afa-af80-b471c598ad34"
      unitRef="shares">15000000</mck:StockExchangedDuringPeriodShares>
    <mck:StockExchangedDuringPeriodValue
      contextRef="ifd08e6599ecc4e5aa8dca445288aaeb0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjItMTUtMS0xLTA_7b29babc-9a3e-4028-9c25-8262b893cd47"
      unitRef="usd">2036000000</mck:StockExchangedDuringPeriodValue>
    <mck:StockExchangedDuringPeriodValue
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjItMTktMS0xLTA_4cc5682c-49c1-44b3-bb25-a7169df679a4"
      unitRef="usd">2036000000</mck:StockExchangedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmZhYzU0OWQyZTMxMjRlMTI4MTVhYjhhOGU4NTY3NWY4XzU0OTc1NTgxMzg5MzY_8d94f901-7692-4f9b-a8ef-7d32260f0c32"
      unitRef="usdPerShare">1.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjMtOS0xLTEtMA_bdd47042-5b86-490c-8ce5-cf6d21d673e4"
      unitRef="usd">294000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjMtMTktMS0xLTA_ac956a6b-a8dc-499f-9192-c81a5d4ac63d"
      unitRef="usd">294000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i818384a7497d4ec3b819a10a8009bce7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtMy0xLTEtMA_f9615e4f-0f32-4bd5-9daa-ab6c806fcb62"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie3f8f7c8825848e3b9c0073f40137455_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtNy0xLTEtMA_732be685-fdeb-44c5-83ee-c3085b1847e6"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i50f4a56f6a4a45cab5ce85b34dc1eb02_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtOS0xLTEtMA_bfba6560-5c70-4148-aad8-e51463968e42"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjQtMTktMS0xLTA_ce3d9111-0abc-4e8e-b5f4-21bc7a26eef5"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ieace64892e6e4c64b170a9943f943cff_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMS0xLTEtMA_4e16190f-1576-4c8f-ad03-c709c17c510f"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieace64892e6e4c64b170a9943f943cff_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMy0xLTEtMA_4f44aa08-b8b3-48b6-b0a8-54fb48c09b20"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06dd26a3871a4b7ebada11dbaa7622fe_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtNS0xLTEtMA_629b05c7-2d68-4b37-9068-fad5ad5ed07a"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a5bbb75dc3b4b22a7678ca731073aea_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtNy0xLTEtMA_bfac7c77-ec74-46b6-8459-0411438e4107"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia36cd1fb5104458194118cf1f7a5b4e5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtOS0xLTEtMA_17ed5458-bfe9-4255-9ce3-cb4bce59a9a9"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6c63db23ba743c9a62c831ddf5c11fe_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTEtMS0xLTA_300ca59f-7b7a-4dce-93ee-c46faf81f4a1"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i47ce9e7fee2540b681fbd42059c7386b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTMtMS0xLTA_b5f97076-a50d-4f4a-af3e-e0f17555db06"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47ce9e7fee2540b681fbd42059c7386b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTUtMS0xLTA_2b6ecea5-f145-44a3-ba1f-04fafae228f0"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8bbfa761b88c4adcbd3850e152c97132_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTctMS0xLTA_f83512bd-9144-4403-82f7-ae41d3f7c9dc"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjUtMTktMS0xLTA_a5448bcd-2059-4767-8939-b4e1fa12b81c"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i405042e0c105499e829dac8d3ddb2458_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjYtOS0xLTEtMA_6c973a4f-f4f1-4fc1-975e-08c4f0f18aea"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id919c60b59754f78a678ad703c842d1b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjYtMTktMS0xLTA_f618dcca-3164-4ef0-9d96-43cbd0940334"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i209c6d9d06f94525a18e4a67e9b962a5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMS0xLTEtMA_917a33ed-9f54-4ebf-9cb5-1653c7cd9198"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i209c6d9d06f94525a18e4a67e9b962a5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMy0xLTEtMA_34d5cc5f-44d4-4be1-a805-3af1a8b15a2e"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice9f595a7fdb4b7cbdd8bf02e8444022_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctNS0xLTEtMA_3cf35bd8-8374-4873-b79f-acf326220261"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7e42c0d706c481b84e088c5d5c7d229_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctNy0xLTEtMA_72fbbb97-9da2-4f2a-a263-f29a6ec5f851"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93e9843c614c4c8790797c45327bd623_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctOS0xLTEtMA_6f20609c-d9f0-4559-b4c5-5eb716d34d07"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i460cb8fdc68d4e3ab755d83b3ce58795_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTEtMS0xLTA_9d18a847-990b-4dcd-b848-7e3bf8355bcb"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id5bccaa8d2ae4c7dab8a934455b32ae4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTMtMS0xLTA_808b06c8-fc99-41dd-bda8-ee3f7b60001e"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5bccaa8d2ae4c7dab8a934455b32ae4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTUtMS0xLTA_4404ea6a-90cb-4af6-8b9e-a59a6fa9e84e"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic23d25bd272041a8865720072fc8a546_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTctMS0xLTA_43329261-d5d7-4f86-b9d8-acc0838dcfba"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i164671a6fa094474b24478df67ffb27e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjctMTktMS0xLTA_80783f9e-cc79-4163-b198-767a9f61b66c"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i8c2be497f4e442e0a366c6eda71cc339_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtMS0xLTEtMA_4cead7d0-c3cb-4740-bede-b4f91990d70b"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtNS0xLTEtMA_65f6e5c5-c2a0-4a4d-bad1-911f36bcdf9b"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtMTUtMS0xLTA_13b6dc27-ea0d-43e4-848b-85beabd1eab7"
      unitRef="usd">-28000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjgtMTktMS0xLTA_27236a71-ec52-4631-9208-819a34686d2b"
      unitRef="usd">64000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjktNS0xLTEtMA_b954dfae-1f1e-4ceb-abd4-a2d4cdfcc808"
      unitRef="usd">151000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMjktMTktMS0xLTA_3d6b956d-384a-4740-aae5-7af522d42b6e"
      unitRef="usd">151000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzAtMTctMS0xLTA_81a8f552-1452-4d8a-bb8c-7621f9b1bb81"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzAtMTktMS0xLTA_0a0ede39-a1b5-4dde-9b2c-93221ebaab5a"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0aece504dbcf4457aacac81f8f54a390_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzEtMTEtMS0xLTA_bac71ff4-0248-4453-b390-8be27391df87"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzEtMTktMS0xLTA_a279d21c-1591-4eb3-86d0-4f98df1de061"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzItOS0xLTEtMA_67101562-77a1-4102-a3f5-c44e627c33fd"
      unitRef="usd">-4539000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzItMTctMS0xLTA_048ec7d8-6801-4be6-a23f-57c888e57fc8"
      unitRef="usd">156000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzItMTktMS0xLTA_557b7d9d-8db4-4077-a8cc-366d6a07e5fe"
      unitRef="usd">-4383000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtNS0xLTEtMjAzMjc_a894ca24-dc8a-473f-b385-f27594716731"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtMTktMS0xLTIwMzI3_27414128-40f0-4e4a-899f-5bdce11b073d"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzMtMTMtMS0xLTA_63764fad-3131-4ae2-bb60-394dae9e58ad"
      unitRef="shares">5000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i40100d3e992e4f978b8850702f43f0bc_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzMtMTUtMS0xLTA_1fa4ce12-a506-42c4-ba44-fe8a3660f789"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzMtMTktMS0xLTA_8c01b253-6969-4c59-a7af-7c071f4b3ede"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjkxNTI2NTJhMzU3OTRmODVhZWZlMDVjMjE0ZDI4ZTk3XzU0OTc1NTgxMzg5MzM_93ac5576-aaae-4574-b3f3-e3a4f970aad6"
      unitRef="usdPerShare">1.67</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtOS0xLTEtMA_ce124a9f-bda1-44d0-b6f1-cae80594be91"
      unitRef="usd">270000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzUtMTktMS0xLTA_e185a11a-9eb2-47f0-8c25-1cd1de096d72"
      unitRef="usd">270000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzYtNS0xLTEtMA_90a8c39b-c251-4b11-8734-d6f528eba709"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ib1ff1dc21c3f4699a9887388b0cea205_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzYtOS0xLTEtMA_8c7d1431-2851-432f-969d-695c2d0b6a1f"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzYtMTktMS0xLTA_067a34e0-602e-448d-8325-d69f8ba46663"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i703f281903e14c92bc829e04ebb959ad_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMS0xLTEtMA_77c45515-df5d-493a-8acf-f8967b24624f"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i703f281903e14c92bc829e04ebb959ad_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMy0xLTEtMA_4b57db58-f00e-4044-9f7c-8626096ff86a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6290fbbe29f84c1db97283a012272162_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctNS0xLTEtMA_04dee46e-b1f2-4002-bb78-9e69964136b5"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0516ac692388404c8f088c9e1ab4cc78_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctNy0xLTEtMA_82102f30-f3d7-4cbf-84dc-ab4c740f4b38"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb86a9ba62104883927379cb8bd96649_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctOS0xLTEtMA_ed53c048-be8b-4944-8e08-64f408714ebd"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9384c8d2c240451493d40ead28d2d250_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTEtMS0xLTA_f7435651-d4dc-41fb-b9e9-060883970338"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i13f69d981df240f483b999053f8a2547_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTMtMS0xLTA_1bd4743a-ad42-40e9-bbba-73aae8a855a9"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13f69d981df240f483b999053f8a2547_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTUtMS0xLTA_0d0174d3-9d16-498c-a1ce-6b25ff0d965b"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a6bb29286494ed2aec32dd02ab9445e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTctMS0xLTA_8c441cc5-a2f2-456d-ba45-20c5f175c72e"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV85Ny9mcmFnOjYxZjJjZDY0YzEyMTRiZTFiOWFkMDA0NWFjMWMwNDI5L3RhYmxlOmFhZTJmNGU3ZGExZjQwYjBiNmZlN2JmMGZmYWE3OGQzL3RhYmxlcmFuZ2U6YWFlMmY0ZTdkYTFmNDBiMGI2ZmU3YmYwZmZhYTc4ZDNfMzctMTktMS0xLTA_e9fd314a-28b1-4541-b1f1-ca3ccb4198c4"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMtMS0xLTEtMA_652bbdee-f61e-4b35-9934-871ba8fd0cc5"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMtMy0xLTEtMA_6bdd1354-378c-4d66-885d-f5cefa08cd16"
      unitRef="usd">1120000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMtNS0xLTEtMA_3282e107-52b7-4643-b092-dd8ce2382bc7"
      unitRef="usd">255000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUtMS0xLTEtMA_305c0994-9732-454d-98c0-d85d1616e7b3"
      unitRef="usd">321000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUtMy0xLTEtMA_994f946b-3df3-4c4e-9eec-672910e53e78"
      unitRef="usd">321000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUtNS0xLTEtMA_39d83d66-bdcc-4a23-8e3d-06f7b89d0b92"
      unitRef="usd">317000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzYtMS0xLTEtMA_3e6c2c5f-adcb-4f97-9185-562564c1a7b5"
      unitRef="usd">566000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzYtMy0xLTEtMA_9cbc9251-34c4-4570-bda5-263b4765b68c"
      unitRef="usd">601000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzYtNS0xLTEtMA_c7314be5-b933-4555-a22c-e2976ba7e6d3"
      unitRef="usd">632000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzgtMS0xLTEtMA_b52eb355-1223-41e4-8c92-eba33e6d7a2d"
      unitRef="usd">242000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzgtMy0xLTEtMA_1c6f6019-1ab2-41bd-b7a8-b7c47de80b54"
      unitRef="usd">139000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzgtNS0xLTEtMA_a9abaa2e-8784-4e24-a6eb-846e6ba04ca9"
      unitRef="usd">2079000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzktMS0xLTEtMA_2d194199-26f6-4222-b845-cbcea7d82f26"
      unitRef="usd">0</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzktMy0xLTEtMA_2ec9ac40-08c1-42ba-8ccf-7019c8512aea"
      unitRef="usd">-1084000000</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzktNS0xLTEtMA_4239b019-f9c2-4741-887c-0efa263b1273"
      unitRef="usd">-194000000</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEwLTEtMS0xLTA_34104b72-e3aa-4654-ba70-cd67511037e0"
      unitRef="usd">908000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEwLTMtMS0xLTA_614cd74f-1e08-441e-8d80-67fcc3efdfef"
      unitRef="usd">342000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEwLTUtMS0xLTA_4f4c6a22-1256-4e01-a849-99b2ac510154"
      unitRef="usd">-189000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzExLTEtMS0xLTA_8fd59cc9-51be-4245-9cd5-464fc3ff1533"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzExLTMtMS0xLTA_83239b96-abc9-4e8f-b4f9-1402b127a0c8"
      unitRef="usd">-252000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzExLTUtMS0xLTA_cbbb18c8-f17c-40c0-866b-3f58abdabc41"
      unitRef="usd">-210000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEyLTEtMS0xLTA_a85d4bd2-44d0-4853-8d54-1add77936ebf"
      unitRef="usd">334000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEyLTMtMS0xLTA_c4128bad-d531-4eca-8952-9ffb7b6d606c"
      unitRef="usd">366000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEzLTEtMS0xLTA_05db85a4-3690-4b32-a772-ab54330626b7"
      unitRef="usd">9000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEzLTMtMS0xLTA_8420d046-eb2b-49bb-b3e5-def2768d14a6"
      unitRef="usd">-33000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzEzLTUtMS0xLTA_b0f877d7-1797-4ebe-89f2-e33955961db2"
      unitRef="usd">86000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE0LTEtMS0xLTA_24372ef7-a27a-4e07-9fae-ee1cf7536421"
      unitRef="usd">-188000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE0LTMtMS0xLTA_c39cfdba-8e58-4dc3-aefe-f89ab6afba89"
      unitRef="usd">-615000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE0LTUtMS0xLTA_092a7a8f-dd65-4d74-87de-52b8c9828d0c"
      unitRef="usd">-52000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE2LTEtMS0xLTA_e147bb44-9a74-48de-986d-0b24dc083596"
      unitRef="usd">-1145000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE2LTMtMS0xLTA_3aebfc50-5f12-4b8f-ac65-fe7b57fab56b"
      unitRef="usd">2494000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE2LTUtMS0xLTA_b09d42a5-659a-4c5f-a4fc-e8495447c315"
      unitRef="usd">967000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE3LTEtMS0xLTA_84a944ec-4618-4cfc-bae2-c1760f88e9aa"
      unitRef="usd">2276000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE3LTMtMS0xLTA_713f322d-0ba3-4479-bced-32fc2787ef25"
      unitRef="usd">376000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE3LTUtMS0xLTA_01ce3bb0-567b-4ba6-85ea-b05cf3784d6b"
      unitRef="usd">368000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE4LTEtMS0xLTA_377536d2-da53-4370-94a1-686dbcfefc6b"
      unitRef="usd">1267000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE4LTMtMS0xLTA_1672f9c4-72fa-4a7a-9dc0-e2ea9f2c3dfe"
      unitRef="usd">3952000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE4LTUtMS0xLTA_e6e9ebbc-fd22-4a86-9008-1cc4337dd483"
      unitRef="usd">1976000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <mck:IncreaseDecreaseinOperatingLeaseLiabilities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE5LTEtMS0xLTA_f9915779-ffa0-48a1-a461-761c0e868f2c"
      unitRef="usd">-362000000</mck:IncreaseDecreaseinOperatingLeaseLiabilities>
    <mck:IncreaseDecreaseinOperatingLeaseLiabilities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzE5LTMtMS0xLTA_e6a2a654-117b-4dc7-861f-23bb2cbd579a"
      unitRef="usd">-377000000</mck:IncreaseDecreaseinOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTEtMS0xLTA_0e43d346-0903-4e14-ab17-aae243620405"
      unitRef="usd">-166000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTMtMS0xLTA_9a232844-1c06-47f0-b9fe-c798686c0210"
      unitRef="usd">-8000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTUtMS0xLTA_f584ec82-a4c1-4f79-9d49-2e71449471d9"
      unitRef="usd">-95000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTEtMS0xLTU3OTY_830b88f6-b22b-42f4-8133-d159eb3b4663"
      unitRef="usd">8067000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTMtMS0xLTU4MDE_f3fbaea0-cae4-486b-8642-9f383e2951d5"
      unitRef="usd">0</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIwLTUtMS0xLTU4MDQ_8c03a39e-d18c-48e1-b767-ad7a76c7d6da"
      unitRef="usd">0</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIxLTEtMS0xLTA_e0c1ebef-0ebb-4a1c-bbe8-e46ae3a90479"
      unitRef="usd">-511000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIxLTMtMS0xLTA_6686ad21-e7e1-4fa4-86da-c9acb4eb4c9f"
      unitRef="usd">8000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIxLTUtMS0xLTA_570ff685-0a67-47b5-9ebb-b25547e4279a"
      unitRef="usd">-68000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIzLTEtMS0xLTA_fb97462c-a1d6-4012-8e5e-82f591d7d240"
      unitRef="usd">4542000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIzLTMtMS0xLTA_09edd739-e695-435c-a7d6-0e4fd82892f5"
      unitRef="usd">4374000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzIzLTUtMS0xLTA_09241b1b-c39f-4d57-a13f-f74556f99162"
      unitRef="usd">4036000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI2LTEtMS0xLTA_92ff2644-9c4e-41f2-b3c3-0bb8d90a2b42"
      unitRef="usd">451000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI2LTMtMS0xLTA_6520c397-bf82-40ce-a660-2e10c0cbb438"
      unitRef="usd">362000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI2LTUtMS0xLTA_1e6fac70-166c-47b6-af64-ef40b8ffaf7e"
      unitRef="usd">426000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI3LTEtMS0xLTA_328ad4a5-e4c4-4987-9dad-89d4a0e794d0"
      unitRef="usd">190000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI3LTMtMS0xLTA_7cb2657f-6da3-44bb-adc4-d34b302a8924"
      unitRef="usd">144000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI3LTUtMS0xLTA_7544c7d9-c5d3-4540-8bac-140c4ae1bc95"
      unitRef="usd">131000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI4LTEtMS0xLTA_b9089d6a-925f-4b4d-85d6-5db20e1a4aaa"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI4LTMtMS0xLTA_781accc4-3057-48f8-9873-57f7f326e1aa"
      unitRef="usd">133000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI4LTUtMS0xLTA_91022de7-e5de-46e4-9855-b9d7b5d67e41"
      unitRef="usd">905000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI5LTEtMS0xLTA_158eafdd-f760-4d9a-8828-9eb63901945c"
      unitRef="usd">400000000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI5LTMtMS0xLTA_b630a2dd-6efe-4398-bf76-44e0dc6188ee"
      unitRef="usd">37000000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzI5LTUtMS0xLTA_32770f4d-d401-4e45-b9f9-b227e919a19d"
      unitRef="usd">101000000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMxLTEtMS0xLTA_892a98fd-e03c-4f81-8420-20375d786a51"
      unitRef="usd">139000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMxLTMtMS0xLTA_286c3c99-4053-4e4f-a6f4-3bb51e712d61"
      unitRef="usd">-23000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMxLTUtMS0xLTA_13b9cf18-9f11-47f6-8352-faa78ae4d19e"
      unitRef="usd">20000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMyLTEtMS0xLTA_ca0d6ddc-381a-47e3-bcc5-a62c48a88025"
      unitRef="usd">-415000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMyLTMtMS0xLTA_0cd6e5aa-f81c-4656-8fc4-5f8eae3442d1"
      unitRef="usd">-579000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzMyLTUtMS0xLTA_f7d3004e-6a7b-4593-ab81-7899cb769e91"
      unitRef="usd">-1381000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM1LTEtMS0xLTA_d79167c9-611d-4729-8f38-0c494d5084d7"
      unitRef="usd">6323000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM1LTMtMS0xLTA_f44a8d03-99ed-4c83-b50f-81feaeefe420"
      unitRef="usd">21437000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM1LTUtMS0xLTA_c90daa6d-52e0-4ec8-bfd4-3d11802cef60"
      unitRef="usd">37265000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM2LTEtMS0xLTA_58cf1f12-660c-4ce5-80e6-2ca011a648c3"
      unitRef="usd">6323000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM2LTMtMS0xLTA_3fc8b443-70ae-42e9-9491-ceec311e2db1"
      unitRef="usd">21437000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM2LTUtMS0xLTA_bc8b49bc-00a1-4f70-a701-fcbb292b2319"
      unitRef="usd">37268000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM3LTEtMS0xLTA_250b45b6-d7a6-4875-9301-0dd5a787c648"
      unitRef="usd">500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM3LTMtMS0xLTA_4c9ddef1-55fe-4883-87e1-9f08fac4fd8c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM3LTUtMS0xLTA_276c139e-47a4-49d1-8b57-53f388abeab5"
      unitRef="usd">1099000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM4LTEtMS0xLTA_37e8f543-e4a4-46bb-b631-0a3c2d9f5a99"
      unitRef="usd">1040000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM4LTMtMS0xLTA_686ccf5d-bd4b-4c31-b4eb-c33341686167"
      unitRef="usd">298000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzM4LTUtMS0xLTA_f0de0f32-1174-4de9-9531-a367ec0ffaba"
      unitRef="usd">1112000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQxLTEtMS0xLTA_7eb49cd6-2667-429c-890f-2b04ab3dba50"
      unitRef="usd">92000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQxLTMtMS0xLTA_a1d97ba0-47ca-46f6-a8c2-62b73c43b834"
      unitRef="usd">113000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQxLTUtMS0xLTA_5679aaa9-a08a-40ca-ad1e-dc524e6af76d"
      unitRef="usd">75000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQyLTEtMS0xLTA_94553dec-a0ef-4eff-b99e-8d6cb2e5b862"
      unitRef="usd">770000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQyLTMtMS0xLTA_7f49ac92-ff74-49ad-b39d-bab520948f21"
      unitRef="usd">1954000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQyLTUtMS0xLTA_ed56d9ef-ac20-4184-8359-2a3fc769b92b"
      unitRef="usd">1639000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQzLTEtMS0xLTA_76f92538-0da8-4fdc-90bd-0b170ed6166d"
      unitRef="usd">276000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQzLTMtMS0xLTA_ce21a6c9-97a9-46ff-830c-c4837424bb35"
      unitRef="usd">294000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQzLTUtMS0xLTA_80850a6b-98fb-437c-a972-524bf67d91f2"
      unitRef="usd">292000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ0LTEtMS0xLTA_165af378-0b06-41bb-980c-6267174f7335"
      unitRef="usd">-199000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ0LTMtMS0xLTA_9faca0f3-84ca-482c-b880-edd76a79f678"
      unitRef="usd">-301000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ0LTUtMS0xLTA_ea2b346b-245e-4c9c-8b22-206f9578929a"
      unitRef="usd">-355000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ1LTEtMS0xLTA_8d66136d-c2a4-4e92-bab4-fb9c56857095"
      unitRef="usd">-1693000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ1LTMtMS0xLTA_37f164d5-897e-4dd6-8787-519118063e13"
      unitRef="usd">-2734000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ1LTUtMS0xLTA_e43c247b-39a1-421a-8fcf-6496f4266883"
      unitRef="usd">-2227000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ2LTEtMS0xLTA_3620160a-97de-4d6a-9ff2-faec39cb404b"
      unitRef="usd">-61000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ2LTMtMS0xLTA_074075dc-c45d-4444-973d-aaeadc6f8f38"
      unitRef="usd">-19000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ2LTUtMS0xLTA_f86f3001-0281-4c25-b510-f4aa2290a6da"
      unitRef="usd">-119000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ3LTEtMS0xLTA_eb99d7e1-1ba5-4b40-8673-2c8313dee3c8"
      unitRef="usd">2373000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ3LTMtMS0xLTA_c0bbf0a4-b802-4bf9-a410-a0b7fa24d051"
      unitRef="usd">1042000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ3LTUtMS0xLTA_d569b870-f81a-47a1-8f13-71af3a3f58e1"
      unitRef="usd">309000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTEtMS0xLTA_c8eabf82-13ad-4f3f-bc6f-6503c02fa5ac"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTMtMS0xLTA_cb355167-74c5-44e5-b5d2-0189d888cbe4"
      unitRef="usd">2981000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i022a2642b16245d083cb80c539e560b3_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTUtMS0xLTA_afcc20c8-ad0c-4c93-bfbc-918b92817040"
      unitRef="usd">2672000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ5LTEtMS0xLTA_28183324-7de4-4668-8ed6-8059c83c8d52"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ5LTMtMS0xLTA_12bc64a5-4b26-4939-89a0-f0dc73908f84"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ5LTUtMS0xLTA_0be5569b-064a-4afb-a58b-366d2bd46ddb"
      unitRef="usd">2981000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTEtMS0xLTYyMzQ_21879f62-d578-4edd-aa63-0541ed2eb1d8"
      unitRef="usd">118000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTMtMS0xLTYyNDE_221fae26-8874-4b31-89e2-256f4e9f430a"
      unitRef="usd">8000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzQ4LTUtMS0xLTYyNDU_c7c75951-1de1-445e-a5b8-6cd6f323ac84"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUwLTEtMS0xLTYyMzE_2d949de6-50a5-4a75-bbf1-f5524e0a2285"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUwLTMtMS0xLTYyNDE_6790cba0-cb7e-49db-8dd1-ff0b8a902f6d"
      unitRef="usd">4015000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzUwLTUtMS0xLTYyNDU_18ade387-2806-444d-89a0-2ec975fc1955"
      unitRef="usd">2981000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU0LTEtMS0xLTk3ODE_414718a8-e900-4816-970e-5c3fa425340f"
      unitRef="usd">220000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU0LTMtMS0xLTk3ODM_979d3d13-21d2-4ec6-8ed9-96c517488c70"
      unitRef="usd">235000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU0LTUtMS0xLTk3ODU_f7f2fcfc-fb28-4d6b-b9dd-a76df72be6eb"
      unitRef="usd">383000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU1LTEtMS0xLTk3ODE_5c8a2649-a8cb-4ae5-bf98-32ddcaa17607"
      unitRef="usd">379000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU1LTMtMS0xLTk3ODM_dc57527e-d0d4-4949-bcbc-949fd1119160"
      unitRef="usd">368000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDMvZnJhZzoxZTlmMDVhYjhmYzU0ODFlYWU0OTUwNGE0ZjM4NGNlYS90YWJsZTo3Zjg1OTFhZDc3MzI0NmI0OTNjZGI4Nzg1YWQwNDJiNC90YWJsZXJhbmdlOjdmODU5MWFkNzczMjQ2YjQ5M2NkYjg3ODVhZDA0MmI0XzU1LTUtMS0xLTk3ODU_db9505f0-cb35-41af-a442-d9a48dde77c9"
      unitRef="usd">262000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDQ1_9be701ec-e0f2-423b-8b63-8d3ab2dffb44">Significant Accounting Policies &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a global provider of healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing with the second quarter of 2021, the Company reports its financial results in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#x201c;RxTS&#x201d;). All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation. The Company&#x2019;s equity method investment in Change Healthcare LLC (&#x201c;Change Healthcare JV&#x201d;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. Refer to Financial Note 22, &#x201c;Segments of Business,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights (&#x201c;variable interest entities&#x201d; or &#x201c;VIEs&#x201d;) and determines which business entity is the primary beneficiary of the VIE. The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The preparation of financial statements in conformity with U.S. GAAP requires that the Company make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The severity, magnitude and duration, as well as the economic consequences of the coronavirus diseases 2019 (&#x201c;COVID-19&#x201d;) pandemic, are uncertain, rapidly changing, and difficult to predict. Therefore, the Company&#x2019;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#x2019;s consolidated financial results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#x2019;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#x201c;Prepaid expenses and other&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. As of March&#160;31, 2021, restricted cash primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#x201c;Other accrued liabilities&#x201d; on the Company&#x2019;s Consolidated Balance Sheet as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marketable Securities Available-for-Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Company&#x2019;s marketable securities, which are available-for-sale, are carried at fair value and are included in &#x201c;Prepaid expenses and other&#x201d; in the Consolidated Balance Sheets. The unrealized gains and losses, net of the related tax effect, computed in marking these securities to market have been reported in stockholders&#x2019; equity. At March&#160;31,&#160;2021 and 2020, marketable securities were not material. In determining whether an other-than-temporary decline in market value has occurred, the Company considers the duration that, and extent to which, the fair value of the investment is below its cost, the financial condition and future prospects of the issuer or underlying collateral of a security, and its intent and ability to retain the security in order to allow for an anticipated recovery in fair value. Other-than-temporary declines in fair value from amortized cost for available-for-sale equity securities that the Company intends to sell or would more likely than not be required to sell before the expected recovery of the amortized cost basis are charged to other income (expense), net, in the period in which the loss occurs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, Net and Allowances for Doubtful Accounts: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s receivables are presented net of an allowance for doubtful accounts and primarily consist of trade accounts receivables from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $198 million and $224 million were included in &#x201c;Receivables, net&#x201d; on the Consolidated Balance Sheet as of March&#160;31, 2021 and 2020, respectively. Changes in the allowance were not material for the year ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the components of the Company&#x2019;s receivables as of March 31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentrations of Credit Risk and Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2021, sales to the Company&#x2019;s ten largest customers, including group purchasing organizations (&#x201c;GPOs&#x201d;), accounted for approximately 51% of its total consolidated revenues and approximately 32% of total trade accounts receivable at March&#160;31, 2021. Sales to the Company&#x2019;s largest customer, CVS Health Corporation (&#x201c;CVS&#x201d;), accounted for approximately 21% of its total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March&#160;31, 2021. As a result, the Company&#x2019;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#x2019;s financial condition, results of operations, and liquidity. In addition, trade receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#x2019;s customer base as well as its geographic dispersion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financing Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses and monitors credit risk associated with financing receivables, primarily notes receivable, through regular review of its collections experience in determining its allowance for loan losses. On an ongoing basis, the Company also evaluates credit quality of its financing receivables utilizing historical collection rates and write-offs, as well as considering existing economic conditions, to determine if an allowance is required. As of March&#160;31, 2021 and 2020, financing receivables were not material to the Company&#x2019;s consolidated financial statements. Financing receivables and the related allowances are included in &#x201c;Receivables, net&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#x201c;LIFO&#x201d;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#x201c;FIFO&#x201d;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LIFO method was used to value approximately 58% and 60% of the Company&#x2019;s inventories at March&#160;31, 2021 and 2020, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $406&#160;million and $444&#160;million higher than the amounts reported at March&#160;31, 2021 and 2020, respectively. These amounts are equivalent to the Company&#x2019;s LIFO reserves. The Company&#x2019;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $38 million, $252 million, and $210 million in 2021, 2020, and 2019, respectively, in &#x201c;Cost of sales&#x201d; in its Consolidated Statements of Operations. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Excluding LIFO reserves, inventory reserves as of March&#160;31, 2021 and 2020 were $263 million and $96 million, respectively. The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment. These charges are recorded in "Cost of sales" in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#x201c;market&#x201d;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March&#160;31, 2021 and 2020, inventories at LIFO did not exceed market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Costs: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes costs to pack and deliver inventory to its customers in Selling, distribution, general, and administrative expenses. Shipping and handling costs of $1.0 billion, $1.0 billion, and $951 million were recognized in 2021, 2020, and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Held for Sale: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. Refer to Financial Note 3, &#x201c;Held for Sale,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant, and Equipment, Net: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the components of the Company&#x2019;s property, plant, and equipment, net as of March&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total depreciation expense for property, plant, and equipment, net and amortization of finance leases was $344&#160;million, $335&#160;million, and $317&#160;million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#x201c;DCF&#x201d;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#x2019; fair values to the Company&#x2019;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently all of the Company&#x2019;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2"&gt;one&lt;/span&gt; to 38 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Software Held for Internal Use: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March&#160;31, 2021 and 2020, capitalized software held for internal use was $513 million and $400 million, respectively, net of accumulated amortization of $1.4 billion and $1.3 billion, respectively, and is included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $117&#160;million, $129&#160;million, and $137&#160;million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Programs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#x201c;Captives&#x201d;), from which it obtains coverage for catastrophic exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company, as discussed in more detail in Financial Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; as well as those risks required to be insured by law or contract. It is the Company&#x2019;s policy to retain a significant portion of certain losses, including those related to workers&#x2019; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#x2019;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#x2019;s premium costs within Operating Expenses in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#x2019;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#x2019; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#x2019;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion in each of 2021 and 2020 and $2.9 billion in 2019. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March&#160;31, 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#x2019;s services arrangements and are recognized as revenues over the periods when services are performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March&#160;31, 2021 and 2020. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Incentives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Reserves: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#x2019;s estimate. The supplier reserves primarily pertain to the Company&#x2019;s U.S. Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Interest expense primarily includes interest for the Company&#x2019;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#x2019; equity accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#x201c;Other comprehensive income (loss), net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations and were not material to the Company&#x2019;s consolidated results of operations in 2021, 2020, or 2019. The Company releases cumulative translation adjustments from stockholders&#x2019; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#x201c;Other comprehensive income (loss), net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Income (Loss): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income. Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of stockholders&#x2019; equity but are excluded from earnings. The Company&#x2019;s other comprehensive income primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency including gains and losses on net investment hedges, unrealized gains and losses on cash flow hedges, and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unrealized gains and losses on retirement-related benefit plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests and Redeemable Noncontrolling Interests: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#x2019;s consolidated entities including Vantage Oncology Holdings, LLC (&#x201c;Vantage&#x201d;) and ClarusONE Sourcing Services LLP (&#x201c;ClarusONE&#x201d;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#x2019;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#x2019; equity in the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 9, &#x201c;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; for additional information related to ongoing controlled substances claims to which the Company is a party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are recognized as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#x2019;s expected useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company prospectively adopted Accounting Standard Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#x2019;s consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Retirement Benefits - Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove, modify, and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#x2019;s consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The adoption of this amended guidance is not expected to have a material impact on the Company&#x2019;s consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="iea92921488274912b519ed84b11ab23f_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzIxOTkwMjMzMDAxNTc_215e1f71-88e7-4593-bb39-85046fd60a3d"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzM1_8956dad5-b514-4aa0-80ed-fa1dfb45e51e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.&lt;/span&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights (&#x201c;variable interest entities&#x201d; or &#x201c;VIEs&#x201d;) and determines which business entity is the primary beneficiary of the VIE. The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzY2_27bd3ec0-2649-4254-ac4d-537039b789a0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTA3_919d3aa1-495a-4b9b-b07a-c74feb37abb1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzgy_51f2db4f-813d-4cab-82ef-e80a6c9adecc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The preparation of financial statements in conformity with U.S. GAAP requires that the Company make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The severity, magnitude and duration, as well as the economic consequences of the coronavirus diseases 2019 (&#x201c;COVID-19&#x201d;) pandemic, are uncertain, rapidly changing, and difficult to predict. Therefore, the Company&#x2019;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods.&lt;/span&gt;The Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#x2019;s consolidated financial results.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzM2_737a6b4e-35b0-4f35-807d-c0dae453ae49">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#x2019;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDc5_27cc79d2-30f1-412a-9621-32f20a08aa4a">Restricted Cash: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#x201c;Prepaid expenses and other&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzA4_c11a339c-4908-4c5a-9c2a-e4991fcef8ea">Marketable Securities Available-for-Sale: The Company&#x2019;s marketable securities, which are available-for-sale, are carried at fair value and are included in &#x201c;Prepaid expenses and other&#x201d; in the Consolidated Balance Sheets. The unrealized gains and losses, net of the related tax effect, computed in marking these securities to market have been reported in stockholders&#x2019; equity. At March&#160;31,&#160;2021 and 2020, marketable securities were not material. In determining whether an other-than-temporary decline in market value has occurred, the Company considers the duration that, and extent to which, the fair value of the investment is below its cost, the financial condition and future prospects of the issuer or underlying collateral of a security, and its intent and ability to retain the security in order to allow for an anticipated recovery in fair value. Other-than-temporary declines in fair value from amortized cost for available-for-sale equity securities that the Company intends to sell or would more likely than not be required to sell before the expected recovery of the amortized cost basis are charged to other income (expense), net, in the period in which the loss occurs.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDY0_6fc9b656-3f7b-4d0c-b0aa-d36777c9d953">Equity Method Investments: Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5MzczOTM3_ab0aa067-b771-403b-aa2b-b70ba605fd7f">Receivables, Net and Allowances for Doubtful Accounts: The Company&#x2019;s receivables are presented net of an allowance for doubtful accounts and primarily consist of trade accounts receivables from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4NjYw_f439cb63-06fc-488f-a19e-62e574fc3f95">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzMyOTg1MzQ5NjczMjg_fce80aaa-8c25-4afc-ab96-805b7fd1a911"
      unitRef="usd">198000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTMwMDY_792ea3fc-cd72-4a9c-ae2c-0159ca85d020"
      unitRef="usd">224000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5MzczOTM4_8805b2ee-9a44-49fa-9abc-1697ec473589">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the components of the Company&#x2019;s receivables as of March 31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <mck:AccountsReceivableCustomerAccountsGross
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzItMS0xLTEtMTUxNDE_cbc1ca6d-cebf-4350-8e62-a378b655a14e"
      unitRef="usd">17106000000</mck:AccountsReceivableCustomerAccountsGross>
    <mck:AccountsReceivableCustomerAccountsGross
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzItMy0xLTEtMTUxNDE_98b5b986-12b8-491d-ac91-f29f9ccc3b7e"
      unitRef="usd">17201000000</mck:AccountsReceivableCustomerAccountsGross>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzMtMS0xLTEtMTUxNDE_f1d54b58-97e5-4722-a32f-530f92b187bf"
      unitRef="usd">2325000000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzMtMy0xLTEtMTUxNDE_bd7372a8-1b9e-4140-80a2-1709d21b50ad"
      unitRef="usd">3014000000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzQtMS0xLTEtMTUxNDE_c1620d1f-2415-407e-93f9-77db01e04fd2"
      unitRef="usd">19431000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzQtMy0xLTEtMTUxNDE_5b5f9621-c7cb-4d64-9b9d-e21c10e209b7"
      unitRef="usd">20215000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzUtMS0xLTEtMTUxNDE_bda03d5a-1878-4a17-b2a8-2ecc90ae446b"
      unitRef="usd">250000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzUtMy0xLTEtMTUxNDE_20dbc792-6bd7-4890-bf39-f896039a5895"
      unitRef="usd">265000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzYtMS0xLTEtMTUxNDE_6a19a8ef-cde6-4d3b-bcda-962cfcf46eaa"
      unitRef="usd">19181000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo2NGFhNmVkY2YyNmE0M2Y0OWIyYjMwNDY4ODNkMGM2My90YWJsZXJhbmdlOjY0YWE2ZWRjZjI2YTQzZjQ5YjJiMzA0Njg4M2QwYzYzXzYtMy0xLTEtMTUxNDE_d9cb34d9-4024-4947-9d5d-60fa8c15fe33"
      unitRef="usd">19950000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzk2_0c01905a-9877-46ba-91c4-a66f3dda5c35">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentrations of Credit Risk and Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2021, sales to the Company&#x2019;s ten largest customers, including group purchasing organizations (&#x201c;GPOs&#x201d;), accounted for approximately 51% of its total consolidated revenues and approximately 32% of total trade accounts receivable at March&#160;31, 2021. Sales to the Company&#x2019;s largest customer, CVS Health Corporation (&#x201c;CVS&#x201d;), accounted for approximately 21% of its total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March&#160;31, 2021. As a result, the Company&#x2019;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#x2019;s financial condition, results of operations, and liquidity. In addition, trade receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#x2019;s customer base as well as its geographic dispersion.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <mck:NumberofLargestCustomers
      contextRef="i3130d916740b4d2393240ae5139a6d53_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzY4MjQ_e232fe06-ca6b-4eb5-aca1-052d1cab8b76"
      unitRef="customer">10</mck:NumberofLargestCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3130d916740b4d2393240ae5139a6d53_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzY5MjU_ebf03638-b86b-4887-a498-c31618c09a15"
      unitRef="number">0.51</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1a9fca715b904e98b76ea386572b0b03_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzY5ODE_48f2645d-74cd-4025-b726-ff26a160fdb5"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i93f771eff0414af9b947ca5a7031556b_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzcxMjc_c3e2c051-fe35-45e1-9da4-169d90a0431e"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie1eb1f08e1664c6cb53a8da1be89cca7_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzcxOTk_bad4bf49-3e83-43f4-8bc7-7cd729e2e937"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FinanceLoansAndLeasesReceivablePolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDUw_38ff9438-e44a-478a-80af-e197965d6206">Financing Receivables: The Company assesses and monitors credit risk associated with financing receivables, primarily notes receivable, through regular review of its collections experience in determining its allowance for loan losses. On an ongoing basis, the Company also evaluates credit quality of its financing receivables utilizing historical collection rates and write-offs, as well as considering existing economic conditions, to determine if an allowance is required.</us-gaap:FinanceLoansAndLeasesReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTE4_beab590b-8c48-410b-8dc0-beb5dffc434b">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#x201c;LIFO&#x201d;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#x201c;FIFO&#x201d;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LIFO method was used to value approximately 58% and 60% of the Company&#x2019;s inventories at March&#160;31, 2021 and 2020, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $406&#160;million and $444&#160;million higher than the amounts reported at March&#160;31, 2021 and 2020, respectively. These amounts are equivalent to the Company&#x2019;s LIFO reserves. The Company&#x2019;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $38 million, $252 million, and $210 million in 2021, 2020, and 2019, respectively, in &#x201c;Cost of sales&#x201d; in its Consolidated Statements of Operations. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Excluding LIFO reserves, inventory reserves as of March&#160;31, 2021 and 2020 were $263 million and $96 million, respectively. The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment. These charges are recorded in "Cost of sales" in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#x201c;market&#x201d;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwMzE2_1c70064c-1f7f-42bc-a573-727456a27169"
      unitRef="number">0.58</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwMzIz_7bf9d436-6b98-4f3a-9225-ac889a691018"
      unitRef="number">0.60</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:InventoryLIFOReserve
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNDg1_c512b0d3-4c38-4c55-a3ba-fc1d08ce7854"
      unitRef="usd">406000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNDky_b880bc80-7942-43e3-9187-3c2509f7baf3"
      unitRef="usd">444000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNzQw_d6b513cd-4d5d-4332-8837-e67dceaf98e9"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNzQ0_85c5ac70-52c4-4d16-91f4-232f05761fa6"
      unitRef="usd">-252000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzEwNzUx_fd398e51-2a95-4060-a835-dc1eae68a54f"
      unitRef="usd">-210000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryValuationReserves
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTI2MDI_04459003-f615-4928-9778-0fa83a440618"
      unitRef="usd">263000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTI2MTI_1cf52139-c138-43e6-92de-5558fa0affa7"
      unitRef="usd">96000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryWriteDown
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MTI1OTM_a1bbb6c5-bfcb-4f15-a592-759f70616b63"
      unitRef="usd">136000000</us-gaap:InventoryWriteDown>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTQ2_170f16d1-e5ff-446d-af1c-cfa87b2b98b3">Shipping and Handling Costs: The Company includes costs to pack and deliver inventory to its customers in Selling, distribution, general, and administrative expenses.</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i52d8e2f4787a4d32a764107acdbc0c3f_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzExNzU5_016080c6-dd1d-441e-896d-22ab5fa5b1bd"
      unitRef="usd">1000000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4f49f517b19c4c2794bc573c91dfd166_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzExNzYz_410ee52a-6424-4bfd-b82d-7d0a54763c97"
      unitRef="usd">1000000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iddad10a5e1484e3ba28181133cb79477_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzExNzcx_cbface8a-1611-4f1a-8f47-d37fdc33e009"
      unitRef="usd">951000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <mck:HeldforSalePolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDkw_6732798c-d19e-48e6-8938-9649a1adcf1c">Held for Sale: Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.</mck:HeldforSalePolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzg5_024d6494-c46b-43fe-b552-4fff066209a9">Property, Plant, and Equipment, Net: Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic7262554200c4a4687b065b0139747a9_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4NjY0_047e0b32-918e-4dc6-8e8a-c1b3c876196b">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5b15db7a10914e64aff0c0319c0b1858_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4Njgy_17e1e6a1-8185-4e7f-9729-026dc20791fb">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4dfc9a103be247469a824e16d2593cc4_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4Njkx_93495acc-722b-48b0-8f5e-5bde03aa4fe0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie77f379fcbbf4fabbb3643c1b75c74a4_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg4NzEy_ef3b4311-5932-4bfe-9167-503b93e86fce">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5MzczOTM5_b4291bc5-b2f9-4489-947b-a868ee6c3b75">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the components of the Company&#x2019;s property, plant, and equipment, net as of March&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzItMS0xLTEtMTQ1MzQ_48e8fb7a-b967-4b63-8745-9d0773e286f7"
      unitRef="usd">156000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzItMy0xLTEtMTQ1MzQ_252f42dd-6c28-41b6-b90d-207592d57b2f"
      unitRef="usd">151000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzMtMS0xLTEtMTQ1MzQ_a509e256-b9a2-4570-8847-214c1c5ab395"
      unitRef="usd">1745000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzMtMy0xLTEtMTQ1MzQ_70e8b584-f8b1-4518-aa9a-e666e4107ff3"
      unitRef="usd">1604000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzQtMS0xLTEtMTQ1MzQ_c892863f-e440-4c0c-98c1-821f04de22c4"
      unitRef="usd">2512000000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzQtMy0xLTEtMTQ1MzQ_4e5675f2-b87b-4a7b-8900-ec8e215fcd63"
      unitRef="usd">2308000000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:ConstructionInProgressGross
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzUtMS0xLTEtMTQ1MzQ_c6421372-c344-4837-b17a-d202eb9aff0b"
      unitRef="usd">382000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzUtMy0xLTEtMTQ1MzQ_f4c7b6bd-bf14-4a9d-904b-d9aefc30e6ba"
      unitRef="usd">131000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzYtMS0xLTEtMTQ1MzQ_8c99cd63-6466-4f0c-aa1f-e7a2379d903f"
      unitRef="usd">4795000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzYtMy0xLTEtMTQ1MzQ_e0dc2c00-a695-448c-a3f8-38d0ed05f674"
      unitRef="usd">4194000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzctMS0xLTEtMTQ1MzQ_9caf710e-ed70-4879-9900-7e3ac954611a"
      unitRef="usd">2214000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzctMy0xLTEtMTQ1MzQ_83f3a009-ec57-45e8-9aef-aba390b56bd5"
      unitRef="usd">1829000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzgtMS0xLTEtMTQ1MzQ_e0d201d6-acef-4f12-b981-b57da249a07d"
      unitRef="usd">2581000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90YWJsZTo0MzZhOWFmMzhjNWI0N2NmYjM5YmEwNWU2ZWVmZDc1OS90YWJsZXJhbmdlOjQzNmE5YWYzOGM1YjQ3Y2ZiMzliYTA1ZTZlZWZkNzU5XzgtMy0xLTEtMTQ1MzQ_82a62ec4-f5c2-4382-bfcc-e5c0db3f5f64"
      unitRef="usd">2365000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDIzOTUzODU_d865f8f6-ff45-4c9c-b220-688502b8d46f"
      unitRef="usd">344000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDIzOTU0MTc_cf64e439-3728-420a-b0d4-8cebd9a0653e"
      unitRef="usd">335000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDIzOTU0OTY_81770b95-2fdf-4e35-9994-43bf849e1ca8"
      unitRef="usd">317000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzIx_ee6ffdbe-8d9a-41d1-bad4-0f5e5187f370">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.&lt;/span&gt;&lt;/div&gt;To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#x201c;DCF&#x201d;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#x2019; fair values to the Company&#x2019;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTEw_04746cfd-ad9e-4536-961c-e1d42af934fa">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently all of the Company&#x2019;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2"&gt;one&lt;/span&gt; to 38 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.&lt;/span&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia82280b01acd4961b7aae7ec8926f663_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzc4_2541aede-be09-4b79-b903-89fdf0423f21">P38Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTU2_eb3dcf66-d237-4f0a-974c-a05bbb6ddf88">Capitalized Software Held for Internal Use: The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years.</us-gaap:InternalUseSoftwarePolicy>
    <mck:CapitalizedSoftwareHeldforInternalUseUsefulLife
      contextRef="ia82280b01acd4961b7aae7ec8926f663_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NTI4_488e328b-c678-4001-83fe-d65afb0a680f">P10Y</mck:CapitalizedSoftwareHeldforInternalUseUsefulLife>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NTk2_8436d022-ab3a-4092-875c-b103be2ed364"
      unitRef="usd">513000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NjAz_21f55d84-67ba-439e-830d-4278efe4c526"
      unitRef="usd">400000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NjQy_d453b0a1-1e20-4312-83ef-bffa8cfb5da2"
      unitRef="usd">1400000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE2NjQ5_b0b1bc50-86b1-4c3d-b264-8a7ac23b9e4b"
      unitRef="usd">1300000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MDAxMjQ_d37b8338-41d3-4240-9e3b-6ae1ba1fc98d"
      unitRef="usd">117000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MDAxMzI_9cda9a37-535c-45f6-9f4e-af672d8bc2f8"
      unitRef="usd">129000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQ5NDc4MDI0MDAxNTY_344efe37-79ec-4310-a970-0eccdde132d5"
      unitRef="usd">137000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <mck:InsuranceProgramsPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDY2_93d53cdf-6661-4a0c-a265-c726b5b17bd2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Programs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#x201c;Captives&#x201d;), from which it obtains coverage for catastrophic exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company, as discussed in more detail in Financial Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; as well as those risks required to be insured by law or contract. It is the Company&#x2019;s policy to retain a significant portion of certain losses, including those related to workers&#x2019; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#x2019;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#x2019;s premium costs within Operating Expenses in the Consolidated Statements of Operations.&lt;/span&gt;</mck:InsuranceProgramsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDk5_01263e40-252b-44c3-b09a-bbfcc714bd50">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#x2019;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#x2019; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#x2019;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion in each of 2021 and 2020 and $2.9 billion in 2019. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March&#160;31, 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#x2019;s services arrangements and are recognized as revenues over the periods when services are performed. The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March&#160;31, 2021 and 2020. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i76008cf481ff411789c581d87a72f149_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODE4_42ba2d20-3421-4f77-a459-c394e3cbb272"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8bb50cd186cb4d44ac0d335a56971982_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODE4_4753e8cf-1e6e-4c30-a617-71695564880e"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i20b5a4c9debc4c86ab2c641342640b2b_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODI1_0c7ee65c-b35a-4832-96f1-94b7ada89935"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9bdf98ffd5304512a88b518b82d6beb4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE4ODI1_5266363f-2fe9-4301-99fa-8d1c17614412"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NDkz_2bf6e611-6641-4cd0-b4a3-49371b21e71e"
      unitRef="usd">3100000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NDkz_db05d647-b755-4c3e-b3be-f58cc8f752e1"
      unitRef="usd">3100000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NTE2_a61b31d3-2a16-41aa-96e9-7aa5ea636678"
      unitRef="usd">2900000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:SupplierIncentivesPolicyPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDMx_26197c61-1f41-4759-b3c9-3777926d1750">Supplier Incentives: Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.</mck:SupplierIncentivesPolicyPolicyTextBlock>
    <mck:SupplierReservesPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTM3_4c9bed00-4829-48b9-8070-492206a815e6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Reserves: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#x2019;s estimate. The supplier reserves primarily pertain to the Company&#x2019;s U.S. Pharmaceutical segment.&lt;/span&gt;</mck:SupplierReservesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzU2_48670e68-3b86-4846-8890-306c29e461aa">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InterestExpensePolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDEy_5bf429aa-2f19-42ac-990d-1c4cec1553f9">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Interest expense primarily includes interest for the Company&#x2019;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.&lt;/span&gt;</us-gaap:InterestExpensePolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDcw_9fc8bbc5-9510-44b6-9396-8c5c9ff58f55">Foreign Currency Translation: The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#x2019; equity accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#x201c;Other comprehensive income (loss), net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations and were not material to the Company&#x2019;s consolidated results of operations in 2021, 2020, or 2019. The Company releases cumulative translation adjustments from stockholders&#x2019; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzE2_cfe5c7b9-dfe6-4a7a-8637-733e0f8f17c0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#x201c;Other comprehensive income (loss), net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings.&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE5NzkxMjA5Mzg5MTQ3_483b32f3-cd16-49af-80ac-3f38df42b7a2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Income (Loss): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income. Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of stockholders&#x2019; equity but are excluded from earnings. The Company&#x2019;s other comprehensive income primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency including gains and losses on net investment hedges, unrealized gains and losses on cash flow hedges, and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;unrealized gains and losses on retirement-related benefit plans.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzk0_699d05d2-1dd2-442d-9a0d-5494d6c9537f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests and Redeemable Noncontrolling Interests: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#x2019;s consolidated entities including Vantage Oncology Holdings, LLC (&#x201c;Vantage&#x201d;) and ClarusONE Sourcing Services LLP (&#x201c;ClarusONE&#x201d;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#x2019;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#x2019; equity in the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 9, &#x201c;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#x201d; for more information.&lt;/span&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzg2_f072d6fe-6c75-4b23-ac9e-3fd5810fd27c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNTAx_13b85a6c-43d5-44ac-9896-765fbb6432ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.&lt;/span&gt;The Company reviews all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; for additional information related to ongoing controlled substances claims to which the Company is a party.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDMy_abb1aacd-d062-4a63-bc5c-d1e093b50d90">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are recognized as incurred.&lt;/span&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwMzQ0_a53ab597-4c5d-4a16-a4c9-eedf8b84ffb2">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#x2019;s expected useful life.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzQwNDAw_b39870c3-f3d4-46e2-957a-fc1e600c1e6e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company prospectively adopted Accounting Standard Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#x2019;s consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Retirement Benefits - Defined Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to remove, modify, and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#x2019;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, the Company adopted ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#x2019;s consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The adoption of this amended guidance is not expected to have a material impact on the Company&#x2019;s consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife3b4b3b997b40d1a537f1ca3f6bb09e_I20200401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzU0OTc1NTgxOTg1MTg_80acdeb8-45a6-42d5-94f6-3c7f5852ac49"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzEwNjg2_e614e211-ca06-423f-8ee8-dd5f16075add">Investment in Change Healthcare Joint Venture &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2017, the Company contributed the majority of its McKesson Technology Solutions businesses to form a joint venture, the Change Healthcare JV, under a contribution agreement between McKesson and Change Healthcare Inc. (&#x201c;Change&#x201d;) and others, including shareholders of Change. In exchange for the contribution, the Company initially owned approximately 70% of the joint venture, with the remaining equity ownership of approximately 30% held by Change. The Change Healthcare JV was jointly governed by McKesson and shareholders of Change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#x201c;IPO&#x201d;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $888 million. Change contributed the proceeds of $609 million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#x201c;LLC Units&#x201d;) at the equivalent of its offering price of $13 per share. The proceeds of $279 million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#x2019;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5% while Change owned approximately 41.5% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a dilution loss of $246 million, primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#x2019;s carrying value. The Company&#x2019;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. These amounts were included in &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statements of Operations for the year ended March&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company recorded an other-than-temporary&#160;impairment (&#x201c;OTTI&#x201d;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#x2019;s investment and the fair value derived from the corresponding closing price of Change&#x2019;s common stock at September 30, 2019. This charge was included in &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statements of Operations for the year ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Separation of the Change Healthcare JV&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV. The separation was affected through the split-off of PF2 SpinCo, Inc. (&#x201c;SpinCo&#x201d;), a wholly-owned subsidiary of the Company that held all of the Company&#x2019;s interest in the Change Healthcare JV, to certain of the Company&#x2019;s stockholders through an exchange offer (&#x201c;Split-off&#x201d;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#x201c;Merger&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Split-off, on March 9, 2020, the Company distributed all 176.0 million outstanding shares of common stock of SpinCo to participating holders of the Company&#x2019;s common stock in exchange for 15.4 million shares of McKesson common stock which now are held as treasury stock on the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 20, &#x201c;Stockholders' Equity,&#x201d; for more information. Following consummation of the exchange offer, on March 10, 2020, SpinCo was merged with and into Change Healthcare, and each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and the Merger are intended to be generally tax-free transactions for U.S. federal income tax purposes. Following the Split-off, the Company does not beneficially own any of Change&#x2019;s outstanding securities. In the fourth quarter of 2020, the Company recognized a net gain of $414 million related to the transaction which is included under the caption &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statements of Operations for the year ended March&#160;31, 2020. The net gain was calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in the Change Healthcare JV at exchange date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversal of deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Release of accumulated other comprehensive attributable to the joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Transaction costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain on split-off of the Change Healthcare JV&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investment in the Change Healthcare Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investment in the joint venture was accounted for using the equity method of accounting on a one-month reporting lag. The Company&#x2019;s accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements. Effective April&#160;1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance and, in the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#x2019;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, in the Company&#x2019;s opening retained earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded its proportionate share of loss from its investment in the Change Healthcare JV of $119 million and $194 million in 2020 and 2019, respectively. The Company&#x2019;s proportionate share of income or loss from this investment includes transaction and integration expenses incurred by the Change Healthcare JV and basis differences between the joint venture and McKesson including amortization of fair value adjustments primarily representing incremental intangible amortization and removal of profit associated with the recognition of deferred revenue. These amounts were recorded under the caption &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the formation of the Change Healthcare JV, McKesson, the Change Healthcare JV and certain shareholders of Change entered into various ancillary agreements, including transition services agreements (&#x201c;TSA&#x201d;), a transaction and advisory fee agreement (&#x201c;Advisory Agreement&#x201d;), a tax receivable agreement (&#x201c;TRA&#x201d;) and certain other agreements. Fees incurred or earned from the Advisory Agreement were not material for 2020 and 2019. Fees incurred or earned from the TSA were not material in 2021 and were $22 million in 2020 and $60 million in 2019. The Advisory Agreement was terminated in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Company renegotiated the terms of the TRA which resulted in the extinguishment and derecognition of the $90 million non-current liability payable to the shareholders of Change.&#160;In exchange for the shareholders of Change agreeing to extinguish the liability, the Company agreed to an allocation of certain tax amortization that had the effect of reducing the amount of a distribution from the Change Healthcare JV that would otherwise have been required to be made to the shareholders of Change.&#160;As a result of the renegotiation, McKesson was relieved from any potential future obligations associated with the non-current liability and recognized a credit of $90 million in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in its Consolidated Statement of Operations in 2019.&#160;At March&#160;31, 2021 and 2020, the Company had no&#160;outstanding payable balance to the shareholders of Change under the TRA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax years ended March 31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After McKesson&#x2019;s separation of its interest in the Change Healthcare&#160;JV, the aforementioned TRA agreement requires the Change Healthcare&#160;JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare&#160;JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the separation transaction in the fourth quarter of 2020, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i60451fdfabe047148d4b51b02b328315_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzQyNQ_d96da3b9-34fb-492e-85a6-d66c34373bc5"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i8b559a4e264f45ee945d6b0221a18668_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzUwMw_fd4d3747-051e-4b9a-b13c-9335e1a3bfd2"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i654d1dad39ce486b88ccef35f4514f39_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE0ODI_0da0778c-9e1a-49f1-8b9c-389221c171eb"
      unitRef="usd">888000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ib7818cbb3de24ccbb1dac5ff7b38d12d_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE1NTU_9189ff7a-6b31-4102-8ada-15695dde9c97"
      unitRef="usd">609000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ia627eaf413b944f6b1c661f64f89cf46_I20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE3MTk_a31ac0ac-9c69-4c67-8967-900f5175cbd8"
      unitRef="usdPerShare">13</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i654d1dad39ce486b88ccef35f4514f39_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE3OTg_5710d57f-dce0-40a9-8055-c117b0a4b713"
      unitRef="usd">279000000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i60451fdfabe047148d4b51b02b328315_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIyMDU_d96da3b9-34fb-492e-85a6-d66c34373bc5"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i259565e15d4a4094b3aced351e91b60f_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIyMjU_3e116396-43ae-433c-9af8-12da1377d971"
      unitRef="number">0.585</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3ac6925e5e124f20b294923d15d675f7_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIyNjE_826c91b3-acdd-4792-8317-07965b6cc062"
      unitRef="number">0.415</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i361b795666d34b31b8211423ea941c60_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIzODg_963089ef-ca00-4933-92e5-3fb0709caec7"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i4e5bd022186748f590c69707cd4dd76e_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQwMDY_34acfaab-0bd2-4e8e-8067-1c7de5493a47"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:ExchangeOfferSharesDistributed
      contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzU2MjA_eb47b93a-3c0c-4dc0-965e-15dbbf20fe6c"
      unitRef="shares">176000000.0</mck:ExchangeOfferSharesDistributed>
    <mck:EquityMethodInvestmentStockAccepted
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzU3Mzk_4abf1ae2-c153-45a2-b2f0-c2a8e47f2b06"
      unitRef="shares">15400000</mck:EquityMethodInvestmentStockAccepted>
    <mck:ExchangeOfferSharesExchanged
      contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzU3Mzk_c6a59160-2359-48b6-9896-a597e0ed2d18"
      unitRef="shares">15400000</mck:ExchangeOfferSharesExchanged>
    <mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted
      contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzYwODU_bba22226-c700-48a6-adcf-ef483d4dc178"
      unitRef="shares">1</mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzYxMjg_bd1ade41-2999-435f-a331-5fcfb7c62740"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzY1MTI_785def8a-4592-40bd-822e-89e7e2ac3fc5"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzEwNjg1_6a42b6de-e633-4dc9-a77c-f05019739cbd">The net gain was calculated as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in the Change Healthcare JV at exchange date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversal of deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Release of accumulated other comprehensive attributable to the joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Transaction costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain on split-off of the Change Healthcare JV&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <mck:EquityMethodInvestmentStockAccepted
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMC0xLTEtMC90ZXh0cmVnaW9uOjJjMTkyZTg0MDMzYzRhMTc4NGVhNWE0MjE4MDBiNDQyXzU0OTc1NTgxMzkwMDA_4abf1ae2-c153-45a2-b2f0-c2a8e47f2b06"
      unitRef="shares">15400000</mck:EquityMethodInvestmentStockAccepted>
    <mck:ExchangeOfferSharesExchanged
      contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMC0xLTEtMC90ZXh0cmVnaW9uOjJjMTkyZTg0MDMzYzRhMTc4NGVhNWE0MjE4MDBiNDQyXzU0OTc1NTgxMzkwMDA_c6a59160-2359-48b6-9896-a597e0ed2d18"
      unitRef="shares">15400000</mck:ExchangeOfferSharesExchanged>
    <mck:EquityMethodInvestmentStockAcceptedAverageCost
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMC0xLTEtMC90ZXh0cmVnaW9uOjJjMTkyZTg0MDMzYzRhMTc4NGVhNWE0MjE4MDBiNDQyXzU0OTc1NTgxMzkwMTM_0265b775-3654-4832-9d95-a9103a9a9a43"
      unitRef="usdPerShare">131.97</mck:EquityMethodInvestmentStockAcceptedAverageCost>
    <mck:EquityMethodInvestmentFairValueofStockAccepted
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzEtMS0xLTEtMA_81d25000-37a9-4cf2-afe1-2d12c91fdef6"
      unitRef="usd">2036000000</mck:EquityMethodInvestmentFairValueofStockAccepted>
    <mck:EquityMethodInvestmentCarryingAmount
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzItMS0xLTEtMA_aee1de87-3f4d-40ac-9ce3-dfc29b76ff6c"
      unitRef="usd">2096000000</mck:EquityMethodInvestmentCarryingAmount>
    <mck:EquityMethodInvestmentsReversalofDeferredTaxLiability
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzMtMS0xLTEtMA_fdd562e4-bd21-4c1c-b4d8-433a5e492ce3"
      unitRef="usd">521000000</mck:EquityMethodInvestmentsReversalofDeferredTaxLiability>
    <mck:EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzQtMS0xLTEtMA_bf79ef95-0f65-40d6-9bbf-bb79bb97f1f5"
      unitRef="usd">-24000000</mck:EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss>
    <mck:EquityMethodInvestmentTransactionCostsIncurred
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzUtMS0xLTEtMA_60d207ee-3280-4c51-8ab2-3b42a79bcb0b"
      unitRef="usd">23000000</mck:EquityMethodInvestmentTransactionCostsIncurred>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90YWJsZTo4OTBlODc4MzQxNWQ0NTcxYWE0OTU4NGMyZmVhMWE2My90YWJsZXJhbmdlOjg5MGU4NzgzNDE1ZDQ1NzFhYTQ5NTg0YzJmZWExYTYzXzYtMS0xLTEtMA_36d2786e-ef13-49c2-93b5-ec039ed82df8"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iedbe6776c92141caaf1984304c817a24_I20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzAwMzI_482289c6-6332-4807-b690-7349cf87b6d3"
      unitRef="usd">80000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQzNjc_92add040-3112-4584-873f-fb84834696a4"
      unitRef="usd">-119000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzAyMTA_6a3cc216-ea4b-469a-87c1-6903791f78f0"
      unitRef="usd">-194000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ibcb31c3511004f7bb84b6fba7982478b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MjY_23ac5aba-7987-4d73-8d07-0f3ba79e448d"
      unitRef="usd">22000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i1e6a6da26e9b4155a7aabc172f840db7_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MDA_63aa0dc1-35b4-432a-8b8e-a49ad15bb09c"
      unitRef="usd">60000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <mck:GainLossonDerecognitionofLiability
      contextRef="i30576561fec8410d980f65c38dfcecbd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MTY_67159958-359b-4473-a701-8df09e6f27a9"
      unitRef="usd">90000000</mck:GainLossonDerecognitionofLiability>
    <mck:GainLossonDerecognitionofLiability
      contextRef="i30576561fec8410d980f65c38dfcecbd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzIxOTkwMjMyNzQ0MTI_67159958-359b-4473-a701-8df09e6f27a9"
      unitRef="usd">90000000</mck:GainLossonDerecognitionofLiability>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="icd767dd763314f3aad75379a29aafa5f_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzgzNjc_86a6b136-49f4-459d-92af-057dcf83feba"
      unitRef="usd">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i9433d8dd83764dfea4d20d7175cc58c0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzgzNjc_8f3649ea-0adf-4cd0-a71f-45fd9ecc9f44"
      unitRef="usd">0</us-gaap:LiabilitiesNoncurrent>
    <mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized
      contextRef="id1030ca9e1fc410c8e4ba04e704c20ad_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2Xzk1OTE_c1d484b5-7fbf-4500-b849-05829d0ec709"
      unitRef="number">0.85</mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized>
    <us-gaap:DueFromRelatedParties
      contextRef="i5e9b372ac3ef458da34c6cb29ae83063_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE5NzkxMjA5MzIwMjIz_d6165dbd-4885-4ee7-bea0-7547d6b2b821"
      unitRef="usd">0</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="id1030ca9e1fc410c8e4ba04e704c20ad_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMTUvZnJhZzpjOTJjNjc2OTZkYzk0YTFkYTk2OTc0ZTJkZTU5MTZmNi90ZXh0cmVnaW9uOmM5MmM2NzY5NmRjOTRhMWRhOTY5NzRlMmRlNTkxNmY2XzE5NzkxMjA5MzIwMjIz_e4e12c34-0337-400a-87de-dfdf0c800cc9"
      unitRef="usd">0</us-gaap:DueFromRelatedParties>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5Mzc_c4c704cd-a66a-4acd-abee-1039a8c9f82b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities that have met the classification as held for sale were $12&#160;million and $9&#160;million, respectively, as of March&#160;31, 2021 and $906 million and $683 million, respectively, as of March&#160;31, 2020. The amounts at March&#160;31, 2020 primarily consisted of the majority of the Company&#x2019;s German pharmaceutical wholesale business as described below. This disposal group had been recorded as assets and liabilities held for sale since the third quarter of 2020 through its contribution to a joint venture in the third quarter of 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;German Wholesale Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2020, the Company completed its previously announced transaction with Walgreens Boots Alliance (&#x201c;WBA&#x201d;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson has a 30% noncontrolling interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration received included a receivable amount of $41&#160;million, primarily related to working capital and net debt adjustments from WBA, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of March&#160;31, 2021. The Company accounts for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $291&#160;million as of the transaction date, which was paid to the Company in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the contribution, the Company recorded losses of $58&#160;million and $275&#160;million (pre-tax and after-tax), respectively, in the years ended March&#160;31, 2021 and 2020, which includes adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#x201c;Operating expenses&#x201d; in the Consolidated Statements of Operations. The Company&#x2019;s measurement of the fair value of the disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods; however, these adjustments are not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the completion of the transaction on November 1, 2020, there were no assets or liabilities of the German pharmaceutical wholesale joint venture classified as held for sale on the Company&#x2019;s Consolidated Balance Sheet. The total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#x2019;s Consolidated Balance Sheet as of March&#160;31, 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of business held for sale to fair value less cost to sell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i2d40932572f640b9bcc963fb3703530a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTI1OTE_40b33387-e12f-4a50-bbbf-d070e07bf7dc"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i2d40932572f640b9bcc963fb3703530a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTI2MDg_a93f1d26-7d8f-4e67-8ffb-df068cf02b6c"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i26588b430f834252bbb0d603ebc07230_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzkx_7853fc3a-8063-4ae8-8f00-8f8cb57ceb51"
      unitRef="usd">906000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i26588b430f834252bbb0d603ebc07230_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzk4_96a1a671-8796-43ac-9653-f4d164e16bcf"
      unitRef="usd">683000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i042fc3b5ed1f4aa3a5c7fc3404044ced_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NDc0MTY_6282e611-cb31-4447-939d-eeba2fdc2136"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="i8b846dbf18184734b8d20351ecc09b72_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4MTg_bb4e03de-5dbc-431a-8b28-eeba6f76ca21"
      unitRef="usd">41000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i042fc3b5ed1f4aa3a5c7fc3404044ced_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4MjU_6282e611-cb31-4447-939d-eeba2fdc2136"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestments
      contextRef="i841091b6641c4e1fa2288424caf2b82f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4MzM_69b7d7e0-5255-4efd-ac54-55f3cf2ed054"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5c09144465e346119dd58fd135e50dc7_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4Mzk_21e54f64-ed89-4f81-b1dc-65f85e037dfd"
      unitRef="usd">291000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <mck:GainLossOnSaleOfBusinessNetOfTax
      contextRef="ia6e4b982be8b4c07a12efc2fd23a51a9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4NzM_1c985067-46f2-48ce-a05c-fdb404269cf8"
      unitRef="usd">-58000000</mck:GainLossOnSaleOfBusinessNetOfTax>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ia6e4b982be8b4c07a12efc2fd23a51a9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTE4NzM_d5daf1a3-3290-4519-8bb9-b4659e9983cb"
      unitRef="usd">-58000000</us-gaap:GainLossOnSaleOfBusiness>
    <mck:GainLossOnSaleOfBusinessNetOfTax
      contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTY4OTA_367e58cb-e303-436d-873a-adb11be5e1fb"
      unitRef="usd">-275000000</mck:GainLossOnSaleOfBusinessNetOfTax>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE2NDkyNjc0NTY4OTA_f3b51c1d-527e-409e-8ea2-1015688fe0ea"
      unitRef="usd">-275000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic5f50743c2174eb7a016ece0cb708476_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5NzkxMjA5MzE0OTg1_656ba047-7f38-4080-9786-a2682d1f84f4"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ic5f50743c2174eb7a016ece0cb708476_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5NzkxMjA5MzE0OTg1_71880b7d-b548-43e9-bb04-d12f247d5d67"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE5Mzg_c0393e5b-72c0-42d3-9f68-65a4f2c7f1b6">The total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#x2019;s Consolidated Balance Sheet as of March&#160;31, 2020, were as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of business held for sale to fair value less cost to sell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzMtMS0xLTEtMA_98b69a09-f144-4c8f-a2f8-b6b471f02ff5"
      unitRef="usd">548000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzQtMS0xLTEtMA_6d8e1b24-01cb-4f12-ad9d-828de8179bbc"
      unitRef="usd">478000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzYtMS0xLTEtMA_d9918a13-5ebd-48af-8c4a-8247542ee05a"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzctMS0xLTEtMA_83a60cc5-704a-46c8-b2b9-db132425e95f"
      unitRef="usd">272000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzgtMS0xLTEtMA_2993d0e3-c56a-429c-9dda-3a519dd562f3"
      unitRef="usd">842000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzEyLTEtMS0xLTA_9ce3136b-d3ef-4352-9434-cd1c0f992984"
      unitRef="usd">450000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzEzLTEtMS0xLTA_d5637146-3e53-4a25-b949-f4884c53f10c"
      unitRef="usd">40000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzE0LTEtMS0xLTA_92c39d02-4cfc-4c79-ae94-e38f1338df60"
      unitRef="usd">166000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i4c88f05a91c64ccd9403c9344a22b92b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90YWJsZToxMmI0ZmYxYjUwZGI0NGRkYTZkYzYzM2RjNTI3ZjFmNC90YWJsZXJhbmdlOjEyYjRmZjFiNTBkYjQ0ZGRhNmRjNjMzZGM1MjdmMWY0XzE1LTEtMS0xLTA_e1687282-ca7e-49cb-8bd3-34e2e58fba75"
      unitRef="usd">656000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
      contextRef="iaaaa8cff6eb04a468bc164e1f8da8570_D20191212-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjEvZnJhZzpjYWQyOGI0ZDM2M2I0MGJkOGI5NmU4MWJlNjZjODliMS90ZXh0cmVnaW9uOmNhZDI4YjRkMzYzYjQwYmQ4Yjk2ZTgxYmU2NmM4OWIxXzE4ODE_01d50483-24f2-4685-ad48-d351dce02cc9"
      unitRef="usd">-3000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzg2NjA_d61b7583-acaf-4f8e-93d3-fc89419b38c7">Restructuring, Impairment, and Related Charges &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges of $334 million, $268 million and $597 million in 2021, 2020, and 2019, respectively. These charges are included in &#x201c;Restructuring, impairment, and related charges, net&#x201d; in the Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included in &#x201c;Cost of sales&#x201d; in the Consolidated Statements of Operations and were not material for the years ended 2021, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of its office space in North America. Where the Company determines to cease using office space, it plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $180&#160;million&#160;to $280&#160;million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. This initiative is expected to be completed in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#x201c;U.K.&#x201d;), which is included in the Company&#x2019;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Under this initiative, the Company expects to incur total charges of approximately $85 million to $90 million. The Company recorded charges of $57 million in 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $62 million, $72 million, and $163 million in 2021, 2020, and 2019, respectively, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $28 million, $44 million, and $33 million in 2021, 2020, and 2019, respectively, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021 and remaining costs the Company expects to record under this initiative, primarily relating to lease costs, are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2018, the Company committed to a restructuring plan, which primarily consisted of the closures of underperforming retail pharmacy stores in the U.K., included in its International segment, and a reduction in workforce. In 2019, the Company recorded charges of $18 million, consisting primarily of employee severance and lease exit costs, with $92 million of total charges recorded through the end of 2019. The plan was substantially completed in 2020 and additional charges were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 25, 2018, the Company announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize the Company&#x2019;s operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, the Company committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material. The Company recorded charges of $15 million and $135 million in 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#x2019;s headquarters described above in addition to various other initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with dispositions and costs related to the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2019 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model cost optimization efforts and U.K. restructuring initiative focusing on underperforming retail pharmacy stores described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include lease and other contract exit costs associated with closures of facilities and retail pharmacy stores as well as project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the years ended March&#160;31, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019 &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;As of March&#160;31, 2020, the total reserve balance was $157 million of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;As of March&#160;31, 2021, the total reserve balance was $151 million of which $99 million was recorded in Other accrued liabilities and $52 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#x2019;s International segment. These charges primarily related to long-lived assets associated with the Company&#x2019;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company recognized charges of $82 million to impair certain long-lived and intangible assets for its retail pharmacy business in Europe within the Company&#x2019;s International segment. These charges related primarily to intangible assets associated with pharmacy licenses within the U.K retail business due to a decline in estimated future cash flows driven by additional U.K. government reimbursement reductions communicated in the third quarter of 2020. The Company used a combination of an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived and intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company performed an interim impairment test of long-lived and intangible assets for its Rexall Health retail business, within the Company's International segment, due to the decline in the estimated future cash flows primarily driven by lower than expected growth in both prescription volume and sales of non-prescription goods. As a result, the Company recognized a charge of $30 million to impair certain long-lived and intangible assets, primarily customer relationships. The Company utilized an income approach (a DCF method) for estimating the fair value of the long-lived and intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Company recognized charges of $210&#160;million to impair certain long-lived assets (primarily pharmacy licenses) for its U.K. retail business, within the Company&#x2019;s International segment, primarily driven by government reimbursement reductions and competitive pressures in the U.K. The Company used an income approach (a DCF method) or a combination of an income approach and a market approach to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Company recorded charges of $35 million to impair certain intangible assets (primarily customer relationships) for its Rexall Health retail business within the Company&#x2019;s International segment. The impairments were primarily the result of the decline in estimated future cash flows for this business. The estimated cash flow projections were negatively affected by a lower projected overall growth rate from the ongoing impact of government regulations in 2019. The Company utilized an income approach (a DCF method) for estimating the fair value of long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the long-lived and intangible assets described above is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company-specific information. Refer to Financial Note 17, &#x201c;Fair Value Measurements,&#x201d; for more information on nonrecurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzkx_381ef7eb-a2d0-48ec-820a-b75d98834f40"
      unitRef="usd">334000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzk1_bef4bb8f-23e1-4b28-b11a-800644fe9104"
      unitRef="usd">268000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzEwMg_a8ffee19-6128-4f06-9940-aca0f65d6a77"
      unitRef="usd">597000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="iea5796edba9442e6b00a331d1b1e9822_I20210512"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxOTA2OTQ_5e10e3c8-5fa9-4926-aa14-d53e0307c394"
      unitRef="usd">180000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="icefee79d5ff5443ca7262dbcfe111692_I20210512"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxOTA2NTE_455026b7-e152-44c2-b6a5-194fcb901db0"
      unitRef="usd">280000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="icfff1c8522e849f6b8c9ddbfa45a1161_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjM2MjA_e618f974-e798-49ed-b222-339468ab67ab"
      unitRef="usd">85000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i46055f5e4516432ba38d8c9b9db6958f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjM2Mjc_8491cf40-f72e-465f-bb38-019e1501573e"
      unitRef="usd">90000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i912d8febc0b34abfb3c6779710303600_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjM2NjY_abfa0687-41f7-4d3e-a57a-86d5c295a387"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0de6ea66ebe14d0aa48b24590c1d9d98_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjU4MjM_dba12f16-a476-4c21-b353-dc9d523931d0"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6b7c3bcfde504c2e81c6aeef0f7c2335_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjU4Mjk_ef4f81e9-aa10-42b8-9d0f-d9e606e51c78"
      unitRef="usd">72000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if2c5f4c8c13a414ca948dcf78225083b_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjU4Mzg_dd5d4e70-7848-48ec-85ae-b75c31f024f3"
      unitRef="usd">163000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i07b3c611cb044e9f8e830461fdf3567b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjc2ODg_8ab68503-8265-4118-a755-159974459a77"
      unitRef="usd">28000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i321f8a74eae848a98872fbdb652c3f4d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjc2OTQ_088a53e1-3b56-4b4a-ad7f-5e68009b9797"
      unitRef="usd">44000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1c1bb20faa42444db36850f067394ea5_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjc3MDM_2c18f855-074c-4675-a18b-b104ef73e15c"
      unitRef="usd">33000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0577d068867b4047b8f768bd9973668f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjkyNzc_73c88be2-23db-4427-8678-6b6a876d3c88"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i80ffc4dde20a400090fcecd0cd478cc8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNjkzNTI_76ba4939-0765-4adc-badf-eabdd7bde7a0"
      unitRef="usd">92000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringCharges
      contextRef="i873585d906e0415888503e1bd163b490_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzEwMTI_7c5c5090-a24c-46dc-bdbc-d02727cf5fa6"
      unitRef="usd">15000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idf5263ca156f4aaf9c2116924eccdf08_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzEwMzQ_82dff0a5-67e7-4295-8325-3047c1f0d3a4"
      unitRef="usd">135000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzg2NTc_a2223cab-9073-44bb-aae0-b0fcaceb08e5">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.755%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#x2019;s headquarters described above in addition to various other initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with dispositions and costs related to the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2019 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model cost optimization efforts and U.K. restructuring initiative focusing on underperforming retail pharmacy stores described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with operating model cost optimization efforts and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include lease and other contract exit costs associated with closures of facilities and retail pharmacy stores as well as project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the years ended March&#160;31, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019 &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;As of March&#160;31, 2020, the total reserve balance was $157 million of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. &lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;As of March&#160;31, 2021, the total reserve balance was $151 million of which $99 million was recorded in Other accrued liabilities and $52 million was recorded in Other non-current liabilities.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItMS0xLTEtMA_4aeecc3b-632f-465d-8fef-b37c2951ca4d"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItMy0xLTEtMA_ac7eef72-3bc4-4624-b1a1-ad7dabfffb35"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItNS0xLTEtMA_791dc3bc-722d-4a77-a096-49dad7e81c4f"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItNy0xLTEtMA_121f1939-8a21-43c3-9783-6b7008de8b4a"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItOS0xLTEtMA_87e418ff-9038-42d3-a9b1-6986ec6bf0a7"
      unitRef="usd">69000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzItMTEtMS0xLTA_1d5efa0e-3617-4f3f-a4d1-e85550a9602f"
      unitRef="usd">104000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtMS0xLTEtMA_fae90241-b740-4db4-b40a-e6cf5ccd19b7"
      unitRef="usd">11000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtMy0xLTEtMA_54b5ff1d-cf61-4b30-9d96-c60e3840f629"
      unitRef="usd">17000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtNS0xLTEtMA_6592a222-6c65-45cd-b2d8-abca44228b70"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtNy0xLTEtMA_7d5d6366-c163-464b-8450-1e9746111f77"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtOS0xLTEtMA_9be30a5d-50fa-4866-9451-faf0afd4cece"
      unitRef="usd">27000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzMtMTEtMS0xLTA_eddfb544-b531-4c39-8b8f-6a8519610433"
      unitRef="usd">59000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtMS0xLTEtMA_5fa89f8a-ef59-48f1-ab2e-f0ac25d52f7c"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtMy0xLTEtMA_de6f821a-e36e-48a0-9ece-f4686c930645"
      unitRef="usd">46000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtNS0xLTEtMA_8c9391a9-d41f-482f-8bc6-1b2544a989e2"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtNy0xLTEtMA_c141800f-51ec-4ab2-b6e5-b429b5c7bb93"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtOS0xLTEtMA_10f39c61-68a2-40c4-8421-799e79b7cb78"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzQtMTEtMS0xLTA_1a08f4e8-9828-454d-a46d-6c413d52e70c"
      unitRef="usd">56000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtMS0xLTEtMA_ecbf1eef-79ce-4008-a2d0-44bd6b4b3a34"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtMy0xLTEtMA_53fa0a77-b7ec-405a-9277-664b40991439"
      unitRef="usd">85000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtNS0xLTEtMA_8aa5f3a0-0a8f-46ca-ac48-68d2ded4ec0b"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtNy0xLTEtMA_4a998a7c-76b7-454c-a4dd-65d84ce54547"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtOS0xLTEtMA_ffa15db7-c450-4b1d-9081-d58751fba84d"
      unitRef="usd">105000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTozNjIzZGE1YTBlOWM0ZTY3YTA4ODBhZDdlODYyODhhNC90YWJsZXJhbmdlOjM2MjNkYTVhMGU5YzRlNjdhMDg4MGFkN2U4NjI4OGE0XzUtMTEtMS0xLTA_e1526492-8803-491c-9150-2f7e0b457629"
      unitRef="usd">219000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItMS0xLTEtMA_4c7d42c4-4ed2-45c7-8db4-ad04a778009c"
      unitRef="usd">12000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItMy0xLTEtMA_a935fadc-2a53-412c-8ed4-4b7abc8da886"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItNS0xLTEtMA_5fdd96d9-5bfb-48a1-8ada-53a5db4e60e1"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItNy0xLTEtMA_5d406628-4333-42a4-afe7-3c3d836a3c2f"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItOS0xLTEtMA_c14ac28c-2038-4498-a0b4-95212890ee78"
      unitRef="usd">30000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzItMTEtMS0xLTA_dbcb0f7b-46a0-4127-a2f5-72920459df59"
      unitRef="usd">47000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtMS0xLTEtMA_848d2ebf-43e7-424b-abf4-53d42493d265"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtMy0xLTEtMA_6d1d52af-bf42-4720-914c-5a25c8ba8922"
      unitRef="usd">13000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtNS0xLTEtMA_2b700343-c5e3-4059-aa1e-0fcb8a2e2009"
      unitRef="usd">19000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtNy0xLTEtMA_d132df7a-1143-4b2f-a226-954431466e4f"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtOS0xLTEtMA_3bf6d473-6a4b-4c0c-b796-3649baa32ad5"
      unitRef="usd">46000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzMtMTEtMS0xLTA_8cacac2e-fec6-4ec3-892c-8a50b7230ca4"
      unitRef="usd">79000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtMS0xLTEtMA_399773ef-19c7-4ac4-9dd8-728fd360668a"
      unitRef="usd">10000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtMy0xLTEtMA_48589b10-098b-4d0d-9010-b45b14a9cdf6"
      unitRef="usd">6000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtNS0xLTEtMA_15c6e0dd-3258-4369-a8de-1b5745bfdd5a"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtNy0xLTEtMA_7c28e2e7-dfa4-4e23-abfb-249d7881c0e0"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtOS0xLTEtMA_cc7bebe8-e367-4b7a-84cd-ee4055887b02"
      unitRef="usd">13000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzQtMTEtMS0xLTA_5cf36d54-383e-4ce7-8ba2-0eca3f0c7801"
      unitRef="usd">30000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtMS0xLTEtMA_5fcea241-c715-4146-84bd-f47681453931"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtMy0xLTEtMA_64ed932b-6486-4db7-a27c-3a9c8f096473"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtNS0xLTEtMA_859d3875-53af-4c49-a645-268d208c1b9c"
      unitRef="usd">24000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtNy0xLTEtMA_7c19ef6a-44ab-450b-aa25-7994bf802008"
      unitRef="usd">-1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtOS0xLTEtMA_0fcebac2-2abe-4e8c-a08e-77a9d4a331ae"
      unitRef="usd">89000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo4OTEzYTJhMzJjYjk0YmFiYjM2NmI3MmY0NjJkNGM3ZS90YWJsZXJhbmdlOjg5MTNhMmEzMmNiOTRiYWJiMzY2YjcyZjQ2MmQ0YzdlXzUtMTEtMS0xLTA_dfc25899-76e8-42f4-9650-0a29ad8dc53a"
      unitRef="usd">156000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItMS0xLTEtMTU5MDk_558f2f16-a97c-4b66-9e1f-b2b0c4e3ea23"
      unitRef="usd">46000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItMy0xLTEtMTU5MDk_ed1c2c91-3a6e-4ba1-97a5-76899bb67db2"
      unitRef="usd">51000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItNS0xLTEtMTU5MDk_f45bca0e-a6c5-48a4-89b4-bf86e60f39eb"
      unitRef="usd">18000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItNy0xLTEtMTU5MDk_c2c5fbb1-d2b6-40e9-a7c1-d449f707b7b4"
      unitRef="usd">3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItOS0xLTEtMTU5MDk_92960052-98d0-4a46-b2a2-e879479b4b5a"
      unitRef="usd">36000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzItMTEtMS0xLTE1OTA5_231a3122-01da-4fc6-8f7a-7c3554e85ce0"
      unitRef="usd">154000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtMS0xLTEtMTU5MDk_57c38250-c6ad-4ea2-a49e-0d9811c9c805"
      unitRef="usd">9000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtMy0xLTEtMTU5MDk_3b4df569-0dd8-41fc-813d-a79684b6fd5e"
      unitRef="usd">83000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtNS0xLTEtMTU5MDk_a9c74322-295c-4f08-8b76-50a93695ecf1"
      unitRef="usd">20000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtNy0xLTEtMTU5MDk_1f33c4a8-9ccb-4191-b49e-2a7b51095d52"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtOS0xLTEtMTU5MDk_570878da-2fe4-487e-8fcc-d949756871b2"
      unitRef="usd">52000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzMtMTEtMS0xLTE1OTA5_12bbcadc-bc7d-4136-ab2c-3c26e7ae3c51"
      unitRef="usd">164000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtMS0xLTEtMTU5MDk_83962b2f-e9bf-4076-9bd3-aa4bf680d5a5"
      unitRef="usd">6000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtMy0xLTEtMTU5MDk_96ac0b88-268b-41f5-8168-5af786c596d4"
      unitRef="usd">24000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtNS0xLTEtMTU5MDk_8348a35c-f785-4a1d-bd3a-44b00c9bae6a"
      unitRef="usd">3000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtNy0xLTEtMTU5MDk_37cbb643-48a7-41d4-9521-21a457208a9b"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtOS0xLTEtMTU5MDk_f7094d5b-deca-4842-89fb-ae1052643a9b"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzQtMTEtMS0xLTE1OTA5_5f20f5fb-f84e-4d79-89b3-94d8aca9f7a5"
      unitRef="usd">34000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtMS0xLTEtMTU5MDk_17ce83d0-1878-4c37-80be-17c2892c8820"
      unitRef="usd">61000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtMy0xLTEtMTU5MDk_0b7494ef-5387-4739-9ae0-ef805ede4f80"
      unitRef="usd">158000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtNS0xLTEtMTU5MDk_d8e61688-c197-42b0-a50f-978064507258"
      unitRef="usd">41000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtNy0xLTEtMTU5MDk_20817f69-cd83-40c1-8bda-60d44fbaa6cb"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtOS0xLTEtMTU5MDk_ca316e8d-573d-4b3d-bd3f-8b97c63d041d"
      unitRef="usd">89000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTphODQ3OGZmZWMyNWQ0MTIxYTFhNDEzOWQ2NTk2ZjhhYi90YWJsZXJhbmdlOmE4NDc4ZmZlYzI1ZDQxMjFhMWE0MTM5ZDY1OTZmOGFiXzUtMTEtMS0xLTE1OTA5_751c978e-279e-4a1e-bf9b-889746e85017"
      unitRef="usd">352000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i1294e78624d84a32b4b75b80df724f52_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMS0xLTEtODk5MA_cbc45eb8-dab2-4a0b-8e24-83899d713687"
      unitRef="usd">35000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9a7bd3f5bbee48eaa0f146d217a2f213_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMy0xLTEtODk5Ng_fee02ac6-7742-4e93-8731-0621d1d2cfa1"
      unitRef="usd">129000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id80b896d088b49df9c9446e7f21d4353_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNS0xLTEtODk5Ng_ec274078-6f57-440c-8cff-9840cf08e085"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="icb32341a67694453bf4b80c090e9acd1_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNy0xLTEtODk5Ng_60de7919-3fab-4857-bfc0-4f071ca66d9c"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i81dcf14d4c484311a890c1aa873abcc5_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtOS0xLTEtODk5Ng_ed4d7027-d860-4b1e-bb58-b0b1047ddb45"
      unitRef="usd">44000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMTEtMS0xLTkwMDQ_3d03024e-2a37-4a5f-b609-8e34ce240c4e"
      unitRef="usd">237000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMS0xLTEtODk5MA_383b0cce-7129-47fd-b1b7-410b93eebafd"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMy0xLTEtODk5Ng_f7c586b6-ca0a-4739-a116-dc6e52529ddb"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNS0xLTEtODk5Ng_c00b3680-c8d2-4727-997a-fc02602ffa32"
      unitRef="usd">24000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNy0xLTEtODk5Ng_99a3692a-f6d8-43c0-b897-782a32dd0860"
      unitRef="usd">-1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItOS0xLTEtODk5Ng_9e48448b-a6d7-4836-b43d-3048130869fb"
      unitRef="usd">89000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMTEtMS0xLTkwMDQ_d5e33d55-82a0-4549-b198-16ed69a2eb78"
      unitRef="usd">156000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMS0xLTEtODk5MA_9de5ac92-6c02-4642-84f1-071e22a44d0b"
      unitRef="usd">10000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMy0xLTEtODk5Ng_7bf31afe-9fd2-4f51-9c8c-47b79c292b1a"
      unitRef="usd">6000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNS0xLTEtODk5Ng_9e4820d8-04fb-46b0-972b-b92e49e4d062"
      unitRef="usd">1000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNy0xLTEtODk5Ng_02f1ded0-6f4c-4418-86fe-95fb8da467f9"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtOS0xLTEtODk5Ng_9860c8db-f81a-461e-9a05-0ce88bc18a13"
      unitRef="usd">13000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMTEtMS0xLTkwMDQ_83912e8a-84fa-4704-b183-f1bfbfa86cb7"
      unitRef="usd">30000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMS0xLTEtODk5MA_0f67c666-87f7-419a-bf03-1852ae885a4f"
      unitRef="usd">15000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMy0xLTEtODk5Ng_8cb28405-8a45-49d0-9efa-8d109b4f6945"
      unitRef="usd">45000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNS0xLTEtODk5Ng_96d23924-640e-40de-9513-7ea22b095d74"
      unitRef="usd">26000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNy0xLTEtODk5Ng_13f162ea-6963-41b2-890a-5818353c48ba"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtOS0xLTEtODk5Ng_9882baeb-74fb-43a9-a411-a19936ca8712"
      unitRef="usd">61000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMTEtMS0xLTkwMDQ_86bca653-73de-4e64-b416-508e96d21493"
      unitRef="usd">148000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMS0xLTEtODk5MA_2e19ec8d-68c4-459d-a593-9c050354f3fb"
      unitRef="usd">-4000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMy0xLTEtODk5Ng_604a4c2b-128f-40c2-b2a3-6e5eb8cff6ff"
      unitRef="usd">-33000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNS0xLTEtODk5Ng_565eb7d1-2e9e-49fe-b10d-c7af3585beea"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNy0xLTEtODk5Ng_d43ced02-1b9f-4d7e-9d00-675dd3ade347"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtOS0xLTEtODk5Ng_0f923628-2914-4ca5-b25b-1f20a4a1fbd1"
      unitRef="usd">-20000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMTEtMS0xLTkwMDQ_d17937d1-0e4c-4cef-bc19-db53dcb6cde9"
      unitRef="usd">-58000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i7b443c41cb334b4084c134a614b5a4aa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMS0xLTEtMA_395e71c0-25b0-458f-8e56-5e28c253d44f"
      unitRef="usd">29000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1cc2495d4fd44412ae23a2d9511fc6b0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMy0xLTEtMA_bff2bfee-79b7-43a1-8978-21941573eca0"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i59d6c47ebd084b828cdbdba1b8f159f8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNS0xLTEtMA_bec30864-86d1-4439-9320-f1424ba7d4f3"
      unitRef="usd">22000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i44f353b74f6e48ea8c63365f74249445_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtNy0xLTEtMA_fdc55140-0812-4dcc-8ac7-17edcf2ead7b"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib36b955ce23d4198b6aa3769dcf60d35_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtOS0xLTEtMA_bb6e53a3-34f1-44f5-bfcd-388df888e4a0"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzEtMTEtMS0xLTA_6ab50347-e8d4-4ae1-803d-734e010412f4"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMS0xLTEtMA_6641619e-bd81-40fa-9e96-36082efff58c"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMy0xLTEtMA_a9ffc41a-c9a1-44cc-8c41-4c3ecae30ae5"
      unitRef="usd">85000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNS0xLTEtMA_36d0c025-3b09-4eee-88d0-a3fba3dd74b4"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItNy0xLTEtMA_c214561b-6bea-4c8e-b033-fa62d8b5e63e"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItOS0xLTEtMA_27713cc6-1c3e-4c34-b8cd-a061d6bc575e"
      unitRef="usd">105000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzItMTEtMS0xLTA_4947fd0a-3d11-47ef-8410-b8a48e3c75ed"
      unitRef="usd">219000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMS0xLTEtMA_4232c852-9690-4daa-8775-27dc8f06a29b"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMy0xLTEtMA_6b4b8458-e0e3-41e4-ab8a-e4db2a5785a5"
      unitRef="usd">46000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNS0xLTEtMA_e43053e1-7b16-4a3d-be8e-66d3e4356652"
      unitRef="usd">1000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtNy0xLTEtMA_33284fd1-b2d3-41b3-a94a-cd4ab86b67ab"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtOS0xLTEtMA_0c74893d-7a5f-4cb7-afb7-b9726a9c1138"
      unitRef="usd">9000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzMtMTEtMS0xLTA_4b344d33-3a7e-4f3d-a511-fee6e9b4a0cf"
      unitRef="usd">56000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMS0xLTEtMA_5827b9b3-d81b-4954-a9bb-6560a97762c7"
      unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMy0xLTEtMA_d62d0ea9-7aa5-44f6-b835-982912b01759"
      unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNS0xLTEtMA_31839492-5f38-4726-9d79-5f5c075f7776"
      unitRef="usd">21000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtNy0xLTEtMA_f4dd6402-76df-4001-8e67-80cacee4c71b"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtOS0xLTEtMA_cb429f39-2eea-4d2b-a022-1dd3278b96ec"
      unitRef="usd">75000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzQtMTEtMS0xLTA_94903bb1-7dfe-4cf7-9118-e52768d0f9ee"
      unitRef="usd">159000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMS0xLTEtMA_f4425bd9-bd21-409e-bfe9-a41678f69df9"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMy0xLTEtMA_b1607556-3a44-4be5-bd48-3e7c31e552e3"
      unitRef="usd">-8000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNS0xLTEtMA_2b6b3f41-3c3a-436a-8993-13352151df61"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtNy0xLTEtMA_3a7e7aea-8b91-470e-b496-c56ccddec36c"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtOS0xLTEtMA_9a0aaccf-4b2f-4962-b1c4-8cbd622f03b8"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzUtMTEtMS0xLTA_3393e65b-5006-4831-bdf1-69b3c1fd69ee"
      unitRef="usd">-10000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i3156368b6aea45b4b87b5079622f2703_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtMS0xLTEtMA_32be0454-75fa-43a1-9f48-200eefcdbb89"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie781b28ab2254939ac913ef650232aa3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtMy0xLTEtMA_ba04143d-cb2e-4cef-912b-76fbf313560c"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7d7e3dfff1504af6a6970090a4e7c85f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtNS0xLTEtMA_6c55f9fb-bade-4ae8-af7d-30854a3117a4"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibbfa7f443c9f4c30be51cebaefbd7dd1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtNy0xLTEtMA_c97c9007-f6f0-45c0-8bf6-ffe35c1b4d4c"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i07652793af6e402c8f56ae5bf525de5d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtOS0xLTEtMA_5a9e6261-4f2c-4a90-acfb-a2383ebe3d0c"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90YWJsZTo5ZTU5ODljOWRkMTI0MGQ0OWZmMWNlNmIwNWY4NDg5Yy90YWJsZXJhbmdlOjllNTk4OWM5ZGQxMjQwZDQ5ZmYxY2U2YjA1Zjg0ODljXzYtMTEtMS0xLTA_6563862d-a844-4e30-bfe0-02b3b21b7535"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM1OTg_798f63e0-fcb3-434f-b7bc-da6961d2c440"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8770b26e8a104e24a96561be14d9b01f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM2MTA_6e15e0f8-130f-451e-9b91-bfd51a2950db"
      unitRef="usd">118000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i47cb8d8061744a318fce0b3384617786_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM2NTk_4360c882-07cd-487c-b320-bb2bd03bab21"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM3NTM_a30bb04c-20e4-4489-94eb-8944f626b181"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i33bc232cff8a4f12a4e890a4672e8218_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM3NjU_c16acb31-526a-41f0-b57b-7db5ad3e007a"
      unitRef="usd">99000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i90e94470ed16447396b9f1012b944606_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzM4MTQ_bbdd3cbe-96ad-4309-a81c-bdeb8187d81c"
      unitRef="usd">52000000</us-gaap:RestructuringReserve>
    <us-gaap:AssetImpairmentCharges
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzYwNDczMTM5NzQyNDg_d106ec8c-1b8b-404c-bfef-767ce2f953a1"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if2f8ead53d3e4be5b9320bb684b9f13a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzYwNDczMTM5NzQyNzY_7f531e65-f340-4892-9872-ffd9b15b3f03"
      unitRef="usd">82000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i9fc5fdf86d854199b0de26fe3d7aef0b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzU0OTc1NTgxNTY3MDE_6b868798-f598-49be-9784-44ca69864660"
      unitRef="usd">30000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1f79d90a93144c60981f623c356fc6bf_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5XzYwNDczMTM5NzQzMDQ_f6c31c24-e142-4552-8b2b-610e3436c485"
      unitRef="usd">210000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i18d5408029404b5aa8938a311b6434f3_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMjcvZnJhZzpkNmRmNDZhNTdmZGE0NGQ2Yjg0M2EyZDRmMGMyYTczOS90ZXh0cmVnaW9uOmQ2ZGY0NmE1N2ZkYTQ0ZDZiODQzYTJkNGYwYzJhNzM5Xzc3NDk_2ea4b361-2fbb-44ce-8b32-c90f14667206"
      unitRef="usd">35000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzY2ODM_71c4fd48-8d55-43f8-949d-45c184158cc1">Business Acquisitions and Divestitures&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021 and 2020, the Company did not complete any material acquisitions. During 2021, 2020, and 2019, the Company did not complete any material divestitures other than the contribution of the majority of its German wholesale business to a newly formed joint venture, as described in Financial Note 3, &#x201c;Held for Sale,&#x201d; in 2021 and the separation of the Change Healthcare JV, as described in Financial Note 2, &#x201c;Investment in Change Healthcare Joint Venture,&#x201d; in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes. However, if the assets of another company are acquired, the goodwill may be deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medical Specialties Distributors LLC (&#x201c;MSD&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2018, the Company completed its acquisition of MSD for the net purchase consideration of $784 million, which was funded from cash on hand. MSD is a leading national distributor of infusion and medical-surgical supplies as well as a provider of biomedical services to alternate site and home health providers. The financial results of MSD have been included in the Company&#x2019;s Consolidated Statements of Operations within its Medical-Surgical Solutions segment since the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of assets acquired and liabilities assumed as of the acquisition date were finalized upon completion of the measurement period in the first quarter of 2020. The final purchase price allocation included acquired identifiable intangibles of $326 million primarily representing customer relationships with a weighted-average life of 18 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final recording of the fair value of the assets acquired and liabilities assumed for this acquisition as of the acquisition date, including immaterial adjustments made during the measurement period:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;as of the Acquisition Date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets, net of cash and cash equivalents acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired, net of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Final amounts as of May 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Acquisitions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CoverMyMeds LLC (&#x201c;CMM&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 3, 2017, the Company completed its acquisition of CMM for the net purchase consideration of $1.3 billion, which was funded from cash on hand. Pursuant to the agreement, McKesson&#x2019;s purchase consideration was subject to an additional $160 million of contingent consideration based on CMM&#x2019;s financial performance for 2018 and 2019. Pursuant to the agreement, the Company paid additional contingent consideration of $69 million and $68 million in May 2019 and May 2018, respectively. As of March&#160;31, 2020, the related liability was nil. &lt;/span&gt;&lt;/div&gt;During the three years presented, the Company also completed a number of other de minimis acquisitions within its operating segments. Financial results for the Company&#x2019;s business acquisitions have been included in the Company&#x2019;s consolidated financial statements since their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1a36ca67ff5f42bbbbcf4d6660b6af27_D20180601-20180601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzQzOQ_250836f9-d9d7-464e-8846-0950fccab8e2"
      unitRef="usd">784000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzEwODA_c61cc7ba-2ccc-47f8-9f76-92c9257afb86"
      unitRef="usd">326000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4ca54959e5e04b8c9414f83bc32f7efe_D20180601-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzExNjE_f55873ca-964d-4d82-bfa9-25f51c949e7b">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzY2NzU_a8efab86-d1b7-40d4-829a-2d577154581f">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the final recording of the fair value of the assets acquired and liabilities assumed for this acquisition as of the acquisition date, including immaterial adjustments made during the measurement period:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;as of the Acquisition Date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets, net of cash and cash equivalents acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired, net of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Final amounts as of May 31, 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzEtNy0xLTEtMA_93ba2b25-325f-466c-8e6f-423d3dac6367"
      unitRef="usd">112000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzItNy0xLTEtMA_02af81f2-79d4-4a03-ab9d-5b663bbcb526"
      unitRef="usd">71000000</mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents>
    <us-gaap:Goodwill
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzMtNy0xLTEtMA_9c1066ac-bbef-495e-a54a-0add92675dbf"
      unitRef="usd">388000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzQtNy0xLTEtMA_427b9ab5-1ffb-4235-820c-0702e698108c"
      unitRef="usd">326000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzUtNy0xLTEtMA_aaea5bb7-6f0b-499c-bf35-434de8e8d9c7"
      unitRef="usd">56000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzYtNy0xLTEtMA_e60d8d04-c0ac-4b5b-bcfa-9684b387921d"
      unitRef="usd">72000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzctNy0xLTEtMA_123a2b22-dc32-49be-b283-22c284017c3b"
      unitRef="usd">97000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents
      contextRef="i60d887dd975b47fcb23c06b79e73a02a_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90YWJsZTo5MWE1YTQzN2IwZjk0MDYyYTM4ZmI5NGNkZTdmMzRiZS90YWJsZXJhbmdlOjkxYTVhNDM3YjBmOTQwNjJhMzhmYjk0Y2RlN2YzNGJlXzgtNy0xLTEtMA_bc6ae8ef-9505-4ad9-a631-eb7d792cf6c8"
      unitRef="usd">784000000</mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1182c1c4af8746449b50307d67f448c1_D20170403-20170403"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzI3MTU_feee1550-b9f4-4c11-bae0-15df6f1719cb"
      unitRef="usd">1300000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i3088cf57426d4c8e9292e7c571001c3b_I20170403"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzMxMzU_dbbe9058-6fb7-441f-8065-5f6a24b6deaa"
      unitRef="usd">160000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i616817b40eb74cfb8ae329d9816e7420_D20190501-20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzM5OTc_d5270b9b-7566-4f35-aba9-3fec7dac406c"
      unitRef="usd">69000000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="id07b7f77830b43c69cfefaf0b8e7b960_D20180501-20180531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzU0OTc1NTgxNTE2ODg_9ffa70e7-6414-4bcc-b7df-b7ffc6b81e3b"
      unitRef="usd">68000000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia99cfa38235e449aa90c06cd0c7c8a59_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzMvZnJhZzo3NTlkNzM5YmY4YjY0MjBkODEwZDA1MjE3OWRhZTdmNC90ZXh0cmVnaW9uOjc1OWQ3MzliZjhiNjQyMGQ4MTBkMDUyMTc5ZGFlN2Y0XzQwNzY_6ffd910c-3022-47ae-af0b-4fdf8a681df2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNTQ_68c53d3c-9744-4f02-a8c7-09e84b25daa7">Share-Based CompensationThe Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#x201c;RSUs&#x201d;), performance-based stock units (&#x201c;PSUs&#x201d;, formerly referred to as total shareholder return units or &#x201c;TSRUs&#x201d;), performance-based restricted stock units (&#x201c;PeRSUs&#x201d;), stock options, and an employee stock purchase plan (&#x201c;ESPP&#x201d;) (collectively, &#x201c;share-based awards&#x201d;). Most of the share-based awards are granted in the first quarter of each fiscal year.&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact on Net Income&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of share-based compensation expense and related tax benefits are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit for share-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes compensation expense recognized for RSUs, PeRSUs, and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2021, 2020, and 2019 included discrete income tax expense of $2 million, $2 million, and $4&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2013, the Company&#x2019;s stockholders approved the 2013 Stock Plan to replace the 2005 Stock Plan. Under these stock plans, the Company may issue restricted stock, RSUs, PSUs, PeRSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserves 30 million shares plus unused reserved shares under the 2005 Stock Plan. As of March&#160;31, 2021, 20 million shares remain available for future grant under the 2013 Stock Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Unit Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs entitle the holder to receive a specified number of shares of the Company&#x2019;s common stock which vest over a period of generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NDY_e4780d27-ecc2-4ddb-b012-e0b781a25964"&gt;three&lt;/span&gt; to four years as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the market price of the Company&#x2019;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March&#160;31, 2021, approximately 82,000 RSUs for the Company&#x2019;s directors are vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a three-year performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally three years. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date. For PSUs that are eligible for cash settlement and designated as liability awards, the Company re-measures the fair value at the end of each reporting period and adjusts a corresponding liability in its Consolidated Balance Sheets for changes in fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PeRSUs are awards for which the number of RSUs awarded is conditional upon the attainment of one or more performance objectives over a specified period. All outstanding PeRSU awards have completed the performance period and are now classified and accounted for as RSUs. The Company did not grant any PeRSUs during the years ended March&#160;31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the Monte Carlo valuations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity for restricted stock unit awards (RSUs, PSUs, and PeRSUs) during 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to restricted stock unit award activity: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted stock unit award cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of seven years and follow a four-year vesting schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the fair value of employee stock options were as follows: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended &lt;br/&gt;March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company did not grant any stock options during the years ended March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The computation of expected volatility was based on a combination of the historical volatility of the Company&#x2019;s common stock and implied market volatility. The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Expected dividend yield is based on historical experience and investors&#x2019; current expectations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The risk-free interest rate for periods within the expected life of the option is based on the constant maturity U.S. Treasury rate in effect at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The expected life of the options is based primarily on historical employee stock option exercises and other behavioral data and reflects the impact of changes in the contractual life of current option grants compared to the Company&#x2019;s historical grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock options outstanding at March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range of Exercise&lt;br/&gt;Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;br/&gt;at Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Exercisable at&lt;br/&gt;Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$183.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of options expected to vest takes into account an estimate of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The intrinsic value is calculated as the difference between the period-end market price of the Company&#x2019;s common stock and the exercise price of &#x201c;in-the-money&#x201d; options. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value on exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received upon exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized related to exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of stock options vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an ESPP under which 21 million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#x2019;s common stock through payroll deductions. The deductions occur over three-month purchase periods and the shares are then purchased at 85% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The 15% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in 2021, 2020, and 2019. At March&#160;31, 2021, 2 million shares remain available for issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNjA_f24dce38-86f1-414b-8d56-a936ed03f242">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of share-based compensation expense and related tax benefits are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit for share-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes compensation expense recognized for RSUs, PeRSUs, and PSUs.&lt;/span&gt;&lt;/div&gt;(2)Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2021, 2020, and 2019 included discrete income tax expense of $2 million, $2 million, and $4&#160;million, respectively.</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia84584b6586641aaa11065062b0d4dcf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzItMS0xLTEtMA_97e6b90f-be3e-4f0c-8776-dd08e0e7ceb6"
      unitRef="usd">137000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i68df8813101f4e9ca695e42eb2c1ba7b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzItMy0xLTEtMA_34e425e5-2832-4cf9-8444-3854e822a115"
      unitRef="usd">104000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i28e93491e63641d6a447af76bfba5be9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzItNS0xLTEtMA_3403e865-ba6f-417d-b38a-8860365c1797"
      unitRef="usd">75000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i74e9a04c993b47eea348dc69be94ad03_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzMtMS0xLTEtMA_134d4b63-922e-424e-adbb-44a461a49688"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i33ea0a3bee2a42b3b14918ca313d0f3f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzMtMy0xLTEtMA_3f35abc3-f3d9-4831-8dc3-06f8b2a73eae"
      unitRef="usd">7000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7752154a30be4b70b7c200da7c5e0314_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzMtNS0xLTEtMA_4c7b7a40-d8c4-4483-a826-62600de82142"
      unitRef="usd">12000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzQtMS0xLTEtMA_500d5003-b309-49f3-9b73-daa388bb594e"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2875e0d883e04e789a166269b0168d5f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzQtMy0xLTEtMA_e38f860a-1dd5-4305-a31e-16aadf0ec67a"
      unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52d6d0051e254f03868cd2b4c4a08616_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzQtNS0xLTEtMA_bf6bd636-fb29-4156-910b-e2af1293f78d"
      unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzUtMS0xLTEtMA_fa455723-dd23-494e-a80b-ca2fe5ef011e"
      unitRef="usd">151000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzUtMy0xLTEtMA_29cd65cf-f4c7-4e5f-ac15-5807fc0dda28"
      unitRef="usd">119000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzUtNS0xLTEtMA_547f186f-7868-487f-9c7c-4a75535329c4"
      unitRef="usd">95000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzYtMS0xLTEtMA_5ada2046-e890-4bdb-98a1-c9aa4f42d17e"
      unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzYtMy0xLTEtMA_6bcbe2f6-b256-4835-ad23-4a6af638ad3f"
      unitRef="usd">18000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzYtNS0xLTEtMA_055b2f49-1742-431c-963c-1e8f0d2e224e"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzctMS0xLTEtMA_2b871116-c9bd-4749-a2ba-ba6a2ab8e62e"
      unitRef="usd">128000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzctMy0xLTEtMA_11cb0a44-0ec0-4a65-9768-76f87fba3003"
      unitRef="usd">101000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpkNWExNDQ4OTRkNWQ0MGM3OTExZTI2NzczMGJhYzI2OC90YWJsZXJhbmdlOmQ1YTE0NDg5NGQ1ZDQwYzc5MTFlMjY3NzMwYmFjMjY4XzctNS0xLTEtMA_27a21806-764f-4a21-b069-99751103e243"
      unitRef="usd">83000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE3NjA_2a58e96f-1416-4041-8924-83a2d50e3f8e"
      unitRef="usd">2000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE3Njc_85f5c322-535c-4312-8b40-4246fbacbe00"
      unitRef="usd">2000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzU0OTc1NTgxNDgzOTc_40dfcaeb-218f-4400-82d6-fd34396dcd19"
      unitRef="usd">4000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1bb3af9567d84570a2e07fa7cc1ca3e8_I20130731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzIyMzk_3f9444b4-c59d-4802-9355-3ced3c79f69e"
      unitRef="shares">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="if9ea335282264bd19c87da915b541a3d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzIzMTQ_1f2b88a1-64c3-41dc-b536-4d286572cb17"
      unitRef="shares">20000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7bca6f61ec8d4af0a1acb791483f3894_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NTI_d6fed5e3-0f2e-402d-beab-7f9c962cced0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested
      contextRef="i7d84699d924747a3b932295e7377ba8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzMyMzY_94c1fcaf-7a60-41fb-8c5d-5c58d3a91a2c"
      unitRef="shares">82000</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3dc1c1e592264d43b77791466a65bd52_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzUx_a8520e9a-a25e-4458-aee2-132bc4baee61">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i3dc1c1e592264d43b77791466a65bd52_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzQwMTU_15d32d13-78a2-4afd-90c5-724a24b1cc9e">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5481893297be481981506a5801e443ba_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzM3_6a487ac4-02ab-464f-a203-7fbe187f4b5a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzODA_5bc80087-90c7-47c0-9ff5-4b20fc6d1379">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the Monte Carlo valuations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzItMS0xLTEtMA_28db7c88-b887-434c-a00d-8353725c4a96"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzItMy0xLTEtMA_a2d60701-6099-404a-ad9b-c1dfea055e6b"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzItNS0xLTEtMA_8833491b-af01-456a-9348-7149e236911d"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzMtMS0xLTEtMA_091fe519-20de-4a2f-a83d-36181c819a3a"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzMtMy0xLTEtMA_951ccf8d-3d15-4b73-9d1d-5d99965f3eab"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzMtNS0xLTEtMA_c046989a-193d-4c35-9e82-be1c901b8260"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzQtMS0xLTEtMA_3cc15a00-e401-47c6-ad47-24f731e5dfbf"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzQtMy0xLTEtMA_8ec435f7-39c0-4bcf-be1d-7b17b4f2c803"
      unitRef="number">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzQtNS0xLTEtMA_46aad932-027e-4b9c-a791-3d11efe752cf"
      unitRef="number">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzUtMS0xLTEtMA_82c5d399-f6c8-40e3-96a8-447e5c92c603">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzUtMy0xLTEtMA_f839a1a8-2542-46f3-bd65-79a0bc8c846a">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplMWFmMDJhMWQ2Zjg0NDkxYmZhZGUzMDRkZjkwMDM3Ni90YWJsZXJhbmdlOmUxYWYwMmExZDZmODQ0OTFiZmFkZTMwNGRmOTAwMzc2XzUtNS0xLTEtMA_50617682-eabf-43ec-9004-dd02c87b2225">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNjM_ef91bbb2-45f8-4496-90a7-0e11f8ac0cf8">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity for restricted stock unit awards (RSUs, PSUs, and PeRSUs) during 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaa9c17219d084d969cda29f0f32fcdaf_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzEtMS0xLTEtMA_9d9627d1-ed88-42e3-83f7-12132e1bc4db"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iaa9c17219d084d969cda29f0f32fcdaf_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzEtMy0xLTEtMA_334b25f4-24e1-4086-add5-894a61958f6e"
      unitRef="usdPerShare">135.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzItMS0xLTEtMA_3aaa40f2-3e40-43f4-9e3f-e1aef7caab79"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzItMy0xLTEtMA_8a27250f-57c2-4506-a71c-8cef04639d64"
      unitRef="usdPerShare">155.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzMtMS0xLTEtMA_35769440-a36d-43b0-b00a-6efeaefee305"
      unitRef="shares">0</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzMtMy0xLTEtMA_87efc27b-33f6-4df1-8c92-3497c24500ad"
      unitRef="usdPerShare">133.70</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzQtMS0xLTEtMA_79e03b33-42b4-4f1b-a857-ae70fb3e660e"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzQtMy0xLTEtMA_ecdbcf09-ea6e-45bd-84e8-4838b6bcd75c"
      unitRef="usdPerShare">147.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzUtMS0xLTEtMA_78bd9ecf-b572-41c7-9e76-83f6465d1895"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpiMTVhOGE3MDE3YTY0NDY5OGY1YzZhY2QyYzY4MmIyMC90YWJsZXJhbmdlOmIxNWE4YTcwMTdhNjQ0Njk4ZjVjNmFjZDJjNjgyYjIwXzUtMy0xLTEtMA_10475703-9701-4dc5-b23e-c61bffffbb63"
      unitRef="usdPerShare">142.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <mck:DataRelatedtoRSUActivityTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNDk_abaf2dc9-bb7a-4d07-a1bf-3cedf512edca">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to restricted stock unit award activity: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted stock unit award cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:DataRelatedtoRSUActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzItMS0xLTEtMA_a99b7d77-2c96-43a3-84be-50a1f5df2271"
      unitRef="usd">79000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzItMy0xLTEtMA_576a6bf2-6129-411c-96da-4bf9b04535a8"
      unitRef="usd">67000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzItNS0xLTEtMA_95291ad6-eba5-4142-a725-98a84f40e26a"
      unitRef="usd">59000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="id3aab7ce31ba4656a356a3fbdf129c4e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzMtMS0xLTEtMA_cdc980c8-5efd-43c8-ba3d-3e44098339cc"
      unitRef="usd">147000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iaa9c17219d084d969cda29f0f32fcdaf_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzMtMy0xLTEtMA_135c3c01-a895-4465-a199-04524e83a5ea"
      unitRef="usd">155000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i00b9e27715eb4321801361f74b4928b1_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzMtNS0xLTEtMA_c1905642-3bf6-4a74-81b6-9d6116381191"
      unitRef="usd">119000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i59271b92dcf64cb58c826f765fd24248_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzQtMS0xLTEtMA_b2c06b17-bd98-4a7b-91ab-e118915da768">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i40f3dad8314e48c7ae2b36cdecb4a49c_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzQtMy0xLTEtMA_f36a96c2-dc47-4621-81c9-55051dd3325f">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i0fae60f0240f44a1b7a45600bb67f1e4_D20180401-20190331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo2Y2UwMzhiZTRhMTk0MDBhYWFhZmVhMTBmMTZiNjI1MC90YWJsZXJhbmdlOjZjZTAzOGJlNGExOTQwMGFhYWFmZWExMGYxNmI2MjUwXzQtNS0xLTEtMA_1fb2b1ad-a6fb-45e9-b3d5-46ceaca6b638">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzYyMzA_d68270e5-1d2a-42e4-853d-dcda15fbb45d">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzUw_4a77ac7c-f9e8-450f-878b-b88c17acd0a6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNDA_c2ea00c0-d10a-4475-bb44-fa7caea82d44">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the fair value of employee stock options were as follows: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended &lt;br/&gt;March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company did not grant any stock options during the years ended March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The computation of expected volatility was based on a combination of the historical volatility of the Company&#x2019;s common stock and implied market volatility. The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Expected dividend yield is based on historical experience and investors&#x2019; current expectations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The risk-free interest rate for periods within the expected life of the option is based on the constant maturity U.S. Treasury rate in effect at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The expected life of the options is based primarily on historical employee stock option exercises and other behavioral data and reflects the impact of changes in the contractual life of current option grants compared to the Company&#x2019;s historical grants.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzItNC0xLTEtMA_18504909-ba9c-4333-b3ba-3c56110c8e13"
      unitRef="number">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzMtNC0xLTEtMA_c86840af-20d1-44d5-83a7-f450819f41c0"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzQtNC0xLTEtMA_61638b72-e268-4e99-a15c-6ee453469847"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTo5MDBlNDYxODMwNjg0ZDE3YTg5ZGI3ZmI3NmM2MDg1NC90YWJsZXJhbmdlOjkwMGU0NjE4MzA2ODRkMTdhODlkYjdmYjc2YzYwODU0XzUtNC0xLTEtMA_358d4121-5318-4f1b-accc-d1a6ffcf7092">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzQ1_0c0a64df-0f65-4262-ae6b-7b4b8caea843"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzQ1_d1aae6b6-bbbd-43c3-a1c6-16d73f74c99a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNDQ_773f4240-9271-4dd6-aa36-79d91bb9c761">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock options outstanding at March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range of Exercise&lt;br/&gt;Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;br/&gt;at Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Exercisable at&lt;br/&gt;Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$183.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i98600c393115470c98af4ebaf984768f_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMC0xLTEtMA_f9deff7d-49f6-4d88-bde3-14359274c282"
      unitRef="usdPerShare">118.41</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i98600c393115470c98af4ebaf984768f_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMi0xLTEtMA_73c5d8c9-6537-4020-862c-8c596d50883a"
      unitRef="usdPerShare">183.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItNC0xLTEtMA_fbb8db71-db6f-43b0-b0cc-702353b73f89"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i98600c393115470c98af4ebaf984768f_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItNi0xLTEtMA_259a52ad-a86a-4b90-93b2-150eef3fd302">P3Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItOC0xLTEtMA_cc083c42-294e-4c14-ab05-5057b7bbca19"
      unitRef="usdPerShare">166.18</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMTAtMS0xLTA_e9fa420d-2a81-4085-92c1-13c2c21c3f2b"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="iac7d90041b41485e9c066b6c9648022c_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzItMTItMS0xLTA_c4275f75-709d-45e6-a7fb-c2bb822aad43"
      unitRef="usdPerShare">171.38</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMC0xLTEtMA_d2181112-f2a1-4262-9c6d-ebf0732d48c9"
      unitRef="usdPerShare">183.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMi0xLTEtMA_9385137f-0cd0-4bc4-bac5-3ed4d125a483"
      unitRef="usdPerShare">237.86</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtNC0xLTEtMA_f5f62aa1-784d-4245-87a4-98d2f07a21a4"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i02828c53ab2e4c0bbecef6130fcd7e11_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtNi0xLTEtMA_1486ffc5-fb15-4aa6-9e99-11675388191f">P1Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtOC0xLTEtMA_6fb16283-e23f-4740-aa51-bffc270e298e"
      unitRef="usdPerShare">216.23</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMTAtMS0xLTA_09dc27bd-88d1-43f8-b817-d6d0f14eccf2"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i8db5d79f8f98449ba80a73798cc2250c_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzMtMTItMS0xLTA_11023946-602e-49bc-9077-a28ae2ca4108"
      unitRef="usdPerShare">216.23</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzQtNC0xLTEtMA_c20ee8e2-528d-405a-a0db-f679070f3fe2"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTplNjY5Mjg4MzU1N2Y0MzdkOTcwMDM0MjU2YzQ4ZGRiNi90YWJsZXJhbmdlOmU2NjkyODgzNTU3ZjQzN2Q5NzAwMzQyNTZjNDhkZGI2XzQtMTAtMS0xLTA_e7772bcf-f085-4a36-ade0-ff9b55d3b7fb"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNzA_5f7fe07c-5de0-472e-bc09-2832b584625e">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of options expected to vest takes into account an estimate of expected forfeitures.&lt;/span&gt;&lt;/div&gt;(2)The intrinsic value is calculated as the difference between the period-end market price of the Company&#x2019;s common stock and the exercise price of &#x201c;in-the-money&#x201d; options.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtMS0xLTEtMA_e3fa10fb-5eba-4162-976f-b502e556d627"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtMy0xLTEtMA_b39aaf10-2521-4279-ac8e-b3ea08776f1f"
      unitRef="usdPerShare">180.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtNS0xLTEtMA_2b8c7057-22fa-4242-8c36-ee280ef925d6">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzEtNy0xLTEtMA_759839e0-ce78-4e6f-bb07-e631348ab0ed"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzItMS0xLTEtMA_b6035590-feee-4b88-9808-e3c104acf0fb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzItMy0xLTEtMA_09b08a75-7203-48e1-adc4-d838f4ebd983"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzMtMS0xLTEtMA_e722bc8c-c445-467d-8300-99b7741dc285"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzMtMy0xLTEtMA_7a26fee8-1f03-4e9b-9022-3c19753aa01b"
      unitRef="usdPerShare">187.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzQtMS0xLTEtMA_e2db3cb9-f08a-49a0-9b63-532abe738364"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzQtMy0xLTEtMA_0c8c52e1-a948-44bb-bd16-f7cfc620ca1a"
      unitRef="usdPerShare">153.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtMS0xLTEtMA_fcb7fdca-5810-48e4-ab99-de08a6a62bb5"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtMy0xLTEtMA_626469b8-1660-4455-98c4-7b09c14d0a12"
      unitRef="usdPerShare">183.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtNS0xLTEtMA_94c403cc-de57-4778-ad61-fd102ec73e99">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzUtNy0xLTEtMA_eb1895cf-4f51-4ee3-a5e5-ec9c12d4e471"
      unitRef="usd">36000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtMS0xLTEtMA_7269892f-1902-4e37-ac54-14442db9be55"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtMy0xLTEtMA_a6825872-5d91-41c5-bf7d-7f427020e83a"
      unitRef="usdPerShare">183.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtNS0xLTEtMA_04f4c3fb-8943-41d9-b1c2-e65946e05b93">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzYtNy0xLTEtMA_d4911faf-6d3c-4b17-8547-d827a5b72f1c"
      unitRef="usd">35000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctMS0xLTEtMA_9e2b6571-0932-4e90-b0a2-4c5eedea7671"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctMy0xLTEtMA_5277bb5e-b4c8-4b09-b7ee-e1fa03a83f23"
      unitRef="usdPerShare">189.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctNS0xLTEtMA_bc9751fd-8e0b-4c3c-9458-b7ddaff2ecb3">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTowNzJmYjE0NTc3Mzc0ZWQ2YTQ1ODRhMTk3ZWY5ZDA5MS90YWJsZXJhbmdlOjA3MmZiMTQ1NzczNzRlZDZhNDU4NGExOTdlZjlkMDkxXzctNy0xLTEtMA_6a0a224f-433c-469b-835d-f24af4f2b11c"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkzNTM_1adb9217-c700-473f-8a66-5b627c3d3456">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value on exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received upon exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized related to exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of stock options vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzItMS0xLTEtMA_80e41214-c2e6-4cd4-883c-2026c021ee24"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzItMy0xLTEtMA_e414f509-c6e1-41f7-a054-195fdabcdc92"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzItNS0xLTEtMA_ff1dc848-03aa-43f5-a1dc-f0345ac9e16a"
      unitRef="usdPerShare">34.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzMtMS0xLTEtMA_6798ed39-56ab-4e8b-9010-de5a0052b885"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzMtMy0xLTEtMA_b6f4e3f7-a2cd-4c1d-a5bc-17f33de51d43"
      unitRef="usd">17000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzMtNS0xLTEtMA_ce59574e-69a9-47a8-99bc-bf11e06b3683"
      unitRef="usd">16000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzQtMS0xLTEtMA_6f830bb9-e337-4d96-9a91-559a99423db2"
      unitRef="usd">38000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzQtMy0xLTEtMA_fcacc732-217e-42ad-9d3f-1b6926b01c65"
      unitRef="usd">66000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzQtNS0xLTEtMA_702c5a13-57cc-433d-a17b-d3873ebb3a26"
      unitRef="usd">29000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzUtMS0xLTEtMA_80c9e9d1-221b-4589-825f-40942f3b6fa3"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzUtMy0xLTEtMA_59f9b57e-0d30-4c78-80af-009737d1b89a"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzUtNS0xLTEtMA_0395c637-7b1b-4fd2-9df3-b177482e6998"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzYtMS0xLTEtMA_1a4e5ab6-cb05-47ef-8de8-e290c463f5d9"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzYtMy0xLTEtMA_2ec0ac12-b7ef-40d7-91fb-3909f5e4c52f"
      unitRef="usd">16000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzYtNS0xLTEtMA_ab72ef8b-2c3f-4543-afd7-a99cc4553cdf"
      unitRef="usd">16000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iabba4ee1a62b45e6bbc176b0dc8941b3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzctMS0xLTEtMA_853a08fd-9c27-490b-9eae-5171bac58137"
      unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i521d39c0b3084c2d99a90fc226922cdd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzctMy0xLTEtMA_a8c8588a-66cf-4579-b4d9-ecfd3f547553"
      unitRef="usd">6000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i79ee321ad30d41dfad64c6a2f32533ec_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzctNS0xLTEtMA_07bb1cfb-9619-4c60-a53c-b16a5ee3692d"
      unitRef="usd">15000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="idba7d670fc874663a124e1d3598d51de_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzgtMS0xLTEtMA_be01cf87-9f78-4f9b-9cf0-f82bdb353f4d">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="idb9bd99da6d3403ba84a0cd1f16c0040_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzgtMy0xLTEtMA_4f8d601a-0267-4e6a-b565-37ad39dd9eef">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3383581875ce407cb2084a70eeee7980_D20180401-20190331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90YWJsZTpmMDE2MzdmYmI1YjI0NjI0ODQ5N2ZjNDAyOTg1ZDcwOS90YWJsZXJhbmdlOmYwMTYzN2ZiYjViMjQ2MjQ4NDk3ZmM0MDI5ODVkNzA5XzgtNS0xLTEtMA_48ec3b66-b5f4-45b2-89dd-df2edc26c0ab">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ia5415cd5dc724d9b839b382de490cae8_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzgzNDc_82761e62-15f1-4267-89f6-767fd152d637"
      unitRef="shares">21000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions
      contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzE5NzkxMjA5MzA5NzQ5_ebf73217-89ae-4ccc-8d3b-61f7c1aec3c0">P3M</mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzg1OTM_fb4d683f-c781-40ff-a5c1-5f014b1b4c9e"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="i679db541eb8441e4866a8cd70f0cb5fc_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzg3OTk_258920fe-91e3-4d9a-a93f-a30d0daf2a96"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ia5415cd5dc724d9b839b382de490cae8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzkyODg_c0e095d5-d677-4fe9-b206-33393bcb48ce"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzUwNA_6a42e495-1280-4bb5-b08e-7c98e3898a45">Other Income, Net&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains on investments in equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses from pension plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from sale of equity method investment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily recorded within the Company&#x2019;s International segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents net realized and unrealized gains on the Company&#x2019;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments and were included within Corporate expenses, net. Refer to Financial Note 17, &#x201c;Fair Value Measurements,&#x201d; and to Financial Note 22, &#x201c;Segments of Business.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes $116 million from the termination of the U.S. defined benefit pension plan and $11 million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 15, &#x201c;Pension Benefits.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents a gain from the sale of an equity investment to a third party included in RxTS during 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzUxMQ_fa73cdfa-97bb-428e-9696-20f9249536f9">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains on investments in equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses from pension plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain from sale of equity method investment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily recorded within the Company&#x2019;s International segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents net realized and unrealized gains on the Company&#x2019;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments and were included within Corporate expenses, net. Refer to Financial Note 17, &#x201c;Fair Value Measurements,&#x201d; and to Financial Note 22, &#x201c;Segments of Business.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes $116 million from the termination of the U.S. defined benefit pension plan and $11 million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 15, &#x201c;Pension Benefits.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents a gain from the sale of an equity investment to a third party included in RxTS during 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzItMS0xLTEtMA_1a5a88d9-7266-48ba-87fe-8c9e148b944e"
      unitRef="usd">12000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzItMy0xLTEtMA_080e4385-29b5-4e1f-8715-30e47a05babd"
      unitRef="usd">49000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzItNS0xLTEtMA_aa7042c8-f97e-4b48-a601-85ba9b3796b9"
      unitRef="usd">39000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzMtMS0xLTEtMA_c87d7174-66fb-468c-9a08-9beb9aa5daf9"
      unitRef="usd">48000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzMtMy0xLTEtMA_63b214ee-5624-4c48-a3e8-129f50a649c8"
      unitRef="usd">36000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzMtNS0xLTEtMA_92689a4a-2bd9-4eed-9c40-ea1de82926cd"
      unitRef="usd">43000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMS0xLTEtMjExOTA_9735c874-7c3a-448f-9e5f-8f50d3f42b40"
      unitRef="usd">133000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMy0xLTEtMjExOTA_31afbfc9-5ab4-4d73-bcd2-a49a9cc26e2a"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtNS0xLTEtMjExOTA_26b00c9e-96c2-432e-a1ee-0dcbaafe2706"
      unitRef="usd">23000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzUtMS0xLTEtMjExOTQ_375747ec-4aa6-461d-b1b2-2f36afaf7fbb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzUtMy0xLTEtMjExOTQ_04325300-8d6c-4795-a2bd-8fe0c23dd07f"
      unitRef="usd">-127000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzUtNS0xLTEtMjExOTQ_aefc5400-e9f8-40e9-a48a-50a7b75d802a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMS0xLTEtMA_d6e03cfd-27bc-419b-b749-066f8f923906"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtMy0xLTEtMA_ac9dd7f2-5d03-4d36-9a7b-02c0440455f8"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzQtNS0xLTEtMA_2486eff4-e2c3-4e8e-9747-9fa70996315e"
      unitRef="usd">56000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzYtMS0xLTEtMA_b687d05c-6c47-4108-9ef7-4625e2a9f75a"
      unitRef="usd">30000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzYtMy0xLTEtMA_fb4afb5b-8126-4e22-88e4-b559c073e77c"
      unitRef="usd">37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzYtNS0xLTEtMA_b7708eab-533f-4fe0-b4b7-991f1ef8cc71"
      unitRef="usd">21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzctMS0xLTEtMA_148b3015-f7dc-4507-b62c-2f855253e1c7"
      unitRef="usd">223000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzctMy0xLTEtMA_3ad81218-f437-4713-9f38-31fdd4460e5f"
      unitRef="usd">12000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90YWJsZTo0ODgzMzE5NWJjZGQ0ZmZjOWJhNzk2YzM3NjdiMDVhMS90YWJsZXJhbmdlOjQ4ODMzMTk1YmNkZDRmZmM5YmE3OTZjMzc2N2IwNWExXzctNS0xLTEtMA_fd052afe-e188-4c0c-90da-f2ebbcd6b5e6"
      unitRef="usd">182000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="iad526e199d5f45e8b0138cf1dc4218d3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzMwMw_db60cb2f-d939-42d4-b49a-1a2c9a479748"
      unitRef="usd">-116000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="ifbba704ea17245a79664996d4d4b9fb9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDIvZnJhZzo5Zjg2N2E2OTI3YzU0ZDIyOGUzMDk1NThjNTEzODhmMC90ZXh0cmVnaW9uOjlmODY3YTY5MjdjNTRkMjI4ZTMwOTU1OGM1MTM4OGYwXzM3Mg_d34f9e01-dcda-447e-b2ad-b436a202503e"
      unitRef="usd">-11000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMjA_186df066-456c-4f46-aed0-f277a2cd137e">Income Taxes &lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) related to continuing operations consists of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reported an income tax benefit rate of 13.8% in 2021. Income tax expense rates were 1.6% and 58.4% in 2020 and 2019, respectively. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to the impact of opioid-related claims of $8.1 billion ($6.8 billion after-tax) in 2021, the impact of the Change Healthcare joint venture divestiture in 2020, the impact of nondeductible impairment charges in 2019, and varying proportions of income attributable to foreign countries that have income tax rates different from the U.S. rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21% to income before income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net tax benefit on intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-free gain on investment exit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of change in U.S. tax rate on temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Refer to Financial Note 2, &#x201c;Investment in Change Healthcare Joint Venture,&#x201d; for additional information regarding the separation of the Change Healthcare JV.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $5 million in 2021 and $7 million in each of 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax rate for 2021 was impacted by the charge for pending and future opioid-related claims of $8.1 billion ($6.8 billion after-tax), as described further in Financial Note 19, &#x201c;Commitments and Contingent Liabilities.&#x201d; The Company recorded a deferred tax benefit of $1.3&#160;billion, which is net of certain non-deductible expenses and an unrecognized tax benefit of $455 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021 and 2019, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. In both instances, the transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#x201c;Intra-Entity Transfers of Assets Other Than Inventory,&#x201d; discrete tax benefits of $105 million and $42 million were recognized for 2021 and 2019, respectively, with a corresponding increase to a deferred tax assets for the temporary difference arising from the buyer&#x2019;s excess tax basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV as described in Financial Note 2, &#x201c;Investment in Change Healthcare Joint Venture.&#x201d; The Company&#x2019;s reported income tax expense rate for 2020 was favorably impacted by this transaction given that it was intended to generally be a tax-free split-off for U.S. federal income tax purposes. In the fourth quarter of 2020, the Company recognized a net gain for financial reporting purposes of $414 million related to the separation transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax expense rate for 2020 was unfavorably impacted by non-cash charges of $275 million to remeasure the carrying value of assets and liabilities held for sale related to the formation of a new German wholesale joint venture within the Company&#x2019;s International segment. Refer to Financial Note 3, &#x201c;Held for Sale,&#x201d; for more information on this transaction which closed in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax expense rate for 2019 was unfavorably impacted by non-cash charges of $1.8 billion to impair the carrying value of goodwill for its International segment, given that these charges are generally not deductible for tax purposes. Refer to Financial Note 12, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax balances consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefit related accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory valuation and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets and systems development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $864 million and $833 million in 2021 and 2020, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The increase in the valuation allowance of $31 million in the current year relates primarily to net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has federal, state, and foreign net operating loss carryforwards of $2.4 billion, $3.9 billion, and $2.2 billion at March&#160;31, 2021. Federal and state net operating losses will expire at various dates from 2022 through 2041. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $783 million with indefinite lives. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits for the last three years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on the lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had $1.8 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate, if recognized. The increase in unrecognized tax benefits in 2021 compared to 2020 is primarily attributable to uncertainty in connection with the deductibility of Opioid-related litigation and claims. Because many uncertainties associated with any potential settlement arrangements or other resolutions of opioid claims including provisions related to deductibility have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; for more information. The decrease in unrecognized tax benefits in 2020 compared to 2019 is primarily attributable to the favorable resolution of an outstanding California tax refund claim which decreased unrecognized tax benefits by $91&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the next twelve months, it is reasonably possible that the Company&#x2019;s unrecognized tax benefit may decrease by as much as $93 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $9 million, $23 million, and $33 million in 2021, 2020, and 2019, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March&#160;31, 2021 and 2020, it accrued $101&#160;million and $91&#160;million cumulatively in interest and penalties on unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign operations of approximately $6.0 billion were considered indefinitely reinvested. Following enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMTA_859dca80-95fb-4509-8807-542dc017c9ed">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzMtMS0xLTEtMA_deedf645-61eb-4934-9741-021e17a2e22b"
      unitRef="usd">-6019000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzMtMy0xLTEtMA_01347301-ea8a-45cb-9c50-e923b91c1bb7"
      unitRef="usd">216000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzMtNS0xLTEtMA_46acfddf-093f-4f80-86d3-76d37c8668d1"
      unitRef="usd">1512000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzQtMS0xLTEtMA_4041cd38-6c8c-41c2-9d4e-9d1142fed778"
      unitRef="usd">985000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzQtMy0xLTEtMA_456307c7-b9c9-4000-af0f-17c0b7b53c22"
      unitRef="usd">928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzQtNS0xLTEtMA_2bc28acc-8246-4983-b531-bc5f43da727d"
      unitRef="usd">-902000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzUtMS0xLTEtMA_c4e5f568-c00d-48e7-aa86-5abba4528ce6"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzUtMy0xLTEtMA_ee95f747-cb8f-41ff-b2d6-5c66f057616d"
      unitRef="usd">1144000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpmM2RkYTY0YmZjNjk0N2M3ODcyNGQ5OTZjN2IyMjFhYi90YWJsZXJhbmdlOmYzZGRhNjRiZmM2OTQ3Yzc4NzI0ZDk5NmM3YjIyMWFiXzUtNS0xLTEtMA_2ed8ddab-fa17-481d-a1b2-a5949f885e8a"
      unitRef="usd">610000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMTQ_0abbc75c-8066-4b3f-98f6-a91828a1a8cf">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) related to continuing operations consists of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzMtMS0xLTEtMA_a1222c21-9d14-42d9-928a-8128a25a6516"
      unitRef="usd">-15000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzMtMy0xLTEtMA_62161e72-0110-4ded-bf42-a3aa03398401"
      unitRef="usd">170000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzMtNS0xLTEtMA_56ed6c40-8b5d-4b51-bc75-4759e44ffec8"
      unitRef="usd">-20000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzQtMS0xLTEtMA_59f7fe13-e7f8-470b-8e52-ebc1f8a80ed9"
      unitRef="usd">47000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzQtMy0xLTEtMA_ad63617d-74ff-4243-b4c8-ffdaa643899c"
      unitRef="usd">48000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzQtNS0xLTEtMA_5681a358-8f33-468e-a696-151724c9f525"
      unitRef="usd">35000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzUtMS0xLTEtMA_d0ee0d3f-8e94-44b4-854b-054523b562fc"
      unitRef="usd">181000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzUtMy0xLTEtMA_7b11271a-bc84-4d6a-a286-946f836b0093"
      unitRef="usd">142000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzUtNS0xLTEtMA_a2193147-e624-4d3a-918f-4af4bb5f1cf5"
      unitRef="usd">152000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzYtMS0xLTEtMA_9edacc37-5f58-41ec-b220-61a4963e12d9"
      unitRef="usd">213000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzYtMy0xLTEtMA_cd2e26b9-095b-44dd-96cf-df275ba5c0d2"
      unitRef="usd">360000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzYtNS0xLTEtMA_2189367f-6bce-4290-8bd3-734919939a43"
      unitRef="usd">167000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzktMS0xLTEtMA_1e0ca83e-997f-4a3e-a98c-742b486d5daa"
      unitRef="usd">-562000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzktMy0xLTEtMA_fec508d1-ac4c-470e-98c3-b24089ec0b15"
      unitRef="usd">-204000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzktNS0xLTEtMA_b04fa20f-48f3-4907-9673-471cb2ff4a48"
      unitRef="usd">223000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEwLTEtMS0xLTA_82eb94dd-3419-4321-a61f-14fb4f0d0e1f"
      unitRef="usd">-204000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEwLTMtMS0xLTA_fc5b047e-9025-4dea-9887-92a58d5697a7"
      unitRef="usd">-105000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEwLTUtMS0xLTA_fecaa9ab-7e84-437e-a09a-4dd659a976b0"
      unitRef="usd">44000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzExLTEtMS0xLTA_e68b70d7-ddc4-4904-b882-47e22705b413"
      unitRef="usd">-142000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzExLTMtMS0xLTA_07afd045-f582-4ccc-a589-5d763ac2784d"
      unitRef="usd">-33000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzExLTUtMS0xLTA_58a7d16e-dc85-46f7-88df-571e2593de0d"
      unitRef="usd">-78000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEyLTEtMS0xLTA_a700691d-165b-41b7-9782-435524d0af1c"
      unitRef="usd">-908000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEyLTMtMS0xLTA_c5973476-7d10-4d55-bdb4-7a31af3bd790"
      unitRef="usd">-342000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEyLTUtMS0xLTA_00df101f-e11b-4f0e-9d05-0c2bc3f558d1"
      unitRef="usd">189000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEzLTEtMS0xLTA_925c7f37-e0ad-4a2f-9d5b-814a794a6fea"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEzLTMtMS0xLTA_fc12f915-9f1b-437b-b528-5e4be6e24acd"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo2OTU0MDgyMmE1YmU0NjE5YTRmODE0ZTY2ZjEwOTQ5YS90YWJsZXJhbmdlOjY5NTQwODIyYTViZTQ2MTlhNGY4MTRlNjZmMTA5NDlhXzEzLTUtMS0xLTA_3f36521f-8e69-4a72-a2c3-9b4948baa193"
      unitRef="usd">356000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzI5Ng_097378c2-01cb-4ad1-9da5-d09b73b4eed9"
      unitRef="number">-0.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzMwMw_1786673f-cb31-43d3-81e0-68ec5203171e"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzM1Mw_d71e3ae5-483c-410f-9ba5-a7d422e85ff7"
      unitRef="number">0.584</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTAwMTc_b7b4d34b-50c3-42f7-a336-2a56782efaf3"
      unitRef="usd">8100000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTAwMjM_12072986-4f44-41ec-876f-351d8cd88041"
      unitRef="usd">6800000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMjM_a3771465-85bf-400b-ab7b-c8c91c6342fb">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21% to income before income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net tax benefit on intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-free gain on investment exit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of change in U.S. tax rate on temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Refer to Financial Note 2, &#x201c;Investment in Change Healthcare Joint Venture,&#x201d; for additional information regarding the separation of the Change Healthcare JV.&lt;/span&gt;&lt;/div&gt;(2)The Company&#x2019;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $5 million in 2021 and $7 million in each of 2020 and 2019.</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgzOA_9c4f6935-946e-4ba7-8e6d-87d76635669f"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgzOA_ebfb3bb2-2cc3-4184-a7c2-d60466030d87"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzItMS0xLTEtMA_65a6154c-b219-4282-95f5-f365d1e4f33c"
      unitRef="usd">-1057000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzItMy0xLTEtMA_e6de8e90-bdbc-4253-aaa1-fab1b8c8e432"
      unitRef="usd">240000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzItNS0xLTEtMA_842bc664-4b82-413b-81b2-ba705cea39a9"
      unitRef="usd">128000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzMtMS0xLTEtMA_d886e335-434f-4e7a-88b4-84cfaca29aa5"
      unitRef="usd">-206000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzMtMy0xLTEtMA_17f33f27-acf2-4f0b-a6a4-1539b93b8ca8"
      unitRef="usd">-41000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzMtNS0xLTEtMA_fc99c821-e7ea-4bcd-a6b0-b90f184c3e33"
      unitRef="usd">70000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzQtMS0xLTEtMA_70c5e508-3ee0-41e0-a203-ebeebab177f0"
      unitRef="usd">-77000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzQtMy0xLTEtMA_bda9f2e2-310a-47ba-b077-10d9cd0730f7"
      unitRef="usd">-81000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzQtNS0xLTEtMA_08cf0a7c-2a69-48a5-ae69-e6bae3bbfab0"
      unitRef="usd">-86000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzUtMS0xLTEtMA_b0367d97-dbf0-4c76-8a99-ebba4bb28e1c"
      unitRef="usd">41000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzUtMy0xLTEtMA_423551a2-bb12-471d-992a-e70e7a1c5029"
      unitRef="usd">-7000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzUtNS0xLTEtMA_8a931409-cf34-4cac-8cc4-19f386b05b8c"
      unitRef="usd">20000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzYtMS0xLTEtMA_17007f41-a1be-4ead-a055-35ada56e3a78"
      unitRef="usd">14000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzYtMy0xLTEtMA_526ccf79-001d-4bc0-b643-2e0819fe0a8e"
      unitRef="usd">7000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzYtNS0xLTEtMA_86d5c752-e21d-4788-bffe-fdb02d8ffd5a"
      unitRef="usd">357000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzctMS0xLTEtMA_158b6eda-10b1-4330-892c-ffff1dac8ff8"
      unitRef="usd">715000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzctMy0xLTEtMA_518e3fb2-c9e7-48e2-be86-9b755b9f2c65"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzctNS0xLTEtMA_c8250e61-127d-4b57-a184-e9e878de8aac"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzgtMS0xLTEtMA_3781ba2b-b167-4739-b8e0-0cb92e506e17"
      unitRef="usd">105000000</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzgtMy0xLTEtMA_e89bcfda-d887-43cb-9c1f-f53051c43dec"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzgtNS0xLTEtMA_27a9114f-7dce-4b8e-8dc9-22f9a8fb27ed"
      unitRef="usd">42000000</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzktMS0xLTEtMA_7868eb81-d968-4a03-bef9-e9b17cf68d26"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzktMy0xLTEtMA_c847d2d4-ed83-4f23-a826-3e33c7c2d556"
      unitRef="usd">-87000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzktNS0xLTEtMA_09403742-12c6-4f79-be04-8ef389996075"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEwLTEtMS0xLTA_e5bd9adb-2c51-4a59-8519-cdda6f07951f"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEwLTMtMS0xLTA_3bad0adc-41ac-49c7-bc0c-ae0010c1497c"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEwLTUtMS0xLTA_50d497df-c8d8-4b7a-a82e-d4cf1c019d33"
      unitRef="usd">-81000000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEyLTEtMS0xLTA_d6937459-647b-4a27-b1f5-c14c342906c6"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback>
    <mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEyLTMtMS0xLTA_5e63a302-3afa-472b-8a14-693090b22b85"
      unitRef="usd">-19000000</mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback>
    <mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEyLTUtMS0xLTA_b966f74e-0dcb-4db7-81bb-1acdb006e301"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEzLTEtMS0xLTA_8eebf86b-4e08-40d9-8dc0-48dbe219a61c"
      unitRef="usd">-20000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEzLTMtMS0xLTA_09a9b6a3-4c6f-4071-932a-86a9a7f87999"
      unitRef="usd">6000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzEzLTUtMS0xLTA_ed8d830c-5af8-4c04-a227-9ddf8d3a762b"
      unitRef="usd">-10000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzE0LTEtMS0xLTA_158f694f-fb00-4011-b263-4ea95eec7535"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzE0LTMtMS0xLTA_007cc7ac-bd69-48ce-88da-2227e0a48b19"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo0YzAzYTk1M2VhZDU0YWU0YTQ1N2ZlZWJhYjIwNGE3OC90YWJsZXJhbmdlOjRjMDNhOTUzZWFkNTRhZTRhNDU3ZmVlYmFiMjA0YTc4XzE0LTUtMS0xLTA_a400462d-607e-41d4-9f8c-bb17a38061ba"
      unitRef="usd">356000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzExNzU_beea5f5c-ff14-4e65-982f-8bcc7bdd5327"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzExNzk_3733f2c5-4d42-42b4-8dcc-a47ec2bbd06b"
      unitRef="usd">7000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzExNzk_78798f70-45c8-4976-b8be-df627bb45ebc"
      unitRef="usd">7000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTExNjU_b7b4d34b-50c3-42f7-a336-2a56782efaf3"
      unitRef="usd">8100000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTExODM_12072986-4f44-41ec-876f-351d8cd88041"
      unitRef="usd">6800000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iff2be0b266e4404fb2d3170fc25c0e2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzIxOTkwMjMyNzIxMjM_94b97687-00c6-4f4f-9a7e-80fdf98f4617"
      unitRef="usd">-1300000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="iff2be0b266e4404fb2d3170fc25c0e2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzIxOTkwMjMyNzIxMzc_10f727aa-7b24-41de-8a95-daf1ea0111be"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTEyNTU_ef6f0609-1c29-4190-ad18-a25adb264fe0"
      unitRef="usd">-105000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTEyNzI_4a5705aa-7806-4258-b12c-555e1a25ca4f"
      unitRef="usd">-42000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzE2NzQ_785def8a-4592-40bd-822e-89e7e2ac3fc5"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzE4NTA_2d6969b8-196d-475a-8192-6c590a0f2a63"
      unitRef="usd">275000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzIyNDk_28bbb74f-4aef-411f-bb63-f93b3b445cac"
      unitRef="usd">1800000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgwOTA_f5e9f853-ce72-41cd-a92c-e724ae9a2201">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax balances consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefit related accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory valuation and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets and systems development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzMtMS0xLTEtMA_0777c9b4-ba70-4c79-9fd6-c67207648f08"
      unitRef="usd">69000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzMtMy0xLTEtMA_da782445-d3f6-4ac0-a9b3-8edfd1887af7"
      unitRef="usd">72000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <mck:DeferredTaxAssetLitigationAndClaims
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMS0xLTEtMjM3MTk_0a34acb6-5054-4db1-a59f-2864481adf7d"
      unitRef="usd">724000000</mck:DeferredTaxAssetLitigationAndClaims>
    <mck:DeferredTaxAssetLitigationAndClaims
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMy0xLTEtMjM3MTk_89110ebe-a2ac-4a67-8a3b-e442bc156291"
      unitRef="usd">0</mck:DeferredTaxAssetLitigationAndClaims>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMS0xLTEtMA_09a3138c-1d1e-42a7-856f-952e83be49b8"
      unitRef="usd">305000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzQtMy0xLTEtMA_671519c0-925a-41d0-8402-cf980a53608e"
      unitRef="usd">331000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzUtMS0xLTEtMA_a9410222-f146-4603-9546-1a6020a9b50c"
      unitRef="usd">974000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzUtMy0xLTEtMA_46a09c32-dc76-4081-b5d4-272a7e358f0a"
      unitRef="usd">828000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <mck:DeferredTaxAssetLeaseObligations
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzYtMS0xLTEtMA_1e97614c-8ece-4dab-9159-03affdd8885b"
      unitRef="usd">539000000</mck:DeferredTaxAssetLeaseObligations>
    <mck:DeferredTaxAssetLeaseObligations
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzYtMy0xLTEtMA_1f89905e-df44-4e73-8bec-28fa9e988ce5"
      unitRef="usd">482000000</mck:DeferredTaxAssetLeaseObligations>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzctMS0xLTEtMA_589c7371-ec91-4a13-971b-e56d7581dad7"
      unitRef="usd">115000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzctMy0xLTEtMA_e80104e0-2abb-4a47-a5ea-115144eec842"
      unitRef="usd">109000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzgtMS0xLTEtMA_f57630e4-5664-48a5-ba7b-d41022d0b92b"
      unitRef="usd">2726000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzgtMy0xLTEtMA_55578414-d151-4d5b-9b51-f2378a770663"
      unitRef="usd">1822000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzktMS0xLTEtMA_c3da8ab1-615e-4042-8de1-23b33eae23c6"
      unitRef="usd">864000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzktMy0xLTEtMA_89ff48ee-7f8e-46c4-b35b-159f9babe843"
      unitRef="usd">833000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEwLTEtMS0xLTA_6533629f-a99d-4a9d-aaeb-327cf6383ed7"
      unitRef="usd">1862000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEwLTMtMS0xLTA_f1ac9b98-7456-4315-9ed1-9e498a9e04f9"
      unitRef="usd">989000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEyLTEtMS0xLTA_bdd09df0-ab60-4e44-8d23-141848eb500d"
      unitRef="usd">1939000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEyLTMtMS0xLTA_e97fa19a-c75b-4a99-8f08-23790c7bcb31"
      unitRef="usd">1947000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEzLTEtMS0xLTA_efcd29ff-e887-46db-aec8-45980f8d48f5"
      unitRef="usd">196000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzEzLTMtMS0xLTA_2c8c59fa-8a21-45ce-9567-0cf677d5dc8e"
      unitRef="usd">202000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE0LTEtMS0xLTA_515cd1b8-7893-4d60-b049-15fc54b4759a"
      unitRef="usd">411000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE0LTMtMS0xLTA_891b7deb-316f-4962-86ad-42b9833d2b54"
      unitRef="usd">531000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <mck:DeferredTaxLiabilitiesLeaseRightofuseAssets
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE2LTEtMS0xLTA_eb080346-f1b2-419e-95d0-e7f4c74931fc"
      unitRef="usd">505000000</mck:DeferredTaxLiabilitiesLeaseRightofuseAssets>
    <mck:DeferredTaxLiabilitiesLeaseRightofuseAssets
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE2LTMtMS0xLTA_630b7a30-50e9-4230-8c72-d3f7952d7d0d"
      unitRef="usd">449000000</mck:DeferredTaxLiabilitiesLeaseRightofuseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE3LTEtMS0xLTA_f83e7782-bccd-48d6-a318-e85a79fe449d"
      unitRef="usd">37000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE3LTMtMS0xLTA_c3f3c2be-0f86-4572-9c23-41233a6e59b6"
      unitRef="usd">56000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE4LTEtMS0xLTA_cf14fe6f-0623-45fd-9165-e59676acb851"
      unitRef="usd">3088000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE4LTMtMS0xLTA_fbcb6359-b0f5-4a4f-a53e-cc5ea1b28e5b"
      unitRef="usd">3185000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE5LTEtMS0xLTA_1d6d03fa-a061-4eae-8906-cbbf69159829"
      unitRef="usd">1226000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzE5LTMtMS0xLTA_aca0da32-7242-47cf-b797-3de8ace96151"
      unitRef="usd">2196000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIxLTEtMS0xLTA_95c6df4d-085f-4783-be1c-70e6a164f15a"
      unitRef="usd">185000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIxLTMtMS0xLTA_124699fb-1423-4e10-bebe-0418fc3250ba"
      unitRef="usd">59000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIyLTEtMS0xLTA_e2f8c290-cdc8-40c0-84fa-1821f77d802d"
      unitRef="usd">1411000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIyLTMtMS0xLTA_f2636c30-86d7-43c7-8cc6-88e0e495b1cb"
      unitRef="usd">2255000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIzLTEtMS0xLTA_7f4e6a90-4113-4aad-89e0-4ecf25af18a3"
      unitRef="usd">1226000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTo1YzhjYjg2MDQwYzg0YzU5YTM5M2NjYTE0ZWU0NGMxOS90YWJsZXJhbmdlOjVjOGNiODYwNDBjODRjNTlhMzkzY2NhMTRlZTQ0YzE5XzIzLTMtMS0xLTA_47940bf5-7330-4ced-a344-b49a9e547e6d"
      unitRef="usd">2196000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzQ3MzE_c3da8ab1-615e-4042-8de1-23b33eae23c6"
      unitRef="usd">864000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzQ3Mzg_89ff48ee-7f8e-46c4-b35b-159f9babe843"
      unitRef="usd">833000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzQ5MzM_8930184a-f2c9-4763-91fb-51d142633bce"
      unitRef="usd">31000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8758a2f6ea4f4877a3355c52d963a658_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzUyMjI_49fc6aba-9069-4edd-a21f-c5f4263d89b3"
      unitRef="usd">2400000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i9be1b4de02944aa881e317723693e477_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzUyMjY_dc7116fb-dc69-44cd-bb18-ffd8ccf90947"
      unitRef="usd">3900000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if8132f157c2a4e22b4c467d61f9c078e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzUyMzM_81a2d699-d245-48b9-ac24-eac1fd269015"
      unitRef="usd">2200000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i2f9c0a94c8b144ce82c5a2e1c8a76a41_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0NzY_a043c6c7-635b-4a7f-8f91-099b330cddd7"
      unitRef="usd">783000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzgxMTY_72744a42-bd4f-43f5-882a-129d5514f731">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits for the last three years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on the lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzItMS0xLTEtMA_c682b0bb-c6e1-458a-85ee-2ade49b72fea"
      unitRef="usd">958000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzItMy0xLTEtMA_d9f3856d-6ddf-4c9d-8f69-2c04b39a0f10"
      unitRef="usd">1052000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i022a2642b16245d083cb80c539e560b3_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzItNS0xLTEtMA_435763e1-72f3-430d-a93c-c3383322f881"
      unitRef="usd">1183000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzMtMS0xLTEtMA_89c5b481-6d47-4ece-9bb7-ab05a88660a4"
      unitRef="usd">53000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzMtMy0xLTEtMA_e78d1595-57b9-4667-af38-5a56ff7e80cc"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzMtNS0xLTEtMA_c05ac5d4-296e-4f2c-93cd-35dbf4da9828"
      unitRef="usd">78000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzQtMS0xLTEtMA_507c1701-b17d-4dcc-b3e6-041a58b59e80"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzQtMy0xLTEtMA_8557c22f-0c1a-4c69-946c-5658baeed9d6"
      unitRef="usd">168000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzQtNS0xLTEtMA_a2f4f422-c0db-4ab6-a074-5f9fb3c5b30d"
      unitRef="usd">234000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzUtMS0xLTEtMA_18f9c1b1-8b2f-444b-9e90-469ed0a32eff"
      unitRef="usd">755000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzUtMy0xLTEtMA_68481664-9ad7-4a27-bb31-520ab19d4fa9"
      unitRef="usd">82000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzUtNS0xLTEtMA_55a469b8-23ca-468c-aa3b-27ec9dd891de"
      unitRef="usd">68000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzYtMS0xLTEtMA_afb1e30f-6c1d-4bfe-8295-36c10bd8d50f"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzYtMy0xLTEtMA_31a45069-6f3e-4007-9324-2d27d2b564c0"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzYtNS0xLTEtMA_867fd56a-8578-486e-b49a-f985dc22b288"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzctMS0xLTEtMA_6d6a2f1e-49f7-4c26-b776-6dd00139d93c"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzctMy0xLTEtMA_e867226f-b8e8-409d-b459-60f35ddc2893"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzctNS0xLTEtMA_af3ebd6f-88bb-45ed-a6a1-20e7ffe8744a"
      unitRef="usd">25000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzgtMS0xLTEtMA_5bffaa07-332a-4649-9797-35f1041ff9fd"
      unitRef="usd">13000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzgtMy0xLTEtMA_b431c0b1-fd42-49c1-81c0-ce7c7b44eda6"
      unitRef="usd">-7000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzgtNS0xLTEtMA_9258a651-afc6-4525-aefe-0fbc7fca39f2"
      unitRef="usd">-5000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzktMS0xLTEtMA_84725607-75e7-4f7b-8082-0ec1adb9e134"
      unitRef="usd">1754000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzktMy0xLTEtMA_6e08b0bd-5251-4ee0-8d64-44035e5c60f0"
      unitRef="usd">958000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90YWJsZTpkYzJkZDdmODBmYWE0Y2JmOGUzYTYwMTFjMDM1ZmY5YS90YWJsZXJhbmdlOmRjMmRkN2Y4MGZhYTRjYmY4ZTNhNjAxMWMwMzVmZjlhXzktNS0xLTEtMA_8116a30f-6408-4d70-b79c-9f5ba7ac2b50"
      unitRef="usd">1052000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTQ5Mzg_debb080b-ccf2-4d46-98b7-f38517922548"
      unitRef="usd">1800000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU3MDA_9e3faf22-d37b-4616-ace9-80259604a412"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzYwODQ_c972d6ab-ad04-4d6a-a00d-b92f3e0e0b52"
      unitRef="usd">-91000000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzU0OTc1NTgxNTQxNDE_44417499-fbab-4c0b-9945-43f24ac91256"
      unitRef="usd">93000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY1NDY_21ed7386-d218-4fc9-a540-d9e513f79c1e"
      unitRef="usd">9000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY1NTM_604aab70-7154-43e5-b642-3e05e00fe898"
      unitRef="usd">23000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY1OTg_04fd6dde-89d3-4f43-aa75-71504f9decc1"
      unitRef="usd">33000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY3MjE_d6574d13-8b6c-47b8-bb16-1cb50dc2d1a3"
      unitRef="usd">101000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4XzY3Mjg_31679ea0-e8fe-4474-b9d3-363eabb45c1c"
      unitRef="usd">91000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNDUvZnJhZzo5MzhmOGM0Mzc5MDg0YjE0YWM0MjUyMzk2OWU3MWMyOC90ZXh0cmVnaW9uOjkzOGY4YzQzNzkwODRiMTRhYzQyNTIzOTY5ZTcxYzI4Xzc1NDk_de76aaec-5ffb-4cd4-831f-5c7b04ccab5c"
      unitRef="usd">6000000000.0</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzQ0MjY_162667b8-e1db-4654-b184-320357ca391a">Redeemable Noncontrolling Interests and Noncontrolling Interests &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, during 2021, 2020, and 2019, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $43 million, $42 million, and $45 million, respectively. All amounts were recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During 2021, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#x2019;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#x2019;s stockholders paid-in capital. During 2020 and 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At March&#160;31, 2021 and 2020, the carrying value of redeemable noncontrolling interests of $1.3 billion and&#160;$1.4 billion, respectively, exceeded the maximum redemption value of $1.2 billion and $1.2 billion, respectively. At March&#160;31, 2021 and 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Appraisal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the Domination Agreement&#x2019;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#x201c;Appraisal Proceedings&#x201d;) with the Stuttgart Regional Court (the &#x201c;Court&#x201d;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#x20ac;0.51 resulting in an adjusted Put Amount of &#x20ac;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#x20ac;22.99, thereby rejecting the lower court&#x2019;s increase, and the recurring compensation shall remain &#x20ac;0.83 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE and Vantage, which were $196 million and $217 million at March&#160;31, 2021 and 2020, respectively, in the Company&#x2019;s Consolidated Balance Sheets. During 2021, 2020, and 2019, respectively, the Company allocated a total of&#160;$156 million,&#160;$178 million, and&#160;$176 million of net income to noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March&#160;31, 2021, 2020, and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of put right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i864d4657d9144642ae333aa935acbc46_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4Nw_17c76198-0e64-4c48-9805-43f8caf7cb74"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i061bc9a2eb8443769ce87eeb86b06600_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4Nw_507640eb-ff32-44e8-810f-6e24e21d158b"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzU0OA_cfad3ffe-b9e6-4054-a411-1a5eb4870e53"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i3bd3e34ab71b46dc924bf5b41dcdda09_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzU1Mg_b225cc62-000d-42e2-839c-182871b1d442"
      unitRef="usd">42000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ie7aa6fa69f9c4cda930b030fe075c224_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzU1OQ_66326eca-efd7-423a-9af8-eab46cda1db3"
      unitRef="usd">45000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="ia5de4bf26a814949a75f192c559706a9_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4Xzk3NQ_18539c34-9dc4-482a-8226-297de4906004"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i3f55ef7798384062876c3372deac9867_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4Xzk3NQ_4a54aa15-1f3d-438e-8fda-38ef8ee89389"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzEwMzg_467851bb-f8c5-48fd-8984-026de3110c8b"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTc3_9946e94f-7b66-485c-a827-1cf192869dda"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTg1_9daf401c-d45c-425d-ab46-7ed0eaaca1be"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i3236582f5f3447ada4545ef44221d9f9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTY5_9946e94f-7b66-485c-a827-1cf192869dda"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i100d57064c664245bb7626bf4404dfc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE0ODQzNDA2OTgxMTkx_691d9bef-f60c-4a25-a773-9e8cb20e22f4"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE5NzU_13dd03d3-9849-4329-b22c-b5f2a9cb7322"
      unitRef="usd">1300000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE5ODI_10818df1-d412-4440-9e6c-e571e085b00e"
      unitRef="usd">1400000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i3f55ef7798384062876c3372deac9867_I20210331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIwMjY_c3e1e427-5df2-4b9e-875b-149b74e75623"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i587fb85617b64a75ac242f855f331d8c_I20200331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIwMzM_e6604e59-67cd-4c43-94dd-12b8d07cb13e"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i3f55ef7798384062876c3372deac9867_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIwODM_1f7e7811-62b3-4a28-b944-00d617b35a7f"
      unitRef="number">0.78</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i587fb85617b64a75ac242f855f331d8c_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzE5MjQxNDUzNDkyNjEw_ff88f493-bd74-4de6-91b4-c513e275bdee"
      unitRef="number">0.77</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <mck:NoncontrollingInterestsPutRightExercisePriceIncrease
      contextRef="idbc43acfc0194bbeb7cffc75f3ccb983_D20180919-20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzI5NDE_4c11a912-ad51-477f-8e62-82d88d7cd99b"
      unitRef="eurPerShare">0.51</mck:NoncontrollingInterestsPutRightExercisePriceIncrease>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i78e6c9a100924eb4a8e0c5dfffff754e_I20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzI5ODM_4f0db03d-88d5-4875-b72e-e7c0d2542fd7"
      unitRef="eurPerShare">23.50</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="ia5de4bf26a814949a75f192c559706a9_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI1Mjg_18539c34-9dc4-482a-8226-297de4906004"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i3f55ef7798384062876c3372deac9867_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI1Mjg_4a54aa15-1f3d-438e-8fda-38ef8ee89389"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i864d4657d9144642ae333aa935acbc46_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI2Mjc_17c76198-0e64-4c48-9805-43f8caf7cb74"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i061bc9a2eb8443769ce87eeb86b06600_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzIxOTkwMjMyNjI2Mjc_507640eb-ff32-44e8-810f-6e24e21d158b"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:MinorityInterest
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM2NzQ_e05c3086-2305-448b-8110-45ebb7c63f58"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM2ODE_e069a09f-f647-4cf5-970f-fc46b0071d64"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i39fe8b1ce4de400880c9ed586d6d03db_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM3OTg_c1aa42e0-9252-4339-b467-58360a30d435"
      unitRef="usd">156000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id1f5f4ec4cae4f6e9da1a608fe5d9874_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4MDI_19748d73-a365-4c40-a724-c82a383ae33a"
      unitRef="usd">178000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i97e4424a4e7440b9964b4ce2f73e59a5_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzM4MDk_8c65e335-3093-46d7-b2b4-224cba494801"
      unitRef="usd">176000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90ZXh0cmVnaW9uOjk1MDQ0MTY4Y2UyNDQ3YzhiZmVkMDAwMzJiMTc3NTQ4XzQ0MzM_ce6d544b-ef21-4643-a128-89bcb8ba198d">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March&#160;31, 2021, 2020, and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of put right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="iae70566f5363452bbc98260415fc04bd_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtMi0xLTEtMjExMjM_13837b4a-544b-4754-99eb-b59a0e639b5e"
      unitRef="usd">253000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="id76995eaf2114e8d988d829663827be2_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtNC0xLTEtMjExMjc_874505a9-1445-4fa9-9866-bd0de6fba5c8"
      unitRef="usd">1459000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItMi0xLTEtMjExMjM_2a0498c1-40bf-49cb-b6a0-87efce928610"
      unitRef="usd">176000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItNC0xLTEtMjExMjc_b799af88-e69f-43fc-980d-aa0c96d69bf1"
      unitRef="usd">45000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtMi0xLTEtMjExMjM_f9857684-57ee-4eac-8ca2-1f4a6f36fa2e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtNC0xLTEtMjExMjc_3c3f96fd-3287-4149-9ad2-90bd3d960fa1"
      unitRef="usd">-66000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzQtNC0xLTEtMjExMjc_6f00561a-0461-44cd-ad7f-ac77d51b2663"
      unitRef="usd">45000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtMi0xLTEtMjExMjM_b4a9ef6e-4c56-4342-b468-722c94f290e0"
      unitRef="usd">184000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtNC0xLTEtMjExMjc_558000e3-7f2a-46d9-8f73-178dc2eb142a"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="idceeec845d0848f3a99c2f9b44226b25_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtMi0xLTEtMjExMjM_1f498caa-cf2c-4ac9-a427-052940fa22bc"
      unitRef="usd">-52000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie2d6dd0a06eb4cb6bf0f17197591851f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtNC0xLTEtMjExMjc_d7b8fcbb-44d4-492e-a748-0b7a7145fefb"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="ia4544e477b1841a4bdb6022ce255ba46_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtMi0xLTEtMA_bc1bda77-e48e-4278-9098-2ca540c0f93a"
      unitRef="usd">193000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ibeede0913be2432eaa8dd89edabc33b8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEtNC0xLTEtMA_56c1059b-fa8a-470c-a663-5af90badd62a"
      unitRef="usd">1393000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItMi0xLTEtMA_f93ae848-8b94-4344-add5-a20fd476e35d"
      unitRef="usd">178000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzItNC0xLTEtMA_6d55a8e5-0d44-4a99-a890-08a019215eb3"
      unitRef="usd">42000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtMi0xLTEtMA_bc4f281a-5ebe-4fe3-91a6-0719cb860f19"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzMtNC0xLTEtMA_8871c238-7b9c-4f95-9d0d-dfc795b7b015"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzQtNC0xLTEtMA_2c7fb98e-c37d-4f38-84b2-955433ab79be"
      unitRef="usd">42000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtMi0xLTEtMA_bf0d9702-85aa-49f9-9270-6954fb973269"
      unitRef="usd">154000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzUtNC0xLTEtMA_519e154a-8706-4aa0-9ede-5e5f367087f8"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i102ec1bcd2a84640806643c3e501f82f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtMi0xLTEtMA_5b73da6f-ce9d-406c-98f9-bd6074e3cf72"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i340398f3d8eb427ab2285890104702d2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzYtNC0xLTEtMA_2ca6cc2c-5cf3-411e-af2a-07fda1e35271"
      unitRef="usd">6000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i8bbfa761b88c4adcbd3850e152c97132_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzctMi0xLTEtMA_b1491f2a-bca3-495b-9f0a-a9cf92fe6963"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i44b9841e941249b08fc5e771cceb886b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzctNC0xLTEtMA_fbfe08b3-4b7c-493c-b86b-bdbe5e27c093"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzgtMi0xLTEtMA_267eacac-bec2-48ea-8b32-a8e749b19621"
      unitRef="usd">156000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzgtNC0xLTEtMA_4ebddac2-562b-4279-b7ec-9e112b498f11"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzktMi0xLTEtMA_320fafe4-af1c-492b-be30-a57e1fa8c807"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzktNC0xLTEtMA_fbb20123-5831-43bb-8c5a-aee224b6635a"
      unitRef="usd">-79000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEwLTQtMS0xLTA_b657be08-87d5-41c5-b28f-1dae33759d6e"
      unitRef="usd">43000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzExLTItMS0xLTA_5c59f65c-7399-4eee-83b5-b9e90b4fa595"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzExLTQtMS0xLTA_2b01be8f-33bf-45ca-b5c2-37e29e57b747"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEyLTQtMS0xLTIwOTkw_63c8e942-37f5-4304-99e6-e184b8a0fdba"
      unitRef="usd">-49000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i31405f59e12c4674922d1c0f5a826abb_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEyLTItMS0xLTA_14f08272-b495-44ea-857d-109fea09ba4d"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="if08832be2ace4c3a8da585d7c87378e0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEyLTQtMS0xLTA_9e981c8f-64d6-4aee-b3c0-798048c4b992"
      unitRef="usd">-3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i3a6bb29286494ed2aec32dd02ab9445e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEzLTItMS0xLTA_0c869186-6f0b-4a3e-accd-3532d8d8541e"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i7f6f0649588c42f2bdddd0e48e3b2d52_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTEvZnJhZzo5NTA0NDE2OGNlMjQ0N2M4YmZlZDAwMDMyYjE3NzU0OC90YWJsZTo0NzI2ZWQ4ODk2ZGI0MjkzODFmYTBkMGI2N2Q4YmY2Yy90YWJsZXJhbmdlOjQ3MjZlZDg4OTZkYjQyOTM4MWZhMGQwYjY3ZDhiZjZjXzEzLTQtMS0xLTA_a206ac2a-cf20-4950-92bf-f92463076909"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzkyMw_9cc67e4c-37fb-4568-9f14-e9836049a88a">Earnings per Common Share&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted loss per common share for the year ended March&#160;31, 2021 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2 million and 3 million of potentially dilutive securities for 2020 and 2019, respectively, were excluded from the computations of diluted net earnings per common share, as they were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Certain computations may reflect rounding adjustments.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzEyMDk0NjI3OTA3NTcy_05dc61f7-00cc-468c-9ce9-8be4ba6cf64e"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzEyMDk0NjI3OTA3NTgw_78b4b2a9-a572-4c89-b576-28f0de2f0d07"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90ZXh0cmVnaW9uOjgzZjY1MWYyYjM5MzRmYzA4YzEzYmNlZmI3ZmEyNWIwXzkyMQ_76f9a234-e6cb-4afc-8f9a-5140c122eaf7">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)Certain computations may reflect rounding adjustments.</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzItMS0xLTEtMA_7ad5e67a-3a29-42fe-9b8e-1ab7b8c9d6bf"
      unitRef="usd">-4339000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzItMy0xLTEtMA_b7ded87f-fcc4-40f9-a53c-07edbffe6216"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzItNS0xLTEtMA_97cd0087-52f4-496a-b6c2-68d5f43674d3"
      unitRef="usd">254000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzMtMS0xLTEtMA_b9d5e71e-c0f8-45d3-b864-89a4f3ef2ea1"
      unitRef="usd">199000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzMtMy0xLTEtMA_8effcdb1-8caf-4e05-9175-db9dd452dca8"
      unitRef="usd">220000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzMtNS0xLTEtMA_0bd174b1-d000-45ad-a990-238dc000c1f1"
      unitRef="usd">221000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzQtMS0xLTEtMA_a1f3c650-aaca-42e3-b89a-9ca9d884f0d9"
      unitRef="usd">-4538000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzQtMy0xLTEtMA_ccf58a36-0100-42d0-9ba7-97674824da97"
      unitRef="usd">906000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzQtNS0xLTEtMA_60bce2a1-629f-42e1-a1c2-8301fb9d7698"
      unitRef="usd">33000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzUtMS0xLTEtMA_4d5bca78-253e-45b0-87a6-5d8a7d26aea5"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzUtMy0xLTEtMA_5cf88de6-71a6-49cc-9659-70f9b6a42871"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzUtNS0xLTEtMA_2148fc4a-064c-400b-8fda-92182b8908f3"
      unitRef="usd">1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzYtMS0xLTEtMA_de7f3781-77f4-4dcc-9715-69a0d3b3e4ed"
      unitRef="usd">-4539000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzYtMy0xLTEtMA_5238b0bc-100c-4a8a-9c0b-709378bc8462"
      unitRef="usd">900000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzYtNS0xLTEtMA_484318c1-302b-4ce4-a759-408e2effd2dd"
      unitRef="usd">34000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzktMS0xLTEtMA_762524df-da76-40e4-952b-dd893ce34d0b"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzktMy0xLTEtMA_20a4344d-160a-48cf-bfea-4e63a82c8fb1"
      unitRef="shares">180600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzktNS0xLTEtMA_47e0a1ec-d8f4-4200-a848-b96b4ecb4619"
      unitRef="shares">196300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEyLTEtMS0xLTA_3fc48b61-69f7-46e6-ada4-23c129b27ab7"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEyLTMtMS0xLTA_decf342f-4a9f-427d-b039-02b797d05724"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEyLTUtMS0xLTA_cccc64df-92ad-4b7f-a102-b1c6e5b3a599"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEzLTEtMS0xLTA_32aa9abd-767e-4105-8aa6-0e46eb9a68d5"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEzLTMtMS0xLTA_f14d444d-bd0c-446c-af6d-0b0ac2f273ae"
      unitRef="shares">181600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzEzLTUtMS0xLTA_6be3b78e-d3e2-4a1d-b90a-16c4fa8b7057"
      unitRef="shares">197300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE3LTEtMS0xLTA_5e75880e-770a-489e-9426-e1cee57417f7"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE3LTMtMS0xLTA_e3986145-40ef-4a72-9e6b-23f6deab1e0c"
      unitRef="usdPerShare">4.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE3LTUtMS0xLTA_99a43231-6877-4e6b-be25-8ecec867f54e"
      unitRef="usdPerShare">0.17</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE4LTEtMS0xLTA_fed113ec-2fb6-4e20-a201-13db5e515634"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE4LTMtMS0xLTA_353636f4-a262-415f-bf69-005540b13bdb"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE4LTUtMS0xLTA_1063c8ef-dbf2-4fd8-b1db-ae79d693d186"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE5LTEtMS0xLTA_7c30861e-d337-4857-9f60-9f7966db727b"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE5LTMtMS0xLTA_620d5ec6-e651-4582-ac4e-2cce35772b5f"
      unitRef="usdPerShare">4.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzE5LTUtMS0xLTA_f3a3509f-17cc-4f36-8b1b-4eea1d002bfe"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIxLTEtMS0xLTA_da86927f-6030-4adc-bc8b-4e9dcd4b5e2c"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIxLTMtMS0xLTA_608ca8c4-64f0-4935-b635-46fc2e2070d6"
      unitRef="usdPerShare">5.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIxLTUtMS0xLTA_9e1b6cae-987a-410c-aee9-4f3028f49a01"
      unitRef="usdPerShare">0.17</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIyLTEtMS0xLTA_95d82939-b64b-48aa-909b-4b6ae3a2763e"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIyLTMtMS0xLTA_a575818e-1fde-4887-80bb-31c08567cae7"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIyLTUtMS0xLTA_0fcfb3d8-64d7-413c-923b-ecd770774b5d"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIzLTEtMS0xLTA_d1e8f89f-eba5-46bc-a6bd-26927d028294"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIzLTMtMS0xLTA_c39c25cb-c061-49b6-9ecf-4becb2c9eb12"
      unitRef="usdPerShare">4.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNTcvZnJhZzo4M2Y2NTFmMmIzOTM0ZmMwOGMxM2JjZWZiN2ZhMjViMC90YWJsZTo5MTQ2ZDc3ZjM5OTc0YmQ2YjU1ZjIzN2JkMWVmNzBkOC90YWJsZXJhbmdlOjkxNDZkNzdmMzk5NzRiZDZiNTVmMjM3YmQxZWY3MGQ4XzIzLTUtMS0xLTA_ecd8f7d7-3dab-46af-8613-5826fe21a60b"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:LessorDirectFinancingLeasesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzQ_d191ecde-c480-4400-af4d-bb6e7865a328">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#x2019;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#x2019;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated statements of operations and cash flows.&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3"&gt;one&lt;/span&gt; to five years. Most real property leases contain renewal options (typically for&#160;five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under operating leases was $576 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $217 million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db"&gt;five&lt;/span&gt; to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $298 million and $272 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorDirectFinancingLeasesTextBlock>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzU_dbfbcb2a-d8bb-4e54-8a01-4bd0fb872590">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#x2019;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#x2019;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated statements of operations and cash flows.&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3"&gt;one&lt;/span&gt; to five years. Most real property leases contain renewal options (typically for&#160;five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under operating leases was $576 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $217 million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db"&gt;five&lt;/span&gt; to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $298 million and $272 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzY_23a342e2-6635-4e5c-b03e-a6d56fe8eb49">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#x2019;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#x2019;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated statements of operations and cash flows.&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3"&gt;one&lt;/span&gt; to five years. Most real property leases contain renewal options (typically for&#160;five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under operating leases was $576 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $217 million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db"&gt;five&lt;/span&gt; to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $298 million and $272 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="i0d9d3f777851405d93c2e2401895ce61_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjc5MTM_1e0dfbd6-88cb-498f-b671-848392341d8d"
      unitRef="usd">2200000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0d9d3f777851405d93c2e2401895ce61_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjc5NDk_0928a2f0-de5a-4edb-83fe-0c46314098d8"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i892cb0c916c746b5913bcd1ffb140a80_I20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjgwMjI_8dd2ece1-5c7c-43f0-ad81-d0299785d2e7"
      unitRef="usd">69000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:OperatingLeaseImpairmentLossNetOfTax
      contextRef="ifc7244d83910406eaec9d88c79969937_D20190401-20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjk3Mzg_432591eb-0116-4514-9fe1-f715701258f9"
      unitRef="usd">89000000</mck:OperatingLeaseImpairmentLossNetOfTax>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i655f79d1e2274f738d115518f92c4d45_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQzNQ_06240fa9-6904-4d3e-877d-870e927bf52f">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i9cfec5575dbf43a9a693ee576ed1162d_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzE5NzkxMjA5MzE0MjU5_2388a906-ac2f-47ca-9ab0-167c73c63115">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="if42165365f8c4ba0b45f5d4a12bda439_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzE5NzkxMjA5MzE0MjYw_44dd6c3d-dd63-4709-9abe-86f5058c6038">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <mck:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzk_67ed1b26-86de-43d0-aa9e-315a257dca38">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzMtMS0xLTEtMA_62337c08-e880-47d0-8f20-55a5c1ba7ad6"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzMtMi0xLTEtNjkxMg_10c8b385-b4fb-4889-8187-e162dfa82318"
      unitRef="usd">1886000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzUtMS0xLTEtMA_c62977cb-5ceb-4397-a1dd-1c1004ffa69e"
      unitRef="usd">390000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzUtMi0xLTEtNjkxNQ_6cdb2905-3337-4c5a-a7af-c0b5de9ac98b"
      unitRef="usd">354000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzYtMS0xLTEtMA_10825e8c-8f9b-45b9-8918-941265e88d6c"
      unitRef="usd">1867000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzYtMi0xLTEtNjkyNw_02cf211d-9cd3-4ede-b395-20104c125809"
      unitRef="usd">1660000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzctMS0xLTEtMA_d5ccf89a-5093-4af8-8e8b-48a7432312ff"
      unitRef="usd">2257000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzctMi0xLTEtNjkxOQ_108c85a7-fdb5-47d2-bfab-b250f5cf8f06"
      unitRef="usd">2014000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEwLTEtMS0xLTA_4405f8ec-3b00-4db7-805e-f13a9f857407"
      unitRef="usd">237000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEwLTItMS0xLTY5MDI_77cdcf45-8d72-4383-83e6-2c6743e78edb"
      unitRef="usd">180000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEyLTEtMS0xLTA_6b1543b1-df40-4ae6-827b-1fb2050923ff"
      unitRef="usd">22000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEyLTItMS0xLTY5MDI_988204b2-5195-404f-9d69-9cb742352337"
      unitRef="usd">15000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEzLTEtMS0xLTA_28d5b570-82bf-4215-beef-195d907275dc"
      unitRef="usd">206000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzEzLTItMS0xLTY5MDI_5117484d-1d08-457f-9331-07365925eb9a"
      unitRef="usd">151000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE0LTEtMS0xLTA_68745a88-d10f-4b30-9063-0c3620921ba9"
      unitRef="usd">228000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE0LTItMS0xLTY5MDI_5e9ae0b3-6370-4aeb-97c3-6e6859b6b27e"
      unitRef="usd">166000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE3LTEtMS0xLTA_436140f7-bfe8-4c4c-9ea4-25a2ae006dc1">P7Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE3LTItMS0xLTY5MDI_cdd2ed1b-2aa2-4f3d-8d05-82968cf6fd5b">P7Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE4LTEtMS0xLTA_e83c5254-315b-40ff-a5c4-ce2e44528d04">P10Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzE4LTItMS0xLTY5MDI_5ec59b33-1578-4e20-971f-6d0f68d7c25c">P12Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIxLTEtMS0xLTA_76920163-9c26-4bf5-afd8-335e5debb4b1"
      unitRef="number">0.0253</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIxLTItMS0xLTY5MDI_c2407319-870c-4c1f-a898-4c4f098fb5aa"
      unitRef="number">0.0303</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIyLTEtMS0xLTA_5d25ae92-ad3c-4a7d-a949-8d40dd044734"
      unitRef="number">0.0271</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo1YmM0NDJhNTU5Y2M0MjI4YmEwNDY2ZjFmOWM4OTgyYy90YWJsZXJhbmdlOjViYzQ0MmE1NTljYzQyMjhiYTA0NjZmMWY5Yzg5ODJjXzIyLTItMS0xLTY5MDI_e2cfbbef-3e22-42cb-ad52-f76aa609e48e"
      unitRef="number">0.0286</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwODM_951390dc-f0ad-457e-bbfa-e4135ec24c29">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;.</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:ShortTermLeaseCost
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEtMS0xLTEtNjgyOA_0c26bc55-8fe0-4fa5-9749-57f2c2fa7767"
      unitRef="usd">32000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEtMS0xLTEtMA_4740930b-3703-4236-9ac1-7de8f939598a"
      unitRef="usd">29000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzItMS0xLTEtNjgyOA_61a4c9ae-e357-49b9-a35d-62b8a44a64e3"
      unitRef="usd">465000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzItMS0xLTEtMA_b35cf367-4f0d-4612-b228-e5051776c628"
      unitRef="usd">459000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzUtMS0xLTEtNjgzMg_fb86007b-ae08-4468-8b3e-efda4b0bef8b"
      unitRef="usd">23000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzUtMS0xLTEtMA_056af442-3cac-4029-aca9-5d095d4056b7"
      unitRef="usd">14000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzYtMS0xLTEtNjgzMg_2fe0ec8d-f994-4ccc-bd10-e5883d81e512"
      unitRef="usd">6000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzYtMS0xLTEtMA_3f3c6e47-0cf7-4b05-8d36-0d209a32194e"
      unitRef="usd">5000000</us-gaap:FinanceLeaseInterestExpense>
    <mck:FinanceLeaseCost
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzctMS0xLTEtNjgzMg_a083e332-5397-4134-8048-3005da78b983"
      unitRef="usd">29000000</mck:FinanceLeaseCost>
    <mck:FinanceLeaseCost
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzctMS0xLTEtMA_511b122a-7437-4d10-9657-3606ce0ac743"
      unitRef="usd">19000000</mck:FinanceLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzktMS0xLTEtNjg0MA_ce57d6f2-a660-448f-9049-85cdbd8f40b5"
      unitRef="usd">125000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzktMS0xLTEtMA_6986e584-6979-4d3e-b1d6-84951cfbb18b"
      unitRef="usd">125000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEwLTEtMS0xLTY4NDA_a3ae30db-5bee-4695-abad-0f02e0d89081"
      unitRef="usd">36000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzEwLTEtMS0xLTA_a15f811c-9ce6-42af-9320-7e8968a92b80"
      unitRef="usd">33000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzExLTEtMS0xLTY4NDA_2d213685-9e66-4663-a7c7-ab0a44df001b"
      unitRef="usd">615000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTpiYTllYTExMmM1NDc0NTI2YTM1MmMyMTgzMWRiNWFmNC90YWJsZXJhbmdlOmJhOWVhMTEyYzU0NzQ1MjZhMzUyYzIxODMxZGI1YWY0XzExLTEtMS0xLTA_665cbc4d-e6fa-47ab-86cd-1f80ad0c405c"
      unitRef="usd">599000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzI2MzA_f7c6e650-5ce1-485c-925d-7fe102f220f6"
      unitRef="usd">576000000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasePayments
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzItMS0xLTEtNzAwMg_d6442e30-c82e-4a65-b161-70ec12739a56"
      unitRef="usd">362000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzItMS0xLTEtMA_ec58cd6d-2331-49fa-9dc0-67ce260971be"
      unitRef="usd">377000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzMtMS0xLTEtNzAwMg_a42e2dd6-89d1-4b99-91e7-1be481879c49"
      unitRef="usd">4000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzMtMS0xLTEtMA_8fe38022-4631-4791-9150-bb7de87934b7"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzQtMS0xLTEtNzAwMg_de5d2027-8a1d-44c1-8da8-ef859e53f3b8"
      unitRef="usd">31000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzQtMS0xLTEtMA_074b235c-a748-430e-8814-f027e7097989"
      unitRef="usd">18000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzYtMS0xLTEtNzAwNw_828e23ca-c284-4007-89f2-07ecc9ff8c34"
      unitRef="usd">321000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzYtMS0xLTEtMA_480fdc2f-4da2-4cba-ba0b-d6b5bd28fd41"
      unitRef="usd">2378000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzctMS0xLTEtNzAwNw_6d5a950b-5f80-4c4b-9dd1-fc037d3b910e"
      unitRef="usd">75000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTplNmRiM2FmYzExY2U0ZjY5ODkxNzlhYTczZDE4ODQ3ZC90YWJsZXJhbmdlOmU2ZGIzYWZjMTFjZTRmNjk4OTE3OWFhNzNkMTg4NDdkXzctMS0xLTEtMA_e0582127-51e2-4f2d-bd36-e4b2caa27294"
      unitRef="usd">166000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0d9d3f777851405d93c2e2401895ce61_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzI3NDg3NzkwNzY4MTc_a0fbc20c-810c-4c01-8e86-5842909b47c9"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwNzI_8879452c-3a08-4e0f-b528-dff0ffea9932">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzQwODU_4b35c5ca-b13f-465c-8bd6-7df5e67a59b2">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzItMS0xLTEtMA_942f0c7c-547e-41b5-b92e-3025162f2bed"
      unitRef="usd">433000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzItMy0xLTEtMA_6a57e3e8-8ae9-4c94-8b2c-dd21e669f8f1"
      unitRef="usd">28000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <mck:LeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzItNS0xLTEtMA_7558c6b1-b4d2-4e88-9c6e-c4ec137f38f6"
      unitRef="usd">461000000</mck:LeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzMtMS0xLTEtMA_c33371a6-d480-483e-a8aa-f963cb4963c2"
      unitRef="usd">401000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzMtMy0xLTEtMA_c8fa8ccc-ef4f-4230-b3ae-5f3efdb22075"
      unitRef="usd">28000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <mck:LeaseLiabilityPaymentsDueYearTwo
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzMtNS0xLTEtMA_8cc07259-8d5e-4e27-ba00-a01bf64f5fa4"
      unitRef="usd">429000000</mck:LeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzQtMS0xLTEtMA_d7ca4e85-4762-44cb-a0be-4cfa2be05c82"
      unitRef="usd">332000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzQtMy0xLTEtMA_6c4fdd46-0353-4be1-8b9b-2e8a9d8c65f1"
      unitRef="usd">27000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <mck:LeaseLiabilityPaymentsDueYearThree
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzQtNS0xLTEtMA_aa475417-4961-4d9c-a007-245caeb50804"
      unitRef="usd">359000000</mck:LeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzUtMS0xLTEtMA_24458042-d6f8-4820-b9f3-c0430aa51e7e"
      unitRef="usd">283000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzUtMy0xLTEtMA_9cf5f783-e29f-4e7f-b3a8-1462d66a0e61"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <mck:LeaseLiabilityPaymentsDueYearFour
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzUtNS0xLTEtMA_05e233ba-26cd-4c86-9b2c-5f37a1219c86"
      unitRef="usd">308000000</mck:LeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzYtMS0xLTEtMA_c608db1e-b096-43bd-a280-0f2a3edfd4b2"
      unitRef="usd">233000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzYtMy0xLTEtMA_03944273-2c44-43cb-ac1f-cd59b9fda581"
      unitRef="usd">24000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <mck:LeaseLiabilityPaymentsDueYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzYtNS0xLTEtMA_0d8da7d4-581f-4cd5-8d39-b284fb0802bc"
      unitRef="usd">257000000</mck:LeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzctMS0xLTEtMA_33cc667e-8513-419b-aafd-09a72d35d2f6"
      unitRef="usd">823000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzctMy0xLTEtMA_25af219f-db13-446e-9033-d77924604ee9"
      unitRef="usd">130000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <mck:LeaseLiabilityPaymentsDueAfterYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzctNS0xLTEtMA_1c25af3c-66cd-4b1b-be3a-5994fc25225b"
      unitRef="usd">953000000</mck:LeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzgtMS0xLTEtMA_f66a2904-46e0-4a55-822a-5a93a047d7ee"
      unitRef="usd">2505000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzgtMy0xLTEtMA_26e81402-9d2e-428c-bd3c-fd2e4277349c"
      unitRef="usd">262000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <mck:LeaseLiabilityPaymentsDue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzgtNS0xLTEtMA_c884af83-ea90-420a-9c42-6c86f695dba4"
      unitRef="usd">2767000000</mck:LeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzktMS0xLTEtMA_4afb7cb2-4f9d-450e-a8b6-440c39956935"
      unitRef="usd">248000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzktMy0xLTEtMA_31438157-ebcb-4b15-abee-146b93db95dc"
      unitRef="usd">34000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <mck:LeaseLiabilityUndiscountedExcessAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzktNS0xLTEtMA_3a17d382-6dc7-4d63-ba8d-b6b3970e9bc7"
      unitRef="usd">282000000</mck:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzEwLTEtMS0xLTA_55e7f36b-f711-4dda-a6a5-4b16ec3ae65a"
      unitRef="usd">2257000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzEwLTMtMS0xLTA_f3b30242-fe90-4c2f-8c37-b35c3b42750f"
      unitRef="usd">228000000</us-gaap:FinanceLeaseLiability>
    <mck:LeaseLiability
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90YWJsZTo0N2JjN2VmNjljOWI0MjY3YWJiOTczYWNlYTc4MjgzOC90YWJsZXJhbmdlOjQ3YmM3ZWY2OWM5YjQyNjdhYmI5NzNhY2VhNzgyODM4XzEwLTUtMS0xLTA_18a53e1b-255f-4be8-938d-85671930e2c3"
      unitRef="usd">2485000000</mck:LeaseLiability>
    <mck:LessorLeasePaymentstobeReceived
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzI5OTk_c114a6ff-2329-4807-baf1-e3dc0ab9e60a"
      unitRef="usd">202000000</mck:LessorLeasePaymentstobeReceived>
    <mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMxODA_6b264863-db61-4e14-b761-3299deb38750"
      unitRef="usd">217000000</mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ib50261dbb728457db6b2202486d75ef0_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMjU_bc2ee05e-b24e-47f5-baf9-98997c260afb">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzIxOTkwMjMyNjI2MTY_62eb89c7-686c-4f38-a84d-48aee2043467"
      unitRef="usd">298000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzM5MjY_1fb42691-61cb-483d-9253-2d186eca56f2"
      unitRef="usd">272000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzM5OTE_51598778-4f0a-4894-b208-b3dd6348a561">P7Y</mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm>
    <mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzM5OTE_79876216-8d50-4fc0-b9ed-a10d6b65b2d9">P7Y</mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzgwODE_bfdca80b-b195-43fd-aebe-bc52cdeb049a">Goodwill and Intangible Assets, Net &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other changes/disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other changes/disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment on an annual basis each year and at an interim date, if indicators of potential impairment exist. On October 1, 2019, the Company voluntarily changed its annual goodwill impairment testing date from January&#160;1 to October 1 to better align with the timing of the Company&#x2019;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from October 1, 2019 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#x2019;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the reporting units was determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#x2019;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#x2019;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#x2019;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#x2019;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill charges listed below were recorded in &#x201c;Goodwill impairment charges&#x201d; in the Consolidated Statements of Operations. Most of the goodwill impairment for these reporting units were generally not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. At March&#160;31, 2021, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment testing performed in 2020 did not indicate any material impairment of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment testing performed in 2019 resulted in the following impairment charges:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reporting Unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Terminal Growth Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill Impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;As described above, the Company implemented its new segment reporting structure in the second quarter of 2021 and its European Pharmaceutical Solutions segment and its Rexall Health business in Canada became part of the International segment. Amounts included herein were previously included within the former European Pharmaceutical Solutions segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Represents pre-tax and after-tax amounts, except for an aggregate $20 million of tax charges related to the March 2019 Retail Pharmacy impairment. Total goodwill impairment for 2019 also included $21 million related to the Company&#x2019;s Rexall Health business, within the International segment, recorded in the third quarter of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Prior to implementing its new segment reporting structure in the first quarter of 2019, the Company&#x2019;s European operations were considered a single reporting unit. Following the change in reportable segments, its European Pharmaceutical Solutions segment was divided into two distinct reporting units, Retail Pharmacy (&#x201c;RP&#x201d;), formerly Consumer Solutions, and Pharmaceutical Distribution (&#x201c;PD&#x201d;), formerly Pharmacy Solutions, for the purposes of goodwill impairment testing. This change required performance of a goodwill impairment test for these two new reporting units which resulted in a goodwill impairment charge as PD&#x2019;s estimated fair value was lower than its reassigned carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Both RP and PD projected a decline in the estimated future cash flows primarily triggered by U.K. government actions which were announced on June 29, 2018. An interim goodwill impairment test for these reporting units identified that their carrying values exceeded their estimated fair value and resulted in an impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;As a result of the annual goodwill impairment test, the carrying values of the PD and RP reporting units exceeded their estimated fair value which required the Company to record impairment charges for the reporting units. These additional impairments were primarily due to declines in the reporting units&#x2019; estimated future cash flows and the selection of higher discount rates. The declines in estimated future cash flows were primarily attributed to additional government reimbursement reductions and competitive pressures within the U.K. The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate. As of March&#160;31, 2019 the entire remaining goodwill balances of both reporting units were impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 17, &#x201c;Fair Value Measurements,&#x201d; for more information on these nonrecurring fair value measurements. As of March&#160;31, 2021 and 2020, accumulated goodwill impairment losses in the Company&#x2019;s International segment were $3.6 billion and $3.5 billion, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets was $422 million, $462 million, and $485 million for 2021, 2020, and 2019, respectively. Estimated annual amortization expense of intangible assets is as follows: $370 million, $270 million, $259 million, $253 million, and $220 million for 2022 through 2026, and $1.5 billion thereafter. All intangible assets were subject to amortization as of March&#160;31,&#160;2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges,&#x201d; for more information on intangible asset impairment charges recorded in 2021, 2020, and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzgwODI_7205a079-d904-4005-869a-e81aa06bd35d">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other changes/disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other changes/disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment testing performed in 2019 resulted in the following impairment charges:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reporting Unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Terminal Growth Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill Impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmaceutical Distribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;As described above, the Company implemented its new segment reporting structure in the second quarter of 2021 and its European Pharmaceutical Solutions segment and its Rexall Health business in Canada became part of the International segment. Amounts included herein were previously included within the former European Pharmaceutical Solutions segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Represents pre-tax and after-tax amounts, except for an aggregate $20 million of tax charges related to the March 2019 Retail Pharmacy impairment. Total goodwill impairment for 2019 also included $21 million related to the Company&#x2019;s Rexall Health business, within the International segment, recorded in the third quarter of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Prior to implementing its new segment reporting structure in the first quarter of 2019, the Company&#x2019;s European operations were considered a single reporting unit. Following the change in reportable segments, its European Pharmaceutical Solutions segment was divided into two distinct reporting units, Retail Pharmacy (&#x201c;RP&#x201d;), formerly Consumer Solutions, and Pharmaceutical Distribution (&#x201c;PD&#x201d;), formerly Pharmacy Solutions, for the purposes of goodwill impairment testing. This change required performance of a goodwill impairment test for these two new reporting units which resulted in a goodwill impairment charge as PD&#x2019;s estimated fair value was lower than its reassigned carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Both RP and PD projected a decline in the estimated future cash flows primarily triggered by U.K. government actions which were announced on June 29, 2018. An interim goodwill impairment test for these reporting units identified that their carrying values exceeded their estimated fair value and resulted in an impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;As a result of the annual goodwill impairment test, the carrying values of the PD and RP reporting units exceeded their estimated fair value which required the Company to record impairment charges for the reporting units. These additional impairments were primarily due to declines in the reporting units&#x2019; estimated future cash flows and the selection of higher discount rates. The declines in estimated future cash flows were primarily attributed to additional government reimbursement reductions and competitive pressures within the U.K. The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate. As of March&#160;31, 2019 the entire remaining goodwill balances of both reporting units were impaired.&lt;/span&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i064068b262474876b81e803f24785e0b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtMS0xLTEtMA_7f224842-e670-4834-994f-b6342ab81e93"
      unitRef="usd">3935000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5ccd5ab037e84574a05e7c5dc7569e59_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtMy0xLTEtMA_d4ade6e8-0ede-4284-bd96-44b348932e15"
      unitRef="usd">1446000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i13ccd1d1dd0a411aa2bfd0ef422868fb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtNS0xLTEtMA_98bd0c53-17d1-4df4-9b9d-907b4c014294"
      unitRef="usd">2451000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i364113e13bbf4a32a9613f4ab676e5a9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtNy0xLTEtMA_509d5cad-b6a0-473e-90c0-1a0ffe2097fa"
      unitRef="usd">1526000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEtOS0xLTEtMA_474ac4fa-3645-4f1b-9bf6-112ffc0cefbe"
      unitRef="usd">9358000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItMS0xLTEtMA_ce9f310a-2a19-49bc-a208-c880145fff7f"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItMy0xLTEtMA_25195a5b-794e-4b45-a53d-cec5e651c9ff"
      unitRef="usd">62000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItNS0xLTEtMA_4c954b47-f3cc-4aa0-8037-03ae5ca1609c"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItNy0xLTEtMA_962cffff-a195-4782-b2b9-ed49d4233e56"
      unitRef="usd">14000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzItOS0xLTEtMA_79fe1135-6dbe-45bf-bcf2-6385283d2eed"
      unitRef="usd">76000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtMS0xLTEtMA_7c9bac9c-e58d-4306-9da7-ba6f6e1d8674"
      unitRef="usd">1000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtMy0xLTEtMA_d52cbbd3-c013-4842-a04d-991e2e9c10b2"
      unitRef="usd">4000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtNS0xLTEtMA_5499f1b3-d47e-4a1b-96ad-cb3bbffd7532"
      unitRef="usd">7000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtNy0xLTEtMA_e90c9bad-4c23-425c-9a70-247e6f6ac324"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzMtOS0xLTEtMA_e133df61-eb26-4b60-b258-cbba10df6146"
      unitRef="usd">12000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtMS0xLTEtMA_ef713b0d-f0ea-401e-9c8a-f13063be7a60"
      unitRef="usd">-1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtMy0xLTEtMTYwMjc_333338b0-84da-4962-8d24-6cb669e3fcd1"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtNS0xLTEtMA_6c99e257-8aea-4e64-9140-4cf0163018de"
      unitRef="usd">-5000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtNy0xLTEtMA_11aa5173-fe19-4b3c-93c4-06deb387f2d5"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzQtOS0xLTEtMA_c082686c-383a-42cb-b5a7-ed5529d28e43"
      unitRef="usd">-6000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtMS0xLTEtMA_d804c622-1dbf-4623-90e2-b6fef17e1b96"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtMy0xLTEtMA_dea0c8a7-3bdf-4e28-acde-fe4e529ebc34"
      unitRef="usd">2000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtNS0xLTEtMA_18a17a2c-2c6b-481c-b20c-66a1ba767bca"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtNy0xLTEtMA_d71d74ab-5298-4cec-8982-cd071f3688af"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzUtOS0xLTEtMA_921cde17-52f1-410e-b1d8-957198e830a8"
      unitRef="usd">2000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtMS0xLTEtMA_d8fd66b3-0d5e-462b-b2a2-763e6fff73b2"
      unitRef="usd">-11000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtMy0xLTEtMA_5ad0136c-db61-4292-b554-ad75fb13df20"
      unitRef="usd">-67000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtNS0xLTEtMA_7c255a4d-c689-44af-88aa-5f5a00833996"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtNy0xLTEtMA_52a2e67e-4bf0-466f-b4f5-c2ec0264ce9e"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzYtOS0xLTEtMA_cd95c18d-eb23-44aa-963c-19995d12c889"
      unitRef="usd">-78000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i8a47ac4fb69943f8aab869a358429d1f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctMS0xLTEtMA_728140a2-3c03-45da-8309-8dd35b8224c9"
      unitRef="usd">3924000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i30c8074ac9194cc5b11720dc788c0285_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctMy0xLTEtMA_bdf7793a-e8bf-4dcc-922e-b77aafff2407"
      unitRef="usd">1443000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idf0f12f556ae4391817c093cf4fca373_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctNS0xLTEtMA_f607ec56-1f6d-4a19-a5e3-faebdfae8a53"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iab002e4a10964495a81aca3a26ea2afc_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctNy0xLTEtMA_bc39b5ce-4725-43f2-9475-78372c829047"
      unitRef="usd">1540000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzctOS0xLTEtMA_046a5541-3ba4-4771-af5e-9a80f962b38b"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtMS0xLTEtMA_42315645-a4cf-40d5-8b16-6e9ae0fbe32d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtMy0xLTEtMA_393e3dcc-cba1-4192-91b2-f802a3209fef"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtNS0xLTEtMA_8bfc5ec8-1f5d-4acc-a821-b063664bb959"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtNy0xLTEtMA_81ad3f75-91a8-4472-9400-1194570c4cfc"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzgtOS0xLTEtMA_6c80e9f8-b0be-4195-ac54-ba5b168e73a1"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktMS0xLTEtMA_108eeabc-9595-4364-a17e-fbb31a963935"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktMy0xLTEtMA_05850d2b-6509-4986-b0e2-1435c9d5ecf1"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktNS0xLTEtMA_84503075-a7d0-47cd-85e8-e0c8e0af5776"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktNy0xLTEtMA_ce64117d-7821-4905-a398-b84002c72d3a"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzktOS0xLTEtMA_332660c3-b262-452a-b684-5745a5cf6cbf"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTEtMS0xLTA_2dfe9610-a450-4bfa-a557-5cf266b84c6a"
      unitRef="usd">-1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTMtMS0xLTA_8cd8d61f-f51c-47a3-83e7-803af079058e"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTUtMS0xLTA_e880e06a-f02f-4376-94b3-824db88bec09"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTctMS0xLTA_4142d4ad-5b82-40fd-ab86-dc8b0d28c8ea"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEwLTktMS0xLTA_eda46a5e-3424-4da2-a21a-67d027f11433"
      unitRef="usd">-1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTEtMS0xLTA_5b096890-92a4-4d67-a2b3-e1f5ffd1dffb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTMtMS0xLTA_a471679f-ea07-4d6b-ac02-2692a0033bf4"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTUtMS0xLTA_4ce7fefd-7c0a-4a07-86b3-179fa7f1d8d0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTctMS0xLTA_dd4df386-8e2c-4d77-ab95-9b172fcc7809"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzExLTktMS0xLTA_87284ff0-95b9-4229-bd08-fe9a9e1f0fdb"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTEtMS0xLTA_e8d6020e-3174-4f4a-ab14-773117079242"
      unitRef="usd">40000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTMtMS0xLTA_04a963ca-6220-4364-9c3f-d4febfb723a3"
      unitRef="usd">156000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTUtMS0xLTA_734f048a-f64d-4770-b3ac-2af33fe67ecd"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTctMS0xLTA_ff9c345d-6916-44c5-84d3-5504dea67a55"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEyLTktMS0xLTA_09d0efec-cc0c-4c92-85f0-f33cc5b839cc"
      unitRef="usd">196000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ib938fa6a5d404ab8951cd038035b8ff7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTEtMS0xLTA_f4f55b27-361a-4d1f-9b9f-025c28ca98f4"
      unitRef="usd">3963000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie5a85046f59343e3874040608ed73655_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTMtMS0xLTA_d0756f2b-3297-42dc-badd-498a1bbb89ec"
      unitRef="usd">1535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9d099d3619b4467b8a30ab61cc9c0d8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTUtMS0xLTA_df821092-9adb-44b8-9d62-7075bbd6485d"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i797fe852990443559f1b76029e7fcf9c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTctMS0xLTA_cdebd48c-7930-408a-a5c7-488d69f69288"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTplZGRjMTIzYTg3MTk0NzliODFhZDZjMTM3Y2I2OTU2NS90YWJsZXJhbmdlOmVkZGMxMjNhODcxOTQ3OWI4MWFkNmMxMzdjYjY5NTY1XzEzLTktMS0xLTA_e30b2132-7d5c-4a58-99cf-8a1a5cf4851f"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:NumberOfReportableSegments
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzU0OTc1NTgxNTExNDE_9acdf32e-8fef-415c-a38a-9860d97cdfd5"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id273e9fcef44447d91bf8cd1482cdbf9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzU0OTc1NTgxNTExNDg_582931f1-d2b5-49af-9be5-7f5c76fd0587"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="iccdd71b92ffa4cb2b159c9a557fb6ba8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzE5NzkxMjA5MzE1MTgz_1903f39b-0ebd-4af8-a887-6da3f59d7b13"
      unitRef="usd">0</us-gaap:Goodwill>
    <mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate
      contextRef="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzItNi0xLTEtMA_a1e9f54a-1fd1-4993-957e-5522a505f017"
      unitRef="number">0.080</mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate>
    <mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate
      contextRef="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzItOC0xLTEtMA_7441f84a-b104-418b-b5c5-34238235e206"
      unitRef="number">0.0125</mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzItMTAtMS0xLTA_3b95ee24-5826-4150-80eb-9f5b319ffd32"
      unitRef="usd">238000000</us-gaap:GoodwillImpairmentLoss>
    <mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate
      contextRef="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzMtNi0xLTEtMA_c328de35-c0aa-4577-90e6-77580c4a8fdd"
      unitRef="number">0.085</mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate>
    <mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate
      contextRef="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzMtOC0xLTEtMA_bb0f05fa-24e8-401b-bc79-2ade963aa761"
      unitRef="number">0.0125</mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if3f79383b2a040e7b26068ace21afdd2_D20180401-20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzMtMTAtMS0xLTA_be2c560f-ece1-4e0f-8e4c-3c8153f0634d"
      unitRef="usd">251000000</us-gaap:GoodwillImpairmentLoss>
    <mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate
      contextRef="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzQtNi0xLTEtMA_c0a121d4-fe6a-4516-a6a5-7c6d002c303a"
      unitRef="number">0.080</mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate>
    <mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate
      contextRef="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzQtOC0xLTEtMA_ddaf2317-383b-4f2a-ad69-e18337211550"
      unitRef="number">0.0125</mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i58b600b3310d490991e3a1f093a3b471_D20180401-20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzQtMTAtMS0xLTA_b20829ef-3f14-4817-821b-c62a16155d7c"
      unitRef="usd">81000000</us-gaap:GoodwillImpairmentLoss>
    <mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate
      contextRef="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzUtNi0xLTEtMA_37312ddf-81cb-4f47-af0d-4d5388eb7814"
      unitRef="number">0.100</mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate>
    <mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate
      contextRef="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzUtOC0xLTEtMA_95a5ec4b-0aa4-4428-9049-909c169e3092"
      unitRef="number">0.0125</mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if2b62b2546f842abaa8ccca05983b1a4_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzUtMTAtMS0xLTA_53d6a104-edcb-4923-b984-5ec2e2ecadee"
      unitRef="usd">465000000</us-gaap:GoodwillImpairmentLoss>
    <mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate
      contextRef="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzYtNi0xLTEtMA_e1d3a01e-6921-4763-819b-1b22ca343d35"
      unitRef="number">0.090</mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate>
    <mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate
      contextRef="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzYtOC0xLTEtMA_a86c1422-19f9-4a6c-8976-f893908d7d1c"
      unitRef="number">0.0125</mck:GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id19129a0706c40f791417ad05d2d1dd4_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzYtMTAtMS0xLTA_0c38d211-cdd8-498c-b2b3-cfa5df04f8e4"
      unitRef="usd">741000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTphNjM4YjdlNDZjZDk0MTc3OTRmM2Y2NTAyYzUzOWM3MC90YWJsZXJhbmdlOmE2MzhiN2U0NmNkOTQxNzc5NGYzZjY1MDJjNTM5YzcwXzctMTAtMS0xLTA_63ab2625-2196-4d49-a0e5-c87385d2fd1b"
      unitRef="usd">1776000000</us-gaap:GoodwillImpairmentLoss>
    <mck:GoodwillImpairmentLossTax
      contextRef="i1f79d90a93144c60981f623c356fc6bf_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzMyMTI_d64be552-272c-438c-821d-69957516a758"
      unitRef="usd">20000000</mck:GoodwillImpairmentLossTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia1bdeaded28d4c20b8bc6c14bf14a03b_D20181001-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzMzMzM_b83088f8-e20c-4ba2-8f52-f29a3111772c"
      unitRef="usd">21000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:NumberOfReportingUnits
      contextRef="i51bc045598984a19b5941cc09fe4a679_D20180401-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzM3MDc_a2fb3b60-acfa-4041-aa72-fb5a5dea9d70"
      unitRef="reportingunit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="i51bc045598984a19b5941cc09fe4a679_D20180401-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzM5ODA_a2fb3b60-acfa-4041-aa72-fb5a5dea9d70"
      unitRef="reportingunit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ie5a85046f59343e3874040608ed73655_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzczODQ_a6a51858-617b-4480-8fc7-308e6ab30675"
      unitRef="usd">3600000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i30c8074ac9194cc5b11720dc788c0285_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc1MTc_a2027d90-c80b-46d5-be07-a1a0fcfb7aaf"
      unitRef="usd">3500000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzgwODA_b98c2fed-9328-4471-810f-c5455e1ebd34">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i525585ece4e54dc0a604cd4df25d2040_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMS0xLTEtMA_5dd47be1-2f67-467c-a7b1-2319ab481f07">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if73673afe5e746dd9e39e057c20d1cf6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMy0xLTEtMA_d401f790-b6dd-48d5-8f01-7d1682eeaed6"
      unitRef="usd">3739000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if73673afe5e746dd9e39e057c20d1cf6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItNS0xLTEtMA_a4d00b7e-5198-4aa1-95a4-b5f828124967"
      unitRef="usd">2269000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if73673afe5e746dd9e39e057c20d1cf6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItNy0xLTEtMA_64edf77c-8c3f-497b-b944-bc19fd55fc42"
      unitRef="usd">1470000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7c7700e033044992bf7e96f6acc26b3f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItOS0xLTEtMA_83e6deab-df0d-4725-a269-a43e87ef4fd8"
      unitRef="usd">3650000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7c7700e033044992bf7e96f6acc26b3f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMTEtMS0xLTA_2776f1be-3552-412a-8f59-0e19073101e5"
      unitRef="usd">1950000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7c7700e033044992bf7e96f6acc26b3f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzItMTMtMS0xLTA_3c767803-9391-4361-acfb-d4ef37d558b0"
      unitRef="usd">1700000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i186279a7a33f4fcfa37e6fef3fe64356_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMS0xLTEtMA_cabf6ccf-5747-4c36-8589-a6f9e3523541">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i35c8579ef483457a80d6870cfb506627_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMy0xLTEtMA_62b2e84a-3a18-4189-9bb9-f0f7439afbde"
      unitRef="usd">1081000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i35c8579ef483457a80d6870cfb506627_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtNS0xLTEtMA_825b8674-82d6-47c4-a0c5-bd819d753b9e"
      unitRef="usd">513000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i35c8579ef483457a80d6870cfb506627_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtNy0xLTEtMA_79fa5b53-567d-4c05-ae95-8850bfd82292"
      unitRef="usd">568000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i77c566e2cc944ab4adc2b416c6c7c147_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtOS0xLTEtMA_30a8d376-87d6-40a2-b9b3-d66f942a26d7"
      unitRef="usd">994000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i77c566e2cc944ab4adc2b416c6c7c147_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMTEtMS0xLTA_b347122c-6a0e-4d19-aff5-dbea87e0f68b"
      unitRef="usd">480000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i77c566e2cc944ab4adc2b416c6c7c147_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzMtMTMtMS0xLTA_2d15524c-39c2-489f-9f7a-8a3ab09f2a92"
      unitRef="usd">514000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i1f4ff464ee184805b122b85d506ac0dd_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMS0xLTEtMA_8a798667-6d96-421b-8895-80d78f6dc965">P23Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if42e75c31e164d77af6f02af0d548d0d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMy0xLTEtMA_b7eafc87-81dd-4e70-a8f1-e27622942abc"
      unitRef="usd">497000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if42e75c31e164d77af6f02af0d548d0d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtNS0xLTEtMA_a65a0e2e-af11-4ea9-a472-cc4fbb619981"
      unitRef="usd">244000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if42e75c31e164d77af6f02af0d548d0d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtNy0xLTEtMA_496fa0de-cf99-4e0b-bd13-874697ba71ae"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaea9dc7de4704cbcb84065259f650ed8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtOS0xLTEtMA_b2473c4a-261f-4633-b351-fdc16f5e523b"
      unitRef="usd">492000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaea9dc7de4704cbcb84065259f650ed8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMTEtMS0xLTA_8506f242-4da1-47b7-b5fb-ba5875939555"
      unitRef="usd">232000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaea9dc7de4704cbcb84065259f650ed8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzQtMTMtMS0xLTA_28a0ba50-d502-493d-abb2-50bb0b5dfee6"
      unitRef="usd">260000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i07691837bf0a422d9cfd06b65bbb66dc_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMS0xLTEtMA_cb46c624-c087-476f-aa96-434ae379e7c2">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMy0xLTEtMA_1175d30c-bb57-4e4b-8b65-ef6e716a41be"
      unitRef="usd">925000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtNS0xLTEtMA_0a02bff6-0b98-42c5-bb18-ea51cfbe8371"
      unitRef="usd">394000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ied7ddc0bcd434aa8978b94ff8f006bc0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtNy0xLTEtMA_3ff7f140-55ae-41a9-a065-65efc9de87c2"
      unitRef="usd">531000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if54e2d3096fe4a5bb88683649ed1f110_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtOS0xLTEtMA_77e5f920-0374-4ee0-9bb9-47da4367a668"
      unitRef="usd">808000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if54e2d3096fe4a5bb88683649ed1f110_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMTEtMS0xLTA_30cbf238-27b9-4da9-979b-7f37377637f2"
      unitRef="usd">242000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if54e2d3096fe4a5bb88683649ed1f110_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzUtMTMtMS0xLTA_6817a536-38bd-45e0-bbff-160aa54ef1b5"
      unitRef="usd">566000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i8b90045a4160435fb93b6eb170a34cff_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMS0xLTEtMA_ad65c191-223d-4fc8-a09e-b523a5fb8ca8">P4Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idad5179cf12841eb8fdb5f299a912be3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMy0xLTEtMA_50a51cb0-febf-4838-86a2-84df08f3c369"
      unitRef="usd">150000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idad5179cf12841eb8fdb5f299a912be3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtNS0xLTEtMA_3c8bd62a-2f12-4a5b-abd4-5e56242f17cd"
      unitRef="usd">122000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idad5179cf12841eb8fdb5f299a912be3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtNy0xLTEtMA_43dbc263-e3a3-41ae-b845-4aef07aa69da"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i463096ed8566457a89faf1810193937b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtOS0xLTEtMA_c7aae583-c3a8-4fa8-bed7-54c374cb7304"
      unitRef="usd">175000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i463096ed8566457a89faf1810193937b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMTEtMS0xLTA_4df51409-df8f-4735-94ff-4641fd521f97"
      unitRef="usd">111000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i463096ed8566457a89faf1810193937b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzYtMTMtMS0xLTA_4d992208-c507-487f-8965-3b4c4a262e7c"
      unitRef="usd">64000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i37afd48eccae41908ebb82b9e0f372ee_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMS0xLTEtMA_8993fb8a-59df-4efb-b788-a108aaa630fb">P6Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i807ddd84576b420db9656e79fe28a804_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMy0xLTEtMA_0d973122-8b5c-47d7-b4c3-27da3ccdfd3a"
      unitRef="usd">254000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i807ddd84576b420db9656e79fe28a804_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctNS0xLTEtMA_c8d9641e-0b0b-4eda-ae79-ebc02ccbcad6"
      unitRef="usd">226000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i807ddd84576b420db9656e79fe28a804_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctNy0xLTEtMA_86ca728a-35a7-400b-993b-42a649314969"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i366c1509c4ae4991b52b1307f982e915_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctOS0xLTEtMA_cf28e589-7d57-47c1-96da-043190f1d6a2"
      unitRef="usd">273000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i366c1509c4ae4991b52b1307f982e915_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMTEtMS0xLTA_121adf68-ac72-414e-ba53-4eccd8501ce1"
      unitRef="usd">221000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i366c1509c4ae4991b52b1307f982e915_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzctMTMtMS0xLTA_875f0fa8-e1c3-42fa-b383-7ae44870e9d7"
      unitRef="usd">52000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtMy0xLTEtMA_b9672d90-569f-4b33-b873-81b645d37528"
      unitRef="usd">6646000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtNS0xLTEtMA_80921061-d5fb-4fcb-9f03-ba6e0cd3100b"
      unitRef="usd">3768000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtNy0xLTEtMA_76dcdeaf-74a8-4fe0-909a-83dc6e28d060"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtOS0xLTEtMA_0edf0951-1985-4b60-83af-a50e0a2c5016"
      unitRef="usd">6392000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtMTEtMS0xLTA_b09d1826-6ace-41c8-8b2d-36c4973fde15"
      unitRef="usd">3236000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90YWJsZTo0MjFhNGY2MDkyOTQ0ZmFkOTFkMjBhNTI3OTNjMmI0My90YWJsZXJhbmdlOjQyMWE0ZjYwOTI5NDRmYWQ5MWQyMGE1Mjc5M2MyYjQzXzgtMTMtMS0xLTA_ee272282-c7a7-4646-8b7f-9828ba01c96a"
      unitRef="usd">3156000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc3MTk_55b48a43-bc26-47cc-9068-061143dc42e0"
      unitRef="usd">422000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc3MjM_1a7e4771-9aef-420e-b472-92a05a805b04"
      unitRef="usd">462000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc3MzA_8b33a8bc-cd54-4ef7-b1cc-4af2e586ada0"
      unitRef="usd">485000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4MjY_882afb3d-7c0d-4f65-a833-683893f344c7"
      unitRef="usd">370000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4MzA_b6d8166b-7ea9-4628-9dc3-734f7c57ffb0"
      unitRef="usd">270000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4MzQ_3de38f63-70d4-4c35-bfb5-f1db3001e811"
      unitRef="usd">259000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4Mzg_b665c79b-d667-4720-a980-1d844f0df4db"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4NDU_67db8aab-7ab9-477b-8fed-b50565720774"
      unitRef="usd">220000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzIvZnJhZzo3ZjIyMDFhZGJmY2Y0NTZkYTczYTY0Mzg3ODFmZmU1Zi90ZXh0cmVnaW9uOjdmMjIwMWFkYmZjZjQ1NmRhNzNhNjQzODc4MWZmZTVmXzc4NzE_78e276d9-07a4-456a-81d0-db45cfb1eed0"
      unitRef="usd">1500000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU4MjM_2b570f9e-8e3f-4318-9e70-fcc492caa323">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65% Notes due November 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due March 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March&#160;31, 2021 and 2020, $7.1 billion and $7.4 billion, respectively, of total debt was outstanding, of which $742 million and $1.1 billion, respectively, was included in &#x201c;Current portion of long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#x201c;2025 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2021, the Company retired its 3.65% $700&#160;million total principal of notes due on November 30, 2020 upon maturity. On December 1, 2020, the Company redeemed its 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above. In 2020, the Company repaid at maturity its &#x20ac;250 million Floating Rate Euro Notes due February 12, 2020. In 2019, the Company repaid at maturity its $1.1 billion 2.28% notes due March 15, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each note, which constitutes a &#x201c;Series&#x201d;, is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#x2019;s existing and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed&#160;by materially similar indentures and officers&#x2019; certificates. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#x2019;s Investors Service, Inc. and Standard &amp;amp; Poor&#x2019;s Ratings Services within a specified period, an offer must be made to purchase that Series from the holders at a price equal to 101%&#160;of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#x2019; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#x2019; consent. The indentures also contain customary events of default provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments of long-term debt are $742 million in 2022, $838 million in 2023, $1.1 billion in 2024, $34 million in 2025, $1.2 billion in 2026, and $3.2 billion thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company entered into a Credit Agreement, dated as of September 25, 2019 (the &#x201c;2020 Credit Facility&#x201d;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during 2021 and 2020 and no amounts outstanding as of March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At March&#160;31, 2021, the Company was in compliance with all covenants. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the $3.5 billion five-year senior unsecured revolving credit facility (the &#x201c;Global Facility&#x201d;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019 and had no borrowings during the six months ended September 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $8 million and an uncommitted amount of $152 million as of March&#160;31, 2021. Borrowings and repayments were not material in 2021 and 2020 and amounts outstanding under these credit lines were not material as of March&#160;31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During 2021 and 2020, it borrowed $6.3 billion and $21.4 billion, respectively, and repaid $6.3 billion and $21.4 billion, respectively, under the program. At March&#160;31, 2021 and 2020, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU4Mjk_1bf7576d-d959-4430-bca9-1532e3f458d2">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65% Notes due November 30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due March 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5a0dc323a371466e8a0168d08ca2e5f0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjkxMjQyN2Q4ZTQyNzQyOTQ5ZjA1ZGEzZDhlMDRmYjEzXzE2NDkyNjc0NDE3MDY_48ea5f11-ecdb-405d-a61e-69860f7d9bcc"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5a0dc323a371466e8a0168d08ca2e5f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzMtMS0xLTEtMA_52cfe527-2f1e-48cb-a8fc-1c0da206266a"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i51455de7ffa1400baa450520b0823664_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzMtMy0xLTEtMA_e8e73d76-66de-4e20-962c-35bd1b371c64"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8cd624dd46b47528454592cac989b47_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmFiOGFjZTM0MjRlNDQ2Yjk5MmU4ZTk3M2Y3YmUxYjg0XzE2NDkyNjc0NDE3MDI_f1df80ee-0d1c-4105-8a0e-cae096e19bcf"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic8cd624dd46b47528454592cac989b47_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzQtMS0xLTEtMA_85ee6805-9c75-472d-9f4e-c8f93e01a520"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i718d836dece1446592aaaa01bd324fa7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzQtMy0xLTEtMA_f513c230-ef3d-4d5d-8344-b01219d2e94a"
      unitRef="usd">323000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjRiZTMyYzRjMWEyYjQ2ZWFhMWU1NmM4MDBiZDkzZjMwXzE2NDkyNjc0NDE3MDY_21df8db8-daa0-4c48-8632-43c1d48ce90e"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzUtMS0xLTEtMA_9e48d14c-9114-4aae-9078-6c5ffc2304cd"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1f0b9a87ad6e4141a43b6aebf1030aae_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzUtMy0xLTEtMA_0f860c34-eafe-4557-ad45-dcd4766b7ed1"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie61256ac66bc4a89bf0d0e09ae475b1a_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzYtMC0xLTEtMC90ZXh0cmVnaW9uOjRkNjE3NTRkMjYwYjQwMTM4NjBkZjhjMDhiOWU2M2NmXzE2NDkyNjc0NDE3MDM_34da9302-6c0b-4bde-9db3-a74a95ee3a3d"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie61256ac66bc4a89bf0d0e09ae475b1a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzYtMS0xLTEtMA_0491d79f-6a69-4bd4-803d-828585ecdbe7"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i587960ff5f064537a59834dc9b5fbc36_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzYtMy0xLTEtMA_a901a855-19a9-4773-97c3-2b19fdfbb0c4"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4c1ce0a35b1b4a30af455e59d15c6150_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzctMC0xLTEtMC90ZXh0cmVnaW9uOjdlZTcwYjVjZjBhMTQ5ZmJhYzhkNmFkMDVmYWQ4NTZjXzE2NDkyNjc0NDE3MDM_cc2fc4d0-673f-4569-b724-8208e66ce075"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4c1ce0a35b1b4a30af455e59d15c6150_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzctMS0xLTEtMA_b220bcbc-6f20-4658-9d15-fcea4d1431fa"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9ea3a78f9a71459f928d5d15a5f30881_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzctMy0xLTEtMA_6a0e95a8-abfa-4b98-b739-74fb6fb8bcd0"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib9a0f7b532354353862735fa61a7edbe_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMC0xLTEtMTAyNDIvdGV4dHJlZ2lvbjpjYTgyMWZmM2RhYWU0NjYxOTJjMmMwYzNkODgwZGZmN18xNjQ5MjY3NDQxNjk0_e5e60ef0-649b-493e-9967-f18ad2badada"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib9a0f7b532354353862735fa61a7edbe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMS0xLTEtMTAyNzU_28910094-7d72-4bff-ab60-58bb8fe4e76a"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3ba3a1f603304391b936ce6bcb7a6a27_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMy0xLTEtMTAyNzU_1123be7b-4544-4ebd-add4-6b742d30534b"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic3407317f0374140aae578c6d0eb0b07_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmI4MDgwMDE4MWM3YTRmMzFhMjI5NjkxY2Y2MzllN2ZhXzE2NDkyNjc0NDE3MDc_c59d8d25-57c9-48f1-bbce-14fcc7291521"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic3407317f0374140aae578c6d0eb0b07_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMS0xLTEtMA_b9804934-69ec-4034-860d-326acd4f314e"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6926f446a23d49a8b4e4110e67b160cb_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzgtMy0xLTEtMA_c8bd518c-5540-44ff-baa3-b24a6bf9bf51"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i133b5953d54f4f1bb1cc4a7cb16391a1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFkY2RlM2FjOTM3MDRmYTI4ZDg2Nzc1ZDM1ZGJiNGRkXzE2NDkyNjc0NDE3MDY_46a5667f-4f88-48e3-a74f-b175cee3038e"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i133b5953d54f4f1bb1cc4a7cb16391a1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzktMS0xLTEtMA_1ecfb657-79a8-43c9-9eaf-54e7ec88b3c1"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibbc40734152a45aeabea7c982026d0fa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzktMy0xLTEtMA_e0c59a48-a852-49e1-8727-edb8657a055b"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i64567396009c44829d2a1fd050d1a1b7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjo2NDJiZWJmMTFiMjM0YWI4OTFkYjhkNzlkNjZkMDNhNl8xNjQ5MjY3NDQxNzAx_259423cb-3cdc-4a74-9198-1099e53399ac"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i64567396009c44829d2a1fd050d1a1b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEwLTEtMS0xLTA_c56af952-983d-480d-93e3-de376fe36eff"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib84ee20fa4f8433396754e0437027fb6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEwLTMtMS0xLTA_edbc0429-f0b9-4903-b655-3033d85d77e9"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifadf20024dc74f81b440ab0ab2eb2913_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo2YWRiZGRhNzZhNGU0MjhiYmU5ZjMyNzU4NTVjYzhlZF8xNjQ5MjY3NDQxNzAy_fc2e2175-37a4-4773-bcf2-b590a2fc7a05"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifadf20024dc74f81b440ab0ab2eb2913_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzExLTEtMS0xLTA_d5b2b843-fdd7-460f-bc5b-99af06c9acdd"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id423c4b7c4a945db8071e337c9c82ed1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzExLTMtMS0xLTA_a184dde3-a914-491f-8efd-992499eb1262"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0bc1a0012fd84f509095b06c9f66d6bb_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZDk2ZGRiNzViYzU0NDI1YTU1MGU4MjkzMTIyZDdmNl8xNjQ5MjY3NDQxNzAz_410d794c-3088-414c-8d52-6d2db328695b"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0bc1a0012fd84f509095b06c9f66d6bb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEyLTEtMS0xLTA_4dd14967-9017-41c2-a61f-8365fa95068b"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i79cf5d2e990240698629bdc50a7c0b88_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzEyLTMtMS0xLTA_7d01890c-b545-43f4-bfd8-e5d5cd658a75"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iad9c1207b15f466a861980e7222a1537_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjphOGU1MjgzZTkyNzc0OGQ2OGQzNmQyNWEzN2RiZDMzMl8xNjQ5MjY3NDQxNzA5_ab95225b-26ed-427a-b3ed-5616a21d4164"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iad9c1207b15f466a861980e7222a1537_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE1LTEtMS0xLTA_d8b916cf-36eb-422c-a09b-99fb9d6491be"
      unitRef="usd">704000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iee10f2cf891e40f2a38c0aced30d76ea_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE1LTMtMS0xLTA_e2989dac-a7f7-4d66-829e-504ee541e1e9"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i392b65805f5f4e48a0907f99ecf50ee2_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo4OWNmZjJjYzViNmY0ZDMwOThhMmEyMzlhMzZlNmFmY18xNjQ5MjY3NDQxNzEx_9599a7e9-05c7-42be-bd6b-75aefcde476d"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i392b65805f5f4e48a0907f99ecf50ee2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE2LTEtMS0xLTA_b3a21c6f-05c8-4855-9619-978922e84c42"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5014024a7cf34617ac4cd1a096cecac1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE2LTMtMS0xLTA_eacc809b-159e-4dec-a705-34889711f315"
      unitRef="usd">659000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ee0c0121e554ad5b84e809395a86c66_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjplYmEwZDViYjdkZjM0ZmYyODE0ZjE0YzNhOTIyYTJjY18xNjQ5MjY3NDQxNzE0_ad0a588f-e4cd-4bb9-8879-384ff395b4c6"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3ee0c0121e554ad5b84e809395a86c66_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE3LTEtMS0xLTA_bc3d6361-a625-428c-b374-48e50d50f598"
      unitRef="usd">587000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i54751c16577f40f1adff8f7e2bff79f8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE3LTMtMS0xLTA_2f2db761-dc5e-4bce-ad5a-4fcf593d43aa"
      unitRef="usd">552000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b5b1fc662a44e0791f2dba244a47860_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo0YjAzNzFmN2QzYzg0MmM1YTJjZTNjYmVmNjZkOThkOF8xNjQ5MjY3NDQxNzE5_8bc2915d-a79f-4d34-8bf7-6516fffec577"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4b5b1fc662a44e0791f2dba244a47860_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE4LTEtMS0xLTA_c8e6081d-51fc-46ab-9f97-35406f128e91"
      unitRef="usd">627000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie1a099094e354b889a5a5c3a182329bc_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzE4LTMtMS0xLTA_cd3ba703-fbe3-4a0d-81f7-362e88026755"
      unitRef="usd">557000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2976b57beaaf4c6b8a89e64c910a5a7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIwLTEtMS0xLTA_d733b9fb-f29b-4dd4-8af3-90ade57f1087"
      unitRef="usd">270000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6d39d3584f824d5dbcfadf658383ee87_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIwLTMtMS0xLTA_604ab7dc-cfbc-4d3c-b1bf-30767ba75e26"
      unitRef="usd">174000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIxLTEtMS0xLTA_aec9e056-0b8f-4c65-8a94-c87294e76c02"
      unitRef="usd">7148000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIxLTMtMS0xLTA_c3fef0ba-6316-49ed-8382-acb30308ccb7"
      unitRef="usd">7387000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIyLTEtMS0xLTA_c014d11b-e54b-4bde-be53-a7c61037ce1a"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIyLTMtMS0xLTA_5e60e191-295c-49db-b23b-db937c7ad27c"
      unitRef="usd">1052000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIzLTEtMS0xLTA_6b765c04-7287-4888-a256-264405d89ce0"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90YWJsZTowMzM1MmRmZTNlN2M0ZDk2YWJlMGE1NzU3Mzk0MGNlZC90YWJsZXJhbmdlOjAzMzUyZGZlM2U3YzRkOTZhYmUwYTU3NTczOTQwY2VkXzIzLTMtMS0xLTA_8a7cd643-1150-4504-9a32-c37f2a8efb51"
      unitRef="usd">6335000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebt
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzQ2MA_132cf115-0f16-428c-95e8-774d1aadaebe"
      unitRef="usd">7100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzQ2Nw_79399694-b1f8-47e0-a262-608e086ac60b"
      unitRef="usd">7400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iba24a5eef2484a6dbc6addbb8b2b3743_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUxMA_74d5232c-75aa-4386-9bb0-ef650970fd58"
      unitRef="usd">742000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4aa607516b08415b8dce58c739355d62_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUxNw_ca232d73-123e-4b15-ab3c-9fb7476a41cf"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2aada2c5a8f5413086253c28368973fe_I20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDc5NTI_d8f72a7a-7da4-4859-a0fb-3921db13bd27"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2aada2c5a8f5413086253c28368973fe_I20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDc5NTY_46760eb5-b0de-4c92-8f7e-908ae36a81c2"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i1c1c7b3092c543bda3ed926c574d2405_D20201203-20201203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDc5NjM_e9d2ccb3-c97b-42b9-807e-0281a1f58ae4"
      unitRef="usd">496000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i61675c05b34a420fb0aef206c120e3cc_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzIxOTkwMjMyNzQ2MzM_041d510c-ffb5-40ac-9db2-1334a3b75916"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i61675c05b34a420fb0aef206c120e3cc_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDk1NDQ_71fcc49d-4cfe-4b3f-a8eb-46c77e6753bd"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i933936a7522f4f269eb80826407de7b6_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDk1NTQ_bd656ce9-2d0f-44bd-9251-7a9af65b8935"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i933936a7522f4f269eb80826407de7b6_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NDk1NTk_2c3e2665-8e98-4c4b-9900-673d097d439d"
      unitRef="usd">323000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ifb20c63e640a48478f01df43a5ecbce5_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NjE_10625be4-33c3-4b86-8eca-32898857216b"
      unitRef="eur">250000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i901c6c235d094bfeab2e2891bf22868d_D20190315-20190315"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE3NTY_e754beb6-5a18-425b-9fad-d7707f260f89"
      unitRef="usd">1100000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7191c4e470a4de89c4f6e0fc96b493c_I20190315"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE3NTk_8667c955-ab3a-4d7e-af5e-bcbe93ecf984"
      unitRef="number">0.0228</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ide437db67fec4724871353bf3fed014f_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzI3ODA_0086f906-f02a-4ce9-8aea-55fe72f332cb"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0MTc_5766e210-f675-4c7d-9f49-d66f0f3b5df6"
      unitRef="usd">742000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0Mjc_16d35105-cbc0-4175-bf49-1a085204d64c"
      unitRef="usd">838000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0Mzc_68b44762-4094-4fcb-921f-041566703553"
      unitRef="usd">1100000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0NDc_217c974d-1a0f-4dc6-a39e-94cac0a8d15f"
      unitRef="usd">34000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0NTc_2d838c09-9a1a-4af1-b14f-ce02b303d7a8"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM0NzA_6cbda89f-70c9-4eda-9d95-5e1004542d07"
      unitRef="usd">3200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3a0059e39d8c4440982d888fd5a4c442_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM1ODM_639e206e-0deb-42c8-a9af-e38e044f4d1e"
      unitRef="usd">4000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="if2d3ff5a5a4b4484a95420609dd9e074_D20190901-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE5NzkxMjA5MzEyNzkw_5fda9d41-5978-42bb-b48e-c98138e5781e">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i16d322c911e24b2f90df8075e4ef4d6c_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM2NzE_993865bc-4309-4ad5-9b09-ef625bd367fd"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ie473d5c5a4eb40bbbc2a53be66040614_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM4MjI_8197e1b7-7822-4f33-bcde-31b6468b8320"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3fdddf6ceeed47308e55c0b30b5a067c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzM4NTA_6aa05816-3673-4d70-aa48-d46178981f2c"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iabf91ccb11c7473fb82ceedddfc105f2_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NTk1MDY_24b93f16-f24f-434d-8f59-6edf852a4d16"
      unitRef="usd">3500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i9864559fa95841a4af3fb0942788d567_D20190901-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE5NzkxMjA5MzE5MDQw_63cef3a9-ec66-4cd0-919b-bdc763b61bb0">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i21fdbc4f6fd449c485c175357858b379_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzE2NDkyNjc0NTk3NTY_c3b0feab-8b23-4d26-b7fa-a78b4d2f3891"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="i4d0a48f582bd40e3b1f786f6699f0b4a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUyNDY_969ed05a-8d59-4936-b888-c1d3a10b2580"
      unitRef="usd">8000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i4d0a48f582bd40e3b1f786f6699f0b4a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzUyNzg_bebff933-9106-4566-b12f-d1bc65c38fce"
      unitRef="usd">152000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia279c8899da54bf6ae860b25947dc8d0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU2MzI_0b92062e-dc9b-46a7-8f29-593086d98232"
      unitRef="usd">4000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MDQ_6ff8ed31-4f78-4b13-830d-294767065aef"
      unitRef="usd">6300000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MTE_633d74df-6622-4cb3-acb6-a12cb59b6ba1"
      unitRef="usd">21400000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MjU_88e8ef66-44b6-4087-a0e6-79aa686360c2"
      unitRef="usd">6300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3MzI_e4d450df-a5e8-4e8a-aadc-9f654d9839da"
      unitRef="usd">21400000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermDebt
      contextRef="i39ac5a2189034cdfb61933a472118b09_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3Nzk_80f4d3c6-8d9e-4695-ad22-11cd86debdff"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia279c8899da54bf6ae860b25947dc8d0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNzgvZnJhZzo4MTkwMGFlNjAzMTg0N2E5YTUxMmY4YzYxYjZiMjIxYS90ZXh0cmVnaW9uOjgxOTAwYWU2MDMxODQ3YTlhNTEyZjhjNjFiNmIyMjFhXzU3Nzk_996d65fc-cb7f-4be6-875f-41bda6444243"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzI5Mzg_933fa1b6-b91d-4964-a63d-c5d70eb58725">Variable Interest Entities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs, if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#x2019;s Consolidated Statements of Operations and Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $662 million and $74 million, respectively, at March&#160;31, 2021 and $695 million and $82 million, respectively, at March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Unconsolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual or other relationships with the VIEs. The Company&#x2019;s most significant relationships are with oncology and other specialty practices. Under these practice arrangements, it generally owns or leases all of the real estate and equipment used by the affiliated practices and manages the practices&#x2019; administrative functions. It also has relationships with certain pharmacies in Europe with whom it may provide financing, have equity ownership, and/or a supply agreement whereby it supplies the vast majority of the pharmacies&#x2019; purchases. The Company&#x2019;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $1.5 billion at March&#160;31, 2021 and $1.4 billion at March&#160;31, 2020, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 18, &#x201c;Financial Guarantees and Warranties.&#x201d; The Company believes there is no material loss exposure on these assets or from these relationships.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="ieadecf82b6ad4545a68ef16b493ea917_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1MDI_9fb7c15f-dd30-4da8-9a05-10710c29e7ea"
      unitRef="usd">662000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="ieadecf82b6ad4545a68ef16b493ea917_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1MDk_9852b5d5-90a1-415a-a0c8-b259bd1531ea"
      unitRef="usd">74000000</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="i4cd94c1fc48d45739e8b1372c7918e91_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1MjI_1101068f-96c1-4062-b3f5-4c368d3d3719"
      unitRef="usd">695000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i4cd94c1fc48d45739e8b1372c7918e91_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzE1Mjk_8b76de4e-a49f-4a5b-9f59-197214660b59"
      unitRef="usd">82000000</us-gaap:Liabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzI1NzI_37638abf-4724-437c-a009-a9e32d13c116"
      unitRef="usd">1500000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xODQvZnJhZzpjMDExMTY0N2FiMjQ0MzEzYTg1ZmU4Y2YwZWFjMTdmZi90ZXh0cmVnaW9uOmMwMTExNjQ3YWIyNDQzMTNhODVmZThjZjBlYWMxN2ZmXzI1OTU_9e717784-1621-463c-aa55-6559565db19f"
      unitRef="usd">1400000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDc2_100c58e7-cef1-4d0c-992e-df809b1a7004">Pension Benefits &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an unfunded nonqualified supplemental defined benefit plan for certain U.S. executives, as well as benefit pension plans for eligible employees outside the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 23, 2018, the Company&#x2019;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#x201c;Plan&#x201d;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#x2019;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future pension benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $105 million was recorded during the second quarter of 2020. Settlement charges were included within &#x201c;Other income, net,&#x201d; in the Consolidated Statements of Operations for the year ended March 31, 2020. As of March 31, 2020, this defined benefit pension plan had an accumulated comprehensive loss of approximately nil.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2020, a cash payment of $114 million was made to settle a participant&#x2019;s liability from the executive benefit retirement plan. As a result, a majority of the remaining recorded unrecognized losses in accumulated other comprehensive loss for this Plan were recognized as expense and a settlement charge of approximately $11 million was recorded in &#x201c;Other income, net&#x201d;, in the Consolidated Statements of Operations. As of March 31, 2020 and 2019, this plan had an accumulated comprehensive loss of approximately $1 million and $12 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway, the United Kingdom, Germany, and Canada. Benefits for these plans are based primarily on each employee&#x2019;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#x201c;SPK&#x201d;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law. In the U.K., the Company has subsidiaries that participate in a joint pension plan. The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe&#x2019;s Management Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company derecognized $187&#160;million of pension liabilities included in liabilities held for sale and $33&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit plan assets and obligations are measured as of the Company&#x2019;s fiscal year-end. The net periodic expense for the Company&#x2019;s pension plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost - benefits earned during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized actuarial loss and prior service costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the changes in benefit obligations and plan assets for the Company&#x2019;s pension plans is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity Premium Transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer and participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity Premium Transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The benefit obligation is the projected benefit obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The divestiture relates to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; These amounts were included within current liabilities and totaled $151&#160;million at March&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actuarial loss of $89 million in 2021 was primarily attributable to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Discount rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($32&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased from 2.03% as of March&#160;31, 2020 to 1.89% as of March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Demographic and assumption changes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($57&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestiture in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actuarial gain of $36 million in 2020 was primarily attributable to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Discount rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($6&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased from 2.13% as of March&#160;31, 2019 to 2.03% as of March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Demographic and assumption changes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($42&#160;million gain): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes mortality, and other changes. The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#x2019;s pension plans, including accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in accumulated other comprehensive income consist of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other changes in accumulated other comprehensive income were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.745%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit (cost)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive loss (income) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $33&#160;million in actuarial losses for pension plans to stockholders&#x2019; equity in 2021 as a result of the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; The Company recognized $127 million in actuarial losses for the pension plans to stockholders&#x2019; equity in 2020 as a result of $116 million from the termination of the U.S. defined benefit pension plan and $11 million from the settlement from the executive benefit retirement plan for a retired executive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected benefit obligations related to the Company&#x2019;s unfunded U.S. plans were $9 million and $10 million at March&#160;31,&#160;2021 and 2020, respectively. Pension obligations for its unfunded plans are based on the recommendations of independent actuaries. Projected benefit obligations relating to the Company&#x2019;s unfunded non-U.S. plans were $162 million and $298 million at March&#160;31,&#160;2021 and 2020, respectively. Funding obligations for its non-U.S. plans vary based on the laws of each non-U.S. jurisdiction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments for the Company&#x2019;s pension plans are as follows: $43 million, $36 million, $37 million, $36 million and $38 million for 2022 to 2026 and $202 million for 2027 through 2031. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#x2019;s pension plans are $24 million for 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.83%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.71&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. For March&#160;31, 2021, the Company&#x2019;s U.S. defined benefit liabilities are valued using a weighted-average discount rate of 2.35%, which represents a decrease of 73 basis points from its 2020 weighted-average discount rate of 3.08%. The Company&#x2019;s non-U.S. defined benefit pension plan liabilities are valued using a weighted-average discount rate of 1.89%, which represents a decrease of 14 basis points from its 2020 weighted-average discount rate of 2.03%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment Strategy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For non-U.S. plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. The following tables represent the Company&#x2019;s pension plan assets as of March&#160;31, 2021 and 2020, using the fair value hierarchy by asset class:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income commingled funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate funds and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held at NAV practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $1.00. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other - At March&#160;31, 2021 and 2020, this includes $36 million and $29 million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity attributable to Level 3 plan assets was not material for the years ended March&#160;31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Multiemployer Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#x201c;POA&#x201d;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#x2019;s withdrawal liability and contributions may increase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contributions and amounts accrued for U.S. Plans were not material for the years ended March&#160;31, 2021, 2020, and 2019. Contributions to the POA for non-U.S. Plans exceeding 5% of total plan contributions were&#160;$22 million, $17 million, and&#160;$27 million in 2021, 2020, and 2019, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately 78% as of March&#160;31, 2021. No amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a contributory retirement savings plan (&#x201c;RSP&#x201d;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to 75% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to 100% of the employee&#x2019;s first 3% of pay contributed and 50% for the next 2% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $102 million, $102 million, and $92 million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/div&gt;The Company maintains a number of postretirement benefits, primarily consisting of healthcare and life insurance (&#x201c;welfare&#x201d;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#x2019;s fiscal year-end. The net periodic (credit) expense for the Company&#x2019;s postretirement welfare benefits was not material for the years ended March 31, 2021, 2020, and 2019. The benefit obligation at March 31, 2021 and 2020 was $64 million and $65 million, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <mck:DefinedBenefitPlanSettlementPlanParticipants
      contextRef="i4e9be4f901904d0db4fe7ad9ae72362b_D20190601-20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzExOTc_c53b7d93-e68e-4941-9cd7-e76f135c30bd"
      unitRef="participant">1300</mck:DefinedBenefitPlanSettlementPlanParticipants>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i4e9be4f901904d0db4fe7ad9ae72362b_D20190601-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEyODc_fe3e4a69-ee99-47b6-8d77-62efbc851eb0"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i4a2621176fea4a8888c6313b92cf10ad_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE0NjI_2fb1a781-c7b6-4b54-86a7-9e598c7e09cd"
      unitRef="usd">-17000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract
      contextRef="ief5ba1ae721343ac88b4d010889406e8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTk_a848ce68-da9f-460f-858b-9a21a14174c0"
      unitRef="usd">280000000</mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ief5ba1ae721343ac88b4d010889406e8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxMTM_705a6402-b251-42c8-9adc-b993dbe2790c"
      unitRef="usd">-105000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE5NzkxMjA5MzM2NjQy_9245818b-09fb-44bd-8a3f-d59732ecd200"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="icb9627a61887468a9b6718ee20810f41_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI0NDc_4355ad03-70b2-481b-8b30-a068ca187515"
      unitRef="usd">114000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="icb9627a61887468a9b6718ee20810f41_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI3Mzk_937172d6-7ccf-4b3f-9a73-5261500da97c"
      unitRef="usd">-11000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9eb73386cbae4db0b0d708fc5a5494fd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI5NTA_b81fb677-48d5-496c-8df5-fd5bcd1076e5"
      unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id7d45b209bd246fa9f5fb6ed35063c90_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzI5NTc_0bd717a7-96b2-4191-85bb-c28ce31cf9cc"
      unitRef="usd">12000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized
      contextRef="ic3d13dff04ec4f91a0b1fe60fc9e3c43_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyOTIyNjQ_2813d134-70b8-432c-b60e-91e1dfee408e"
      unitRef="usd">187000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i3877ec01b10348049e885c6fbd8c2093_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyNzY5MzI_533f9637-9c71-4e0f-aab5-e4a2e108e13c"
      unitRef="usd">-33000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTQw_94f9658c-fce2-4386-8a80-21782ea126a5">The net periodic expense for the Company&#x2019;s pension plans is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost - benefits earned during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized actuarial loss and prior service costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtMS0xLTEtMA_3ed14b37-027a-45f9-85ce-5db6d5a65254"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtMy0xLTEtMA_37dd5345-f4f2-4072-930d-3c48dbb3535e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtNS0xLTEtMA_a18c2f0b-2ba0-4300-a46c-9d710ae488d2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtNy0xLTEtMA_5ad67877-94d9-4cd1-b372-a11592406d16"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtOS0xLTEtMA_9c006327-e9b4-443c-96a1-e0b7a0a61fdb"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzMtMTEtMS0xLTA_e5a9308c-1dc0-47c3-80f2-1ff0650f2893"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtMS0xLTEtMA_ae599365-6162-44c7-bc55-04f778e7e641"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtMy0xLTEtMA_635e2596-2e2d-4ec2-a460-2c22f165232b"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtNS0xLTEtMA_d0050a72-9a23-405b-b73c-8715dae09114"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtNy0xLTEtMA_82bdbe91-89ce-427d-9768-44fbf6b532b2"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtOS0xLTEtMA_fe4c6d46-9484-416a-80c7-4a4a9a7475c7"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzQtMTEtMS0xLTA_55d617fc-a1c0-4096-ba5c-983ef0958f27"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtMS0xLTEtMA_a45b2082-ccaf-4a99-83a9-6d34fda99260"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtMy0xLTEtMA_1c8b1ef3-bf15-4ba2-98f1-a993773c9389"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtNS0xLTEtMA_b15682f0-61f4-495b-aeac-877de00967b4"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtNy0xLTEtMA_1f634ed6-b548-4db0-9e71-12fde1031f4d"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtOS0xLTEtMA_f131bd28-91fc-416a-94de-282882e959c7"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzUtMTEtMS0xLTA_0955eebc-1154-4735-b58d-379e65fe3958"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtMS0xLTEtMA_ba34f32f-5d72-4101-97eb-22d631938359"
      unitRef="usd">0</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtMy0xLTEtMA_7f027b87-6ee3-480b-8c30-903952d3af97"
      unitRef="usd">2000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtNS0xLTEtMA_5f9f8e2c-b935-4db9-bbc5-88a8d24f6e33"
      unitRef="usd">5000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtNy0xLTEtMA_d616f6e0-6355-4865-a3b6-279281d3c847"
      unitRef="usd">5000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtOS0xLTEtMA_e56a7c8d-b091-4475-b6b8-6d6039145d46"
      unitRef="usd">6000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzYtMTEtMS0xLTA_9c69d005-83e8-4d1b-a005-db55fc2a3e04"
      unitRef="usd">4000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctMS0xLTEtMA_2434a1af-55d9-46a0-b07a-8fa7084ed21b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctMy0xLTEtMA_1b855ade-70d7-4a61-9a4e-bb45deb0bc7b"
      unitRef="usd">-127000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctNS0xLTEtMA_baba3374-609f-4ad3-9a21-d970860b347c"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctNy0xLTEtMA_f5d4b78a-d72b-4f6e-8ff5-ad17a813b4a2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctOS0xLTEtMA_5e2bad70-ef90-4e32-a5f9-b614fa80adf7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzctMTEtMS0xLTA_9180468e-109b-4958-97f4-e4461f855cbb"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtMS0xLTEtMA_040bc6e2-3028-40cd-8b05-47c4cedc2715"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtMy0xLTEtMA_57feb9b9-159f-42fe-960c-33c0d5d98f60"
      unitRef="usd">131000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtNS0xLTEtMA_9adbd380-6c48-4448-87e7-232d5f5c4848"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtNy0xLTEtMA_495b6a1f-c1da-48ab-94c6-4af2bdcca93e"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtOS0xLTEtMA_954ac25a-571e-446f-8130-b1acebefcb5e"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTplOGFhYjE2MzdkZWE0MzY1OWRkN2UxZDgwMDg3MTM5Yi90YWJsZXJhbmdlOmU4YWFiMTYzN2RlYTQzNjU5ZGQ3ZTFkODAwODcxMzliXzgtMTEtMS0xLTA_d014f428-de9a-44d2-9180-cea4fb7a973a"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzQxODE_f88822b8-38fa-4f4b-87fb-244aa50e6557"
      unitRef="number">0.10</mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTQx_0dbdd503-9352-45da-8289-c5ed991523be">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the changes in benefit obligations and plan assets for the Company&#x2019;s pension plans is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity Premium Transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer and participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity Premium Transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The benefit obligation is the projected benefit obligation.&lt;/span&gt;&lt;/div&gt;(2)The divestiture relates to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; These amounts were included within current liabilities and totaled $151&#160;million at March&#160;31, 2020.</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtMS0xLTEtMA_ee1e2f1d-ce37-4d2e-9e61-604405f99a24"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iad18cf43caca4fa9b52b9f44c52fa56a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtMy0xLTEtMA_3cbe714f-7449-4717-ba38-5b4c562db200"
      unitRef="usd">439000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtNS0xLTEtMA_949dbcdd-175c-4a05-954a-eaf534cde0da"
      unitRef="usd">896000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4352db6f20a74338aa9b3bada49da7c4_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzQtNy0xLTEtMA_616626ad-d42c-44f5-8b93-fd0eb0d5d34f"
      unitRef="usd">990000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtMS0xLTEtMA_77fdd58b-939b-485d-8d51-94c8f4f0c4dc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtMy0xLTEtMA_f2d3f7ae-8d69-44b3-8ccb-e82d7586ab5c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtNS0xLTEtMA_421761c2-b969-4de9-bc0f-de869648bed0"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzUtNy0xLTEtMA_290355f7-2707-4c96-8166-e06ab59b78e5"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtMS0xLTEtMA_ea648ff5-9461-41a2-9428-85c80b208119"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtMy0xLTEtMA_7f002487-6b86-4719-8c0a-085b45a27c6f"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtNS0xLTEtMA_dad6ee45-71da-46c7-a2cb-88cfe072d3b9"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzYtNy0xLTEtMA_ee54eba3-becd-4c6a-9e6b-1d0f389bd771"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctMS0xLTEtMA_d2ce6353-d39b-4b18-bc39-7323e0e1b3ee"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctMy0xLTEtMA_c4c84b6a-f26b-4a58-a7d4-7a09d54772ff"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctNS0xLTEtMA_26298699-7a40-429e-b064-8c3f5537e9f7"
      unitRef="usd">-89000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzctNy0xLTEtMA_c2acffbd-5ad6-4d5f-9fa3-f1c24b49d0e7"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtMS0xLTEtMA_0b28a194-6c81-4cbc-8a41-8ca7560e6514"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtMy0xLTEtMA_e099381e-acad-4744-a62f-0d4d0e3678e1"
      unitRef="usd">179000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtNS0xLTEtMA_100b5be1-abe1-44a1-9d6a-f6495e157ffb"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzgtNy0xLTEtMA_ecbbce55-45e9-4374-9fb3-720cf1dcb60f"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktMS0xLTEtMA_1f856629-89d8-4700-892a-fab8c0561067"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktMy0xLTEtMA_d4a44f0f-52ec-41a1-83da-b706bf1cc90a"
      unitRef="usd">-276000000</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktNS0xLTEtMA_c627d0ef-8797-445f-a396-1cf97b342581"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzktNy0xLTEtMA_b9c92e36-5a0c-4e13-b6a3-db0e66194744"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTEtMS0xLTA_8dede175-3992-49f4-b004-3e70426aed5d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTMtMS0xLTA_3ee6625c-22a0-4fb0-bbe7-ef924bf04df0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTUtMS0xLTA_8226ddd5-483d-439f-bbe7-ac4e8bdd6df1"
      unitRef="usd">187000000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzExLTctMS0xLTA_110f882d-8210-4f05-bec4-d75a947441c2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTEtMS0xLTA_8d9fb4cc-c93e-4e41-8fce-8caf739bebca"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTMtMS0xLTA_a4bd5c0d-c8ed-447c-afb8-6fd09f334e1f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTUtMS0xLTA_cc04dc7a-3349-413b-8f42-5867bff47887"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEyLTctMS0xLTA_7328d523-3a12-4080-b9c8-44d755e57119"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTEtMS0xLTA_a918e292-9cc3-4cba-b947-f7bd6722b8bd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTMtMS0xLTA_730a37ed-295d-4b00-9f0c-c6d269c82cd5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTUtMS0xLTA_2b5d2f13-edf7-4bc9-8d96-65773dab39a8"
      unitRef="usd">77000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzEzLTctMS0xLTA_cb67e9d6-177f-4b03-aa20-049c1397093c"
      unitRef="usd">-52000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTEtMS0xLTA_c9393f0f-da38-4067-bef1-764d023e1e77"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTMtMS0xLTA_781cb22c-cef1-4198-b692-4fbf85caf562"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTUtMS0xLTA_d0274399-211d-4a78-b205-b4e32fc43c78"
      unitRef="usd">875000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE0LTctMS0xLTA_bc9dcd09-1ae1-4952-9436-f99e3d88906a"
      unitRef="usd">896000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTEtMS0xLTA_6e93a16d-0524-4c46-94bb-ff5cf6e0967d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iad18cf43caca4fa9b52b9f44c52fa56a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTMtMS0xLTA_84ff4c69-c333-43b2-8baf-60b662d5f6ec"
      unitRef="usd">322000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTUtMS0xLTA_bb13f42e-5e17-4add-a9ec-e50fd4f366c1"
      unitRef="usd">594000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4352db6f20a74338aa9b3bada49da7c4_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE3LTctMS0xLTA_ecd8bbcb-7f38-497b-b307-964574eba398"
      unitRef="usd">642000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTEtMS0xLTA_aa0f96f0-6762-4f71-9b53-0a567b3c8936"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTMtMS0xLTA_82a62bfb-27c4-4d2c-9fd4-b994e0a12a95"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTUtMS0xLTA_9f70fbe4-9244-47f6-a045-96d47cf368e6"
      unitRef="usd">87000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE4LTctMS0xLTA_22b632cf-9b01-44c5-9d10-b9116f14567b"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTEtMS0xLTA_2c654b3c-c04d-4ace-b065-67eaf53feae7"
      unitRef="usd">1000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTMtMS0xLTA_f2c6c6c6-e721-4187-ac94-9d99921de688"
      unitRef="usd">116000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTUtMS0xLTA_1874f5a0-bec2-418d-92d3-4e11a7652921"
      unitRef="usd">27000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzE5LTctMS0xLTA_09391f1f-72ea-47c6-82b3-a1f8d8dbe154"
      unitRef="usd">28000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTEtMS0xLTA_01b33c34-7d1c-455b-af11-ffa70cc68e5a"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTMtMS0xLTA_5d6b804d-b957-4588-9870-7912678f7b1f"
      unitRef="usd">179000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTUtMS0xLTA_b18c7208-ce4c-4385-8d8a-3226122e2403"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIwLTctMS0xLTA_1a99c1ae-5fb8-4d98-ab22-f4d679282cf7"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTEtMS0xLTA_1a20fd14-f324-4094-8b2d-68eb86ff1174"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTMtMS0xLTA_7bfefe53-4e75-43ef-bc5e-2aa96f959220"
      unitRef="usd">-276000000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTUtMS0xLTA_ff779524-f5a2-4594-a295-b014f84b67b2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzIxLTctMS0xLTA_79b5d25d-364e-463a-bdd4-56df55fcffec"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTEtMS0xLTA_9e22d3a0-aac3-49ad-8a13-390b981d52ec"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTMtMS0xLTA_09dafb0d-28ca-4e22-87ba-4185d058be53"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTUtMS0xLTA_1fe92d58-df3e-4bee-be98-e2ce9b75ac77"
      unitRef="usd">61000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI0LTctMS0xLTA_95384820-371a-4089-a386-78fcf85b31d0"
      unitRef="usd">-36000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTEtMS0xLTA_37bf5031-a443-481f-890f-ed3d4af68798"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTMtMS0xLTA_b60e3b29-42c5-4248-9277-5bcfd8c5053c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTUtMS0xLTA_2df78aac-8b75-41f4-8152-c7e6fc0d4906"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI1LTctMS0xLTA_b3d1467a-6a39-441f-9a56-dda17f9d75df"
      unitRef="usd">594000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTEtMS0xLTA_790f0b72-b10e-413b-874f-67756e0fdb1b"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTMtMS0xLTA_8ac96f82-f96a-476b-9ae9-8762abb464cd"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTUtMS0xLTA_044a9d75-536d-4078-92ee-ec411cad60b0"
      unitRef="usd">-140000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzI3LTctMS0xLTA_f0c5b09a-adca-4cf4-a4c4-4d8aecd32a07"
      unitRef="usd">-302000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTEtMS0xLTA_715578e3-e84a-4f59-85e0-ea570219d8a2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTMtMS0xLTA_dcc9e9bc-0d5d-4267-83d3-53bf3f28a43a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTUtMS0xLTA_fc02d298-d76a-430f-a81e-302c7770fa13"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMwLTctMS0xLTA_353d2f58-3d12-4489-b9d7-8333a13159c3"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTEtMS0xLTA_7416500b-cdee-42e4-b47a-8b185bc7eb81"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTMtMS0xLTA_ceb4c02d-e294-4f52-9dd6-1a11d6c90479"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTUtMS0xLTA_92233d2c-603c-4ee8-af16-df2add5fc65b"
      unitRef="usd">9000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMxLTctMS0xLTA_d536adf0-a980-4a00-aeb2-db9e0c76d1bb"
      unitRef="usd">162000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTEtMS0xLTA_3fe6dabd-702a-4b9c-8a47-ce831434b56f"
      unitRef="usd">8000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTMtMS0xLTA_2d3c7a64-edb6-46c3-9fc3-c2f4d2e10587"
      unitRef="usd">9000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTUtMS0xLTA_ef4f268f-b9d3-4837-a19b-f97814bdce43"
      unitRef="usd">185000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMyLTctMS0xLTA_090f1a43-57b2-4ca2-95b8-5377849520e6"
      unitRef="usd">189000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTEtMS0xLTA_3bf9a2b0-61ac-481f-91bb-38f84f6d7fa1"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTMtMS0xLTA_e5ef1741-e038-460e-994f-a3ecb947b848"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTUtMS0xLTA_6c1f36f8-6ec8-45b5-9334-dba7c1a4aaf6"
      unitRef="usd">-140000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo4YzM2NDQ1MTYyOGI0ODhjYThkMTA3ZDIzNDVkYjVmMy90YWJsZXJhbmdlOjhjMzY0NDUxNjI4YjQ4OGNhOGQxMDdkMjM0NWRiNWYzXzMzLTctMS0xLTA_e12bc774-2f28-4c53-aa5c-a0356c4ea22c"
      unitRef="usd">-302000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ie471c931528e4e2f9855c322fe699fec_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyOTIyMDE_6e40eee4-733d-4279-b919-6bf575139882"
      unitRef="usd">151000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyNzkyOTI_26298699-7a40-429e-b064-8c3f5537e9f7"
      unitRef="usd">-89000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1MTI_1ec20be3-5f5d-408c-b631-80030e693bae"
      unitRef="usd">-32000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1Mzk_bdfe5976-2102-4a3c-9184-87fe99952245"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1NDY_deb2e032-1481-4d1d-ad39-d38cd4dc11de"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI1MjU_9786745b-f1eb-4784-a0c1-2fc649416a8e"
      unitRef="usd">-57000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODI0OTg_c2acffbd-5ad6-4d5f-9fa3-f1c24b49d0e7"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODM0NDY_52399aaf-c17e-463a-8103-17fbc99e87ca"
      unitRef="usd">-6000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i4352db6f20a74338aa9b3bada49da7c4_I20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODM0Njc_384bac3c-f6f5-4dfb-bdbf-6ea5361b492d"
      unitRef="number">0.0213</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODM1MTk_cab86767-218a-4ff9-a992-44b4b5d081b9"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE5NzkxMjA5MzM2NjQ3_5d061866-ae22-4c82-93c4-3400e1ed7351"
      unitRef="usd">42000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossInflation
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODMyNjA_dc3a83a9-dd56-49f5-92f0-0045a493c176"
      unitRef="usd">23000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossInflation>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTUz_08bf1c87-3c63-477b-901f-e1f98b274761">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#x2019;s pension plans, including accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtMS0xLTEtMA_86ab113d-c796-4645-9d1f-8053147b09fc"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtMy0xLTEtMA_1bd4643a-8147-4f34-aa4a-7ea1f8dd0117"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtNS0xLTEtMA_7c93d104-1839-4eb0-9727-9e1d380039dc"
      unitRef="usd">875000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzMtNy0xLTEtMA_f9811365-de1f-4590-be39-710521282073"
      unitRef="usd">896000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtMS0xLTEtMA_b0d429eb-c741-45cf-8ef1-27bf5cbed91f"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtMy0xLTEtMA_8f1840b5-d004-4f2a-a816-7d8d7db6339d"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtNS0xLTEtMA_fcb0056c-6b3f-4431-9c54-ed29609388c8"
      unitRef="usd">847000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzQtNy0xLTEtMA_94b9e288-a600-4049-b884-09866906a987"
      unitRef="usd">856000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtMS0xLTEtMA_12c9ad82-a336-4a87-8875-c60207180d77"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtMy0xLTEtMA_ac28617f-75cd-4180-8244-19c38675cbd0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtNS0xLTEtMA_e047b450-f6e7-4063-850e-cb0250da2034"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo3Mzc2M2YxOWM4YzM0MzY5YmI3ZTcxMjg4MWNhMzQ5NC90YWJsZXJhbmdlOjczNzYzZjE5YzhjMzQzNjliYjdlNzEyODgxY2EzNDk0XzUtNy0xLTEtMA_5999c620-e5de-413b-be80-efc1b5df4511"
      unitRef="usd">594000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDc3_b0cf572c-623d-45ee-9def-17b322b8a9eb">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in accumulated other comprehensive income consist of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtMS0xLTEtMA_c8221446-3839-4458-b8d9-789ac45a29bd"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtMy0xLTEtMA_8d8d3f33-61ea-40b2-b254-a4c2b54e2502"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtNS0xLTEtMA_666d48b4-e32f-4e41-9123-c37c8e334fb8"
      unitRef="usd">-120000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzMtNy0xLTEtMA_42e33570-04b9-4fe0-9afc-a9c17d8901a8"
      unitRef="usd">-149000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtMS0xLTEtMA_2913fe81-2c96-43e5-b54b-7caae5069184"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtMy0xLTEtMA_c3500e6a-f730-4101-aba0-56960ae8d885"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtNS0xLTEtMA_8b7d3f61-6115-40b5-b039-828d4b1074b7"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzQtNy0xLTEtMA_99d3e33b-fcad-40a8-84bb-5e24f5cc4a1f"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtMS0xLTEtMA_03ffb3e9-cb9e-4112-b2eb-7382452d56ef"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtMy0xLTEtMA_f346aaaf-f7e1-49c8-8719-2e329b139dac"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtNS0xLTEtMA_1ad1569b-627f-4318-988d-e3428fe96e10"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpiMWQ4YWFiMWJjN2Y0MWUyYmRjOTczMjk3ZmI1YzI2NC90YWJsZXJhbmdlOmIxZDhhYWIxYmM3ZjQxZTJiZGM5NzMyOTdmYjVjMjY0XzUtNy0xLTEtMA_1b63b988-ae45-4ba2-a072-061fbb83f9c1"
      unitRef="usd">146000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MTAw_b04dfc11-1ae6-4d02-a138-1f921fb551f7">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other changes in accumulated other comprehensive income were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.745%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit (cost)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive loss (income) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtMS0xLTEtMA_3b128926-e899-42dd-8f1d-2eacb5b47c3f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtMy0xLTEtMA_3d0b486b-0272-471f-a1a1-0908fe8f02af"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtNS0xLTEtMA_8492ff0f-4fde-462b-8431-7f9757c483c6"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtNy0xLTEtMA_94cacf92-2cd8-4cfd-bf8b-48c47dbcb39e"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtOS0xLTEtMA_f1d700ba-9d2b-4770-b4c7-02ba746610f8"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzMtMTEtMS0xLTA_cbe280c5-dd1c-42e3-af54-85422d93fc8e"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtMS0xLTEtMA_7e86b4b0-861a-4b63-94a9-2bd1604e1406"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtMy0xLTEtMA_16e25987-b3d1-452d-9ea2-61ac037427bf"
      unitRef="usd">-129000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtNS0xLTEtMA_f2bf8160-17aa-4106-9f25-073ed6a61e0c"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtNy0xLTEtMA_3316947a-de74-4380-856d-5c0df76a2373"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtOS0xLTEtMA_5db4d9a3-583c-47b1-80ec-25fded90b354"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzYtMTEtMS0xLTA_893967a3-6818-4d27-b15f-f031dd4bc98b"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctMS0xLTEtMA_140aefb6-19c6-4e2b-bed7-31d183e36bed"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctMy0xLTEtMA_c465fd71-8777-4da5-8c50-c45a10363fda"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctNS0xLTEtMA_4743370a-c9fe-41c5-9f12-be112e55e380"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctNy0xLTEtMA_249a6a05-5d54-443a-bcd1-3877b46108f4"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctOS0xLTEtMA_ea73ace8-6470-4c9d-b123-7d219e7f3fb5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzctMTEtMS0xLTA_7ab9a3d8-cfa8-480f-bf6d-0f1f302c2e61"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtMS0xLTEtMA_7adc413a-5c65-4d3c-80f2-c1d2d3b0096d"
      unitRef="usd">0</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtMy0xLTEtMA_e94a2284-3e59-4446-8be1-8bf2072da46a"
      unitRef="usd">0</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtNS0xLTEtMA_8b23310d-9295-47c3-b33c-9722307eb161"
      unitRef="usd">0</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtNy0xLTEtMA_fb38c1e5-bba5-40ad-903f-0f0c42767bd6"
      unitRef="usd">-15000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtOS0xLTEtMA_e56304f3-ba2d-447b-b05f-dd12e66e23a9"
      unitRef="usd">6000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzgtMTEtMS0xLTA_58a3c62f-7017-4e31-9d5e-c8de8c236460"
      unitRef="usd">12000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktMS0xLTEtMA_c75e08bb-414a-4572-91ac-a40b39572722"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktMy0xLTEtMA_6e32b79a-563b-4065-a9c8-ff1314d3e6f6"
      unitRef="usd">-132000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktNS0xLTEtMA_6c31760a-1a8a-4b81-b026-0b67bf13e84f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktNy0xLTEtMA_a878f4ef-d797-4560-a92e-8f6cf6cc5461"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktOS0xLTEtMA_08445fa6-fec3-4b6b-ba9d-e3309e549281"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTo1MTE4ZDU4N2UyMzA0NTIzYTU0ZDFlNDhmNTdjZTM2Mi90YWJsZXJhbmdlOjUxMThkNTg3ZTIzMDQ1MjNhNTRkMWU0OGY1N2NlMzYyXzktMTEtMS0xLTA_f1d42e25-3547-424f-ad49-ff5cd048389d"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ifd98e54551df4f7484c8d4d12a663576_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzIxOTkwMjMyODY0MjM_d43e0e6c-52ec-4204-8898-24cad597d61d"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ieef839e73eff43848516318cebe57433_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU0MDI_850ae69d-ea6e-4147-b4da-ddde5ba7e037"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="iad526e199d5f45e8b0138cf1dc4218d3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU0OTI_db60cb2f-d939-42d4-b49a-1a2c9a479748"
      unitRef="usd">-116000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="ifbba704ea17245a79664996d4d4b9fb9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU1NjE_d34f9e01-dcda-447e-b2ad-b436a202503e"
      unitRef="usd">-11000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if80d3a019b9947fca48a1095d9bfbf33_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU3NDI_e9afe555-12fd-4e6a-a7cc-3c0ba8f67c4b"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i9eb73386cbae4db0b0d708fc5a5494fd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU3NDk_d0ad0d56-019f-4205-b025-4a34a7422d60"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8a9ed363669a4fdfa3cc41d133ad481b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU5NjM_2b22eeb4-b039-4185-87cd-1ba21e989dd6"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia504be01cf094a55828dfdd970c95bf7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzU5NzA_cfa70245-a466-4ca8-b4b8-7eac2e1c7b23"
      unitRef="usd">298000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxNjg_ae00863f-d196-44fa-ba1a-8311782803fd"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxNzI_9a677b1c-afdd-496d-9f61-44889f41b171"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxNzY_bb991266-18d7-4627-b110-353cf1233551"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxODA_aa99ae56-66d8-416f-9de5-c50cee831eb4"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYxODc_ea8cbdfb-2f70-410a-9616-6b73cd801c3e"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzYyMDc_2ccf0022-8f70-408a-b0a8-d53817c40fe9"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="id79c7f3385b140858233d773cf42bb7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzY0NDY_df8dc69b-4557-4144-a849-056035c687b1"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDk4_5262fe80-4e4f-4108-bf45-80a0109ce002">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.83%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.71&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.18&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtMS0xLTEtMA_78fec52c-73fe-4ab9-baf0-b0a78f0f41e7"
      unitRef="number">0.0308</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtMy0xLTEtMA_9b93fd7e-17c9-4d9c-918b-4e757c1d3c1e"
      unitRef="number">0.0366</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtNS0xLTEtMA_1eb6c1f5-4f8c-4c79-907e-75af8215f486"
      unitRef="number">0.0383</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtNy0xLTEtMA_2d015a30-c5f3-4505-980e-6cc62fc01e0f"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtOS0xLTEtMA_71218dd8-101c-4412-b051-9eb05893b57d"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzQtMTEtMS0xLTA_cb9535ac-0281-4db4-8e6b-8cfcf3ba7174"
      unitRef="number">0.0235</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzUtNy0xLTEtMA_66a2fbc9-dd27-470c-b6eb-17574f2d6d1a"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzUtOS0xLTEtMA_c0112fd5-43cc-4b73-b1fa-dbbc75c5e522"
      unitRef="number">0.0293</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzUtMTEtMS0xLTA_a002e318-ed4c-4558-921b-fa3f36fb3f37"
      unitRef="number">0.0313</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtMy0xLTEtMA_49f3c969-e4ee-4c8d-93f1-a24037c44485"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtNS0xLTEtMA_947304bf-eb10-4a6c-acef-dcadaccbb297"
      unitRef="number">0.0525</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtNy0xLTEtMA_626efc90-94ba-41a1-96e4-4710f5f280a1"
      unitRef="number">0.0256</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtOS0xLTEtMA_4fed17db-3492-4117-919e-84d3dc26d36e"
      unitRef="number">0.0301</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzYtMTEtMS0xLTA_a1befc13-7e35-4dc9-9159-805d782c74d0"
      unitRef="number">0.0371</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtMS0xLTEtMA_5b1f830f-3423-4f9d-9503-4bd7f991231b"
      unitRef="number">0.0235</mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtMy0xLTEtMA_a61254bc-bd58-4ff9-92b3-e8942f727614"
      unitRef="number">0.0308</mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates
      contextRef="i6248bb1cc85b45a3b152bd43e2fbeb91_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtNS0xLTEtMA_2edcdd25-b331-4faf-829e-bf4c39729b3c"
      unitRef="number">0.0365</mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtNy0xLTEtMA_5d0ebe14-0cdd-4e58-acf4-7931635dac6e"
      unitRef="number">0.0189</mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtOS0xLTEtMA_a496536d-eeb3-42a6-a7fb-3b8da2baade9"
      unitRef="number">0.0203</mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzgtMTEtMS0xLTA_5a4fbd23-3c1a-4636-a5fb-0ba5640e5bf2"
      unitRef="number">0.0213</mck:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates>
    <mck:BenefitObligationsAssumptionsRateIncreaseinCompensation
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzktNy0xLTEtMA_f7c0df9e-56ee-4e41-b492-a705c7c0751f"
      unitRef="number">0.0320</mck:BenefitObligationsAssumptionsRateIncreaseinCompensation>
    <mck:BenefitObligationsAssumptionsRateIncreaseinCompensation
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzktOS0xLTEtMA_8ff9768c-0a4c-44ba-bd59-851d58a66530"
      unitRef="number">0.0293</mck:BenefitObligationsAssumptionsRateIncreaseinCompensation>
    <mck:BenefitObligationsAssumptionsRateIncreaseinCompensation
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZTpkNmFjZTBlMzVjZDY0ZTljODc1ZmU1YjA2YzBhYWRlNi90YWJsZXJhbmdlOmQ2YWNlMGUzNWNkNjRlOWM4NzVmZTViMDZjMGFhZGU2XzktMTEtMS0xLTA_01344846-7242-4b41-b9c4-d589cc09c2fc"
      unitRef="number">0.0318</mck:BenefitObligationsAssumptionsRateIncreaseinCompensation>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i0a67a17e8f57467fb75aa5fa8a60e378_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzcxNDY_bf445f0a-0a56-488a-9b43-723bf76e4dea"
      unitRef="number">0.0235</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints
      contextRef="id5561711868a406dba2571e3837b5f92_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzcxODE_2b787e3f-a6c9-4f6e-81d3-58fda6a285c1"
      unitRef="number">0.0073</mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i752dc55059cc4447a0accfa4c957834d_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzcyNDM_b0afd216-b483-438d-9c57-1dcb50872afb"
      unitRef="number">0.0308</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzczNjU_a767259c-96ad-469d-8dd9-182fafaf6548"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzc0MDA_960646bc-78b9-4be1-86db-231fdd90e44a"
      unitRef="number">0.0014</mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzc0NjI_a4fa0c60-af99-4d15-95af-a54faafad41c"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDc5_995b888c-457a-4d8d-bec1-4c7cd8739e3c">The following tables represent the Company&#x2019;s pension plan assets as of March&#160;31, 2021 and 2020, using the fair value hierarchy by asset class:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income commingled funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate funds and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held at NAV practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaf49a496e76a4343af193f0f4a7974df_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMS0xLTEtMA_42e60c13-c899-43fb-911b-007570d6ec53"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iff7247931a914ff28d1893274243b53a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMy0xLTEtMA_45e8a913-1401-495a-a238-bae090e1a25b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i63e7186c429a445e93197d83b847b0f1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtNS0xLTEtMA_f7cdfbaa-0746-4a6b-b590-257ffc57accb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd37c0efe2444846b8dbc5093721ff2d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtNy0xLTEtMA_3a36d165-4e6b-4229-89ba-540f80d0d5b2"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia64a863540ee4b698d1bfb5e37c210e8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtOS0xLTEtMA_f2bcd68f-ff02-4c5b-8d7c-f382f0684e92"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia086abbf885e4851977fa3b0dc5873b4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMTEtMS0xLTA_6b0936e0-2ec0-41ba-8bb9-9537169f991b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieddab407ff0b4324b0c636ff14ea949d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMTMtMS0xLTA_f8676a0a-a66d-4713-9f56-7d577e8c4e4c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i52ce91aa281c4dacbc249f21d1c8cb63_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzMtMTUtMS0xLTA_62ce0ef6-4579-4bf5-a439-11655c390f38"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iebcc6ceb48874567b7361b7a9293eb5a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMS0xLTEtMA_f9a423d7-dbdd-4b88-af4d-83f1f23485de"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0e199c99040b47adbfe27d08e7241826_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMy0xLTEtMA_668e6896-1da0-4da2-a960-789f402255b3"
      unitRef="usd">117000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9de1d4c7fe7f434aa5351ea9e7492d11_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtNS0xLTEtMA_6c7f2038-fe9c-452a-84cc-69b778e0e82b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i76d6e4ce540141978ff1ca84f802062f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtNy0xLTEtMA_966b7b07-cb0c-4f72-bd2f-6fd2d1319545"
      unitRef="usd">181000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e3fc200020647f1b1811620c34c8b73_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtOS0xLTEtMA_96a88808-bd37-411c-ab49-538f798eba29"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i251a6c64448049b085a70bfdf3b66f0d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMTEtMS0xLTA_8b76a577-3c51-4d80-a70e-7ae9814d2b13"
      unitRef="usd">75000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4d8680e23f234d63971e7108407c5ba6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMTMtMS0xLTA_f9dcc866-9d3a-42f7-9d11-c01f5b967b0d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id1a00b451ff94034895b6946d7a38db1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzYtMTUtMS0xLTA_9ca4edcb-9721-424f-b8f1-de72f6e450cd"
      unitRef="usd">128000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ba0213d39194a988ddbaf8d509a9ff9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMS0xLTEtMA_0e652fbd-cd0b-4214-ac81-8318a831e700"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6660febcd05a4ddd91b2880f7aa36913_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMy0xLTEtMA_4af3baab-1867-4858-9d30-55618e7e6cd2"
      unitRef="usd">144000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i63eb6a5f45a34ec1b15088e8d927fa66_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtNS0xLTEtMA_2d74afee-507e-457a-85c1-a65e87de24bd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6ed65ff56e894a1286cad47c9f8a5d88_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtNy0xLTEtMA_94802e26-54ba-4d9b-a404-3e78c7e62097"
      unitRef="usd">149000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i02cdbba97e7740f58868b386a457b134_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtOS0xLTEtMA_fcf1ce63-eaa2-42be-a5d8-cfdb87f7204c"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6baf74c2370245c78b8481e1f70d7407_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMTEtMS0xLTA_4060edcf-f655-44ff-8c0b-67d34a259f09"
      unitRef="usd">139000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8c9d21d88c6642b49925de8143031180_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMTMtMS0xLTA_20c5ca40-1dd5-4e2e-83d7-727cc2a8a906"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7137372572264ce2af8c977e3e539757_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzgtMTUtMS0xLTA_b946c251-c5fe-407d-87ff-b5ec504d628a"
      unitRef="usd">145000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i93548af7026745198b9efa38f1eec08d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMS0xLTEtMA_1bc9de82-a5b9-4f5e-b971-cfad5b0fd331"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3b6e42fbe1ee49f4a2526d4ce9934227_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMy0xLTEtMA_36ca70f6-ccf8-4b44-af80-dd8fe7a550f0"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2d9c1363fee943e8884e04ee49ac6551_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktNS0xLTEtMA_8b07d0f8-7d81-489e-b4c8-deea93db688d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id52a3fc127ad472a8539e3ee6bb1d8ef_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktNy0xLTEtMA_38d718a8-7aba-4b9f-8684-97117f0cda98"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4165a5bc7db3475f9aba7f68b27c0c23_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktOS0xLTEtMA_160bebb6-f278-48db-90d9-d84be069d4bb"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic55b1ddc17a1405aa6e108d536b9ba0c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMTEtMS0xLTA_92ba1410-283e-4e2e-ba14-03710f3d5107"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i48a05b66006e4eb1908e988b90b7c584_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMTMtMS0xLTA_916d7a9b-1fac-4a1f-981c-88532cdec385"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3e0faaa4d4d048a391122a9b7f845605_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzktMTUtMS0xLTA_5107cccb-07c8-4350-a3ca-65670ca693e5"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34cdfe04f367491a94ee3b1a4e525875_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTEtMS0xLTA_ca4e11b5-9424-423e-a271-aeaa8fb1addf"
      unitRef="usd">51000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i922690c523a74696a506676b6c3c8293_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTMtMS0xLTA_8528fc57-4a9b-4bb0-87cd-4241aab2c619"
      unitRef="usd">222000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3da32ab3fea74b268e5f8d39e57ab030_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTUtMS0xLTA_0e3cf339-64d2-410c-8fc7-843bcd3049f3"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib686c0f367e5401cb4d26df1ffa0ab31_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTctMS0xLTA_e220fc2b-d09a-497c-9208-db2c7847b5c2"
      unitRef="usd">274000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie9cb2b02f0a347969390424b0f1f5db9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTktMS0xLTA_d771761a-46d8-4863-aabb-7be5270b8ae3"
      unitRef="usd">107000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c6a46adee414a2ebe17ba74ea9a1405_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTExLTEtMS0w_87541cba-4fda-4c04-877f-76d9194a2343"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69f649e07f96460d9704c43f741f4af4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTEzLTEtMS0w_bf150165-8136-4a8e-869c-85bf7d1a7b2c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic24c319a97c0492aadc927a233e73092_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzEyLTE1LTEtMS0w_7b7a755d-bd47-42b7-8605-2bbdd0130bc9"
      unitRef="usd">208000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iadc03f35a99e4203abcbc456a09c3804_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTEtMS0xLTA_d7b98c48-cbfd-431b-add5-b56eb4f04983"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7f5537dbd7704790be3e79071a25edb0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTMtMS0xLTA_4e4869cb-cc0b-44da-be02-04dbafb33150"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i86d4143c9b1147849d5c123548037925_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTUtMS0xLTA_bd2c12b5-347c-40fd-89d4-7a40b21a7f87"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6aaf48c142ae4eeb8c19be8ab65b1e29_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTctMS0xLTA_262b1781-2a9e-4bb1-bc5b-584b86d2d2a7"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i00b4fef7c31c4a70876df028d549534e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTktMS0xLTA_5e85e620-8783-4ec5-9ba8-6169bbb9ceda"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4bfc6674c5834a339d83ac6ffe6cba98_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTExLTEtMS0w_d8812f11-baa1-4166-9a51-0ebfe030f5dd"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic63f6364c6b240679b6ac191aaf72880_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTEzLTEtMS0w_e457dc3b-5f21-4c5f-a721-293c0381fe40"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idfb3425ba7cd445f84b23ec22c53919b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE1LTE1LTEtMS0w_659ad977-4180-4ce3-8a02-583bd429974f"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iafacf2945ba549808ec2d53831cb3ac2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTEtMS0xLTA_91f49469-71d3-49db-a20a-2eec14a3dc42"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84f0be6b3b254094b68a2267dc7b119b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTMtMS0xLTA_85670248-765a-4e2f-a1f9-4e75c5562e7d"
      unitRef="usd">517000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i30ec3913d2a24972a6ed10647552acc7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTUtMS0xLTA_040328bc-b073-4415-af89-dfe7fab49a6c"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i75aeb536cafe4a8ca7661d227b781a7d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTctMS0xLTA_c226a771-9174-40ed-8514-a9829637b8d4"
      unitRef="usd">683000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iae17de65aad448a1be8ef9cde1a3083b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTktMS0xLTA_60e7ab77-d8d4-4413-8ab3-2f9a530343cf"
      unitRef="usd">215000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if8be00e7305947d29917c0a90318f87b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTExLTEtMS0w_3bae4281-be5c-4125-af67-fad2c1a617a5"
      unitRef="usd">334000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i522f5c831bd24654aa4f2e255332199f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTEzLTEtMS0w_f2a41dec-55f0-4aac-9c2b-b6b4a0797195"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i752cfd53540f4acd8c7907a47b064fa7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE2LTE1LTEtMS0w_c395ac81-f6d8-4d15-bc97-41c5e4ceb2b8"
      unitRef="usd">552000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if06c71ba2610427fabe2fd8eba480224_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE4LTctMS0xLTA_387ad720-e3e9-496e-9ab2-0a2b44ae2cda"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibe8bbd8b67344a6184b0aafa7b5e6d28_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzE4LTE1LTEtMS0w_cdbd0744-1d61-457f-9120-1b5e2808ea0a"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03a442011c4b4e62a01c94084b029d73_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIxLTctMS0xLTA_b29eaa9a-caee-40f5-8ade-7cc4f70bb758"
      unitRef="usd">42000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i667557a44ad64ee88484a6c4fb179948_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIxLTE1LTEtMS0w_f0c8ac66-662c-416d-98fb-e53a61df16e7"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIyLTctMS0xLTA_e4a37c61-39b9-47c9-8e52-84deedfc6004"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibfbaff200cdd4e6dbe70e17c97261f39_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90YWJsZToyYzAxNThjMTY3NDg0OWM4OTJkNDBkYzM3MzNlY2I1OS90YWJsZXJhbmdlOjJjMDE1OGMxNjc0ODQ5Yzg5MmQ0MGRjMzczM2VjYjU5XzIyLTE1LTEtMS0w_d75d8d54-d34f-4c7d-b5e1-3c1ef40d9713"
      unitRef="usd">594000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <mck:UnitValueOfCashAndCashEquivalents
      contextRef="ia182f02d29944e6e98fc4ad018ea349c_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEwNTEy_830d6fd0-3155-459b-9688-65ca8ca3bb01"
      unitRef="usdPerShare">1.00</mck:UnitValueOfCashAndCashEquivalents>
    <mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue
      contextRef="i86ee3888e9874369a385166f1dc2d756_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEzMDQx_d38152ae-3d58-4841-af9d-78cff4240ba8"
      unitRef="usd">36000000</mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue>
    <mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue
      contextRef="ifccd58ee2c094daf8d0a763a2263760d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzEzMDQ4_1943b021-10b1-49c0-82d6-39674679f11e"
      unitRef="usd">29000000</mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue>
    <mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjA2_e315c421-caf3-4de1-94c4-f8e4198fe732"
      unitRef="number">0.05</mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i482d755915844552a319acd0ebad87c2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjQy_7ea2f860-ef17-4866-9f26-3879458fb3a4"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i93db1ef79ed8464f99c86cdad017aecb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjQ2_84d59901-5adc-415c-993e-fca8b6b6c84c"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5762ed35e28c4e2fae4d5c37556457b8_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1MjUz_c8e0cb31-ae5c-47ab-87af-2ff2ff8e18ab"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <mck:MultiemployerPlanFundedStatusPercentage
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1Mzkw_cf820a0c-c2ce-49b6-b9e4-ac6f064e633b"
      unitRef="number">0.78</mck:MultiemployerPlanFundedStatusPercentage>
    <us-gaap:MultiemployerPlansWithdrawalObligation
      contextRef="if65c96e5196c41e1bd6da83734b674a0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1NDAz_1e5134c8-ec37-41f8-8ce2-c8f36001493d"
      unitRef="usd">0</us-gaap:MultiemployerPlansWithdrawalObligation>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1Njk1_62e9b277-537a-4424-924e-95b23c429aff"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="id8cadf8c988e45fb883101ea1a6a10f3_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1ODQ5_f83433a9-f9d5-4c8d-bb7d-4391ba1dea0a"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <mck:EmployeeContributions
      contextRef="id8cadf8c988e45fb883101ea1a6a10f3_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1ODc2_14b1aa4c-d7d8-4357-a7bc-a177903d3149"
      unitRef="number">0.03</mck:EmployeeContributions>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i6dd62e97be4e40009772be77a6677117_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1OTAy_68b662a2-6994-43c6-beb0-308f4674a5bc"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <mck:EmployeeContributions
      contextRef="i6dd62e97be4e40009772be77a6677117_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE1OTE4_cbd8e288-8c68-4952-bb83-20cc35f570f6"
      unitRef="number">0.02</mck:EmployeeContributions>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE2MjU4_9392c548-9829-4dce-a0c0-ac3e1f62f886"
      unitRef="usd">102000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE2MjYy_2e3b3900-2f59-4195-8f32-3b511ae799bf"
      unitRef="usd">102000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE2MjY5_f66c9450-da81-4831-b6fd-d56d4d04e0bd"
      unitRef="usd">92000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i0c346010601f41a8883754f4737da9a4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDY1_ada76b66-d37f-403f-87df-465489d51b72"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie25f16fc97a74b6186d5dbaa0dabe3da_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTAvZnJhZzowNjlmM2ZiNzM2ZWQ0NzIxYjJiNDdhMjBkY2YwMTQ4MS90ZXh0cmVnaW9uOjA2OWYzZmI3MzZlZDQ3MjFiMmI0N2EyMGRjZjAxNDgxXzE3MDcy_cc6fe8f1-c48d-40ae-8d96-88962e02a799"
      unitRef="usd">65000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzEwNTEz_11a45ec6-068f-4188-9f74-e1420ee39cd9">Hedging ActivitiesIn the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. &lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency exchange risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021 and 2020, the Company had &#x20ac;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Consolidated Statements of Stockholders&#x2019; Equity where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. In December 2019, the Company prospectively de-designated from net investment hedges &#x20ac;250 million of its Euro-denominated notes which matured in February 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2019, the Company also had &#xa3;450 million British pound sterling-denominated notes designated as non-derivative net investment hedges. On September 30, 2019, the Company de-designated its &#xa3;450 million British pound sterling-denominated notes prospectively from net investment hedges as the hedging relationship ceased to be effective. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $118 million in 2021 and gains of $39 million and $259 million in 2020 and 2019, respectively. Ineffectiveness on the Company&#x2019;s non-derivative net investment hedges during 2020 resulted in gains of $34 million which were recorded in earnings in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the years ended March&#160;31, 2021 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated as Hedges &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021 and 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million and $1.5 billion Canadian dollars, respectively. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#x201c;Accumulated other comprehensive loss&#x201d; in the Consolidated Statements of Stockholders&#x2019; Equity where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the years ended March&#160;31, 2021, 2020, and 2019. In 2021, cross-currency swaps with an aggregate gross notional amount of $999 million Canadian dollars matured and the remaining cross-currency swaps will mature in November 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2019, the Company also had cross-currency swaps designated as net investment hedges with a total gross notional amount of &#xa3;932 million British pound sterling. In 2020, the Company terminated these swaps due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million in 2020. This gain was recorded in earnings in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from the Company&#x2019;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $119 million in 2021 and gains of $76 million and $53 million in 2020 and 2019, respectively. There was no ineffectiveness in the Company&#x2019;s hedges for the years ended March&#160;31, 2021 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#xa3;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#xa3;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At March&#160;31, 2021 and 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion and $2.9 billion, respectively, which are designated as cash flow hedges. These swaps will mature between May 2021 and January 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#x20ac;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#x201c;EURIBOR&#x201d;) for the &#x20ac;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 13, &#x201c;Debt and Financing Activities,&#x201d; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $42 million in 2021 and gains of $98 million and $28 million in 2020 and 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations were not material in 2021, 2020, and 2019. There was no ineffectiveness in the Company&#x2019;s cash flow hedges for the years ended March&#160;31, 2021, 2020, and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in value included in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At March&#160;31, 2021 and 2020, the total gross notional amounts of these contracts were $39&#160;million and $29 million, respectively. These contracts will predominately mature between April 2021 and December 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. Changes in the fair values were not material in 2021, 2020, and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the non-derivative net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#x20ac;250 million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they are offsetting matured in February 2020 and were not designated for hedge accounting. Changes in the fair value for contracts not designated as hedges are recorded directly in earnings. In 2020, losses of $44 million were recorded in earnings in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations, which offset the ineffectiveness on the Company&#x2019;s non-derivative net investment hedges noted above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;(current)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Refer to Financial Note 17, &#x201c;Fair Value Measurements,&#x201d; for more information on these recurring fair value measurements.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i9bd0ad5cd9f64967ab1d489f14880abc_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzE0OTk_0471c5ea-d5e0-4888-a4f4-2fd2a08cd286"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2c4bea63e16a4f178e9d9a0b8adb9aa6_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzE0OTk_dbd71a1c-b085-4291-b1fe-45623b263a7d"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8874cbe0e0bd4d968ce32dccacb9e82d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzI1MjQ_732de181-4f33-4fd7-8bcd-9101063fcc4c"
      unitRef="eur">250000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1f7e095fc24d45e9a294900b86a6d643_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzI2MTc_d873f7bd-5188-4885-a76c-da43d98905ce"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5180872f1daf4367ae60ec035bbdeeb2_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzI3NjY_836ed81e-20bd-4112-8cc3-c4076da14876"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMwMDM_f0bcb044-179b-4a1b-b49f-46938ad131f7"
      unitRef="usd">-118000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMwMTA_5061b6c8-193b-49a8-a295-53acdd1bf587"
      unitRef="usd">39000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMwNDA_9c4d65ec-74b4-48d3-8d15-bf608477a21e"
      unitRef="usd">259000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzMxNTM_d8666de6-4b14-434d-a9c2-6fe5990ead3d"
      unitRef="usd">34000000</mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i817dc0da95ba4e5d978cb261392a4458_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNDk3MjE_108fdc12-3be6-4fb1-afb8-fd4d27a394ff"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibe1e06122bde42dea54156fed96f14ab_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNDk3NDM_c5acfe8c-2bf1-405d-93b0-bf3bcaa360e3"
      unitRef="cad">1500000000</us-gaap:DerivativeNotionalAmount>
    <mck:DerivativeNotionalAmountMatured
      contextRef="i817dc0da95ba4e5d978cb261392a4458_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNDk5OTc_149bbbd1-cdfa-4643-9af5-29d9dc86bb93"
      unitRef="cad">999000000</mck:DerivativeNotionalAmountMatured>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5c95a543404e41e2af0a9d67836a7894_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzQ5MjA_fcb85d10-e950-4fc8-9419-86e540de8a9b"
      unitRef="gbp">932000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i4912f098ebbb49ec84aab8167ce6c62f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzUyMTQ_2e51945c-99d3-4b1a-a6ad-4bd66f5663b4"
      unitRef="usd">84000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="i4912f098ebbb49ec84aab8167ce6c62f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzUyNTQ_dad7615e-c11d-48a0-b736-f3a22f76180a"
      unitRef="usd">34000000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="ia231762ec9524000b72d1100dc01e0b9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0Nzk_94bc3b02-7ffb-4ff5-9ec4-8352ce08f2a7"
      unitRef="usd">-119000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i817e532872ff41b49bff73a8ac0e47c5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0ODY_0cbac356-ebb6-46a6-9d7f-692032f06d41"
      unitRef="usd">76000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i53fd7c4598e7493daae729bcc3ff421e_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU1MTY_78f109e7-8842-4498-aa26-765491267f9a"
      unitRef="usd">53000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:LongTermDebt
      contextRef="i5180872f1daf4367ae60ec035bbdeeb2_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU4MzU_836ed81e-20bd-4112-8cc3-c4076da14876"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5180872f1daf4367ae60ec035bbdeeb2_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzYxODc_836ed81e-20bd-4112-8cc3-c4076da14876"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i53702046a4124ad485291bebe82245b0_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzc2NTM_9e128c9a-6bd9-4089-b9aa-f9f46fa26e31"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i12d54840073946439b15c638a7e7457f_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTA1NzM_fdf9a92d-33c7-4e79-af39-05acc09b5de3"
      unitRef="usd">2900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE2NjE_f675e728-a4f8-4dff-8524-b5913443dda6"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE2Nzc_f5e0cdd9-683f-4d0a-bb7a-6ac8b6ce5722"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE2OTM_f675e728-a4f8-4dff-8524-b5913443dda6"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE3MDg_f5e0cdd9-683f-4d0a-bb7a-6ac8b6ce5722"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21004c9f5a8c4f50a7843faadd219c08_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzU0OTc1NTgxNTE3MjM_f675e728-a4f8-4dff-8524-b5913443dda6"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib82c3ffdbb3a41a5aec156304f17e31c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzgyNTM_9cd4fc5a-0461-46f1-a415-ef6481319052"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5299bd1dd919404fbdaf72f5fea0b8af_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzgyNjA_42a9d23a-d571-4c36-a223-0cbcfbb3c28e"
      unitRef="usd">98000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5c5c584197cb47379b1b7c14225ff68f_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzgyOTA_f79f513f-0212-4115-8b41-6d448cf08e7e"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia984cf8845c74e7289319379358fa6fb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzkwMDI_dc111f1e-6457-4500-9619-9a30f4ceb227"
      unitRef="usd">39000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i01610a464cf24d10b1649f93c6dd325f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzkwMDk_c365e99f-5055-4524-aa97-775f345d379c"
      unitRef="usd">29000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if65491e199804aaa88bd166f8ca3be43_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzk4MzQ_6b86f17a-e27d-413c-bf75-20a47d77d32d"
      unitRef="eur">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ib007a62583634542927bd84b71663f81_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzEwMTUy_6b43050c-f461-4c19-8fdb-c2b6c722d5be"
      unitRef="usd">-44000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90ZXh0cmVnaW9uOmZmYTc2MGNlOGJiYzRlMzZhZDM5MzZhOTA2MTk4NzkyXzEwNTAz_bd77b8ee-7cf8-465f-8b09-0c4cf80ec16a">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;(current)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic0c9fbb71f394a7681cd8e128c4ca678_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtMi0xLTEtMA_707fa1e1-f585-484f-af02-d99aceec491e"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icfa2fbd8be98466d8391902894ef72d2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtMy0xLTEtMA_816f3f88-6075-42eb-a675-37011b214e83"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia0e75b865efa47ec9f317da6494e4d4d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtNC0xLTEtMA_229b7a3a-aba6-42f3-a4fc-d4b6434df5ba"
      unitRef="usd">826000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifd3f0773896b4e48973d8fa8546e4b4f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtNi0xLTEtMA_abb1184b-f476-46a1-a58e-dcd120ff2e7b"
      unitRef="usd">112000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1388407356724e0ea750cc0fcc36009e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtNy0xLTEtMA_3746b6e6-d1e0-46f6-8b78-928c4ef57d85"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i08745885db4845b2929c65f0e1a8560d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzUtOC0xLTEtMA_831e0526-f128-4144-b105-a8c64425c3a7"
      unitRef="usd">1279000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i90cf6f7bcf9f490b8486918cc3e7f3a8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtMi0xLTEtMA_98fdb91c-9a0a-4011-8bf7-232f39c4e2b5"
      unitRef="usd">72000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5fbf63d8d1d545b2bdcd18abc08e8ac8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtMy0xLTEtMA_a6f49106-281b-4142-9f09-d0854de3397e"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7854a867193e4d57bbd9c6cd7fc41e84_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtNC0xLTEtMA_08e21029-1cb3-4a3d-9c31-f5c49e2b5590"
      unitRef="usd">2663000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i95fc81c6ff294b6fb53c554a85f12552_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtNi0xLTEtMA_2fc08d49-218d-4cd2-bcc7-0bebcd9e47bf"
      unitRef="usd">182000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ied797e934f764283b9613debb2b85b60_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtNy0xLTEtMA_fed1983b-c96c-4ac4-946f-cf76486152cc"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia427b71cb3fc4506aa62b238fa8e4181_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzYtOC0xLTEtMA_bdd709e9-0548-497b-9410-9763f878daef"
      unitRef="usd">3313000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ied59589914674a3e8f6c2970536feb07_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMi0xLTEtNDA4MQ_9ec65aee-5ea4-42fb-b645-cc34da52cbc7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ied59589914674a3e8f6c2970536feb07_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMy0xLTEtNDA4NQ_df86951e-db73-4f11-8cd9-5a2dd40e4f48"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ied59589914674a3e8f6c2970536feb07_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNC0xLTEtNDA4NQ_49457b6e-17fc-417a-8471-4e8c9eb5d01b"
      unitRef="usd">704000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNi0xLTEtNDA5Mw_63d37162-071d-4d38-969f-10a77a382729"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNy0xLTEtNDA5Mw_9f8d0e0d-2c7b-490e-aa27-cce9321d7dd9"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia2831e06d2b0437cbe43c76fcdb43fe7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctOC0xLTEtNDA5Mw_9c5fde7f-738d-4d26-835d-7454d9f6e253"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMi0xLTEtMA_bfde96a3-1121-4187-86c3-0ddc4a22cdca"
      unitRef="usd">76000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctMy0xLTEtMA_7cec01cc-6ee3-4203-97ec-7675d4515960"
      unitRef="usd">146000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia49068b8e285481ea485b20083b13688_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNi0xLTEtMA_ca6b1ae1-1f91-481f-99ee-54e0dcd8b802"
      unitRef="usd">294000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia49068b8e285481ea485b20083b13688_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzctNy0xLTEtMA_773609ed-5de6-4282-b719-fbbe58befee1"
      unitRef="usd">19000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2d3478fa53f14391b83ba8ebc23863e8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktMi0xLTEtMA_be99d302-f48b-4cf0-9c58-aa986875e5c4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2d3478fa53f14391b83ba8ebc23863e8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktMy0xLTEtMA_7403b78b-b3f0-4ca3-b7b7-a04fd617cfab"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i2d3478fa53f14391b83ba8ebc23863e8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktNC0xLTEtMA_a5d9f386-c535-4526-8985-c7e5e9f2674b"
      unitRef="usd">29000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4a217938b29b4446aff7ba0b8ec251f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktNi0xLTEtMA_f8540eff-989c-4175-ab6e-c38c30aea244"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4a217938b29b4446aff7ba0b8ec251f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktNy0xLTEtMA_3c27e230-6b3f-44ab-b693-03f433b2e76b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i4a217938b29b4446aff7ba0b8ec251f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzktOC0xLTEtMA_53b94d58-1788-4421-b85a-6fecadaa1ad2"
      unitRef="usd">24000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTItMS0xLTA_301f462c-43ba-496f-b2ad-699778819f74"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTMtMS0xLTA_2d1d2aa2-0195-4ec0-994e-c79e20faf0d8"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i6eb5d33751ee4770ba01ae6f4e6488d6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTQtMS0xLTA_9acd6b80-b93c-4348-b25e-9a04d8ef0579"
      unitRef="usd">10000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1cbe7452a1e9407e9cef048f9838a43c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTYtMS0xLTA_7df64524-387a-4e17-8ba8-25fd4466d206"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1cbe7452a1e9407e9cef048f9838a43c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTctMS0xLTA_13c68187-ccec-4c62-9ae2-111821a552bd"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i1cbe7452a1e9407e9cef048f9838a43c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzEwLTgtMS0xLTA_427a36bc-0076-402b-810a-9c6755d1b542"
      unitRef="usd">5000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6e07f2f6223f4fadb6d3a4b0459ad972_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTItMS0xLTA_04b29028-a5a0-4249-8125-d774cfa965cb"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6e07f2f6223f4fadb6d3a4b0459ad972_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTMtMS0xLTA_b015e6dc-c757-4147-ab62-a0d7c764c79e"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id9c2e845aabd4458a28f546f452aa7cb_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTYtMS0xLTA_836a929d-bb69-4ac1-8985-fa52f191ad7a"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id9c2e845aabd4458a28f546f452aa7cb_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xOTYvZnJhZzpmZmE3NjBjZThiYmM0ZTM2YWQzOTM2YTkwNjE5ODc5Mi90YWJsZTo0NjlmZjljMTg3YTY0MmYzOGY1NmY0YThiOGU5ZDE2OS90YWJsZXJhbmdlOjQ2OWZmOWMxODdhNjQyZjM4ZjU2ZjRhOGI4ZTlkMTY5XzExLTctMS0xLTA_e5e7e59c-e87c-40ee-8295-96c6f51d982a"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzUyMTc_6c1736b2-ef59-488c-ae81-1122adefaeeb">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at March 31, 2021 and 2020 included investments in money market funds of $1.6 billion and $2.0 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#x2019;s marketable securities were not material at March 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 16, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s derivatives including interest rate swaps, forward foreign currency contracts and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $269&#160;million and $170&#160;million at March&#160;31, 2021 and 2020, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. During 2021, several of the Company&#x2019;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities, while others were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of 2021. Net gains related to the Company&#x2019;s investments in these equity securities were approximately $133 million for the year ended March&#160;31, 2021. These gains were recorded in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations. There were no other material changes in the carrying value of these investments during the year ended March&#160;31, 2021. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s International segment and goodwill of the Company&#x2019;s Europe Retail Pharmacy reporting unit within the International segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s International segment. Refer to Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges&#x201d; and Financial Note 12, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no liabilities measured at fair value on a nonrecurring basis at March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021 and 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is also recorded at cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 12, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information regarding goodwill impairment charges recorded for certain reporting units during 2021 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges&#x201d; under the heading &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Lived Assets Impairments&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzE2NDkyNjc0OTEyMjE_9f8c215f-1344-4d2d-8c47-49cdae4f6299"
      unitRef="usd">1600000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzE2NDkyNjc0OTEyMzY_d2f641eb-c10f-47f5-a9ba-6dcc0044c976"
      unitRef="usd">2000000000.0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQwNjg4_1c0a59cb-d909-4ead-adf4-52018b1ff2d8"
      unitRef="usd">269000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQwNzAz_ec6d879d-1fc6-4af9-bcc4-16ef992db5cc"
      unitRef="usd">170000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQwODI3_98fc916a-a53b-46b5-91fa-3726c76b20c2"
      unitRef="usd">133000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia738d64059fd4e028976c6a7a8405915_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQyNDYz_31bf6b87-e407-40d2-be29-6a98188965d6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id6e2683da2654d0d952236373c6802fc_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzEzMTk0MTM5NTQyNDYz_7add210c-ec9e-4183-a7c0-88e460ea303c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90ZXh0cmVnaW9uOjQ3ODRhMzUxOGQwNzQ1M2NiNmRhMTdiOTNmNWU3ZjFhXzE5NzkxMjA5MzQ4MTY5_25170707-6855-4db9-9478-faa0e0d021d1">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is also recorded at cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i281f035f8d7243408d9c4ff727319f57_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItMS0xLTEtMTYxMzg_a4d444c8-def6-49f2-a3ab-1b5f9564c160"
      unitRef="usd">7148000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i565d983f5a0443089f472cb1d490b842_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItMi0xLTEtMTYxMzg_995c8bc6-d4e8-4180-8d28-33856f9200ab"
      unitRef="usd">7785000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i94edb97965974ee69d4b3074e0161dc4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItNC0xLTEtMTU0NTU_48414662-9c4a-4633-96ce-020ba9e1419e"
      unitRef="usd">7387000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i94fb664a24dd4a318195465e100eff7d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDIvZnJhZzo0Nzg0YTM1MThkMDc0NTNjYjZkYTE3YjkzZjVlN2YxYS90YWJsZTo0MTMyM2IwOTA3MTQ0YmM4OGE5ZWI2ZjI1NjUyNWVlOC90YWJsZXJhbmdlOjQxMzIzYjA5MDcxNDRiYzg4YTllYjZmMjU2NTI1ZWU4XzItNS0xLTEtMTYxNDA_725a989d-8246-4bb8-8985-3efa66a8041f"
      unitRef="usd">7792000000</us-gaap:DebtInstrumentFairValue>
    <mck:FinancialGuaranteesAndWarrantiesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzMzNzM_12023d41-c484-4a48-b47f-22d95e020bb6">Financial Guarantees and Warranties&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with certain of its customers&#x2019; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#x2019; inventory or its customers&#x2019; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#x2019;s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYwNw_af6d397b-2d02-4293-8753-eb30ffd6bb25"&gt;one&lt;/span&gt; to two years. Customers&#x2019; debt guarantees generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY2NQ_b7165f1b-8051-446f-8b5c-d34606827cfc"&gt;one&lt;/span&gt; to ten years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#x2019;s customers&#x2019; debt guarantees are secured by certain assets of the customer. At March&#160;31, 2021, the maximum amounts of inventory repurchase guarantees and customers&#x2019; debt guarantees were $329 million and $143 million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees are as follows: $268 million, $26 million, $33 million, $11 million, and $15 million&#160;from 2022 through 2026 and $119 million thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021, the Company&#x2019;s banks and insurance companies have issued $146 million of standby letters of credit and surety bonds, which were issued on the Company&#x2019;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and its workers&#x2019; compensation and automotive liability programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#x2019;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</mck:FinancialGuaranteesAndWarrantiesTextBlock>
    <mck:GuarantorObligationsPeriod
      contextRef="ia3f06168993540edb69d2eaf0d4aad1a_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYxMw_1513a701-8ef0-4297-a15a-1f5746d3e8af">P2Y</mck:GuarantorObligationsPeriod>
    <mck:GuarantorObligationsPeriod
      contextRef="ie94373a23dc74d088079c736cb431ae4_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY3MQ_aca599be-f572-4d09-a0c1-d3c86cdfb3c1">P10Y</mck:GuarantorObligationsPeriod>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="id8aaa878041344688e3f4286b29f0360_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzk2MA_13f590d3-642b-431b-b7ec-a63a5fe82648"
      unitRef="usd">329000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="ide8bc86e5ceb4bf5b7a0cfc3b386f8f3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzk2Nw_3d472dae-5ed2-42cd-8ce7-f3202c736b2a"
      unitRef="usd">143000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <mck:GuaranteeObligationsExposureExpiringinYearOne
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzEwOTI_cf7b6a05-3d96-42c0-9fb7-bf9d568dea2a"
      unitRef="usd">268000000</mck:GuaranteeObligationsExposureExpiringinYearOne>
    <mck:GuaranteeObligationsExposureExpiringinYearTwo
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzEwOTY_6cd9f412-f4c5-48fa-8ee8-94dff571f486"
      unitRef="usd">26000000</mck:GuaranteeObligationsExposureExpiringinYearTwo>
    <mck:GuaranteeObligationsExposureExpiringinYearThree
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMDA_39a0bcb3-7da3-4ac8-85a1-1ef27034149b"
      unitRef="usd">33000000</mck:GuaranteeObligationsExposureExpiringinYearThree>
    <mck:GuaranteeObligationsExposureExpiringinYearFour
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMDQ_281d026a-872e-49ea-9514-f14aa565675c"
      unitRef="usd">11000000</mck:GuaranteeObligationsExposureExpiringinYearFour>
    <mck:GuaranteeObligationsExposureExpiringinYearFive
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMTE_0c5f4270-b278-49f4-84df-083085053c54"
      unitRef="usd">15000000</mck:GuaranteeObligationsExposureExpiringinYearFive>
    <mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzExMzc_1ea29151-1150-47c2-bb0a-6261161b37cb"
      unitRef="usd">119000000</mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ibeef638bf5d34fbab16454219b83a7ce_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzEyMTU_8e579538-016c-4c29-a502-be91019d7323"
      unitRef="usd">146000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMzNzcx_9ae6edb5-eefd-4f2c-8167-810180bc4c74">Commitments and Contingent Liabilities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#x201c;MDL&#x201d;) in the United States District Court for the Northern District of Ohio captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: National Prescription Opiate Litigation,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Case No. 17-md-2804. At present, there are approximately 2,900 cases under the jurisdiction of the MDL court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case began on May 3, 2021. These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for December 6, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma. The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also named in approximately 300 similar state court cases pending in 38 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and two New York county governments, is scheduled to begin in June 2021, the cases brought by the Ohio and Washington attorneys general are scheduled to go to trial in September 2021, and the case brought by the Alabama attorney general is scheduled to go to trial in November 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions and other government entities (&#x201c;governmental entities&#x201d;). The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#x2019; representatives regarding a framework under which, in order to resolve claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by the Company, of which more than 90% is anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the governmental entities that would participate in any such settlement. The framework contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless concluded that there was sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disclosed in its financial statements for the quarter ended December 31, 2020 its determination that discussions under that framework reached a stage at which a broad settlement of opioid claims by governmental entities was probable, and for which the loss could be reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of that conclusion, and its assessment of certain other opioid-related claims, the Company recorded a charge of $8.1 billion ($6.8 billion after-tax) within &#x201c;Claims and litigation charges, net&#x201d; in the Consolidated Statements of Operations related to its share of the settlement framework described above, as well as those certain other opioid-related claims. There was no change to the estimated liability as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In light of the uncertainties, as described below, of the timing of amounts that would be paid with respect to these charges, they were recorded in &#x201c;Long-term litigation liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021. In addition, for the same reasons, the amount of loss that the Company ultimately might incur may differ materially from the amounts accrued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discussions with attorneys general and other parties continue. If the negotiating parties agree on terms under the framework for a broad resolution of claims of governmental entities, then those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. In some cases, discovery has been paused during the parties&#x2019; discussions. While the Company continues to be involved in discussions regarding a potential broad settlement framework, the Company also continues to prepare for trial in these pending matters. The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as 3 cases brought by governmental entities in Canada. These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, including the uncertain scope of participation by governmental entities in any potential settlement under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 8, 2018, the Company was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Manchester v. Purdue Pharma, L.P., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within&#160;90 days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company was served with two &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-2233, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State of California ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Two cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AIU Insurance Company et al. v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ace Property and Casualty Insurance Company v. McKesson Corporation et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#x201c;TCPA&#x201d;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#x2019; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#x2019;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#x2019; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#x2019; claim for treble damages. Plaintiffs&#x2019; moved for summary judgment on the same day. On December 24, 2020, the court declined to decertify the class but modified the class definition to distinguish between physical faxes (kept in the class) versus online or e-fax recipients (removed from the class). On March 19, 2021, the court denied summary judgment for plaintiffs on the issue of liability but found that McKesson&#x2019;s affirmative defense of prior consent fails as a matter of law and precluded McKesson from presenting individualized evidence of consent at trial. On McKesson&#x2019;s motion for summary judgment, the court demurred and will let the issue of treble damages go to the jury. Trial has been scheduled for October 18, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2017, two investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#x201c;Dragonfly GmbH &amp;amp; Co KGaA&#x201d;), a subsidiary of the Company, in a German court in Stuttgart, Germany,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No.&#160;18 O 455/17. On December 30, 2017,&#160;four&#160;investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#x2019;s takeover offer in its acquisition of Celesio AG, filed a complaint,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#x2019;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December&#160;19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; matter. Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof), which was rejected on November 17, 2020, making the dismissal final and binding. With no further right to appeal, Plaintiffs filed an objection against the decision of the Federal Court of Justice on November 27, 2020, claiming their right to be heard had been violated. On March 16, 2021, the Federal Court of Justice (Bundesgerichtshof) issued an order granting the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Polygon &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plaintiffs leave to appeal. On March 15, 2019, the lower court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; matter. On November 13, 2019, plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof). On March 16, 2021, the Federal Court of Justice (Bundesgerichtshof) issued an order granting the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Davidson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plaintiffs leave to appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 5, 2018, the Company&#x2019;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#x201c;kickbacks&#x201d; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#x2019; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#x2019;s decision on the United States&#x2019; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#x2019;s claims under the False Claims Act. The relator sought a re-hearing en banc at the Seventh Circuit, which was denied. The relator&#x2019;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020. On February 10, 2021, the relator filed a Petition for Writ of Certiorari at the United States Supreme Court seeking review of the Seventh Circuit&#x2019;s ruling.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2013, the Company&#x2019;s subsidiary, U.S. Oncology, Inc. (&#x201c;USON&#x201d;), was served with a third amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Piacentile v. Amgen Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#x2019; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#x2019;s motion to dismiss the claims pled against it, with leave to amend. On November&#160;16, 2018, the relators filed a fourth amended complaint. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 17, 2014, U.S. Oncology Specialty, LP (&#x201c;USOS&#x201d;) was served with a fifth amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hanks v. Amgen, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CV-08-03096 (SJ). Previously, the U.S. declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#x2019;s motion to dismiss. Following the relator&#x2019;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#x2019;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 3, 2018, a second amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint was filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities against McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc. and US Oncology Specialty, L.P., alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 12-CV-06440 (NG). The United States and the named states have declined to intervene in the case. On October 15, 2018, the Company filed a motion to dismiss the complaint as to all named defendants. On February&#160;4, 2019, the court granted the motion to dismiss in part and denied it in part, leaving the Company and Oncology Therapeutics Network Corporation as the only remaining defendants in the case. On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of another complaint filed by the same relator, alleging the same misconduct and seeking the same relief with respect to US Oncology, Inc., purportedly on behalf of the same government entities, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-05125. The United States and the named states declined to intervene in the case. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#x2019;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marion Diagnostic Center, LLC v. Becton, Dickinson, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#x2019;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. Defendants filed a motion to dismiss the amended complaint, which the district court granted on March 15, 2021. Plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit on March 23, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, a group of independent pharmacies and a hospital filed a class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reliable Pharmacy, et al. v. Actavis Holdco US, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 12, 2018, the Company received a class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evanston Police Pension Fund v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#x2019;s motion for class certification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2015, The Great Atlantic &amp;amp; Pacific Tea Company (&#x201c;A&amp;amp;P&#x201d;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re The Great Atlantic &amp;amp; Pacific Tea Company, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp;amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Adv. Proc. No. 17-08264.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the Company&#x2019;s subsidiary NDCHealth Corporation dba RelayHealth (&#x201c;RelayHealth&#x201d;) was served with three purported class action complaints filed in the United States District Court for the Northern District of Illinois. The complaints allege that RelayHealth violated the Sherman Act by entering into an agreement with co-defendant Surescripts, LLC not to compete in the electronic prescription routing market, and by conspiring with Surescripts, LLC to monopolize that market, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Powell Prescription Center, et al. v. Surescripts, LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 1:19-cv-06627; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 1:19-cv-06778; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Falconer Pharmacy, Inc. v. Surescripts LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 1:19-cv-07035. In November 2019, three similar complaints were filed in the United States District Court for the Northern District of Illinois. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 1:19-cv-7445; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Whitman v. SureScripts, LLC et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 1:19-cv-7448; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;BBK Global Corp. v. SureScripts, LLC et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 1:19-cv-7640. In December 2019, the six actions were consolidated in the Northern District of Illinois. The complaints seek relief including treble damages, attorney fees, and costs. Subject to final court approval, plaintiffs and RelayHealth reached an agreement in June 2020 to resolve the class action lawsuits and RelayHealth paid into escrow an amount not material in the context of the Company&#x2019;s overall financial results. The settlement does not include any admission of liability, and RelayHealth expressly denies wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company was served with a first amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hart v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017 and August 2018, respectively, the Company was served with&#160;two&#160;separate Civil Investigative Demands by the U.S. Attorney&#x2019;s Office for the Eastern District of New York relating to the certification the Company obtained for two software products under the U.S. Department of Health and Human Services&#x2019; Electronic Health Record Incentive Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April and June 2019, the United States Attorney&#x2019;s Office for the Eastern District of New York served grand jury subpoenas seeking documents related to the Company&#x2019;s anti-diversion policies and procedures and its distribution of Schedule II controlled substances. The Company believes the subpoenas are part of a broader investigation by that office into pharmaceutical manufacturers&#x2019; and distributors&#x2019; compliance with the Controlled Substances Act and related statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 12, 2019, the New York Department of Financial Services sent a Notice of Intent to Commence Enforcement Action to McKesson Corporation and PSS World Medical, Inc. for alleged violations of the New York Insurance Law and/or New York Financial Services Law, and seeking civil monetary penalties, in connection with manufacturing and distributing opioids in New York. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the United States Attorney&#x2019;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV is also part of the investigation. On April 23, 2021, McKesson received correspondence from the Belgian Competition Authority seeking civil penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IV. State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#x2019;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#x201c;OSA&#x201d;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#x2019;s decision on procedural grounds. The Company has accrued a $50 million pre-tax charge ($37 million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March&#160;31, 2021 and in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet as of March&#160;31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The due date for filing such a petition is May 17, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;V.&#160;Environmental Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Primarily as a result of the operation of the Company&#x2019;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at five sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on a determination by the Company&#x2019;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#x2019;s probable loss associated with the remediation costs for these five sites is $10 million, net of amounts anticipated from third parties. The $10 million is expected to be paid out between April 2021 and March 2051. The Company has accrued for the estimated probable loss for these environmental matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been designated as a Potentially Responsible Party (&#x201c;PRP&#x201d;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at 14 sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. At one of these sites, the United States Environmental Protection Agency has selected a preferred remedy with an estimated cost of approximately $1.4 billion. It is not certain at this point in time what proportion of this estimated liability will be borne by the Company. Accordingly, the Company&#x2019;s estimated probable loss at those 14 sites is approximately $28 million, which has been accrued for in the Consolidated Balance Sheets. However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VI. Value Added Tax Assessments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in various countries outside the U.S. which&#160;collect value added taxes (&#x201c;VAT&#x201d;).&#160;The determination of the manner in which a VAT applies to the Company&#x2019;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received&#160;assessments for VAT&#160;which are in&#160;various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions.&#160;Certain&#160;VAT assessments relate to years covered by an indemnification agreement.&#160;Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.&#160;However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or&#160;results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VII. Antitrust Settlements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $181 million, $22 million, and $202 million in 2021, 2020, and 2019, respectively, which were included in &#x201c;Cost of sales&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VIII. Other Matters &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings and claims will not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="idcf9ef2946a445b3af2f2e36d9726303_I20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzM0ODY_58a5b539-836f-43f3-ad1f-596bf36af4ce"
      unitRef="case">2900</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts
      contextRef="i5fe8ab04e6f547139155bb2d610a399b_I20200113"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzM5MTg_e08f88d7-4b6f-402f-ad63-54b3bbed0790"
      unitRef="case">3</mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i489dd58bf6eb415bb081e0bb67be780c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzQ3NDM_22c5a3c2-7c6e-46f6-8081-b57b3a829e27"
      unitRef="case">300</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="ia7becbc8d137484d97debb021a37e776_D20171205-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzQ3ODM_25f274a4-8682-4fcd-89ea-cacfe721256e"
      unitRef="state">38</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i51f39bcd0abc4530b8f9a45566eff664_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMyOTA4NjM_a7c864a4-1064-4244-a724-05e11cb95789"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ia7becbc8d137484d97debb021a37e776_D20171205-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzQ4NDI_7407bd35-658b-4a2e-b30d-94234d5164cc"
      unitRef="stateattorney">26</us-gaap:LossContingencyNumberOfPlaintiffs>
    <mck:LossContingencyNumberofCounties
      contextRef="i489dd58bf6eb415bb081e0bb67be780c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzUzMDE_0aad32be-83e6-4216-80df-5c0fb7af6164"
      unitRef="county">2</mck:LossContingencyNumberofCounties>
    <mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges
      contextRef="i245fe60a1a194d789edf2b7c72c37e2d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU4MTk_cbd0f247-3be1-4db2-a0d9-eb663c1d28ed"
      unitRef="company">3</mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i766ba6b8f9cf468f8ffca287b3b91d7a_D20191021-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU4OTk_2c4aa8bf-7bcc-4c66-8213-4c7aff6d6237"
      unitRef="usd">21000000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="i766ba6b8f9cf468f8ffca287b3b91d7a_D20191021-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU5MDc_8086558b-150a-40be-bdb2-b58913252fc0">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i5d07872c38ef46b8904d51cac9def92e_D20191021-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU5MzY_e1868fa3-ae7e-451a-9655-eaa0827bd959"
      unitRef="usd">8000000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation
      contextRef="i81c7bc7242d74503a6137340007d1f16_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NzkxMjA5MzczOTkw_98eba4de-05cf-491a-b1f5-63b77b174d61"
      unitRef="number">0.90</mck:LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation>
    <mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges
      contextRef="i245fe60a1a194d789edf2b7c72c37e2d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzYyMzM_cbd0f247-3be1-4db2-a0d9-eb663c1d28ed"
      unitRef="company">3</mck:LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMyOTUwMTk_f3b1a175-9d1e-40d7-802f-e40cef3adab9"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionAfterTax
      contextRef="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMyOTUwMjg_65378c18-95ff-4503-bbc4-292aadaa9644"
      unitRef="usd">6800000000</mck:LossContingencyAccrualProvisionAfterTax>
    <mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal
      contextRef="id47f6d83c6e74e48a98de97db2204260_D20190225-20190225"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMDEwOTc_1ecf8af1-6e71-4ff1-a08a-98bab1aeae78">P90D</mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if9fc6847924f490e8b2c037e203b3e48_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NzkxMjA5Mzc2MTQ5_88921444-e070-4738-93f8-78eadc54b51e"
      unitRef="complaint">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofRelators
      contextRef="ia64a274f0b7d4166afaa7f5a3c655f98_D20191201-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMDIwMTk_7a2eeb8f-7967-4f49-97f4-aa6b1409f7e3"
      unitRef="relator">2</mck:LossContingencyNumberofRelators>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i66d60389839f46b4a37688dfbe3d091d_I20201023"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NzkxMjA5Mzc0MDAx_06a61e90-db1b-425e-8f61-85eef49676fa"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="ideb9993f891b42a9b62b094fea769814_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEyNDM3_ef0598c0-34d9-4206-bc03-11c08f2c72eb"
      unitRef="usd">500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="i9e7ce3047a83413690e5e7de38e566c3_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEyNDQz_9e1f660d-ff48-4e95-9245-620ae12d77ad"
      unitRef="usd">1500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyClassActionNumberofFaxesRemainingintheClass
      contextRef="i69de364d379c40dc8fe389a7c7c04ab8_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEzMzEx_7d8dfc27-3a75-456a-9f37-2dea51ecb625"
      unitRef="fax_number">9490</mck:LossContingencyClassActionNumberofFaxesRemainingintheClass>
    <mck:LossContingencyClassActionNumberofFaxesReceived
      contextRef="i69de364d379c40dc8fe389a7c7c04ab8_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEzMzYw_24339272-36a2-43b2-8195-16f50b8b83ab"
      unitRef="fax">48769</mck:LossContingencyClassActionNumberofFaxesReceived>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i4dbc322ec79448d1be4e868ba2ba06cd_D20171229-20171229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzEzNjQ2_d45ded8c-27ac-4df3-a609-d5fa8a755726"
      unitRef="investmentfund">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i325d4bdea1e649a3a53c4623ba9c8558_D20171230-20171230"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE0MDAz_4fc31d87-c62d-4763-9376-4e1cfa088dd4"
      unitRef="investmentfund">4</us-gaap:LossContingencyNumberOfPlaintiffs>
    <mck:LossContingencyNumberofRelators
      contextRef="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE3MTkw_e8407ce0-46b1-43c6-94a8-404a849a782f"
      unitRef="relator">2</mck:LossContingencyNumberofRelators>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE3MjQ3_387b332e-b8b4-4e69-a6d9-1695325d07d8"
      unitRef="state">21</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberofAdditionalDefendants
      contextRef="ib47720ed909a48f0b05cab831c66167f_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE3MzA0_cf904c10-c385-47f4-b610-070b6dda47c2"
      unitRef="defendant">5</mck:LossContingencyNumberofAdditionalDefendants>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="ibe2ccd127a8d4663b1bebbcc74fb5b01_D20180403-20180403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5Mzk5_9145571c-7bb8-4fc3-97d1-06ff33a2e079"
      unitRef="state">30</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberofCitiesFiledOnBehalfOf
      contextRef="i2ed46708d24e42d5b26a1ec4e6a3ed61_I20180403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzE5NDQw_2c97b927-46bc-43fc-9ea5-be34459b1634"
      unitRef="city">2</mck:LossContingencyNumberofCitiesFiledOnBehalfOf>
    <mck:LossContingencyNumberofFormerOfficers
      contextRef="ib77506c67e6348619cb8db92d4005f93_I20181212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIzMzcz_d7e4c430-1f47-4ab8-a2b6-4599b0e55e3d"
      unitRef="officer">2</mck:LossContingencyNumberofFormerOfficers>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i85d1442fd2694c819407a70aafa1bffb_I20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI1NzYw_7fbfbac0-eb6e-4591-ba0c-2d43428585da"
      unitRef="complaint">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i241bdb994a38412ea8d52d2de2c21019_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI2Mzkz_efb322af-f170-4a5e-855b-f622a3989fd7"
      unitRef="complaint">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if6bbf73876be402592d7ed83f5fa934f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI2NzEy_4ed24d30-4f2a-439b-bf63-a59f10dc1d89"
      unitRef="complaint">6</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="icaa7143e43f54500bac344b182f4e41a_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMTgxMjA_fa59dbb2-95aa-4be0-b70b-04cb3460daa5"
      unitRef="state">27</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib6cab553ef4649228197f51778134e0f_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI3OTM5_d1154ca2-7661-46fe-a1e6-d21ef9de0ebb"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:NumberofSoftwareProducts
      contextRef="ib6cab553ef4649228197f51778134e0f_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzI4MTAx_69257d15-9316-4f98-a15e-8715fa765868"
      unitRef="softwareproduct">2</mck:NumberofSoftwareProducts>
    <mck:OpioidStewardshipActNewYorkAnnualSurcharge
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzU0OTc1NTgyMTM1ODg_267e79fe-540f-4680-be43-cf393755b3ca"
      unitRef="usd">100000000</mck:OpioidStewardshipActNewYorkAnnualSurcharge>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i56b06f9b88e745caa7ce9e463ac4f6b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMjYzMTQ_f97e8556-2947-436e-8454-250e57b07f1e"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionAfterTax
      contextRef="id02805e7f2944185bec84529e72a977d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMjYzMjE_154d9036-97b0-4cfe-9ab8-b1481f5b5dc6"
      unitRef="usd">37000000</mck:LossContingencyAccrualProvisionAfterTax>
    <mck:SiteContingencyNumberofSites
      contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMwNjY2_adedcb55-191d-44c2-9307-7be8533aa65d"
      unitRef="site">5</mck:SiteContingencyNumberofSites>
    <mck:SiteContingencyNumberofSites
      contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMTI1_adedcb55-191d-44c2-9307-7be8533aa65d"
      unitRef="site">5</mck:SiteContingencyNumberofSites>
    <us-gaap:AccrualForEnvironmentalLossContingenciesGross
      contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMTM3_710f2f52-e3f1-4f27-870c-88e0c84e0c6b"
      unitRef="usd">10000000</us-gaap:AccrualForEnvironmentalLossContingenciesGross>
    <us-gaap:AccrualForEnvironmentalLossContingenciesGross
      contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMTky_710f2f52-e3f1-4f27-870c-88e0c84e0c6b"
      unitRef="usd">10000000</us-gaap:AccrualForEnvironmentalLossContingenciesGross>
    <us-gaap:SiteContingencyTimeFrameOfDisbursements
      contextRef="i27c1da308c4b4144b44b8bf3d8fb146b_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMjMw_19390ff1-6c30-4c81-b2cd-f3f24b27889b">April 2021</us-gaap:SiteContingencyTimeFrameOfDisbursements>
    <us-gaap:SiteContingencyTimeFrameOfDisbursements
      contextRef="ia01db295201a4e96a3ef82db44b6fdc5_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxMjM3_edb7b3e0-00aa-4318-bac3-da97ae0e8ae3">March 2051</us-gaap:SiteContingencyTimeFrameOfDisbursements>
    <mck:HazardousSubstanceSites
      contextRef="i043439014160460cb387b7eff982bfc3_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxNTQx_af569406-7258-4ced-90d6-fc34eb22b66d"
      unitRef="site">14</mck:HazardousSubstanceSites>
    <mck:NumberofSitesSelectedforPreferredRemedy
      contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxODE2_26b506c8-f319-4a97-8d16-613ee499e650"
      unitRef="site">1</mck:NumberofSitesSelectedforPreferredRemedy>
    <mck:EstimatedEnvironmentalAssessmentAndCleanupCosts
      contextRef="i043439014160460cb387b7eff982bfc3_D20200401-20210331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMxOTU3_562b69b1-e6ab-4202-bf10-669d9a736e1e"
      unitRef="usd">1400000000</mck:EstimatedEnvironmentalAssessmentAndCleanupCosts>
    <mck:HazardousSubstanceSites
      contextRef="i043439014160460cb387b7eff982bfc3_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMyMTM1_af569406-7258-4ced-90d6-fc34eb22b66d"
      unitRef="site">14</mck:HazardousSubstanceSites>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i0f68a24f235c40b5829d9d37c436e1ab_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzMyMTYx_07e95df6-f222-4575-b118-b9a825c364ed"
      unitRef="usd">28000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMzAyMjA_5881ebf1-2f24-4acf-95e2-d028bc1edced"
      unitRef="usd">181000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMzAyMzQ_67ebe760-3d07-4eb4-96ac-d6205320c579"
      unitRef="usd">22000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMTQvZnJhZzpmNWM2YWM0ODBhZjQ0ZWYyODE2ZDYxYzM5M2VkYmZiZS90ZXh0cmVnaW9uOmY1YzZhYzQ4MGFmNDRlZjI4MTZkNjFjMzkzZWRiZmJlXzIxOTkwMjMzMzAyNDk_62a4c465-374e-45fc-b314-7571cdae99ce"
      unitRef="usd">202000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4Mzg_42655130-55b8-413d-b2a2-1e614ca2b86a">Stockholders' EquityEach share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the quarterly dividend was raised from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. Dividends were $1.67 per share in 2021, $1.62 per share in 2020, and $1.51 per share in 2019. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#x2019;s future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the share repurchase activity over the last three years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share Repurchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except price per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Price &lt;br/&gt;Paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate &lt;br/&gt;Dollar Value of &lt;br/&gt;Shares that May &lt;br/&gt;Yet Be Purchased &lt;br/&gt;Under the &lt;br/&gt;Programs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase plans authorized in May 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase plans authorized in January 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to the Company&#x2019;s Split-off of the Change Healthcare JV as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of shares purchased reflects rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;$8&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; on the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the last three years, the Company&#x2019;s share repurchases were transacted through both open market transactions and ASR programs with third party financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Company retired 5.0 million or $542 million&#160;of its treasury shares previously repurchased. Under the applicable state law, these shares resume the status of authorized and unissued shares upon retirement. In accordance with the Company&#x2019;s accounting policy, any excess of share repurchase price over par value is allocated between additional paid-in capital and retained earnings. Accordingly, its retained earnings and additional paid-in capital were reduced by $472 million&#160;and $70 million, respectively, during 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2020, the Company completed the Split-off of its interest in the Change Healthcare JV. In connection with the Split-off, the Company distributed all 176.0 million outstanding shares of SpinCo common stock, which held all of the Company&#x2019;s interests in the Change Healthcare JV, to participating holders of the Company&#x2019;s common stock in exchange for 15.4 million shares of McKesson stock, which are now held as treasury stock on the Company&#x2019;s Consolidated Balance Sheets. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change with each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. See Note 2, &#x201c;Investment in Change Healthcare Joint Venture,&#x201d; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Comprehensive Income (Loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $62, $(30), and $(71)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $6, $(12), and $(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit of $2, $(8), and $5 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $1, $1, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax expense of nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of $9, $33, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) (7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2021, 2020, and 2019 include net foreign currency translation adjustments of $(60) million, $1 million, and $(61) million, respectively, attributable to noncontrolling and redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2021 primarily includes adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2021, 2020, and 2019 include foreign currency adjustments of $(118) million, $39 million, and $259 million, respectively, on the net investment hedges from the Euro and British pound sterling-denominated notes. 2021, 2020, and 2019 also include foreign currency adjustments of $(119) million, $76 million, and $53 million, respectively, on the net investment hedges from the cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The 2021 and 2020 net actuarial gains of $8 million and $2 million, respectively, and 2019 net actuarial loss of $5 million were attributable to noncontrolling and redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into &#x201c;Cost of sales&#x201d; and &#x201c;Operating expenses&#x201d; in the Consolidated Statements of Operations. The related tax expense was reclassified into &#x201c;Income tax benefit (expense)&#x201d; in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2020 primarily reflects a reclassification of losses in 2020 upon the termination of the Plan from &#x201c;Accumulated other comprehensive loss&#x201d; to &#x201c;Other income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; in the Company&#x2019;s Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s accumulated other comprehensive income (loss) by component are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4_75d01ff9-39a1-40b7-8607-146b3544e925"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTg3MTAw_98b9dc5e-ed05-49e2-a2a4-ded17e39b5a7"
      unitRef="usdPerShare">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2fa25f7377e2432b8ee48290f92300f5_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTg3MTA3_574dbd04-db2c-41e6-b7ad-ea29f849877f"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzM5OQ_d571f2ec-53cc-4b4e-a53c-f74cf3d4544f"
      unitRef="usdPerShare">1.67</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQxOQ_0f10697a-7834-442a-b44b-6adbb0cdd05b"
      unitRef="usdPerShare">1.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ0Mg_86593dd4-a9ba-482b-b537-18be2b16347e"
      unitRef="usdPerShare">1.51</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:AcceleratedShareRepurchasesTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4NDc_467c37a7-05e2-4e8c-a942-9569487dd5d1">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the share repurchase activity over the last three years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share Repurchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except price per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Price &lt;br/&gt;Paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate &lt;br/&gt;Dollar Value of &lt;br/&gt;Shares that May &lt;br/&gt;Yet Be Purchased &lt;br/&gt;Under the &lt;br/&gt;Programs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase plans authorized in May 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase plans authorized in January 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to the Company&#x2019;s Split-off of the Change Healthcare JV as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of shares purchased reflects rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;$8&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; on the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.&lt;/span&gt;&lt;/div&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i022a2642b16245d083cb80c539e560b3_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzItNi0xLTEtMA_e5bf677b-6c82-4b3d-b40c-a508ff3075ef"
      unitRef="usd">1096000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2c1aa1b3a0dc420f9bef7793ceda75bd_I20180531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtNi0xLTEtMTMyMDY_9da50cf5-18c8-4ac2-a1a5-8aeb86e4ee92"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtMi0xLTEtMA_b71721c1-5e3e-4d9e-948c-d905a0579ea4"
      unitRef="shares">10400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtNC0xLTEtMA_93396d32-44f5-46cb-89d9-08f2a78a94ca"
      unitRef="usdPerShare">132.14</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5404354b708746c0a38e3406da9bcef7_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzMtNi0xLTEtMA_9245afe0-9656-4678-a4d5-151efb2fa5ec"
      unitRef="usd">1377000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtMi0xLTEtOTYxMg_b22b4cd2-2030-450f-8444-0cc949cf03a3"
      unitRef="shares">2100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtNC0xLTEtOTYxOQ_b5000591-9140-4820-a839-50f86f23a15a"
      unitRef="usdPerShare">117.98</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib4a973e40e134f4e84310937fd7ec2e9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtNi0xLTEtOTYyOQ_423b8cff-5abd-4df4-9b1a-2696df96deb2"
      unitRef="usd">250000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzQtNi0xLTEtMA_2a6039e9-80ce-4e60-8de5-358d8a8b7044"
      unitRef="usd">3469000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id903d050fec841a29536a88e85b3a251_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzgtMi0xLTEtOTY5Ng_03acef57-11bb-4936-b835-266fffedfbc2"
      unitRef="shares">9200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="id903d050fec841a29536a88e85b3a251_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzgtNC0xLTEtOTcxNA_e6c20c52-9c20-4b03-9b8d-d48d77a16a7d"
      unitRef="usdPerShare">144.68</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id903d050fec841a29536a88e85b3a251_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzYtNi0xLTEtMA_7553776e-8428-4b88-8c37-5c9bf04213f3"
      unitRef="usd">1334000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzctMi0xLTEtMA_8a25b554-d300-4792-b5c8-53fcd569f67a"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzctNC0xLTEtMA_4419574e-07c8-4fa8-84ca-422d71bf393b"
      unitRef="usdPerShare">127.68</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if29a8bbfc75c4682876b8797c9b1cdeb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzctNi0xLTEtMA_c670c4d3-8cfc-4652-8e1a-3a2ef4be0bd9"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzgtNi0xLTEtMA_fba23d6a-6d91-4de7-98eb-3554bf537453"
      unitRef="usd">1535000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i4f355bd7dad94edaa42f6261dbd8637e_I20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzExLTYtMS0xLTEzMjA2_a90f71eb-27e8-4c4b-b2a0-14ff383116b7"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEzLTItMS0xLTEzMjA2_32edac1d-0491-4e29-8b3f-712ef78b72a4"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEzLTQtMS0xLTEzMjA2_2032c0e8-e154-4918-b699-94867a716a53"
      unitRef="usdPerShare">160.33</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEzLTYtMS0xLTEzMjA2_372d7873-3991-48cb-8477-c103744e5127"
      unitRef="usd">750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTpkZDIxOGFlNmYzODY0M2Q0OGFmOTYzYTZjYWJhMGNhMi90YWJsZXJhbmdlOmRkMjE4YWU2ZjM4NjQzZDQ4YWY5NjNhNmNhYmEwY2EyXzEwLTYtMS0xLTA_0cc76499-9762-4313-a9f5-aad46f15126a"
      unitRef="usd">2785000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <mck:AccruedShareRepurchases
      contextRef="i9c441ae8aa364ac5981834da3de52970_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTg4NDM3_6edeb597-3425-4ceb-a352-0bb8a35bf288"
      unitRef="usd">8000000</mck:AccruedShareRepurchases>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzM2MTM_ab407e80-fcc8-4622-a22f-5f56b378b8b6"
      unitRef="shares">5000000.0</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredParValueMethodAmount
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzM2MTk_82db3502-abfe-4431-9420-1c8ebb54a458"
      unitRef="usd">542000000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
    <us-gaap:TreasuryStockRetiredParValueMethodAmount
      contextRef="ifabe33c854fa4cf08fbf7622ac0e16cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQwNDA_ccde832f-8306-417d-8503-d1bb445d52e5"
      unitRef="usd">472000000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
    <us-gaap:TreasuryStockRetiredParValueMethodAmount
      contextRef="icc4e534ae10841f5acf7569bfbdc28d6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQwNDc_d6ed9e0f-2595-4573-9f28-c5d79edc68cb"
      unitRef="usd">70000000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
    <mck:ExchangeOfferSharesDistributed
      contextRef="i63b13d6d7fdc4db998f4aad71d5d3642_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ3MTM_c18fcd73-fb6a-4bbe-9a9a-dcd355645751"
      unitRef="shares">176000000.0</mck:ExchangeOfferSharesDistributed>
    <mck:EquityMethodInvestmentStockAccepted
      contextRef="i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ5MDE_39f4a7d9-b5e1-426d-a14e-40064e026a98"
      unitRef="shares">15400000</mck:EquityMethodInvestmentStockAccepted>
    <mck:ExchangeOfferSharesExchanged
      contextRef="ie31c0b14f01a4c1db78adec3abc1a4a2_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzQ5MDE_7daf8abd-e5e3-41a4-9bf6-523565c16474"
      unitRef="shares">15400000</mck:ExchangeOfferSharesExchanged>
    <mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted
      contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzUxODM_bba22226-c700-48a6-adcf-ef483d4dc178"
      unitRef="shares">1</mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2d4681be8b8c4b5bb03e4f419041f9c7_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzUyNDM_bd1ade41-2999-435f-a331-5fcfb7c62740"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzc4NDU_af5d55af-cad5-4100-b20c-d00455e51c45">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $62, $(30), and $(71)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $6, $(12), and $(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit of $2, $(8), and $5 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $1, $1, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax expense of nil, nil, and nil&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of $9, $33, and nil &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) (7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2021, 2020, and 2019 include net foreign currency translation adjustments of $(60) million, $1 million, and $(61) million, respectively, attributable to noncontrolling and redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2021 primarily includes adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#x201c;Held for Sale.&#x201d; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2021, 2020, and 2019 include foreign currency adjustments of $(118) million, $39 million, and $259 million, respectively, on the net investment hedges from the Euro and British pound sterling-denominated notes. 2021, 2020, and 2019 also include foreign currency adjustments of $(119) million, $76 million, and $53 million, respectively, on the net investment hedges from the cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The 2021 and 2020 net actuarial gains of $8 million and $2 million, respectively, and 2019 net actuarial loss of $5 million were attributable to noncontrolling and redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into &#x201c;Cost of sales&#x201d; and &#x201c;Operating expenses&#x201d; in the Consolidated Statements of Operations. The related tax expense was reclassified into &#x201c;Income tax benefit (expense)&#x201d; in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;2020 primarily reflects a reclassification of losses in 2020 upon the termination of the Plan from &#x201c;Accumulated other comprehensive loss&#x201d; to &#x201c;Other income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; in the Company&#x2019;s Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWI2M2E5ZTQyMDRjMzhhMTgyOTBkMTI4NDJiNDU4XzU0OTc1NTgxMzkwMDg_be988693-67b4-4b6a-b4db-2d7ef099f252"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWI2M2E5ZTQyMDRjMzhhMTgyOTBkMTI4NDJiNDU4XzU0OTc1NTgxMzkwMTY_89cba88c-205e-4b20-9c10-4bdba9674cd1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjMxOWI2M2E5ZTQyMDRjMzhhMTgyOTBkMTI4NDJiNDU4XzU0OTc1NTgxMzkwMjQ_79ee6432-452b-462c-a3e1-1b4fdbb9713e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMS0xLTEtMA_1ab98349-92e9-4778-b635-5ea25c016c05"
      unitRef="usd">312000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtMy0xLTEtMA_246add55-fcea-4ef3-9892-3986e07cb5cd"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzMtNS0xLTEtMA_f75fd46b-bc2c-44b4-a92a-6e16808e8a11"
      unitRef="usd">-431000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIyMDAxNzFlYTJkYTQxOGM4NzkwMmViYTdjYWE3YmMwXzU0OTc1NTgxMzg5Njg_ae0a11ea-202e-43f2-bc00-6a47479becdb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIyMDAxNzFlYTJkYTQxOGM4NzkwMmViYTdjYWE3YmMwXzU0OTc1NTgxMzg5NzU_7d8e1689-2cde-4e5c-b6d8-c0fccda783e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMC0xLTEtMC90ZXh0cmVnaW9uOmIyMDAxNzFlYTJkYTQxOGM4NzkwMmViYTdjYWE3YmMwXzU0OTc1NTgxMzg5ODQ_fb8316e6-ad8e-49d4-b144-2314c6b9a249"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMS0xLTEtMA_42a9f658-ee78-4009-b43a-7ee9c4c119c2"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtMy0xLTEtMA_efa3456f-1c2e-47c5-8cc7-3a9591a897d8"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzQtNS0xLTEtMA_81c69c80-871e-486f-850b-a74300ffc318"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzUtMS0xLTEtMA_79e95c9f-9b15-4a79-8148-fcad870ae9a1"
      unitRef="usd">359000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzUtMy0xLTEtMA_d595913f-fc67-47a2-854f-9c3049cf8a56"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6c6ddcffbe24a5ea670209a1ecc37cb_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzUtNS0xLTEtMA_27deafc5-d8da-4656-b109-62b8b9ecb357"
      unitRef="usd">-431000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMC0xLTEtMC90ZXh0cmVnaW9uOmM3NDIyMDY2YmI1MTRhOGU4NjQ5NDMwNDMxYjYyOGZkXzU0OTc1NTgxMzkwMjU_38d490b3-3773-4776-ac13-c3a2fdf0c073"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMC0xLTEtMC90ZXh0cmVnaW9uOmM3NDIyMDY2YmI1MTRhOGU4NjQ5NDMwNDMxYjYyOGZkXzU0OTc1NTgxMzkwMzY_bdd0f530-e0b1-488f-8e09-7bc7b76519c3"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMC0xLTEtMC90ZXh0cmVnaW9uOmM3NDIyMDY2YmI1MTRhOGU4NjQ5NDMwNDMxYjYyOGZkXzU0OTc1NTgxMzkwNDU_c5ad975f-2156-4eea-aec3-9d39b9204518"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMS0xLTEtMA_4f4a7efd-afb5-4aff-8137-16d9750325df"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctMy0xLTEtMA_4afe4493-abc4-4ff7-8a3a-c40fd7b594b0"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzctNS0xLTEtMA_4a487b63-8be4-4b5a-b307-2389b7f442cf"
      unitRef="usd">241000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmRhNzI4MzQ4NjQ5ODQxZWY5MjBlN2U5OTk3OTc3M2NhXzU0OTc1NTgxMzg5Njc_fe5d114d-7e4f-4919-b9ca-ea6765f92c24"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmRhNzI4MzQ4NjQ5ODQxZWY5MjBlN2U5OTk3OTc3M2NhXzU0OTc1NTgxMzg5NzY_5e62752a-00cf-4a7e-b2e0-8a505658fb31"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmRhNzI4MzQ4NjQ5ODQxZWY5MjBlN2U5OTk3OTc3M2NhXzU0OTc1NTgxMzg5ODQ_b6246d13-5ce2-4446-94f1-aea9dde8ed84"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMS0xLTEtMA_4c672433-05f3-493d-a0e6-ee377b349164"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtMy0xLTEtMA_59019a1b-70bf-4a3f-a335-8a7cfcbe5a5a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzgtNS0xLTEtMA_d3253dfe-ab22-4755-ac1c-ac741c0946ab"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzktMS0xLTEtMA_998813f7-0442-470e-9c25-0b378131ed31"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzktMy0xLTEtMA_32be45aa-5c41-4bd5-acaf-b167999803b4"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00c6dcc996c542ce806943993094a62d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzktNS0xLTEtMA_fdeed4c2-cba2-4bf8-9bdf-43e2eee4609a"
      unitRef="usd">241000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjplYzNmZTc2YmJlZGE0ZWVkODFkNzZkOGJhNmQzYzI0OF81NDk3NTU4MTM5MDIw_b5e33a13-39cd-4a65-ac13-c9020416d643"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjplYzNmZTc2YmJlZGE0ZWVkODFkNzZkOGJhNmQzYzI0OF81NDk3NTU4MTM5MDMw_c59a6671-1aa2-410b-96bb-264bd7448646"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjplYzNmZTc2YmJlZGE0ZWVkODFkNzZkOGJhNmQzYzI0OF81NDk3NTU4MTM5MDM4_ba1cf1eb-b9cd-4fd6-a02f-3f441bcbc5ee"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTEtMS0xLTA_5d87b989-6cfc-4cc1-a185-7952cf6ff9ce"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTMtMS0xLTA_02cc7973-bd9a-48e7-a5f1-fe2ae3e0c517"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2e04822e0566406b894ca9c180380691_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzExLTUtMS0xLTA_6361c371-4efb-4566-9460-f2cf3adb8e42"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="icba0d73afdaf4b6d95e21bc354b2880d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo4NWEyZjZkYTc2NjE0N2U3YmJhM2Q5M2EwYTc4NjE2YV81NDk3NTU4MTM4OTY4_dac2c6fa-19d0-4741-bc10-25d0321502dc"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i03252b88bd734ce7a56608ddb4d375e6_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo4NWEyZjZkYTc2NjE0N2U3YmJhM2Q5M2EwYTc4NjE2YV81NDk3NTU4MTM4OTc3_dd1631d8-569d-4946-9d40-6a1cf2bdcd59"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id3c5d000b0d24643ae449965b3c153e6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjo4NWEyZjZkYTc2NjE0N2U3YmJhM2Q5M2EwYTc4NjE2YV81NDk3NTU4MTM4OTg2_dae9013c-d2d1-4cf4-8f5b-bf308f75e2b0"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTEtMS0xLTA_81c0c57a-db64-4ff8-8387-0e981b781bba"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTMtMS0xLTA_86c7a596-fb62-4a46-bfe8-559631d94274"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2e04822e0566406b894ca9c180380691_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEyLTUtMS0xLTA_a2143970-8e37-4a85-bcce-ba3267164704"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEzLTEtMS0xLTA_06d1f360-f942-4992-89a7-04d233b3b573"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEzLTMtMS0xLTA_fae8e3bc-a1b4-4edf-b6b8-78b583fddf7a"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e04822e0566406b894ca9c180380691_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzEzLTUtMS0xLTA_adf6cb82-d82d-4a45-8b61-0b1798e2624f"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YjBmZGIyNWU0MGQ0ZjA1YTkzMzJlNzc5MDU1NmFmMF81NDk3NTU4MTM5MTAy_307740a1-6f9f-4522-a90b-4ebcc72e05d4"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YjBmZGIyNWU0MGQ0ZjA1YTkzMzJlNzc5MDU1NmFmMF81NDk3NTU4MTM5MTEw_80fb6fdb-a741-4161-a35a-1d727ce49a2b"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YjBmZGIyNWU0MGQ0ZjA1YTkzMzJlNzc5MDU1NmFmMF81NDk3NTU4MTM5MTE2_72501057-7c70-4d83-a63a-b758ce998454"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ideef425eabb04ab1a5e71cbf9973e5f2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTEtMS0xLTA_46723e4f-2f1d-4e93-813b-bb7aba27cbc5"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib47ea8d9084a4afca5dba67392106eea_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTMtMS0xLTA_60abe25f-d907-4d72-99b8-b93c3b0caf71"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibb2e27caae16447596fd19fbd3c9a88d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE1LTUtMS0xLTA_2578931e-00e9-4d47-82ea-41f9a566354d"
      unitRef="usd">-51000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZWViMzI4ODllODA0YmYzYmI4NThjNWEzZGZjODRiOF81NDk3NTU4MTM5MDUw_b69401f2-2ab7-48e4-8096-e2a557297834"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZWViMzI4ODllODA0YmYzYmI4NThjNWEzZGZjODRiOF81NDk3NTU4MTM5MDU4_a91731c9-8843-4853-bb7a-e825e6d39ee4"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5ZWViMzI4ODllODA0YmYzYmI4NThjNWEzZGZjODRiOF81NDk3NTU4MTM5MDY4_739965d0-3f5b-4c52-ac26-621f0ef09c82"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i63ce45207fbd4b11992c8b235c7acdc4_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTEtMS0xLTA_27f527e0-b169-42aa-acf7-b823f16b5651"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8458e101d22b48b086cd13c117b50596_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTMtMS0xLTA_03ec55f9-0219-42d5-9392-fd670ca5af58"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifa299a34d5fc4bc9b76f73609f2764c6_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE2LTUtMS0xLTA_e6a43301-61c8-48b8-a774-8602e99bb397"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1NjdmZjU0ZmRjY2Q0ZWRmYWFlYTBkYjFhN2RlYTVlZl81NDk3NTU4MTM4OTg1_643fdc60-4722-4957-a254-a6b943b46ceb"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1NjdmZjU0ZmRjY2Q0ZWRmYWFlYTBkYjFhN2RlYTVlZl81NDk3NTU4MTM4OTkz_ec4f2340-44a5-49aa-a75c-57c0218353cc"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1NjdmZjU0ZmRjY2Q0ZWRmYWFlYTBkYjFhN2RlYTVlZl81NDk3NTU4MTM5MDAx_a1d6ea72-bb18-43a8-a6cb-a24229534a70"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i25daf5026b554fff9b18eed266aeb5b3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTEtMS0xLTA_56d0e3ad-4378-4cff-a0f2-4ff125e033eb"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0c768d5a4a684f049a881df6f6e2b57b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTMtMS0xLTA_e1f744b6-0c00-4ffd-b64f-f5c3d7f67c40"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id4560aec4e3b49c4bac2fdf164699f86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE3LTUtMS0xLTA_1b4d63d7-3e9e-4011-9dc0-0fcd8c631f86"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MTg1ZTIwMzlkYTg0NWZlYTg1YTM4NjY3MjBhY2VmMV81NDk3NTU4MTM4OTk2_fa4bca0e-4582-445a-95db-1ba8a09a6955"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MTg1ZTIwMzlkYTg0NWZlYTg1YTM4NjY3MjBhY2VmMV81NDk3NTU4MTM5MDA2_da76a5cc-fe84-4daa-ba3f-c6b4f88712f0"
      unitRef="usd">33000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id2556775e1fe47e6992440fb0541be59_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MTg1ZTIwMzlkYTg0NWZlYTg1YTM4NjY3MjBhY2VmMV81NDk3NTU4MTM5MDEy_8702ee4b-4ccb-42fd-a492-75d04bae4e5f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTEtMS0xLTA_6bc9f60f-30e6-4dcc-bf82-24d3695d52f5"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTMtMS0xLTA_0090ce75-de70-4de4-936a-912b0542208c"
      unitRef="usd">-94000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id2556775e1fe47e6992440fb0541be59_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE4LTUtMS0xLTA_06c954e1-f1d6-4f22-af3f-3e3ee5bd693c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i789b2e56d72a48608c130e472e7fae0b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE5LTEtMS0xLTA_b7e89a2c-7e91-4609-83d8-979257766305"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iced705cb6a4d4c61953c3ea929fae8f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE5LTMtMS0xLTA_aa8274e0-a3a6-476d-a0fc-864f12123b3b"
      unitRef="usd">129000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id2556775e1fe47e6992440fb0541be59_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzE5LTUtMS0xLTA_3fbde136-519f-4317-8af1-8248eaa1dcec"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzIxLTEtMS0xLTA_c39a8cc4-ac14-4f3c-bef5-63bb32486747"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzIxLTMtMS0xLTA_c44c6c52-2c56-45ca-bd98-90e1168f7305"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTowNjA5Y2UyYTM1Mjc0NWFlYjI4YzUyZTliM2Y5MzQ3My90YWJsZXJhbmdlOjA2MDljZTJhMzUyNzQ1YWViMjhjNTJlOWIzZjkzNDczXzIxLTUtMS0xLTA_d745f4d5-778c-49fd-8a41-a3de70c1bff6"
      unitRef="usd">-198000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0c24314d9c3e4d9f94843d3a48b7eede_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY1NDI_c89e9a30-e115-4e84-9e0e-347857211a95"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieaed4a2b4af4445f83330c94eec2f1a2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTgzODU5_68751899-bd14-43f4-8274-6d13ced6d12f"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1234f72c09014e849c5e914cbc33f91a_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTgzODY4_e48ecfb7-46cb-4a4e-b7f5-264b7810a48c"
      unitRef="usd">-61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY3NDI_d3408258-068a-4276-91f9-e033fd299545"
      unitRef="usd">-118000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY3NDk_8b378c53-affa-422e-8a1a-45cb1912e17a"
      unitRef="usd">39000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY3NjY_c708125c-1728-4af2-ae0e-95ef111cccc9"
      unitRef="usd">259000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="ia231762ec9524000b72d1100dc01e0b9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY5MTc_5fbebb68-2e30-440f-afb2-9be5088da1b3"
      unitRef="usd">-119000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i817e532872ff41b49bff73a8ac0e47c5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY5MjQ_96f487a1-bec7-443f-a9d7-754cdf82bfa7"
      unitRef="usd">76000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i53fd7c4598e7493daae729bcc3ff421e_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzY5NDE_9911ff1c-0176-421a-9b29-1ce89956ec4c"
      unitRef="usd">53000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i739cbdd44da747b7add6dc8608dd1b5a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzcwMzY_16b2a392-e6c6-4948-8d1f-c57bcbf0f780"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i15be07b9acdf4513a30f3849808f530c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE0ODQzNDA2OTgzOTQz_812deb45-a7b5-434c-9883-657b3dbb02b7"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i07af8a5be55944b695812fe13bfcd58b_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzcwODg_e70db43c-d9bf-4b87-a420-03ca895f348c"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90ZXh0cmVnaW9uOmE3YTNhN2Q5YmE1ZDQzMjJhMzIzNzYwYjAxNmNkYzViXzE5NzkxMjA5MzE2OTQ3_ce9737aa-87f2-4810-bed9-f808ebc0b637">Information regarding changes in the Company&#x2019;s accumulated other comprehensive income (loss) by component are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec9cc36803c34f05a0d2e66ae17760bd_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItMS0xLTEtMjMzNTM_6de58c01-f6d8-44b6-bf56-f9da9ed8f190"
      unitRef="usd">-1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38c5b221e50b470489c015c3be354825_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItMy0xLTEtMjMzNTM_d16474f9-e9c6-4f9a-a5fe-134e4c0e0041"
      unitRef="usd">53000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0dc447cc3eef4e94805a56f586f3f29b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItNS0xLTEtMjMzNTM_9d7b5e2d-25c5-49d2-bd91-ed08ae0af16e"
      unitRef="usd">-37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5380417ed05b451283f8c1532ae7d259_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItNy0xLTEtMjMzNTM_5b949908-d741-4fd5-a8d6-d31f5bef986a"
      unitRef="usd">-237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40ae5de5a7ed451daaf6f336a3613e5b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzItOS0xLTEtMjMzNTM_ac3a0fd8-56b1-4697-8a7c-578f6422592c"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtMS0xLTEtMjMzNTM_6ada95ae-c281-41a5-a476-dfec44a71cd2"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtMy0xLTEtMjMzNTM_444e9438-fed9-46c0-9726-979afb0002ed"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtNS0xLTEtMjMzNTM_2b62bebe-3ab0-4e81-ad3e-f16ab19f9fd6"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtNy0xLTEtMjMzNTM_8b775a51-85dd-435b-932c-ffcf309676d9"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzMtOS0xLTEtMjMzNTM_282d7fb1-5229-49cc-9c76-6af4b5aa9b24"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtMS0xLTEtMjMzNTM_4de92bc5-4ff7-4a62-a3d9-a27ff06df1e5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtMy0xLTEtMjMzNTM_0e241807-6caf-4f08-ab89-e423656bd997"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtNS0xLTEtMjMzNTM_18bc5662-4477-4723-9737-50ea3420cd9c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtNy0xLTEtMjMzNTM_03672151-cdc2-472e-9609-c4c0ea8be832"
      unitRef="usd">-96000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzQtOS0xLTEtMjMzNTM_4bf4e168-0498-49d1-9cb2-c5453776775d"
      unitRef="usd">-96000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtMS0xLTEtMjMzNTM_c08df965-1679-49cd-be5a-d25d40f4421f"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtMy0xLTEtMjMzNTM_0473006c-3ed4-447f-bda6-b7d2261e8e8d"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtNS0xLTEtMjMzNTM_9e710c5c-1d80-41b8-b9d0-eb9a6cc396e1"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtNy0xLTEtMjMzNTM_484da5c8-1e0d-4e8f-b3ff-222880fb865b"
      unitRef="usd">129000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzUtOS0xLTEtMjMzNTM_81a2ac96-6bf0-4f7b-a55d-ae22f33e4190"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtMS0xLTEtMjMzNTM_8ff06ada-2a2c-47b1-832d-83215f66892a"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtMy0xLTEtMjMzNTM_1f0fa80a-864f-4ce7-b5c3-4b964bb9718e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtNS0xLTEtMjMzNTM_f23556c3-e408-4322-b95c-94d15dcbcbff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtNy0xLTEtMjMzNTM_f2f3dbaa-ae84-4c7c-a00a-bd014c51e6a4"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzYtOS0xLTEtMjMzNTM_1c174b50-2c95-4367-9dcd-f6b31d0d68f6"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id1ad0f2916c441a7909e87601b7f48f2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctMS0xLTEtMjMzNTM_bfb96a4b-6f83-4258-a4d7-046ed86f6076"
      unitRef="usd">-152000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i49da1197585148a08970cd158baac052_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctMy0xLTEtMjMzNTM_532d45de-cc1f-4266-a75f-5f7a6e20f587"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4ef852eede8d45c6a9d3b74a9d5f326c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctNS0xLTEtMjMzNTM_b84656f1-f068-4fba-acba-8d846eb62a68"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icb6790cde47e4d1393cafacf95f4bc22_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctNy0xLTEtMjMzNTM_9216a48e-2cd7-498a-9405-7e0d0b82d2f7"
      unitRef="usd">127000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzctOS0xLTEtMjMzNTM_5eac08b2-645b-4757-a0d9-c4149e96cfba"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9a8afb096ba4b8086b849fdbc536601_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtMS0xLTEtMjMzNTM_b67a3c69-768d-464c-a9fd-1074e92452ca"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3429f651eb54a16929355b743eaba52_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtMy0xLTEtMjMzNTM_d41dd1f1-cf6d-4ec2-a940-a0c4a69ce1ad"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffce4b8d4569411a9a36db18bed95dc2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtNS0xLTEtMjMzNTM_d0f473a8-f4c0-471a-b830-7dbabf47b8bc"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26c1e0d879d74d0ba80ac1c15a6e17d3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtNy0xLTEtMjMzNTM_b61c9c29-65c7-41fc-89dc-e6e18e968ada"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6c63db23ba743c9a62c831ddf5c11fe_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzgtOS0xLTEtMjMzNTM_41ad64ed-c8ab-4477-b8c9-bc06e060c9ce"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktMS0xLTEtMjMzNTM_c64cba9e-7934-471b-8b86-e6f3e2a2a481"
      unitRef="usd">312000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktMy0xLTEtMjMzNTM_3bf9c532-c76b-4699-b93a-2fb83434b0ff"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktNS0xLTEtMjMzNTM_5d900dca-2119-426f-be31-e8cd6a1c3e62"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktNy0xLTEtMjMzNTM_333341ba-4c12-4ec9-aeb5-a12f4a3a1597"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzktOS0xLTEtMjMzNTM_3d766a52-0ae6-43b1-b8ea-5e6d6d6fbe67"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTEtMS0xLTIzMzUz_bea31833-9238-4e65-ad82-842d249bdd53"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTMtMS0xLTIzMzUz_3c3fbf84-e818-45eb-9093-c645f0c8c3c1"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTUtMS0xLTIzMzUz_bc1c6a17-d1e9-4c79-aad0-2ffe8e548277"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTctMS0xLTIzMzUz_9f53b0a7-4ccb-4d63-9334-317c04db524c"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEwLTktMS0xLTIzMzUz_956f1a84-fa89-4845-8112-0428cb81fa20"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTEtMS0xLTIzMzUz_19337cb2-880b-4a73-b562-4da8a2de45a5"
      unitRef="usd">359000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTMtMS0xLTIzMzUz_e13a1828-0b88-4b35-be81-a57c21c74d48"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTUtMS0xLTIzMzUz_6b9a3af7-4fd8-445b-9ceb-06c9d2c8c049"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTctMS0xLTIzMzUz_6c9d9fd8-5d47-444d-9332-85c8b6aaff58"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzExLTktMS0xLTIzMzUz_632747d2-7d99-4eae-8ffc-1d2053764182"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTEtMS0xLTIzMzUz_551e5615-cb70-4515-8661-a9fb0398f7f3"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTMtMS0xLTIzMzUz_bae3fd75-0a6b-4b7e-9aa0-91b49757c8e4"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTUtMS0xLTIzMzUz_f123968b-11d3-4963-9421-9df9796edb4e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTctMS0xLTIzMzUz_d6eb4cb3-2a32-45cf-9763-f9aaed98471d"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEyLTktMS0xLTIzMzUz_9e892289-d0f0-46f8-8535-c47db1b1a2f4"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTEtMS0xLTIzMzUz_00b470ef-5912-40ca-bca0-7bafe277f556"
      unitRef="usd">419000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6c5373d38bfe47ecb2d1622106cececf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTMtMS0xLTIzMzUz_d012ca36-4e10-4f68-8620-659441a464f4"
      unitRef="usd">-174000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic78eb7aac2344120a7225255baf73b7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTUtMS0xLTIzMzUz_62f34fc1-e5d3-4e1d-8211-376f1e985f1c"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaf0e50e00c5c436386d95313d826a485_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTctMS0xLTIzMzUz_0494ba4f-1f9e-466d-9065-b31912e28849"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzEzLTktMS0xLTIzMzUz_0f771789-905c-4af4-9131-c2a8c83a8853"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i621e3a8fa6994bd5a5330f05ec7cdff3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTEtMS0xLTIzMzUz_f51a1848-fcd4-49d3-989f-6de860ddc8ae"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie174ba8ffb9244afb1dd4b6122d4fbd3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTMtMS0xLTIzMzUz_b061b93b-b2ea-463d-ab62-754056634fca"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba47de0abc2f48d494cd9612200292a8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTUtMS0xLTIzMzUz_04f9578c-61db-498d-bdcc-09a466606da2"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i17c5e4430f874e8f99d8a1bf5f30f24c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTctMS0xLTIzMzUz_ab114808-110d-4097-800a-ff42e88ac2d8"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9384c8d2c240451493d40ead28d2d250_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjAvZnJhZzphN2EzYTdkOWJhNWQ0MzIyYTMyMzc2MGIwMTZjZGM1Yi90YWJsZTplZjZlODZjYTRlM2E0NDk0Yjc5NDc4M2Y3OTU5MGQ4Ni90YWJsZXJhbmdlOmVmNmU4NmNhNGUzYTQ0OTRiNzk0NzgzZjc5NTkwZDg2XzE0LTktMS0xLTIzMzUz_ef2da6c8-b381-441b-964c-5d640687bd5a"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzIxNjE_294e5ed1-44e9-43bf-91ae-f1dae9ee9571">Related Party Balances and Transactions&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, a public benefit California foundation (&#x201c;Foundation&#x201d;) was established to provide opioid education to patients, caregivers, and providers, address policy issues, and increase patient access to life-saving treatments.&#160;Certain officers of the Company also serve as directors and officers of the Foundation. During 2019, the Company paid cash of $100 million to the Foundation to settle an outstanding pledge it made in 2018. During the fourth quarter of 2020, the Company also contributed $20 million to the McKesson Foundation, which supports the Company&#x2019;s employees and their community involvement efforts, with a special focus on cancer. A portion of this contribution was directed to an emergency employee assistance fund administered by the Emergency Assistance Foundation, an independent nonprofit organization, to provide support for employees impacted by the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $178&#160;million, $141 million, and $137 million, are included in the Consolidated Statements of Operations for the years ended March&#160;31, 2021, 2020, and 2019, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, 2020, and 2019, the Company&#x2019;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $111&#160;million, $60 million, and $34 million, respectively. Trade receivables related to these transactions from this investee were not material as of March&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;Refer to Financial Note 2, &#x201c;Investment in Change Healthcare Joint Venture,&#x201d; for information regarding related party balances and transactions with Change and the Change Healthcare JV.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i04923cda81624c0c88a55ac1efd640f3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzU0OTc1NTgxNDI3MDE_3ad7e536-5dc5-491c-a861-d7ab59c95bb3"
      unitRef="usd">100000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i88386d48d0584a11aad721e5144c887a_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2Xzg1Nw_b88c66bc-090e-49eb-904e-43f7ceb889a5"
      unitRef="usd">20000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia7481f6650044b3dba08713c24b295ca_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzEzMTk0MTM5NTM1NDk5_a31400ec-2c0e-405a-9e9d-e4b31377d296"
      unitRef="usd">178000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ie85e4307493243a5b472a5635d3adc29_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE1MDI_957f1413-821a-4bbb-8adf-0ffae119ff28"
      unitRef="usd">141000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia887d330153d49cf8839b2dd8a1d6605_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE1MDY_3fa07a77-f674-44e9-8a08-8e1cb07b5496"
      unitRef="usd">137000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i4b60cdb02b3c4589b40ac24c56bb249e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzEzMTk0MTM5NTM1NTM2_686c8142-a3e0-4ee5-8edd-91444f063279"
      unitRef="usd">111000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i944454336222406cbbe7e294bceecc04_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE4OTI_4cc7fea9-00a7-4f04-ab4d-ab3b3daf0962"
      unitRef="usd">60000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i175e65bdb63d42c090c72de7f9bdc403_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjYvZnJhZzoyNTc0YWNkMDg0M2Y0ZGFkOWQxNzI0YmM3ZjRjMjU3Ni90ZXh0cmVnaW9uOjI1NzRhY2QwODQzZjRkYWQ5ZDE3MjRiYzdmNGMyNTc2XzE4OTk_39642216-d9f9-4a6e-b2a7-9c9981f5a123"
      unitRef="usd">34000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzIwMzQwOTY1MTU3MDU4_d0afd8bb-dcea-48e0-b8b7-30a9fde2c88e">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 13 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of high-quality products through a network of distribution centers within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve the Company&#x2019;s biopharma and life sciences partners and patients. RxTS works across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other, for retrospective periods presented consists of the Company&#x2019;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the consolidated totals is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (7) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment expenditures for long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 7% of the International segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 39% of the RxTS segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for 2021, 2020, and 2019 includes credits of $38 million, $252 million, and $210 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2021, 2020, and 2019 also includes $181 million, $22 million, and $202 million, respectively, of cash receipts for the Company&#x2019;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; and operating profit for 2019 includes a charge of $61 million related to a customer bankruptcy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for 2021 and 2020 includes charges of $58 million and $275 million (both pre-tax and after-tax), respectively, to remeasure to fair value the assets and liabilities of the Company&#x2019;s German pharmaceutical wholesale business which was contributed to a joint venture, as further discussed in Financial Note 3, &#x201c;Held for Sale.&#x201d; Operating loss for 2021, 2020, and 2019 includes long-lived asset impairment charges of $115 million, $112 million, and $245 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges.&#x201d; Operating loss for 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion (both pre-tax and after-tax), respectively, as discussed in more detail in Financial Note 12, &#x201c;Goodwill and Intangible Assets, Net.&#x201d; In addition, operating loss for 2019 includes a gain from an escrow settlement of $97 million (pre-tax and after-tax) representing certain indemnity and other claims related to the Company&#x2019;s 2017 acquisition of Rexall Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for 2021 includes charges totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s RxTS segment&#x2019;s operating profit for 2019 includes a gain of $56 million recognized from the sale of an equity investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#x2019;s investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2019 includes a credit of $90 million for the derecognition of the TRA liability payable to the shareholders of Change. Operating loss for 2020 and 2019 also includes the Company&#x2019;s proportionate share of loss from the Change Healthcare JV of $119 million and $194 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net, for 2021 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 19, &#x201c;Commitments and Contingent Liabilities." Corporate expenses, net, for 2021 also includes net gains of $133 million associated with certain of the Company&#x2019;s equity investments and a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for 2020 includes settlement charges of $122 million for the termination of the Company&#x2019;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment assets and long-lived assets by geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="iea92921488274912b519ed84b11ab23f_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzMzk2NjY_215e1f71-88e7-4593-bb39-85046fd60a3d"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="iccdd71b92ffa4cb2b159c9a557fb6ba8_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzMzk5Mzk_367c21f9-2120-423f-b3a7-3cb347072f29"
      unitRef="country">13</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="i9d099d3619b4467b8a30ab61cc9c0d8e_I20210331"
      decimals="-1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzU0OTc1NTgxNzM3NDQ_eeeaae28-f5bd-4813-8eea-e8bf91951c30"
      unitRef="numberofproducts">275000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzYyNjQ_48c22930-6508-4a91-9ebf-91fee91db8ee">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the consolidated totals is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (7) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment expenditures for long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 7% of the International segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 39% of the RxTS segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#x2019;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for 2021, 2020, and 2019 includes credits of $38 million, $252 million, and $210 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2021, 2020, and 2019 also includes $181 million, $22 million, and $202 million, respectively, of cash receipts for the Company&#x2019;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in Note 19, &#x201c;Commitments and Contingent Liabilities,&#x201d; and operating profit for 2019 includes a charge of $61 million related to a customer bankruptcy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for 2021 and 2020 includes charges of $58 million and $275 million (both pre-tax and after-tax), respectively, to remeasure to fair value the assets and liabilities of the Company&#x2019;s German pharmaceutical wholesale business which was contributed to a joint venture, as further discussed in Financial Note 3, &#x201c;Held for Sale.&#x201d; Operating loss for 2021, 2020, and 2019 includes long-lived asset impairment charges of $115 million, $112 million, and $245 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 4, &#x201c;Restructuring, Impairment, and Related Charges.&#x201d; Operating loss for 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion (both pre-tax and after-tax), respectively, as discussed in more detail in Financial Note 12, &#x201c;Goodwill and Intangible Assets, Net.&#x201d; In addition, operating loss for 2019 includes a gain from an escrow settlement of $97 million (pre-tax and after-tax) representing certain indemnity and other claims related to the Company&#x2019;s 2017 acquisition of Rexall Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for 2021 includes charges totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s RxTS segment&#x2019;s operating profit for 2019 includes a gain of $56 million recognized from the sale of an equity investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#x2019;s investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2019 includes a credit of $90 million for the derecognition of the TRA liability payable to the shareholders of Change. Operating loss for 2020 and 2019 also includes the Company&#x2019;s proportionate share of loss from the Change Healthcare JV of $119 million and $194 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net, for 2021 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 19, &#x201c;Commitments and Contingent Liabilities." Corporate expenses, net, for 2021 also includes net gains of $133 million associated with certain of the Company&#x2019;s equity investments and a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program. Corporate expenses, net, for 2020 includes settlement charges of $122 million for the termination of the Company&#x2019;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28dbc2c61dc9438f8c868b20dbecdd2d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMtMS0xLTEtMA_c6034d96-93fd-48d2-abbe-5d9305e8d276"
      unitRef="usd">189274000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i440ec2ec8f1c44cd80edd4a74cb333b9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMtMy0xLTEtMA_d9a14ce2-e032-4fde-a866-53404bc86eae"
      unitRef="usd">181700000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14a2c0c157ca4b96abb1b4665b27847c_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMtNS0xLTEtMA_7f04aa11-7a3c-421d-b42f-3e0964ffe029"
      unitRef="usd">166189000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzQtMS0xLTEtMA_d71d35af-0c46-4747-abe1-20f51195da1a"
      unitRef="usd">35965000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzQtMy0xLTEtMA_77047f70-37cc-438d-8d12-23dc9bdcc8c3"
      unitRef="usd">38341000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzQtNS0xLTEtMA_974dbfda-5cfb-4161-984e-83341a83e3fa"
      unitRef="usd">38023000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzUtMS0xLTEtMA_0532ed76-d238-4244-a825-3a3fdabaf608"
      unitRef="usd">10099000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cfd1b3aa1ad409692852b5dac18feef_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzUtMy0xLTEtMA_7503abdd-f9f9-4ec8-9498-368ec6d7b386"
      unitRef="usd">8305000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i573770b6d3a94d0387b01cf824758b6e_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzUtNS0xLTEtMA_2350bc39-f5d3-4322-b0bb-c7bfb10d1234"
      unitRef="usd">7618000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i446e2679c7d54adfaaa65913157f866f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzYtMS0xLTEtMA_23c770b9-85e1-4540-ae78-cf4f211859be"
      unitRef="usd">2890000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice65da80b2be4a598701b12640e24cff_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzYtMy0xLTEtMA_c12d54f9-8780-43ff-b79f-b2e7f78284e4"
      unitRef="usd">2705000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia42e59ef5f2b45d2973487b75779a397_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzYtNS0xLTEtMA_b9caa84b-ab85-4025-bfac-bb22bf66536f"
      unitRef="usd">2489000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzctMS0xLTEtMA_8f6fbb93-90da-4ff9-9724-6275c66e9041"
      unitRef="usd">238228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzctMy0xLTEtMA_af0075cb-989f-47d6-9868-8b728cdc1184"
      unitRef="usd">231051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzctNS0xLTEtMA_c1778371-dff4-4694-b8ee-e9ba05fd867f"
      unitRef="usd">214319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEwLTEtMS0xLTA_b5072033-13ff-4994-a6e6-dbc6f3354590"
      unitRef="usd">2763000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEwLTMtMS0xLTA_90d97206-a225-4c4a-a5d6-c2c88ad98f78"
      unitRef="usd">2745000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEwLTUtMS0xLTA_9879b884-eb84-4dbf-8906-817a1b67a6ef"
      unitRef="usd">2710000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzExLTEtMS0xLTA_96a3a37c-edea-405b-923d-cb642917384d"
      unitRef="usd">-37000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzExLTMtMS0xLTA_786a44c5-5ba2-4cf2-863b-4c71ca17e667"
      unitRef="usd">-161000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzExLTUtMS0xLTA_dbb1101f-a865-48db-ab5f-2d48486a3cf7"
      unitRef="usd">-1903000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEyLTEtMS0xLTA_9ce663e4-d1d8-4637-a390-754c5d417fc7"
      unitRef="usd">707000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEyLTMtMS0xLTA_5328846f-e247-4f44-9362-d0c77a1e9883"
      unitRef="usd">499000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEyLTUtMS0xLTA_7c8c65f6-7cab-40c6-8806-7df17b608dba"
      unitRef="usd">455000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTEtMS0xLTcyMjE_d4218f13-5933-4bf5-b857-f4c9d52255a7"
      unitRef="usd">395000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTMtMS0xLTcyMjE_fee54346-6631-458f-a568-ff09612e221a"
      unitRef="usd">396000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTUtMS0xLTcyMjE_5b57a908-d835-4209-b1db-77852a3bda1b"
      unitRef="usd">355000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTEtMS0xLTA_5c5d5e1d-d082-4d6b-ae5a-982b3655e43c"
      unitRef="usd">0</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTMtMS0xLTA_78da07fd-2bb5-47a0-b4f3-6099757b4eab"
      unitRef="usd">-1113000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzEzLTUtMS0xLTA_fa4eac45-84a9-434d-9ad7-f7de699d15c6"
      unitRef="usd">-104000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE0LTEtMS0xLTA_1c6265bf-6900-40bc-b211-26ca35524b60"
      unitRef="usd">3828000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE0LTMtMS0xLTA_ea085212-d984-44a4-ba51-27587215a366"
      unitRef="usd">2366000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE0LTUtMS0xLTA_af38d434-46e4-4110-a3da-a3515705281c"
      unitRef="usd">1513000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE1LTEtMS0xLTA_8a740d2a-21ee-48df-ba3a-5652d15ac1d7"
      unitRef="usd">8645000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE1LTMtMS0xLTA_42986523-221f-4fb8-8de6-da1cdb773e9c"
      unitRef="usd">973000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE1LTUtMS0xLTA_2af9973f-394a-4358-a509-640fbae2f3ec"
      unitRef="usd">639000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:InterestExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE3LTEtMS0xLTA_ea394c92-edb2-4ad7-b1f0-bfe036ab3bbd"
      unitRef="usd">217000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE3LTMtMS0xLTA_14e37bdc-76aa-4526-940e-48a80680d61a"
      unitRef="usd">249000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE3LTUtMS0xLTA_25f611d1-9074-4181-9fc1-7cefbdf5dde3"
      unitRef="usd">264000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE4LTEtMS0xLTA_81ebf2cc-5660-4f21-96b7-e16a3d9164bf"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE4LTMtMS0xLTA_305503c8-c734-4631-8e23-15a49593c923"
      unitRef="usd">1144000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzE4LTUtMS0xLTA_df8a017f-3161-41c9-b93c-8fd49930ba75"
      unitRef="usd">610000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DepreciationAndAmortization
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIxLTEtMS0xLTA_efd6e821-8f32-4828-bf59-e4f27c10850d"
      unitRef="usd">211000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIxLTMtMS0xLTA_35a19c5c-9b44-4ffc-ae07-936d6e373d15"
      unitRef="usd">208000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIxLTUtMS0xLTA_7c718ae4-1ebd-4993-b358-70832855a6f8"
      unitRef="usd">227000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIyLTEtMS0xLTA_c7c9ec80-8329-4412-a2d0-3b79d2086813"
      unitRef="usd">334000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIyLTMtMS0xLTA_68d1cc52-c25a-48ea-93ad-eb06e6c6e757"
      unitRef="usd">357000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIyLTUtMS0xLTA_ff687e03-f7c3-4703-abbb-7259dbe95c9a"
      unitRef="usd">392000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIzLTEtMS0xLTA_dcf7d514-af9e-421a-b038-322bef8bbe3a"
      unitRef="usd">130000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIzLTMtMS0xLTA_69185f43-c124-45fb-bd1b-d01834dbaa0a"
      unitRef="usd">136000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzIzLTUtMS0xLTA_52c5114d-4adb-48c9-94c1-b22adb1baf8a"
      unitRef="usd">118000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTEtMS0xLTcyNTA_57b3e4a7-fa89-45d9-ab93-7ae9bef19968"
      unitRef="usd">87000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTMtMS0xLTcyNTA_8c0c36eb-0c07-40d2-9905-c8dc3c9c99d7"
      unitRef="usd">85000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTUtMS0xLTcyNTA_8255b02c-b375-4cd5-8bf6-c16ef4f5dbb9"
      unitRef="usd">90000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTEtMS0xLTA_8c2eb633-8361-4d7f-b6c1-bd5ccc85c7a2"
      unitRef="usd">125000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTMtMS0xLTA_438ae199-4ff5-4a88-9d2f-a0a9c8fe61e8"
      unitRef="usd">136000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI1LTUtMS0xLTA_debf0bdf-3930-483a-bb8c-5ee534f4df92"
      unitRef="usd">122000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI2LTEtMS0xLTA_c0cd1012-02b3-463e-9dca-3ecf0d7fae2d"
      unitRef="usd">887000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI2LTMtMS0xLTA_acc254a6-21ea-472a-a33f-79f5aae481c2"
      unitRef="usd">922000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI2LTUtMS0xLTA_fbcfcc81-ef79-48f2-bfac-67541b3f031b"
      unitRef="usd">949000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI5LTEtMS0xLTA_f3316f93-8a95-4c4b-a973-2b67f0ea1a17"
      unitRef="usd">246000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI5LTMtMS0xLTA_a61e2d6d-1b50-4701-96c5-3be8ea34d149"
      unitRef="usd">109000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzI5LTUtMS0xLTA_2e6816b9-49d3-4553-9c10-bbb393e9d21d"
      unitRef="usd">103000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMwLTEtMS0xLTA_efaf497b-5e05-4fe4-9610-725b82b5db17"
      unitRef="usd">212000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMwLTMtMS0xLTA_72ef5110-4223-4d3b-a38c-608ecab58787"
      unitRef="usd">218000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMwLTUtMS0xLTA_408b06b1-49fb-4b23-978e-b61fc9ffe204"
      unitRef="usd">199000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMxLTEtMS0xLTA_6d10709c-37b6-4423-a5c2-86cffc240c5e"
      unitRef="usd">57000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMxLTMtMS0xLTA_e593bee5-8b1c-4c54-af1d-731199aa5e46"
      unitRef="usd">36000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMxLTUtMS0xLTA_c8bc427a-9cd6-440b-b800-7d3e22fbc5b9"
      unitRef="usd">116000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTEtMS0xLTcyOTE_f56a4d15-87bf-4916-a99d-716b4410d677"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTMtMS0xLTcyOTE_acf19b1b-bc70-436f-b0d4-ab39f86af908"
      unitRef="usd">23000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTUtMS0xLTcyOTE_8e773b13-ecce-4431-9326-71715cbe2d6d"
      unitRef="usd">14000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i93911baafae14119b73921f40093ba4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMzLTEtMS0xLTA_ddc47e28-1473-4b8c-87ed-cf4d7888ae11"
      unitRef="usd">104000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if25e2fbbf181449aae9774d4bea34877_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMzLTMtMS0xLTA_dcb070c7-10c0-49c0-817e-54dafa2ad2f9"
      unitRef="usd">120000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i092c23031111426996897acf81001bca_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzMzLTUtMS0xLTA_edbcfc98-66a9-49db-94c6-a3d03a0b1e57"
      unitRef="usd">125000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTEtMS0xLTA_f931e9eb-3445-4004-9053-ee316f92c48b"
      unitRef="usd">641000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTMtMS0xLTA_c6873a6b-11aa-4747-a954-eed1516179dc"
      unitRef="usd">506000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZToxNTliNWQ5ZTgzZjA0ZGFjYTFkODMyNTlkM2EyN2NiZi90YWJsZXJhbmdlOjE1OWI1ZDllODNmMDRkYWNhMWQ4MzI1OWQzYTI3Y2JmXzM0LTUtMS0xLTA_fa5e335b-adce-4552-b102-3038c482c420"
      unitRef="usd">557000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDE_4c6732c1-0ab8-4219-a547-ee47e8533fed"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDE_c1cff88f-2d4c-4b6a-8b86-09896fa5ee32"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDE_dfa43487-0c41-47df-8652-dc3323863e39"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="id3777a0f6a8d4b408cf26bd00494d365_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTM_7536067e-9f35-400d-85b5-4a1d01bd2cb6"
      unitRef="number">0.07</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ibc15ae5b3fd3480ca21ba8e3a0b8de42_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTM_c56c6060-d752-424a-833c-9cde8ddd4456"
      unitRef="number">0.07</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i2fa41eaf428d4b2b85aca69b695a27ec_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTM_ec4186ab-a9ed-43bc-bb81-b5fdac48cc54"
      unitRef="number">0.07</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ie646339ac3a34ac8a5f27c412de8f7b6_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTc_3b80081b-4603-45b7-a097-543f059e690b"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i4db4c2e41d2849fdb0f0d74b7774c02d_D20180401-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTc_4ec15a31-903c-4e3a-802d-0d21b9dee768"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ib93a81f917924f8e9af2ecf6a1b6d8f3_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNTc_832abce6-37a1-4add-b86b-4d08eb675ff5"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i08e6eed8d42b42a4b0f3101e95c29770_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDU_75ef80fa-be68-44af-acb8-edd4e1e95cc4"
      unitRef="number">0.39</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic4e6c66a207e4ebf824c0eee71af22cd_D20180401-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDU_d2657b73-302c-42a6-8ad6-d8071b0341d0"
      unitRef="number">0.39</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i76fbbe767a6043be9b9213e2a38ddaa2_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjYyNDU_dde7983f-a4a3-440b-b379-47c2c1e014f4"
      unitRef="number">0.39</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzI5NjI_6e36f6ea-5276-41e1-bcce-3e6d7d180dc3"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzI5NjY_aa1345b0-6a9a-4bc1-9591-a4ac64076ec4"
      unitRef="usd">-252000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzI5NzM_8fb81f3c-2f41-45ae-80b1-1ea1f7145aee"
      unitRef="usd">-210000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i364eb575dc1d42bfb1a9fea0de9fe70f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjU5ODQ_5881ebf1-2f24-4acf-95e2-d028bc1edced"
      unitRef="usd">181000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i682feb6b89bc4aa98b0f304c7997f718_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTk4NzM_67ebe760-3d07-4eb4-96ac-d6205320c579"
      unitRef="usd">22000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i7dd97f676a674eedaa0efce3823c1d86_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTk4Nzc_62a4c465-374e-45fc-b314-7571cdae99ce"
      unitRef="usd">202000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i56b06f9b88e745caa7ce9e463ac4f6b6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDE2NzQ_f97e8556-2947-436e-8454-250e57b07f1e"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i14a2c0c157ca4b96abb1b4665b27847c_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzMyNzA_ed3ae486-12cc-410e-a547-b1da6980a917"
      unitRef="usd">61000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i37e52c8b4b824321aa0ff56c256f2680_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTg5MDE_1af1af30-1d4d-4c19-9d77-91bb5dcd276e"
      unitRef="usd">58000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax
      contextRef="i37e52c8b4b824321aa0ff56c256f2680_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTg5MDE_af76dd76-3a3f-4137-8f26-110017af2515"
      unitRef="usd">58000000</mck:EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax>
    <mck:GainLossOnSaleOfBusinessNetOfTax
      contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjI0MDY_367e58cb-e303-436d-873a-adb11be5e1fb"
      unitRef="usd">-275000000</mck:GainLossOnSaleOfBusinessNetOfTax>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iaa2802e26e94498dbbe5b886f74f3de7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjI0MDY_f3b51c1d-527e-409e-8ea2-1015688fe0ea"
      unitRef="usd">-275000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:AssetImpairmentCharges
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjMwODg_f0642153-666b-403e-8b81-332fb586ce68"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="idf04f3da3f5c47bba577bd9161f45ea1_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNTY5ODc_cd9f2420-7107-47ec-9a06-5ff76c0428a8"
      unitRef="usd">112000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjMwNzg_06dff2e7-92a9-434f-bb12-7a19b84c6330"
      unitRef="usd">245000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDc_a6efd2c7-98a6-48c3-bd67-449114874d25"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if2253d65296d42f9a1419e0f2f79d920_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDc_ea546acb-4ff9-4810-afec-17c4f35e31ec"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDQ_74ba2270-0e3b-4b0a-b107-5c33bcec7c6c"
      unitRef="usd">1800000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLossNetOfTax
      contextRef="i7647567c879249be9980c6b4d1384a4a_D20180401-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjM3MDQ_cbc3ec39-1caf-4e5b-a680-f53bc1d1ecee"
      unitRef="usd">1800000000</us-gaap:GoodwillImpairmentLossNetOfTax>
    <us-gaap:ProceedsFromPreviousAcquisition
      contextRef="ib4526ff802af4c7fa6b4487275290425_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjQ1OTE_381a49b3-a2ad-4e0b-8726-b10f8185b27d"
      unitRef="usd">97000000</us-gaap:ProceedsFromPreviousAcquisition>
    <us-gaap:InventoryWriteDown
      contextRef="i5daa252cdd9747ef81d838f5da7691f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDM0MjE_a1bbb6c5-bfcb-4f15-a592-759f70616b63"
      unitRef="usd">136000000</us-gaap:InventoryWriteDown>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ia42e59ef5f2b45d2973487b75779a397_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNjAxNTE_ba6609e3-8d41-4b29-ac78-1c1792d19868"
      unitRef="usd">56000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzM5ODY_212283e9-a3ff-45e1-a73e-3d66735cf989"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQwMzU_98e75c31-a83c-4936-b036-80d9f623eefa"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ia8e2f0245e70409a810d9f04368c3edf_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzMyOTg1MzQ5MjQxNDY_785def8a-4592-40bd-822e-89e7e2ac3fc5"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <mck:GainLossonDerecognitionofLiability
      contextRef="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDYzMjE_c3143cb0-ebe9-4737-a52e-8980bce19369"
      unitRef="usd">-90000000</mck:GainLossonDerecognitionofLiability>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iffd00748603f4a9080c3102d09966644_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDY1NTE_123b7160-614d-43f1-80f6-ecdf23f1f279"
      unitRef="usd">-119000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i915762cfdcd348c8ac340fac0cbb9f05_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDY1NTk_50d6a00a-7f42-40dc-96ab-ed2afafd39cc"
      unitRef="usd">-194000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i0ae3484746e74b3eac6d10bbc14d835c_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDQwNzU_f3b1a175-9d1e-40d7-802f-e40cef3adab9"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzMyOTg1MzQ5MjYxMjE_445e6cb6-69a9-459f-bd01-71870ac4d918"
      unitRef="usd">133000000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i60c4775af5034c77bdf45a4edf0c4a19_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzQ5NDc4MDIzNDQ2NzU_a48a92b9-bc20-4f74-84f1-5eb2562831d4"
      unitRef="usd">-131000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ife654ef064054349ba8dfe58caeb245e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzU1NzY_62e7c8dc-85f9-450a-ae74-f4c941ae8e4a"
      unitRef="usd">-122000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="icbd9d23495db4b029833f9c192227a5c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzU2ODc_832b9b0c-a179-42b4-bdd6-664ba1cceecb"
      unitRef="usd">-82000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90ZXh0cmVnaW9uOmFkNjk3MmM0ZjI0YjQyNGM4MDU4M2E5MGE5NjViN2EyXzYyNDY_7b9f5f24-d4a6-4f88-b693-f36ae42fbc11">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment assets and long-lived assets by geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i3156368b6aea45b4b87b5079622f2703_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzMtMS0xLTEtMA_10a6745b-bcfc-4c3c-9734-13ffd63409a8"
      unitRef="usd">35236000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7b443c41cb334b4084c134a614b5a4aa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzMtMy0xLTEtMA_ac148bfa-1258-4422-89e0-1d1877771afe"
      unitRef="usd">33541000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie781b28ab2254939ac913ef650232aa3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzQtMS0xLTEtMA_4265102a-22d3-4a77-ab99-f31d240fb339"
      unitRef="usd">14987000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1cc2495d4fd44412ae23a2d9511fc6b0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzQtMy0xLTEtMA_63272eb9-1506-418d-9d3d-fedf31a2dcb0"
      unitRef="usd">14994000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7d7e3dfff1504af6a6970090a4e7c85f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzUtMS0xLTEtMA_49e8870c-5bd4-4d3f-aa61-09af340c6306"
      unitRef="usd">5986000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i59d6c47ebd084b828cdbdba1b8f159f8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzUtMy0xLTEtMA_76b95fd2-7259-4f8c-93bf-bab446c00d3f"
      unitRef="usd">5395000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibbfa7f443c9f4c30be51cebaefbd7dd1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzYtMS0xLTEtNzM2Ng_fd9abb1b-8557-4ea4-ac21-f7a5d4d1db4f"
      unitRef="usd">3446000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i44f353b74f6e48ea8c63365f74249445_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzYtMy0xLTEtNzM2Ng_6b7b5260-9c93-4155-8f82-e96ac0cf7065"
      unitRef="usd">3786000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i07652793af6e402c8f56ae5bf525de5d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzctMS0xLTEtMA_4f078613-7ad1-4393-adb9-b6c077124555"
      unitRef="usd">5360000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib36b955ce23d4198b6aa3769dcf60d35_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzctMy0xLTEtMA_a483374f-547c-4098-b827-daa1f48578d7"
      unitRef="usd">3531000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzgtMS0xLTEtMA_2ecae84a-81b2-43d8-bc84-79d6fb7d7c3d"
      unitRef="usd">65015000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzgtMy0xLTEtMA_71b021dc-3989-415d-8b04-f4f456254faf"
      unitRef="usd">61247000000</us-gaap:Assets>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="ida17c5841f1c46d28608950ca8175e62_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzExLTEtMS0xLTA_63b96ef7-6b4b-44a6-9ba7-d15b66b8bc12"
      unitRef="usd">2110000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i2310b3bfad364c4897f644c867bc31cb_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzExLTMtMS0xLTA_2353196f-a7c5-4660-a6c6-198c9d2e2662"
      unitRef="usd">1873000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i3a2364550eaa48c195ef408353004029_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEyLTEtMS0xLTA_55bde92f-ec15-4b0e-bf2d-09ba3ec0385a"
      unitRef="usd">984000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="if74e45a0662448e0b98940f6a00fba1a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEyLTMtMS0xLTA_c2fe50c7-5ded-456e-8e47-744ed676ac96"
      unitRef="usd">892000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEzLTEtMS0xLTA_9f0acb52-299e-42ea-bd1e-05bc54fcedb5"
      unitRef="usd">3094000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMjkvZnJhZzphZDY5NzJjNGYyNGI0MjRjODA1ODNhOTBhOTY1YjdhMi90YWJsZTowMWJlZDY5NWE3NmU0ZDFmYjVkMDlkMDI0MzUwMTc1Mi90YWJsZXJhbmdlOjAxYmVkNjk1YTc2ZTRkMWZiNWQwOWQwMjQzNTAxNzUyXzEzLTMtMS0xLTA_10a955d4-450d-4ef5-b9b4-beafa7b18a7e"
      unitRef="usd">2765000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90ZXh0cmVnaW9uOmY1ZGU2NTQyYmQ0NjQ2ZGViODk5OGRmODM5MDkyZTdlXzM5MjU_0bcccb16-2c9e-4e34-964c-443b4111deeb">Quarterly Financial Information (Unaudited)&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year. Selected quarterly financial information for the last two years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Third &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fourth &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) after income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:33.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:33.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to McKesson Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Third &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fourth &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) after income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:33.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to McKesson Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;(2)As a result of the Company&#x2019;s reported net loss for the third quarter of 2021 and the second quarter of 2020, potentially dilutive securities were excluded from the per share computations for those quarters due to their antidilutive effect.</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90ZXh0cmVnaW9uOmY1ZGU2NTQyYmQ0NjQ2ZGViODk5OGRmODM5MDkyZTdlXzM5MDk_465adb90-b356-4978-a129-3d4b6321ffb5">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year. Selected quarterly financial information for the last two years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Third &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fourth &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) after income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:33.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:33.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to McKesson Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Second&lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Third &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fourth &lt;br/&gt;Quarter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) after income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:33.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to McKesson Corporation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;(2)As a result of the Company&#x2019;s reported net loss for the third quarter of 2021 and the second quarter of 2020, potentially dilutive securities were excluded from the per share computations for those quarters due to their antidilutive effect.</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItMS0xLTEtMA_2ce346d2-d035-4f4f-b7b0-fa84f5093d0f"
      unitRef="usd">55679000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItMy0xLTEtMA_ac467e22-c6fd-4611-b91c-e116cb27c2b5"
      unitRef="usd">60808000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItNS0xLTEtMA_b27832a2-b62c-4723-8772-d7878ad65abe"
      unitRef="usd">62599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzItNy0xLTEtMA_2e540b71-75d0-4c99-89fc-e9448b86a50d"
      unitRef="usd">59142000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtMS0xLTEtMA_a62a609f-01d9-48c7-aea4-ec8c13fb61b6"
      unitRef="usd">2700000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtMy0xLTEtMA_0ad52893-bd2c-4dd7-8bfc-47de67adf4ef"
      unitRef="usd">3000000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtNS0xLTEtMA_f4004040-f062-4720-bce5-12dac395a2e2"
      unitRef="usd">3151000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMtNy0xLTEtMA_c8e36f37-17fe-455c-85f2-153e3534066e"
      unitRef="usd">3297000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtMS0xLTEtMA_957c85d7-5e9e-4d2d-b80c-f1a4d0a133db"
      unitRef="usd">495000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtMy0xLTEtMA_62416dbe-813f-463c-a4af-f0e97f917621"
      unitRef="usd">627000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtNS0xLTEtMA_18cca83d-0705-4717-a61d-e47779f96464"
      unitRef="usd">-6174000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzUtNy0xLTEtMA_99bbbee0-c786-485c-8b05-376fb633bbe6"
      unitRef="usd">713000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtMS0xLTEtMA_33f3a755-aa3b-4296-ab0b-66a9907ae375"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtMy0xLTEtMA_949cde40-a9da-40f3-9a65-ce16dbcf7507"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtNS0xLTEtMA_f4353fbe-cd2b-4e01-a5a4-466d800f4a57"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzYtNy0xLTEtMA_7ae6dfdd-a9d2-418f-b0e8-d5571adeb2ee"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctMS0xLTEtMA_e72a84d0-78ce-4603-bf14-7aec215c27fb"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctMy0xLTEtMA_8b7f7552-ba34-45d5-bf4a-5baa0159a6ed"
      unitRef="usd">627000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctNS0xLTEtMA_312cef3b-feb7-465b-9d83-07f340a24da4"
      unitRef="usd">-6174000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzctNy0xLTEtMA_4a74e272-0a4b-45b8-bb40-20ea3f0bdc63"
      unitRef="usd">713000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtMS0xLTEtMA_855e5043-55e2-42c7-84a0-61a7c8d610a1"
      unitRef="usd">444000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtMy0xLTEtMA_53bdee3a-a827-4bca-8c00-0016e9a0a2a2"
      unitRef="usd">577000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtNS0xLTEtMA_335b6e47-e681-49ed-a2af-20bc1dad42d3"
      unitRef="usd">-6226000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzgtNy0xLTEtMA_e62c6030-9750-44c7-b026-abc2a0297119"
      unitRef="usd">666000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTEtMS0xLTA_2e48e87f-944b-41c3-abb2-917de193c437"
      unitRef="usdPerShare">2.72</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTMtMS0xLTA_d0d973e5-299b-4542-ad9d-0c60c388df2d"
      unitRef="usdPerShare">3.54</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTUtMS0xLTA_845e118e-90ab-401c-810f-608f82130260"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzExLTctMS0xLTA_fb9f2c0c-b17c-482c-b6cc-834e9737c97d"
      unitRef="usdPerShare">4.15</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTEtMS0xLTA_456fcb01-f616-4261-8658-46c41efa84d4"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTMtMS0xLTA_7df720f2-5e72-4eb7-8a2c-953f84c782d4"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTUtMS0xLTA_0f2ecfd6-87bb-4185-9467-868b4bb6900d"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEyLTctMS0xLTA_82e4d5f6-0c5e-4a10-a841-78e07752fbff"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTEtMS0xLTA_e84bc68d-085c-481e-b229-676b60f89509"
      unitRef="usdPerShare">2.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTMtMS0xLTA_a7a7a805-bb40-40bc-9c15-91f8ae56fcc2"
      unitRef="usdPerShare">3.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTUtMS0xLTA_9fb56a4d-e16a-4902-802c-a3653699f222"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzEzLTctMS0xLTA_f9fd3790-b97e-4250-989a-c5fee6dca67a"
      unitRef="usdPerShare">4.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTEtMS0xLTA_f0dcb6ae-dc0a-4841-bac0-9f5813500dcd"
      unitRef="usdPerShare">2.74</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTMtMS0xLTA_46fbf528-37f7-4d36-b46d-b519df75348b"
      unitRef="usdPerShare">3.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTUtMS0xLTA_d071be04-bbab-485b-9f44-7644d7e6bfd9"
      unitRef="usdPerShare">-39.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE1LTctMS0xLTA_0756697d-a8f9-4911-bb6b-875a9a5ce6a3"
      unitRef="usdPerShare">4.19</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTEtMS0xLTA_67ede1b1-b00e-483c-ad4a-8e2358fe36e7"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTMtMS0xLTA_821fd331-b397-4b8a-b085-5a450bd3105f"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTUtMS0xLTA_c4af8437-2400-467a-8ab4-0107125bbe95"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE2LTctMS0xLTA_baf15262-df59-4dfb-b5f6-3e39e97b3b86"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7f1c076ae5d74b14b7c19d269076784d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTEtMS0xLTA_ad57a512-ffb2-4fe4-90a7-f2813d1a4544"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTMtMS0xLTA_260f75c2-7f3f-400e-a6bf-cee3c9bb6449"
      unitRef="usdPerShare">3.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3277781fb87042f0a0ea4449af7f7e1a_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTUtMS0xLTA_a7c9cf04-29e6-43db-85b7-48773d28407b"
      unitRef="usdPerShare">-39.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE3LTctMS0xLTA_b7b096c5-765c-432f-a9c4-9ffdc914c1f7"
      unitRef="usdPerShare">4.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTEtMS0xLTE2NzA1_03ac4787-c201-4db6-8a3c-0190853f7045"
      unitRef="usd">55728000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTMtMS0xLTE2NzA1_d626ba45-ea50-4d21-82ae-0a1d7afa94f8"
      unitRef="usd">57616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTUtMS0xLTE2NzA1_92bb01fa-7dc7-457f-8e6b-056323ec1add"
      unitRef="usd">59172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzE5LTctMS0xLTE2NzA1_95f619d9-4c63-4c31-8a1a-c9b53b5c6e21"
      unitRef="usd">58535000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTEtMS0xLTE2NzM4_2ab955c5-65dd-4dc7-846e-551dc4a286c3"
      unitRef="usd">2787000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTMtMS0xLTE2NzM4_2e02032c-3c88-413d-ae8d-3987f6544a0d"
      unitRef="usd">2867000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTUtMS0xLTE2NzM4_09853840-7f95-44a1-9ea1-f3994c9189bf"
      unitRef="usd">3033000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIwLTctMS0xLTE2NzM4_e3e90ee8-2677-4f1d-b0db-763283ca519e"
      unitRef="usd">3336000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTEtMS0xLTE2NzA1_edf59faf-5ebc-4345-bc80-7073126b428d"
      unitRef="usd">483000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTMtMS0xLTE2NzA1_ad957127-fe02-4f39-a7f4-9fd0815185dd"
      unitRef="usd">-676000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTUtMS0xLTE2NzA1_88d997bf-4bfb-44de-9a17-1382857df16b"
      unitRef="usd">247000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIyLTctMS0xLTE2NzA1_d390672d-e6b1-4681-8365-3220e5da2fe7"
      unitRef="usd">1072000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTEtMS0xLTE2NzA1_7af85847-0bda-4339-9529-0d5d9c714618"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTMtMS0xLTE2NzA1_9a3803fc-4bd3-4bc4-90f4-0fcc83b2ffae"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTUtMS0xLTE2NzA1_9f4acff8-7775-4a14-b1f9-c7552792b071"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzIzLTctMS0xLTE2NzA1_03564a0c-8ce4-4b5e-b930-c7fc69d497e5"
      unitRef="usd">6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTEtMS0xLTE2NzA1_e913c3fc-02bd-42b1-973f-276bf8e4099b"
      unitRef="usd">477000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTMtMS0xLTE2NzA1_2780338d-0928-439d-85bf-704f1f185c12"
      unitRef="usd">-677000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTUtMS0xLTE2NzA1_9a4e8c75-2b16-4f2c-94d2-7e84523acdd0"
      unitRef="usd">242000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI0LTctMS0xLTE2NzA1_b7dcf06c-f524-46a6-8de3-c43192b73642"
      unitRef="usd">1078000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTEtMS0xLTE2NzM4_29c33fe6-8fbd-47c5-b28a-5a4cdb382c05"
      unitRef="usd">423000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTMtMS0xLTE2NzM4_4aaf1b52-8fbb-4d8e-a36e-69e02f244cf2"
      unitRef="usd">-730000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTUtMS0xLTE2NzM4_1866a4fb-7c5d-47e4-9bf2-a946aac7ea0a"
      unitRef="usd">186000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI1LTctMS0xLTE2NzM4_9f3947a7-0a9a-4a44-a300-11492e84a0a4"
      unitRef="usd">1021000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTEtMS0xLTE2NzA1_ca4e4ea0-043d-42cf-91dd-9cb515dc798f"
      unitRef="usdPerShare">2.27</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTMtMS0xLTE2NzA1_279dd6eb-1ec2-4797-88e2-ef817881aaaa"
      unitRef="usdPerShare">-3.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTUtMS0xLTE2NzA1_0e2a6651-ae2a-479a-95b4-53a5e94ba8bf"
      unitRef="usdPerShare">1.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI4LTctMS0xLTE2NzA1_2835ec56-3997-4b60-8e2d-cd988319dbb8"
      unitRef="usdPerShare">5.82</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTEtMS0xLTE2NzM4_1b808a84-fb84-4299-8b22-aa85df398c6a"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTMtMS0xLTE2NzM4_c91f8b10-7176-4eeb-82c0-5d3945968ba9"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTUtMS0xLTE2NzM4_864b3359-5281-48d2-8638-99b8e6c58564"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzI5LTctMS0xLTE2NzM4_ada3d498-5cae-46b2-a1de-2afb2fc07df6"
      unitRef="usdPerShare">0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTEtMS0xLTI2NzM0_5b834e6b-7e4b-432d-b863-4ab0cc2cd042"
      unitRef="usdPerShare">2.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTMtMS0xLTI2NzM0_e9c0aa63-a8fc-4dfe-bdc6-f59a39f91235"
      unitRef="usdPerShare">-3.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTUtMS0xLTI2NzM0_5c8fd699-7ca8-43c9-8293-f134f37b87e2"
      unitRef="usdPerShare">1.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMxLTctMS0xLTI2NzM0_5ceab9ff-b8a7-453a-812a-7aada7174157"
      unitRef="usdPerShare">5.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTEtMS0xLTE2NzM4_21c67a66-1760-4785-8b70-458e87c3519d"
      unitRef="usdPerShare">2.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTMtMS0xLTE2NzM4_45a381e7-bc5c-4812-9dbe-07b27994bb97"
      unitRef="usdPerShare">-3.99</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTUtMS0xLTE2NzM4_e76dea2a-86ed-4162-90b8-d13699162221"
      unitRef="usdPerShare">1.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMyLTctMS0xLTE2NzM4_783624d1-7393-4128-bb00-f13e07f19ad2"
      unitRef="usdPerShare">5.86</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTEtMS0xLTE2NzM4_9b1acd21-80fe-4d49-9a19-023b333bdec4"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTMtMS0xLTE2NzM4_6115ec9b-86cc-4c28-864d-900f601ade2e"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTUtMS0xLTE2NzM4_ac5e0fdc-a590-49d2-b561-f03f26fe7cbf"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzMzLTctMS0xLTE2NzM4_3eb0c24c-2b9f-4cb1-aa99-f3b3e94f8bbe"
      unitRef="usdPerShare">0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9c1c1eede7b24d69968db39cac9d3a57_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTEtMS0xLTI2NzM2_57819691-888e-4e7c-88b0-1c4ea1f22428"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ief6b2a7ba4984149b9fff9bb627ba1c7_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTMtMS0xLTI2NzM2_dc7aa938-0bfa-4d6e-8214-5a3a7dc6dff5"
      unitRef="usdPerShare">-3.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3851353c3c094c63b77676057f7ecdde_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTUtMS0xLTI2NzM2_369c4bdf-87cb-4029-a87f-5733c87c15b9"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i03c2736eaff64b2bbc6543c0b67eb86c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMzUvZnJhZzpmNWRlNjU0MmJkNDY0NmRlYjg5OThkZjgzOTA5MmU3ZS90YWJsZTo1NDVjYTk4MmI3NjY0OWZkYWQ2YjIzNmZhZGVjZjZhMi90YWJsZXJhbmdlOjU0NWNhOTgyYjc2NjQ5ZmRhZDZiMjM2ZmFkZWNmNmEyXzM1LTctMS0xLTI2NzM2_0fc674c6-2716-4d1f-bae7-2eb33107be0f"
      unitRef="usdPerShare">5.89</us-gaap:EarningsPerShareBasic>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90ZXh0cmVnaW9uOmQ5NjA4MTVmNzI4ODQ1Y2E5ODg4OGMyYzRkMjY3NWI0XzE2NQ_0dc64606-bf26-42c2-81de-2e9c2666f27c">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Charged to Other Accounts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions From Allowance Accounts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at End of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credited to other accounts and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts shown as deductions from current and non-current receivables (current allowances were $250 million, $265 million, and $279 million at March 31, 2021, 2020, and 2019, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Primarily represents reclassifications to other balance sheet accounts.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2bdb37666904471ea46cdc51ef04aaf9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtMS0xLTEtMA_8352a29f-a8d4-4d47-bcc1-8839c752298f"
      unitRef="usd">252000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtMy0xLTEtMA_bc3f9cfc-a9f6-4c62-8bb3-151b317c1aa6"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtNS0xLTEtMA_fe6ca49b-4689-432a-bab8-7a1a509bd9ec"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="icaf62fe9a49242bca472e12f3f77b3f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtNy0xLTEtMA_aa7c74e8-b03e-4ac0-b681-602570dfe7d3"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iab5c8e5207d049d0a2b702571549ad35_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzMtOS0xLTEtMA_23c87789-33d3-47d7-add4-af451d5432a4"
      unitRef="usd">211000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3215d0d8384a40fba66e6eab5a09fb04_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtMS0xLTEtMA_fbb690f8-1b29-4c67-8490-b26614aefd97"
      unitRef="usd">30000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtMy0xLTEtMA_4e15450b-6fc7-472c-a327-5e76c6389344"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtNS0xLTEtMA_0270666d-5169-41d4-bd70-d5050151aba0"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i7072af69c6334d9cb7ccf889c55441cf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtNy0xLTEtMA_13364216-f34f-447d-9260-415c6cddbc55"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idfe85c1cae3f4955b9ab92d284409069_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzQtOS0xLTEtMA_9bb8da36-7a48-45c1-900c-c7a6fb22cacf"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtMS0xLTEtMA_e9f0c55c-0b68-431d-ac13-266d004a9e25"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtMy0xLTEtMA_3d6aed1e-fed5-42a6-a786-811c6d538c0c"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtNS0xLTEtMA_586c6499-3e84-49b2-9644-1e9f6815a863"
      unitRef="usd">10000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtNy0xLTEtMA_d5de94d3-dc35-41f9-bbd9-78be60e03040"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzUtOS0xLTEtMA_313d5b75-2cc6-40c5-8c5d-c1ae35935cc9"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i17077ebbd39449f5af1aad884f3154eb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtMS0xLTEtMA_3edc0877-c3df-40f6-a6ea-5c22562e94ca"
      unitRef="usd">273000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtMy0xLTEtMA_37828c6f-c353-419b-a483-cd42dda0fe08"
      unitRef="usd">91000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtNS0xLTEtMA_3dd6ad6c-1e9c-4f9b-ab65-caffc781a0e3"
      unitRef="usd">-19000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib1f9d6bcdc5144e08a16f869d779e93e_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtNy0xLTEtMA_0e2ccaee-6198-4d52-84fc-fd9e58657c96"
      unitRef="usd">93000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2bdb37666904471ea46cdc51ef04aaf9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzgtOS0xLTEtMA_03b52895-0bbc-42d5-a157-0e6f193d35af"
      unitRef="usd">252000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i23fd853d831a42d78a02ffd4cf5ac851_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktMS0xLTEtMA_dac53c99-cda8-448d-99ba-c7acf9569913"
      unitRef="usd">24000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktMy0xLTEtMA_d0f62749-e739-46d4-88b2-5eeb5615e08a"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktNS0xLTEtMA_c8e1fc8a-c34f-49e1-8228-cba7aa6f9182"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i33dfd5f2c65e47098d9e7d603d757cc4_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktNy0xLTEtMA_69b189d8-3df7-45b0-872f-c2c01243c474"
      unitRef="usd">-6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3215d0d8384a40fba66e6eab5a09fb04_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzktOS0xLTEtMA_15f4f10e-c700-47f3-b7f0-1f90ab02dc13"
      unitRef="usd">30000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTEtMS0xLTA_e51835cb-be81-450b-8ef5-dc8027a682d2"
      unitRef="usd">297000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTMtMS0xLTA_b1e2d13d-faee-44de-8149-3bab8363136d"
      unitRef="usd">91000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTUtMS0xLTA_0adcf47c-992b-40b8-99ca-fffaaa0bb190"
      unitRef="usd">-19000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTctMS0xLTA_90de3794-208b-4b35-a951-52e256b711f6"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEwLTktMS0xLTA_92eaef36-cf37-4eb9-974b-8440ceaabf90"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if946cdebc5f04a91a11501d5fecd0111_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTEtMS0xLTA_b86f9809-765c-47bc-805b-fb091a8c8fbc"
      unitRef="usd">187000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTMtMS0xLTA_5e077293-3e80-4a9e-93c8-ada44177915b"
      unitRef="usd">132000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTUtMS0xLTA_2401aad4-59b6-4ed2-acdd-01b627292032"
      unitRef="usd">-1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ifee0febf3eb649f0a059478116a62eda_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTctMS0xLTA_85217ba2-86e5-44ab-bc03-30e32c3de618"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i17077ebbd39449f5af1aad884f3154eb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzEzLTktMS0xLTA_6099d89b-13ca-44a0-97e4-7b3bd713f5f8"
      unitRef="usd">273000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ifc939e12662e498ca3e1db10c83b89a6_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTEtMS0xLTA_ae9c14f7-be91-48d7-a1cd-1029b24cf0aa"
      unitRef="usd">39000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTMtMS0xLTA_49ccf1e3-02c4-49e1-a3b7-4d45ffb649ea"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTUtMS0xLTA_117c8f53-8b7f-4e34-8e6b-5921ba19259b"
      unitRef="usd">-15000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib0d062c72ab346b6b0cd23feffd6f626_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTctMS0xLTA_352caea5-b170-4671-a663-405a86adde3f"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i23fd853d831a42d78a02ffd4cf5ac851_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE0LTktMS0xLTA_4c66affa-1fe7-4df3-8755-d24f896aae69"
      unitRef="usd">24000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i022a2642b16245d083cb80c539e560b3_I20180331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTEtMS0xLTA_4b115291-7739-42de-962a-180975411db0"
      unitRef="usd">226000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTMtMS0xLTA_d0f1d1bd-94ad-42bf-81e8-581e2ce1c375"
      unitRef="usd">132000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTUtMS0xLTA_1c3596d0-630e-4f6f-b1a4-899c0deb9d6e"
      unitRef="usd">-16000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTctMS0xLTA_421677d9-bc23-42d0-8c30-b47df31f97c2"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZTphMTgwZDJjMThlMWY0NWM2YjdjNDRkMmIxN2YwMGY5My90YWJsZXJhbmdlOmExODBkMmMxOGUxZjQ1YzZiN2M0NGQyYjE3ZjAwZjkzXzE1LTktMS0xLTA_e31134cd-bd50-4417-a7c4-55559a609e4c"
      unitRef="usd">297000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib6fcf90e365b49d3bc8fc8b908d184c5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzItMy0xLTEtMA_a0d358a2-759b-4a43-beb6-ed149f503ee8"
      unitRef="usd">40000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i316723b66fa24fcd88e37d193316fd03_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzItNS0xLTEtMA_7766acfb-d6d9-4f90-99fa-d9c7f6917870"
      unitRef="usd">93000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4255c61bac0b4de1850d7e4a694151da_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzItNy0xLTEtMA_dbe14361-e5dd-481e-a5d5-8e6d842ddfbe"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i1401c1c016fb4cc5a4325e0076ce4cfc_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzMtMy0xLTEtMA_27f412b2-517d-42fa-afba-10a4a5de2819"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i511a93c4c27f432094e7f2f67db30fc4_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzMtNS0xLTEtMA_89f24363-8e92-4454-b7dc-6ea28d654db4"
      unitRef="usd">-6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i912ede9886ea43629d3666f2abe8894a_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzMtNy0xLTEtMA_68a48e22-447c-496a-aa2d-c7ee05555300"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic5118698b0524b279b93760d74efaa12_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzQtMy0xLTEtMA_828f8a4b-cbd1-4933-9d1a-5b2ed6c10392"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iec28e1b69349490ab2aeef52f7393928_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzQtNS0xLTEtMA_69023297-9519-4b9e-9d2b-2d0f6d4a458f"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzQtNy0xLTEtMA_3b9b6763-9984-424c-a9fa-0fe58fb0161b"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMS0xLTEtMC90ZXh0cmVnaW9uOjdiYjAyMTFlMzdhOTRmZTVhNTdhMzRhOTliNGM2MDEwXzU0OTc1NTgxMzkwODI_4c703ac9-97ad-49a0-bbef-e12d04e20394"
      unitRef="usd">250000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMS0xLTEtMC90ZXh0cmVnaW9uOjdiYjAyMTFlMzdhOTRmZTVhNTdhMzRhOTliNGM2MDEwXzU0OTc1NTgxMzkwOTk_73541841-5d84-4a21-b591-a18dd62f136f"
      unitRef="usd">265000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMS0xLTEtMC90ZXh0cmVnaW9uOjdiYjAyMTFlMzdhOTRmZTVhNTdhMzRhOTliNGM2MDEwXzU0OTc1NTgxMzkxMTU_99e00b3a-9096-4223-ac6d-f2f520ef4cd1"
      unitRef="usd">279000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idb72c0ed76ca44d78a6182d86a49bb8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtMy0xLTEtMA_edc87e76-0fed-4ce7-8f18-4cc43461cc5f"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6d8ec19e753d451794e088409f68157c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtNS0xLTEtMA_40793e0b-73a5-4982-9314-e4d13652de2f"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i56c41e20baa14761a136adaf102659bb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yNzcvZnJhZzpkOTYwODE1ZjcyODg0NWNhOTg4ODhjMmM0ZDI2NzViNC90YWJsZToyNjExZmIzYjMxMzg0NzZlYTU0NTUxNjZiY2QwNDNiMC90YWJsZXJhbmdlOjI2MTFmYjNiMzEzODQ3NmVhNTQ1NTE2NmJjZDA0M2IwXzYtNy0xLTEtMA_90cff12e-bd1b-4eab-a160-98fc560180d7"
      unitRef="usd">297000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040743144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,186,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">DOCUMENTS INCORPORATED BY REFERENCEPortions of the registrant&#8217;s Proxy Statement for its 2021 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock, $0.01 par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A0.625notesDue2021Member', window );">0.625% Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Notes due 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK21A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member', window );">1.500% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member', window );">1.625% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member', window );">3.125% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A0.625notesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A0.625notesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041409672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 238,228<span></span>
</td>
<td class="nump">$ 231,051<span></span>
</td>
<td class="nump">$ 214,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(226,080)<span></span>
</td>
<td class="num">(219,028)<span></span>
</td>
<td class="num">(202,565)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">12,148<span></span>
</td>
<td class="nump">12,023<span></span>
</td>
<td class="nump">11,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(8,849)<span></span>
</td>
<td class="num">(9,182)<span></span>
</td>
<td class="num">(8,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Claims and litigation charges, net</a></td>
<td class="num">(7,936)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="num">(334)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(597)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(17,188)<span></span>
</td>
<td class="num">(9,534)<span></span>
</td>
<td class="num">(10,868)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(5,040)<span></span>
</td>
<td class="nump">2,489<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(217)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">(5,034)<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">695<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="num">(4,339)<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(199)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (4,539)<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">5.01<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">181.6<span></span>
</td>
<td class="nump">197.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">180.6<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042771080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (4,340)<span></span>
</td>
<td class="nump">$ 1,120<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">184<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="num">(198)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="num">(4,170)<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to McKesson Corporation</a></td>
<td class="num">$ (4,316)<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="num">$ (98)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038131848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 6,278<span></span>
</td>
<td class="nump">$ 4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">19,181<span></span>
</td>
<td class="nump">19,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,246<span></span>
</td>
<td class="nump">16,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">665<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">45,382<span></span>
</td>
<td class="nump">42,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,581<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,493<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">2,878<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">2,581<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">65,015<span></span>
</td>
<td class="nump">61,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">38,975<span></span>
</td>
<td class="nump">37,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">3,987<span></span>
</td>
<td class="nump">3,340<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">44,103<span></span>
</td>
<td class="nump">42,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">6,406<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,411<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">8,067<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,715<span></span>
</td>
<td class="nump">1,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities (Note 19)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized, 273 and 272 shares issued at March 31, 2021 and 2020, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">6,925<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">8,202<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 115 and 110 shares at March 31, 2021 and 2020, respectively</a></td>
<td class="num">(13,670)<span></span>
</td>
<td class="num">(12,892)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; equity (deficit)</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">5,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">5,309<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity</a></td>
<td class="nump">$ 65,015<span></span>
</td>
<td class="nump">$ 61,247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652127404264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">273,000,000<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (shares)</a></td>
<td class="nump">115,000,000<span></span>
</td>
<td class="nump">110,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035579000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustments: adoption of new accounting standard</div></th>
<th class="th">
<div>Opening retained earnings adjustments: adoption of new accounting standard </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance</div></th>
<th class="th">
<div>Adjusted balance </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Other Capital</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, common stock (in shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2018</a></td>
<td class="nump">$ 10,057<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,188<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 12,986<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="num">$ (7,655)<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 10,211<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,188<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 13,140<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="num">$ (7,655)<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance, treasury common stock (shares) at Mar. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Retirement of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2019</a></td>
<td class="nump">8,287<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,435<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">8,298<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,435<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12,420<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockExchangedDuringPeriodShares', window );">Change Healthcare share exchange (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockExchangedDuringPeriodValue', window );">Change Healthcare share exchange</a></td>
<td class="num">(2,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2020</a></td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="num">(4,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,925<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,202<span></span>
</td>
<td class="num">$ (1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2021</a></td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockExchangedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Exchanged During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockExchangedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockExchangedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Exchanged During Period, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockExchangedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652032997400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parentheticals) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
<td class="nump">$ 1.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
<td class="num">$ (1,934)<span></span>
</td>
<td class="num">$ (1,627)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037536200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (4,340)<span></span>
</td>
<td class="nump">$ 1,120<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and other asset impairment charges</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">2,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(908)<span></span>
</td>
<td class="num">(342)<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">(Gain) loss from sales of businesses and investments</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="num">(2,494)<span></span>
</td>
<td class="num">(967)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(2,276)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">3,952<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseinOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(362)<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="nump">8,067<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="nump">511<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">4,542<span></span>
</td>
<td class="nump">4,374<span></span>
</td>
<td class="nump">4,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(451)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="num">(426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(190)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="num">(905)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(139)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(415)<span></span>
</td>
<td class="num">(579)<span></span>
</td>
<td class="num">(1,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">6,323<span></span>
</td>
<td class="nump">21,437<span></span>
</td>
<td class="nump">37,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(6,323)<span></span>
</td>
<td class="num">(21,437)<span></span>
</td>
<td class="num">(37,268)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuances of long-term debt</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,040)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
<td class="num">(1,112)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquityAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases, including shares surrendered for tax withholding</a></td>
<td class="num">(770)<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
<td class="num">(1,639)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
<td class="num">(292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(199)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,693)<span></span>
</td>
<td class="num">(2,734)<span></span>
</td>
<td class="num">(2,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of year</a></td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
<td class="nump">2,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of year</a></td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Less: Restricted cash at end of period included in Other Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of year included in Prepaid expenses and other</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">6,278<span></span>
</td>
<td class="nump">4,015<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest, net</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes, net of refunds</a></td>
<td class="nump">$ 379<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseinOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseinOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033194072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global provider of healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. Commencing with the second quarter of 2021, the Company reports its financial results in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (&#8220;RxTS&#8221;). All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. Refer to Financial Note 22, &#8220;Segments of Business,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights (&#8220;variable interest entities&#8221; or &#8220;VIEs&#8221;) and determines which business entity is the primary beneficiary of the VIE. The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior year amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires that the Company make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The severity, magnitude and duration, as well as the economic consequences of the coronavirus diseases 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing, and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#8217;s consolidated financial results. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. As of March&#160;31, 2021, restricted cash primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Consolidated Balance Sheet as of March&#160;31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketable Securities Available-for-Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company&#8217;s marketable securities, which are available-for-sale, are carried at fair value and are included in &#8220;Prepaid expenses and other&#8221; in the Consolidated Balance Sheets. The unrealized gains and losses, net of the related tax effect, computed in marking these securities to market have been reported in stockholders&#8217; equity. At March&#160;31,&#160;2021 and 2020, marketable securities were not material. In determining whether an other-than-temporary decline in market value has occurred, the Company considers the duration that, and extent to which, the fair value of the investment is below its cost, the financial condition and future prospects of the issuer or underlying collateral of a security, and its intent and ability to retain the security in order to allow for an anticipated recovery in fair value. Other-than-temporary declines in fair value from amortized cost for available-for-sale equity securities that the Company intends to sell or would more likely than not be required to sell before the expected recovery of the amortized cost basis are charged to other income (expense), net, in the period in which the loss occurs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, Net and Allowances for Doubtful Accounts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s receivables are presented net of an allowance for doubtful accounts and primarily consist of trade accounts receivables from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $198 million and $224 million were included in &#8220;Receivables, net&#8221; on the Consolidated Balance Sheet as of March&#160;31, 2021 and 2020, respectively. Changes in the allowance were not material for the year ended March&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,181&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,950&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2021, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 51% of its total consolidated revenues and approximately 32% of total trade accounts receivable at March&#160;31, 2021. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of its total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March&#160;31, 2021. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses and monitors credit risk associated with financing receivables, primarily notes receivable, through regular review of its collections experience in determining its allowance for loan losses. On an ongoing basis, the Company also evaluates credit quality of its financing receivables utilizing historical collection rates and write-offs, as well as considering existing economic conditions, to determine if an allowance is required. As of March&#160;31, 2021 and 2020, financing receivables were not material to the Company&#8217;s consolidated financial statements. Financing receivables and the related allowances are included in &#8220;Receivables, net&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LIFO method was used to value approximately 58% and 60% of the Company&#8217;s inventories at March&#160;31, 2021 and 2020, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $406&#160;million and $444&#160;million higher than the amounts reported at March&#160;31, 2021 and 2020, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $38 million, $252 million, and $210 million in 2021, 2020, and 2019, respectively, in &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Excluding LIFO reserves, inventory reserves as of March&#160;31, 2021 and 2020 were $263 million and $96 million, respectively. The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment. These charges are recorded in "Cost of sales" in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March&#160;31, 2021 and 2020, inventories at LIFO did not exceed market.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes costs to pack and deliver inventory to its customers in Selling, distribution, general, and administrative expenses. Shipping and handling costs of $1.0 billion, $1.0 billion, and $951 million were recognized in 2021, 2020, and 2019, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. Refer to Financial Note 3, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant, and Equipment, Net: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March&#160;31, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense for property, plant, and equipment, net and amortization of finance leases was $344&#160;million, $335&#160;million, and $317&#160;million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2">one</span> to 38 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March&#160;31, 2021 and 2020, capitalized software held for internal use was $513 million and $400 million, respectively, net of accumulated amortization of $1.4 billion and $1.3 billion, respectively, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $117&#160;million, $129&#160;million, and $137&#160;million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;), from which it obtains coverage for catastrophic exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company, as discussed in more detail in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within Operating Expenses in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion in each of 2021 and 2020 and $2.9 billion in 2019. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March&#160;31, 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March&#160;31, 2021 and 2020. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Incentives:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; equity accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income (loss), net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material to the Company&#8217;s consolidated results of operations in 2021, 2020, or 2019. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income (loss), net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income. Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity but are excluded from earnings. The Company&#8217;s other comprehensive income primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency including gains and losses on net investment hedges, unrealized gains and losses on cash flow hedges, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrealized gains and losses on retirement-related benefit plans. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#8217;s consolidated entities including Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;) and ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 9, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to ongoing controlled substances claims to which the Company is a party.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are recognized as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standard Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify, and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The adoption of this amended guidance is not expected to have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033083400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investment in Change Healthcare Joint Venture</a></td>
<td class="text">Investment in Change Healthcare Joint Venture <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2017, the Company contributed the majority of its McKesson Technology Solutions businesses to form a joint venture, the Change Healthcare JV, under a contribution agreement between McKesson and Change Healthcare Inc. (&#8220;Change&#8221;) and others, including shareholders of Change. In exchange for the contribution, the Company initially owned approximately 70% of the joint venture, with the remaining equity ownership of approximately 30% held by Change. The Change Healthcare JV was jointly governed by McKesson and shareholders of Change. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change received net cash proceeds of approximately $888 million. Change contributed the proceeds of $609 million from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;) at the equivalent of its offering price of $13 per share. The proceeds of $279 million from the concurrent offering of other securities were used by Change to acquire certain securities of the Change Healthcare JV that substantially mirrored the terms of other securities included in the offering by Change. As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5% while Change owned approximately 41.5% of the outstanding LLC Units. Accordingly, in the second quarter of 2020, the Company recognized a dilution loss of $246 million, primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. The Company&#8217;s proportionate share of income or loss from this investment was subsequently reduced as immaterial settlements of stock option exercises occurred after the IPO. These amounts were included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations for the year ended March&#160;31, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded an other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations for the year ended March&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation of the Change Healthcare JV</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV. The separation was affected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly-owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (&#8220;Split-off&#8221;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#8220;Merger&#8221;).</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Split-off, on March 9, 2020, the Company distributed all 176.0 million outstanding shares of common stock of SpinCo to participating holders of the Company&#8217;s common stock in exchange for 15.4 million shares of McKesson common stock which now are held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 20, &#8220;Stockholders' Equity,&#8221; for more information. Following consummation of the exchange offer, on March 10, 2020, SpinCo was merged with and into Change Healthcare, and each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and the Merger are intended to be generally tax-free transactions for U.S. federal income tax purposes. Following the Split-off, the Company does not beneficially own any of Change&#8217;s outstanding securities. In the fourth quarter of 2020, the Company recognized a net gain of $414 million related to the transaction which is included under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations for the year ended March&#160;31, 2020. The net gain was calculated as follows:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the Change Healthcare JV at exchange date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of accumulated other comprehensive attributable to the joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on split-off of the Change Healthcare JV</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investment in the Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment in the joint venture was accounted for using the equity method of accounting on a one-month reporting lag. The Company&#8217;s accounting policy has been to disclose any intervening events of the joint venture in the lag period that could materially affect its consolidated financial statements. Effective April&#160;1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance and, in the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, in the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded its proportionate share of loss from its investment in the Change Healthcare JV of $119 million and $194 million in 2020 and 2019, respectively. The Company&#8217;s proportionate share of income or loss from this investment includes transaction and integration expenses incurred by the Change Healthcare JV and basis differences between the joint venture and McKesson including amortization of fair value adjustments primarily representing incremental intangible amortization and removal of profit associated with the recognition of deferred revenue. These amounts were recorded under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of the Change Healthcare JV, McKesson, the Change Healthcare JV and certain shareholders of Change entered into various ancillary agreements, including transition services agreements (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;) and certain other agreements. Fees incurred or earned from the Advisory Agreement were not material for 2020 and 2019. Fees incurred or earned from the TSA were not material in 2021 and were $22 million in 2020 and $60 million in 2019. The Advisory Agreement was terminated in 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company renegotiated the terms of the TRA which resulted in the extinguishment and derecognition of the $90 million non-current liability payable to the shareholders of Change.&#160;In exchange for the shareholders of Change agreeing to extinguish the liability, the Company agreed to an allocation of certain tax amortization that had the effect of reducing the amount of a distribution from the Change Healthcare JV that would otherwise have been required to be made to the shareholders of Change.&#160;As a result of the renegotiation, McKesson was relieved from any potential future obligations associated with the non-current liability and recognized a credit of $90 million in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statement of Operations in 2019.&#160;At March&#160;31, 2021 and 2020, the Company had no&#160;outstanding payable balance to the shareholders of Change under the TRA.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement executed in 2019 between the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax years ended March 31, 2020 and 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare&#160;JV, the aforementioned TRA agreement requires the Change Healthcare&#160;JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare&#160;JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of March 31, 2021 or 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the separation transaction in the fourth quarter of 2020, the Company recorded a reversal of the deferred tax liability related to its investment. Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033260808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities that have met the classification as held for sale were $12&#160;million and $9&#160;million, respectively, as of March&#160;31, 2021 and $906 million and $683 million, respectively, as of March&#160;31, 2020. The amounts at March&#160;31, 2020 primarily consisted of the majority of the Company&#8217;s German pharmaceutical wholesale business as described below. This disposal group had been recorded as assets and liabilities held for sale since the third quarter of 2020 through its contribution to a joint venture in the third quarter of 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Wholesale Joint Venture</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed its previously announced transaction with Walgreens Boots Alliance (&#8220;WBA&#8221;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson has a 30% noncontrolling interest.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration received included a receivable amount of $41&#160;million, primarily related to working capital and net debt adjustments from WBA, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of March&#160;31, 2021. The Company accounts for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $291&#160;million as of the transaction date, which was paid to the Company in the third quarter of 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the contribution, the Company recorded losses of $58&#160;million and $275&#160;million (pre-tax and after-tax), respectively, in the years ended March&#160;31, 2021 and 2020, which includes adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#8220;Operating expenses&#8221; in the Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. As a result of finalization of working capital amounts contributed and other adjustments, the Company may record additional gains or losses in future periods; however, these adjustments are not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of the transaction on November 1, 2020, there were no assets or liabilities of the German pharmaceutical wholesale joint venture classified as held for sale on the Company&#8217;s Consolidated Balance Sheet. The total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#8217;s Consolidated Balance Sheet as of March&#160;31, 2020, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less cost to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033059624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $334 million, $268 million and $597 million in 2021, 2020, and 2019, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations and were not material for the years ended 2021, 2020, and 2019.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of its office space in North America. Where the Company determines to cease using office space, it plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $180&#160;million&#160;to $280&#160;million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. This initiative is expected to be completed in 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Under this initiative, the Company expects to incur total charges of approximately $85 million to $90 million. The Company recorded charges of $57 million in 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is expected to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $62 million, $72 million, and $163 million in 2021, 2020, and 2019, respectively, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in 2021 and remaining costs the Company expects to record under this initiative are not material. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $28 million, $44 million, and $33 million in 2021, 2020, and 2019, respectively, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021 and remaining costs the Company expects to record under this initiative, primarily relating to lease costs, are not material.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2018, the Company committed to a restructuring plan, which primarily consisted of the closures of underperforming retail pharmacy stores in the U.K., included in its International segment, and a reduction in workforce. In 2019, the Company recorded charges of $18 million, consisting primarily of employee severance and lease exit costs, with $92 million of total charges recorded through the end of 2019. The plan was substantially completed in 2020 and additional charges were not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2018, the Company announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize the Company&#8217;s operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, the Company committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material. The Company recorded charges of $15 million and $135 million in 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:18.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.755%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with dispositions and costs related to the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2019 consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model cost optimization efforts and U.K. restructuring initiative focusing on underperforming retail pharmacy stores described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include lease and other contract exit costs associated with closures of facilities and retail pharmacy stores as well as project consulting fees.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March&#160;31, 2021 and 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;As of March&#160;31, 2020, the total reserve balance was $157 million of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March&#160;31, 2021, the total reserve balance was $151 million of which $99 million was recorded in Other accrued liabilities and $52 million was recorded in Other non-current liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company recognized charges of $82 million to impair certain long-lived and intangible assets for its retail pharmacy business in Europe within the Company&#8217;s International segment. These charges related primarily to intangible assets associated with pharmacy licenses within the U.K retail business due to a decline in estimated future cash flows driven by additional U.K. government reimbursement reductions communicated in the third quarter of 2020. The Company used a combination of an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived and intangible assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company performed an interim impairment test of long-lived and intangible assets for its Rexall Health retail business, within the Company's International segment, due to the decline in the estimated future cash flows primarily driven by lower than expected growth in both prescription volume and sales of non-prescription goods. As a result, the Company recognized a charge of $30 million to impair certain long-lived and intangible assets, primarily customer relationships. The Company utilized an income approach (a DCF method) for estimating the fair value of the long-lived and intangible assets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company recognized charges of $210&#160;million to impair certain long-lived assets (primarily pharmacy licenses) for its U.K. retail business, within the Company&#8217;s International segment, primarily driven by government reimbursement reductions and competitive pressures in the U.K. The Company used an income approach (a DCF method) or a combination of an income approach and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company recorded charges of $35 million to impair certain intangible assets (primarily customer relationships) for its Rexall Health retail business within the Company&#8217;s International segment. The impairments were primarily the result of the decline in estimated future cash flows for this business. The estimated cash flow projections were negatively affected by a lower projected overall growth rate from the ongoing impact of government regulations in 2019. The Company utilized an income approach (a DCF method) for estimating the fair value of long-lived assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the long-lived and intangible assets described above is considered a Level 3 fair value measurement due to the significance of unobservable inputs developed using company-specific information. Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; for more information on nonrecurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033161752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Acquisitions and Divestitures</a></td>
<td class="text">Business Acquisitions and Divestitures<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, the Company did not complete any material acquisitions. During 2021, 2020, and 2019, the Company did not complete any material divestitures other than the contribution of the majority of its German wholesale business to a newly formed joint venture, as described in Financial Note 3, &#8220;Held for Sale,&#8221; in 2021 and the separation of the Change Healthcare JV, as described in Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; in 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes. However, if the assets of another company are acquired, the goodwill may be deductible for tax purposes. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Acquisition</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Specialties Distributors LLC (&#8220;MSD&#8221;)</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2018, the Company completed its acquisition of MSD for the net purchase consideration of $784 million, which was funded from cash on hand. MSD is a leading national distributor of infusion and medical-surgical supplies as well as a provider of biomedical services to alternate site and home health providers. The financial results of MSD have been included in the Company&#8217;s Consolidated Statements of Operations within its Medical-Surgical Solutions segment since the acquisition date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets acquired and liabilities assumed as of the acquisition date were finalized upon completion of the measurement period in the first quarter of 2020. The final purchase price allocation included acquired identifiable intangibles of $326 million primarily representing customer relationships with a weighted-average life of 18 years. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final recording of the fair value of the assets acquired and liabilities assumed for this acquisition as of the acquisition date, including immaterial adjustments made during the measurement period:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;as of the Acquisition Date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets, net of cash and cash equivalents acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired, net of cash and cash equivalents</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Final amounts as of May 31, 2019.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CoverMyMeds LLC (&#8220;CMM&#8221;)</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2017, the Company completed its acquisition of CMM for the net purchase consideration of $1.3 billion, which was funded from cash on hand. Pursuant to the agreement, McKesson&#8217;s purchase consideration was subject to an additional $160 million of contingent consideration based on CMM&#8217;s financial performance for 2018 and 2019. Pursuant to the agreement, the Company paid additional contingent consideration of $69 million and $68 million in May 2019 and May 2018, respectively. As of March&#160;31, 2020, the related liability was nil. </span></div>During the three years presented, the Company also completed a number of other de minimis acquisitions within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034453208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based CompensationThe Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#8220;RSUs&#8221;), performance-based stock units (&#8220;PSUs&#8221;, formerly referred to as total shareholder return units or &#8220;TSRUs&#8221;), performance-based restricted stock units (&#8220;PeRSUs&#8221;), stock options, and an employee stock purchase plan (&#8220;ESPP&#8221;) (collectively, &#8220;share-based awards&#8221;). Most of the share-based awards are granted in the first quarter of each fiscal year.<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on Net Income</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.539%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs, PeRSUs, and PSUs.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2021, 2020, and 2019 included discrete income tax expense of $2 million, $2 million, and $4&#160;million, respectively. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company&#8217;s stockholders approved the 2013 Stock Plan to replace the 2005 Stock Plan. Under these stock plans, the Company may issue restricted stock, RSUs, PSUs, PeRSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserves 30 million shares plus unused reserved shares under the 2005 Stock Plan. As of March&#160;31, 2021, 20 million shares remain available for future grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs entitle the holder to receive a specified number of shares of the Company&#8217;s common stock which vest over a period of generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMzYvZnJhZzpiYTNlOTc5YjRmNzQ0ODgxYmVlNmE0M2VkMDg0MTQ0Yi90ZXh0cmVnaW9uOmJhM2U5NzliNGY3NDQ4ODFiZWU2YTQzZWQwODQxNDRiXzI1NDY_e4780d27-ecc2-4ddb-b012-e0b781a25964">three</span> to four years as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the market price of the Company&#8217;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March&#160;31, 2021, approximately 82,000 RSUs for the Company&#8217;s directors are vested.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a three-year performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally three years. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date. For PSUs that are eligible for cash settlement and designated as liability awards, the Company re-measures the fair value at the end of each reporting period and adjusts a corresponding liability in its Consolidated Balance Sheets for changes in fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PeRSUs are awards for which the number of RSUs awarded is conditional upon the attainment of one or more performance objectives over a specified period. All outstanding PeRSU awards have completed the performance period and are now classified and accounted for as RSUs. The Company did not grant any PeRSUs during the years ended March&#160;31, 2021 and 2020. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs, PSUs, and PeRSUs) during 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of seven years and follow a four-year vesting schedule.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the fair value of employee stock options were as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended <br/>March 31, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company did not grant any stock options during the years ended March&#160;31, 2021 and 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The computation of expected volatility was based on a combination of the historical volatility of the Company&#8217;s common stock and implied market volatility. The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Expected dividend yield is based on historical experience and investors&#8217; current expectations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The risk-free interest rate for periods within the expected life of the option is based on the constant maturity U.S. Treasury rate in effect at the grant date.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The expected life of the options is based primarily on historical employee stock option exercises and other behavioral data and reflects the impact of changes in the contractual life of current option grants compared to the Company&#8217;s historical grants.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March&#160;31, 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$183.20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during 2021:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ESPP under which 21 million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock through payroll deductions. The deductions occur over three-month purchase periods and the shares are then purchased at 85% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The 15% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in 2021, 2020, and 2019. At March&#160;31, 2021, 2 million shares remain available for issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033305384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income, Net</a></td>
<td class="text">Other Income, Net<div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses from pension plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of equity method investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments and were included within Corporate expenses, net. Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; and to Financial Note 22, &#8220;Segments of Business.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes $116 million from the termination of the U.S. defined benefit pension plan and $11 million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 15, &#8220;Pension Benefits.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents a gain from the sale of an equity investment to a third party included in RxTS during 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033060648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(902)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported an income tax benefit rate of 13.8% in 2021. Income tax expense rates were 1.6% and 58.4% in 2020 and 2019, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to the impact of opioid-related claims of $8.1 billion ($6.8 billion after-tax) in 2021, the impact of the Change Healthcare joint venture divestiture in 2020, the impact of nondeductible impairment charges in 2019, and varying proportions of income attributable to foreign countries that have income tax rates different from the U.S. rate.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21% to income before income taxes is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-free gain on investment exit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of change in U.S. tax rate on temporary differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for additional information regarding the separation of the Change Healthcare JV.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $5 million in 2021 and $7 million in each of 2020 and 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rate for 2021 was impacted by the charge for pending and future opioid-related claims of $8.1 billion ($6.8 billion after-tax), as described further in Financial Note 19, &#8220;Commitments and Contingent Liabilities.&#8221; The Company recorded a deferred tax benefit of $1.3&#160;billion, which is net of certain non-deductible expenses and an unrecognized tax benefit of $455 million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2019, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. In both instances, the transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; discrete tax benefits of $105 million and $42 million were recognized for 2021 and 2019, respectively, with a corresponding increase to a deferred tax assets for the temporary difference arising from the buyer&#8217;s excess tax basis.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV as described in Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture.&#8221; The Company&#8217;s reported income tax expense rate for 2020 was favorably impacted by this transaction given that it was intended to generally be a tax-free split-off for U.S. federal income tax purposes. In the fourth quarter of 2020, the Company recognized a net gain for financial reporting purposes of $414 million related to the separation transaction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax expense rate for 2020 was unfavorably impacted by non-cash charges of $275 million to remeasure the carrying value of assets and liabilities held for sale related to the formation of a new German wholesale joint venture within the Company&#8217;s International segment. Refer to Financial Note 3, &#8220;Held for Sale,&#8221; for more information on this transaction which closed in the third quarter of 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax expense rate for 2019 was unfavorably impacted by non-cash charges of $1.8 billion to impair the carrying value of goodwill for its International segment, given that these charges are generally not deductible for tax purposes. Refer to Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,196)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,196)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $864 million and $833 million in 2021 and 2020, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The increase in the valuation allowance of $31 million in the current year relates primarily to net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has federal, state, and foreign net operating loss carryforwards of $2.4 billion, $3.9 billion, and $2.2 billion at March&#160;31, 2021. Federal and state net operating losses will expire at various dates from 2022 through 2041. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $783 million with indefinite lives. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had $1.8 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate, if recognized. The increase in unrecognized tax benefits in 2021 compared to 2020 is primarily attributable to uncertainty in connection with the deductibility of Opioid-related litigation and claims. Because many uncertainties associated with any potential settlement arrangements or other resolutions of opioid claims including provisions related to deductibility have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; for more information. The decrease in unrecognized tax benefits in 2020 compared to 2019 is primarily attributable to the favorable resolution of an outstanding California tax refund claim which decreased unrecognized tax benefits by $91&#160;million. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefit may decrease by as much as $93 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $9 million, $23 million, and $33 million in 2021, 2020, and 2019, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March&#160;31, 2021 and 2020, it accrued $101&#160;million and $91&#160;million cumulatively in interest and penalties on unrecognized tax benefits.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign operations of approximately $6.0 billion were considered indefinitely reinvested. Following enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033297112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily relate to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, during 2021, 2020, and 2019, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $43 million, $42 million, and $45 million, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe have a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). The exercise of the Put Right will reduce the balance of redeemable noncontrolling interests. During 2021, the Company paid $49 million to purchase 1.8&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $49 million, and the associated effect of the increase in the Company&#8217;s ownership interest on its equity of $3 million was recorded as a net increase to McKesson&#8217;s stockholders paid-in capital. During 2020 and 2019, there were no material exercises of the Put Right. The balance of the associated liability for Redeemable noncontrolling interests is reported as the greater of its carrying value or its maximum redemption value at each reporting date. The redemption value is the Put Amount adjusted for exchange rate fluctuations each period. The Redeemable noncontrolling interest is also adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. At March&#160;31, 2021 and 2020, the carrying value of redeemable noncontrolling interests of $1.3 billion and&#160;$1.4 billion, respectively, exceeded the maximum redemption value of $1.2 billion and $1.2 billion, respectively. At March&#160;31, 2021 and 2020, the Company owned approximately 78% and 77%, respectively, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Appraisal Proceedings</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court (the &#8220;Court&#8221;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#8364;0.51 resulting in an adjusted Put Amount of &#8364;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#8364;22.99, thereby rejecting the lower court&#8217;s increase, and the recurring compensation shall remain &#8364;0.83 per share.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE and Vantage, which were $196 million and $217 million at March&#160;31, 2021 and 2020, respectively, in the Company&#8217;s Consolidated Balance Sheets. During 2021, 2020, and 2019, respectively, the Company allocated a total of&#160;$156 million,&#160;$178 million, and&#160;$176 million of net income to noncontrolling interests. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March&#160;31, 2021, 2020, and 2019 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/>Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of put right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033098696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Common Share</a></td>
<td class="text">Earnings per Common Share<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted loss per common share for the year ended March&#160;31, 2021 was calculated by excluding potentially dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 2 million and 3 million of potentially dilutive securities for 2020 and 2019, respectively, were excluded from the computations of diluted net earnings per common share, as they were anti-dilutive.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.211%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)Certain computations may reflect rounding adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042720472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorDirectFinancingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3">one</span> to five years. Most real property leases contain renewal options (typically for&#160;five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under operating leases was $576 million in 2019.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $217 million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db">five</span> to 15 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $298 million and $272 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3">one</span> to five years. Most real property leases contain renewal options (typically for&#160;five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under operating leases was $576 million in 2019.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $217 million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db">five</span> to 15 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $298 million and $272 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by derecognition of existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment, primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyMzk_aa24e1b9-e681-4c22-ac2c-a4b579df8768">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzU0OTc1NTgxNDkyNDg_eec58f57-25bd-4469-a022-751e94acc3c3">one</span> to five years. Most real property leases contain renewal options (typically for&#160;five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under operating leases was $576 million in 2019.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;padding-right:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $217 million that are not reflected in the table above. These operating leases will commence between 2022 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xNjYvZnJhZzo4NDhjMDcxNGY1ZTU0ZTlmYWY4N2UxMzU1Mzg5YjI3Yy90ZXh0cmVnaW9uOjg0OGMwNzE0ZjVlNTRlOWZhZjg3ZTEzNTUzODliMjdjXzMzMTk_26c51c35-d99b-4b89-8b31-06248d70d3db">five</span> to 15 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily leases certain owned equipment, that are classified as direct financing or sales-type leases, to physician practices. As of March&#160;31, 2021 and 2020, the total lease receivable was $298 million and $272 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March&#160;31, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorDirectFinancingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorDirectFinancingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034610184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:25.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.774%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.534%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.043%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Impairment Charges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis each year and at an interim date, if indicators of potential impairment exist. On October 1, 2019, the Company voluntarily changed its annual goodwill impairment testing date from January&#160;1 to October 1 to better align with the timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from October 1, 2019 as retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units was determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#8217;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#8217;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill charges listed below were recorded in &#8220;Goodwill impairment charges&#8221; in the Consolidated Statements of Operations. Most of the goodwill impairment for these reporting units were generally not deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. At March&#160;31, 2021, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for 2021 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment testing performed in 2020 did not indicate any material impairment of goodwill.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment testing performed in 2019 resulted in the following impairment charges:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.584%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except rates)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarter Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reporting Unit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Terminal Growth Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill Impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">As described above, the Company implemented its new segment reporting structure in the second quarter of 2021 and its European Pharmaceutical Solutions segment and its Rexall Health business in Canada became part of the International segment. Amounts included herein were previously included within the former European Pharmaceutical Solutions segment.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Represents pre-tax and after-tax amounts, except for an aggregate $20 million of tax charges related to the March 2019 Retail Pharmacy impairment. Total goodwill impairment for 2019 also included $21 million related to the Company&#8217;s Rexall Health business, within the International segment, recorded in the third quarter of 2019.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Prior to implementing its new segment reporting structure in the first quarter of 2019, the Company&#8217;s European operations were considered a single reporting unit. Following the change in reportable segments, its European Pharmaceutical Solutions segment was divided into two distinct reporting units, Retail Pharmacy (&#8220;RP&#8221;), formerly Consumer Solutions, and Pharmaceutical Distribution (&#8220;PD&#8221;), formerly Pharmacy Solutions, for the purposes of goodwill impairment testing. This change required performance of a goodwill impairment test for these two new reporting units which resulted in a goodwill impairment charge as PD&#8217;s estimated fair value was lower than its reassigned carrying value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Both RP and PD projected a decline in the estimated future cash flows primarily triggered by U.K. government actions which were announced on June 29, 2018. An interim goodwill impairment test for these reporting units identified that their carrying values exceeded their estimated fair value and resulted in an impairment charge.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">As a result of the annual goodwill impairment test, the carrying values of the PD and RP reporting units exceeded their estimated fair value which required the Company to record impairment charges for the reporting units. These additional impairments were primarily due to declines in the reporting units&#8217; estimated future cash flows and the selection of higher discount rates. The declines in estimated future cash flows were primarily attributed to additional government reimbursement reductions and competitive pressures within the U.K. The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate. As of March&#160;31, 2019 the entire remaining goodwill balances of both reporting units were impaired.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; for more information on these nonrecurring fair value measurements. As of March&#160;31, 2021 and 2020, accumulated goodwill impairment losses in the Company&#8217;s International segment were $3.6 billion and $3.5 billion, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.144%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $422 million, $462 million, and $485 million for 2021, 2020, and 2019, respectively. Estimated annual amortization expense of intangible assets is as follows: $370 million, $270 million, $259 million, $253 million, and $220 million for 2022 through 2026, and $1.5 billion thereafter. All intangible assets were subject to amortization as of March&#160;31,&#160;2021 and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges,&#8221; for more information on intangible asset impairment charges recorded in 2021, 2020, and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034390120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March&#160;31, 2021 and 2020, $7.1 billion and $7.4 billion, respectively, of total debt was outstanding, of which $742 million and $1.1 billion, respectively, was included in &#8220;Current portion of long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2021, the Company retired its 3.65% $700&#160;million total principal of notes due on November 30, 2020 upon maturity. On December 1, 2020, the Company redeemed its 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above. In 2020, the Company repaid at maturity its &#8364;250 million Floating Rate Euro Notes due February 12, 2020. In 2019, the Company repaid at maturity its $1.1 billion 2.28% notes due March 15, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each note, which constitutes a &#8220;Series&#8221;, is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed&#160;by materially similar indentures and officers&#8217; certificates. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc. and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase that Series from the holders at a price equal to 101%&#160;of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments of long-term debt are $742 million in 2022, $838 million in 2023, $1.1 billion in 2024, $34 million in 2025, $1.2 billion in 2026, and $3.2 billion thereafter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company entered into a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during 2021 and 2020 and no amounts outstanding as of March&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At March&#160;31, 2021, the Company was in compliance with all covenants. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the $3.5 billion five-year senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019 and had no borrowings during the six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $8 million and an uncommitted amount of $152 million as of March&#160;31, 2021. Borrowings and repayments were not material in 2021 and 2020 and amounts outstanding under these credit lines were not material as of March&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. During 2021 and 2020, it borrowed $6.3 billion and $21.4 billion, respectively, and repaid $6.3 billion and $21.4 billion, respectively, under the program. At March&#160;31, 2021 and 2020, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033163992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs, if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#8217;s Consolidated Statements of Operations and Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $662 million and $74 million, respectively, at March&#160;31, 2021 and $695 million and $82 million, respectively, at March&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual or other relationships with the VIEs. The Company&#8217;s most significant relationships are with oncology and other specialty practices. Under these practice arrangements, it generally owns or leases all of the real estate and equipment used by the affiliated practices and manages the practices&#8217; administrative functions. It also has relationships with certain pharmacies in Europe with whom it may provide financing, have equity ownership, and/or a supply agreement whereby it supplies the vast majority of the pharmacies&#8217; purchases. The Company&#8217;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $1.5 billion at March&#160;31, 2021 and $1.4 billion at March&#160;31, 2020, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 18, &#8220;Financial Guarantees and Warranties.&#8221; The Company believes there is no material loss exposure on these assets or from these relationships.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035120488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Pension Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an unfunded nonqualified supplemental defined benefit plan for certain U.S. executives, as well as benefit pension plans for eligible employees outside the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future pension benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $105 million was recorded during the second quarter of 2020. Settlement charges were included within &#8220;Other income, net,&#8221; in the Consolidated Statements of Operations for the year ended March 31, 2020. As of March 31, 2020, this defined benefit pension plan had an accumulated comprehensive loss of approximately nil.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, a cash payment of $114 million was made to settle a participant&#8217;s liability from the executive benefit retirement plan. As a result, a majority of the remaining recorded unrecognized losses in accumulated other comprehensive loss for this Plan were recognized as expense and a settlement charge of approximately $11 million was recorded in &#8220;Other income, net&#8221;, in the Consolidated Statements of Operations. As of March 31, 2020 and 2019, this plan had an accumulated comprehensive loss of approximately $1 million and $12 million, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway, the United Kingdom, Germany, and Canada. Benefits for these plans are based primarily on each employee&#8217;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#8220;SPK&#8221;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law. In the U.K., the Company has subsidiaries that participate in a joint pension plan. The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe&#8217;s Management Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company derecognized $187&#160;million of pension liabilities included in liabilities held for sale and $33&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit plan assets and obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic expense for the Company&#8217;s pension plans is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:43.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans is as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity Premium Transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity Premium Transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The divestiture relates to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included within current liabilities and totaled $151&#160;million at March&#160;31, 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial loss of $89 million in 2021 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($32&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased from 2.03% as of March&#160;31, 2020 to 1.89% as of March&#160;31, 2021. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($57&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestiture in 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $36 million in 2020 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($6&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased from 2.13% as of March&#160;31, 2019 to 2.03% as of March&#160;31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($42&#160;million gain): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes mortality, and other changes. The difference between actual inflation and assumed inflation in our U.K. pension plans resulted in a gain of $23&#160;million.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive income consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive income were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:44.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.745%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit (cost)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss (income) </span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $33&#160;million in actuarial losses for pension plans to stockholders&#8217; equity in 2021 as a result of the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; The Company recognized $127 million in actuarial losses for the pension plans to stockholders&#8217; equity in 2020 as a result of $116 million from the termination of the U.S. defined benefit pension plan and $11 million from the settlement from the executive benefit retirement plan for a retired executive. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected benefit obligations related to the Company&#8217;s unfunded U.S. plans were $9 million and $10 million at March&#160;31,&#160;2021 and 2020, respectively. Pension obligations for its unfunded plans are based on the recommendations of independent actuaries. Projected benefit obligations relating to the Company&#8217;s unfunded non-U.S. plans were $162 million and $298 million at March&#160;31,&#160;2021 and 2020, respectively. Funding obligations for its non-U.S. plans vary based on the laws of each non-U.S. jurisdiction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for the Company&#8217;s pension plans are as follows: $43 million, $36 million, $37 million, $36 million and $38 million for 2022 to 2026 and $202 million for 2027 through 2031. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#8217;s pension plans are $24 million for 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:40.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.83%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.71</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. For March&#160;31, 2021, the Company&#8217;s U.S. defined benefit liabilities are valued using a weighted-average discount rate of 2.35%, which represents a decrease of 73 basis points from its 2020 weighted-average discount rate of 3.08%. The Company&#8217;s non-U.S. defined benefit pension plan liabilities are valued using a weighted-average discount rate of 1.89%, which represents a decrease of 14 basis points from its 2020 weighted-average discount rate of 2.03%.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For non-U.S. plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. The following tables represent the Company&#8217;s pension plan assets as of March&#160;31, 2021 and 2020, using the fair value hierarchy by asset class:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.679%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $1.00. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other - At March&#160;31, 2021 and 2020, this includes $36 million and $29 million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity attributable to Level 3 plan assets was not material for the years ended March&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#8220;POA&#8221;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#8217;s withdrawal liability and contributions may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributions and amounts accrued for U.S. Plans were not material for the years ended March&#160;31, 2021, 2020, and 2019. Contributions to the POA for non-U.S. Plans exceeding 5% of total plan contributions were&#160;$22 million, $17 million, and&#160;$27 million in 2021, 2020, and 2019, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately 78% as of March&#160;31, 2021. No amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contributory retirement savings plan (&#8220;RSP&#8221;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to 75% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to 100% of the employee&#8217;s first 3% of pay contributed and 50% for the next 2% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $102 million, $102 million, and $92 million for the years ended March&#160;31, 2021, 2020, and 2019, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postretirement Benefits</span></div>The Company maintains a number of postretirement benefits, primarily consisting of healthcare and life insurance (&#8220;welfare&#8221;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic (credit) expense for the Company&#8217;s postretirement welfare benefits was not material for the years ended March 31, 2021, 2020, and 2019. The benefit obligation at March 31, 2021 and 2020 was $64 million and $65 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033289080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging ActivitiesIn the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. <div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, the Company had &#8364;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. In December 2019, the Company prospectively de-designated from net investment hedges &#8364;250 million of its Euro-denominated notes which matured in February 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2019, the Company also had &#163;450 million British pound sterling-denominated notes designated as non-derivative net investment hedges. On September 30, 2019, the Company de-designated its &#163;450 million British pound sterling-denominated notes prospectively from net investment hedges as the hedging relationship ceased to be effective. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from net investment hedges recorded within Other comprehensive income were losses of $118 million in 2021 and gains of $39 million and $259 million in 2020 and 2019, respectively. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during 2020 resulted in gains of $34 million which were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March&#160;31, 2021 and 2019.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million and $1.5 billion Canadian dollars, respectively. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March&#160;31, 2021, 2020, and 2019. In 2021, cross-currency swaps with an aggregate gross notional amount of $999 million Canadian dollars matured and the remaining cross-currency swaps will mature in November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2019, the Company also had cross-currency swaps designated as net investment hedges with a total gross notional amount of &#163;932 million British pound sterling. In 2020, the Company terminated these swaps due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million in 2020. This gain was recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $119 million in 2021 and gains of $76 million and $53 million in 2020 and 2019, respectively. There was no ineffectiveness in the Company&#8217;s hedges for the years ended March&#160;31, 2021 and 2019. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At March&#160;31, 2021 and 2020, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion and $2.9 billion, respectively, which are designated as cash flow hedges. These swaps will mature between May 2021 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#8364;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 13, &#8220;Debt and Financing Activities,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were losses of $42 million in 2021 and gains of $98 million and $28 million in 2020 and 2019, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations were not material in 2021, 2020, and 2019. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the years ended March&#160;31, 2021, 2020, and 2019. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in value included in earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At March&#160;31, 2021 and 2020, the total gross notional amounts of these contracts were $39&#160;million and $29 million, respectively. These contracts will predominately mature between April 2021 and December 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in the fair values were not material in 2021, 2020, and 2019. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the non-derivative net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#8364;250 million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they are offsetting matured in February 2020 and were not designated for hedge accounting. Changes in the fair value for contracts not designated as hedges are recorded directly in earnings. In 2020, losses of $44 million were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations, which offset the ineffectiveness on the Company&#8217;s non-derivative net investment hedges noted above. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:26.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.286%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(current)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div>Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; for more information on these recurring fair value measurements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033086024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March 31, 2021 and 2020 included investments in money market funds of $1.6 billion and $2.0 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at March 31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 16, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $269&#160;million and $170&#160;million at March&#160;31, 2021 and 2020, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. During 2021, several of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities, while others were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of 2021. Net gains related to the Company&#8217;s investments in these equity securities were approximately $133 million for the year ended March&#160;31, 2021. These gains were recorded in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. There were no other material changes in the carrying value of these investments during the year ended March&#160;31, 2021. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2020, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges&#8221; and Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no liabilities measured at fair value on a nonrecurring basis at March&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and 2020, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is also recorded at cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,792&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of the reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 12, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information regarding goodwill impairment charges recorded for certain reporting units during 2021 and 2019. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges&#8221; under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Assets Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033289080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Guarantees and Warranties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FinancialGuaranteesAndWarrantiesAbstract', window );"><strong>Financial Guarantees And Warranties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FinancialGuaranteesAndWarrantiesTextBlock', window );">Financial Guarantees And Warranties</a></td>
<td class="text">Financial Guarantees and Warranties<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Guarantees</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain of its customers&#8217; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#8217; inventory or its customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#8217;s inventory repurchase agreements, among other requirements, inventories must be in resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzYwNw_af6d397b-2d02-4293-8753-eb30ffd6bb25">one</span> to two years. Customers&#8217; debt guarantees generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8yMDgvZnJhZzo3Njg2OGQ2ODEwYjE0YmJiYTQ2OWI5ZjI4OWQ3Mzg5Yi90ZXh0cmVnaW9uOjc2ODY4ZDY4MTBiMTRiYmJhNDY5YjlmMjg5ZDczODliXzY2NQ_b7165f1b-8051-446f-8b5c-d34606827cfc">one</span> to ten years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#8217;s customers&#8217; debt guarantees are secured by certain assets of the customer. At March&#160;31, 2021, the maximum amounts of inventory repurchase guarantees and customers&#8217; debt guarantees were $329 million and $143 million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees are as follows: $268 million, $26 million, $33 million, $11 million, and $15 million&#160;from 2022 through 2026 and $119 million thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, the Company&#8217;s banks and insurance companies have issued $146 million of standby letters of credit and surety bonds, which were issued on the Company&#8217;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, and its workers&#8217; compensation and automotive liability programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#8217;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinancialGuaranteesAndWarrantiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Guarantees And Warranties [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinancialGuaranteesAndWarrantiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinancialGuaranteesAndWarrantiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial guarantees And warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinancialGuaranteesAndWarrantiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033086024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Case No. 17-md-2804. At present, there are approximately 2,900 cases under the jurisdiction of the MDL court.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case began on May 3, 2021. These two West Virginia plaintiffs are not expected to participate in any broader multistate resolution of opioid-related claims. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for December 6, 2021. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma. The Cherokee Nation is not expected to participate in any broader multistate resolution of opioid-related claims.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately 300 similar state court cases pending in 38 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trial in the Supreme Court of New York, Suffolk County for a case brought by the New York attorney general and two New York county governments, is scheduled to begin in June 2021, the cases brought by the Ohio and Washington attorneys general are scheduled to go to trial in September 2021, and the case brought by the Alabama attorney general is scheduled to go to trial in November 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to be involved in discussions with the objective of achieving broad resolution of opioid-related claims of states, their political subdivisions and other government entities (&#8220;governmental entities&#8221;). The Company is in ongoing, advanced discussions with state attorneys general and plaintiffs&#8217; representatives regarding a framework under which, in order to resolve claims of governmental entities, the three largest U.S. pharmaceutical distributors would pay up to approximately $21.0 billion over a period of 18 years, with up to approximately $8.0 billion to be paid by the Company, of which more than 90% is anticipated to be used to remediate the opioids crisis. Most of the remaining amount relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. In addition, the proposed framework would require the three distributors, including the Company, to adopt changes to anti-diversion programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the framework, before the distributors determine whether to enter into any final settlement, they would assess the sufficiency of the scope of settlement, based in part on the number and identities of the governmental entities that would participate in any such settlement. The framework contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless concluded that there was sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disclosed in its financial statements for the quarter ended December 31, 2020 its determination that discussions under that framework reached a stage at which a broad settlement of opioid claims by governmental entities was probable, and for which the loss could be reasonably estimated. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of that conclusion, and its assessment of certain other opioid-related claims, the Company recorded a charge of $8.1 billion ($6.8 billion after-tax) within &#8220;Claims and litigation charges, net&#8221; in the Consolidated Statements of Operations related to its share of the settlement framework described above, as well as those certain other opioid-related claims. There was no change to the estimated liability as of March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the uncertainties, as described below, of the timing of amounts that would be paid with respect to these charges, they were recorded in &#8220;Long-term litigation liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021. In addition, for the same reasons, the amount of loss that the Company ultimately might incur may differ materially from the amounts accrued.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions with attorneys general and other parties continue. If the negotiating parties agree on terms under the framework for a broad resolution of claims of governmental entities, then those potential terms would need to be agreed to by numerous other state and local governments before an agreement could be accepted by the Company and finalized. In some cases, discovery has been paused during the parties&#8217; discussions. While the Company continues to be involved in discussions regarding a potential broad settlement framework, the Company also continues to prepare for trial in these pending matters. The Company believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as 3 cases brought by governmental entities in Canada. These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, including the uncertain scope of participation by governmental entities in any potential settlement under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2018, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Manchester v. Purdue Pharma, L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within&#160;90 days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with two </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Coverage Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AIU Insurance Company et al. v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ace Property and Casualty Insurance Company v. McKesson Corporation et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On July 16, 2015, plaintiffs filed a motion for class certification. On August 22, 2016, the court denied plaintiffs&#8217; motion. On July 17, 2018, the United States Court of Appeals for the Ninth Circuit Court affirmed in part and reversed in part the district court&#8217;s denial of class certification and remanded the case to the district court for further proceedings. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On March 5, 2020, McKesson moved to decertify the class and moved for summary judgment on plaintiffs&#8217; claim for treble damages. Plaintiffs&#8217; moved for summary judgment on the same day. On December 24, 2020, the court declined to decertify the class but modified the class definition to distinguish between physical faxes (kept in the class) versus online or e-fax recipients (removed from the class). On March 19, 2021, the court denied summary judgment for plaintiffs on the issue of liability but found that McKesson&#8217;s affirmative defense of prior consent fails as a matter of law and precluded McKesson from presenting individualized evidence of consent at trial. On McKesson&#8217;s motion for summary judgment, the court demurred and will let the issue of treble damages go to the jury. Trial has been scheduled for October 18, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2017, two investment funds holding shares in Celesio AG filed a complaint against McKesson Europe Holdings (formerly known as &#8220;Dragonfly GmbH &amp; Co KGaA&#8221;), a subsidiary of the Company, in a German court in Stuttgart, Germany,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.&#160;18 O 455/17. On December 30, 2017,&#160;four&#160;investment funds, which had allegedly entered into swap transactions regarding shares in Celesio AG that would have enabled them to decide whether to accept McKesson Europe Holdings&#8217;s takeover offer in its acquisition of Celesio AG, filed a complaint,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson Kempner International (BVI) Ltd. et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No.16 O 475/17. The complaints allege that the public tender offer document published by McKesson Europe in its acquisition of Celesio AG incorrectly stated that McKesson Europe&#8217;s acquisition of convertible bonds would not be treated as a relevant acquisition of shares for the purposes of triggering minimum pricing considerations under Section 4 of the German Takeover Offer Ordinance. On May 11, 2018, the court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dismissed the claims against McKesson Europe. Plaintiffs appealed this ruling and, on December&#160;19, 2018, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. Plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof), which was rejected on November 17, 2020, making the dismissal final and binding. With no further right to appeal, Plaintiffs filed an objection against the decision of the Federal Court of Justice on November 27, 2020, claiming their right to be heard had been violated. On March 16, 2021, the Federal Court of Justice (Bundesgerichtshof) issued an order granting the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polygon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plaintiffs leave to appeal. On March 15, 2019, the lower court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> similarly dismissed the case. Plaintiffs appealed this ruling and, on October 9, 2019, the Higher Regional Court (Oberlandesgericht) of Stuttgart confirmed the full dismissal of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> matter. On November 13, 2019, plaintiffs filed a complaint against denial of leave to appeal with the Federal Court of Justice (Bundesgerichtshof). On March 16, 2021, the Federal Court of Justice (Bundesgerichtshof) issued an order granting the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Davidson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiffs leave to appeal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2018, the Company&#8217;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#8220;kickbacks&#8221; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#8217; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#8217;s decision on the United States&#8217; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#8217;s claims under the False Claims Act. The relator sought a re-hearing en banc at the Seventh Circuit, which was denied. The relator&#8217;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020. On February 10, 2021, the relator filed a Petition for Writ of Certiorari at the United States Supreme Court seeking review of the Seventh Circuit&#8217;s ruling.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#8217; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#8217;s motion to dismiss the claims pled against it, with leave to amend. On November&#160;16, 2018, the relators filed a fourth amended complaint. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;) was served with a fifth amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hanks v. Amgen, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV-08-03096 (SJ). Previously, the U.S. declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#8217;s motion to dismiss. Following the relator&#8217;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#8217;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2018, a second amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint was filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities against McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc. and US Oncology Specialty, L.P., alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG). The United States and the named states have declined to intervene in the case. On October 15, 2018, the Company filed a motion to dismiss the complaint as to all named defendants. On February&#160;4, 2019, the court granted the motion to dismiss in part and denied it in part, leaving the Company and Oncology Therapeutics Network Corporation as the only remaining defendants in the case. On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of another complaint filed by the same relator, alleging the same misconduct and seeking the same relief with respect to US Oncology, Inc., purportedly on behalf of the same government entities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#8217;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic Center, LLC v. Becton, Dickinson, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#8217;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. Defendants filed a motion to dismiss the amended complaint, which the district court granted on March 15, 2021. Plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit on March 23, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#8217;s motion for class certification.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, The Great Atlantic &amp; Pacific Tea Company (&#8220;A&amp;P&#8221;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re The Great Atlantic &amp; Pacific Tea Company, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Adv. Proc. No. 17-08264.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company&#8217;s subsidiary NDCHealth Corporation dba RelayHealth (&#8220;RelayHealth&#8221;) was served with three purported class action complaints filed in the United States District Court for the Northern District of Illinois. The complaints allege that RelayHealth violated the Sherman Act by entering into an agreement with co-defendant Surescripts, LLC not to compete in the electronic prescription routing market, and by conspiring with Surescripts, LLC to monopolize that market, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Powell Prescription Center, et al. v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-06627; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-06778; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Falconer Pharmacy, Inc. v. Surescripts LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-07035. In November 2019, three similar complaints were filed in the United States District Court for the Northern District of Illinois. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7445; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Whitman v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-7448; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BBK Global Corp. v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7640. In December 2019, the six actions were consolidated in the Northern District of Illinois. The complaints seek relief including treble damages, attorney fees, and costs. Subject to final court approval, plaintiffs and RelayHealth reached an agreement in June 2020 to resolve the class action lawsuits and RelayHealth paid into escrow an amount not material in the context of the Company&#8217;s overall financial results. The settlement does not include any admission of liability, and RelayHealth expressly denies wrongdoing.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017 and August 2018, respectively, the Company was served with&#160;two&#160;separate Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York relating to the certification the Company obtained for two software products under the U.S. Department of Health and Human Services&#8217; Electronic Health Record Incentive Program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April and June 2019, the United States Attorney&#8217;s Office for the Eastern District of New York served grand jury subpoenas seeking documents related to the Company&#8217;s anti-diversion policies and procedures and its distribution of Schedule II controlled substances. The Company believes the subpoenas are part of a broader investigation by that office into pharmaceutical manufacturers&#8217; and distributors&#8217; compliance with the Controlled Substances Act and related statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 12, 2019, the New York Department of Financial Services sent a Notice of Intent to Commence Enforcement Action to McKesson Corporation and PSS World Medical, Inc. for alleged violations of the New York Insurance Law and/or New York Financial Services Law, and seeking civil monetary penalties, in connection with manufacturing and distributing opioids in New York. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the United States Attorney&#8217;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV is also part of the investigation. On April 23, 2021, McKesson received correspondence from the Belgian Competition Authority seeking civil penalties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $50 million pre-tax charge ($37 million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March&#160;31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March&#160;31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The due date for filing such a petition is May 17, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V.&#160;Environmental Matters</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily as a result of the operation of the Company&#8217;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at five sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a determination by the Company&#8217;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#8217;s probable loss associated with the remediation costs for these five sites is $10 million, net of amounts anticipated from third parties. The $10 million is expected to be paid out between April 2021 and March 2051. The Company has accrued for the estimated probable loss for these environmental matters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been designated as a Potentially Responsible Party (&#8220;PRP&#8221;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at 14 sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. At one of these sites, the United States Environmental Protection Agency has selected a preferred remedy with an estimated cost of approximately $1.4 billion. It is not certain at this point in time what proportion of this estimated liability will be borne by the Company. Accordingly, the Company&#8217;s estimated probable loss at those 14 sites is approximately $28 million, which has been accrued for in the Consolidated Balance Sheets. However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VI. Value Added Tax Assessments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various countries outside the U.S. which&#160;collect value added taxes (&#8220;VAT&#8221;).&#160;The determination of the manner in which a VAT applies to the Company&#8217;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received&#160;assessments for VAT&#160;which are in&#160;various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions.&#160;Certain&#160;VAT assessments relate to years covered by an indemnification agreement.&#160;Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.&#160;However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or&#160;results of operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VII. Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $181 million, $22 million, and $202 million in 2021, 2020, and 2019, respectively, which were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VIII. Other Matters </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings and claims will not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033118248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' EquityEach share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the quarterly dividend was raised from $0.41 to $0.42 per common share for dividends declared on or after such date by the Board. Dividends were $1.67 per share in 2021, $1.62 per share in 2020, and $1.51 per share in 2019. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#8217;s future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the share repurchase activity over the last three years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in May 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to the Company&#8217;s Split-off of the Change Healthcare JV as described below.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">$8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last three years, the Company&#8217;s share repurchases were transacted through both open market transactions and ASR programs with third party financial institutions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company retired 5.0 million or $542 million&#160;of its treasury shares previously repurchased. Under the applicable state law, these shares resume the status of authorized and unissued shares upon retirement. In accordance with the Company&#8217;s accounting policy, any excess of share repurchase price over par value is allocated between additional paid-in capital and retained earnings. Accordingly, its retained earnings and additional paid-in capital were reduced by $472 million&#160;and $70 million, respectively, during 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2020, the Company completed the Split-off of its interest in the Change Healthcare JV. In connection with the Split-off, the Company distributed all 176.0 million outstanding shares of SpinCo common stock, which held all of the Company&#8217;s interests in the Change Healthcare JV, to participating holders of the Company&#8217;s common stock in exchange for 15.4 million shares of McKesson stock, which are now held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change with each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. See Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for more information. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.590%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $62, $(30), and $(71)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $6, $(12), and $(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit of $2, $(8), and $5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $1, $1, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of $9, $33, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021, 2020, and 2019 include net foreign currency translation adjustments of $(60) million, $1 million, and $(61) million, respectively, attributable to noncontrolling and redeemable noncontrolling interests.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021 primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Consolidated Statements of Operations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021, 2020, and 2019 include foreign currency adjustments of $(118) million, $39 million, and $259 million, respectively, on the net investment hedges from the Euro and British pound sterling-denominated notes. 2021, 2020, and 2019 also include foreign currency adjustments of $(119) million, $76 million, and $53 million, respectively, on the net investment hedges from the cross-currency swaps. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 2021 and 2020 net actuarial gains of $8 million and $2 million, respectively, and 2019 net actuarial loss of $5 million were attributable to noncontrolling and redeemable noncontrolling interests. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into &#8220;Cost of sales&#8221; and &#8220;Operating expenses&#8221; in the Consolidated Statements of Operations. The related tax expense was reclassified into &#8220;Income tax benefit (expense)&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2020 primarily reflects a reclassification of losses in 2020 upon the termination of the Plan from &#8220;Accumulated other comprehensive loss&#8221; to &#8220;Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the Company&#8217;s Consolidated Statement of Operations.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive income (loss) by component are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034524392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Balances and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Balances and Transactions</a></td>
<td class="text">Related Party Balances and Transactions<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, a public benefit California foundation (&#8220;Foundation&#8221;) was established to provide opioid education to patients, caregivers, and providers, address policy issues, and increase patient access to life-saving treatments.&#160;Certain officers of the Company also serve as directors and officers of the Foundation. During 2019, the Company paid cash of $100 million to the Foundation to settle an outstanding pledge it made in 2018. During the fourth quarter of 2020, the Company also contributed $20 million to the McKesson Foundation, which supports the Company&#8217;s employees and their community involvement efforts, with a special focus on cancer. A portion of this contribution was directed to an emergency employee assistance fund administered by the Emergency Assistance Foundation, an independent nonprofit organization, to provide support for employees impacted by the COVID-19 pandemic.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $178&#160;million, $141 million, and $137 million, are included in the Consolidated Statements of Operations for the years ended March&#160;31, 2021, 2020, and 2019, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March&#160;31, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 2020, and 2019, the Company&#8217;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $111&#160;million, $60 million, and $34 million, respectively. Trade receivables related to these transactions from this investee were not material as of March&#160;31, 2021 and 2020.</span></div>Refer to Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for information regarding related party balances and transactions with Change and the Change Healthcare JV.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033171480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and RxTS. Other, for retrospective periods presented, consists of the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 13 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment brings together existing businesses, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve the Company&#8217;s biopharma and life sciences partners and patients. RxTS works across the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 7% of the International segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 39% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for 2021, 2020, and 2019 includes credits of $38 million, $252 million, and $210 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2021, 2020, and 2019 also includes $181 million, $22 million, and $202 million, respectively, of cash receipts for the Company&#8217;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; and operating profit for 2019 includes a charge of $61 million related to a customer bankruptcy.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for 2021 and 2020 includes charges of $58 million and $275 million (both pre-tax and after-tax), respectively, to remeasure to fair value the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture, as further discussed in Financial Note 3, &#8220;Held for Sale.&#8221; Operating loss for 2021, 2020, and 2019 includes long-lived asset impairment charges of $115 million, $112 million, and $245 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges.&#8221; Operating loss for 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion (both pre-tax and after-tax), respectively, as discussed in more detail in Financial Note 12, &#8220;Goodwill and Intangible Assets, Net.&#8221; In addition, operating loss for 2019 includes a gain from an escrow settlement of $97 million (pre-tax and after-tax) representing certain indemnity and other claims related to the Company&#8217;s 2017 acquisition of Rexall Health.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for 2021 includes charges totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s RxTS segment&#8217;s operating profit for 2019 includes a gain of $56 million recognized from the sale of an equity investment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#8217;s investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2019 includes a credit of $90 million for the derecognition of the TRA liability payable to the shareholders of Change. Operating loss for 2020 and 2019 also includes the Company&#8217;s proportionate share of loss from the Change Healthcare JV of $119 million and $194 million, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, for 2021 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 19, &#8220;Commitments and Contingent Liabilities." Corporate expenses, net, for 2021 also includes net gains of $133 million associated with certain of the Company&#8217;s equity investments and a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for 2020 includes settlement charges of $122 million for the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033241368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information (Unaudited)</a></td>
<td class="text">Quarterly Financial Information (Unaudited)<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year. Selected quarterly financial information for the last two years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth <br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) after income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to McKesson Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth <br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) after income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to McKesson Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div>(2)As a result of the Company&#8217;s reported net loss for the third quarter of 2021 and the second quarter of 2020, potentially dilutive securities were excluded from the per share computations for those quarters due to their antidilutive effect.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034711000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:34.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions From Allowance Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at End of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for doubtful accounts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for doubtful accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:55.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credited to other accounts and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown as deductions from current and non-current receivables (current allowances were $250 million, $265 million, and $279 million at March 31, 2021, 2020, and 2019, respectively)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primarily represents reclassifications to other balance sheet accounts.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041493736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span>The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights (&#8220;variable interest entities&#8221; or &#8220;VIEs&#8221;) and determines which business entity is the primary beneficiary of the VIE. The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior year amounts have been reclassified to conform to the current year presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires that the Company make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The severity, magnitude and duration, as well as the economic consequences of the coronavirus diseases 2019 (&#8220;COVID-19&#8221;) pandemic, are uncertain, rapidly changing, and difficult to predict. Therefore, the Company&#8217;s accounting estimates and assumptions may change over time in response to COVID-19 and may change materially in future periods.</span>The Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the U.S., and includes several provisions related to employment and income taxes, including provisions for the deferral of the employer portion of social security taxes through December 31, 2020. On December 27, 2020, the U.S. government enacted the Consolidated Appropriations Act, 2021, which enhances and expands certain provisions of the CARES Act. These legislative acts are not expected to have a material impact on the Company&#8217;s consolidated financial results.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted Cash: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities Available-for-Sale</a></td>
<td class="text">Marketable Securities Available-for-Sale: The Company&#8217;s marketable securities, which are available-for-sale, are carried at fair value and are included in &#8220;Prepaid expenses and other&#8221; in the Consolidated Balance Sheets. The unrealized gains and losses, net of the related tax effect, computed in marking these securities to market have been reported in stockholders&#8217; equity. At March&#160;31,&#160;2021 and 2020, marketable securities were not material. In determining whether an other-than-temporary decline in market value has occurred, the Company considers the duration that, and extent to which, the fair value of the investment is below its cost, the financial condition and future prospects of the issuer or underlying collateral of a security, and its intent and ability to retain the security in order to allow for an anticipated recovery in fair value. Other-than-temporary declines in fair value from amortized cost for available-for-sale equity securities that the Company intends to sell or would more likely than not be required to sell before the expected recovery of the amortized cost basis are charged to other income (expense), net, in the period in which the loss occurs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Equity Method Investments: Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables, Net</a></td>
<td class="text">Receivables, Net and Allowances for Doubtful Accounts: The Company&#8217;s receivables are presented net of an allowance for doubtful accounts and primarily consist of trade accounts receivables from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock', window );">Allowance for Doubtful Accounts</a></td>
<td class="text">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Receivables</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2021, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 51% of its total consolidated revenues and approximately 32% of total trade accounts receivable at March&#160;31, 2021. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of its total consolidated revenues in 2021 and comprised approximately 19% of total trade accounts receivable at March&#160;31, 2021. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLoansAndLeasesReceivablePolicy', window );">Financing Receivables</a></td>
<td class="text">Financing Receivables: The Company assesses and monitors credit risk associated with financing receivables, primarily notes receivable, through regular review of its collections experience in determining its allowance for loan losses. On an ongoing basis, the Company also evaluates credit quality of its financing receivables utilizing historical collection rates and write-offs, as well as considering existing economic conditions, to determine if an allowance is required.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LIFO method was used to value approximately 58% and 60% of the Company&#8217;s inventories at March&#160;31, 2021 and 2020, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $406&#160;million and $444&#160;million higher than the amounts reported at March&#160;31, 2021 and 2020, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $38 million, $252 million, and $210 million in 2021, 2020, and 2019, respectively, in &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The lower LIFO credits in 2021 compared to 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Excluding LIFO reserves, inventory reserves as of March&#160;31, 2021 and 2020 were $263 million and $96 million, respectively. The increase was primarily due to charges in 2021 totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory within our Medical-Surgical Solutions segment. These charges are recorded in "Cost of sales" in the Consolidated Statements of Operations.</span></div>The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text">Shipping and Handling Costs: The Company includes costs to pack and deliver inventory to its customers in Selling, distribution, general, and administrative expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HeldforSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text">Held for Sale: Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant, and Equipment, Net: Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div>To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA4ZjliYWY4MTBjMDQxMmU5M2VhNmVmZmM2ZDIyOTk1L3NlYzowOGY5YmFmODEwYzA0MTJlOTNlYTZlZmZjNmQyMjk5NV8xMDkvZnJhZzpkZDJjMTVlYzY2MTk0MTI0YjVlMTJhNmVmMjg5NmU1OC90ZXh0cmVnaW9uOmRkMmMxNWVjNjYxOTQxMjRiNWUxMmE2ZWYyODk2ZTU4XzE1Nzcy_057311aa-15e4-4b9f-b79f-a8b5be622be2">one</span> to 38 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Capitalized Software Held for Internal Use</a></td>
<td class="text">Capitalized Software Held for Internal Use: The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_InsuranceProgramsPolicyTextBlock', window );">Insurance Programs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;), from which it obtains coverage for catastrophic exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company, as discussed in more detail in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within Operating Expenses in the Consolidated Statements of Operations.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March&#160;31, 2021 and 2020, respectively. </span></div>Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion in each of 2021 and 2020 and $2.9 billion in 2019. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March&#160;31, 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March&#160;31, 2021 and 2020. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SupplierIncentivesPolicyPolicyTextBlock', window );">Supplier Incentives</a></td>
<td class="text">Supplier Incentives: Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SupplierReservesPolicyTextBlock', window );">Supplier Reserves</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpensePolicyTextBlock', window );">Interest Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text">Foreign Currency Translation: The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; equity accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income (loss), net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material to the Company&#8217;s consolidated results of operations in 2021, 2020, or 2019. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income (loss), net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income. Other comprehensive income refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of stockholders&#8217; equity but are excluded from earnings. The Company&#8217;s other comprehensive income primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency including gains and losses on net investment hedges, unrealized gains and losses on cash flow hedges, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span>unrealized gains and losses on retirement-related benefit plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling Interests and Redeemable Noncontrolling Interests</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#8217;s consolidated entities including Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;) and ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 9, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for more information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span>The Company reviews all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to ongoing controlled substances claims to which the Company is a party.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are recognized as incurred.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company prospectively adopted Accounting Standard Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs in a cloud computing arrangement that has a software license. As a result, the Company began capitalizing eligible implementation costs for such contracts and recognizing the expense over the service period. The adoption of this amended guidance did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company retrospectively adopted ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires the Company to disclose the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates, and an explanation of reasons for significant gains and losses related to changes in the benefit obligation for the period. The amended guidance also requires the Company to remove disclosures on the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit costs over the next fiscal year. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to remove, modify, and add disclosure requirements on fair value measurements. Certain requirements were applied prospectively while other changes were applied retrospectively on the effective date. The amended guidance removes disclosure requirements for transfers between Level 1 and Level 2 measurements and valuation processes for Level 3 measurements, but adds new disclosure requirements including changes in unrealized gains or losses in other comprehensive income related to recurring Level 3 measurements and requirements to disclose the range, and weighted-average used to develop significant unobservable inputs for Level 3 fair value measurements. The adoption of this amended guidance resulted in changes in disclosures but did not have an impact on the Company&#8217;s Consolidated Statements of Operations, Comprehensive Income (Loss), Balance Sheets, or Cash Flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the Company adopted ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which changed the impairment model for most financial assets from one based on current losses to a forward-looking model based on expected losses. The forward-looking model requires the Company to consider historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount in estimating credit losses. The amended guidance requires financial assets that are measured at amortized cost be presented at the net amount expected to be collected. An allowance for credit losses is established as a valuation account that is deducted from the amortized cost basis of financial assets. The guidance also requires enhanced disclosures. This guidance was adopted on a modified retrospective basis and did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures. Upon adoption of the amended guidance in the first quarter of 2021, the Company recorded a cumulative-effect adjustment of $13 million to the opening balance of retained earnings, primarily as a result of adjustments to allowances for trade accounts receivable.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued with the intent to simplify various aspects related to accounting for income taxes.&#160;The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The guidance is effective for the Company in the first quarter of 2022 and&#160;early adoption is permitted.&#160;The adoption of this amended guidance is not expected to have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldforSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Held for Sale [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldforSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_InsuranceProgramsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_InsuranceProgramsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SupplierIncentivesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplier Incentives, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SupplierIncentivesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SupplierReservesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SupplierReservesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 35<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=121565518&amp;loc=SL120269220-210453<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL120267969-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922895-210455<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 35<br> -Paragraph 13A<br> -URI http://asc.fasb.org/extlink&amp;oid=121565518&amp;loc=SL120267917-210453<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 35<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121648281&amp;loc=SL120267834-210445<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 30<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=121647444&amp;loc=SL120269210-210444<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919260-210447<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL120267845-210446<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919253-210447<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919272-210447<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 30<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=121647444&amp;loc=SL120254536-210444<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL120267966-210447<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 30<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121614247&amp;loc=SL120267897-210452<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL120267862-210455<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL120267859-210455<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL120267853-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLoansAndLeasesReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5144-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (b,d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLoansAndLeasesReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 10<br> -Section 05<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28365394&amp;loc=d3e23770-108382<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035105800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of receivables</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2021 and 2020:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,181&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,950&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment, net</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March&#160;31, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038120632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Net Gain on Split-off of Change Healthcare JV</a></td>
<td class="text">The net gain was calculated as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the Change Healthcare JV at exchange date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of accumulated other comprehensive attributable to the joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on split-off of the Change Healthcare JV</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034351864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and liabilities of German wholesale joint venture classified as held for sale</a></td>
<td class="text">The total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company&#8217;s Consolidated Balance Sheet as of March&#160;31, 2020, were as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of business held for sale to fair value less cost to sell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #020000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033121096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of details for charges recorded</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:18.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.755%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with dispositions and costs related to the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March&#160;31, 2019 consisted of the following:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model cost optimization efforts and U.K. restructuring initiative focusing on underperforming retail pharmacy stores described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with operating model cost optimization efforts and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include lease and other contract exit costs associated with closures of facilities and retail pharmacy stores as well as project consulting fees.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March&#160;31, 2021 and 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;As of March&#160;31, 2020, the total reserve balance was $157 million of which $118 million was recorded in Other accrued liabilities and $39 million was recorded in Other non-current liabilities. </span></div>(2)&#160;&#160;&#160;&#160;As of March&#160;31, 2021, the total reserve balance was $151 million of which $99 million was recorded in Other accrued liabilities and $52 million was recorded in Other non-current liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033052552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Fair Values Recognized of Assets and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the final recording of the fair value of the assets acquired and liabilities assumed for this acquisition as of the acquisition date, including immaterial adjustments made during the measurement period:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;as of the Acquisition Date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets, net of cash and cash equivalents acquired</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired, net of cash and cash equivalents</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Final amounts as of May 31, 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035642712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of components of share-based compensation expense and related tax benefits</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.539%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs, PeRSUs, and PSUs.</span></div>(2)Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2021, 2020, and 2019 included discrete income tax expense of $2 million, $2 million, and $4&#160;million, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to estimate fair value of PSUs</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of restricted stock unit award activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs, PSUs, and PeRSUs) during 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DataRelatedtoRSUActivityTableTextBlock', window );">Schedule of data related to restricted stock unit award activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted-average assumptions used to estimate the fair value</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the fair value of employee stock options were as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended <br/>March 31, 2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company did not grant any stock options during the years ended March&#160;31, 2021 and 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The computation of expected volatility was based on a combination of the historical volatility of the Company&#8217;s common stock and implied market volatility. The Company believes this market-based input provides a reasonable estimate of its future stock price movements and is consistent with employee stock option valuation considerations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Expected dividend yield is based on historical experience and investors&#8217; current expectations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The risk-free interest rate for periods within the expected life of the option is based on the constant maturity U.S. Treasury rate in effect at the grant date.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The expected life of the options is based primarily on historical employee stock option exercises and other behavioral data and reflects the impact of changes in the contractual life of current option grants compared to the Company&#8217;s historical grants.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of options outstanding</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March&#160;31, 2021:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$183.20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8211;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during 2021:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div>(2)The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock', window );">Summary of data related to stock option activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:60.979%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DataRelatedtoRSUActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Data Related to RSU Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DataRelatedtoRSUActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034527608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock', window );">Schedule of other income, net</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses from pension plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of equity method investment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments and were included within Corporate expenses, net. Refer to Financial Note 17, &#8220;Fair Value Measurements,&#8221; and to Financial Note 22, &#8220;Segments of Business.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes $116 million from the termination of the U.S. defined benefit pension plan and $11 million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 15, &#8220;Pension Benefits.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents a gain from the sale of an equity investment to a third party included in RxTS during 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the detailed components of other nonoperating income. May include methodology, assumptions and amounts for: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042784488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income (loss) from continuing operations before income taxes</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(902)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax expense (benefit) related to continuing operations</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21% to income before income taxes is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-free gain on investment exit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of change in U.S. tax rate on temporary differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 2, &#8220;Investment in Change Healthcare Joint Venture,&#8221; for additional information regarding the separation of the Change Healthcare JV.</span></div>(2)The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $5 million in 2021 and $7 million in each of 2020 and 2019.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax balances</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.938%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,185)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,196)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,196)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of gross unrecognized tax benefits</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.245%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033257448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Schedule of Changes in Noncontrolling Interest</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March&#160;31, 2021, 2020, and 2019 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/>Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of put right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033299896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.211%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)Certain computations may reflect rounding adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040986472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental balance sheet information</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease costs and supplemental cash flow information</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount for the year ended March&#160;31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Leases</span>.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $202 million which are due under future noncancellable subleases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034460632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:25.998%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.774%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.534%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.043%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment testing performed in 2019 resulted in the following impairment charges:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.584%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except rates)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarter Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reporting Unit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Terminal Growth Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill Impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Distribution</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">As described above, the Company implemented its new segment reporting structure in the second quarter of 2021 and its European Pharmaceutical Solutions segment and its Rexall Health business in Canada became part of the International segment. Amounts included herein were previously included within the former European Pharmaceutical Solutions segment.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Represents pre-tax and after-tax amounts, except for an aggregate $20 million of tax charges related to the March 2019 Retail Pharmacy impairment. Total goodwill impairment for 2019 also included $21 million related to the Company&#8217;s Rexall Health business, within the International segment, recorded in the third quarter of 2019.</span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Prior to implementing its new segment reporting structure in the first quarter of 2019, the Company&#8217;s European operations were considered a single reporting unit. Following the change in reportable segments, its European Pharmaceutical Solutions segment was divided into two distinct reporting units, Retail Pharmacy (&#8220;RP&#8221;), formerly Consumer Solutions, and Pharmaceutical Distribution (&#8220;PD&#8221;), formerly Pharmacy Solutions, for the purposes of goodwill impairment testing. This change required performance of a goodwill impairment test for these two new reporting units which resulted in a goodwill impairment charge as PD&#8217;s estimated fair value was lower than its reassigned carrying value. </span></div><div style="margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Both RP and PD projected a decline in the estimated future cash flows primarily triggered by U.K. government actions which were announced on June 29, 2018. An interim goodwill impairment test for these reporting units identified that their carrying values exceeded their estimated fair value and resulted in an impairment charge.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">As a result of the annual goodwill impairment test, the carrying values of the PD and RP reporting units exceeded their estimated fair value which required the Company to record impairment charges for the reporting units. These additional impairments were primarily due to declines in the reporting units&#8217; estimated future cash flows and the selection of higher discount rates. The declines in estimated future cash flows were primarily attributed to additional government reimbursement reductions and competitive pressures within the U.K. The risk of successfully achieving certain business initiatives was the primary factor in the use of a higher discount rate. As of March&#160;31, 2019 the entire remaining goodwill balances of both reporting units were impaired.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.144%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,392&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,236)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034514056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of long-term debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65% Notes due November 30, 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due March 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652147085384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of net periodic expense for pension plans</a></td>
<td class="text">The net periodic expense for the Company&#8217;s pension plans is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:43.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of changes in benefit obligations and plan assets for pension plans</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans is as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity Premium Transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity Premium Transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div>(2)The divestiture relates to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included within current liabilities and totaled $151&#160;million at March&#160;31, 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of defined benefit plan amounts recognized in other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive income consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive income were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:44.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.745%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit (cost)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss (income) </span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:40.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.83%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.71</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Summary of pension plan assets using fair value hierarchy by asset class</a></td>
<td class="text">The following tables represent the Company&#8217;s pension plan assets as of March&#160;31, 2021 and 2020, using the fair value hierarchy by asset class:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.679%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033058008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of information regarding fair value of derivatives on a gross basis</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:26.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.286%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(current)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034626616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is also recorded at cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,792&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034673560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of shares repurchased over last three years</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the share repurchase activity over the last three years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in May 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase plans authorized in January 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations. It also excludes shares related to the Company&#8217;s Split-off of the Change Healthcare JV as described below.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">$8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of comprehensive income (loss)</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.590%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on net investment hedges arising during period, net of income tax (expense) benefit of $62, $(30), and $(71)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges arising during period, net of income tax (expense) benefit of $6, $(12), and $(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit of $2, $(8), and $5 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax benefit of $1, $1, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax expense of nil, nil, and nil</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of $9, $33, and nil </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021, 2020, and 2019 include net foreign currency translation adjustments of $(60) million, $1 million, and $(61) million, respectively, attributable to noncontrolling and redeemable noncontrolling interests.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021 primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 3, &#8220;Held for Sale.&#8221; These amounts were included in the current and prior periods calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Operating expenses in the Consolidated Statements of Operations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2021, 2020, and 2019 include foreign currency adjustments of $(118) million, $39 million, and $259 million, respectively, on the net investment hedges from the Euro and British pound sterling-denominated notes. 2021, 2020, and 2019 also include foreign currency adjustments of $(119) million, $76 million, and $53 million, respectively, on the net investment hedges from the cross-currency swaps. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The 2021 and 2020 net actuarial gains of $8 million and $2 million, respectively, and 2019 net actuarial loss of $5 million were attributable to noncontrolling and redeemable noncontrolling interests. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into &#8220;Cost of sales&#8221; and &#8220;Operating expenses&#8221; in the Consolidated Statements of Operations. The related tax expense was reclassified into &#8220;Income tax benefit (expense)&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">2020 primarily reflects a reclassification of losses in 2020 upon the termination of the Plan from &#8220;Accumulated other comprehensive loss&#8221; to &#8220;Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the Company&#8217;s Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text">Information regarding changes in the Company&#8217;s accumulated other comprehensive income (loss) by component are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035117976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of segment information</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.821%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (7) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 7% of the International segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 39% of the RxTS segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, Operating loss for Other reflects equity earnings and charges from the Company&#8217;s equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for 2021, 2020, and 2019 includes credits of $38 million, $252 million, and $210 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2021, 2020, and 2019 also includes $181 million, $22 million, and $202 million, respectively, of cash receipts for the Company&#8217;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; and operating profit for 2019 includes a charge of $61 million related to a customer bankruptcy.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for 2021 and 2020 includes charges of $58 million and $275 million (both pre-tax and after-tax), respectively, to remeasure to fair value the assets and liabilities of the Company&#8217;s German pharmaceutical wholesale business which was contributed to a joint venture, as further discussed in Financial Note 3, &#8220;Held for Sale.&#8221; Operating loss for 2021, 2020, and 2019 includes long-lived asset impairment charges of $115 million, $112 million, and $245 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 4, &#8220;Restructuring, Impairment, and Related Charges.&#8221; Operating loss for 2021 and 2019 includes goodwill impairment charges of $69 million and $1.8 billion (both pre-tax and after-tax), respectively, as discussed in more detail in Financial Note 12, &#8220;Goodwill and Intangible Assets, Net.&#8221; In addition, operating loss for 2019 includes a gain from an escrow settlement of $97 million (pre-tax and after-tax) representing certain indemnity and other claims related to the Company&#8217;s 2017 acquisition of Rexall Health.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for 2021 includes charges totaling $136 million on certain personal protective equipment and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s RxTS segment&#8217;s operating profit for 2019 includes a gain of $56 million recognized from the sale of an equity investment.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#8217;s investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2019 includes a credit of $90 million for the derecognition of the TRA liability payable to the shareholders of Change. Operating loss for 2020 and 2019 also includes the Company&#8217;s proportionate share of loss from the Change Healthcare JV of $119 million and $194 million, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, for 2021 includes a charge of $8.1 billion related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 19, &#8220;Commitments and Contingent Liabilities." Corporate expenses, net, for 2021 also includes net gains of $133 million associated with certain of the Company&#8217;s equity investments and a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program. Corporate expenses, net, for 2020 includes settlement charges of $122 million for the termination of the Company&#8217;s defined benefit pension plan and a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Schedule of segment assets and property, plant and equipment, net by geographic areas</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033297944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of quarterly financial information</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly results of operations are not necessarily indicative of the results that may be expected for the entire year. Selected quarterly financial information for the last two years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth <br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) after income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to McKesson Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.03)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third <br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fourth <br/>Quarter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) after income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to McKesson Corporation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.24&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.99)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div>(2)As a result of the Company&#8217;s reported net loss for the third quarter of 2021 and the second quarter of 2020, potentially dilutive securities were excluded from the per share computations for those quarters due to their antidilutive effect.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035972216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>customer</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">LIFO inventory (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves (excluding LIFO reserves)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,849<span></span>
</td>
<td class="nump">9,182<span></span>
</td>
<td class="nump">8,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software held for internal use, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Capitalized software held for internal use, accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized software held for internal use, amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns', window );">Sales returns from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(5,309)<span></span>
</td>
<td class="num">(8,287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,057)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery, equipment, and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">38 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife', window );">Capitalized software held for internal use, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery, equipment, and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,202)<span></span>
</td>
<td class="num">$ (8,202)<span></span>
</td>
<td class="num">(13,022)<span></span>
</td>
<td class="num">(12,409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,986)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
<td class="num">$ (154)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13 | Retained Earnings | Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberofLargestCustomers', window );">Number of largest customers | customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | CVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | CVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Sales Revenue, Net | Distribution and Retail Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Sales Revenue, Net | Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capitalized Software Held for Internal Use, Useful Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CapitalizedSoftwareHeldforInternalUseUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberofLargestCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Largest Customers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberofLargestCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_MachineryEquipmentAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_MachineryEquipmentAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mck_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mck_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mck_DistributionandRetailBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mck_DistributionandRetailBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mck_ServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mck_ServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034324456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrentAbstract', window );"><strong>Receivables, Net, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AccountsReceivableCustomerAccountsGross', window );">Customer accounts</a></td>
<td class="nump">$ 17,106<span></span>
</td>
<td class="nump">$ 17,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Other</a></td>
<td class="nump">2,325<span></span>
</td>
<td class="nump">3,014<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Total receivables</a></td>
<td class="nump">19,431<span></span>
</td>
<td class="nump">20,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">$ 19,181<span></span>
</td>
<td class="nump">$ 19,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AccountsReceivableCustomerAccountsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Customer Accounts, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AccountsReceivableCustomerAccountsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042434856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">1,745<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Machinery, equipment, and other</a></td>
<td class="nump">2,512<span></span>
</td>
<td class="nump">2,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant, and equipment</a></td>
<td class="nump">4,795<span></span>
</td>
<td class="nump">4,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(2,214)<span></span>
</td>
<td class="num">(1,829)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">$ 2,581<span></span>
</td>
<td class="nump">$ 2,365<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037713464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 10, 2020</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesDistributed', window );">Shares distributed in split-off (shares)</a></td>
<td class="nump">176,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,309,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">5,309,000,000<span></span>
</td>
<td class="nump">8,287,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,057,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (48,000,000)<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized', window );">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Due from Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember', window );">Separation of Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesDistributed', window );">Shares distributed in split-off (shares)</a></td>
<td class="nump">176,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesExchanged', window );">Shares of common stock exchanged (shares)</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted', window );">Number of shares converted into per share converted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,022,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,202,000,000<span></span>
</td>
<td class="nump">13,022,000,000<span></span>
</td>
<td class="nump">12,409,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,986,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 154,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Prescription Technology Solutions | Tax Receivable Agreement (&#8220;TRA&#8221;) | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossonDerecognitionofLiability', window );">Pre-tax credit representing reduction in TRA liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net cash proceeds from IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 888,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from other security offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc. | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member', window );">Change Healthcare, Inc. | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Contributions made in exchange for additional membership interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 609,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Transition Services Agreements (&#8220;TSA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Total fees charged under the TSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Pre-tax other-than-temporary impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,000,000<span></span>
</td>
<td class="nump">194,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossonDerecognitionofLiability', window );">Pre-tax credit representing reduction in TRA liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (90,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare | ASU 2014-09 | Retained Earnings | Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Distributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Exchanged</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossonDerecognitionofLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Derecognition of Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossonDerecognitionofLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041773016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Change Healthcare Joint Venture - Net Gain on Split-off of Change Healthcare JV (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain on split-off of the Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember', window );">Separation of Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesExchanged', window );">Shares of common stock exchanged (shares)</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentFairValueofStockAccepted', window );">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</a></td>
<td class="nump">$ 2,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentCarryingAmount', window );">Investment in the Change Healthcare JV at exchange date</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability', window );">Reversal of deferred tax liability</a></td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss', window );">Release of accumulated other comprehensive attributable to the joint venture</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentTransactionCostsIncurred', window );">Less: Transaction costs incurred</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain on split-off of the Change Healthcare JV</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAccepted', window );">Shares repurchased (in shares)</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAcceptedAverageCost', window );">Cost of shares repurchased (in usd per share)</a></td>
<td class="nump">$ 131.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentFairValueofStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Fair Value of Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentFairValueofStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAcceptedAverageCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted, Average Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAcceptedAverageCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentTransactionCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Transaction Costs Incurred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentTransactionCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentsReversalofDeferredTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Reversal of Deferred Tax Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentsReversalofDeferredTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Exchanged</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041388808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Nov. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember', window );">German Pharmaceutical Wholesale Joint Venture | Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of investment in joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember', window );">Walgreens Boots Alliance Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Notes payable assumed</a></td>
<td class="nump">$ 291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses', window );">Cumulative foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax loss on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossOnSaleOfBusinessNetOfTax', window );">After-tax loss on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnSaleOfBusinessNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Sale of Business, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnSaleOfBusinessNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042248200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total Assets held for sale</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total Liabilities held for sale</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total Assets held for sale</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total Liabilities held for sale</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of business held for sale to fair value less cost to sell (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652043649192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>May 12, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring and asset impairment charges</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Pre-tax charge</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Retail Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Rexall Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | U.K.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Pre-tax charge</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | International | U.K.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | International | U.K.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember', window );">Employee Severance, Exit-related Costs and Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Pre-tax charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=mck_IntangibleAssetandStoreAssetsImpairmentMember', window );">Intangible Asset and Store Assets Impairment | Rexall Health | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember', window );">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs | Employee Severance, Accelerated Depreciation and Project Consulting Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Pre-tax charge</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Employee Retention Expenses, Asset Impairments and Accelerated Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Pre-tax charge</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember', window );">Operating Model and Cost Optimization Programs | Employee Severance, Exit-related Costs and Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Pre-tax charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring incurred to-date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_IntangibleAssetandStoreAssetsImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_IntangibleAssetandStoreAssetsImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_OperatingModelAndCostOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038186776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit-related costs</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit-related costs</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit-related costs</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit-related costs</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit-related costs</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040590312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">$ 352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(159)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652127410616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Acquisition of Medical Specialties Distributors (Details) - Medical Specialties Distributors LLC (&#8220;MSD&#8221;) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 01, 2018</div></th>
<th class="th"><div>May 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Net purchase consideration</a></td>
<td class="nump">$ 784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_MedicalSpecialtiesDistributorsLLCMSDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_MedicalSpecialtiesDistributorsLLCMSDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652147169752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Fair Values Recognized of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Amounts Recognized</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,493<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_MedicalSpecialtiesDistributorsLLCMSDMember', window );">Medical Specialties Distributors LLC (&#8220;MSD&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Amounts Recognized</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents', window );">Other current assets, net of cash and cash equivalents acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents', window );">Net assets acquired, net of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Assets Net of Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_MedicalSpecialtiesDistributorsLLCMSDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_MedicalSpecialtiesDistributorsLLCMSDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652114473048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Acquisition of CoverMyMeds (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 03, 2017</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase consideration paid in cash, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 133,000,000<span></span>
</td>
<td class="nump">$ 905,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_CoverMyMedsLLCMember', window );">CMM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase consideration paid in cash, net of cash acquired</a></td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Additional contingent consideration that may be paid</a></td>
<td class="nump">$ 160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Cash payment for contingent consideration earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 68,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_CoverMyMedsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_CoverMyMedsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038198504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax expense (benefit) related to adoption of amended accounting guidance</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested', window );">Vested RSUs (in shares)</a></td>
<td class="nump">82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mck_PeRSUsMember', window );">PeRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock award contractual term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (shares)</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions', window );">Period over which payroll is deducted to purchase shares</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of market price for share purchase</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Percentage of market price deduction for share purchases</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mck_A2013StockPlanMember', window );">2013 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee service share based compensation period to purchase shares through payroll deductions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_PeRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_PeRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mck_A2013StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mck_A2013StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035002008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Components of Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit for share-based compensation expense</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense, net of tax</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034547960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details) - RSUs and PSUs<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility (percent)</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (percent)</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (percent)</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042131976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details) - RSUs and PSUs<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod', window );">Cancelled (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted- Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per shares) | $ / shares</a></td>
<td class="nump">$ 135.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">155.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1', window );">Cancelled (in dollars per share) | $ / shares</a></td>
<td class="nump">133.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">147.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per shares) | $ / shares</a></td>
<td class="nump">$ 142.13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652147063544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details) - RSUs and PSUs - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037506680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details) - Options to purchase common stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility (percent)</a></td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (percent)</a></td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042914040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Options Outstanding (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeOneMember', window );">Range One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices lower limit (in dollars per share)</a></td>
<td class="nump">$ 118.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices upper limit (in dollars per share)</a></td>
<td class="nump">$ 183.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 166.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 171.38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeTwoMember', window );">Range Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices lower limit (in dollars per share)</a></td>
<td class="nump">183.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices upper limit (in dollars per share)</a></td>
<td class="nump">$ 237.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Life (Years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 216.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 216.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038492152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 180.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">187.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">153.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 183.29<span></span>
</td>
<td class="nump">$ 180.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Stock options outstanding, remaining contractual term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock options outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options vested and expected to vest (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Stock options vested and expected to vest, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 183.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Stock options vested and exercisable, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 189.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Stock options vested and expected to vest, weighted average remaining contractual term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Stock options vested and exercisable, weighted average remaining contractual term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Stock options vested and expected to vest, aggregate intrinsic value</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Stock options vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041468712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details) - Options to purchase common stock - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per stock option (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value on exercise</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received upon exercise</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefits realized related to exercise</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of stock options vested</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which stock option compensation cost is expected to be recognized</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038480920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings, net</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net gains on investments in equity securities</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember', window );">Termination of U.S Defined Benefit Pension Plan | Pension Plans, Defined Benefit | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember', window );">Retired executive | Settlement of Executive Retirement Benefits | Pension Plans, Defined Benefit | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033117048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) from continuing operations before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (6,019)<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
<td class="nump">$ 1,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">985<span></span>
</td>
<td class="nump">928<span></span>
</td>
<td class="num">(902)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="num">$ (5,034)<span></span>
</td>
<td class="nump">$ 1,144<span></span>
</td>
<td class="nump">$ 610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652129546488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">$ (15)<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(562)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(204)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(908)<span></span>
</td>
<td class="num">(342)<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (695)<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652036523160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax expense (benefit) rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.80%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">58.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount', window );">Impact of opioid-related claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax', window );">After-tax impact of opioid-related claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">908<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Net discrete tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Non-cash pre-tax charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">864<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">958<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">958<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">$ 1,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would Impact income tax expense and the effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Decrease in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Amount of decrease in unrecognized tax benefits that is reasonably possible in the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax expense (benefit), before any tax effect, related to accrued interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Accrued interest and penalties on unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare | Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Non-cash pre-tax charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_PendingAndFutureOpioidRelatedClaimsMember', window );">Pending and Future Opioid-Related Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Decrease in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember', window );">Capital Loss Carryforward | Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_PendingAndFutureOpioidRelatedClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_PendingAndFutureOpioidRelatedClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652251369144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax expense (benefit) at federal statutory rate</a></td>
<td class="num">$ (1,057)<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax effect of foreign operations</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Unrecognized tax benefits and settlements</a></td>
<td class="nump">41<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses', window );">Non-deductible goodwill</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims', window );">Opioid-related litigation and claims</a></td>
<td class="nump">715<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit', window );">Net tax benefit on intellectual property transfer</a></td>
<td class="num">(105)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax-free gain on investment exit</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Impact of change in U.S. tax rate on temporary differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback', window );">Capital loss carryback</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (695)<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Capital Loss Carryback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Litigation and Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042085336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components Of Deferred Tax Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Receivable allowances</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DeferredTaxAssetLitigationAndClaims', window );">Opioid-related litigation and claims</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation and benefit related accruals</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Net operating loss and credit carryforwards</a></td>
<td class="nump">974<span></span>
</td>
<td class="nump">828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DeferredTaxAssetLeaseObligations', window );">Lease obligations</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">2,726<span></span>
</td>
<td class="nump">1,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(864)<span></span>
</td>
<td class="num">(833)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total assets</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory valuation and other assets</a></td>
<td class="num">(1,939)<span></span>
</td>
<td class="num">(1,947)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets and systems development costs</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(411)<span></span>
</td>
<td class="num">(531)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets', window );">Lease right-of-use assets</a></td>
<td class="num">(505)<span></span>
</td>
<td class="num">(449)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total liabilities</a></td>
<td class="num">(3,088)<span></span>
</td>
<td class="num">(3,185)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">(1,226)<span></span>
</td>
<td class="num">(2,196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Long-term deferred tax asset</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liability</a></td>
<td class="num">$ (1,411)<span></span>
</td>
<td class="num">$ (2,255)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxAssetLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxAssetLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxAssetLitigationAndClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Litigation and Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxAssetLitigationAndClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxLiabilitiesLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041315352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at beginning of period</a></td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
<td class="nump">$ 1,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions based on tax positions related to prior years</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to current year</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions based on settlements</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions based on the lapse of the applicable statutes of limitations</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation', window );">Exchange rate fluctuations</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of period</a></td>
<td class="nump">$ 1,754<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037397240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 19, 2018 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Annual increase in interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying amount of redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">$ 1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying amount of redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right (in euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 23.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue', window );">Maximum redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of outstanding common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease', window );">Put Right increase (euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring compensation (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring compensation (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price, Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interests, Maximum Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652036500200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Beginning balance</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercises of put right</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Ending balance</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="num">(79)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Beginning balance</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">1,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercises of put right</a></td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Ending balance</a></td>
<td class="nump">$ 1,271<span></span>
</td>
<td class="nump">$ 1,402<span></span>
</td>
<td class="nump">$ 1,393<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037599544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 713<span></span>
</td>
<td class="num">$ (6,174)<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">$ 1,072<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
<td class="num">$ (676)<span></span>
</td>
<td class="nump">$ 483<span></span>
</td>
<td class="num">$ (4,339)<span></span>
</td>
<td class="nump">$ 1,126<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(199)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,538)<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 666<span></span>
</td>
<td class="num">$ (6,226)<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="num">$ (730)<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
<td class="num">$ (4,539)<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">180.6<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">181.6<span></span>
</td>
<td class="nump">197.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 4.15<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="nump">$ 2.72<span></span>
</td>
<td class="nump">$ 5.82<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.03<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">4.15<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">3.54<span></span>
</td>
<td class="nump">2.72<span></span>
</td>
<td class="nump">5.85<span></span>
</td>
<td class="nump">1.03<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">2.24<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">4.19<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">3.56<span></span>
</td>
<td class="nump">2.74<span></span>
</td>
<td class="nump">5.86<span></span>
</td>
<td class="nump">1.06<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">2.28<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">5.01<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.03<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 4.19<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 3.56<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
<td class="nump">$ 5.89<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652033190040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from diluted earnings per share</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035982088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 2,257<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">5,309<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 10,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LessorLeasePaymentstobeReceived', window );">Minimum sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments', window );">Future lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived', window );">Total lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember', window );">Real Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal option increments for leases (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Noncancelable lease terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Noncancelable lease terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OperatingLeaseImpairmentLossNetOfTax', window );">Impairment charges</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,202<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
<td class="nump">12,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Opening retained earnings adjustments: adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LessorLeasePaymentstobeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Lease, Payments to be Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LessorLeasePaymentstobeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OperatingLeaseImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Impairment Loss, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OperatingLeaseImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652120354520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental balance sheet information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">$ 1,886<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">2,257<span></span>
</td>
<td class="nump">2,014<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Property, plant and equipment, net</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (Years) - Operating leases</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (Years) - Finance leases</a></td>
<td class="text">10 years 1 month 6 days<span></span>
</td>
<td class="text">12 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - Operating leases (percent)</a></td>
<td class="nump">2.53%<span></span>
</td>
<td class="nump">3.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - Finance leases (percent)</a></td>
<td class="nump">2.71%<span></span>
</td>
<td class="nump">2.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042055992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of lease costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 615<span></span>
</td>
<td class="nump">$ 599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034579832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental cash flow information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="num">$ (362)<span></span>
</td>
<td class="num">$ (377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">2,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040285720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of lease liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">2,257<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 2,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities Payments Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040706840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="nump">$ 9,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">$ (1,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">196<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">9,493<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
<td class="nump">9,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">3,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">40<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">3,963<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">3,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">1,443<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1,776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">156<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">1,540<span></span>
</td>
<td class="nump">1,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers and other adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="nump">$ 1,540<span></span>
</td>
<td class="nump">$ 1,526<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040589272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Goodwill Impairment Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Pharmaceutical Distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate', window );">Goodwill impairment, discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate', window );">Goodwill impairment, terminal growth rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Retail Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate', window );">Goodwill impairment, discount rate (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate', window );">Goodwill impairment, terminal growth rate (percent)</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Pharmaceutical Distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate', window );">Goodwill impairment, discount rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate', window );">Goodwill impairment, terminal growth rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Pharmaceutical Distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate', window );">Goodwill impairment, discount rate (percent)</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate', window );">Goodwill impairment, terminal growth rate (percent)</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Rexall Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Impaired, Method for Fair Value Determination, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Impaired, Method for Fair Value Determination, Terminal Growth Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_PharmaceuticalDistributionsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_PharmaceuticalDistributionsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652043636344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($) </div>
<div>reportingUnit</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,493<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
<td class="nump">9,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_EuropeanPharmaceuticalSolutionsMember', window );">European Pharmaceutical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reportingUnit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember', window );">Retail Pharmacy | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GoodwillImpairmentLossTax', window );">Tax charged related to impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=mck_RexallHealthMember', window );">Rexall Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GoodwillImpairmentLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Impairment Loss, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GoodwillImpairmentLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_EuropeanPharmaceuticalSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_EuropeanPharmaceuticalSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652036426680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 6,646<span></span>
</td>
<td class="nump">$ 6,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,768)<span></span>
</td>
<td class="num">(3,236)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 2,878<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,739<span></span>
</td>
<td class="nump">3,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,269)<span></span>
</td>
<td class="num">(1,950)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,081<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(513)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Pharmacy licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(244)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 925<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(394)<span></span>
</td>
<td class="num">(242)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 531<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(226)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040309064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 422<span></span>
</td>
<td class="nump">$ 462<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2022</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated annual amortization expense, after 2026</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035270648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 03, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 7,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="num">(742)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,052)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 6,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 3.65% Notes due November 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 4.75% Notes due March 1, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 2.70% Notes due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 2.85% Notes due March 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 3.80% Notes due March 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 0.90% Notes due December 3, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 7.65% Debentures due March 1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 3.95% Notes due February 16, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 4.75% Notes due May 30, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 6.00% Notes due March 1, 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 4.88% Notes due March 15, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 0.63% Euro Notes due August 17, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 1.50% Euro Notes due November 17, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 1.63% Euro Notes due October 30, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Notes | 3.13% Sterling Notes due February 17, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember', window );">Lease and other obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035827096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 15, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,148,000,000<span></span>
</td>
<td class="nump">$ 7,387,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,040,000,000<span></span>
</td>
<td class="nump">298,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,112,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Scheduled principal payments of long-term debt in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">742,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Scheduled principal payments of long-term debt in 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">838,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Scheduled principal payments of long-term debt in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Scheduled principal payments of long-term debt in 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Scheduled principal payments of long-term debt in 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Scheduled principal payments of long-term debt, thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member', window );">3.65% Notes due November 30, 2020 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember', window );">4.75% Notes due March 1, 2021 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember', window );">7.65% Debentures due March 1, 2027 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,000,000<span></span>
</td>
<td class="nump">167,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember', window );">6.00% Notes due March 1, 2041 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,000,000<span></span>
</td>
<td class="nump">282,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember', window );">4.88% Notes due March 15, 2044 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 411,000,000<span></span>
</td>
<td class="nump">411,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember', window );">Floating Rate Euro Notes due February 12, 2020 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember', window );">2.28% Notes due March 15, 2019 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance, net</a></td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member', window );">4.75% Notes Due March 1, 2021 | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mck_LongtermDebtCurrentMaturitiesMember', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 742,000,000<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_LongtermDebtCurrentMaturitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_LongtermDebtCurrentMaturitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652038112648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mck_GlobalFacilityMember', window );">Global Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Amount borrowed under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember', window );">Senior Unsecured Credit Facility (the 2020 Credit Facility) | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="nump">4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Amount borrowed under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember', window );">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mck_GlobalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mck_GlobalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034375224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Commercial paper issuances</a></td>
<td class="nump">$ 6,300,000,000<span></span>
</td>
<td class="nump">$ 21,400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Commercial paper repaid</a></td>
<td class="nump">6,300,000,000<span></span>
</td>
<td class="nump">21,400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">7,148,000,000<span></span>
</td>
<td class="nump">7,387,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity (up to)</a></td>
<td class="nump">4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652034417288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">VIE consolidated assets</a></td>
<td class="nump">$ 65,015<span></span>
</td>
<td class="nump">$ 61,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Unconsolidated VIE maximum exposure to loss</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Variable Interest Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">VIE consolidated assets</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">VIE consolidated liabilities</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652043442840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>participant</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 127,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Percentage of eligible compensation (up to percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Contribution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,000,000<span></span>
</td>
<td class="nump">102,000,000<span></span>
</td>
<td class="nump">92,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember', window );">First Part Of Pay Contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company match employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EmployeeContributions', window );">Employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember', window );">Second Part Of Pay Contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company match employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EmployeeContributions', window );">Employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized', window );">Pension liabilities derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive loss derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets', window );">Unexpected actuarial losses (as a percent) (exceeding)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Expected benefit payments in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Expected benefit payments in 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Expected benefit payments in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Expected benefit payments in 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Expected benefit payments in 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Expected benefit payments in 2027 through 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contributions in next fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_UnitValueOfCashAndCashEquivalents', window );">Unit value of cash and cash equivalents (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanSettlementPlanParticipants', window );">Number of plan participants elected to receive settlement payments | participant</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement payments made</a></td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax pension settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract', window );">Annuity contracts purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (20,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Weighted-average discount rates for actuarial present value of benefit obligations (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 129,000,000<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">439,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints', window );">Increase (decrease) in basis points</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES | Pension Plans, Defined Benefit | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES | Pension Plans, Defined Benefit | Unfunded plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax pension settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Amounts of plan exceeding total plan contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated pension obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Amounts of plan exceeding total plan contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="nump">17,000,000<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,000,000)<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate', window );">Actuarial loss resulting from discount rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000,000<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Weighted-average discount rates for actuarial present value of benefit obligations (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
<td class="nump">2.13%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges', window );">Actuarial gain (loss) resulting from demographic and assumption changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (57,000,000)<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation', window );">Actuarial gain (loss) resulting from the difference between actual inflation and assumed inflation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 875,000,000<span></span>
</td>
<td class="nump">$ 896,000,000<span></span>
</td>
<td class="nump">$ 990,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
<td class="nump">2.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints', window );">Increase (decrease) in basis points</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset', window );">Percentage of total plan contribution - exceeding (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_MultiemployerPlanFundedStatusPercentage', window );">Funded status (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlansWithdrawalObligation', window );">Amounts accrued for liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit | Norwegian Public Service Pension Fund (SPK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue', window );">Amount of plan asset value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="nump">$ 29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit | Unfunded plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,000,000<span></span>
</td>
<td class="nump">298,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember', window );">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits | UNITED STATES | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember', window );">Termination of U.S Defined Benefit Pension Plan | UNITED STATES | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember', window );">Settlement of Executive Retirement Benefits | Retired executive | UNITED STATES | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Inflation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanSettlementPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Settlement, Plan Participants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanSettlementPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EmployeeContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EmployeeContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_MultiemployerPlanFundedStatusPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Multiemployer Plan, Funded Status, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_MultiemployerPlanFundedStatusPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_UnitValueOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unit value of cash and cash equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_UnitValueOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansWithdrawalObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansWithdrawalObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=mck_NorwegianPublicServicePensionFundSPKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=mck_NorwegianPublicServicePensionFundSPKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040769752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets', window );">Amortization of unrecognized actuarial loss and prior service costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment/settlement loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the year</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets', window );">Amortization of unrecognized actuarial loss and prior service costs</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment/settlement loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652036483480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of period</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer', window );">Annuity Premium Transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of period</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants', window );">Employer and participant contributions</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan', window );">Annuity Premium Transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of period</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Total</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of period</a></td>
<td class="nump">896<span></span>
</td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="nump">89<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer', window );">Annuity Premium Transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestiture</a></td>
<td class="num">(187)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact and other</a></td>
<td class="nump">77<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of period</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">594<span></span>
</td>
<td class="nump">642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants', window );">Employer and participant contributions</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan', window );">Annuity Premium Transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact and other</a></td>
<td class="nump">61<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of period</a></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Assets</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Total</a></td>
<td class="num">$ (140)<span></span>
</td>
<td class="num">$ (302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Annuity Premium Transfer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Contributions by Employer and Plan Participants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in benefit obligation of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(9)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037489672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">847<span></span>
</td>
<td class="nump">856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 735<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652031931288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service credit</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042769144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract', window );"><strong>Amortization of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service credit (cost)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax', window );">Foreign exchange impact and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in net periodic benefit cost and other comprehensive loss (income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract', window );"><strong>Amortization of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net actuarial loss</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service credit (cost)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax', window );">Foreign exchange impact and other</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in net periodic benefit cost and other comprehensive loss (income)</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035642904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details) - Pension Plans, Defined Benefit<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic pension expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rates</a></td>
<td class="nump">3.08%<span></span>
</td>
<td class="nump">3.66%<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates', window );">Discount rates</a></td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic pension expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rates</a></td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of increase in compensation</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.93%<span></span>
</td>
<td class="nump">3.13%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="nump">2.56%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates', window );">Discount rates</a></td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
<td class="nump">2.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation', window );">Rate of increase in compensation</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.93%<span></span>
</td>
<td class="nump">3.18%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BenefitObligationsAssumptionsRateIncreaseinCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Benefit Obligations Assumptions Rate Increase in Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BenefitObligationsAssumptionsRateIncreaseinCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652039317592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Cash and cash equivalents | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Cash and cash equivalents | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Cash and cash equivalents | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Cash and cash equivalents | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Equity commingled funds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Equity commingled funds | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Equity commingled funds | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Equity commingled funds | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Equity commingled funds | Assets held at NAV practical expedient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Government securities | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Government securities | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Government securities | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Government securities | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Corporate bonds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Corporate bonds | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Corporate bonds | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Corporate bonds | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Fixed income commingled funds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Fixed income commingled funds | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Fixed income commingled funds | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Fixed income commingled funds | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Real estate funds and Other | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Real estate funds and Other | Investment Assets at Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Real estate funds and Other | Investment Assets at Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Real estate funds and Other | Investment Assets at Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans | Real estate funds and Other | Assets held at NAV practical expedient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanOtherFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanOtherFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652036810136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Other Postretirement Benefits Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652039326360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 7,148,000,000<span></span>
</td>
<td class="nump">$ 7,387,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Gains (losses) from net investment hedges</a></td>
<td class="num">(118,000,000)<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
<td class="nump">$ 259,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax', window );">Gains recorded in earnings for ineffectiveness of Company's non-derivative hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) recorded in other comprehensive income</a></td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="nump">2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractsandCrossCurrencySwapsMember', window );">Forward Contracts and Cross Currency Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) recorded in other comprehensive income</a></td>
<td class="num">(42,000,000)<span></span>
</td>
<td class="nump">98,000,000<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Derivatives Not Designated for Hedge Accounting | United Kingdom, Pounds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">39,000,000<span></span>
</td>
<td class="nump">29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember', window );">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges | Derivatives Not Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gains (losses) from contracts not designated as hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gains (losses) recorded in other comprehensive income</a></td>
<td class="num">$ (119,000,000)<span></span>
</td>
<td class="nump">76,000,000<span></span>
</td>
<td class="nump">$ 53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | November 2018 Cross Currency Swaps | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DerivativeNotionalAmountMatured', window );">Notional amount of derivatives that matured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 999,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from termination of swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Settlement gain recorded in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Notes | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DerivativeNotionalAmountMatured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Matured</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DerivativeNotionalAmountMatured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractsandCrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractsandCrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652043393640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Derivatives not designated for hedge accounting | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Derivatives not designated for hedge accounting | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting | Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting | Other non-current assets/liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">2,663<span></span>
</td>
<td class="nump">3,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives designated for hedge accounting | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 704<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNoncurrentAssetsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNoncurrentAssetsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652032959800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Investments in money market funds</a></td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities of growth stage companies</a></td>
<td class="nump">269,000,000<span></span>
</td>
<td class="nump">170,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on securities</a></td>
<td class="nump">133,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Measurements, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value on a nonrecurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042041704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, including current maturities</a></td>
<td class="nump">$ 7,148<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, including current maturities</a></td>
<td class="nump">$ 7,785<span></span>
</td>
<td class="nump">$ 7,792<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652042046904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Guarantees and Warranties (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearOne', window );">Guarantee obligations, expiring in 2022</a></td>
<td class="nump">$ 268,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearTwo', window );">Guarantee obligations, expiring in 2023</a></td>
<td class="nump">26,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearThree', window );">Guarantee obligations, expiring in 2024</a></td>
<td class="nump">33,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFour', window );">Guarantee obligations, expiring in 2025</a></td>
<td class="nump">11,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFive', window );">Guarantee obligations, expiring in 2026</a></td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter', window );">Guarantee obligations, expiring after 2026</a></td>
<td class="nump">119,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember', window );">Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">329,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember', window );">Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">143,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">$ 146,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Five Thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuarantorObligationsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuarantorObligationsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652028633848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">17 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 25, 2019</div></th>
<th class="th">
<div>Apr. 03, 2018 </div>
<div>state </div>
<div>city</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>investmentFund</div>
</th>
<th class="th">
<div>Dec. 29, 2017 </div>
<div>investmentFund</div>
</th>
<th class="th">
<div>May 17, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 16, 2013 </div>
<div>relator </div>
<div>defendant </div>
<div>state</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>complaint </div>
<div>relator</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>site </div>
<div>case </div>
<div>company </div>
<div>county</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>site </div>
<div>case </div>
<div>company </div>
<div>county</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>site </div>
<div>case </div>
<div>company </div>
<div>state </div>
<div>stateAttorney </div>
<div>county</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>case</div>
</th>
<th class="th">
<div>Jan. 13, 2020 </div>
<div>case</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>complaint</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>complaint</div>
</th>
<th class="th">
<div>Aug. 13, 2019 </div>
<div>fax_number </div>
<div>fax</div>
</th>
<th class="th">
<div>Dec. 12, 2018 </div>
<div>officer</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>case </div>
<div>softwareProduct</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge', window );">Annual surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember', window );">Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | stateAttorney</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCounties', window );">Number of county governments that brought case | county</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember', window );">New York Opioid Tax Surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionAfterTax', window );">After-tax charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember', window );">Environmental Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SiteContingencyNumberofSites', window );">Number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingenciesGross', window );">Remediation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HazardousSubstanceSites', window );">Hazardous substance sites, number | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberofSitesSelectedforPreferredRemedy', window );">Number of sites selected for preferred remediation | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts', window );">Estimated environmental assessment and cleanup costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Estimated loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember', window );">Environmental Litigation | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SiteContingencyTimeFrameOfDisbursements', window );">Time frame of disbursements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">April 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember', window );">Environmental Litigation | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SiteContingencyTimeFrameOfDisbursements', window );">Time frame of disbursements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">March 2051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionAfterTax', window );">After-tax charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember', window );">In re: National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember', window );">In re: National Prescription Opiate Litigation | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts', window );">Number of cases selected for remand to other federal courts | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation', window );">Portion expected to be applied towards the opioid crisis remediation (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember', window );">In re: National Prescription Opiate Litigation | Pending Litigation | Three Largest U.S. Pharmaceutical Distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges', window );">Number of largest distributors | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Expected payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember', window );">United States ex rel. Manchester v. Purdue Pharma, L.P., et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal', window );">Period within which party can be substituted</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member', window );">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofRelators', window );">Number of relators alleging violations | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember', window );">Insurance Coverage Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass', window );">Number of faxes remaining in class | fax_number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesReceived', window );">Number of faxes received | fax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Damages sought per violation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Damages sought per violation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember', window );">Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | investmentFund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember', window );">Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | investmentFund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member', window );">United States ex rel. Piacentile v. Amgen Inc., et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofRelators', window );">Number of relators alleging violations | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofAdditionalDefendants', window );">Number of other defendants in case | defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member', window );">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCitiesFiledOnBehalfOf', window );">Number of cities filed on behalf of | city</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember', window );">Evanston Police Pension Fund v. McKesson Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofFormerOfficers', window );">Number of former officers | officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember', window );">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member', window );">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember', window );">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ConsolidatedActionsvSureScriptsLLCMember', window );">Consolidated Actions v SureScripts, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember', window );">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberofSoftwareProducts', window );">Number of software products | softwareProduct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Environmental Assessment And Cleanup Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EstimatedEnvironmentalAssessmentAndCleanupCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HazardousSubstanceSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of sites that hazardous substances were allegedly disposed at.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HazardousSubstanceSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:positiveIntegerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Portion To Be Used For Remediation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualProvisionAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Provision, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualProvisionAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Remaining in the Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesRemainingintheClass</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyDamagesSoughtPerViolationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Sought Per Violation, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyDamagesSoughtPerViolationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofAdditionalDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofAdditionalDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCitiesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cities Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCitiesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofFormerOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Former Officers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofFormerOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofRelators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of Relators</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofRelators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of States Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStatesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Party Substitution Period to Prevent Case Dismissal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberofSitesSelectedforPreferredRemedy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Sites Selected for Preferred Remedy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberofSitesSelectedforPreferredRemedy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberofSoftwareProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Software Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberofSoftwareProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, New York, Annual Surcharge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActNewYorkAnnualSurcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SiteContingencyNumberofSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of sites requiring environmental conditions to be addressed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SiteContingencyNumberofSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6395460&amp;loc=d3e13647-108346<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingenciesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount of the accrual for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingenciesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SiteContingencyTimeFrameOfDisbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated time frame of disbursements over which the accrued or presently unrecognized amounts may be paid out for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SiteContingencyTimeFrameOfDisbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_InreNationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ConsolidatedActionsvSureScriptsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ConsolidatedActionsvSureScriptsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652035230216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 10, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
<td class="nump">$ 1.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Total authorization outstanding for repurchases of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,785<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="nump">$ 3,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Additional authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesDistributed', window );">Shares distributed to stockholders (shares) | shares</a></td>
<td class="nump">176,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net foreign currency translation gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="num">(198)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Gains (losses) from net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAccepted', window );">Shares repurchased (in shares) | shares</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AccruedShareRepurchases', window );">Accrued shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net foreign currency translation gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember', window );">Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net foreign currency translation gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember', window );">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gains (losses) recorded in other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (119)<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember', window );">Separation of Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesDistributed', window );">Shares distributed to stockholders (shares) | shares</a></td>
<td class="nump">176,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesExchanged', window );">Shares of common stock exchanged (shares) | shares</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted', window );">Number of shares converted into per share converted (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AccruedShareRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Share Repurchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AccruedShareRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Distributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Exchanged</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredParValueMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredParValueMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652127375832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Share Repurchases (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Additional authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Beginning balance</a></td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="nump">$ 3,469<span></span>
</td>
<td class="nump">$ 1,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Ending balance</a></td>
<td class="nump">$ 2,785<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="nump">$ 3,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember', window );">Open Market Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share (in dollars per share)</a></td>
<td class="nump">$ 160.33<span></span>
</td>
<td class="nump">$ 144.68<span></span>
</td>
<td class="nump">$ 132.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="num">$ (750)<span></span>
</td>
<td class="num">$ (1,334)<span></span>
</td>
<td class="num">$ (1,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.68<span></span>
</td>
<td class="nump">$ 117.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="num">$ (250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041378056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="num">$ (198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustments, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax', window );">Reclassified to net income, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Unrealized gains (losses) on cash flow hedges, tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Net actuarial gain (loss) and prior service credit (costs), tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Amortization of actuarial loss, prior service and transition obligation, tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax', window );">Foreign currency translation adjustments and other, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">312<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">359<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Unrealized gain (loss) on net investment hedges, tax</a></td>
<td class="nump">62<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification to income statement, tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized gains (losses) on cash flow hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Amortization of actuarial gain, prior service cost and transition obligation, net of income tax (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Changes in Retirement-Related Benefit Plans, Foreign Currency Translation Adjustments and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification to income statement, tax expense</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification to income statement, tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Translation Impact On Pension Plans, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652037651096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 10,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="num">(198)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">5,309<span></span>
</td>
<td class="nump">8,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,780)<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">312<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">359<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(60)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">419<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,361)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(174)<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (1,480)<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652031695768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Balances and Transactions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_McKessonFoundationMember', window );">McKesson Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Contributions made</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">Investee | U.S. Pharmaceutical and Specialty Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities | California Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Pledge payable balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_McKessonFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_McKessonFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_U.S.PharmaceuticalandSpecialtySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_U.S.PharmaceuticalandSpecialtySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_CaliforniaFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_CaliforniaFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652045155768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>segment </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>country </div>
<div>numberOfProducts</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment', window );">Net gains associated with equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate Expenses, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,645)<span></span>
</td>
<td class="num">(973)<span></span>
</td>
<td class="num">(639)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember', window );">For Two Counties In re: National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember', window );">Shareholder Derivative Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate Expenses, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax pension settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Pre-tax other-than-temporary impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossonDerecognitionofLiability', window );">Pre-tax credit representing reduction in TRA liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLossNetOfTax', window );">Goodwill impairment, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 1,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GainLossOnSaleOfBusinessNetOfTax', window );">After-tax loss on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax loss on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Disposal Group, Disposed of by Sale, Not Discontinued Operations | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Pre-tax other-than-temporary impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax', window );">After-tax other-than-temporary impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity operates | country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Rexall Health | Third Party Seller of Rexall Health | Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPreviousAcquisition', window );">Proceeds from escrow settlement related to previous Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Rexall Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Pre-tax charges related to customer bankruptcy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | New York Opioid Tax Surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Net cash proceeds from settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical surgical products | numberOfProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain from sale of equity method investment, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Other Than Temporary Impairment After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnSaleOfBusinessNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Sale of Business, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnSaleOfBusinessNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossonDerecognitionofLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Derecognition of Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossonDerecognitionofLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in earnings from investment in debt and equity securities measured at fair value with change in fair value recognized in net income, and recognized from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity) to investment in debt security measured at fair value with change in fair value recognized in net income (trading). Excludes other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_RexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_RexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_ThirdPartySellerofRexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_ThirdPartySellerofRexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652039650728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Schedule of Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues (1)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 59,142<span></span>
</td>
<td class="nump">$ 62,599<span></span>
</td>
<td class="nump">$ 60,808<span></span>
</td>
<td class="nump">$ 55,679<span></span>
</td>
<td class="nump">$ 58,535<span></span>
</td>
<td class="nump">$ 59,172<span></span>
</td>
<td class="nump">$ 57,616<span></span>
</td>
<td class="nump">$ 55,728<span></span>
</td>
<td class="nump">$ 238,228<span></span>
</td>
<td class="nump">$ 231,051<span></span>
</td>
<td class="nump">$ 214,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,828<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">1,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate Expenses, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,645)<span></span>
</td>
<td class="num">(973)<span></span>
</td>
<td class="num">(639)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,034)<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">887<span></span>
</td>
<td class="nump">922<span></span>
</td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,113)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues (1)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,274<span></span>
</td>
<td class="nump">181,700<span></span>
</td>
<td class="nump">166,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">2,745<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues (1)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,965<span></span>
</td>
<td class="nump">38,341<span></span>
</td>
<td class="nump">38,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
<td class="num">(1,903)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues (1)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">8,305<span></span>
</td>
<td class="nump">7,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues (1)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,890<span></span>
</td>
<td class="nump">2,705<span></span>
</td>
<td class="nump">2,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GrossProfitNetofExpensesIncludingOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Profit, Net of Expenses, Including Other Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GrossProfitNetofExpensesIncludingOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652040977880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segments of Business - Segment Assets and Property, Plant and Equipment, Net by Geographical Area (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 65,015<span></span>
</td>
<td class="nump">$ 61,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">3,094<span></span>
</td>
<td class="nump">2,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">984<span></span>
</td>
<td class="nump">892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">35,236<span></span>
</td>
<td class="nump">33,541<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">14,987<span></span>
</td>
<td class="nump">14,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,986<span></span>
</td>
<td class="nump">5,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">3,786<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 5,360<span></span>
</td>
<td class="nump">$ 3,531<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant and Equipment, Including Net Capitalized Software</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652043293368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) - Schedule of Quarterly Financial Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 59,142<span></span>
</td>
<td class="nump">$ 62,599<span></span>
</td>
<td class="nump">$ 60,808<span></span>
</td>
<td class="nump">$ 55,679<span></span>
</td>
<td class="nump">$ 58,535<span></span>
</td>
<td class="nump">$ 59,172<span></span>
</td>
<td class="nump">$ 57,616<span></span>
</td>
<td class="nump">$ 55,728<span></span>
</td>
<td class="nump">$ 238,228<span></span>
</td>
<td class="nump">$ 231,051<span></span>
</td>
<td class="nump">$ 214,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,297<span></span>
</td>
<td class="nump">3,151<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">3,336<span></span>
</td>
<td class="nump">3,033<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
<td class="nump">2,787<span></span>
</td>
<td class="nump">12,148<span></span>
</td>
<td class="nump">12,023<span></span>
</td>
<td class="nump">11,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAbstract', window );"><strong>Income (loss) after income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Continuing operations</a></td>
<td class="nump">713<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="num">(676)<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="num">(4,339)<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">713<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="num">(677)<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 666<span></span>
</td>
<td class="num">$ (6,226)<span></span>
</td>
<td class="nump">$ 577<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="num">$ (730)<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
<td class="num">$ (4,539)<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 4.15<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="nump">$ 2.72<span></span>
</td>
<td class="nump">$ 5.82<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.03<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">4.15<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">3.54<span></span>
</td>
<td class="nump">2.72<span></span>
</td>
<td class="nump">5.85<span></span>
</td>
<td class="nump">1.03<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">2.24<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">4.19<span></span>
</td>
<td class="num">(39.03)<span></span>
</td>
<td class="nump">3.56<span></span>
</td>
<td class="nump">2.74<span></span>
</td>
<td class="nump">5.86<span></span>
</td>
<td class="nump">1.06<span></span>
</td>
<td class="num">(3.99)<span></span>
</td>
<td class="nump">2.28<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">5.01<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.03<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 4.19<span></span>
</td>
<td class="num">$ (39.03)<span></span>
</td>
<td class="nump">$ 3.56<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
<td class="nump">$ 5.89<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="num">$ (3.99)<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139652041946264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expense</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount', window );">Current allowances</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowances for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expense</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember', window );">Other allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember', window );">Written-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember', window );">Credited to other accounts and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>142
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/CT4&,IAKD8!0=')V,,)3+8$)M8TO5V+@JLD7Q+Q JI4ZM'8,QILC096K\Q
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MR4-9E5*AQU,-P!X5T,^*<T[F<I.#29ZSE:H$P)*\:/1:O6 " :=98GC!8I;
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MM8EY?N#G$\F2[,Q\9%*=P-DP5)<DX-I O5\Q)G<3?0R7UZ[I7U!+ P04
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M'#4SG-3_?BRRW=@RPT.*4!0\W!",1HK2DL6H_4*/T1K8B@<]F'\5TG&4/8"
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MX9)QCG6C>K9&'W-+=ECZ<UKXXVWPQX5+@<0*1FE$HQK\<#N^^1[>?\>^MX7
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M*G,%/)\)H5\VN8'JQV/P#U!+ P04    "  V@:Q2Z39(VW0)   N*@  &
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MMU<7;9CV)N4UDUI.:E3RA0X9?4QU[9/MY<3VC1+KYKK>@U!*K)J72\ZTLS<
M_?U""/7VQOS [HKHQ?\!4$L#!!0    ( #:!K%)2=NB,QBD  %>'   8
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&ULY5U;<]M&EOXK**UGUZZB:)&2$EOC
MN$J6G8EWG=AE93(/6_L $DT2,0APT(!DY=?O^<XY?0-!6?;D8:NV:L812: O
MI\_]UB]NF_:3W1C399^W56U_.-ITW>[BZ5.[W)AM;J?-SM3TRZIIMWE'']OU
M4[MK35[P2]OJZ?SDY+NGV[RLCUZ^X.\^M"]?-'U7E;7YT&:VWV[S]NZ5J9K;
M'XYF1^Z+C^5ZT^&+IR]?[/*UN3;=WW<?6OKTU(]2E%M3V[*IL]:L?CBZG%V\
M.L/S_,!OI;FUT=\9=K)HFD_X\+;XX>@$"S*56788(:?_W)@K4U48B);Q3QWS
MR$^)%^._W>@_\MYI+XO<FJNF^D=9=)L?CIX=9859Y7W5?6QN?S*ZGW.,MVPJ
MR_]FM_+LZ?PH6_:V:[;Z,JU@6];RW_RSPB%ZX=G)@1?F^L*<URT3\2I?YUW^
M\D7;W&8MGJ;1\ =OE=^FQ94U#N6Z:^G7DM[K7EZ7Z[I<E<N\[K++Y;+IZZZL
MU]F'IBJ7I;$OGG8T"1Y]NM0!7\F \P,#SN;9STW=;6SVIBY,D0[PE%;GESAW
M2WPUOW?$G_-VFIW.)MG\9#Z[9[Q3O^53'N_TP'@CV\S^^W)ANY90Y'_NF>#,
M3W#&$YS]>3#]EP;,?LF[OC59L\K>[TR; ]UM=I']O/PO8RVA_E73[AKY/GO\
M[__V;#X_^:O[<<*?9W_-FC;K-B;3GZ^:[2ZO[]RO3[+29GFVKII%7F6[MKDI
M"]-BQHW)JVZSS&E^V^]VU5VVW! O(!RMB:B)?+O,-E7/:YH0&7=Y20-L<J*H
MY=TD6S;;;5^7W5W6U(3+S?HNR^LBLSNS+&E@&HU&GO!WT4QE+>P(&_*C3\.&
M=WG;U::U1$S=QLUFZ+$EK9Y6UJ_HJ ED+2W);09_RH,$TDFV;FY,6V/]5J9O
M"#JTXW:=U^4?"F/:9[2JKJ%/U<Z-R.!LP16RK2GHI&J,RW\*#(M^Z0:/H6C:
MFW))ITK#A1%V-"/6DN5=]&U'_'&2V7QEJCL9:-G8[MBL5H:Y774WI</?TBZ6
M0!B&!MZV9MG0P__L"4YRC*"M"?^F)T]'13A#$Y;T_U59YS4.A+ZUQ.]XYZNF
M;_6I?%%AT#6#ZR+[^_1ZFGU(H#[)WM8T5<V P\>?!0['UWV[9H!<!RS!1C[0
M3,NVW/$9_VJ6FUJPPS_F,?GCYU^O'9I.L\L*L"T)FW4]";)L<ILMC($\6>:V
M XQ)"D!$Q'O':+/O_VJSFJ2*&X;X0\]((W#NVQ;?$KV534$S&DL?>9)I]NO(
M4.:?/;!\:[H-/5_6-\9VNKSL:I/7:Y/]%)#@W;LKO[_]7__S-[??27:[*9>;
M[);V97=5V1TWJU6V:IMM( :: 'O#<='QIV=^,@D@*>MEU1/+Q@OO&=D);J#8
MM@$Y I]TN];MUQ33[*-9T:,$R!\]DOS2=":;SR>.F5PK9F#25[T%(5C/=S#)
MMDF)>IJ]RFW)SW^(('O!D"74)9HOBYRFCS#3TC-&IL$!Y<0G^02 ^#4MB+ZF
M26CAQ!QDDWBD+>AU(Y3Q=^)#],LU!@KH!63V7'!MB*WD%7$Y>MGL\'@>&#+A
M':UE5T5O_^WR\D- SH<MGW8='1X?BIS@@8=I/80&#:WJN+FM:53;+VQ9E'D+
MX0!@;//?FY;03W\GB-,JZ%RKRH!E $[TZ#3[D85 8P>K3,:[)<PPH]2"P5N[
M*7<0%@0$8F&$NMGLY.0OPEK *D"%M&9\K VPGZ8W6%'5T NTE6;)W$2Y7PVQ
M($L%A$LP$:(<BRF$]^ (K,.T7\*0>=>UY:+OW&B'1G)XJ&1R%6_\.H%S$*["
M9FPDEGDXQ3A2$RM@E<">U(K:YDOA69N<B(BIS50EJ7,\"\T<P$V/3?34L4PL
M*1D[AF$\,F/P&),Q.-B((_%<+/# VDVU G 4,K3@C':+,<H5_0PH8P4.?^2(
M,3<=&!C'3<.([UZ'S"1L(88DHZ03YY5MZ*RLP?_\.]VF;?KUAA9-NU$IRWBC
M8[.D"P1U0UC(1^H.4*8BS(P4&7WVM[=OK"==G$5AZ)TM^(_RS85R([]KV2\1
M,DP4.JG:T &7^%N1EL;<!Z<BC,6O3"&U L]/6&!/7032+TWQUDL(%K;I0D&'
M]*7L(1;:14._$+<31',@)BK@T\*3^:*LL%,Z=/.9T*HD8D\1>57U!CR1#[,1
MG*=S /P"!]JI[CEAKJH\$ R-H(^E"N8F^$CLI;20]!]8B%R,BLF5/')G<K*V
MS+H$2M39)4&KRF:\!E,7_!V9!;3YT]F4^#8S&T:=6^P'[+Z8,%]L(9U,K?I4
MSIIAN>PK&I[GL!L\!=P;96G1<B#IEA6A+T/*Z=A7AK0?.@I1.7C(? M8Q+3>
M^A>!!TQM$'6.QSE=@M].-8F_6U;KWUC2]!C!!&HBQ7+'"$8%@W 5S(,C$ $'
MO0P2B59$)],:*U@98] V_T3GYN=C46K)9-_)COGYG/5+T4,]#]9=*QO]5B%-
MG)64+'K2C4>(51'AEBMH&:S8B(!R2_0S"U5:0UA+&R9%.R>D[B [F?+[5GDK
MT<&MH3-7>H FW&S+):^8H"*XHI1(^@%IJS=EVQ,I$V;E8%SSD]GSH)R]_^WM
MZ^/9<\]F:#>%H?&$,'H:C1&$3)]\5Q9B'M6$UVM1<[$QX".KHG2LI!1WO!-"
MW :6SQA61BK'X9/:YCJ74C)L!9P.G?H.6\6$;O6J)/@7,"*Q6>@Y4/1[5GM5
M]W/<+T#FLB1B^T@"S:QD4V\<3*\-X3;0CPXU@.SRXYMK?.-A!NW5U"3)H)LX
MRIY_SQ;_B<,H(*\,KSJ1E<-V]JCE7;>F8J0 >]ONJN:.=6Q]"VI!EW\&UPH2
M-GIYI39P ::!@14-9"2"821\;2,([7;(XWIA]MHLS79!;ZC?XF2:O:_#MVYO
M$[^SR-[TH-A31RYWM%CB-,I]"(03-=Q$$IAZ$_0.\QFH2 3D.93?IV[+'P0?
M*6%$10S7$OR@Z=,21&.&-*&QS%+!RFPM]RB2E82;=+K-. ,]P ?4C"3K-+<;
M7B[_\8:XTDU>,7^X8!UK0]*?L+ JZ1?([X4<YK:I#7A5^XD5/MAFPE5V/>$.
MD6DA'(_8.BDN1&YL]W=R5+S]UAB, D<5E$\($.6$6"NKU4N:TY;B/&3[)-A'
M2[=L_L.$9>N.HF_X73+;6C!_FF*5EVU&O_7FP+.B&91,>ZS \8R7EY?'+4-Q
MB"X)+%8]SIS]%7B O00%\6@+,YY!$@X!<",.J1KMZP<\-5A?84#F7HGEA16D
M7^>MJKXP6H@%BLVO<HX]5@X#A^*66![I(HG!$=/JF[YM)MDK.L62 +<C)DC&
M">%AY?GI55[G]&+MUA'M"_S-?%X:I:P@L&P/@W!QQU__: KF*?H:Z6'T,]N(
ML1<MXDGBKR)E'CJ%@EH&Y;>([-9MOF7!*,KM[X2%%GQ>X![KDB2JRS5S<_'Q
MV$^ %!9O-\1ZCJ%,QKX#\*,5D5>#U>O<@)-@ 1\D"6BU@0X=J9!3V1&AL+I-
MD]*B5V6EC"2:#S[2CIB$G. ^XD%'HF=*YA6,W!?R'U%^+0[V=U8=&C ;803\
MO/"E%L_T)%=R@B:OF;Y2FSM218G(::N&C<!(L\JM'\X4@41+FY"N2J$/4*%*
M9I.FMKI5/B!G1^ +?5C<(61!'CM=#6;,_;;C*S$"LVOXYJ'7B&&O6JMCW,,%
M!^)B,\V*Y2GG29H3$)!_W9B*9>7"D *[PC,$-E(EJI(G#UY&V(>TBC7)I5TB
M'FG!Q(B\!N -#!@-9<UZ^Z)IV^:6(*YHNJ_9DA0F>LV[<>@7O?'&92YJ72*J
MH8.JJ5"ROZXEG&#Z8D4/FKF0C.P?*D^5$=I6Y1^!8(=;%3&>9["OL9**@ CX
M_).F5SR!+XN-*'A'6U&(F+\X\B4HLIG$_A/+HKYS(J5C42DK2E3\IBW"JAQ%
MXY6 =()'I+ZU/:_,S^)MUW$I>ABQ /8]M)KB,Q$EDY#J8-C*I:.K8P+1\37)
MG&S<"MN&UZU_W6D9;/ E(UD::7)8SHEJ.I"@#R;#A] 6]M#7K<D%,]9YJ8P-
M3B6L'*XFE3F>!/+/F3C*.0I!7%(6AKTK4MIX^\!DY77QL:OY0R_:KEE^VC05
M7"L*236 B?B[P1'QZD0%' 4VV2BJ>SE%"RX![T]@;_[&"#JI8#F&U^38,0G(
M@R4"26Y/M&XY#7@"FB4SLB)U^0?/$.M!:C(Q\YZH3MF!^1$D&!7D[>B@%<2Q
M=QO.Y:JY92&&X,1DX,I$($)U+#@8U-10E[-7%$HR;#CZ0L=,"ZSNQ.M4X2A5
M4<^]+JY6 LOVSJG_D=^#@U"U"X2(3@CIW!;BR(83\E:X"%9%3*7<,<J R$FK
M$J,H4N/>WP-^FSZLG&T+0^(/(_$:F6J/HISW)$;!H;7.&RP8-RV,6AKHE@UF
M]JA7Y2=3W8DW#:BT,,[P+_P;"[8SQ<QQ6K[?IT)_L-P%^^:9W#=YNY;!A%&K
MD?58R?D)4][$T; &2Q+/%;M]&1V)CM_(CG\6_V7D KOX,_UAD_\S#K%8]S/
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M\(/]""0Y\L*](J@_5&&_E:FJ3(U\PTC3DX3-O21%GP%*QBFT'Z=?TNE"KY<
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M(U C!\II ]#CVGY-G)^LK@VG%^IJ.'+A_,H*84[<[30S76*#&)^9!LZTE01
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M 65M!K=1^/COH4Y 072.'E;C2*>,8O&2F(M,,R?RAS 4@S4*8GD@1ADW*VD
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M@$)H:D)_(Q4)2;(1)1^/H&>[ %1JEZ@C&7AZ=CJ>)-*49VE./.X.8>PU@SI
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M7$F*GD]J:GP3)Z<"#B\JN=Q=Y&63U_"!8BM6V'O.;-U0EB8R[=M43'8@(;<
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MGS3 O!T)6Z#+2Y13,B5&3U8U!"L$\@S(3.PK6AO:7/ R.A^L;744P_[UK#J
M,&J2]<PA7JKXB%3889[/#X;PUB0(JF-V$D05B8B%6287-EN@0-9IJ6SFL9$)
M^3:]U3@S2SBDL@E8A(4;C%[)L5%(/J4UQY0I>,#/<)42TS*-UH4$MFPYS'%0
MS4PYFQ.?8>DDEQ RRX@\6"8Q&[(R()'%3R@WK\0M"@W* HBZ:*X1+>WD8<NZ
MM?V<T!Q7K&&\YGX/R%;Y5@SOPZ]=C8H8H\3D96:!U$Y!%(:ORPSB'<MY3]A
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M^*1]V3O)<VI*(0X=TG.4]N'*.5O+J\."W>YHVYWOZW+P&X+>H5_D,BL8U!'
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M@=9OX/6E8<W:@7?0_=O-_@%02P,$%     @ -H&L4D9-Z4L>$   ]BT  !D
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M^ #L\5%X[1D_U:?8H]Y,U>I(X(0\9U"4K<91MYEIH@(I?U]FTO/)')S5[=E
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M+W=O<FMS:&5E=',O<VAE970Q-RYX;6R]66UOVS@2_BN$+[M( =>V9#MVFA?
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M(X'&4-,&/%\I9:L;8E!_QKK^+U!+ P04    "  V@:Q2T8Y3;],$  !X#
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M[9DMOY[.9V(ZN]H)G_3JE;C.29^_RT:GA^P\F@B8ST]-!L;!?=W-Q>R@?ID
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M    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;*U::W/;QA7]*SNJVI%F:(H
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M%1?!9;7L8MSX/;D4'S9;J0T1I(V&+%0]#NNES7L )4!."I P1J71WC&:2"=
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M),H&*O)+;'P*ZG@V;^L4AHI?@1"7)EOJJ;/")OOZ>0,].:S,\_GOLS\C2A"
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M#UXNH*K)[)(_$IA-9_QD. _=DW XN62=T2<(Z!\0;/]U'J$>MR0Q#R".7(*
MX7P4AJ6)>[B:-*[8&4>S<558E\.'7AD3'!U4EAYZZ?<5AOI4)I_-4\M-SX?3
M08.]\/!J/#^X&K98#QM=B6<]1'2:K%A1"Q)._+J@CC<*7I0_U/D $7C><Z0U
M"EI;\$MQQOVF;/(4B#P-=:,*Z>Y4V0GPUS+UY,'/9'UKX[__^"H MMGO2M[-
MKJ;+NOVN3^&N&A\A(KA7_*DEO?5!ZG#?(U9WJZ\YK]U'C/5R]RDHM+72R(B)
M6F+KH#\=GR'?\>>5[B+/MOQ)(Y()D(1_KA5"TM "/%]FT*&_H .J;US?_ ]0
M2P,$%     @ -H&L4GP\Z3SP"P  F!\  !D   !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&ULK5G[<]NX$?Y7,*ZOD\S(LD0]G=>,'TGKSMTE$^?:'SK] 2(A
M"0U)\ #2MO[[?KL GY9]Z;0S44Q!NXM]?KL WST8^]WME2K%8Y;F[OW)OBR+
M-^?G+MZK3+JQ*52.7[;&9K+$5[L[=X55,F&F+#V/)I/E>29U?O+A':]]L1_>
MF:I,=:Z^6.&J+)/V<*52\_#^9'I2+WS5NWU)"^<?WA5RI^Y4^5OQQ>+;>2,E
MT9G*G3:YL&K[_N1R^N9J3O1,\'>M'ESG69 E&V.^TY?;Y/W)A!12J8I+DB#Q
MYUY=JS0E05#C]R#SI-F2&+O/M?1/;#MLV4BGKDWZ#YV4^_<GZQ.1J*VLTO*K
M>?BK"O8L2%YL4L?_BP=/.YN<B+ARI<D",S3(=.[_RL?@AP[#^CF&*#!$K+??
MB+6\D:7\\,Z:!V&)&M+H@4UE;BBG<PK*76GQJP9?^>%&;4HA\T1\TKG,8YWO
MQ"4Y2I=:N7?G);8@PO,XB+ORXJ)GQ$TC\8O)R[T3'_-$)7T!Y]"M43"J%;R*
M7I3XB[1C,9N.1#2)IB_(FS4&SUC>["6#;[2+4^,JJ\0_+S>NM$B.?[T@?-X(
MG[/P^?_+F_^#./&SR7=GI;(9LA!TL4&EN%(EPFQ%N5=B:U*4')C>"#@QWK,7
M7]WF2*,T146XU^Q3^F\B?AO?C<4-.*05N2DA_M7TM7@5O1:S\7+QD_B5UY)*
MX>E>91MEQ6PR\KRGXL]_6D?3Z"V>5I.)F(]7/0Z_>PAA0SN+9B(:KR9=RAL5
M>]G3!5-'8D[R\(G&ZV,R/=FL(9N-UY-GR>;080HB__]D?'%\[QD3+\0"1+6R
M*W8"XJ'R$EGSU*Z5F"[]9S:^Z&GZ26UL!;S#CTRY%DL(7A[UTZ%VZD5CT7(\
M.6814<T1NW7$G_EXO7[.[OE<S*=3_@#( %,Y@,5:E<>';JAGK^&2Y>PG\;&R
MIB/JLMH!AL1T%>*WFLS%<AF)Z7@Q>4+<)$<@7W!"+!<7(#\B^W-<FDXJ+<5B
MO1*+100G3D%]A^Q.*>N/>7,5'+6,B&4E?E8 9ZX6@^RWPFQ2O9,$_4Y$*T1]
M-1??3"E37RZKT72^QO^S-;$Z]T9<LU-*41C+#6,UAY&C";3Q;&F_WD[%<C2?
M+/GO;+9@)W[;*^C@G2H!+E7N%'R-FB2]\*W:&)N@F+E,.PJ&DKTV62'SPY@+
M[S;'9@JNARYE1[!VHI 'N4F5<"K39S+/*YFFQ#4[QK4]'O2.F%8"8\HWLI&Q
MYUNK$U?"ZJT;ND'G<5HED+>!VSV,)!Y&R.3AWF>)RDT6' !?6 8H-Q:790>D
M.,^(G>!E)$Y7XZG8>-#B92S,ZX411@-7*&[NZ6'$GFRC_"#AVZIT)=BP$?_\
ML-?8YY3"FW6%3MM=AD))3# TP0/#0C1Y.\P8".][A^FF;XFE/.+*:X3>I#IA
M;US)%!BOQ!WU<GCD<SZ$)+BB(P6 GQ6I(E8IB@K)%$.!K;)4,-#D#_'M%0D+
MEO "TP:57Y/.D MIL2[@3IF9"J9"\"D!8_#<>)AOHI7T;*(2Z=^J7(F9]871
MJF:Y>RF) !V4M",R$B,@M[Z&RR?(6'RQ)E8J<0A6K! II)LU&;3 QI3C4,!5
MY-.1R!6KGJ#ODQG.XT3M+?6(&=<IAT##%G$ZOUBV!MY43$.VD4I"T6 S2-9^
M8*PJ-=6\QCZ^>YZN6I>%]&P]"[WR)DKX_6F#K0HL8P*%)N6AGQG38YF!S97*
M@@:^RYQ2N_U1#?H-&W3&@J>C01?GV&7-CI4C9\72[4G0GMQ,']*NJ,,5P,ZS
M-T&@V%3.43IOX '*K*.F%5*#I&RT82.1M;/E_&VT:-W\*34 5PC^BO(:-IZV
MC43>@6&[Z<4/;=?%"HPF$7IO?K3W3B_&XB-E,_T\"M!#DUJIRXJ[1%V!=_!"
M4WTCJAV9_VC_&+0/)K8R_^Z$^MU7W(,&..-I0-D@D7K$Z$C. NLHE!'.7F>E
M.:._6*IH[GE9(9T3YJDD1SOMHFYP@;>0+-LAOC:G#G @OV*=E70:L4.%D9PP
M9H4RU;&R+B@K\%QJ+($1,/E;P:?#WRLN.;@9M)2L>Y,F8&ISFUVPU8^L:, L
M2S+Z$<]D73]8-FTWIT'\P$YY6A C LL'[(CJ(?4!>[8<4?/SE0!F$ID5'"RP
MQZ3YK0=,=:\\KM(7$X=.J6B%6RK-%5+$**4=+R)[2FN&D61/T=0@T7X?\IV5
M"5/+VNT;.G]33NG\'J9GM*FGLKY,$ O&73!]TB4>;O-X/,)QSB1MGMPRLX%?
M(?9>$[02&>]^1^&60/ _RZQX*[X88QN^K[Q'P^6CP1V&VBRBB:@44-0@^V3N
M04%D-'=N%-R<<$B+"H5%0UZYAT>#70'R51-PBI3WL<]^XIQ.IC_5#L,G[V;G
MT1[7V6$DBK2"V#BV59/WC I-&I5F)#952:D2Q@2>-6@WZNTD$$ 2M&?T;'.\
M@4>K4E_6SZ<[9Y1J:VDD4'__QIA"-G(N/<:J\!,EB86#>4C0/%AP 1 5,BC1
M@0K_"A#$U*5'(1@';_ZP*LBZN)U81B)3=L<9[Q20A=&%KGLVY-G2EW2 ',),
M"6PO'94*4ERD&AUW1 R*O$B^-,+)5)VE-,=O9/Q=X%B>.QE[3<DTQ?$*&1,+
M&K.H9\,NQ)/U3:D[=WP'3L@?N!RZI,YP(4ER$=^R4#/@4F3("/<ZU+/N-5U
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M?D\&X]$H7I-L,Z)?&7B:/THTC1:1 0EK=P\*$> 1\)/)%5C'HD */ !)0&>
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MK[! H ';/2Q*7RDL$R_J%*_\_Q&6H[(R--;U$-K!,I8R9/WLMR@E;4V5GTX
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M!V?\F>LQFTU'+)I$TP?FFU6[G-%\LX'YKH66MQSMS]YGQNH"W,H:QK.$=17
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M72C1GQ$JSS ="!BY)BFRT.?!Y.2D2X2V5*Z5M$+1CFHK,=H,"$JQ.*NHK1\
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M#N#]VJ%$^ALQ,'[K7_\#4$L#!!0    ( #:!K%+=V'A,V2@  $:&   9
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M$EV1"3GL!R1V+C..;UGKRU$&PP4/=O[N,5$_!>:09$=RBU1E[8-F#_EQA]+
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M=*$W*U-R)!_CBRBSC1RLO.#9@5Z<N(*!+[.K"U^SBILK)DC R\]M>0-8X]M
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M,555=,"K16O/&I_BOG(G0*77^8MGS4\OGN4U_"^%_\#C@O_7^*J%5ZI1/[W
M<+">@=&L^3UK/^Y-]H)O826+'_<N)C]<3/>>P9.^^4\O-@",/BI\L22>$EW
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M 9[/<T!!_X4.J'] ^NJ_4$L#!!0    ( #:!K%*-NU"*^ 0  +L+   9
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M\GA$OGLJ=HOHFO0\6[B(QU[ZK/"Z9B\'\/O2N;A;B(/]>_WB7U!+ P04
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MR.[J)C.HR:[H#$I+#]+;F<]YYMK)7T'\<.IC1<EE74HML3>*2<RT%":?R3E
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M?-D:NJR0N83K_">4!1[3N52-[!A8R,A"QFD/24AB(9,D@;=4"<Q1;P'M&6&
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MS3IZ#9IN&/5LBETJMEN02X0TTAK4PJ=_P,."KP0-L,!7O(2BP]D4AO8:*D?
M*N.9T7_40*//QG/4;,*^BL]A;,A1W6Z+5DADLEV)NY:WR.SBXU9E CXJ8=>S
M-^EITFJVH"@)L+?GQJ7GA,N(H N$\/3B13,KQ@=3VCFFSB0<43<!-'"<_3.^
MJ_KN(<?J^F?@[Z:<X_Y&P ,8,42@C\:HHAM1#$3%J%!^MPT9=W]!X$-)VK@W
M]\+>U8(?\<#77K[Y$.O<4(8J1;,EDL$<F2)F^IN?")2VNDN)/2'.Y*!0SN%H
MMK$)32?0"J3OEH!0(ZO@8R/+55AA&UG8^]P@2[V/&7I%.<C@/I'FJPT&$_<I
M 4;5:<! SL8QC)\:C, B&NA3:>3.?JLW^*!Z?=1XDW1 RKB?9>&A77C(AH>H
MZ,EQ$0")7Q*V<JW<5T&0.&Y Z@9T'[K,4P)UJ7-W+7\-Q0"@]S"/7!8K(B_Q
M"2D'C>XV'*LE/WGV @_F](24!4,$%EU1YGKC@O'2P!S!>CG%Y^&M\#R8AZ!Q
M+ (EHHUZ"^DX>X]2APBY_=%V#R 74X##?\AV/OP24$E*A:*)#,- "+0X8:&>
M5@0!%LZC\80R!%LI!"B,*W^C!Z$VJ$S)OY J):_,D<;D()5@,#,VD($)]"J6
M$-_Q=:+ M)Q/"R,=:")JL1[]C3;+XB4Y?;0T2*Y D1&$1?2J6JP$MG$!;>/V
MX3:8[5GB/>;#7'L*?Q6V@CJ<?F#=AO@<#R*CZYDCR"DZAO43@^KAA06!OK $
M)T2+_-M%&8>E>B;"F!*8!ZSM?!P0^X^ZSF_ NA^2]P>^>I;I3WBX+5<3]$!/
M-7- 56$BC>%Q8GC#;=SD"C>02'Z#@!(JM&DQ^;W2<ZDY^[:K\0(CD'F8@0R#
MX^PR_ 970M%WBNJB\Q$N]' O=!5",H W2A7_PD762&Y7%#]D=1VP9.)MD-A4
ME@<0(.?@<]]2#/]K5=]4G!#%R &\6;7?38A8/#<&\1K;ID!Z+K67Q&RPO!C9
MLQ96BO <E*@@J(Y'=D0KD@Q<&J$QA-SA1]?^-%-:,K(%XQW>E_<ZM7]A]^BK
M[D1ZM['4HVO&VC2>4$(;%I,<'E?B15!<Q/YXB_IZ>%$3 :XPD!"%E,"#O3H-
M!4W1YKG4M@UF4[JE4>D+4,SY.'SRLFJQT@M/D[V103%\Y!AGV06CBK ,NRP/
MAU?]>V(:]]*JB2Y7.S;<*4F >V? \FZT=!G(GM3,2<$9"PMZ*LE-S>H@NJ(&
MKFJ*DS1<%<<7,\C.V!$$7.%\'!1X80AR0%NZJE?M#>[2>XJ76%N,]NT7-^AQ
M_F6#I[[ZTK^G)B0&+'0 ;ZH6.@#02?T 8F>49O'E<M1,]4Y*:S#L30(*A@6=
M<W1ID_AS<3O.&#(FHX;5R'FE<C83&VI4<@(X<#X.Y0LE4Y^D^&GP>!X[2'H,
M9&J0KS!0:Z4>-96SQ>T%X/#(O KO) T"/*2('XL05,37<@>!,EKPU&P+K-G3
MAD,U<!PUI>X)QPB^21)C]=:._A'$MG!>;/@N*.HBGVID#OR@8NM8^2ER!G@J
M8&>H;B2!U5.&&.^JCEPM+*# 2SLG% 7^\YV_OGZ%RSK#(+V/R:.;'BS<"PI(
M$"3H?8C"3'QY4ER*B\R)>?V02Y9P2%1?5YH;W\#!8*'L)=F<0QJ0L!=QP4,*
MK(Y:"2A1%;H9A[1I45H\4U//F:C2!2],,$R#$B6TE]U@&YMK&X)G$AYE __:
MPO&6UH>E[HZ10:\+1X'.E72#L"Y$A=@'&.#2)/R9J.P^-52*?4W#>@VF!/["
M+X-9D-E%C>SXA(;^K!?N'44VV/D]SJXZ8/* H&64@O5T-EC@S5"CJ%QY52.<
M@/E-,#RR7; /P8W6/*1*EJ8\@5,;U'5 ]VT!QGY<L17UF:A[?2:&&#_P#H\E
MNE*"2A^]D?56Z[;^JO#R/,!EY^-PUL^,,438# 9^#O67&1\%>S^=N1WX:3\=
M[20K<30T]%FFOQS(OF"% VH1C)^VA5N1-E%_APZN7I0(<")O\8Z#ERO;-%R\
M1+4?_KK:$D02[3.4;_4<*=;GL4X%NQELS0DX?E5:SB99CV61JJTZJC^1=;)
M:1"8?EF*-T/#]:8_UMVKR]!J?EV"-CY.3G[+?@IIR_F,D!T)\/IV )JP7X;
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M)R4BU"_=&C1(8$WZ)X@B.A5AY]X^G_A,$W,[!ON+BC&5(>SG8WZ'"E!C6-G
M85'013*_/O[*Z7I,/TDGD#T:L@V'F@K.$$_.$S$*H*-!(39$'$H_SLZC&C%,
M@"D?!BY+)"OI?)-"$"M)I<7&FS=J&,C([2\PU,"%M"N1?!BUE8LWYDO,U,'_
M[\"[F : -W&G1[!*^X12O:*NY59\7 &WSQ4:SN<^5))A'7>UI!_5'F6"0;,3
MA^@ MF^L(&Q, P6LRGP<77+)Y>J_F=L#RN?AK_>P^UI^PW$L>JS%QZ*$'B=7
M8GR&UE?[3%WH4>8O?57TN543R]SZ"&</Z[&2DACO1TM[!7REW^Q+TD<!E49
MT)AM&>D[U(12TFHP*M@278/ PB^R3:SRD#T]9,6&PRP*:TX\>N6\):ZMO;%V
M9$F*T<"I%MI,],"<' FTE5EJ@Q"VL5'@&%>G=*06>4E=?UA3R-,IC@5-G(9
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M<X',G%/ 2S?)ZTJBPY\.SO)/4X*::R=XFW 48?;]\6%ID&\8Y%9@ZBN+7_%
M]>$ZJ@W+=ATVE%IO6LKHFM:7= *=,+PN_OD!8A( J <V:(+\'CK)XUC(#Q]W
MTGT6TY(PPSVWRH&EWA.A6G'S[QZT-R!['Z"2Z'0._=%C?JEHKB8/P.? 1\V9
MZ.M^XX#O*Q3WZ6O*S%Q$^F-0.S]MJ)$T)X9E2.%,.3>4:K DH)>ZYY0E/O2B
MF"(3G^_HQ7K,C6ERYY6T)K1[->5XU4YZ +9[:S4X_^H*3'X(#HLMU(<MN9?X
M2@KG'^&EJ.N%;L_65!6J4/&_DUGI@PH'HI$@^F5]=\^WX$X#!O=T'(.+UFM
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ML\D _9O[<Z&\L&KC7N@OE+4J<].UX&@O:0&>+Y6R]04Q:/[BN?@+4$L#!!0
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M_7$UUZ8$(?X\ A^T\(&%#YZ GU5%D4KPU(@4!$E%OI!4!U22UU$#^ATR[/?
M16"DPLB8C**T]N5&:,*_I4H1<?J,8,_%VAJT_S('A](4^V />;>0A:EWD9%E
M1B*/*4[T0E6Y(=A*#JP/^.%TS-><L_>!2@Z $[4\J3 06DNCZ1EY0]=Q\':'
MTVE$-U590B,J5&FE5TM2>S!I(N9)FIA$\G;_E#?[84"O5+XZL6(>VX%CH@F>
M4>306\6F.X[O#;UP8M^.&]"+)+=F;C2\+7FSN1]2 ?,;:Q_YJ4H*]LJ0<K@"
M.WW>[TZ=0\JEK="QG-O5'B\..]K8"<^)\-5M1%YVQ=@7V)LR0A31!YMQ9'PB
M/D/#%1P@.0L_:&KA^[]+4>K!8_=-1E/\3?9U=IV12ZZ'QR/\'6H\!O1&H4_/
MR1\Y_-J#]483%U^]$4CP_$C4A6W4A4>CXT9EA<IA;6W-;/5=*(TA.TEW8V<A
M])J6B(4OQ>/Q$]^N^83#I])&EG(GZ*S5ZY3X1 !V8VNV!F5J.G1 P7MFBW?Z
M*-3L=!"%%(2GNY:V4V=TE3$'_Q9;'AZ*3<\G4/YECF,EX+#P,=\B"@]RT@H
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M]V,G^J[#HP=-_EF%F\")^H]&KSG +0^0,*@-@@.,\@^:*MTTT6$P^Y^<GAM
M:,@K;1R"D1P4N9WGUPV<]>7SDJ +!Z*=)QCX6HOZ_H$>[:!7+O1]U"\*L8L#
MWM9!3FLO.V<"/)Q>Z1*%1H3\>\_JU^JM\:5_6;I<[E\YPZ9'@B4I)MC::0]Z
M1TS[U[C^PJJY>W4Z5M:JF?LZ%3P1FA;@_D2!B187I*!ZEW[Q7U!+ P04
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MQZ@CDX,_07^0WE:"_5)PD6WWU^[E=-]<$R:*(VV]@[:>4=N;6*9M)&<+R (
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MAFDY(- &W^1Z,.FF,@ T9X!ZXL&?X#8G<?1:.I,D8W1?39EI' 6C<'863E'
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M+/%) F4-<'XII7GOV%NO?>3R_U!+ P04    "  V@:Q2GS.6N/T"  "@"
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M13[[N-Q[+W>A0GV9@KY,0>,O/.+O T7X?;-46L*R_',B7MC'"YMXT9%XWR"
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MY?_HJ1YKC)"?9X+%M3!8$(=)]9<\UX[8$,!VAX!9"YA#!:Q:P-H6<#H$[%K
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M?0)=70B6EI^A/C A6%S^7%(X!?%B #R?,R96%\67K>L/T4__!%!+ P04
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M%&"((&$B_R<O12$V ,!3#\ % )\*" M N N(#@":!:"Y"V@> +0*0.M40%0
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M?P3+;XQ<9E]Y'J2!+6QVN8!&R)0U@-\?I33K&SM ^2GR\E]02P,$%     @
M-H&L4NI1ECIO!0  <!P  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N>&UL
MO5E;3^,X&/TK5C4/,Q*0V.X5E4K0S&J1!BVBP^[#:A],:MIHDKAKNQ2D_?'K
M7(@;VS$5MQ=(TO-=CC_G.[$]W3'^2ZPIE> Q2W-QUEM+N3D- A&O:4;$"=O0
M7/URSWA&I+KEJT!L."7+TBA+ Q2&PR C2=Z;3<MGUWPV95N9)CF]YD!LLXSP
MIPN:LMU9#_:>']PDJ[4L'@2SZ8:LZ(+*V\TU5W=!XV699#07"<L!I_=GO7-X
M&N%185 B_DSH3NQ=@X+*'6._BIO+Y5DO+#*B*8UEX8*H?P]T3M.T\*3R^+=V
MVFMB%H;[U\_>?RO)*S)W1- Y2_]*EG)]UAOWP)+>DVTJ;]CN=UH3&A3^8I:*
M\B_8U=BP!^*MD"RKC54&69)7_\EC/1![!G#888!J V0:]#L,<&V #S7HUP;]
M<F0J*N4X1$22V92S'> %6GDK+LK!+*T5_20OZKZ07/V:*#LYNZ%"\FTLMSS)
M5T?@,MN0A*NZRB- \B6XH2F1= GF:\)75(!CL*@F"&#W(**2)*D :O8U@!L:
M,[Y4%E_K7[\IF]M%!+Y^^0:^@"0'5TF:JHJ+:2!5_D4605SG>E'EBCIRA0A<
ML5RN!?B>JQ!M!X$BWK!'S^POD-?C%>$G ,,C@$($'0G-#S</'>;1P>9PXF&#
MFUKBTA\^I)9@SH2L:R@H?Z#@[Q\*#RXES<0_GFC])EJ_C-;OB+:@#Y23/*9E
M$)IM4O9$Z3&O9TRLPHLCD%/I*G3E>E2Z+EK3PPR&_6GPL#_V-J8_:D,BAYN!
M=M.B-6AH#;RTOC\FLDW"E7_E8[@7># QTK<A(P,2V1 X[$A_V*0_]*9_+H02
MBZ1YC459'1+'JM/RDM.2*H&($U*T71>UH4UM:%"S(3@TJ#D@'<Q&#;.1E]E/
M)DGJ2GADA4+0+(:-@2:KR,;@ 7+G/&YR'GMS_F-3#'KQ-B[HJBK'?^#V9'$"
MKE6_S$A,MS*)35JM4),FU.037GX8:MT(/^[UKWVWZF',H+D+@XR2.3#]H;MD
M<$\1X3MT@-I)*SUH4G!@3 8V9-)! &D"Z(-[0!U@/RNK/#;$+&'DP'151VL<
MQ*]K [5=NP^823LPV$S:Q@QA1]9:*Z%?+)V-X#*7E.=E$;PM &KM@H//: ):
M;*!?;=[6!&R-0,@LF -CULLA6%WUTEH#_6)S8 ]PR,K(9.# 6%/.QHQQ!P4M
M/="O/>_0!<:^[EK3LS&FKCH@J.-; &JU@Y-7MH&)/98#,VD;8[:*R(&!@[$[
M;:15$_E5T]D'KNBR^ @X7FSYJK@ "Y9NI;U&:L?4>H;@)S0%I.4'^>7G34T!
MV9)Q;'9Q!\98.T0.".PJGI8>Y)>>PYH"LO7#7-DX(.87:^3 H+"#@98AY)>A
MM_>$.H#GDV;^,B1R0#KZ'=+:A_P+M\Z.@.QEEE40&X*L*>5PTZ$S2 LH\@NH
MLQ]<<RIBGFS*C;&?-%[G+&6KI\/:@I8X-/J,MJ#U"/GUZ&UMP2%%9@UMB-DY
M(@>F:]YI)4)^)3JP*]AR8GY1OPR)O)#VGI&6).R7I+?W!&ROPDQN+T,B+Z3-
M34L?]B_E.GL"MI==YGQR0*SYY,!TS">LY1/[Y7/.^(85 ^_;$=S;$OR,/4&L
M%09_X*X@MF5A:.[D.##6YI,+T['PQ%I?\'ML#&*'DIA+ @?&_*Z.')BNS2BL
MU09_].8@MA=;5H%LB+7@<6$ZR&D]PZ_<'ZSMVIO-YI+  1J;GV1^3)5VL'<4
MDU&^*H^TA)HOVUQ6YQ+-T^;8[+P\+#*>7\#3J#K\TFZJL[@KHI8)N0 IO5<N
MPY.1FBJ\.MZJ;B3;E <^=TQ*EI67:TJ6E!< ]?L]8_+YI@C0'#+._@=02P,$
M%     @ -H&L4OY$'R^$!@  G"0  !D   !X;"]W;W)K<VAE971S+W-H965T
M-C(N>&ULM9IK;]LV%(;_"F'T0PO4L7FSG<(QD-@;5J#9@GC=/BLR8PN51(^B
MFP;8CY\H*Z;$FX39_9+X\O+HY>TYU+'F+UQ\*W:,2? C2_/B9K"3<O]I-"KB
M'<NBXHKO65Y^\\Q%%LGRK=B.BKU@T:9JE*4C-!Y/1EF4Y(/%O/KL02SF_"#3
M)&</ A2'+(O$ZQU+^<O-  [>/GA,MCNI/A@MYOMHR]9,?MT_B/+=Z!1EDV0L
M+Q*> \&>;P:W\-.*3E6#2O%7PEZ*QFN@NO+$^3?UYO/F9C!6CEC*8JE"1.6_
M[VS)TE1%*GW\4P<=G*ZI&C9?OT7_M>I\V9FGJ&!+GOZ=;.3N9C ;@ U[C@ZI
M?.0OO[&Z0U3%BWE:5'_!2ZT=#T!\*"3/ZL:E@RS)C_^C'_5 -!K B:<!JAL@
MLP'Q-,!U ]RW :D;D&IDCEVIQF$5R6@Q%_P%"*4NHZD7U6!6K<ON)[F:][44
MY;=)V4XN'EDAQ2&6!Y'DVX_@<[:/$E'.J_P(HGP#'ED:2;8!RUTDMJP 0[ ^
M+A# G\&MFK-$OIY4DH-6// EB9Z25$G>KYB,DK3X4(;XNEZ!]^\^@'<@R<%]
MDJ;E BCF(UEV1YD:Q;7UNZ-UY+$.$;CGN=P5X)=\PS;M *-R'$Z#@=X&XPX%
M(]Y'X@I@^!&@,8(.0\O^S<>.YJO>S>%UH#?X-+6XBH<]\9:\D. V3;:YFD_P
MD$9Y("HY12555.*)>L>V29ZKR7V*RH@Q<TW<,<2T"J'(\WT!Z70^^MX<2UN#
ML-:TO-&3-QKT9BSFQ%C,HEZF\7$QNXP?XT^:IM1<M(S;&D@G;<V*6IW#%+D[
M-SEU;A+LW.\\'\91L0O9GUC6AJ:UI4.#QVYKTY.U:=#:4MG:1Z]JJ)V^IO8U
M(37'U24B,[>SV<G9+.CL#[ECPN5HYKC8V##DT%"/G^N3G^N@GY)4'5OGVK&Z
MH&',I3&VU\K6>+<7'.MD,0X/YYZ)2*H>K-FVFFWP+_AZM;X"#^6BS**8'602
M1VF ,["1F> %^061CHO.)U@=HS5^YH)U:##U#+&&-L0_F6'U!=H0,ZT[--A8
M00[-!'JZI[,'#*>//A2K0S0O;&Y-AZ2Y?]OF=/J X?S1R3%HLW^(K;%UB*!O
M76CZPS#^O22#-M"MT7(PGW@,:>;#,/2[409MHEO)U*$Q]]G*H?'N,YT88$=F
M<*'L<RZ9R"-U1Q*&F.8]O+X@Q) F,0J3N!?$ZABM'6P>!QP:V)B!MCW-;@1_
M,L7J"S1]S:CIW=:8I%LY--"7Q9'.(2B<0_I@#-GI84BLX7>()AYW.H>@< [I
MY!BRT6YSS"4BGGV'= ) X03@Y1AR('UF6G)H,/98TMA'8>QWDPS92+<W4K=F
MY=#X-YM.#:@C-;A0=L\VZB0V7!_$5KT :YX>I'VGW;ZFIC^:7I)K&LLHC.5^
M7+-/Y@B9T^'0^#:6ICD*']\O@#7[7$Y,YXZC.S$7DB.,YVR&=4[!X9S2!VK8
M3A=#$QQA3=N<SB@XG%$ZF89MT ^M<Z]3Y%D66&<#',X&7J9A!]TM2T%-VU&C
M]!/. -U(PS;=L>G,<9-@;+.52^,;3YTC<$>.< 'M0; B%LF^*A?_R>)=SE.^
M?>W%-:QS :87Y!K6C,9A1O?B&K;/Z=9JL26>_(<URW'X)'\^U;!]0C>IYI"8
M6V'ET/@ZIQ,*#B>47E"S<X5Y"Q64M*WI;(+#V:0;:3;E;7P$->T2K\X$I*/.
MXP,:L=%NCE10TO:CX4_"\._&&;'!;JY A\1<@ Z)9P$2G1Q(.#DLN=CS$F<L
MP!&BP4XN6M1O5/4O4=:WC]_8O*%W:(BGUD TE<G/+NP3Q\E[;-Y/.D0SLQ@1
MUK3[I[,#.;^V3QQ%'&OP'1KH6\$Z/Y SR_O$P?:I-;@.D:^>2#3>R?\L\!-7
MA=^TY- @'ZPTULFY-7YB,]OZ-<2A,??:JM9,>^PUJME/>[ ?W,:Q.)1;ZNT7
MW,1<E.WHFN3TDD5]JBE++U#4I_91&T)/+8AJ)--SS]K4/B1?6[\JVAJ_-XUU
MVJ/: DJ\Q <AU(#WG,_&+ZZ7/"]3341Z@?,R=1R&/2RFFG;TW+IV':"Y[:A9
M?G!H+&NCQF,;&2NYKQY_*4#,#[D\/K1P^O3TB,UM]6")\?D=_+0Z/BBCPQR?
MV[DOTTF2%R!ESV7(\=6TG$UQ?!3F^$;R??5PR!.7DF?5RQV+-DPH0?G],^?R
M[8VZP.F!I,5_4$L#!!0    ( #:!K%*>=30>? (  -@%   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8S+GAM;)54;4_;,!#^*Z<,347:R%N!#M)(T&H:$YT0
M%>/#M ]N<FTMG#C83@O_?F<G1-V6=MJ7QG>^Y[E[SKU+ME(]Z36B@9="E'KL
MK8VI+GQ?9VLLF#Z1%99TLY2J8(9,M?)UI9#E#E0(/PJ",[]@O/32Q/GN5)K(
MV@A>XIT"71<%4Z_7*.1V[(7>F^.>K];&.OPTJ=@*YV@>JCM%EM^QY+S 4G-9
M@L+EV+L*+R:G-MX%?.>XU3MGL$H64CY9XR8?>X$M" 5FQC(P^FQP@D)8(BKC
MN>7TNI06N'M^8__LM).6!=,XD>*1YV8]]D8>Y+ADM3#W<OL%6SVNP$P*[7YA
MV\8&'F2U-K)HP51!P<OFRU[:/NP PN$>0-0"HC\!\1Y W )B)[2IS,F:,L/2
M1,DM*!M-;/;@>N/0I(:7]A7G1M$M)YQ)KVM-'JWA*GNNN>:VMQI8F<.4VJL-
M-[5"#1]W[T$N888YSYB >8499\)P"IIR;11?U$8J#8,I&L:%/B;L/X-O;R<P
M>/]N%$7!Y6P^=:?PTD(?YE,8'!W#$? 29EP(6U_B&Y)N!?A9*_.ZD1GMD?FU
M+D\@"#] %(2C'OCD,'S&7B%NT)]^1_O4[Z[I4=?TR-'%_]%T^'%+/K@Q6.B?
M!W+$78[8Y1CNR?&--D!5JVQ-_W'(J&D\1\5LIK[N-5SGCLL._B8]'PT3?]-3
MP+ K8'BP@)O2L'+%%P*!:8VF[]4FP[_RQM%9?][3+N_IP;R/;G(Q![8AP2L$
MP9<(@U=D2A_WU7"8+AR!@_8]B;\S=W;GS9A:<1H?@4OB"D[.B5HU>Z0QC*S<
M*"ZDH<%VQS6M7E0V@.Z74IHWPTYWM\S37U!+ P04    "  V@:Q2)&PS>%4#
M  "6"@  &0   'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6RM5FUOVRH4_BO(
MFZ966FMCYW5+(K5Q=^^D=JL:;?M,[),$#9L,<++=7W\/Q'6]QG9SK_8E <SS
M<CAP8+*7ZKO> !CR,Q.YGGH;8[;O?%\G&\B8OI1;R/'+2JJ,&>RJM:^W"ECJ
M0)GPPR 8^!GCN3>;N+%[-9O(P@B>P[TBNL@RIGY=@Y#[J4>]QX$'OMX8.^#/
M)ENVA@68+]M[A3V_8DEY!KGF,B<*5E/OBKZ[H9$%N!E?.>QUK4UL*$LIO]O.
MQW3J!=81"$B,I6#XMX,Y"&&9T,>/DM2K-"VPWGYD_^""QV"63,-<BF\\-9NI
M-_)("BM6"/,@]W]#&5#?\B52:/=+]N7<P"-)H8W,2C ZR'A^^&<_RX6H 6BO
M!1"6@/!40%0"HN> J 70*P&]4Q7Z)<"%[A]B=PL7,\-F$R7W1-G9R&8;;O4=
M&M>+YW:C+(S"KQQQ9G9=:!S1FEPE/PJNN<V>)BQ/28P)U(:;0H$F%^0#XXI\
M9:+ W@,D<IWS?R E<D6NM 93$B@<LN!;SI9<(!O.QN]%AN-G,1C&A3Y'MB^+
MF)R]/B>O"<_)'1?"RDY\@Q%97WY2NK\^N ];W-\Q=4DB^I:$04@;X//3X4$#
M/'X)_JM$TW$#^N9D\>=P'Y-893*L,ADZOJB%[RJ316[JR>D@C2K2R)'V6DC_
MDC+=8WJ:4G- #AW2UJ/=;-P;1Q-_5T] PZ1H$/P^Z:9I4G]43?K->:]RWNMT
M?@<I3Y@@BRTDG FW$V.NC>++PDBER>WMG)R]>34*P^#]W2)V+?K^O&/1^I5T
M_\]E8E"1#CKC03+@.[84T'1.XL'1$E(:-J_@L%(<=BI^-AM06(.4@MP0YD[Y
M6Y+CY86'/F%ZXTZZ:P >_1T38*-F91UH<GD0'-1<#FFSR5%E<O1_-V@\.E*+
M1BV[:ES)C3OE/N:&Y6N.62@7I$EW?*P;#IIU:?!4IX,3LB%DOKXPH+(.^9*H
MKM]ODZ]=$[13?EYN _%4V!NUZ9'VQ;!E']*GRD;#_Q3[2R;"8Q/C88N)ITI(
MNTOA)W@\!-46?_DT--H[+G?#4>^9/;]VI=L7&]X6:XXWLX 5HH++(98@=7@$
M'3I&;MTMOY0&WPRNN<&'(R@[ ;^OI#2/'?MPJ)ZBLW\!4$L#!!0    ( #:!
MK%+W$^J6\0(  -,)   9    >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;+V6
MWV_:,!#'_Q4KVD,K=4U((($*D/BQ=96&A%IU>YCV8)*#6$WBU':@_/<[.VG$
M(&3L8>,!8N<^=]_S';:'.RY>9 R@R%N:9')DQ4KE=[8MPQA2*F]Y#AF^67.1
M4H5#L;%E+H!&!DH3VW4<WTXIRZSQT,PMQ7C("Y6P#):"R")-J=A/(>&[D=6Q
MWB<>V296>L(>#W.Z@2=0S_E2X,BNO40LA4PRGA$!ZY$UZ=S=#[2],?C&8"</
MGHG.9,7YBQX\1"/+T8(@@5!I#Q1_MC"#)-&.4,9KY=.J0VKP\/G=^V>3.^:R
MHA)F//G.(A6/K+Y%(EC3(E&/?/<%JGQZVE_($VF^R:ZR=2P2%E+QM()10<JR
M\I>^5>MP *"?9L"M /<8\,X 7@5XEP+="N@> ]TS0*\">I<"?@7XEP)!!02F
M6.7JFM+,J:+CH> [(K0U>M,/IKZ&QHJP3'?BDQ+XEB&GQM-"XHR49!*^%DPR
MW1^2T"PB<VP1J9@J!$CR\? ]X6LRXUL0B_T"(DFNYJ H2^0UFCT_S<G5A^NA
MK5"<#F&'E9!I*<0](V22BUOB>#?$=3I! SYKQQ=T3[R.H0<-]/QBNM] ?_H3
MC=)+W.TTX)\OQYT&_/YB_#AU&YNA[@BW[@C7^//^HB/(CZ\X1QX4I/)G2PRO
MCN&9&-TS,9:%"&/<0$B(W<8B$-1$R2F+",M(2&5\0S+<A['3] !W+-0B(&HJ
M3ADJ,*'TQKL=>SW'?(;V]K ,IX8=SVNRO#^U'#C'/G]+O%LGWFU-?+98M"Q?
MK_;2^V<E\NL8_G\KT=1O6'G':5O0H)89M,J<1)%)GR9:J&+9!C)UI%G%5.&>
MN2<K,/J;% :G"OU6@?U:8+^]XF=4->T3_1,19X(/ZN"#]N"Z,#G=ISH\7EO.
MKQ%0D376;C8X$>4/FOXT\P;#?N,*V@?'E;[NX ZV87CJ)+!&U+D-L/M%>84H
M!XKGY@1;<87GH7F,\=8%0AO@^S7GZGV@#\7Z'C?^!5!+ P04    "  V@:Q2
M4$Z45>0$   _%P  &0   'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6S-6%%O
MZC88_2L6NI-::;>)'0JTHDAMZ;8[K7>HK'</TQY,8HC5),ZU'6BG_?C93AK3
M A]LNP_TH22.O^/S'=LG\3=<"?FD4L8T>LZS0EUU4JW+RR!0<<IRJLY$R0KS
M9"YD3K6YE8M E9+1Q 7E64#"L!?DE!>=T="U3>1H*"J=\8)-)%)5GE/Y<L,R
ML;KJX,YKPP-?I-HV!*-A21=LRO1C.9'F+FA1$IZS0G%1(,GF5YUK?'D7]6R
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MTM#!ZIHKNBNALA/H^4)*\]JQ"]2WK^$_4$L#!!0    ( #:!K%+&4=?($@,
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M0(P+MA;F5FY^PV)#%\[?7 KM/V%3K&T',%]K(Y/"V")(>)I_LX>"B!V#J,Z
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M@ZSWDOB#,!$\.M.&$TIH!9F^$/)_;L;AJ2\B/<E]M]LB_1I:JY)/HC>N847
M0Y)?:0%I%H/79++SG,D>:45U3%9B0)K5(+_L7S:RZ>Q4=9MT?WZQ)57I)[VW
M++=%M,&!I:P2!7*D*AQ7<,ES6:!1K]7OUN"L=($T"\/_4'('A]XZ6@D#;1:&
MURJY/PA#?,EM^GU<B01]J4@<72>*2$]R3[HM&M6P6JD";5:%UZ^X1<!#<E_I
M FW6A==D,CJ,R7"GYTM0+7UGJV$NUZG)V[]RMNR>+_.>L5J>M]ZV4UIRRZS
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M+;N_+;M?V@N>+3N:B$SQ;,&RZ!']^07DT*5B:?Z78Y5@NTI0KD+<JRA8A3T
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M-?7H-Y]0ZUMTI.+0K)=S\_&VYLAA"+)9?Z)Y57$\0'IA/WB4]+NM'J*>AMO
M84^!9J0/YZKFV<"GQ9T+X'$;^,+IBMNNV._9U_DZ,\#C;O!8'L%9I7J[_#+0
M#Z2=U&,UB-W2X[FSW/RR:3I0ALXE\+A-?.:OMKU6>!6O?M.&%1IV2T?8!NYA
M4P?-3.H!>-<)@*J_#'PJ,/,!],XS\+AI/):&EEL._NMG<WM^,,6XS^91)4/6
M@#MOP./F4+=99;>9@=P$![@9F0)NGP\2Q\)\JNET:!UT?H#'#6&PZ6*WPP=Q
MVH?RB)+9 %/G WC<".J^(896:,/G=OP@CK*L3^B3X2P98.R\ 8^;@[7_]7D+
M;6 +?<9]\\*Z5A!@XAB&3T8N%]3UCK>S#/(;RY#E-C!,%=?(U93TX1+7#RY+
M5L-Z1,G ="2=99!QRQ@@'2UNDS*]*JZ[U'TR0I+^3 @OSEOVL OGCRTO-1)L
M W'130H=0]7GQ_K&R'UU!%M) P>ZZG('9VZFK ">;Z0TYQM[JFM/\<M?4$L#
M!!0    ( #:!K%*^]U "M@,  $0,   9    >&PO=V]R:W-H965T<R]S:&5E
M=#@Q+GAM;*V72V_;.!#'OPHA]- "3?2PY4=A&XBM[FX/ 0)GTQX6>Z"EL4V4
M(K4D%:?]]$M2LBI+E#==]!*+Y'^&\^/P,5F<N/@JCP *O>24R:5W5*KXX/LR
M/4*.Y2TO@.F1/1<Y5KHI#KXL!.#,&N74CX)@XN>8,&^UL'T/8K7@I:*$P8-
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MRO]QI/'K-'Z99MA6VRPK<"*G\4K*!"=J/L=/J4YRPE8D$[:6S=QA@[[G_>J
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MW=7PPF3$E>&+0<UZHY',J0YRP#^U$O$>*?%W3_GQ>JTZ.9AP,L*M0894SK+
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MD=+R?KQ\8/10W%&^4,9H7'S=$S\@:0[@OV\I9:>'?(#Z?RF,_@502P,$%
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MUI\<]4"+TF["ET+#EMX>;N$SC4I3 -?70NC7@=G7MQ]^LU]02P,$%     @
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M!,(8Z.<)Y^HX,0'*B];L/U!+ P04    "  V@:Q2"%+9M:,"  #"!P  &0
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M*9&5AUM&8R8+@+Z_%D*]G!0/:/ZE8/$_4$L#!!0    ( #:!K%+G$R^!,00
M %\5   9    >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;+U8T6[B.!3]%2N:
MD5JI2V('$J@ J12FT]%V5+6:W8?5/IC$$&N2F+5-Z4C[\6LG(882$IC-] 42
MYY[C>Z]/CA4/-XQ_%Q$A$KPF<2I&5B3EZMJV11"1!(L.6Y%4/5DPGF"I;OG2
M%BM.<)B!DMA&CN/9"::I-1YF8X]\/&1K&=.4/'(@UDF"^8\)B=EF9$%K._!$
MEY'4 _9XN,)+\DSDM]4C5W=VR1+2A*2"LA1PLAA9-_#ZSG4T((OX@Y*-V+D&
MNI0Y8]_US7TXLAR=$8E)(#4%5G\OY);$L692>?Q3D%KEG!JX>[UE_Y05KXJ9
M8T%N6?PG#64TLOH6",D"KV/YQ#:?25%03_,%+!;9+]@4L8X%@K60+"G *H.$
MIOD_?BT:L0-0/-4 5 #06T#W", M .ZI@&X!Z+X%>$< O0+0.W4&KP!XIP+\
M N!GBY5W-UN:*99X/.1L [B.5FSZ(EO?#*U6A*9:BL^2JZ=4X>3XCK%P0^,8
MX#0$]ZG$Z9+.8P)NA"!27(&OZFWX#911]\D*4ZZD*%7P:BT%N)@2B6DL+E78
MM^<IN/AP"3X FH('%:_$)H:V5'GJV>R@R&F2YX2.Y.2"!Y;*2(!9&I*P C^K
MQT-40V"K!I5=0MLN35 MXP/F'>#"*X <.*A(Z+8>/B5!">]7P*?U\"_K5,&=
MH_#9R<DC6 '_=#K<J8#?_73K]I;"+07K9GQNDV#_^ET] ?>2).+O&MYNR=O-
M>+M-O-1(/(@P7Y*JCN=<?L:EW?YE[*GB7G:[>AB"]B/N#B.@/_#+H+TR>F49
MO=HRU"M,>(JUS>.XIBU>R>>UVFZ_Y/5;;'?.Y=6UVV]L]V$$]'VONMW]LHS^
MZ>T&_X)'54*" [*6-% #4RHDI_.U?E[3M$$YVZ#5Q8".V06<<Y?C"H14!&RM
M%H9C2<#%BO! C5]6&5@#?;_C.!_K$MW9KN#YB:HU4%NCZO=2\<GHE'SK9X$=
MU*O-%YE\47LZGQ9D>RIV^]42A<8QH7N62)^R'7NKU1]U=1KWA-UVI6D,#=8[
MVO^4YJ2!'CJ'VBP6HQ[8[_3J-6TL%GKOH.E)PRP5FB[J/!NW7Z>Q?-BBYT_@
MH5]WO=Z^IT\K@E /[@?-*H)VMH_]8HSQP_=P?FBL'[;K_<AX/_JUWM] W^3]
MR'@_>A?O;YBE2>_(>#]JT_O1H??W8;5*D;%^=)[U_YQ*D=D&4+O; #+; /JU
MVT #_:!)I<;-T;NX><,LC2HUKHS:=&5TZ*5^]YA,C9FB\\STB;QBE=%G@F,9
MU55I[!.U:Y^NL4_W;/L\WK_;@FQOPWK;/GOG."<ABDB?U F0*3W_4"Y'R]/
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MIR@,]/L%Y^KUIDA0GW]-_@=02P,$%     @ -H&L4O$!4J+E @  :PD  !D
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M<M'2Y$?7\JMK^6-T:5"Y#YQ3T>ZC5.69YQ*(4'+P:L?%2EWJ=5/.W=YT0IK
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M2*V$SI$7^I/:7=2I+&W:1+64>6"0ZM=4Z13C/G@)II$ K!O;K0&?96_ =G/
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M%](TT-\O4KW0BAOS9L;N?:7Q?U!+ P04    "  V@:Q2&N#5*;\#  "V#@
M&0   'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6RU5UUOVS84_2N$L(<$R")1
M\D=2V 82J]D*M$ 0-]O#L =:NK:(4J1+TG8#],>7E&1)L2W:6QL_6.+'.3R\
MO#PB1ULAOZ@,0*-O.>-J[&5:K][YODHRR(FZ%BO@IF4A9$ZT*<JEKU822%J
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MYS> E'%U03Z3V?2&G)]=D#/"2G+'.-=7H%(7M0+#XRZ::-=UM.!(M#LJ+\G
M_T0"+_![X./WP[U]N*OS;I,/VN0#RS?X6/(OY-</[4DF"(7Z?2+.H(TSL''"
M8W$FMV2A"R8XRRE"3JA2@+WUJXD22V3^@<]9''E^E+K/W3+U>/E!F+1>>RK#
M5F5X4N6LW--H1.M&8\6F(+"KA-I(("@(%ZI7>4T>=S3YD><=".]Q"CM.>[JC
M5G=T4O=X3_71?CYQCW$;*?ZO_9*T<9)_U2_)FX+&<7!0]!Z?+U%_S8>MPN''
M%')=&,9["EW+'+YIV"0\4/G691@<B'0[<\Z\,7H>K%BI"(>E!GF7B6X46<_M
MVD!1V=$W%Z@'J5VN]5,'TCCH\Z40^&J8:=H^GME?4$L#!!0    ( #:!K%)%
M>+;FB0H  *$Z   :    >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6R]6UMO
MX[H1_BM$< Z0!4YBZRXOL@%R=]KN-EAON@]%'QB9MM6CBP]%Y5*<'U]2DD7)
MI(9VFGH?-K;,&0XYH^^;&5%G+SG]O5@1PM!KFF3%EZ,58^O/HU$1K4B*B]-\
M33+^RR*G*6;\*UV.BC4E>%X)I<G('H_]48KC[.C\K+KV0,_/\I(E<48>*"K*
M-,7T[9(D^<N7(^MH<^%[O%PQ<6%T?K;&2S(C['']0/FW4:ME'J<D*^(\0Y0L
MOAQ=6)_O0U<(5"/^$9.7HO,9B:4\Y?GOXLO]_,O16%A$$A(QH0+S/\_DBB2)
MT,3M^*-1>M3.*02[GS?:;ZO%\\4\X8)<Y<G/>,Y67X["(S0G"UPF['O^,B7-
M@CRA+\J3HOH?O31CQT<H*@N6IXTPMR"-L_HO?FTVHB/@V ,"=B-@;PG8UH"
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MM'X?LO["\G7ULMQ3SEB>5A]7!,\)%0/X[XL\9YLO8H+VK=3S_P)02P,$%
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MS-R!01YQP$:Y<;CJZ-PKP':!,+%&86/ZV',@P4;P<:=NE_](AVU1[V/2Y.8
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M,.C/E7P$(J8,Y/J"4K$;J%=#^:P<_0502P,$%     @ -H&L4B,$.XWF @
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MAT2PI DWCW+W"?* KBQ?*+E.?\DNM_4<$B;:R#@'HX*8B>R?ON2)* '\U@E
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MN"#EC<#%(WNL-GW503!!&K!:BGR_@X176S,\JRQ4Q6=Y)V/DF:8)I.AA)US
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M=2DH6PDE@:+>W2A@IAG-QD"]]G_W0B/-BM]6])J!<0YT7VJ-!\,-3/<^IG\
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M994\V96SC=?IQI7SC=<)QY4SCM<IQVG.ZZOEFZ[]/M7T_%2*)9)&'O#,05I
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M)E=?JE<G6LS3[WC/0FN1I(<S1H&^C0#<GPA8$=F)>4#^_P7._P-02P,$%
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MAOY^?8I*S%WX2K%&I*$6H>O]$+])->9NO/!](OOP':= /ZE,:@&;ZC/K )(
MDMIBJ\4;56,Y* .ND6F@$NBX!+Y )B>=07_:R6(_R941VH; ++I\=>V8 W9;
MG4".,&"O_0G4>[D"?2+[T!T)P2-9Z+43J$HTY7Y>(]($WY$1]+/1\1.HAG\J
M\:[*G-<#1HZ!D)^!QBLI*9\^@_LU69;F3$N,@QSCH%89!^UL$-IG'%2EDZB4
MP!H1"!LX!SG.07[.^;44'M/RD",4%+6:0<<#Z&TV%:BZ8XAZY30>OJM CAR0
M?U_1UD0,CDJPHQK4ZN8$.6) ?F*85";E 5T555M\'Y7WB#5"$/6:$NJH /FI
MX!33\@_!IYD9#2[MH'TYPZ[GX[#-G&'7OS%LO:WF+G:STT.E#-;(P'Y#7\6.
M%+"?%$Z<P&\'S3R\<\S4ZCD3=CT<'WG2],K6BJOK_T$EDU69AC49=M2 _=1P
MBCQRP3]M$YD5KPH.ZZ38$0!N=7> 7<O&_MW!49T45]?ZJ-O%Y?15I3"&N"&#
MKO=C?^^_YII*JC2X,YEZNV4.=KT>#UH]\W6M.WKAP.@4I[[ABSL[K\@^=$<&
MT9%D\,HV$M400AE^5:0)OF.#Z-!+A%?,FMSFW@E[6-X5U B5T08[%TCV]NZ&
MR#GC"B1T9G3"LY[I@')S(;9YT6*9W2D]"*U%FCTN*#%!MP+F]YD0>OMBKZF*
M:\G1_U!+ P04    "  V@:Q2H.=]=O8"  !T"   &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q,3(N>&ULS5;?3]LP$/Y73M$>0&(D3:"EJ*U$RZ8A 4(@V,.T
M![>YIA:.76RGA?WU.SMI"+1DV]ORD/C'?7??G<]W&:R5?C0+1 O/N9!F&"RL
M79Z&H9DM,&?F4"U1TLY<Z9Q9FNHL-$N-+/6@7(1Q%'7#G'$9C 9^[4:/!JJP
M@DN\T6"*/&?Z98Q"K8=!)]@LW/)L8=U".!HL689W:.^7-YIF8:TEY3E*PY4$
MC?-A<-8YG?2=O!=XX+@VC3$X3Z9*/;K)13H,(D<(!<ZLT\#HL\()"N$4$8VG
M2F=0FW3 YGBC_:OWG7R9,H,3);[SU"Z&P4D *<Y9(>RM6G_#RI]CIV^FA/%O
M6%>R40"SPEB55V!BD'-9?MES%8<&@/3L!L05('X/Z'T 2"I XATMF7FWSIEE
MHX%6:]!.FK2Y@8^-1Y,W7+I3O+.:=CGA[.@KXQH>F"@0KI"90B,=D37P&:Z9
MULS%&/;.T3(NS#ZMWM^=P]ZG_4%HR;A3$<XJ0^/24/R!H02NE+0+ U]DBNE;
M?$BD:^;QAODX;E5XQ?0A))T#B*.XLX//Y._A40N=I YDXO4E?PSD 9P9@Q1#
M)E.XY&S*!;<<S2; *5#ZWN*LT)K+S$M=*ZGKA3$SW,"/2S( %Q9S\[.%WE%-
M[\C3._J WH5<H;'EV7()N9+X0GFD'ZE0S N9FETG6JKL>96N'*Q&G6Y4/8-P
MU0SVMF@<;8F^87Y<,S_^%^;X5'#[ L:%JPRKFD-&.NT"C*7" S.5+YFDG5TN
ME;:Z39[=_DZ/MB4[O5:'NK5#W5:'[NFLF>"_*!$R*K.P)Y2ANT5)\>K4+NK=
M;4))TD:H5Q/JM1)JIFZS"!R\R<N6)#RI#9W\CW>D7]/KM\:AR2/?\&!T/QSM
ME:^1KO& ;#*9.B:[CJN_=2/>9UB;1.E V"CL.>K,]SM#&5Y(6];X>K5NJ6>^
MDX2OXF4_IGJ7<6E X)R@T6&/\EN7/:Z<6+7T;6*J+#4=/US0;P%J)T#[<Z7L
M9N(,U#\:H]]02P,$%     @ -H&L4I9"X*R4 @    <  !H   !X;"]W;W)K
M<VAE971S+W-H965T,3$S+GAM;,U544_;,!#^*Z>(!Y 82=.6=*BM!.W0D&!"
M5+"':0]N<VTM'+NS+Q3^_<Y."(65CI=)>TELY[[/W]T7G_MK8^_=$I'@L5#:
M#:(ET>HDCMULB85P1V:%FK_,C2T$\=0N8K>R*/( *E2<)LEQ7 BIHV$_K%W;
M8=^4I*3&:PNN+ IAG\Y0F?4@:D7/"S=RL22_$ _[*[' "=+MZMKR+&Y8<EF@
M=M)HL#@?1*>MDU'FXT/ G<2UVQB#SV1JS+V?7.2#*/&"4.&,/(/@UP..4"E/
MQ#)^U9Q1LZ4';HZ?V<]#[IS+5#@<&?5=YK0<1+T(<IR+4M&-67_%.I^NYYL9
MY<(3UG5L$L&L=&2*&LP*"JFKMWBLZ[ !:'7> :0U(/THH%T#VB'12EE(:RQ(
M#/O6K,'Z:&;S@U";@.9LI/8N3LCR5\DX&IX+:>%.J!+A"H4K+;)%Y. 33/B'
MR4N%8.8P$M8^2;VH(AT(G<,71Y++B#F\<#@?/,8IP85V9,N*:W^,)*1R!\QZ
M.QG#_MX![('4<"658B]=/R9.Q0N*9[7LLTIV^H[L*V&/H-TZA#1)6UO@HX_#
MD]?PF O85#%MJI@&OLX[?*_KLX.PW1"V V'[K[8<PJES2%7-+Z682B5)<J5K
MNW+@PW"#L]):+\!'?3/:-@MGPDD'/RYY [@@+-S/'?(ZC;S.SGPOC5Y\(K0%
MGY@I';*7,U7F?CN_+9O.ORB5-@C=9F[%G@5VWV<>AEFKT^O'#YL6;@EJ][(F
MZ)7P;B.\NU/X2UUW5.&X(3O^'TW*&GG9/S4I^[/^6:_[QJ1M09_3-R;%&_W)
MWPU\_!92.U X9UARE+%IMNJWU83,*K2LJ2%N@&&XY"L*K0_@[W-CZ'GBNV!S
MZ0U_ U!+ P04    "  V@:Q2%"4WU;<#  !E$0  &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q,30N>&ULM5A1;]HZ&/TK5K2'39J:V($ $R"M[=U=I56W:K6[
MAVD/)OD :XF=:YO22OOQLQT:4Q$,V@4>2)SX.]_Y3N)C.^.UD#_5$D"CIZKD
M:A(MM:X_Q+'*EU!1=2%JX.;.7,B*:M.4BUC5$FCA@JHR)DF2Q15E/)J.W;4[
M.1V+E2X9ASN)U*JJJ'R^A%*L)Q&.7B[<L\52VPOQ=%S3!3R _EK?2=.*6Y2"
M5< 5$QQ)F$^BC_C#99K8 -?C7P9KM76.;"DS(7[:QDTQB1++"$K(M86@YO (
M5U"6%LGP^&\#&K4Y;>#V^0OZ)U>\*69&%5R)\ALK]'(2#2-4P)RN2GTOUI]A
M4U#?XN6B5.X?K9N^62]"^4II46V"#8.*\>9(GS9"; 40O"> ; *(X]TD<BRO
MJ:;3L11K)&UO@V9/7*DNVI!CW#Z5!RW-76;B]/03XY3GC);H[Q65E&L A2@O
MT#<J;9.9YMMKT)25ZMTXUB:E#8SS#?QE T_VP&.";@772X7^X@44KP%BP[4E
M3%X(7Y(@XBV5%RC%[Q%)"/[Z<(W>OGD7@$U;'5('F^Z!W50O)/IG5K(%M:^,
M0M^_F&[H1D.E?@22]-HD/9>D%TX"@(1/\A[!4\TDXPO$N*V*=,G<  \<L!UI
MCU.2#1/W&\>/'9SZ+:?^"3BE79P:X.P5IQ"EK*64G8!2KXM2MD,I34.4!BVE
MP0DH];LH#78H81RB-&PI#4] *>NB--REU ]1&K641O^+$IUKD'M9C3J$&H5H
MX<2;7'(DL>W1?<,?P0[Y9W0/]4KF2^/N6S88&/!XRU[Q^7P%$Y^&'%.@2?-*
M>3-1L&I5V2<@U$I"IX&3W3%#PKI[4\7I'^A^Y:8UD I=PTR'ZO?&BGMGE-E[
M)3[*+/](YEVWQ+V@-V'OESALF _:S-BS9_0%M+:RBCFZDE"PH+;>^O#@C-IZ
M.\-A/]LBGSORR"PBE:W,6$>GHL.=.1'W@A,0]D:&PTYVR[A[HK_0J:V#>-,B
MR?ET)]ZA" Z6:L<@6K15UB"9*+KT/H"#T3-0&:+DW8R$W>R0^D<;"/%.1<ZX
M_B/>ITAX!7B\V&&<PV)[3R-A3[O=F-<97G5O8"0[H_K>R4AX%7>\^F$<XM0/
MENYMCX1M[Y#\Q[_KWMS(Z'QJI]Z_TO"BZVBU#^#@9+_<\=;.UXBT</M[A7*Q
MXKK9!+=7VV\('YN=L^_>?( P&\L%,SJ4,#>AR<7 #!O9[.F;AA:UVT?/A#9/
MQ)TN@18@;0=S?RZ$?FG8!.V7E>EO4$L#!!0    ( #:!K%)^E;I<P@P  .Y"
M   :    >&PO=V]R:W-H965T<R]S:&5E=#$Q-2YX;6S%7'MOVS@2_RI$[M4%
MTL1Z2VT:H'72)HW3>IMV%X?#X4#+M$VL7DM13K+HA[\A)9NV)5%*NKK+'XD?
MG.%P9OB;!ZF<W:?LMWQ%"$</<93D;XY6G&>O3D_S<$5BG)^D&4G@FT7*8LSA
M+5N>YADC>"Z)XNC4'(W<TQC3Y.C\3'XV9>=G:<$CFI I0WD1QY@]OB-1>O_F
MR#C:?/"%+E=<?'!Z?I;A);DC_%LV9?#N=,ME3F.2Y#1-$".+-T=OC5=WQF@D
M*.207RBYSW=>([&669K^)MY<S]\<C81()"(A%SPP_%F3,8DBP0H$^;WB>K2=
M5!#NOMYP?R]7#ZN9X9R,T^A7.N>K-T?^$9J3!2XB_B6]OR+5BAS!+TRC7/Y&
M]]78T1$*BYRG<44,$L0T*?_BATH3.P2&W4)@5@3F 8%IM1!8%8%U2."W$-@5
M@=V7P*D(G$."MD6[%8%[0& Y+01>1> =:BEH(? K O]PAC:1@HH@.""PS3;#
MC3:6&_4FV1K[T-INJWMLS&T<VMMHLX:Q,;AQ:/%VDHW)C9K-V[S*V!C=J%F]
ME61C=N/0[J;71K(QO'%H>=-H(]F8WJC9OE6PC?$-:?W3<O?*K7^!.3X_8^D]
M8F(\\!,O)'Y(>MCQ-!%8=\<9?$N!CI^/TSBF',"+YP@G<S1.$TZ3);Q'$XIG
M-**<DAR]N" <TRC_Z>R4PZR"]C2L9GA7SF"VS/">S$Z0Z1PC<V0$#>1C/?G;
MC)V@D27)_9QC3D+*'QOX7.CY7)#P!%DCR<>CR9KD<M7OBV3>P.RR!S,SZ,GL
MO9[9+7Y$AB=Y6=_N+M"+OS9I^4,/-1ENR861"/.4 >*39([!M$)M#3RO]#P_
M%A&HS! \S5$;C^L^:C=*ZX=IG$40?WDE8 .[CUVZ8EN1C$I9.06?@&@GN./D
M,4R+I-%!;H9C/?EAUE*]\M=;#II)2/MDM_K)/H<<?-,JK29F:&#QJ</P. %G
MTK/XK&?Q*5UOMYNR>P.?:8_5U/RG@<_/'?NC6&Z69 0+_/"?I(AGA,&K!EY?
M>OBT89:0E"X6-"1-KGS70Z)J9;Y0<IXN^#UFD(JF\R(\6.,IX/H6W,TMN)MR
M"JMEBDF:YPK10P'D_YK &'3-29S_6S.#M9W!DC/8;8M(D@)'D"FS<(79LLE1
M/I8</,E!I-[K<TB-RY^ST_7N!NT]<M)GY-Z"[.V";.V"KB68TR66B3BX6HK>
M0SJ>LE*1C,X*H4T$GU\G(507.8%1Z'-&4SI_*7&-S-%5FF>4XXC^(?F4H?6"
M8+[*-4IWMC(Z YG5W<[@:K7P26X.E"[0=LOE*"=L#6O[CEH0X6/)T]TQBE4S
M<8\Q$_V8O05YVP5Y/1=4 BU:T C6 B:>D16.%N*;[Z@MQDV\ND1^LT#^5B"_
MIT"E>NEBD6\DV$2 )DG\FB2FVRQ)L)4DZ&UK$7'0,ET3EI0I(5]ACF8L+:!@
ME'87YF\+3!^#NG 'YN\<,=&-V%N?,5(I[DB_0BBX_PD%=[5+T5?\@.Z:$6M_
MAITDVAAH1QH*RPU3#[4+3MA+#K*7@B,&N0/D>'.T01W I'&93?P#=BL,(L*J
M?$60R.(K2,L)YQ$1UFW,OLP:L%J>#E<-%2D,?:BX3-:4I=*O(&),MA+IE*-0
MV["',H!"7</IBR%40,AW^;=1BT[-B9V#C= ]9*(=LK\&A>N&'MB_@.7GM/2$
M,,UYWBB^VQI=#U?1=^2DS\C]-2EH-_38?H7_P&R>%N#SQ0P - E)::%C5"9Y
M.DO5D=VP6P12T&[TQ?;24<K&'FS01<I0QJ J8TQN6V4+C81UQ#<.K= Y9*(=
MLK],%3<,?>"XA#PIEL!#]K8VSB&7S<4;F?:$$<%)D6G<+:B[AJW/YDR%_:8>
M^Y60$4!$T_05@]WI3;_1VWN/G/09N;\@%6I,XUDP"BYT2Q,:%[&N<-BI'(8J
M'4P5$4Q]1/A*8X(6#,<R3LUI/BM8+D-3LZ$Z2I&,T4A6V#KA5$0Q]86 3L_X
MH4O/*JB80^7RI@)]4P_Z3]6SGMLMALP)].QH]:S0V^S(S*560<531O*0T4PJ
M&3(UV+3]L@13 ;/I#Z5LA8JF'A7'PR5G9ATH_8ZRUU) :>F!\G^27EIU7'3]
MCA4H9+3TR#C&"9YCV)__SQK>4@AK#=:<V>G.Z#'Q>75\Q72OW#WLU'0.F6B'
M[*]'@;+5U9T!;WR%?APS+ 70UE  ;2F MH9HMUCU/HD9U'MJ?49-ND;M+TR!
MNZ4']Z?9"]8Z)<E<;,U^1E3 ;PT%_)8"?JMW'T4T<_>S?LCU!7P XJ0 F PM
MR)PP4$B8%HSG[4;^9-7[(2V[R%90;W= _7+)R%+H'L>BEX/(0U:*"O+-",HP
M;3K&NK'KZ+T%[[:VJT)O6X_>TY1)'SB0!6=91.6[>RCR<AENTK*- XZ4TWRO
MC'J1$19"[&DZ0/O8(4 P.AF-_M:X[F<23IY!N*\]%4QL?7/H3]AH\.'7%2,P
M3H3_G*-O)W<G: IQ/L8A@8@9 M\+FI?Q$X*I3G 5H6QKH)UI[[3T]5%#[<RH
M6MI\9QFRHRG3FD:GL3MC8?>0B7;(_JI48++U[:AG[V*G7IL:7=M8A3);'\HN
M-T)D^%&V &!'TK19$#TGPT>/!.O=3 4B6Q^(OB54"'57-O_)@TAJ3Z"02\(5
M^ ,XQQI<O6#S@E0>?XPF)].38T0XPI%.!!6#[*%BD*UBD*V/05.I;'1/^0H2
MVOL5A4HMPXP_0GP11QUEAXSR I31=).C@WTP0G/\J#W"4D'(T0>A?8O WGP;
M@_ A*'YCG3%F$;HA440>9>Y]"ZO!)$*WX644T67*^3$R@I?A^J5I6M:Q'"/9
M"6YC2-PA\";TB0S''\8O@:GCN8&E*W =%=B<H<X&' 7_CA[^.Q)(S;'Y=<6Y
MQX&+HT#=Z5MV5!<]H'@"K2]%P%G3-*H*JN^H_1[(M5,O']KD4H' Z2H?\H+)
M_O!8G''A9<]JP=DYF1VJ6G 4Q#H#5 NW3D.&WZ)/A:J.'E6_,L#+*X(COD+C
M%65IQL35U5"4U1OL/!'0>AO>D#R''&.<LBQE4M_=V.HH;'6&PE9'8:O3-[]?
MX <B\TY0O7!I@-HPPKEP:'6SI.F*BE-/Y@,[:(FYKH)2M^-\LR992&CI#<WW
M6WZN&.X*8OL >2V2**QS]1GMG^$0O1K9KH)&=Z@VBZOPSM7CW06. 4M@$Y;G
MY)G()S8PUW0?T*U?7W':4B]7H9NK1[<_2_F=W6U7P:$[V$V5G:LJ>CA\LO(;
M3B+;M:^PT-5CX32-'I>@T\L"%$\@V[K\O:"0>'W.0,6\2,3K6RQS37%-M,D<
M)2FZ2B-1FN7H0SR[0G_'<?8:='B";C[@MSJ-*;1TAT)+5Z&EVQ<M]^ZW=%^\
M=7M? /$40'IZ@+S :SH7&KXA<9: 6-<)V"'9%,LOWOUR_1.:\'GS+ODQLW@*
M/+VA$D5/H:'7-U%\FEDNO'J:V').[BG8]/2PV5R432D6+1P:$6&%MS'H8@_!
M='I06.D-=5_$4^#G];XO\HP[9Q^\^O4/L^7,WE-@Z?7-'9^=F7_P>F>2WL[U
MO+[W\\K^J+JZ+K.K\N+9]L-&J>HW.5INRW@**#W]18YF!_T<)[2*LZ$X!!/.
MV1%6M4ZK,-4+!G):7T&EWS>7?([3COUZ8FFUA%9? :.OSRIW"I[R:91&F5H>
M"QE7S'NXJZ]@U-?#Z.4:)SD' 2#J4R@GI]7#?S*RM[B"SCP*,OVAVJ6^PD:_
M;[M4/$HI7\DK[@(6VF^[?_'K/<XV/2L(]?40.DWO2730S1X3$;QW(_5=L?D^
M/T:3R7CS7=D2DK%^R>29[D$W^RZ-BA+P@*J)DTZ?"G-]=RB;*?ST^^+G4QM
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MQ6XVP(/]P3W;ACH[,.;3A&SIFNJ'Y$["DU%Q"5A$8\5$C"3=S 97^/(&3S)
M3O&5T9UJW*/,E$<AGK*'3\%L8&8:44Y]G;$@<'FF2\IYQ@GT^%8R'50R,V#S
M?L_])C<>C'DDBBX%_Y,%.IP-Q@,4T U)N;X7NU]I:= HX^<+KO)?M"MIS0'R
M4Z5%5()!@XC%Q96\E(YH +![ F"5 *L-<$X [!)@OQ?@E #GO8!1"1BU ?8)
M@%L"W-SWA;-R3Z^()O.I%#LD,VK@EMWDX<K1X& 69YFUUA+>,L#I^5H+_RD4
M/*!2_8*NOZ5,OZ*/: T9'*2<(K%!ZY!(BNYIDDH_A" J=+ZBFC"N+H#R8;U"
MYV<7Z P92&64"K$8/<1,JP^-@UO&.602G)TU'Z>&!B,R50R_5'A1*&R=4!A;
MZ%;$.E3H.@YH<,C  .LK%UA[%RRL7HZW1 Z1C3\@R[1PAT++]\/-#OCJW7 \
MZ8!?]\,_D[A7^9NWI+_NA8][7&E7V63G[.P3[*Y\'WJ&))H&'6GS]V] CCYI
M&JE_>H0YE3 G%^:<$A8$+.M.A".2ZE!(]F\['PH/%FR\G$W6:9_GT'<A5,]-
M/QT3.4VB PU'E8:C?G<DB10O#/H?12O!.9'H*^%I754*Z9!HE$7A+Y@B"XKN
M2F\%4$)0D_ >SJ382A*I'I^YE49NK\\6=,OBF,5;:,><Q#[M*D#WR!5X9(\.
M_;4\)K(==W)(M.K@9$[<;J=ZE0E>KPE0]F_H[QW'VQNW]3\F.C9R=4QT8.2!
M_N-*_W&O_G_ 1P%$7#Y!P+]($BN2S]B^Z$XJUI/_O_RP68\.L]>2+T)#[?V>
M1H^0J'5*URE\#IV^& $7G8V^8)]=ZJ(;>JU =5%-AGAR\->*6Q<&FT.G.W*X
M,2QQ?\MY!N]N*4HD\^&7L  E8'MN8VYMD%>YJD^[#2^DC)O:N>;0MMNF=] Y
MSM =M\WMH+.M(3YEKU7;:_TD#0S7(P;;O3$HY<HJL[MZ_J)DTBS=C][(;#NX
M@PK;MM/V;R>9YYUP;SW \!L3K*=>^WQ5SQ_\Q@#Z(0VA'BZX?[I\9T-8ENS[
M&\*JBPJ2_40PZK&"^^?*CZGM92GEH!8MKZ-F.^BP-YR,3]A1CQ<\_EEJMIY+
M>/+]-;LLF1R4F=O^4%MU45FC]I>:T5B)(BJW^?*JD"_26!>K075:+<A7^5K8
M.E_@RU6QYM9LBJT;9CA\3"G$Z098FD,/:E$6BVSQH$62+UZ/0L,:E]^&L/Q3
MF1' ^XT0>O^0":C^G3#_#U!+ P04    "  V@:Q2#8UTP>D&  "P)0  &@
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M P>N:: I_=Y(YVMB#(]V0;:9JMH NHN#O2L?:"H['NA5IP5D,Z8%U6Q,52A
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M?>/Y9C*>T5[I7Z8 L.2A%-*,@\+:S8<P-%D!)3,]M0&);U9*E\SB4J]#L]'
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M3QB8= +"N<5PY!2G-IF_*\DU#+&,YG&FHO)45'6]!3;:>FQ\OPR\L=M8J,Q
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MA,9H%%(P98S3M#2W274=9F$<ZGRZ=1-Y "QV!1:[N["81!C'U6F&S]1!PM8
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M;7B)7K]Z@UZAK$"W69YK07725[IU]3WZH[8EY\N6D(Z64'0K"S6MT(=B+,:
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M#N)%&$1D$N^?[NPIN7J*@]TRE'SY@5R31U4$EKN($[$BM<H!ET$8I9GNZ7%
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( #:!K%(H_52P90@  %12   /
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ME\^3FT4B9I=B-I_<$L@!@!P<#?)\]GE.((< <OB*D&?CZ_'-^40D5Y/)(B&
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MJ'I'@-Y1]8X O:/J'0%Z1]4[ O2.JG<$Z!U5[PC0.ZG>":!W4KT30.^D>B>
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MKGIW@-Y=]>X O;OJW0%Z=_>P-T#OKGIW@-Y#]1X O8?J/0!Z#]5[ /0>JO<
MZ#U4[P'0>ZC> Z#W4+T'0.^A>@^ WD/U'@"]AXMU 'I;\+D.P&\++M@) ,$M
MN&0G  RWX**= %#<@LMV L!Q"R[<"0#)+;AT)P LM^#BG0#0W(++=P+ <PLN
MX D$T7V R2@P?8))$-U'F(@*TV>8B [3AYB($M.GF(@6T\>8B!K3YYB('M,'
MF8@BTR>9A";37)1IA"K37)9IA"[3HL_J":*[--,(;::Y.-,(=::Y/-,^M,]<
MUM^/\_*VZ.^U&_"1>J\OOSN_??[KY=\W_5?KE>OI_8SE\@]02P,$%     @
M-H&L4BQ;9EBH @  /48  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS=O-;IM
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M2P$"% ,4    "  V@:Q2!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #:!K%)F4VD@[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M #:!K%*97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ -H&L4A_BFO5=!P  420  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M #:!K%*.&P?YQ08  #H=   8              " @: /  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    "  V@:Q2N$1J!=@#  !7#   &
M            @(&;%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ -H&L4DP/IC;K!@  ,1T  !@              ("!J1H  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #:!K%*=W/*VX@(  (()
M   8              " @<HA  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    "  V@:Q2$ANT#,<)   9-P  &               @('B)
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ -H&L4NUS-X@4
M P  A @  !@              ("!WRX  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( #:!K%+I-DC;= D  "XJ   8              "
M@2DR  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  V@:Q2
M4G;HC,8I  !7AP  &               @('3.P  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ -H&L4@UMB*#]#0  -2P  !D
M     ("!SV4  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M"  V@:Q2\O'%W&$'  !>$P  &0              @($#=   >&PO=V]R:W-H
M965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #:!K%+)1O6&^PX  )DW   9
M              " @9M[  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!
M A0#%     @ -H&L4O(?5TE]!@  UP\  !D              ("!S8H  'AL
M+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  V@:Q2%Q[W:74/
M  #8+0  &0              @(&!D0  >&PO=V]R:W-H965T<R]S:&5E=#$T
M+GAM;%!+ 0(4 Q0    ( #:!K%(;,A<2< 0  .<)   9              "
M@2VA  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ -H&L
M4D9-Z4L>$   ]BT  !D              ("!U*4  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    "  V@:Q29"T8=\8(  #2&@  &0
M        @($IM@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( #:!K%+1CE-OTP0  '@,   9              " @2:_  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ -H&L4KYN6R\E#   <U<
M !D              ("!,,0  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    "  V@:Q240\6=RX/  #O*@  &0              @(&,T
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( #:!K%)\/.D\
M\ L  )@?   9              " @?'?  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ -H&L4CI\^*RF!@  U!   !D
M ("!&.P  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  V
M@:Q2IBUB=3H9  "G4P  &0              @('U\@  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( #:!K%(X^>72- X  ,\W   9
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M970R."YX;6Q02P$"% ,4    "  V@:Q2C;M0BO@$  "["P  &0
M    @($Q9 $ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M #:!K%+_4[D9P0\  #PO   9              " @6!I 0!X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ -H&L4IC616I+!   S L  !D
M             ("!6'D! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    "  V@:Q2I N8"P $  "8"0  &0              @(':?0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( #:!K%+U)$W3<"L
M $F7   9              " @1&" 0!X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ -H&L4JQ&2AM? P  %P@  !D              ("!
MN*T! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  V@:Q2
ML7-0G2$#  "&!@  &0              @(%.L0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( #:!K%*)\!=;;P,  'H'   9
M      " @::T 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ -H&L4I].JR5/!@  Q14  !D              ("!3+@! 'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  V@:Q21H6FB2L#  #L!@
M&0              @('2O@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( #:!K%)(L;W)+ @  .X9   9              " @33" 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ -H&L4FJ$%?F
M!   Z@D  !D              ("!E\H! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    "  V@:Q2H<  56<'   9%   &0
M@(%.SP$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #:!
MK%*@S'AP2 ,  /P(   9              " @>S6 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ -H&L4L[TZXZ9 P  <P@  !D
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M=#0W+GAM;%!+ 0(4 Q0    ( #:!K%*UUH$G>@,  &0(   9
M  " @;KZ 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
M-H&L4MAH^(>Q @  XP4  !D              ("!:_X! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    "  V@:Q2@=JR%14*  !7'P  &0
M            @(%3 0( >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( #:!K%*#^*H]*PL  -L@   9              " @9\+ @!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ -H&L4N1#P>Y<!
MJ0L  !D              ("! 1<" 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    "  V@:Q2'BNM/_ (  !>-   &0              @(&4
M&P( >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( #:!K%(_
MQR5@C@(  / &   9              " @;LD @!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ -H&L4I\SEKC] @  H @  !D
M     ("!@"<" 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #:!K%)-=I[+"P8  )8<   9              "
M@6M  @!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ -H&L
M4NI1ECIO!0  <!P  !D              ("!K48" 'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    "  V@:Q2_D0?+X0&  "<)   &0
M        @(%33 ( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( #:!K%*>=30>? (  -@%   9              " @0Y3 @!X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ -H&L4B1L,WA5 P  E@H
M !D              ("!P54" 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    "  V@:Q2]Q/JEO$"  #3"0  &0              @(%-60(
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( #:!K%)03I15
MY 0  #\7   9              " @75< @!X;"]W;W)K<VAE971S+W-H965T
M-C8N>&UL4$L! A0#%     @ -H&L4A?4A?E> P  ]0P  !D
M ("!D&$" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    "  V
M@:Q2XV9JMP8#  ")"0  &0              @($E90( >&PO=V]R:W-H965T
M<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( #:!K%+&4=?($@,  "L*   9
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M970W,RYX;6Q02P$"% ,4    "  V@:Q2+YI6+O<#   J#   &0
M    @('(>@( >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (
M #:!K%(M$BZ+#P0  (L/   9              " @?9^ @!X;"]W;W)K<VAE
M971S+W-H965T-S4N>&UL4$L! A0#%     @ -H&L4H(\-X&J @  C@<  !D
M             ("!/(," 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"
M% ,4    "  V@:Q2%Z>*56H#  #M"P  &0              @($=A@( >&PO
M=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( #:!K%(NWR/R# <
M !(A   9              " @;Z) @!X;"]W;W)K<VAE971S+W-H965T-S@N
M>&UL4$L! A0#%     @ -H&L4@B?6_!W!   )@\  !D              ("!
M 9$" 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    "  V@:Q2
MM):8UDT$  #1#P  &0              @(&OE0( >&PO=V]R:W-H965T<R]S
M:&5E=#@P+GAM;%!+ 0(4 Q0    ( #:!K%*^]U "M@,  $0,   9
M      " @3.: @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%
M  @ -H&L4OX+_8./!0  V1H  !D              ("!()X" 'AL+W=O<FMS
M:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    "  V@:Q2K71O3!8%  "%&0
M&0              @('FHP( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+
M 0(4 Q0    ( #:!K%+*4R='D08  +$@   9              " @3.I @!X
M;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ -H&L4F)XW?!/
M @  3 4  !D              ("!^Z\" 'AL+W=O<FMS:&5E=',O<VAE970X
M-2YX;6Q02P$"% ,4    "  V@:Q2&0_ (#D%  #-&0  &0
M@(&!L@( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( #:!
MK%+]'KU(Q ,   0.   9              " @?&W @!X;"]W;W)K<VAE971S
M+W-H965T.#<N>&UL4$L! A0#%     @ -H&L4H#E@Q - P  = D  !D
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M=#DR+GAM;%!+ 0(4 Q0    ( #:!K%)3 YFLFP0  +H3   9
M  " @:+0 @!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @
M-H&L4DPWB4E,!0  "QL  !D              ("!=-4" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-"YX;6Q02P$"% ,4    "  V@:Q2\0%2HN4"  !K"0  &0
M            @('WV@( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4
M Q0    ( #:!K%).H5 L908  &PF   9              " @1/> @!X;"]W
M;W)K<VAE971S+W-H965T.38N>&UL4$L! A0#%     @ -H&L4H4]"C-L!@
MNR0  !D              ("!K^0" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX
M;6Q02P$"% ,4    "  V@:Q2&N#5*;\#  "V#@  &0              @(%2
MZP( >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    ( #:!K%+'
MMN.YT@(  '4(   9              " @4CO @!X;"]W;W)K<VAE971S+W-H
M965T.3DN>&UL4$L! A0#%     @ -H&L4OF[*[9_ @  2 <  !H
M     ("!4?(" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%
M  @ -H&L4D5XMN:)"@  H3H  !H              ("!"/4" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%     @ -H&L4IT.#U@A!   4!
M !H              ("!R?\" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL
M4$L! A0#%     @ -H&L4F1.L9W8!@  ,"4  !H              ("!(@0#
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @ -H&L4DC'
M(U(4 P  8@H  !H              ("!,@L# 'AL+W=O<FMS:&5E=',O<VAE
M970Q,#0N>&UL4$L! A0#%     @ -H&L4B,$.XWF @  W0@  !H
M     ("!?@X# 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%
M  @ -H&L4M[#9&D+!   30\  !H              ("!G!$# 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#8N>&UL4$L! A0#%     @ -H&L4E^SCH+! P  $0\
M !H              ("!WQ4# 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL
M4$L! A0#%     @ -H&L4MIA]W9>!P  -3D  !H              ("!V!D#
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @ -H&L4@:#
MVYXS @  *P4  !H              ("!;B$# 'AL+W=O<FMS:&5E=',O<VAE
M970Q,#DN>&UL4$L! A0#%     @ -H&L4GS#;&&<!@  .R   !H
M     ("!V2,# 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%
M  @ -H&L4J,78AOL!   HAP  !H              ("!K2H# 'AL+W=O<FMS
M:&5E=',O<VAE970Q,3$N>&UL4$L! A0#%     @ -H&L4J#G?7;V @  = @
M !H              ("!T2\# 'AL+W=O<FMS:&5E=',O<VAE970Q,3(N>&UL
M4$L! A0#%     @ -H&L4I9"X*R4 @    <  !H              ("!_S(#
M 'AL+W=O<FMS:&5E=',O<VAE970Q,3,N>&UL4$L! A0#%     @ -H&L4A0E
M-]6W P  91$  !H              ("!RS4# 'AL+W=O<FMS:&5E=',O<VAE
M970Q,30N>&UL4$L! A0#%     @ -H&L4GZ5NES"#   [D(  !H
M     ("!NCD# 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L! A0#%
M  @ -H&L4C?)J5D2!P  0"$  !H              ("!M$8# 'AL+W=O<FMS
M:&5E=',O<VAE970Q,38N>&UL4$L! A0#%     @ -H&L4K9A8,)(!   6A
M !H              ("!_DT# 'AL+W=O<FMS:&5E=',O<VAE970Q,3<N>&UL
M4$L! A0#%     @ -H&L4@V-=,'I!@  L"4  !H              ("!?E(#
M 'AL+W=O<FMS:&5E=',O<VAE970Q,3@N>&UL4$L! A0#%     @ -H&L4D89
MU)@6!P  12D  !H              ("!GUD# 'AL+W=O<FMS:&5E=',O<VAE
M970Q,3DN>&UL4$L! A0#%     @ -H&L4CW#BJA2 P  #@L  !H
M     ("![6 # 'AL+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L! A0#%
M  @ -H&L4JJMOU,F"@  "S@  !H              ("!=V0# 'AL+W=O<FMS
M:&5E=',O<VAE970Q,C$N>&UL4$L! A0#%     @ -H&L4C'&_]X[!P  %RD
M !H              ("!U6X# 'AL+W=O<FMS:&5E=',O<VAE970Q,C(N>&UL
M4$L! A0#%     @ -H&L4CFFJ'^^ P  Z X  !H              ("!2'8#
M 'AL+W=O<FMS:&5E=',O<VAE970Q,C,N>&UL4$L! A0#%     @ -H&L4@A"
M.*^L!@   2(  !H              ("!/GH# 'AL+W=O<FMS:&5E=',O<VAE
M970Q,C0N>&UL4$L! A0#%     @ -H&L4L5@]>0.!0  =1<  !H
M     ("!(H$# 'AL+W=O<FMS:&5E=',O<VAE970Q,C4N>&UL4$L! A0#%
M  @ -H&L4GK'U5%N P  [A8   T              ( !:(8# 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  V@:Q2EXJ[',     3 @  "P
M@ $!B@, 7W)E;',O+G)E;'-02P$"% ,4    "  V@:Q2*/U4L&4(  !44@
M#P              @ 'JB@, >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M-H&L4AH[I/=K P  5$D  !H              ( !?),# 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ -H&L4BQ;9EBH @  /48  !,
M             ( !'Y<# %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     (4
,A0"T)   ^)D#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>665</ContextCount>
  <ElementCount>820</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>223</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>30</UnitCount>
  <MyReports>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210071002 - Disclosure - Investment in Change Healthcare Joint Venture</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture</Role>
      <ShortName>Investment in Change Healthcare Joint Venture</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210111003 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210151004 - Disclosure - Restructuring, Impairment, and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment, and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210201005 - Disclosure - Business Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</Role>
      <ShortName>Business Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210251006 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210361007 - Disclosure - Other Income, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNet</Role>
      <ShortName>Other Income, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210391008 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210471009 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210511010 - Disclosure - Earnings per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShare</Role>
      <ShortName>Earnings per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210551011 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210621012 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210691013 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210751014 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210771015 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210881016 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210921017 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210961018 - Disclosure - Financial Guarantees and Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FinancialGuaranteesandWarranties</Role>
      <ShortName>Financial Guarantees and Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210981019 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>211001020 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>211061021 - Disclosure - Related Party Balances and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RelatedPartyBalancesandTransactions</Role>
      <ShortName>Related Party Balances and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>211081022 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>211131023 - Disclosure - Quarterly Financial Information (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited</Role>
      <ShortName>Quarterly Financial Information (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>211161024 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230083002 - Disclosure - Investment in Change Healthcare Joint Venture (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables</Role>
      <ShortName>Investment in Change Healthcare Joint Venture (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230123003 - Disclosure - Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleTables</Role>
      <ShortName>Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HeldforSale</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230163004 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230213005 - Disclosure - Business Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables</Role>
      <ShortName>Business Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230263006 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/ShareBasedCompensation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230373007 - Disclosure - Other Income, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetTables</Role>
      <ShortName>Other Income, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/OtherIncomeNet</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230403008 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230483009 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230523010 - Disclosure - Earnings per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShareTables</Role>
      <ShortName>Earnings per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsperCommonShare</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230563011 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/Leases</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230633012 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230703013 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230783014 - Disclosure - Pension Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsTables</Role>
      <ShortName>Pension Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/PensionBenefits</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230893015 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230933016 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>231013017 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquity</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>231093018 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>231143019 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables</Role>
      <ShortName>Quarterly Financial Information (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240094004 - Disclosure - Investment in Change Healthcare Joint Venture (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails</Role>
      <ShortName>Investment in Change Healthcare Joint Venture (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240104005 - Disclosure - Investment in Change Healthcare Joint Venture - Net Gain on Split-off of Change Healthcare JV (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails</Role>
      <ShortName>Investment in Change Healthcare Joint Venture - Net Gain on Split-off of Change Healthcare JV (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240134006 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240144007 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240174008 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240184009 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240194010 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240224011 - Disclosure - Business Acquisitions and Divestitures - Acquisition of Medical Specialties Distributors (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Acquisition of Medical Specialties Distributors (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240234012 - Disclosure - Business Acquisitions and Divestitures - Fair Values Recognized of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Fair Values Recognized of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240244013 - Disclosure - Business Acquisitions and Divestitures - Acquisition of CoverMyMeds (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Acquisition of CoverMyMeds (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240274014 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240284015 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240294016 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240304017 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240314018 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240324019 - Disclosure - Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240334020 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240344021 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240354022 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240384023 - Disclosure - Other Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetDetails</Role>
      <ShortName>Other Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/OtherIncomeNetTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240414024 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240424025 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240434026 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240444027 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240454028 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails</Role>
      <ShortName>Income Taxes - Components Of Deferred Tax Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240464029 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Gross Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240494030 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240504031 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240534032 - Disclosure - Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails</Role>
      <ShortName>Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240544033 - Disclosure - Earnings per Common Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails</Role>
      <ShortName>Earnings per Common Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240574034 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240584035 - Disclosure - Leases - Supplemental balance sheet information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails</Role>
      <ShortName>Leases - Supplemental balance sheet information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240594036 - Disclosure - Leases - Components of lease costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesComponentsofleasecostsDetails</Role>
      <ShortName>Leases - Components of lease costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240604037 - Disclosure - Leases - Supplemental cash flow information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails</Role>
      <ShortName>Leases - Supplemental cash flow information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240614038 - Disclosure - Leases - Maturities of lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails</Role>
      <ShortName>Leases - Maturities of lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240644039 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240654040 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Impairment Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Goodwill Impairment Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240664041 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240674042 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240684043 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240714044 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240724045 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240734046 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240744047 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240764048 - Disclosure - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/VariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/VariableInterestEntities</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240794049 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240804050 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails</Role>
      <ShortName>Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240814051 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240824052 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails</Role>
      <ShortName>Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240834053 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240844054 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240854055 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails</Role>
      <ShortName>Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240864056 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails</Role>
      <ShortName>Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240874057 - Disclosure - Pension Benefits - Other Postretirement Benefits Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails</Role>
      <ShortName>Pension Benefits - Other Postretirement Benefits Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240904058 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240914059 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails</Role>
      <ShortName>Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240944060 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>240954061 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>240974062 - Disclosure - Financial Guarantees and Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails</Role>
      <ShortName>Financial Guarantees and Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FinancialGuaranteesandWarranties</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>240994063 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241024064 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241034065 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241044066 - Disclosure - Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241054067 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>241074068 - Disclosure - Related Party Balances and Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails</Role>
      <ShortName>Related Party Balances and Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RelatedPartyBalancesandTransactions</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>241104069 - Disclosure - Segments of Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails</Role>
      <ShortName>Segments of Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>241114070 - Disclosure - Segments of Business - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails</Role>
      <ShortName>Segments of Business - Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>241124071 - Disclosure - Segments of Business - Segment Assets and Property, Plant and Equipment, Net by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails</Role>
      <ShortName>Segments of Business - Segment Assets and Property, Plant and Equipment, Net by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>241154072 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule of Quarterly Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails</Role>
      <ShortName>Quarterly Financial Information (Unaudited) - Schedule of Quarterly Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="mck-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>241174073 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>125</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="mck-20210331.htm">mck-20210331.htm</File>
    <File>mck-20210331.xsd</File>
    <File>mck-20210331_cal.xml</File>
    <File>mck-20210331_def.xml</File>
    <File>mck-20210331_lab.xml</File>
    <File>mck-20210331_pre.xml</File>
    <File>mck_exhbit23x3312021.htm</File>
    <File>mck_exhibit1016x3312021.htm</File>
    <File>mck_exhibit21x3312021.htm</File>
    <File>mck_exhibit311x3312021.htm</File>
    <File>mck_exhibit312x3312021.htm</File>
    <File>mck_exhibit32x3312021.htm</File>
    <File>mck_exhibit414x3312021.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20210331_g1.jpg</File>
    <File>mck-20210331_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>148
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20210331.htm": {
   "axisCustom": 1,
   "axisStandard": 60,
   "contextCount": 665,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 1245,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://mckesson123.com/20210331": 2,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 11
   },
   "keyCustom": 142,
   "keyStandard": 678,
   "memberCustom": 119,
   "memberStandard": 98,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://mckesson123.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210071002 - Disclosure - Investment in Change Healthcare Joint Venture",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture",
     "shortName": "Investment in Change Healthcare Joint Venture",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764048 - Disclosure - Variable Interest Entities (Details)",
     "role": "http://mckesson123.com/role/VariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794049 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804050 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
     "shortName": "Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i752dc55059cc4447a0accfa4c957834d_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814051 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
     "shortName": "Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0a67a17e8f57467fb75aa5fa8a60e378_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824052 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
     "shortName": "Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0a67a17e8f57467fb75aa5fa8a60e378_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0a67a17e8f57467fb75aa5fa8a60e378_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834053 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0a67a17e8f57467fb75aa5fa8a60e378_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844054 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854055 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
     "shortName": "Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id5561711868a406dba2571e3837b5f92_D20200401-20210331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0a67a17e8f57467fb75aa5fa8a60e378_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864056 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
     "shortName": "Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i75aeb536cafe4a8ca7661d227b781a7d_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0c346010601f41a8883754f4737da9a4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874057 - Disclosure - Pension Benefits - Other Postretirement Benefits Plan (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails",
     "shortName": "Pension Benefits - Other Postretirement Benefits Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0c346010601f41a8883754f4737da9a4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210111003 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904058 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iec28e1b69349490ab2aeef52f7393928_D20190401-20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914059 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
     "shortName": "Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i4d0205f86cce4c5ab5c3495a4d4ccc16_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944060 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i281f035f8d7243408d9c4ff727319f57_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954061 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
     "shortName": "Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i281f035f8d7243408d9c4ff727319f57_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:GuaranteeObligationsExposureExpiringinYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974062 - Disclosure - Financial Guarantees and Warranties (Details)",
     "role": "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
     "shortName": "Financial Guarantees and Warranties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:GuaranteeObligationsExposureExpiringinYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActNewYorkAnnualSurcharge",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994063 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ia7becbc8d137484d97debb021a37e776_D20171205-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mck:LossContingencyNumberofStatesFiledOnBehalfOf",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024064 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i4f355bd7dad94edaa42f6261dbd8637e_I20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241034065 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails",
     "shortName": "Stockholders' Equity - Schedule of Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i9e8cc055588b4b2fa95358db10082a0b_D20200401-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044066 - Disclosure - Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails",
     "shortName": "Stockholders' Equity - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054067 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
     "shortName": "Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i39478e6541ce4affa6e616fffbaa911b_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210151004 - Disclosure - Restructuring, Impairment, and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment, and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i88386d48d0584a11aad721e5144c887a_D20200101-20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074068 - Disclosure - Related Party Balances and Transactions (Details)",
     "role": "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
     "shortName": "Related Party Balances and Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i88386d48d0584a11aad721e5144c887a_D20200101-20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241104069 - Disclosure - Segments of Business - Narrative (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
     "shortName": "Segments of Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114070 - Disclosure - Segments of Business - Schedule of Segment Information (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
     "shortName": "Segments of Business - Schedule of Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:GrossProfitNetofExpensesIncludingOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241124071 - Disclosure - Segments of Business - Segment Assets and Property, Plant and Equipment, Net by Geographical Area (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails",
     "shortName": "Segments of Business - Segment Assets and Property, Plant and Equipment, Net by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241154072 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule of Quarterly Financial Information (Details)",
     "role": "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails",
     "shortName": "Quarterly Financial Information (Unaudited) - Schedule of Quarterly Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241174073 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i022a2642b16245d083cb80c539e560b3_I20180331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210201005 - Disclosure - Business Acquisitions and Divestitures",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures",
     "shortName": "Business Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210251006 - Disclosure - Share-Based Compensation",
     "role": "http://mckesson123.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210361007 - Disclosure - Other Income, Net",
     "role": "http://mckesson123.com/role/OtherIncomeNet",
     "shortName": "Other Income, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210391008 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210471009 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210511010 - Disclosure - Earnings per Common Share",
     "role": "http://mckesson123.com/role/EarningsperCommonShare",
     "shortName": "Earnings per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorDirectFinancingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210551011 - Disclosure - Leases",
     "role": "http://mckesson123.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorDirectFinancingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210621012 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210691013 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210751014 - Disclosure - Variable Interest Entities",
     "role": "http://mckesson123.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771015 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210881016 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210921017 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:FinancialGuaranteesAndWarrantiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961018 - Disclosure - Financial Guarantees and Warranties",
     "role": "http://mckesson123.com/role/FinancialGuaranteesandWarranties",
     "shortName": "Financial Guarantees and Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:FinancialGuaranteesAndWarrantiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981019 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211001020 - Disclosure - Stockholders' Equity",
     "role": "http://mckesson123.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211061021 - Disclosure - Related Party Balances and Transactions",
     "role": "http://mckesson123.com/role/RelatedPartyBalancesandTransactions",
     "shortName": "Related Party Balances and Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211081022 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211131023 - Disclosure - Quarterly Financial Information (Unaudited)",
     "role": "http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited",
     "shortName": "Quarterly Financial Information (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211161024 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230083002 - Disclosure - Investment in Change Healthcare Joint Venture (Tables)",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables",
     "shortName": "Investment in Change Healthcare Joint Venture (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230123003 - Disclosure - Held for Sale (Tables)",
     "role": "http://mckesson123.com/role/HeldforSaleTables",
     "shortName": "Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230163004 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment, and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230213005 - Disclosure - Business Acquisitions and Divestitures (Tables)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables",
     "shortName": "Business Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230263006 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230373007 - Disclosure - Other Income, Net (Tables)",
     "role": "http://mckesson123.com/role/OtherIncomeNetTables",
     "shortName": "Other Income, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230403008 - Disclosure - Income Taxes (Tables)",
     "role": "http://mckesson123.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230483009 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230523010 - Disclosure - Earnings per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsperCommonShareTables",
     "shortName": "Earnings per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230563011 - Disclosure - Leases (Tables)",
     "role": "http://mckesson123.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230633012 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230703013 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783014 - Disclosure - Pension Benefits (Tables)",
     "role": "http://mckesson123.com/role/PensionBenefitsTables",
     "shortName": "Pension Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230893015 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230933016 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231013017 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231093018 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231143019 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)",
     "role": "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables",
     "shortName": "Quarterly Financial Information (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:AccountsReceivableCustomerAccountsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails",
     "shortName": "Significant Accounting Policies - Receivables, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:AccountsReceivableCustomerAccountsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails",
     "shortName": "Significant Accounting Policies - Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i63b13d6d7fdc4db998f4aad71d5d3642_D20200309-20200309",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mck:ExchangeOfferSharesDistributed",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094004 - Disclosure - Investment in Change Healthcare Joint Venture (Details)",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
     "shortName": "Investment in Change Healthcare Joint Venture (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "id1030ca9e1fc410c8e4ba04e704c20ad_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104005 - Disclosure - Investment in Change Healthcare Joint Venture - Net Gain on Split-off of Change Healthcare JV (Details)",
     "role": "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
     "shortName": "Investment in Change Healthcare Joint Venture - Net Gain on Split-off of Change Healthcare JV (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i8656c0823df4499fbaf59dbdf95aee4f_D20200309-20200309",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:EquityMethodInvestmentFairValueofStockAccepted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134006 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i841091b6641c4e1fa2288424caf2b82f_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144007 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i4c88f05a91c64ccd9403c9344a22b92b_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i4e5a221fc8fe4aa4b77701dfdf51b2a1_I20180331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174008 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184009 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194010 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveSettledWithoutCash2",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i1a36ca67ff5f42bbbbcf4d6660b6af27_D20180601-20180601",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224011 - Disclosure - Business Acquisitions and Divestitures - Acquisition of Medical Specialties Distributors (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
     "shortName": "Business Acquisitions and Divestitures - Acquisition of Medical Specialties Distributors (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i1a36ca67ff5f42bbbbcf4d6660b6af27_D20180601-20180601",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234012 - Disclosure - Business Acquisitions and Divestitures - Fair Values Recognized of Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Business Acquisitions and Divestitures - Fair Values Recognized of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i60d887dd975b47fcb23c06b79e73a02a_I20190531",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244013 - Disclosure - Business Acquisitions and Divestitures - Acquisition of CoverMyMeds (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails",
     "shortName": "Business Acquisitions and Divestitures - Acquisition of CoverMyMeds (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i1182c1c4af8746449b50307d67f448c1_D20170403-20170403",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274014 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284015 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Components of Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i59271b92dcf64cb58c826f765fd24248_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294016 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
     "shortName": "Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i59271b92dcf64cb58c826f765fd24248_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iaa9c17219d084d969cda29f0f32fcdaf_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304017 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iaa9c17219d084d969cda29f0f32fcdaf_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i2fa25f7377e2432b8ee48290f92300f5_D20200701-20200731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (Parentheticals)",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:DataRelatedtoRSUActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i59271b92dcf64cb58c826f765fd24248_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314018 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
     "shortName": "Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:DataRelatedtoRSUActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i59271b92dcf64cb58c826f765fd24248_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i3383581875ce407cb2084a70eeee7980_D20180401-20190331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324019 - Disclosure - Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
     "shortName": "Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i3383581875ce407cb2084a70eeee7980_D20180401-20190331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334020 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails",
     "shortName": "Share-Based Compensation - Summary of Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344021 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idba7d670fc874663a124e1d3598d51de_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354022 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idba7d670fc874663a124e1d3598d51de_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384023 - Disclosure - Other Income, Net (Details)",
     "role": "http://mckesson123.com/role/OtherIncomeNetDetails",
     "shortName": "Other Income, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414024 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424025 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
     "shortName": "Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434026 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444027 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454028 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
     "shortName": "Income Taxes - Components Of Deferred Tax Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464029 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Gross Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:PutRightValueInterestRateSpread",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494030 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:PutRightValueInterestRateSpread",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504031 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iae70566f5363452bbc98260415fc04bd_I20180331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i3f95ede5c5794af680d351d91df5c7c6_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534032 - Disclosure - Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
     "shortName": "Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iec28e1b69349490ab2aeef52f7393928_D20190401-20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544033 - Disclosure - Earnings per Common Share - Narrative (Details)",
     "role": "http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails",
     "shortName": "Earnings per Common Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iec28e1b69349490ab2aeef52f7393928_D20190401-20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i0d9d3f777851405d93c2e2401895ce61_I20190401",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574034 - Disclosure - Leases - Narrative (Details)",
     "role": "http://mckesson123.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic32796e7987843a3ab52213be0ff70a9_D20180401-20190331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584035 - Disclosure - Leases - Supplemental balance sheet information (Details)",
     "role": "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
     "shortName": "Leases - Supplemental balance sheet information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594036 - Disclosure - Leases - Components of lease costs (Details)",
     "role": "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails",
     "shortName": "Leases - Components of lease costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604037 - Disclosure - Leases - Supplemental cash flow information (Details)",
     "role": "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails",
     "shortName": "Leases - Supplemental cash flow information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614038 - Disclosure - Leases - Maturities of lease liabilities (Details)",
     "role": "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails",
     "shortName": "Leases - Maturities of lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i6d8ec19e753d451794e088409f68157c_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644039 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654040 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Impairment Inputs (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Goodwill Impairment Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i06ff9ccb94444a299cd674339d636bfd_D20180401-20180630",
      "decimals": "3",
      "lang": "en-US",
      "name": "mck:GoodwillImpairedMethodforFairValueDeterminationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i32c25f72120e40daae16f72d04c63d1d_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664041 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i30c8074ac9194cc5b11720dc788c0285_I20200331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674042 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684043 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714044 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "if9ba0d15a0ed41b1ae9439d4894c23d3_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724045 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "idb72c0ed76ca44d78a6182d86a49bb8e_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "iabf91ccb11c7473fb82ceedddfc105f2_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734046 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "i9864559fa95841a4af3fb0942788d567_D20190901-20190930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744047 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210331.htm",
      "contextRef": "ic5118698b0524b279b93760d74efaa12_D20200401-20210331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 223,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "U.K."
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "United Kingdom, Pounds"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A0.625notesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.625% notes Due 2021 [Member]",
        "label": "0.625% notes Due 2021 [Member]",
        "terseLabel": "0.625% Notes due 2021"
       }
      }
     },
     "localname": "A0.625notesDue2021Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1.500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025 [Member]",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes due 2025"
       }
      }
     },
     "localname": "A1.500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1.625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026 [Member]",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes due 2026"
       }
      }
     },
     "localname": "A1.625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2013StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2013 Stock Plan [Member]",
        "label": "2013 Stock Plan [Member]",
        "terseLabel": "2013 Stock Plan"
       }
      }
     },
     "localname": "A2013StockPlanMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3.125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029 [Member]",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes due 2029"
       }
      }
     },
     "localname": "A3.125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMarch12021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due March 1, 2021",
        "label": "4.75% Notes Due March 1, 2021 [Member]",
        "terseLabel": "4.75% Notes Due March 1, 2021"
       }
      }
     },
     "localname": "A475NotesDueMarch12021Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccountsReceivableCustomerAccountsGross": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Customer Accounts, Gross",
        "label": "Accounts Receivable, Customer Accounts, Gross",
        "terseLabel": "Customer accounts"
       }
      }
     },
     "localname": "AccountsReceivableCustomerAccountsGross",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AccruedShareRepurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Share Repurchases",
        "label": "Accrued Share Repurchases",
        "terseLabel": "Accrued shares repurchased"
       }
      }
     },
     "localname": "AccruedShareRepurchases",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Amortization of actuarial gain, prior service cost and transition obligation, net of income tax (expense)"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Net actuarial gain (loss) and prior service credit (cost) arising during the period, net of income tax (expense) benefit"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Changes in Retirement-Related Benefit Plans, Foreign Currency Translation Adjustments and Other"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe",
        "verboseLabel": "Exercises of put right"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring compensation (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental balance sheet information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_BenefitObligationsAssumptionsRateIncreaseinCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefit Obligations Assumptions Rate Increase in Compensation",
        "label": "Benefit Obligations Assumptions Rate Increase in Compensation",
        "terseLabel": "Rate of increase in compensation"
       }
      }
     },
     "localname": "BenefitObligationsAssumptionsRateIncreaseinCompensation",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Assets Net of Cash and Cash Equivalents",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Assets Net of Cash and Cash Equivalents",
        "terseLabel": "Other current assets, net of cash and cash equivalents acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsOtherAssetsNetofCashandCashEquivalents",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of Cash and Cash Equivalents",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of Cash and Cash Equivalents",
        "totalLabel": "Net assets acquired, net of cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CaliforniaFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "California Foundation [Member]",
        "label": "California Foundation [Member]",
        "terseLabel": "California Foundation"
       }
      }
     },
     "localname": "CaliforniaFoundationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CapitalizedSoftwareHeldforInternalUseUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized Software Held for Internal Use, Useful Life",
        "label": "Capitalized Software Held for Internal Use, Useful Life",
        "terseLabel": "Capitalized software held for internal use, useful life"
       }
      }
     },
     "localname": "CapitalizedSoftwareHeldforInternalUseUsefulLife",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_ChangeHealthcareInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare, Inc. [Member]",
        "label": "Change Healthcare, Inc. [Member]",
        "terseLabel": "Change Healthcare, Inc."
       }
      }
     },
     "localname": "ChangeHealthcareInc.Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ChangeHealthcareLLCChangeHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "label": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "terseLabel": "Change Healthcare"
       }
      }
     },
     "localname": "ChangeHealthcareLLCChangeHealthcareMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York [Member]",
        "label": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York [Member]",
        "terseLabel": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York"
       }
      }
     },
     "localname": "CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted",
        "label": "Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted",
        "terseLabel": "Number of shares converted into per share converted (shares)"
       }
      }
     },
     "localname": "CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_ConsolidatedActionsvSureScriptsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Actions v SureScripts, LLC [Member]",
        "label": "Consolidated Actions v SureScripts, LLC [Member]",
        "terseLabel": "Consolidated Actions v SureScripts, LLC"
       }
      }
     },
     "localname": "ConsolidatedActionsvSureScriptsLLCMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate Expenses, Net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CoverMyMedsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CoverMyMeds, LL (\"CMM\") [Member]",
        "label": "CoverMyMeds, LLC [Member]",
        "terseLabel": "CMM"
       }
      }
     },
     "localname": "CoverMyMedsLLCMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DataRelatedtoRSUActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Data Related to RSU Activity [Table Text Block]",
        "label": "Data Related to RSU Activity [Table Text Block]",
        "terseLabel": "Schedule of data related to restricted stock unit award activity"
       }
      }
     },
     "localname": "DataRelatedtoRSUActivityTableTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]",
        "label": "Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]",
        "terseLabel": "Davidson Kempner International (BVI) Ltd., et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA"
       }
      }
     },
     "localname": "DavidsonKempnerInternationalBVILtd.etal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DeferredTaxAssetLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Lease Obligations",
        "label": "Deferred Tax Asset, Lease Obligations",
        "terseLabel": "Lease obligations"
       }
      }
     },
     "localname": "DeferredTaxAssetLeaseObligations",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DeferredTaxAssetLitigationAndClaims": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Litigation and Claims",
        "label": "Deferred Tax Asset, Litigation and Claims",
        "terseLabel": "Opioid-related litigation and claims"
       }
      }
     },
     "localname": "DeferredTaxAssetLitigationAndClaims",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DeferredTaxLiabilitiesLeaseRightofuseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Lease Right-of-use Assets",
        "label": "Deferred Tax Liabilities, Lease Right-of-use Assets",
        "negatedTerseLabel": "Lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeaseRightofuseAssets",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.",
        "label": "Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets",
        "terseLabel": "Unexpected actuarial losses (as a percent) (exceeding)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)",
        "label": "Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)",
        "terseLabel": "Amortization of unrecognized actuarial loss and prior service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rates",
        "label": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rates",
        "terseLabel": "Discount rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRates",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points",
        "terseLabel": "Increase (decrease) in basis points"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes",
        "terseLabel": "Actuarial gain (loss) resulting from demographic and assumption changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss, Discount Rate",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss, Discount Rate",
        "negatedTerseLabel": "Actuarial loss resulting from discount rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossInflation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Inflation",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Inflation",
        "terseLabel": "Actuarial gain (loss) resulting from the difference between actual inflation and assumed inflation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossInflation",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Annuity Premium Transfer",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Annuity Premium Transfer",
        "terseLabel": "Annuity Premium Transfer"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseforAnnuityPremiumTransfer",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Contributions by Employer and Plan Participants",
        "label": "Defined Benefit Plan, Contributions by Employer and Plan Participants",
        "terseLabel": "Employer and participant contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsbyEmployerandPlanParticipants",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset",
        "label": "Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset",
        "terseLabel": "Percentage of total plan contribution - exceeding (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanOtherFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Other Funds [Member]",
        "label": "Defined Benefit Plan, Other Funds [Member]",
        "terseLabel": "Real estate funds and Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherFundsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "label": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "terseLabel": "Annuity contracts purchased"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanSettlementPlanParticipants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Settlement, Plan Participants",
        "label": "Defined Benefit Plan, Settlement, Plan Participants",
        "terseLabel": "Number of plan participants elected to receive settlement payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementPlanParticipants",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_DefinedContributionPlanMatchingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan Matching [Axis]",
        "label": "Defined Contribution Plan Matching [Axis]",
        "terseLabel": "Defined Contribution Plan Matching [Axis]"
       }
      }
     },
     "localname": "DefinedContributionPlanMatchingAxis",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_DefinedContributionPlanMatchingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Defined Contribution Plan Matching [Axis]",
        "label": "Defined Contribution Plan Matching [Domain]",
        "terseLabel": "Defined Contribution Plan Matching [Domain]"
       }
      }
     },
     "localname": "DefinedContributionPlanMatchingDomain",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DerivativeNotionalAmountMatured": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Matured",
        "label": "Derivative, Notional Amount, Matured",
        "terseLabel": "Notional amount of derivatives that matured"
       }
      }
     },
     "localname": "DerivativeNotionalAmountMatured",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "terseLabel": "Consideration receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized",
        "verboseLabel": "Pension liabilities derecognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Assets, Current",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermAssetsCurrent",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Long-term Liabilities, Current",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedLongtermLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "label": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "negatedLabel": "Accumulated other comprehensive loss derecognized"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of business held for sale to fair value less cost to sell (1)"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DistributionandRetailBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution and Retail Business [Member]",
        "label": "Distribution and Retail Business [Member]",
        "terseLabel": "Distribution and Retail Business"
       }
      }
     },
     "localname": "DistributionandRetailBusinessMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Capital Loss Carryback",
        "label": "Effective Income Tax Rate Reconciliation, Capital Loss Carryback",
        "terseLabel": "Capital loss carryback"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCapitalLossCarryback",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit",
        "label": "Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit",
        "negatedTerseLabel": "Net tax benefit on intellectual property transfer"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Litigation and Claims",
        "label": "Effective Income Tax Rate Reconciliation, Litigation and Claims",
        "terseLabel": "Opioid-related litigation and claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLitigationAndClaims",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount",
        "terseLabel": "Impact of opioid-related claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmount",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount, Net of Tax",
        "label": "Effective Income Tax Rate Reconciliation, Litigation and Claims, Amount, Net of Tax",
        "terseLabel": "After-tax impact of opioid-related claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLitigationAndClaimsAmountNetOfTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EmployeeContributions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.",
        "label": "Employee Contributions",
        "terseLabel": "Employee contributions (as a percent)"
       }
      }
     },
     "localname": "EmployeeContributions",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "label": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "terseLabel": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation"
       }
      }
     },
     "localname": "EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee service share based compensation period to purchase shares through payroll deductions",
        "label": "Employee Service Share Based Compensation Period To Purchase Shares Through Payroll Deductions",
        "terseLabel": "Period over which payroll is deducted to purchase shares"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]",
        "label": "Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]",
        "terseLabel": "Employee Severance, Accelerated Depreciation and Project Consulting Fees"
       }
      }
     },
     "localname": "EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]",
        "label": "Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]",
        "terseLabel": "Employee Severance, Exit-related Costs and Asset Impairment Charges"
       }
      }
     },
     "localname": "EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EnvironmentalLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental Litigation [Member]",
        "label": "Environmental Litigation [Member]",
        "terseLabel": "Environmental Litigation"
       }
      }
     },
     "localname": "EnvironmentalLitigationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EquityMethodInvestmentCarryingAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Carrying Amount",
        "label": "Equity Method Investment, Carrying Amount",
        "negatedLabel": "Investment in the Change Healthcare JV at exchange date"
       }
      }
     },
     "localname": "EquityMethodInvestmentCarryingAmount",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentFairValueofStockAccepted": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Fair Value of Stock Accepted",
        "label": "Equity Method Investment, Fair Value of Stock Accepted",
        "terseLabel": "Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)"
       }
      }
     },
     "localname": "EquityMethodInvestmentFairValueofStockAccepted",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment Other Than Temporary Impairment After Tax",
        "label": "Equity Method Investment Other Than Temporary Impairment After Tax",
        "terseLabel": "After-tax other-than-temporary impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairmentAfterTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)",
        "label": "Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)",
        "terseLabel": "Release of accumulated other comprehensive attributable to the joint venture"
       }
      }
     },
     "localname": "EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentStockAccepted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Stock Accepted",
        "label": "Equity Method Investment, Stock Accepted",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentStockAccepted",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_EquityMethodInvestmentStockAcceptedAverageCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Stock Accepted, Average Cost",
        "label": "Equity Method Investment, Stock Accepted, Average Cost",
        "terseLabel": "Cost of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "EquityMethodInvestmentStockAcceptedAverageCost",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_EquityMethodInvestmentTransactionCostsIncurred": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Transaction Costs Incurred",
        "label": "Equity Method Investment, Transaction Costs Incurred",
        "negatedTerseLabel": "Less: Transaction costs incurred"
       }
      }
     },
     "localname": "EquityMethodInvestmentTransactionCostsIncurred",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentsReversalofDeferredTaxLiability": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Reversal of Deferred Tax Liability",
        "label": "Equity Method Investments, Reversal of Deferred Tax Liability",
        "terseLabel": "Reversal of deferred tax liability"
       }
      }
     },
     "localname": "EquityMethodInvestmentsReversalofDeferredTaxLiability",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EstimatedEnvironmentalAssessmentAndCleanupCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Environmental Assessment And Cleanup Costs",
        "label": "Estimated Environmental Assessment And Cleanup Costs",
        "terseLabel": "Estimated environmental assessment and cleanup costs"
       }
      }
     },
     "localname": "EstimatedEnvironmentalAssessmentAndCleanupCosts",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanPharmaceuticalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Pharmaceutical Solutions [Member]",
        "label": "European Pharmaceutical Solutions [Member]",
        "terseLabel": "European Pharmaceutical Solutions"
       }
      }
     },
     "localname": "EuropeanPharmaceuticalSolutionsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EvanstonPolicePensionFundv.McKessonCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evanston Police Pension Fund v. McKesson Corporation [Member]",
        "label": "Evanston Police Pension Fund v. McKesson Corporation [Member]",
        "terseLabel": "Evanston Police Pension Fund v. McKesson Corporation"
       }
      }
     },
     "localname": "EvanstonPolicePensionFundv.McKessonCorporationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ExchangeOfferSharesDistributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Offer, Shares Distributed",
        "label": "Exchange Offer, Shares Distributed",
        "terseLabel": "Shares distributed in split-off (shares)",
        "verboseLabel": "Shares distributed to stockholders (shares)"
       }
      }
     },
     "localname": "ExchangeOfferSharesDistributed",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_ExchangeOfferSharesExchanged": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Offer, Shares Exchanged",
        "label": "Exchange Offer, Shares Exchanged",
        "terseLabel": "Shares of common stock exchanged (shares)"
       }
      }
     },
     "localname": "ExchangeOfferSharesExchanged",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_FinancialGuaranteesAndWarrantiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Guarantees And Warranties [Abstract]",
        "label": "Financial Guarantees And Warranties [Abstract]",
        "terseLabel": "Financial Guarantees And Warranties [Abstract]"
       }
      }
     },
     "localname": "FinancialGuaranteesAndWarrantiesAbstract",
     "nsuri": "http://mckesson123.com/20210331",
     "xbrltype": "stringItemType"
    },
    "mck_FinancialGuaranteesAndWarrantiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial guarantees And warranties.",
        "label": "Financial Guarantees And Warranties [Text Block]",
        "terseLabel": "Financial Guarantees And Warranties"
       }
      }
     },
     "localname": "FinancialGuaranteesAndWarrantiesTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_FirstPartOfPayContributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Part Of Pay Contribution [Member]",
        "label": "First Part Of Pay Contribution [Member]",
        "terseLabel": "First Part Of Pay Contribution"
       }
      }
     },
     "localname": "FirstPartOfPayContributionMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]",
        "label": "Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]",
        "terseLabel": "Floating Rate Euro Notes due February 12, 2020"
       }
      }
     },
     "localname": "FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For Two Counties In re: National Prescription Opiate Litigation [Member]",
        "label": "For Two Counties In re: National Prescription Opiate Litigation [Member]",
        "terseLabel": "For Two Counties In re: National Prescription Opiate Litigation"
       }
      }
     },
     "localname": "ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ForwardContractsandCrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts and Cross Currency Swaps [Member]",
        "label": "Forward Contracts and Cross Currency Swaps [Member]",
        "terseLabel": "Forward Contracts and Cross Currency Swaps"
       }
      }
     },
     "localname": "ForwardContractsandCrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]",
        "label": "Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]",
        "terseLabel": "Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges"
       }
      }
     },
     "localname": "ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Eight Eight Percent Notes Due March Fifteenth Two Thousand Forty Four [Member]",
        "label": "Four Point Eight Eight Percent Notes Due March Fifteenth Two Thousand Forty Four [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "FourPointEightEightPercentNotesDueMarchFifteenthTwoThousandFortyFourMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Seven Five Percent Notes Dues March One Two Thousand Twenty One [Member]",
        "label": "Four Point Seven Five Percent Notes Dues March One Two Thousand Twenty One [Member]",
        "terseLabel": "4.75% Notes due March 1, 2021"
       }
      }
     },
     "localname": "FourPointSevenFivePercentNotesDuesMarchOneTwoThousandTwentyOneMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GainLossOnSaleOfBusinessNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Sale of Business, Net of Tax",
        "label": "Gain (Loss) on Sale of Business, Net of Tax",
        "negatedTerseLabel": "After-tax loss on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusinessNetOfTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GainLossonDerecognitionofLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Derecognition of Liability",
        "label": "Gain (Loss) on Derecognition of Liability",
        "negatedTerseLabel": "Pre-tax credit representing reduction in TRA liability",
        "terseLabel": "Pre-tax credit representing reduction in TRA liability"
       }
      }
     },
     "localname": "GainLossonDerecognitionofLiability",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GermanPharmaceuticalWholesaleJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Joint Venture [Member]",
        "label": "German Pharmaceutical Wholesale Joint Venture [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Joint Venture"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleJointVentureMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanWholesaleBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Business [Member]",
        "label": "German Wholesale Business [Member]",
        "terseLabel": "German Wholesale Business"
       }
      }
     },
     "localname": "GermanWholesaleBusinessMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GlobalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Facility [Member]",
        "label": "Global Facility [Member]",
        "terseLabel": "Global Facility"
       }
      }
     },
     "localname": "GlobalFacilityMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GoodwillImpairedMethodforFairValueDeterminationDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Impaired, Method for Fair Value Determination, Discount Rate",
        "label": "Goodwill, Impaired, Method for Fair Value Determination, Discount Rate",
        "terseLabel": "Goodwill impairment, discount rate (percent)"
       }
      }
     },
     "localname": "GoodwillImpairedMethodforFairValueDeterminationDiscountRate",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Impaired, Method for Fair Value Determination, Terminal Growth Rate",
        "label": "Goodwill, Impaired, Method for Fair Value Determination, Terminal Growth Rate",
        "terseLabel": "Goodwill impairment, terminal growth rate (percent)"
       }
      }
     },
     "localname": "GoodwillImpairedMethodforFairValueDeterminationTerminalGrowthRate",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_GoodwillImpairmentLossTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Impairment Loss, Tax",
        "label": "Goodwill, Impairment Loss, Tax",
        "terseLabel": "Tax charged related to impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLossTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GrossProfitNetofExpensesIncludingOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Profit, Net of Expenses, Including Other Income",
        "label": "Gross Profit, Net of Expenses, Including Other Income",
        "terseLabel": "Operating income"
       }
      }
     },
     "localname": "GrossProfitNetofExpensesIncludingOtherIncome",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsCustomersDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Customers Debt [Member]",
        "label": "Guarantee Obligations Customers Debt [Member]",
        "terseLabel": "Guarantee Obligations Customers Debt"
       }
      }
     },
     "localname": "GuaranteeObligationsCustomersDebtMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Five",
        "label": "Guarantee Obligations Exposure Expiring in Year Five",
        "terseLabel": "Guarantee obligations, expiring in 2026"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFive",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Five Thereafter",
        "label": "Guarantee Obligations Exposure Expiring in Year Five Thereafter",
        "terseLabel": "Guarantee obligations, expiring after 2026"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFiveThereafter",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Four",
        "label": "Guarantee Obligations Exposure Expiring in Year Four",
        "terseLabel": "Guarantee obligations, expiring in 2025"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFour",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year One",
        "label": "Guarantee Obligations Exposure Expiring in Year One",
        "terseLabel": "Guarantee obligations, expiring in 2022"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearOne",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Three",
        "label": "Guarantee Obligations Exposure Expiring in Year Three",
        "terseLabel": "Guarantee obligations, expiring in 2024"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearThree",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Two",
        "label": "Guarantee Obligations Exposure Expiring in Year Two",
        "terseLabel": "Guarantee obligations, expiring in 2023"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearTwo",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GuaranteeObligationsInventoryRepurchaseGuaranteesMember",
        "label": "Guarantee Obligations Inventory Repurchase Guarantees [Member]",
        "terseLabel": "Guarantee Obligations Inventory Repurchase Guarantees"
       }
      }
     },
     "localname": "GuaranteeObligationsInventoryRepurchaseGuaranteesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GuarantorObligationsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Period",
        "label": "Guarantor Obligations, Period",
        "terseLabel": "Debt guarantee period"
       }
      }
     },
     "localname": "GuarantorObligationsPeriod",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_HazardousSubstanceSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of sites that hazardous substances were allegedly disposed at.",
        "label": "Hazardous substance sites",
        "terseLabel": "Hazardous substance sites, number"
       }
      }
     },
     "localname": "HazardousSubstanceSites",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "positiveIntegerItemType"
    },
    "mck_HeldforSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale [Policy Text Block]",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldforSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment",
        "label": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment",
        "negatedTerseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs",
        "label": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs",
        "terseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncomeTaxExpenseBenefitDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Discrete Items",
        "label": "Income Tax Expense (Benefit) Discrete Items",
        "negatedLabel": "Net discrete tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDiscreteItems",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseinOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Liabilities",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseLiabilities",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_InreNationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "In re: National Prescription Opiate Litigation [Member]",
        "terseLabel": "In re: National Prescription Opiate Litigation"
       }
      }
     },
     "localname": "InreNationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InsuranceCoverageLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Coverage Litigation",
        "label": "Insurance Coverage Litigation [Member]",
        "terseLabel": "Insurance Coverage Litigation"
       }
      }
     },
     "localname": "InsuranceCoverageLitigationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InsuranceProgramsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]",
        "label": "Insurance Programs [Policy Text Block]",
        "terseLabel": "Insurance Programs"
       }
      }
     },
     "localname": "InsuranceProgramsPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IntangibleAssetandStoreAssetsImpairmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset and Store Assets Impairment [Member]",
        "label": "Intangible Asset and Store Assets Impairment [Member]",
        "terseLabel": "Intangible Asset and Store Assets Impairment"
       }
      }
     },
     "localname": "IntangibleAssetandStoreAssetsImpairmentMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "International Segment [Member]",
        "terseLabel": "International",
        "verboseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths [Member]",
        "label": "Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths [Member]",
        "terseLabel": "Investigation into Factors Contributing to Increase in Opioid-related Hospitalizations and Deaths"
       }
      }
     },
     "localname": "InvestigationintoFactorsContributingtoIncreaseinOpioidrelatedHospitalizationsandDeathsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]",
        "label": "Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]",
        "terseLabel": "Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640"
       }
      }
     },
     "localname": "KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Largest Customer [Member]",
        "label": "Largest Customer [Member]",
        "terseLabel": "CVS"
       }
      }
     },
     "localname": "LargestCustomerMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities Payments Due [Abstract]",
        "label": "Lease Liabilities Payments Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due",
        "label": "Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDue",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 6.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due After Year Five",
        "label": "Lease, Liability, Payments, Due After Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Next Twelve Months",
        "label": "Lease, Liability, Payments, Due Next Twelve Months",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 5.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Five",
        "label": "Lease, Liability, Payments, Due Year Five",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 4.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Four",
        "label": "Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Three",
        "label": "Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Two",
        "label": "Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseandOtherObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease and Other Obligations [Member]",
        "label": "Lease and Other Obligations [Member]",
        "terseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "LeaseandOtherObligationsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments",
        "terseLabel": "Future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LessorLeasePaymentstobeReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Lease, Payments to be Received",
        "label": "Lessor, Lease, Payments to be Received",
        "terseLabel": "Minimum sublease income"
       }
      }
     },
     "localname": "LessorLeasePaymentstobeReceived",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term",
        "label": "Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Portion To Be Used For Remediation",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Portion To Be Used For Remediation",
        "terseLabel": "Portion expected to be applied towards the opioid crisis remediation (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPortionToBeUsedForRemediation",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LongtermDebtCurrentMaturitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Current Maturities [Member]",
        "label": "Long-term Debt, Current Maturities [Member]",
        "terseLabel": "Long-term Debt, Current Maturities"
       }
      }
     },
     "localname": "LongtermDebtCurrentMaturitiesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LossContingencyAccrualProvisionAfterTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Provision, After Tax",
        "label": "Loss Contingency Accrual, Provision, After Tax",
        "terseLabel": "After-tax charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvisionAfterTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Received",
        "label": "Loss Contingency, Class Action, Number of Faxes Received",
        "terseLabel": "Number of faxes received"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesReceived",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesRemainingintheClass": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "label": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "terseLabel": "Number of faxes remaining in class"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesRemainingintheClass",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyDamagesSoughtPerViolationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Sought Per Violation, Value",
        "label": "Loss Contingency, Damages Sought Per Violation, Value",
        "terseLabel": "Damages sought per violation"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtPerViolationValue",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberofAdditionalDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional Defendants",
        "label": "Loss Contingency, Number of Additional Defendants",
        "terseLabel": "Number of other defendants in case"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalDefendants",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "label": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "terseLabel": "Number of cases selected for remand to other federal courts"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCitiesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cities Filed On Behalf Of",
        "label": "Loss Contingency, Number of Cities Filed On Behalf Of",
        "terseLabel": "Number of cities filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberofCitiesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCounties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Counties",
        "label": "Loss Contingency, Number of Counties",
        "terseLabel": "Number of county governments that brought case"
       }
      }
     },
     "localname": "LossContingencyNumberofCounties",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofFormerOfficers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Former Officers",
        "label": "Loss Contingency, Number of Former Officers",
        "terseLabel": "Number of former officers"
       }
      }
     },
     "localname": "LossContingencyNumberofFormerOfficers",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofRelators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of Relators",
        "label": "Loss Contingency Number of Relators",
        "terseLabel": "Number of relators alleging violations"
       }
      }
     },
     "localname": "LossContingencyNumberofRelators",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStatesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of States Filed On Behalf Of",
        "label": "Loss Contingency Number of States Filed On Behalf Of",
        "terseLabel": "Number of states filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Party Substitution Period to Prevent Case Dismissal",
        "label": "Loss Contingency, Party Substitution Period to Prevent Case Dismissal",
        "terseLabel": "Period within which party can be substituted"
       }
      }
     },
     "localname": "LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Expected payment period"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes",
        "label": "Loss Contingency, Settlement Agreement, Terms, Number of Companies to Adopt Anti-Diversion Programs Changes",
        "terseLabel": "Number of largest distributors"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementTermsNumberofCompaniestoAdoptAntiDiversionProgramsChanges",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_MachineryEquipmentAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery, Equipment, and Other",
        "label": "Machinery, Equipment, and Other [Member]",
        "terseLabel": "Machinery, equipment, and other"
       }
      }
     },
     "localname": "MachineryEquipmentAndOtherMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_McKessonFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "McKesson Foundation [Member]",
        "label": "McKesson Foundation [Member]",
        "terseLabel": "McKesson Foundation"
       }
      }
     },
     "localname": "McKessonFoundationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSpecialtiesDistributorsLLCMSDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Specialties Distributors LLC (\u201cMSD\u201d) [Member]",
        "label": "Medical Specialties Distributors LLC (\u201cMSD\u201d) [Member]",
        "terseLabel": "Medical Specialties Distributors LLC (\u201cMSD\u201d)"
       }
      }
     },
     "localname": "MedicalSpecialtiesDistributorsLLCMSDMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MultiemployerPlanFundedStatusPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multiemployer Plan, Funded Status, Percentage",
        "label": "Multiemployer Plan, Funded Status, Percentage",
        "terseLabel": "Funded status (as a percent)"
       }
      }
     },
     "localname": "MultiemployerPlanFundedStatusPercentage",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opiate Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NewYorkOpioidTaxSurchargeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York Opioid Tax Surcharge",
        "label": "New York Opioid Tax Surcharge [Member]",
        "terseLabel": "New York Opioid Tax Surcharge"
       }
      }
     },
     "localname": "NewYorkOpioidTaxSurchargeMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "label": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Gains recorded in earnings for ineffectiveness of Company's non-derivative hedges"
       }
      }
     },
     "localname": "NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right (in euro per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePriceIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price, Increase",
        "label": "Noncontrolling Interests, Put Right, Exercise Price, Increase",
        "terseLabel": "Put Right increase (euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePriceIncrease",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NorwegianPublicServicePensionFundSPKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norwegian Public Service Pension Fund (SPK) [Member]",
        "label": "Norwegian Public Service Pension Fund (SPK) [Member]",
        "terseLabel": "Norwegian Public Service Pension Fund (SPK)"
       }
      }
     },
     "localname": "NorwegianPublicServicePensionFundSPKMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due May 30, 2029 [Member]",
        "label": "Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NotesDueNovember302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due November 30, 2020 [Member]",
        "label": "Notes Due November 30, 2020 [Member]",
        "terseLabel": "3.65% Notes due November 30, 2020"
       }
      }
     },
     "localname": "NotesDueNovember302020Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_November2018CrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2018 Cross Currency Swaps [Member]",
        "label": "November 2018 Cross Currency Swaps [Member]",
        "terseLabel": "November 2018 Cross Currency Swaps"
       }
      }
     },
     "localname": "November2018CrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical Surgical Products",
        "label": "Number of National Brand Medical Surgical Products",
        "terseLabel": "Number of national brand medical surgical products"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberofLargestCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Largest Customers",
        "label": "Number of Largest Customers",
        "terseLabel": "Number of largest customers"
       }
      }
     },
     "localname": "NumberofLargestCustomers",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberofSitesSelectedforPreferredRemedy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Sites Selected for Preferred Remedy",
        "label": "Number of Sites Selected for Preferred Remedy",
        "terseLabel": "Number of sites selected for preferred remediation"
       }
      }
     },
     "localname": "NumberofSitesSelectedforPreferredRemedy",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberofSoftwareProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Software Products",
        "label": "Number of Software Products",
        "terseLabel": "Number of software products"
       }
      }
     },
     "localname": "NumberofSoftwareProducts",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Point Five Zero Percent Euro Notes Due November Two Thousand Twenty Five [Member]",
        "label": "One Point Five Zero Percent Euro Notes Due November Two Thousand Twenty Five [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "OnePointFiveZeroPercentEuroNotesDueNovemberTwoThousandTwentyFiveMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Point Six Three Percent Euro Notes Due October Two Thousand Twenty Six [Member]",
        "label": "One Point Six Three Percent Euro Notes Due October Two Thousand Twenty Six [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "OnePointSixThreePercentEuroNotesDueOctoberTwoThousandTwentySixMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OpenMarketTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Transactions [Member]",
        "label": "Open Market Transactions [Member]",
        "terseLabel": "Open Market Transactions"
       }
      }
     },
     "localname": "OpenMarketTransactionsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OperatingLeaseImpairmentLossNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Impairment Loss, Net of Tax",
        "label": "Operating Lease, Impairment Loss, Net of Tax",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLossNetOfTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OperatingModelAndCostOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Model and Cost Optimization Programs",
        "label": "Operating Model and Cost Optimization Programs [Member]",
        "terseLabel": "Operating Model and Cost Optimization Programs"
       }
      }
     },
     "localname": "OperatingModelAndCostOptimizationProgramsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OpioidStewardshipActNewYorkAnnualSurcharge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, New York, Annual Surcharge",
        "label": "Opioid Stewardship Act, New York, Annual Surcharge",
        "terseLabel": "Annual surcharge"
       }
      }
     },
     "localname": "OpioidStewardshipActNewYorkAnnualSurcharge",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Allowances [Member]",
        "label": "Other Allowances [Member]",
        "terseLabel": "Other allowances"
       }
      }
     },
     "localname": "OtherAllowancesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax",
        "label": "Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax",
        "negatedTerseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "label": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "terseLabel": "Foreign currency translation adjustments and other, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherNoncurrentAssetsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Noncurrent Assets / Liabilities [Member]",
        "label": "Other Noncurrent Assets / Liabilities [Member]",
        "terseLabel": "Other non-current assets/liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PeRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PeRSUs [Member]",
        "label": "PeRSUs [Member]",
        "terseLabel": "PeRSUs"
       }
      }
     },
     "localname": "PeRSUsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PendingAndFutureOpioidRelatedClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending and Future Opioid-Related Claims",
        "label": "Pending and Future Opioid-Related Claims [Member]",
        "terseLabel": "Pending and Future Opioid-Related Claims"
       }
      }
     },
     "localname": "PendingAndFutureOpioidRelatedClaimsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value",
        "label": "Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value",
        "terseLabel": "Amount of plan asset value"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PerformancebasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-based Stock Units [Member]",
        "label": "Performance-based Stock Units [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformancebasedStockUnitsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PharmaceuticalDistributionsReportingUnitJune2018OneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Distributions Reporting Unit - June 2018 One [Member]",
        "label": "Pharmaceutical Distributions Reporting Unit - June 2018 One [Member]",
        "terseLabel": "Pharmaceutical Distribution"
       }
      }
     },
     "localname": "PharmaceuticalDistributionsReportingUnitJune2018OneMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PharmaceuticalDistributionsReportingUnitJune2018TwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Distributions Reporting Unit - June 2018 Two [Member]",
        "label": "Pharmaceutical Distributions Reporting Unit - June 2018 Two [Member]",
        "terseLabel": "Pharmaceutical Distribution"
       }
      }
     },
     "localname": "PharmaceuticalDistributionsReportingUnitJune2018TwoMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PharmaceuticalDistributionsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical Distributions Reporting Unit [Member]",
        "label": "Pharmaceutical Distributions Reporting Unit [Member]",
        "terseLabel": "Pharmaceutical Distribution"
       }
      }
     },
     "localname": "PharmaceuticalDistributionsReportingUnitMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]",
        "label": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA, [Member]",
        "terseLabel": "Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH &amp; Co. KGaA"
       }
      }
     },
     "localname": "PolygonEuropeanEquityOpportunityMasterFundetal.v.McKessonEuropeHoldingsGmbHCo.KGaAMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]",
        "label": "Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]",
        "terseLabel": "Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC"
       }
      }
     },
     "localname": "PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]",
        "label": "Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prescription Technology Solutions Segment",
        "label": "Prescription Technology Solutions Segment [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant and Equipment, Including Net Capitalized Software",
        "label": "Property, Plant and Equipment, Including Net Capitalized Software",
        "verboseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Annual increase in interest (percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range One [Member]",
        "label": "Range One [Member]",
        "terseLabel": "Range One"
       }
      }
     },
     "localname": "RangeOneMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Two [Member]",
        "label": "Range Two [Member]",
        "terseLabel": "Range Two"
       }
      }
     },
     "localname": "RangeTwoMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RealPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Property [Member]",
        "label": "Real Property [Member]",
        "terseLabel": "Real Property"
       }
      }
     },
     "localname": "RealPropertyMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "label": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "terseLabel": "Maximum redemption value"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMaximumRedemptionValue",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance-based Stock Units [Member]",
        "label": "Restricted Stock Units and Performance-based Stock Units [Member]",
        "terseLabel": "RSUs and PSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsandPerformancebasedStockUnitsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RetailPharmacyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Pharmacy Reporting Unit [Member]",
        "label": "Retail Pharmacy Reporting Unit [Member]",
        "terseLabel": "Retail Pharmacy"
       }
      }
     },
     "localname": "RetailPharmacyReportingUnitMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Derived revenues (percent)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns",
        "terseLabel": "Sales returns from customers"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RexallHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rexall Health [Member]",
        "label": "Rexall Health [Member]",
        "terseLabel": "Rexall Health"
       }
      }
     },
     "localname": "RexallHealthMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount",
        "terseLabel": "Current allowances"
       }
      }
     },
     "localname": "SECSchedule1209ValuationAllowancesandReservesCurrentAmount",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award Data Related To Stock Option Activity [Table Text Block]",
        "terseLabel": "Summary of data related to stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]",
        "label": "Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used to estimate fair value of PSUs"
       }
      }
     },
     "localname": "ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_SecondPartOfPayContributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Part Of Pay Contribution [Member]",
        "label": "Second Part Of Pay Contribution [Member]",
        "terseLabel": "Second Part Of Pay Contribution"
       }
      }
     },
     "localname": "SecondPartOfPayContributionMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2020 Credit Facility)"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeparationofChangeHealthcareJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separation of Change Healthcare JV [Member]",
        "label": "Separation of Change Healthcare JV [Member]",
        "terseLabel": "Separation of Change Healthcare JV"
       }
      }
     },
     "localname": "SeparationofChangeHealthcareJVMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services Business [Member]",
        "label": "Services Business [Member]",
        "terseLabel": "Services Business"
       }
      }
     },
     "localname": "ServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlementofExecutiveRetirementBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement of Executive Retirement Benefits [Member]",
        "label": "Settlement of Executive Retirement Benefits [Member]",
        "terseLabel": "Settlement of Executive Retirement Benefits"
       }
      }
     },
     "localname": "SettlementofExecutiveRetirementBenefitsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Seven Point Six Five Percent Debentures Due March One Two Thousand Twenty Seven [Member]",
        "label": "Seven Point Six Five Percent Debentures Due March One Two Thousand Twenty Seven [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "SevenPointSixFivePercentDebenturesDueMarchOneTwoThousandTwentySevenMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]",
        "label": "Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]",
        "terseLabel": "Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs"
       }
      }
     },
     "localname": "ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period",
        "negatedTerseLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested",
        "verboseLabel": "Vested RSUs (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_ShareholderDerivativeActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Derivative Action",
        "label": "Shareholder Derivative Action [Member]",
        "terseLabel": "Shareholder Derivative Action"
       }
      }
     },
     "localname": "ShareholderDerivativeActionMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SiteContingencyNumberofSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of sites requiring environmental conditions to be addressed.",
        "label": "Site Contingency Number of Sites",
        "terseLabel": "Number of sites"
       }
      }
     },
     "localname": "SiteContingencyNumberofSites",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_SixPercentNotesDueMarchOneTwoThousandFortyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Six Percent Notes Due March One Two Thousand Forty One [Member]",
        "label": "Six Percent Notes Due March One Two Thousand Forty One [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "SixPercentNotesDueMarchOneTwoThousandFortyOneMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockExchangedDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchanged During Period, Shares",
        "label": "Stock Exchanged During Period, Shares",
        "negatedLabel": "Change Healthcare share exchange (in shares)"
       }
      }
     },
     "localname": "StockExchangedDuringPeriodShares",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_StockExchangedDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchanged During Period, Value",
        "label": "Stock Exchanged During Period, Value",
        "negatedLabel": "Change Healthcare share exchange"
       }
      }
     },
     "localname": "StockExchangedDuringPeriodValue",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]",
        "label": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]",
        "label": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SupplierIncentivesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Incentives, Policy [Policy Text Block]",
        "label": "Supplier Incentives, Policy [Policy Text Block]",
        "terseLabel": "Supplier Incentives"
       }
      }
     },
     "localname": "SupplierIncentivesPolicyPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_SupplierReservesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]",
        "label": "Supplier Reserves [Policy Text Block]",
        "terseLabel": "Supplier Reserves"
       }
      }
     },
     "localname": "SupplierReservesPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized",
        "label": "Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized",
        "terseLabel": "Percentage of net cash tax savings realized or deemed realized under TRA (percent)"
       }
      }
     },
     "localname": "TaxAgreementReceivablePercentofNetCashTaxSavingsRealized",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_TaxReceivableAgreementTRAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "label": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "terseLabel": "Tax Receivable Agreement (\u201cTRA\u201d)"
       }
      }
     },
     "localname": "TaxReceivableAgreementTRAMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TerminationofU.SDefinedBenefitPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of U.S Defined Benefit Pension Plan [Member]",
        "label": "Termination of U.S Defined Benefit Pension Plan [Member]",
        "terseLabel": "Termination of U.S Defined Benefit Pension Plan"
       }
      }
     },
     "localname": "TerminationofU.SDefinedBenefitPensionPlanMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]",
        "label": "Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]",
        "terseLabel": "Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits"
       }
      }
     },
     "localname": "TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThirdPartySellerofRexallHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Party Seller of Rexall Health [Member]",
        "label": "Third Party Seller of Rexall Health [Member]",
        "terseLabel": "Third Party Seller of Rexall Health"
       }
      }
     },
     "localname": "ThirdPartySellerofRexallHealthMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Eight Zero Percent Notes Due March Fifteenth Two Thousand Twenty Four [Member]",
        "label": "Three Point Eight Zero Percent Notes Due March Fifteenth Two Thousand Twenty Four [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "ThreePointEightZeroPercentNotesDueMarchFifteenthTwoThousandTwentyFourMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Nine Five Percent Notes Due February Sixteenth Two Thousand Twenty Eight [Member]",
        "label": "Three Point Nine Five Percent Notes Due February Sixteenth Two Thousand Twenty Eight [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "ThreePointNineFivePercentNotesDueFebruarySixteenthTwoThousandTwentyEightMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point One Three Percent Sterling Notes Due February Two Thousand Twenty Nine [Member]",
        "label": "Three Point One Three Percent Sterling Notes Due February Two Thousand Twenty Nine [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "ThreePointOneThreePercentSterlingNotesDueFebruaryTwoThousandTwentyNineMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TransitionServicesAgreementsTSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Services Agreements (\u201cTSA\u201d) [Member]",
        "label": "Transition Services Agreements (\u201cTSA\u201d) [Member]",
        "terseLabel": "Transition Services Agreements (\u201cTSA\u201d)"
       }
      }
     },
     "localname": "TransitionServicesAgreementsTSAMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "label": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "terseLabel": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al"
       }
      }
     },
     "localname": "TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Eight Five Percent Notes Due March Fifteen Two Thousand Twenty Three [Member]",
        "label": "Two Point Eight Five Percent Notes Due March Fifteen Two Thousand Twenty Three [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "TwoPointEightFivePercentNotesDueMarchFifteenTwoThousandTwentyThreeMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Seven Zero Percent Notes Due December Fifteen Two Thousand Twenty Two [Member]",
        "label": "Two Point Seven Zero Percent Notes Due December Fifteen Two Thousand Twenty Two [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "TwoPointSevenZeroPercentNotesDueDecemberFifteenTwoThousandTwentyTwoMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Two Eight Notes Due March Fifteenth Two Thousand Nineteen [Member]",
        "label": "Two Point Two Eight Notes Due March Fifteenth Two Thousand Nineteen [Member]",
        "terseLabel": "2.28% Notes due March 15, 2019"
       }
      }
     },
     "localname": "TwoPointTwoEightNotesDueMarchFifteenthTwoThousandNineteenMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_U.S.PharmaceuticalandSpecialtySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical and Specialty Solutions [Member]",
        "label": "U.S. Pharmaceutical and Specialty Solutions [Member]",
        "terseLabel": "U.S. Pharmaceutical and Specialty Solutions [Member]"
       }
      }
     },
     "localname": "U.S.PharmaceuticalandSpecialtySolutionsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitValueOfCashAndCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unit value of cash and cash equivalents",
        "label": "Unit Value Of Cash And Cash Equivalents",
        "terseLabel": "Unit value of cash and cash equivalents (in dollars per share)"
       }
      }
     },
     "localname": "UnitValueOfCashAndCashEquivalents",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA",
        "label": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]",
        "terseLabel": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA"
       }
      }
     },
     "localname": "UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]",
        "label": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]",
        "terseLabel": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al"
       }
      }
     },
     "localname": "UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]",
        "label": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]",
        "terseLabel": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al."
       }
      }
     },
     "localname": "UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Piacentile v. Amgen Inc., et al. [Member]",
        "label": "United States ex rel. Piacentile v. Amgen Inc., et al. [Member]",
        "terseLabel": "United States ex rel. Piacentile v. Amgen Inc., et al."
       }
      }
     },
     "localname": "UnitedStatesexrel.Piacentilev.AmgenInc.etal.Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]",
        "label": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]",
        "terseLabel": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931"
       }
      }
     },
     "localname": "UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation",
        "terseLabel": "Exchange rate fluctuations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves, deductions credited to other accounts [Member]",
        "label": "Valuation Allowances And Reserves Deductions Credited To Other Accounts [Member]",
        "terseLabel": "Credited to other accounts and other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves, deductions written off [Member]",
        "label": "Valuation Allowances And Reserves Deductions Written Off [Member]",
        "terseLabel": "Written-off"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductionsWrittenOffMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WalgreensBootsAllianceJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walgreens Boots Alliance Joint Venture",
        "label": "Walgreens Boots Alliance Joint Venture [Member]",
        "terseLabel": "Walgreens Boots Alliance Joint Venture"
       }
      }
     },
     "localname": "WalgreensBootsAllianceJointVentureMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero Point Six Three Percent Euro Notes Due August Two Thousand Twenty One [Member]",
        "label": "Zero Point Six Three Percent Euro Notes Due August Two Thousand Twenty One [Member]",
        "terseLabel": "0.63% Euro Notes due August 17, 2021"
       }
      }
     },
     "localname": "ZeroPointSixThreePercentEuroNotesDueAugustTwoThousandTwentyOneMember",
     "nsuri": "http://mckesson123.com/20210331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r707",
      "r708",
      "r718",
      "r719",
      "r967",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r707",
      "r708",
      "r718",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r256",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r276",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r256",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r276",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r85",
      "r177",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r199",
      "r207",
      "r316",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount after cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r199",
      "r207",
      "r316",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustments: adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r199",
      "r207",
      "r316",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r199",
      "r207",
      "r316",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of executive officer.",
        "label": "Executive Officer [Member]",
        "terseLabel": "Retired executive"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r287",
      "r460",
      "r463",
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r559",
      "r569",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r846",
      "r929",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r559",
      "r569",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r846",
      "r929",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r287",
      "r460",
      "r463",
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r283",
      "r460",
      "r461",
      "r850",
      "r928",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r283",
      "r460",
      "r461",
      "r850",
      "r928",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r495",
      "r559",
      "r569",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r846",
      "r929",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r495",
      "r559",
      "r569",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r846",
      "r929",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r194",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r284",
      "r285",
      "r460",
      "r462",
      "r931",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r284",
      "r285",
      "r460",
      "r462",
      "r931",
      "r952",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r981",
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r289",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r194",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.",
        "label": "Accelerated Share Repurchases [Table Text Block]",
        "terseLabel": "Schedule of shares repurchased over last three years"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "ASU 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r182",
      "r829",
      "r879",
      "r913"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Pledge payable balance"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r290",
      "r291"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "totalLabel": "Total receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r389",
      "r409",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Estimated loss"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingenciesGross": {
     "auth_ref": [
      "r389",
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount of the accrual for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies, Gross",
        "terseLabel": "Remediation costs"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingenciesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "verboseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r96",
      "r102",
      "r105",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r95",
      "r102",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r95",
      "r102",
      "r105",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r62",
      "r380"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r89",
      "r102",
      "r714",
      "r784",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r89",
      "r102",
      "r105",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax",
        "verboseLabel": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r102",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r91",
      "r102",
      "r105",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized gains (losses) on cash flow hedges:",
        "verboseLabel": "Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r102",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r97",
      "r102",
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "terseLabel": "Accumulated pension obligation"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r99",
      "r101",
      "r102",
      "r906",
      "r941",
      "r945"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r98",
      "r102",
      "r105",
      "r196",
      "r197",
      "r198",
      "r714",
      "r936",
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Total Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "verboseLabel": "Weighted average life (years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Less: Restricted cash at end of period included in Other Noncurrent Assets"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r48",
      "r616"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r613",
      "r614",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital",
        "verboseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r160",
      "r366"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r663",
      "r664",
      "r665",
      "r666",
      "r852",
      "r853",
      "r854",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r571",
      "r573",
      "r619",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r251",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r573",
      "r605",
      "r618"
     ],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Share-based compensation expense, net of tax"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowances for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r295",
      "r322",
      "r325",
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r54",
      "r295",
      "r322"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "terseLabel": "Pre-tax charges related to customer bankruptcy"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r160",
      "r359",
      "r366"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Potentially dilutive securities excluded from diluted earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r160",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Long-lived asset impairment charges, before tax"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r174",
      "r264",
      "r271",
      "r278",
      "r309",
      "r707",
      "r718",
      "r779",
      "r872",
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets",
        "verboseLabel": "VIE consolidated assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails",
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "netLabel": "Assets",
        "terseLabel": "ASSETS",
        "verboseLabel": "Segment assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r83",
      "r174",
      "r309",
      "r707",
      "r718",
      "r779"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r377",
      "r383"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale",
        "totalLabel": "Total Assets held for sale",
        "verboseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r574",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r742",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r28",
      "r379"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r552",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r552",
      "r565",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r692",
      "r693",
      "r695"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Net purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Additional contingent consideration that may be paid"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r691",
      "r694",
      "r696"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]",
        "terseLabel": "Amounts Recognized"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r170",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r160",
      "r390",
      "r396",
      "r402"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.",
        "label": "Capital Loss Carryforward [Member]",
        "terseLabel": "Capital Loss Carryforward"
       }
      }
     },
     "localname": "CapitalLossCarryforwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r970"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "terseLabel": "Capitalized software held for internal use, accumulated amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r969",
      "r971"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized software held for internal use, amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r968"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "terseLabel": "Capitalized software held for internal use, net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r58",
      "r162"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r163",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r33",
      "r163",
      "r170",
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r154",
      "r162",
      "r168"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r154",
      "r783"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r172",
      "r174",
      "r215",
      "r219",
      "r220",
      "r222",
      "r224",
      "r236",
      "r237",
      "r238",
      "r309",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r72",
      "r410",
      "r880",
      "r912"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingent liabilities (Note 19)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r428",
      "r953",
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common stock, $0.01 par value"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized, 273 and 272 shares issued at March 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r108",
      "r110",
      "r111",
      "r123",
      "r890",
      "r922"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r110",
      "r122",
      "r705",
      "r706",
      "r729",
      "r889",
      "r921"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r110",
      "r121",
      "r704",
      "r729",
      "r888",
      "r920"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r246",
      "r247",
      "r287",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r246",
      "r247",
      "r287",
      "r777",
      "r778",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r246",
      "r247",
      "r287",
      "r777",
      "r778",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r241",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and Receivables"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r246",
      "r247",
      "r287",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of total consolidated revenues (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r246",
      "r247",
      "r287",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r715",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Schedule of Changes in Noncontrolling Interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r170",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "auth_ref": [
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by description of stock conversions.",
        "label": "Stock Conversion Description [Axis]",
        "terseLabel": "Stock Conversion Description [Axis]"
       }
      }
     },
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "auth_ref": [
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The unique name of a noncash or part noncash stock conversion.",
        "label": "Conversion of Stock, Name [Domain]",
        "terseLabel": "Conversion of Stock, Name [Domain]"
       }
      }
     },
     "localname": "ConversionOfStockNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r496",
      "r545",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.",
        "label": "Corporate Joint Venture [Member]",
        "terseLabel": "Corporate Joint Venture"
       }
      }
     },
     "localname": "CorporateJointVentureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r280",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r131",
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r396",
      "r397",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r323",
      "r324",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.",
        "label": "Credit Loss, Financial Instrument [Policy Text Block]",
        "terseLabel": "Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "CreditLossFinancialInstrumentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "verboseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r659",
      "r669"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r181",
      "r659"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r659",
      "r669",
      "r671"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r659",
      "r669"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r244",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in earnings from investment in debt and equity securities measured at fair value with change in fair value recognized in net income, and recognized from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity) to investment in debt security measured at fair value with change in fair value recognized in net income (trading). Excludes other-than-temporary impairment (OTTI).",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment",
        "terseLabel": "Net gains associated with equity investments"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r873",
      "r875",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r797",
      "r799"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value of liabilities",
        "verboseLabel": "Long-term debt, including current maturities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r70",
      "r178",
      "r441",
      "r442",
      "r443",
      "r444",
      "r796",
      "r797",
      "r799",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of facility"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Amount of decrease in unrecognized tax benefits that is reasonably possible in the next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r660",
      "r669"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r660",
      "r669"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r630",
      "r631"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Long-term deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r175",
      "r660",
      "r669",
      "r670",
      "r671"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "negatedLabel": "Deferred tax benefit",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r42",
      "r43",
      "r649",
      "r874",
      "r901"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r630",
      "r631"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Long-term deferred tax liability",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r660",
      "r669"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r655",
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Net operating loss and credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Compensation and benefit related accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "terseLabel": "Receivable allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r651"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r631",
      "r652"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedTerseLabel": "Inventory valuation and other assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r657",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Fixed assets and systems development costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r97",
      "r102",
      "r516"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r102",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r102",
      "r516"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r102",
      "r516"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "verboseLabel": "Prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r485",
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedLabel": "Actuarial loss (gain)",
        "terseLabel": "Actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit": {
     "auth_ref": [
      "r471",
      "r511",
      "r539"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.",
        "label": "Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit",
        "negatedTerseLabel": "Actuarial losses from pension plans",
        "terseLabel": "Actuarial losses from pension plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r469",
      "r493"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r36",
      "r469",
      "r470",
      "r493",
      "r545",
      "r871",
      "r903"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan",
        "terseLabel": "Annuity Premium Transfer"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsTransferredToFromPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Weighted-average discount rates for actuarial present value of benefit obligations (percent)",
        "verboseLabel": "Discount rates (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "verboseLabel": "Discount rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r520",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of increase in compensation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of period",
        "periodStartLabel": "Benefit obligation at beginning of period",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r480",
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r523",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r487",
      "r496",
      "r498",
      "r543",
      "r545",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Amounts of plan exceeding total plan contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "negatedTerseLabel": "Divestiture"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "verboseLabel": "Expected benefit payments in 2027 through 2031"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "verboseLabel": "Expected benefit payments in 2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "verboseLabel": "Expected benefit payments in 2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "verboseLabel": "Expected benefit payments in 2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Expected benefit payments in 2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "verboseLabel": "Expected benefit payments in 2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r506",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "verboseLabel": "Expected contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r471",
      "r510",
      "r538",
      "r545",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r484",
      "r496",
      "r498",
      "r499",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of period",
        "periodStartLabel": "Fair value of plan assets at beginning of period",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r469",
      "r493",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of period"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r471",
      "r476",
      "r509",
      "r537",
      "r545",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost on projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r507",
      "r535",
      "r545",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r489",
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r472",
      "r514",
      "r542"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "negatedTerseLabel": "Curtailment/settlement loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r472",
      "r514",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedLabel": "Pre-tax pension settlement charges",
        "negatedTerseLabel": "Pre-tax pension settlement charges"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r474",
      "r508",
      "r536",
      "r545",
      "r546"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost - benefits earned during the year"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "terseLabel": "Settlement payments made"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r529",
      "r530",
      "r533",
      "r534",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Contribution expenses"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Company match employee contributions (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Percentage of eligible compensation (up to percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r160",
      "r378"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r160",
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization [Abstract]",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r160",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r734",
      "r735",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative asset, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]",
        "verboseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r84",
      "r86",
      "r744",
      "r845"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of derivative asset, gross fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r84",
      "r86",
      "r744",
      "r845"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of derivative liability, gross fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r743",
      "r745",
      "r749",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r740",
      "r743",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r748",
      "r750"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gains (losses) from contracts not designated as hedges"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r734",
      "r735",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative liability, notional amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r735",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amounts of derivative"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r733",
      "r736",
      "r737",
      "r740",
      "r741",
      "r747",
      "r749",
      "r756",
      "r758",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r183",
      "r733",
      "r736",
      "r740",
      "r741",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting",
        "verboseLabel": "Derivatives Designated for Hedge Accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r376",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r17",
      "r374",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r383"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses": {
     "auth_ref": [
      "r788"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)",
        "negatedTerseLabel": "Cumulative foreign currency translation adjustment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r377",
      "r383"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r160",
      "r376",
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "terseLabel": "Charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r22",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r552",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r551",
      "r555",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r182",
      "r829",
      "r878",
      "r914"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due from Related Parties",
        "terseLabel": "Due from Related Parties"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation",
        "verboseLabel": "Earnings (Loss) Per Common Share Attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r124",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r213",
      "r215",
      "r222",
      "r223",
      "r224",
      "r228",
      "r229",
      "r891",
      "r923"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r124",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r215",
      "r222",
      "r223",
      "r224",
      "r228",
      "r229",
      "r891",
      "r923"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r783"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r633",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory federal income tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r621",
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "verboseLabel": "Tax expense (benefit) related to adoption of amended accounting guidance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r606"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax",
        "verboseLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period in years over which restricted stock unit award cost is expected to be recognized",
        "verboseLabel": "Weighted-average period in years over which stock option compensation cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r605"
     ],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "negatedTerseLabel": "Tax benefit for share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefits realized related to exercise"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock purchase plan",
        "verboseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r201",
      "r210",
      "r212",
      "r235",
      "r316",
      "r440",
      "r445",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r791",
      "r936",
      "r937",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Pre-tax other-than-temporary impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest in Joint Venture (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r125",
      "r126",
      "r160"
     ],
     "calculation": {
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Net gain from sale of equity method investment, pre-tax",
        "totalLabel": "Net gain on split-off of the Change Healthcare JV",
        "verboseLabel": "Gain from sale of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r59",
      "r265",
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Carrying value of investment in joint venture"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVenture"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r59",
      "r153",
      "r170",
      "r307",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Net Gain on Split-off of Change Healthcare JV"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Investments in equity securities of growth stage companies"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r302"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Net gains on investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r302",
      "r925"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Investment Assets at Fair Value",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r762",
      "r763",
      "r764",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r762",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of information regarding fair value of derivatives on a gross basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r545",
      "r763",
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r762",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r762",
      "r763",
      "r765",
      "r766",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r496",
      "r498",
      "r503",
      "r545",
      "r763",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r496",
      "r498",
      "r503",
      "r545",
      "r763",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r545",
      "r763",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r545",
      "r836",
      "r837",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r762",
      "r763",
      "r765",
      "r766",
      "r767",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Measurements, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r742",
      "r747",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r803",
      "r811",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 2.0,
       "parentTag": "mck_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r806",
      "r816"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "negatedTerseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r802",
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiability",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r805",
      "r816"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r801"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r803",
      "r811",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 1.0,
       "parentTag": "mck_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r819",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - Finance leases (percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r818",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (Years) - Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinanceLoansAndLeasesReceivablePolicy": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for financing receivable.",
        "label": "Financing Receivable [Policy Text Block]",
        "terseLabel": "Financing Receivables"
       }
      }
     },
     "localname": "FinanceLoansAndLeasesReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Estimated annual amortization expense, after 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r360",
      "r363",
      "r365",
      "r369",
      "r851",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r365",
      "r855"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r360",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r365",
      "r851"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FixedIncomeFundsMember": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments.",
        "label": "Fixed Income Funds [Member]",
        "terseLabel": "Fixed income commingled funds"
       }
      }
     },
     "localname": "FixedIncomeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r496",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r551",
      "r555",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Non-U.S. Plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r160",
      "r717"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Pre-tax loss on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "auth_ref": [
      "r160",
      "r892"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.",
        "label": "Gain (Loss) on Sale of Derivatives",
        "terseLabel": "Settlement gain recorded in earnings"
       }
      }
     },
     "localname": "GainLossOnSaleOfDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "(Gain) loss from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r125",
      "r126",
      "r160",
      "r883",
      "r924"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "negatedLabel": "Pre-tax dilution loss"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Litigation settlement charges"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r346",
      "r348",
      "r870"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetofCashandCashEquivalents",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and other asset impairment charges"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r170",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r349",
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r160",
      "r347",
      "r351",
      "r357"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Goodwill impairment",
        "negatedTerseLabel": "Goodwill impairment charges",
        "terseLabel": "Goodwill impairment charge",
        "verboseLabel": "Non-cash pre-tax charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLossNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss, Net of Tax",
        "terseLabel": "Goodwill impairment, after tax"
       }
      }
     },
     "localname": "GoodwillImpairmentLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "terseLabel": "Other changes/disposals"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r353",
      "r682"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "verboseLabel": "Acquisition accounting, transfers and other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r128",
      "r174",
      "r264",
      "r270",
      "r274",
      "r277",
      "r280",
      "r309",
      "r779"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Guarantor Obligations [Line Items]",
        "terseLabel": "Guarantor Obligations [Line Items]"
       }
      }
     },
     "localname": "GuaranteeObligationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor obligations, maximum exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r740",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r160",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges, before tax"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r129",
      "r161",
      "r205",
      "r206",
      "r207",
      "r208",
      "r221",
      "r224",
      "r703"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to McKesson"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) after income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r180",
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r116",
      "r264",
      "r270",
      "r274",
      "r277",
      "r280",
      "r868",
      "r884",
      "r894",
      "r926"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r180",
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r174",
      "r200",
      "r264",
      "r270",
      "r274",
      "r277",
      "r280",
      "r309",
      "r704",
      "r779"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Continuing operations",
        "totalLabel": "Income (loss) from continuing operations",
        "verboseLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r114",
      "r124",
      "r200",
      "r205",
      "r206",
      "r207",
      "r208",
      "r215",
      "r222",
      "r223",
      "r881",
      "r885",
      "r891",
      "r916"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r114",
      "r124",
      "r200",
      "r205",
      "r206",
      "r207",
      "r208",
      "r215",
      "r222",
      "r223",
      "r224",
      "r891",
      "r916",
      "r919",
      "r923"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r18",
      "r21",
      "r676",
      "r917"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Discontinued operations",
        "terseLabel": "Income (loss) from discontinued operations, net of tax",
        "verboseLabel": "Income (loss) from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r118",
      "r124",
      "r219",
      "r222",
      "r223",
      "r891",
      "r917",
      "r919",
      "r923"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r219",
      "r222",
      "r223",
      "r731"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r117",
      "r160",
      "r261",
      "r305",
      "r882",
      "r915"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture",
        "verboseLabel": "Equity in earnings, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r552",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Discontinued Operations Disclosures"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r639",
      "r646",
      "r648",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r634",
      "r647",
      "r654",
      "r667",
      "r674",
      "r677",
      "r678",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax expense (benefit), before any tax effect, related to accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r175",
      "r211",
      "r212",
      "r262",
      "r632",
      "r668",
      "r675",
      "r927"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "totalLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r170",
      "r628",
      "r629",
      "r647",
      "r648",
      "r653",
      "r661",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r627",
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Impact of change in U.S. tax rate on temporary differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "terseLabel": "Tax-free gain on investment exit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Tax effect of foreign operations"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax expense (benefit) at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount",
        "terseLabel": "Non-deductible goodwill"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Unrecognized tax benefits and settlements"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "Research and development credit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r224"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "verboseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r362",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r362",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r170",
      "r364",
      "r847",
      "r848",
      "r849",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r115",
      "r258",
      "r795",
      "r798",
      "r893"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpensePolicyTextBlock": {
     "auth_ref": [
      "r169",
      "r170",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.",
        "label": "Interest Expense, Policy [Policy Text Block]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpensePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r149",
      "r156",
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest, net"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r170",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Software Held for Internal Use"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "LIFO reserve"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r343"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "negatedLabel": "Credits associated with last-in, first-out inventory method",
        "terseLabel": "Credits associated with last-in, first-out inventory method"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r77"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r29",
      "r78",
      "r170",
      "r231",
      "r340",
      "r342",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r77",
      "r194",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves (excluding LIFO reserves)"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvesteeMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A corporation that issued voting stock held by an investor.",
        "label": "Investee [Member]",
        "terseLabel": "Investee"
       }
      }
     },
     "localname": "InvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r134",
      "r257"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r27",
      "r61"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r820",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of lease costs and supplemental cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Leases, Operating [Abstract]"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "negatedTerseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Noncancelable lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal option increments for leases (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorDirectFinancingLeasesTextBlock": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's direct financing leases.",
        "label": "Lessor, Direct Financing Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorDirectFinancingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r66",
      "r174",
      "r272",
      "r309",
      "r708",
      "r718",
      "r719",
      "r779"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "VIE consolidated liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r53",
      "r174",
      "r309",
      "r779",
      "r877",
      "r909"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r68",
      "r174",
      "r309",
      "r708",
      "r718",
      "r719",
      "r779"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r762"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value on a nonrecurring basis"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r39",
      "r40",
      "r174",
      "r309",
      "r708",
      "r718",
      "r719",
      "r779"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Noncurrent liability"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r15",
      "r17",
      "r21",
      "r377",
      "r383"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale",
        "totalLabel": "Total Liabilities held for sale",
        "verboseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Pharmacy licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r39",
      "r875",
      "r902"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "verboseLabel": "Credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility borrowing capacity",
        "verboseLabel": "Credit facility borrowing capacity (up to)"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r65",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r72",
      "r410"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Aggregate amount expected to be paid"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Notes"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r39",
      "r434",
      "r875",
      "r905"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Total debt outstanding",
        "totalLabel": "Total debt",
        "verboseLabel": "Total debt outstanding"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r185",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Scheduled principal payments of long-term debt, thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r185",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Scheduled principal payments of long-term debt in 2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r185",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Scheduled principal payments of long-term debt in 2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r185",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Scheduled principal payments of long-term debt in 2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r185",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Scheduled principal payments of long-term debt in 2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r185",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Scheduled principal payments of long-term debt in 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r70",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r414",
      "r415",
      "r416",
      "r417",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r414",
      "r415",
      "r416",
      "r417",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r414",
      "r415",
      "r416",
      "r417",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of complaints served"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities Available-for-Sale"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r22",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Business Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r76",
      "r174",
      "r309",
      "r779",
      "r876",
      "r908"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests",
        "verboseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest (percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "verboseLabel": "Percentage of outstanding common shares"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r76",
      "r130",
      "r702",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interests [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlansWithdrawalObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.",
        "label": "Multiemployer Plans, Withdrawal Obligation",
        "terseLabel": "Amounts accrued for liability"
       }
      }
     },
     "localname": "MultiemployerPlansWithdrawalObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Equity commingled funds"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r154",
      "r157",
      "r161"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r21",
      "r106",
      "r109",
      "r119",
      "r161",
      "r174",
      "r200",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r221",
      "r264",
      "r270",
      "r274",
      "r277",
      "r280",
      "r309",
      "r779",
      "r886",
      "r918"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net income (loss) attributable to McKesson Corporation",
        "totalLabel": "Net income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r106",
      "r109",
      "r211",
      "r212",
      "r711",
      "r728"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r228",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r663",
      "r664",
      "r665",
      "r666",
      "r852",
      "r853",
      "r854",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Foreign",
        "verboseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r445",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "netLabel": "Noncontrolling interests",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated for hedge accounting",
        "verboseLabel": "Derivatives Not Designated for Hedge Accounting"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/OtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r264",
      "r270",
      "r274",
      "r277",
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r812",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r804"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r802"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r807",
      "r816"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "negatedTerseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r801"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r819",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - Operating leases (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r818",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (Years) - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r800"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r655"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Federal, state and foreign net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAdditionalCapitalMember": {
     "auth_ref": [
      "r137",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a category to capture additional Paid-in Capital other than attributable to capital contributed by shareholders in excess of the par or stated value of the common or preferred stock issued by an entity. Certain entities report two components of additional Paid-in Capital consisting of (i) capital in excess of par or stated value and (ii) other additional capital. This member is only to be used if the entity distinguishes between additional Paid-in Capital and other additional capital in its financial statements. If using this element, the preparer would be expected to elevate the Other Additional Capital [Member] to the same level as the Additional Paid-in Capital [Member].",
        "label": "Other Additional Capital [Member]",
        "terseLabel": "Other Capital"
       }
      }
     },
     "localname": "OtherAdditionalCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r88",
      "r100",
      "r780",
      "r782",
      "r790"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "terseLabel": "Foreign currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r99",
      "r103",
      "r104",
      "r515"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Prior service credit (cost)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Amortization of actuarial loss, prior service and transition obligation, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r102",
      "r113",
      "r784",
      "r786",
      "r791"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedTerseLabel": "Unrealized gain (loss) on net investment hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r91",
      "r99"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gains (losses) on cash flow hedges",
        "verboseLabel": "Gains (losses) recorded in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "negatedTerseLabel": "Unrealized gains (losses) on cash flow hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax": {
     "auth_ref": [
      "r100",
      "r782",
      "r790"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax",
        "negatedTerseLabel": "Reclassified to net income, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r107",
      "r110",
      "r113",
      "r120",
      "r440",
      "r784",
      "r789",
      "r791",
      "r887",
      "r919"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of tax",
        "verboseLabel": "Net foreign currency translation gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r107",
      "r110",
      "r704",
      "r705",
      "r713"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r107",
      "r110",
      "r704",
      "r705",
      "r713"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r97",
      "r99",
      "r515",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in net periodic benefit cost and other comprehensive loss (income)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r97",
      "r99"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r100",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "negatedTerseLabel": "Net actuarial gain (loss) and prior service credit (costs), tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r95",
      "r99",
      "r515"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net actuarial loss (gain)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r99",
      "r103",
      "r104",
      "r515"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Actuarial loss",
        "terseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]",
        "terseLabel": "Amortization of:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r466",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r468",
      "r469",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Gross, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReceivablesGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Cash payment for contingent consideration earned"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r139",
      "r142",
      "r184"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchases, including shares surrendered for tax withholding"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "terseLabel": "Payments to purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r151",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired",
        "terseLabel": "Purchase consideration paid in cash, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "terseLabel": "Contributions made in exchange for additional membership interests"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Productive Assets [Abstract]",
        "terseLabel": "Expenditures for long-lived assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r495",
      "r497",
      "r503",
      "r522",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r545",
      "r547",
      "r548",
      "r550",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r38",
      "r469",
      "r470",
      "r493",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41",
      "r469",
      "r470",
      "r493",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability, Defined Benefit Plan [Abstract]",
        "terseLabel": "Amounts recognized on the balance sheet"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r467",
      "r469",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r550",
      "r551",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans, Defined Benefit"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "terseLabel": "LIFO inventory (percentage)"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r523",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r574",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not measured at fair value.",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "terseLabel": "Assets held at NAV practical expedient"
       }
      }
     },
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "verboseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r25",
      "r56",
      "r57"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from issuance, net"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Notes payable assumed"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.",
        "label": "Proceeds from Divestiture of Interest in Subsidiaries and Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r139",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Proceeds from termination of swaps"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Net cash proceeds from IPO"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Commercial paper issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r143",
      "r608"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Net cash proceeds from settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r144",
      "r179"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "verboseLabel": "Amount borrowed under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from other security offering"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r145",
      "r148",
      "r184"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPreviousAcquisition": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash inflow representing an adjustment to the purchase price of a previous acquisition.",
        "label": "Proceeds from Previous Acquisition",
        "terseLabel": "Proceeds from escrow settlement related to previous Acquisition"
       }
      }
     },
     "localname": "ProceedsFromPreviousAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Repurchase of) Equity [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "verboseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r143",
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received upon exercise"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r21",
      "r106",
      "r109",
      "r152",
      "r174",
      "r200",
      "r211",
      "r212",
      "r264",
      "r270",
      "r274",
      "r277",
      "r280",
      "r309",
      "r704",
      "r710",
      "r712",
      "r728",
      "r729",
      "r779",
      "r894"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r62",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r61",
      "r379"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Total property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r34",
      "r35",
      "r381",
      "r911"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net",
        "totalLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Property, Plant and Equipment, Net [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Other, Gross",
        "terseLabel": "Machinery, equipment, and other"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r170",
      "r381",
      "r956",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r34",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r34",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]",
        "terseLabel": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Financial Information (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r47",
      "r55",
      "r910",
      "r950"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "totalLabel": "Receivables, net",
        "verboseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Net, Current [Abstract]",
        "terseLabel": "Receivables, Net, Current [Abstract]"
       }
      }
     },
     "localname": "ReceivablesNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r294",
      "r299",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables, Net"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r102",
      "r105",
      "r113",
      "r784",
      "r788",
      "r791"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Reclassified to income statement, net of income tax expense",
        "negatedTerseLabel": "Amounts reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r100",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassification to income statement, tax expense"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r271",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of segment assets and property, plant and equipment, net by geographic areas"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Redeemable Noncontrolling Interest, Ending balance",
        "periodStartLabel": "Redeemable Noncontrolling Interest, Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests",
        "verboseLabel": "Carrying amount of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r523",
      "r828",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r828",
      "r832"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Total fees charged under the TSA",
        "verboseLabel": "Contributions made"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r523",
      "r828",
      "r829",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r523",
      "r828",
      "r832",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r826",
      "r827",
      "r829",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Balances and Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Commercial paper repaid"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt",
        "verboseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r23",
      "r33",
      "r168"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of year included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units",
        "verboseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r391",
      "r393",
      "r401",
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring incurred to-date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r391",
      "r393",
      "r401",
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected total pre-tax charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r391",
      "r393",
      "r401",
      "r403"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "negatedLabel": "Restructuring, impairment, and related charges, net"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r160",
      "r390",
      "r396",
      "r402"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total",
        "verboseLabel": "Pre-tax charge"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r392",
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Reserve balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Cost Alignment Plan"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r390",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r392",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "verboseLabel": "Restructuring and asset impairment charges"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r49",
      "r445",
      "r616",
      "r907",
      "r940",
      "r945"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r201",
      "r210",
      "r212",
      "r316",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666",
      "r936",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanFundingStatusAxis": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Axis]",
        "terseLabel": "Retirement Plan Funding Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanFundingStatusDomain": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Domain]",
        "terseLabel": "Retirement Plan Funding Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r551",
      "r555",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r551",
      "r555",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsOtherPostretirementBenefitsPlanDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r255",
      "r256",
      "r269",
      "r275",
      "r276",
      "r283",
      "r284",
      "r287",
      "r459",
      "r460",
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedScheduleofQuarterlyFinancialInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r171",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r127",
      "r951"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues (1)"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r817",
      "r822"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r817",
      "r822"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Offering price (in usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r246",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
     "auth_ref": [
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received",
        "terseLabel": "Total lease receivable"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r531",
      "r532",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r102",
      "r789",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Summary of pension plan assets using fair value hierarchy by asset class"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofCoverMyMedsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionofMedicalSpecialtiesDistributorsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresFairValuesRecognizedofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Fair Values Recognized of Assets and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "verboseLabel": "Schedule of components of share-based compensation expense and related tax benefits"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax balances"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.",
        "label": "Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of defined benefit plan amounts recognized in other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r529",
      "r530",
      "r533",
      "r534",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r529",
      "r530",
      "r533",
      "r534",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of changes in benefit obligations and plan assets for pension plans"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r2",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and liabilities of German wholesale joint venture classified as held for sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r21",
      "r174",
      "r308",
      "r309",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r360",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r355",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r355",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGuaranteeObligationsTable": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.",
        "label": "Schedule of Guarantor Obligations [Table]",
        "terseLabel": "Schedule of Guarantor Obligations [Table]"
       }
      }
     },
     "localname": "ScheduleOfGuaranteeObligationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of net periodic expense for pension plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the detailed components of other nonoperating income. May include methodology, assumptions and amounts for: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.",
        "label": "Schedule of Other Nonoperating Income, by Component [Table Text Block]",
        "terseLabel": "Schedule of other income, net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of quarterly financial information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/QuarterlyFinancialInformationUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r176",
      "r830",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r394",
      "r395",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r394",
      "r395",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of details for charges recorded"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r264",
      "r267",
      "r273",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r264",
      "r267",
      "r273",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Schedule of segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r574",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of restricted stock unit award activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Schedule of Share-based Compensation Data by Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of options outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r581",
      "r591",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of weighted-average assumptions used to estimate the fair value"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r707",
      "r708",
      "r718",
      "r719",
      "r720",
      "r722",
      "r723",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r251",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r287",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r251",
      "r253",
      "r254",
      "r264",
      "r268",
      "r274",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses",
        "terseLabel": "Shipping and handling costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r170",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r160",
      "r390",
      "r396",
      "r402"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Percentage of market price deduction for share purchases"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per shares)",
        "periodStartLabel": "Beginning balance (in dollars per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Stock options vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Stock options vested and exercisable, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value on exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per stock option (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Stock options outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r583",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Stock options vested and exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Stock options vested and expected to vest, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Stock options vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Stock options vested and expected to vest, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r572",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r170",
      "r574",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices lower limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number of Options Exercisable at Year End (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number of Options Outstanding at Year End (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices upper limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Stock award contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r599",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options outstanding, remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options vested and exercisable, weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options vested and expected to vest, weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of market price for share purchase"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Life (Years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance common stock (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r813",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SiteContingencyTimeFrameOfDisbursements": {
     "auth_ref": [
      "r388",
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated time frame of disbursements over which the accrued or presently unrecognized amounts may be paid out for an individual site.",
        "label": "Site Contingency, Time Frame of Disbursements",
        "terseLabel": "Time frame of disbursements"
       }
      }
     },
     "localname": "SiteContingencyTimeFrameOfDisbursements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r422",
      "r429",
      "r699",
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r251",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r287",
      "r355",
      "r384",
      "r393",
      "r403",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillImpairmentInputsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandPropertyPlantandEquipmentNetbyGeographicalAreaDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r172",
      "r174",
      "r215",
      "r219",
      "r220",
      "r222",
      "r224",
      "r236",
      "r237",
      "r238",
      "r309",
      "r440",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r74",
      "r196",
      "r197",
      "r198",
      "r201",
      "r210",
      "r212",
      "r235",
      "r316",
      "r440",
      "r445",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r791",
      "r936",
      "r937",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r235",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Additional authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Total authorization outstanding for repurchases of common stock"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Retirement of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Retirement of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r45",
      "r46",
      "r440",
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock",
        "negatedTerseLabel": "Stock Repurchased During Period, Value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r46",
      "r51",
      "r52",
      "r174",
      "r298",
      "r309",
      "r779"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "McKesson Corporation stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r174",
      "r196",
      "r197",
      "r198",
      "r201",
      "r210",
      "r309",
      "r316",
      "r445",
      "r613",
      "r614",
      "r615",
      "r665",
      "r666",
      "r701",
      "r702",
      "r727",
      "r779",
      "r784",
      "r785",
      "r791",
      "r937",
      "r938"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Cumulative effect adjustment",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Cumulative effect adjustment",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r173",
      "r445",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r815",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r792",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r792",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r792",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r636",
      "r646",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of gross unrecognized tax benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r781",
      "r786"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "verboseLabel": "Gains (losses) from net investment hedges"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": {
     "auth_ref": [
      "r90",
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.",
        "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "terseLabel": "Gains (losses) recorded in other comprehensive income"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price paid per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r73",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredParValueMethodAmount": {
     "auth_ref": [
      "r46",
      "r440",
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the par value method.",
        "label": "Treasury Stock, Retired, Par Value Method, Amount",
        "terseLabel": "Retirement of common stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredParValueMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r73",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance, treasury common stock (shares)",
        "negatedPeriodStartLabel": "Beginning balance, treasury common stock (shares)",
        "terseLabel": "Treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r46",
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Shares repurchased (in shares)",
        "verboseLabel": "Total Number of Shares Purchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r46",
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "verboseLabel": "Treasury stock retired (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r73",
      "r448",
      "r449"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury shares, at cost, 115 and 110 shares at March 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r440",
      "r445",
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Shares repurchased",
        "verboseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r663",
      "r664",
      "r665",
      "r666",
      "r852",
      "r853",
      "r854",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/InvestmentinChangeHealthcareJointVentureDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r496",
      "r895",
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r625",
      "r679",
      "r899",
      "r946"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign operations"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnfundedPlanMember": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r526",
      "r530",
      "r531",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan in which retirement benefits are payable directly from general assets of employer sponsoring plan.",
        "label": "Defined Benefit Plan, Unfunded Plan [Member]",
        "terseLabel": "Unfunded plan"
       }
      }
     },
     "localname": "UnfundedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r626",
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of period",
        "periodStartLabel": "Unrecognized tax benefits at beginning of period",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r641"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r643"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Reductions based on settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r642"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "verboseLabel": "Accrued interest and penalties on unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "negatedTerseLabel": "Decrease in unrecognized tax benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions based on the lapse of the applicable statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r645"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would Impact income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r239",
      "r240",
      "r242",
      "r243",
      "r248",
      "r249",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "verboseLabel": "Increase (decrease) in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r186",
      "r192"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expense"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Charged to Other Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions From Allowance Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r721",
      "r724"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Unconsolidated VIE maximum exposure to loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r707",
      "r708",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Consolidated Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r814",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r214",
      "r224"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding:",
        "verboseLabel": "Weighted-average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r213",
      "r224"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 30
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.T)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868742-224227"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e639-108305"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b,d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5144-111524"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32006-111567"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120269210-210444"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120254536-210444"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121648281&loc=SL120267834-210445"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL120267845-210446"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919260-210447"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919272-210447"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267966-210447"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267969-210447"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121614247&loc=SL120267897-210452"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120267917-210453"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120269220-210453"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267853-210455"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267859-210455"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267862-210455"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2599-110228"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB TOPIC 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e12803-110250"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4815-112606"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30755-110894"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=28365394&loc=d3e23770-108382"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919391-209981"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r972": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r973": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r974": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r975": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r976": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r977": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r978": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r979": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r980": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r981": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r982": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r983": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r984": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r985": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>149
<FILENAME>0000927653-21-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-21-000039-xbrl.zip
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M7P3/6?"*PXN#>X*.+=EY7Y0V$JAZU0I(D6Y%V@(C);V)]K@K34].&:\+D7A
M<*&0)R,W@.A+<%P[O*[B+UO$KC2]\A):1C*^[?45@Z>H.2I;Y6UTK*A'TTR_
MOQ+]Q?.G1S@YQLSSV2"O<#'Z2F:77,[%(2D;N/4.0.4XY%;#R_G$+FT$1+=3
M+& E^&@K &GY7U$(6B,:JD6Q>'L3?:R;T85VN2QZSGQRN/AW/)POR@/U"RKK
M!2#+XM9%>J,UF+RV\HJ\J&^'F]&5GDYXFB>#Q9#9 >>CT7@X/CSM*6( BK/A
M'*O. +E$Q44D<X!,UMI>E13KDJ/JP(QZKD631=180"6?3'2&7,&L8V6NFP7L
MK9O/]0.<V0N:49$A!G0I!J5)&]&;; 3\#0-X749W_3A'A( 9*OF4P-:(2-$G
MM"Z"247W8 NT+AGFE63$6)6CDL A)YT@9T=:!Z,D@(@Q*[&[&P'1;4<0RUQ+
MUK)W377.(X--.NJ05;*Y0LUH@]T(?-8802P1*HG#E1%_ID6R "2'4:-@A,8S
M&JP=7H;9 V>V$L1,+)1-]KID\4^QQAS;@)<JQ+F47A5/[9*C6G\6((!GXT/*
MH3C 4A'1M^0J[4*-WO=JB[/N]LGUXTQ)>BUZ=!(G@HC+Y'0NRD9E'<5:.UR)
MH(O]=B6S""Q^T"GPU24+EFT,T%+65.02K'<=SF'ILL!<8LI!42D5ZW4BL9J!
M(EJ%Y'7.*:O2AT*;'1>8RX,JI% Y.I.2 K#.I:HI>&42AYIKZL-V;]UU9BNJ
M09>-J\%HHQA4063MY6U1D+TM^D)@AHN!KF15!U+=K_OU</.!H[1CU1+\>C'!
M<JJYE>L#:.4U2<1YT1!-+M2+VGVK]1XWOOTS/AE/VMX);<_PRTDX,QP,SW7%
MZ96#-E$G9@GG@J9D:D7(9$B[E!,Z"0?($_:@#ON::-2R5C[<^D<>'T[PY*BY
MT$N[O2S*R?3$("M?Q5%F2LVNH'C27'P :U/QUE,M5Q?'1^57;Y![QH@_,2Q7
M0Y4'@^EL,J SUWWEC)_F(VXMO/(]MK]DB;X<ZI?CP*JM06)32P:%3!S(>.6C
MM(O16,OYLN\MSWKHP-;#)Q?)*T7BH%2!)!&;9HNZBF!$2Q!TC_BT),/QYWL[
M]R_ 7S_/JB%OR#CP-8)!0HPY9U0NB2W3>%&02_>I>,S6;EUD .C;+QREDS8)
M)<+U&93X1 TZ8%&NF)85N>73;9G-3207:BJ,A8N)!;)1%"G[K(&J!E26SIRB
M5N=.49LMN;[46+W#X?!?C,/9T<J]G58W]G;:_&4"?=BT9G+QD]LG'VAQL4%,
M^_63RXUR<;G/[2#S><6F*2MPXCA3!-2)7 *=LTJ5 7U(/5)L-R#GV2  CJ[-
M5%V,VFZB5'+&N>@X,["#DA5Z!;E J4:<F^#:HS'*1P-A,3\9O.4B5@9'AP,:
M\MWIE&?3>Z>[^'H\N3_$Z;62'O?GT]GXF">+#5<;R$>#DXW<<+4&ZX/%RHX#
M^%(2V\2J[4RGBL[5=W_PL,OXKF:F+(>@% LF"B E0S5P\M5CSL:3[4'B:4\@
M6UXNEH[>A(1MB]26VUC1!O:5JZWLP3J_Z>;TO(+PW<,)+WSM1II2ZW)T(7&%
M:,$%C*KX&%2NY)07_#?4E-X"MJLQHZ&M>V>3<]LFEP!+-@3:2Y05),X*&VI&
M;Q>N)9I0,9P5/##K"%$YTL90=$7Z%F95^I3.^I=P>R*@R75&AYMM1"L8#BY;
MS=I#"0%;R4N#514'L:@.%XGI/KHK,:/(F$H.A2%(B$B9VJY9$CZFZIWB$C?4
MC-XV8,LSI"KXI*,-5!6",27E6I0G[XC(^Y(WW9 >3+#P,4[>3.^.RN+-'A[S
M1AI3+J&4K"@7L( 84XB4Q(W&J@3QW.'Z,OU >#75LARP*59)2-_6#U.KLQZM
MA\1%5ZW5AAK4=8"V/*,J_4I,ID.)'Y0$])62)<^D@T)[L>A[HXWJAV3F>SC]
M],1--*X%B]-!O*<V;8<$BK60JZ;53].&V&ZJ<;UMI%=B9,$W RORU'F_&*M)
M%6N;3M7))M%&FVIDUPC>$I?U2U18(')N&^OII"*+DS246%4;#/.F&]O]V1%/
M_@XF-BK1KZ45?_,$;>5R\LYS2)5-Q*A@0TWL+>&[FD5!WF?M5,H@?3,E3<Z0
MMBK4% TGW8.2&SV!;'GFU*$JV1J+-FCPGB,J[6-1,:-AU^4JI!>M_X!I]E@:
M8#)O)WY,W-@;SWCZ8,Y[X[>+<ZUJ#;>LO*(GX]'AC"?'[>Z?%FE^,L;1]"F>
MMHUL>M)WG0;G"H=:48-2A A..:-(12/]&KK?=__61%B>1<@Q%V^@%!"_&UPK
M3@PNF8PYQ430@YG,I4'RU=1[-)Y/GHX'H]ES?LNC1^)6GO(DRR$7G)SNXB0?
M[8_XX+?QP=%X/L51.?A-#CA=R?*AU<REZEBB]84S:P O7$'YHS05:Z!B#^92
MMX2YW;T*$XGJT"(]N( FC9S )@GJ$F1C2P\&3WX//@'E(WJO>#*^AMX#Z2/M
MFH\&=<8\^@3#)2[]Z8A?6IZ9T551PABP> G\02-8\LA4A2D*D;MO9K:LN7U;
MPUX;YS%[3Q*5BH"IJBA620+4X,3T]-_6/!P<'LT^XRD6CN)W*7,TX:4YLXZ0
M9HFQ4 S)JUI=VW#5V= *^5HH.9&KE*WOOZG9DF;IE@:RSJS0BE4A:*6FJ@34
M[)((G>RUZ_%(R@+WC[3YC(>Z3)O9T2?$::IVPWBSQ#)EC!9#K F#ED"[)A.+
M:^K85:MBU#TV-EO>K-#>B!A6-9"SQCJPSK95!M95]!H#%^I!>;ONA-UW55+7
MU;:5YG,]L2&6L!7-\(ME039I2M9G%LE+ 3V:[1!,Y[FPQ/%;"RI8':JR =IF
MZ\@NQ.PE["%%J@?CM[^'S"(^/HN4!^\NB5<Y7OZ>3SZZE,^-CRW.WC!OLL0-
MF9/Q%4",A2V0,!(P:*W8!])>Y1[DQ&Q9LX9U.=:22\X6!Q6J)M(Y X8LG!$O
MA+J_MN:C=MT;C/@SD?(CILD<)Z="JM]1KPO1NV'46>+VIY2;GP+M#()#1F(A
M3HIR$W%5%?MK<+;46;'5\>!\L,FKEFD$T:1B1/P6Y501FT,]5C@?X^+3199"
MVC .+-%\1& V8B>@1K!6V! <L 0_09E6^K:_YF/3.;#$>60L53 V4'(0&F@"
MB79(_F^83-(]GD<6S_"YD;*K O71>'*36?^^\6-Y-J* L1DHB"1-X I%%31;
M*RHC1\.EQR.K?V=^+'$Q+&6-2FE32X3J5%+)D?(Y5>^+)^J^_>C.J-F'Q*6%
M=%W\==.Q_@5/;S#4WQ6STI9]N6(X)7$]RJ?H3:*2G9+X15'LP:+W+6W68&VP
MI*R-"J1=!>\Q>IVBXF",1"_.]CAJ64SLG0^PG06_9Q"VTHD7,-Z='\ZGL[^0
MM-@W][3$_<58JVIRC4DSR"NT,2O,7*PJP7./1TBVA%G-TLADR+NH7!4+PQ!1
M%$VH*;'X*R71<G\MC*"^X$L;3+N41G"9+Q>K.SY-(I!S-HPR2\QT4QI$Q8AR
MJ1:\;GN:YR*B./G,&7./0Z0M959E99A5EJ!)LVL[T+HV$A=5LFU;:)]]#XK&
M=D?^7I#T#_S@?IZ-/\=1.:4O-@:"TUE[%T(5':.QM")$@0W5&E+=QDN;09@E
M9M*2(UW%E!@$8!62KJ80&@"$$'T/,FF[0YB/DY%M</ 299[+\PT'H\/KDY*?
M\*9-8O;$TG!3+DDE8.N 8DSHT&6+.AIK$N6MI=DHXBS/XI@4/+E C%@A>XH8
M$WO(22NA4.AM+FT#\@GCE 64196*?1H.#G%%.U>L)C&MV%2LBU"C@>(*Y3;M
M)V&NC:)$8V]36]<&S1(ST,4EHV.N!B*@%V@\ED(4R9 -T(/YUWLXQ%'FYT?,
MLR?CO&C]2_!< N[^?#*1:^_B;#X9S :]*2@)B%Z)_O:D(F@)UDIF%W.PR3I7
MO.E^]^DJ1DOT/H@%39;XN3K05D5OG,TF6A]3L/5\9;,VRG85H^[(EG5E[VLC
M=%@"%R10SH&L8)0=6"IHN23CLPM0#"AW5MZN<6%G2XH.DN):W;PKM/BCNGG7
M#OV*NGE>^^"R<F0E7#:JDD+QT,JWR4>V^3P(TKJ[N[+]S0LY:7UI&[>O65AJ
MQ<E[#,Z8"M7XQ!15-!Y4*!PN4B2%%9UU_;_;GR&X*_D!NFFFS2."N51T\\N(
M\&$S2)Y//MD"<C =@]'ASL,7SRY.O_'FCY6,RMY*<*Q05'^(5>E2P4H<D$FD
MY?FVM^?E5SLM+'\W)V4XQK8YYC,QP)<'5C\.=/#P[>5$NP\C'IO P.N;W]ZT
M\.LU.?P5#BPIG7TVUA65@"JW?%X3DZ9J3/2QG%/,:K=S\:*K%.N.!+HH_"'_
M+K*L_C2]JHW>M0]7SS"[H]T-&';]T*_97CGHI#.T76L0"L>4H7I6-2=/D.Q"
M(FV)U3MB?72>U[GR-4GD##84\J%RAF @!FV=I;9[8U$:^K2YPQ^39@'<.6D6
M Y+GKS>RN+A%I5S;[K;$#  J15-BC+4X!/G G%N U-T@Z8_!?#&21Q!!5]K7
MRS(!]^5Z@]DCS(.AM,35&S[CM^/A6U%-5P]:M?5YSJ/!>/+AUUZ]N9"X\>N+
MGNBKS4Y:3O!63;&U.A0^$K3A]>0DF/<JM5V:58!S$93.-EG?,G7+U+^@O-(-
MMY:_1NNOL+O:%VM,3EJS 3(UJ5*C"HZ!*Q2?NV]WEX?O?1QA&>#HP7@XQ,F]
M-F4Q/7HZGH_*Q12[J*46@$Z?SVDX.!XLK7ML1(_LBJ66*,(6E\50,X$BHFQ0
M!")[+Z+0:]@8@=@37FR<I5Z30JZEE.HS,Q=AN(KL7%9D%3E4/N3N3^YOV=P5
M-J\DLP&I)ITS:9V#$+12-$+61MJLE:L]".$^QY8&V8_#,>&P9VXP10_.I2J!
M2FS%V;$*)"J!"3$6YT./ I9UX;)^>6YT+=0&0VL!2!FBRSHXZT)TD6Q(5V9W
MMB#>!,0;>NXE@@BE3<U5%PT54&Q)UQ!]]3ZEJ@AZ4/+^C]SHD\&(]^O9$7WQ
M5":D'&-*!1U0]<C1*S(N02@YEAZL9_@C0.Z/CX]YD@<X?(K2*#W!Q":4D,WH
MF)2%7"IYG:Q%"$;K*'ZK^WF17<%DB7MU8.%<Q6QY+&W3,?21JUY,R3$FW>$*
M"=/)3-I\-!T/!T6L=GG8'FO U_:)_ 4G@S:C\EA^\X2GL\51IT\G@V.<G-[C
M$5>YNKSL21>2;I,@ZRHR0> *-G$D;8/)(>G(J<-KAWL$UU?UK@]90">B.^29
M3N343[*!FBBZ]/W%I6Z<$02<B*&FA3 LJA!4#E@2<C#6&SK7C/Y",_KN:L9G
M/!M,N)WT=(BCYR>-(I.K.>=Y/!_-)J=W7CS_^I#]ZNT^':)X>G9"^W+Z0-@V
MXG)&NQ4(G^NRU=]<MOHER58T7IQO\)4E>HSR)WNK+263JU98KL<>6Q[U@4=?
M$/XLB4=<':%NUD=;L"C"F\0L:24"')3G>,ZCT(,8=LNC#^0(MQY&*_0!=6")
MI /X4"DX1%<QHI>@.L3NJM$M?58C>#,E;P)Z':,P(F(B'T3ILE%1JPKZS+)H
M=6Y9M-E28]74^(M/\&@^*H/1X?,9SN;3Z_-"5;[DT@Y;N5G3ZL9F39LE95<S
M!6NCSX0,I>T(4X**-3MTD*"6[D9M6^ZNE[LK&?,IH8 CHQ(5 [YBJJZ2YV*=
M"/R<U$4J]I:.6SK^<;;WDC;/*MJ66A5PAIHT*M*5?5L:P#:?ES107?;LCT=Y
M?,P-C@5$EU?/WQV5NZ4,&B]Q^& PS<-Q&^*9WCN5-R?C*0Y_G(SG)U.YQ'#>
M0&W'2.L,1G,N^]**9]4I+LVE\>081[\>C8<L)_.]^53H-OVSA/$;_Y0K3W5_
MB-.IM,WE?O79 __%PU+'D_9 >^/9YW_"BHWC%5_]_]G[TJ:VDB;=OZ)@[MSI
MCFCQUI*UN6<<@0&[>=N V]#MB[\X:LD"V4)BM-C&O_YF'8G5V 9;(!WYQ,SK
M!LY>^63FDU59F3^R2&&-P<AXH# #+ .'UJJH<T@VDLF4T\W@;+K9KH%E \MO
M;$>_)=^\CN$?X)M)*<T-YY8")F"ZU'%3I0V#E2:H[$2-TB.7Q=/_.([FD(](
M7E@!EH;L3($$%[Q-N92R\1@$**S1QN,&1W/<7:P%V*I/H54!E)>!JY(G(U'D
M@,%-)G'LQ3)#@Z.%QY&]TS+#C' $5B2CE./* B@EO.3.Q])DUR=KXI+YM;-3
MG_8'V#GLW2*BJSVLYN/FG$R!8S8.DP5-(:B+5L?D$^/&8PS+Y>9^0EC-Q^LI
MHT695$-A(Y"K*W._*DHR8!J4"7:YO-[/"*NY.,%D7#192N)2')A55DB9C)$Q
M@PBA#G5S%TF>]].M3(D4E6+*Q5+IP'CF8\P>HE/&2FC6>VJ"B%DV(N.6%%1&
M'SUD[P(%0"X#1$5^06G?++G4 A$S7/4(.?A<6NG&E !U"F@8<A.=$9IG68-D
M^(84W*O) $E>)&B"B#= [MZ3U9 4Z'IPR9L(2V$R?CJ S-""9*VBTZBXTQ$X
M\I!T\E8:"4$;\#78XM0 Y%YI*(+AT4FNA,42@#JK*/X4(F/9EH@U:,WRP*1C
MB19,%Q3<LW./.3F+"I0JI7"S 0O1)DA<>*VE,KI&Z_0-RI<!Y?-?]D?,5CHT
M$C.%FA:LXEI2W(D!5:&0RS6//4N5V"GM2W W;WX\H4.7N@7M$WX[O>JI_?SW
MZMY5$%V"E^^E/1R-NM4[]_/%^T]/77K(SV>./5N6I*>'!^? Y.C!>LZ<2H[B
MZRQKT YI6>95OO,-%B"5=8:,VWJ'26JIM?.04_8R4FB6N)0^@>5A*>!8QY"L
M06>9A%8, C(>,W/@E;+"IIR2,RPZ%7(-VOHUZ%PT=,YPB20#&4VGT6@/91=Q
MYDYFEL$;9R#EQG9^_>E/?6?PC^^.\<GI^8]_T/>4G@"GS_$]=J^]PME)6[V3
M\6A8G3&S?C[7>#)]YI/3\N_:<(BC=2)[A_W!9\4_/K]HW0^/*"8M_]G\WW'G
M/860O1I0Z>^1V?:D]L<D(A]VK@W-YG#4.:9AV\WGEYS_<!&GU\0/Y6P$&">Y
M=QQR)B_$K9/"@  9E*Q!L;3Y:GJC7 ]F$$6CZ3_42%JBX59'$.3:02'IO#/)
MRF#!!)9YH^F-IM=.N1[4 ,F::'I,TD2&&064UBDZV!2B8DX:P<G%IT;3&TVO
MG:8OBG)Y#=YJJ8 A0M"."'/(02&I'.D4VF;BI@F-&TV?GZ;/<!*,6>U#R-8J
M+.NWSICL96 I*FMD@$;3&^5:$(/X4X;&,RR\G9(/P$PN_0&D@%!:?.N<.:!W
MX)9CCTBCZ0NDZ4UH/!]-5R*BX]X+RR,D'T,4X++@B4<;@Y:-IC>:7CM-7Q3E
MPA"CCAB@U(=5V@0C-0_&.^$D!M6L)2U]:+P]'HU]M^1"-+I<[VDNAMRYZ$J&
M<@#C4\@H3&(6C0!NA6YTN5&?)KRMARZ[A#Q!-!E-!@G>*ZDX1;9HP(G$FY7?
M1I<747V6*("=83D3G31"1 6, W?&YLRCMY M,7DMFLS,1I<749<717TLRAP%
MX9J4!4SF@5O.M6!10K04KS;S/TV(VNAR/::;A.)>1UURG!BXP*SRAH6<L@Q:
M9]:LVC3JTX2H-=%E2%9;AD)F(2%IZ0Q'PYD%9J(*7C>ZW.CR JK/$H6H,VQI
MQ3UC 13/V4%IW.)4T YT,E[:%!:X+W:CRS^Q+B^*^K#@*>*523KNP#MK4PH^
MVZ28\XY4JIGAJ5&(^K,IT?T:N;_W]@?5-YRN]=*S_GL<],K'U&3N26O-,H:8
MF/*04G(\"&M9-MY+[?ARU,>Y1\5>*%WZV0+%1K&_NK,V:*]R::<$&'G@BEF+
M-I$&9J^;7(DZ*?8BZ=)#1(V-8G]%L3%IE;/2:(F*<V%U] E,=-EZE:QM%+M1
M[$:7;AG6BIA"\,Z@,<"RLE;;(*WVI?\2E\UNNB:L;13[X11[=O-5.OAL( II
MF  5C0T6+$>>#4NDZ4TEPSKI4A/6-HI]GBL571*<:&[4&D0 YX1*:#E()CFW
MK%'L&BGV(NE2$];.5[$-ET8:H8P0&B(*GTG5C4&)2CJC&H_=*':C2[?N5ZW
M$@%F0AM0W-G@,'MI,T>,S#:UUIJP]MXU:+T_..D/Z. &AM$>QO&@,Z*3ZFEL
M%F6^2@:-(') 4F1P&;Q00B=RE\Y)$,(TBMWH4A-JUU"Q17*12RTSH@.)UEI
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MSJ!_4K;2=^)6+U;T9/7]ZG;\L_2E[*WW!R?]076'!R NLLU4FYO;*/>U4W]
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M3BG4I3#YZ=N#5Z^[.Q3R;K]]>GRP?WA]Y0=V/KVD>VU^I.O$-KWCSMLM3N]
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MW5*I+Y;[_N]_6,'-[\/6"+MX4J3>FK0UOVRM/"EI/<S5'MG<0:<TI)LN:^$
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MRQZ#*"_!K(/-00LI:RY K"1N0\8PG,O%&;KF=".E@2.*R]#H6-Y!46+1'L=
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M#T@:X?%\IL:1_35)<, [HH8ADIWSJ(1!E<8SU8-KL 81D!^ \3*L!7TZD2Z
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M%U\T!0*!%F,:DYVY+_"B$;1()/Z:G.CK (<<%.MU)M7*=QVI@=ZDOW+H(D[
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M,4([CF2H?<H47@22B=[N@S#]A<*$1<NSXXH< =^3E%%J$C P\5'92SN=B(R
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M$:.&(H'9.3H%/?6K:#W3<:]>=A$UP) (871*^5(^/?PO-9K[AFUBY_X3R&W
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MEUPBON=%3!ND1>"B(PD/E30SF1?:1 739ZBCBM,PL8:.TB;R2&G:X8KAC$Y
M.K*$EX/()%<L-S,>6C):_ <<C+KGQC[@-V#3/FZZ$0/9Z0L,%"R&.)? T4V!
M+84J 0.52KV/@'IR/GJ)IUUHFQNM6?J6BP:[,#ZT!6?F!"W&T4&&HTJ>9EW
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M3<)UA5R:L!1<PQ&)NKF G/3M="G&BY44&$]-N1NH/U)H6U)9I*TDW\I4.?-
M-)4):W=/OJ^E]A].[>\YM2^958&)%#P/@*=#IYTCM- F+.@\6R6S"BFE2#-N
MJWI_#F]'6=](.A"7)W)M*-]7UZSZ"ZW0=U><!;BDF[!).W5^9[&E !PWVE1
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M?0/./DFBE)=(1W,GLV"O-!DZ\LDK<NV2H&2'$6QB 2AMH*"AU*E.B89_X-L
MB4I#=ADOC>+Z Y<#R'6.B2^KYD(K@!20_58R62ZR0Z3JC#X#K5*Z=6%=X!]I
MEQ+VST6=J$ *TXK:8@M.Z_2*BWG:)58':Q)+XWY%4"VF2)K 4F%BD&D]Z6H<
M[6]4$E];%X"@)-X=%[7T.F[:2+*C')>/]0.5XZ8Z.]588EY]'0-/K1#44U (
M;W/*6D=C>PMF+);@?QT[?&U%$^/GA,?2\6@JV+3SUR,84A&AIXU7G6KUE5TW
MZ+0G9YIF_EPK$,M<BNW<,0ER?(7Q5XW'Y,JRY/6"J=IY>;(U<0F<+[?:]\,1
M&DLN;$%/TD7N4$$>&[ ,FQ;#OA93+-8XC5\MRSD)J)6',E\MRRF,34@P:LQ-
M*R$&EK$NC4BTO&3VD_>HM&3A6S.&.4<4E&J*T'/=.IBUR$RW3D%Q NKADO[-
ME_3S=R!!Q!D/1M6PGN@9^\U6*E*)Q]^:TQ(&&3GT8(E%>?FM7)PUTE\"@^/,
MN@P[:>RZ_+854XMR%W1NDFZTLDOBRZ"41H,*1;+P9DG>HZN_6+-QS38JH?G0
M^=7R2 J'X*65^U*[XZ;=*-R4K')I\7G1EHK 86!2%<PRQ\-322VB;CE#*KM&
M0']A)!"X19)/L,;UVG^VU)$,+>$)C\]0/;9Z^K,3R@'#/Y[!U:&Y$\+%UD3?
M=\*]BYZ5S-(M#U)*.ONS?T"YVO/*91.X:23I ;JN"$/?:=QFTZ<,$H\6R/^W
MX+R+]5ZU%]$;NEB<?SRTK7HSF&<)Z1&@P,42N1B3;%7'E8W*1:2 K&0@RA2;
MOCECEL):-H]O^%HA*G0-<%F\F'G[SG$F'-"*?F/64'$E,^OD5 B-!M,M.RT@
MHQ-I-#["[*(HJ9WU2B@S&S'M*M+@4F2*5.H#%U<F=9JY<1L)5@B_HI70"7\X
MB]Y639HXS?$2Z@.9$=P3\KP3R+^6_L*J+F0S]STD<E+O/.XD#O@(VX2]:61@
M/7-7<>G 96O(.K3(=!!-.R%0T1Z,.I6/,OQRI$6U;4!13PE2[KE_&(]-Z$,Z
M]=,'.]>488$(R4O'V7'8<H%:S+KJN#3J3-N[F2T3;^P8LS#+>JA7Q7EC\=#+
M7TV ,U($,CGKC'.=;6!,G:-?IT"';X8NYX.Q]-@FV?!AAJG&%K[J(EVR"MG.
M*F!7Y7CN(GF('&]VN:Y:GL'L7+Z=?TN"]*]!8W]X6=(O'K*DMV(L#UG26UB[
M_#LBB=&'] VL8YR'+T.+093J6+CZN/OB.OR,\*Z+0+"G91 +H7(5S(6/A_ E
M%6KA._1A&B0^*9E]?CYLU=%Z!U:*1".I)?UN5(_#MO :R?YQCY3T3HIM#<6[
M]\5'^OB%RSC K8ZJ4,O'5/4[\)9# I]B=R*:3&<1*+:$--44KU:] U?R:%<O
MJ=<B ;PI6B+=&E7J*HR3B(UU$?-8'-:,X8==L0/7=[:HFHXA?1:"U"B<#X'6
MOJ4.&F,:UYQ:4!ICY$MULQF/*5[@E!4=I >3_"2)F<6"EI8ZW,/%PQUPI-*P
MN8 EQM9<N7MJ1&M2; SI[0H0,.X?LPSKFHUE.YJ.6DO>*,@S6QPP=[!>UWID
M<J1.TXF(E0MB<X^SB;:W)C9_=C0JD:.'8-2?D#-.=KHOWKF.9!PA1ST"1GP_
M:U8K#0F<!H=MO2?J_F7-K0>RP\?4=>!Q[LD!+%U"U:38^\%B^V7?Q;IB)"P<
M+U#VPP_'D9-PY].__RN&0=Z,5.<%J OF\*6Z6]8;[%JZ+7GU[9/L9%/6QTV>
MO:@7!_8R_F.D:2Q U35$$G%12V^&<ED6,:1DS6I19YR%BALII!^:[^PG39]/
M3"U/:!.GGY/ZNS))NF,DM$!-^+)'^%N9F$4=7N)'<8(KF%USH:W(P*,]94)'
M7@@-\RR9OWIWO,GB\<?QV?1C^0WH^?/2,ECR'C_ '^E/\F-\)2[$:2 5;7F5
M=!8L;_+[-RX7EXJ';I&D^3"LB2W-ZYC3$OW.,0>T1T +:XR,A2ER,/CW9/]&
MGFV*5X#8G1IE"6B%V4KXE..7Y8&>"@=/0G<&"ZF;B;%&*M+7R$]94V4(ZIG-
MT&+:4=C69 +8_RP9=LE1Q[G83]*[YX6FF5Z+32&-E9(M>/$Z]E:2F.="0C9J
ML\!7TH\LB4J=7^).&4##K84U;ESMK.2(^H.HVV2&?#D:<P7US:.>1.4J=C#R
MS HMIIXZ;4_=2>)HB5]]2\7K]&LV8?R+4'7,J80.)=M=E7#O+1:#$B"4M6HV
M2OD2:*YL*JEWH@B-%0RV5/S0&RKM/5=%-],(4_)I"?+J /259VY?JJY)GCM1
M^;\IMMIZAK)R>Z0P\%:-(\'C-R0#S4W7BC(P9MH)_9>1YQI$X]!S0?9_Q#0T
MS.Y(^PNI#<H6:B>)'5EO2N;C34720#TZ2\L3DCGCZ%1I_/)#.J/P.I]7),9'
M,;%R^I3 05CT(?]&@S HWX($/^'/>+"E'531TF'T:^K;YTH;9"J]:.H9?8W6
M.G>/6\L2<%*&Y0W_W@:X^/ $_60QX3TK)LM==LG&BU&\VB:R54Y(HU2IP4NY
MTQH2Y$A0L'%G4;^]U1?"*5$!(.Z7R9_Y5I5JUNN98'ZA:$H5YI#QK4'G2SZ+
M>9>FQM.*IFE*GCLY81K:U*250Y=5_=:R09<=9>X[55"#7,E"%))V00.]DV<Q
M?D:+>W87"U_#"T7W)IJ:Z1621%D]Q$.->[F\Q+C_@ WXO8$:O/L1R"S0#J5A
M)5#VC$'920_H>V*[NXK=B#^7O)C6.NK)-)]P@OU@-6@?5)3YH7/./AD%PJ!*
M2&QJ"9@[R"FYIPWXXWRDB"V$=R,L=]DQ6#]>7 KC)=1J1TRN'HUF.*HW;EL-
MR!_Y-_C)>N)=S:=SMTE13(5^4JB,'26"L\<H3.YQ.PG2W%$5\40ZKS=V5V;<
MCV\4+1C<<@IWG #V4=G*UB:TPBZZ).WLX'Q4V+Q.2.D44>M \UJ!U^71#A#=
M;A8S0>2I1<$\Z**BD=5;M$RR4+JR.ZBYV&T7I0ROR+B(#S#9/T%G\@Z 0V'@
M6,;9]7@TM#5I0GG16O\)88:! R?2>$]4YDLO*6-4[%( K72-#.TE2\6U/9<L
MI984U=BH 3L9D$BG[#[LM;-_%[S2G0BGDPW+8'3M%S2% 12"'!F8-G7ME'R%
M[6O,]\+2E@5%8;G[+2Y+6PAM)$,:G5:D[Y!]:U1P!+X*W+84+9G0EPY?>OGB
M"-L4S*:LTXLYCF;\<YOC ?6_8+XR\9W3[UJ4W-=D@6-$MP]M<*<^-S&BC=^D
MU55Y+!'H^.!,4/3!J%>]P1;7Y3N"\>)*"O**X@G8ZV34- IKL'./C=*UB["V
MG1$1]SD#+2?7B!ZJ% #NZ/J.&=9@1K]2[:Z WZH$,I V8*'J[3&T9LP WR$-
M$^8JK-(K755'VB0U_)>,1B]U":*;Z^X+ 3HF%W%9)5B^?4N34>/AAV:DMP+<
M\.4#N.%6C.4!W'"O2L!1CXH;0/>=F?U&H10U<JX]4K"I1L'J*OH'9+138^BB
MNB?VX,\(=&C+G=@+E6O$PD--XN,-G6?66.[2WTBY22<I"SHG#%.%GZTQP03&
MX9P3-<ZZ.>KW] *G&TP,/-K)+A(XQW YFAV8XG]'=+-P?3TY_"^7\XY$KS(E
M"0@D/SG\TGX"^TY5\SH#RR(TG:72X=CO#$A+F&+9C;0%3]_TZ?L/[NF3_8-#
M[&9D 60))NH#%FIGT=%?1?ZYZJMW+-EVN9-%5HP/SBVS%.Z49GHYN'@#FXB.
M!AN+B:0.B/TGH2S"$D+U>WSH!9VJ>Z*)KKDPHV97'"E1K[(J.,*^9[FX%J8N
M_SVD4:M1#,J]UC2_W14^#$\<4=N-,/N[41&X9=3W4<9D-70<G0@5=4RB8%NK
MI=03>421 Q *<*BEW&"7!TY'*8EP/Q$]NV476;K9BY^8KF>4HPP;7'D\0KM5
ME:Q*U!K\$C26]Y;+OF?X=TT=$>D_L(?80?;=U OC.C+-A/26.H/W!5]GITFM
M+</&ELV8G]<>.5K%R6G&M^[T<&R0>IB^'GNL6IL!</&:F3:<R*5\BKZ\T59I
M\-?ZO&P;!9[%)I"Y$)3[YL>N-C/FWRZ1T6;WM/1*C>]F&K/Y6FH\[+1(Q-]]
M*RG2(U<$&'N"PEQ>N?5X892QU+#MFV&+G:Q;- +X+V_H7K*<G72-<^3G5"E
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MI2^P#C9Q)*GKO:YMA(XRSKS<7AR5\)4QODU)A"S675$^+@LT</..C6+B+8>
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M8K=-HUB+N;1I%#>N_GZDY?PLH5P$1/3><LNYIZ*]HCJ$4K4L\B@TO71GRG>
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M^HA _R""HHH%-XCO!#L'HV6>G'TV2B90UGGF3[@8<$C=HX>F?3$6#.)]-5'
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M')==Q\PNO&JUCX=EQG<)D$B@*!.#+^5+E/EPESL'B[PI]]LLW9*MR3I$E*G
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M#P]K%(N_$$V"\&.!>DNX,OU:7C92%E9#DQM'M$$?(;L0G \+V$.*SE)V#B@
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M_+NK^_3I317JDY!ONMZ),>PPKTA 5VN30<C3QO?3B-0H"G>H#@5Z7D8AI2S
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M&O,\MVZ+>C<+^.R*@?D<P(@YH!4V>9W@RLEIY.:(.9EK&:5"UT"#>1:N6TE
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MR(&!3T!I7Q67$C;75CG#:_6?"SU$SLD?C'=:[0%8=>\W(N"N$HF@="A3M/$
M_0'-9?62EUWJ7E$$;>C>HQ3Y?-7<9LW@K,]>O_(S1TLFK"S?&)T1RB*0\>3E
MJSQ),HYN7?*BZS:<>F00^N>(;Z%?028MN=;GX%&8^O1.I?ZIXY945Y,%$56A
M/O"<0D9K'%;J9^7G,VT\F^$R*IMK,IFD#P#&(@TT=M,>&_.[_C(+0,]9TB-=
MXFAP(C!IC9-+Q/[2?6(IPD&U9-25C$'<33G\'!M>\Y*$\H3P3("[L&VJJT%0
M0B/-"^V2D%L5?FQ549A/'"N:4H/M4P%2!Z4D @H2;&)<ABYOYC@QWO,[>"V1
M!%$2/[6Y<3P=TFQRSPGVX'%$65!."#R./N#B0389_(Q3:BC'D!*ON'9?P_'A
M)G:]W] CXL@MDH-:PGEPO8(**OM& YD\;F=^..L\YW/%JD!XAS\:F?HTGSL8
M,IN)(*@T:!A7,/$<X>RV839&*\VP?H16FZTWA:!,6R6]K PVM".2?]?A.R>(
M]FWAKN :=2ZF1E'YBY=KP^8,\^ \A-ASQ+O<G=A/PEF@<V=3=2JF$Y.?)12^
MU4BSHM_;0H\/(+V\O8X.@W_&].92^N!V*&&/W\-RYK.PTJF4*^A&V<):V#26
M^AF2'N=&5^V=0OT$-;*DZ(P4<P(3ZR1)$-OH,R%OXPF]Q18._=[.;SH#&1L9
M&X%+/$,A2)ME.;LS71AOQ)@![Q!<O'_B[7BHZ'AOY;)!&P$+0-^9?,'Y$Q'%
M6W:3C,$196J:J\L1-Z;%1!M&,V&T@S:,MA9S:<-H;1AM ^S4YEWY.(W2*-S1
MU]%[SIO7=L!I[$>3?$L\G#H>04F(2>BS<5FM>MOM#'H]S"%D/U.@5,BPO7#[
M<PN+@+>DI@K/P/J)UJX8B474Q1<I[79.O8:U,X;LK8+R!K%*S@1$- 8R \<+
M?M>G$J:1PJ4;I#7$7W1LNC,VT#K5JK[.,:Q/OQIT)PVC4-T%>,:9DCPW=U[\
M]8+9?:VZ'H?HY*)D9EJ30 2+.TW<4.GP+\%F1\,K&$>*$I6&6>J'U*4H-GO-
MFVI\GG) 6"U3L-. HY68R"S%C^40S9_<*)IL%50R(*5OK@Z)5,PS_:V.D9A0
M%SF)SU/NH<YH8^'L\GAG?6"9+%%7N0%BIY!;3(Z)T<A MF=*VJ'[W((^ ]K,
M&-O+&V7^1%'S50>QJD/3R$)6U&BK)'_)[DSC<J0?.MQF@G"2%YP:.J]= >IH
MEZQ(@JU33BFON4)(SP?];L\;2B$3^2E],=5P&OTCRK74":^-(QPY S#M4*,R
ML')*3#G3;=O)J5N />$=8WUM7JDVXM^1@XBV!,,(VFH3EI38!!@G4FI5C'4N
M&NTU.P&8QMC%/'-2]D1'.L!$Q7'B?J>-HNE?L0[ NT$^<G$ZF^8'[Q(3O^UH
M>V=*)H<]<AY0%TW9HW./IV[TG;)1T>$,]'1:U.NS=D)TUN;LVN>V>]L2X/K:
MW/'(94_F(OK8[K.8C""#*/Z?8YP7*Z,$E$E$$AB'!;<DLR)),UR]CX*1+A'%
M$8<<C-=.$:PFL]<+>D$Q6L-&?L8>-,26T\8Q5>#"*RGGD0L';<[W2;TXEPHV
M<?UYY :]K3_!M7Y9+#:*UVH1HR\6(OX8&+9O&/;ZC&HI(K*Q>]PP]H4:3<24
M]"=*YY5KGT@E/?U,&\1U-(8:C&,^]C,# ^D<G#USIP1NR&4YCKMC_JYTO9\4
M]9+4@Y,GMNIPAJW&%@2%R="%)UP7J9F- QQ&W<^DPG/!S6>WK,[W=@I79MT!
M=@V@H&$FDA)'Q8:+1K*1?C1G?B9?!WU<NFRN@3[Y_5-,%,9D>RJ_9T>UR%A<
M)/ZAH6VQ>3EG^Q(GD)< @USSUHK9X(P+]P[[U@'#ZZ$;5FT]CCH5FRN7K7".
MY%PP\*4XP8SN3J+!CO-OJA\W+&!IV*9..W.,(X.LNXB"?Y+4^3-,G5_$V+_#
M=8<BI</-^LRB(S>^(4 1K@/[RFXS[:Y3'>HTXZ,XH_-3/PBR$N'"MN0FT)U:
MEE1*797+LL*,W#?BP_:I=%_@8G\57+V02%A95UH:2B:H2$Y E\IZOH8N8#]#
MME]R4WR@KQD]BH\)1#D%A3CX/\RYR)(RZ:<%,:O+R-PTE^"<H_,4@V0(V4!&
MDAD,69!JJ;6D.R% 79BM,D$YKKHX3XM(("^,K!(YPDQ(<71:J+@AZ^4\>MQY
M93W:5]>I.7]-^(SJ>AKC;(X+L^:YQ:).?0M1'V9;),]^@G-<X7O+QP_ELL77
M](Y?L;]TPG7D)H*\!?'S9K\$W>4>>R?H8B]1[]X.^?->ERBB9@'"I8P1)Y*I
MU@1=7#0#MUAT$N6B8%1Z28G&Z29(,7/YTJK3C=!@N1#F'&G9XH2J]$T^Q8H@
M++^#2_5DFD78V:=_Q!<*GPW, /?C/Z@OD2TA87YS9@K3'JBK E7$"G-]/#LQ
MN86ZXQ*9,*;MJ7 W7UB(UUR2S9YI'3,A851-(JV$7M$N!2I#&1ER9!/U!Z>N
MV5I]L!-Z$=4*210'=L5D!G-G#5C**3E%M&Y[EI:HFB7V>W=G1G"!BE[O7^+=
M#"<#VG\IJ;GDULGS4DDO[K_@B4IBE2APLUM.=[1"21#HA^ -G#C0<$"@@/FQ
M]5?1@G@=\-@)?6NK2,^XM=,IQCJC8MZ8F.&1.^A+A@I\++H/L*L UL]B4K)N
M\>5LNUF5KA =@NH\<4+8WJ\EC$D:#[86_R);2"_1*W9>0XG7V$%;##@BQ;,3
M4>U\SME+&+18F,6@J<"R!:+#G#^K6OTC?K'S'M]TXN2Q"@,U16@T:8"5H=($
M6F^5-N[*W+ :3XC@@G 2IB:O$9S4&0I_8OYMDMBV13.KP+;;]BT^QJ55K)7X
M58B7@+>R7*1+J%F4_)HFR4UW]/#8[4%@3I@FER'S2D+F+[;@O=)BYR26<L)1
MQ 4"4U5$!J";YYVIL?(Y#IRRRDX*0TRA<;X&&'%)'C.GN1ZY; K,0ECB?<]J
MX1R,8WB5PW_%HL"<R"7U[$PB+I6PLOZH(SUO@?[>JF%68HY/?^ B&*Y$<^=@
MU)(@!'U-6]7%,C2$\J  "<$-,)*0S&%1ZUG0Q Z&8>6FK-(= B=I5TZ$@'J1
MEG!F,6?E%#VAO"BF<2R/IG?B$/(N4OJ=T4%3_1UFV#_4IN@?2:QU$[QEXMC$
M#6;Y"WZ,5BOF]6#"E9'1F.Y#[BVT-5AGQK0;$(VP!XQYA&V)^X>T=)3+W@ML
M2\M*RU5*TA4C(/3D#QTV?.!R^DM,>,J(DY:$'-W1Z43*HJ%PH2]7:E-]M"^V
MDNLOFM%'F 8HK_PRY0E4@,#FM>R\=#'G_<1QZ&EG 1E,S_=[53@P37.X<786
MXDU8T0B1E':;>&/OSFO/DK8,(UNA8U1MLBG5II:8U)+#-K5D+>;2II:TJ277
MZ>Z/M.;/;\[^>/_ES/OXUOOXZ0V?V]DRU';OTUXU ^8"JT@Q77A4=<8+M/?+
MVU"C*!#Z1L"H_ Y5T4QS]5+_XQ7J<K%_]3)*:'KTHU?5P\<7H.9$J)S\$GH?
M?RTR]?BXNW_01[%:9/"?4+]8)&Z7).Z/13C[W=Y^=V_O>.[7O6Y_[G>+ACWL
M'NT?WFC41=\-NH/C@W:N&S+7_>[NP<WFLVC4?O?X:'>#YKK<:?U(?&LT+".G
MR"%34 $>RJ)_/=M]YF7I)?][\,QJ9"$5] RFW[U^52+%:C0C0%AVK$/)'.F"
M+]XEIAU2AY")IVB[ZW@]"&7?WJ:RDV9#^OO+[ ++Y8?>AWG7#ZWZ/V3;OJGE
M1LQ=Y^[,,GNXR&=-6V()0VX>K4C OM(UY^GE;=:6G5+.4F6+5F&<ZI[@[;WI
M&X(.A24H9JD5SR6G;=VY7KMS-]NY_O%=2*F#[=R<!0RYK2ON-4GDN9S@!]\X
MOK(C4PP"I4:C5S?=DR8%!P9Y> \:;<=G:?=2)X([6WW/6Q,E;^$V/+^_];OK
MSO"5:[7PP>Y19S X8L_]O6T"?KOB9BRZG&XUG[J ;RG]J5!ZO]/;[[>4WE+Z
MME-Z?Z^SVS]^PI1N7C"X0SVND>H?Y?17]%?M/B%*6!/!M.()_6.N#=82,&S/
M4U)/MX& 5S:I1_1_C6?2/W[\S5BX])\)89B[S=Z(C67Q&\C&"_>E/^CT]U;E
MW%7WXKXYMT:8-](SMO=\>X-558OV?#?G?/N=P_V]]GR;+J?U.<(5[^E5W1\+
M+N;VR![FR :;?60W#:]LMC[L*H72Q/PV)MY6$/)^M]^[F2'W"+;:9I/?K?P)
M6T)L@Y;86F)[*&);V=!MB:TEMAMFG_9[,]FE+9G=\28/IRV=#8Y:.GM@.GM2
MCO,O*6(,"N11<DZ]LQ$MZC:6[K9E)C0M\=$%R377TV&G?[2"Z%@S?T5+<)M&
M<,>=_=V]EM[6Z4RVFM[ZO<[1P48+N"?G0S]:U1?T^&>V)FS^(.;Y-I':B_Y@
MDT3#-I#9TPPQS3.?$(V9>A=@\97/D-79G"J?)^?4..P.;E@!T+HV6D_MBCNP
MU^W?,/6Z);:6V%:.0?4.6V)KB>UA*DIZ;;RS#40]E$5UO()WKZ6S=0I$/?8F
M+%SR1P+9C9(@G2AJV=0&GC;9+SNX:3'"&CEF6XK;)(KK;WAJ=DMPFT9P1YM/
M<3?5)@YU6LOF*; ??E\&)K&-XEUO".RVH96-#*W,3TAS^_GL8$.?M1*X;_XN
ML;N%\C-LKBRMDKG)*W="BI(+E5/;".SIP'B?;O>47],(OOH3OB\SM7V6_,+-
MHTX<@U<;YRBZ#9C,!A[3BWZGW]NH5-\G=T";Y0#;ON-9.06DMU$E&D_^P/8.
M-R\I8)4B:]VV(TFI;=""U[9/KM.33\$+_PX1HD&'UOE+VY= >$V55?]PDXS:
M[7-"7',\>\?M\:SQ\1QL=.7'YA_/RJKQ1KGPVO,ZV-CCNDO7Y>#H.M?E\9IY
M+M]16H/W(D[S_ ?V508IM7K$7'')&D^37'=;YC0(;!Q_NRSQ;4/!>['?Z:U2
M7;BFT+-/%"A[<32UT]];%=^P/=Z-.=Z#FZ*-;>/AKN?YK:J,[.^U?M5-.K"C
MS<L2OYT*>3/_V^-U_WIGM#[0 Q.%8)4OQ \WOX/IQMH^BZ^+X_WMR:W:SB-Z
MT6]1%];X=';W-]=9T"8FMH1^F\3$_8VE_'O/\%LW9>=:EUCK_G(H>Z^SN[M"
M!&R+3>AM.]I^IS\X:#TDVWJ\@Y5[MVSQX:[G^:VJ9>P=K:!FK)DKY2D>V.[>
MYL&_/(;_:]T"I6&4BV*H0D<OI!IQ1-,J_.]/S#GVHK^Q]LT3.)SM<+MLY^&T
M#=<>_X!6U;..VARUC3JOPU7*;=;LP)Z.^^V#*G26&2M;K9^MZF>[07+#-MKJ
MVW:TZ&=K,Y&V]G@'^ZOF#6SQX:[G^:WN9VO+X3?IP'9WCUL_V[K[V1SUSR^*
M+!J6A3^,E5>D7I(FZ&_+TCC&2&PD%:$W"\2NM65S'<Y#6VNXQL<S&&RNF?DD
MCJ=U4F_2K;U2']LU/J^GDRZX<_?9@D^[2'/&)3:C&OT>_*;R/$V\TS2;IAR(
MO#=#<]L 7E=>_Z,SY'4^POTMSL5KR?AID/%Q;\N]H2TA/PU"WFT3++?+C_CB
MH+=10)MK(AU6W.7YW;-67/H&6U(W+;Q:PHFL?ZS?MT]//(+1ZXBY73BI,"W1
MIJG+N;LPJ]M9KL<LMWZ,)XZ&_SJ*RT*%%@Y?G!93E<%V3"8IS&B,J/<W\6+<
MJ<;2CM&.<1]CW%&@=@.R]4Z7J8R]=9QB@XW9IB4^NAIZ383LJ#O8Z%J!EMXV
MB=[VNL>KYN6T)->2W&W6UNOV5VV"OGXD]_0R 0X.-NI:6A,N?Q"_VW9E,-P'
MX-'3J>!YW5P7W;:UVXAHP?:%=Q9?*KWN9D5SGMCYM&RT+L>T>M[F=J PM^'&
M=7&%[AZNL]KS)85]7M4\>;))/BNO_]&9Z3Z<IFN3XW-+]U9+QMM!QGO=F\*;
MMY3<4O(Z+?SF+MY-H>0GZ/\]W*C2O361#ZW_=YW\O[?+N[Q#F_4><P7;6:[E
M++=^C)OZ&N3X6 B![%KFTB?9LFH5Z>,Y)[[2'RK<\6%*_KGR0DG2=!,R<R\M
MB[SP$USM;5 U5MG0]5%'%L-S'?2ZJ\+@WX*\[EE%679*M]$YMY$(COHM$3QY
M(C@^[*X*V-X2P>81P<KQKL%-W;^;2 _;9MRV9*Q1K5LJ7O<SJE(Q63T_4A$5
M_&\87?S[G_!?>I83/SN/$FV:N@O]J\R+:'1UUZLZONX2'> 2AE-OQQOZ>91[
MTS1*BMPZ7#9D!1]^AQ6 ]30M"\IO\Y*T\";*QY*W41G/7X^,LK</KYFF>80_
M?IFI&$:Y4*\NH[ 8RSF[OQ)2[MF?^$.@:;#AYO[$V:E (5CBPRM,M%.[1]6]
M</][;!QB4[!*=X:9\K_M^".8[$L_OO2O\F<_5HD!*$$&/SSHXA;65S]WC:/1
MG:SQL&&-3)2A"J1H\25())7A4S G?VWFXHTS-?K7L_\3]8Y&QT-_=-3O!;V]
M_D =[RK_0(U&P4$X&!P?[__OX;-_?Z&JS'3D88D7D$_^SQ_]?\\EZH>GM::U
M/_OW[\%O;\[./G[P3C]^_O3Q\\F7=Q\_+"-9]JN2Y5'7\/;=AY,/I^].WGN?
MW_SY[LU7[\6I3J?]868M/,5__W.8_?CO)C:;7:Y(DH-&65IQ86%E\2-<>LV[
M\EE=*-B"ZR\*65]_\-@+7"@4S7*B) "AEZO0&Z695XR5=Z7\+/<43#'T?O>S
M8,S&YFZ_XPUZ@[[G)R'^HT>WCY_!4T5*/\Q4/E4!7B/>-(M@-!X)_@U; TOP
MPI+JK.&O;ZKP0'.Z+,8=G$%<HCKDJ>^P$_C:89G#C//<NXR*,7P<P=[!]P'L
M83I16=ZA+Z+$2\O,^Z-[UO4^C?ULX@>J)+W)R]7Y!':XBPNP[Y)7P:KQ;QPQ
MS,IS#WX31_\E:=7!V0;*[ J\"9>;J$N8?NR723"&Z4VS-"R# KZ$]1>1'\.7
MZ6B4PXN&5S)"J$8Q7\Q^GJ=!Y*.WDY8SS'B1L!/G*H'C"W@:09J WI?#3[K+
M$MFF,='/60J'^BE+1U&Q)8S$2YKRDIJ9:0$OU5G(\HW#-D+GOZN0;(*S$K8'
MB?P,]2\L;=#D#G0$S)<@$>)@H9H@\>)43C_^^>[U3O_8*Q"QFF@:GR \:X1
M0#JEIG+?HH)8#9\(@>W,MW 3^TD0Q;&?77EY.9W&$6QB9>P+/PB0;9O9 M]7
M)B/_ A0#O-HC6'E0\%L_?7I#;TSAH<PC9=1A,V"\[%Q9^1$!GR1%"O,(QOA-
MWO4JIW#IP\3D/5?R'A0J5UH,P%I04L$,"V#7BN18M#=X"++&ZM[ >\\S?Y)[
MRTBDF:G:3:E.%B?AAR@2]&;E/ ^SX79?,CPS_,$HRO+"^[N$ X"=A(4BF;DR
M%B:>E5,F&_@Z3 /8R9S2W ]?X7&A\'*["8(@4QF2*!QU "2@XAC!-6(CZ=-
MP03PV./T$E[JD%UM;UF8IA@"BF,X9CQ=H:U1"N9+D?GX?MQ&^66$A_LD!84G
M,F+VFFV4$4U7Z_*"HYEC76X%[5PA =)19;"N!&YC((LDN(+[&?@P.0?BB^%
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M^@G<4>@*"]BEQ4U2HD+![J*[A#3HRL1%>\<IJ+]+5,C9=B8U6Z\(E/'WI+@
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MB+6Z.P]K]4Z799#J%D(Q#Z?>3K59WRH0V&NZJ ^_PZ*P-5,IG662M/ FRD^
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MG);(V@;)8:T*[@Q4N. _T07#S/L\\A)MDW.W;[(TGUPGXGT*JL4"J!^B50V
MH\F O*X9.B#%SJH3$QZVON;!T,2S<*[\= )_!%;&@\A*$]MS%]Z(;DS';H2'
MUNL>T':KV;AW9N/6Z [PA@J40[I[1V4&FX@L"G=5O(%^Q<V^)VX +N$J^'/;
MW5:XM-^O>28;O<S(FAE1@5;]KXRJSXWC3_W$#WV:V)LRP^Z^U[EX>!4%=;J>
MP'6#HOSYH'\\?SK2ZEV[O^H.4*?1, PU24/QGI(S-IV"?AG]5SSE(R!O\OK(
M#9--,2RBO+'R0Y$H?#DVSOP5?K5*+/$Q=:7-OF3FQO[H-BF3D7\!)S?$!NM
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M$6O:.DO<R\LII3:9A\ZS]+(8$PE<HC4)_XN#%"H8)[ %YU=52IGZ&?P1QVA
MCI"/T>\BWAB%'C;*A -.;ITQ[(QQ&I*WU]3:F<7]O=7-8I;=MGBBGD2S- ]J
MUFOB*9^COZ,,;CG85Y4'\' MIOK\^-#1N>26H,1'3C/PD$@F"7I[\,TIR7=1
MJV8OB$-WKCA\]7[D[!U8<QC)RXU'P51D -D#%YPG9@C?2>NHN:D*_[L$JDER
M6*507[Q?/I^8ZW;J7]%3\ELGD$SG>,J"A6<:P'<=N'6#KAF*O]>CM7KC>D6,
M^]TCDQXD.A/'DF#ZGUDK^Z0U.'VB]H%/ADAL$ H^_U1U:+YVFM[/#O+IM1F$
M<QF0B4H@XUPK<DAU<S*6/Y)C-5<-R^MXSP>[1X9-+GW*S4 &^2\P0CE->6#2
MSD91EA<FKJT#XGQEPD"<8 TL7L:%1,/!'DK@U&HS[GI?*EJEWFDKW2B&(K(*
M;BT\Q%R'UVN#X;;T#U\Y:5JCDGR^@9^/X2)/+W.CR.8J%D,/#E7T$U0FT5KS
M,,S&4VO<*.]<):#LQ'IV6, '!B3H"1&R/<H7D+>@:)/8F);9-,UEO,H2%LVS
MM@%^P03!$@GI5@[V/ 7=.I%TA&@R++-<R5\T(2W(T<^NBHA26%#VHD>_0B]H
ME/!A1/DWW)2\# )X;E3B.OU@'*D+5UJ;.\-1N(AFI#(.9H^Z5E#0;M"G9:Y8
MS#;M=]<[*68+X_K''0\$'"?Q.&Q48Y_7,YPP]D,X%X>RSC5?#_V8LG-:6V%#
MK'++"D9%6MZT1)&]NS^H7/ZWLS'9\;2D@V"PM]]@)!O_ /+<,@Z ZPQT+\Q@
M+@FI8G<E&QRYL"EFSXJY3@TY3ODJ F%=3;QG_S[)-R3?^"-0Z$4$+P%F^0C4
M_9,PPQKEFG5J.3M:9"C1D(@ 2-Y0\A]+D@79?UA?EH((H&PEO+3(5A!&SE\"
MPYUU:PIAI\KUG04U""Q'/W__<J;UEX:7>"JAPC.T^&+7=6,>D/C[*9>GL6)0
M6TY3%J2K\8DRB/^<P(?1-)Y1V$"MR-(\K[[J!+WV/% ':_0D)1.,/2F]A]EB
M21L:G0VZ>H&5>V+BY0UOI%M&//[-(TB88$:Y_U0;K#&!-.2[9%'R9Y.>@P
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M"B&D8-U^_('7*PD/N%^53^66K_ \HBO;)/SHL3C)B;0,/I&9R*YC7X;N97U
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M?=X>&!#M,JW=R:W2AN $+@R0>JD3XF=I+TW</DC BBMI0RJ&L*'OI^V<^G[
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ML,E6S;/*M,(F1AA\;8.%&4S9?BE$>52HA#VIZ-4P:=8Z6#>G@EI!'GRK^TN
MC9*47P$69-LL*?O3;I=JNZ4 81R1]V.&D<U"6-,D^R4FVRLS3F.N3J:QV$!>
M-(/)O+E-@@S=S[=1T5353CK+M2*U-%+T\!84F5!N%'*ALXZ1JCA8J@Q,-3V>
M&27:VWW%TB7&<R$_N9B^O#\:WY9>Y<HBQN=-2K:3)G5T@"(@:JX3:ZZ6;]/N
M.6N\)%;N/95^2SR* ,\"J)LS*)8"#.IQD1[5!(I!29@F6&2J71E+$=.<<]D
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MU2.4K@#2K$(1E0XC>+.XG3J<;O>=PX.2?D,C;$L>OI8=O).W>=6<./],8!M
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MX*&]*"?S+QKK_9XJT:;F1RV%^G#4VURHU\\F//0#ZK:.>_WF@.I\0-WN<7-
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MVU:D8[<]W(*.%6%V[T^8^V8!7*(L=S[KO7 ^A3#^87 AJE,_QU[B$SZVEV?
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MJ#NW4<5@LW.+.U?J>/6"D"ZJ!1&">K?80L;0]XT7,HXB>Z(+^-B/!PQPT!F
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M-0__3%1:(JY($+X ]C9[@^?SUO$R;O5*YYW%AIS.XF0NX4"*TF>*M/QW[B5
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MA">!-PCZTHJ?(Z%9QG]CB9]'4^\F3HA DH74&0V?8GU<_VTAA<9"[3.K(IQ
MQ/I<,\DV'$;5W"NW2E^U<-;D'CI"52.*HR,B,5A@PKZ^UT,+Y<5"%R54$J"A
M&?U!W8.,MA#/@SCPC]33D] +9@SCX ?I)$]3MJ\:4(XM03E(#X7;^!=MLWT6
M-P$,CK,U?R34)<12DTLZBV=@0<ZT_&;OQQ5*L ]&?VD]$> 2?J8S^O'?S#V;
M,#V)](?@[;5(:]7HN-6\?R""-W)^S6%3NS8V7>(%%-4TD0'<=HH,P%Y,DWB&
MR&%]%X\!_Z-+"&(*((JV:DH00/P&8O* #$@X4(K6(@H<T'%!("%%J:/Y.?82
MO^V\TZ\1GB"8O<-C U%F[E'\H;OP0X?5=/AQX)9_=$?D3D%=G&#GA((]9>0A
M6Y]$7!BS=I*)9CD25$CB);':98,FX=MD.)(60?XSPDYCR"@S#FC*7A#9.$4H
M'Q$WTJ#)T:8XC)$3HM8SQS,@@$D+ADHA--K84[ <1FIL6;%*HY_;YLP4=/DX
M(3- ;J[920W625!P'*XL[0=>$]WC80'>%LZG.^J7_D0GTQUI/,BR,^)48TLB
M!J6G;2A$V%20G>_818=;='J5"%H,PV8B'!=C9/,51=@^Z$ A000Z%:AM+,QF
ML(DICV&.!\1&;]C_L=,^Z1'AZ"@7>NWF"E3OC9A.><+.KQX,#!83;9<[>*LD
M9RF$1>]9Z(:E<9O E@ELC9K 5BWFT@2VFL"6UF"&SZW ;*G(XQX@2BD*_0N^
M#]"?],-RC:V^ZAG!=VK?@X5/BH"4\2TB7*>D?I/K'Q80@"4)^HVE!L1F"]B%
M8%L#E9ZCY1APBQL%^_*TJ&^C4?MDT-L%]*W7;1]W'Q[PR^VTAV[OP1&_W/9Q
M9[=1F\DVD]UDLILAZMT73^YQ'NVZFR"TU1 ;ZC]@J:6+R=J'"D!WO@GPW$:+
MK>%9?HE7H0;L1/@'A(+V)WLU'A]][R!W[P(FXY"#K==LX,X;V,,-'#0;N,L&
MGI*3=K#-775(0(9+J"K2B5[IM1#9??I9U!/=JOE \X&Z?^"IP:DL#TBA.$>W
MY%052Z/G<!09792BJ8\2H1ZT3^[7A\-=V8C#60HDLLV1'AJ>7M42ZUV&?-QR
M^R?[W3.QH;E]H[G^GG?I;"ANSRC.;8V..PW--33WI#37'>Q_7_&&YO:)YGHM
M]^09:>X9NE?7W<J[X*J[Z,H)*?'5BNWOI]G7?>M4VWT;-=K:WZ:NW=:@,]B[
MKJXOKO/N_C7>?6%'=-P<4=V/:.!NBQK8'-$3']%)]QFYJ''F+ZIY6)2QGPI=
M[UX*W:9F8/U8J#O8?X_0@1]1KSFAFI_0 7BX#OV$#@CV[C!/R-U:W7YXEYWZ
MEII8GP[@H77Q9HQFC,<8XZD-DF?)8YQ.'R"1<5-)VXS1C%$#;-*ZF_WGJA,)
MEG?JSG3[Z0?HOTP@4[<U=(\;=V?-#VDT:HZHWD?4&S9<5/,CZ@ZWS?1MCNBI
MHZ-;I^\T<9W'/(]/JK7NWN?M#!X .'4?&:K5&^R(@-=X0)_ND+:_FII#>NI#
M>D8O=7-"&UE)3;BTYB=$?6Z[/SY[N*?QX3U%ZLY:[$#Z_N,TU7YD??+-\&5Z
M"_O'VY8N-B9TX^5HCJB4D])X<VM^0MTF [SF)^2ZS\A$NWH*9>,8V3VV^V"-
MI<H-;Z56^<S-77;KC[)NCS;NS'6@Y;@/MS\U9_!1J]??T>?R8'OT1.Z 3>7"
MMM7I#2\UO$3E4JU1?T?G6,-*#2LUK&3E>;2Z@QUC-0TK-:S4L))E9+?<[HZQ
MZ8:5&E9J6,GR*+8Z>\M*Y$SYGN!U?EH)9-6#K2A$T1#F:!W0T]%C8"&MC6P1
M%)+5(O;)OU[<J./VH(N[\%EH^*69E^4)P:@JW,8S!D_56+\&(-I*_FI)V%3L
MZ(00T#-$TTT0M<E"C20D)['8\6DMQOE>GG*WQJ<,[!ZDA DN?&<61,$LA^-<
MWI-+HE8RJC*<8<A(><474N?:NU$$$ 4(#2Z!0?&/3#&(91!'%A9UD"*RN./Y
M>'P2)C>8S?., 'BYC*3M?!93!,V,%["!78T-_(&F4(+^78_VZ\WG,!6<X$JX
M7Y:A;N?HWS3#64Q(K!K$;#V([EZ2<*]N)'RNP+Z+H-UC$8EID"FT6@,;GD?3
MG$##]1.A)]'C%-7C WC\-J*L?A_151&CCEX[T$/NU^V0/VF [,1(+ UNS4#'
MB" \%I-X)@A%6V$(!]_@K!/$0S:W% %S'_QM,ZC;*9XZ\\4D<13W/C!B!,?D
MI81IG"2(5$X@TXATK-ZYBF/$8TX<F-%-,(&ITL'#^P+%[D1H+,E07"'*LC,.
MF)'CR%9;VLZ7:U&ZS.86@84$GHU [3<PA3BYTU.0(),2<-H"F]P.,7V?B6I8
M-Z+2\M]3@-E*-;F]#B;7")X-.@A03^X!664"X;.O;;A[U$-14DQ@IT%X)*E4
M:ZWS)S#QJD=(D$AX<W%#!$NDI1\DX.X\(LH$DIH)08\$28'Z2#6)X3VCCP01
MG'N6;R:>Z@)FNQ;NE:##)7QM80.8=<>@##KBFSQ0@J&/PY!*A>W'EV.X5C!;
M?3?DM!*@MD7K#@-O'(1!AO)H@F8UJ\$Y*-I)YB'%>=\<E9$(IA9O&FG::1H#
M!=G*,M$OZ"U>B$9<R[GU2,E-XF^D+('0>WW<.U%@A@M(]=$=:$1@ @JC3)'@
MG7D@807\CR^DU"1D^J(>!FM0@MZL"3CN]4G;!?E,7Z2EQ?,@#OPC-= D]((9
MS-7#VR&=),&8%D2;\R@2:&=(9FEL?$E$Y/,%\;LZ)=QN:7X\\IQ7SA NS E?
MM=*>,2;39W$3P$=PUF4[:J3MJ#,;51F>9"#N*Q1W'^29(EUM;6BQ?T"=ZS([
MRT$3JT6"5(H&GVYP)P^9R)0_ :<&?R%A,;7)=N*EU[ '61;*#UO4RO(Z@"FE
M\%R$AB?0-.B8?C#!1VZ#[!J>]]*8A;@ZV;M-A7+-A= %<.O8B[ZF$H0[S1/R
MR$Q(5PK8@H<-2M,<=N.UVQ\J.8&;#(<9^>,[4+BR#&\[^-,$MXX/ \82P.WC
MF!BC4MHI7>Q6)/HC4G,?BVLOG-) >/:S.,VT>J8%C;IH]<W"Z["N6B1^=%_=
M+9IS2(HY7?# Z6#62?UN#B9"D('LF< 7>"73P,^!>N')@H-+Z06W<?+5T@IP
M[V XEGHT?_C*+,:<<4L(@OR]2KS9QK?['A 2'#VH8,0G41S1D<#]S9X4OHJJ
M-6TZ25M<I/DX#7S<\);SV^3? NZTR'F?)_%<M$&\HG:'1_LN!F[G;3Y5VA_?
MGZ7/I]= 0M=QZ$LB+8W)-.XYY()FFR-SWDCI]PG^^S/^(.7;6ZG T9A$U_!#
M;]C_L=MMCT9(/?P3^3]1<J!A0X(-UDR^+'4MR^O,=H?>H(,A0<1,[PK^,PY(
MYI)>Y#E85,"F[#P',DRO<:?$+#C2PP,KXHC_! H&"O@9]> 4N;L%')JF)!.+
MQ"D_G=CJ,5!@ -0$LPYA^CY0JA?X.+3>-7MK3FD(M3<LF<4W6$/ JC7.1V\A
M6^E )CF(&/Q%]6F"!S<@GK;S+B?''"M*MX*G]KH_TD+)-AC=M@R_JQ_ED540
M0':=Q/G5M9YYNCAUN;<K*,N>7H<8O]O!:Q3+9J2(BV)'N\&7?VN%.2EYKH\U
M)XL5*0H!G=#1K;>D".F85[PQ<%N>+7]E <#UF>3*L%-*#K7^[[7NQC<'=CD:
M [E^/?(0V_4'+[SU[M)7WQ<%*DA3.?CQL(U;6%[]TC5.IP^RQH6.96C7TE;[
MJ.<35_Y YBM7#_VO5YNY.->)F/[CU?\$G9/I:.Q-3]S.I--WNV+4$]Y03*>3
MH=_MCD:#_W<,QAY' Z:D*^*%^[_?>S\M)>JGI[6JM;_Z":3"^\O+BX_.V<7G
M3Q>?3[^<7WS<Q#4X*-[,S[J&7\X_GGX\.S_]X'Q^_\?Y^S^=-ZRN@V;U=F$M
M/,6?_G><?/]3%9OMJS+R9>NK!=V("=D=>%VSY@@J!<IJ' 'T03 /DN0.7[KQ
M0G0P)_37F?>-@@;XC=F<;E7^'081WN1:CHKOH6[#%^3"PT&J;X!3:<W8X2\P
M?*[1)\JW_S3,T87"KA/Z!N@,02S-HO(T-UZ^%Z:Q^:PUKHE]X$)8\X_Q4B-E
M JX_#(F@D1"1]]W+,C#7\TPYO=;<FBWIJ MLW1 ]^/ JKQHM19P#G' $&G\"
MEO;DKK@G</=6NU/D-=SML%ZXV^981D=9<4!7AMON:5<&?@[^T%=_:,'+Z1SM
M[QN!WA28->A8T@FYE'9XU*X:I.V<1]H'0T<"NY9'4^\&Q#3.?/7F% EF++);
M(5CUQ$6PP03_^+U]V79\6+R'!YN'P ?^#1P0.H@"L 8GV9(MC#=4_?%#T@@C
M/S^1FG+S*V6YK!9N.C@.L8(=V\YE#D1FOIF"U89K' OC8@,RDYKM1Y$M(^=E
M,U#NCR"JL&>,TP.7Q$'R+3R[-1>W18<AJ.5HL$M+F=EF[MW1D;.#)T&3G#3E
M@C4"6R--J4[[I$>65)G=2' X;Y!&C'/*C% T1C80/E6V0+[2OF0A6_%5OD$F
M\54$.T<A1Z 8E&2T4#+TYO,PF,@H%6V$+;>K/@;L*#@;0GR;!VA3 B'^?_:^
MO:N-'.G[J_3AV7>?F7,0TU*KNZ5DEW,8(%EV@\D F3S)/W/4DAHZ\85UVR'D
MT[\E]=5@$PP&;*,].P3LODBJJI_JIBK@\\KW:J*9YJ9FSS)V6^7]RG()[[!Y
M%6"\G&5%)L;(IF:,O#S[[O5@6<[K-!X0=RMU\+Y,ECM5LR-M3IOT9HT>TPQ(
M:_* +?]%2ROC@_[9P([AXF(HLMPLP'!@\-#4 MWRCN"IL 5T/4PV&Q,/UE0#
M>!9O.1F-1Z,S,1S!8(QS!J:Z8](UNK7SQ7@:@</&W8*]^FDV[%4$&("!;[\V
M]GT-7]/-]WIBB^'99C4+:[(VD2]!? >7A6%<$-DXP/X][H/]&E9.LH_G6;=
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MII.Y<H>6%T(.9O)LI8=<@-YV54M2H6"U^/\GW$MJYCWH?].EX0B7[1:&[K]
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M7Q[R?E(<R8GR^M#<B?+:D16'I2@3$.6Y:@@ZP5X?#F#/Y\AP@OTX9"6X%.P
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M7EIK#D,-+QS9/APB]_*Q//?@AIYYN])PF5:F:];^=UGTS=J1(^]XW(7%P(%
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M)LBO%28K.?J[]V6LSDH<.#UOSZF4^AE44 ,8K4$7T86_[38%@&%29EJ6]&V
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M:$QU'IVU^8(P,"8ZB@*?(1K*!"5:,Q32E%-&>1B;RA^8T27*HW.YL(MV12_
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MO#]QA,7)^1+*>6/3Q+&.$JHH I$6L*U''/&012C1A,8J"%+"^,9V<'-;7^7
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M%1:$*4I8FB:8Z#A-U<8VWZ3\9DLTYW18&VE] A7!2>M]I;75+UU%6-,T18$
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M"Z-'%*X[Y[!8$KWB74V28PT3^J8=%#U8H^B<POQW_@J 4BP%K4()#G!$6(*
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M_@</-L8"IH(=K>+U+O"MLX99)/8_7O8OP(<Y8S]1O ,4G_%I4$@76I"BN"@
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M]2&(MCX$G=4)6!#5EF56*G>\XQ?)@%TV5M]S9P"Q^8'8/'5&I<^A1,5 %2X
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M(0+=D%PXF  ?!1O?86_6@8WOF(T72%]Z953B4R(XA@P)9H@6(B'.VB)7A00
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M?Q#"=ZP+Z1&-7V(AF7#? $,U7I17/_"KE?F!Y)GV'"=A8G8Z'JNJ<;>@HPQ
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M'V;*#V'VO\+DGQP_OLX.OGV&[_<RX$L.OT\.$UZX1*<,TT= 8[ &- :T]1E
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M61F*XC2VRX!L0L!\F'G/DA>"L;NU]0R';475A=X09-"B*HZ:S0.B:I.'0>'
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MR;-52=<<RJ@]E5'O'!Z J?G2Y4;PO>C&8]IU+J=&=C78EZI<-$%U0=^UTS$
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M0JVIE@*4LXQ/F<AN'C.L_>;+!-:#D@,R]"?43H/Z&1#"#LW=5!M")%4TX&(
M2J;S!GM[[+@JHEVU\-BXP35IA[H45LORU!.8C4V9]F1;<EZT9]U\\Y_O9'LW
M)]G>X7MR3#E1!#L"M FM6D(ZP*'4@#C"C:-8Y1)/&?O"YI;FF;6.4<6YY%CQ
MC.;>Y,^)0&9-+<);=/4C$V'//Y52$J!@6[RX&HPC3*/?"_U4__:X^GW62;?5
MN>44'(;4YJ@L*_%KO5D%3Y->G8KDQK!8JC;Z:V?G7=.<#$>_5RF]RDR]Y7P+
ML,BIMJ501C&P.?.4J,*M\]^R9B[5)V_*0KHUJIJ@K!O9#Z_)A\GNFLC$%.F=
M&4F86B7,U.SYI\X\7S;]E [G1L]#^>K$4157YV'$=W:\H3/OO%B?_-Z=&FO[
MCDD?VHMN(D^NH.++"J)S;X ]Z;:-&BS8&/#[8TWT#X91;^Q6HCJJ&X%O"FS\
M%TL_O'?S#1X'6!N8&0R0\?]0B@T0$AJ044$-TR(CN5O3<W%_T*]G<LKZG+0%
M/EAC[5ETL^=][W$/SXE1=:O1-[&,:\[Y^7 0]FV1!4M^7]GL.LU*4-;6%CF@
M8).'3G%=1A[V]'][D][?^=5@>%Z$TK?\RU5'\V2HHC]OP%7UDS]$+TLH[1IC
M0AQ"];A0<9JJGI+_=BXK/-Z))XQ.(]!Q/'ECMVUYBS>7P\&Y[>S\5?%P3'Q4
MH^,(G=1#?Z1^ZP^N^N%T?^7/]E%WX*_>K)4<FT%9!EJTS\2I+G7I&/5'G@QM
M 5]\GZF*Z<%JOBY.NT,#SN4PX(!7J<]J5N].UU;T'N/S^M\RXB%V#OHZ0?W^
MEY_ 8(YL=O[YYU4U8<77RHE*+!X].;P<'>R_Z7P,Z,7A;A_+WHU__GDW)CTI
MOS>>YE3W&]S#1OM/48Q<K4YXRF?9\^?(Q68P9 NTA'QK<H^.IR$Z?D._F1.!
M1,=9>9'H4D:!?L(_\=Q;81%=(3;^R&22!7'W\Q1*8(N<[9S)C/@%$WV1P['N
MF+>26W4%,W^Y8[%&W,RA)/CR(CSA#J-RSE#OJ%HH$*DF*%O&C"T+J,.X.O,^
MK+A<0F%C++FNM4H]><?[8] T?X:Z[5<UQ740)6ZG;ZKNXW?!9'K!]L()/G8P
MQX8Y"YC.,^#GFP"IA?5^M\DX@L[@7*^IO1!7&<1E[M37>4V;8T+Q2#P"0>HH
M:)ZIC;*C9GXCMK?-N[#PC3>K"N6)BA1Y)0/02FDVE)UXO>M&!T<PJ#<G@/MC
M.4XH8 IO!V(TMF@P*3%/8M?.J!O*E0O\^13=6VS($^T2M2CP4A'>,FP=0L9^
M]?HVXL]$Y[3QU'/9-?-JIOQAU!M<6_LL0HXEDY=7=!6/E^ZVJ>30 ;_SXQ@1
M[W%+%C@>C5=X-/1/<,% SC*G%*,$2SL9:)29"0#W-#?"4LPTAUHHE7E?2V06
MPJDJY#51D"&DV&G(P/JHQFZL38[$S[7F][(UO+)_-RNNLL )EK359MDK'&W)
M)M)6:F3V=_ ;WY1@6.>#4 \4K*B>/0D@6KKD+AMVC#R3)ZF)/BC!LGNCT9K?
MH.#KR:M1T8A_<MDK>SW& 4^O72_B: J&/V\EEKJX'PRLB&P483J*_&Q)J+'5
M^1Q;Q9.'TAW5+5COOZAH[*4'2V]\^U]+T$W5*[*6D_!:LM9PV9V$^XS/COTO
M)<E<>814[=IA)%O>X[@*#7[I$;$/K7L:68Q<.=C"J(^XX D=+#A!7>WG9UAL
MI9,R1#EP?C%B.V'X/'[=F]2F6S" ESV1<>U"#UWXR5WVIJCP4N5H*,:,:%WA
MS_%/H8$\R(L*IGI8Z>0A-[KX9L("5&G2L;@46=(0M4W]I$7O:!JH+KC_ N]4
M\/S22Y<!Z=B@6'5X-N=UW(Y8%8Z.)VFKL^?M\4&<\6[EZU\&S_2L()B-KE(I
M:*D /]XRHJ1]CT+HI2!"NF^6E>I%*V<WAMA[]GM@4S3^?7J#\W$G:=_O]/KD
MG/G-E>Y>9D5C87HHA[WH_.^E?]_HC ?@W>I-_9%X.D-4:ILP+%.L:3ZU"2$G
MON6Y_W.W<+BG1/S"SEOTZK(DK,4>JJJDR\U4NV-UQ6!8;:RD9^3X:V,(!V]+
M] N!.I/&)B#;7BQ?*5<O=HO:1 L4&:>^^WUKIB'OHK4S*K10!/J8B0R6/F^"
MR)7WO-U :>MX&W6\J*WC78NQM'6\+[V.]\ZZW F+VS'#+((*2J8H(1G/&>8:
M,Y5S):%9<T;.>V0&[W0QMIN'R?>NO4H-*;INX-]Y.I=G[O0!'4_*T$:22G)2
M"ULPYB*Z<'7A[#-ROE%6_=D?H^49&M!T:U354@T"F'S-&DFVY1SK;Z81T# N
MHO$<NH5^C _5$GHH5 :6C(S&!C<A/B]DP4\&_A9%W5A$R1W>8N6- ]:%(S 8
M7G=DL0Q%?>G@<GC1&5V/+NQ9W44H \JVNMG\D._]6;ICS,F8;E$+4#?K:A68
M9>%:&27V?RW:KH+I43A:#:+3F@>7[/SK&4GGIY=S'EV,=BJ4Y,"R_.9']^)@
M^+H[\H:/[.V$JKDXP0<!4]#[^8%!-"1BVKC*_NN]ZV.I%))2&V @PX!*1H#2
MF08&62B(RJ 1ZUJBWUC/SJO3"-3RN. 4;XJ(I/<"0O]Q#>%A LVS":'3 ,YN
M! U*8+M4'#4=0-CJO"I DRO54,(7)VT8XAB%%UQ6G R&8XCC=+X4+O5,9E/O
MC4: MIK'.W5E$8#0H=T2! (7$]N=4UUZ*AJS?EM6M2_C.6GB<Y<^U:.RM_]9
M!':\PE3%"[[D9--[>"RSP)4@<D!U9KR.0 P$2DC@?6?'%:?.*?R,F==+@>C4
M)6)]0K*-;%5%\ZMK8RT0Q&(<4:?<3XP2I4[E8+.-"[UCF6(TFFQ58YZTT6V0
M#^F^D:2H&,!FV,]7MM=+I9S7\[+S58!SQ@T:!:$7!5A%:5*:6K*M!(*ORN:G
M6) 2N/NXU&#>L+V)Z[]=X3@W<3<3R&:8W>+RV6,IP\957=#X,=U1H\0U@'.&
M@*-_ZGA=*BTY1K>(T>->"0U0._3&BK3X\APUNNX00;<GC.-9VNND4.98<BO4
MT=CHUG"7ICLT)E=B"MAO-+J,9 ]O(R"B-Z1/NF.Q;\;I+Z[/ [I'K^C_DN5.
M:C3ZGX53,21(9#U@7%8J!6!9J4\WJ_V60 "T'-7CUE6M[FAFQUH!T#@<HT45
MM5Q%X5IZ^;3Y96SB JE2V7^MO"(V>&UU/A;PKK$_,-25A+:1@-L;XLTU9.&^
M23-U7F9Q3Q/<:[<_Z_7*&JMZ"B.ZI]VSF&.)Q71?&]"/XU?>+  ,:^/T9E6O
M2GX70'TII>W?;7HT,VY9HW7Q^[CT6:O)'*>6RRR[7^'@R/:ZSFY-@R_4;9-?
M:Y7XO;13:>EWPT%_$# :H]78-J>4_LS.U;$B@N=0$^"(H8 RBX'(<@F<1I9!
M&/Z=RA,CI R#S/I/%<6*"Z9$KI524###,5W<MF&/K4B7=J%"B-(KLATS. _B
M/I:Q3E/(GL=1LEM"L@['H;:26*RIX[UB&O,E=^3T]'P,"-AR:#J?SJ/)499E
M[GS\5)5S!CXQ@++-7UWAO#R@8W&\C3J@\U=AA$3=F)PUD"H.^[('/GDKZ./
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MQ4T:$^G'\]T.$^2;O\]R^P\;RCA2EBNNJ<J4@L1K58J$=YF=T'D!^$ 0G*I
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MK<Z?,@0_!JGX1O9E[]I/V@3[JTU- K8  8F!H<:;CBJC,[UC\V7,(/4UV=)
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MIGO=?GSK$OSEX*IOAZ/3[GF1X98G]L_K)DY,^LH:Y;<?TTA_K5,I-^;8,H1
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MR(6PN5],K0)1^:J:$MH=O(8[>&6!^78'/YR37"^ZEY [:CD0''- ,VJ I,P
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MZ7E;=#3%P38KLG=//O9;9V*VW9#DY9$DX]/6QZW..V\#G$EM+^.H'PHZ?M:
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M 9%12A!ES%*W,J:_=O>N[^Y=>=ZCW:<_O4]KJ0^B'#,T)X!)[Z!2#350N6"
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M(H7F#@I&<Q+((5M5VJK25I4^BZ1>JTI7J$IK:3N>"4-XG@4D.0>HI@)(1C.
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M\Z).N]=JO(1JO+!T>:W&CQ<X3Z?31:(X"5#<I'E$/"B3CW,S!,JMK;<FJ9P
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MF6#H;9LY7.FQ%=D[%[TWU8A?L,]V<+J[Y7_N[.^(W9_OSW:WOAP&@F7TVB,
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M:U9W@=<^[H!AS4,]CK:7<PS]N;[GI6\[L2.?KRM%)&4 <V9_SK49 H9/'D/
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MW[GJD-3X--7KQJ4'H:YF=G^BLU%@F]9Q99]N35G+UQDVBS]O1->Y>9C#40_
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ML?UQ/UF5"S\L,LHYQ"F0DY%&PM8F0X'6F$SF,HU<CW=LH=V1)6VWAK2="R:
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M:<*4BZ@ >XW5! >3,&=2>Q9#&LIJ,@_?_29H3X/S[3@XS#;-B!H^ 0GDI_P
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M<M;LU.BQ50>_C%X;IM[DFJS>]YCMO77O>Z=PI?41P?W>[6UT3]T@G;;AO5P
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M2?\:16L4K5&TOC7@10#L9$8F(=*69R@XU@CL"XR<,AZ9))Q5UE,G5G5KP+I
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M%K_5SM<:QE:1&BT04+"RF\,[JOLP'GL"\K@WS.J?6//)9D<3G*EE=&+/B]"
M?>X4.5:4FX UB2#_@(DC+!/  7P'+?P.G;=\7H ]6(J"F,TBWX)-\6L00">-
M7K4(>85'MZCWBC\:MIP)K.IF^31Y75Z)?=+N9'*IL (&4A%2B#<G)#Q#2,1<
M34AY;9+]T>Z4'XRW**\;B/1VO]?MP>#SQKR%18:1M1JVHON8^D.Z&2#I<*#A
MBF&Z\Z4 =Y7I '>%X*KVPFQ0\<DKY+='WB_P_<=#;Q0-TCID ^8@J:5%%N.
MG*&)11RQ$X"\AERB4@_N3-X:WQ2]W-7O:Z:5ONMW,K-DOFK!B(K>66P"6)W
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MCEM4ZO-<"8Z,B0XY82R.DADG@+6IF(_K#^["NB_:S]\NR0-7(-7=QC,K#FN
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M/0JL^.W?C5U@]Z__.<;^Y-\M^Y?I[W\[NOCZ[0O9_>L+0,*NV+WX= +]\B_
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M.PS;$X*FEAA*N1#*B!B$H(8G3"1([%DGRR429LT,PH-9*9]5A<J8S[K"G%<
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M=<@(4(Q"T(;YR'C ;N,-:#Y;J[J$L8[[K2</W]7O4O/PP_+PV"]#L>6,\X"
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M]2:-3QFO]M.?W;@-$K)7$\B 0/;>?3_$AFI+$T8A"@OR,3BDP9!$V'/)8'O
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M8_\HPGN>G,*D;_=[16ZC8I^IAZE2.XO=7%2^ECJM5N>L]VIRPLY^OTSZ8'H
M97FB79)-R2GP5BU[VHNO1C^\'J&NV2[:5EST^L1V#YOM$0.)TVMD4CRO_/CU
M63/TCS+.MW!I%(?>W_#)PX^WBH^F*+#\3/(M@OF-'^,M<N-GO[HM$5N<WOSQ
MKV[[ZT<*\4B-I7>Z[1T+G-PHU<Q=:J&4LVBE5L2*/=>U=X#84*O;KC^J,;(Y
M85?6H?2+&;UK<<-7S3X\S-_!@OZVVZ[!<UH@*^ZV\?RFHQR_BJ2LX*AG>[J0
MU[W+4N7SZ3,\#S 6<A[H-CC!398D/C\==;K],KG,E6VM#GA79R-O.1MY+]7_
MJT.2Q43,&[@NG8%G<D+R%)SI%MSW';2I3AIO/6[L[]*#_3J!W\_K^X<7]2\?
MFXTO[T\:;Z:<\Y-_'>U]^>NHOO_N_.#B,VY<?"#UXZ]'\!SX??<G. L_O_ZQ
M2^#Y^#\7[RZK)#6.#\_W=KYA3Z7S0B"=(D8\68&,X@8)E:BGR2HEU<8V6U2^
MP54[Z'VG]E2GP"NFNX7IP./6D3AI&#?<8.NHA:X0-"EFF*$Z,QTQ(Z:[PW'P
MBND6QG3UG6]<<6P8=H@IS!"G3")C/4$J1)U@@(31%E2?61>6>Z*M>\M3G%,[
M\&8*SI>ZE>8)=-;DCIJ*?>9FG]UIG26)Y=[8B"(3"G$8(629"$A2IRWG5O+(
M-K:Y?'""U2JEX>KB=.$JH<+IPG **L$QX1.3 ,^$ ^*24.0HU2@*+ @X0EY2
M#1@5#Y8)"\3HJI5@7.E[O(03#Q.;X K=]&I5D@@L_![/ZQC3?;9"[ISDDBX7
M=E36I6 ,U$EHT,OKGKW8?] ^R.=MCA<NFW]1W&M\H"H;/9>-_CRNI2_JA]^2
MTQ)CY9"-.>,PEQIIQT!:IV"YPRXF[7)]P96O57!_"_CBL;MP*5UA]W&Q"_H:
M"VD3YQ0Q;SWBF((/[*U!(F C H>/7:XQ,F\]],?$[4M0C+]6&+MY<3[V^C7
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MB*-<C%KO^ :](;[QT,&L3BDOJG]6VP0M4R%6GN<]C<_/:7%( R5,:H%,E&"
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M['Q+RLLH!4;"1X*X%AX9*@)2*1),$\ H29 8ZGK\?I26-F,D#]*,Z3],Y%W
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M E+BFFAE/#<;V]=3?M[]W$1UI'F%4?LD>?4JU"X,M: G=(I,8TH1EUE/*$,
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M6&3TS1$@&FXW7%3RMML]SSZ_+0XT98EQ.&* ,_ !<OPS=5JMSEGOU4/M=+F
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M>0D#6&BXA$&JZG)+9Z?#\>@AIXR(7&O:<I\0QT$@[8A$,AH;<7*1T5"M1;X
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MV'/XZ4<SGO6*%[YJ43?V!JU^KR05VY_JBJWG,1^RB4DP$6K9O,01@4Z^:J]
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M=82&V'N[\Q!H9%,PA8K:V5$3I"9X+X-6OS3GL^=/J51K0+'E["XL09Z6)X7
M2/"]VH^\6Z6@8:#XF*<:T'9^2#?:7@\L.7S1VV[W/#^^^/)6[=E*!+YJ$N&?
MG5P]]L^2Q=Z"H]HYCKY?V&K :+['2 N,#>N@T C>]HYJ"08U^[?P41<:7 />
M.SPLC+T[KWW>^K\MF#<_0"N6L1,_U 7%]"K4@6VWP0GV\'W@FS)]'@B,3!1;
MM9UVMMCPJB=W(:_I.=S,P]U,S2QTCVP_?PMFX^1,ZQ6N=PS%=_+',^=N[IL)
M++2O8V!*U6:4999LM@>%%IKUE[%I/1PFGN?O]17LLV;H'XW"^6-7#>.8^.H2
MZWK9CMQ\R=.7Y)T-!(+55(>-_7O4'37GU!Y&Y( HOJ,B;/+*ML[L>6_C]TE2
M $88WEV5VP2F7__&ETQI(2]YK<QOQEO1UR&[1,6 OQH  77+_0;_L"O3EMI1
M-YOQ_VEBG8RS"9QW,.>$1L.BE3$E+P.EQHAO:F-[OY#B("?>9 4 :OP?O]OM
MV\AZ.$T)G77JX^E+0A?SK^[_[]VG3WN-VIN]CW_N?=S9W]UKK.-[O-]M[#3>
M[.[\N];8VW_WJ?;;FY)B8IC>T%+\.\5!0ZW$O:1".*N]XD%0+7ER-!*1I!52
MAXW;.F.11GEF"[$-F"?F%*6,R^@,H<(08KRS+ ;KEV3,Q:H9\YT>F.W24HV6
M',"^#FX(!V;[6?KRTT9Q>"WH@6SZ0!U,V]:[6,V1AASZ(^-K.."%EZ&BZW:T
M=^G^3#TSNSG9S.?W'L:=KB[NC=9*1C(D0 /@*4,)TQMIF*E[#B7K+Z5-[H%R
M :D52Z\(>N<(!@*D;!B>WZ@!J\:RA1./_-5]IQIL^Z7'6(;EQEYR3#YU8_/$
M#;J]./PM#(9Z*K?10]_&?C,+AKS<T.O!\WKC,;M"C.46=IN][_DE>@/OX7MI
MT,K/]T?-^"/WC(]=\(C;XTM:<-="B?0*&5_XID7#SV&\?1_&:_B(06_H:\[J
M']!SQ<PJPMCE>C,CFV5 NM"7@/IN'J(3>'INR.6<=;:5W=CB:I?UZC5W)?=E
M<[A5_DJ)7==@\S'[+*8B>O&^PQTU$[C;L8CFO6^VH3^:,#D:G7ZL$;59&\88
M\NF 6G$\H%8'[PJF0!DS&T8>"FR==(KX7NER%_.Y/530X!8"+ ?=;N[9,22?
MC-WJQE$<+J;"#W@39I,?G S**/,LZFEU>KTK5$Z'$F=&E\M!GF>M(@JK!>8R
M"<,XBTPK\(NQQ#H&Q:00WW9SJZ\MA.E[+U'$L'/UWC>L6I@7%Z#P\/N';SFQ
M+M%"(TF40YQKC'3R"C$8#FD=PU*)C6VV=7UK2LT-ERWR])IG_!GV&BMNO2&&
M>R\<(8KBX)76'E-=CC^NQO^QQY_4]W/L%E,5#$8P)C#^,@CD(E;($HN33TY9
MF_+X7S]1,QK_O+S4.\TV^$=LG=\>(QJ2NIS)Z4N2Z\!LMGW8S$[4#C!@]I_&
M7Z)\\T:.,#?]Y&3V@A MC7984.ZH,LXP)7%0/"9K25'#!"9S&64=L=KD9/WD
MCT RM.)>>I]->OPW=&2X:E'9H,+#VX?'_K/5\=]?W&0]/,O15&>TIRD&9!C5
M0%:*('"+$_*""Q%)=('Q#5!WWI[FF$IW$&^,LJR8AM@=L_MYDTDW%"N"5]/2
M%K.@UNSEH&XJEN5ZKQ[J&0]7\$91JV(3'KQQRY[VXJO1#Z]!+9ZV[/FK9KMH
M=W'1Z\DGS#C$43RO_'@8]C%F2V&5(S_#LQO#!P^#0EM%4&AJBV/Y&:5;&M_\
M,=XB-W[VJ]N:+4;N=]=?/Q$\X(6W56\1IM:DK68+DW5IZV/UJ\)R;=I:S0'"
M^9WN>LO)L]N/SY)KWUURWAU]FSX:2[LS<BCO<,SIUIX@XAGT!)[HB3M.CJ6>
MVKE\R>*&KYI]>)B_PVF5W]YF-= M0@/#[6J]O]_EN-L<)PU6>^"_%+^ ]OR'
MZ_Z^O0,MLX>Q^/GC*#)6?G*20V 7A90K_O G/*X3BA]_.XC0APOKM[L<;WLV
M_?]'%]SUHA??#*/BH^X>M/M5C]ZC1\>"(M=G;M6A\W=H(_8?,$%?9)=5J*Y0
MO>(=>E=4WS<!YWU[:I9HA)LLZ3CSFT$/1BAVRT,,61X>-4][]TJ(\,!^6<&L
MI;\*( LJA!;11QX%#QY;B;D//"0J L4<SPP@3^_+#8/N.4C+Z<CR+^+)EZ)U
MG!]*J4K6-+I<GO'NX/KQ^Z/&'P>T_O8[M.$#_GKR_OO>_OOO]>-_'C7V=QD\
M][A^LHOKYU-GO(^A#5_>X:_'!V=[^[NB\?;CR<&7#Z+^!?[^QSM2/_;PCO7S
M@^,/%_^YV!V>[RX2DXD0N'(1ABA)A;A4'EGEX%=&C'5<DX35QC:AHT64X4S8
M?G1\W#D[Q;R@>V[9)^9^_V>372(I)A6S*8JHN S!1&8B%LI3'(A/\H;E^'E.
M#/Z"APH!N/9G!Y^<>LZOJEN"94C*8.1@[!#702"=P%BH0*2F,=H8Y,8VVU3,
M+"C=V<IDCZB(L"+"6P.7:\.$8X[;N":KN'%.;FQ<R3++ \9.122(T8A;2Y 1
MEB,GDJ::4&XDR#*Z2>5U;KP6I:UHL:+%9T.+:\.*C=BO&'!>!KQ2AY+'D!2X
MH]JSA+A1#CG#@0$],2D(D3S/Q<$VN5I4"OZ*!BL:?(XTJ+Q2&$?@.<RY,=0E
M%8U,TGI/I6/IAEW+E9N\1"+<NY*"FD49HG4H%+56%17(@NQ#EK.H54P\!9W=
M9"DJ(JR(\,41X3QN\G*9L'*3%Q1"S+PXS%!+E9*)N(A83I/'";4Y=9E!.!*#
M%2.81)%5HIE!CI6?7/'B\^7%M:'%RD^^#P76+RF0>265Q@P99@CB3)*<L@GD
M(H^)*?"4M<-%DFZ\-OKPOF52UF;/R:?8_='TL68/N[$\!;V(,M_KOZ6$:$F5
ML<HR!GZ-3Y:I*!/,XQ0E9T)66TI6DY'JXUM*O'5)>I^04%PA[IE$6FAP6&4R
MD0G*!"<Y7]-"MI14E>[O>G9=>"V4B8EKQH6R&@>I%09+(; $U%6;)5805&/A
M<.IHU-PB9HD&1P?P9)PS*.&D.#,VN1"SE<?ZP;7A9EN5IZBF\4)1/$\(X_XP
MKN(43XS>L>5\38734G&D:?C_V7OSIC:2=%_XJR@XY]SHB2"9W)?N\SJ"-K@O
M/2/1MG%[X!\B5Q (B:O%&#[]^V15:0$$9I%!0/5T>S J565E/LOOV27BRG-D
ML1?(!4U,4((Y ]PK"'N$DZ)FV]>H?&LS^F=RZ%2_*I.L<((A(54 T(H%LM$(
MI+7 +@5-J:' H5+7VO7ULJE27D@9J?>&<^NX#9XZ3J277GG"U<V.L!H(_U1&
MG0F',FQU8 IL2I55*;84.>,8"A+,2TXME4&MO#.&UXSZPACU7I&\G\^I-0Q>
MD!$[$ZYSC"M"J4?2XHAX( ;9E 0*+EJM(DY2NY5W7#\F6%?S[9M6L#4.?@B+
M3L-)-! A*/>(&4\1UR8ADY1%VC+KL$G4%D"8+)-^?6@!\XN)%TV&^G3:/G8'
M\5'ER:\H7)1X2ESR&(D&I2$<Z!:G10"CVGH<0ATN6DZ)\W$V7*2M,EI*A63(
M0Z8I<6!T9\L;!Z63#-Y(L?*.LD56(#]*4\]AH]>GJ1.G40G/2"22!Z5LD@E3
MFW 07 <<%N"QJDWA!W'.U&?E5+3):X4TR06T46%D=2(H4B4IS<:P\X"FC5I0
MWL<SI+B]44:]5^WGS^?4VA1>#._.%GA* 28PC6#_$@*\:W-"OZ+(>YZ<D\08
M34#K\>LP^]YIJS7;ODW]6EO"#^#0J7;E1B:+0T0^&0,<BAUR@3"D%9=&.:N(
MC<"AXGK,MM:NKX9-;1YTZE6(7&'NG7>:8RFH,$D*'(.N(T+/Q*@S$2%'N6*>
M6T0E28A+QI!C@J 4/)%)1$%9=BH;6C/J"V/4^\#@)^#4&@8OR(2=B0AI@66B
MG"(>+.!@Y53N<0*JU@JMA&%&B,+[<YUY:QR\M'R[7&Q;X^"'L.A,1$A;#.R(
M41 8^-2P@*QS% GL''8BI!@EL*A<5'E174%T!Q;;Z=L03VS_N)HGFO]:L$1=
M253(%:RD(9HIE[#EE ;C4\#22>&<DS+X.C2TG*+GRZ5*(L>EEY0CC[4"<" 3
MLC8'B1BWD2D3E:<+:TY;)W'<=0IJ4"%X['S(YV"U4=H9GI).&#C,XSHT]%R<
M,W5>$:)$8-@CYP1P3N0.:1!^*"89%9&6$Q=7WAEZ?3AFG26YW(QZ'YOX"3BU
MMHD7P[LSH2%L,74I281=[OU)<YV0(QI%*XA/+@*J(2OOV)P,YSI)<FG9=KFX
MMC:)'\"A4^W*4E*)<(R$L!%QDH.W&+2K%#%Y$Z(N<*E@=2GN*V;3)'BD@+&,
M3)%;L"NUEII);F(@B1!<AX:>B5%G0D-*19$,Q0@SQ0$&1UQ6S7,5+&=262GU
MRCN-ZZJ^E\:H]\J0^OF<6L/@!9FP,Z$A,%]=HDPCJC++!M"R1AF'5&***269
M2C2G2#TF-%3S[9M6L#4.?@B+3D-#4A-E!9.(:1<0%Z!?'9BN"'2GM7!\B3B1
MJ^;E$NG75U\LM!/]81>>=7!>5PEE.0+6,\9<6 X4QYE(SC GHR,*6\9]2G4H
M:#E%S>YL*,@&*3PQ<$24@:1)7H/);2)R@C(+9ZJ]!23/ZR*AI]30P09!E/&)
M4,U)=#H%)Q(UQAI"761U).BY&&?JJQ(XNXT=1BFZA+@&/*VEI4CSD+!.S#-I
M5MZ1A0T/J+.LEM$$?@).K4W@Q?#N3"2(>8#5DEI$X=Q0MH&0=8$C$84$NS<1
MY4/.?ZB3(U\0VRX7U]86\ ,X=*9(B 7GJ60H,LMR) @0J>8">#4FK*R5)MB5
M=_31_N6:2Y>72[G,/JH8M)"R:.YHDDU$$TP,,TRY.A#T3'PZ$PCRP(M1:(8\
MLQK,1_C#Q:"0X)XI[IUBF(,F58_.AZH9=8E1\!-P:HV"%V3!S@2"P%(5A&.#
M0M)@PBHF4,Z'05QRDH*@)!D%S$NNIUO4,'AI^7:YV+:&P0]AT>8,BQI#*=;(
M"ZP0URHA;:1 S''/+94T*K_R3CZZ:5Q=(G1W#ML>'L9^70U4]%]7-@6NH_<V
M<F*PCLYIZDS$B2D:8QT"6DXAXR\UBC.&):<M$B: \H^Y2EAIC2S!VH*IS7!R
M(&/J8J"GU,T:JQ""!K4L':<X.)#Z,BJ3(M568UZ'@)Z+<:9.*AR,8H12I)WP
M.?=1(5#+#%$5+/,^I,"RDTHL4TO7FE$7;?P^ :?6QN]B>'<F!.1U,&#F1H0=
M=J#T@D46#@U%YS'UWGD;<O$]O9YA52=!+BW;+A?7UK;O SATJEVU]%;!82 F
M+)B^&-@4@"KP*K62&T:XR0D6CP\!U5RZO%S*I/1$8.,YV)?&$">H(PRK9#2-
MAH@Z!/1,?#H; DI4QSR'5H5<$J\\04:".L6<$8,3"=+F<@+UZ'Z.-:,N,0I^
M DZM4?""+-B9$!"AQ(8D-;)>4<0)C[E#' - #/:K%ICXF-LET\>$@&J^?=,*
MMH;!#V'1:0A(*Y%P3JR(Q -CTF218YHA!2?&M<+1Y,%\XM%=6)>@%,CU^B'V
M47DS6,&P,>AUVJ$Q9ID'A8A"^]OXP=7W4;[X5Z(+F? LE42]H>U,#@86^+ (
M]UVWZT;Q]Q.?\=C[5I_#$?Y*;J6#N3)Y'C4\JTC^[_M&8A>W/Z]&5P6GJ,<Q
M*.DMYT%I*XFF04O+C7,ZWNRRF8DX_MH=G83>L/J\MA-_JB([N#15QTA%@\%(
M2),0=[F=N%8,:>(D%X$I0?7*.[DJ^:.K6A?-0T^4L53+VEK6+HL]_[S"MC;U
M%R-^9P)>&ALX+TE0R&W@>?(.F81!!EL9L0\,2,2MO&.K2E[WJ-\[W;.6O+7D
MK27O"T2YM;/F 4)VBG&5##Y$FY#B13E,[HN&C46:!2\CU0%+O/*.KFJUJ,JU
M6M+6DK:6M ^2M#+HZ(F)2K# <STPCUAKCDV2F@CE;_9]U_Z$YY*U,W%GT)$)
M&T$0,5H@[B0&,0NBUPH<L:5>8"*S/X$M;$!9+6MK65O+VH?Y$YY7V-;^A 6Y
M<V=2!QPV 2P3B:3UN5FWUT@[&A"3GAO%4HA$9(<"98_)H:U%;RUZ:]'[<F%N
M[5!XB)2=9G_$2!6EFB*O<A:TY!*DK$K(:*J=Q<0;:;.4)>+51,V*[)%_#BW0
MT"0[XDKIX4Q.QXGM'[2[X^42>EFB'8T&PW8Z+W_5[H;8?:[$#YK9=A9\-.+W
MT]@=Q$8O-=H3KFG8@FT:9W;0^.][<+D7A&AIM,."<D>5<88IB8/B,5E+Z-Q*
MW >R^^Q;;*>K'/_BV7WO/X?8G_S=M5_-:/LHG#2/MLZ:7S\<[\+]]XX^DM;)
MI\/61>NP!>RZO>%Y\RL\>>?OD_]<>-;<.=X7PG%M.4.Y@U5.B/;(8*D1EH1P
M%CRG$:^\XW.ZRS6 Y#KPP^J]CCYZJB-QTC!NN,'640N,+&A2S(#QJ_/1$S,^
M^L=)^OKH;S[ZH^8^L2IRI0@R-B;$*8[(<461H18+J[%PN1T2E[<=?1X[>B_.
M9\#MN71)*\V99=8)2@ES$:>DL#7%\>OJ^($.ZN/_.<=_L;ZO'6-6.X]\$'DL
M2E+($6!_;A.-0DL;;.9\?;T;UOCX\U$TLH!>S7_BDAKRL:TV^G%P&N'J;[%S
MOM;8!+UVDNU9N*([LIV&O;-J:0_@)WA0I],[&_QZ+UI[YJR F5?<+-^P!4O;
M.8N=;[$)ZSQ\TR3(FT>[^UI3FQP+2'F<^WE+@:QF#$G-M&&)<>X5X$5UO2WQ
MPY3/TE'$;K3]G;/>VR8$D$4.[#XBI4,J6@.& ]7(!,^08CPI+U1*+H<B7SDA
M'/9C?..D\'&?A<ATDG#V.(!:\DP@EYQ B03',"91DUSD(\QK)H4/O5'_C5/"
M 0@%*7R>]12DS+6:%"-K-$8D:,X3#HD'ERGA>JWFP_'I<E(#7/NFJ:&U\65?
MJN"TM: B;#&[3SFD4PS("2RD .)0BN?BOYM5Q!BNTL;PL-\;'1SFO\@GHQ']
MTVAD/0UC_QJAF+=(*!>;^TI'JF0P""L+"D1(BS0)& 7'A4^.Q!@ 2Y"U.7:-
MJP@E]\R+-N_J6F.]TYGG\8(+&H.1.P(CIS'L739HP& !6Z9I^_ZP]&HRLEK^
MD FCLI(H7FM<KJIZJ7Y"X(K8SYL 5&N[O@WV7:LWC V^VO@__Z6!(W_[% ?#
M_L@/1_UV]V"UL75R:MO]$UAVR7R?8A'L;+P_A->.@]7B6^2W@E]A7R/L?\DY
M>7/AWZO'T6A/;MCPY3W  /79]1O@XKDFZMJ5BC8@A<SD;3!/"UJ8/8WJ;;F
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M*%>W]Q)> ,E]]H<QC#IQ.^6M**3PVZ:[XWWBDA* W5$P FP\SC!RWAI$!*-
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M[/FR,67MQIR+,+DG/F++0+<Y;L%>2V P1&$"$5X24:?7/C_K^5L09NCL[7A
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M^=(_1]W88/W2&3<E1?@%4%2T ._.H^VO9M$%I^@+237^5FD KC7^ZO=\C&$
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M-N<DA&+=,VD55:K)W)7E4//E)(EQ<EM!SCFO[+0?OV5BZA38[+1C?9QYW_L
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MWQLG12I3U3%D2C9E!X!K54PO%0#/-+0M\Q+'Z&Z0I7Q.@<_(\!+OYR!*]E4
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MP3DFF(BU+*QE82T+[]"0FG+M'/%>"\>%98X(Z@)GD287G2E+>/2TCU M"Y=
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MGB@,[5*$-<M!.R7 ,(@).2\BHM8:F8PPE.(<PYL.QR^DB4H!\?)%XLOVO'A
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M6%@(8GD)8@[1G*)4/&.VF CR1*N8]5$CR15&W)N '*$,J4")B2JQY$11*EX
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MM/WX?HC,6IA[6>H[;1#4[7:NRE+G-S?]Z#KCPBPO6D9W][;W@Y/8.YI0,,S
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MQ75[UJP-:B;[WSPUEZ>2<.6H5%9'3CCV!KX04H3_BVB#%QKN4\_76$FM4]:
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MJI,7"O'L:^'.8:25#[G5'['642^)V=FGE+8,^W@9E@7+J'4L16!81Z6.(NG
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MY9ZXQAQ_/!^,NEDY/QO&GAUW/\8?\X8C5NY>7GH[BGF G?T?R-^N.(;OH7>
M:\=HQVC'^.X=$U>D_U*URKVR<%_^>](=7VP^H/2.%'<[Q@W'>/+ECPE+KXBS
M5!+,:<[[BS0%'9WE&E/:-K.\6_\+;^8V,:UL4!2CR*)!W,B(C'4484L=YS92
MG]N!$'R/JA_O(\^W8[1R=/M'#4;M7-!.*@:L*(GF#EN;K'(BRD#;-BUW+D>;
M?NS@ E:<(Q(D05RHA P!N4I@LV@N,;48!.E]:H-V!<8.W=%YSU[DR<;+6;R]
MLKWR6U[9$FI[Y8.X<DL^ZX=QSL/E)SH\= ?48QWC,E"]AAH?'ZC&S').,2&>
M.QXEM9AXPW'&UM0$Q5KGQ%V"ZE>?F\X)1TVTUECD;8RY%;A VH:(E/<\*>R<
M$GIGGV\K->0>9;6U8]SS,9Z\')52":% EMH@>8Q:<\VM!+YT1!G#6^?$G<O1
MAG,B8:^MEQ))27-)A S(Z.10%,Q*$A*1,3=IWU9%Q)WTN%O,,ZD&@QE<D>)W
MKR%VZ6K7 3.CW[&%"VX3"[SNPFPAR:=]Q@-_QFW'?;))]UM?GT>#%Y(4WL@H
MB &00")Q00:KF6+<2<5M>V+:W>*%BZ;=%;EERDN"F'$&<>4-TE%0I'F(,20O
M,>8[^XK=NC)\V^SRG4+*]UETM\]X>L]HU76KKK>=>Y"<30D,>!\"CS*XJ' D
MH D4E20QTYKW=ZVN&^9]4"+DP[908#PA[E5 3D10WY[$Q'$PBK"=?6&V=<;I
MG>OKXASX^]BZ7MPO[Y1IM]N?V/)2=1%!HZ+CS [?=?O3"1.8\8_U1W4]RG16
M5<T'T8U/RG3F92#5=-Y/1N-NNEBL#,FW;9NSS56,3:>,W5R"BH<(5XY*977D
MA&-OC*8A1?@CH@T^N\Y_('^K*&#U[PW9R+N=U/T,OW3[\$U<\_5P^?CWW7+^
M^R!'"^&NC_#5&:S6J),&P\ZGTZX_[220")V/621TNJ/.6;2CR1 &G(Q@Y [<
M5U6ZP.VC4SN,'3OJV+6%+_G+_F#<Z<6/,<_H4W=\VNV7$1J/..W&H1WZTXLR
MKWP/O$MO$N"&,O(PPDKZ;B\_O#N.9YWQ /[+CIC&[/=6J:ZS6,)R.?5=04K?
M@I*NUA&%E)[;T6E9&9]_B$ %L&QEPU!G\W?U$L(.#89C-([#L\9J570 ^V#'
MG3/;[8_A3R=8F'NGUX5!0B:TLAG=LMJG]F.FK#X0$=R<E52U=:/.('7^\S(E
M]EL<OLDTLMR5C&B:,,U]>S@HLVAT\MP&3'2TC!M_\J(H,XX)6F>$TJE2._,?
MGOT)CZO55UZ.@W[(_[R<K\5,E>$'JLK^^M<I]F?_Z-M_F@G,D;[^Y]LO?YV]
M M4%SWCQ.SM\_W/W\.P5/J(O+[)J^NL]J+P7[S[_Z\O+3T?'+R].-,-!IH 1
M(T(@+HQ#1FJ-I/"YTR5S#I.=?;*'5[.*]SK'I[7<J D(_FE2U8+T&44_&7;'
M7:",N8QI?)@% .RC&Z->]P.0%) &/ ?X CC.CSKQ[/S4 F]D3F\\XLR.FZ.>
M G-T/ @D(,-_3X!GQQ=[G1==$!-C(.!2C.<W\D46+[YG1Z-NZE8"YM<LG#ID
M09A<@['.!OUX 5,;?HA3?IJ_\JH4K@1K8:2*T?IP6_$A3UD)%'3W8[YA.#@K
M(A)NC,/>15F,V1+^F+\:Q6N^Q^.0@!LT'\B_-YGH8O5U4Y7EU2F$ +1ZZ[WX
M]V0PAI_/AUT?*RVY<7?R\S+CP,@595QCOV"\ZD?Z"+?NYPW2 75^&0"@[!=M
MU/@\*QD0!EFON,&4IT!@P&4 06!]1Z,)#.B &N"C(6" =[-Q1GDI4X1M@8_M
MNPB8(?.+'PS/!\.,?JH1;_"(^DZ0@R 27O7/)_",##Y@^S.A5,CN+(Y/!P'6
M\]W%3#BLDLRH"ZMKAW78:)5.*E#6K9^1%7.FF(&#=?^84?6,[LH NYW8+8(F
M3,7>(&.YZ6^[U2,GKBCLKNW!!05T37J]3A&I\/*SP?8ZAY/>N'L.#ZDGG*=2
M?NR,+\[CJ)Y*1@E3GLC?9M+_&/MA, 3!?@KV)&Q$YWP ) [SA1GV8=[Y&C^$
MS]#Y</"Q&_(596!8OVZ8+NTF*LG/A7W,&PIO\-399Y/\6]# FZ1@_ S*MO\.
M=G1H,[(>W*F2VNW0W3P%MJAU'\>F_;%L<,%&'=<B(TXY;\4JRY;6,(*\&5?"
M9US#+A 0?1!FPTH^C#JY2!^V#^1'0P;5@S8V ]CM/!OL<2ZY)J-")DOB:RJR
MLF4U ID!!&"SD!R!D G=D1],^N-"(5DZ5G H]0:?@%KR2I_'LMP=>P[V7W<$
MZ+P29#4NJB8+A'8.0"]+,6!Y6T'*U06X(;4L-2A8\3DTR*?>'IY['JPV1/C4
M#>/3J4.N<5=-;7A^BW6C06\RWGQ+@RBS?HK#.R)!0N32\C3^/IVU0CH'PD(.
M=N(#L@EF^\SV/MF+T<[?%YD/.*\>755=)Y9??^-+IK25EU1K7K+B=K ):PW]
MK"+^TK[BO^V]F4OG=)@MWO_H8IV,LTD3[#$G-!H6K8PI>1DHF,'B1.WL'Q<>
M 69^GHWE?DXOL?M?*12_$_VM6XZ=_4/_?R_?O'E]U'G^^H_?7O]Q</SJ]=%#
M?(^?7QT='#U_=?!KY^CU\<LWG1^>5R(FAN7^*.7OM4X_ZPVS.A EO.%:FWS2
M(7>.2YV(IX95KI$RZ,$XMP!5C!)AJ%&.\1"H-BXRX6-DE"?*XL[#U8RE0@&T
MX<&X<Y@]?I5CDV4!CRDIBB/[?79!175GEO;H<@_3\I%K$A9*:QV-5IQ)8YD6
M1,I$@J=!";DYJP$@\YG-&_!Y_*P_.0N#<?U]T]GT6P3C8= _Z(?R+K^!FAS&
M,<#NK)-60RNC64"E>*@>?%#E%IZH+_D=3@+31% ;$0M"(ZXY <UC E+:I\0I
MQ\[JG7TF5_Q0'2#'7M[[3"0W(8CD/3PJ1NJQX0$$<,!629;/X6-*XK Y;M82
MQ#<G"'Y"#&<..!(1[ CBQF.D:9"(&:FX5"81 A*/FHT$D0,<H_-8C.EL^8+V
MG.=GUIB[@GHY=E$9[V]^^[^,BK,IVO?9\-V=?IP1]F#XSO9!JM7AAW-[@>P(
M70PFZ-V@,[H8Y1#$NPD 6J"R.58_&@P_Q7==>/+<(Y$'Z(X[IX,>P-O^ -0Z
M .'^!1I\ZI?1BRL YI3C>F60\XJ:.KVN==U>MX+O&2W7=^;)E#G5UYT#G74G
M9Q6TAX&*P5 &@B68VG/P2N>V&^:^@GH5UL[XT^F@H'(PW4>GQ170L;X8 <6G
M$"T,"&!^#.;_>;6F\>R\-[@ N0[#?HCQ/%N8\#JU20(,8&&- >MGJ#\933^O
M)EB)^#Q*L7*FX:7,P,.NFQ3W0.'X<HN]J.W$GR?#S&S5KC7"&L!YDV&_]@U7
M*U(TR?0-NMF S?Z/XLBP?=#3V;%0[V#>_IEU5>W&L,B OB^@K#?HOZL<THWU
M*BZD1^)MR(16O%(E_#.NMJ! 4EC(RA9CS>3GSB<[*O$]$)/P1-CCJ9/J(MKA
MJ)-MPW"IIK^VR2_71H17E_+;K5P9\5EW#(_SUUC+XE*;L481_8^'2*;2:,:G
ML8@QVP$UZ>!U@5G.%MY_)J_R.E1NBD(GF9N*2(#9]RH9CARLANWVLRRP[X8Q
M5KZLXA+UF>^RLA_TT3""\!O%XIRHGU/YW_.X?^Z]*0*>8J)VLP@&I3YH3#=,
M96!6W^]!R R&(3\Q]@L)'YP/QO%#S+Z)?N>'_^\_-*7XQ]]>'Y2?R(]_VX57
MA84,=CP87FQXU9$_C6>5V[8+\S\_M2!)_,7B7+,(MJ"T*A_/3)< >PU 9DY=
M.W-!_5LU2E8+CX>:AMW1AT($BWJEVLI17%[?0D+95Q2Z*<5A"6=G;^2H^#+1
M!IJ;IAT G0T^%=HJH&'TK/-#MTZYJ(7:&BI9G4'>J4$_SI7?F04]$F>*N/9V
MPT<%^A7VF.\\O&L5)URO24<_PJ2FL^JF@D'6:MS1>'#>F' #X53JM?()9E"0
ME1JH]'>5Q[VIA*<S=X,AO$]-@  K:A;<.,,LPF&6C6F.FY+A=# 855(A3W)U
M:T?960W3R&NS9H-W%T:KISC,D;YAO< VSQ2>,24(4$IG1<DOJ/ B:NH%6 =
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MW,( 'EPC3'7S6.><<U[-77/ 1'-OY,'H?ZJ>E(T+IA&)H_B46>SEI\/C/R^
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MC[,\>\SN42D+XH"#OY;%3+I)XL9I%J.SPP*/*[;9/5]DZ8*#-^<\XV&:"N7
M;@'%)]W4X6[FP=)E293)7 29![M'389W3\-QV7H5TZK\4)AD1<XS9'E"(V7L
M,M(B=S+"C9G2=N^*ORN[1)6+QGK8>^AL5>JIC)D=>+ZX;1[3)X:U=]D>K:(6
MGM%8;HJK^5674&O0+%_T7?U[ATB$CH]JL9-PSI,83\T#V%M)HM"Y3R+AI[D;
M1.[#^/[N1D(TSG-G6QSH"7AU,^US_OWSJ(AOO5/>^P<[YUZ0AZDK R=BOG!
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MW.3N1I$/UKJ[^!8[-#B+(GF-XOO6DC"B#"BZZCFKX(\''U_=G,<RD7GFQT[
MX]!A8<2=- _ #DK%0T]EX!M!=)ANL0%Z3-0*ABZN-JC$IC0+9W>K99I'/7*7
MX*RKQ* .5/*9B\G9];G/@B#U8]\)(NX[+!"^DWA@KKTH#UV1B"3@X+6Q9 L\
MZ$$YT65Z-)NDS32/1],KL3&..JU.N6FMHFY;>2*5I"] 10;1WQ6B&]K:HLF
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ML9@8ZO:2;-S+CK(S7\$THO<_-]K%JHKN3[$!&F7G*H6[G$+ )45[C^M*][K
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MLI<8&F=91?/R*)T91L*-\E0DB8I9B BT3*6*10'/6!Z)R&#.F,:<+2E/)WJ
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M=TY-4/Y$ZM(69T<C650-0Z4YH<3(<3G3C/(0?+W5=9H%-; ":]CV03A^V_1
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M ('8R,%7EH/#O??GD<]9QJ+0"6!-'!;FF2,"CSEQ&'N9Y"I-,P5RX*X6!-V
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M \HIB7(_X%Z((9(7;Z?+S4^^>[7TQ%V)QX1(G^M(1)LXZ%OLWM:CN(7=R_Q
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MO_UCHO8>"R&T=CP76AN1DTL=7$N#CKN?=*^LMW\>$8FO_K.W?1.)&053ZDE
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MY-=Y!6=X$%D@6IWS(KAU@\M67)'G]-/IW-2+5A@<#0/^8]^JJ"\>?<4Z\)K
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M&9 E/"+ 4<DCIM(:/6^53V3$8T=XP@3\8Q*<TA:6AUGGX07[F/ T?*E>6!6
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M35(;3+D=#'HM=UXPQER_#%_*J]\#XYYM?I:6'H!\/"T^,/$ND(8(EQN\4A+
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M[ 5(*=*<!LJ-"T&PE77^X-*5^H"?Y=7U!402ZW[*2Z_X.S<5GWF67-(<14U
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M3\K!WB+G+48*G-M(E4I"R)5U3NIDS[<#""\\"%I#PSVA82+H&3"AWC*)>"1
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M2>.K-/5(:4H9EI-7WE@?A'/E'BES(H*V5F=-E^(TK31UYS2U?493ED2+/*7
M,29!X*:"DU%!8,$8%ZW)VC0T)1YA%$^EJ4=*4[JD,6:EE5-:I!2=(RF'Q WC
MJ%\9M0R/9J6I.Z>IMU.:,MIZ8P0DCU]*YC48BZQEJ';4*UTZ034T1=L43GS?
MR=8/9G:?*^JTB@:W^*XKZG$FE_TP3UGB[ 1-+@MFHO#,&^F"4]8K*QW3*=S
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M-Q:^5_U>2"D.BN/L]_3!';Q)P^%!:JSC)RQXLUZSMW+WQ1_OI3$T^8Q+GID
MY*",=)081,(,<E.*H<0N4G,Y,NIVA](26I96(5B:$.Q]$H6)E$[%<TV 1Z(!
M45KZ=+D 43$B.2-!:GME8<_;'TE+Z!M9Y6"Y<A#>*^9$$$H"QSW!$RD'\)P*
MT%+3$%VR-I03B7Q+$,Z?2'CL!#?8Q]^&U#T>#J[U8@[VBR.PG%)X0@W[:()V
M#LI6H1%UME<;G:VC3C'(ALTG76M.38\G-_96SFL_2>6)RM8;D[20P3D=DDU"
M<1=$5C=J0G)CZ?R]-QB,_ 8?TE$X?19"_\0=H,S^W1W@,*N %@%]\9+M?/WC
M?;8EH%XJ8%;H4LH4528A!3!)DM2>Z$Q+MY'K-:8BB"73IOBERY8?I9$L?.X.
M]Z]V9@^&S;5][!QTG>\>%,]VX[YK7OUFB'\JPE6<#>]Z_4]G[]M]\ZQQ[>?B
MK,97Q^X@G P&HP_>Z>&[J%WOE)<S\@M^Z&%W.+[302(]$X=AY_?QIZ*6MMZ\
MFO[2O.0:X9_U'=Q6^*EP+)! I0[% :6<]]0+I:1G:#[HL$QJ?G9PT/OLCD+Z
MM==_T3OQPWQR\&RDIPY>%\[XN_@\_^QWAVDWYZ?,UMNG.U]+^1SNDC ** L!
M!"5IE&KB:73*&K3E2D=-=;VV-FLCH( @S_8.43R]._K4/SD>AM/'>8\H5L&'
M^.UXTM[EV[KFL!M99HS,. W'-W1SXI[K)%DP7GC#!&<45;*<I0I,JLR4N4E%
M_AOC_F5S1[C=V*9;9S>$S>WCWKX[VDN'I;YH_W0+5ZC;+W][PM"?5=0^R.T7
M+]]3E_%?3@ MZ0@B4 LV:@V6>H_V=61:I;E2E^]C[TM8R_S[_JS</.ZY+W7_
M9_;?9:UBU JXXQF/ :[!X#X!+47OM,M,4HEZT&5/\O7GPKP&G'/,$):82E8(
M:Z+W2:*^K+(6F<=TDUJ9-_<I%M'YS76/BJZ\>_0&Y6 W__-D@$P[&.RDX6ZN
M C)QZ^!GO'CWGJ-)+TWPD'@)6^<J0BD= BYZ2G&G$LW?"EM_X.V>G!+7;7G=
MZIFMSMQ+&F@LMTIHM!.+-E%R#"BA4AF3$TD.C79]N:+B]63P@^^A/73<3S!T
M7T81S(6&RT\_7C3Q49'LHWWN!B=HP.,/&8F[\[<[.$F-B32J"=@\XV!JRTP"
MZBZJ0+\E%(VCSO'YB]3/^[V#-, =[_BQ!,R$"Q4Q[7?]R9E2^['71<.I.+=Q
M1-<;8;]VC]#PZ.+C&W.,GUEC_R\=Q$:]*D*W,3&ZK@B6^O;5[<6ZB)WNV9EV
M6PTM,R9Y5))9%07+UE%!;2*996VC94O5T)H"(]-C>'1G4Y$W0M[VY]T7']YG
MH@2CDH-2)=N \%2RQ"EPSK*71H54,DDHO8R\V_G.8R:%;/'(ET%H[YW4VD=+
M%<U")D>7Z3NOV_\-)>R=W'T1WH=H,Q.,@*;%:ZY3 .N( IE1.PM$,..:[5^J
MVUP)+94.IB0:69\LVOQ!>1$I-\*)FU0[KB*P' ;8^?KA/5$Q9Y;0\&*EFC$7
M&;RG#+2CUAL1%.<$SU[Q+08X?YH>]W$K^MV#TUE'33\-7?=@<BJ>GIV">(+@
M0?;<';GH&E%Z>=+O'8_.O'-GW6&O1(J/GG+YZ!-G1]]K-,CZ)P$/3CSHUCO3
MS1])ZNOQD,:B\+VS\8I#\4.O%S_CS%?L,/QM/.SI@A2UM%H>YR'!MY$52]1J
M9 $A89P"80(''Q7RH["4"J-%9'+.I@P/O<]U?V?V-SDIE$/+4N2,E&<H 9?Q
MZ*,ZH'(B$Z<IK&VJ&Z39W-KUL.@A:)8G$?;)2\0?[[7PCC%-@"2.8N&)*W7T
M-,C N0\IZ*#"G#TF'WI_+S%[W><_W@<?> K< @TN@TBE<J(R!++$;:81<5_B
MU>C&3;R._A:.AOF4&LK.M)K)'C?/WSH:NJ,/W9)),:JAN=[!W3Y39:Z),)C1
M:\Y?L7YP^-%-GI([ZI1FT+W/,R$+\^HT7DBF<C:$N2R"SJXTUC6::3S]T*#X
M7EFG6T?%O.JGO[N]DT%39G24S50/O4;T_Z"E%R,WU"$3<2A=A5#TB0?<%55X
M+AMJRLUX7-NTEZO)3#UJ5\OXM/9CD;*0^L,B3^7"]/"HA!HT5_V-[RH<N.[A
MX&*(YT7_&4J%[KCI+A8!?)V^.!3^4;[=X[S>E:MPO3M'#8D;A#9-K*8F^[B\
M<J[XII*0+EDH07A")Y3A:+C)^&NM+,UFF3KU61QX$\7QHO>Y4LLHI&D;/^/E
M>T>]]RI(\+E1JJD$)RT#+6W61%'E%1]G;%['+?COA#E0;@9-] #*S7"<^5OR
M<8^;TVC*)A,:.1X5E,:3]:1QWD^"PD]G#/21\SY]"<7O?O:"QTDD:A6(Y,HJ
M!#<*"&NTE3EU$B=8DC9EF1FJ)Y%97>IH>BVUMHY;O4R=Y.KP@-=X<N$JQNEU
MX(ONX+@W*.^O3()*RK,O.ZBD>*<4L8F#B26?Q#,++FB#ZGHI2Q6I->4Z0GZ#
M2$IPY(>CLM33[/[FVJV)RYTD]D\S^A\G!^BV<<"U=1K&6L%,Z!>.]Y)G=6['
M:HZ$:&$4X5DX2]#XYI2P2*Q52@GQO6NF><SO!>+ GIY)OBUW7[Q[SRACAB<$
M-\]HALM$P6F>@$>E-)<A6U,J&6]<<>WD9QQNI13]2/T<2=4]"\E2XD'>#'OA
MT];1FQ,_Z,8NBLEN_[) I:><:?C'Y^VO;]];D[3$_0%G2LE#R]%R)?C%D&BS
M8CRE7$)$Q#>.!C<8]$*WT1FOC96_::F78]<?=M$D/46ARR4RPJ.AVY3(N95^
M8A++A"$0-(J;=8:661'!E0D\Q4E:(5W&K7C53^:(5]_=^T"W44_9_OC'EQTD
M+FUD1%/3(6>A?2.(CV 82V!LTHFYP'.0:YN"7FZQ?@,ORCFOR""AB+F)_Z/4
M3^B6T&K<KF\))HK5X?%!*L^)S07HM\H-77WG>2']HBG>,*\\6RJU8B''4 J!
M!X,+(TAV@03O4:YOX@.\76!E[^A%&FN 98R]/,D].7W"8CQKL+_[6@QVY%'!
M@R>0?"K5Y;A&@[T18T-\2!39%<]?^XT<I$D.7)Q=[DE$W-[K9S.I1L?NM"GZ
M,Q'LDB6WWSO =S8G]DB,KQ%&U NOR=J^BKS1:BQUQ$KNP3!-T_%&SSLK]745
M;%9!<]AJ:JH5*2_N[JMIO-[SCL6<%FN2,NXU5004+2D&/%-4%[*"%&)F^%-F
M)2>8TLL7O;>^U[U7YJN2<3O)^/1>DJ@<(0YT%N4<CZ%DBWM(D;GL<N0V!)0,
M>_TY?OYF[W%Z$4S;O C/>_UB2R.Y3VM/GA667$[:-'$)@2NT4$D+SY,+*E+B
M?4 *,6B:?N]:81[/P4W3II^>FV 6L7]\WD'[+W-/'=42;*0E12#J4O(^0Q(D
MI,Q==*7.G-FX(FW47TX;+8K 56G118YZQ]U>-\+DU:-+R[FO[N?-C-Y8ZWQ?
MNL^K0!-K\R%*J]U8QE\D/WQV%$>'TIL4T"HITWU[U+]@<;[\4J:%"U,S*+]K
MC+[[4K1X(612P2M0MD3N2IO!1]PS38TF+HAH:0G>YOSF+I')'=PUJ2V7O.>#
ML1_NMHX/18+06KHL"1>AI )D(9U(,>,?'+5++?)7#,4SC)V9&R]'6,-Y-((W
MTJ5VTE,6M7/LRPK[.F&<9=Z"#XR R%J $:A.R^295,QP&D41M6\F[5]?M0(Y
M[*1?2B@4$ZZ)Z!E56_G[W"W.N9"D"Z9D,42[?S?5CCMCL?M.F$F3<]4[.,!7
M#$[\8%@^?H"LCL+:ZX_O(#_TW>'&=WEYYNYB9HRW#0E/2B(-$R6(%%Q8[TS,
M)0_2X5(CX._$M'R1,NI?\9_I"+\9OCIP1Z_/KM$0"A.*?G&2]GHSA8?H$\;(
M6[KS]=U[Q9(.!JT'(TLDL42+PJ'>"%D$*ZA+)@F'N/A&V:DS3\HP]0^[1V[6
MCW)19.-HFSI^M$^=(HSEY<>X86,BOB2 <^L&/MK(4/!D],(39@WGV09J&6/:
MC?3?.[L4&2=G[/5^1R7A0[,64W%[RL+&2K*6X<C G@1 /1B%C7F!YWW$XU\)
M[VCIT!T\JL#?D+492AQIN6/M]G&:K[9MYNNSPZ8HT$R"%$)OT!TT!YH[+*[+
MKV<$T$1 ]IOS\BS:=YR(?'S21W /KCY+S]*+9T(HQUT/W'%W.%*Z.X->'GXN
MSL]1&<VF:,M!YV209GLYQ!+86=3#LPO7"V,L#E?4&$O.%U+0.,/J+%:K.24W
M.O-415]E<:.D+?+&-T@C;[]?2-\>S,K;#?;N6JFYHE/%^<X4YUI7+,'X/']<
M%.4$;>V#D63NYE$0_*C!4!-1MM=#(WO0.^C&YCC!S_[G02]\>G+G1NDJ].Z]
M]K9$O@F(HJ2S96.@5-2&S)5+@F4?*"YQPM/UN#3XZ)^D:UM^7(6YNX#<#9N
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MXD2)<9.Y*@@/PSEOSRD(-AFC20#IHP 1>0:'IB(0ZS(7)"A.U-JF1/W@$;I
M*E;/BI_9J(+0R4=B2K\C$Z*/WE%O$+TVFZH?/!A6I_J!5M[*'!EH)FV)NPE@
MN<_@G1="!4(0O06KW%ZNK5Y=!G>)M%?]4N:T>]S ;"^%_2/\X ^G"VH)3\(R
M\3X[G8O'TF81./%)TI"\2]E''2.M6L+#,,^[,RUAY^LVV_GP/D?;=#T%(V5I
MB.T$N, H9.W0KHPT>H'LP]?%%25SJB?AT>!5E(KVW&N151(F.5,:>BB9M6#"
M"B&KIO!@>#T]AU?EM9=,$;#!<A!42C#9,$BEC3T)I9"J+'C5BVOV]^=,F,3
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M>7O G1W3*],"3L@-J6_7J^V;7=7HAM#L+EK T=N]LP[VP08K'TUSO3.O0O/
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MT .# 8<FL[%G.MQS851]:A,P&)YN+^A5K%>Q#GJN<Q%7@IX6]BS7=2/302Y
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MQXX;> C%[MX[?]I]U;I-Z[:=UFV:S+TVZNS'2)UASGALNV88VYY)>$!-ZI'
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M2OP3">== ?EKD'V5 XU;WC$?TJRM>V2L1X3]L;9E4J..*52([I2)V2*"+2<
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M*2E%HV8;1K,E6LWZV"%]M9R!L4,"+6]#[)!0RYD).R20.K;O*:576U/ UJ9
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M''6[X!:QH,6-7FH<W;$LRHU/_2SO,[@+/A)$#X\',&G'N37'+YWKL!M"U1/
M2O-P&L .>F)=EVL-?I3M*QY"<,-SX$7=-)?:X%"2?<&R?7N71+UF\9+JC4':
MZZ7M0VMT"PORM-7OS;]E3 OG_7:;98/I/GWY#L1R2A!G0B%5?C:ST92XX6:0
M<?;#9#&T]I"U[M@@WSL8D[2==,R)GEVE4^9WP9J RIO1!5N%I"LVL$#2_THL
M/Z8!BWUDA19!F%.;,Q<P*'0CC"EU_O'VWEU+B ,4%.% F'+Y-!A5QN?EY^<L
MV:7G>'IU=7EA'%]^_G3Y^>CZ[/)BUH2MSD*6W<!$+%:J#:\I/@$U=>C,TF<@
MFU04HT6>01>;(&.+=7-^6/[R-DKR;HL-#I..;*F\Z>WX^\0+)M6C>)_Z>K0>
M&I9:$X6-7;RY^+HAORI5]-AW7L/UT-QO0<'/_6[14XG?(.[Z'^LT*/+6_E2_
MX5)G[4]U&Y3,__:Q3P6CST/N4H]=TN6R!";O+07@<R]%^/%@KR;RRZL#N5S
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M8Y":Y]!?_2#)FXGQY</O^\;'7M0HWGF2AGU9(GWLK:+SQ&,N10W9LI? 0LG
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MH;10&KY6AB^LX6L7X LO!5\?D@[KR!J&SPE?&KVT3M1"[:I0-4*O$KLTA.T
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MMN\^P>PUQ[\S&V;ELDEVB]X[_K42 I?N3,( 5\  *<NN@ 'B_O'PRVT8#.+
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MZB ]DZ39!;DW(#)/5BM+Y -A"P@[)*_,>H6?N@XQJ7>G&QM=46W1@83DIYC
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M9ASPZS_DQB$!@S2P$J+[41"@YI\B_4LR\VIPU[U"G?;QQ<EYJ#R=M$XN)(D
MN>UKG\GI<7ME9->2F>2VKWLF&">-(=,8]TK>'6(=]^<VC8_V>]LX?CU^-'[C
M24XA>U&^SZWCXEE7@[ON%<J(*P[]HGBJ$C<P#/0IZ;T;!*/SIE] ;?#0:LQ_
MY[GO"%'&=8[^1"[R?^ @:E5W;O57:@(__$;F"QO=B# '.S2^O]T_>.8QYX^8
M<] D6Y"OS,)9NU_F+U^[[/BW+WJGF#UWT%'=O'IG,1YP@[IKTE"](R\.<,L2
MK%/KE23,U<AB+5ZJ[?'6O3+95EWXD(1PU)<T"=>!&ZI:9P^>WT6,P8X; _>#
MV 5,D;'0F<!.*+(OMD'9T%4JC%7D87R;A3D&H$W5PGG 3A1V+PG4SVE=]]86
M81\CC^ ]FSNC"S@:@XB0#B#B;EH1#E*0-Z>.HJ&D+!$%<.OH$YY#'*90 ,_B
MC+H^6)4%8K#*+AJZBCDAC!W3I$(Q0-L;C[?R89#9.'9T3:9\8\#W-*84"L((
M#5 Y&E 5NFX1L482_LBTB,H-J7.GOQ-71,047'F6QE/S?5!OOK#8DI 1.J]Q
M^_3>J1?DA'>9*W8H$BT^J;M<S,EB"+?&6S='J-^!-/'&8T42@S*>*8,3E:[C
M !Z'&&QJTW\5,'DUR!NJYPUYQ(*=<>>QL@;KS>HF.!\/V%<JPTXTJWO8V89"
MPGO+A<6].#\*(DU*HFDH[Z&TM/F=\HB^XQ5QX+2Y)2_PO[[#3>I''31-X+S4
MG3*'EM"_PA[J9IU0JO#D5R%7A(M;?H.K MK4Z]K'H)R4<#5A"CPU*4 6GU$R
MJ+J)B>^5,9N'Y7YCW)&$]U1NJ#1]0W?2@+\1@<TPQ*L@NZP\JKJSBC 5>P"#
MHQY_1"5,GHE,J$167#Y3ET+25/:67-;><G[:\*8W!*Z;V7.2//&N<D@6&/EK
M3_%JY%??)B>M]E6F-K*2<[4YPKK78KTJ =:E2I8H6GD3,X?S2^%HZ-'? ;J<
M<J'%.;;XLC"S;=V47'LCC%=:"GR=/, ]\O[V1<6=N*I'7(6'U\95B"#?05<-
M"#8OX3X;$@-="W1"B?G ["DF-278O$)'G6I/#?77B6(@JP(R*@WR*RK"WX3B
MJU)3I 2:NG?CD,0U/63NBW3+ND=?IE07*#LB=8L:07LT]O BLC_!%[I "1*I
M;3PF\=[&+S>Z2UUN!E53+FSK,>RJ=)6O4GOM 4T#AQ^5X>64QUZ(W-DI@VMF
MTJ!"8MNZ1C%A#E[SX.V=0^;4GX=E<K;)GBO125.U=<$!F'GL(@*L&DK!H/:"
M2N6!_N5^)VB"$;.#SN IP?H.U Z_8H*,A,6JZ*#V4@LCLM"=, IO+3[ZUV^R
M:J4JL'5+[;7+CT2:X]0A_"](BL@21\&HVZ!#>*QCLH77 <A;BD'T:+<YF$@Z
M=V59JCOMLV:WP+KQDH@<Z 2KD<<P2J"[RL K'^G,KX+B!-D.KWI(YTH1SOFP
MS3Q^PO*-:L7L\EK7O=?'T*N00=T9!>T11TX-#-A<"XE;B]J4I!-MB;7N58E>
MZ(@S>($?O^/[;C9N0]FV58>O>>\.V!NQP&P@KN%0D>)/>%J,(-/(#[]@E5+^
M(QS=/(!RRNNVKUI2(V8);Q4T7@>6>+Y^^#CJ9K&\&EH81%/D))/"U1V)D'F%
MQ[U<6.]_$6MW:%J5O G,1U-SV>LRM;HK*?B]L]AMQ0FKU"4MHPALC*^I?N#6
M=2L,G@;#D N=TY/6R;G$)2P#JUML)5,]V*0SAXX-7>1\='7'^@VSAY>8.$^-
MF4ZL1Z,'S#QEGM>^-EY/3DY/L3P"0F.Y0(N"K6Q3)?CNEV[[^OSRXOJTK9Z,
M4O<(ZZ96"?]PHH)%NFA^Z6BBJOIJINK/BW*CF,+#.)IJ4.NGXXE;.QRVQ[)E
M>N\]@!D2$ZQ;;)K=,/^L^(%#:*K7"HW&T#L0US@+(F'8!):HJ[LS+!.HOV(>
M#WK("UEX<X2U)E+=,2Q,$6J ][9#PAHF286ZOX!3E*A6P]P.9]UR;T-M0B3X
M2&LU5H2]H9I+>"G;%Y>R-W@IF[S[Z* 1.^4P[LTR;I.\N+W5/7THHH3'C"OM
MX@870ZA?0:\O>3_\(X?2A/OCU)V#J*#LVZ;$RZ0"6??>S*J=UGM?\$<,X4^*
MC@MJ\\KQL,7&,'RB8U*9K##S!@B;>K"E\ZD?H=<9',;$>3T>^([I$^'Q>#@>
M',O=<9OCJYM9<E/N>)YA2-/R&7MKX T->NCJP6-^0+R@YEKPAD20PVP]NUA7
M<N);#W12$$I9%D_MEVQ!;?&U9R'SW0>Y[1M+V="RO,,"; H*61%$W;MT*X5H
M-VI68]6K1%ASE]G!C26/(8G**XK*EZ[K\X*Q/=V8\9]$<Z_ ?JD$]V[\QZKE
M/,L=YA7I!,W5!++=X*#/XL'&)HGD+*[HH7+LD!FZ5UX)C?P#);WLY=$W=?D2
M$TBKQF['_*<O9@PRP_&"-W-QVHF**P.8@Q/<WN)5 R;18#P/SS19"0(J[8*1
MOH[\%QA[W4>/^D8?O[$*Q 7'TE1V#X,+8)^^!+6*AY$S]=Z$IG1"<> B?[MC
MP/:'\0!;)$),>'0DV-G)3._$TR\\)P7=8/BD)?R!(N15MTA1"&;MXVJF&YF7
M#.&1HSV\WTO4G@VO@'@&WQT%8P5^G*6KSS+?47B7K*HNZM[KZX&6]PGU+WA%
M5#FW)!.VH2IC^NP--&*4Y980X?,%S+F?O%DI+!RZ#<J&KE).8 3W_3&G=$!%
M#%=WY8XO%H,%7'^^/B>_(;-MW1NWN'!2P;DL!VRH?9_VN VHSI_)L,CK<6<.
MK!9%PY7UW<DQU4WOL*+ZB+Z+ RA=4;UO8(I!NJ Z@*A5:]\.=]TKE*1J[QUD
MS5?=\;YE1$7VO([5/N^^MEK7K=.AI-#AMECK7A6E@B0HKS'QG]G?'9PN>[/;
MVY4XR<;84,F"+WLQBYIH%XJ*1.XK1CB.%",MU>'KYH980UV>MN2E=W.;USV/
M.$YCXK!YSJL#J]G].<450_L]40NE2.'=9:]--8&+GZ+>Z*ZH\==$:?=0D.5(
MO#!AY"[*2>-%%=9"UR49;TK8FLH0>99.AD_M*:@W+^R?L+A,QZ$N!K(E'A>\
MP1P_LHE]55&O35WLM>>2HCC\$9EB.TEM&S7@NL5Y88G^N/:CL,2&A#E3W0[<
MLR!)8U=8> S3.&%MB[<!JNFX[K5%!38H48X^O(ZZBU$!LN84@34_@WAL*=&-
MV.0>&SA8G0LC#0EHJW/J@OJJZKPHB;3V:_ZX[$=.6-?+,KLRB-!G[N&T=7Q^
M3G.!Z\6E0KHH[2P+Z^.+-<@/,ON18ZCYL<3MXT+_4E&@KW"L>K )\$%2$O@Q
M,18N,_]04@AU(UQUKT"7OE)+Z/N<-J^@@,SA,'!?EL"KS\>CXX[G,<<F2[<_
MF<#$0,. #ST=(\-L48#*X)'/O$2VQ++<36=UKZ%")MHV66RURX1<NZ>\I=18
M"TG]?K=O5Q%4PK$T54D/+EE7+E>Q/@<ABF'9Z@@:$$P=UPR+WC. D0=7?NXM
MP?=<D9#H^O.(#9))4GIU<X1U2[(U99''3/*:4:\43S/I:R#*\ V](<2[[/@N
MG/^/ZF7X'1Q5"M?M5?90-[>(]S"&!&LM \63RO$@,'KR@H,*XG2W0EIORG.6
M^._ZH!3.B0/[_D7BWE &KYOPRF\?!,69@-UGA+?:_CF%#)1UO[1=8>Q2W;%3
M?\$8J:2=.2;&S&86FR[+.1;+X:A[^XG2WNM%*J/12LQ4->"ZYQBG:/0GLOQC
M$;(>0^1;6UMB;:H=]@3*KGAW[Q'F,2N0LNH8&FJGJ1; KJ:,=E-V0U3E^I&9
MQ$+7-7,]]"'. _>]VOU :31US[OW;O *?6 B!4J8&Q&KR*DB :MY'X\ -".>
M$'_.W[K%0#6K0$_,>2-3"J>*#ZJK$204)'R@H\%OLM@,=0QU<V5./"C89W-\
M8Q<=E^6C2=>A:Z9HY^SR?,4B;9^T3B1U=8IAZJ::K.*>W*M5 D,#W%K 4'@'
M%<9?H >ABP^'B/0(8SEZTQ>2\Z(4BKKI&SXO&9=E"6WG\ M_-Z4H05@-OIEF
M$$_<D(2]=OPI3"D5]2I]=:0:W'4SR! ON'V"P6XA1[]1;Q92.2IWA&8R_+_)
MJ_A8: )XOF/G,\[6>!OJ#(TS@YZH31)/B*T_^0U<D9,;Q/V;JOE'U?12-Y<-
MF+6<AL]OZ;:XW^LOT*CP;;SJXY>9J-%4\W3][OJK>R77%*5;?:Y/B3MBOO"9
M?Z-,!,3QH!Y5=4N&I:%[<80U#4P,WNE/P&Q/OGLE?0=0"EDWH>^HXWJ;S$T.
M6/?4[FW7YZ_B=IFH1:L:1:, V)BYA5X#'OFRE.O1<L &J,_XF$#@36>3Y^/1
M6EQNG/(H.=[*HJF;JGG5H_DMP1VUB-FW;\A,MR;]2>D2U-E(:G=>"$7C"78:
MKZ:+N2$MM522;)BZ:7B/*1E3&E[Y\'*US GN?^*T#9D$*H6D[CF/_,7"HL0)
MPRQ4A9$4K@&R",0$-R!L\\['I\?Z"\JH&=0L%#6-)$JB.H*ZZ;CBV!S!5P.&
M.&'.P D> AE">S/_Q5]E^)JE#A:KBCP-\1,VL@1.*5C=]+N%GEYY;"?(2!X(
M+,IM/>K(> 7%H65PS72[")\@X1=KA<\5I!LVU-2(GX$T K4ERO@3QJ7'Y.]N
MET/2T)7(CLV]@X./&XL@8[8(\<U'T]2HT%"R/N@.6-!>%)DD%<5I@+H+9J@4
M#@Q*8G)55G><Y8M>H$5LCK"AO+\:*? ,ZH/+G>#$[+T;Q)559E0%;VB4012E
M.4+?;H93TN7W6WV;J#G35T^"2I#7?<Z'E@^^,E[V7DD-MNX9EGBN0E09$Q5F
M=_,XLZR'AFXD;BW&QF)WQH^":*IXZ%G$$14,%PXQ:$#/HKR"#= U5,C*0M!
M$+S3N3_'=N(YXF)?]\;X&LH]0>UI80XH!7(60=0M3R+5H/>.(>TD\ 'B=G>(
MQ\/+9<4Z9, -Y?,1?<]*<E@]X7AZ@_STW A7W:1?KSK>62P<!EL1)-4M;%$]
ML@1X!)DWT\'L7?Y.O!LR"*-/08?"U.'(9SX$N" ^([<<P(Y[K?EERNKJU_R
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M*B.-]7>NHG"7=B(*LNC&4 +83"=G', ;J+9N5$G)'8]D%9C4@.LFZK/M1(\
M 7T"YZF['BL^)$&\/"8XKGE5Q_&CXP6O*E?;35,OFF2I];)C00VZ;J8)2EGS
M6ES$O -:A3RNX"I0 Z[W8%\K3!D'>41[F%L1@44A;%O5*I>*R&HW@-?*,4EN
M_[(;U\VH.05&T2VU=972'"1U!_W$[,4FO7=B^!A?"RH8=?B/H>25I5J70E(W
MF?%)Z-7L RQ#&D2E+15?/"N)I.XY!S6!0[M^P&!.$8$RKD*CN.'BVC#;HJU;
MD_OY(ZR5:\S@&/WE;_\#4$L#!!0    ( #:!K%+FL.&+E4X  )!= P 4
M;6-K+3(P,C$P,S,Q7V-A;"YX;6SEO6MWFSF.)_Y^/D5M[]OE%.^7.=.SQ^4D
MU=Y_*LXDJ>Z=5SJ\@+&F9<DKR:FD/_T?E&1;MF5;%_+1D_3TG)0O,@D"/X(
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M11*3BY"2@"3;/+/<FL0=K?BCW!(<"K-'[S#;"+!>3?:']'V<Y/D??@H#R;(
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M@53JJQ<&C--LG2;/DT,'71,#WN.2T88,3!B2D@K6@G0ZQI8@VDS6CN5M?B@
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ML(MD.]^0-WY8SCFJ4NDR2*1/TO(P%%@@V5AK*<TQ!WE,^/70?^X5ZO:1XW'
MMO#1M&=H0PN%?KZB1$8MB.-X4EEDB0X!36Y[U&.@E_YU_P"WLRR/ KF%%^>#
M@M*KA,A%)2O@$;>(8(3+D(PU.KC4I/=QB\X$W74(ZAG@=I;D<?"VJ*'F><K"
M:(+'>XE"153)%K4Q4FF2EC2'(Y18Z;E_WC^\[2K)SO'VH):IU#2[TA>/+VK
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M]>3M[R>?SL[Q]Z_^\_>3MV=O_NOLW:\GIZ?GO^.']CD(JM-0XPAHRYC^">Z
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MB8+6@ZO'%$0K3*,NWGCJJ*QMW249(Q]@-/]TD& X>#Z>#6=?7HQS-SGWRXG
MBQF<3P?)1&UT" 2X$40:[TG(2N"N(%),B2LO-] Y7:G'%.)/'[I//^,HR"FG
MY8LB4DHH6ZZ*_WXW@H6D]YO7:A-]C[\[R,%1J8PGF3E%I-:!>!=P?\N,)I2O
M%D95F,GU,6]BO]*3)Y/5+):OS)[O5#$$JK,XZRH(<,$.@O_QAVZ28/++C[0&
MD4_&XPL_>@L?N\EL8*5ET2,*Q=%,D2EE8E,2!&2@GN.<&.,5";T^]LD0N[=
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M,TRF7%'/2&+>$"F90:\B 6$1T,H(SL0H:O-^ \%IL;Z_<#=P?M@16P$U ;\
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MW7DII1:,T3*P1*@JF$J>CG-%\5'7LY"XUT=^SX9ZU_._%4VH)N,&%R9/.Q3
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MCC:-9B&")4Q1E(+.E#C0FGB;N5#4\6!$T\ND3:B^'6NG/DD-.M@LL:QN,GJ
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M!(T@2BW^,XC5:K'U 72J!DAM+FKVO^L#<%4 M ?$Z@G/O: ]@"E2G=,=%.8
M/FK[,?V0*@5<646)X5#R-&P@/F9.5&*6)8/;<>J3SO3H->8NB^01*,PN-!Q9
M4:["K5?.N>">)1J)4XA0YI!+4HXG62G&8H1,>Q55J;,WK8$[<M)U W)WV9T.
M86:K5?/7G]=D]Q*_G?]@_GF1S5O(/Y2___[VQ:4<T?Z"TK"/<?%3[,Y_GLOP
M:J,>CF_=(%ZK//\*9J7E7S=^]W$TG'4Y;[IP?%9BHT;3FQ.8#L\_CNXSBIO
M^/E*)C=EM<1R0\L>2#KP>0;C!.G''X;IEQ^'(66:D@LI6"U]BHY*&C,N74[K
MI*T<-$'4N /6RZNF3B9XG;(C8$O&:?:E3J'G^*T1-G)JI6E3Y:LWQ$/<R,W/
M_LT/)_.V]=TR]19?\X\S2 /J#%6E7QEU02R.9EWTF3";/&@:O E]#J1W&_5Q
M=X?;03VN>Y4-!5_YDF(STJ=^,ODR'']8M-$=,&F,40PEX!(CLI0*M<X(DI@4
MC@< %</>BG%SK&]('0X0<N7CIBT3?PLE/LB/NOP,,DPFD-[[SU?M=*FPD+((
M)#E:"L0I1H(2AB0?!'=2,*_DWEIQS^#?D)K4I*%B3Y;M@-_""/P4%SE<WQ;F
M**1Y(< 2]3Z!L^)??8+A91OX 3JU7 :EB;4@4?/11PH22A\,A ^)!J/ZW'[7
M0?,-:593HBJV#-@^@VO7RT^[Z6SZ8M'9.0U*H3*J5"(^B42D\4!"-(Z@(^6-
M39&#ZW,LOMNHWY#J5!%\@QK.VQ1]T:UYU2/^]?C9</JQPS5UX#)'/SE8DE(Y
M!M9H?UGC."E'_4I0ZV\%8=3,2^L/].1TZRB,5:P>.G\7/L>YR_HZXS[\[@Q=
MUNGJHS2 Z+4 5/I<.LA+9A1Q26>B-5"/ZV9F_9:<.\8X.26H*M2*=>&V+WPW
M'3?#1)8F.:*R*H9[E,0J].-8*3,4N&-^/2%^AVWF6W63]Q=QQ:([/>$]0=/<
M?X"R!P[0U-84@!*;>,F9,)IXH)$D7)><=(%J[^HHP[51OU6]V%?P#0HA]+QP
M#EI%3:TB/KA4,KP#6D91D&AL!&^$$KE)?95^\"KJD1^-'MRJ:,#)IC.7'XH0
MTNPO<=1-(?WRXVQR 5<?=N,9?)X]'\WC5G[Y<;JHB/M@S?JXA2BM*K5D D5Y
M9DN<YXPP)RD%E2'I/E4'O_5F?3OI3*UF?;MP=]R6:WV0?6_65XO:_KW7]N'E
MN)HCE,T: "%E9DN%BD@\5Y9XY[5*5 7F^]R]/5J-:=6LKY'"[$+'@X6[.BIC
MLC&A#Y!Q[CY)XFQ 4T^DS$"P!#[WL+$?:;AK38;VBG'=1;P/631&:,VXLVCG
M,X&28"5X,T1+ A<@C8LNBR;5I$ZD:,P^)DQ3CBK>2_6I;M 'VO>B,0>3ND,A
MD'T8.7+1F.BHEIY[7&[!X;;K&/$9W=%LN(@^NZAU.@EEJ54TII6N[$+$0Q2-
M,8Q:5VY):1*A9"8)XK3AA%F:+'#@.K$>-LK75S1F)V)V+1JSBU2/$JCZ.XQ2
M[B:EL<$>\:77__7A8:%;L:Q%<[+(F/$LB&B,C$HY[Q@:E-GQ1*/R?+ %UKZ"
MF9L;^X3?WGY&52%MPK4F*JV<#%Y2X3V5WJE@64(;VWL$F;SU@SLA[BNP5WXR
MF8=O[Q^Y?-?3J@KQ;JQKXLS LX@6C!="XF)@%7.4BJB%!,EY&MSUX /[KLP#
M6*ZZVOJ1'T=X=P8P>S).3U*:2\&/G@VGY1SW8@+37[^LKIO_-NDN/I;PAM%%
M&HX_E-_I2JCS!:1EJ[-N?/W,VJ-J*!.)DZ6TE3#HFR<AB96"*E0ID:%)9;DC
MSO'@:O33*<RFK_.-T>\>_&F)+1G/!AY$E)H% D[@!B. $VNIP5V&<I2R=%DV
M"=;8'_+Q-^C'JNVWRN$?1PT:G%*L0B^'L!]\W&=!F&30DBFU];+*:,ED1W+0
MH=A+W$ 31^) W-]5>9LJ'U,A&CB]?PS'W60X^_*BY-7#=/;ZSS%:^&?#CV]@
M$A&?_P"_?GG5C<L$D#Y\S(?%KPQL!LN4,@2W<5%"CX%8[1"XT"KRJ'WB31K;
M[8WXNPYOT^'C*$'E^/-=WC64U# MO[DJ)#7(N'L8W# ($X$3Z2@GP=A(3! I
M9)$TU[R'LWXXDN^JN>EHX,@,5PQ:OSN^=3K(3"OKRBV+M)E(HQBQV2D"GN7(
M;-2LC2V[!<]W]=LM0'DW AM$NK^9=!$@37]#P3X;%EC#DF;[.O]Z,<5YHW4]
M'4B>'#AMB' L$:E4)#ZD2&+T1DE-P;6Q-'M@^ZYOV_2M-K$58^!7$*^B\A=M
M75?(!L)+*80 @BLKOA-.).)%, 22IE0Q'U1NTDQ]&Z#O6K9-RZI06#GB?ANF
M5S![G=_[SP-;0GEU"?15I027TJ4JA@TD.^F-B"E%&7L8:_>-\UUK-IEB5=EI
MT!YWCP.E00##')4"%TY7RJRD4JQ'4.(,2([_8XHW:<2]!];O2EGQ)'$GXAND
M#.Q[8E2,3A%=:;]B2XUTB(R$7+J%.<9="AP7[2;U2O8%_%UK:Q\:[J0"#9IQ
M[0#UMVX"PP_+8\ZXJ 4^FO^D["73LIF@+<NS\RJ7>IW<:S0X.-JR+)2T868B
M%^C(ISYU*W=6Z=H3^:[JVU3]056F16^8]H)?Q&EFQY@1(1,AJ2$R,(6VE0&B
M0U9&2$-U:A+F>J3Y'2OG[&MY3QZC6CUTUMOQ9#./630Z>UOJ+@892FNRI(D-
MAA/M8H(4O,BLR0'&<:;W4&'ICU*QC_[R[:Q@#>YZ=P)\+;2S#^R6$?-[XGZ8
M:/K'J$IWF62-]> 1J3&H'()DB7!5=F=O/'$!<*DP/'.?1;+0IP[QUZV^]\3W
MG[#V[D)_Y<R!O\'DW(__>89<('!8'9XN@]O19Q&*\T24C FM1BV(4U;.,R=B
MY!1\OX/MNP8YOG]Z%)JZ%C)N$#5X]4(M8;U;&,:+MX$S'21$M%R8P8FFA):+
M@4P@YY0EJ, $:[$PW8GJN[FXW5RL1V>#W,<EEE4E@!Y@6MIN-] \C$56D:UU
M/3A8U W,HYN@E'*XMIER!I$$+GQ>X\(7&.&"!RW I;Q>I_>KX?T>4^98M.\B
MX<IVQ3Q><^P7"^(2U:KU:684S:A(A-"JE.)D:&O)2*RP+OK@F(E]\A"WC_
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M#Y8GCW:#LOX>6ZDVIN\*N^GL\<%8;UFC>5O,6*GK4@J\=.-_3H;HYW1_CME
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MLEM;XL( WZ4^D:@UD[1?UNH!<YGB,;>UV<#AFXT>EB),:T'0;0LD.(7;3Q#
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M=?4EW>#$XK+RYZMN?#,/P\;(:9*.9"]+Z*9*Q)M<[DQBH$'AFZ":&)A;$9V
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M+J+]W:V^Y<39K7%WRZ_!OH;CO(YY>_NV>"?+8N=&QV;!38!(OJW3RB8/1>?
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MSXZWEMY,#[ \D750#V>)W#(IZVA!(0V+4B'3 7RV,:&6(\[EOD#\/Y+#^#W
M_QB,#-V*91VKF^%-+ETPZ ,HQUPBKT8;@A;$ "R!E\)*'X+9,?GW=UBY\]0G
M[J>>HJ3Y(!(>,*/D*R7O_YYO&[/89*U+BLGH%=,N.!:2YRR:+(I%79SMU$WG
MSE-?='VBA ^NZS%;W]P24+/9!5U>UKZQ35=.=_)3!:U/Q[6UQB.=&PC*Y*0%
MUX%G$14^VL>F&].#*O7.-(11-=SUS>W5?9(,=G3O?$Q&6:N$TQIB]CH["#F0
M/+@7H![5?5<BSM^_"*4#],"\+8:1GYQ9T%'708+!R6(X;8X7U4/A]=G[%YTX
M>!Q2C@0EQPPH3\=+\2PZ#DQSF3"74ERXK-D?I_%Y*59!LU4P6.^*$7!T23V.
MWFS;$VP,L>6=V1J_SE:+*7F):<-C+B$;76<-\*J/D$OM6E!8$BD&26:SA<L:
MNWT$<R\+Y-R(:1!.>KN8)\2\_(6$?[MCX9;V3,LVBD)4ULJ"NFRE9+&V=N<V
M>>5SBCXU:13X*&7?'1Z'U56#+-Y.0RK>PS\_X(RTM:I\;&E_<]OK6$XRH/5"
M1@9.U$MKB^259LW(MC6VZ&!,:-(A:S .OCMPGD?WH^6]=NAIM'< UU?S1TQ4
MUC$6C+2UQ\0T)%7'8UCFO P2>4DEMKMR;<#0=P?QBT!&@SS2=J.WDD_)6(A,
MB%"K2G)@0?HJ=^LRK7(2=Q-S^&4LVZC;>G-L-,@$'7F@E@,M7 &RQP0GR=?+
ME>@ML%2\S<KHR$-X4BOA.8UEN\#ET1]%9\CE[-X935JAI2J>":\CV7BT^+U0
MA3FEN;$9A%=M!K=\CTT1^Y@\9]'XI21>WNU-I23G8$-AV5E.!U;@C(RVS&P1
M*BM)+HIH$@=_9DT1CP+"@TT1CU'(4^DGUX6GEZ:(QS=%/ HK8S26.T713P7$
M6<N0K%2LE%R8EDDSX#RMF_IE4V30V*8HX\F ]ZBFB!>'W6/T.VI3Q"(+VD"V
M#21;$]?0LV@16%8(!F0B"ZC)$?W<FR(>I?#.31&/T=8H31'?K#[BXM<9_1M_
MQYU=MU.RT<X#^N<,/431[OBR9(KW56C>Z.)S-$I(RUWR0F=2WN0P<3V$M+;I
M3LG+VON8H06VC[K=C"E#/C/PJ%-46F4>)5IE1495ORG$Y#%">PCO]*RV_<\9
M6GQ=,LY <"XAA!@X:*F-UZHH&XW&$D/Q=K+_D3VMEHU_]PX_SQ>KZ>S#K[/U
M?,<;=F_\7J^,S%[7W%A3;]8AL&!0,3HSM8DQ!L/;3+CK0%S?(_#7=42IOF8C
MV>W(F F/V850L':;5TQGLTZR,0R!0S+:%Z^:G("'"#K# 3@T-G8/M$%DWR#!
M:4/-Z_ERG2#P\_]>3U=??L/5QWG^1O%R(ITH6 >J1A>(2&X4"]Q')BP6ZT4-
MRC?II-.)NF>)EJ&UTL*B7I/U!Z;K!<D;E[_\]?OT7R2^2O8D9Y"B0&$!J@B0
M>^8-S\P8(Z)27!0MFQC5#Q#U#($RF X:)/;\5 6,^29WHSH'KVJCLL44KK8D
M_OKI$^8IK/#6A<6K9?5!YK/U5DF'_^928YINGE/O/7Y<T*=6$Y*;<XHKE@1$
MILGT8KYZ!AX\1X]2@&MR;+5F[!GB]**PT"#_9_\6_0[AJM[+;5E\,_MINOP\
M7\+5A&@#!6 9CYB9+D0O60&)6;*$LQ*E<-EDM.FQA#Y#+#;558-,F[4O]/M\
M-O^,"]A(I%H'=?+=;(D3'; HD(7)H'@=>U\86$NB ./ FY1L:=+0]V&RGB%N
M!M1#@]24PX1)Y>JLD,2RY<2X1C(#JD%0 M<I%X=%--EJOB=L#"/]!MD7S0]>
MS6M; 3IX'<] _JLU9&1JS62)6@(X"QF>OA'6*^WE,/A^^'+SP\TMMW#*9J<#
M4T60$2.\8M%8QQ)M)/0&&T6;K?P$6D=+96F]<EOKZ5+24F[J<]_"8O7E_0)F
M2TCK_.(?OMS^R?KJ,*K( R;/<JX=:H.H<Z13[29M)$8#"5R3G//N)%Y 0DL;
ML,Q'45J#8-!M>F[N_[I0U#(KY3Y)Y\DI::7$![#20P/C8,,'JXK7GI4U9:"0
MQ4*4%6UY%#RZ@$T"RF-AXI%4C?-!XAC!#PB%Y6(U^?D?3->KZ5^T>Y9IPL7-
MA;[QQBE0@B51YQVGZ%GT(.O0XYRY#C6)H ,4Z VW8$#_VH7 81+&]T?Z*F8^
MJ%0;7"O]#JOK!=9FWFLO:(/DG!*O21N8:\<A*P.+-D8FA?%H T))3=*W]]#R
MO=@/?=70X%9@??$Y_;3QNZJ[M?Q]OGIU53](W&X/K@XTMC0=NA!Y'F.BMT;O
MW30V4D<#.Z(3K44XF['V(K,R,ZTYDB\8:FL$F2SG7.7<I,7/^2#SB*UQ%L0<
MHX6!&S_6.4C3V7HGG9<__^./G4#11FHU7K0]*;GS$:Q@689 ^VN"VO[ L>(+
M=Q*"U_:QQ*H37CN^S3&\WN;C"'W@9I%_X&JUB:W,RU?CZ1VNIHM-:=2&Y.4-
MH3X >(V"62[)Z':93"BN'1/1)K2V&.^[H..HESXS;+03>!-?=4M71>O7;'JP
MD(.KOA<B42648>24$5ZC$KQX*TMH8KON)^=[,5\'4$:#N_[[5-TLD"YTM0UX
M[2?L7&&O_LI[% \])#_*YK$UH'DF7]Y%ENM6IA.7##CM<> \+\*H*$.386CC
M(N+1H-=X@#A&X"T:I'TS>)9W3:&;4RY"AB)\85$DLG\<<D:G'AUZ%JWR]%]I
M4W/T&&'G"(4-H<+=IF=#RK]!>.PNTW]\GL^6\\7K^K$JZ[HJ,"I(F QSKJ:%
M)Q69U]DP%96S)AIMH=$=W".4?9^V1U\5-4@+>Y# FS74A<3Q+)*]-%Z"<=);
MN\=@IX=JFILL^TG5E:3:[=\3F4S7PSF@4HPK+4UT,F@S_EYT,8;,.<!SC$8:
M@(:HP.5JFFX%=)Q4*)%8-*8(IJVM(UJU9,XB!,5!E4ZW>,>G@=TCY=PFS  :
MVTV>[R?N >V7-+^>K19?)G_^,?&NJ)P%65 0:U)TY,Q;X5ER,A=G8I1JC\*7
M6W$O,?W'A_E?_^?FB1N%W_QC5]??WCJ^;OO*?MY+<*/,3MGDJ[Z'?TXJR;[]
MZ?ZEQ =IV2W IGU5003K;2#KW0>O)*)*!87&6'!R@*Q3!7-RQ?K]9PPJI ZU
MZAP=< >@2[8ZICK= WA,)F%(A, [HNI9J'[K2=^&@VR^65?6C_,9V>O79+*_
MV>1*UXP7).,=;WWP]/+V(=\^J)*&E<6.>CV6K*4FI]4D4K&)UF@N9-& 2607
M)HW$<BHPOJ9?+]^4MXOY7]-J<OTR7]SZE9OLF/?S?;0-@H^AB!@4)DTDLX.6
M8EQT.4"Q7.K@<^!!"A]**F"US7?0TD!(IX+F=UC4A_Z%@VC_WM,&5>/#M.[H
MPUB,@@MCI>3:N.PE*)F""\B=<KY,'GKP$)7_].2-[C[@+'UY_36EGG85J27X
MVDH]D96"CD65@!45"AJ'R><F/M^#5/6NTBP%ZTBJ;UO;.X+O/NQ.0MT\C>&,
M.+5,<P3FR4PCFR]I'E"(H)JDD70G\1RWQ$,AYEY)9AO%-(C<[J>T%AC-TO1J
MN@D!K'Y!>AM<_;&"U34][\N=7Y[00K<^%I*/5E!O/!(#(1,3)3M=!!0#32Z3
M!Z#]^8.NG2J;9,1MB;E#=976NHB-#N@ETAL_3J#DF".7+%H;F"9OB8&)CI$;
MA5E*@5PV[.#2@<+GA*PV:ADP&;>FY72!_VM2P8?-0ICE'Z]@^FGYZE,-94QR
MBC('&9E&I9G.!5G,==Z*59%6# 0GTB,666\BG@-DQM7$@-DPO0G_'5=O"GUD
M$A6(VA*RWL7R&D]+S)-?PK)P&*2SB-&WAM*6F!=(G:J9!C></V'!Q:(.O[GA
MX2:%^>8J?^*< %>,9F[=_\I:QR#4.UY0G$N9=:.N9(_0]1PPU$(%#9I>_#E;
M?!U^\6U,V'*3QTHT+Q"6Y"YO_IX4*[@LSC#OD'9*+17SI19&1:, M<0DFPP6
M.HK*YX2>=NH9L%-&W2X/P/NGZ9)H6]U((GL0L4ZA#0&0U1G9S.M8$X=";6.:
M! C1X9SJ\J[G ((F<KVO=S=ZZRXEE.29<X8:Z%3,WC+(Y +*1#^0.5GOO]/6
M70U]]99*N@\JW]MTN:'C7XOY]>??YVO$;Z)9F+\&LRK)E?0WL_]>3%?XT_SO
MV:1P+X4L@9E@B.Z4"@/A)5.:W$%M+%IGFM@T)Q+\G$ VBM+N@RWT!=N_YO/\
M]_3JZM=/GV&ZJ MCT_Z3K'.70Z #U$FFG:&O$KF(4:)/4CH$;-*9:3\YSPDH
M PA\3S"P=VQZ:ZP3RZ^62UPMZZ30C8-W=37_&V:)C"PCR[I!7;:)>+>Q]H05
MEJD,":PI#GF;_>5QVIX30H96Q1ZX] X>WR=IE^H?/];Y'[_.;B)-&) GY(5%
M$VT=*6.)X.*K[Z=1.ANE;6+X'$OH<P)24R7M057O_@YOMFT0ZY;X(RP67\I\
ML1YA.=&&K'ETBEGG!=,A(O/!!I80BI11NF2:C#,]3-)S0LI @M^#B=X5DP?B
M !.46O%B"N-1D.<7@F&QIDEGAZ(.0?"N34>8 _0\)S0,(?(]4.@=TSU U_N/
ML/KO^?55KB956GT-7V_O64D2/"D2A:JS,307CH&IM_[1R(069 I-0KVGD?L=
M &E(A>W!V<B182A0Z+_(?':UR9KES$/F+ )WWA+%!IMD^_2(#)_B'FR>\^OL
MP&M_7;ZCG\]G$*^^O*5#9%IKZ @YT7L7F)?5M_52LR PL%S(Z[5*@M9-]NB3
MJ'U."Z^]NO:LN][1U%L17]AVA'F+,[BJTTE>S?)V[M&V/3;JI&4NM74OK^T^
M9&!0P_\\!2$]"B%TD\KX(^E\3L!JJ:(]D.H=2ST$_QLRW\QNY<B^2FEQC7EB
M;';%YLB<K[TR(28&V5DF7,E1:6/M;DY!TPW](5J?$[1:JVH/O'I'3_^<Y>ER
MM9C&ZQ7FGV$Q(XDLWY1?Y@N<?IC]<1V7TSR%!:V-"0I9E,_(3"8+6M?F!,'2
MYBJ4<V0XZU!RHPODKB0^+S U4<R>-+J!INC=%<*F!8%28 (G7YN#K2E:DM!M
M!&>*0]0B"FU*DXWH($5C->X?X?SJ)>Q+Z<O_-2GT=LAF741N09-;HF/MA%-'
M6I7"@E&T,09NA$DJDHG7 CH'*3I7ZX^!%#YO(?@&2=U[";LU5[L+>2V;>CQ"
MWWD:>@RDS2X8Z:F*,R#&*Q,QNYK'J3+3MF9TZIR9B3:B*)I.S29VRUF0\DCS
MCO, Y1@-- #(C_!YNH*KW9N!;3-6B Y2-$S[8)F6QA'C(K#B-:14,LK<Y%[F
M0:K&MV0'U>&\E0(:U+2MJ?IZM)(]_<.7;=/H6R?N>HWD9)*D4Y<AN/58 4/.
M&MEM(2=GI? ZI29EH=U)?%Y&2B/5-.CK?Y?2&RIO5DX7TEI:+ _0=AYKI95:
M'T1/?YTT.)D>(E&CAV0#;8N2]EKMUZ-OC*8#&5Q!=);')K<RH\/E$9/E M!R
MC"H&[N?_%F>92'HUR[]<KYG^/)U/\TWGB4W9TLTQFG@04O- S$=B7BO#O."6
M2:\%\,@EP,[,^;T)^IU?.+Z),IB*YJWEV\!,J278FX[QU\OI#)?+FUZ?RS7R
M2](^U3!RAGI+00IE 5"RX,A(2UX8GYMTU'V0JN=EC RG@ 9=V6]HV<XJZ$!,
M2XOC#C7GL3$&U-8N#GJ+NH$A<9>HI$+A7'N6#.V#6M;&BU(&ID#S;+--QC>)
MG8Z@]T>,A;'4?HR$![8(UM>)FWMKN+JA:GM$%6%-B(K%4CWIA&3_*'+94?)(
M= GIL%N-WJ$WG&UV^2EBGP\NLP;'^M>SZM7UZN-\,;V9>QF@H*8_F$^%J,HZ
ML1B\KR$7LF>*S[)-2M9^<I[703Z R!N4^]^GZ@;S7>AJ.PUP/V'G.=>'4-ZC
M>.@A^99MCG;IB\IA+$25)>^&Z"-*0Z+3S7H1-%A40HZT29SQQ!\3$,<(O&'C
M\1\W[91O#K"L GCI)%,&B5/P@07/%7.&E^J62MZFKF0O-6?,P.FEK ,]QT^7
M=*L(P*M9?DV_>?5?UXOI,D_7@[.W]RA)*ETL,)Z<IC,1@/D8.+.DP&QE<1K:
MQ0 .T_5,(#&D]!OL#3=Y87<!"R4G!&+0&\0Z9Y)LVTB 5;6OD7?%8YMR^GW$
M/!,8]);S@)=/=0#ZM\% ^YM$W/\N8KW571^22CLII0K,(-"&5CUCCUZR%(,U
MR6>?7!<#HM/P^3Z$/@__8U1U#=ANJM)]B*Z;%=6%LB-\E$Z >IBD<;V3<54[
M;ZJ7 0^G#A2F%&H%9F3H56T!&A0#;A-#9[/S"IW&+M;KQ2+F@/=RJ8 Y1AT#
MQS4WE?S_B7"U^IA@@:]?_[C[K9OC%E,6X%5AQ=;-%VJW+!2&*9NY,AF5ESM5
M4WO#G)U?.)[I,K2&YJW%VV0ZY/KN]2TL5E_>+V"VA+09R_'E]D\V.8M"F)2\
M8";4YJ]61 8@:SMA%<GW#RHDWL*^[4[B\[!<&JMFP':&^RC=9BMWH*CM-,A=
MDLXU_+&-$A_ 2@\--!GZ>(\RB)DVM9Q8<8X<.%V;$:ELF)"NT*EA [29=S$6
M)AX=Z7@N2!PC^!:9X?/%Y_F"B/JO.4GOWV1T77\]!EUTWD@%3,4BF98Z,\^3
M9TZ;B% ,ET&WP,0#-)UCN&,_E>TF@@\D[X-F1Z/)@'=;A_^ J[\19[M=/[;U
MO;\<F"OV:I:_SM&X^<@@ YU:$S?H?*A1);D[-M'K8J7,)HNL30C16P#O4@@2
M<W9\<AZA#C%+[E9;M!_@JC9*&WY4W /O:#8)KBM?.YH6T><L8\FY2"V2C;2Q
M1!5BX=$9[M2A06_=6#Q58?]:S)?+ TT"!M%6EQ<,JJJC.=K1DY)*&!NY@:0T
M^!Q*BB9EBTKR(HN>G,[<44IZAQGQ4_6/?J=53RN9ODM/^;!MW;"$63[PDQ,T
MUN=M_=4W&*\[NL2H>"83(/&2=>(9:(\M,EN543NGTV0@ML=2[,E#;_N_\ZQ*
M[C!45\>D8];:":-KO "R4E*0_K66=8?MH^J>0WA[O'F ,9M#OOVL(#AJC*<0
MQ=#_R2?(4B>M/1E5$+2DY2^R2+H/' 8>^_G;=+:^"=X^__77GAP*HU0Y<X:B
M-N:(W+* (3 94@1(A/#8I!7708KZQ-)?S6;7<$4V[/5B0=*L)@Z25[_I=;7X
MXR,L<#4_(/%)*2HK\O#(\^**:4\.'@2KF.4Y%A^-*]8\L@[ZTC"^HSL,,&X'
MW$?308,8_.^XVEA>M>3JU6K3AJBNW_?SQ];R!$(T)7D@@B60O(2O"=6*&0"!
M19'?)66+A=2#YJ<.M['5-O#-WX%%\/9Z]6[ZX>/JYW]PD:9+?+N8)IS$J RW
M!ICB/M#*\)S1PC#,@W5.2I>M[E+F>,P[GSH\FLIXX+F<6X)JYW?<DED#)W]\
M7B#D2=1%>4VD&1XS(Q.4,W V,D*O\C9(#KET4/\CKWD.&A]2D@TJ%M_"EW5A
MUB_SQ3O\?+U('V&);\JC^Y0 %):'S 3$PK1Q@D4?$@M%)1>BB$4UF>MR(KU/
M'4ECJFO JIJZ (ZA<VV.+;]]@I9'*IP6B&'6FL2T*D2XDYD9@=GHI$+(JL-&
MTXN(IPZ><;4P8,KCVG[/_]_U)A%K^7[^*N?IIGKP+4SSK[.;CD;;8_--V>ZV
MDU1'2F#DS,E @$]DOD=GD&7TP>H4>-IMV['?>SKI[<\!,"/(O4G"R</0WF1U
MD1/X:3Y;]\"J32<V,VN*D@F$4BPYA4P[+5G,)C"?G ,O9 RV41;3J20_=9B-
MK+0!QW9N=M1'HFF_P3_33]>?ZN]]^ESULC8!)R'7S% B669+D@J8F"\>69)>
M.,&C*-!E:/V)KW_JF!E+\@W&<>X*XLW?,UPL/TX_OZ5=E/99^( _?'E+1R_A
M6MC",?C$;"KK-I"">9LX41YC)O? 0[!CA$$?H/&I(ZFU6@:<L7ELY& [M&7B
M4S)>U$TQ!9*+*_05F6S,"R&BEB0<W<5Z/N7=3QT>H\B\Q0#.73%,I/7.TFM9
MT0X(M,83:+UEQ1IT' OHT*0R>9>0IXZ(003<8H;F _'F ^$ ;91(V6I68NVV
M$JUA,4C'4I&<9,$E\B;SE(ZF]+E@IJV*6HS0W)7#IFS!F1@2^IIF:C+3IMC:
M)-BQ'&T616#(NHRQEXPZ16*<;>1X 5_*](@Z!07_][K6ROU%?[RGCZV3U%."
M*#EMB:G&&W5(F8&(F2DRQ!%UT":TZ7^VGYYS%0$-H.C=)@@#"+Q%][O[9'VM
MEGN<L*:=$ ]1=J:NB$/H[W%,]!#^J.A0UDNO1& ..=0@CF4^J]I.3GDN+8<(
M329#C(R*QWHFC@J*8V3>'@PWM2=>.GIM*(S.5<.TR)I%.D%93@JLX]R:TB3Y
M:R\U9VBR.(RV'L; ":(>,+,IXW3R&C_ U<^SU;9'F+3"0HF"<9_KW20YS.0^
M96:+U5%EKY/9<Y6\W I\B>D_/LS_^C_TZ(W&Z8M=1>]Y[=.W!OK*<L"4D4K*
MAHH;P':AX_"!?[1N;[][W".]MQ+F TIPP(WZ'CVUV9K/7#%1^[EK2VB/7"<F
MP4AKK5)RW_BF"]3D@6.XF2*/$=S &7V_W:2C_WR]F'_&K\,JM_VRHK=8@K6,
MNT24.6<8H%,L:Q6*#G2XR)VQD'NCPP^_9;QCM)_DYTW$-N#169N2?+V;6,,3
M I F@F;>F3JQB193\$!GN#(JAEAL"%TZ#79JVG/GS4__[.PGS 'S\.X0LBWM
M[D#*T&V\=F@8OV]7#VWLTVD/40[<>6N7I&*3M<(07&TD6][7#I7%:;+E2R!;
M7GG<O?^_<*T^T%NKC5*/D>"X)ZI!61*L$_>]8AIM8%X4S8POR)6PNN@NN1V7
M<J+V%G[W0_48R0UXJ%;*_@WK2WZ8U4%#B^OEFQG^,;]>I.GLPQ^X^&N:</GZ
M]8_;]AC<(N<Y5[\YU2E'GGDM%4.=(@J%F&*7NH=CWODT]=U,JBVB4=MQ)5\S
MS6Y:$:RW+>T@&&\32S:1!"19&I$L#I9X01-UDM(WF9[^(%5/WP0;7O@-QD'L
MT+2=<M:!J);7&7NI.O. I_[:F[<2?8,=8S]Q*G%KHR*+9E-E(12+@B<6R5]4
MF@N199/!M"/BH>O@IY'@<(S$!S8%'\M"O3G:Z/R421O%L@F1Z01D_EH0C [5
M3#0:2.@Z& S=WC;^G<4 :CDBL_<$F38HRSY0#7%#7"![J50S*><ZW8Q8)G]'
M*V9]1&NXY3PV2;=[D*JG#(SAQ7YP)QBR;UV/;AO;EM3SLND-O)S.#C_CL?><
MI8U*$P[.VHJEO4YVVKG$ -Q" F&<U#KP()+UR:-UR(W/HD\[ER;,M&H)(QV&
M$H V>E-[K,<Z;=!(9(7V$&Y#BMDU20\9O"7,UP?/_UK;2+_.=E_QCB3[RWSQ
M-RSRQ$ON.$K'# 9D&A!9<)H()6M)!Z_IZ&O2#+<3=9>4EWL,/NXE80ZNB@;V
MQKV$\ZRC#K)D%DUM2Q/J[%1%[C8*G40VQJK<I%3Q C+ZA]?78]G]QPB[@:=Y
M?.8X658VT8)@(F M4D+#/)*A)86--F7GK6K2,?DI)/<WAT];=0V8LK,E^,WJ
M(RZJF;[ C]7)_PN_T4_,O"GOX9^W\\5:+UW8B4[G;+QG(=%*T=I;%K, 9F1T
M(80B=6Y2N3@P'\\1F^=4]8!7YH<K\[8U>#_AS=_7N)JON9Z$&$6T&%C!6OL+
MZ)D721**N$M6<K*PXR/NT"GO?4XP:B[W!O'[>Z=Y\4F[DCPK"4*MU=,L:&L8
MMR:B2<EA;E*3\K#I=#QC/7HF"'*)@XB*"8TU4I(+"Q(<4RK*& L9T]!HRL83
M:G31?#,>28$->JST:6](X@DFF\RL(8))1B0Q$R.A183:Q]C)T,1S>5I=*<]I
MI0ZJP@%;KK0R8KC*B0QO5^>2 ]-(1T.P9(@CD'%CBPE%J"=GKQY[DY6N8+F<
MEFE:]\6=E_?XJ0Z(67S9[$*K^>LIQ.D5?3D)/GO#=23_)&7:?$Q@X)5A&:67
M*3KG>.A@2!WSSN>T IO*>\"6(X?LEJV)5V>M_#1=;H!9AZP< N9_SJ^(DN5$
M&ZE2IAW#6_(8M$<RO& ]_RYSYQ4XY$W6V5 ,/"<0GE6Y0_8\Z=&H#L% X9"8
M-KZ656;:]]$70E#MG5^,-,5VV,>>3(/ ICO:"#H8LG'*29XL&L>CCHDPCI9I
MH8!!D9;Y$#-@X@E=%\#TBR",ZBB&&,#QS%G*GC-=:N3;TTD4L].TV).TL4D@
M>2A'L?]IM\EN+#;EHC(PS[DFS1?!0,O$3 E.6(4\\"YU-L^EZ4FO^[;> KZ8
MIB</9KJY$(3)4K&H99W.J J#6K5-OGI$)X+,I4U+@Z>3,WR4TH_*&3Y&^*/E
MAG8AZB5G^%CM=4H2/47TH^'">$W&50#F$B?B@@,RG2&PXJQR0<MH19-H[%/)
M&1X>#L=(O,6%_D.9K8E;Z8Q6S-5NZ[HZ^CY+SQ2"<L(GP=MT0'D*2<5'Z6TW
MX#F4T >N/>N8\*S(N_81%%GBBBSQ$".#9(!%$1+G -KR(7I&/WU]-Y+I* G#
M/\-B1F0N/Z_CPN3;K.<PG)"W>^!!_=-GNU"XD\6:C!)HO36V) U.>A-2G:,6
M7#;.>SUYG-@!A'CR$-$'']=*H!U&?V**7!/.119: _E<M4-8XD%%I4.2^8!8
M>T[UW/_0;\G$/\!RFF"6?YI>7:\P[__UT_/1!WU]*^4-(8T=91<3"X 5*8BD
MC8" W&69O,&L0\%#RNXOF ' ,< TUXX/;J70HV:PDNT 4, :P2VYM"XD4:33
M,>9D<P!^0%4/,7.4$E[7X.$I0K[Y8'\A[J-@M[(!N"]:&T\GO$X@ IVV$2Q"
MKGT@>)K<)^8$(9R\Y]_Y^% "Z;"G TIE5.9D;RJ2#D+,,3AT)F8+&<3D$&$G
M"&> 97G@04,)[*AE5VPV16=9^SV1_9XB<J,P6:F3U(%VR //[.?)O2;:$5]O
MXO;+M)A^ON'U)E!:R+JL6&>\YHO7RQ,&REB6C+&>(_FOOLD(UD?HZIV!07L7
M27'V8?V&;S?5.@:34DU+BLD3NY$\=1"1E9HACP6RM4UBG@?H&=^-&1(/]W)W
M!Q!Z@]*4NV2M;_7>E#^7^(HDL9H(@]H+[AAYU[;V#BDL%(VU)K,D%Z!DV^0"
MZ4&JGC,N^BB@25^5>?J?CYL<@8V/_^LL75UG(O>8%"VPW)-K'EAP1C%-SC\C
MRAW]H6PQW NR(=I<I@Q!_O/"VQE4.F#12PT/W5TQOW[Z#--%C3[?3KR;>!?(
M@"#Z.-;1RS8GYLE$94X7J7**7D&7<H$N[WH>^&@BV0&+1N[R?I?2][CX]*;\
M6&$*:37)(DAOM61.T'ZI0^#,2XDLZ!12K<HF*[.=V?80:<\#*HU4T:!Z9!^%
M[W"&?\-5)73BN<PQ.\Z,JPDRBM-^EDH=Y>V4$3(+&YH,P7Z$KN</DU.5<!\C
M)\\FWF^ +=_5>\Q_/N-LB;3E34JPTIHU-8(,L%+( --DK5M$6424Y->WJ89\
MB*KGA8_A%#!@K4P]#BO3\\6:JNW8]M4\$G833O_"/,E&**T(L]S6P1Y)".:Q
M!.95\%[6)HO8Q<9XY#7/0]E#RW/ PI0M:;M[U/J/W^>K+[BJD5Z<)<R_7*^N
M%WB'A8D5CD,,GBEE:H*#]2Q6ASYEKK2IS<15EXZB/4AX7A 90P_WX=-[.O!#
MI/_?6Z3?M9#$)'O:R)0JS+G:>I-;Q8"3G>24H+]ED%HWB;&<2._SP-J82FM0
MU/,'7.%R/6"JW@DN,*U^F<Y@EKX>HC=&5MU8JQN_72/OYS]\VVXU22EQGEF4
MZP&5,;)H4B1N$#2=M@%MDU&00Q#_O% XNCJ'+N'9G.QK-NJOPP$V_AMK>!/S
MJ[]HO7T@TJOD;WN.DX(Y:QX<BP+(!#!*,BB61(G2>BE$"KSK63H$/<\#9F?3
MT) E/P\+:).1'I4)P<3$LC:UND$*%FA'9DEY%ZU6Z'9;M;:\KQNUVJ/](=E?
MY$^C\B-K=,*1?.@8)X!SVD>#B(:%')+"4F+Q37I 7V3EQV"J/ZK^XQ@5C);G
MWX6HE_J/8[77*>'_%-&/5Q=4&R'Q[)G)BI:!*H;Y%!U+,6A;N U"-NF(\E3J
M/X:'PS$2;P"#=S7W:/8M"_,F'9T;%Q0WGJ&5M<VDRPR,E0Q5"CXG^D9ITC9\
M/SF74@-PE*[N=5CJ+>B!Q_?]>/WI^FJ=@/9S*60]O\7%=)[?E%=YOCX8UX 7
M)H7,BV4Y!L[TIJL">!8M<.[(1TNQ2[9#I_E@70AZ+K9#$P4,F)O0A;Z;5=&%
MPJ$'!'8C;?RY@<.K] B\]-#'P%,&.U):E$DBQLR(9%=GK1D6G2\LH<)(YVK4
MO(N+>_&(>6 FX24 YA@UC R4;ZU<MG5RNFCEK6$RU<E\B79O<)B8U<;5WB?)
MYRZ-FX8YCW:(&W<T7@OE'G,X]=',P);,NSHU8C/326.)9#(Q+H5D6@C'8E%0
M+?7@59)"N<',E:]O?4XVR6FB''@$\9J(&UAU(6-HZ^+6^\<W(4[4P*X.>XAO
MX#W^-CG6*H$9/<N>$SG&U!Y;H)FMDYB$@ZC$L.NSI18?.-:'5>(Q4AM8>;^1
MI#Y=?]KV)L@9! _(^+H'EW*>^9P+<QI$'0U02WZ'4M^=-X][M)XL^_D0@AOX
M</P-_KE%B$4GE'&!S@4P3&O'F=>Q,!DE%@XZFD[MMKMI\/:;GZ &3Q9<@SC=
MVSJG>K'Z\O8*9JM7LUP#5)^K]?7#E_5=>]UJ/#JE=,X,M*U;32A$8@;&N??2
M!4L,-\F!Z$#;<S&16JFC0;KX01(K@3?.01<26UX#=:#Q/)="@^NW*WYZ*F?,
MG><6J72TV9@%LE+J7 UM"X,D#+,"C Q%YV+&W7E:X^>12Z1+@,\Q.FD FQ^N
MIU>U#N_F^!0A*ZNB8MYA';9,II#7/C(0PO 20[:Y26.YNV2,?Y$TN*;F@XFY
M00'V5^YNR/$N2X-.,R%0,^VU(\Z@U%@4<! %8VB2P[1#Q_-3>Q]!#[C8-PW.
MX&K+[M96]ID<FQ29=:D0"E-@02O+HA<E19'!Z,?Z>>Q_\O-1Y "2.WC;-V0;
MN$TFY1_7GS]O\M;@*@*)(N'R(^)J.BOSQ:?UV(B^K5N.>,5035U.Y6JGW8M0
M.<9LDHO1: T^B%1;"JE@DE!HXJ0/@R<HZUO*RKQ<U>^D^7*U[*N?AY\ZE$J.
MH'U'"S:Z$DVT'G6A=:,!7/ >40N1(IE8DR/9Z+E*$BP_EJOYWXU6R ./;[$Z
MNG*SVT-*H5=1"BS:Z>Q(.X6^XD9JSIV79L_*Z,;8"<KY#5;7"Y(%;A5_==.U
MAK[35S-=GCV46H[F8T<G)M:HAW5%<45.APKH+&H=3$"?(6V;4QW)TE$*^==\
MGO^>7M$6F'\EG<\^3./5ID5,;<QP@A8>>6!_T1]#\>Z^E(Q1KM .1-Z>EQF\
M3Q(BR3U"MCY,NA,_H)!/;D?7Z;&M!=ZA?5V,(:5D+7B7M+4B6BM12P59<^V@
M/"+VGFWM'G[XMU:8/WZL<>HEV:8?\>[LD'G9/N/TS:D%%:U5.X!L=C<\,@$R
MS\DIB#IH$S%F&[4-F#0M1?X($DXCJ)\;O7W:ZZ\5+T'G3/).+%N5F,XB,) "
M6 [:*V)..=.D<\,]2OI&"+8/?'=KSI,%)UW*R("4PS3&PF("R:)(R7!1?,8F
M2>=[:!G?P>RGZ]VX0%_Q-H@);4F:D)DABD%D2<K M*EU=@8Y2T)(7Q "L=U2
MS>?3[<G:.*#=HT39(+:[I>-5^M_KZ0+S3V0JSCYL,L0F-@KGA-(LADCPK=,Q
MO"/:LN1<.6L,MTWZC#Y$U/-1?6^1#Y@CODO;V^M%^DBNPJN4ZJE8C\=OD_@F
MICCAI$C,0^6>=C$69<6LC$62399-;'(#T(FZYP.0X930H-_=ELCU+,'=*8,3
M(;P+WA%X.6BF4W!$)@0FDU0H!"BCFA0=/4C5\T%&?Z$WR%+8$G>W/^,DDQN3
M@Q<LUX1E#;S4"F]DW.10'1QE?9/YO/O)>3X8Z"'F!MWJME01ASC],/OQ>K'
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MW,5_\Q:S'1Z@?W.]A)!0)<UK"-W7-!O!P8<Z?]?3A6T<LZ9TB1".@^8$>'4
MM>Q@UJ#H\\T2'MD9;^-ZL6L%]$]N%F 92<[78KJ4R>9+'IRR"ICV6922M+Q?
MV?DHKX9@.2%63::2'9P:*>1<+<$[2_ASG9?T#S[>]Q*WUE&]RIO<,:EXB$R
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M;SQ*#L;@-.8'0>P.[58$F\%'G_-\A;?OS;_.Z]_\A*O9ZMUB5ILL<*LS<BN
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MM@UB\:X%Y4ZDQ6TO4O1N<=M'.0=J3MH%XH\6M\.UNT>7TGU4<R 6Q:RX=ZZ
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MG\'-4S)[F[@%(J+@1&J/.V,)O%!A>?24@_--&G]LAG,"K*DH[P:EM<M8VZK
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M(&AF1O+&*]\.[IC!\WU9LCV5IY(RFE9 ;<3X;NC#<#2<70Y8I)$:APZ:<F4
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M$9]S7&@/3AY'^4\[+C1?U*+A%7H'S$E-K&.:2*44<5EDPCAX9I1-4C69 ?X
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MM):=_>[!=IS.?FV4^A!S]M3(@4G#&0B(Z&L*J@M$A\Y$]($X;CW7*J,'VN2
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MYU3(:E%:87LJB-0";24CRF66!4N]\S0W*?VY%]4ID*&>V!ML"2]BO#B_F _
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M!%W:7(J@?6"4_6>NQ!Z]S7?@SF'G2NRB^!8C=*Y7=VL^X"HJNL?*.$\^E>%
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M*%?_E$B(EGAJ TE"LYR2")*%)F=#?XQ':HIS./;=.2X:Z:_!S=/=#>0QQM8
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M?371(C#(/H5(DDN\S/$IC0"M))'+*(TU0'F?Y,2'GG-B9*@JU@V1M[T#M]L
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M^#9H8DV.>%"!", 48FYR[;0%SV$M@3K*ZNI+ND'CA*L6E._+.*V;';%STL:
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M4MJ&O67O/OBWH2YA+E^H/MA:6F_W8#N.A=9*K_?29W^=-+"D[H,8O.%.&$M
MZ=(J%( $K8LG+RW^) &D)M;2P>GR@$7T!-BRBRJ.EYIJL@>J@B5.)T3IG"3>
M"TZ"Y\)+GFT,JH<9\Q2S#JLKZ7$9JKM(N'*&ZGOX\[^[R?\@L&Z8OO@?G^=-
M B=?5]U@#$CA@2423:G$,4C]4#H_44EMMMZA6=]G]-(#CSD1C5>4Y=;7_?_^
M=4U&[_#;^1_,?UYD\ GR?Y7___'I[96\$!\:S=V8<?$+>H)_G<MJE0?1Y955
MO3+%NI4I=L,">PTS/QQ-;R.<#L^_C> !!CSN.7^]7M7MU2X?=HL/K=8'/V8P
M3H!Z&::__668@3KF>)*12VG V\@\*L]);9@$/-L?]\C]3OM[K&84%\PS)P92
M.*^LLJB9,EW=YI+NXAEAR#O<8+P+MLG]71]P^]?>?@?T.Z<OPG0V\7$V8&"E
M=QH(C>@82+">6,X5R3)0!<ISBZ9Y@\6N SG\OE:="W?+;O>0=9/I<7,\OZ(D
MRGY>(/UK.#M[=3&==><P>?-C&9]X,9WBRPAE7QXH*8QP&;U%K@.1DDH2F,*-
M6'B18G),N4;#M7?&>HRBW'T4O)DMS;33,A]S$3(MAL*5*+P(D!GJ5F001&8A
MB:,>B+9.!:T$SZ9)*Y][,)W@%E-+ [6#O1,$\G'2Y>'L/<RZ_.;'-W0UX3H$
M^F%V!I,%Y@'+R@30GB13IFA $B0(Z8E,P<OL4[:T5^QWAV<>G@G5%-4=0,J5
MV7"51WHEA"52/TXW(.(:!IR9#)Q;$B)#?\)8W-"44<1'%Y61TG'!>G"A_Q-/
M@PF-)%RQBNOZ<FT&Z.7/EO@&BC')!%"B$\/-#[T%XM#'(SH&CAZD5I$V2=5=
MP_'\:5!#P'?UO7>^Q?7J5H;-<'Q1MJ:K>Z^7@&<B+'X/;1J8OOF!4L#G#\=^
M<CD_(M]WXW)AAN(=S06V6.% X,DI5 02EDE5>' :B50V7#)'I?.V2<Y_PS6=
M$@^?AN+O<GKOFZ;7\&T"<;A(81VG%^?%N/OWXMN5Z!+NLY R)]'J1/"%$\1;
MGXABW$NFK4JQ3:+%P]A.T RNK9$&!]\]$ <\)RN5X<3HTFPA9-RC10("1NKH
MK6 I]AFS5),L1TB6J*W#_AS920$M^J#YRWDD]$NWG%6(1GVZB/,*?'3U9S=V
M9*I\I%KA/EQL=XB4^(RFO..,*YH=I^L73)4:HO5%>(*;2QOM-+"U'@0ZT"D!
MU0Z(RBZB,>A"J=NSQ%-!$^7&!=5DHWD0V>%ITTBKNW)G)Y4TV'H>DU#DLK6,
MH0O)U7PPF6'$ 7X;&;-.2ZVU:+()/0)K15[YT>B(FU!K/6VBUG\56:39_RE9
MKI#^]I?9Y *N?XAV.?R8O1G-DV3_]I?IXLE[\_$J[79U)[B\)5PT-'!9AF $
MR;Y<"TLJ4(("2 9M\!^56)N*J'M1/:=<P)THL4[!:JIIL8\ML*P:E/0 TS+?
M[Q::XV3X5=36.@_V%O7_W]ZU]<25Y.#W_2\EU<5U>UF)!;*+1"XS@5G-$W+=
M9I!8>K:!B;*_?EU-((0 .>=TU>D&YH4 07U<_EPNN\YGNSO^J6@EZC16J[AG
M4%_&>>$*RP)1</H.79\3JC_N/Z#JS07[& TW?IUP_/'#[TCN+>:KRSK1Z]O6
M%%ERE)9RMSI<C^*I8AG2JBA%I*.W2(_E?O^?!]\@//F0C24Y4Y2_Z*&YQM2Z
MU<W>^1<6X+=200H4(5-\3#DZI?R8)47?8%D=HP<NFBP4#,#S\2<\5S ;Z:SQ
MYGR;T\JRKI:_K?Y=G%VM+GN_%5"#M<#1,YF<8^22:,TJ HN!2QV#) F'C(X>
M]+#GBF][33:\U:P"WF7K'N7X^_GB;/';YT?DS!ABAJA9@JJ%5#Q#3, PIBP-
M93\Y_H@:.?:9SQ7X;GIM>.7T1-,Y&[*/T6MFLI*U36A@+G+)'!0=+=(IHH<0
M?UY)4\XI"5DCY7?OT7HSM&R 3*^N)^<HH(:T9IRBY;EZ<F*]YI*RL&+)/]7!
MUPR#JF-WG3"(.4DWA&.\A<B/[\G9'/@QRIVQ)V?2J*/@%'XZ3U^2-2QH@HJB
M3Z6,"E&K+J.'M[LGYRBP!O;D'*/I67MR*JF=RJ!9O5=@ ,DQ"GH$*TJ&2)$)
M\#[<KFWOR;F.$;31=F/'?WOI='?0^LK;@8U20%!,&5$8*&T9:HMU:J70CI?H
M!U70#O+\CTKQ&N+!-A TSA"^K.RN2#<=+@8(U3HF?%2:^8/"1F@M>JFZM7]X
M5#@,7B01D$6MH4[!!>:=1*8+!.3!\S2H4^\VXO]$:#@G_&,TW!#V.Z.*"UH>
M8T+&G>(,(L<ZC,30=SDI;53,_@&:[K.9\=Q0_=^/>1ZCNPZQ'049Q[>MWZ-7
M(=36X2YK.IE\9CX&LD^>#40ZF+AW/:*Y.S(\9U#75>FFJMRO?W--5L+S]&&Y
MH CH\G.=&7I)/^__]^KTC_H7[_)E^/R-/UMF;%H'WT22+I7R[75TKY8^BNR1
MDCF=- !F##R9$)7V E(*7#Y42]]$J!FJ[6.V4B,E0CSK.J2D]O9P/#*N2[:>
MBZ)RERJ..:KM[S$)$T(,G-(]#H[V>Y"6@ON(M>]?]1E)<]OE3N194'3'V,%]
MI[J&GCN<FE^8G4(KH;FG#-P42=X=<TWE+!,F FCM:?]V(:MMBE&[#@@/XCE*
M@SUH^7==YLX=EWF[1I7 R9"!V6PR SK!60"K&:W3:#1DM*6+[_JA9"]PC[=%
MHS'MX5'A;FNQZ9C=Q3].+_'L]'\Y?5R4RT^XS"<N(()4D6*^.DE'6]HETE"4
MKZ3C&H*U94CQ^]3G;X!WWQ;&Q<P8; D%/V4ADDZ2>56KN(NAC8086 S1B>B+
M$]B'"/W,*?CK.*#>.&V:@O_$2\OLLJ1SF[9DK;J%2!I;;4G.,8.5/,HXY)Q[
M)9R.4:#_F-,Q1OFS3=D<(-.KXW2, FK0N,T)6I[+ B"6>@TA&69_W>^1!9W)
MW*&*EH-(*3Q/Y,=S.IH#/T:Y,W(Z%-?9&(%,:HZT3J20J?C"+)A@M<D>9=^>
M7EO)Z1@%UD!.QQA-S\KIT ( C026;*W 1Q%K5E]7;#,XD;5.72J(MYW3L8X1
MM-%VC\SDR6*BR)VRUU4BL7:2,H*%8A5I(%)TC3[9W.6%T(LIQIP2)[:'ID.O
MDV]Y\$.$>=7%F*/0>K(J;XJJ^Q?CIB(\!LDBUY*!<Y8%KBTK4I*Y:Y(W=(D:
MMKT8LQWL8S0\:S&FMZ&4VI 697W!+7.=/IZ <3JW!$*T7O !MYM;78PY2OF#
MBS'':&Z^8DQMT7.K,O.E#J8*WC)OZMQW00)&!9YBG0%X;F\QYE0P&^EL(\68
ML@:76"C(%+1<4)'\D/.>80(=N0^4Q [9I,^B&',JONTUN<EB3$YG348?F*PL
M<0#IF/.46[CDA( ((KHX /'G5(PY%?AN>FU-M7Z<4AJSYLY%EE>C5("<$#HI
MF4FZ>.XR2OR+@M_B^KX-!/-1\ <(]3HI^&/0&D;!GZ#JV2CX04J3<A;,6T?Q
M":\QI[7(=+0"4%KNQ9!KG&W$?QH%OSG\8S3<AX*??41=0F#6U=O)K#USW'*F
M9 SH("*J!^@"+X2"/TK]WU/PQ^BN,P5?B@S!4.A21*HE?L6Q())A"HO)(+2*
MMLM<W"VDX$\!=5V5SD+!_^D*EY1+GGU^<WJ.Y_$4S^Y$*L?G>)5.+_.]]_V#
M&/4#/WA]@OR4%=SCNYOH-1?."(4*P%#X[$)QLF3@F4>E3L8OI@,(JW!Q2G'#
MJ(^?"Y"'5G,/%O# >4[%AJ1 E^2EL-JC43E$HV49",OW"^L SM=9@D_^_?0*
ME2YBS 7V.MJYOU>5S<9B"C%&X X#\.)0<J%MYF#%0*.8KJAQ%4[''SX<[K_=
M?W>T\_.ON^_??7Q_>+"W<[2_]^;@W<Z[W8.=PX]']&/]@X^[_]K?.S[<_V7G
M\'CGZ. ]_?_>3\<[AP=O?CUX]\^=W=WWQ_1'4VJ;FLO0H*JIKU[NV8P*M>=U
MM1) 2)J.<(TZ!>\Q:!#.G715T68-9HV:N%ZB;*'Y#/$\H>@BC -CT$*4%,7Y
M5,>9><-M4DZVMZ+URN)J1/L+GEW=C* @1W=V6C[7F8YQE7!<[)U>5*;OU3(?
MWE*6G7/!^1PI)/6:0:0PU6>GF#1@LK<V4EC4*C\?+=VZV<W;Q9_YFJ+_]=%G
M9XM/Y/?S!0GQ<[[(RS_SQ<^+L[,WB^4G7*83#L9K5:=JVEHC;V-DWF7/Z/2!
MDC6E8YKWR((FR#IOMM37MNYG4;VAZY!+/RWH/_"L_NJ$ZSKP00DF/<D'E( P
ME[-D1O(L=$%NXQ!FZVC[&B3=_.]1NN.\Z U2!X;+TT+NKD;9IZ/%[N)B58GT
M91:?Y('KZ&B[@:QSRX1DSOG(2C329/ AEBY5.Y.D?>V6U@+$#MRZ@4*OIG[>
MN/X3'BV7Q5M&F5GM,V8X(X<O:,N$$B*JXDN7B\,IPOYE=VM#V&&VU-,R[^75
M4*/%^<4)97/>B80,5].2BI0D)[K:FEAYJ0PO80,^[JN K]V\)D+588SFL(,^
M&RY][6WM()-H)@B&HA[T"C"[A"B@2XG]A&AL'&/GX_[NS9V7D-P_\#R\XQ2N
MELM:(_V?Z@Q.;'()I%3,B#K_M/;WK];"@):"W&<)6?_@+F$]"5YB7C,C)HW?
M[0_5SS6]12>'D(1C6=<Q']$G%G2A'Q7%-9"-\8/*-IK>)\Q2*#Z?*?4%9=-U
MXL,\Y!%]RC7-O5BO%%>,$K5 2PN!.5-W![CBI:U=K;K0_X>)-S<QK;-IC H%
M)D$T>S)]4]HR0,:>541#A-Q,<5$/D,>%E-,1VI0UA> 5G<Z>*5O[:NK:,YT[
M8-YR74J1/*D-W/%ML%1I6XQH## =C.=6-$K$=I<YG5X>+BYNN$+%I" J?5P;
M)$\L/=:I#9Y!3H;B:HH39)?:YZ>$FC^=;0_C_>9OK3!H7!=U?1]SN^@;@7A,
MD5-\N)K:#-Y%YK++S((#3]&B]O=[.CZ8BSWXX2\(W#8*;%P?-?2FY-_+T\O+
M?/Z^E)NI6S8J%9)FVM>;$R]=;6NH&?=1!<U!9$P#0)_Z_!=F%[/ T+C>:JC,
MUP[LN^O<FS8?)5%X'P49>R0?5G6'E=0*NJ KVH5@?4,[>E*85VI4[0!Z]-;]
M$7KPEU_7+P$O\M__]G]02P,$%     @ -H&L4C#=/6SQ*@  ="P  !,   !M
M8VLM,C R,3 S,S%?9S$N:G!GG;IW6!/-^^B]]-ZDURA5*:(@@K0H/H* @"!%
M$ B*2!,0D2*$1+K4" @H*A$142D!Z35T%.DM4J0C'1+J0MJ)S_F=WWO>[_7^
M\9XSV6NOS.SNS-SWW.4SFU!_46<!7A-#8T. CHX.F*)] .HD<!5@H*?_>] *
M(^U@8F5B8F1D8F=A86;E9.?DY&#GX.#B/L'+Q<W'S<'!*\3+QR\@*"C(R2,L
M(B0@<D) 4.!O)W0,M&<8F=B8F-@$N#BX!/Z/"[49X&,%].E>,=!) _1\= Q\
M=-1V  ( =$QT_Q;@OPH=/6V.S"RL;.P<M!LJ>0%Z.@8&>D:&O[.F70VG70<8
M^9A.G#I_A9G?\BZ+M+^ 6D1J+JN,05F+H-4@7E;]WN-(-G8A81%1,3EYA=-G
M%"]H7-34NJ1]]9]KAD;7C4UN6=O8VMVV=W"][_; W</3*^!)8%!PR-/0J.B8
MV+CG\0EIZ2\S,K->O<[^D/<Q_U/!YR]?OY575%95U]36M;:U=W1V??_1/30\
M,CJ&^S4^,3>_L+CT9WEE=8VPL[NW?W ('AW_E8L.8*#[7^7_4RX^FESTC(P,
MC"Q_Y:*C#_Y[ Q\CTZGSS">N6++<]>>75HM@%3!(S2UK89-1M\(+WGL\R"XD
M>V%.CO!7M'\E^_\G6.3_E63_+=C_(]<$P,E 1UL\!CX "I#%P18"S 14G7V#
MYE\_-]7ORA@O+O<U%E[6/)LZ,]T$IP)Q6?"+5."]82,50,A0@?GUKU0@\AD5
M^%&U#MG?]Z$">4R(FZ%V8TN7W#C=A+7KIT#XNF;[K#_[.R6'KC5D)!68?8_F
M)OG,]\I<KBX;W3RKH?2R,L'[LZ6K;4",\E6\VN55F$7*TTU8E)#FT&KUV.&C
M\\:SJ6Z&+(QJ;R-Y1NPV"UKZ):\1E.;0<;I&''&:8_X_%"I>M:&(*V)_>G=^
MN=2ZF3X(7'Q:? -Y00E^?0/$Y.B?14SF,($Z"XD8CK7,NG=;N5[/AQI?7A_\
MXL8I+!>G);.+"1O3N'[!3''W9JW?V8DQH6Q#O8PK"GN"8#Q!I_,6_#(8,P_A
MNS'YQK(QS1\7HQP4L9ED>\F07FLB[0#-?K%?_<S2WOP7^ TR]W^KQ_R_U3..
M8$ ,2DF1W^]MVAZV'52/E:T.?;1*'+&1+95UY0R9Q2VH(.*H0,M9*K!H26BA
M @632#)=X6C/SEM]8<ZUX<9^\3-]9;=[K#U&*U\?D)^Z=\Q,W&F&,-G])$A5
MH">4Z[/,*J1\?G)WN1#?'Y<!.!VB,SS,+P+*>;]NN!O-ZW7#YPF^[91(5)T!
M=!Q2HK1C:CNF6DFV6K8<*?G4A*T-D,7QU[H'Z1DKD C.0?8OR?YA#BF#>C<6
MM(^3&C,$GR*,5H3*J #3Y8'<&K=AN"@R@%776&_(T(+$R$!:,Q.FL(?/3<:/
M:EBPK%WT=_^3.3TGU[P_&8'N:[H"WB&>(QF!'5[531)X8M6K.WX',8N)C"SD
MH2X5*D#'7.\G0&G&BNBJ%U1.>!R$#IV<&EP-OF<,'!BRWR:>EF^LG7W\U6^\
MV^$8K6=QOL]+U5.DJI%G"!D-%2.I$MHN9]GA&WN&)Z\J9*CU,Q@.ZM--/#YG
MSH-/=\1VH282VR#EOP\R?.8Y] S^F!EJIJF6=A8!5G1]MT/'4!N]^,]P25 G
MUT/MVM(:\ZF L"[YX*-7D$\&%,$="Y(@!\70@A&)*^ZB1%?NWG;4D##4_(6)
MN[5^_E6#H;#JP?;"P'XRE,)^#;]\LZFJ$F6"^R?]>]D9#QD&V5D(=LU[#73C
M-TA3-;S9MN*-1[<N4!1]9"A-\U1@H .QX.0MA(#@%[P<8MJ#JFRK* ^'KS_Z
M_+56%N?L]RP_ZI&U[;*\T6O;+L/')0=J"'FXR0"%/\3PL!UQLI9X$>U5V[H
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M0A)\'6:+F(16WB4LYC7K"]91@01$#].(JK2OJAS#%@,5T!U)";<8:KHL>45
M4^-8TE%%>_2NK1>I8&G$/^.TY3L1:.+C/\EYTV"<=>7PDTE[5;^MC[??5\<$
MJY=I >QD>W(J%7 K5'U&$7&Z:GU]6]<5\>SW%%U&]:WOL>HK.CG+D_0-[A2V
M:OQZ2W"H<]Y\9QW*BO#R1 7SV&7UNWS$HO?[JOU]>N=_+6^S@U/KYU_^P0\,
MJI#Z&^=();R1'=:CC0V135=HAD(#NQ\2@S2'.8T^YK##[>^PD 3:*-?_H*C
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ML-_$"6<>^[6'*Y[F^VY9Y.D2XSR>)FTAM8:<E6XRJ#)-;"/N_=Z<#-AZ='3
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M*=DD(DOI;U1KT\\S'??\SQ!#5J= Y666Z%83J.V[[8'C?@I;.4&1"IB"R5]
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M+/_/ODHDIX3-GVD:35:1'[,>!%P^!8W-P6FB/3$37DS^LRQ@9RT%'H'V*)E
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M& 4O8"H$LW%8/KK86[HQ&$O4]U8\VZ^>5S^LJ]8U(=>@<J0G%'N#0^D)H/0
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M%CE,3[91X],CKQOOE03*6Y\\=*]9RS]HV_4)@6!^0FDR\@,8_!W3$HRW_BQ
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M7S:BB2_@RS0PCY%V1(C\IUGA1S!QNK->+',_V%C14?9X>Z/?*8[?Z\9:6,;
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M:A*A"X(Q;T >HOL# W1!6X$T"R#FPKDGS5Y?CXE5FA+HOZ,IA>K4/R\C[9>
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M09!V+_<8$VVTXAS&\M)T-FS17:Z'/98C%JS/9KT+'/GQ.NDJ63<P]6!M@^9
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MOG(^>ZO:^NJP%=%S>ZJB-11W.88<W]OK.7O]C^*8N 8B*XYIP[B^M",:4:?
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MMA1BEK)DF.@E383XV293-Y2ENFDV658A6S+FAN/H;? 9F<AUYI:&'7KLS]Q
M=V>-6MW'R#6]JSTL\[K\?%\=!1LV+/A=>0P?NN)M(=@8P]EYE@.#^GQO<>_
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MT#O7]4-8KRXAN:SR00JDV19,'#L>^Q'!?2GO.5COJ0%T[/#U3;"-)I+M5KM
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MN(XYV0]J8H1I3D,8A8)7/2EYY6_H&<;[UW5/K:\*2-N4Z)U@=IZKE#H6A,4
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M?*E<WZG=TXU^W:"^?&3#JT#GH2WJU7L#6],<C>SR\0@#UP^LWMG^\+]5[;+
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M'&K41&=MOWQP[U;^.[@_))C.QP14^8?<;EKVV_'OQP.G5%9.08K\\RATA??
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MB%\=:!:]N,B%J.PH>K<]V7XL;[WRVO[4P9'?4G?J<H037X4;BX,\>K&4P[S
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MUX57FU+G!_7PXC\=ZG=%%[B,7QMWR6_*R'BCN<^!?B#V_, >2-)[B @$ A&
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M8QB/&\%7U'&OQL8QT_V+]R6=2E^%ZY4.5'P]#<L*V&[Y_6S9V86&6Y_-CO*
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M#A?B7V+&"*UG9U8_QT F0)&3=R:IHGZ7%!1*+$MC+"QE7J%:E;&ZOY_7'Q*
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MT^-\7]5:AXG;Y7.+)G_HGJ^(>O,PG33AQU@ NEH0*=/;V1DL:6#N*IW4 4L
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M(W39Q&#J)][X^0RXBF<?C>_4#U5\TP[;0@'%RE$X(]P*/HF$/@*<W5VJEH%
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M23+,[=LILG@HXYU%JT)#<F S6A&3AT9-]T;5_7/?38;%O;8#=3DK\*Q)HZ>
M\9L,&-LM#8/DEA(44NB9L_)(^D.*_ ;D7[?C/X4P=EKFKP,BGM6<RLQ/0.7:
MF2+6TM<:'XL[ 0W2E[M]+,X9^;]0,##[J42P%7:A&RRSB'2JMK50LHVQ,JW6
MJ8A'H;?]*(*1#N9U(72.!N3WGZY]E\^HS"[]>O_XQ=8OKX/,KWK$%$($)S[6
M9;C+_\B_(BSR;DO":'>*W9#K.=FAWR#J-6^WI,VT7Z&*"^5N",KQ"9Q=QD4K
M#&S'8_MVH5A=DWW!\:JX6HRO?$QMK_#" RWFLL.G=/(H)?D2[H;[=9WM:%7
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MN1"+D$":)(RZCD.3P)\D>'9*TKE-DU^KG/X!\D9JD&_%7@!\>UO4JR"0=BJ
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MC=.,.&SETV1^;$K+1[$?Q\@AD# N_0GN!C#Q1* >!Q10)GR*C?JO/;_]['R
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M_#>JF_RZ>/I:Y?2/)I&]FQ27H8]#GWL)9!&E$$78@83&TK/GJG1:XJ-0K[Z
MQEASFU;:TR/%)OF?U27-!I4Q.P8Q%U3XGEPM>5P%JQ/Y$T8\A@R3V/5IZ+(
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M:%N'NM?$JUNW*87DIXV-O_1L?'&ORC_8\RI&A]^F^S&>L)/Z*:-C_M*A&7_
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MX8>LJJ:HP95GL#X.*U>MQ:WI:DH7>CWBM(GD-.SX3&+0BKP K=!U.4LI=7V
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MI\O(1TX4>!$,*)6+0QICF B,(*.!YP1!%"!J5&+K+&GFYH%URJB)K5,'-/K
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MH4<)=/S8@\C!!.+8D5,3<T,U73F^6?S'</RYS4=M#U>5?<T;"<&/;0#_+PM
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M :L!Z;T#31MY/J;K3HCYZ,4#$S\KG#'R])%7ZO6Z$DW.:9O+PAT>"1I))R'
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MI63U-&=?*UQ4>C2@-;;)$_]2@O$>_J[V$59=$&_3+%-[([D ?^>X,*U'H&.
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MM?$2U(;,9IJ&*8M%#!-"$MU0 4$2$PQ9'*0I03+BOF4DQ 7G<YJH";U-_7=
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M[DFW;5/.Q.NMW*1C#_8/-G$P-[)[4-DMZOW&E;F/VB*^C-4&SX=$6240L2B
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M\E1(]9\'$Q0AM:@G&!+/(U PYB>2X !)HZR3[DWG]@Y_UQLS#OZA-F \?UB
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MDPA%1#"?QD:GT?-2:VYTU9P(U]!4)GH-S@*('T#K![2"H-:P2DUL= 1[)1?
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MPM/;D:9/9CJJ[<%$I>/?M@\S^0^RNBN$6)>_Y/FFO%JM,MV_Z7_GV7KSNQI
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M07W3<8ZCFL<X9SC)("*8Z?]D=AF5$.O_TCBB+*%X?F^G]MN6KK>C8?M\S%=
MV*09,GE3+I?&BJX4N.]N(.@%?"%3+A*B(%5) 5%",UCDVITIT@+G49ZG4JH:
M^'=+Q]Z=P6!O1GPET*5>W +#[>92! !P8,_@"6Y:1/#S.7/0(P&M$X2P26C'
MAQHY$:U3WY?):-V7]UOU]).NUU*4VVNZ7C^JU=ILS5ID+@EE+!5Y#C&/M+&6
M4D :XP@2GA8B(YED6>*S^IT9;VJKH'G3*WE!6^"+N'/.0>YF,@(".;#IN!!#
M;SOBB$Q(>W)NR%'MBJ/^S^V+ZVU^=F:SWLZO32=SN;[7+M6C>:"M3V-,8<%H
M#JF@Q@]A*20()S"EN8@3$2.,,Q?#<FJ J5F2MHSUF^]1ZW<2QFYC$0*<@:V#
M-R[.]N"<\AT&0-_:^OCU;\\__)//'N5+/Z=9\VF?O:XOQ][=W6IISX]M$<P\
M2SDA$J60"1F;SBP%9 QS*"22"::YRKD7$\'S :;W+1OYP*:B@_N?T4]1##3
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M/5JOC?MD P2/ATOJ/)^K/^A:-#Q([S4.%8/_EW7)*X^K7-Z\-81B2E&:9H)
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ME;-5&VD&AC=XQS)##7=F8_Z:^6D4 BV-6MTE3B<C];&) = -;"XOD6AL2QH
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M)[0 '<N,?E.A\I>ZVOU$#XJ7-?!O*C7_,C/DHZ:W=*E*7G?FV2-:,6D:3&>
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MA[:)3_C;9F"O#V@K!/8:61/9FJ6OKS-+[D'$<6=KI!#C"+/F%8$,!W)'?#+
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MW\CS,GBVP[I\T-IHR?7*KI=XO<)K55JV$5AE[$[+J@'>- K]I>Y3;)P%K57
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M2._T$8/Z9PP95WI#02F/59Q$*/)J4G"!+%-;AW[]Z=M/?FO+)1/AMFR,!._
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M>A-97Q>A:&5K&2'38UKU/S^9)66D1M=P,GM@8#K+0;>+ +/ 2P2%-!:5BU)
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M'X9XD(3J<,HKAV.0$$@\+F @(HH#+PD2')ON$FY%F]L^$OZ21O\?J),5^4:
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M5H(W/VJ39$.64B\1NA&Q#Q$+U>ZGO>))$G#/\]5NR*V">P?(,+=-KU(![.L
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M]X/&/$8/#6.1K^)9K#9"7U@V@<MW)-?I=PO*2)*D 84B1431B(<AB=-4T8A
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M6"TB%BOSAZ:0>HD/4:3LGU39/# ,$.,Q#;' 5I%,AU/,C:^V$H(?6D3(E8R
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M'+B^O?EL$HQ[I[Z!Q1=1WLKOY.<U+:IF0PM,,6',"Z&7$*J,SU1 &L415*<
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MP@(JM]$]YZ>=.(C'&(?#6!WS1P>6H&X3GG?U/!<"DT &$8-QXNGP=2)A2L,
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M^UKO[O/-U7'W\LX=>*7CR?(J4EK[1G2@*^CHY/#";R+@G5X6CBWSM!>-$ZW
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M9:'GX<GJ*)Q7H%LIP>#3ET7O5L%-176=5#?I\KW8YTD,/:8S$##S88H3#]*
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M0F"(XX"I'P76">=^ZEN5SYX9;VX.N!6W#C5%J1ZF'Z#<-K8';9.:=0Z>&VU
M1QU+QWS&%H:NUAW"(SO/U^#>V>!G[S3-4''J!L\,.:UC,]/_P%497F;?M_F;
M4#Y-39QJ/7N?J==I$25^BE(:082)"@P3+]0Q80+#R/=0E)!0(J-ZN6,WGYM;
MJ832^45^\([^ EIQS7LP'Z#7[QLNQ63L@WI+.*SZ*9_2^X+NR0>WG*Q7\BEE
MNIV13WYF*(]?^9R79/E[D6^>;UXQ!5__S,J%CT7,<$)A'.,8(J+"A#2.U/HN
M9&GH2\8YM:IS/3/>W%[E5EQ0R0M>"ZSB?R6R-<U?/^!F88!#&$=^^R]"<  +
MH!$N;OD ^X><F!G02/]#CD"SRRXIP6@<EUK<?/S^)?N=9"M-1+J(O"1F04I@
M("(?(BX%Q%&20II&8>Q'"1+,RL'T#38W[Z);]3XHV4J][Y-UB@"R5=6>?/VB
M5B.M(D/*+$Y@;N9C7"$YLH-I2BEV<EZ!CW^!7SY= 2TL>*?%=<@29H**^^J(
M$^.]03U$O^;'*R#.7#/XN"U;B\_9=\'WB_/5>[4(<"R0YQ,HF A4X.)+B!%-
MH"\0H[%'9" ]N\R%_@'GE\+P:9^,8\#Y^QF0H]1GGH<)I#''$.F<;H(3!CE#
M(L:^YS,A;3(:W$$\16J#=M\WI"A>],&E3;]<0W2-#R8=83;^@:02%%:2'I*=
M]%/F#CF'-$#%\?ECWXA3GSL::'_DO-'DJH$E:KH)Y&^D%%QW#A&KLHXNBT+7
MEE9M0%YV'VE..:]_D(+?/NL/EK^K#Z[+3ZN[JK/17T7V\+C>-IJL_OB>K,5'
MDA5_(<N-6% O4C[)]Y7_CT,55Z(0ID'LPP0'::(L&-'8*"OYC>2?6ZC:"@Q)
MTZ'U08L,N&Y-(970X+N6NFZ)6_5TS2NUG?3+G?K1,?.[,WX@1G;DE5J0:KU
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MI16AX;3BS\U%'K1'>ZZ/P;(5>!&Z]UFN?@]^/&;L$>C(I,B83F6L6Z5ME%*
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M4P.M9.:[QL=^9(=6*P K#<!.A3HRTW';LV#:*%UMKAK*,B6$.T]W&9(NW=]
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MBM#C$(4QAZD7IU!2&J4!02$+D.G!R-Z]Y^9U*O':U^!O6D+#1-=CN)T_U+@
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M679RXTTURTYF1+M)UBG>?9.LFX&FFV2= O-JDG5[Y^'4U?<- ^XB)$D8AUX
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M@X)'#*)(1#!A'H>A#'D#%F992'VK56_3EN>V5K!K^'^"QG3+16ICT W7E\>
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M%<VK:' A,">4>PPR1M4BA?#4.7<.XX0R/\2,1EX\8)'B<&LS74/HC 7YQEK
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M!8RC*$JLE-X&6S(W#NZF>)TG8,?V01/@ 9UC-5$>%_*))M0OT6Z]T-.*73]
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M(]HYMPAN*^>Y).6=*IG*<SE<Y'0MORF+Y:0QN_;T,MY,.FQDSORJ-?:V;EZ
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M6%/K>4"ZY->!EDQ*LN>AM<^T9S[-_ABQ$J55":K?5S=$%0#K=*0W0KT\44>
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MO@"*YXJL.W=?[1YB:L+NJS%!ME!F&@GLJ<2:G()NI^$T +D^62>;QTVG]#3
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M/;M\?%SF3(EAZ J8M?S5U_PA;\;+:A'[ ?63-(2(A0(B3D(HVPYA'$8DC.+
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M+2JO%[BMGS",S4[)_S<E6SX6#P_%ZB,IRV?YM\L'Q;N+B/F)H%X"/>XCB(C
M,/68#U.!J$]QR)F(;=AMN"ES8[L?ITL]V9'<&;W$<!B%7NQ#/XP\B'Q*H:J
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MOVIZG;44^,>D<V,?T)UNCB:*](X^5TZQ7S_PG@@*7SC 9-%B/T#TP\B>GCA
M:4!*P>K=G>,M^:F[).C\CC4K5HTTM1:<6:W4R[9DU778,S6M4FP^B5J]IS5M
MJ9:V*(MC#$F2"XCR((=YP%(8(\P%)CFG.7,5(O!IH-57?'J= AVQKLE/0-MO
ML?K&%SV7=)]VXQ.H6Z<<"NJ]SN_Y97+ZZ9I(]J#SJ\O#T'%O[1IXZMNB[QSH
MO .=>Z8[J'EOZ^)KS:2#<L)KS>A4P@I3SZR;^,(8Z)_29O ZWG32#6/ ]$39
M890!!AQ"[\CF7GV0MW7!R.IM4>VNG:LOXJ'<Z#O/W]=%_1_;M8B"$-^LQ6^B
M:5.;91&- P81#2.( A% '"($4REX'C+!DMRJP\-%5LSMZ/G4$=#WQ.%\,WA.
M+(Z=4R ]]HGS.,@5V'D!M!L  NT)T*X Y0OXL_'&(4MH^&PX'#2GF)6ISIAC
MSH[;^?)25$\=+0<_>[I3Y:7N/SE07ORP2_H@[X0.FM(W_<>GLOZ7J*_+>_61
M9N98=:_[>*R-_D&X#$/*:9I3R+,L4:N3[I$<BPR*G&<8)PBCT*G_T$ [YK8^
M?5(?&UU"N#(U1$V5JQKWWO$N9^BLV%WO3(#UR"M4UVYY+Y;25<L:Q)4?X%'M
M[G>>+(#V14>L.V]\MV,>C*;_5LWNIKQ"&^?!>+W<XGGXXSQJ)G0]C-YNQ954
MWWJM)?5>'4&6&4)QGB8<(I['Z@\<P3P1"4QI0)(@Y2SF3H)/3J//C2)O[\1&
M$&VAAYK_HY#;,>%H0([,?\<T A:ZI0X5X#,I%.<9D!OI.&W_R ("YV ;75C@
MJ &O+SAP#ALK(8*S#[E,H.!JWXFF+0D5;84&B7$:9V$.$R$4AXE(0HIE##G'
MB&2I($A:=3ZV'G%NE+6K'.]9O.A*P\5 &:KSN-MQF%<T1^:M2X$<7"Q_%IPQ
M"MR/#_HJ1>EG,3A62'[^C4-E\-0I=\OJ[4:WV5WS7F=(_?].=O>VU&J<X5*$
M,D4R(9"&4D*4AQABEB0P"ED84R1ECIF;(I[+\'/CI"?6[Q32U?H/N;6,[L")
ML..E\> =F:2>(JMS"EO3C5KWPORYD^S6&RX_FKR7X>97/L_)@HF5](:@<RBJ
M-^@I TMKZI+]^T-5;05_:P;\+#9%R9LBCW?W#ZOR40CSHL_J(WRGMGPF960I
MI6110CD4F53;+IDF, ^3'.K20)[&:<R3W*EV9I@=<R,^[8$Y_)025,9VL%VK
MV0"B=<%D)5;@3;%N_]VRY<^E\V5'BQ/,PLC\:(P#C0N@\0$T3BR:^I=J 3I'
M0//BSI4FW\UCF<ME8'JM8QEHRK2%*I?A=5")<N'C/+3V[O<3OBV_""[$O?Y9
M!^)UK*]<J2=]ZUJP+;%,6*X^UA"3G*JC+(T@84$.0RYC)C!G$CM=6UQ@R]QX
MM=?;^GE3Z_43!TRNF_; \5+CDGFSX]:)9F-D?CW?-'OO#'CJS:Y?Y$@-M8=A
M.EK[;4=S7J]9]S#<3K;V'OC(893;94=I^J[5?EGWS7DPK7+4\]IH54)P& 9Y
MUC2;U/W-8)Y* 1E)0TZIX#ES.IY;C#DW"NU,;A+Z:W-VW)F] -KP@<%"FPFP
MXTC/L(Y]T5NNO\&/IEWB[=.R/O^Q0@=D?#*:S;"3,I<##L\9RN6M P4C5ZOR
MAS[^O2\WC0J&)L,N93+@B(E,P(!G6K,^(U!O^&!,6"ZR. B"W$T<\L1@<^.>
MG:V5D9GBY9;6<KL"A#%=K>>X5SL)LQW1^ )O[-/LNVO0]6Q> *TDFB_ SO9%
MIY6C;?>8/N<"DE>QQE/C32O,:.'Y@0BCS7L&:W8]J]EJ?[RAJ^*;2>EL?U'I
MR_4E2F5*:,AA$J:Z/4^4P3P*$!1)R#@*<,:2P*%R:J 95M^CZ>NC.A/!@[+1
M6;/+:1[LN&@,6*<59NP7C"YV?]N;O_M=99(_O*IY#8'.LZJ7DPE3JWL-P><%
ME:]!CQEX)=$N>#?R<-RFNK_J28:O3RG>WIH#J/A9_Z)0^?<RS6F(:$RAS#*N
MCH)I @G/0RA0(N*,IC2.K%031K=T;ONWSE%]K<';+WU77]K(+#3>@LV^84&Q
M;A5DV!/EZ3:*]T9+*;K>?8SVP;"\'9G#=(^]X^S-]$OT#EI'^ZTIU$Q;:(P;
MEX'V&1BG?0J*C3TQ7N]B1C-VVMN:L3$_N,\9?4#?X<<=O3 1)CB7"8P#KH[^
M3.W,<4C4T9]G0<YY&*K#OY_HXU]A 7G8!2(?=H%(L0]$KH5E';O#!%P:?9PA
M49\,YX[*MO8P31.)?!W^LT?!/@YY(2,9"?&B>B@KLOIU4VX?%..MMEI*4?U6
MW[L4ZZW@;35*V3#D%6,;]<M><YVVX_@RBL.,B)! TPT<"4DA)@F#),:AS$0D
M,FF5X>/5JKGQ6K/O(8VY[BTC_<[8:99[M7D8.PC1^@2,4[KE6>L6Z/L%=HYU
M'=!:W_I]TQ:@=>\U9L^AU<1KS.)$!>23SJ9;LPK?J)]J:.%MK.F:7OB&YTEC
M#.\/=U]9^V5/.@]W27(18B0#F$1!JA,+!,Q%BF#$TRC':8:3,+%I0OW2PYW6
MN5?J/<W*$ZD\Y^$[OUI= LK(B\ZS&L?KRZ"PI_Y+()F(P5V@<2+@8[Z?X-&#
MMTQ&A\>,[;/:T=<,5,LHUN)&-E>/[PDS99E?A$YK4%SY2[G9E#_4#]=$S9MN
M2!['/$4YEY!(H26<L@AB3#F,4I['"!/)$Z=@N-OP<]O(_ZZ#0_=%K2MI*%GI
M>7%4Q7!#WRXB,1ZF(_.C-MPH6C0)"IWMNJ-Q:SW8F0\Z^SW*7@S"S:O:A9L%
MTXI<#$+G0-MBV%,&2UH4M3"Y=L^[_JH]854M,Q;2F.01S ,BU68,8TA#SF"0
M$,G41BVA<>S66_[<D"[?MFG:P1NSFL99^FO5!,6==2Q.XVS'6SZQ&W\GITQM
MTSA?:)=N[/6J3F&%C&=!BM-C3JU!887 "[(3=N_SE6-ET57W%R'+C=;O7%(2
M<Q%$"-* 8K6;2B-((AE#RI'@$B$41,3F,.C'G%D>'R_-M7*:#SN>F@[EL8.@
M+V9BG>L"_J9QZ&\F@70!J'%,RPZ/F:$U!.%Q$[:<+'KE_*TAZ)U/YQKTU"$A
MM$U5?R:;^D9^)H_]-K=M\K9(1!S(/-.=MSA$E"80<\9@*!)"N/I[G*:V=T[G
M!IO;"=38"[3!X$;J_GQ/NC"[1)?.@&P3>/,'W>C;MU.H#5#\/0N?2[#.'XR3
M!>\N@],QH&>'S\D WYE'3!CPLW/F:0#0\CT#RY'VK/Y6*#YGC;*\^GDEZJ9!
MC#HC;NKB_YK?'\U+6":Y)#EG&10Z=<F(?6 J(H@CA-)<HIR'>$ ]@2_[K+Y'
MTQ<:]'=?O.>?2=4A/<<<JY]\S:K=%GG229IFS>A/3-^G!=AY9>:H[]<"/$NX
M6CS-N/)8=>49<*\56KYLF[::RS.B!Y5?OI\_H/-6JV?27T.J91RF49Q$%**4
M4]W2%L&<18J\"28QBI#$F;#=3K\XPMSVT#ME']:W$KPA%2! @<X4RI9%!\=1
M/;]_OABKD0EP!],3 R_%Q:$+U*7X3+0;OKT3;66+OLMZ^IFZ)USHINJF_.5!
M[>$*5CRH+W3U=W![5U2@J,4]V&@ZJ+0N;O/Y*TI>,%T"LVG$]TN@3MO-(\I=
M*56S/^@^KN2;>/*&?5?3ZN^>ND*=FHU3W9U>?-]T79I.F?VDV]+)%[IS[544
MA'$C'*7FHCT5!BA#N4@9%#*.%=_J7KPBBB 269"'(4U89%7=?VR N3&M-K'3
M3U/_8,\=+Z)WGE(OQ61D1GT&QX"XPXNXV%/JI?A,Q*C..#DQV2D03A#9BV^;
MC,=.&=VGL9.O&UAIJ[7P?E$+"]<!7[&NS.Q?;39JRDRSV%\>]R]I%=ZO?I -
MOWDP)/J'J-2>5V]A?SX(IH_5I?[5S;:N:K6(:?G2;]\VYL3]07/ONBI8TX8Y
M0IQ@D4C(B=9CXCB!.4YB2!C.LY@Q@E#L5(G[6I[,C9>;[U;9> 6^&[>:"JO6
M,;V'T+]6Y]?.(ZV9U[CDTBC]U:&WK=K]*WPT1EZ>C(.0:@]!'P70@T%O9ONO
M:Z$ !@O=S<B@L0!_[#]3[WJ?J3_,9ZJ'R@+L< $[8'QU$)_-Y'JM#'XU9Z:M
M''[M.3NH+'YU@]R6[VI3+YMZ!O9X];.HEE+W:$H$@S*1 B*U=D(JU>$CC1"*
M1) G ;>*\SQ_\-P6M\XV\*>VSG)S?8#6Z67C$@Q&9G%;]ZU9])BO)TA-O:5'
M:.IOS\GLX)F3<,LQ3[JO^M%_GS!9[).H?R7JRZ^3;42U3U4*9!1&>@>,<A1!
M1$@.:9IBR&*2)2S.6<2D%[6NX3;.](9-BQ$3W2%[4Y 56)U*U!Q_&NUVHY//
MRISSSYXHQ"R ]G'WE]DDHYT!_]53TX[9-_]$M3/(>DE;.S?&T.909E"=NO%X
MJ[:)E6(AO1.\HI7IX+D,$IE$.**0YKJI9I9S2%B8PC21,LCC5(K,*;YQ;L"Y
M[=2ZID3&8-"W6&U>6IL=5:;/8FY'P#Z1')E4+P-Q0&\G.V3\=G,Z,^;$_9OL
M$#CLV&3YOF%L\P_!OZE#I!E%/_:N>&A5U0.>)0EB7&M*,8BXI(IF> P3FL=9
M$M \S)TZAAP=:6[\TAH*^I8.5*\_CJX=H7C!;&0F&0:7,X.<A<(G=1P?;%+.
M..OS<[(X_X;+NWY_*;[=U3?R]ZHID%I&C+ DR=7I,LD53^@<(,K489-S=;:D
M68X)<=J.G!AK;DSQV;/:W"F8[0C#$W@C4\8S&0=C*"PE5*8VM9%="^_^(>_*
M)JOUHH[>1P ;JW_W\^%>K5OW$;]/]>8^]I:!]$**C0E:5V_%IOBNIOB[.D\U
M2@E?[X2H/^IYU$K0C_L7F)0;M0'2'39^>6R9[ZVHBF]K\UJC4KB4:9*P/,8P
M8R)1[,1RF),PA"$F 1<9CT3BM(L9S]2YD9OVM+E2JT#/UP5HO07&7=#YN]!W
M?/O7@<[GMOF/<=%Q]S3BQ\*236<QV6.3\93S[,[/HT^!5WH?S]II5X?143]8
M7,8?T3T;\\-:9[.TJ;/%NB[?J\'*3;7/]EQ_J\L/;09ML;YY*,J";YH3^S_*
MZJ&HR:K=LE1J<_A6D/JN:R84)BR@*>>0299"%$D):81"F(4B"%#.68"0;5;G
MF(;.;5UZXJM.+RI!ZRWHNZOS1CJ'C8J\<1FV/H/G3IN]>^.V?5[EJ)^/TTO4
MG&9]Y 5J] D?D%$[ZLS;9^;.Y1,P48;O##X)3CG#4TS/B=SC48>?+(=Y"A#[
MN="3C#=0A5&HP[9HY6C7W\Q)O-.A??R-U-N-^N_SOD0\2KC$%+*,Q!"A%,.<
M:1DSQCGCL?K,I$[AN0$VS&T'T5I9J -/*5O!66=Y]4OFQ.[T.3+2(Z_:C?4+
ML+._B_;M7%B SHE16TI< *-7T<8!9DRKW#@<IP/YQ@L>-3!IKB_B_:FL7Y3O
MUGD:.F'C9OU/98!X6_Y8+U.<!CDB"10101#%:0YQC'*8RU"2, @#P; +/0XU
M9&X<>7U'-M^$Z:B[$?=J K>;)I-?[:VDCA@-J.88/$EV?#D%]".3YO,.!<J+
MH[T)3&/>-]J7OP&U&S;N0*[\\9C3=B&B7O/7AMHR;:[:A8@=Y*5=^KP!77YV
MX34UGGHZ635BKX:W!5_B6* X5GM)Q8RZ 3"3D.(L@&D6I&&.!4]19MV[Y_18
M<R/%SLA>X3[?1RM!?4=J<-^8[M#EY0S>Y^- 'E$<F]]VEAIN:\!LC&UW@SZ1
M<^AZXP_!J7K97(*D6V\:.VQ.=9PY\X3I^LC8N?*D.XSE6]QY]E>QN2?KSVJ?
M=:^F>%L7C*S^>:<\470O_J,LUO4?ZF.D!FFC@B2.&<LB#M,@T=H/,8:42@8#
M2D,>\41W&[;E7<>QY\;#C?G@J?U@YP P'H#6!7L^<9V1\\P\(LXC,[43Q ,"
MZ*Y8VW/YB)A/Q.TM]H/!=J+W@7"=H'O7)TY&_P-=[2\'0Q\Q+*KQ3Z'3K 2_
M^JYV^M_$IZU^YHTT!<-5KP3X%U(5;!F%,B19&D'*(J%U+U*(LPRK?3IB<<H2
M'-HUU1PT^MR6"&,4>%.L067L=6P'[X:\77QB-#Q'7@HZNT%K.&@LUZ>?QO:G
MR@S&?'\QB$&H^0P\N!DP:;1A$#;/0PS#'C*Q*- N/>BJJK;WC33"EZ+Z]_N-
MT+H'0IE:?R&U6)*$DEPF"60"QQ#A5'<6%AR&)(F0B$04Y$XD.+K%<R-.;2.4
MRDA]OVZL!!LML_+&3>)RNAFW(]]9S>/(A.U!D6>?% IZ?NM4_>K?0+L..M^!
M=GX&HCNN\S0+<1UKH_\:(CJN<^!-+,=YX)&6K^J,FL_[<B-%H<\'U8?U9Z/9
M^FSY??=3T6Q1B<^;@HEE3),@00&"2:*5/TD4:?D. 4.6THRG$4;,*M;^6@[,
M;7&[UNG$JY7B.WTRX.5J13:55L-M3@F^US;?'P=/2]TK3O(,5K[*5HRN!X/.
M(FR 6("#XU '!C!H3+@4CC2/DZZ,OGV8UT(YT@PYKYMCV>&N+7?S8ZUX_JYX
M,')I$<%AR"B%,LIUR(HBB#$BD&5Y$&=22A%9K6\'3Y[;PK,SSEE>[BE@IU>
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M,DI@$.@B1!$JYI !@2P*9<0DE3EGRP>C'?FU5EM'^T#L8)M<OC;/+1LWQK@
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M>/60R2S>>=.DB'<VO_K+B0\P6?UVE& \6GWR25@LYSXN1TZ+D&@VQ&::B83
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MGIA4P+J X)'/[P0"=0P@Z$.  X+@.@#[]G::9_.+J]0/O$4O>S%*)FJC0R#
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MXM7JNIP7NG2 I;;*5?NMU#3B^>^O[5G?HF\ /[=2NQM+:EC6N;BMSIE(9,3
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M'P4U?N2_SA$9E1GUI;6UEI9("!$W"^!$"Z5BC(PQT_"Q:_U.I=7@UJ]J^@Z
M#[/GOCPY^^>;=Z?_.NMQ<[WYS)J[Z".4][]=EBS;F\GLS\4UZ#*/'%QDQ&CG
MRLQ>A2;(:9*@#,M@&2U4I4S5XT3MW18'EN4SW\]GQ?"F%]]^QQ7Q=GJ*80;J
M;'I^$I=HDI=CN!%#"D*F8'%-!!U1#$:0H ##'!>89!Y Z2IIE>>3VLS&N1^6
M'G32J:NS)N;5(7-YO"QEK".9=3;<9*)\&6BL Q K01+NE,X.987A50V\W9 P
M+(YJJ_O!T-:=)-\$:NZ4DY;+6-,XGL"=JNB/L^<*TRL134HH!1'0&XA>$^N=
M(4DZ\"G2:$V5TLP:S SKVQT8R8.CH8DU\0KPV7&\4O+(:$&MST"H4))(7IKV
MB9R),^C5*OR'YSHGN;>(&-::#@^*^R>\N^JG@2CW1IAO9O.3BY(K_^\U(T&
M3"9'8H)%B2CA2<A*X]:!.PKC,BI1Y>SC48J&M7S-H:X?S34 P5]FL_3G>#(Y
MF:*TEGYZ/@X3.%DL4+07G_UX7E@<<0?6&VIPVTB>R!31D:'>$!I 6:FYX5"E
M>4H7XH9MY=,<,'O7Y\"7SV[D6(2_3F/]"LM/,V3O"VQ$?WW<N"K ^/C)3S_"
MQ>?9W,^_W>*:B2"%UHZH( 21%#1QGB=BC69 \54%W\O=]$O1L$U^FH'N@&IN
MI_SFX5GIJPT]:]%\]%]A,4H:N8#"%@-7LOB)N"0X 9&#IXIK6F?*22?JANW_
MTPR<ZVFT);1^04'/YM_>O7US^@$5/?^R:>'R\I.?GY=[#XP;+1-)W"4BI;#$
M4^.(M2I&X65RMA)0GR9LV-X\#6*T1STVX,U>R^E=67&OOY9^0S"263'& A!F
M2AXN"E.Z")66%)9;:1634&6RP59JAFV-TQP"]]=8 [#[Q8^G172GTS,_@=.\
MGFQ4G.[%2'"I%2_3:&2(1)8S"R>3)#*#<M;$#'5NIC]!T[#=:YJ#8%_::^*:
MP(KX4F") EP+]&I-@>3:.IW1ORA]A"EX7%->$&9+J\P4RHE:%2OX&$7#]I1I
M#H;]:*X)$#YT?:^%MFE*<BVQ"%F%4'JX@\0%%H(B+I?37,^\UPH$KK[#1#2/
MD3AP*YGF<%I)N4T<]CSD#24.XR^E;GTQ\EGA!J ,QFJ!$:FS)!ZH()$GA?N$
M#=(?:+S(+:I:FP+1#QB^B[E=]=)2#'V?IZMH;%QZM%OI>41.<J8HLI0L<4+P
MTM[:&\@F"E&E2NA)JEJ;W7 @K.VJEY:Q=A+C[!+WE/?^VVK0E $=(G.>\% :
M,Y4)ODY@R ]&*)&R\J;.W.WO4M;:J(8#86X?_0Q_9'.'F?'T;I#_;NS#>+)R
M2$9:!"IE$@B/O#+=FH00/7$NQ!"!92>[- E\QB-;FZS0*YYJBK^!/,O693*_
M1$M9<NE72R6II%VBG.3 ,RX51HF5:*>U"8E2'825!]HZMU#7VI"$PYFSO?34
MF$E[.WV'"^A\T\I^E38?T63!\A)320T$5U7 *!T2H8%ZR0P')_(.IFS+HUH;
M,%#=A.TK[B9-URK?<U]T&->/O'7&<(&.I4^.2!,=<=))E)H%J8VDGAXHS'R,
MQ-;:^Q_(B/6BL282=-TKB4>2HBN@N"+&!EA;:8?>)K%491\,=<KD&FCL3N*P
M$<*!B[(K:6YW"SG#-5 3D^OZG^V"%(G:0 'A@ZL/@W%T(T))8XH *3J&(3FK
M<K7E^:0V<RGT(%>I^M)9$SEA=%>O&JS'_W,YG@-RBZMM^:T,]5J>3%.I5ON\
M*CT#(0P&38SH[$(93)<(LL:(35Q$,"A57\56=B>QR:M8O<'E_E6L.IIK8@=_
MP-O9+"__1"V,O$\9M+=$NA+3"QE(P-V&&&695XFB1.5!0'A%49.7I@Z&N9WT
MTB;$7EPNQE-8+& ]^:>(=?-*&ID@A?&,$ZMB*@L(UX[%F$Q0?"$9W$?JW&I^
M#I%-.HH' V)?VFL#F_-9!$B+]9BUE027EW,XS5?=Q-Y.SR[#8IS&OAS;H*T_
MR7D\&2,!BU%DWJBD#%&1HL=C%7*+/!-KLM1)*NY8E<&3^Q ];-KZT-@]E'8;
M2 Q=K=,WL_EMME>YABWR'4F%09PT0)BEE$@?#?$9@!AOT%?Q,3)>96+>,^D<
M-L\]D*VMH<,FS&UW>8XLU2HS5_K*EXD'2>%W,7H"QF<6LJ(Q5\E>=B=QV/3Y
M@:%927/MYHO>C*=^&A\1)#-><@SPE"K%&U9;XAA8$I%S!L)RZN,!L?D$J<.Z
MJH?.%_6ELS;R1;=V@+-/L_GR(\PO7D%8CC252# MW0ELZ4ZPKNAU:/9]B@ID
MT+0*_!ZEJ,EL4&]@>,*IW%TO34#L WS>>!RG^1XK2D0;M<#56!I@) '$>TU)
MSBQJ$PV-M$J1_Z,4-9G\J06Q?O323MG@[27S=K&X1*%A$/9N-CV_9HQ1(V)&
M\\]$4D12+XG-9;A>]I%I1K4)59KZ?9^T)K,]AS!N/6BJ@;CX]EJZPX>E*CF;
M/$;UY=IT"HEXX0 ]D11LD#$K6]W$/1MGA\[,',+"[:R5-@W<34O;TWRO72ZD
M)'A2@3!ED#D)GC@E.9'*,^Z]Q."]SI%*)_*:3+4<PM#UI+$&C-UV\[T>8_#[
M-)4L4D1=C+_ R70]P.]%:;W\<G91;@BN=%W.-&\ZI*R:-)]^+B\L1CHSP4W(
M)-M0!FL$0VQTE%A/(\K)1YNKQQV]<S5L[%(#AIVV]"$PT<("N<FPWA;WK=;W
M(\W+>"VA,8J+*.& L@XF,$(=MU&Z()BM@_+ODC9L#'0(J/:KG8;\@VMG9]L@
MP9&SRE-J)>&X<>%&EA@)(N)R DI-,) 55#V+V4Y6D_GM:OY ?QIJ"':WENRM
MM;4Z3]HBR)&34F;+.%'>()=!NC)@FI,R9)I1=,.9J!(2/9/.8<O&!W14^]9A
M QMR=VF.C,M(/LTD*54F34=*7'2.J$P=AH8\>5FEW*([B<,VQ#DP,"MIKH$3
MP=<Y0URB9_,5'9#I.7Q JWPZ+<R6_XJ_\\5/RCK\ "C'<42;O:J"*I.H;__B
MUCM'&9BTQFE2CD;1+=*:6*HY ; VE/-26J>1705>ADU453M3'%KK#1CCO9A=
M]_M[>-MI$S7>%NM:U",K<G0L<Y)+TV"9*4=?OI19::V4,2%QJ#/L[:!L#IM6
MJ[9<&L9* UO(?F8#*8JZG/+IE"F1(AL2LBW-M:F@-D6>:15/I_ZV4"U<;!/G
MS]+DGK.(40+S90/@53%G%QS&QJR$RJF,S8@H<9NM3B[G*'V50X[ZX*T64C8*
MWN=HLI%!VB<IC8O6_.1*D*\G*\F6XNZSR\^?US_=O/QVFF?SB[6FKR1N/1<)
M_38"I=^[1#'@-A,\4<R;;"3GUE;I)=@'\<.&H-6 ?'"]-N"-WUV8+R_G10,C
M::T6@@*1P4AD0CF"T?-J^"I&U]P**JN8UZW4##U#ZM"@>%#%L*^&VLD5;W:#
M>WO R?*EG\^_H4^^'LFK=0S.>4\"C:7$<;V&@3C<$9@RTDI1)8W1B;JA9TL-
MC,;^-=A$D>HVT5U+]DIN03H:1,:]1064&W>K>C2%/\K@?;FWE:J<7'0A;NC)
M4@/#LG?]-; U7]T??._'J33NX0*RBBX1YJA 0Q_0Y%.9B$#2%:6>&EEEGN,]
M.@8>M-R[HA]T4MI=ZDV YGI<SQ4'/CGAM ]EQ*1;EW,')E$D-*C(C<J45TGT
M/"1EX,8R]:&SE^Q[0\_??WX@WW?XB]5+JU?*7WV _$/Y^ON'M]>??Q'_@,5B
M-F5<_(2LK#_];'P^'>=Q+%U(UGU><9M_/YN,8SF,O$/[8GR!$KZ+I0=] Y_^
MO)]OJ+Q/_^9C[V!B7XKAZQ*F"=*/>V8$'CSF&E!*1I:4L9NNI2R7QI&EM"A8
MEHWE-(4J;78>)VE?$_/"+\:+T_S^]O+%7?XIH7]$.;^8E!H7GC-W1AH2M%:X
M*I(B7C%%(O5!9:]Q651IW;P/T0,'H/U@Z[ZQ.I@6C]&LU3)OAS-S0YF[Y(.-
M&11QFGN"89XD5C!TXA-W40;0SE4Y;JUG[E[.I@O\R+0N4BX?_NUF(8"'K"G/
M1%"72VU+Q*T]1H(QKO.1*65#E2SN4T0U:ZZ>@XT'>8>^M-" C_YFO(A^LCZ>
M'EGKJ'?<$6<SQA?9X'<9/-'>.2NI3YY5\0]N$S%P3JL.8G:6<@,(>8]$S]>D
M?X X\8O%RM"O-'(]8ND5+.)\O+HB,3* X82.DF1F2XT=PZW9:2!9>,ZUU,JF
M*F[5<PD=.$U5!VE5M=4 &G]?W<!8+,<7JYY5"IT[JB$0+:DITST,P>7EB!;<
M&)IC5KG*18*[9 P\C[P.DO:0= ,XV7XV<'^S9N = Z6)*O&*U*5!$#5 (@O6
M)D&IEU4VO$[4#3P6O)+OU+M>F@7;@\*3K4R/LE%1:<T(B%AZX&/\ZE@*A**7
M@ Y"<*Y.G_A]B!YX&O@AH5E!BPT@]E<__P.699K,&<3+^>K6PH83E4V"' U1
MKMQ=0+I1A)82AMZI<\)A>%/EQ/MQD@:>_%T';3UIH $LK>_#_@K+3Z7"N;3'
MN[BU,*2DD4LG2/ EVK$EVDF)H_:I#2[R"+Z*A_8D50,/\JZ#J/[TT "H;HTI
MO>\<)!YHBL4)5>445*%SX$!*8A2U-LBD&:]R]OPX20,/Y*X#IYXTT "67N(C
MQ\LR\'ES5\]/WDY10I=E?=SGS0M<)CXX8AGP<MW9DZ!R("PY)ADS#BROXHX]
M@\BA)VM7\K]JJ:D%",Y6/4?FZTELX\4?:V;+=Z.D;%#,,F2 2R(]8R@S="*M
M$%(Z:1F/M?+VC]'4#6!'F+?O10D-X&F]0N#=S$]+6=MJ/NGBQF)?.9*.!JI1
M.KD,JE]5L7G*$W%42B%MX%)7RN=WH*X;QHXOT]^W8AI V]4<[V_WK;"6@7OE
M&-$JEDN*CA8K[(G@.08+22A5J9QK.T'=,'5L.?U>Q-\ C,Y@@B^=_P)3F/M)
M&3Z1+L;3\6)ED;_ ZZ^E_]86;Y."%D%&PIE&T3&IB+4> QDM9!3&40M5_/W=
MR.T&P6,[##B Z@:>5/Q/F*0\FY_Y*R-]PX65+-ER9< +0&OMRI&^@T2RI64X
MI-/!W$MA;!U0_/@3NF'F6%+]/4JS :/UZ.B[!Q%)3DD+G1'F)N">KBEQY3Z4
M-HYGX#$K466F9E<"NX'LV)+V5=33 .Q^F<W2G^-),;5O44W3\S%ZCR>+!2P7
M5R]=G3R4;$MP:=T[6.;@B8.<B98\6Q% 2:B"N\X4=@/>L>7OZRBH >3=YP8C
MFO$2WN$NGS8,L1 ]5<79% '7$WA. LV($9TSQM$*A*]2X/-=RKHA[=CR^OTJ
MI V$P7SJ)[\OKH=\;ACA4EJ38R0NZY61SL1FS4G*$!1+*4M3"UG;*>J&J&-+
M[?>C@($=]K?3Q>6\Y%K0!3B?^XL'P8=WRKJH C&Z1,="<N)8S(2C&T 59YXR
MV\%M_]YSNA6L'DLROG?)-F!O/L 7F%Y":2CZ<C9=R>9?X^6GEY>+Y>P"Y@^R
M*F SAJV\M.TPI>.R1@'23+Q/@H(M;9ZKG%@_C\QNL#NV%'U%50ULKE8W/L>W
MFL]O5M6#E(GS6C#<RU4"W,MY-L0F[0B/@JG,-8^4=;!:'1_7#47'DH2O)>=&
MH/,!M3/_\C#+ANY?2@ZC6@.J3$7E0*SFDD#@DE*OLK\_2NI)R#SRF&Y0.9;<
M>M]R;6";N[[R?9\/Z3$,<((1+PL?W&ETZ@P:36II5-)KK2IYU=L)ZH:D8TN1
M]R+^)F"T;CJQR>G?YT8I#F"3(K@V$I&2HK"H422HD*(2 &A JX5HCY+5#5+'
MDD&OH(H&@/5F-H?Q^73=-0SYP!!C@1(J4W5.IFGUXV2EL@>&6&20*1D@0B$P
M9)0)>92:^&2I0?EZ&JI@;F>*N\'QV'+MAU%@ TA]!?/Q%W_+>;QUO;<,'/5<
MH!. HI-&VQ43I/B+,3*79:B2;7^<I&Y8.[;T>D\J: !,9:[8'#ZA 4=FUD["
M(Q&)<H:##"2ITD&#^]*:)PIB5.194B.#J3(1MBN!W8!V;-GU*NII G:WFA2<
M78;%.(W]'*5VNAZE<^N&P,U;(;U&"=^ZBF*\%UGX0+*S@"X&0\E:B"1Y2:66
M3/@Z%82]4-\-L,>6O#^\8AM \_8QC>N9C*L3V$VR9S6X<<-B9#JX["VQ91*/
M+#TYG%3E?,QYF8T)3-,:V-V!UFZM"([E#.%02FL EV5DWGAYU5VTI*Q1B.@<
MCQ^Z+5%JXSDS"!=F<<5Q3G!#P> -J%;2A6!3%3AV)[$;"H_M2*&2BIH WP)Y
M6BQF<5PL?#DH>?UUO#R=OQHO/L\6?G(SD>QTOKK'?!F7EW-D_P'G+DC%&:/$
M&E$&EGE#7)E:9F401DH17*ASZZDW%KJ!]UA.,@96<0/@?G&Y&$]A48:2AO'T
M=EIA%)-2SHE,N!'EU,\$# "1$X[^N4V<19>JW%!_G*1NX#N6LY&>5=  F'Z#
M/V_):#Z;XK<1;EV/?I"SUUEP+2/)W)22T:1)$,Z0X#UW$(5UJ4J:Y[F$=@/>
ML1VE5%77,?8 _;BZAGV7@_T[@&X^M7K_SVW4U^_^Z0VD:)DC$,N-SJ QDO"N
MW%376H"3PK(Z0XVJ=?\\BY\@74[@-&^>L?AMMH3%U5W#ZT&T-]<-;R5-;9*!
MADBBDZF4;&EBH_0D6A$S<X$YJ.+@[4%SL[U#GX.L!S'Q@738P*;[Z-6,&XX"
ML\:"X01RYAAP@2VM,!DQPI6624%06@65WR>MV3:D^X"O9XT<XT[Z"I9^/.E]
M*[WZV.I[Z5;ZZV^F41D69"B''^7"NC% ' ^)*)#9.G3TJ*Q20E1O,WW"QSR=
MOUQ-XWT[O?V.,=IE1,G*F1F)E"6%,ITWE6Y*TEL28K#%V>7>0XP"JEQ\WXOJ
M9C?4YZ#K&;%"SWIL8$M]T,'DQ;>/^*<G7\>+D0\TJ>R Y @4-P;KB%<ID Q
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M&F,^*DJS?",-"4(X DE(+P)E+-2Y,=X+^=W _A<]#!H  ?L>B'^\!_^___Q
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MF:(LA?U<EH$/*I1JU&2)Y"F:8 T+NDH7@^XDMC!4N0["M@_J[EUMO44IPQC
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M 4H74Y32AM $3+LN<"=X-9L4=80=KXFD>D3@K1PPH5U1.B%PRR,HAKJ>V1A
MSJ.*Q$W6ILG:$VN:UHRU <%S2-M3(A/G7+Y%XNE&,LOR51W_/Z]"$1,3K_.
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M%_%LGE[31K":+][/LB@4(1D-FB6LK=PB1(ZA&GU.X9CPMC0!XLXK[+RGYCA
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M1L4S"&UK&C(90Q^19&)%$:'(['#ZXY9>R@QZA-XAAS-[XF#JUEVX^A@6__I
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MHM 8F59-L@CNK:.CVZM1!/U5E+0_USL S5746!N ;RG B$)*2UZ]JTT&6&9
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MT0_3?PGSU3_#V<7E[/I+$[ L=Q4_/*3X38_6#U[5D0[:Q^7>,8[=>4:>LN=
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MO5R'LR-?Y5XY>LOR+YR__T ,>?495^$]WAIU_A?]S7KY\_EZ_I$X]DN8K^I
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MG]0Y*?5SA=Z7[W.'F_W<Q+8JHPY%J(/)Y[4;\?5BM::P414K30T',,JZC="
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MW*$/CLVZMKEW^'M+1_?3GSC[ W]?S-=?5I.DC,I**D**)#Z9UW5C:H1B@Z9
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M!B+;J/%%WK770EF4UYLAUJOI?/T%7X?E\OMT_GF;Y5G<'.'3ASRWH*+]33Z
M=$:Y^&-*0GIOP 2GZT8\0NPFXX]%IA)$M+&)]1G[XJ^'=Q)SYHSQ $P$2:YX
M0O#%!-"Z/K(&AKXTF3GP"#TOZ<(_!C<'7/A'JZ.'RYYTLUE!]M,5G78R&!_Q
M\R:%^NJOZ6J"*H@DM89L-3$CBZ>KP#*0F)$Y*7AA3<:@/4G5N @;1._[6!I,
M"3T@:DO[SXNO83J?Q.)8BL:",'7"2QU[%<BE(+$$FZHK''(;ZW27BI$1,YQV
M]W%SLJA'+A'^Y\?W7\+R:TAXM9ZF,-LQ\CM^C;@D1I)RLBY+EW6%7$D"7)U)
M4#@6ZUC@41Y2(/'D1T:&Q.F*6[20XLAPV.QXFV^DO\^%3$&98B6PK&)=7HIU
MH+@ [M%$[K6+Y9#2S<>_,&XX. P0!I+?R"CX'?,&Q5?+SYO_7\RN*D>K^PPY
MZ[@H!&M66 #E3"*&#()DJ8A0LO V'@"(@SXV;G?),-@87JHCP^0]J2$MI]\J
M%Y\P?9DO9HO/WQ_A"[FQ3-0)AHFYZN$G")@8I*A#\AH]\X=<)<=\<]Q9&L.
MIIF,._!/K]WV-^2+_4:.V6KB5<X92ZJ+0Q.HS#V$NOPQ>[I 64[2MEE)_P,E
M(]]%#2*;\X3=$5H^+&:S7Q?+/\,R3TRPPJ:,$'1$4!@+Q$1W:N0I:<:+(\^]
M)5[NT-)'MN5$[3Z"E5-%W1%:)@85+YHL;1+"@]*&#*]&LHF<"U<P>!)32XCT
M@8N3-?D(,HX2Z\EP^(;+Z2)3U+Y<#PJ*5^G_KJ9$Q,]7R^G\\_O-5R;DA%O+
MI8+HXV;BF0%GB:-<Z;%&:V::9-B>(JJ/%[*AP7.V^#NR+^^OENE+6.&KM*E2
MKH\S^7^N5NOM'FM=++>"DPL?JK3(YD(4]92(6#L?-E4S+3'U)'7CQE2MP#6<
M0DY&V1^XC(N!<?9N_067O\W3LE:$_HS;_Y]P[JQWEHX*JTO>DK?$6/ @DI#(
M>9!:-ID:\B15XX9=K7!UO@(ZLEJ_??T6ILMZ)-XL5JM)IB [>\<AQ_KZ%E@!
MHAR!Z>QK^"V-:UJN=9^<<8</ML+/&2(_MW]E4.B03'#Z>?[ZBJB8I^^?EF&^
MFFVT\X\PG6]XBR:HB$Z"U9NM J[NKC (G!FG0BPANZ9% ,^3..X\P580&U@U
M7=U_DQ"XTBE8R,[5!)>F>);[ *(HP75F)*@F<RJ/BN.:S0%L%L<=(]8SX[A?
MYG<MT25KS7ZTP;_-OUVM5ZVJRI[[7OOZL:,X'J52K%! %RFL@XBU@9/3_X0H
MR'WBA4G,EM#]\KMC'DOD,B-%<<@AJ%*K2>LXS2PY&,-4##G$E%T+YO\&E6+'
MX.;02K%CU-&!%_]T&8NGF]Q:7Q._OB[^CH$L.BJPR=2!B&3O99,6JQ=8*7:4
MWH^J%#M&"3T@ZMY;I28-%^\9("NV^@0&HC>E-FL3-]E29-O$-+^82K&CM/MD
MI=@QHNZW-(@KGX7E'EA-J&VFNSAAR$1;)@QW06AQR-O^F:5!%ZH1.TIEAY4&
M'2._+J*R#_AML:RYU7_.I^O-D4C>"51%0+*LCJ.W GP2!6Q4*O(0@O!-4D@_
M4-+GR_TY-\UYPN[@=KG'P.X448R:4O:"]*EJXI1D061+B%&5H(,,!IM4(S]
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M.ZZ_+')9+'^EW_XKS*[P9Z0O?9UNDU0_[P:O?@AK)#;KG)Q2'UP\>6Z6PM%
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M2!XFIX]QDBV\D),$W@%L]BN17Z5T]?5J5D=5[D_)5-G&N-DSKDE6%,!!M$&
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MW4GL77&U0MEM8BVPS(ILB]/<-.E3.J&7NTV)W^0;,]CLD]^HX-8*N//)<.9
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MKX=2;%TW<<E*\!R(-S)4KB348 (29>3<^F"-;?)R?""]W2+R$-0\A<E&*NP
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MHG<_O)[A(^(I]7BN+O;5[&N^"$'R&.OXK*@#*"8+!&L36"&<5RF)?'^JV'2
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MS"OSCSD.QU=5E_A[^@'E]?PE7L8ZKV@V_WCG#67[ ;4 Y+9\)4DZ'Z0"6V(
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MH*)% \#HTIF@C-_I'+AAJ48O#%3A CS%,!!S1..U3EHVJ5KOMHP_.98I-??
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MPXF>VAN>!IT/G=^)U'PN7G%SPHSB&[>?U,1#[J*R S\I*#?WMG"(PA$@<M&
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ML)1[&)TQ9!;!@2R>)LG:$E)E.NE0 EO)_CHRZ/934%/ Z_?-G<XM)%)G0\C
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M83Z/RFDM2FM\%LNC=TK@K;/@-8D\B$2=JE(,-HR\1FJMFP3D@<IL **WI/G
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MW6@433M1N088IU%6"P?QC]OP)(3E94G"Z[[-5CT[1E(3K8* UANWG2%@J<N
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MB@(:@%+??[EPL8FSRUU=MRA;<;/;C. Q! >>QP3"9/10K2\E9X%%0I,G2M9
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M-=#UT[JVS!6N-C[L.?=4"J703B>ND"=;BCN,0??2>QL=QCUUK-L0XMJZKJ\
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M*0EXH#,70[FW*^_!UH%BI0%6()F1*B]6AU8:3>%7[PF '8J.=M%&([>H ^M
MC<7#6@11,BO1>RR=J[Q*&FV_+5U,@\RTRM/\J$6Z4YBT"J ;2T\-F+:A!2N&
M16X8!B]$& LBX7^<5Q%(TB0Y:J7D56ZFQJPEJI8-5QU]-;0T>:;M75&=?/VZ
M[/Z:?4$QON[F\ZM$\VTFUOK"K7]SW_\SK5^E]U>_$G]?H&+7%UN!K#[@[_W2
M+?]TRW@NHG8F&HGA-AX (G "5MH(Z,$8:HVD0KD!X4)=*J>M-J^&V\;4VZR=
M'52=2HF*Q#)>9E_BI@Z)@L^>@/:(51F,8_R(99RCE1>/[H"V!KKQZI-W0<#>
M6/^:EK,N?ER[Y?IXG4""Y-P&FT#;,CR140,FNP11,8PSK?=65<IE&:D3R.@>
M;>,H'EVKN^/5;O"Z2)_+P36U=291FRRT BVS*3F.#GD- 63,47.;.?55<E@J
M6^?1?>7&<7TD!!QHG7]>W,;[\?)>GLG&[$KN3YU<F%U6KIT?L[<4CI,SDUS.
M/"CTS&6IPG7.@#,F _?:&,D#I:S.8VSMG)GMT).GY']U<1TR12'@25/*)(3B
M)2&X7&&+S!TSC)-<I;'8+D0VG4NS"X:>&$\SKJ::"-^>FI&JE$5^=(#0,T.#
M!Q^E@RB$\3'H&&*E;+5#AQ+7? 6H!(:=9A7OHID&8/;8S"@\+%V6Z&"4SGS:
M8_AGI0<IM$L^2Z+]_\PJWEG; V<5#Q=] _BI/!>RY"R1TFD^)B] R(#2$$F5
MX2S<*^<IH?^NPT&//CMY!]P==SCH+B!H:TO\4,>PG9!W@"08BRZ6:=2.:@XB
M$U9F^3'0+/B0/=&6UAZ:.#)+;<Y^'F4K3*G\YK;!EO]?4 >G;G7QR[S[LR_L
M.40BCG.-OIH%9K4OPR,D>(H"TIZKP),4MLX3<7W6VAP?/=:VF!P,TR>>#AVK
M^GXYZY8?T_+;+"2WN"V\IT2U?N9 #=EF1SPDSLK\'HJB<DE 8LJIC&ZKR4.:
M2DW,1IO3IG??(PV(<B=$O)#-<_*E2.%?/2"Z?!+6EVXY<_,BJ-LB+(](*,8^
MDWU6?O;,SV>?^]\Z0)XZL%)5+8%++D$8%L!Q9\!HDV(4.FI'1MQA4_+:YLSK
MNMOPQ6"KZ;VZ5ZSXC' \SSG0TO111/0"/"^EF41#\-E(PN3]I-4]-EX%PJ?M
MCW_,732UUML*C9XT,P=XPR1$K1,7P$K$*"1'W247\'R7-">6I0^J<FA4B;5I
MF_A7#8U: $-;VV/KVOX0)5Y+XDFFDV5)<$$AZ#+-V^L(1@D"%L_(J(T3C-1^
MF=V?^FE'$50%^9%4VA:.GWJ1?'N=^&QUX3!Y,*P??1L%&*$<F&BBHS9Q8ZN\
MZNY*Z.25-\=YZ*VJOP;P>4C+1:65<R)[T%3A5BS]:,N4+4B):9ZE9"*R&E"M
MWC9S8M3N":81FVGNHMD&0'R7D7*G/$#6F_"C%-'-NGC-N]3!!:LY!&HURIQ&
M\#YPH)Y22HBU6E=Y7QN3B1=AG,>!^62Z;R*%?%##4AFDL)YJT#DA5U8F<,(E
M"();[[UTZ#\=VT[OA-2:)91M&.2]=+6_Y>W6;EX5?W<N>&[U>-RZ_B?+V0J]
M^]>7RQ+.]MNP/WFH#=KA><.R\V7B@@1T\2U"RSB63#+\[BR+NEC=EY')2RRG
MQ_51,-" ]_&4A!^2P:97TLG5F\!&(G=/L5N=4,MY=G;ZYD-R\U()\CO&XQ_=
M/)TMW\XP1(_]CQ>I14<2BR$#<3&BSX9!NE-9@W)<DI2-#[I*OF8;[$_[ M7$
M?FL8;X?Z2I^FC'<+LSZ6X0)>@>4R@$BEVHH(5%JR6AHM#)%'[\3_.+G3/B0U
MLQE&TF<[X'TPUNG"[(=@IA^&$:+/CEL0+#$066KPI966=LQ;[8V)LLHEXE "
MIWV_F3X^/51GC7L]/USK7SM[&1>_*XW"N$M2:1L<!%/FQVI1.@#BKK211*D(
MQMRV2H^IT3B8]J&F&7-;3^OM6."G^']?OM$[6OU/O>]6ZV4_OK:X5;??<V]]
M_08_J?O6_P0*Y>><4UB?,Y6"BXR"IC$52R# 4A7 $9^YH(8:5L5Z'X.Y:6=C
M-[-7)L'*R]A&M_/J[H<E@P6WF2!R-Q/O%%F>K?OCEG/-J/<@59D!*R@>MS$H
M(,:9,B'8^E"E!\STK$\\-;R9/=@@T*;ND_Z(M&Y='* 1<F%]MK@23R^!_L[.
ME\0034$1)D HA5QR'R!P+7),G-)PY\QZN(OZWA1,/-[\**@^HHY>X)BDTWZZ
M]VJV&* +?RNSJ4H'F0.)J=U49DQ9':?/C#*14I4].%,J'RG-8,K%(TE1YKXA
M79TF*W7[S&PU<K;I/O6J-)LJTD;Y7]FN95%4.7-6K[[?_,Q[][VO02@=J#9)
M3IDKYZ)QX+.-(%QIG1D41E94IAQMYEY72<89C8.I6SR,AKY[O4(FT7$#5T1/
MM\W@+"D3. (J8_@BBG Q6@E@.1.">&GP8*RSH9MM7S,14G;J;;.+VAK X,-I
MS#910D,FX#!$!L$=!^N-!1*UB-0JJNHT+7MQO6UVTO:@WC:[B+X!_%1N:Y)9
MED&1!$P3W*<<G7/'109M'$TF2Y1^[0*%_R:];7;"W7%[V^P"@K:VQ-CM33(&
MO=8F!BYD/*R<4&"544"E(YPZC)1CE4NY_UZ];4;:"E,JO[EM4*>=2<I4N9C!
M;^;H*06.J 0QHCRDM\;Z([1Z^N_2VV:\;3$Y&)H8,K5#/Y/?%VYS&7]3&KAM
M=.""4L$(B*QDY"L;P.72UL<GF8V1*M29'SP&\2TVIQD)Y,=1:%M6_K'[T>W^
M%"I9$PVDR#@(IB-XA5\Q;2/AN'&9K8W4IRELL4G+2' <435-F,YGKW\>N_VY
M>5]**%"5B0+A2\/,P"S8,@%:"ZDSB]S*.I'EX:1// JWC3NXXP*@!4-[=OKF
M1V_H?:^O;674AULC-WB0)J2RE06:#I&"05?(>(A<T8S^D!?45S&UPVEL8.3W
M$>%SUS)7TF4#,+W_3K2/2W^.0B0NH1=D="EQ(D& )<R!H9%&*;02I-Y@RX/)
MG[B*OA:Z'AK.<UQ5-S-&[9#F 1B46B5,*=_CZ-/9A!Z^%PKP[.,^,F4BR8W4
MRC12+W\D0!]+J0V8Z7&[ C!F/,GE?IZ6UEG"@\5@%9+6CJ O9VBN4EEY](X0
M]>KLCX3PR=3^,E*KKUG3E%G+;0;"RK.N-!2L,QQ4"HHQ9IG25=R/T3I"U*N<
M;\ 6[Z6FAIM!W.9I%\])4<9=Q@!:.H[RQ9,'?& ,6 R$&F(#=T=/T=^#CXE+
MTQL"="WE-W%GM[< -OHX)Y)XY8,%Q5.Y+LH&?-88-G@E@[:*T!B;0ON&[HEK
MS5M']Q[*;<"2CQ3Z>D(E\L8AJS(:5W )EB8+G&5IG'/&BBJ0/N(M1[TB]9=U
MR[&+JAL>1_PA]8$"BGK]_96;NT5(JVWW_DT?E7T*189\ZA@5'SM3/U+IQNUU
M;R]VG3X?41;"LP1*E>;3@@FPAN=2["25H9)C3%4G@GZ:L,.O&1[^_->S59AW
MJ\ME^H0B?H6_\L>YI\R$4G@E30SHT 2%1T!*0#1G7&H;+*WBS>Y X[3WNJ.B
MZ/[-0!U--5HG-\ 2[%_WML.''\FJU:Q+>Q:6-/EL7508EFM:+O@5.$H\A.BL
M=3G1Z"LUVZEKW&Y>PA];Z=7W'_ZE?_6VQ&5GT1$(/(1-N;/+I9]EY%0S'ZB7
M589.[$5MXP9O%V0]7G562WL-7/-?F8./%RFMWW97K>Q*W4K*G&1B&!"IT"/6
M,H 3,@-1*CD:G="F2D^AQPAJI:ZL&A:Z"HII%&!7J6OE I9:(X%$DT!PY<%)
M(<$DQZ-V-,1\-(BU4$@VCLH'X&@/^3> I,T-TN:AZ>W,^=E\MIZE;5:L5-XZ
M9@P$S529SH.6WF($GRPA6:*]E[1BB^Y'J&H/3_NH_L&;O#'TT "HAIGS?A=J
M7R9 !0G.$0<B^P0^9 FY5-=(K9'M*OF@PTEL)>_S6&=D)>4U!LNK+:MI=L)G
M7L:58^P>>!EA3@CHY*G-F0F3JE1<WR>E39__4*4_@:T]-#!Q'ZI3-Y_E;KF8
MN5^ZR\6FY?25@6:,6%]Z]A*)^A8"O_(4K71*$:USYD&J(7VF'E^A'7CLH[=N
M="%.#(7?PC_Z&Z%[/&B1E":N#":R90)N:4H@- H(+;)2Q":6V0 @//;YTQY&
M(\)@% $V<*9L2HW3MJ2'1F]DC!ER]&5."M?(!Y/HJ'&MM7)2Z2K1UX]D3)M5
M-Q)*1I!P _BX[F/RZG(U6R#D/Z;/7Z[[F&3O$-": 5.EN;8LM>46)90\(80Q
MKK*H<ROY%%73HN?X#N]X*FH!;QO:K_:=2Y)ES4IY#$%C&F("EQ0!)1W-W(44
M7)6<]Q^H:*21T.':O8N;O44]L?/R^T\??WI_X99?D*K+]2R4&XWX\6L*,S=?
M?__8S2_[?79E<"U-+I.DD)TRV38P!S[R!%0([Y+ G2?] (]FIT4GALS^BNV.
M(>4&S,PCMOGM=9U>I,Q)I+KPHT!P:L!0'?#4SMRK%#,Q55*YGR-LVC3N9FYS
M]E-4 \ ["0$CAO7JO?M>9'.+O5E:7=V?GBQB20?;_.6<.:>,"A*",QD$+>V%
M&7=@&$V,"QN3JW+%LS.E[83XAP/E?D^$BEIK ):/2._D2\_V6;[UO7.A'<.X
M1:"3(2/@WR0X;@S8I)@W&!;).J/4=Z"QG6N&T:%82U--)/M_2-_2XC*5^K(?
M]]BYXE$;'1P0@B>'<%F!4<F#ML&;@'PX6ZE8\!&*VKFCJ "Q,;30: K?-GSJ
M\C:@VB-5[X$/&:6U_#.TC=42?K/,A_2U9*(O/E\G1F5'L@K.0Q#>@(A>@I54
M0DQ"4L6]1]14#+?O$3329<+UYSZ4E4J-CXQ@I")T+!GV/O0M!$"703_".%ZI
M9_$ VIJ((@]#R2-W#J-I9,13J[:9Z6.A<8S-U4?5,3D/T5G;\##.G*(:?602
M+0A)"'Z% :-S+&J1\*RJU+>EEN&YZ79U9X4WB]PMO_1Z>O7]ZA]OH"]CTI%(
M![B/$/J*6C"!X]&=B*:9J)QDG<JN_>AMU$#M@J8GIDI4TUPCKG; :'4VG_4<
MG>63U2JM^]:J6]ZZTVZQZN9E-G7II'!=QF%H<)1%D$I1$%9:<$0J"(Q)9C1S
MHD[Y^+X$3YS_5 .D1]'=B_'?W[GE$C_U6SI@Y-3S'UKGL'V:]MK'KO>42FLP
M*C0N@O#)8+AH(GBI8@HJI5"GMVHCQVY_.2VBR%J@HZE)>8]W(8/G2D/PCDO"
MHG.V3D//W6EM]+C=!44''K<[:ZR!J]6G'W Y-YD3)2!PBQ&/Q;#*\LR!!*:Y
M4YS92B'WP1D4QQC75 <3.^5/[**@%M#VP]MO+,-0R\2'["*&ZL91,#HH8#*7
MHM\D,ZEIX-O/G]A)NT_F3^PBZHGS)_KN$HM> VY^Q<75,W[*T1CF+5@?6'DQ
M<& %UZ6HR*:@+>=Y2++$XRLT<8;MH[)N=/E-G47S\<?LCA\98=(S%$Y?_./Q
M4"<8*:A<]KKF@6=C,*(=DC7SU")-1&8'8F$\*4Z=$9YB3__E\G/_YS:_YPZ^
MC;?*^C)) !T^(2,M;=@)V,0C55*4#(\AZ>%#%ILXCW,4>(POU8EA\A[5$):S
MKX6+3RE<++IY]_G[(WPI0WV6*8%,68#(5('WPO0M%[6,07'%!Z!EES4GSH\:
M!3359-R ?[I#H5:0TCLK.5""_Q'HV8-#DL#DZ"VE)O'T/Z651XR3*JFN,5!>
M[5T5LTI,"TB6X<FMO 0?> 2:; S44Y]R];92+81/M93^?&'E+AIH $.GW1)W
M'S+Q?[O98OU/%.WE<EOSHP2W5D@*EA56RKP/;UV&F&CVR1&=>)4P_ F:VD'5
M/NKNZLA^0ABMENM;!GW3,?*WM+[HXLTPT/O?3>F=^Y+ZW1>-R#EP#T8Q] -$
MR?6C)(%Q66;E>!1L2((<TG$+7_BWN]@ZE-!6JK/JGIE'5>?$L'V,CZN-[165
MBD2,9G+Q@LN)X 1!&3)IB0I""S_DAGL0,)\F91J;=UPH=%7T,G7C@HLR8.OO
MR<W7%P&%_?;MZ=UO75E[SHQ&ZYY!9XRVA-(!K%(<K+5)<\=3M'<2:![N8S!T
MP>D@-:9VN]JB;L _NS;TOR]FZTT#+1,-=>@9>(>T"Z4<V$ L<&)B\,E2YRMU
MS[U#22LU7<<*(P]11&M(NMIN5' N/>$092CI7PG]S4PB!"*MMI'Q'.MCJ8UX
M\2#M/H65/40]\;GU(?WEYO.-Y=Q>]49#-!I?D")9/,QUZ;.,(F%.Z&!+2Z*<
M!QQ0]S^Y(;7OHZAN-*DU8"&V3\TG 0_IU>RZ9:-4FB2>'>0<,V!@ZL%Z;X D
M'QQ-,F02:EB)1^B9=H+.L<^=,932*+;*E\NT=?V,SM077\\Y5D;!&UJ$Y"%3
MDV@4P;,Z+0F?I6SBQI=CZ'\ IO971GNGE;0^J.0Q=G"Z5#%' 49$"2HPFC5+
MQ##S D^KD=7V]-FUBPPGOLDY+37$:?FU7,M>7S\$KC67AH.+L8RM+B-*$]<0
MN2&6*B5)&M)#=]#]S4,$3#L)ZY@7A@>+?V+XH&@NE^'"K=+)9]Q*12!W6=I>
M]E-OA*89N"J7\BQ%\ HY,RD[FV-,C(]V63V8JNGN<@Y7?%=;"Q.?39\N9LO-
M<]''-)^G99<?L+1H2[-W)D)296@7)1HLL090D#+10$RZVRWLP=-JR%K38:62
M>KN*LI[Z66V; ?QKZCXOW=>+DHFU<?VH$(XE#RP$#"LC5V!%T&4$MTF<>*&(
M'\L,/4K%M//PCOH@-HHBID;31A*W6;C:;TDE0S2ED!+M[SLD6%>F6QN6*2%>
M.3;DE7\8FAZC8L(WKG&TVXTMZ@GQTC>-6GX_/STYIR&:+"T#$GQYQ),,#"=X
MKAOA?# \2?5 A?MJBXY5"C]][K[][>H3-P"Y^LM=?-RL.B$8QE%==Y <IWX7
MOUQV7[>O99$[;C(&@(PA[T(D"B8("M1H*8W2EKCQ7L%O+3Q-BN+X$#A(H U<
MVWU(Z]FR-X_OYV[Q\6LISUZ^O3W/QX=,1.(1')49K:0J50.10!9.FTRXMJS*
MY?"SE V"D'GI#DH=1;6.O&U_\ZB%CDJ RB27'2G 2%HZ\ B?O=6^TIRD ;1-
M_:XU*AIVP=H>JFD ;4AU6JUGH3"T[7A/4Y8!C73,4>)N1%D9Q3($$I 12S*M
M,Z/F/BD-8VD?;7>CBKX!/_GWC^=44:?*4W'I 0;"QPBEO 6BL5[1D(T)#W1\
M/\A/_OWCM+@X5&_=04)LP&;\N#$^X6]M\AY==(%&#<J6O$<=/!@G!"1:TK:Y
M0'>Q2M;\P^0,PHC]]_2"]E))D\"Z,K,D,)M,<L -97AHXU?.,89_Q;T2HHC4
M#[GX&P%:[3DY^RG[6?SL(?D&$/0^+5:HA<+$ZG7*LT6*K]("O]B67QH=,.QT
M&G1?="F,!>\4FFO.,B,A$,^J3"AYCK#6$+6/^KN*NICX;NCM;#W[W*OCM+SD
M].]]46MA& 6B+&XW8@F&%,("YSSF0#1584COQT$W1/>7'X87\M+/MQ%DWQ1R
M;FTM+PG:9&6AS",KY=\H#J0;O E>XZ;S28^6I_$8$=-=.!^JU$?QL:>$)WXO
M?W?5G>9V*X&SKS.W3C?<75E-K[UG>*:CBDLCRD0,B@GMLI"!99YQ&ZDA+3V&
MK]@*2/;5;%==S!.#YY=N^>G/KL\JF*75F\4R[< G)2[H*!U(%]*5*$6YH4?[
M;%/TB9LA/3\.H6&Z-X_1 78T54P,N8\7*-N+;HZJ>9V6LV]]3]23<(L9*6S)
MU%40*,/]DW'_H 09!,EB$M;J>P]H#^+JV86FJ4^N IYQA3IY;NJVH3&2W\\X
MV>06&,$R6E.P.BOD('JPD3B(V0NNF3)$#GDU&YB=^A )PXZS%]\M<R0=-(>B
M[9LT%X&3,CZ3A3*V60EP1*"ME#Q[HIU2;DC1Q)XXFMI['D.Q3^)D#RDW</MS
M]C65[MR+S]N>H=MAET[)\C_P?6:E\0J,S@&M:.(^48D\5KF9?H2>EG"SCZ*[
M\:7> 'BNF]*\ZQ8_MFS+46F=7(+L603<8N6>RDG@S,=L. ^<59GR\2A%TSG,
M50 TCN0;@-#KV>IKMW+S7Y?=Y=?3N5NM9GEV*_<@**L<H0:H-*4LUF>TSRR!
M]S%$DG5VHLKE\S-T#;-'_S9]\<;44MN@N]J;-N6@<TQ 1,0=:20#IVR$8&5T
M+"6#/L.18=?",]JH.!B.L3V4TAK*-G])\2SCMG1SM-OK,ABN6^"FO<1O;QR"
MFV'CI S.X24?PKK2W*9(,N=RQ1$H)\:Y;%5U .Y(=+/8W <_3Z&SIC(; .Z;
M1>B^I)NI F[N%B%]O$BI3( ^B7&VN9^[F6RX>O7]!P&M\"/FE_%J^N%]N?3&
MP@F5RVP"4+HTTV2EDY-&=1@BI%0N,N6K%/$?A[UAF^'%=P%L&#,-[*2=&+Q5
MURAHM(EE#5%2 B(IM%2EH1 UQBC)M!:*5;?^P^F=UO"W"+VG3H]*.)CX>>/7
MA$9E\1\7^(G(:-KVG[CNI$<=4\I#TLJA:?$8E4:G(&?!8\Y,TCCD:>/)11IR
M/VJIN*LA[P;LY-MNM3KMQ?0Y+<*L;-!WKG0X/LLWW]ZTX.;!"<*4!15[#XII
M,,D[4*45I-/>4U>E#=UP$H?A\-^FV6$EW36'RBNNM@^63C/+M8$D5>F>DS#(
M5:HX]QA7*!U3BE5.Z"=HFM;^U8+!DVC;7R<O)WE)9Y>(] :LBLB5M0*<XPR\
M8]P)EDWP<L#1V7KRTN@*WB^':1=I3XVA].=_=LL_D)%N%C^YOS[V35.6G[?E
MPSH)[A*-$'1)1-:XS7QI44 $,=DXBV[KD$;1SRPS[8"8*F@94:X-G&)/> %O
MT67L7Z3.K8F1E=&0Z(7J4FH>P!+BP$4TU0(QD7F5Z\8AQ VS1_\V33Q'UU<#
M&'QW67;.6=XP542T??@^SSIS21U%3LK\0"Y+[^2$875PDEF;E.!5_/G'26IB
M?N>(ZN^JZ*(A5/6YH\L^>?0_+F;AXF<\#];?-]%V6IW': B&O0$4D^5%G%$P
M4J.]CDSEF#7'4Z$FPIXFKXD)H?71-J*.IG:[KCC:.I6OEFX1[PS!?+_LXF7
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M "MML)5#VWIW$M*]%R&//F01)]D^AEOWT.+,<'AUQM]S=LD:<7L5AH_T0I%
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MHW15*/[XLZYO[Z_+Q64Q6'RU4!1[>:-T@A3)0K285; <HDS'MW^ G/.Q[W1
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MAF]HA[9SDM=G%_\X/]EPYO2VULLUDL]:IV+!QC:0.:K0".PLB)AULL)(PC(
M,/L^?]XKYZZ8>A*3/!/8[1PME0_KW4Z[C%F_CNFKA:/5+'ECM>+LIFMLQ,#&
M5@S5AI1\G!"#CPHS;U_%(@ YG;%F)NT?FC"]ON)@#(&/^,@>7V,K%&,?#YPF
M:5#..(K>9U6'\&U->N'Q>A3Q<A<2[_Z99W]S+2 5^-OZ=]KQ)CZ^%7]>GYYR
M=/H'GI>5,"[R9K=0O6SEMJT&*5"$;(2I9)'3J2Z%"GO(NOR;D3V1LWY:,RX
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MS-KD*)\1GUKH8-"L]5!P(EN#[1X#> +OJMF_DV!*<?/NAVU*./I@C?3,<5'
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M5,1+;BID]":*&9D)>LPHNY>Z%+&'=8\.J1U!HHD@I$0(0J"S2<P'?><;]2/
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M "4SMU4P;UMUCGNPT7OFR?DM'U*@N7>P$GNFY>51!.!!'61ZD(ZK*0/QZLC
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M0LK#L?4%X-Y3P)#!41HC#KLUO!^@)Q;W)TSJ2=F=7)^V*)%>.-GQMDO%P1K
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M3;W;^$[;O8ZJXX[&X"%*DS0D\<L5UDIP"\8[Y<: 6$=A3TCNJN1[]WE<EHJ
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M 1F-NGH)!E3C3VZ/:D,4R>$:*9(S77A/(A1FMRF\"IS6#(X4P:2)[O\?[((
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MUTB[G/[?4TKWEY\.7K_[H04,S]1NB]D+M59=;1-N%0P#T*PZU]!A^;:=WI:
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MI#&*4]*LK(.^I-F]I/E (P3X6/P5OO+5VW<C\%<T_%H[:J!>58D.E_,<I@,
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MT=;0B+94V;90?;9#(S8B06A=7!=X%EK(3W#_!J(:!?2AZ6\B!YW&W]:,M-]
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M\K[S&4T/6UZHVXL>HZ(G6RD*TD!H6GK-]<:L"]WHCN5)\RM[-U[KM.3D<$6
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MJ%^6U)T[TXF1.1N;0@ZS*M5T$T[_'>P_S(TIZ[Q.E"$03[%6;F')4AL.IVD
MG34X+!98HL 6!G.(8=LX0[6WY+FZRQ!WQ8AK[JK27LG&$HHC)4 \%A;#Y4)2
MT" (95[0-L+)R3<W:$,;3X?EX/5>M',3*1<:"C<+P<[:TT84WJ'T[J37$'"7
MNTCZR?<!L0ZT40N-#4/88.7,A!=F4WJ"_N?J:+K#G0/JE82[6^/VZB2N"VR;
MAJUJ"NI)<>+WMK%ZRP\<==1Y,1LX^>((*4+O//"PI[/I&-IA??HMI28:K&6E
MRL@YENSJMKQ6N\H 6])R0TW?XJK;#G6WN&ZCO;HZ^HV5=Y7RW'%*]W@:J:]8
M3(FH)Z.,:)#P_@Z"FWJ+N*8B[.[[UR]8K2"_!.HI!(6DP7&J?]7D_ZK%A8W4
M.534@67SCG1UGNLG$590$(H.KY"0&W,!A*FBL'Q@=#BJKP%B@OHG9BF2=9SI
MGGKAB>5'H(QFZJ,^ !U!,P\2Z =*KTH].(GN=#^N6G"J<_@K)(6LWF6XNM.V
MD0-3/*OMX$81"P6,F@91S?"1 @C-VKV22NAQ1)%7LNQ!PM$AW)4I(9)"W:C3
MT L];%'ZCI!:3[*>9I]H <$9W3XY,O9640=QTS+:. 5:Q(GBAG4D]?3" 9@M
MH=K>J/[A_U@=6\&-1]04/"=O[5>BU#NR+S#-)-8BP\Y,B:@!:19#ZK>;XXW-
M9PD7)SL:6'ZN4,YIU]L"_AG$D3/:\F()' ?/23?6 +<FF+8A4O-A=:3&34(U
M% H>+JC=D'F3-SMN?41T]X&;[U/A7PH25\(H"EH3,4)+6HEY&#1\H(94VVYE
M4:A,FOP@6+RQ;BBU;O[SW5=/#5.C)_X2ES#]<.Z 6C(T#S49E('W*8_O@G#J
MN=R;PJI;/#U;]X/F1_BVM=$U#YS:TV/6OD>6-."$1.8D2Q(ICT!)^4QDC.WR
M#AT$JA6JA'ROS^4"!5MP6 $BT72KJ5S&U6" O.8-U38W%]YWJ*64B1]AFMY0
MB^)85:(F([1 N0[.KW-9^H:-9!#GY:A-HF1NFP1% :O@D"8A<8Q#W*DOA.,T
M0*9-W3TX+N&'?V8#C^(ZOLO>G.G&KJ"B1_&DX)*\N%76[:-)2D4O@BN^U W5
MFDV!>CJ8P96U?CY2ILC,<?33R]^H'%K#BL2]$B:T>DA*EQ#BI0A!#/&9"?Y+
MNR<15W3C_]H.Q;!L56E"=S))$2-E/N,PN,/Z<?'F4#(M$U2C/I%6PQ2?D,#4
M&1*E#V%PZ](E[I!(\V$Y"(JX\,6UTZ56SGM8FJ6/$>V2N,46948>LFY]S%-P
MM739DT,N'T.7L<R3[7)<)R+7[9$^<1@G+SJT&UR;%D/X&W]M$/;W,5:NE5//
M>?"U=KT^?#@1L"YR HO_REB?("5R?(0&P[<DM"ZNF4;=R!B$A$ V ^Y4VK9<
MY,RICICZD\6%"3HW.UDQ0$EO ]T0NSYWLQ-,=4)].S0+^ J5,$-C%!/%8=?0
MB9#4<+0W_USH/ABPLV@M::@._[-Y#MW)&B$P<1IN'[K3(DH33'10?&';DP(H
MU"*-FV&Y?>LB?*VSAZ65EF;8(^>_,6K?&::)S< +29O87@+:ZM4,7&VVRODV
M\9\2 '7P#(!Z!D#]R#/KR>'=CW%FG>.6U.8B:\L;?1#UF."41FBKW%S-.%':
MO)..[8+M7 C=5 MZH[JE2*D]!T2KLG])T7*I$RZ5-*PD4IF.MS?F89D,%['%
M],GL6&)SONQP^$-%S5LE06O%F/X\5NJ3UP)\WX[GN#%)\!4!#[APN;G'&=^$
M9 _:E<8/2K=E*;+J%J:-0]Q7CN^Z0XX%^'"""'8'BQH91:T;D(YMY^H68>I(
M[N.0+[AT/9*O0GH2- ]5"-JF9#W"98Y<"UN63![7P<9'3R WDC7/7&;0+CW3
MX^+UK0P;L)2AI*0,=A:J$XT;%BJNXS5+H?EWQ6TMJKB3Z@[>[9#_P4!C83/6
M;/N<5P 'FF3-9I>[N^+*/3XG#FD 0S!FHVQ,G& ZJ>6.P&:T4B+CF+D4&@ E
M2\:$6?U<1^XG:WLP(.BY&A/E5LG (#K<IL5C\W&LEIYZ\N*8Q[!,_M E2ZF.
MIU$$&4F90XZ_2$39.U5IS$H *>>B/+@/DIF-&9V"J&DWM*QP\FCX1SFZ"LWA
M0"E/D#IJH6P>1?O;,GJY3[3%E?PD3<C4O(XA+$BP)*1(=]F7?K5I'M9W 0<$
M6;2S[FZ3)IKJIKVY38**;"*;5']HOP#KC6%5"+?VO2R]B7?U#Y<C61U$1!:(
M@4,0VG9&>0K4I(.]L]:<A'E28^KYX#2^WN"]_.2%%X\6Y;^6,K<K.A@ZF.B-
MQ>\2Q\DQPH=WVP%8D&H/WG9*D3#I)M.+J"$71GJFRZMQ6"Y;BT'$;,7;\ <F
M+]60"D:E@6Q_B;G8C8-Y#4%'ZZKH3D+0$T;9O=3IBY&@HEH#0VK:3G0TU,0K
MF\2L$3M?IA\!I^-6#$/6#V"]EN>2>2&,W<0-Y9DG=@^4MG",GR# ?EC4.9:*
M%>$9W"<"[GJ9#5]&$IA*:.'DX#:!= >&7[>*:+@PWFQ NYD@>SEAA\S 7,M!
MFZ&M2/V,%YC5M8RL6H^E5KG:J_#9G1828X1EE(@< WTQRZK+:"MP>B4SN W=
M.H^0P4E"0^26+_)^Y&G(TI=-*] AH&1#T^W]B<MX9[]Z+CD:M@[3SD1#:I)G
M15Q6FFNU<\L,E4H*LIJ<![%03+"W71Z37&PY(\!,5J,/<:^U9XZ)9F^ @,S5
MA,(&F![C'RQFNTV5M\4Q;7,0ZRU-.@4Y0^^4X$3!U4=/P_ :2HI1<5AWVW>6
MHKYZI#5TKL9(E#[U9J!B7%A>2K0-89#G2(.'&P_!&16<3A3@)T(\7%#:&?^D
MU*?SP<(X#ZLQ&KPAF<-97S:I3Y3IT?#L) .OAOT-/$\E<&TQZR[%XX)*V'=9
M=?$MI(PTY64"![BU2C"E*DZ6=#^TG9,R\EU)S*5/GE%^>*I8R&H(QH]-DM9:
MCQ3*<5!<=*/[M[8[$0;24@K.,83APLTC _P;57">X@;+JAQ-5+<7RMT:$2D]
MT 3YK;,T0<C5J&TGM3V677 7MTXH!QR&CR&]9LC_VM^ R*OITVJBV1&=-@6Z
M@Y@X<9(L_7D8PR.I37HJS=-FONR;T  3?/<I.BZB]U(W@7QW[-!01QO1'7,D
M1K,_NR$+YRH4L9*/ -, V],JC10:;!3LX()07,VCG2A0B\2E:V*D4O_BG578
M>31(J4D)I\7P:/F\<[VS;99-WX/H:L112)2@(QUNEY,FL3["/CMIM+LZM&%S
MT5?7Q,S !^L*<-8Y+>]TT<+\?NN816"&"5TM&PL%,C>-H&XWSI/Q>J?N08H^
M$A,5M+4452H<>=QH YO[CC+NK8 @(= OOFQ,]!]95YC7,&X[Q8'!-52EX7!)
M.@1\U!]@0V1_;XUD_T.0WE;![;(;J38]VNX <3O2A$2?%!@19%)Z2[RXB<P*
M)<R7)I.P*%B:T8QKUAM,FD@7'T.+;+WNL-6(0N_2IGC!/5S#;T49F*.F.JT.
MVN7#43K_I=0IW,S8Z1&A5T.T =Z-1K 3-W>> SNT$#2\S1N:K*!^E%SE=_V2
MXV!4_9,EF[*7]]=H+Y^AR95G:1PB"2GUX%Z!;=V *?F]!75(GQ8IKN5AWG'J
M "C[H-;=4G>'Q1P),TO,0,-//647AKS #H4C6'[7CM7.$)?;F6'4GV>:G9/'
MQ49T/[+(,]V(,!+^$M>,&P>:YW$*I<9+R5G 6+?C[6X^@+Y!#,X#OG@ZNW?0
M,[RIML,/G^%-*P%OVLSV=KL':W2 7(O7>O#J[?&RR9.'WM;Q=I?5%WC7X$T3
MNZY!HFL&323,G14:O6; J?'F!13,*8*MW[;A4!HK4Z:<Y2X]B6YF,PFF/8V1
MG0)N:F'NUH'><I;#L%,)GE9H]VJ<KQR;$-"L\Y!(27RUQL?"^9W"^7)ZP()0
M2[PK)->H\ R(:'5VW[XYXM9LS$ULD/ON]]<(?L9\U(D6J:5Z<'N+@4&.$&(+
M"AG*34YURE/LJ*U[O>GA[>[@HU_N;H7;6_O;$LG<TJO#5J6N(M"S/7%G^YLL
MDAD=9SZED8J<M/%8'T,4^;1X9X2P\"#=F>)7Z^MPR(<K?C5Y=A%_!5\ZA:\H
ME<RF\2+]N5? 2L)OU#KZD%W1$++9LY9Y.J48,Z?*:V,]>4L5K&6X-;UAG&.;
M(CW)8M'IQ5*F'J=@O@21[D#LO,<^73<XMVWW,DR#F6AX05PP(UGFA09 L3A:
M3\EJR<=AI)4+@0KNLCCZ%BG9WO&.L1F=[6_=_:V<$>K/UB;\U>L2I^*<UH%)
MNNM[$8+]5V$\I]:/G;@X3&=XHSD>Y'+53@8\'VL'YLLEEG*>__</.C$72L/O
MOZ4T_-G[\XOSF_/+B^O-,$L(3A8&$\I5_-NA1YD;I6 E[>Q*NJ;!SZ###(6B
M;E<@U@,%US]V8X-EVG6K8]916XP7O\JYN<1AS; L&ZP[RS0N-<$,-T@C0\;6
M#)7WJH,\1.>D7)];8;X\#6N]/80V1#=F;55U"B55W^_;U9ZHW7OJ/9N]=3=C
M6ZU0Z'P=MM4)]KI=G<WT':2.S7!6ZC#V4LNQOH>EZA8$62PAM*^&5>*I]%:7
M3<+!-HX+K *LD!T8?2N#-^(0I.H8]LDH5D/O[*L**T)W7\)@0MN0M=XK/)]U
MBQDHQ^24VO89YH, CZPJ.A W/L5'-3$1%W;C;T+8JV!58WW19NSV%0JNK\-N
M/T-R,:Q $83:ZFS\8 9]V9:3D<+FPQ3?#Y"VX0/V+$ ;TSN-"P-LRPDC09IM
M6V(AXA^:%N(7W*KARNEI4&E?7=C41D*.1I!5?$:?_L"<V9;P!8H=K+G@IBJ0
MDFB-S8S$+=[V)DEEB_D6TF*(+$D*[^APQWO?H!K3*@B-"04;-9:UP(5H?G2V
MO_%Z'2F14>@O4N^2V#4'SM^+@V_I_#;$A%BA@.LZ*)7W]#KOHT+<^ II%.:)
M1!)33=G"S(>PIV0]X_%81;2U>#SV 02!AYU\A;&3W:.M8!O_]NKMN]TMT"ER
MAI]]#4$EP>X_1B1H4'#\B&[1A 42'F4\*X:6\:R&_]WQ0 7-9#4F-%^-P1"?
M:=)R;@B8)KE5P!!WCUZ]T^S;TZU8@9JA-M$R7YZE3&]'9KL9>_9PAV??]=\5
MWCN_9UD$JAFI=E=KYXB(VR@-$\!Q)+(,OBB&Z^OB!#G^O/L\+DOE *\[;/A-
M:DW9)W3'L(0([LX1*RU:HIL9N,^J&%:I7O&H*F,QXK%<%/,Y=+S'EBY&7L'Q
M^C#0E</_/WM?VMPVEF3[5Q ]$=-2!*RPK,7V5+R)4,ERE5[;LD.2:Z8_O8!(
M4,*8!#@ *9G]ZU]N=\4%2,E:0)A?NLLB"=PE;]Y<3IX,UONJF'70YB 8'T7>
M8>L(;3>$E2<R*^?=B,*84#D!]:/"X/F@F*8&N:]?0["&V:S,P,)24"R*.J3!
M?(G6R513(.8:>T<T15BRXX( 0GUJ_?![JR2ASB<P/8&YT U=(CPJL\:\$+ %
M.5(I2T4BQ:)@=5(JQ,"[ MECI[B9<][IA#(I3!K]BV[(\6I'>Y1D8P0/!<ZV
M5RUO*547,*A9@JW$$ 'RPNN[/J2)RYHW-BVP!_DRM.B4A L4N0KVF*M^I/$M
M8?8S[;NQ8M3=99K.#9?O$W7UJSMB.)Q,YC/:7H(_DPOZYB""!5'M++@4K^&T
MI(-4VW:U[8RE02PC^LL$ZP68=5_Z:DC.4;5@M6*[+:$Q_X9@H2G*GHC-2>NY
M'.@UEA6K^"""OSJI24V9HLJK2-U1YLKIXI#^R(C ,*C^F@[G!A=G)[@.0PBO
M#2[NV7%QUGE]!%S<"TG35[LG4.TL7\,9JE2'@$ %JNH[0H?:TJ"6_V7Q_ F<
M9>]U- 115-\%5YQ*'U=\2"CEI\DM8![JZ1QN)*CPM+5PV<P.XWC#1?.[O2Y*
MTAXQN'++@&W1!':=PZ=J66QLC[+V[[DV63T)HHN#97+<^DC_0O>AJ<PX5<6V
MURP!OVJ]MB=!R</U#'"<_)AFLET?X!+M3I!#Q_?9(54Y=XQD9,1S7%G8$S$H
MY"M_4*;^C(]C4MF80V^Z_8JQO5U/$>3MZJST^6%>PH%4IIJ[)_KKW3H+#Y_U
M;HF/F -V!(%$)QA64W%"4&F5Z#1%6Z&3E8:SJ2<B]WX]10Z3VI)M\E+;W1'
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M6HJ2X$M<3T(SO*899SQCE-A1"FN4C-6?D,Q+<P@W$(_7F*(];KLVW*.H WN
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MZV%=>5\LY4W=\=K4'7?/ F[,66PJD/MI(_OUEYL*Y)4JD*U#\9-ER"I8N"E
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M/S@&#@=8P7I2_YZ4A9>UN,NKH)7#E;35_ H#[!B40VREP3J&"E>2JL*8GL!
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M*I_>!)=@.4HLDPZR&B&R'%/L4CN@/J(4=,DU]B#"GP?_@"<0O:J%:C@\.#C
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M5%  BA:5D/ 9<]&#KIPP%&!T.:8_$H0$-4_,L"*K.-,=M;\3RX\P&7[JPQV
MBJ#I!PGR Z4WS2.XB6Y5"RXG.!4<?H>DD-6[#%<UU]9RH MFE1WL%:Y0P,@W
MB!S#1XH>%%%W)Y70XX@BK^2L 0A'EW H4T*\A*HWIZ84NM^B-%TA3ANRAOZ>
M: '!'5V_.0KV5E$'<9\R.C@56L3CE'O4D=33"Z_ ;!FDV[UJ&?Z/[M@*=CS"
M4?"<O#6[1*EW9%Q@9DFL/X:3F1,Y S(K#JC%;HD_])\E])OL:&#)>8IR3J?>
M%.VW<$6V=.+%LC<.GI-N=/"V.IC6$ZGYU!VIL9-0GD+!RP6U&Y)M\F''HX^
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M_>95#%!2QT#UP';GKD^"+DYPCX-?OU>E8V9E'&9$:Q@:.I&0:EIV_^-*M;Z
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MA"N_B3EQ2 ,8@3$[+";$ Z:26O8(3$8K)RZ.UJ50 "A9,B;):J8ZLK>L[L&
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M<*UX)P=@T%?;M7Z"0_ @R(J:BFZC2A<=\]QV(,H.I=?N?J\HCZ/P<0$A"*V
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M. 8O1+\-_GM!<>:FWQ+S LQA.*>^$B<_$H0 5?K.;5I/VA5[Z863+>BKPK;
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M4(=>V8Z%9*ZD-@UM0 7 P^R\PP!@VXY^EQ6WYNK-/C(KT0>Z@ZM@N"7122?
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M^L2")W=#7LMPAEISJ#XDTC'A#K4PHJ^W@V'!*2UJ/<+>3"EH+IQKET<#Z_]
M(LI:RDC/A"J6]<P<!VN1"8%F"3'^N8KS^G:?*^?--2.,!P$Z^*BC6\RRJ)3@
M.Z)]3-A]00]H4C!V0UJX' 2"\/K4A@0!_$[%Y$TR?4C$+ZOU>L:/%'J$(2)9
M<D\+&'TF'4%@B64W_5(;@PD2QOI$%U"+D;9M%=:V0T /<IKP/+*Z]$_TPKGH
MB1UPH5 QWC4K6*8>S &LEM&SJ^U5):\>.6JQ_@.55S1$B!/*2EEBYI4S$=C]
MIQJ!JBU*+YUMR]*'HGC34IVFY-)@*Q8DHYK*=W;W1-S"]#!6XIYZ^UO9JOZ#
M!92_E+-@7?'XID;0I)$OQ(Q*.MN>-,WJZZ60)/((?6+'477'%<NJ.1)!;CQ'
MK.= :IDP*?5XK1IFUX=&'(V):7G3II5K7J>$]U2]3Q08M!/?P?X.1'48T4+3
M=R('WF-U:T&6[R8!3V-4.Q_PV)]-[XI2T7NY-3+N=X_,&?<5,I%*[PA1KSR6
M@/.<K<VYU?V\@ZU]5V9,"R4L4J^JF0*\NB<O#=WNS&8.XMHNW0E.HBR6#D]J
MI1M80WZ>-GK<+D\./!H#K5PY3J%+52EF(4GEAZBJ_D1:&_Y4UV_)UT*\K6+2
M8]7+"35/;31.D3]GV^&D%I6D,7H\YOJ2U8X!FE&0?C;@P;KF]X>;_K-AI2M\
MM4@[62(:YHHM@;W*[6M5#EHC:*#PS#>1?E[.CK;#TD$_+CJ;71PB#$R] T?X
MK9<@\)_@(YF-&B4^(\PB"G.#Q*PWX='K1[P]U [+FQDW<RXO$I(&RZW"H.!X
M-B;7<$:JTU80O%.LD\.ZTOY=*3R*TE3!LFM;S!YU+J>L^^Q[P0KS/@D9D M;
M5'BEJQ8CH"5O(PI-(UP:>LBV2XTS46LG%4BW*',U_M9J#\B.6X0=;8H,H:P*
M1FRQ88.9HIR:YF0,9TD#1=\P\Y_D0^^@UIIJ]#"U .1"$[6@46FIO%8MXE^]
MYBJ("6PW1571-GRKT2S7U4 (O7ZEGRR:>(OT#*I9OL/8RA[13%L>UC87UXRD
M3@3O[3\_&P9=8]2(4*J2Y),9I#:B.$""LB<'.^7%FF =5Q:K._X1\N_J^AS?
M"]?;!LKS-_0GWPI0\WH#J%E[^I/N'M[OP77+D'VRKB+8;&QIK%(_XND0T*9J
M\]QH8YAOV E+1B<\] Y/B]PR 5642_=VYX3G+#WR)2/T,RUF538W74=TO]ZZ
M^S.:<;,]-J4QYL:I<OL05L?M8@?3$Z(:J<2\#9ELQG-M@[3%X6HL3D]"-]>-
M-+)!_XC#RS(%CB(8A0CCY KJ62;VF\"$:7&&,ZXT0RPK&FR5BP5-D=!^K$[6
M):"@:S65Z]3D^VH6X[H4Y:ISP==-))C5"%N!"P3#@(E<BIX+Z9WDM,7PK-0[
M"91,7M!#/P//E<123?U)2VN+*5X5LG%?E5:5R>GU. 5![XDTOUDC:7X'BOD!
MG8@/T4,'Y#GEG@")(F&R*E!#F]=19]5 P-KWP"WZ%Q;I.;RJENFKJ21+U ST
M1/C>KI'PG464T8-%H&36ZDN'3&L *\7Z:,9LTXWM1<F<M0F-_4&4*06;6B4[
M4FRRW AQA%(49))0W D-2?M0Z)CQ5[D XV)(X&)0,F-B?L6*[&HB_RQ,QSY_
M.,6J3NQ3IX,.-J*R$OYVBC\EXL5DPKF$T$J$4;E9'$>5E&$A>+Q(*J>:UFH=
M@-0-.J"K$7,J8#>:D>SP,[E^CZ1#P^9 OK(TF>'@N-EV2&%&=+"D^;8)P=+U
M"8)E)CB,8397#N,DJJ9]DJ,.=G>*'%!P'1AFKW/%*:9\'NJ NB*TJO&3^\@:
M^[.('6SY4S^9D0'<.A2L8(SA9<23I$_+TL%N-$8M*V#2PIR2^I$@+C7R6)-\
M(7%<J-.QJK0E1[\@,[TADZ&+VA@)(DPR319^+@QN9E.ZE^*2GQ9A$*ODO#3$
MKC"9S8Y'*5@$1K*8!@$AX<IRA$;/J;7-.*TJ/'Z$7T<:M"F */*;%?F,<G58
M*O1*?1^)GA'4-)<RZ9Y_^G!!WQP&C$@S=<<^27('.\L822;5+[%;[:1R>$^Z
MC=FP=MTBB%:2$1_573KQ8@8,*G)4K]3_JF=K-*GF_B4XF&XGTO/SJH-M:3C;
M3J9%&X.A"L@C+P2ZF>C'Y+HKB>IF8?((( I#YORBY<:*1^PX-^_32O[:O95,
MVQ9.0,UPUI34V@RL#EIJWL^,6:IX1Y,GD!?\?9_6Z[0[ZW6TLTO,6YR:(HR/
M []KNI*(<4$453J6QF\VYL(Q,##AQGW#5/45]3(E^P7T\BA)573+4N7$J\=Y
M1"FR^HIVHSJ1Z>^75^2Z.M[J!KFE#"/IR?UP%TVK@I%[W!O-Z<!.*2OK=5+D
M]<5N>*-BEJN:?JL]#C9>Y8Y\+J,3Q5[%!G<P[8;*L6;*Z\:W18TH8(DIBDSU
M)3MOV]K,=)Y2ELE]@9 M!E]SSX?F3-:F4$Q4P>2QL&@6%Y*"&GTALQ8VP5-6
M)J]&:EB[.TP'S_>RC95(N=!0N)4!=A2>U^*;%N&PE\- <&/V)*D[/T14VMW,
M!]<V#,&$$^M->&+:<8C?)>!F?P.XZ1F#S2J/W__NSO%[N'- [87PR%$X59?W
M= E=7G.@="D]G>:HA$QHWE#J#CT57DR@3:XW(HC0&8\"[+"L^W=Z7**P<=+*
ML=IPG63D'#JV#]S2J5IE #@=O2-%W&+; )XS>/D#EPZ0[ARZ;%',<GYW?*4'
M-)&2SUA&B2 G?4+2(.'Y'FH;MZU@_73V]XIL%ZQ&3%_B\A1Q0I[=-%<?U>GH
MG#"PECJ+O3DR!-A#59=G.^^$C15$KL4H)'S 7*"CJWP,/1U9;,GG""% [2]F
M6(556.F!^B>*.T(8C'JFPQV "ICI&PG2 Z4WR0,PC^Y5"RLG%N4=?H>DD&T.
M&:[J>ZWE0)?-*N>L5F1%AVW=2G>L<2G04437G51"SR.*/)/3%N ;68:^Q AQ
M9JKFKII8Z&F3TG:$.&V\6AK$HED.9W3SY"@XA((ZB/M\T<:IT$W+$N[Q1E)/
M#[P!6SI.MGO5S?NW[M@*=I#,4?"<JS6K1)EVY%U@UE.L0H:=F1-% [)^QM2C
MN<0+Z_<2:ECV?K'P/$$YIUUO2O<7\)@N:.6,)9KL>)!N=/"U.L+;$ZGYT!VI
M43FGFC+!@P4U&Y+ \D;';8_@[38<\T,NK$M19DL7A>4=\2)@I)&6IZ' ;Y(1
M5;0;.10"DSHK"!8JK1L@S4_%#V[<"TL+W?$?Z11>/WYT0 WY>0P@&4VCX*),
M[Z-X'MB,FT+P7+T\<?R3WH^@;&NC9Y[X:B\/3_L:65+8$A*9DR++I!(")>4C
M43 V*SE45-*I28GYVI K RJVWK#80]([1E/9/*O1#5+LUU3;HVGOM@,MIZ3[
M'6;D-:$HCC7)DLD=6I]<\QFZ#):AYB"Y2<OI79,Z25\VB:H*9L&B2D*Z&(NN
M4_T0CM((^355L]UT"G_\;W$34* QM(G$"]4'%53T73JIN/PT;5 .A&B.4GV+
M0(C/5?^Q>@^=EH9?\$NG_8V4Y#)?'/WUZF<JU5<((G&MA/_,C9&J<EG\*:(-
M8[QGAO]2KLF0V0;POZ:A+TS;;*ICR?*2(D:)7L91=(_<!N+)H60:_J=:+2[-
MAJXS(8%Q>1&E;5]T:Y,D[I!(\V%Y$U5I%8I;IZJJK.>P-$O;']HE:8,C2H\\
M9MWZG*=@MW39BZ,KGT.7L<R3[7+L<N*K;D(7',(I*X]V@]_FU0B^X]4&87^?
M8I':=!Y8-[Y2;M>'#R>"RT4F8/%=&=83Y=2G 5' L)8$S,4Y4P ;&8,09,AF
MP)U*VQ8]8-6).*5V7FFELR#UQD^,15+;0/6/=M]=[P1=B.!NAWJM7I5DS,LX
M3(G8T#=THB'5[0+J7U>J)0OL+)I+&JK%^JSO0U>R1HATC(:[;>XTZ-$$_AQ5
MG]CVI. )=13CWE%VF[<A/M;:P])Y2O'JD>-?&W5H#5/'9>"!I$U,6PME]2K>
MK29'Y4O8Q-W2!B^.D7T.;7"*63+=]9[D\%IM\1;CAH*S36$NDP5[M<GC9YT*
MV+.%@$Q.*!$%F>)/9H>)O++E3C%(*;:<)M(YCZAD/$^OO8=AAEOFE%,ZSSKC
M'EG9T>B;BEK0)4%K@'B_G_/_Q0'57[?C.1I'$GQ)& .N_JSO<88R8<6\<E)P
M0>FR(D>6TDK3XJ=M-<VVH6F=K4^OLF=#NW(J^IV6/RIB6":WB/5%2A^K@MWF
MV)0L )*<X,&;Q*!MIJQ'N%:,"PJG4Z:,\W#PT1W(0&?-\RC3HD_/M!C/;3/#
MI@'E?2C4C>V#7.)FS3W%Q9!Z*A2?J3@$U2SU$MQQ W9%^0<#384=5K&7<[06
M7!.2-9.S\[?GE&M"3L?0 $9@)@R+,3&!J52!/0*3)\B)T6#A5"BLDTP9TV2U
M,R;92]:T#4'0RV1,1%M3Q@#1X3:OGIO4H%MZZL4K#)[#,OE#U7WD*E)!L3DD
MN8W9LY587? NR5-6 D@T-RS![\X6=E^TJDKF?A19964G\$LYNBI5"$^))) Z
MZN6J;T7[V_""V7<T%6I\)T7K5/\= P.0IDFHE>Z+3^UJ4]^L[0<<:F'1+OPM
M)76<RDXF,NU\,C3I05+]L5D!UANC625<Q0\R]3J2T#Y<CA%XV%Q,>AN'(#38
M#.B4!+Z'L]-I]L#LJ"EQZ%L=>!?LY>\2GG:P@:=MX&DO>,"\>.'/LP7UKZ2
M[9*L%0_=O'9#;4Y$L6W8HFQZI6D##J%5H$-X'<#1A8$O:1G3"IXAOUHZBLNC
M<5@V#XL&OVREV_ %\^@J] 0#T$#A?DJYC(UC=S7MBR9_Y<\YT!WNB@>IP!?+
M-1DZK3.II3D1S5"GKF*2\C'M?9BZ!9AL6RD,6=V #]NRE$0+P>DF=N1.W]$_
M4#I74ER"")M>4<]B*D.$>W S"+CJ53%Z-90X5$83)]:DCIM;92"NJ4[#A?$6
M-W3$$#JO))B0'IAMSBK?J!&87_  /;N&'%@=KKDY\<VO\-Y>LYTQZC)*!(F!
MOECD:A2T%3B;4FB(ANJ/1\CT+*,A<E\7>3XR,!3YJ[IK8G&GLO=C=YW%:;PW
MJUY*2H9=EMR;5\AUK@R.VYFB_?5NF5&29!69\M:-6"@FV,"N3$DNMJP18.*J
MU@&[U071MDN] 4!$/E1&L2S,AO$?IF:@28*WQ2%L;1VJ+4TZ!>EK[Q.!A(Z2
M$MU?3=DI&<6$H[C;H345[NR1UE"I&2U1RA1; ("Q$7@Y$3+$45DBP1UN/,1B
MS.!THG@^4=WAA-+.^%_*=%H+%J=E/!NC%Q:3CU:T)8_:1)EN#??."G"UV0E&
M(T_BU*9FPF8O75()AS;!,SZ%E)%B<\W JC2F,F90Q?.7%H>F/5)! 142<VF&
MIY4?GBH&G1J#16YRHDY_D2JQO&8;R&A_U_1QXTCZ1L$YAHA;N/A.8_SN9G">
MX@8K9B7Z37;#D_LUHDAZH@GRL[<T1FC3J#<G-=R677"?-DXH"P>&MR&]IFG]
MFFM /.JTM(I#^8Y.FPIC%)@GL7(J[6D7S1"I_$PJ#56^I^R;6.,00OLN*EBG
M]I*_EX$_H*U9S+7HCCD\J(C([3B:]2L4L2D? ;KU>J!4&BDTV"C8I@51MXK2
M/4M +1)-M [<2_U5,)AA>]$HITXDG 7#H^7CSM7.MIXV=0T"J1$V(:$K3_;;
M3">]Q/H(^R/ML;M#"/8HV.J*.!?X8.T &YW5UT[5)U"*2"5]KW5N]$2E,CFU
MQ=P1JEH[%79O[E]"+6VL.^/OK1('J>_(=*C:E$W,<F&_XYXOV,'WKN V'X@)
M OT2RL;$H ;K"OT8AFCG.##X#15D6"R1%K4>M:KHB>R_7B/9_Q#EM[/H=M7=
M4NL>K3]KT0Q_(H4G1>L$B)3?$N-M)F^%$A9*)TF8%*S"J ?;W2Z2.OS*Q] R
M6\\?2[VC?)#T(EYR#SMPK6$!YJ@N1',QNGPX2GN_G-J!ZS>VVI6HV1!M@%>C
M$6PE<ZS[P ZM!/ANDMDZ5:UN);\*?1]R<)8*?8JL+WMY?XWV\@!-KK+(TQCI
M1:G1=@>V=0V5%+;6SB$QVC#ALAUF%*<V?[(/G!:6J@4L)NZ8V60!^'T>)&9B
MR OT*!R![MMVK'*&N+).#\.]G^YH3AX7&]'M0*) -\;"],PKG#/N#JCOQWD]
MAW&24].IZKGK[ZN!OD$*S@,^>+ZXC55?MF:'VI4O86*R/W"P^_9XU82SHV#K
M>-MWGD;!%?@IQ$BJ(;V*=1!)1A<%G:X8N:?])$%7<O!UZ^=MV.[C1-=Z%J5-
M/*(ZX$RB>4M?6:L*ECI V\5TMQP_UKQ3 DP4JC*')Y.]/D$?6C<9)A*Y<IA6
M.')>62NG!BR M"RX1-J,&>ZN(<W.WMLW1]Q_C?E<-03:7G\%A6:(ATM.1QVI
MH]M;#+EP[ 5I^V4HUR45>\ZQ(;%JZ*:&M[>#MWZUMQ5O;^UO2XQH2\T.G]<*
MCJW>]L1^6^DWKAOU2J)3FD^(#DO'*I%(,24#'$7$"@_2?E-<M;8VAJRV<-7D
MWE7Z&;R4'%91RD%U=T7ZNE7 I@37<-H D<:N"=GBMY;WM##M"U^5Y\;X2(9>
M5<EPX_5&:8F]C=1+5LN^7BJUOFD.!T,T5 U<K>>8NZO^T*:W7H$)!AUGK(CE
MY4ZF>:D!4)2#YE/R!;(X#*RR$4_1?9$.OT1*MG>"8^PX9]H#^]?*&J%:MB9)
MJIJ7E@;RJFEV%</).D-/V6EG380&NK&VUAQ/.C&=DP'/1^? ?+7"FKC3__E&
M)^92"<[]MY3@'+P_/3N]/CT_N^J'64+HL3B:4!3X_RR.B4?]/U;2UJZDW]2*
MW)4#5R74(0C$^B:!WS\W&?PJ[;KNF'742N"'_Y)S<X7#6F!9UJA+5FE<*I8.
M;BI%AHPIOC MQ.LY^[HWDU +]]CIAR#<"ZK[:J,\3GA]VCYOELVA=F\IG*LW
MT'W&;75XL.D V+[Q#S>(KU4AOKY,2M?J7.E05'X=SI43[.C<G=/D*_A*ZY&R
MW"*CICYE;3?+DUL09'$%T,$8S;(@R6]5 298=N.TPGK"&1)?8W!!0YDXNIEX
MAGURER:C8/ YB6=4S7 .@XE-&V,'>:,85OV7Z(%RN"])MD-&$"%VI)A5'C!/
M2*%716_$)>+X20Q[%=Q*JJ?KQW;O4.!^';;[ #G*L.1*T&_=V?G1 A:T+2O;
MA3V[*7<0(0/$!^QT@%Y6\"ZM-&BN)/P%J;9MB09*A&0".X;P3&?<X.'2ZH0P
M4]$J(66[$XXU@L/B/=H4".;CMH1V4#Q!12DW3R*IKE:XSZ$$AK:#238SU:M+
MJ3%$K615<'2X$[RO,98I'83F= (;-96YP(FH+SI[H/A[%2N44:@5<7LK^MZ!
ML0$2XC*L@#W).70HY; .2N4]/2[X/4%,>H<T"M--(A>J8G]A D784S*?Z7B<
M#&EK\7C,#0A>#SOY$J.'>T=;T39^M_OVI[TMT"ERB \^QZ"28/<?(\HTJCB"
M2I<H[@-)$#!6%I,K>%C#?^$ /EO,V$U(08<($>^I4WYV$H1><JN"(>X=[?ZD
MF.7G6VD":H::2\O[\EO*Z^W(V_9CSQ[N\-O[_K_#>^>7HAB":D;&WF[M'!%Q
M$Z=D+CF.Q4^C3PF7 JC"!SG^@H<RG4X3"]3M,>+[U-"R3>B.80H1.%XB#ENT
MA)]@N,VJ&,UR->/#V305*Q[KHS&C2<=[:IAGY!&<L8HC52KO+7!761NOS4$0
M0<H]P=(1DF\(,T^\6,ZS$>$QIE(%ZF*%Z:.XF"2F*D _AB 3TVF9@H6E8%X4
M=TN\&4.MDZE>0<PU=H_H%6'*3@H"'[E]$)!/[($[37"UB>ERP!>J,=C)9Q_*
MVA3-&"X9Y B2,O_)["9+8VQ74$9#3B:/,4-+@4@!0DIQ+2AA>.7 VN.F'9,9
MMC1F"F5FJ.U7_&3I\ D'N:?<P/0^+:<S'ZNO>LE84GP,0QDFNA4:@L[*6\4L
M-J\11H,RL%1$<XT:RXOME].\O;)>B0V)%%6R\/0SXM5\6^^JB/1'C/#C2BW3
ME4K0!_R")<\RU2BH8?B$X :KB4'ZMY=;TI[HLY\7ZC.T/*A<A)9Q"2%5" >F
MXP'1RI$77 K!*2> DD6E1BA<2(4\094R8WT344:;&="?JA9ZLB GRQTPHRC-
M$![G.6%J)"76T>Y"8C7EM96@IVW5HG:+LB=3_*YUBJ];= /#(3SL H*OY\HV
M:=M,=2FICB'P :T[>+7M'.9-(2;V5P]$VCD>H]Z!!2:(/X5"7A\&,"&J91"7
MF[;LER1.M(_16-!0VAMSU4H984T,-Y&0WD5R-*@&PE:6;4&,MGX8]6A;7MBM
MEQI"< N*K%*<]YY"2]5)XS/21%B3:)TI%GN=8(OV=X-A--?@=? *J<)OR9OX
M\J^:6 3>0]V=(U^$B)TLK,\U;X<AI>&\_=FU9E5B['AG[C&483 &,>!(GIH6
M&VBE#,\GSDW:-(ET#:R\'%N1^@K=6:4RXU2%R37Z?_RI]=B=GD3=C];3V1Y\
MGJ2R7N] ,W;'X=:Q9G8!% ("O>J4Z'LK"PDD:EA^\@OA)LYX/T:5C0"MO6Z_
MXCT_KJ<(\G)U5OKJ(4="Y? OR#KL28#_S3H+#^_U;HF/V .V'T&BXPWQJ)@5
MJ+1*=)JB9]"),T.8U1.1>[N>(H<)5LE\U-*LW1' *)C<S:LTYI)FHN?); ,O
MUW$B$"R3RHT<3;>@WQ5& U]1NG1HDLQ4PH'Q*;N\NJ6"E1.R66*7FQ$3$)93
MPXUBA9Y4M1GL8(<^5C[I6$3E$)$I0#/%L4]Z@_"QR=.O] RSI6>J$C>8X,XE
M9LC*9K_7I\Y:"+=KWH2J-9(<ZR78@^6BD85LW]\E*K.&/=R@,E>$RK2.J!ZA
M,F$>U_+X:\"$NG/JO1!<*IH:"!0"FXYV@ZW#'PUW6\2\/MZCY_?XMZ3"Z(H=
M3-E[^^;  C5*39>-O,*2Z6T)3T^Q)V*%&T]P1W;+T24P4D]#1C66-UR(B,*)
M;X"@&L/<VGO-Z6]Y8\%[]<2.W=M;SYTLX9(+JFOLT"Z^TWU1N65D+ R<%+#4
MP0*G,(;I3B1FC_M5%ZC:'8^E]I*7YO1TYQ NT?R>C%YRPT,]D<_7ZRF?+3'O
M#DGJ@B;%K7HY,GKYV+'+6:'>('@>8^QX1I$W@#9\U)H :/I#AE[\\4-"#X9K
MFI$-CDN:<Y6:+G4,%KTV1-OB]\0$64E'%Y@9Y?WHCK[*A0F)C!W9N6X3Q&7H
M'&%;,@[[(3WEF#-OL"7N8:._L#?C5+MXY+R1-0PA]L7O= WX=F]J!?;VUU4U
MH$CE_5$&E(_$W<607.J^72?V8=(XIY>A)O@P3=2]%J>>+U 4<VG=TD(48!J0
MQ19!UVB9*,%ZB?Y!J^@'W9;]NZ*<UEV6[NR#BH97CW915'!$(<$%03G_M21T
M?5&X:PK*;O(C=4?BIG?@V)K2/KNTP4>S6\'VWC_XJ?E&%7W.NM?REHGBR*9M
M:2K 36%[B[3_V!Y"Q>&FP__\(3TZC-X<'1SLO[W9__'@\&#OS>'P[9NCU_M[
M1V]VCPY&;_ZUM__#)N[ZU7'7EM=9++3/>=$WG#@2OO?GE[\'Y^^#XW\>7[X+
MCG^Y' Q^'YQ=+S-L9],L_;(OM-66>ULP^P975^=GP<GYY<7YY3$2"W5^T%<7
M@Y/3XP_!Z=D)K,SI'P->K,Z/^V)PB=)U#,,.KJ[/3WX+/IZ=7E\%QV?O@LO!
MU?7EZ<GUX)W]U1=:+RM]RU\NC\_P-2X^7EY]A'\&U^?!]:\#\/?W]N7=+CX<
MMTO9$U[MR7F=#G.-=8=J[.W.T1[. RVD5H7],*2OFR  8;)5*!L-NP$;SJ%!
MHK(D;$%<:9;*BZN/AO\1?=\&GY+[^TOK]^%"MYG!%4Q2K^"*W#Y"N'BMB':*
MING;/:]O\-3_?[O_4\C_ANWZAIX%MZ]Q9C%IQI0+<J<%V-,)0QOL;D!U&YCO
M2BR75,>6SX6K<U(6XUEVRU3%^([D/YCNK<3!J%JR(&PAKQB./+=8LCR#U#T@
M*6RA_B7QTMOB/BEQ+D\LYCE>#&J,JA,!COOI><JC='-?VA:]PZJJ0[KJ<(>K
M%_Q':Y\T5_=H_I;0I:HN36O4)RLJ4$CM:MB":(,JYJ<8_5JC"O:JVA;MJN]&
M-,^:Y:"% $_%%2*K$,2E;=W;LYLE>!^25<52([;OTP_)[AK1V.+V'Q.&;=@R
M>6EUNELI67D_BL*VCE^ZT^CR O%ZQTR67R)L0?BE@&W<@182=F'A+8ZI1ML\
M=;0/6IG1=!K%=\SJHD)'Q_S3IM$C3[D'L5==B30']*AV<X]J4TH1[(C]T/[K
M@&[EPBW^>-ZDZ6IKPCLDUD=O'A%KLZ"#J$0+&)V=%<OV,1(Q<#!>^NN11+O$
M[ FWPZT7V'(./G0ITN&/,=*L)&+':V"U%)9.)6%JL.[-K66X[&$'I>"M2 ==
MWQU-MV&<309(F.L3FNC>H 3>IZ,I$4?%A*4\W/T/S?<DG,)6P]S$")F!M% O
MA,B_Z.0J"KJ2&D"2?\C.(A*/1%.%W&P*!8+$V$#CA57:B\'T#I8&J:<TE-'*
M,Q+C?I19IE\M45GJGA,JS=[,"+$>-8W@1OX9HQRZ=X(LK8I]ZZS6 8A"P6N5
MDE:@%B.9-XEBCC89K[2J9JH</0K.847_Q/M<:G4NB+=';&D#FB.UWAN)[AI'
MYB(%?NT"2Q3PZT(Q?KRK<ZW:ALSQ+7*Z3#M@T/3D[%\KD[8S_HRW4V",?!^5
MULTWH.Y <0Y-*M_'S22-E P#Z)9"_58MJ%\3.N3&G;;5BOV9BM+]Z&1[VZ73
MR92K6#<;G,;HU/LET8I5&\XA6][&D-9*.\:;9,K*P _IN,%Y,]$!ETK%-<F%
ME-1"4BI-D/AG'&WX&R*A(PSI0U%^6HYF]29A K7FJ/Y6!5Y $C>1\=*NX3 (
MLAU0PW?L$YDE:#OA687#BSTMG WGE#G5+3BIV (27*9S5M_*X?JROX(YA\,V
MU$A;/7O#)]-I&R%L5HPC2:413:$%S.;&HMS4W3GQT4W9W:K*[EZHRF[CJR_I
MJ]=,O8%10C=S1=.#7>$7EZYUJD+/P^I++,2*:4WQ#H+.Y<"]G-+FU/94?#_<
M%51H3LZV*L.#^Z3Y#-G_+>7=;D' -YAZT"H<W!XDW?-4&;F'[I=;+=9QH>T+
M*9VS2+":H0[F*Y9^A,7HR6RQ+0G(;N[7M#O[]6CG\$?JU(;;#9?0M^':+!5T
MRIO5^J$5XEIFZ4.RDJA+*,IY'%5WI@@'+[F/LIFJ/BU1VF ?U?H_6I:HOG1K
M3RC^* ; J;U:2*N6PK+N\L(+1'?\!^7RXR4D9HS=*YDZ]V:E,/A@Z[4UJ34_
M 0;I\&)H8+(WAHD56!,DJ)P6%NW+9N9;9WY?9AY4<<FLW*$*TR::GH-#A&E5
M"^!RS7(<94D^C$JI30Z#LI@1+&98/.@NJWF"T<ZIW>M!%[5Y&V(81_3JL5HT
M<SBX;HU'(S <!E1U0=;"PK>KO9?A^VC<N<X=33'M.AB>?-DX0[>.9QRF7E>(
M>V?2K1<GMS>+9]S0W*WO/893,0OV0@08OEG(9(UOD1<2(^8;LU_'FA*=L821
M25:Z+(XF5+>8PB93+82M.*=.EGT)F>MZ';$=.F/W=][@1#1[S]3[SG"?WRC/
ML>E\9;%8&UNM*T<QI2E,D#_D[$>:4R=C&!"CZH1$J(K&W&.<* U1=]UC($>,
M23"*BPS<@TJ.93X()&!O]A&%'8K9;5/_8/&P6,8Z#:+O[:F.*8A@UV,<6TH)
MJVM*OZ&*<2R3ND"J7DI?J-R%^EDCA^U)4-0)'NO%^P=]B2B?=&<W/IN'VHGZ
MW)U'/$^1/=P>)2@4KZ?YC;Q,VL_/X5BZKJ)9!V,V^)@"[ 324)#(33IA)RC>
M[ /68LM:%&>VQH@D,45$:D8?-++R-/"-R_N-7=XZ(A2W <;>$5TDO'XUD+B7
M.TA.<4=PEI$_EE9.XN-C*3K_U&<W!=A8$\T'3N\\39H7V0^+S $\^.#2$?C9
M?_W+P8\_O=9XB4>,A+I1\"2;H!2<A3&7+(.#M &!-<*.6@\;N_O;V]TKW^?8
M8M)BOGS9/4X^XN+]/9+&LYYFF,+2MM HQ80RKG-/ -U=Z_KX.!,TJ)ZF+['B
M_,>Y,OA:+*0&9>YR\$*,RR#(RQ>B32D/SBZKJMAH*6FK=XTR9U<K:LTNUVC.
MMJZCP\;1N+G:::^71*'=)."G,^#MB745O8$<=PYVQ&>'@X!9RJUGE<N0FKKH
M85I>+9^%*!6,J<C*$H&@QHU)@IN#"5O [ ?@D]L(]N#TC[X$&]8J'?XN)5CK
M,!B (7"/8>7IJF%L>DB)&9(5VBX3T$(,.[,(UOU;@6I6P6L8RBU]]Z%FA*2-
M_7BP2/#+&$O'>R&A%WHD6XBB#N"%<SA%N$$N*V"[\5D#QKRM@P3.OBXD91#[
M1LL[N>&W:))TYTZ"I,M;9D1Y)O9C0@)IW0H7;AR7,YI>T/R8B-GB@VZ[98QA
M#8%.LY+-QA/X\7C!H)NH]K8@)7@R0P1Z42=/7%(^6GUK6N2@L%@X<.5,F-1_
M,*N6$.H4M505WE'D8=$)Z!&Y#=#,+E?< ,TV0+--&-_4%*SX;.UOX*<[HL$!
MWDW-P)?7#*!S@"&>6MV ?)PN+!Y85##@-X?F8(1@]C1II:2IN<2M+M>7%QRT
MWG)3>=#?RH.UU[D=4KH4;-_@OMMPW[4\O.# .P+\]BB_ETC4?_$^W-M]\_A&
M7&$*82OJSCX\V'F[MQR@._^"X]H)B,BOAB))I/NMA-17YSH[O^PWK3WD/1V&
M%DZHG+QLO&0)H\PH*H*&$?VEXCN+0L2T!#98\-NEO>G1I3'?V&3H\]F;MJY^
M-^G--["VYSM#K310CQ!NM(<O;3:D"FF69AEKB+HJ"IL'B)L>J]W//CMF$RLM
M:@_Z65$%>\S]MQ(1/NP,KF!_?VGVI#;RPG:ZV!7;WP/M&>K01CTQ2@ZL>44[
MR:] ;19*WNI(+6)9U5K=.&2)!A43ZH?H6,0X&B846>%4RP+0T$U9?*+^43J[
M!<\L<;6&_EC#L$@J"S:XZ 9B[(D6Q.65MG(4'P!U0"&(HOB$L#6P(RA=85,#
MX4TJC]HRB@>44S7BSI'P9+Y"Q0Y\KSO++4M!)[KD@087(O-6K])KD5'0:FU9
MILC63,\3A>T$M6V'N&WW=M[L$V+BU\O!X-6?@^/+%I;XGK K=8WA=I&"KS$B
M=H#S<7E6\R_BX&UC-K<P70THUU=1\%K9\B^AQNW)GEA+;MP.Y8*60)L](\@,
M' .4U\75ADWP6!6<:O;3Y\6,;;CREI+</B'&C#@KW:^:/,*I8#*/I]\SCLSU
MHCN,'ZNY^YW&C5F:U9K:-(^SF?9<Z*556:^KERM7>C>8,T>9;C!G/<.<;<IS
MOH+%=L-(V\/2D VZ[(O198@CJU/2,K;L2V%E7XXD>QX &9,-N8QD&QS9=XTC
MZ[ N7:ORJ UJK+.HL8Z"Q3H/'.G.]EN>_',Q5HQ,@T=*L+\E<*SS(M A&7A.
M<KJ&9A ZBNBKD&[>./5Z(]TZ+)OK7.*U@;1M(&U=A+3UI:-4=R!M2\3B,%F!
MB#:#_.HD@.VCDIJV:$<]V-&6$2')G)&M13F:!_ 5:NW!1T4Y2BA75J?5X52)
M!4F07=G:0UR=T1Z^&ZL%7DDJ&/;.W.F&9XR*9L8+IN1B@Z/[%C@ZOR#U!QWW
M1W? <:]W]M_B1%Q=#$Y.CS\$[\\OWP].KS]>#H+CLW?!Y>#B^,_?!V?7P>7'
M#X.K?AP6Q[G$TRP;1Y&KUW5*/<Z1NY:2MH7<B)W%NJJSTG5K*<EO83/ICILJ
M^RL:9YA4<9G>\/?[S,$5JJ%4R;]G&'^L<33OD6I\+81=K*/8KODZ!M<#<Z)U
M<CT[!'@\P$EX.E0]5'*F6N76#R Z _ PH)-H&'I"]Y03F,$*1GB89?#)C76N
M]@0-U34<'RCSQ4D@.(2-3;YE4!R<$2)#Q8>:VI:%5B[%WNMVCZ+NWPS3*B[N
MZ8#W*I^:XF&-LT#A6->&[$H\E$B=B$T@IMA4@W)!M5'X)'02S7T-.$CN0:L5
MXS06AEZPSC)8ER%%/&XDY.RKGK"ZK^?<<L**\(S!QIOA-,@DN/Z7F!Y;\ B$
M'3%KH_:HMH,'K-P0V%$-&V:>2A$9OT/'V;X% -KO$8!SL '@;  X?87&,BFG
M8Y\Y6E799]$-J&?1C]QHJAE0"P,XMM%$O4G@#$^L@+<;6%PBS^S&U9YL"G8X
M(MPY[ U"H*LX*R0H24Y&13B3:?0IH4*P&7ZG>*Y]GC,VO)*>3X'\3/\YTK?$
MHPZ<C2'(41*7"9J0('@8^\RG:03G;DXF*!_%G_+B(4N&MTF(9V"$M\6/\)&[
M;W^Z V=!16&55P161C)%?\>Z#\-EII@;B:=(M8^_2\KIG(R%_);" =[^6K7(
M+NX"?:I+FL.)?!A8!DJ[!S2B)\N(/P)O$QH^/! M9?CWG)"^;=<2>@7>83B+
MIU2O&6$;HDKG<-KFDU;%GGH!Y\+LXA8L9E.KRQ4L"VR:8IQ@ZZN*HV%H9)B_
M8:ICM@@Q&51-:8E"@GC/IKP:MV4TAE\.DPP337-LCC:E3@)#Q":# XO-?3(0
M91@!!8B0JSG*</WX9B/0&'G<D LP:Y*HQ#087#!,[F$9)Z1*Y&;P:%!B%3X*
MX?,3GF>9,F=*%"")!6@ZGR2J2](TN2U F&A:G2MHA_C;MJ%PTF:YTY$Z_#%^
M;$S:Q3*&@HI ;O@F^8RV6\6K%<\E6S &\6,1I*1N3S1BYQ T/_S7^RC-:*U!
M;L:3*9QVL&=F94[R,BSBF33D0J7 TA/EW T _-9Q]53EH@!^G@T/.A1DN9+K
M**139#:T'D<DS<A(]T[P)A%^-DEQ$^BP)^Z]&PSVQ+B#0=NP;B\3V1L*SX\Z
M]1.(!<>)R4]"37N#.H)TC'E_4JYF>UA(&P6MX2Q.V_%O])\=02^MK'EIXNU]
M$OG.I85=D4??OB&V7 XS1=@B*/S]7:X0'8*3(\):=[&UUS^$Y8QQ$Y&\Z+_(
MIT<11D&Y 3$=XQ\6EB!D^<0L%"$%& #.9P@^ ,42M@;&-;E-)HKNS:S"&":S
M$6#WA&EJAO_H5H0S];A">V>HT6%2X=IR7]6K$OQVS&YB#AILG8* NK=1GOZ?
M?A"YL# G6&"H&F]:80T<2B7;C+0]/"2IQSUP+7$+Z<%8W_NQ%W4SAL^AJ:3S
MZOG5I:R6Y8WVWNS7=UW:KVRTZ_W*&IC$(X?GR?XI0^6%13&B=,W68L7K%'6I
M1 *<'1'8;1,VKA8(@R EJ OK#:R8!,4*;:&HJ+\V1@DZ*L]T[%!SAK;:KETP
MU1<@HCU D#[)_J [LK^_P\F*TQP,%C9?(CAQP$*3G8 ?ARWG36BGK)2#XTL@
M-T4JU-@<,J@0RPZK0@'/2LPRS%A%.8]#0^I#CFLS6(Y^B-@?<N)256 *GRK/
M^I$Q\&&*,4;R?N:2X(N?*)LAGS94%UQ8Y1 \D% ?55(\ZCZE6:,@CV%8(1J?
M<P:<]D3ZWW=)^G\D2VU 9[X8(CFYM=J@P" "?'Y;%,-@%)'%AH!0^AIDL9Q-
MT/@?1F.\0XA)GR@M*Q4E*4<(>3#BI,P,$OK9U)@R:C<LM7N^!(#<88GXI3L2
MT; %QDG2R)TM/K2;W;SR(G\UY(C@K$Q"^MLVI*FYZL&//U'(*G]5%1D\2&1#
MT0WX!Q!IA,(BA:4%IR?IW^L&TH*CZ!IO07V^,=939%3BCW81>2SB&S\)B%&#
M5VP=;\,W)2&Y07(YC,\@47RD&H,TM[<(!.(,]OX]A^5N4D;8%AS_4,@H!FN#
MKU/U9*6.'02Q,HI=:KH_C*ZU&O"!E8D'Y:RD="OO%I3S_P53LQH*\I!C>&E^
M#R]/6=A9GJ"5"T8!1HZJ.VIJR=,/HC+C5#*%966E%:T&Q1-A!'PG7"+[1HPU
MA%^@!PG;GD+[.ONL7<>"X&MDPG#@D=^#0CRM@]338^+&\MN(7 S'87<O9<0!
M.@@4^E4WJMHF>L,"X8"%-TGH526AV]33D[/2W45W=@C<>;3SFJS<DU^/SWX9
M!*=GP<GYV?7E^8>^P/Y/1_7JC2@XN8OR6S($3E2$GZVC\1@.#@;=.74CF(<#
M?3V2M)XZG0,^R:,,PRMP]DPQB95\COGV6U&NHID#^<S0]5'HTBVZ=R!##BA,
MT4L)T^ 6CD,2O@U]'OP1MK$$*KP5IR(I*OE*,03A;R-N4^Z265DT!P[KP1_;
M^ES4M 4*J34:\5&GBR1I=NN3+L/1#KNN:(DU<GPQ R&=G0+DTNP--"CS#8X/
MO*DLBA4\3'?<Q5F\+Z8<Z];+9VH80%R(5->UF=GPP[[7M2]#59D?8] !"_)!
M<"PXGR_QBS_W#H'C#58V@*R@FB#[9[5XR"NOL8^YUQ)Q]!C!QZ@?(D(-X90/
MTQ]5%08-!6=B!WJ4E4O%AF4PQM GWCH=IA'F<K<=OLJK67F?WN-K8H=E>#FS
M$>3-2@E4*D3DP.PB+<Z\C.31U,@O^2:-'X0P_\)SKV*DD<4P815Z*DG$] 87
M36@,;D7J8&9:,4>"0-RR+-)9I6*<WE>ER>0;82Z?"LID%$MNEFU,KX.BD2W!
M(V@H#O^0?"OK# 8S\U4UHX00-WC7I7B@ZL'!F5AP910E 7=8GT;Q79K<)]S9
M&AQ/>)<R_(+7#-4FG?NIZ5H6!J&P/'I^FA5/MY4@YWBM87/YJSS4U-DJK6AJ
M?9K[["9B_"[NA]RZ5O)F+<%SNZS0KON-6!WS3?7C>=P8S\$UHJ9F-4&VSXEU
ME^/+KY7C%4F;X1>,*(]/3J,<!OKL.39KJ<ZJ,+@K'K"4-)2C5([/>ZL.UA?8
M 1<0O*B<P%=7"6:12+H(.R"T7;[TI#J 3IAFIWSL6CL(@F?E+QCEE+ID*ZFC
MA-6EQ_'H8B[;JGWLP8 W2NFMFCR[$,_PWM-:M;W-EJ>%^!^G.WL_PNJK/4QC
M&T4I$NF4GT#A.7)ILT0Z)+3JU;E.]G3T-*NN83XIY:6%U\X;-Q60Q)]KUHUO
MYBUSJ'VZP[IJJ9^1]9O0A3R#A#L1QJ1G/4!2L?(\9DX,]E)5XV>JZ?6>!,J^
MV(61,^D1+\886Y:]Y-"1M8ITBP7?+,, T6Y4=-*G93+*"'I'U1<O($%//A1$
MTM7>)CDK1=LSV0OMRI+^2VRJ6Y]ETNS1/%!XD8JRB/3 5)K@23Z7*_B(R(@/
MS&@&ZUJE&IA2S;\70FT=+%X[1_L\G_/%*0K[8'//M; W!QOYV:T*?4D]V\5C
M[:K]6.M)Q*U#S494/?7%\>7UZ<GIQ3&63I_^\NOU%>^BWT^O3@8?/AR?#<X_
M7O4E#->A MQ'V3<L"E3<$E=1MNK&ZWZ>357"*6J-#_WS!_ ^JKMT$EQ@JGA>
MQR!6R72:)>IPU<U*[! C386V)R9)7K'^0>,"(:<4'0,UE(B+@V,E0!#5M+*A
M8D\@^TA94C_[ZZ]4)G%""3)-1N,.EG[_Y,)IWZO-\@QS<KY4+[YK-4H958W!
M-)E--D-\72UJ]"$VCZQPJ^(Z],06[5IU]<+.016V0Q FP YT1VGEFIU@K&,Z
M95:G*LG0F!<VE3"82%E61&_#>+&8;>E%&Z*UH5@MFQ"JD@JP*IVZ@"C 0$U*
M6V&(J6T8.]NJ; (2I"W"O/R(XC1BY%&O"7CX=0H[-SA5^_;CSM6.4)PEB<W4
M=YH3\OJ*P]_SX)@JK?JQ6;I6?;IHLYP5+"1W188+>TF4T:MFFI7$0UW+YH)=
M8CP,XB=1V&CW))^3,DZ;A-#:QQ N[&5=DB&QB_)N998E@_\QM-H1AP=E[KPL
M!$_>ID+W7&?]@',SLHF:-*O>5S,V^88MQS7Y*RVGLB;#?J29R%KMW'5JW  [
M=T"A#;2UKE6%@:&37/$FUKN*^> ,N;YU!L84K4'+4=F2HUE)6]]7$M!>.@ 7
MV&E'.6]*E2CDJE?]5(W!-;?6M-N\:]0-:C!S!>!6@0>BH"<HMR0M3>#$K;_W
M,/#C?D9 -\SZ!H)EB\[1!H*UX0'Y'LD_+>U =LK[HDS0\C]!1D?$5G3 E7$1
MUG>2[!S-$&AM(-58C)K<$[6D$$!YZ//L\IAHB')#]SIVP4@"?:*"V>0^ BV=
MWP99$5/IM8I+VX7:7')$&C]+;N%GA-.-/H.%@^ =>C;6G[[G@P8!+&'=4EH<
MYV"_R;Z="G9X*\O;CL'0:033>&,JKV/8N1ACC#ZRN@VJ^S0)XAS.+T,XF%+X
M*$^0N8$HR4NJ\:THJF&OA]U$D"<[BX@)9!3%>% J;K'(B(.=)Z)1T;P7:IX:
MYQ]ZO"C=Q#-F6N?IX@5F1,$WG4:?.#0/1Z; J\PKH/#$--RTXJ,<JS%O"[BB
M)R;IT1JIL%.KG/2L@%E,8_ICQ9H+*P[L2E>12<6K?PN6E%U4X_ *^W>GKN&
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M' UX0#HGYJL5EDW]<7KZC<[,QS/?>]2R\X?_>C=X?WIV>GUZ?G;5#[ODGW1
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M/@6>?[\IAG/XS]UTG/W7_P=02P,$%     @ -H&L4I,LBE6G!   *"H  !D
M  !M8VM?97AH:6)I=#(Q>#,S,3(P,C$N:'1M[5I;<^(V&'WOK]"RT^[+^L8M
MQ"',$"#$FPL9<";3OG1D)$!=V?)((H3^^LH7LB'@["ZT@13G@=B6]%V/CC[9
MJG]H]UKN[[<=,)$^!;=W9U=."Q0TP[@OM0RC[;;!A7M]!<JZ:0&7PT 025@
MJ6%T;@J@,)$RM UC-IOILY+.^-AP^T8DJFQ0Q@36D42%1CUZHGXQ1(U?ZA\T
M#;39<.KC0((AQU!B!*:"!&-PC[#X"C0M[=5BX9R3\42"HEFTP#WC7\D#3-HE
MD10W%G+J1G)?-V(E=8^A>:..R ,@Z+1 O'+MN(BL:K5:,LLF*GLU5*T>H0HT
MRY5*Y<C\TU)&&JI[,D;(.<6G!9\$V@1'^NUR)90G,X+DQ+9,\]="W*]1'[%
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M2U&W!8"''I991%L1D%P/+B"?9TA]+QQ>X59X]2=4Y&ZGV[5G<0Q&Q"=8-?T
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M:@DE/'/=#X!K\*(AWL5?TH;S#2A^2R4<=ULNC0/WH'OHI/VS)<+=PKX=06S
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M)HK&3D0S*"\JJ"Y+4LPQ  -8?U->XHB.ENZO;X6_<9(!'&!C(?JP6C/C5<(
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MZY^']-/3*EG];7=XM'/0^^O.<-3[V[I1]X:'!\]O?=3#H^'1[F;#/J5SX+.
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MJ AB.#A#K^6ON0M%+[2EKXDT*)W.I,A-5C\Q_T$CLAUSXXI/2WH/PU*-8+
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MP%M[S0C_-(N_'GYEY5K5RB@$ DQG5PPR.+M5W?_-PD #_6!G179)@MX56W_
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M%OV.Y>=1;C*_?ZRQH,?>[O.M\9.'E,;ZCKM?/N@(P[KT@]\1<C/8-9;^RIL
M<EH5\45T\DGK.(Z1J^5L#)H.U>/9>?G;\3]V1Z^']&GT,M+C[]_J^/MV>#/^
MP:V.?[ R_M&MCG]DQ@\RQNW+&'LWDS&>CHMD"?],JUGVZO\#4$L! A0#%
M  @ -H&L4L/Q<4 ;M08 6A%) !               ( !     &UC:RTR,#(Q
M,#,S,2YH=&U02P$"% ,4    "  V@:Q2D!I4CR0P  #A$ ( $
M    @ %)M08 ;6-K+3(P,C$P,S,Q+GAS9%!+ 0(4 Q0    ( #:!K%+FL.&+
ME4X  )!= P 4              "  9OE!@!M8VLM,C R,3 S,S%?8V%L+GAM
M;%!+ 0(4 Q0    ( #:!K%)KIM?1!D8! -I<#@ 4              "  6(T
M!P!M8VLM,C R,3 S,S%?9&5F+GAM;%!+ 0(4 Q0    ( #:!K%(PW3UL\2H
M '0L   3              "  9IZ" !M8VLM,C R,3 S,S%?9S$N:G!G4$L!
M A0#%     @ -H&L4HR@RU;B\P  0&(! !,              ( !O*4( &UC
M:RTR,#(Q,#,S,5]G,BYJ<&=02P$"% ,4    "  V@:Q2JLT!39AZ @"2Z1D
M%               @ '/F0D ;6-K+3(P,C$P,S,Q7VQA8BYX;6Q02P$"% ,4
M    "  V@:Q21(],M/N= 0!/,!, %               @ &9% P ;6-K+3(P
M,C$P,S,Q7W!R92YX;6Q02P$"% ,4    "  V@:Q2%(E?_?<#  #4"P  &
M            @ '&L@T ;6-K7V5X:&)I=#(S>#,S,3(P,C$N:'1M4$L! A0#
M%     @ -H&L4NN+G4)B4P$ HW<* !L              ( !\[8- &UC:U]E
M>&AI8FET,3 Q-G@S,S$R,#(Q+FAT;5!+ 0(4 Q0    ( #:!K%*3+(I5IP0
M "@J   9              "  8X*#P!M8VM?97AH:6)I=#(Q>#,S,3(P,C$N
M:'1M4$L! A0#%     @ -H&L4KB'RP5?"   =2@  !H              ( !
M; \/ &UC:U]E>&AI8FET,S$Q>#,S,3(P,C$N:'1M4$L! A0#%     @ -H&L
M4@(/A(1N"   @R@  !H              ( ! Q@/ &UC:U]E>&AI8FET,S$R
M>#,S,3(P,C$N:'1M4$L! A0#%     @ -H&L4HWBPIHS!@  4B0  !D
M         ( !J2 / &UC:U]E>&AI8FET,S)X,S,Q,C R,2YH=&U02P$"% ,4
M    "  V@:Q2?@>+3/<R  "\PP$ &@              @ $3)P\ ;6-K7V5X
J:&EB:70T,31X,S,Q,C R,2YH=&U02P4&      \ #P#[ P  0EH/

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
